data_2fwu_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2fwu _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . 0.591 ' HA2' ' OG1' ' A' ' 528' ' ' THR . . . . . . . . 0 N--CA 1.401 -3.667 0 N-CA-C 110.804 -0.919 . . . . 64.21 110.804 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 3.7 mp -125.98 102.65 10.39 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 106.363 -1.718 . . . . 74.44 106.363 177.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -123.4 106.1 10.37 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 108.071 -1.085 . . . . 75.13 108.071 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 13.6 t -139.67 159.63 41.73 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 108.188 -1.041 . . . . 75.33 108.188 -176.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -84.64 153.6 23.05 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.429 -0.952 . . . . 71.31 108.429 175.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -77.53 -32.27 53.9 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.353 -0.98 . . . . 74.54 108.353 176.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -133.4 134.76 24.24 Favored Pre-proline 0 C--N 1.314 -0.942 0 N-CA-C 108.873 -0.788 . . . . 70.53 108.873 178.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -81.86 -16.54 8.81 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.401 2.067 . . . . 71.45 111.938 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 69.7 t -136.61 131.96 48.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 107.824 -1.176 . . . . 73.25 107.824 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 6.3 t -133.93 139.61 46.24 Favored 'General case' 0 N--CA 1.406 -2.633 0 N-CA-C 108.501 -0.926 . . . . 75.23 108.501 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -109.46 124.43 51.04 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 109.737 -0.468 . . . . 75.21 109.737 178.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 15.5 m -127.13 157.55 38.58 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 107.905 -1.146 . . . . 74.13 107.905 -178.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 35.5 t -82.13 156.4 24.52 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 109.541 -0.54 . . . . 74.35 109.541 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -83.4 -7.94 59.48 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.26 -1.015 . . . . 63.13 108.26 174.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 14.0 t -98.78 15.71 24.52 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 115.688 -0.687 . . . . 63.23 109.298 -177.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 12.7 tt -99.62 161.47 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 N-CA-C 108.915 -0.772 . . . . 74.12 108.915 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -94.9 -70.69 1.09 Allowed Glycine 0 N--CA 1.43 -1.753 0 N-CA-C 110.554 -1.018 . . . . 71.1 110.554 176.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 36.7 mm -114.73 126.24 72.24 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 C-N-CA 123.006 0.522 . . . . 74.51 109.668 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 521' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.55 140.06 38.54 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.768 -1.197 . . . . 75.41 107.768 173.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -124.73 137.6 54.33 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 123.777 0.673 . . . . 73.4 111.021 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . 0.606 ' O ' ' HA ' ' A' ' 570' ' ' THR . 45.7 t -122.99 137.45 56.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 109.048 -0.723 . . . . 74.24 109.048 -179.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -80.92 131.72 35.37 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.66 0.743 . . . . 75.13 112.927 -177.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 6.7 t -114.76 134.39 57.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 CA-C-N 114.327 -1.306 . . . . 74.51 107.873 177.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -86.94 139.49 30.56 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.238 -1.023 . . . . 75.15 108.238 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . 0.418 ' CZ ' HG22 ' A' ' 567' ' ' ILE . 31.7 ttp180 -93.95 158.59 15.56 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 116.202 -0.454 . . . . 74.21 110.514 -173.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 528' ' ' THR . . . . . 0.591 ' OG1' ' HA2' ' A' ' 503' ' ' GLY . 5.1 t -56.38 145.82 26.12 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.746 -0.661 . . . . 75.4 111.448 176.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 23.8 t -81.61 -12.74 58.62 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 108.79 -0.818 . . . . 75.24 108.79 178.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -109.02 52.94 0.61 Allowed Glycine 0 N--CA 1.429 -1.767 0 N-CA-C 109.592 -1.403 . . . . 72.42 109.592 177.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -82.83 95.49 7.94 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-O 121.591 0.71 . . . . 74.53 109.129 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -133.78 25.02 4.01 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 114.854 -1.066 . . . . 73.43 111.665 -178.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 175.76 -169.5 42.21 Favored Glycine 0 N--CA 1.416 -2.644 0 C-N-CA 120.097 -1.049 . . . . 45.42 111.141 -174.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -102.23 121.85 43.06 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 122.887 0.475 . . . . 62.3 110.822 -176.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 79.6 t -125.53 135.73 63.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 123.403 0.681 . . . . 63.31 109.651 -178.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 536' ' ' ILE . . . . . 0.469 ' O ' ' HA ' ' A' ' 594' ' ' PRO . 22.8 mm -101.18 129.17 52.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 115.881 -0.6 . . . . 73.43 109.874 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . 0.423 HG23 ' HB3' ' A' ' 594' ' ' PRO . 33.2 t -122.15 105.57 36.95 Favored Pre-proline 0 C--N 1.319 -0.751 0 N-CA-C 108.715 -0.846 . . . . 71.35 108.715 176.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -73.01 152.05 50.93 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.068 1.845 . . . . 65.01 110.828 177.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 539' ' ' TYR . . . . . 0.432 ' CD1' ' HG ' ' A' ' 560' ' ' LEU . 50.9 p90 -147.38 157.88 43.75 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.409 -0.589 . . . . 74.24 109.409 178.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -149.52 155.43 40.33 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 120.979 0.419 . . . . 73.42 111.17 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 10.4 p -96.4 113.39 24.97 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.062 -0.972 . . . . 74.41 110.871 176.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.6 mp -83.0 115.62 25.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 105.517 -2.031 . . . . 74.32 105.517 173.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . 0.442 ' HB3' ' O ' ' A' ' 546' ' ' ALA . 47.8 mt-10 -53.5 -49.84 66.66 Favored 'General case' 0 C--N 1.32 -0.686 0 O-C-N 124.156 0.91 . . . . 75.54 112.667 -174.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 70.26 -101.67 0.92 Allowed Glycine 0 N--CA 1.44 -1.098 0 C-N-CA 120.522 -0.847 . . . . 74.12 111.259 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 8.8 t -113.62 0.23 14.55 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.869 0.842 . . . . 62.21 109.295 178.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . 0.442 ' O ' ' HB3' ' A' ' 543' ' ' GLU . . . -95.33 170.98 9.0 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 108.132 -1.062 . . . . 73.24 108.132 175.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . 0.411 ' HD2' ' OE2' ' A' ' 543' ' ' GLU . 9.6 tpt180 -130.46 122.72 28.23 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 118.012 0.369 . . . . 74.5 110.189 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -82.48 -166.4 38.46 Favored Glycine 0 C--N 1.306 -1.135 0 CA-C-N 116.01 -0.541 . . . . 65.34 111.868 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 78.83 13.93 82.58 Favored Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 120.948 -0.644 . . . . 62.13 112.587 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 84.37 13.92 72.45 Favored Glycine 0 N--CA 1.435 -1.373 0 C-N-CA 120.212 -0.994 . . . . 63.23 111.891 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -79.81 -69.92 0.55 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.4 0.619 . . . . 73.52 109.982 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -109.41 -35.05 6.36 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 107.692 -1.225 . . . . 75.33 107.692 -176.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 553' ' ' PHE . . . . . 0.451 ' HA ' HG12 ' A' ' 576' ' ' ILE . 14.7 p90 -145.54 164.06 32.81 Favored 'General case' 0 N--CA 1.423 -1.817 0 CA-C-N 115.096 -0.956 . . . . 75.2 108.544 173.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . 0.42 ' HB3' ' HB3' ' A' ' 574' ' ' LYS . 1.0 OUTLIER -95.45 106.82 18.93 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 105.477 -2.046 . . . . 73.42 105.477 179.082 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -72.62 149.53 43.83 Favored 'General case' 0 CA--C 1.49 -1.333 0 CA-C-N 116.093 -0.503 . . . . 71.15 110.095 -174.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 5.6 t -139.57 131.6 27.9 Favored 'General case' 0 N--CA 1.403 -2.779 0 CA-C-O 121.669 0.747 . . . . 72.21 111.274 -177.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 557' ' ' CYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 539' ' ' TYR . 12.5 p -142.38 104.91 4.49 Favored 'General case' 0 N--CA 1.418 -2.037 0 N-CA-C 107.541 -1.281 . . . . 72.42 107.541 175.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -151.11 -149.33 5.02 Favored Glycine 0 N--CA 1.408 -3.171 0 N-CA-C 109.867 -1.293 . . . . 73.22 109.867 -176.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -136.94 133.44 35.66 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 120.858 0.361 . . . . 73.51 110.715 -173.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . 0.432 ' HG ' ' CD1' ' A' ' 539' ' ' TYR . 92.1 mt -93.45 123.16 36.56 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.979 -1.119 . . . . 74.4 107.979 173.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -97.89 113.53 25.38 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 116.097 -0.501 . . . . 70.1 110.136 -177.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -103.99 144.36 31.64 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 109.639 -0.504 . . . . 63.13 109.639 176.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . 0.4 ' HB2' ' H ' ' A' ' 566' ' ' GLU . 42.7 mt-30 -136.56 179.85 6.11 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.059 -1.089 . . . . 75.23 108.059 -178.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 31.6 t30 -73.73 -34.77 64.93 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.669 -0.863 . . . . 74.2 108.669 176.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -87.64 -36.34 17.52 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 114.969 -1.014 . . . . 75.33 111.397 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 566' ' ' GLU . . . . . 0.4 ' H ' ' HB2' ' A' ' 563' ' ' GLN . 10.5 tp10 -77.33 117.08 18.48 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.77 -0.826 . . . . 74.22 108.77 178.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 567' ' ' ILE . . . . . 0.418 HG22 ' CZ ' ' A' ' 527' ' ' ARG . 6.5 pt -109.2 163.39 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.143 0 N-CA-C 109.317 -0.623 . . . . 65.02 109.317 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 568' ' ' VAL . . . . . 0.455 HG23 ' H ' ' A' ' 569' ' ' LYS . 2.3 p 44.49 -171.73 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.569 1.699 0 C-N-CA 125.543 1.537 . . . . 72.55 111.821 -177.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 569' ' ' LYS . . . . . 0.493 ' HA ' ' HE2' ' A' ' 569' ' ' LYS . 0.0 OUTLIER -173.3 158.41 3.56 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 107.142 -1.429 . . . . 75.21 107.142 174.78 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 570' ' ' THR . . . . . 0.606 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 24.1 p -134.37 137.73 44.33 Favored 'General case' 0 N--CA 1.423 -1.796 0 O-C-N 123.744 0.652 . . . . 71.34 109.316 175.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 2.9 mp -88.29 114.31 26.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 106.148 -1.797 . . . . 72.52 106.148 171.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 9.4 p -95.81 111.88 23.75 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 123.215 0.322 . . . . 62.24 110.429 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 573' ' ' VAL . . . . . . . . . . . . . 46.9 t -118.82 137.69 51.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.33 -0.618 . . . . 74.52 109.33 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 574' ' ' LYS . . . . . 0.42 ' HB3' ' HB3' ' A' ' 554' ' ' GLU . 38.7 ttmt -95.71 130.65 42.55 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 123.926 0.767 . . . . 74.55 110.218 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 58.9 t -95.76 143.63 11.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 107.852 -1.166 . . . . 73.23 107.852 176.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 576' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' A' ' 553' ' ' PHE . 28.9 mm -112.16 161.12 11.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 108.154 -1.054 . . . . 72.03 108.154 -177.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -77.68 144.43 37.35 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.021 -0.733 . . . . 72.11 109.021 176.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -57.89 136.9 57.09 Favored 'General case' 0 CA--C 1.484 -1.562 0 N-CA-C 115.453 1.649 . . . . 74.24 115.453 -174.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 5.6 pm0 -107.06 -26.01 11.33 Favored 'General case' 0 N--CA 1.421 -1.876 0 CA-C-N 113.413 -1.721 . . . . 63.44 112.38 -176.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 580' ' ' GLU . . . . . 0.406 ' HG2' ' CD2' ' A' ' 581' ' ' TYR . 0.1 OUTLIER -110.38 -69.26 0.88 Allowed 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 112.753 0.649 . . . . 72.33 112.753 -170.002 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 581' ' ' TYR . . . . . 0.406 ' CD2' ' HG2' ' A' ' 580' ' ' GLU . 32.1 p90 -162.35 153.71 18.03 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 104.422 -2.436 . . . . 74.1 104.422 -176.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 582' ' ' GLU . . . . . 0.442 ' HB3' ' OE1' ' A' ' 648' ' ' GLU . 20.3 mt-10 -102.98 136.6 42.5 Favored 'General case' 0 C--N 1.274 -2.708 0 C-N-CA 117.604 -1.638 . . . . 74.44 115.23 -172.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 12.8 ptpt -153.62 167.06 30.82 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 113.239 -1.801 . . . . 74.03 106.177 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -86.52 123.4 31.69 Favored 'General case' 0 CA--C 1.488 -1.431 0 N-CA-C 105.656 -1.979 . . . . 72.43 105.656 169.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.66 173.67 7.3 Favored 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 108.691 -0.855 . . . . 73.21 108.691 -171.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 8.6 t -153.61 146.77 24.66 Favored 'General case' 0 N--CA 1.428 -1.531 0 C-N-CA 120.042 -0.663 . . . . 74.43 111.774 -174.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -130.96 149.8 52.41 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-N 114.237 -1.347 . . . . 74.22 109.891 177.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 588' ' ' PHE . . . . . 0.416 ' HA ' ' O ' ' A' ' 642' ' ' LEU . 25.7 m-85 -104.06 133.36 49.13 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.094 -0.706 . . . . 74.11 109.094 -176.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . 0.447 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.4 OUTLIER -106.01 123.77 48.52 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 105.895 -1.891 . . . . 70.43 105.895 175.845 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -130.71 145.66 51.99 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 107.615 -1.254 . . . . 73.13 107.615 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 591' ' ' ILE . . . . . . . . . . . . . 27.5 pt -106.05 152.48 7.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 108.934 -0.765 . . . . 72.15 108.934 178.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -97.97 -150.51 26.37 Favored Glycine 0 N--CA 1.429 -1.802 0 C-N-CA 120.792 -0.718 . . . . 71.31 112.873 -177.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.414 ' OE2' ' HB3' ' A' ' 595' ' ' ARG . 1.4 tm-20 -79.49 121.3 82.55 Favored Pre-proline 0 C--N 1.297 -1.681 0 C-N-CA 123.589 0.756 . . . . 71.4 111.426 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 594' ' ' PRO . . . . . 0.469 ' HA ' ' O ' ' A' ' 536' ' ' ILE . 68.7 Cg_endo -81.33 145.9 15.3 Favored 'Trans proline' 0 N--CA 1.43 -2.231 0 C-N-CA 121.817 1.678 . . . . 74.23 110.083 176.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 595' ' ' ARG . . . . . 0.414 ' HB3' ' OE2' ' A' ' 593' ' ' GLU . 14.2 ptp180 -136.7 143.75 43.53 Favored 'General case' 0 C--N 1.273 -2.733 0 CA-C-N 116.286 -0.416 . . . . 72.42 109.991 -177.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -77.25 126.83 31.57 Favored 'General case' 0 N--CA 1.416 -2.155 0 N-CA-C 106.001 -1.851 . . . . 72.31 106.001 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 43.6 t . . . . . 0 C--N 1.311 -1.067 0 N-CA-C 107.855 -1.165 . . . . 64.01 107.855 179.995 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 6.3 mtp-105 . . . . . 0 N--CA 1.441 -0.91 0 N-CA-C 107.412 -1.329 . . . . 74.22 107.412 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -76.1 155.76 37.99 Favored 'Trans proline' 0 N--CA 1.438 -1.776 0 C-N-CA 120.856 1.038 . . . . 73.21 110.07 168.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.68 -173.54 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 107.798 -1.186 . . . . 74.43 107.798 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -87.29 -179.77 6.47 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 123.291 0.37 . . . . 74.43 111.622 -178.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -99.69 -125.18 5.4 Favored Glycine 0 N--CA 1.438 -1.188 0 CA-C-N 116.175 -0.466 . . . . 54.43 113.983 -176.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -84.54 -71.4 0.52 Allowed 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 112.41 0.522 . . . . 75.42 112.41 -177.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -117.67 107.94 14.82 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 122.466 1.127 . . . . 74.41 112.436 -174.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 3.6 p -108.19 92.05 3.9 Favored 'General case' 0 N--CA 1.404 -2.747 0 CA-C-N 114.269 -1.332 . . . . 74.44 109.855 177.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -178.33 129.44 0.13 Allowed 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 104.826 -2.287 . . . . 75.03 104.826 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 642' ' ' LEU . . . . . 0.519 HD21 HG23 ' A' ' 523' ' ' VAL . 42.6 tp -132.37 114.52 14.46 Favored 'General case' 0 C--N 1.274 -2.681 0 N-CA-C 108.692 -0.855 . . . . 74.21 108.692 177.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -99.05 104.81 16.87 Favored 'General case' 0 C--N 1.273 -2.734 0 N-CA-C 107.069 -1.456 . . . . 72.12 107.069 178.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 33.7 t -92.94 105.12 16.42 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 N-CA-C 108.551 -0.907 . . . . 75.4 108.551 -179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 3.9 mp -88.94 115.08 28.16 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 N-CA-C 107.469 -1.308 . . . . 72.24 107.469 175.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 646' ' ' ILE . . . . . 0.457 HD12 ' N ' ' A' ' 646' ' ' ILE . 2.9 mp -95.48 106.43 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.453 0 N-CA-C 105.383 -2.08 . . . . 73.44 105.383 -178.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -97.95 132.15 43.78 Favored 'General case' 0 N--CA 1.399 -3.017 0 CA-C-N 115.249 -0.887 . . . . 73.31 109.275 -178.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 648' ' ' GLU . . . . . 0.442 ' OE1' ' HB3' ' A' ' 582' ' ' GLU . 15.2 tt0 -67.32 144.29 55.94 Favored 'General case' 0 N--CA 1.408 -2.527 0 N-CA-C 107.878 -1.156 . . . . 74.14 107.878 -177.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 23.1 t . . . . . 0 N--CA 1.444 -0.748 0 O-C-N 124.442 1.089 . . . . 73.11 113.342 -170.165 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . 0.652 ' HA2' ' OG1' ' A' ' 528' ' ' THR . . . . . . . . 0 N--CA 1.415 -2.735 0 N-CA-C 111.787 -0.525 . . . . 54.44 111.787 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . 0.401 ' H ' ' CB ' ' A' ' 528' ' ' THR . 4.1 mp -119.23 113.97 43.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 107.436 -1.32 . . . . 74.33 107.436 177.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -123.94 119.74 30.47 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 109.228 -0.656 . . . . 74.5 109.228 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 14.8 t -148.54 167.54 25.11 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.78 -0.452 . . . . 74.53 109.78 -174.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -99.66 162.33 13.08 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 107.441 -1.318 . . . . 75.44 107.441 173.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.18 -24.39 13.57 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.203 0.525 . . . . 75.3 111.314 176.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -116.66 122.96 30.98 Favored Pre-proline 0 N--CA 1.436 -1.152 0 N-CA-C 108.382 -0.97 . . . . 74.3 108.382 171.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -80.71 -9.96 13.17 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 121.961 1.774 . . . . 74.31 111.48 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 75.3 t -141.28 135.96 32.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 107.521 -1.289 . . . . 74.44 107.521 -178.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 5.6 t -136.68 146.71 46.22 Favored 'General case' 0 N--CA 1.41 -2.439 0 N-CA-C 108.005 -1.109 . . . . 74.24 108.005 177.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -116.69 131.3 56.99 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.429 -0.582 . . . . 75.11 109.429 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 22.3 m -127.26 160.87 35.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 CA-C-N 115.762 -0.654 . . . . 74.43 109.753 -175.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 71.1 m -75.73 153.03 37.32 Favored 'General case' 0 N--CA 1.403 -2.803 0 CA-C-N 114.72 -1.127 . . . . 75.31 108.083 175.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -88.36 -24.8 23.01 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.054 -1.058 . . . . 72.31 111.121 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 23.3 t -102.6 70.16 1.12 Allowed 'General case' 0 N--CA 1.419 -1.982 0 N-CA-C 107.862 -1.162 . . . . 72.43 107.862 176.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 18.8 tt -135.85 152.47 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.503 0 N-CA-C 106.73 -1.582 . . . . 75.41 106.73 176.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -84.93 -59.21 2.0 Allowed Glycine 0 C--N 1.287 -2.154 0 C-N-CA 120.239 -0.982 . . . . 73.42 111.667 -178.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 36.5 mm -125.98 126.01 69.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 109.486 -0.561 . . . . 73.14 109.486 -178.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 521' ' ' MET . . . . . 0.483 ' HE3' ' CG2' ' A' ' 573' ' ' VAL . 0.0 OUTLIER -101.6 134.88 44.05 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 106.38 -1.711 . . . . 45.32 106.38 171.721 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -121.49 137.54 54.68 Favored 'General case' 0 C--N 1.308 -1.206 0 O-C-N 123.68 0.613 . . . . 73.52 110.523 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . 0.535 ' O ' ' HA ' ' A' ' 570' ' ' THR . 41.7 t -121.1 138.26 52.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 N-CA-C 108.119 -1.067 . . . . 63.33 108.119 179.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . 0.449 ' HD2' HG22 ' A' ' 568' ' ' VAL . 29.1 mmtp -88.16 116.07 26.1 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.867 0.841 . . . . 72.02 111.84 -176.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 22.9 t -97.19 135.62 30.77 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 CA-C-N 114.545 -1.207 . . . . 73.13 109.178 -178.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -79.68 138.86 37.49 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 123.687 0.617 . . . . 65.45 109.804 -178.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . 0.5 ' HG2' ' N ' ' A' ' 528' ' ' THR . 50.5 ttp180 -86.29 160.28 19.18 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.274 -1.01 . . . . 73.24 108.274 178.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 528' ' ' THR . . . . . 0.652 ' OG1' ' HA2' ' A' ' 503' ' ' GLY . 5.3 t -65.43 146.76 54.48 Favored 'General case' 0 N--CA 1.412 -2.347 0 CA-C-N 115.657 -0.701 . . . . 74.32 110.388 172.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 38.0 t -62.37 -46.36 88.99 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-N 114.963 -1.017 . . . . 71.15 109.042 175.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -114.1 117.28 4.09 Favored Glycine 0 N--CA 1.415 -2.743 0 N-CA-C 109.914 -1.274 . . . . 64.42 109.914 -177.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -131.69 119.93 22.06 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 109.372 -0.603 . . . . 74.11 109.372 178.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -114.94 74.96 0.9 Allowed 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.559 -0.534 . . . . 75.54 109.559 175.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 124.92 -143.39 14.54 Favored Glycine 0 N--CA 1.433 -1.528 0 C-N-CA 120.38 -0.915 . . . . 53.11 112.628 177.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 534' ' ' ASN . . . . . 0.423 HD22 ' HG3' ' A' ' 561' ' ' GLU . 2.8 t-20 -114.25 134.01 55.24 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.031 -0.729 . . . . 72.11 109.031 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 59.3 t -126.45 131.45 71.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 109.458 -0.571 . . . . 73.3 109.458 -178.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 536' ' ' ILE . . . . . . . . . . . . . 39.7 mm -98.89 125.92 52.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 109.061 -0.718 . . . . 71.32 109.061 178.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 40.6 t -115.82 107.24 48.66 Favored Pre-proline 0 C--N 1.306 -1.325 0 CA-C-N 115.839 -0.619 . . . . 70.25 109.356 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -73.52 145.95 38.46 Favored 'Trans proline' 0 C--O 1.238 0.484 0 C-N-CA 122.539 2.159 . . . . 74.54 111.951 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -147.96 161.3 41.61 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 109.34 -0.615 . . . . 72.23 109.34 178.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -157.9 153.95 27.12 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 109.237 -0.653 . . . . 73.41 109.237 177.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 2.7 p -90.76 128.75 36.79 Favored 'General case' 0 C--N 1.293 -1.886 0 O-C-N 123.625 0.578 . . . . 72.33 110.152 175.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.7 mp -95.05 117.92 40.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 106.244 -1.762 . . . . 75.2 106.244 174.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . 0.517 ' HB2' ' O ' ' A' ' 546' ' ' ALA 0.289 0.0 OUTLIER -60.89 -51.51 68.98 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 114.685 1.365 . . . . 74.3 114.685 -176.759 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 67.63 -79.95 0.17 Allowed Glycine 0 N--CA 1.448 -0.532 0 O-C-N 123.266 0.354 . . . . 70.31 113.833 175.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 7.9 t -125.64 -1.7 7.37 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 120.956 0.408 . . . . 62.25 110.325 -178.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . 0.517 ' O ' ' HB2' ' A' ' 543' ' ' GLU . . . -111.11 174.54 5.81 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 108.6 -0.889 . . . . 72.54 108.6 177.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . 0.456 ' HD2' ' N ' ' A' ' 547' ' ' ARG . 2.4 mpt_? -112.77 128.78 56.52 Favored 'General case' 0 CA--C 1.487 -1.454 0 CA-C-O 121.548 0.689 . . . . 71.53 112.414 -175.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -84.6 -174.16 50.2 Favored Glycine 0 C--N 1.277 -2.731 0 CA-C-N 114.052 -1.431 . . . . 61.24 112.532 -177.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 69.78 16.33 72.16 Favored Glycine 0 C--O 1.222 -0.644 0 N-CA-C 114.196 0.438 . . . . 55.01 114.196 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 84.5 6.21 86.06 Favored Glycine 0 N--CA 1.438 -1.208 0 C-N-CA 119.989 -1.101 . . . . 64.42 111.297 -177.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -74.12 -43.94 55.65 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 110.542 -0.17 . . . . 72.34 110.542 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -132.27 -28.88 1.65 Allowed 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.577 -0.897 . . . . 54.31 108.577 175.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 553' ' ' PHE . . . . . 0.415 ' HA ' HG12 ' A' ' 576' ' ' ILE . 35.1 p90 -144.12 158.39 43.75 Favored 'General case' 0 C--O 1.249 1.053 0 N-CA-C 107.183 -1.414 . . . . 74.51 107.183 170.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -89.93 119.44 30.29 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 106.974 -1.491 . . . . 74.4 106.974 178.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -75.45 99.03 4.06 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-N 115.966 -0.561 . . . . 74.15 110.738 -176.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 556' ' ' THR . . . . . 0.486 ' CG2' HG23 ' A' ' 573' ' ' VAL . 10.1 t -89.8 97.03 10.96 Favored 'General case' 0 N--CA 1.41 -2.453 0 CA-C-O 123.295 1.521 . . . . 75.53 110.48 -178.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 1.6 p -109.4 106.62 16.47 Favored 'General case' 0 C--N 1.275 -2.65 0 CA-C-N 113.8 -1.545 . . . . 71.22 107.903 175.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -154.92 -157.84 8.42 Favored Glycine 0 N--CA 1.414 -2.804 0 N-CA-C 110.705 -0.958 . . . . 73.25 110.705 -174.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -142.77 131.24 22.33 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 109.584 -0.524 . . . . 63.34 109.584 -175.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 95.1 mt -89.89 138.01 31.86 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.835 -0.62 . . . . 71.24 109.379 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 561' ' ' GLU . . . . . 0.423 ' HG3' HD22 ' A' ' 534' ' ' ASN . 39.9 tt0 -104.46 106.54 17.08 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 109.384 -0.598 . . . . 74.14 109.384 -179.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -100.08 132.22 45.57 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 109.9 -0.407 . . . . 61.24 109.9 177.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -116.43 160.81 20.02 Favored 'General case' 0 C--N 1.289 -2.06 0 C-N-CA 119.635 -0.826 . . . . 74.22 109.617 177.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -69.93 -25.11 63.5 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 122.214 1.007 . . . . 75.23 109.545 176.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -90.85 -6.27 54.46 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.386 -1.279 . . . . 62.22 110.821 -178.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -118.96 154.82 32.41 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.899 -0.778 . . . . 64.44 108.899 -177.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 9.4 pt -124.77 164.2 23.83 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 108.318 -0.993 . . . . 63.12 108.318 170.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 568' ' ' VAL . . . . . 0.449 HG22 ' HD2' ' A' ' 524' ' ' LYS . 1.5 p 49.97 155.5 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.576 1.944 0 C-N-CA 127.072 2.149 . . . . 75.04 115.734 179.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 569' ' ' LYS . . . . . . . . . . . . . 5.8 mmpt? -140.69 166.29 25.15 Favored 'General case' 0 CA--C 1.486 -1.487 0 N-CA-C 107.806 -1.183 . . . . 73.34 107.806 172.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 570' ' ' THR . . . . . 0.535 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 18.2 p -137.49 133.49 34.67 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 123.825 0.703 . . . . 70.52 110.603 175.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 3.1 mp -84.77 122.36 38.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 106.591 -1.633 . . . . 71.2 106.591 172.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 10.2 p -98.2 109.08 21.9 Favored 'General case' 0 N--CA 1.418 -2.074 0 N-CA-C 109.838 -0.43 . . . . 74.25 109.838 178.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 573' ' ' VAL . . . . . 0.486 HG23 ' CG2' ' A' ' 556' ' ' THR . 58.9 t -110.55 123.7 66.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 N-CA-C 109.869 -0.419 . . . . 73.53 109.869 178.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -77.91 113.23 15.6 Favored 'General case' 0 N--CA 1.433 -1.29 0 O-C-N 124.036 0.835 . . . . 74.32 109.067 175.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 57.1 t -87.24 130.32 37.27 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 107.624 -1.25 . . . . 71.44 107.624 177.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 576' ' ' ILE . . . . . 0.415 HG12 ' HA ' ' A' ' 553' ' ' PHE . 37.4 mm -94.98 150.04 4.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 108.312 -0.996 . . . . 74.21 108.312 -175.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -68.51 139.81 55.66 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.329 -0.619 . . . . 73.31 109.329 176.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.66 -177.74 6.67 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 112.898 0.703 . . . . 73.14 112.898 -173.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -166.71 -38.19 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.462 0 N-CA-C 114.566 1.321 . . . . 72.31 114.566 -173.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 580' ' ' GLU . . . . . 0.534 ' HG2' ' O ' ' A' ' 581' ' ' TYR . 0.1 OUTLIER -99.77 -168.08 1.55 Allowed 'General case' 0 C--O 1.25 1.104 0 C-N-CA 122.71 0.404 . . . . 74.21 111.887 -169.022 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 581' ' ' TYR . . . . . 0.534 ' O ' ' HG2' ' A' ' 580' ' ' GLU . 27.8 p90 -65.48 151.12 47.14 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 106.819 -1.549 . . . . 74.24 106.819 174.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -130.31 154.81 47.25 Favored 'General case' 0 N--CA 1.412 -2.338 0 C-N-CA 118.467 -1.293 . . . . 64.34 113.918 178.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -133.82 -174.51 3.55 Favored 'General case' 0 C--N 1.274 -2.692 0 N-CA-C 103.648 -2.723 . . . . 74.43 103.648 176.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -72.69 107.04 4.95 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.594 -1.261 . . . . 73.11 107.594 173.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . 0.252 0.0 OUTLIER -113.28 143.7 43.97 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 119.921 -0.712 . . . . 75.14 111.351 -179.041 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 586' ' ' THR . . . . . 0.439 ' HG1' ' C ' ' A' ' 644' ' ' VAL . 3.5 t -155.81 148.96 24.52 Favored 'General case' 0 N--CA 1.418 -2.072 0 CA-C-N 115.215 -0.902 . . . . 71.54 109.764 -172.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -120.14 142.15 49.2 Favored 'General case' 0 N--CA 1.414 -2.272 0 CA-C-N 114.576 -1.193 . . . . 74.42 109.665 176.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 588' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -98.92 133.5 43.11 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.561 -0.904 . . . . 74.3 108.561 -175.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . 0.455 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.5 OUTLIER -108.01 127.17 53.53 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 106.323 -1.732 . . . . 62.43 106.323 176.365 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -127.95 126.86 42.24 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 109.242 -0.651 . . . . 74.23 109.242 176.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 591' ' ' ILE . . . . . . . . . . . . . 17.0 pt -94.22 128.66 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 N-CA-C 106.351 -1.722 . . . . 74.52 106.351 171.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -93.35 -144.75 15.7 Favored Glycine 0 N--CA 1.431 -1.674 0 CA-C-N 115.793 -0.64 . . . . 63.11 114.386 -171.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -77.43 116.35 57.13 Favored Pre-proline 0 N--CA 1.435 -1.195 0 CA-C-N 114.635 -0.782 . . . . 71.14 109.155 -178.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -76.3 160.25 35.99 Favored 'Trans proline' 0 N--CA 1.446 -1.31 0 C-N-CA 122.475 2.117 . . . . 74.41 111.283 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 8.3 ptp85 -135.31 139.07 44.04 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 109.046 -0.724 . . . . 75.42 109.046 -178.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.39 129.19 34.98 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 105.954 -1.869 . . . . 75.45 105.954 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 69.7 t . . . . . 0 C--N 1.312 -1.043 0 CA-C-O 121.905 0.859 . . . . 73.44 110.393 -178.672 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.207 -1.135 0 N-CA-C 109.527 -0.546 . . . . 75.24 109.527 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -75.6 153.89 39.3 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 121.863 1.709 . . . . 73.24 111.754 178.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.3 pp -130.96 179.78 4.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.798 0.666 . . . . 72.42 112.798 -177.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -76.71 153.4 35.13 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.793 -0.64 . . . . 74.35 109.473 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -83.93 -135.72 2.93 Favored Glycine 0 C--N 1.304 -1.239 0 C-N-CA 120.917 -0.659 . . . . 71.32 114.18 -175.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -70.32 -56.97 5.41 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.168 0.508 . . . . 74.42 110.449 -176.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -148.26 122.53 9.6 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.429 0.633 . . . . 71.41 110.096 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 55.2 p -108.59 91.49 3.67 Favored 'General case' 0 N--CA 1.406 -2.665 0 CA-C-O 121.907 0.86 . . . . 74.24 109.118 178.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -166.39 130.19 2.06 Favored 'General case' 0 CA--C 1.491 -1.295 0 N-CA-C 107.81 -1.181 . . . . 64.41 107.81 -177.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 642' ' ' LEU . . . . . 0.494 HD22 HG22 ' A' ' 523' ' ' VAL . 29.3 tp -137.91 110.53 7.55 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 108.531 -0.914 . . . . 75.35 108.531 176.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -93.92 109.69 21.39 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 107.188 -1.412 . . . . 75.2 107.188 176.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 644' ' ' VAL . . . . . 0.439 ' C ' ' HG1' ' A' ' 586' ' ' THR . 34.7 t -96.59 105.44 17.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 109.982 -0.377 . . . . 75.42 109.982 -177.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 3.7 mp -87.86 120.16 36.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 108.418 -0.956 . . . . 75.51 108.418 178.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 646' ' ' ILE . . . . . 0.433 HD11 ' H ' ' A' ' 646' ' ' ILE . 2.1 mp -101.7 107.47 21.62 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.746 0 N-CA-C 105.938 -1.875 . . . . 64.51 105.938 -177.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -110.53 145.92 36.93 Favored 'General case' 0 N--CA 1.406 -2.627 0 C-N-CA 120.273 -0.571 . . . . 72.54 110.294 -178.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -53.33 132.8 39.82 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.004 -0.998 . . . . 72.04 110.091 -178.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 3.6 m . . . . . 0 C--N 1.298 -1.661 0 C-N-CA 124.444 1.098 . . . . 63.04 111.681 -173.549 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.419 -2.47 0 N-CA-C 112.624 -0.19 . . . . 72.12 112.624 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 4.1 mp -122.75 114.81 43.83 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 108.54 -0.911 . . . . 74.23 108.54 178.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -128.88 98.75 5.06 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 107.753 -1.203 . . . . 74.32 107.753 174.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 15.4 t -134.99 156.83 48.36 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 116.044 -0.526 . . . . 74.42 109.679 -173.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -85.41 154.28 21.95 Favored 'General case' 0 CA--C 1.487 -1.476 0 N-CA-C 108.583 -0.895 . . . . 73.2 108.583 175.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -84.38 -26.92 28.02 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.099 -1.075 . . . . 73.33 108.099 173.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -111.26 121.22 41.03 Favored Pre-proline 0 N--CA 1.436 -1.174 0 CA-C-N 114.636 -1.165 . . . . 74.02 109.98 -178.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -85.7 -18.48 3.77 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 121.206 1.271 . . . . 75.32 109.51 169.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . 0.425 HG23 ' HB3' ' A' ' 643' ' ' GLU . 67.6 t -149.32 131.13 5.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 C-N-CA 125.953 1.701 . . . . 71.1 106.972 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 14.9 t -130.49 143.73 50.95 Favored 'General case' 0 N--CA 1.421 -1.902 0 N-CA-C 107.676 -1.231 . . . . 74.45 107.676 177.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -109.76 131.99 54.56 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 107.504 -1.295 . . . . 73.33 107.504 178.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 24.7 m -130.19 154.89 41.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 CA-C-O 121.312 0.577 . . . . 72.24 110.077 -178.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 65.7 m -77.08 150.0 35.7 Favored 'General case' 0 N--CA 1.397 -3.103 0 CA-C-N 114.493 -1.23 . . . . 74.42 109.955 178.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -71.69 -29.3 64.43 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.813 0.816 . . . . 65.24 109.659 174.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 39.7 m -107.95 75.07 0.98 Allowed 'General case' 0 N--CA 1.418 -2.033 0 CA-C-O 122.129 0.966 . . . . 73.23 109.462 -177.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 13.3 tt -145.3 161.04 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.214 0 CA-C-N 113.069 -1.878 . . . . 74.42 106.027 176.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . -92.51 -75.71 1.31 Allowed Glycine 0 N--CA 1.434 -1.449 0 C-N-CA 120.002 -1.094 . . . . 42.11 110.894 177.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 34.6 mm -107.68 127.03 63.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 109.866 -0.42 . . . . 75.22 109.866 -178.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 521' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.95 139.99 37.8 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.075 -1.454 . . . . 72.34 107.075 172.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -113.7 155.67 25.15 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 121.419 0.628 . . . . 72.3 111.709 -176.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . 0.675 ' O ' ' HA ' ' A' ' 570' ' ' THR . 12.1 t -135.77 126.07 42.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 115.118 -0.947 . . . . 71.12 108.479 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . 0.446 ' HD2' HG21 ' A' ' 568' ' ' VAL . 31.2 mmtp -79.7 126.08 30.47 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.507 0.67 . . . . 72.12 112.088 -179.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 19.1 t -110.67 122.87 65.95 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 107.367 -1.346 . . . . 73.53 107.367 176.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -78.82 144.93 34.59 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.073 -0.714 . . . . 71.41 109.073 -178.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . 0.473 ' HG2' ' N ' ' A' ' 528' ' ' THR . 40.3 ttp180 -88.23 151.81 22.4 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.451 0.643 . . . . 64.32 110.764 -175.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 528' ' ' THR . . . . . 0.473 ' N ' ' HG2' ' A' ' 527' ' ' ARG . 4.6 t -59.97 139.63 57.29 Favored 'General case' 0 N--CA 1.418 -2.049 0 CA-C-N 114.514 -1.221 . . . . 63.3 110.525 172.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 23.3 t -73.92 -40.65 62.98 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 108.553 -0.906 . . . . 75.32 108.553 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -90.57 56.63 3.46 Favored Glycine 0 N--CA 1.434 -1.459 0 N-CA-C 110.392 -1.083 . . . . 64.11 110.392 177.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -70.14 99.88 1.56 Allowed 'General case' 0 CA--C 1.505 -0.767 0 C-N-CA 122.972 0.509 . . . . 64.1 110.884 -178.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -127.33 100.22 5.96 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 115.708 -0.678 . . . . 73.32 109.899 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 533' ' ' GLY . . . . . 0.52 ' H ' ' HB3' ' A' ' 564' ' ' ASN . . . 102.67 165.23 26.19 Favored Glycine 0 N--CA 1.42 -2.42 0 C-N-CA 120.695 -0.764 . . . . 41.11 113.161 177.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -79.72 123.11 27.38 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.383 -1.34 . . . . 74.44 107.383 176.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 65.7 t -124.32 139.48 50.54 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-N 116.19 -0.459 . . . . 74.03 110.023 -175.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 536' ' ' ILE . . . . . 0.462 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 30.2 mm -104.24 139.18 25.94 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 109.014 -0.736 . . . . 63.33 109.014 178.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 41.9 t -118.4 108.53 41.58 Favored Pre-proline 0 C--N 1.306 -1.3 0 N-CA-C 109.474 -0.565 . . . . 73.23 109.474 177.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -73.93 138.85 26.47 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 122.117 1.878 . . . . 65.35 110.885 177.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -146.46 161.47 40.35 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 120.804 -0.358 . . . . 73.34 110.531 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.31 147.65 23.87 Favored 'General case' 0 C--N 1.317 -0.807 0 O-C-N 123.518 0.511 . . . . 73.33 111.495 177.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 16.7 p -84.8 132.34 34.43 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 116.2 -0.455 . . . . 72.33 110.039 173.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.5 mp -93.63 124.22 46.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 106.271 -1.751 . . . . 72.54 106.271 173.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . 0.402 ' HB3' ' O ' ' A' ' 546' ' ' ALA . 2.7 mp0 -57.12 -52.67 64.36 Favored 'General case' 0 C--O 1.243 0.712 0 O-C-N 123.818 0.699 . . . . 74.42 110.765 -178.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 71.08 -81.91 0.44 Allowed Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 115.45 -0.795 . . . . 62.55 111.946 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 11.1 t -132.9 5.47 3.9 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.677 0.751 . . . . 74.33 109.806 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . 0.402 ' O ' ' HB3' ' A' ' 543' ' ' GLU . . . -106.2 178.83 4.45 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.841 -0.618 . . . . 75.35 109.612 178.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . 0.475 ' HD2' ' CB ' ' A' ' 551' ' ' GLU . 1.7 tmt_? -129.03 124.26 34.46 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 107.677 -1.231 . . . . 74.14 107.677 -175.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -82.9 -151.36 10.16 Favored Glycine 0 C--N 1.321 -0.264 0 C-N-CA 121.321 -0.466 . . . . 72.05 112.715 -177.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 66.6 19.4 69.01 Favored Glycine 0 C--N 1.314 -0.672 0 CA-C-N 116.689 0.244 . . . . 65.31 113.289 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 76.7 32.3 50.87 Favored Glycine 0 N--CA 1.437 -1.289 0 C-N-CA 120.748 -0.739 . . . . 51.22 111.614 -178.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . 0.475 ' CB ' ' HD2' ' A' ' 547' ' ' ARG . 8.1 tp10 -101.41 -65.75 0.96 Allowed 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.865 -0.42 . . . . 71.51 109.865 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -101.38 -34.05 9.76 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 106.526 -1.657 . . . . 73.4 106.526 177.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 553' ' ' PHE . . . . . 0.45 ' HA ' HG12 ' A' ' 576' ' ' ILE . 20.4 p90 -149.46 164.56 34.68 Favored 'General case' 0 N--CA 1.419 -2.023 0 CA-C-N 113.99 -1.459 . . . . 65.42 108.054 175.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . 0.447 ' HG3' ' HE2' ' A' ' 574' ' ' LYS . 0.5 OUTLIER -94.56 112.3 24.06 Favored 'General case' 0 C--N 1.282 -2.368 0 N-CA-C 105.805 -1.924 . . . . 74.52 105.805 176.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -76.94 101.06 5.8 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-O 122.525 1.155 . . . . 62.14 110.736 -175.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 556' ' ' THR . . . . . 0.454 ' CG2' HG22 ' A' ' 573' ' ' VAL . 8.9 t -91.44 121.8 33.47 Favored 'General case' 0 N--CA 1.396 -3.148 0 CA-C-O 122.395 1.093 . . . . 75.14 110.967 -178.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 10.4 p -136.83 119.25 15.79 Favored 'General case' 0 N--CA 1.41 -2.43 0 N-CA-C 106.56 -1.644 . . . . 72.44 106.56 177.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -170.12 -152.91 8.29 Favored Glycine 0 N--CA 1.415 -2.724 0 N-CA-C 110.596 -1.002 . . . . 72.52 110.596 -175.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 559' ' ' GLU . . . . . 0.462 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 34.7 mt-10 -135.03 127.47 30.48 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 122.364 0.265 . . . . 64.42 111.124 -176.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 96.1 mt -88.19 155.6 19.68 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.346 -0.612 . . . . 75.34 109.346 177.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -123.37 119.29 29.64 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-O 121.039 0.447 . . . . 74.22 111.471 -178.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -113.82 148.39 36.69 Favored 'General case' 0 CA--C 1.502 -0.881 0 C-N-CA 123.981 0.912 . . . . 75.33 109.492 176.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -127.87 167.55 16.43 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 120.243 -0.583 . . . . 72.43 109.45 177.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 564' ' ' ASN . . . . . 0.52 ' HB3' ' H ' ' A' ' 533' ' ' GLY . 32.1 p30 -66.87 -24.51 66.13 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.272 0.558 . . . . 72.11 111.142 178.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -102.72 -5.1 24.11 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.577 -0.738 . . . . 72.5 111.0 -177.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -115.35 134.86 54.72 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 116.4 -0.363 . . . . 72.41 110.599 -175.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 567' ' ' ILE . . . . . 0.439 ' HA ' ' HD3' ' A' ' 527' ' ' ARG . 9.5 pt -114.09 164.73 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 C-N-CA 120.969 -0.292 . . . . 73.4 110.267 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 568' ' ' VAL . . . . . 0.446 HG21 ' HD2' ' A' ' 524' ' ' LYS . 1.2 p 49.54 165.82 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.566 1.559 0 C-N-CA 127.301 2.24 . . . . 73.21 114.488 179.266 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 569' ' ' LYS . . . . . 0.432 ' HE3' ' HA ' ' A' ' 569' ' ' LYS . 1.0 OUTLIER -161.0 160.81 31.13 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 106.087 -1.82 . . . . 73.12 106.087 177.289 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 570' ' ' THR . . . . . 0.675 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 19.8 p -133.89 127.58 32.82 Favored 'General case' 0 N--CA 1.427 -1.601 0 O-C-N 123.478 0.486 . . . . 64.53 110.964 177.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 2.9 mp -76.62 125.45 36.4 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 107.016 -1.476 . . . . 70.14 107.016 173.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 24.4 m -99.44 109.37 21.94 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 120.859 0.361 . . . . 72.11 110.342 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 573' ' ' VAL . . . . . 0.454 HG22 ' CG2' ' A' ' 556' ' ' THR . 40.1 t -116.45 120.07 63.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 108.97 -0.752 . . . . 71.13 108.97 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 574' ' ' LYS . . . . . 0.447 ' HE2' ' HG3' ' A' ' 554' ' ' GLU . 38.8 ttpt -82.1 126.6 32.21 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-O 121.457 0.646 . . . . 75.23 110.938 177.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 82.5 t -91.51 134.84 28.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 107.982 -1.118 . . . . 64.12 107.982 178.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 576' ' ' ILE . . . . . 0.45 HG12 ' HA ' ' A' ' 553' ' ' PHE . 21.9 mm -105.69 160.05 5.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 107.475 -1.306 . . . . 74.43 107.475 -177.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -68.77 132.17 46.37 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 116.387 -0.37 . . . . 64.44 110.103 177.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.36 128.85 37.98 Favored 'General case' 0 CA--C 1.49 -1.342 0 CA-C-O 121.808 0.813 . . . . 72.14 111.405 -178.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.18 -0.82 38.04 Favored 'General case' 0 C--N 1.275 -2.642 0 CA-C-N 114.02 -1.445 . . . . 73.11 113.335 -175.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 580' ' ' GLU . . . . . 0.532 ' HG2' ' O ' ' A' ' 581' ' ' TYR . 0.5 OUTLIER -137.29 -174.93 3.89 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.93 -0.481 . . . . 72.31 110.706 -176.63 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 581' ' ' TYR . . . . . 0.532 ' O ' ' HG2' ' A' ' 580' ' ' GLU . 28.5 p90 -65.63 154.32 39.13 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 108.706 -0.85 . . . . 71.23 108.706 174.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -86.0 152.26 23.06 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 114.988 1.477 . . . . 74.03 114.988 -176.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -157.71 172.74 17.97 Favored 'General case' 0 N--CA 1.433 -1.283 0 C-N-CA 126.77 2.028 . . . . 75.34 105.611 176.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -80.77 97.68 7.43 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.075 -1.454 . . . . 75.13 107.075 176.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.68 136.0 53.32 Favored 'General case' 0 N--CA 1.416 -2.152 0 CA-C-N 115.365 -0.834 . . . . 74.14 110.363 -175.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 586' ' ' THR . . . . . 0.435 ' HG1' ' C ' ' A' ' 644' ' ' VAL . 3.9 t -151.33 146.97 26.38 Favored 'General case' 0 N--CA 1.421 -1.917 0 CA-C-N 115.137 -0.938 . . . . 75.41 110.483 -174.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -122.18 155.62 35.4 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 114.6 -1.182 . . . . 71.42 109.628 177.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 588' ' ' PHE . . . . . 0.512 ' HA ' ' O ' ' A' ' 642' ' ' LEU . 34.9 m-85 -110.71 145.73 37.51 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.721 -0.474 . . . . 74.04 109.721 -174.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -116.25 119.62 36.32 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 106.491 -1.67 . . . . 73.33 106.491 176.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -125.5 138.78 53.99 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 108.847 -0.797 . . . . 61.34 108.847 -178.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 591' ' ' ILE . . . . . . . . . . . . . 27.3 pt -103.73 151.03 6.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 108.502 -0.925 . . . . 73.13 108.502 176.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -93.72 -150.09 26.26 Favored Glycine 0 N--CA 1.427 -1.918 0 N-CA-C 110.855 -0.898 . . . . 64.14 110.855 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -86.3 119.63 71.7 Favored Pre-proline 0 C--N 1.301 -1.53 0 N-CA-C 108.552 -0.907 . . . . 73.53 108.552 178.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 594' ' ' PRO . . . . . 0.465 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 12.9 Cg_endo -57.47 149.13 68.09 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 122.37 2.047 . . . . 74.42 111.175 177.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -128.66 132.84 48.1 Favored 'General case' 0 C--N 1.291 -1.959 0 O-C-N 121.996 -0.44 . . . . 74.32 110.306 -173.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -77.43 128.12 33.7 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.671 -1.233 . . . . 71.44 107.671 -177.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 597' ' ' VAL . . . . . 0.428 ' CG2' HG12 ' A' ' 536' ' ' ILE . 52.2 t . . . . . 0 C--N 1.315 -0.92 0 CA-C-O 121.869 0.842 . . . . 73.41 109.373 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.43 -1.442 0 N-CA-C 105.894 -1.891 . . . . 75.22 105.894 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . 0.465 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 18.2 Cg_endo -63.17 144.81 92.88 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 121.203 1.268 . . . . 73.31 110.485 175.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.3 pp -122.48 169.25 14.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 113.46 0.911 . . . . 74.41 113.46 -177.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.85 168.34 19.63 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 123.788 0.835 . . . . 62.5 112.106 -176.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -113.18 -157.51 12.72 Favored Glycine 0 N--CA 1.437 -1.282 0 N-CA-C 115.704 1.042 . . . . 72.05 115.704 -174.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -42.65 -59.32 1.96 Allowed 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 128.107 2.563 . . . . 64.33 114.751 -173.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 10.6 p80 -140.06 109.63 6.28 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 122.019 0.914 . . . . 75.51 111.812 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 11.0 p -114.61 91.71 3.71 Favored 'General case' 0 N--CA 1.411 -2.412 0 CA-C-N 115.008 -0.996 . . . . 71.52 111.102 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 641' ' ' LYS . . . . . 0.439 ' HD3' ' N ' ' A' ' 642' ' ' LEU . 1.0 OUTLIER -175.23 137.25 0.39 Allowed 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 105.353 -2.091 . . . . 75.41 105.353 178.779 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 642' ' ' LEU . . . . . 0.512 ' O ' ' HA ' ' A' ' 588' ' ' PHE . 27.6 tp -135.31 114.14 11.94 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 108.775 -0.824 . . . . 74.43 108.775 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . 0.425 ' HB3' HG23 ' A' ' 511' ' ' VAL . 28.6 tt0 -98.31 110.04 22.69 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 107.127 -1.434 . . . . 74.1 107.127 176.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 644' ' ' VAL . . . . . 0.435 ' C ' ' HG1' ' A' ' 586' ' ' THR . 22.0 t -97.46 102.08 13.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 109.77 -0.456 . . . . 75.25 109.77 -177.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 4.0 mp -89.15 120.18 37.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 N-CA-C 107.799 -1.186 . . . . 74.45 107.799 177.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 646' ' ' ILE . . . . . 0.462 ' N ' HD13 ' A' ' 646' ' ' ILE . 2.8 mp -99.83 106.71 19.55 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.505 0 N-CA-C 106.724 -1.584 . . . . 75.23 106.724 -176.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -104.87 155.43 18.93 Favored 'General case' 0 C--N 1.279 -2.497 0 CA-C-O 121.237 0.541 . . . . 73.44 111.565 -177.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -60.84 162.61 6.6 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.052 -0.976 . . . . 62.54 113.479 -174.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 CA--C 1.557 1.223 0 CA-C-O 123.184 1.469 . . . . 75.42 107.654 177.939 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . 0.496 ' HA3' ' OG1' ' A' ' 528' ' ' THR . . . . . . . . 0 N--CA 1.406 -3.328 0 N-CA-C 114.128 0.411 . . . . 71.21 114.128 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 4.0 mp -125.61 134.88 65.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 123.879 0.871 . . . . 74.0 108.927 -173.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -131.2 127.62 38.29 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.343 -0.614 . . . . 74.3 109.343 173.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 506' ' ' THR . . . . . 0.432 ' HB ' ' HA3' ' A' ' 637' ' ' GLY . 15.0 t -154.25 164.49 38.48 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 109.443 -0.577 . . . . 72.55 109.443 -177.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -94.8 157.67 15.83 Favored 'General case' 0 CA--C 1.493 -1.242 0 N-CA-C 108.647 -0.871 . . . . 75.21 108.647 175.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -93.75 -33.81 13.46 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 106.882 -1.525 . . . . 72.42 106.882 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -95.61 120.9 62.75 Favored Pre-proline 0 CA--C 1.49 -1.362 0 CA-C-N 114.285 -1.325 . . . . 60.34 110.097 175.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 510' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 641' ' ' LYS . 2.7 Cg_exo -80.88 -20.88 7.33 Favored 'Trans proline' 0 N--CA 1.44 -1.643 0 N-CA-C 108.251 -1.48 . . . . 72.41 108.251 165.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 99.2 t -145.06 138.73 22.16 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 C-N-CA 124.876 1.27 . . . . 75.43 109.061 -178.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 10.1 t -137.02 138.99 41.08 Favored 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 107.025 -1.472 . . . . 74.22 107.025 175.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 75.7 m-70 -109.99 116.13 31.04 Favored 'General case' 0 CA--C 1.488 -1.414 0 N-CA-C 109.064 -0.717 . . . . 73.42 109.064 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.622 HG12 ' SD ' ' A' ' 521' ' ' MET . 33.4 m -109.18 155.58 10.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 CA-C-O 122.024 0.916 . . . . 73.24 112.226 -174.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 515' ' ' SER . . . . . 0.477 ' O ' HG23 ' A' ' 518' ' ' ILE . 51.0 m -77.89 156.88 30.07 Favored 'General case' 0 N--CA 1.389 -3.502 0 CA-C-N 113.597 -1.638 . . . . 73.34 110.286 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . 0.415 ' HB2' ' O ' ' A' ' 647' ' ' GLU . 20.8 tp10 -87.7 -18.68 28.95 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 107.847 -1.168 . . . . 73.32 107.847 177.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 30.4 m -96.66 18.37 14.43 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.601 -0.727 . . . . 71.41 110.739 -176.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 518' ' ' ILE . . . . . 0.477 HG23 ' O ' ' A' ' 515' ' ' SER . 13.9 tt -102.81 152.22 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.631 0 N-CA-C 108.388 -0.968 . . . . 75.41 108.388 -177.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -92.89 -70.05 1.14 Allowed Glycine 0 N--CA 1.424 -2.133 0 C-N-CA 119.832 -1.175 . . . . 71.03 110.777 176.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 42.6 mm -117.34 125.21 73.87 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 N-CA-C 108.657 -0.868 . . . . 75.31 108.657 -176.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 521' ' ' MET . . . . . 0.622 ' SD ' HG12 ' A' ' 514' ' ' VAL . 22.6 ptt? -95.96 136.55 36.25 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 107.322 -1.362 . . . . 74.12 107.322 172.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 29.3 mp0 -115.79 107.56 15.2 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 108.191 -1.04 . . . . 74.43 108.191 177.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 570' ' ' THR . 35.0 t -98.03 128.05 49.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 109.582 -0.525 . . . . 75.03 109.582 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -73.87 156.61 37.53 Favored 'General case' 0 C--N 1.317 -0.837 0 O-C-N 123.71 0.631 . . . . 74.11 111.141 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 27.2 t -127.74 144.4 37.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 N-CA-C 107.067 -1.457 . . . . 61.42 107.067 176.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -75.74 140.0 42.17 Favored 'General case' 0 CA--C 1.493 -1.237 0 N-CA-C 109.363 -0.606 . . . . 74.41 109.363 177.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . 0.463 ' CZ ' HG23 ' A' ' 567' ' ' ILE . 35.8 ttt180 -91.03 147.22 23.23 Favored 'General case' 0 N--CA 1.414 -2.24 0 CA-C-N 115.238 -0.892 . . . . 73.55 109.246 -176.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 528' ' ' THR . . . . . 0.496 ' OG1' ' HA3' ' A' ' 503' ' ' GLY . 4.2 t -59.54 146.48 40.46 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 114.737 -1.12 . . . . 71.4 112.122 177.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 15.7 t -79.54 -15.6 57.41 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 108.128 -1.064 . . . . 72.15 108.128 176.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -118.75 93.76 0.57 Allowed Glycine 0 N--CA 1.432 -1.598 0 N-CA-C 109.396 -1.481 . . . . 72.25 109.396 176.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -102.17 93.37 5.19 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.393 0.616 . . . . 72.25 110.572 -177.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -116.52 115.03 25.01 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.738 -0.664 . . . . 74.34 111.698 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 77.64 -121.17 5.72 Favored Glycine 0 N--CA 1.435 -1.372 0 CA-C-N 115.208 -0.905 . . . . 73.2 113.275 173.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 534' ' ' ASN . . . . . 0.515 HD22 ' HG3' ' A' ' 561' ' ' GLU . 2.6 t-20 -139.44 127.6 22.5 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.262 -1.014 . . . . 73.34 108.262 -178.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 54.8 t -123.52 124.57 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.742 0 N-CA-C 109.496 -0.557 . . . . 73.02 109.496 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 536' ' ' ILE . . . . . 0.439 HG23 ' HB3' ' A' ' 559' ' ' GLU . 29.9 mm -93.66 120.53 43.21 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 CA-C-N 114.966 -1.015 . . . . 71.13 109.135 178.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 21.9 t -113.84 104.57 55.06 Favored Pre-proline 0 C--N 1.303 -1.451 0 N-CA-C 109.242 -0.651 . . . . 74.34 109.242 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -70.79 153.05 64.39 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 121.961 1.774 . . . . 75.41 110.978 177.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 539' ' ' TYR . . . . . 0.404 ' CD1' ' HG ' ' A' ' 560' ' ' LEU . 52.7 p90 -150.97 159.93 44.25 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.021 -0.733 . . . . 73.2 109.021 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -155.15 154.98 33.14 Favored 'General case' 0 C--N 1.316 -0.851 0 O-C-N 123.721 0.638 . . . . 75.42 110.605 177.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 18.0 p -93.4 116.11 28.66 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.853 -0.612 . . . . 73.32 109.369 174.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.5 mp -83.35 122.29 37.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 105.608 -1.997 . . . . 72.44 105.608 174.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -51.86 -39.45 58.93 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.115 0.783 . . . . 74.42 113.115 -175.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 74.74 -86.68 0.75 Allowed Glycine 0 N--CA 1.437 -1.273 0 N-CA-C 110.521 -1.032 . . . . 65.23 110.521 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 11.3 t -143.17 14.07 1.84 Allowed 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 122.488 1.137 . . . . 73.3 108.899 177.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -96.74 -167.64 1.59 Allowed 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 114.714 -1.13 . . . . 73.03 109.512 177.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . 0.469 ' HG3' ' OE2' ' A' ' 551' ' ' GLU . 0.0 OUTLIER -136.23 122.79 20.88 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 106.97 -1.493 . . . . 75.31 106.97 -178.944 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -78.7 -153.97 7.42 Favored Glycine 0 C--N 1.303 -1.261 0 O-C-N 123.587 0.554 . . . . 70.44 112.802 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 63.92 10.5 39.59 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 114.909 0.723 . . . . 63.01 114.909 177.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 86.18 14.19 67.13 Favored Glycine 0 N--CA 1.433 -1.561 0 C-N-CA 120.285 -0.96 . . . . 50.54 112.02 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . 0.469 ' OE2' ' HG3' ' A' ' 547' ' ' ARG . 31.8 tt0 -84.59 -61.45 1.79 Allowed 'General case' 0 C--O 1.236 0.393 0 N-CA-C 109.574 -0.528 . . . . 74.32 109.574 178.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . 0.412 ' HB3' ' H ' ' A' ' 547' ' ' ARG . 17.4 t70 -105.71 -36.95 6.9 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.628 -0.879 . . . . 74.54 108.628 177.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 553' ' ' PHE . . . . . 0.471 ' HA ' HG12 ' A' ' 576' ' ' ILE . 14.0 p90 -147.97 162.61 38.98 Favored 'General case' 0 N--CA 1.428 -1.525 0 N-CA-C 108.37 -0.974 . . . . 75.3 108.37 173.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -93.9 111.42 23.12 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 105.898 -1.89 . . . . 72.33 105.898 178.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -81.68 123.53 28.8 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-O 121.873 0.844 . . . . 74.23 110.419 -175.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 10.2 t -119.89 140.97 50.03 Favored 'General case' 0 N--CA 1.412 -2.338 0 CA-C-O 121.84 0.829 . . . . 63.3 110.664 -174.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 5.9 p -144.85 134.08 22.9 Favored 'General case' 0 N--CA 1.413 -2.324 0 N-CA-C 106.638 -1.615 . . . . 74.22 106.638 177.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -167.82 -153.87 8.34 Favored Glycine 0 N--CA 1.412 -2.954 0 C-N-CA 119.715 -1.231 . . . . 75.11 110.83 -175.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 559' ' ' GLU . . . . . 0.439 ' HB3' HG23 ' A' ' 536' ' ' ILE . 35.7 mt-10 -140.86 124.89 17.25 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 122.961 0.504 . . . . 74.03 109.828 -174.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . 0.404 ' HG ' ' CD1' ' A' ' 539' ' ' TYR . 95.4 mt -90.36 134.81 34.08 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 110.113 -0.329 . . . . 64.14 110.113 178.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 561' ' ' GLU . . . . . 0.515 ' HG3' HD22 ' A' ' 534' ' ' ASN . 43.7 tt0 -102.47 100.89 11.04 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.461 -0.791 . . . . 72.44 111.208 -176.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -99.62 144.63 28.49 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 109.202 -0.666 . . . . 72.03 109.202 174.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -138.78 171.28 14.57 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 109.82 -0.437 . . . . 73.03 109.82 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 19.4 p30 -64.72 -27.53 68.97 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 116.098 -0.501 . . . . 73.34 111.26 176.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -100.97 -23.88 14.44 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 116.159 -0.473 . . . . 62.51 111.783 177.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -85.38 128.56 34.76 Favored 'General case' 0 C--O 1.248 0.974 0 N-CA-C 110.227 -0.286 . . . . 75.21 110.227 -178.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 567' ' ' ILE . . . . . 0.463 HG23 ' CZ ' ' A' ' 527' ' ' ARG . 1.5 pp -116.42 138.49 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.024 0 N-CA-C 109.028 -0.73 . . . . 74.34 109.028 -179.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 568' ' ' VAL . . . . . 0.438 HG13 ' O ' ' A' ' 567' ' ' ILE . 1.4 p 58.66 153.75 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.153 0 C-N-CA 126.554 1.942 . . . . 73.43 113.88 177.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 569' ' ' LYS . . . . . 0.533 ' HA ' ' HE2' ' A' ' 569' ' ' LYS . 7.2 mmpt? -141.1 165.93 26.18 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.92 -0.77 . . . . 74.34 108.92 175.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 570' ' ' THR . . . . . 0.539 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 7.2 p -134.48 141.81 46.87 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 124.202 0.939 . . . . 73.21 110.886 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 2.7 mp -95.4 120.88 45.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 106.656 -1.609 . . . . 71.24 106.656 173.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 8.5 p -97.39 121.81 39.71 Favored 'General case' 0 N--CA 1.427 -1.618 0 O-C-N 123.683 0.615 . . . . 75.05 110.193 178.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 573' ' ' VAL . . . . . . . . . . . . . 52.1 t -130.51 134.72 61.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 N-CA-C 109.032 -0.729 . . . . 71.0 109.032 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -89.8 120.0 30.67 Favored 'General case' 0 C--O 1.248 0.985 0 O-C-N 123.705 0.628 . . . . 74.2 110.458 177.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 99.5 t -84.57 125.43 40.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 107.74 -1.207 . . . . 72.33 107.74 175.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 576' ' ' ILE . . . . . 0.471 HG12 ' HA ' ' A' ' 553' ' ' PHE . 31.1 mm -96.44 147.5 6.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 106.899 -1.519 . . . . 75.23 106.899 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -64.76 125.48 24.94 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 123.533 0.521 . . . . 53.33 110.387 -178.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -52.25 115.32 1.68 Allowed 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 114.636 1.347 . . . . 74.43 114.636 176.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.03 -38.16 66.63 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 112.633 -2.076 . . . . 74.32 109.035 176.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.98 -176.35 3.53 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 114.963 -1.017 . . . . 74.02 113.169 -176.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -52.74 153.71 3.1 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 126.159 1.784 . . . . 73.35 109.972 175.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 582' ' ' GLU . . . . . 0.499 ' OE2' ' HB ' ' A' ' 646' ' ' ILE . 33.1 tt0 -130.2 113.81 14.91 Favored 'General case' 0 C--N 1.287 -2.118 0 C-N-CA 119.05 -1.06 . . . . 73.42 111.988 178.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -89.26 -157.73 0.47 Allowed 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 106.285 -1.746 . . . . 74.52 106.285 173.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -75.19 76.69 2.33 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.392 -1.336 . . . . 73.41 107.392 171.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -104.42 128.96 52.41 Favored 'General case' 0 N--CA 1.402 -2.838 0 N-CA-C 107.715 -1.217 . . . . 73.31 107.715 -179.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 586' ' ' THR . . . . . 0.456 ' HG1' ' C ' ' A' ' 644' ' ' VAL . 2.9 t -151.92 153.63 34.5 Favored 'General case' 0 N--CA 1.393 -3.276 0 CA-C-N 114.845 -1.07 . . . . 75.42 110.093 -172.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 587' ' ' PHE . . . . . 0.521 ' CE2' HD12 ' A' ' 646' ' ' ILE . 0.8 OUTLIER -119.92 148.77 43.1 Favored 'General case' 0 N--CA 1.422 -1.858 0 O-C-N 124.668 1.23 . . . . 75.13 108.648 175.365 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 588' ' ' PHE . . . . . 0.4 ' CD1' ' HE3' ' A' ' 641' ' ' LYS . 13.8 m-85 -107.26 133.18 52.2 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.769 -0.456 . . . . 72.42 109.769 -172.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -102.91 130.42 49.95 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 106.054 -1.832 . . . . 74.21 106.054 173.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -139.33 151.18 46.19 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 107.149 -1.426 . . . . 71.5 107.149 178.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 591' ' ' ILE . . . . . . . . . . . . . 23.4 pt -107.24 152.14 8.91 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 O-C-N 123.234 0.334 . . . . 74.31 110.18 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -95.7 -164.42 34.26 Favored Glycine 0 N--CA 1.435 -1.38 0 N-CA-C 111.648 -0.581 . . . . 71.23 111.648 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -68.74 114.77 24.75 Favored Pre-proline 0 C--O 1.248 1.011 0 C-N-CA 122.572 0.349 . . . . 74.53 110.067 -177.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 594' ' ' PRO . . . . . 0.556 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 39.3 Cg_endo -69.39 134.08 27.86 Favored 'Trans proline' 0 N--CA 1.439 -1.725 0 C-N-CA 121.816 1.677 . . . . 73.52 109.774 177.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -122.89 127.08 48.49 Favored 'General case' 0 C--N 1.282 -2.349 0 CA-C-O 121.218 0.532 . . . . 75.22 111.651 -172.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -75.31 125.79 29.68 Favored 'General case' 0 N--CA 1.428 -1.525 0 N-CA-C 106.82 -1.548 . . . . 74.03 106.82 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 94.7 t . . . . . 0 C--N 1.297 -1.712 0 N-CA-C 112.38 0.511 . . . . 75.25 112.38 -176.692 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.888 0 CA-C-O 121.347 0.594 . . . . 74.42 111.69 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . 0.556 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 8.0 Cg_endo -70.25 143.13 47.56 Favored 'Trans proline' 0 N--CA 1.432 -2.112 0 N-CA-C 105.815 -2.417 . . . . 74.21 105.815 162.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.0 pp -129.43 -178.28 2.41 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 N-CA-C 115.54 1.681 . . . . 74.23 115.54 -174.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 2.5 tp -70.79 148.22 48.12 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 113.635 -1.62 . . . . 74.2 109.959 -178.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . 0.432 ' HA3' ' HB ' ' A' ' 506' ' ' THR . . . -89.39 -133.04 4.78 Favored Glycine 0 N--CA 1.423 -2.219 0 C-N-CA 120.631 -0.795 . . . . 73.54 111.698 174.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -98.09 -54.2 3.15 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 122.638 -0.331 . . . . 75.23 111.555 -175.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -124.58 93.98 4.06 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 122.285 1.04 . . . . 74.43 112.904 -178.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 3.1 p -100.7 91.21 4.53 Favored 'General case' 0 N--CA 1.404 -2.75 0 CA-C-N 114.545 -1.207 . . . . 73.22 108.992 174.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 641' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 510' ' ' PRO . 21.0 tptm -169.76 130.44 1.03 Allowed 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 106.992 -1.484 . . . . 74.43 106.992 -175.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 642' ' ' LEU . . . . . 0.458 HD22 HG23 ' A' ' 523' ' ' VAL . 41.5 tp -132.57 103.45 6.16 Favored 'General case' 0 C--N 1.272 -2.778 0 N-CA-C 107.225 -1.398 . . . . 74.42 107.225 175.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -91.4 104.91 17.37 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 107.196 -1.409 . . . . 72.04 107.196 178.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 644' ' ' VAL . . . . . 0.461 HG23 ' HE1' ' A' ' 521' ' ' MET . 21.6 t -92.4 99.03 9.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-N 115.904 -0.589 . . . . 74.11 110.085 -176.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 3.5 mp -87.6 127.12 41.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 107.928 -1.138 . . . . 74.31 107.928 177.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 646' ' ' ILE . . . . . 0.521 HD12 ' CE2' ' A' ' 587' ' ' PHE . 1.7 mp -101.58 141.62 17.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 106.691 -1.596 . . . . 75.54 106.691 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 516' ' ' GLU . 2.0 pt-20 -135.43 159.65 40.92 Favored 'General case' 0 C--N 1.264 -3.144 0 N-CA-C 107.38 -1.341 . . . . 74.53 107.38 178.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -72.62 77.1 1.09 Allowed 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 121.829 0.823 . . . . 73.32 110.296 174.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 4.3 t . . . . . 0 C--N 1.317 -0.844 0 C-N-CA 129.372 3.069 . . . . 71.35 115.886 177.326 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . 0.619 ' HA2' ' OG1' ' A' ' 528' ' ' THR . . . . . . . . 0 N--CA 1.414 -2.825 0 N-CA-C 114.979 0.751 . . . . 72.23 114.979 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 4.0 mp -138.58 96.3 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 N-CA-C 105.624 -1.991 . . . . 73.21 105.624 171.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -120.86 108.32 13.78 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 108.869 -0.789 . . . . 75.15 108.869 178.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 11.4 t -139.26 160.81 38.93 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 108.02 -1.104 . . . . 72.15 108.02 -176.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -85.68 148.9 25.66 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.675 -0.491 . . . . 75.04 109.675 175.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -73.51 -31.23 63.59 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.435 -0.95 . . . . 73.32 108.435 177.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -138.72 135.89 18.23 Favored Pre-proline 0 N--CA 1.44 -0.964 0 N-CA-C 109.431 -0.581 . . . . 75.01 109.431 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -82.2 -13.04 10.28 Favored 'Trans proline' 0 C--O 1.218 -0.485 0 C-N-CA 122.671 2.247 . . . . 72.44 112.08 178.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . 0.414 HG23 ' HB3' ' A' ' 643' ' ' GLU . 70.6 t -140.63 137.66 35.79 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.858 0 N-CA-C 108.365 -0.976 . . . . 72.14 108.365 -178.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 4.9 t -143.6 137.06 28.07 Favored 'General case' 0 N--CA 1.419 -1.993 0 N-CA-C 107.925 -1.139 . . . . 75.32 107.925 177.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -106.82 126.49 52.37 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 109.106 -0.702 . . . . 75.32 109.106 176.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 29.1 m -126.92 161.47 33.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 115.751 -0.659 . . . . 70.24 109.373 -175.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 33.8 t -85.54 161.86 19.15 Favored 'General case' 0 N--CA 1.424 -1.759 0 N-CA-C 108.527 -0.916 . . . . 73.33 108.527 178.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -99.3 -11.83 20.89 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-O 121.376 0.608 . . . . 73.01 109.366 177.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 48.8 m -91.41 8.94 33.84 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.637 0.732 . . . . 70.13 109.885 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 13.6 tt -90.29 157.16 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 N-CA-C 108.122 -1.066 . . . . 74.14 108.122 -178.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -88.48 -57.07 1.91 Allowed Glycine 0 N--CA 1.438 -1.199 0 C-N-CA 120.201 -1.0 . . . . 61.34 111.282 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . 0.404 HD12 ' HA ' ' A' ' 574' ' ' LYS . 44.9 mm -127.39 136.65 60.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 108.778 -0.823 . . . . 74.43 108.778 -178.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 521' ' ' MET . . . . . 0.432 ' HE3' HG13 ' A' ' 644' ' ' VAL . 0.0 OUTLIER -111.03 133.28 53.54 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.077 -1.453 . . . . 72.1 107.077 171.103 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 -117.38 128.78 55.37 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 109.294 -0.632 . . . . 74.11 109.294 -176.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . 0.604 ' O ' ' HA ' ' A' ' 570' ' ' THR . 20.5 t -119.81 134.87 61.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 N-CA-C 109.746 -0.464 . . . . 70.11 109.746 179.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -80.39 129.45 34.51 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 113.792 1.034 . . . . 72.52 113.792 -177.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 3.3 t -112.46 133.5 58.02 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 N-CA-C 106.644 -1.613 . . . . 74.44 106.644 177.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -86.76 139.67 30.49 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 120.477 -0.489 . . . . 72.35 109.723 -178.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . 0.463 ' HG2' ' N ' ' A' ' 528' ' ' THR . 37.6 ttp180 -86.96 157.73 19.42 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.103 0.478 . . . . 65.04 111.176 -176.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 528' ' ' THR . . . . . 0.619 ' OG1' ' HA2' ' A' ' 503' ' ' GLY . 4.2 t -58.36 158.48 7.29 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 125.006 1.323 . . . . 71.21 111.674 173.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 32.8 t -87.94 -7.37 57.22 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 115.021 -0.99 . . . . 72.04 109.406 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -132.13 110.39 0.94 Allowed Glycine 0 N--CA 1.436 -1.324 0 N-CA-C 109.409 -1.476 . . . . 72.34 109.409 178.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -155.35 92.85 1.45 Allowed 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 109.3 -0.63 . . . . 65.22 109.3 -175.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.54 23.8 13.88 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 115.318 -0.856 . . . . 75.03 111.085 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . -177.26 -168.26 36.8 Favored Glycine 0 N--CA 1.42 -2.392 0 N-CA-C 110.461 -1.056 . . . . 65.11 110.461 -174.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 534' ' ' ASN . . . . . 0.45 HD22 ' HG3' ' A' ' 561' ' ' GLU . 2.9 t-20 -85.37 132.82 34.17 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 123.482 0.713 . . . . 75.55 110.304 -177.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 58.0 t -128.13 124.74 63.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 108.871 -0.789 . . . . 63.13 108.871 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 536' ' ' ILE . . . . . 0.41 HG21 ' HB3' ' A' ' 559' ' ' GLU . 19.7 mm -97.85 127.8 49.87 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 CA-C-N 115.921 -0.581 . . . . 75.33 109.931 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . 0.49 HG21 ' HB3' ' A' ' 594' ' ' PRO . 41.5 t -117.1 103.74 51.48 Favored Pre-proline 0 C--N 1.309 -1.187 0 N-CA-C 108.684 -0.858 . . . . 74.11 108.684 176.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -71.95 144.47 43.04 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.193 1.929 . . . . 72.35 110.769 178.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 539' ' ' TYR . . . . . 0.449 ' CD2' ' HG ' ' A' ' 560' ' ' LEU . 49.0 p90 -145.75 167.31 23.46 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 109.414 -0.587 . . . . 74.13 109.414 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -158.97 157.14 30.73 Favored 'General case' 0 C--N 1.308 -1.222 0 O-C-N 123.711 0.632 . . . . 74.53 109.781 177.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 3.3 p -93.17 113.6 25.88 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 115.143 -0.935 . . . . 70.31 110.546 175.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.3 mp -78.47 118.01 24.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 N-CA-C 104.781 -2.303 . . . . 74.42 104.781 173.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -53.65 -43.12 68.55 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 124.019 0.825 . . . . 52.14 112.76 -174.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 67.19 -89.71 0.17 Allowed Glycine 0 N--CA 1.451 -0.327 0 O-C-N 123.491 0.494 . . . . 71.51 112.258 176.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 7.4 t -137.2 20.06 2.97 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.3 0.571 . . . . 74.04 110.166 178.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -119.37 166.41 13.08 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.465 -0.939 . . . . 74.14 108.465 175.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.72 114.04 25.74 Favored 'General case' 0 CA--C 1.488 -1.438 0 C-N-CA 120.012 -0.675 . . . . 71.23 112.643 176.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -94.77 108.81 3.74 Favored Glycine 0 C--N 1.291 -1.928 0 N-CA-C 110.061 -1.216 . . . . 74.52 110.061 178.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 154.43 8.76 0.08 OUTLIER Glycine 0 C--N 1.295 -1.735 0 C-N-CA 119.341 -1.409 . . . . 62.22 112.703 -178.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 109.3 5.18 30.42 Favored Glycine 0 N--CA 1.431 -1.649 0 C-N-CA 119.234 -1.46 . . . . 71.2 113.585 178.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -84.29 -70.39 0.58 Allowed 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 117.614 0.707 . . . . 63.24 109.212 177.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -101.31 -39.56 7.54 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 108.276 -1.009 . . . . 74.23 108.276 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -139.33 160.88 38.8 Favored 'General case' 0 C--O 1.262 1.715 0 CA-C-O 121.238 0.542 . . . . 72.13 109.617 179.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.21 119.28 29.56 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 106.675 -1.602 . . . . 72.4 106.675 179.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -67.06 101.81 0.92 Allowed 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 122.979 0.512 . . . . 73.55 109.671 -178.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 556' ' ' THR . . . . . 0.428 HG21 HG21 ' A' ' 573' ' ' VAL . 12.4 t -100.78 110.75 22.87 Favored 'General case' 0 N--CA 1.413 -2.308 0 CA-C-O 122.689 1.233 . . . . 72.03 110.779 -176.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 1.7 p -133.39 96.69 3.78 Favored 'General case' 0 N--CA 1.413 -2.297 0 CA-C-N 114.234 -1.348 . . . . 74.11 108.66 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -147.03 -153.33 5.88 Favored Glycine 0 N--CA 1.408 -3.167 0 N-CA-C 110.518 -1.033 . . . . 64.4 110.518 -173.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 559' ' ' GLU . . . . . 0.41 ' HB3' HG21 ' A' ' 536' ' ' ILE . 33.3 mt-10 -133.73 124.64 27.02 Favored 'General case' 0 C--N 1.29 -2.001 0 O-C-N 123.605 0.238 . . . . 73.55 111.289 -172.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . 0.449 ' HG ' ' CD2' ' A' ' 539' ' ' TYR . 93.2 mt -80.99 133.03 35.42 Favored 'General case' 0 C--O 1.247 0.929 0 N-CA-C 109.765 -0.457 . . . . 74.1 109.765 177.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 561' ' ' GLU . . . . . 0.45 ' HG3' HD22 ' A' ' 534' ' ' ASN . 43.9 tt0 -96.78 98.19 9.94 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 115.986 -0.552 . . . . 74.32 111.475 -178.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -96.98 150.88 20.27 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 107.004 -1.48 . . . . 72.12 107.004 172.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -156.53 172.7 18.08 Favored 'General case' 0 C--N 1.28 -2.434 0 O-C-N 121.926 -0.484 . . . . 72.23 111.044 -178.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -52.14 -47.15 65.54 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 124.687 1.195 . . . . 73.25 111.012 -177.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -90.15 4.84 49.25 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 114.061 1.134 . . . . 75.21 114.061 -177.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 24.8 tp10 -121.79 126.63 49.27 Favored 'General case' 0 C--N 1.309 -1.189 0 O-C-N 121.76 -0.587 . . . . 74.41 110.555 -178.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 567' ' ' ILE . . . . . 0.434 ' HA ' ' HD3' ' A' ' 527' ' ' ARG . 4.9 pt -111.39 159.72 11.18 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.868 0 N-CA-C 109.266 -0.642 . . . . 72.33 109.266 174.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 568' ' ' VAL . . . . . 0.406 HG11 ' O ' ' A' ' 567' ' ' ILE . 1.4 p 50.14 176.28 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.57 1.748 0 C-N-CA 125.955 1.702 . . . . 73.03 111.487 -176.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 569' ' ' LYS . . . . . 0.5 ' HE3' ' HA ' ' A' ' 569' ' ' LYS . 0.0 OUTLIER -165.72 167.83 16.71 Favored 'General case' 0 C--N 1.313 -1.017 0 O-C-N 120.911 -1.118 . . . . 73.4 108.28 173.941 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 570' ' ' THR . . . . . 0.604 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 7.1 p -132.28 138.66 47.94 Favored 'General case' 0 N--CA 1.421 -1.881 0 O-C-N 123.719 0.637 . . . . 71.4 109.971 179.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 3.3 mp -90.66 117.07 33.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 106.618 -1.623 . . . . 74.23 106.618 170.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 15.7 p -95.29 110.8 22.75 Favored 'General case' 0 N--CA 1.426 -1.646 0 CA-C-O 121.059 0.457 . . . . 74.03 109.892 177.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 573' ' ' VAL . . . . . 0.428 HG21 HG21 ' A' ' 556' ' ' THR . 48.6 t -108.73 132.29 57.08 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 N-CA-C 109.113 -0.699 . . . . 61.22 109.113 -179.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 574' ' ' LYS . . . . . 0.404 ' HA ' HD12 ' A' ' 520' ' ' ILE . 22.3 tptm -86.91 119.74 27.45 Favored 'General case' 0 N--CA 1.434 -1.262 0 O-C-N 123.569 0.543 . . . . 75.14 110.463 179.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 56.3 t -89.91 132.87 33.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 106.674 -1.602 . . . . 71.11 106.674 175.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 39.5 mm -94.32 153.36 3.45 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 N-CA-C 109.16 -0.682 . . . . 65.13 109.16 -173.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -61.73 106.36 0.67 Allowed 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.582 -0.896 . . . . 72.51 108.582 172.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -62.29 142.18 57.88 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 113.944 -1.48 . . . . 70.31 112.949 -169.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -80.18 -51.91 8.39 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.844 0.83 . . . . 72.21 110.052 -177.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.64 -156.27 0.69 Allowed 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.803 -0.814 . . . . 70.55 108.803 -176.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -113.51 150.28 33.15 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 105.557 -2.016 . . . . 74.15 105.557 172.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 41.1 mp0 -126.68 -174.43 3.13 Favored 'General case' 0 C--N 1.282 -2.365 0 N-CA-C 108.785 -0.82 . . . . 64.23 108.785 176.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -85.64 -158.75 0.41 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 106.633 -1.617 . . . . 75.11 106.633 174.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -85.63 79.81 9.23 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 106.437 -1.69 . . . . 74.1 106.437 173.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.55 168.03 12.92 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 115.411 -0.813 . . . . 74.23 110.131 -172.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 5.0 t -155.29 149.92 26.33 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-O 121.742 0.782 . . . . 74.24 112.873 -173.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -126.55 148.68 49.71 Favored 'General case' 0 N--CA 1.412 -2.33 0 CA-C-N 112.894 -1.957 . . . . 74.21 108.167 174.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 588' ' ' PHE . . . . . 0.505 ' HA ' ' O ' ' A' ' 642' ' ' LEU . 28.3 m-85 -105.61 129.74 53.79 Favored 'General case' 0 C--N 1.292 -1.935 0 N-CA-C 109.177 -0.675 . . . . 74.41 109.177 -175.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.83 121.09 39.34 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 106.034 -1.839 . . . . 75.54 106.034 176.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -125.34 129.89 50.86 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 109.712 -0.477 . . . . 72.24 109.712 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 591' ' ' ILE . . . . . 0.406 HG21 ' HB3' ' A' ' 539' ' ' TYR . 22.8 pt -98.44 138.4 23.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 107.229 -1.397 . . . . 73.51 107.229 174.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -91.06 -144.95 13.29 Favored Glycine 0 N--CA 1.431 -1.642 0 C-N-CA 121.0 -0.619 . . . . 71.32 112.897 -176.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -83.33 119.28 73.73 Favored Pre-proline 0 C--N 1.301 -1.516 0 N-CA-C 109.451 -0.574 . . . . 73.12 109.451 -178.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 594' ' ' PRO . . . . . 0.49 ' HB3' HG21 ' A' ' 537' ' ' VAL . 30.2 Cg_endo -67.15 152.7 79.36 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 121.966 1.777 . . . . 73.54 111.016 176.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -137.21 133.42 35.12 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 110.051 -0.351 . . . . 74.42 110.051 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.01 130.91 36.04 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 106.643 -1.614 . . . . 63.34 106.643 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 16.8 t . . . . . 0 C--N 1.293 -1.884 0 CA-C-O 122.071 0.939 . . . . 74.25 109.954 -177.457 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 15.2 mtp85 . . . . . 0 N--CA 1.431 -1.401 0 N-CA-C 108.412 -0.958 . . . . 71.32 108.412 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . 0.489 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 51.0 Cg_endo -73.08 139.58 29.93 Favored 'Trans proline' 0 N--CA 1.441 -1.578 0 C-N-CA 121.545 1.497 . . . . 75.21 110.697 176.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.4 pp -126.68 -175.96 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 111.904 0.335 . . . . 72.13 111.904 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -77.61 178.29 7.41 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.228 0.537 . . . . 75.32 111.29 -174.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -96.58 -85.18 1.74 Allowed Glycine 0 N--CA 1.421 -2.343 0 C-N-CA 120.554 -0.831 . . . . 51.23 111.606 178.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -127.53 -66.78 0.86 Allowed 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 115.509 -0.346 . . . . 72.31 110.08 -175.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 13.3 p80 -123.14 119.05 29.11 Favored 'General case' 0 C--O 1.246 0.9 0 CA-C-O 121.627 0.727 . . . . 61.03 111.51 -177.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 6.3 p -109.12 90.98 3.46 Favored 'General case' 0 N--CA 1.412 -2.356 0 CA-C-N 115.145 -0.934 . . . . 73.32 108.747 175.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -177.49 132.1 0.16 Allowed 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 106.49 -1.67 . . . . 74.04 106.49 -176.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 642' ' ' LEU . . . . . 0.508 HD23 HG21 ' A' ' 523' ' ' VAL . 41.8 tp -138.24 111.83 8.2 Favored 'General case' 0 C--N 1.29 -2.007 0 O-C-N 123.705 0.628 . . . . 74.24 109.61 177.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . 0.414 ' HB3' HG23 ' A' ' 511' ' ' VAL . 35.7 tt0 -90.74 104.01 16.64 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 107.392 -1.336 . . . . 75.31 107.392 177.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 644' ' ' VAL . . . . . 0.432 HG13 ' HE3' ' A' ' 521' ' ' MET . 39.8 t -95.01 110.07 23.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.804 -0.813 . . . . 71.01 108.804 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 3.9 mp -91.82 117.74 35.76 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 N-CA-C 108.013 -1.106 . . . . 64.11 108.013 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 646' ' ' ILE . . . . . 0.451 HD11 ' N ' ' A' ' 646' ' ' ILE . 1.5 mp -107.13 109.54 28.53 Favored 'Isoleucine or valine' 0 CA--C 1.473 -2.018 0 N-CA-C 106.115 -1.809 . . . . 62.42 106.115 -176.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -111.33 150.35 29.83 Favored 'General case' 0 C--N 1.249 -3.787 0 C-N-CA 120.417 -0.513 . . . . 73.55 111.401 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -63.3 133.9 54.92 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 105.552 -2.018 . . . . 72.52 105.552 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 8.2 t . . . . . 0 C--N 1.318 -0.763 0 CA-C-O 121.827 0.822 . . . . 74.4 112.05 -169.175 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . 0.497 ' HA2' ' OG1' ' A' ' 528' ' ' THR . . . . . . . . 0 N--CA 1.398 -3.838 0 N-CA-C 110.938 -0.865 . . . . 64.22 110.938 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 2.9 mp -123.58 105.81 16.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 108.096 -1.076 . . . . 75.42 108.096 -178.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . 0.415 ' CE1' ' HB ' ' A' ' 528' ' ' THR . 93.1 m-85 -114.9 121.49 43.37 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.178 0.513 . . . . 75.1 110.59 178.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 13.8 t -147.21 163.01 37.71 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.022 -1.103 . . . . 74.03 108.022 -177.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -85.61 148.32 25.97 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 120.844 0.354 . . . . 75.3 110.961 176.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -84.44 -20.5 31.68 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 107.264 -1.384 . . . . 75.04 107.264 176.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 509' ' ' GLU . . . . . 0.409 ' HG3' ' O ' ' A' ' 511' ' ' VAL . 1.9 tp10 -129.01 120.58 20.34 Favored Pre-proline 0 N--CA 1.431 -1.389 0 CA-C-N 114.734 -1.121 . . . . 63.43 108.169 -178.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -80.38 -24.3 5.51 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 120.908 1.072 . . . . 75.54 110.147 173.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . 0.417 HG22 ' HB3' ' A' ' 643' ' ' GLU . 76.4 t -142.93 129.02 17.13 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 C-N-CA 124.561 1.145 . . . . 75.02 108.722 -178.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 14.6 t -128.2 142.94 51.03 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 108.284 -1.006 . . . . 74.14 108.284 177.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 52.6 m80 -108.42 120.85 43.6 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.861 -0.792 . . . . 74.04 108.861 175.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 23.1 m -118.13 150.15 20.36 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.394 0 N-CA-C 107.919 -1.141 . . . . 74.24 107.919 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 2.7 t -83.95 152.71 24.33 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 108.74 -0.837 . . . . 74.34 108.74 -178.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -70.33 -21.08 62.95 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 120.934 0.397 . . . . 73.03 110.928 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 45.2 m -90.35 12.21 19.04 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-O 121.226 0.536 . . . . 74.41 110.709 -175.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 12.7 tt -86.57 153.46 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.877 0 N-CA-C 108.871 -0.788 . . . . 74.41 108.871 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -90.98 -63.92 1.2 Allowed Glycine 0 N--CA 1.432 -1.596 0 C-N-CA 119.959 -1.115 . . . . 71.24 110.568 178.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 37.1 mm -120.25 121.44 65.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 107.905 -1.146 . . . . 72.41 107.905 178.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 521' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.92 136.37 35.32 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 106.907 -1.516 . . . . 73.32 106.907 174.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 522' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 48.9 mt-10 -124.41 138.26 54.38 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 124.093 0.871 . . . . 71.11 109.949 -178.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . 0.594 ' O ' ' HA ' ' A' ' 570' ' ' THR . 39.7 t -129.23 140.87 48.06 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 N-CA-C 109.055 -0.72 . . . . 74.15 109.055 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . 0.553 ' HD2' ' CG2' ' A' ' 568' ' ' VAL . 34.1 mmtp -85.34 134.35 34.1 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 122.243 1.02 . . . . 75.51 113.18 -178.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 4.2 t -110.57 146.94 15.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-N 113.926 -1.488 . . . . 65.2 107.349 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -87.3 135.58 33.26 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 109.567 -0.531 . . . . 75.41 109.567 177.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . 0.516 ' HD3' ' HA ' ' A' ' 567' ' ' ILE . 39.2 ttp180 -83.27 150.38 26.2 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-N 115.6 -0.727 . . . . 75.21 110.468 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 528' ' ' THR . . . . . 0.497 ' OG1' ' HA2' ' A' ' 503' ' ' GLY . 1.8 t -50.12 147.36 4.15 Favored 'General case' 0 N--CA 1.435 -1.198 0 C-N-CA 125.866 1.667 . . . . 73.42 113.2 174.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 19.2 m -65.07 -38.05 89.53 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 114.4 -1.273 . . . . 71.41 110.035 176.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -107.45 103.24 1.92 Allowed Glycine 0 N--CA 1.419 -2.451 0 N-CA-C 108.994 -1.642 . . . . 63.12 108.994 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -122.13 65.76 0.92 Allowed 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.046 0.45 . . . . 71.43 111.281 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -117.1 90.76 3.4 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.101 -1.444 . . . . 74.21 107.101 175.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 142.4 -138.31 8.38 Favored Glycine 0 N--CA 1.419 -2.464 0 N-CA-C 110.153 -1.179 . . . . 74.41 110.153 -175.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 534' ' ' ASN . . . . . 0.428 HD22 ' HG3' ' A' ' 561' ' ' GLU . 2.8 t-20 -146.14 131.34 18.42 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.841 -1.17 . . . . 75.53 107.841 -178.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 59.2 t -131.01 132.7 63.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.156 -0.683 . . . . 75.21 109.156 -177.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 536' ' ' ILE . . . . . . . . . . . . . 44.0 mm -105.35 131.04 55.64 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 109.665 -0.495 . . . . 64.32 109.665 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . 0.421 HG21 ' HB3' ' A' ' 594' ' ' PRO . 20.1 t -118.12 102.36 50.83 Favored Pre-proline 0 C--N 1.311 -1.089 0 O-C-N 123.307 0.38 . . . . 74.11 110.09 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -73.78 138.64 26.56 Favored 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 122.372 2.048 . . . . 72.32 111.604 178.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 539' ' ' TYR . . . . . 0.418 ' CE2' HG21 ' A' ' 571' ' ' ILE . 51.5 p90 -142.72 160.6 40.0 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 110.353 -0.24 . . . . 74.11 110.353 -177.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.67 160.03 41.14 Favored 'General case' 0 C--O 1.247 0.938 0 O-C-N 123.595 0.56 . . . . 72.12 111.432 176.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 31.6 p -96.67 127.03 42.26 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.665 -0.698 . . . . 71.53 111.495 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.8 mp -93.72 111.52 25.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 106.142 -1.799 . . . . 74.41 106.142 172.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -51.88 -53.34 41.85 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 124.348 1.059 . . . . 70.54 111.693 -176.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 68.95 -98.06 0.53 Allowed Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 121.1 -0.571 . . . . 72.33 111.969 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 8.8 t -111.29 -1.91 15.88 Favored 'General case' 0 CA--C 1.553 1.058 0 CA-C-O 121.969 0.89 . . . . 73.31 109.589 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -93.8 171.12 9.07 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 108.067 -1.086 . . . . 73.25 108.067 174.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -126.67 121.55 32.44 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.009 -0.737 . . . . 75.54 109.009 -176.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -79.53 -164.58 28.85 Favored Glycine 0 CA--C 1.518 0.223 0 CA-C-N 116.234 -0.439 . . . . 75.24 112.892 -177.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 77.58 15.95 80.79 Favored Glycine 0 C--N 1.307 -1.058 0 N-CA-C 112.372 -0.291 . . . . 70.42 112.372 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 69.97 32.9 69.77 Favored Glycine 0 N--CA 1.431 -1.671 0 N-CA-C 110.5 -1.04 . . . . 74.12 110.5 -176.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -96.81 -64.58 1.03 Allowed 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 109.025 -0.731 . . . . 73.23 109.025 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -102.6 -36.62 8.28 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 106.807 -1.553 . . . . 74.11 106.807 177.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 553' ' ' PHE . . . . . 0.419 ' HA ' HG12 ' A' ' 576' ' ' ILE . 11.7 p90 -146.59 163.68 35.03 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 114.735 -1.121 . . . . 74.14 108.565 174.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -91.79 105.43 17.71 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 107.022 -1.473 . . . . 71.22 107.022 177.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -71.19 139.38 50.14 Favored 'General case' 0 CA--C 1.486 -1.488 0 N-CA-C 108.343 -0.984 . . . . 75.01 108.343 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 11.0 t -138.16 138.43 38.61 Favored 'General case' 0 N--CA 1.396 -3.149 0 C-N-CA 118.842 -1.143 . . . . 74.33 111.989 -175.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 23.2 p -131.04 119.75 22.45 Favored 'General case' 0 N--CA 1.415 -2.216 0 N-CA-C 106.255 -1.757 . . . . 61.04 106.255 173.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -147.83 -170.67 16.1 Favored Glycine 0 N--CA 1.41 -3.057 0 C-N-CA 120.136 -1.031 . . . . 70.45 111.236 -172.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -139.09 106.6 5.57 Favored 'General case' 0 C--N 1.293 -1.885 0 C-N-CA 122.75 0.42 . . . . 73.43 109.869 -175.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 91.3 mt -73.71 136.79 43.75 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-N 116.043 -0.526 . . . . 72.43 110.198 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 561' ' ' GLU . . . . . 0.428 ' HG3' HD22 ' A' ' 534' ' ' ASN . 44.6 tt0 -105.62 114.71 29.04 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 116.102 -0.499 . . . . 71.31 111.235 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -111.17 148.74 32.1 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.656 -0.868 . . . . 75.43 108.656 174.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . 0.407 ' H ' ' HB3' ' A' ' 566' ' ' GLU . 4.2 pt20 -159.51 -178.16 6.92 Favored 'General case' 0 C--N 1.285 -2.225 0 N-CA-C 108.713 -0.847 . . . . 75.11 108.713 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -69.08 -29.98 68.2 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 121.712 0.768 . . . . 51.14 110.728 -178.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -82.74 -0.98 50.13 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.749 0.785 . . . . 73.54 110.798 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 566' ' ' GLU . . . . . 0.407 ' HB3' ' H ' ' A' ' 563' ' ' GLN . 8.2 tp10 -120.74 142.66 49.33 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.704 -0.623 . . . . 74.12 110.542 -175.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 567' ' ' ILE . . . . . 0.516 ' HA ' ' HD3' ' A' ' 527' ' ' ARG . 2.4 pt -133.58 150.78 32.31 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.273 0 N-CA-C 106.035 -1.839 . . . . 75.03 106.035 170.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 568' ' ' VAL . . . . . 0.553 ' CG2' ' HD2' ' A' ' 524' ' ' LYS . 1.2 p 49.77 -177.71 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.59 2.497 0 C-N-CA 124.7 1.2 . . . . 75.33 111.78 -175.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 569' ' ' LYS . . . . . 0.526 ' HE3' ' HA ' ' A' ' 569' ' ' LYS . 0.2 OUTLIER -173.94 164.55 4.21 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 107.979 -1.119 . . . . 75.23 107.979 176.032 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 570' ' ' THR . . . . . 0.594 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 36.3 p -127.1 142.85 51.42 Favored 'General case' 0 N--CA 1.436 -1.174 0 O-C-N 123.477 0.486 . . . . 70.34 110.907 177.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 571' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 2.5 mp -91.78 122.48 43.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 N-CA-C 105.849 -1.908 . . . . 73.44 105.849 170.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 9.7 m -97.25 109.86 22.53 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 109.966 -0.383 . . . . 53.23 109.966 -179.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 573' ' ' VAL . . . . . . . . . . . . . 62.2 t -120.94 130.85 74.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 109.305 -0.628 . . . . 74.3 109.305 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -91.36 132.25 36.31 Favored 'General case' 0 C--N 1.312 -1.052 0 O-C-N 123.509 0.506 . . . . 71.43 111.064 179.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 64.0 t -97.66 137.99 23.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 108.063 -1.088 . . . . 72.31 108.063 177.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 576' ' ' ILE . . . . . 0.419 HG12 ' HA ' ' A' ' 553' ' ' PHE . 30.4 mm -103.11 160.49 4.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 107.369 -1.345 . . . . 72.34 107.369 -177.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -69.99 133.69 47.52 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 109.502 -0.555 . . . . 74.33 109.502 177.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.33 137.84 57.2 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.352 0.596 . . . . 71.03 111.033 -174.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.78 -35.89 3.8 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 115.925 1.824 . . . . 75.0 115.925 -171.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 580' ' ' GLU . . . . . 0.495 ' HG2' ' CD2' ' A' ' 581' ' ' TYR . 0.0 OUTLIER -93.63 -60.38 1.78 Allowed 'General case' 0 C--N 1.313 -1.01 0 O-C-N 121.482 -0.761 . . . . 75.21 112.75 -170.52 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 581' ' ' TYR . . . . . 0.495 ' CD2' ' HG2' ' A' ' 580' ' ' GLU . 31.4 p90 -164.38 153.97 13.9 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 106.561 -1.644 . . . . 72.13 106.561 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -89.87 143.81 26.48 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 119.618 -0.833 . . . . 73.34 112.218 -177.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -169.74 168.8 8.81 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 107.472 -1.307 . . . . 74.51 107.472 175.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -88.39 78.47 7.93 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 107.988 -1.115 . . . . 74.42 107.988 174.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.02 166.66 22.09 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 108.243 -1.021 . . . . 72.34 108.243 -177.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 6.9 t -154.06 144.36 22.16 Favored 'General case' 0 N--CA 1.415 -2.213 0 C-N-CA 120.258 -0.577 . . . . 73.43 111.178 -173.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 587' ' ' PHE . . . . . 0.452 ' CE2' HD12 ' A' ' 646' ' ' ILE . 3.6 p90 -126.02 148.54 49.28 Favored 'General case' 0 N--CA 1.418 -2.072 0 CA-C-N 113.799 -1.546 . . . . 73.2 109.407 176.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 588' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -104.77 130.99 52.77 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 108.791 -0.818 . . . . 70.33 108.791 -174.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . 0.452 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.4 OUTLIER -99.83 124.98 45.69 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 106.308 -1.738 . . . . 75.43 106.308 176.922 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -124.44 132.12 53.5 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-O 121.013 0.435 . . . . 75.42 110.11 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 591' ' ' ILE . . . . . . . . . . . . . 24.8 pt -101.33 143.86 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.085 0 N-CA-C 107.224 -1.398 . . . . 75.12 107.224 174.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -89.41 -148.84 19.69 Favored Glycine 0 C--N 1.292 -1.905 0 N-CA-C 110.47 -1.052 . . . . 55.51 110.47 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.424 ' CD ' HH21 ' A' ' 633' ' ' ARG . 23.4 tt0 -82.09 128.49 67.83 Favored Pre-proline 0 C--N 1.29 -2.013 0 N-CA-C 108.997 -0.742 . . . . 64.11 108.997 177.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 594' ' ' PRO . . . . . 0.421 ' HB3' HG21 ' A' ' 537' ' ' VAL . 55.0 Cg_endo -71.55 146.36 49.33 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 121.965 1.777 . . . . 74.14 109.944 173.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 16.0 ptt-85 -126.93 138.19 53.25 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.593 -0.692 . . . . 74.11 110.003 -175.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -81.8 129.15 34.64 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 106.938 -1.505 . . . . 73.34 106.938 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 89.6 t . . . . . 0 C--N 1.307 -1.277 0 CA-C-O 121.245 0.545 . . . . 62.23 110.073 179.256 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 633' ' ' ARG . . . . . 0.424 HH21 ' CD ' ' A' ' 593' ' ' GLU . 20.7 mtp180 . . . . . 0 N--CA 1.447 -0.582 0 N-CA-C 109.81 -0.441 . . . . 74.55 109.81 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -68.42 147.47 71.37 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.268 1.979 . . . . 74.32 110.475 177.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.3 pp -135.1 -175.06 1.26 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.753 0 N-CA-C 114.623 1.342 . . . . 71.42 114.623 -173.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -78.01 154.87 31.08 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.195 -0.911 . . . . 71.34 110.641 -177.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -96.48 -107.74 2.41 Favored Glycine 0 C--N 1.297 -1.621 0 C-N-CA 120.664 -0.779 . . . . 73.02 112.685 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -89.53 -65.4 1.02 Allowed 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 121.494 0.664 . . . . 73.11 110.953 -176.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -133.81 116.51 15.78 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 115.381 -0.827 . . . . 71.32 111.645 -174.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 22.1 p -104.42 90.89 3.68 Favored 'General case' 0 N--CA 1.396 -3.161 0 N-CA-C 107.887 -1.153 . . . . 73.22 107.887 175.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 21.5 tptm -175.71 135.36 0.3 Allowed 'General case' 0 N--CA 1.425 -1.701 0 CA-C-N 113.758 -1.564 . . . . 73.44 107.204 -175.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 642' ' ' LEU . . . . . 0.511 HD23 HG21 ' A' ' 523' ' ' VAL . 41.5 tp -138.22 110.1 7.19 Favored 'General case' 0 C--N 1.276 -2.606 0 N-CA-C 107.611 -1.255 . . . . 63.42 107.611 173.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . 0.417 ' HB3' HG22 ' A' ' 511' ' ' VAL . 21.4 tt0 -93.59 106.98 18.9 Favored 'General case' 0 C--N 1.275 -2.644 0 N-CA-C 107.475 -1.306 . . . . 72.25 107.475 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 25.6 t -96.81 105.6 17.33 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 109.346 -0.613 . . . . 72.31 109.346 -176.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 3.5 mp -91.54 120.42 40.56 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 107.521 -1.289 . . . . 75.1 107.521 176.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 646' ' ' ILE . . . . . 0.492 HD11 ' N ' ' A' ' 646' ' ' ILE . 2.7 mp -97.74 109.28 23.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 105.928 -1.879 . . . . 73.23 105.928 -177.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -93.3 148.49 22.0 Favored 'General case' 0 N--CA 1.399 -3.007 0 CA-C-N 115.518 -0.764 . . . . 75.21 110.889 -174.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -73.0 69.46 0.98 Allowed 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 124.416 1.086 . . . . 74.02 110.993 -178.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 14.4 m . . . . . 0 C--O 1.243 0.755 0 C-N-CA 128.422 2.689 . . . . 74.53 115.525 177.55 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . 0.682 ' HA3' ' OG1' ' A' ' 528' ' ' THR . . . . . . . . 0 N--CA 1.412 -2.921 0 N-CA-C 116.751 1.46 . . . . 72.04 116.751 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . 0.477 HG23 ' CA ' ' A' ' 637' ' ' GLY . 3.5 mp -111.35 136.25 48.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 125.521 1.529 . . . . 75.22 111.471 -168.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -132.6 123.58 26.7 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.898 -0.779 . . . . 72.52 108.898 170.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 506' ' ' THR . . . . . 0.417 ' HB ' ' HA3' ' A' ' 637' ' ' GLY . 14.7 t -150.52 163.15 39.15 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.233 -0.654 . . . . 74.54 109.233 -176.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -84.35 159.74 20.81 Favored 'General case' 0 CA--C 1.495 -1.145 0 N-CA-C 108.486 -0.931 . . . . 75.33 108.486 173.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -81.34 -44.29 17.83 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.385 -0.968 . . . . 72.15 108.385 176.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -124.93 137.06 28.9 Favored Pre-proline 0 C--N 1.313 -0.993 0 N-CA-C 109.076 -0.713 . . . . 75.2 109.076 177.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 510' ' ' PRO . . . . . 0.525 ' HA ' ' O ' ' A' ' 641' ' ' LYS . 94.6 Cg_endo -90.66 -6.72 4.19 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.0 1.8 . . . . 75.2 112.734 178.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 74.3 t -143.04 132.99 21.9 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.318 0 N-CA-C 107.02 -1.474 . . . . 74.33 107.02 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 4.1 t -141.42 143.63 34.02 Favored 'General case' 0 N--CA 1.411 -2.4 0 N-CA-C 106.697 -1.594 . . . . 75.15 106.697 178.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 28.7 m-70 -114.52 127.85 56.02 Favored 'General case' 0 CA--C 1.484 -1.595 0 N-CA-C 107.471 -1.307 . . . . 72.43 107.471 177.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.618 HG11 ' SD ' ' A' ' 521' ' ' MET . 33.7 m -113.19 164.43 9.12 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.355 0 C-N-CA 120.271 -0.572 . . . . 74.32 110.853 -173.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 35.4 t -87.5 145.01 26.43 Favored 'General case' 0 N--CA 1.406 -2.657 0 N-CA-C 107.255 -1.387 . . . . 73.42 107.255 176.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -79.38 -9.98 59.71 Favored 'General case' 0 C--N 1.279 -2.495 0 CA-C-O 121.604 0.716 . . . . 72.51 109.801 177.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 39.3 m -97.62 17.06 18.65 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.508 0.67 . . . . 75.31 109.874 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 10.8 tt -96.38 158.25 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.366 0 N-CA-C 108.724 -0.843 . . . . 75.32 108.724 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -102.89 -59.35 0.74 Allowed Glycine 0 N--CA 1.43 -1.738 0 N-CA-C 111.018 -0.833 . . . . 75.15 111.018 178.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 36.1 mm -123.36 126.85 73.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 109.224 -0.658 . . . . 72.5 109.224 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 521' ' ' MET . . . . . 0.618 ' SD ' HG11 ' A' ' 514' ' ' VAL . 25.3 ptt? -104.03 139.34 39.28 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.132 -1.062 . . . . 75.01 108.132 173.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -120.25 120.13 35.22 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 123.882 0.739 . . . . 74.31 110.72 177.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . 0.6 ' O ' ' HA ' ' A' ' 570' ' ' THR . 40.4 t -106.33 130.78 57.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 CA-C-N 115.56 -0.746 . . . . 74.34 109.831 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -77.93 131.84 37.63 Favored 'General case' 0 C--O 1.246 0.894 0 CA-C-O 121.784 0.802 . . . . 72.34 113.114 -177.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 11.4 t -114.7 135.22 55.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 107.42 -1.326 . . . . 65.42 107.42 177.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -82.55 151.22 26.52 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.416 0.626 . . . . 75.52 111.408 -175.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . 0.42 ' HD2' ' HA ' ' A' ' 567' ' ' ILE . 43.7 ttt-85 -98.47 143.55 28.78 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 114.658 -1.155 . . . . 63.55 110.447 -174.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 528' ' ' THR . . . . . 0.682 ' OG1' ' HA3' ' A' ' 503' ' ' GLY . 4.6 t -58.9 151.29 22.05 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.539 -0.755 . . . . 75.24 112.441 177.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 35.6 t -77.89 -17.94 56.75 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 115.224 -0.898 . . . . 72.22 108.736 176.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -109.87 52.52 0.63 Allowed Glycine 0 N--CA 1.442 -0.912 0 N-CA-C 111.232 -0.747 . . . . 63.15 111.232 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -82.36 92.61 7.02 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-O 121.543 0.687 . . . . 75.25 109.665 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 2.6 ppt_? -133.5 20.36 3.95 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 114.771 -1.104 . . . . 72.41 112.038 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . -177.16 -179.38 47.47 Favored Glycine 0 N--CA 1.427 -1.959 0 N-CA-C 109.524 -1.431 . . . . 63.03 109.524 -177.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 534' ' ' ASN . . . . . 0.413 HD22 ' HG3' ' A' ' 561' ' ' GLU . 2.5 t-20 -90.41 125.02 35.42 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.047 0.451 . . . . 74.15 110.082 -179.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 60.1 t -123.95 128.39 74.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 107.533 -1.284 . . . . 75.54 107.533 176.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 536' ' ' ILE . . . . . 0.535 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 46.5 mm -99.57 135.82 33.36 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.238 0 N-CA-C 109.425 -0.583 . . . . 74.43 109.425 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 42.5 t -120.15 109.38 37.24 Favored Pre-proline 0 C--N 1.307 -1.268 0 CA-C-N 116.06 -0.518 . . . . 73.11 109.608 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -74.07 143.69 32.8 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.16 1.906 . . . . 73.54 111.64 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 539' ' ' TYR . . . . . 0.408 ' CD1' ' HG ' ' A' ' 560' ' ' LEU . 45.1 p90 -144.35 160.66 40.66 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.598 -0.519 . . . . 74.11 109.598 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -160.48 160.58 32.22 Favored 'General case' 0 C--O 1.243 0.721 0 O-C-N 123.788 0.68 . . . . 73.31 110.543 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 2.6 p -100.22 108.14 20.16 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 123.676 0.61 . . . . 71.43 111.53 176.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.5 mp -81.7 128.24 38.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 107.378 -1.341 . . . . 74.21 107.378 178.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -63.61 -62.94 1.33 Allowed 'General case' 0 C--O 1.237 0.413 0 O-C-N 123.585 0.553 . . . . 72.51 111.212 -178.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 72.71 -72.48 1.04 Allowed Glycine 0 C--O 1.227 -0.292 0 CA-C-N 116.256 -0.429 . . . . 75.4 112.205 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 545' ' ' THR . . . . . 0.437 HG22 ' H ' ' A' ' 586' ' ' THR . 6.0 t -138.59 -2.11 1.8 Allowed 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.056 0.455 . . . . 71.1 110.233 178.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -96.1 171.03 8.86 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 108.969 -0.752 . . . . 70.21 108.969 174.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . 0.445 ' HG3' ' HG3' ' A' ' 551' ' ' GLU . 2.3 tpt180 -115.65 112.46 22.14 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.902 -0.777 . . . . 73.32 108.902 -178.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -95.95 166.92 25.05 Favored Glycine 0 CA--C 1.499 -0.962 0 C-N-CA 121.408 -0.425 . . . . 52.35 113.409 -176.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 100.52 23.44 10.21 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 111.526 -0.63 . . . . 62.23 111.526 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 91.07 6.45 66.82 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.833 -0.698 . . . . 62.23 111.396 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . 0.445 ' HG3' ' HG3' ' A' ' 547' ' ' ARG . 12.3 mm-40 -76.18 -71.23 0.4 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.553 -0.536 . . . . 75.31 109.553 -178.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -111.4 -27.65 8.54 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.197 -1.409 . . . . 62.33 107.197 178.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -141.68 156.68 45.63 Favored 'General case' 0 C--O 1.256 1.415 0 CA-C-N 115.031 -0.986 . . . . 75.02 109.063 174.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.45 126.77 36.01 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 106.261 -1.755 . . . . 74.21 106.261 178.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -79.02 112.04 15.83 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.77 0.319 . . . . 74.23 111.784 -173.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 556' ' ' THR . . . . . 0.411 HG22 HG23 ' A' ' 573' ' ' VAL . 11.1 t -109.51 122.88 48.41 Favored 'General case' 0 N--CA 1.418 -2.026 0 CA-C-O 122.269 1.033 . . . . 75.44 110.052 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 1.7 p -142.07 133.04 25.93 Favored 'General case' 0 C--N 1.277 -2.572 0 CA-C-N 114.475 -1.239 . . . . 73.51 107.894 178.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 179.9 -148.98 8.28 Favored Glycine 0 N--CA 1.422 -2.289 0 N-CA-C 110.34 -1.104 . . . . 74.42 110.34 -176.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 559' ' ' GLU . . . . . 0.535 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 47.5 mt-10 -143.54 133.62 24.28 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 122.964 0.506 . . . . 73.52 110.706 -176.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . 0.408 ' HG ' ' CD1' ' A' ' 539' ' ' TYR . 87.4 mt -94.21 146.17 24.19 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 123.319 0.648 . . . . 74.3 110.117 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 561' ' ' GLU . . . . . 0.413 ' HG3' HD22 ' A' ' 534' ' ' ASN . 44.0 tt0 -105.67 112.85 26.09 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-O 121.075 0.464 . . . . 70.51 111.752 -178.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -109.66 144.07 38.53 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.59 -0.892 . . . . 74.42 108.59 171.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -145.99 -171.42 3.7 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.459 -0.941 . . . . 74.23 108.459 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 31.9 t30 -78.87 -39.15 35.98 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 107.24 -1.393 . . . . 75.22 107.24 172.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -88.45 -2.48 58.62 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.731 -1.122 . . . . 65.14 110.978 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -116.83 123.87 48.14 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.964 -0.754 . . . . 74.54 108.964 -178.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 567' ' ' ILE . . . . . 0.42 ' HA ' ' HD2' ' A' ' 527' ' ' ARG . 1.5 pp -119.13 139.91 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.73 0 N-CA-C 108.6 -0.889 . . . . 73.41 108.6 -178.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 568' ' ' VAL . . . . . 0.411 HG11 ' O ' ' A' ' 567' ' ' ILE . 1.2 p 56.11 160.18 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 C-N-CA 126.625 1.97 . . . . 71.22 113.462 179.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 569' ' ' LYS . . . . . 0.463 ' HE3' ' HA ' ' A' ' 569' ' ' LYS . 0.0 OUTLIER -148.03 162.89 38.44 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.511 -0.743 . . . . 72.15 109.089 175.444 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 570' ' ' THR . . . . . 0.6 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 11.7 p -135.1 134.3 40.13 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 123.921 0.763 . . . . 71.2 110.942 178.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 3.1 mp -85.51 118.37 32.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 106.62 -1.622 . . . . 62.32 106.62 172.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 19.1 m -98.73 120.62 39.47 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 108.709 -0.848 . . . . 73.42 108.709 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 573' ' ' VAL . . . . . 0.411 HG23 HG22 ' A' ' 556' ' ' THR . 33.2 t -123.67 134.52 66.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 N-CA-C 109.15 -0.685 . . . . 70.11 109.15 -178.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 57.9 tptt -88.25 116.26 26.32 Favored 'General case' 0 N--CA 1.435 -1.193 0 O-C-N 123.815 0.697 . . . . 74.22 109.221 177.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 59.1 t -87.03 133.8 29.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 107.72 -1.215 . . . . 72.45 107.72 178.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 42.8 mm -96.66 158.22 3.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 107.984 -1.117 . . . . 73.12 107.984 -177.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -67.78 119.48 12.55 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.645 -0.872 . . . . 73.32 108.645 176.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -67.32 122.65 18.35 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 114.822 -1.081 . . . . 72.05 111.628 -173.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.57 -23.75 24.23 Favored 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 125.502 1.521 . . . . 71.43 113.557 -172.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -117.67 176.84 5.0 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 118.648 -1.221 . . . . 73.35 111.283 -177.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -60.59 154.37 21.29 Favored 'General case' 0 C--O 1.253 1.283 0 N-CA-C 108.256 -1.016 . . . . 61.51 108.256 174.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 21.0 tp10 -84.25 101.55 11.99 Favored 'General case' 0 N--CA 1.414 -2.229 0 C-N-CA 118.049 -1.46 . . . . 63.55 114.091 -175.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -97.22 134.07 41.02 Favored 'General case' 0 N--CA 1.406 -2.665 0 N-CA-C 101.961 -3.348 . . . . 70.41 101.961 160.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -76.11 77.89 2.94 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-O 121.733 0.778 . . . . 73.22 112.391 -174.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.67 167.22 18.45 Favored 'General case' 0 N--CA 1.412 -2.357 0 N-CA-C 106.519 -1.66 . . . . 64.53 106.519 176.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 586' ' ' THR . . . . . 0.437 ' H ' HG22 ' A' ' 545' ' ' THR . 3.5 t -155.93 144.92 20.53 Favored 'General case' 0 N--CA 1.404 -2.741 0 C-N-CA 120.402 -0.519 . . . . 74.01 110.736 -176.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 587' ' ' PHE . . . . . 0.438 ' CE2' HD13 ' A' ' 646' ' ' ILE . 2.5 p90 -112.34 149.54 32.3 Favored 'General case' 0 N--CA 1.418 -2.028 0 CA-C-N 114.198 -1.364 . . . . 75.15 108.865 177.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 588' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -106.47 131.31 53.8 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 116.052 -0.522 . . . . 75.23 109.735 -173.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . 0.476 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.4 OUTLIER -102.77 118.44 36.83 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 105.016 -2.216 . . . . 73.1 105.016 173.231 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -129.82 144.51 51.34 Favored 'General case' 0 C--N 1.273 -2.728 0 N-CA-C 108.306 -0.998 . . . . 75.14 108.306 -178.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 591' ' ' ILE . . . . . . . . . . . . . 27.0 pt -106.27 152.76 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.853 0 N-CA-C 108.748 -0.834 . . . . 74.34 108.748 178.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -99.14 -163.74 29.75 Favored Glycine 0 N--CA 1.419 -2.46 0 N-CA-C 111.362 -0.695 . . . . 74.45 111.362 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -66.75 121.18 76.4 Favored Pre-proline 0 C--N 1.298 -1.645 0 C-N-CA 123.211 0.604 . . . . 75.43 110.612 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 594' ' ' PRO . . . . . 0.415 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 18.9 Cg_endo -67.25 140.84 54.73 Favored 'Trans proline' 0 N--CA 1.437 -1.819 0 C-N-CA 121.856 1.704 . . . . 62.5 110.461 176.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -121.88 122.29 39.08 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 115.696 -0.683 . . . . 74.11 110.101 -173.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -75.51 123.9 26.25 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 107.858 -1.164 . . . . 73.35 107.858 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 21.8 t . . . . . 0 C--N 1.298 -1.645 0 CA-C-O 122.418 1.104 . . . . 71.55 109.348 179.703 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 67.9 mtt-85 . . . . . 0 CA--C 1.508 -0.641 0 N-CA-C 109.347 -0.612 . . . . 74.13 109.347 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . 0.415 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 39.7 Cg_endo -74.83 142.68 28.75 Favored 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 121.635 1.556 . . . . 72.13 110.548 177.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -131.97 -170.77 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 CA-C-O 121.126 0.489 . . . . 75.22 109.899 -177.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.78 160.53 21.2 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 115.791 -0.641 . . . . 74.34 111.196 -178.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . 0.477 ' CA ' HG23 ' A' ' 504' ' ' ILE . . . -85.81 -98.53 0.74 Allowed Glycine 0 CA--C 1.483 -1.928 0 CA-C-N 115.337 -0.847 . . . . 75.14 111.771 177.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -114.52 -49.29 2.83 Favored 'General case' 0 C--N 1.281 -2.392 0 C-N-CA 119.752 -0.779 . . . . 73.54 110.151 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -131.4 119.15 21.24 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.958 0.885 . . . . 64.03 113.099 -176.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 23.8 p -115.27 91.15 3.52 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 107.385 -1.339 . . . . 75.0 107.385 173.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 641' ' ' LYS . . . . . 0.525 ' O ' ' HA ' ' A' ' 510' ' ' PRO . 22.6 tptm -175.27 137.04 0.38 Allowed 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 106.434 -1.691 . . . . 72.43 106.434 -174.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 642' ' ' LEU . . . . . 0.476 ' HB3' ' HB3' ' A' ' 589' ' ' LEU . 38.7 tp -140.69 105.07 4.85 Favored 'General case' 0 C--N 1.277 -2.55 0 N-CA-C 107.961 -1.125 . . . . 75.02 107.961 172.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -94.35 105.05 17.03 Favored 'General case' 0 C--N 1.276 -2.625 0 N-CA-C 106.646 -1.613 . . . . 70.13 106.646 178.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 644' ' ' VAL . . . . . 0.451 HG23 ' HE3' ' A' ' 521' ' ' MET . 32.5 t -94.28 106.15 17.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-N 115.765 -0.652 . . . . 72.01 109.571 -177.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 3.7 mp -89.36 126.32 42.33 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 N-CA-C 108.026 -1.101 . . . . 74.41 108.026 179.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 646' ' ' ILE . . . . . 0.438 HD13 ' CE2' ' A' ' 587' ' ' PHE . 1.7 mp -104.54 140.29 23.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 107.866 -1.161 . . . . 74.43 107.866 -177.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -158.4 140.05 13.63 Favored 'General case' 0 N--CA 1.429 -1.508 0 O-C-N 123.722 0.638 . . . . 74.41 110.822 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -41.62 136.5 1.86 Allowed 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.138 1.375 . . . . 74.42 110.561 176.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 34.9 t . . . . . 0 C--O 1.243 0.72 0 C-N-CA 126.518 1.927 . . . . 63.01 114.238 -171.623 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.543 0 CA-C-O 121.44 0.467 . . . . 72.34 113.758 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 1.7 mp -107.24 130.31 59.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 N-CA-C 107.956 -1.127 . . . . 62.41 107.956 177.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . 0.415 ' HA ' ' O ' ' A' ' 526' ' ' LEU . 97.9 m-85 -116.21 121.39 41.91 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.115 0.483 . . . . 74.15 111.071 -178.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 11.8 t -139.39 156.19 47.15 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.037 -1.098 . . . . 70.2 108.037 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -82.65 154.41 24.92 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.526 -0.916 . . . . 73.41 108.526 174.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -77.29 -27.71 53.12 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 109.301 -0.629 . . . . 65.04 109.301 176.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -140.51 135.99 16.29 Favored Pre-proline 0 C--N 1.315 -0.897 0 N-CA-C 108.878 -0.786 . . . . 73.43 108.878 177.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -85.13 -13.84 6.26 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 121.765 1.643 . . . . 72.21 111.654 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 71.7 t -139.0 133.85 41.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 107.693 -1.225 . . . . 63.14 107.693 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 5.4 t -134.05 136.21 43.86 Favored 'General case' 0 N--CA 1.402 -2.834 0 N-CA-C 108.077 -1.083 . . . . 72.03 108.077 178.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 32.6 m-70 -108.37 114.75 28.85 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.541 -0.911 . . . . 73.43 108.541 177.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 16.7 m -118.93 162.49 17.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 CA-C-N 115.935 -0.575 . . . . 60.42 110.093 -174.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 515' ' ' SER . . . . . 0.414 ' O ' HG21 ' A' ' 518' ' ' ILE . 62.2 m -81.2 148.92 29.3 Favored 'General case' 0 N--CA 1.392 -3.37 0 N-CA-C 108.096 -1.075 . . . . 72.41 108.096 178.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -85.55 -22.35 28.15 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 118.719 -1.192 . . . . 73.34 110.632 176.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 16.0 m -90.12 30.39 1.1 Allowed 'General case' 0 C--N 1.293 -1.874 0 CA-C-O 121.605 0.717 . . . . 74.25 110.023 -176.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 518' ' ' ILE . . . . . 0.414 HG21 ' O ' ' A' ' 515' ' ' SER . 13.7 tt -112.81 150.87 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.015 0 N-CA-C 107.342 -1.355 . . . . 75.02 107.342 -178.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . 0.535 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . -81.83 -61.93 1.99 Allowed Glycine 0 N--CA 1.426 -1.975 0 C-N-CA 120.098 -1.049 . . . . 72.1 111.06 178.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 35.8 mm -120.82 133.45 67.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 CA-C-N 115.482 -0.359 . . . . 74.22 110.199 -177.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 521' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.28 141.23 48.42 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.147 -1.427 . . . . 75.1 107.147 171.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 522' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 44.9 mt-10 -126.38 145.28 50.52 Favored 'General case' 0 C--N 1.316 -0.89 0 O-C-N 123.584 0.552 . . . . 72.41 111.445 -178.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . 0.618 ' O ' ' HA ' ' A' ' 570' ' ' THR . 30.2 t -132.58 138.99 50.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 108.512 -0.921 . . . . 65.34 108.512 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -84.0 133.17 34.69 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 113.043 0.757 . . . . 74.21 113.043 -177.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . 0.598 ' O ' ' HA ' ' A' ' 568' ' ' VAL . 10.7 t -113.46 125.49 70.74 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 N-CA-C 106.725 -1.583 . . . . 75.13 106.725 177.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' A' ' 505' ' ' PHE . 2.1 mm? -91.3 140.81 29.43 Favored 'General case' 0 C--N 1.28 -2.427 0 CA-C-O 120.794 0.331 . . . . 74.32 110.397 -176.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . 0.426 ' HG3' HH11 ' A' ' 527' ' ' ARG . 27.9 ttt85 -114.24 93.78 4.51 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 105.06 -2.2 . . . . 64.32 105.06 173.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 1.4 p -121.55 -168.68 1.73 Allowed 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 114.712 -1.131 . . . . 70.23 111.967 -173.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 39.6 m 35.01 32.62 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 126.419 1.888 . . . . 74.35 114.134 -172.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 129.43 151.95 7.47 Favored Glycine 0 N--CA 1.418 -2.53 0 N-CA-C 111.67 -0.572 . . . . 71.2 111.67 178.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -127.75 -125.44 0.23 Allowed 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 107.798 -1.186 . . . . 64.35 107.798 176.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 69.37 127.29 0.03 OUTLIER 'General case' 0 C--O 1.244 0.77 0 C-N-CA 124.516 1.126 . . . . 74.44 113.593 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 533' ' ' GLY . . . . . 0.401 ' H ' ' HB3' ' A' ' 564' ' ' ASN . . . 86.81 162.36 37.32 Favored Glycine 0 N--CA 1.437 -1.278 0 CA-C-N 115.125 -0.943 . . . . 75.53 113.316 175.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -90.81 122.96 33.98 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.271 -1.381 . . . . 75.5 107.271 176.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 62.4 t -125.31 125.67 69.45 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 N-CA-C 109.58 -0.526 . . . . 71.22 109.58 -178.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 536' ' ' ILE . . . . . 0.437 ' O ' ' HG2' ' A' ' 595' ' ' ARG . 40.1 mm -100.25 125.37 54.02 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 N-CA-C 108.396 -0.964 . . . . 72.32 108.396 177.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . 0.429 HG21 ' HB3' ' A' ' 594' ' ' PRO . 38.6 t -113.54 107.54 53.03 Favored Pre-proline 0 C--N 1.296 -1.757 0 CA-C-N 116.368 -0.378 . . . . 73.51 110.391 -177.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -74.59 147.19 35.48 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.408 2.072 . . . . 74.02 111.308 178.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -147.85 156.9 43.21 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 108.255 -1.017 . . . . 75.23 108.255 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.96 150.9 28.8 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 123.399 0.437 . . . . 72.23 111.42 178.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 1.1 p -87.54 118.17 26.84 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 123.684 0.794 . . . . 74.52 112.075 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.7 mp -84.83 123.66 39.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 107.545 -1.28 . . . . 75.0 107.545 176.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -54.3 -54.02 45.87 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 124.225 1.01 . . . . 75.35 113.059 -175.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 72.18 -90.37 0.51 Allowed Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.898 -0.668 . . . . 71.22 112.203 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 8.9 t -124.84 -0.78 7.93 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 121.935 0.874 . . . . 73.35 109.299 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -94.9 175.79 6.51 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.586 -0.734 . . . . 71.43 109.926 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . 0.511 ' N ' ' HD2' ' A' ' 547' ' ' ARG . 4.5 mpt_? -101.58 173.05 6.6 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.716 -0.22 . . . . 74.41 111.296 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -62.54 -175.42 2.52 Favored Glycine 0 C--O 1.252 1.23 0 N-CA-C 116.116 1.206 . . . . 72.24 116.116 -174.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . -58.9 119.93 20.16 Favored Glycine 0 N--CA 1.439 -1.113 0 CA-C-N 114.087 -1.056 . . . . 61.23 114.362 -175.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 83.89 4.98 88.33 Favored Glycine 0 N--CA 1.438 -1.189 0 CA-C-N 115.287 -0.456 . . . . 72.24 112.028 176.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -103.04 -67.22 0.89 Allowed 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 108.408 -0.96 . . . . 71.51 108.408 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -104.54 -38.33 6.81 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.764 0.793 . . . . 75.4 109.125 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -138.17 160.77 38.56 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 108.276 -1.009 . . . . 75.12 108.276 176.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -86.42 110.34 19.66 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 105.411 -2.07 . . . . 74.42 105.411 176.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -67.61 100.83 0.93 Allowed 'General case' 0 CA--C 1.485 -1.54 0 CA-C-N 115.551 -0.749 . . . . 74.45 110.587 -174.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 556' ' ' THR . . . . . 0.446 HG22 HG21 ' A' ' 573' ' ' VAL . 9.6 t -97.98 95.88 7.78 Favored 'General case' 0 N--CA 1.393 -3.298 0 CA-C-O 123.31 1.529 . . . . 74.11 110.019 -177.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 1.9 p -115.44 97.76 6.35 Favored 'General case' 0 N--CA 1.399 -2.976 0 CA-C-N 113.015 -1.902 . . . . 75.11 106.93 176.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -152.79 -156.21 7.45 Favored Glycine 0 N--CA 1.402 -3.586 0 N-CA-C 110.612 -0.995 . . . . 63.14 110.612 -172.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 559' ' ' GLU . . . . . 0.428 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 41.5 mt-10 -137.11 135.82 37.77 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-O 120.717 0.294 . . . . 74.35 110.885 -171.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . 0.402 ' HB3' ' HG2' ' A' ' 569' ' ' LYS . 80.2 mt -93.92 138.11 32.41 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 109.284 -0.636 . . . . 71.4 109.284 175.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -103.39 106.32 16.8 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.77 -0.65 . . . . 74.23 111.385 -175.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 562' ' ' PHE . . . . . 0.558 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 88.7 m-85 -109.15 143.57 38.37 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 116.088 -0.506 . . . . 75.31 109.8 176.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -119.24 -167.88 1.48 Allowed 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 108.154 -1.054 . . . . 75.41 108.154 -178.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 564' ' ' ASN . . . . . 0.401 ' HB3' ' H ' ' A' ' 533' ' ' GLY . 27.6 p-10 -78.33 -42.15 31.5 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 109.636 -0.505 . . . . 72.42 109.636 178.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -89.35 -29.69 18.94 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.575 -0.738 . . . . 72.12 110.684 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -79.37 108.19 12.7 Favored 'General case' 0 C--O 1.248 1.012 0 CA-C-N 115.878 -0.601 . . . . 74.14 110.17 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 567' ' ' ILE . . . . . 0.432 ' O ' HG12 ' A' ' 568' ' ' VAL . 6.1 pt -110.17 166.19 5.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 108.049 -1.093 . . . . 71.5 108.049 174.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 568' ' ' VAL . . . . . 0.598 ' HA ' ' O ' ' A' ' 525' ' ' VAL . 0.9 OUTLIER 58.77 155.83 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.56 1.336 0 C-N-CA 125.681 1.592 . . . . 74.03 112.564 -178.814 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 569' ' ' LYS . . . . . 0.558 ' HB2' ' CZ ' ' A' ' 562' ' ' PHE . 0.0 OUTLIER -161.94 166.62 25.87 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 106.985 -1.487 . . . . 74.42 106.985 179.492 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 570' ' ' THR . . . . . 0.618 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 7.0 p -127.52 138.68 52.98 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 123.427 0.454 . . . . 65.01 111.363 175.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 571' ' ' ILE . . . . . 0.457 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 3.2 mp -88.61 115.18 28.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 106.763 -1.569 . . . . 72.31 106.763 171.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 24.2 p -92.82 109.49 20.92 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 109.365 -0.606 . . . . 75.12 109.365 178.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 573' ' ' VAL . . . . . 0.446 HG21 HG22 ' A' ' 556' ' ' THR . 43.6 t -112.69 129.94 67.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 N-CA-C 109.328 -0.619 . . . . 75.15 109.328 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 574' ' ' LYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 519' ' ' GLY . 86.9 tttt -89.09 124.12 34.02 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 123.814 0.696 . . . . 74.21 110.156 176.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 46.5 t -91.07 131.61 37.78 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 N-CA-C 108.312 -0.996 . . . . 74.45 108.312 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 30.1 mm -101.03 160.65 3.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 107.784 -1.191 . . . . 75.12 107.784 -177.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -76.91 147.73 36.82 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 110.061 -0.348 . . . . 60.15 110.061 177.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -69.98 132.4 45.87 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 114.55 1.315 . . . . 72.21 114.55 -175.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 579' ' ' GLU . . . . . 0.409 ' H ' ' CD ' ' A' ' 579' ' ' GLU . 0.0 OUTLIER -96.59 -26.27 15.3 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 112.533 -2.121 . . . . 74.12 111.394 179.599 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 580' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 581' ' ' TYR . 0.1 OUTLIER -105.11 -174.97 2.66 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 107.192 -1.41 . . . . 74.25 107.192 178.813 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 581' ' ' TYR . . . . . 0.426 ' O ' ' HG2' ' A' ' 580' ' ' GLU . 24.6 p90 -69.25 145.14 53.38 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 106.31 -1.737 . . . . 75.42 106.31 176.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 582' ' ' GLU . . . . . . . . . . . . 0.528 18.6 pt-20 -93.79 121.03 34.81 Favored 'General case' 0 N--CA 1.408 -2.56 0 N-CA-C 117.673 2.472 . . . . 73.44 117.673 -175.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.19 170.94 11.88 Favored 'General case' 0 N--CA 1.417 -2.108 0 CA-C-N 111.407 -2.633 . . . . 73.1 106.476 178.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -67.71 119.31 12.24 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.36 0.6 . . . . 64.31 109.468 -177.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 585' ' ' LYS . . . . . 0.434 ' HD2' HD11 ' A' ' 646' ' ' ILE . 1.6 tmmm? -122.58 142.51 50.55 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-N 115.003 -0.999 . . . . 74.43 109.911 -171.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 6.8 t -148.22 142.99 26.7 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-O 121.14 0.495 . . . . 73.3 110.698 -175.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -129.64 148.23 51.51 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-N 114.113 -1.403 . . . . 75.33 109.802 177.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 588' ' ' PHE . . . . . 0.532 ' HA ' ' O ' ' A' ' 642' ' ' LEU . 27.2 m-85 -104.14 138.3 40.83 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.978 -0.556 . . . . 74.42 109.672 -176.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . 0.492 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.5 OUTLIER -113.01 115.24 28.08 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 105.642 -1.985 . . . . 73.4 105.642 175.573 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -125.59 133.37 52.3 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 109.148 -0.686 . . . . 64.33 109.148 178.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 591' ' ' ILE . . . . . . . . . . . . . 22.0 pt -85.58 146.96 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-N 115.808 -0.633 . . . . 74.21 109.412 178.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -93.54 -148.43 23.6 Favored Glycine 0 N--CA 1.427 -1.905 0 C-N-CA 120.911 -0.662 . . . . 71.33 111.496 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -75.56 117.04 60.42 Favored Pre-proline 0 C--N 1.295 -1.786 0 N-CA-C 108.866 -0.79 . . . . 71.3 108.866 178.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 594' ' ' PRO . . . . . 0.429 ' HB3' HG21 ' A' ' 537' ' ' VAL . 57.8 Cg_endo -72.81 134.34 21.68 Favored 'Trans proline' 0 N--CA 1.433 -2.045 0 C-N-CA 121.573 1.515 . . . . 61.11 109.408 176.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 595' ' ' ARG . . . . . 0.437 ' HG2' ' O ' ' A' ' 536' ' ' ILE . 14.2 ptm180 -108.29 121.15 44.31 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-O 121.028 0.442 . . . . 74.35 111.057 -172.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -76.7 118.44 19.33 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 105.786 -1.931 . . . . 75.14 105.786 176.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--N 1.29 -2.001 0 CA-C-O 121.905 0.859 . . . . 73.04 109.46 -178.113 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? . . . . . 0 N--CA 1.435 -1.209 0 N-CA-C 108.919 -0.771 . . . . 74.31 108.919 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . 0.413 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 4.9 Cg_endo -75.5 154.52 40.22 Favored 'Trans proline' 0 N--CA 1.44 -1.645 0 N-CA-C 107.073 -1.933 . . . . 72.02 107.073 166.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.6 pp -135.48 173.66 13.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 C-N-CA 118.804 -1.158 . . . . 75.41 113.928 -175.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -75.67 146.99 39.8 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.969 -1.014 . . . . 73.34 110.232 -179.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -94.04 -132.16 6.39 Favored Glycine 0 C--N 1.289 -2.044 0 CA-C-N 115.604 -0.725 . . . . 75.12 113.821 -176.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -69.68 -56.48 7.12 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 111.955 0.354 . . . . 71.44 111.955 -175.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -137.07 114.62 11.08 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.889 0.852 . . . . 75.05 112.274 -178.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 17.5 p -119.68 91.84 3.64 Favored 'General case' 0 N--CA 1.416 -2.158 0 CA-C-N 115.219 -0.9 . . . . 74.03 110.568 177.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -178.71 126.0 0.1 Allowed 'General case' 0 CA--C 1.482 -1.642 0 N-CA-C 103.988 -2.597 . . . . 74.0 103.988 176.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 642' ' ' LEU . . . . . 0.532 ' O ' ' HA ' ' A' ' 588' ' ' PHE . 51.7 tp -115.82 112.99 22.77 Favored 'General case' 0 C--N 1.263 -3.189 0 N-CA-C 108.653 -0.869 . . . . 73.35 108.653 177.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -97.55 103.47 15.41 Favored 'General case' 0 C--N 1.273 -2.734 0 N-CA-C 107.204 -1.406 . . . . 65.53 107.204 178.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 21.8 t -91.95 106.74 18.05 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.289 0 N-CA-C 108.15 -1.056 . . . . 74.1 108.15 -178.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 4.0 mp -90.99 115.87 31.05 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.293 0 N-CA-C 107.019 -1.475 . . . . 74.55 107.019 173.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 646' ' ' ILE . . . . . 0.496 HD12 ' N ' ' A' ' 646' ' ' ILE . 3.2 mp -101.9 112.05 33.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 107.606 -1.257 . . . . 74.54 107.606 -175.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -111.2 138.2 47.94 Favored 'General case' 0 C--N 1.275 -2.671 0 CA-C-N 115.629 -0.714 . . . . 74.32 110.889 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -48.75 136.17 14.01 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.888 -1.051 . . . . 74.01 110.811 178.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 8.6 t . . . . . 0 N--CA 1.426 -1.667 0 CA-C-O 122.191 0.995 . . . . 63.1 109.987 -175.338 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . 0.448 ' HA2' ' OG1' ' A' ' 528' ' ' THR . . . . . . . . 0 N--CA 1.406 -3.314 0 N-CA-C 113.486 0.154 . . . . 74.12 113.486 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 2.8 mp -81.84 102.03 7.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 107.483 -1.303 . . . . 65.53 107.483 174.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . 0.413 ' O ' ' HA3' ' A' ' 637' ' ' GLY . 42.9 m-85 -115.5 124.02 50.03 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.043 -1.095 . . . . 73.3 108.043 178.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 11.6 t -155.71 168.75 26.17 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.343 -0.984 . . . . 74.33 108.343 -174.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -87.43 151.4 23.09 Favored 'General case' 0 CA--C 1.494 -1.19 0 N-CA-C 107.639 -1.245 . . . . 74.12 107.639 175.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -87.0 -39.49 15.62 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 109.367 -0.605 . . . . 72.43 109.367 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -110.08 128.63 25.04 Favored Pre-proline 0 N--CA 1.437 -1.084 0 N-CA-C 108.469 -0.937 . . . . 73.33 108.469 176.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -79.42 -14.65 12.93 Favored 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 121.93 1.753 . . . . 73.21 112.373 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . 0.448 HG23 ' HB3' ' A' ' 643' ' ' GLU . 73.6 t -138.99 135.76 42.57 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.854 0 N-CA-C 108.755 -0.832 . . . . 63.44 108.755 -178.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 3.5 t -137.76 138.47 39.3 Favored 'General case' 0 N--CA 1.408 -2.536 0 N-CA-C 107.8 -1.185 . . . . 73.11 107.8 177.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 23.4 m-70 -108.57 124.53 50.61 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 108.366 -0.976 . . . . 71.04 108.366 178.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 32.1 m -123.2 159.49 27.29 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.383 0 CA-C-O 121.433 0.635 . . . . 64.34 111.777 -173.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 41.2 m -75.58 152.33 37.73 Favored 'General case' 0 N--CA 1.399 -3.002 0 CA-C-N 114.012 -1.449 . . . . 74.32 109.961 -179.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -78.08 -48.38 16.19 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 121.408 0.623 . . . . 62.21 111.889 178.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 29.7 m -90.3 38.61 0.94 Allowed 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 122.157 0.979 . . . . 63.42 110.12 -171.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 17.4 tt -105.79 155.83 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.433 0 N-CA-C 105.855 -1.906 . . . . 75.13 105.855 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . 0.446 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . -89.93 -57.08 1.75 Allowed Glycine 0 C--N 1.289 -2.063 0 C-N-CA 119.108 -1.52 . . . . 75.22 111.185 178.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 34.3 mm -126.29 136.41 60.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 CA-C-N 115.27 -0.465 . . . . 71.12 109.847 -176.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 521' ' ' MET . . . . . 0.416 ' HE1' HG13 ' A' ' 644' ' ' VAL . 0.0 OUTLIER -114.19 130.74 56.61 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 106.419 -1.697 . . . . 74.13 106.419 170.161 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -113.07 122.84 48.78 Favored 'General case' 0 C--N 1.313 -1.019 0 O-C-N 123.379 0.425 . . . . 72.42 110.265 -176.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . 0.617 ' O ' ' HA ' ' A' ' 570' ' ' THR . 43.4 t -103.32 126.76 57.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 CA-C-N 116.246 -0.433 . . . . 71.44 110.521 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 27.8 mmtp -78.22 134.96 37.51 Favored 'General case' 0 C--N 1.317 -0.843 0 O-C-N 123.853 0.721 . . . . 74.3 111.801 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 21.5 t -115.0 142.12 29.06 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 N-CA-C 108.656 -0.868 . . . . 73.25 108.656 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -69.57 167.47 16.78 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-O 122.305 1.05 . . . . 74.32 113.448 -178.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 3.4 tpm_? -106.88 158.81 16.73 Favored 'General case' 0 N--CA 1.426 -1.668 0 CA-C-N 114.027 -1.442 . . . . 73.43 109.574 -175.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 528' ' ' THR . . . . . 0.448 ' OG1' ' HA2' ' A' ' 503' ' ' GLY . 3.3 t -73.03 160.5 31.97 Favored 'General case' 0 N--CA 1.432 -1.374 0 C-N-CA 124.003 0.921 . . . . 72.3 110.215 176.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 22.2 t -85.2 -11.67 54.41 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 108.575 -0.898 . . . . 65.54 108.575 178.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -146.51 100.74 0.23 Allowed Glycine 0 N--CA 1.438 -1.194 0 N-CA-C 109.943 -1.263 . . . . 72.03 109.943 177.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -90.36 88.55 7.24 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.115 0.483 . . . . 71.15 111.754 -176.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 -137.76 100.23 4.13 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.373 -0.973 . . . . 75.34 108.373 174.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 123.17 154.63 9.07 Favored Glycine 0 N--CA 1.429 -1.825 0 C-N-CA 120.117 -1.039 . . . . 71.43 112.365 178.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 534' ' ' ASN . . . . . 0.431 ' HA ' ' HA ' ' A' ' 563' ' ' GLN . 2.6 t-20 -98.54 119.94 38.11 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-O 121.375 0.607 . . . . 74.32 109.557 176.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 89.9 t -122.45 135.59 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-N 115.124 -0.944 . . . . 64.11 109.202 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 536' ' ' ILE . . . . . 0.579 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 43.3 mm -102.81 133.4 46.66 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.062 0 N-CA-C 108.961 -0.755 . . . . 74.33 108.961 178.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 63.6 t -119.55 110.36 37.31 Favored Pre-proline 0 C--N 1.297 -1.683 0 N-CA-C 109.772 -0.455 . . . . 75.3 109.772 178.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -74.11 152.73 45.94 Favored 'Trans proline' 0 C--O 1.24 0.592 0 C-N-CA 122.644 2.229 . . . . 74.23 111.93 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 539' ' ' TYR . . . . . 0.428 ' CE1' ' HG ' ' A' ' 560' ' ' LEU . 53.7 p90 -152.61 159.5 43.23 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.676 -0.861 . . . . 73.43 108.676 -178.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.35 150.96 16.72 Favored 'General case' 0 C--N 1.309 -1.16 0 O-C-N 123.613 0.57 . . . . 74.42 110.23 179.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 7.3 p -82.17 121.93 27.24 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 114.98 -1.009 . . . . 74.23 110.858 173.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.5 mp -93.17 118.49 39.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 105.259 -2.126 . . . . 71.11 105.259 171.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -48.15 -55.36 10.54 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 124.316 1.046 . . . . 73.22 112.406 -175.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 72.47 -102.3 1.17 Allowed Glycine 0 N--CA 1.442 -0.939 0 N-CA-C 110.702 -0.959 . . . . 54.45 110.702 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 11.4 t -118.68 -0.36 11.32 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 122.334 1.064 . . . . 73.04 109.359 177.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -88.62 143.61 26.83 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 108.342 -0.984 . . . . 61.11 108.342 173.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . 0.422 ' HG3' ' HG3' ' A' ' 551' ' ' GLU . 27.6 tpt180 -90.19 119.13 30.25 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.826 -0.805 . . . . 75.34 108.826 179.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -86.45 174.29 46.69 Favored Glycine 0 C--N 1.306 -1.13 0 C-N-CA 120.503 -0.856 . . . . 71.12 113.15 -176.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 86.0 36.2 10.38 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 121.148 -0.549 . . . . 75.54 113.416 176.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 87.87 10.8 68.95 Favored Glycine 0 N--CA 1.44 -1.055 0 C-N-CA 120.261 -0.971 . . . . 73.32 112.82 176.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . 0.422 ' HG3' ' HG3' ' A' ' 547' ' ' ARG . 7.8 mm-40 -92.72 -71.83 0.63 Allowed 'General case' 0 C--O 1.213 -0.862 0 N-CA-C 109.412 -0.588 . . . . 74.31 109.412 179.032 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -97.55 -30.05 13.09 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 108.626 -0.879 . . . . 74.22 108.626 176.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 553' ' ' PHE . . . . . 0.486 ' HB3' ' CE2' ' A' ' 587' ' ' PHE . 46.4 p90 -149.76 155.24 39.81 Favored 'General case' 0 N--CA 1.419 -1.989 0 CA-C-N 115.312 -0.858 . . . . 65.14 110.198 178.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -82.54 123.2 28.97 Favored 'General case' 0 C--N 1.276 -2.6 0 N-CA-C 104.48 -2.415 . . . . 74.44 104.48 175.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -60.77 121.11 11.47 Favored 'General case' 0 CA--C 1.488 -1.423 0 CA-C-O 122.237 1.017 . . . . 60.32 111.575 -175.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 98.4 m -120.22 112.64 19.32 Favored 'General case' 0 N--CA 1.388 -3.555 0 CA-C-N 114.5 -1.227 . . . . 71.1 111.806 -171.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 20.7 p -145.63 128.97 16.83 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.846 -1.168 . . . . 73.54 107.846 176.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -165.86 -155.61 8.84 Favored Glycine 0 N--CA 1.422 -2.295 0 C-N-CA 120.462 -0.875 . . . . 73.14 111.139 -176.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 559' ' ' GLU . . . . . 0.579 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 42.1 mt-10 -143.09 125.63 15.8 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 123.06 0.544 . . . . 65.42 110.269 -176.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . 0.428 ' HG ' ' CE1' ' A' ' 539' ' ' TYR . 87.7 mt -88.7 135.79 33.33 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 122.723 0.409 . . . . 75.14 110.776 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 561' ' ' GLU . . . . . 0.423 ' HG3' HD22 ' A' ' 534' ' ' ASN . 45.4 tt0 -96.38 108.57 21.11 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.601 -0.727 . . . . 73.32 110.593 179.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 562' ' ' PHE . . . . . 0.404 ' CE1' ' HG2' ' A' ' 569' ' ' LYS . 8.0 m-85 -107.74 116.92 32.82 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.234 -0.654 . . . . 74.42 109.234 173.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . 0.431 ' HA ' ' HA ' ' A' ' 534' ' ' ASN . 3.5 pt20 -119.56 -175.26 2.91 Favored 'General case' 0 C--N 1.29 -1.995 0 C-N-CA 119.068 -1.053 . . . . 73.12 112.023 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -59.06 -47.53 84.9 Favored 'General case' 0 C--N 1.318 -0.774 0 O-C-N 123.86 0.725 . . . . 75.21 109.667 177.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -77.74 -67.19 0.75 Allowed 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.278 -0.873 . . . . 75.45 111.233 -178.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 566' ' ' GLU . . . . . 0.431 ' H ' ' HG3' ' A' ' 563' ' ' GLN . 15.3 tt0 -56.27 113.86 1.74 Allowed 'General case' 0 C--O 1.247 0.922 0 O-C-N 123.783 0.677 . . . . 72.21 112.629 -178.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 10.4 pt -102.36 169.14 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.407 -2.591 0 N-CA-C 106.64 -1.615 . . . . 74.41 106.64 173.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 1.7 p 40.55 124.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.559 1.306 0 C-N-CA 127.069 2.147 . . . . 65.41 116.628 177.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 569' ' ' LYS . . . . . 0.404 ' HG2' ' CE1' ' A' ' 562' ' ' PHE . 32.8 mmmt -116.85 157.43 25.63 Favored 'General case' 0 C--N 1.265 -3.103 0 CA-C-N 114.921 -1.036 . . . . 72.44 110.16 178.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 570' ' ' THR . . . . . 0.617 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 1.8 p -129.88 125.27 35.2 Favored 'General case' 0 C--N 1.278 -2.538 0 CA-C-N 114.784 -1.098 . . . . 63.13 111.307 179.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 3.6 mp -84.52 111.12 19.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 106.277 -1.749 . . . . 71.14 106.277 173.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 3.1 p -95.66 109.45 21.72 Favored 'General case' 0 N--CA 1.417 -2.093 0 O-C-N 123.87 0.731 . . . . 73.4 109.918 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 573' ' ' VAL . . . . . . . . . . . . . 59.9 t -111.82 133.68 56.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 108.916 -0.772 . . . . 73.32 108.916 -178.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 574' ' ' LYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 519' ' ' GLY . 41.4 ttmt -84.81 117.14 23.68 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-O 121.444 0.64 . . . . 75.31 109.676 177.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 60.2 t -89.44 143.74 10.56 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 N-CA-C 107.08 -1.452 . . . . 75.04 107.08 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 576' ' ' ILE . . . . . 0.41 HG12 ' HA ' ' A' ' 553' ' ' PHE . 26.0 mm -111.81 132.3 60.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 C-N-CA 119.975 -0.69 . . . . 72.55 109.196 -177.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -59.65 137.53 58.01 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.301 -0.863 . . . . 73.03 108.873 178.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 578' ' ' ASP . . . . . . . . . . . . 0.413 15.9 m-20 -59.31 119.65 7.81 Favored 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 117.144 2.276 . . . . 75.23 117.144 -171.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 6.1 pm0 -97.07 -14.07 21.81 Favored 'General case' 0 N--CA 1.401 -2.888 0 CA-C-N 110.483 -3.053 . . . . 73.24 112.948 -172.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 580' ' ' GLU . . . . . 0.62 ' HG2' ' O ' ' A' ' 581' ' ' TYR . 2.4 pm0 -128.5 -167.23 1.74 Allowed 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 122.897 0.479 . . . . 71.33 110.016 -173.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 581' ' ' TYR . . . . . 0.62 ' O ' ' HG2' ' A' ' 580' ' ' GLU . 52.5 p90 -58.3 153.41 15.44 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 107.709 -1.219 . . . . 71.44 107.709 170.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -93.34 134.44 35.55 Favored 'General case' 0 C--N 1.275 -2.668 0 C-N-CA 116.654 -2.019 . . . . 72.33 113.36 -176.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.93 130.79 18.12 Favored 'General case' 0 N--CA 1.412 -2.331 0 N-CA-C 104.584 -2.376 . . . . 74.45 104.584 171.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -66.3 123.72 20.72 Favored 'General case' 0 CA--C 1.488 -1.434 0 N-CA-C 107.364 -1.347 . . . . 74.22 107.364 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.87 166.71 18.56 Favored 'General case' 0 C--N 1.285 -2.216 0 CA-C-N 115.604 -0.725 . . . . 73.14 109.902 -168.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 6.5 t -156.22 145.41 20.59 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-O 120.797 0.332 . . . . 64.14 110.866 -173.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 587' ' ' PHE . . . . . 0.486 ' CE2' ' HB3' ' A' ' 553' ' ' PHE . 3.4 p90 -125.33 147.76 49.01 Favored 'General case' 0 N--CA 1.42 -1.965 0 O-C-N 125.068 1.48 . . . . 74.31 109.644 176.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 588' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -100.95 127.4 47.46 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.393 -0.966 . . . . 74.22 108.393 -176.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . 0.45 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.5 OUTLIER -100.96 117.19 34.53 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 104.898 -2.26 . . . . 74.04 104.898 175.707 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -126.13 125.9 43.28 Favored 'General case' 0 C--N 1.281 -2.372 0 C-N-CA 120.233 -0.587 . . . . 72.43 109.708 -177.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 591' ' ' ILE . . . . . 0.419 HG21 ' HB3' ' A' ' 539' ' ' TYR . 14.8 pt -87.44 138.67 18.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 N-CA-C 107.828 -1.175 . . . . 74.11 107.828 173.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -98.88 -136.91 9.54 Favored Glycine 0 N--CA 1.429 -1.819 0 C-N-CA 120.381 -0.914 . . . . 64.44 114.023 -173.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -84.64 118.36 70.86 Favored Pre-proline 0 C--N 1.294 -1.842 0 C-N-CA 124.555 1.142 . . . . 74.15 110.133 -176.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.11 150.82 72.61 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.354 2.036 . . . . 72.3 111.488 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -132.57 132.11 42.21 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 109.429 -0.582 . . . . 75.21 109.429 -177.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 596' ' ' LEU . . . . . 0.4 ' HB2' ' HD3' ' A' ' 634' ' ' PRO . 0.0 OUTLIER -80.09 134.61 36.2 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.336 -1.357 . . . . 74.43 107.336 -178.605 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 58.1 t . . . . . 0 C--N 1.303 -1.42 0 CA-C-O 121.868 0.842 . . . . 73.14 109.098 178.086 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 80.7 mtt180 . . . . . 0 N--CA 1.428 -1.557 0 N-CA-C 107.963 -1.125 . . . . 74.3 107.963 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . 0.4 ' HD3' ' HB2' ' A' ' 596' ' ' LEU . 74.5 Cg_endo -94.26 151.47 2.05 Favored 'Trans proline' 0 N--CA 1.428 -2.336 0 C-N-CA 121.504 1.47 . . . . 74.1 110.816 173.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.2 pp -112.91 173.37 2.81 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 CA-C-N 116.375 -0.375 . . . . 71.13 111.451 -178.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 14.0 tp -78.91 158.37 28.07 Favored 'General case' 0 N--CA 1.433 -1.296 0 O-C-N 123.182 0.301 . . . . 73.34 110.432 -177.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' A' ' 505' ' ' PHE . . . -76.44 -107.04 0.13 Allowed Glycine 0 N--CA 1.435 -1.424 0 N-CA-C 115.032 0.773 . . . . 73.03 115.032 -177.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -127.5 -70.66 0.7 Allowed 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.033 -0.729 . . . . 65.54 109.033 -175.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 12.8 p80 -132.84 114.76 14.46 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 109.059 -0.719 . . . . 75.3 109.059 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 30.8 p -98.46 91.3 5.12 Favored 'General case' 0 N--CA 1.407 -2.622 0 CA-C-O 121.626 0.727 . . . . 71.41 109.885 -178.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -170.96 129.9 0.77 Allowed 'General case' 0 CA--C 1.498 -1.036 0 CA-C-N 115.437 -0.801 . . . . 75.23 109.311 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 642' ' ' LEU . . . . . 0.461 ' CD2' HG23 ' A' ' 523' ' ' VAL . 27.8 tp -137.08 109.88 7.59 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 107.45 -1.315 . . . . 74.44 107.45 172.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . 0.448 ' HB3' HG23 ' A' ' 511' ' ' VAL . 19.3 tt0 -94.34 104.1 16.09 Favored 'General case' 0 C--N 1.273 -2.741 0 N-CA-C 107.12 -1.437 . . . . 70.32 107.12 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 644' ' ' VAL . . . . . 0.416 HG13 ' HE1' ' A' ' 521' ' ' MET . 25.4 t -95.56 108.01 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.194 0 N-CA-C 109.559 -0.534 . . . . 75.42 109.559 -177.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 3.5 mp -94.84 124.81 47.49 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 107.233 -1.395 . . . . 73.22 107.233 177.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 646' ' ' ILE . . . . . 0.51 ' N ' HD13 ' A' ' 646' ' ' ILE . 2.8 mp -104.35 115.68 46.72 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.438 0 N-CA-C 107.601 -1.259 . . . . 75.43 107.601 -174.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -121.16 168.92 11.05 Favored 'General case' 0 N--CA 1.419 -2.007 0 O-C-N 123.608 0.568 . . . . 60.24 109.585 -175.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -69.95 157.9 36.61 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 112.766 0.654 . . . . 65.43 112.766 -172.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 20.2 t . . . . . 0 N--CA 1.439 -0.994 0 N-CA-C 106.573 -1.64 . . . . 74.45 106.573 175.335 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . 0.614 ' HA2' ' OG1' ' A' ' 528' ' ' THR . . . . . . . . 0 N--CA 1.415 -2.738 0 CA-C-O 119.947 -0.363 . . . . 72.43 113.063 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 3.7 mp -116.31 112.39 39.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 107.1 -1.444 . . . . 74.23 107.1 175.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -119.7 125.56 48.98 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.57 -0.9 . . . . 72.22 108.57 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 506' ' ' THR . . . . . 0.413 ' HB ' ' HA3' ' A' ' 637' ' ' GLY . 15.1 t -155.44 169.44 24.25 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 109.77 -0.456 . . . . 74.23 109.77 -174.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -98.81 161.15 13.8 Favored 'General case' 0 C--O 1.249 1.063 0 N-CA-C 106.243 -1.762 . . . . 71.52 106.243 172.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . 0.43 ' HG2' HD21 ' A' ' 526' ' ' LEU . 3.4 pt-20 -99.17 -27.93 13.58 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 120.387 -0.525 . . . . 75.41 110.734 176.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -114.26 119.16 40.85 Favored Pre-proline 0 N--CA 1.43 -1.463 0 N-CA-C 107.647 -1.242 . . . . 74.25 107.647 174.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -83.39 -4.28 10.92 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 121.902 1.735 . . . . 71.01 111.951 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 88.3 t -143.27 134.9 23.66 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.069 0 N-CA-C 108.036 -1.098 . . . . 72.41 108.036 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 4.7 t -139.5 151.49 46.19 Favored 'General case' 0 N--CA 1.404 -2.766 0 N-CA-C 108.099 -1.075 . . . . 62.44 108.099 176.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 513' ' ' HIS . . . . . 0.456 ' CD2' ' HB ' ' A' ' 645' ' ' ILE . 47.0 m80 -117.3 116.86 28.05 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 109.168 -0.678 . . . . 72.21 109.168 179.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.683 HG13 ' SD ' ' A' ' 521' ' ' MET . 31.0 m -111.6 153.13 13.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 C-N-CA 120.469 -0.492 . . . . 75.52 110.909 -177.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 515' ' ' SER . . . . . 0.501 ' HA ' ' OE2' ' A' ' 647' ' ' GLU . 40.5 t -76.59 143.88 39.97 Favored 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 114.945 -1.025 . . . . 64.31 109.715 -178.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . 0.425 ' CG ' ' HB3' ' A' ' 578' ' ' ASP . 35.4 tt0 -68.71 -10.24 55.22 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.449 0.643 . . . . 74.43 111.195 178.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 20.5 t -115.49 21.93 13.61 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 109.317 -0.623 . . . . 65.21 109.317 -177.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 518' ' ' ILE . . . . . 0.426 HG21 ' O ' ' A' ' 515' ' ' SER . 15.1 tt -90.29 151.0 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 N-CA-C 108.847 -0.797 . . . . 75.23 108.847 178.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -96.35 -63.94 0.94 Allowed Glycine 0 N--CA 1.429 -1.822 0 C-N-CA 120.05 -1.071 . . . . 70.22 111.517 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 30.3 mm -119.04 118.18 56.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 109.635 -0.505 . . . . 75.45 109.635 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 521' ' ' MET . . . . . 0.683 ' SD ' HG13 ' A' ' 514' ' ' VAL . 25.1 ptt? -99.91 129.48 46.0 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 107.153 -1.425 . . . . 74.02 107.153 173.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 522' ' ' GLU . . . . . 0.555 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 30.9 mt-10 -117.43 130.18 56.3 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.849 -0.614 . . . . 72.15 109.95 175.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 570' ' ' THR . 29.3 t -113.52 130.08 68.18 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 CA-C-N 115.207 -0.906 . . . . 75.22 109.117 -178.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . 0.427 ' HD2' HG22 ' A' ' 568' ' ' VAL . 32.3 mmtp -75.42 126.81 31.77 Favored 'General case' 0 C--N 1.31 -1.122 0 O-C-N 124.045 0.841 . . . . 74.34 112.4 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 8.9 t -105.16 140.27 23.69 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 N-CA-C 107.188 -1.412 . . . . 74.52 107.188 177.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . 0.43 HD21 ' HG2' ' A' ' 508' ' ' GLU . 2.4 mm? -90.3 139.39 30.71 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 120.804 -0.359 . . . . 71.52 110.033 -178.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . 0.464 ' HG2' ' N ' ' A' ' 528' ' ' THR . 39.0 ttp180 -76.26 158.45 31.56 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 115.349 -0.842 . . . . 73.11 109.186 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 528' ' ' THR . . . . . 0.614 ' OG1' ' HA2' ' A' ' 503' ' ' GLY . 3.2 t -61.87 160.75 11.51 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 123.855 0.862 . . . . 72.22 111.03 173.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 23.1 t -78.81 -26.49 44.29 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 108.673 -0.862 . . . . 72.31 108.673 178.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -121.14 104.52 0.96 Allowed Glycine 0 N--CA 1.442 -0.941 0 N-CA-C 109.579 -1.408 . . . . 62.42 109.579 178.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -100.8 98.47 8.98 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 120.848 0.356 . . . . 64.22 111.539 -176.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -130.85 119.82 22.77 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.862 -0.608 . . . . 71.45 110.08 178.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 86.6 -177.85 48.6 Favored Glycine 0 N--CA 1.438 -1.207 0 C-N-CA 120.693 -0.765 . . . . 74.52 112.433 176.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 534' ' ' ASN . . . . . 0.492 HD22 ' HG3' ' A' ' 561' ' ' GLU . 2.8 t-20 -99.07 130.58 45.41 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.15 -1.055 . . . . 73.34 108.15 178.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 58.7 t -127.6 131.37 70.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-O 120.84 0.352 . . . . 73.15 110.095 -176.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 536' ' ' ILE . . . . . 0.459 HG21 ' HB3' ' A' ' 559' ' ' GLU . 33.1 mm -98.41 129.76 48.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 N-CA-C 109.266 -0.642 . . . . 74.13 109.266 177.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . 0.405 HG23 ' HB3' ' A' ' 594' ' ' PRO . 21.6 t -118.56 101.54 50.72 Favored Pre-proline 0 C--N 1.314 -0.978 0 N-CA-C 109.156 -0.683 . . . . 73.24 109.156 179.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.21 151.12 54.48 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.943 2.428 . . . . 72.33 112.131 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 539' ' ' TYR . . . . . 0.432 ' CD1' ' HG ' ' A' ' 560' ' ' LEU . 45.4 p90 -149.45 162.43 40.13 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 109.385 -0.598 . . . . 72.12 109.385 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -157.59 156.27 31.6 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 123.797 0.686 . . . . 74.11 109.919 177.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 3.2 p -91.12 122.22 33.58 Favored 'General case' 0 N--CA 1.423 -1.816 0 O-C-N 123.636 0.585 . . . . 73.33 109.78 173.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.7 mp -92.7 118.63 38.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 105.915 -1.884 . . . . 73.41 105.915 174.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -50.25 -46.05 54.62 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 124.361 1.038 . . . . 74.12 111.656 -176.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 67.34 -106.24 1.61 Allowed Glycine 0 N--CA 1.426 -1.971 0 N-CA-C 110.616 -0.994 . . . . 73.44 110.616 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 11.5 t -118.81 6.64 11.49 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-O 121.615 0.722 . . . . 74.41 109.973 -178.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -86.06 170.32 12.35 Favored 'General case' 0 N--CA 1.442 -0.874 0 O-C-N 122.029 -0.419 . . . . 54.24 110.468 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . 0.448 ' HB2' ' HB2' ' A' ' 552' ' ' ASP . 29.8 mmt180 -69.76 174.05 5.57 Favored 'General case' 0 CA--C 1.502 -0.886 0 CA-C-N 116.007 -0.542 . . . . 73.32 110.964 176.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -68.46 172.89 34.19 Favored Glycine 0 C--N 1.295 -1.731 0 CA-C-N 114.954 -1.021 . . . . 65.43 114.157 -176.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . -62.37 123.35 30.73 Favored Glycine 0 N--CA 1.435 -1.386 0 CA-C-N 115.131 -0.535 . . . . 62.33 111.797 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 95.94 -17.75 58.71 Favored Glycine 0 N--CA 1.437 -1.295 0 N-CA-C 111.553 -0.619 . . . . 72.43 111.553 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -84.72 -66.61 0.87 Allowed 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 109.123 -0.695 . . . . 73.22 109.123 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . 0.448 ' HB2' ' HB2' ' A' ' 547' ' ' ARG . 1.2 m-20 -107.47 -22.37 12.57 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.664 -0.414 . . . . 72.22 111.728 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -151.87 151.94 31.94 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 108.849 -0.797 . . . . 74.23 108.849 177.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.49 122.06 30.74 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 106.048 -1.834 . . . . 75.13 106.048 177.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -74.38 105.99 5.79 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.128 0.489 . . . . 71.03 111.231 -175.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 13.5 t -104.08 119.99 40.13 Favored 'General case' 0 N--CA 1.414 -2.271 0 CA-C-O 122.324 1.059 . . . . 74.13 109.917 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 1.2 p -136.96 105.01 5.63 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-N 114.608 -1.178 . . . . 74.12 108.728 178.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -151.34 -152.3 5.83 Favored Glycine 0 N--CA 1.416 -2.663 0 N-CA-C 110.743 -0.943 . . . . 64.14 110.743 -174.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 559' ' ' GLU . . . . . 0.459 ' HB3' HG21 ' A' ' 536' ' ' ILE . 52.2 mt-10 -142.47 129.28 20.53 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.163 0.506 . . . . 74.12 110.952 -175.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . 0.432 ' HG ' ' CD1' ' A' ' 539' ' ' TYR . 92.8 mt -91.17 139.47 30.72 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.527 -0.761 . . . . 73.11 109.678 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 561' ' ' GLU . . . . . 0.492 ' HG3' HD22 ' A' ' 534' ' ' ASN . 28.2 tt0 -100.26 115.68 30.49 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.517 0.675 . . . . 75.32 111.474 178.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -109.37 158.82 17.54 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 107.355 -1.35 . . . . 73.03 107.355 171.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . 0.407 ' HB3' HD21 ' A' ' 534' ' ' ASN . 10.6 pt20 -165.87 179.24 6.0 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 109.803 -0.443 . . . . 75.13 109.803 177.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -59.47 -32.31 70.13 Favored 'General case' 0 C--N 1.322 -0.612 0 O-C-N 124.083 0.864 . . . . 73.3 110.468 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -88.85 -12.41 41.98 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.406 -0.816 . . . . 72.43 111.249 -177.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -100.96 132.79 46.2 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 113.244 0.831 . . . . 74.14 113.244 -176.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 3.9 pt -120.27 156.11 23.25 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.065 0 N-CA-C 105.823 -1.917 . . . . 72.44 105.823 170.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 568' ' ' VAL . . . . . 0.427 HG22 ' HD2' ' A' ' 524' ' ' LYS . 1.0 OUTLIER 48.11 178.34 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.578 2.03 0 C-N-CA 125.708 1.603 . . . . 70.02 113.003 -177.403 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 569' ' ' LYS . . . . . 0.402 ' HG2' HD12 ' A' ' 560' ' ' LEU . 1.4 tpmt? -172.01 163.59 6.12 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 106.067 -1.827 . . . . 73.03 106.067 175.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 570' ' ' THR . . . . . 0.55 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 11.5 p -135.58 141.26 45.13 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 123.45 0.469 . . . . 62.23 110.779 176.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 571' ' ' ILE . . . . . 0.555 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 3.5 mp -97.28 122.13 48.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 N-CA-C 106.166 -1.79 . . . . 62.45 106.166 169.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 40.4 p -99.96 118.69 36.9 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 109.329 -0.619 . . . . 72.35 109.329 177.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 573' ' ' VAL . . . . . . . . . . . . . 45.2 t -117.48 126.64 74.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 108.887 -0.783 . . . . 74.41 108.887 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -77.89 106.73 9.93 Favored 'General case' 0 N--CA 1.421 -1.907 0 N-CA-C 108.608 -0.886 . . . . 72.42 108.608 174.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 62.1 t -84.19 119.81 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.378 0 N-CA-C 105.757 -1.942 . . . . 75.33 105.757 175.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 39.4 mm -76.87 131.09 35.49 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 106.776 -1.565 . . . . 73.14 106.776 -177.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -60.29 99.16 0.07 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 122.092 0.949 . . . . 71.34 109.773 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 578' ' ' ASP . . . . . 0.425 ' HB3' ' CG ' ' A' ' 516' ' ' GLU . 19.1 t70 -61.64 133.77 56.01 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 114.346 -1.297 . . . . 63.42 113.93 -172.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 579' ' ' GLU . . . . . 0.444 ' H ' ' CD ' ' A' ' 579' ' ' GLU . 0.6 OUTLIER -96.36 -13.83 22.96 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 113.599 -1.637 . . . . 74.14 113.883 -173.973 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -124.99 166.76 15.76 Favored 'General case' 0 C--O 1.264 1.826 0 C-N-CA 117.936 -1.506 . . . . 73.5 113.491 -176.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -71.86 153.37 41.94 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 107.664 -1.235 . . . . 74.33 107.664 178.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 582' ' ' GLU . . . . . 0.43 ' HG2' ' CD ' ' A' ' 648' ' ' GLU . 6.1 pt-20 -148.79 166.1 29.48 Favored 'General case' 0 C--N 1.278 -2.531 0 N-CA-C 108.619 -0.882 . . . . 73.44 108.619 176.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 583' ' ' LYS . . . . . 0.451 ' O ' ' HB2' ' A' ' 584' ' ' ASN . 34.1 mmtp -106.59 30.22 6.23 Favored 'General case' 0 C--N 1.286 -2.186 0 CA-C-O 122.814 1.293 . . . . 74.21 107.825 176.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 584' ' ' ASN . . . . . 0.517 ' ND2' ' HA ' ' A' ' 647' ' ' GLU . 19.9 m120 80.26 96.12 0.05 Allowed 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 110.902 -2.863 . . . . 72.4 111.491 178.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.14 163.0 19.02 Favored 'General case' 0 N--CA 1.434 -1.267 0 C-N-CA 119.434 -0.906 . . . . 73.44 109.955 176.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 6.0 t -148.49 143.77 26.92 Favored 'General case' 0 N--CA 1.415 -2.188 0 CA-C-O 120.97 0.415 . . . . 65.5 110.059 -177.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 587' ' ' PHE . . . . . 0.408 ' CZ ' HD13 ' A' ' 646' ' ' ILE . 3.1 p90 -129.38 149.62 51.08 Favored 'General case' 0 N--CA 1.418 -2.042 0 CA-C-N 114.305 -1.316 . . . . 75.43 108.711 177.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 588' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -106.81 136.25 46.96 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 116.41 -0.359 . . . . 75.33 110.086 -172.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . 0.432 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.4 OUTLIER -105.87 122.97 47.2 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 105.466 -2.05 . . . . 74.43 105.466 174.87 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -130.67 135.38 47.78 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 109.627 -0.508 . . . . 73.33 109.627 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 591' ' ' ILE . . . . . 0.402 HG22 ' HB3' ' A' ' 539' ' ' TYR . 19.6 pt -96.93 141.06 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.552 0 N-CA-C 106.839 -1.541 . . . . 71.44 106.839 173.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -95.9 -134.13 7.77 Favored Glycine 0 C--N 1.295 -1.729 0 C-N-CA 120.604 -0.808 . . . . 44.43 113.026 -175.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -85.19 116.05 63.82 Favored Pre-proline 0 C--N 1.303 -1.438 0 C-N-CA 122.958 0.503 . . . . 63.02 110.667 -177.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 594' ' ' PRO . . . . . 0.437 ' HA ' ' O ' ' A' ' 536' ' ' ILE . 59.8 Cg_endo -75.16 137.07 20.9 Favored 'Trans proline' 0 N--CA 1.431 -2.191 0 C-N-CA 121.316 1.344 . . . . 74.51 109.377 173.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -129.96 137.9 50.56 Favored 'General case' 0 C--N 1.285 -2.213 0 O-C-N 121.876 -0.515 . . . . 75.04 111.548 -175.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -77.18 124.81 28.35 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 107.905 -1.146 . . . . 73.54 107.905 -176.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 23.1 t . . . . . 0 C--N 1.298 -1.644 0 CA-C-O 121.301 0.572 . . . . 74.1 109.667 -179.59 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 . . . . . 0 CA--C 1.494 -1.199 0 N-CA-C 107.734 -1.21 . . . . 75.0 107.734 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -66.17 142.05 65.74 Favored 'Trans proline' 0 N--CA 1.437 -1.82 0 N-CA-C 108.204 -1.499 . . . . 75.14 108.204 171.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.3 pp -122.88 176.26 4.99 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 N-CA-C 113.677 0.992 . . . . 73.23 113.677 -173.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.91 152.21 28.2 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 114.881 -1.054 . . . . 73.22 108.5 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . 0.413 ' HA3' ' HB ' ' A' ' 506' ' ' THR . . . -80.74 -135.96 1.69 Allowed Glycine 0 C--N 1.293 -1.851 0 C-N-CA 120.864 -0.684 . . . . 73.21 113.668 -176.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -83.56 -58.67 2.72 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 120.125 -0.63 . . . . 74.14 109.969 -177.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -125.75 94.38 4.1 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 121.85 0.834 . . . . 72.35 111.905 -178.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 17.8 p -96.03 90.67 5.64 Favored 'General case' 0 N--CA 1.407 -2.595 0 N-CA-C 107.878 -1.156 . . . . 74.34 107.878 174.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -172.5 134.4 0.66 Allowed 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 105.583 -2.006 . . . . 73.43 105.583 -175.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 642' ' ' LEU . . . . . 0.486 ' CD2' HG21 ' A' ' 523' ' ' VAL . 37.1 tp -134.93 106.34 6.8 Favored 'General case' 0 C--N 1.277 -2.583 0 N-CA-C 108.02 -1.104 . . . . 72.43 108.02 177.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -87.66 104.25 16.35 Favored 'General case' 0 C--N 1.277 -2.565 0 N-CA-C 106.748 -1.575 . . . . 74.31 106.748 178.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 644' ' ' VAL . . . . . 0.406 HG23 ' HE3' ' A' ' 521' ' ' MET . 40.1 t -94.06 106.02 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.155 0 N-CA-C 108.372 -0.973 . . . . 73.33 108.372 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 645' ' ' ILE . . . . . 0.456 ' HB ' ' CD2' ' A' ' 513' ' ' HIS . 3.8 mp -93.38 126.89 45.75 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 106.615 -1.624 . . . . 74.43 106.615 176.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 646' ' ' ILE . . . . . 0.531 HD12 ' N ' ' A' ' 646' ' ' ILE . 2.4 mp -99.11 124.02 52.12 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.249 0 N-CA-C 106.626 -1.62 . . . . 64.04 106.626 -177.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . 0.517 ' HA ' ' ND2' ' A' ' 584' ' ' ASN . 0.0 OUTLIER -109.07 152.44 25.04 Favored 'General case' 0 C--N 1.266 -3.024 0 CA-C-N 115.598 -0.728 . . . . 73.43 109.518 -178.599 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 648' ' ' GLU . . . . . 0.43 ' CD ' ' HG2' ' A' ' 582' ' ' GLU . 25.5 mt-10 -83.79 75.31 10.1 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-O 122.327 1.061 . . . . 72.55 110.788 -176.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 18.2 m . . . . . 0 N--CA 1.446 -0.675 0 C-N-CA 129.024 2.93 . . . . 74.41 115.31 -176.987 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.41 -3.074 0 N-CA-C 113.803 0.281 . . . . 73.21 113.803 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . 0.442 ' H ' ' CB ' ' A' ' 528' ' ' THR . 3.6 mp -119.57 96.48 4.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 107.463 -1.31 . . . . 75.54 107.463 173.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -108.71 115.04 29.34 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 106.135 -1.802 . . . . 74.32 106.135 178.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 506' ' ' THR . . . . . 0.44 ' HB ' ' H ' ' A' ' 638' ' ' GLU . 15.0 t -147.71 164.33 33.91 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 120.232 -0.587 . . . . 73.04 109.478 -173.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -94.35 160.24 14.76 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 107.658 -1.238 . . . . 73.32 107.658 173.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -91.04 -33.46 15.5 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 107.445 -1.317 . . . . 74.51 107.445 -179.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -124.16 134.95 25.84 Favored Pre-proline 0 N--CA 1.414 -2.241 0 CA-C-N 114.369 -1.287 . . . . 75.31 109.538 179.087 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 510' ' ' PRO . . . . . 0.606 ' HA ' ' O ' ' A' ' 641' ' ' LYS . 81.9 Cg_endo -85.76 -4.64 9.02 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 121.82 1.68 . . . . 74.23 111.416 174.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 81.9 t -143.64 134.71 22.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 C-N-CA 123.882 0.873 . . . . 72.32 108.672 -178.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 14.6 t -134.06 132.12 39.62 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 107.265 -1.383 . . . . 74.4 107.265 175.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 28.5 m-70 -100.52 121.63 41.89 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.485 -0.931 . . . . 65.22 108.485 177.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.649 HG13 ' SD ' ' A' ' 521' ' ' MET . 33.0 m -115.02 156.66 15.93 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 CA-C-N 116.27 -0.423 . . . . 73.44 109.983 -177.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 22.9 t -82.89 133.12 35.13 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 107.822 -1.177 . . . . 74.24 107.822 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -68.31 -7.52 31.74 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 112.07 0.396 . . . . 75.45 112.07 -177.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 45.6 p -103.09 8.02 38.78 Favored 'General case' 0 C--N 1.313 -0.992 0 O-C-N 121.63 -0.669 . . . . 71.11 110.655 179.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 12.4 tt -80.23 152.02 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 N-CA-C 109.536 -0.542 . . . . 74.14 109.536 -177.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -91.23 -61.45 1.26 Allowed Glycine 0 N--CA 1.426 -1.982 0 C-N-CA 120.253 -0.975 . . . . 73.02 110.996 177.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 28.3 mm -121.18 128.42 76.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-O 121.068 0.461 . . . . 60.04 110.849 -177.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 521' ' ' MET . . . . . 0.649 ' SD ' HG13 ' A' ' 514' ' ' VAL . 24.0 ptt? -107.95 140.71 40.68 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 107.3 -1.37 . . . . 73.44 107.3 171.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -119.61 113.0 20.03 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-O 121.185 0.517 . . . . 71.43 109.957 -178.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . 0.643 ' O ' ' HA ' ' A' ' 570' ' ' THR . 47.3 t -93.04 126.45 45.47 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.31 0 CA-C-N 115.258 -0.883 . . . . 71.21 109.769 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . 0.409 ' HD2' HG21 ' A' ' 568' ' ' VAL . 31.4 mmtp -87.47 142.6 27.74 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 124.329 1.018 . . . . 73.41 111.427 -178.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 26.8 t -120.0 132.8 68.69 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 N-CA-C 107.016 -1.476 . . . . 73.54 107.016 176.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -71.84 139.01 48.7 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-O 121.322 0.582 . . . . 75.44 110.902 -179.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . 0.482 ' HD3' ' CZ ' ' A' ' 562' ' ' PHE . 13.6 tpt85 -79.37 127.4 32.04 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 114.839 -1.073 . . . . 75.25 110.001 179.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 528' ' ' THR . . . . . 0.442 ' CB ' ' H ' ' A' ' 504' ' ' ILE . 2.6 t -60.67 146.65 44.86 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 113.979 -1.464 . . . . 73.15 111.561 175.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 32.6 t -61.58 -35.58 78.24 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 115.143 -0.935 . . . . 75.33 109.239 176.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -120.6 110.01 1.67 Allowed Glycine 0 N--CA 1.423 -2.185 0 N-CA-C 110.489 -1.044 . . . . 64.23 110.489 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -127.14 112.29 14.99 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.326 -0.99 . . . . 74.13 108.326 176.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -119.01 102.61 8.88 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 120.891 0.377 . . . . 73.54 111.192 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 93.54 -153.72 21.42 Favored Glycine 0 N--CA 1.43 -1.724 0 CA-C-N 115.534 -0.757 . . . . 61.43 112.261 175.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 534' ' ' ASN . . . . . 0.503 HD22 ' HG3' ' A' ' 561' ' ' GLU . 2.4 t-20 -104.24 126.16 51.12 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.183 -0.673 . . . . 73.54 109.183 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 55.6 t -121.16 136.42 58.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 123.284 0.634 . . . . 73.21 109.529 -177.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 536' ' ' ILE . . . . . 0.507 HG21 ' HB3' ' A' ' 559' ' ' GLU . 18.7 mm -101.65 129.26 53.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-N 116.321 -0.4 . . . . 74.41 110.18 178.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . 0.429 HG23 ' HB3' ' A' ' 594' ' ' PRO . 39.1 t -118.84 108.85 40.33 Favored Pre-proline 0 C--N 1.317 -0.844 0 N-CA-C 108.812 -0.81 . . . . 75.55 108.812 177.107 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -72.34 143.07 38.4 Favored 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 122.033 1.822 . . . . 74.44 111.177 178.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 539' ' ' TYR . . . . . 0.509 ' CE1' ' HG ' ' A' ' 560' ' ' LEU . 35.3 p90 -152.13 155.5 37.97 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 109.865 -0.42 . . . . 63.11 109.865 -179.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -153.36 154.9 35.41 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 116.208 -0.451 . . . . 73.42 109.979 176.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 16.8 p -93.71 110.29 21.92 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 115.603 -0.726 . . . . 73.12 109.264 176.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.6 mp -77.57 118.87 25.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 105.69 -1.967 . . . . 73.2 105.69 176.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -54.83 -36.64 65.23 Favored 'General case' 0 C--N 1.319 -0.728 0 O-C-N 124.28 0.987 . . . . 74.45 113.578 -173.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 69.93 -97.81 0.59 Allowed Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 111.636 -0.586 . . . . 65.43 111.636 177.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 6.9 t -122.95 -0.27 9.02 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.472 0.653 . . . . 63.23 110.553 177.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -99.07 -170.26 1.89 Allowed 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 107.6 -1.259 . . . . 72.11 107.6 177.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . 0.435 ' HD3' ' N ' ' A' ' 548' ' ' GLY . 0.0 OUTLIER -138.12 130.14 28.59 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.34 -0.985 . . . . 74.43 108.34 -178.767 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 548' ' ' GLY . . . . . 0.435 ' N ' ' HD3' ' A' ' 547' ' ' ARG . . . -76.89 -146.15 2.12 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 111.346 -0.702 . . . . 72.54 111.346 177.087 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 64.44 15.69 59.58 Favored Glycine 0 C--N 1.314 -0.671 0 CA-C-N 117.077 0.438 . . . . 53.23 113.404 178.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 77.49 18.64 77.52 Favored Glycine 0 N--CA 1.431 -1.65 0 C-N-CA 121.172 -0.537 . . . . 74.11 112.166 -178.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -84.33 -70.62 0.56 Allowed 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 121.359 0.6 . . . . 65.31 109.491 178.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -100.63 -39.11 8.04 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 107.331 -1.359 . . . . 72.52 107.331 -178.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 553' ' ' PHE . . . . . 0.451 ' HA ' HG12 ' A' ' 576' ' ' ILE . 25.1 p90 -144.72 166.27 25.7 Favored 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 108.109 -1.071 . . . . 72.44 108.109 173.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -98.56 109.12 21.93 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 106.409 -1.7 . . . . 64.42 106.409 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -75.83 122.62 24.37 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-O 121.693 0.759 . . . . 71.42 111.038 -175.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 7.3 t -111.14 112.63 24.57 Favored 'General case' 0 N--CA 1.409 -2.514 0 CA-C-O 122.081 0.943 . . . . 61.1 109.957 -177.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 4.4 p -126.17 116.66 21.67 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 114.724 -1.125 . . . . 74.54 108.773 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -170.71 -156.27 11.26 Favored Glycine 0 N--CA 1.403 -3.547 0 C-N-CA 120.09 -1.053 . . . . 74.31 110.945 -176.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 559' ' ' GLU . . . . . 0.507 ' HB3' HG21 ' A' ' 536' ' ' ILE . 49.1 mt-10 -133.11 126.5 31.88 Favored 'General case' 0 C--N 1.284 -2.269 0 C-N-CA 122.368 0.267 . . . . 74.24 110.37 -176.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . 0.509 ' HG ' ' CE1' ' A' ' 539' ' ' TYR . 74.9 mt -82.42 136.26 34.98 Favored 'General case' 0 CA--C 1.5 -0.948 0 CA-C-N 116.064 -0.516 . . . . 74.22 110.88 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 561' ' ' GLU . . . . . 0.503 ' HG3' HD22 ' A' ' 534' ' ' ASN . 43.1 tt0 -98.32 102.33 14.04 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.096 -0.956 . . . . 75.33 108.9 178.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 562' ' ' PHE . . . . . 0.482 ' CZ ' ' HD3' ' A' ' 527' ' ' ARG . 1.3 t80 -111.37 147.95 34.05 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 106.559 -1.645 . . . . 72.14 106.559 -179.155 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -141.68 179.13 7.01 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 121.559 -0.713 . . . . 73.31 111.065 -173.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -77.63 -35.48 52.62 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 109.314 -0.624 . . . . 74.23 109.314 175.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -84.09 5.04 27.57 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 122.123 0.963 . . . . 74.41 109.599 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -121.56 146.51 46.88 Favored 'General case' 0 N--CA 1.422 -1.869 0 CA-C-N 115.09 -0.959 . . . . 72.4 108.874 -179.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 3.3 pt -135.27 155.92 38.17 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.629 0 N-CA-C 106.707 -1.59 . . . . 71.32 106.707 173.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 568' ' ' VAL . . . . . 0.409 HG21 ' HD2' ' A' ' 524' ' ' LYS . 0.9 OUTLIER 51.01 170.13 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.624 0 C-N-CA 125.52 1.528 . . . . 75.22 112.048 -174.824 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 569' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -159.27 149.58 19.25 Favored 'General case' 0 C--N 1.283 -2.303 0 O-C-N 120.394 -1.441 . . . . 73.32 107.653 176.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 570' ' ' THR . . . . . 0.643 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 9.4 p -124.4 123.8 40.96 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 113.162 0.801 . . . . 61.44 113.162 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 2.8 mp -85.83 114.29 25.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 104.857 -2.275 . . . . 74.22 104.857 171.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 572' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 521' ' ' MET . 24.9 m -102.55 109.2 20.75 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.191 0.52 . . . . 70.4 110.106 -177.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 573' ' ' VAL . . . . . . . . . . . . . 25.5 t -111.53 137.06 45.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 115.735 -0.666 . . . . 70.42 109.687 -176.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -95.05 123.87 38.77 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 124.021 0.826 . . . . 71.34 110.087 178.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 57.9 t -94.33 133.47 35.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 107.03 -1.47 . . . . 71.12 107.03 175.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 576' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' A' ' 553' ' ' PHE . 25.9 mm -98.55 160.3 3.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 109.261 -0.644 . . . . 73.22 109.261 -175.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -64.7 109.51 2.05 Favored 'General case' 0 C--O 1.247 0.94 0 C-N-CA 123.096 0.559 . . . . 74.42 110.054 177.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -55.93 127.7 31.62 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 124.211 0.944 . . . . 71.52 110.913 -172.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -110.32 -30.5 7.67 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 115.752 1.76 . . . . 75.54 115.752 -167.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 580' ' ' GLU . . . . . 0.421 ' HG2' ' CD2' ' A' ' 581' ' ' TYR . 0.0 OUTLIER -103.81 -72.26 0.71 Allowed 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 115.009 1.485 . . . . 75.53 115.009 -162.493 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 581' ' ' TYR . . . . . 0.421 ' CD2' ' HG2' ' A' ' 580' ' ' GLU . 6.3 p90 -141.47 154.03 45.3 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 107.572 -1.27 . . . . 74.25 107.572 -174.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -109.87 108.14 18.34 Favored 'General case' 0 C--N 1.27 -2.854 0 C-N-CA 119.137 -1.025 . . . . 74.43 109.809 -177.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 9.9 mmmm -139.03 169.38 17.89 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 105.73 -1.952 . . . . 73.14 105.73 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -74.94 98.72 3.64 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 108.008 -1.108 . . . . 74.11 108.008 175.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.09 147.21 30.28 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-O 121.202 0.525 . . . . 72.24 111.196 -178.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 4.1 t -152.41 152.12 31.64 Favored 'General case' 0 N--CA 1.422 -1.858 0 CA-C-N 115.372 -0.831 . . . . 75.42 109.643 -175.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -133.83 160.02 38.89 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-N 114.695 -1.139 . . . . 75.4 109.68 177.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 588' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -116.33 138.38 51.38 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 120.625 0.25 . . . . 73.31 110.379 -171.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . 0.462 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.6 OUTLIER -106.28 122.26 45.88 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 105.447 -2.057 . . . . 74.4 105.447 173.161 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -129.6 130.78 46.1 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 107.343 -1.354 . . . . 75.21 107.343 178.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 591' ' ' ILE . . . . . 0.416 HG23 ' HB3' ' A' ' 539' ' ' TYR . 27.4 pt -103.75 147.82 9.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.495 -0.928 . . . . 74.55 108.495 179.027 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -94.29 -168.45 37.33 Favored Glycine 0 N--CA 1.425 -2.1 0 N-CA-C 111.621 -0.591 . . . . 52.23 111.621 -178.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -77.67 127.18 83.06 Favored Pre-proline 0 N--CA 1.428 -1.556 0 N-CA-C 107.881 -1.155 . . . . 74.5 107.881 -178.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 594' ' ' PRO . . . . . 0.604 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 72.0 Cg_endo -71.77 171.17 17.02 Favored 'Trans proline' 0 C--N 1.324 -0.715 0 C-N-CA 123.384 2.722 . . . . 74.3 112.934 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 7.9 ptp85 -150.22 151.41 32.99 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 107.076 -1.453 . . . . 72.34 107.076 177.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -81.04 131.49 35.31 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 104.879 -2.267 . . . . 63.51 104.879 178.144 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 597' ' ' VAL . . . . . 0.493 ' CG2' HG12 ' A' ' 536' ' ' ILE . 99.3 t . . . . . 0 C--N 1.31 -1.133 0 CA-C-O 122.435 1.112 . . . . 62.34 108.584 178.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? . . . . . 0 N--CA 1.442 -0.874 0 N-CA-C 106.862 -1.533 . . . . 74.33 106.862 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . 0.604 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 11.9 Cg_endo -64.94 132.7 33.16 Favored 'Trans proline' 0 N--CA 1.441 -1.588 0 N-CA-C 107.562 -1.745 . . . . 74.43 107.562 167.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.5 pp -112.69 161.28 11.69 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.371 0 C-N-CA 120.194 -0.603 . . . . 70.0 111.442 -178.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 10.0 tt -63.1 154.57 30.55 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 124.34 1.056 . . . . 72.44 112.184 -178.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -79.77 -125.41 0.53 Allowed Glycine 0 N--CA 1.431 -1.664 0 N-CA-C 116.298 1.279 . . . . 71.4 116.298 -173.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 638' ' ' GLU . . . . . 0.44 ' H ' ' HB ' ' A' ' 506' ' ' THR . 34.6 tt0 -90.75 -72.96 0.55 Allowed 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.699 -0.751 . . . . 72.54 112.668 -169.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -130.84 127.93 39.61 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.113 0.483 . . . . 62.12 110.191 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 17.1 p -129.51 92.78 3.41 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-O 121.92 0.867 . . . . 73.22 112.743 -175.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 641' ' ' LYS . . . . . 0.606 ' O ' ' HA ' ' A' ' 510' ' ' PRO . 20.5 tptm -156.12 139.15 15.43 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 106.147 -1.798 . . . . 73.44 106.147 178.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 642' ' ' LEU . . . . . 0.462 ' HB3' ' HB3' ' A' ' 589' ' ' LEU . 21.8 tp -138.21 103.64 4.98 Favored 'General case' 0 N--CA 1.409 -2.491 0 N-CA-C 108.154 -1.054 . . . . 71.3 108.154 173.378 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -93.11 107.63 19.39 Favored 'General case' 0 C--N 1.274 -2.681 0 N-CA-C 106.847 -1.538 . . . . 74.14 106.847 176.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 644' ' ' VAL . . . . . 0.451 HG23 ' HE1' ' A' ' 521' ' ' MET . 24.0 t -93.24 104.89 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.004 0 N-CA-C 109.057 -0.72 . . . . 73.44 109.057 -177.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 4.0 mp -91.22 118.99 37.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 107.281 -1.377 . . . . 73.55 107.281 176.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 646' ' ' ILE . . . . . 0.451 HD12 ' N ' ' A' ' 646' ' ' ILE . 2.5 mp -100.15 108.0 22.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 106.607 -1.627 . . . . 74.25 106.607 -176.078 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -114.23 152.39 31.34 Favored 'General case' 0 C--N 1.281 -2.405 0 O-C-N 123.371 0.42 . . . . 75.24 111.241 -175.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -58.1 133.55 55.67 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.321 -0.854 . . . . 71.22 110.09 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 33.5 t . . . . . 0 N--CA 1.436 -1.151 0 O-C-N 124.218 0.949 . . . . 63.4 112.383 -174.148 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . 0.513 ' HA2' ' OG1' ' A' ' 528' ' ' THR . . . . . . . . 0 N--CA 1.414 -2.812 0 N-CA-C 112.352 -0.299 . . . . 63.34 112.352 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 3.8 mp -123.26 104.95 15.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 N-CA-C 107.756 -1.202 . . . . 75.4 107.756 175.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -118.62 112.42 19.82 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.775 -1.194 . . . . 75.51 107.775 176.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 14.9 t -141.62 155.22 45.74 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 120.392 -0.523 . . . . 75.51 110.25 -174.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -81.19 144.81 31.36 Favored 'General case' 0 CA--C 1.489 -1.372 0 N-CA-C 107.559 -1.274 . . . . 74.51 107.559 175.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -65.28 -43.71 90.3 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 123.88 0.737 . . . . 72.31 109.757 178.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -123.93 125.71 25.8 Favored Pre-proline 0 N--CA 1.425 -1.675 0 CA-C-N 115.625 -0.716 . . . . 75.42 109.257 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 510' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 641' ' ' LYS . 58.4 Cg_endo -73.52 -16.61 24.16 Favored 'Trans proline' 0 CA--C 1.53 0.298 0 C-N-CA 122.163 1.909 . . . . 74.33 111.708 176.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 83.1 t -133.82 131.78 56.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 109.013 -0.736 . . . . 63.23 109.013 178.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 6.0 t -132.84 143.37 49.49 Favored 'General case' 0 N--CA 1.406 -2.65 0 N-CA-C 107.568 -1.271 . . . . 75.03 107.568 178.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 36.1 m-70 -114.59 127.72 55.94 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.379 -0.971 . . . . 62.3 108.379 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.535 HG13 ' SD ' ' A' ' 521' ' ' MET . 34.1 m -124.86 158.94 32.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-O 121.015 0.436 . . . . 74.51 111.128 -174.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 515' ' ' SER . . . . . 0.401 ' O ' HG23 ' A' ' 518' ' ' ILE . 34.9 t -77.74 148.91 34.64 Favored 'General case' 0 N--CA 1.414 -2.227 0 CA-C-N 115.22 -0.9 . . . . 72.51 110.787 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -68.45 -17.67 64.25 Favored 'General case' 0 N--CA 1.422 -1.844 0 CA-C-N 114.827 -1.079 . . . . 75.0 108.512 172.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 43.6 m -108.75 22.06 16.43 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 116.056 -0.52 . . . . 73.42 111.375 -176.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 518' ' ' ILE . . . . . 0.401 HG23 ' O ' ' A' ' 515' ' ' SER . 16.1 tt -92.36 159.68 2.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 109.317 -0.623 . . . . 73.2 109.317 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . -106.22 -67.08 0.67 Allowed Glycine 0 N--CA 1.417 -2.621 0 C-N-CA 120.281 -0.962 . . . . 74.42 111.179 177.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 33.5 mm -120.66 124.2 71.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 109.604 -0.517 . . . . 61.41 109.604 -177.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 521' ' ' MET . . . . . 0.535 ' SD ' HG13 ' A' ' 514' ' ' VAL . 24.6 ptt? -103.86 137.73 41.45 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 107.109 -1.441 . . . . 74.12 107.109 172.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 15.8 mp0 -114.16 97.37 6.31 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 108.788 -0.819 . . . . 72.03 108.788 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . 0.573 ' O ' ' HA ' ' A' ' 570' ' ' THR . 26.5 t -84.26 131.72 33.27 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 CA-C-N 116.1 -0.5 . . . . 62.2 110.308 -177.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -85.27 128.14 34.58 Favored 'General case' 0 C--O 1.247 0.966 0 N-CA-C 113.211 0.819 . . . . 74.34 113.211 -176.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 21.6 t -117.35 123.84 72.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 CA-C-N 114.251 -1.341 . . . . 75.25 107.773 177.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -81.69 141.71 33.36 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 109.487 -0.56 . . . . 74.44 109.487 -176.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . 0.459 ' HG2' ' N ' ' A' ' 528' ' ' THR . 39.3 ttp180 -86.77 161.06 18.58 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.498 -0.774 . . . . 71.31 110.851 -175.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 528' ' ' THR . . . . . 0.513 ' OG1' ' HA2' ' A' ' 503' ' ' GLY . 5.7 t -67.68 142.53 56.32 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-N 115.11 -0.95 . . . . 71.12 110.478 173.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 21.9 t -63.85 -38.85 92.64 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 115.216 -0.902 . . . . 73.32 108.924 176.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -100.37 80.14 0.47 Allowed Glycine 0 N--CA 1.431 -1.679 0 N-CA-C 110.329 -1.108 . . . . 51.34 110.329 177.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -93.68 107.8 19.62 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 109.279 -0.637 . . . . 72.52 109.279 178.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 19.4 mmt180 -119.49 111.06 17.64 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 120.889 0.376 . . . . 72.32 110.723 -179.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 89.33 -126.45 8.24 Favored Glycine 0 N--CA 1.426 -2.022 0 C-N-CA 120.111 -1.042 . . . . 74.42 113.504 175.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 534' ' ' ASN . . . . . 0.495 HD22 ' HG3' ' A' ' 561' ' ' GLU . 2.6 t-20 -135.85 124.16 23.27 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.278 -1.008 . . . . 74.41 108.278 -177.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 72.1 t -125.04 125.42 69.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 109.326 -0.62 . . . . 75.41 109.326 -178.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 536' ' ' ILE . . . . . 0.414 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 36.6 mm -100.57 125.03 54.48 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.134 0 CA-C-N 115.447 -0.797 . . . . 72.53 109.103 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 30.0 t -116.82 112.41 40.53 Favored Pre-proline 0 C--N 1.312 -1.031 0 CA-C-N 116.202 -0.454 . . . . 64.52 110.682 -176.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -74.28 140.62 27.83 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.481 2.121 . . . . 74.31 112.227 177.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 539' ' ' TYR . . . . . 0.489 ' CD1' ' HG ' ' A' ' 560' ' ' LEU . 48.5 p90 -140.99 156.18 46.09 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.004 -1.11 . . . . 73.54 108.004 -179.39 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -154.99 157.82 38.24 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 123.28 0.362 . . . . 73.12 110.659 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 1.6 p -95.09 124.6 39.22 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 115.1 -0.954 . . . . 75.5 108.812 174.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.5 mp -93.35 128.35 44.85 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 106.275 -1.75 . . . . 74.05 106.275 175.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -57.9 -50.23 74.03 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 123.782 0.677 . . . . 72.3 111.377 -176.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 69.4 -101.59 0.85 Allowed Glycine 0 N--CA 1.434 -1.477 0 CA-C-N 115.652 -0.703 . . . . 63.43 111.973 178.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 10.0 t -125.89 14.72 8.0 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 122.323 1.058 . . . . 72.01 109.26 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -116.94 152.92 33.53 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.114 -1.069 . . . . 64.45 108.114 176.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . 0.455 ' HG2' ' HG3' ' A' ' 551' ' ' GLU . 31.8 ttp180 -89.47 130.1 35.86 Favored 'General case' 0 N--CA 1.422 -1.841 0 CA-C-O 121.101 0.477 . . . . 74.34 111.116 -178.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -96.49 -176.92 35.73 Favored Glycine 0 C--N 1.301 -1.402 0 C-N-CA 120.884 -0.674 . . . . 73.24 112.774 -175.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 80.72 26.63 53.39 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.927 -0.654 . . . . 71.45 113.002 177.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 92.08 11.29 60.21 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.743 -0.742 . . . . 74.34 112.953 177.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . 0.455 ' HG3' ' HG2' ' A' ' 547' ' ' ARG . 5.8 mm-40 -88.99 -70.51 0.65 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 117.273 0.537 . . . . 54.4 110.287 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -98.86 -27.02 14.1 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.575 -0.898 . . . . 74.23 108.575 174.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 553' ' ' PHE . . . . . 0.627 ' HB3' ' CE2' ' A' ' 587' ' ' PHE . 40.8 p90 -151.46 154.2 36.11 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.569 -0.741 . . . . 75.25 110.055 176.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.99 129.6 34.81 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 104.948 -2.241 . . . . 75.0 104.948 174.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -86.19 113.48 22.25 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.212 0.529 . . . . 71.3 111.112 -172.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 11.3 t -111.51 104.85 13.3 Favored 'General case' 0 N--CA 1.415 -2.206 0 CA-C-O 122.443 1.116 . . . . 74.54 110.587 -176.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 1.6 p -123.8 110.94 15.53 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 114.778 -1.101 . . . . 74.21 109.295 176.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -163.01 -153.91 7.42 Favored Glycine 0 N--CA 1.418 -2.547 0 N-CA-C 110.296 -1.122 . . . . 54.33 110.296 -175.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 559' ' ' GLU . . . . . 0.414 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 39.0 mt-10 -137.99 136.34 36.83 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 120.77 0.319 . . . . 75.04 111.084 -176.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . 0.489 ' HG ' ' CD1' ' A' ' 539' ' ' TYR . 82.7 mt -93.85 147.82 22.72 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.375 -0.83 . . . . 74.43 109.866 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 561' ' ' GLU . . . . . 0.495 ' HG3' HD22 ' A' ' 534' ' ' ASN . 40.4 tt0 -104.82 107.73 18.84 Favored 'General case' 0 N--CA 1.424 -1.754 0 CA-C-O 121.213 0.53 . . . . 74.55 112.152 -178.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -101.74 146.86 27.17 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.443 -0.947 . . . . 72.21 108.443 172.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . 0.4 ' HB2' ' H ' ' A' ' 566' ' ' GLU . 51.7 mt-30 -144.2 -176.66 5.1 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 108.171 -1.048 . . . . 73.25 108.171 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -74.77 -31.58 61.81 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 107.76 -1.2 . . . . 75.32 107.76 174.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -78.87 -49.47 12.82 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.796 -1.093 . . . . 74.11 110.384 177.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 566' ' ' GLU . . . . . 0.4 ' H ' ' HB2' ' A' ' 563' ' ' GLN . 59.6 mm-40 -65.53 139.41 58.47 Favored 'General case' 0 CA--C 1.503 -0.838 0 CA-C-N 115.725 -0.67 . . . . 71.23 112.276 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 567' ' ' ILE . . . . . 0.451 ' HA ' ' HD3' ' A' ' 527' ' ' ARG . 21.6 pt -115.8 -170.67 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.412 -2.372 0 N-CA-C 105.649 -1.982 . . . . 74.33 105.649 172.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 3.1 p 0.55 127.71 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.07 0 C-N-CA 128.027 2.531 . . . . 74.21 116.682 173.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 569' ' ' LYS . . . . . 0.461 ' HA ' ' HE2' ' A' ' 569' ' ' LYS . 8.8 mmpt? -105.74 164.69 11.73 Favored 'General case' 0 C--N 1.271 -2.835 0 CA-C-N 114.683 -1.144 . . . . 74.24 109.605 178.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 570' ' ' THR . . . . . 0.573 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 5.1 p -137.58 119.3 15.08 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.068 -0.969 . . . . 52.35 110.781 178.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 3.4 mp -86.92 106.4 15.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 107.291 -1.374 . . . . 74.21 107.291 176.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 4.1 p -84.27 109.13 17.55 Favored 'General case' 0 N--CA 1.415 -2.204 0 O-C-N 123.976 0.798 . . . . 65.31 109.685 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 573' ' ' VAL . . . . . . . . . . . . . 44.0 t -113.89 128.44 70.81 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 N-CA-C 108.75 -0.833 . . . . 74.5 108.75 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 574' ' ' LYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 519' ' ' GLY . 58.8 tptt -83.4 103.49 12.8 Favored 'General case' 0 N--CA 1.417 -2.116 0 O-C-N 124.087 0.867 . . . . 75.41 108.827 177.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 71.5 t -78.75 135.1 26.56 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 105.995 -1.854 . . . . 65.53 105.995 176.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 32.3 mm -98.64 139.88 19.59 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 N-CA-C 108.715 -0.846 . . . . 72.12 108.715 -176.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -53.43 117.44 3.08 Favored 'General case' 0 C--O 1.244 0.783 0 O-C-N 124.302 1.001 . . . . 73.51 108.558 175.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 578' ' ' ASP . . . . . 0.449 ' OD2' ' HB2' ' A' ' 582' ' ' GLU . 25.3 t70 -62.29 120.28 10.69 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.265 -0.879 . . . . 55.31 112.462 -173.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -81.78 -19.13 41.9 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 114.55 1.315 . . . . 75.51 114.55 -172.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -131.38 -164.02 1.39 Allowed 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 119.668 -0.813 . . . . 75.22 110.703 -177.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -62.74 152.36 35.93 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 107.444 -1.317 . . . . 73.43 107.444 173.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 582' ' ' GLU . . . . . 0.449 ' HB2' ' OD2' ' A' ' 578' ' ' ASP . 42.5 tt0 -122.2 110.47 15.77 Favored 'General case' 0 N--CA 1.411 -2.39 0 C-N-CA 118.298 -1.361 . . . . 74.24 113.256 -172.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -79.54 -179.72 7.0 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 113.79 -1.55 . . . . 74.33 107.333 173.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -77.47 84.17 3.87 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 106.455 -1.683 . . . . 74.42 106.455 172.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . 0.262 0.0 OUTLIER -108.61 145.06 35.49 Favored 'General case' 0 N--CA 1.414 -2.262 0 CA-C-N 115.512 -0.767 . . . . 73.33 111.426 178.329 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 586' ' ' THR . . . . . 0.408 ' HG1' ' C ' ' A' ' 644' ' ' VAL . 2.9 t -151.39 149.35 29.21 Favored 'General case' 0 N--CA 1.397 -3.094 0 CA-C-N 114.93 -1.032 . . . . 74.45 110.232 -174.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 587' ' ' PHE . . . . . 0.627 ' CE2' ' HB3' ' A' ' 553' ' ' PHE . 2.2 p90 -117.97 146.77 43.76 Favored 'General case' 0 N--CA 1.416 -2.171 0 CA-C-N 114.097 -1.411 . . . . 74.14 107.789 176.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 588' ' ' PHE . . . . . 0.519 ' HA ' ' O ' ' A' ' 642' ' ' LEU . 17.1 m-85 -107.36 142.87 36.48 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 120.707 -0.397 . . . . 73.42 110.218 -171.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.17 125.6 54.3 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 106.424 -1.695 . . . . 73.23 106.424 175.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -133.75 149.22 51.46 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 109.087 -0.708 . . . . 70.35 109.087 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 591' ' ' ILE . . . . . . . . . . . . . 27.5 pt -109.16 147.97 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.348 0 N-CA-C 108.485 -0.931 . . . . 74.43 108.485 176.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -102.38 -140.3 10.96 Favored Glycine 0 C--N 1.302 -1.344 0 C-N-CA 120.631 -0.795 . . . . 52.42 112.529 -177.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -77.8 115.06 47.01 Favored Pre-proline 0 C--N 1.315 -0.934 0 C-N-CA 122.623 0.369 . . . . 73.44 110.041 179.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.93 146.15 29.13 Favored 'Trans proline' 0 N--CA 1.444 -1.434 0 C-N-CA 121.577 1.518 . . . . 72.1 109.182 176.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 3.2 ptp180 -123.03 138.26 54.73 Favored 'General case' 0 C--N 1.297 -1.674 0 C-N-CA 119.561 -0.856 . . . . 75.04 110.527 -174.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -86.69 118.23 25.96 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 107.42 -1.326 . . . . 54.41 107.42 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 59.2 t . . . . . 0 C--N 1.304 -1.411 0 N-CA-C 108.534 -0.914 . . . . 72.43 108.534 -179.346 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 . . . . . 0 N--CA 1.427 -1.579 0 N-CA-C 107.239 -1.393 . . . . 74.14 107.239 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -79.28 153.31 24.28 Favored 'Trans proline' 0 N--CA 1.429 -2.267 0 N-CA-C 107.937 -1.601 . . . . 70.11 107.937 166.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 8.8 pt -122.86 -178.99 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 C-N-CA 119.7 -0.8 . . . . 72.11 109.98 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.55 -176.67 4.16 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 115.835 -0.621 . . . . 71.22 109.631 -178.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -83.54 -125.16 1.07 Allowed Glycine 0 N--CA 1.429 -1.811 0 C-N-CA 120.694 -0.765 . . . . 62.42 113.263 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -114.5 -59.94 1.95 Allowed 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 115.121 -0.54 . . . . 74.24 110.243 -176.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -107.52 93.82 4.75 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 122.068 0.937 . . . . 75.42 111.445 -178.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 23.7 p -109.46 91.27 3.58 Favored 'General case' 0 N--CA 1.41 -2.453 0 CA-C-N 115.389 -0.823 . . . . 73.5 109.788 178.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 641' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 510' ' ' PRO . 0.3 OUTLIER -168.92 129.26 1.13 Allowed 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 104.305 -2.48 . . . . 73.01 104.305 -178.021 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 642' ' ' LEU . . . . . 0.519 ' O ' ' HA ' ' A' ' 588' ' ' PHE . 37.0 tp -125.4 112.78 16.7 Favored 'General case' 0 C--N 1.276 -2.588 0 N-CA-C 108.094 -1.076 . . . . 71.14 108.094 175.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . 0.406 ' HB2' ' HE2' ' A' ' 641' ' ' LYS . 23.6 tt0 -98.07 107.2 19.63 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 107.175 -1.417 . . . . 74.45 107.175 177.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 644' ' ' VAL . . . . . 0.46 HG23 ' HE3' ' A' ' 521' ' ' MET . 26.6 t -95.05 103.18 14.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 N-CA-C 109.193 -0.669 . . . . 71.24 109.193 -178.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 3.9 mp -89.79 120.93 39.39 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 N-CA-C 108.401 -0.963 . . . . 74.43 108.401 178.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 646' ' ' ILE . . . . . 0.48 HD11 ' CE2' ' A' ' 587' ' ' PHE . 1.5 mp -104.83 128.64 58.38 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.764 0 N-CA-C 104.982 -2.229 . . . . 74.15 104.982 -178.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -147.22 170.66 16.77 Favored 'General case' 0 C--N 1.282 -2.356 0 O-C-N 123.551 0.532 . . . . 75.22 112.078 -176.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -52.77 137.45 31.57 Favored 'General case' 0 C--O 1.249 1.037 0 CA-C-N 114.738 -1.119 . . . . 74.32 109.692 178.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 9.4 t . . . . . 0 N--CA 1.422 -1.842 0 CA-C-O 121.945 0.879 . . . . 74.24 111.897 -174.29 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . 0.646 ' HA2' ' OG1' ' A' ' 528' ' ' THR . . . . . . . . 0 N--CA 1.403 -3.505 0 N-CA-C 110.585 -1.006 . . . . 74.34 110.585 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 3.1 mp -90.38 103.61 14.47 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.475 0 N-CA-C 108.783 -0.821 . . . . 62.13 108.783 177.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -117.15 109.37 16.83 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 106.728 -1.582 . . . . 75.34 106.728 175.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 12.5 t -150.62 164.39 36.17 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 109.196 -0.668 . . . . 73.42 109.196 -175.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -96.53 165.2 12.28 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.075 -1.083 . . . . 73.12 108.075 175.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.1 -30.97 9.89 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 120.781 -0.367 . . . . 74.42 111.919 175.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -107.85 123.7 37.04 Favored Pre-proline 0 C--N 1.311 -1.091 0 N-CA-C 108.714 -0.847 . . . . 75.22 108.714 173.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -82.43 -13.11 9.97 Favored 'Trans proline' 0 CA--C 1.532 0.381 0 C-N-CA 121.926 1.75 . . . . 75.11 111.549 177.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . 0.412 HG21 ' HB3' ' A' ' 643' ' ' GLU . 75.2 t -138.74 133.19 41.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 108.524 -0.917 . . . . 71.33 108.524 -179.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 5.4 t -136.45 145.86 45.7 Favored 'General case' 0 N--CA 1.41 -2.45 0 N-CA-C 108.613 -0.884 . . . . 71.3 108.613 176.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 27.8 m-70 -110.46 137.82 47.66 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.935 -0.765 . . . . 65.51 108.935 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.574 HG12 ' SD ' ' A' ' 521' ' ' MET . 27.7 m -126.74 151.53 33.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-O 121.197 0.522 . . . . 73.24 110.432 179.15 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 515' ' ' SER . . . . . 0.402 ' O ' HG21 ' A' ' 518' ' ' ILE . 43.5 t -76.32 146.95 38.49 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 107.849 -1.167 . . . . 74.24 107.849 176.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . 0.684 ' HB2' ' O ' ' A' ' 647' ' ' GLU . 33.4 tt0 -74.98 -7.4 53.52 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-O 121.905 0.86 . . . . 74.25 109.683 176.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 10.7 t -110.28 22.72 15.18 Favored 'General case' 0 N--CA 1.415 -2.207 0 N-CA-C 108.382 -0.97 . . . . 75.03 108.382 -177.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 518' ' ' ILE . . . . . 0.402 HG21 ' O ' ' A' ' 515' ' ' SER . 15.0 tt -94.02 155.61 3.18 Favored 'Isoleucine or valine' 0 C--O 1.247 0.948 0 N-CA-C 109.087 -0.708 . . . . 74.34 109.087 178.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -101.42 -70.45 0.89 Allowed Glycine 0 N--CA 1.419 -2.457 0 N-CA-C 110.66 -0.976 . . . . 65.33 110.66 177.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 32.3 mm -116.81 114.04 44.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 CA-C-O 120.689 0.28 . . . . 62.11 111.029 -177.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 521' ' ' MET . . . . . 0.574 ' SD ' HG12 ' A' ' 514' ' ' VAL . 24.7 ptt? -92.98 137.65 32.17 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.755 -1.202 . . . . 75.15 107.755 173.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -123.76 114.64 20.19 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 121.4 0.619 . . . . 75.23 110.794 178.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . 0.541 ' O ' ' HA ' ' A' ' 570' ' ' THR . 20.5 t -103.54 138.09 29.35 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 CA-C-N 114.639 -1.164 . . . . 75.23 108.414 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp -85.13 145.89 27.4 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.664 0.745 . . . . 73.34 112.329 -177.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 7.9 t -123.13 131.49 73.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 106.49 -1.67 . . . . 72.01 106.49 175.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -77.54 140.6 39.76 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.064 -0.717 . . . . 75.24 109.064 -178.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . 0.469 ' HG3' ' HA ' ' A' ' 567' ' ' ILE . 2.7 tmm_? -96.12 135.29 38.1 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 109.202 -0.666 . . . . 70.34 109.202 -176.1 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 528' ' ' THR . . . . . 0.646 ' OG1' ' HA2' ' A' ' 503' ' ' GLY . 6.0 t -50.85 147.04 5.26 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 125.083 1.353 . . . . 73.14 114.557 -177.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 35.2 t -63.21 -55.11 27.72 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 114.55 -1.204 . . . . 51.31 107.811 173.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -85.95 95.5 2.02 Favored Glycine 0 N--CA 1.423 -2.171 0 N-CA-C 109.5 -1.44 . . . . 64.03 109.5 178.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -111.64 98.93 7.77 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 121.092 0.472 . . . . 64.44 110.24 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -125.01 131.78 53.35 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 109.299 -0.63 . . . . 75.44 109.299 177.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 81.07 -144.54 24.94 Favored Glycine 0 N--CA 1.422 -2.286 0 C-N-CA 120.828 -0.701 . . . . 60.34 113.254 175.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -140.2 121.74 15.18 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 107.858 -1.164 . . . . 72.02 107.858 179.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 58.1 t -126.75 131.74 70.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 108.803 -0.814 . . . . 75.02 108.803 -178.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 536' ' ' ILE . . . . . 0.606 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 42.5 mm -94.92 129.63 44.81 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 108.888 -0.782 . . . . 74.12 108.888 178.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 67.9 t -111.97 110.73 54.04 Favored Pre-proline 0 C--N 1.295 -1.783 0 N-CA-C 109.37 -0.604 . . . . 75.54 109.37 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -73.96 155.95 47.88 Favored 'Trans proline' 0 CA--C 1.512 -0.625 0 C-N-CA 122.513 2.142 . . . . 72.2 111.495 178.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 539' ' ' TYR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 591' ' ' ILE . 48.2 p90 -150.41 156.34 41.3 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.295 -1.002 . . . . 74.43 108.295 177.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -152.44 147.9 26.81 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 112.188 0.44 . . . . 74.55 112.188 176.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 3.5 p -84.34 120.92 26.82 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-N 115.474 -0.785 . . . . 72.55 110.94 176.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.8 mp -88.84 119.92 36.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 N-CA-C 105.728 -1.953 . . . . 71.05 105.728 173.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -52.47 -41.01 62.97 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 124.479 1.112 . . . . 75.43 112.716 -174.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 72.34 -92.05 0.57 Allowed Glycine 0 N--CA 1.435 -1.369 0 N-CA-C 110.825 -0.91 . . . . 73.41 110.825 178.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 10.2 t -146.14 18.13 1.39 Allowed 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 121.382 0.611 . . . . 72.3 109.812 177.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -101.08 161.03 13.89 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.619 -1.252 . . . . 64.42 107.619 176.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 18.5 mmm180 -63.86 173.23 1.88 Allowed 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 113.75 1.019 . . . . 74.24 113.75 -179.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -71.34 -178.47 28.7 Favored Glycine 0 C--O 1.254 1.355 0 CA-C-N 114.254 -1.339 . . . . 62.11 114.281 -175.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . -59.87 119.38 18.09 Favored Glycine 0 N--CA 1.441 -1.005 0 CA-C-N 114.737 -0.731 . . . . 74.51 113.287 -176.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 95.28 -10.41 69.51 Favored Glycine 0 N--CA 1.435 -1.399 0 N-CA-C 111.712 -0.555 . . . . 63.42 111.712 178.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -98.51 -68.36 0.81 Allowed 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.782 -0.822 . . . . 71.35 108.782 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -94.22 -38.29 11.13 Favored 'General case' 0 CA--C 1.492 -1.264 0 C-N-CA 118.862 -1.135 . . . . 74.22 111.414 175.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 553' ' ' PHE . . . . . 0.407 ' HB3' ' CE2' ' A' ' 587' ' ' PHE . 48.0 p90 -145.04 155.63 43.47 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 108.316 -0.994 . . . . 71.52 108.316 -179.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -83.56 119.24 24.48 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 105.329 -2.1 . . . . 75.02 105.329 174.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -73.53 104.23 4.42 Favored 'General case' 0 CA--C 1.498 -1.035 0 CA-C-O 121.267 0.556 . . . . 61.33 110.043 -175.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 556' ' ' THR . . . . . 0.423 HG22 HG21 ' A' ' 573' ' ' VAL . 11.5 t -103.36 100.8 10.69 Favored 'General case' 0 N--CA 1.395 -3.175 0 CA-C-O 122.793 1.282 . . . . 64.52 110.978 -176.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 1.8 p -116.61 94.45 4.62 Favored 'General case' 0 N--CA 1.409 -2.502 0 CA-C-N 114.085 -1.416 . . . . 71.41 108.47 174.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -142.34 -157.54 7.19 Favored Glycine 0 N--CA 1.407 -3.291 0 N-CA-C 110.029 -1.228 . . . . 71.0 110.029 -174.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 559' ' ' GLU . . . . . 0.606 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 49.3 mt-10 -142.23 137.09 30.48 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 120.647 0.26 . . . . 63.14 111.315 -173.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 95.5 mt -96.82 144.94 26.31 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 123.415 0.686 . . . . 72.24 109.681 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -102.88 113.25 26.54 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 120.923 0.392 . . . . 74.52 110.665 -178.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -109.08 132.51 54.04 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 110.076 -0.342 . . . . 70.21 110.076 175.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -121.96 174.22 7.04 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.457 -0.897 . . . . 75.43 111.343 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -64.68 -38.03 89.59 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 114.122 -1.399 . . . . 65.34 110.222 176.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -94.34 -33.89 13.01 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.529 -0.76 . . . . 62.13 112.269 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -78.19 132.15 37.47 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.51 -0.313 . . . . 71.13 111.681 -177.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 567' ' ' ILE . . . . . 0.469 ' HA ' ' HG3' ' A' ' 527' ' ' ARG . 7.8 pt -109.94 163.29 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.617 0 N-CA-C 109.732 -0.47 . . . . 75.44 109.732 178.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 568' ' ' VAL . . . . . 0.504 ' O ' ' HG2' ' A' ' 569' ' ' LYS . 1.4 p 45.53 171.93 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.574 1.882 0 C-N-CA 127.278 2.231 . . . . 72.54 114.553 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 569' ' ' LYS . . . . . 0.504 ' HG2' ' O ' ' A' ' 568' ' ' VAL . 0.0 OUTLIER -158.98 163.98 35.97 Favored 'General case' 0 CA--C 1.497 -1.095 0 C-N-CA 124.39 1.076 . . . . 73.31 108.235 173.698 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 570' ' ' THR . . . . . 0.541 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 4.7 p -135.4 133.96 39.22 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 124.112 0.883 . . . . 74.44 110.352 177.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 3.3 mp -93.03 106.26 17.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 106.618 -1.623 . . . . 74.5 106.618 172.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 572' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' A' ' 521' ' ' MET . 13.0 p -88.14 112.02 22.24 Favored 'General case' 0 N--CA 1.424 -1.733 0 O-C-N 123.575 0.547 . . . . 74.44 109.797 178.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 573' ' ' VAL . . . . . 0.423 HG21 HG22 ' A' ' 556' ' ' THR . 42.4 t -115.54 131.22 68.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 109.148 -0.686 . . . . 75.23 109.148 -178.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -88.01 112.69 22.88 Favored 'General case' 0 N--CA 1.423 -1.784 0 O-C-N 123.929 0.768 . . . . 74.33 109.516 176.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 62.9 t -85.88 133.61 29.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 N-CA-C 106.42 -1.696 . . . . 73.24 106.42 176.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 25.8 mm -97.78 159.9 3.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 107.914 -1.143 . . . . 74.42 107.914 -174.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -71.35 114.22 9.19 Favored 'General case' 0 C--O 1.25 1.13 0 N-CA-C 110.007 -0.368 . . . . 74.22 110.007 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -56.82 142.71 39.91 Favored 'General case' 0 C--O 1.246 0.921 0 C-N-CA 124.614 1.166 . . . . 72.42 110.969 -176.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 579' ' ' GLU . . . . . 0.432 ' OE1' ' HG3' ' A' ' 580' ' ' GLU . 0.0 OUTLIER -124.88 -28.35 3.5 Favored 'General case' 0 C--N 1.289 -2.055 0 C-N-CA 125.115 1.366 . . . . 75.32 112.31 -170.439 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 580' ' ' GLU . . . . . 0.432 ' HG3' ' OE1' ' A' ' 579' ' ' GLU 0.3 0.0 OUTLIER -111.49 174.07 6.04 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 114.647 1.351 . . . . 71.32 114.647 -172.653 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 31.7 p90 -48.8 148.02 2.38 Favored 'General case' 0 CA--C 1.522 -0.122 0 O-C-N 124.778 1.298 . . . . 71.33 110.287 -178.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -122.99 106.5 10.9 Favored 'General case' 0 N--CA 1.408 -2.573 0 C-N-CA 118.265 -1.374 . . . . 75.34 114.177 -173.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -98.45 -158.48 0.67 Allowed 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 104.902 -2.258 . . . . 74.01 104.902 169.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -83.05 88.34 6.87 Favored 'General case' 0 C--N 1.282 -2.353 0 C-N-CA 118.903 -1.119 . . . . 73.03 108.4 174.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . 0.315 0.5 OUTLIER -100.85 138.36 38.0 Favored 'General case' 0 N--CA 1.425 -1.684 0 C-N-CA 119.429 -0.908 . . . . 75.22 111.81 -179.014 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 4.1 t -152.42 150.21 29.41 Favored 'General case' 0 N--CA 1.405 -2.681 0 CA-C-N 114.699 -1.137 . . . . 74.44 109.79 -175.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 587' ' ' PHE . . . . . 0.407 ' CE2' ' HB3' ' A' ' 553' ' ' PHE . 4.1 p90 -124.35 151.23 44.59 Favored 'General case' 0 N--CA 1.411 -2.395 0 CA-C-N 114.221 -1.354 . . . . 71.13 108.335 176.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 588' ' ' PHE . . . . . 0.494 ' HA ' ' O ' ' A' ' 642' ' ' LEU . 16.5 m-85 -113.35 142.04 46.33 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 116.471 -0.331 . . . . 64.42 110.281 -171.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.71 131.7 54.14 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 106.481 -1.674 . . . . 75.1 106.481 175.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -141.77 144.4 33.95 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.396 -0.964 . . . . 64.14 108.396 -179.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 591' ' ' ILE . . . . . 0.544 HG12 ' OG1' ' A' ' 640' ' ' THR . 20.0 pt -96.37 168.01 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 O-C-N 123.699 0.624 . . . . 74.33 109.691 177.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -118.03 -154.27 9.76 Favored Glycine 0 C--N 1.303 -1.288 0 C-N-CA 120.444 -0.884 . . . . 71.23 113.675 -177.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -76.93 118.24 70.47 Favored Pre-proline 0 C--N 1.319 -0.751 0 N-CA-C 108.664 -0.865 . . . . 73.02 108.664 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -66.72 138.19 48.28 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 122.398 2.065 . . . . 73.32 112.071 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 595' ' ' ARG . . . . . 0.535 ' CG ' ' HB ' ' A' ' 536' ' ' ILE . 7.2 ptm180 -116.03 119.48 36.02 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.69 -0.686 . . . . 75.13 109.822 -174.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.96 129.0 38.31 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 107.92 -1.141 . . . . 73.15 107.92 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 597' ' ' VAL . . . . . 0.476 ' CG2' HG12 ' A' ' 536' ' ' ILE . 11.6 t . . . . . 0 C--N 1.317 -0.842 0 CA-C-O 122.696 1.236 . . . . 70.24 108.286 178.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 . . . . . 0 C--O 1.218 -0.57 0 N-CA-C 108.773 -0.825 . . . . 74.41 108.773 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -74.31 154.17 45.89 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.39 2.06 . . . . 70.41 113.188 -175.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 1.9 pp -144.09 -169.81 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.31 -0.859 . . . . 75.43 110.775 -176.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.61 164.1 19.94 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 123.082 0.239 . . . . 73.32 110.621 -179.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -81.16 -85.29 0.7 Allowed Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 121.317 -0.468 . . . . 71.45 113.78 -177.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -143.02 -63.58 0.41 Allowed 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 120.465 -0.494 . . . . 74.44 110.425 -178.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 10.7 p80 -127.68 114.77 17.77 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-O 121.913 0.864 . . . . 75.43 111.598 178.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 640' ' ' THR . . . . . 0.544 ' OG1' HG12 ' A' ' 591' ' ' ILE . 0.7 OUTLIER -111.4 92.28 3.98 Favored 'General case' 0 N--CA 1.416 -2.131 0 CA-C-N 114.811 -1.086 . . . . 62.33 109.674 177.361 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -169.88 125.44 0.81 Allowed 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 106.503 -1.666 . . . . 63.45 106.503 178.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 642' ' ' LEU . . . . . 0.494 ' O ' ' HA ' ' A' ' 588' ' ' PHE . 31.3 tp -130.43 110.09 11.21 Favored 'General case' 0 C--N 1.277 -2.553 0 N-CA-C 108.312 -0.996 . . . . 72.54 108.312 177.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . 0.412 ' HB3' HG21 ' A' ' 511' ' ' VAL . 43.1 tt0 -92.31 107.22 19.05 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.062 -1.088 . . . . 73.53 108.062 178.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 644' ' ' VAL . . . . . 0.457 HG22 ' HE3' ' A' ' 521' ' ' MET . 24.3 t -97.73 104.56 16.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 109.248 -0.649 . . . . 74.22 109.248 -179.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 4.5 mp -86.69 128.21 39.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 108.903 -0.777 . . . . 73.32 108.903 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 646' ' ' ILE . . . . . 0.448 ' N ' HD13 ' A' ' 646' ' ' ILE . 1.2 mp -110.81 106.94 21.73 Favored 'Isoleucine or valine' 0 C--O 1.255 1.377 0 N-CA-C 108.158 -1.053 . . . . 73.34 108.158 -177.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . 0.684 ' O ' ' HB2' ' A' ' 516' ' ' GLU . 8.0 pt-20 -109.19 -161.4 0.76 Allowed 'General case' 0 C--N 1.268 -2.958 0 CA-C-N 113.718 -1.583 . . . . 75.31 107.864 -178.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -81.5 -173.1 4.19 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.3 -0.63 . . . . 74.1 109.3 177.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 23.1 t . . . . . 0 C--N 1.299 -1.59 0 N-CA-C 108.213 -1.032 . . . . 64.3 108.213 175.965 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . 0.457 ' HA2' ' OG1' ' A' ' 528' ' ' THR . . . . . . . . 0 N--CA 1.409 -3.113 0 N-CA-C 112.248 -0.341 . . . . 71.22 112.248 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . 0.425 ' H ' ' CB ' ' A' ' 528' ' ' THR . 3.1 mp -93.57 98.46 8.28 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 N-CA-C 107.826 -1.176 . . . . 74.34 107.826 174.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -113.9 114.73 26.63 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.922 -1.14 . . . . 72.5 107.922 176.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 506' ' ' THR . . . . . 0.424 ' HB ' ' HA3' ' A' ' 637' ' ' GLY . 15.0 t -149.02 162.66 39.49 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.876 -0.787 . . . . 74.23 108.876 -176.183 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -81.71 152.19 27.17 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 108.023 -1.103 . . . . 74.12 108.023 176.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -76.14 -24.85 54.9 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.551 0.691 . . . . 71.34 109.691 178.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -139.45 132.78 15.58 Favored Pre-proline 0 N--CA 1.424 -1.765 0 CA-C-N 115.144 -0.935 . . . . 72.2 108.683 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 510' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 641' ' ' LYS . 84.5 Cg_endo -84.33 0.33 9.19 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 122.122 1.881 . . . . 72.33 112.202 176.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . 0.443 HG23 ' HB3' ' A' ' 643' ' ' GLU . 69.3 t -145.57 135.33 18.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 124.193 0.997 . . . . 73.34 108.413 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 6.2 t -142.03 140.79 32.73 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.198 -1.408 . . . . 64.25 107.198 177.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -110.79 133.55 53.25 Favored 'General case' 0 CA--C 1.492 -1.258 0 N-CA-C 108.325 -0.991 . . . . 73.3 108.325 178.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.655 HG13 ' SD ' ' A' ' 521' ' ' MET . 34.0 m -129.62 159.89 41.18 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 CA-C-N 116.209 -0.451 . . . . 73.24 110.288 -174.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 515' ' ' SER . . . . . 0.401 ' HB3' ' HB ' ' A' ' 518' ' ' ILE . 47.3 t -77.7 150.48 34.47 Favored 'General case' 0 N--CA 1.415 -2.216 0 N-CA-C 107.564 -1.273 . . . . 75.45 107.564 177.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -88.43 -7.06 57.22 Favored 'General case' 0 C--N 1.286 -2.156 0 CA-C-O 122.315 1.055 . . . . 70.24 108.946 178.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 33.0 t -100.29 2.43 42.62 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 114.97 -1.014 . . . . 75.21 109.16 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 518' ' ' ILE . . . . . 0.401 ' HB ' ' HB3' ' A' ' 515' ' ' SER . 15.0 tt -78.52 151.99 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-N 115.979 -0.555 . . . . 71.33 110.039 -176.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -87.52 -70.78 1.29 Allowed Glycine 0 N--CA 1.43 -1.719 0 N-CA-C 110.094 -1.202 . . . . 73.41 110.094 176.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 31.7 mm -112.54 126.31 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 CA-C-O 120.935 0.398 . . . . 62.35 110.178 179.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 521' ' ' MET . . . . . 0.655 ' SD ' HG13 ' A' ' 514' ' ' VAL . 23.1 ptt? -105.46 142.96 34.3 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 107.167 -1.42 . . . . 74.34 107.167 173.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -121.03 151.61 39.58 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 121.395 0.617 . . . . 73.31 111.555 178.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . 0.629 ' O ' ' HA ' ' A' ' 570' ' ' THR . 33.0 t -130.83 137.17 56.59 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 107.832 -1.173 . . . . 71.33 107.832 -179.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -90.43 127.33 36.18 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 113.024 0.75 . . . . 74.54 113.024 -176.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 22.9 t -112.57 121.95 65.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 107.291 -1.374 . . . . 72.52 107.291 176.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -75.42 145.08 41.83 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.893 0.854 . . . . 75.04 112.687 -174.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . 0.411 ' HG3' ' O ' ' A' ' 528' ' ' THR . 11.2 tpp85 -75.62 133.08 40.98 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 114.073 -1.422 . . . . 71.5 109.202 173.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 528' ' ' THR . . . . . 0.457 ' OG1' ' HA2' ' A' ' 503' ' ' GLY . 3.0 t -57.64 159.85 4.81 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 114.56 -1.2 . . . . 75.32 111.965 174.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 35.7 t -62.04 -37.87 86.57 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.73 0.812 . . . . 43.12 109.126 178.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -137.63 122.78 2.57 Favored Glycine 0 N--CA 1.425 -2.099 0 N-CA-C 109.961 -1.256 . . . . 74.42 109.961 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . 0.401 ' HB2' ' CG2' ' A' ' 528' ' ' THR . . . -130.25 114.01 15.12 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.332 -0.988 . . . . 75.13 108.332 176.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -120.79 90.09 3.25 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.696 -0.853 . . . . 74.33 108.696 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 533' ' ' GLY . . . . . 0.476 ' H ' ' HB3' ' A' ' 564' ' ' ASN . . . 122.57 -178.86 16.3 Favored Glycine 0 N--CA 1.437 -1.256 0 N-CA-C 110.96 -0.856 . . . . 75.4 110.96 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 534' ' ' ASN . . . . . 0.506 HD21 ' N ' ' A' ' 535' ' ' VAL . 0.2 OUTLIER -91.92 131.1 37.49 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.27 -1.011 . . . . 74.22 108.27 179.223 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 535' ' ' VAL . . . . . 0.506 ' N ' HD21 ' A' ' 534' ' ' ASN . 89.8 t -119.1 139.03 47.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-O 121.059 0.457 . . . . 73.24 110.143 179.2 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 536' ' ' ILE . . . . . . . . . . . . . 42.1 mm -105.44 125.01 60.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 108.949 -0.76 . . . . 75.53 108.949 178.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 22.0 t -113.49 106.24 54.38 Favored Pre-proline 0 C--N 1.302 -1.482 0 O-C-N 123.35 0.406 . . . . 74.32 109.909 -178.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.9 145.37 25.11 Favored 'Trans proline' 0 CA--C 1.533 0.454 0 C-N-CA 122.369 2.046 . . . . 75.33 111.71 178.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -142.45 163.05 33.89 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 110.212 -0.292 . . . . 73.25 110.212 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -151.76 153.78 34.98 Favored 'General case' 0 C--N 1.308 -1.196 0 O-C-N 123.6 0.563 . . . . 74.34 110.618 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 4.1 p -99.24 125.14 44.78 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.796 -0.638 . . . . 72.04 110.363 173.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.7 mp -96.06 118.52 42.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 105.937 -1.875 . . . . 72.24 105.937 174.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -55.84 -50.56 70.23 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 123.868 0.73 . . . . 75.45 112.273 -176.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 69.51 -103.49 1.11 Allowed Glycine 0 N--CA 1.431 -1.645 0 N-CA-C 111.099 -0.8 . . . . 73.34 111.099 -179.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 9.1 t -109.63 -3.96 16.51 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.337 0.589 . . . . 71.45 110.311 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -96.01 171.54 8.56 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.927 -0.397 . . . . 75.43 109.927 176.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 31.7 tpt180 -115.4 119.51 36.47 Favored 'General case' 0 C--O 1.247 0.968 0 N-CA-C 109.253 -0.647 . . . . 72.34 109.253 179.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -86.75 -154.03 24.8 Favored Glycine 0 C--N 1.311 -0.828 0 C-N-CA 120.874 -0.679 . . . . 73.12 112.37 -179.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 72.07 17.44 77.18 Favored Glycine 0 C--N 1.316 -0.567 0 CA-C-O 120.151 -0.249 . . . . 62.43 113.558 178.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 83.85 27.16 38.94 Favored Glycine 0 N--CA 1.439 -1.145 0 N-CA-C 110.817 -0.913 . . . . 74.41 110.817 -178.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -99.32 -69.75 0.75 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 120.711 0.291 . . . . 73.54 110.333 -178.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -102.99 -27.91 12.33 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 106.879 -1.526 . . . . 75.15 106.879 177.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -146.23 158.2 43.86 Favored 'General case' 0 C--O 1.252 1.213 0 CA-C-N 114.526 -1.216 . . . . 74.31 108.438 174.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -87.81 116.61 26.08 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 106.121 -1.807 . . . . 73.33 106.121 178.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -75.78 132.81 40.68 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.3 -0.63 . . . . 73.41 109.3 -175.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 8.9 t -133.76 117.89 17.44 Favored 'General case' 0 N--CA 1.412 -2.348 0 CA-C-O 122.038 0.923 . . . . 75.13 111.534 -175.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 8.0 p -130.23 100.64 5.47 Favored 'General case' 0 N--CA 1.424 -1.77 0 N-CA-C 107.628 -1.249 . . . . 74.41 107.628 174.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -145.77 -159.71 8.3 Favored Glycine 0 N--CA 1.411 -2.968 0 N-CA-C 109.984 -1.246 . . . . 60.33 109.984 -174.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -136.1 136.77 40.41 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-O 120.678 0.275 . . . . 74.33 110.635 -175.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 89.1 mt -95.16 134.25 38.1 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.642 -0.708 . . . . 73.34 109.415 178.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 561' ' ' GLU . . . . . 0.423 ' HG3' HD22 ' A' ' 534' ' ' ASN . 43.9 tt0 -93.32 97.03 10.33 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.703 -0.851 . . . . 73.54 108.703 176.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -101.88 108.27 19.7 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 106.838 -1.542 . . . . 74.1 106.838 -178.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -97.49 172.4 7.77 Favored 'General case' 0 C--N 1.278 -2.506 0 CA-C-N 116.415 -0.357 . . . . 70.54 110.94 -174.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 564' ' ' ASN . . . . . 0.476 ' HB3' ' H ' ' A' ' 533' ' ' GLY . 2.6 p-10 -79.0 -16.04 57.44 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.98 0.895 . . . . 54.1 109.107 175.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -96.07 -54.79 3.19 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.211 -0.904 . . . . 75.12 109.195 176.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -63.78 138.48 58.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.614 -0.721 . . . . 75.02 109.692 177.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 21.8 pt -106.0 -172.23 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.41 -2.466 0 N-CA-C 108.219 -1.03 . . . . 74.04 108.219 -178.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 3.4 p 3.19 126.47 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 128.832 2.853 . . . . 75.54 116.165 173.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 569' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -110.16 149.07 30.62 Favored 'General case' 0 C--N 1.259 -3.342 0 CA-C-N 115.112 -0.949 . . . . 71.34 110.502 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 570' ' ' THR . . . . . 0.629 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 16.0 p -122.53 128.16 50.43 Favored 'General case' 0 N--CA 1.415 -2.21 0 CA-C-N 115.259 -0.882 . . . . 72.33 110.188 177.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 3.3 mp -84.0 104.21 12.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 107.033 -1.469 . . . . 62.41 107.033 174.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 11.0 p -84.72 111.17 19.34 Favored 'General case' 0 N--CA 1.419 -2.009 0 CA-C-N 115.758 -0.655 . . . . 72.43 110.084 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 573' ' ' VAL . . . . . . . . . . . . . 57.6 t -114.24 136.57 50.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 109.143 -0.688 . . . . 75.34 109.143 -178.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -95.15 125.05 39.53 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 124.123 0.89 . . . . 75.22 111.18 -178.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 81.8 t -93.59 132.84 36.63 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 N-CA-C 107.745 -1.206 . . . . 75.23 107.745 175.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 40.3 mm -91.6 160.44 2.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 109.535 -0.543 . . . . 75.23 109.535 -173.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -52.4 119.1 4.08 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 124.043 0.937 . . . . 72.12 109.671 175.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -90.69 151.31 21.3 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.1 0.476 . . . . 75.2 111.952 -175.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.91 -26.73 2.87 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 114.194 1.183 . . . . 64.11 114.194 -172.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 580' ' ' GLU . . . . . 0.4 ' HG2' ' O ' ' A' ' 581' ' ' TYR . 0.0 OUTLIER -112.23 178.21 4.38 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 118.741 -1.184 . . . . 73.45 113.263 -166.943 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 581' ' ' TYR . . . . . 0.4 ' O ' ' HG2' ' A' ' 580' ' ' GLU . 47.8 p90 -61.94 154.34 26.68 Favored 'General case' 0 C--O 1.247 0.969 0 CA-C-N 114.803 -1.09 . . . . 75.22 108.922 175.013 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 582' ' ' GLU . . . . . 0.456 ' HG3' ' O ' ' A' ' 583' ' ' LYS . 5.8 tp10 -94.31 152.78 18.4 Favored 'General case' 0 C--N 1.284 -2.251 0 C-N-CA 119.023 -1.071 . . . . 63.21 110.633 179.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 583' ' ' LYS . . . . . 0.456 ' O ' ' HG3' ' A' ' 582' ' ' GLU . 18.3 ptpt -137.85 -172.16 3.18 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 103.365 -2.828 . . . . 74.31 103.365 176.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -79.54 91.69 5.2 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.254 -1.758 . . . . 75.34 106.254 170.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 585' ' ' LYS . . . . . 0.442 ' HD2' HD13 ' A' ' 646' ' ' ILE . 4.7 tmmm? -106.67 109.23 21.08 Favored 'General case' 0 N--CA 1.396 -3.165 0 N-CA-C 106.756 -1.572 . . . . 75.31 106.756 -172.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 4.6 t -142.44 145.76 34.11 Favored 'General case' 0 N--CA 1.392 -3.35 0 CA-C-N 113.823 -1.535 . . . . 75.13 109.306 -174.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -128.85 155.57 45.02 Favored 'General case' 0 N--CA 1.412 -2.35 0 CA-C-N 114.408 -1.269 . . . . 73.45 108.858 178.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 588' ' ' PHE . . . . . 0.497 ' HA ' ' O ' ' A' ' 642' ' ' LEU . 23.5 m-85 -109.67 138.13 46.49 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-N 116.36 -0.382 . . . . 74.23 110.23 -171.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . 0.433 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.8 OUTLIER -110.94 125.76 54.02 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 105.777 -1.934 . . . . 73.0 105.777 176.297 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -127.94 131.24 49.34 Favored 'General case' 0 C--N 1.284 -2.248 0 C-N-CA 120.613 -0.435 . . . . 74.44 110.289 179.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 591' ' ' ILE . . . . . . . . . . . . . 15.2 pt -93.66 134.02 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.621 0 N-CA-C 106.758 -1.571 . . . . 63.31 106.758 171.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -86.83 -146.95 10.64 Favored Glycine 0 C--N 1.3 -1.47 0 C-N-CA 120.965 -0.636 . . . . 73.11 111.586 -176.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.568 ' OE1' ' HD3' ' A' ' 633' ' ' ARG . 35.0 tt0 -88.57 123.87 67.11 Favored Pre-proline 0 N--CA 1.425 -1.695 0 N-CA-C 107.967 -1.123 . . . . 75.1 107.967 177.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -68.42 162.13 41.94 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 123.084 2.523 . . . . 75.43 111.428 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 29.9 ptt85 -130.12 143.45 50.8 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.263 -0.643 . . . . 75.21 109.263 178.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -85.37 128.56 34.76 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 106.188 -1.782 . . . . 74.13 106.188 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 87.2 t . . . . . 0 C--N 1.312 -1.026 0 CA-C-O 121.307 0.575 . . . . 75.43 109.829 -179.579 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 633' ' ' ARG . . . . . 0.568 ' HD3' ' OE1' ' A' ' 593' ' ' GLU . 95.1 mtt180 . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 106.739 -1.578 . . . . 71.21 106.739 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -76.08 146.79 29.29 Favored 'Trans proline' 0 N--CA 1.429 -2.3 0 N-CA-C 107.348 -1.828 . . . . 72.52 107.348 166.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 1.9 pp -126.57 -173.27 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 114.494 1.294 . . . . 64.21 114.494 -172.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.46 150.6 39.83 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.389 -0.823 . . . . 74.42 109.672 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . 0.424 ' HA3' ' HB ' ' A' ' 506' ' ' THR . . . -76.69 -71.13 1.21 Allowed Glycine 0 C--N 1.297 -1.598 0 C-N-CA 120.763 -0.732 . . . . 73.04 112.58 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -150.36 -59.72 0.19 Allowed 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 120.408 -0.517 . . . . 74.45 110.619 178.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 16.7 p80 -120.43 99.63 6.68 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.735 0.779 . . . . 70.21 111.921 -179.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 36.4 p -98.62 91.26 5.05 Favored 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 109.278 -0.638 . . . . 73.31 109.278 177.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 641' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 510' ' ' PRO . 1.3 tmtp? -177.26 133.14 0.18 Allowed 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 106.159 -1.793 . . . . 71.54 106.159 -178.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 642' ' ' LEU . . . . . 0.497 ' O ' ' HA ' ' A' ' 588' ' ' PHE . 27.9 tp -133.84 118.03 17.51 Favored 'General case' 0 C--N 1.276 -2.602 0 N-CA-C 108.511 -0.922 . . . . 75.01 108.511 177.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . 0.443 ' HB3' HG23 ' A' ' 511' ' ' VAL . 33.6 tt0 -99.25 107.44 19.75 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 107.06 -1.459 . . . . 74.43 107.06 177.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 644' ' ' VAL . . . . . 0.429 HG22 ' HE3' ' A' ' 521' ' ' MET . 38.9 t -95.37 109.84 23.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 108.949 -0.76 . . . . 75.32 108.949 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 3.9 mp -94.86 119.9 43.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 N-CA-C 108.413 -0.958 . . . . 73.51 108.413 177.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 646' ' ' ILE . . . . . 0.515 HD11 ' N ' ' A' ' 646' ' ' ILE . 1.8 mp -107.88 134.51 49.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 105.798 -1.926 . . . . 73.21 105.798 -176.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -136.48 161.48 35.73 Favored 'General case' 0 C--N 1.277 -2.549 0 N-CA-C 112.31 0.485 . . . . 75.44 112.31 -172.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 648' ' ' GLU . . . . . 0.417 ' HG2' ' HB2' ' A' ' 582' ' ' GLU . 31.2 mm-40 -61.17 100.38 0.12 Allowed 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 106.189 -1.782 . . . . 73.43 106.189 172.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 10.5 m . . . . . 0 C--N 1.307 -1.265 0 C-N-CA 128.254 2.621 . . . . 71.04 115.871 -169.95 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.421 -2.34 0 N-CA-C 111.151 -0.779 . . . . 72.24 111.151 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 3.9 mp -122.27 111.39 30.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 109.255 -0.646 . . . . 74.41 109.255 -178.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -128.35 104.29 7.64 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 106.492 -1.67 . . . . 75.23 106.492 173.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 506' ' ' THR . . . . . 0.411 ' HB ' ' HA3' ' A' ' 637' ' ' GLY . 15.0 t -152.02 162.95 40.28 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.631 -0.878 . . . . 75.35 108.631 -175.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -91.77 168.78 11.22 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.749 -1.204 . . . . 74.43 107.749 172.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . 0.404 ' HB2' HD21 ' A' ' 526' ' ' LEU . 21.5 tt0 -99.74 -35.88 9.65 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 107.944 -1.132 . . . . 74.03 107.944 179.251 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -111.31 134.98 20.99 Favored Pre-proline 0 N--CA 1.419 -2.021 0 CA-C-N 114.377 -1.283 . . . . 64.12 110.239 -178.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -81.19 -18.7 8.49 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.554 1.503 . . . . 75.21 111.095 173.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . 0.402 HG23 ' HB3' ' A' ' 643' ' ' GLU . 93.2 t -138.04 141.5 38.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 123.81 0.844 . . . . 74.44 108.853 -177.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 8.1 t -137.3 140.81 41.78 Favored 'General case' 0 N--CA 1.416 -2.168 0 N-CA-C 107.526 -1.287 . . . . 75.23 107.526 174.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 55.4 m-70 -105.76 130.04 53.84 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.585 -0.895 . . . . 74.14 108.585 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 24.2 m -132.33 156.45 42.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 N-CA-C 108.862 -0.792 . . . . 75.33 108.862 -179.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 40.3 t -82.42 149.16 27.8 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 107.934 -1.136 . . . . 63.01 107.934 178.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -82.3 -7.5 59.63 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.85 0.833 . . . . 75.42 109.062 176.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 9.4 t -95.77 10.01 38.5 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.905 -0.776 . . . . 75.4 108.905 -178.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 12.4 tt -91.68 155.34 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 108.66 -0.867 . . . . 75.51 108.66 -177.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -91.44 -63.44 1.18 Allowed Glycine 0 N--CA 1.43 -1.755 0 N-CA-C 110.47 -1.052 . . . . 74.14 110.47 176.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . 0.407 HD13 ' HA ' ' A' ' 574' ' ' LYS . 34.4 mm -116.51 117.02 54.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 109.92 -0.4 . . . . 73.44 109.92 179.012 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 521' ' ' MET . . . . . 0.414 ' HE1' HG11 ' A' ' 644' ' ' VAL . 0.0 OUTLIER -96.41 128.66 43.53 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 106.609 -1.626 . . . . 73.24 106.609 172.238 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -117.36 138.74 51.59 Favored 'General case' 0 N--CA 1.424 -1.751 0 CA-C-N 115.829 -0.623 . . . . 73.24 111.269 178.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . 0.52 ' O ' ' HA ' ' A' ' 570' ' ' THR . 22.1 t -121.09 134.34 64.8 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.087 0 N-CA-C 106.176 -1.787 . . . . 73.33 106.176 175.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 569' ' ' LYS . 55.2 mttp -91.91 163.04 14.16 Favored 'General case' 0 N--CA 1.416 -2.171 0 C-N-CA 120.325 -0.55 . . . . 74.31 111.904 -178.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 16.0 t -128.5 141.98 45.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-N 115.512 -0.767 . . . . 65.44 109.115 -175.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . 0.404 HD21 ' HB2' ' A' ' 508' ' ' GLU . 2.0 mm? -78.24 139.08 38.92 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 107.554 -1.276 . . . . 74.35 107.554 178.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 48.2 ttp180 -92.79 140.5 29.45 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.729 -0.788 . . . . 73.42 111.199 -175.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 4.2 t -55.17 149.02 13.07 Favored 'General case' 0 N--CA 1.413 -2.28 0 CA-C-N 114.044 -1.434 . . . . 73.41 111.97 174.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 26.1 t -80.62 -15.89 55.46 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.386 -0.824 . . . . 73.51 109.038 177.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -127.54 110.92 1.24 Allowed Glycine 0 N--CA 1.433 -1.517 0 N-CA-C 111.163 -0.775 . . . . 75.42 111.163 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -165.06 76.11 0.27 Allowed 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 123.334 0.653 . . . . 75.45 110.173 177.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -90.36 81.53 6.02 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.751 0.786 . . . . 75.24 110.064 177.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 533' ' ' GLY . . . . . 0.498 ' H ' ' HB2' ' A' ' 564' ' ' ASN . . . 149.37 -118.97 0.99 Allowed Glycine 0 N--CA 1.414 -2.772 0 CA-C-N 114.828 -1.078 . . . . 74.44 112.071 179.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 534' ' ' ASN . . . . . 0.508 ' ND2' ' HG2' ' A' ' 563' ' ' GLN . 2.8 t-20 -145.07 131.3 19.49 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 107.234 -1.395 . . . . 74.12 107.234 -178.099 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 46.8 t -128.36 133.86 65.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 109.387 -0.597 . . . . 74.03 109.387 -178.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 536' ' ' ILE . . . . . 0.469 HG23 ' HB3' ' A' ' 559' ' ' GLU . 28.5 mm -98.28 126.48 51.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 109.217 -0.66 . . . . 73.11 109.217 178.176 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 36.1 t -116.65 103.38 52.59 Favored Pre-proline 0 C--N 1.301 -1.513 0 N-CA-C 108.579 -0.897 . . . . 73.31 108.579 177.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.56 146.93 50.64 Favored 'Trans proline' 0 C--N 1.331 -0.391 0 C-N-CA 122.264 1.976 . . . . 75.3 111.169 179.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 539' ' ' TYR . . . . . 0.528 ' CE1' ' HG ' ' A' ' 560' ' ' LEU . 36.0 p90 -151.14 161.58 42.46 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 109.689 -0.485 . . . . 75.14 109.689 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -155.67 148.6 24.35 Favored 'General case' 0 C--N 1.309 -1.174 0 O-C-N 123.471 0.482 . . . . 73.23 111.933 178.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 2.4 p -85.82 121.09 27.98 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 115.957 -0.565 . . . . 74.44 110.967 175.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.8 mp -86.96 116.99 30.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 105.271 -2.122 . . . . 71.32 105.271 172.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -55.2 -43.43 74.4 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 124.163 0.914 . . . . 73.44 112.146 -174.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 67.96 -94.06 0.29 Allowed Glycine 0 N--CA 1.439 -1.101 0 CA-C-N 115.733 -0.667 . . . . 73.31 111.757 178.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 9.2 t -124.41 -2.07 8.04 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 120.788 0.328 . . . . 70.51 110.488 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -91.19 155.54 18.52 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.71 -0.478 . . . . 74.12 109.71 178.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 22.1 tpt180 -94.55 108.31 20.27 Favored 'General case' 0 C--O 1.25 1.097 0 N-CA-C 109.546 -0.539 . . . . 73.4 109.546 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -89.66 -163.57 39.37 Favored Glycine 0 CA--C 1.507 -0.422 0 C-N-CA 121.124 -0.56 . . . . 73.44 114.046 -175.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 77.75 12.38 84.52 Favored Glycine 0 C--N 1.321 -0.281 0 CA-C-N 115.433 -0.384 . . . . 73.44 113.593 178.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 95.79 4.56 60.32 Favored Glycine 0 N--CA 1.437 -1.251 0 C-N-CA 120.46 -0.876 . . . . 71.13 111.644 -178.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -73.98 -69.86 0.42 Allowed 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.912 -0.773 . . . . 72.01 108.912 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -107.8 -34.12 7.05 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.861 -1.163 . . . . 75.52 107.861 177.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -135.95 157.27 47.25 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 108.464 -0.939 . . . . 74.11 108.464 174.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -88.14 121.02 30.06 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.855 -1.165 . . . . 73.05 107.855 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -78.67 100.96 7.25 Favored 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 109.263 -0.643 . . . . 75.53 109.263 -177.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 13.9 t -98.51 98.51 9.68 Favored 'General case' 0 N--CA 1.396 -3.134 0 CA-C-O 123.439 1.59 . . . . 63.35 111.538 -175.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 1.6 p -110.27 129.86 55.65 Favored 'General case' 0 C--N 1.274 -2.675 0 N-CA-C 106.518 -1.66 . . . . 71.34 106.518 172.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 178.64 -156.66 19.49 Favored Glycine 0 N--CA 1.42 -2.422 0 N-CA-C 110.367 -1.093 . . . . 72.24 110.367 -176.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 559' ' ' GLU . . . . . 0.469 ' HB3' HG23 ' A' ' 536' ' ' ILE . 40.0 mt-10 -135.97 133.92 38.06 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 121.295 0.569 . . . . 75.35 111.683 -175.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . 0.528 ' HG ' ' CE1' ' A' ' 539' ' ' TYR . 55.7 mt -87.84 132.77 34.06 Favored 'General case' 0 CA--C 1.491 -1.312 0 N-CA-C 108.795 -0.817 . . . . 74.34 108.795 174.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -105.84 107.37 18.34 Favored 'General case' 0 C--N 1.274 -2.71 0 N-CA-C 108.451 -0.944 . . . . 74.13 108.451 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 562' ' ' PHE . . . . . 0.402 ' CZ ' ' HG2' ' A' ' 569' ' ' LYS . 0.1 OUTLIER -100.59 132.41 45.99 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 107.744 -1.206 . . . . 62.25 107.744 -179.2 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . 0.508 ' HG2' ' ND2' ' A' ' 534' ' ' ASN . 6.8 mt-30 -119.81 165.05 15.07 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.2 -1.0 . . . . 74.4 110.699 -179.086 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 564' ' ' ASN . . . . . 0.498 ' HB2' ' H ' ' A' ' 533' ' ' GLY . 7.8 t30 -62.57 -33.46 75.01 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.879 -0.6 . . . . 73.32 111.296 179.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -99.27 -3.66 33.64 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.858 0.837 . . . . 53.02 111.145 -177.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -102.98 130.34 50.03 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.725 -0.609 . . . . 75.11 109.406 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 2.0 pp -112.04 145.27 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.728 0 N-CA-C 108.414 -0.958 . . . . 74.42 108.414 179.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 568' ' ' VAL . . . . . 0.408 HG23 ' HD3' ' A' ' 524' ' ' LYS . 1.8 p 58.91 133.78 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 126.482 1.913 . . . . 75.41 114.79 176.288 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 569' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 524' ' ' LYS . 32.6 mmmt -117.82 164.06 15.59 Favored 'General case' 0 C--N 1.284 -2.268 0 O-C-N 121.32 -0.863 . . . . 65.04 109.868 176.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 570' ' ' THR . . . . . 0.52 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 6.3 p -132.72 134.26 44.56 Favored 'General case' 0 C--N 1.279 -2.499 0 O-C-N 124.413 1.071 . . . . 73.34 111.851 177.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 2.2 mp -91.17 103.92 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.836 0 N-CA-C 105.207 -2.145 . . . . 74.21 105.207 170.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 4.5 m -91.93 112.64 24.64 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 108.479 -0.934 . . . . 73.52 108.479 -177.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 573' ' ' VAL . . . . . 0.408 ' CG2' ' HE3' ' A' ' 521' ' ' MET . 61.7 t -116.0 121.88 68.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 109.543 -0.54 . . . . 71.04 109.543 -178.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 574' ' ' LYS . . . . . 0.407 ' HA ' HD13 ' A' ' 520' ' ' ILE . 23.0 tptm -80.09 120.73 24.63 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-N 114.908 -1.042 . . . . 74.35 110.548 178.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 60.0 t -94.32 132.36 38.6 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 N-CA-C 105.953 -1.869 . . . . 74.22 105.953 174.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 34.3 mm -88.84 159.98 2.87 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 107.221 -1.4 . . . . 75.24 107.221 -175.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -71.53 115.34 10.6 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 109.199 -0.667 . . . . 64.22 109.199 178.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -61.24 144.44 53.79 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 114.897 -1.047 . . . . 64.33 112.612 -173.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -92.21 -49.06 6.38 Favored 'General case' 0 C--N 1.29 -1.995 0 C-N-CA 124.289 1.036 . . . . 70.14 110.424 -176.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.09 -152.64 0.53 Allowed 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.396 -0.82 . . . . 73.04 109.1 -174.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -111.67 152.12 28.06 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 107.32 -1.363 . . . . 75.32 107.32 176.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 36.4 mp0 -128.98 164.81 22.38 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.501 -0.555 . . . . 72.54 109.501 175.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 10.0 mptt -87.59 -152.0 0.19 Allowed 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 105.771 -1.937 . . . . 73.43 105.771 173.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -57.83 113.05 1.68 Allowed 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 109.115 -0.698 . . . . 74.23 109.115 172.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.32 118.73 23.74 Favored 'General case' 0 N--CA 1.409 -2.496 0 N-CA-C 106.362 -1.718 . . . . 74.41 106.362 -174.198 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 3.9 t -150.7 146.86 26.73 Favored 'General case' 0 N--CA 1.418 -2.04 0 CA-C-N 115.487 -0.779 . . . . 74.44 110.795 -172.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -126.58 150.63 48.75 Favored 'General case' 0 N--CA 1.419 -2.011 0 CA-C-N 113.891 -1.504 . . . . 70.33 109.225 177.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 588' ' ' PHE . . . . . 0.417 ' HA ' ' O ' ' A' ' 642' ' ' LEU . 22.3 m-85 -108.37 139.25 43.36 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 109.381 -0.6 . . . . 73.23 109.381 -174.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.93 134.36 50.95 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 107.04 -1.467 . . . . 64.01 107.04 176.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -143.05 136.96 28.89 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.803 -0.814 . . . . 72.14 108.803 -179.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 591' ' ' ILE . . . . . 0.53 HG12 ' OG1' ' A' ' 640' ' ' THR . 22.0 pt -101.95 162.48 3.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 109.206 -0.664 . . . . 73.21 109.206 178.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -111.15 -162.96 17.92 Favored Glycine 0 N--CA 1.43 -1.732 0 C-N-CA 121.259 -0.496 . . . . 74.35 112.103 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -67.88 118.11 54.86 Favored Pre-proline 0 C--N 1.309 -1.195 0 C-N-CA 123.979 0.911 . . . . 72.15 108.803 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 594' ' ' PRO . . . . . 0.454 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 58.1 Cg_endo -73.16 146.56 41.08 Favored 'Trans proline' 0 N--CA 1.437 -1.82 0 C-N-CA 121.916 1.744 . . . . 64.34 110.593 178.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 14.9 ptt180 -128.24 133.71 48.87 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 109.704 -0.48 . . . . 74.04 109.704 -175.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.99 131.82 41.78 Favored 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 104.988 -2.227 . . . . 64.12 104.988 178.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 597' ' ' VAL . . . . . 0.42 ' CG2' HG12 ' A' ' 536' ' ' ILE . 23.8 t . . . . . 0 C--N 1.308 -1.233 0 CA-C-O 121.821 0.819 . . . . 73.12 110.767 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 . . . . . 0 N--CA 1.447 -0.612 0 N-CA-C 109.46 -0.57 . . . . 72.21 109.46 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . 0.454 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 10.1 Cg_endo -60.86 145.01 99.66 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.591 1.527 . . . . 72.32 109.527 172.153 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.3 pp -123.42 175.96 5.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 114.054 1.131 . . . . 74.53 114.054 -176.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . 0.455 ' HG ' ' N ' ' A' ' 637' ' ' GLY . 33.3 tp -68.93 158.65 34.19 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 124.8 1.24 . . . . 75.35 112.716 -176.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . 0.455 ' N ' ' HG ' ' A' ' 636' ' ' LEU . . . -83.06 -100.02 0.52 Allowed Glycine 0 N--CA 1.427 -1.91 0 N-CA-C 109.642 -1.383 . . . . 65.45 109.642 172.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -126.22 -73.13 0.63 Allowed 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 119.801 -0.76 . . . . 73.45 111.632 177.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -107.02 114.26 28.23 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 118.715 -1.194 . . . . 63.11 113.122 -174.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 640' ' ' THR . . . . . 0.53 ' OG1' HG12 ' A' ' 591' ' ' ILE . 1.1 t -107.08 91.53 3.7 Favored 'General case' 0 N--CA 1.41 -2.437 0 N-CA-C 108.367 -0.975 . . . . 75.1 108.367 169.364 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -172.17 121.83 0.46 Allowed 'General case' 0 C--N 1.279 -2.466 0 N-CA-C 105.726 -1.953 . . . . 73.14 105.726 178.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 642' ' ' LEU . . . . . 0.509 HD22 HG22 ' A' ' 523' ' ' VAL . 35.9 tp -129.91 113.13 14.24 Favored 'General case' 0 C--N 1.271 -2.829 0 N-CA-C 108.077 -1.083 . . . . 71.44 108.077 178.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . 0.402 ' HB3' HG23 ' A' ' 511' ' ' VAL . 30.0 tt0 -95.11 104.77 16.65 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 107.469 -1.308 . . . . 72.21 107.469 179.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 644' ' ' VAL . . . . . 0.414 HG11 ' HE1' ' A' ' 521' ' ' MET . 30.9 t -94.98 106.66 18.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 109.483 -0.562 . . . . 73.11 109.483 -177.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 3.9 mp -88.78 118.29 33.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 108.444 -0.947 . . . . 72.21 108.444 175.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 646' ' ' ILE . . . . . 0.461 HD12 ' N ' ' A' ' 646' ' ' ILE . 2.8 mp -100.73 107.21 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 N-CA-C 106.63 -1.618 . . . . 73.23 106.63 -177.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -103.69 136.42 43.43 Favored 'General case' 0 C--N 1.279 -2.48 0 CA-C-N 115.671 -0.695 . . . . 74.14 110.832 -176.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -67.47 142.03 56.76 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.626 -0.879 . . . . 73.12 108.626 -177.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 21.2 t . . . . . 0 N--CA 1.431 -1.39 0 N-CA-C 114.072 1.138 . . . . 74.21 114.072 -169.558 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.419 -2.448 0 N-CA-C 109.71 -1.356 . . . . 75.51 109.71 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . 0.635 ' O ' ' HB ' ' A' ' 528' ' ' THR . 3.6 mp -108.87 97.77 6.15 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.263 0 C-N-CA 126.04 1.736 . . . . 74.43 109.235 -176.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -103.16 124.85 49.36 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 122.035 -0.415 . . . . 74.3 110.087 -178.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 15.3 t -145.89 159.54 43.07 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.378 -0.601 . . . . 73.21 109.378 -178.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -89.21 155.85 19.14 Favored 'General case' 0 CA--C 1.485 -1.549 0 N-CA-C 108.372 -0.973 . . . . 73.14 108.372 174.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -89.98 -34.57 15.95 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 106.84 -1.541 . . . . 75.1 106.84 175.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -96.61 118.84 64.86 Favored Pre-proline 0 N--CA 1.436 -1.137 0 CA-C-N 114.549 -1.205 . . . . 72.43 110.847 176.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 510' ' ' PRO . . . . . 0.584 ' HA ' ' O ' ' A' ' 641' ' ' LYS . 1.2 Cg_endo -83.22 -16.96 6.87 Favored 'Trans proline' 0 N--CA 1.443 -1.456 0 N-CA-C 108.72 -1.3 . . . . 75.15 108.72 166.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 78.7 t -144.63 139.56 23.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 C-N-CA 125.575 1.55 . . . . 65.14 107.268 -179.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 11.4 t -138.63 148.01 43.57 Favored 'General case' 0 N--CA 1.414 -2.234 0 N-CA-C 107.66 -1.237 . . . . 61.14 107.66 174.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -115.87 127.48 55.05 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 109.024 -0.732 . . . . 74.14 109.024 177.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 18.2 m -130.24 154.2 40.11 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 N-CA-C 109.103 -0.703 . . . . 73.13 109.103 -176.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 34.2 t -78.03 154.81 31.1 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.782 -1.192 . . . . 72.35 107.782 177.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -89.06 -6.83 56.84 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 122.195 0.998 . . . . 71.13 109.019 173.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 34.0 m -92.26 17.3 9.9 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-O 122.314 1.054 . . . . 73.4 108.744 177.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 9.5 tt -100.99 154.43 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.06 0 N-CA-C 107.064 -1.458 . . . . 74.41 107.064 177.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -95.71 -63.61 0.97 Allowed Glycine 0 N--CA 1.427 -1.946 0 C-N-CA 119.745 -1.217 . . . . 71.21 110.348 176.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 29.0 mm -116.41 127.73 73.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 114.725 -0.737 . . . . 70.4 109.865 -178.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 521' ' ' MET . . . . . 0.401 ' HE1' ' HB ' ' A' ' 573' ' ' VAL . 0.0 OUTLIER -109.99 135.88 50.14 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.76 -1.2 . . . . 72.32 107.76 172.888 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 522' ' ' GLU . . . . . 0.527 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 36.8 mt-10 -121.15 135.26 55.2 Favored 'General case' 0 CA--C 1.493 -1.25 0 O-C-N 123.947 0.779 . . . . 75.12 110.711 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . 0.52 ' O ' ' HA ' ' A' ' 570' ' ' THR . 18.9 t -123.03 140.47 46.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.91 -0.774 . . . . 65.54 108.91 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -85.35 141.53 29.96 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.912 0.863 . . . . 72.13 112.603 -178.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 21.3 t -111.88 119.49 60.12 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 N-CA-C 105.154 -2.165 . . . . 74.22 105.154 172.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -62.16 136.05 57.77 Favored 'General case' 0 CA--C 1.504 -0.804 0 O-C-N 123.522 0.514 . . . . 75.42 110.625 -174.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 14.2 ttp180 -84.73 138.7 32.47 Favored 'General case' 0 N--CA 1.423 -1.782 0 N-CA-C 108.612 -0.884 . . . . 75.5 108.612 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 528' ' ' THR . . . . . 0.635 ' HB ' ' O ' ' A' ' 504' ' ' ILE . 10.3 t -94.41 169.59 10.1 Favored 'General case' 0 N--CA 1.397 -3.096 0 N-CA-C 114.81 1.411 . . . . 71.22 114.81 -171.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . 0.309 5.7 m -49.9 -34.06 19.16 Favored 'General case' 0 N--CA 1.417 -2.124 0 C-N-CA 130.658 3.583 . . . . 70.14 111.35 171.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -121.3 68.41 0.42 Allowed Glycine 0 N--CA 1.428 -1.856 0 C-N-CA 120.722 -0.752 . . . . 75.22 113.203 -177.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -87.88 83.41 7.1 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 106.704 -1.591 . . . . 73.24 106.704 173.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -121.05 137.3 54.72 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 115.744 -0.662 . . . . 74.02 112.321 -174.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 533' ' ' GLY . . . . . 0.464 ' N ' ' HB3' ' A' ' 564' ' ' ASN . . . 69.27 -121.32 11.28 Favored Glycine 0 N--CA 1.438 -1.173 0 CA-C-N 114.741 -1.118 . . . . 45.0 111.966 176.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -136.47 124.15 22.41 Favored 'General case' 0 C--N 1.286 -2.175 0 N-CA-C 106.079 -1.823 . . . . 45.12 106.079 177.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 57.5 t -126.57 122.97 62.15 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-O 121.398 0.618 . . . . 74.2 109.494 -175.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 536' ' ' ILE . . . . . 0.446 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 40.2 mm -97.57 127.21 50.1 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.451 0 CA-C-N 115.444 -0.798 . . . . 72.34 109.968 -178.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . 0.426 HG22 ' HB3' ' A' ' 594' ' ' PRO . 86.1 t -113.0 102.31 54.6 Favored Pre-proline 0 C--N 1.308 -1.22 0 CA-C-N 115.448 -0.797 . . . . 72.44 110.18 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -74.74 150.31 39.31 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.667 2.245 . . . . 75.04 111.635 178.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 539' ' ' TYR . . . . . 0.496 ' CE1' ' HG ' ' A' ' 560' ' ' LEU . 17.4 p90 -154.9 165.95 35.08 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 110.246 -0.279 . . . . 73.53 110.246 -178.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -157.86 157.47 33.28 Favored 'General case' 0 C--N 1.316 -0.864 0 O-C-N 123.659 0.599 . . . . 72.43 110.142 177.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 2.1 p -96.46 112.17 24.01 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 123.337 0.655 . . . . 72.11 109.775 173.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.5 mp -81.01 122.96 37.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 107.917 -1.142 . . . . 73.41 107.917 177.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -55.31 -52.73 62.5 Favored 'General case' 0 C--O 1.242 0.704 0 O-C-N 124.223 0.952 . . . . 65.12 110.851 -178.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 71.53 -80.11 0.54 Allowed Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.837 -0.619 . . . . 65.04 113.179 175.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 12.8 t -134.43 -7.47 2.55 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.452 0.644 . . . . 72.31 110.04 -179.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -80.36 -176.37 5.62 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 121.181 0.515 . . . . 54.2 111.723 -179.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . 0.623 ' HB3' ' OE1' ' A' ' 551' ' ' GLU . 56.9 mmt-85 -85.58 177.29 7.78 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.652 -0.703 . . . . 63.4 110.917 177.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -64.38 174.57 13.22 Favored Glycine 0 CA--C 1.538 1.521 0 CA-C-N 115.166 -0.925 . . . . 53.15 114.354 -177.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . -67.63 122.84 18.26 Favored Glycine 0 N--CA 1.441 -0.997 0 CA-C-N 115.259 -0.471 . . . . 70.14 112.46 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 82.98 2.94 90.68 Favored Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 110.634 -0.987 . . . . 74.55 110.634 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . 0.623 ' OE1' ' HB3' ' A' ' 547' ' ' ARG . 38.2 tt0 -96.53 -69.99 0.73 Allowed 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 108.958 -0.756 . . . . 64.51 108.958 -178.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . 0.522 ' CB ' ' HB2' ' A' ' 547' ' ' ARG . 17.4 t70 -106.63 -25.57 11.73 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-O 122.004 0.907 . . . . 71.43 109.006 177.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -142.84 152.68 42.42 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 106.65 -1.611 . . . . 74.42 106.65 174.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -87.48 122.7 31.55 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 107.06 -1.459 . . . . 65.0 107.06 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -79.54 123.14 27.31 Favored 'General case' 0 CA--C 1.491 -1.298 0 CA-C-O 120.888 0.375 . . . . 65.13 110.725 -174.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 12.1 t -123.98 107.32 11.2 Favored 'General case' 0 N--CA 1.404 -2.762 0 CA-C-O 122.531 1.158 . . . . 73.34 110.773 -178.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 3.6 p -129.09 130.07 46.02 Favored 'General case' 0 N--CA 1.42 -1.968 0 CA-C-N 114.622 -1.172 . . . . 73.51 108.679 177.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 174.66 -151.39 12.46 Favored Glycine 0 N--CA 1.41 -3.073 0 N-CA-C 109.81 -1.316 . . . . 61.14 109.81 -177.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 559' ' ' GLU . . . . . 0.446 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 70.5 mt-10 -129.71 126.66 38.78 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-O 120.933 0.397 . . . . 64.54 111.533 -175.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . 0.496 ' HG ' ' CE1' ' A' ' 539' ' ' TYR . 83.7 mt -79.67 122.76 26.95 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.787 -0.82 . . . . 74.41 108.787 175.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -93.22 110.01 21.53 Favored 'General case' 0 N--CA 1.419 -1.976 0 N-CA-C 109.194 -0.669 . . . . 71.33 109.194 -178.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -129.26 150.52 50.6 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.054 -0.976 . . . . 71.0 108.373 -179.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . 0.484 ' H ' ' HB3' ' A' ' 566' ' ' GLU . 7.3 pt20 -148.88 178.53 8.6 Favored 'General case' 0 C--N 1.288 -2.07 0 O-C-N 121.882 -0.511 . . . . 73.13 110.746 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 564' ' ' ASN . . . . . 0.464 ' HB3' ' N ' ' A' ' 533' ' ' GLY . 3.7 p-10 -61.89 -33.1 73.61 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 124.347 1.059 . . . . 60.13 111.447 -176.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -91.46 -6.55 52.5 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.864 0.84 . . . . 74.44 110.425 -176.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 566' ' ' GLU . . . . . 0.484 ' HB3' ' H ' ' A' ' 563' ' ' GLN . 9.6 tp10 -98.94 155.54 17.36 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.497 -1.298 . . . . 72.42 107.497 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 1.7 pp -126.75 140.58 48.53 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.625 0 C-N-CA 119.654 -0.818 . . . . 75.41 109.263 177.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 1.1 p 53.51 176.58 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.524 0 C-N-CA 126.14 1.776 . . . . 75.34 113.649 177.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 569' ' ' LYS . . . . . 0.513 ' HA ' ' HE2' ' A' ' 569' ' ' LYS . 6.7 mmpt? -146.63 153.9 40.86 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 109.119 -0.697 . . . . 71.32 109.119 173.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 570' ' ' THR . . . . . 0.52 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 12.0 p -136.72 133.11 35.75 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 124.13 0.894 . . . . 74.31 110.5 178.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 571' ' ' ILE . . . . . 0.527 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 2.4 mp -95.66 117.8 40.51 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 107.129 -1.434 . . . . 74.4 107.129 174.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 4.1 p -102.1 109.47 21.19 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 123.698 0.624 . . . . 74.43 110.498 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 573' ' ' VAL . . . . . 0.401 ' HB ' ' HE1' ' A' ' 521' ' ' MET . 48.0 t -112.32 136.66 47.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 N-CA-C 109.467 -0.568 . . . . 64.1 109.467 -178.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 58.8 tttp -92.72 126.08 37.64 Favored 'General case' 0 C--N 1.309 -1.159 0 O-C-N 124.046 0.841 . . . . 74.52 109.849 178.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 47.6 t -94.12 132.42 38.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 107.482 -1.303 . . . . 75.1 107.482 177.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 30.5 mm -97.43 146.35 7.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 C-N-CA 120.605 -0.438 . . . . 75.25 109.989 -174.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -61.95 145.14 53.8 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.4 0.68 . . . . 64.35 110.561 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -70.61 134.35 47.51 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 116.032 1.864 . . . . 74.14 116.032 -175.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 579' ' ' GLU . . . . . 0.46 ' HG2' ' HG3' ' A' ' 580' ' ' GLU . 0.1 OUTLIER -110.94 -24.82 10.16 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 112.882 -1.963 . . . . 73.22 109.431 177.824 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 580' ' ' GLU . . . . . 0.46 ' HG3' ' HG2' ' A' ' 579' ' ' GLU . 0.0 OUTLIER -133.14 178.72 6.68 Favored 'General case' 0 C--O 1.249 1.052 0 N-CA-C 113.232 0.827 . . . . 73.42 113.232 -179.063 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -66.49 152.67 44.72 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.644 -1.162 . . . . 75.22 107.889 177.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -126.29 138.38 53.59 Favored 'General case' 0 C--N 1.293 -1.849 0 C-N-CA 117.385 -1.726 . . . . 72.53 113.011 -176.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -97.21 -158.35 0.66 Allowed 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 106.819 -1.549 . . . . 74.12 106.819 176.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 -79.15 93.54 5.21 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 106.072 -1.825 . . . . 74.44 106.072 170.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 3.8 tmmm? -98.91 121.9 41.47 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 108.364 -0.976 . . . . 71.21 108.364 -172.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 4.9 t -147.01 144.51 29.2 Favored 'General case' 0 N--CA 1.414 -2.226 0 CA-C-N 114.9 -1.046 . . . . 71.14 109.291 -177.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 587' ' ' PHE . . . . . 0.44 ' CE2' HD12 ' A' ' 646' ' ' ILE . 2.5 p90 -125.9 146.68 49.74 Favored 'General case' 0 N--CA 1.419 -2.016 0 CA-C-N 114.542 -1.208 . . . . 70.33 109.235 176.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 588' ' ' PHE . . . . . 0.42 ' HA ' ' O ' ' A' ' 642' ' ' LEU . 30.2 m-85 -102.53 128.52 49.14 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 109.294 -0.632 . . . . 75.11 109.294 -175.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . 0.466 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.5 OUTLIER -101.36 125.72 48.04 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 104.59 -2.374 . . . . 72.24 104.59 173.506 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -137.9 134.29 34.83 Favored 'General case' 0 C--N 1.273 -2.743 0 N-CA-C 108.92 -0.77 . . . . 74.0 108.92 -178.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 591' ' ' ILE . . . . . 0.414 HG21 ' HB3' ' A' ' 539' ' ' TYR . 28.8 pt -96.64 145.56 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.651 0 N-CA-C 108.158 -1.053 . . . . 75.43 108.158 178.255 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -89.62 -151.52 24.96 Favored Glycine 0 C--N 1.292 -1.879 0 N-CA-C 111.09 -0.804 . . . . 75.51 111.09 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -80.88 125.85 79.06 Favored Pre-proline 0 C--N 1.297 -1.68 0 N-CA-C 108.964 -0.754 . . . . 74.2 108.964 178.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 594' ' ' PRO . . . . . 0.426 ' HB3' HG22 ' A' ' 537' ' ' VAL . 38.4 Cg_endo -69.71 153.07 69.62 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 121.878 1.719 . . . . 75.4 110.841 176.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -129.79 132.38 46.51 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.844 -0.535 . . . . 73.41 111.488 -177.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 596' ' ' LEU . . . . . 0.438 ' HB2' ' HD3' ' A' ' 634' ' ' PRO . 0.0 OUTLIER -87.13 125.9 34.44 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 108.221 -1.029 . . . . 74.23 108.221 -179.567 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 CA--C 1.565 1.55 0 CA-C-O 121.949 0.88 . . . . 72.55 109.802 -179.452 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 . . . . . 0 C--O 1.215 -0.719 0 N-CA-C 108.589 -0.893 . . . . 72.45 108.589 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . 0.438 ' HD3' ' HB2' ' A' ' 596' ' ' LEU . 70.8 Cg_endo -75.77 157.19 39.64 Favored 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 121.924 1.749 . . . . 72.33 111.196 178.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 29.7 pt -132.03 178.21 5.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 CA-C-O 121.655 0.74 . . . . 74.53 111.048 -173.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -94.05 152.47 18.76 Favored 'General case' 0 N--CA 1.423 -1.805 0 N-CA-C 106.768 -1.568 . . . . 75.21 106.768 171.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -81.26 -126.04 0.75 Allowed Glycine 0 C--N 1.29 -2.014 0 C-N-CA 120.871 -0.68 . . . . 62.53 113.445 -176.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -87.5 -50.27 6.65 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 112.072 0.397 . . . . 64.12 112.072 -175.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -132.99 110.6 10.36 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.999 0.904 . . . . 73.15 112.939 -177.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 22.3 p -120.32 92.47 3.78 Favored 'General case' 0 N--CA 1.422 -1.861 0 CA-C-N 115.423 -0.808 . . . . 74.32 110.698 176.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 641' ' ' LYS . . . . . 0.584 ' O ' ' HA ' ' A' ' 510' ' ' PRO . 0.2 OUTLIER -170.51 127.55 0.79 Allowed 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 104.564 -2.384 . . . . 74.15 104.564 178.204 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 642' ' ' LEU . . . . . 0.472 ' CD2' HG22 ' A' ' 523' ' ' VAL . 43.8 tp -117.23 107.06 13.97 Favored 'General case' 0 C--N 1.274 -2.713 0 N-CA-C 108.386 -0.968 . . . . 73.23 108.386 177.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -90.71 100.97 13.72 Favored 'General case' 0 C--N 1.275 -2.64 0 N-CA-C 107.306 -1.368 . . . . 73.53 107.306 178.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 19.3 t -91.74 103.55 14.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 109.181 -0.674 . . . . 73.12 109.181 -177.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 3.8 mp -93.42 123.97 45.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 105.704 -1.962 . . . . 74.33 105.704 174.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 646' ' ' ILE . . . . . 0.444 HD11 ' N ' ' A' ' 646' ' ' ILE . 2.8 mp -97.76 129.15 48.35 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 N-CA-C 108.447 -0.946 . . . . 72.13 108.447 -173.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -92.38 117.31 29.79 Favored 'General case' 0 N--CA 1.403 -2.787 0 CA-C-N 115.69 -0.686 . . . . 73.42 110.744 -179.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 33.0 tp10 -61.58 141.37 57.81 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 114.257 -1.338 . . . . 74.3 107.763 178.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 6.5 t . . . . . 0 C--O 1.241 0.623 0 C-N-CA 123.245 0.618 . . . . 71.24 109.654 -176.816 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . 0.516 ' HA2' ' OG1' ' A' ' 528' ' ' THR . . . . . . . . 0 N--CA 1.41 -3.077 0 N-CA-C 114.868 0.707 . . . . 61.51 114.868 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . 0.404 ' H ' ' HA ' ' A' ' 528' ' ' THR . 3.5 mp -129.32 90.53 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 N-CA-C 106.036 -1.839 . . . . 74.14 106.036 174.07 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . 0.498 ' CZ ' ' HB ' ' A' ' 528' ' ' THR . 89.3 m-85 -112.11 110.52 20.85 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 109.176 -0.676 . . . . 72.04 109.176 179.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 506' ' ' THR . . . . . 0.47 ' HB ' ' HA3' ' A' ' 637' ' ' GLY . 11.7 t -149.25 167.61 25.55 Favored 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 107.229 -1.397 . . . . 74.12 107.229 -177.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -94.75 155.0 17.02 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.565 -1.642 . . . . 73.03 106.565 173.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -90.92 -29.74 17.29 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 107.426 -1.324 . . . . 64.14 107.426 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -112.5 130.9 22.94 Favored Pre-proline 0 N--CA 1.425 -1.711 0 CA-C-N 114.964 -1.016 . . . . 75.12 109.454 174.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -84.59 -10.17 8.73 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.203 1.935 . . . . 63.04 111.193 176.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 94.3 t -141.29 135.52 31.88 Favored 'Isoleucine or valine' 0 C--O 1.244 0.813 0 C-N-CA 123.929 0.892 . . . . 72.25 109.645 -177.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 7.3 t -139.22 138.35 36.77 Favored 'General case' 0 N--CA 1.413 -2.317 0 N-CA-C 107.066 -1.457 . . . . 75.03 107.066 174.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 25.1 m-70 -107.64 132.87 52.85 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 106.643 -1.614 . . . . 74.02 106.643 177.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.68 HG11 ' SD ' ' A' ' 521' ' ' MET . 34.6 m -120.27 159.04 22.0 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 CA-C-O 121.826 0.822 . . . . 75.15 111.534 -174.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 515' ' ' SER . . . . . 0.537 ' O ' HG23 ' A' ' 518' ' ' ILE . 51.6 m -82.02 142.08 32.67 Favored 'General case' 0 N--CA 1.387 -3.592 0 CA-C-N 114.13 -1.395 . . . . 61.23 107.971 178.132 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -80.12 -20.84 44.09 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 120.066 -0.653 . . . . 70.44 110.792 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 47.8 m -94.73 22.7 6.07 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.705 0.764 . . . . 52.55 110.613 -177.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 518' ' ' ILE . . . . . 0.537 HG23 ' O ' ' A' ' 515' ' ' SER . 16.2 tt -97.09 149.71 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.756 0 N-CA-C 108.367 -0.975 . . . . 75.32 108.367 -179.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -83.49 -54.58 3.08 Favored Glycine 0 N--CA 1.43 -1.764 0 C-N-CA 120.359 -0.924 . . . . 73.01 111.39 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . 0.418 HD13 ' HA ' ' A' ' 574' ' ' LYS . 34.2 mm -132.72 125.4 52.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.85 -0.796 . . . . 74.14 108.85 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 521' ' ' MET . . . . . 0.68 ' SD ' HG11 ' A' ' 514' ' ' VAL . 23.7 ptt? -94.23 137.75 33.04 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.833 -1.543 . . . . 74.02 106.833 172.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -125.35 140.43 52.82 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 123.387 0.429 . . . . 61.23 110.947 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . 0.589 ' O ' ' HA ' ' A' ' 570' ' ' THR . 39.7 t -124.32 126.09 71.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 108.716 -0.846 . . . . 64.54 108.716 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -77.77 117.42 19.13 Favored 'General case' 0 C--N 1.311 -1.105 0 O-C-N 123.784 0.678 . . . . 74.35 110.933 -178.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 25.5 t -98.8 140.17 19.03 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.289 0 CA-C-N 115.241 -0.89 . . . . 72.42 110.858 -175.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -68.7 144.62 54.36 Favored 'General case' 0 C--O 1.238 0.457 0 O-C-N 123.956 0.785 . . . . 70.33 109.187 177.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . 0.405 ' HG2' ' N ' ' A' ' 528' ' ' THR . 27.1 ttp180 -99.16 157.77 16.14 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.343 0.592 . . . . 73.32 110.926 -173.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 528' ' ' THR . . . . . 0.516 ' OG1' ' HA2' ' A' ' 503' ' ' GLY . 5.1 t -65.9 135.03 54.24 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 115.547 -0.751 . . . . 72.35 110.179 173.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 22.6 t -81.87 -37.35 27.07 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.515 -0.92 . . . . 74.23 108.515 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -87.34 98.03 2.34 Favored Glycine 0 N--CA 1.418 -2.512 0 N-CA-C 108.168 -1.973 . . . . 51.53 108.168 175.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . 0.442 ' HB3' HG22 ' A' ' 528' ' ' THR . . . -149.38 100.66 3.04 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 120.854 0.359 . . . . 73.42 110.282 -177.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . 0.408 ' HD2' ' N ' ' A' ' 532' ' ' ARG . 7.5 mpt_? -119.82 12.8 12.21 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 108.4 -0.963 . . . . 74.33 108.4 172.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . -155.22 -166.16 15.11 Favored Glycine 0 N--CA 1.437 -1.291 0 CA-C-N 115.006 -0.997 . . . . 71.32 111.013 -172.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -97.8 134.54 40.82 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 122.926 0.49 . . . . 70.43 109.982 -178.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 535' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 595' ' ' ARG . 61.3 t -133.06 131.45 58.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 123.025 0.53 . . . . 73.4 109.856 -178.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 536' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 594' ' ' PRO . 35.1 mm -103.82 138.17 29.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 110.033 -0.358 . . . . 75.22 110.033 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 48.8 t -126.28 110.19 23.81 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 110.086 -0.338 . . . . 75.03 110.086 178.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.04 154.41 37.67 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.369 2.046 . . . . 75.52 111.754 178.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -147.23 161.66 40.48 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.243 -0.651 . . . . 72.03 109.243 177.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -152.5 157.57 41.32 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 123.724 0.64 . . . . 75.32 109.782 178.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 2.7 p -99.93 122.66 43.18 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 123.469 0.481 . . . . 71.42 110.649 174.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.4 mp -91.08 112.52 25.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 106.242 -1.762 . . . . 73.34 106.242 174.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -52.13 -50.68 61.22 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 124.246 0.966 . . . . 71.23 111.823 -178.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 67.18 -94.68 0.26 Allowed Glycine 0 N--CA 1.442 -0.903 0 CA-C-N 116.058 -0.519 . . . . 71.42 112.24 176.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 8.0 t -119.19 9.39 11.73 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 120.759 0.314 . . . . 73.13 110.575 -178.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . 0.43 ' HB2' ' HD3' ' A' ' 585' ' ' LYS . . . -98.78 166.31 11.37 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.847 -0.427 . . . . 64.51 109.847 178.065 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 2.8 tpp180 -75.55 167.33 22.1 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 108.024 -1.102 . . . . 73.23 108.024 178.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -65.02 177.25 10.64 Favored Glycine 0 C--O 1.254 1.393 0 CA-C-O 121.513 0.507 . . . . 55.24 114.36 -178.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . -57.03 127.55 45.13 Favored Glycine 0 N--CA 1.439 -1.141 0 CA-C-N 114.718 -0.741 . . . . 71.03 114.115 -177.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 94.95 -10.23 70.24 Favored Glycine 0 N--CA 1.434 -1.459 0 CA-C-N 115.311 -0.444 . . . . 75.15 112.565 176.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -91.08 -70.84 0.66 Allowed 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 120.405 -0.518 . . . . 75.31 109.754 -179.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -96.03 -37.9 10.44 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-O 121.572 0.701 . . . . 64.23 109.97 175.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -142.46 156.82 45.21 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 108.115 -1.069 . . . . 72.33 108.115 -177.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -87.42 117.41 26.19 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 106.519 -1.66 . . . . 71.15 106.519 178.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -72.38 107.15 4.81 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.75 -0.659 . . . . 72.2 109.791 -176.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 9.6 t -106.58 126.66 52.55 Favored 'General case' 0 N--CA 1.413 -2.32 0 CA-C-O 122.123 0.963 . . . . 64.52 111.565 -173.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 20.5 p -136.99 109.77 7.57 Favored 'General case' 0 N--CA 1.414 -2.244 0 N-CA-C 107.367 -1.346 . . . . 73.22 107.367 175.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -152.92 -161.69 10.46 Favored Glycine 0 N--CA 1.418 -2.505 0 N-CA-C 110.607 -0.997 . . . . 73.41 110.607 -174.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -139.18 131.25 27.98 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 122.983 0.513 . . . . 71.04 110.454 -176.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 87.7 mt -92.99 143.73 25.95 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 123.725 0.81 . . . . 74.4 109.123 179.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -102.62 123.59 46.61 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-O 121.414 0.626 . . . . 71.5 110.618 178.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -121.35 157.49 30.32 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 108.26 -1.015 . . . . 71.23 108.26 173.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -162.92 -178.93 6.41 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 109.769 -0.456 . . . . 74.34 109.769 176.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 -63.74 -36.36 83.6 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 124.108 0.88 . . . . 75.34 111.587 178.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -90.11 -17.26 28.01 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.399 -0.819 . . . . 74.51 112.309 -176.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -109.58 128.65 55.36 Favored 'General case' 0 C--N 1.31 -1.123 0 O-C-N 121.844 -0.535 . . . . 73.24 111.081 -174.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 4.7 pt -109.43 159.45 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.125 0 N-CA-C 108.735 -0.839 . . . . 72.23 108.735 176.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 1.3 p 49.25 160.89 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.573 1.855 0 C-N-CA 127.081 2.152 . . . . 71.54 115.182 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 569' ' ' LYS . . . . . 0.473 ' HE3' ' HA ' ' A' ' 569' ' ' LYS . 0.0 OUTLIER -153.23 162.54 41.19 Favored 'General case' 0 CA--C 1.484 -1.578 0 N-CA-C 107.463 -1.31 . . . . 74.42 107.463 173.114 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 570' ' ' THR . . . . . 0.589 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 4.9 p -136.87 127.96 27.79 Favored 'General case' 0 C--N 1.291 -1.938 0 O-C-N 124.169 0.918 . . . . 71.04 110.815 178.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 3.3 mp -79.38 106.93 11.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 107.432 -1.321 . . . . 75.44 107.432 174.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 7.3 p -86.42 111.95 21.02 Favored 'General case' 0 N--CA 1.415 -2.2 0 O-C-N 123.645 0.591 . . . . 61.21 110.419 179.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 573' ' ' VAL . . . . . . . . . . . . . 42.3 t -114.39 130.7 68.23 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 N-CA-C 109.089 -0.708 . . . . 74.52 109.089 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 574' ' ' LYS . . . . . 0.418 ' HA ' HD13 ' A' ' 520' ' ' ILE . 86.1 tttt -86.87 121.88 29.97 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 115.476 -0.784 . . . . 75.13 110.292 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 56.5 t -90.06 139.37 17.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 107.015 -1.476 . . . . 74.54 107.015 176.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 31.3 mm -103.52 158.31 5.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 107.842 -1.17 . . . . 74.02 107.842 -175.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -67.31 126.56 29.65 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.019 -0.734 . . . . 55.42 109.019 178.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -76.23 130.43 38.18 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.818 -0.628 . . . . 75.33 110.45 -171.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -92.29 -35.34 13.82 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 113.842 1.053 . . . . 74.11 113.842 -175.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.58 -178.99 3.6 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 120.251 -0.58 . . . . 74.14 111.009 -174.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -71.48 152.43 43.05 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 106.419 -1.697 . . . . 75.3 106.419 175.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 582' ' ' GLU . . . . . 0.448 ' HG2' ' O ' ' A' ' 583' ' ' LYS . 40.7 tt0 -145.14 141.81 29.07 Favored 'General case' 0 N--CA 1.409 -2.495 0 C-N-CA 118.517 -1.273 . . . . 74.04 111.597 -174.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 583' ' ' LYS . . . . . 0.448 ' O ' ' HG2' ' A' ' 582' ' ' GLU . 97.3 mttt -94.57 -179.29 4.84 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 106.555 -1.646 . . . . 74.42 106.555 174.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -74.78 94.49 2.75 Favored 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 119.819 -0.753 . . . . 73.24 109.125 178.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 585' ' ' LYS . . . . . 0.43 ' HD3' ' HB2' ' A' ' 546' ' ' ALA . 0.0 OUTLIER -102.73 170.43 8.01 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 115.828 -0.624 . . . . 74.04 109.319 -179.56 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 2.8 t -151.79 148.96 28.48 Favored 'General case' 0 N--CA 1.418 -2.043 0 CA-C-O 121.486 0.66 . . . . 70.33 111.502 -177.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -128.84 150.09 50.47 Favored 'General case' 0 N--CA 1.411 -2.409 0 CA-C-N 113.537 -1.665 . . . . 70.3 107.321 174.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 588' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -108.51 135.98 48.88 Favored 'General case' 0 C--N 1.29 -1.993 0 C-N-CA 120.555 -0.458 . . . . 74.15 110.5 -169.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . 0.416 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.3 OUTLIER -102.85 129.58 49.57 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 105.8 -1.926 . . . . 72.11 105.8 175.712 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -132.97 127.08 33.42 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 109.392 -0.595 . . . . 72.54 109.392 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 591' ' ' ILE . . . . . . . . . . . . . 16.3 pt -94.17 138.43 20.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 107.945 -1.132 . . . . 73.01 107.945 174.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -97.64 -145.3 18.75 Favored Glycine 0 N--CA 1.43 -1.746 0 N-CA-C 115.049 0.779 . . . . 65.11 115.049 -172.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -84.99 119.67 72.82 Favored Pre-proline 0 C--N 1.302 -1.462 0 CA-C-N 114.081 -1.059 . . . . 63.24 109.827 -174.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 594' ' ' PRO . . . . . 0.409 ' HA ' ' O ' ' A' ' 536' ' ' ILE . 43.9 Cg_endo -72.5 156.01 54.51 Favored 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 123.082 2.521 . . . . 73.3 114.202 -177.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 595' ' ' ARG . . . . . 0.509 ' O ' ' HA ' ' A' ' 535' ' ' VAL . 5.7 mmp_? -115.37 118.15 32.43 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 123.713 0.805 . . . . 73.24 109.284 -175.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -82.5 117.99 22.92 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 104.793 -2.299 . . . . 72.24 104.793 169.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 17.0 t . . . . . 0 C--N 1.304 -1.396 0 CA-C-O 121.776 0.798 . . . . 75.44 112.787 -172.833 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 21.8 mtm180 . . . . . 0 N--CA 1.443 -0.79 0 CA-C-O 121.187 0.518 . . . . 74.41 112.32 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . 0.454 ' HA ' ' H ' ' A' ' 503' ' ' GLY . 61.3 Cg_endo -77.16 148.82 27.69 Favored 'Trans proline' 0 N--CA 1.437 -1.834 0 C-N-CA 121.795 1.663 . . . . 75.14 109.532 173.193 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 11.6 pt -137.33 -171.74 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-O 120.956 0.408 . . . . 74.24 110.351 -178.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.48 164.42 14.83 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 115.482 -0.781 . . . . 75.23 110.227 177.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . 0.47 ' HA3' ' HB ' ' A' ' 506' ' ' THR . . . -82.35 -106.51 0.43 Allowed Glycine 0 N--CA 1.435 -1.428 0 CA-C-N 115.917 -0.583 . . . . 50.22 112.99 -176.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -107.99 -54.16 2.53 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 119.889 -0.724 . . . . 73.04 111.003 -176.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 14.5 p80 -133.84 116.16 15.34 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 121.79 0.805 . . . . 75.51 111.423 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 16.2 p -104.3 91.24 3.83 Favored 'General case' 0 N--CA 1.408 -2.552 0 N-CA-C 109.091 -0.707 . . . . 73.44 109.091 174.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -171.65 126.25 0.61 Allowed 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 105.898 -1.89 . . . . 73.34 105.898 -178.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 642' ' ' LEU . . . . . 0.494 ' CD2' HG21 ' A' ' 523' ' ' VAL . 42.6 tp -126.28 110.97 14.01 Favored 'General case' 0 C--N 1.281 -2.398 0 N-CA-C 108.086 -1.079 . . . . 73.51 108.086 176.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -90.9 102.97 15.73 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 107.569 -1.271 . . . . 72.31 107.569 178.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 41.2 t -93.2 110.9 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 N-CA-C 109.333 -0.618 . . . . 71.33 109.333 -179.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 3.5 mp -93.07 125.6 45.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 108.425 -0.954 . . . . 74.12 108.425 176.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 646' ' ' ILE . . . . . 0.514 ' N ' HD13 ' A' ' 646' ' ' ILE . 2.1 mp -110.72 131.14 62.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 N-CA-C 107.424 -1.324 . . . . 74.33 107.424 -176.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -131.22 157.35 43.48 Favored 'General case' 0 C--N 1.28 -2.448 0 N-CA-C 108.511 -0.922 . . . . 75.43 108.511 178.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -56.5 117.97 4.36 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 106.307 -1.738 . . . . 72.11 106.307 170.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 2.9 t . . . . . 0 C--N 1.312 -1.028 0 O-C-N 125.802 1.939 . . . . 74.01 113.784 -165.258 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . 0.447 ' HA2' ' OG1' ' A' ' 528' ' ' THR . . . . . . . . 0 N--CA 1.403 -3.564 0 N-CA-C 110.08 -1.208 . . . . 74.22 110.08 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 4.1 mp -91.82 119.34 39.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 108.712 -0.847 . . . . 75.4 108.712 178.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -123.48 126.04 46.0 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 109.627 -0.508 . . . . 71.3 109.627 177.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 506' ' ' THR . . . . . 0.415 ' HB ' ' HA3' ' A' ' 637' ' ' GLY . 8.8 t -153.41 165.18 36.62 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.522 -0.918 . . . . 74.1 108.522 -177.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -89.31 162.65 15.72 Favored 'General case' 0 C--O 1.251 1.136 0 N-CA-C 107.228 -1.397 . . . . 73.45 107.228 173.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -88.42 -44.43 10.75 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 106.293 -1.743 . . . . 75.32 106.293 178.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -105.36 133.73 20.02 Favored Pre-proline 0 N--CA 1.42 -1.93 0 CA-C-N 114.502 -1.226 . . . . 74.42 109.495 176.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -87.21 -10.63 5.59 Favored 'Trans proline' 0 C--O 1.219 -0.469 0 C-N-CA 121.956 1.77 . . . . 71.53 110.824 175.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 81.5 t -142.42 138.89 29.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 C-N-CA 124.378 1.071 . . . . 74.02 108.441 -176.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 11.3 t -142.09 141.71 32.75 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 107.726 -1.213 . . . . 74.13 107.726 174.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 35.5 m-70 -108.94 130.4 55.45 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.486 -0.561 . . . . 70.24 109.486 178.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 26.4 m -128.71 162.47 35.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 CA-C-O 120.937 0.398 . . . . 73.4 110.221 -176.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 45.9 t -84.24 156.68 21.89 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 108.412 -0.959 . . . . 71.14 108.412 175.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -88.91 -6.77 57.06 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-O 122.089 0.947 . . . . 75.25 109.659 174.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 8.7 t -96.99 6.34 48.8 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 108.707 -0.849 . . . . 75.51 108.707 179.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 12.5 tt -85.11 151.03 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.623 0 N-CA-C 108.69 -0.856 . . . . 73.44 108.69 -178.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . 0.452 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . -89.61 -63.38 1.29 Allowed Glycine 0 N--CA 1.426 -2.023 0 C-N-CA 120.366 -0.921 . . . . 75.4 111.098 179.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 32.1 mm -123.64 124.26 69.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 109.458 -0.571 . . . . 74.02 109.458 -179.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 521' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.6 135.51 44.12 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.597 -1.26 . . . . 64.1 107.597 172.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 522' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 42.7 mt-10 -120.93 132.29 54.86 Favored 'General case' 0 CA--C 1.494 -1.206 0 O-C-N 123.522 0.514 . . . . 71.23 110.713 -177.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 570' ' ' THR . 29.4 t -112.67 123.46 68.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-N 115.37 -0.832 . . . . 71.22 108.888 178.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp -79.78 122.77 27.02 Favored 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 123.468 0.707 . . . . 71.54 110.408 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 21.9 t -101.21 150.97 5.59 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 CA-C-N 115.405 -0.816 . . . . 72.11 109.126 -178.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -95.43 153.53 17.65 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 108.974 -0.75 . . . . 75.42 108.974 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . 0.442 ' HD3' ' HA ' ' A' ' 567' ' ' ILE . 67.1 mtm180 -94.21 176.81 6.18 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.201 0.524 . . . . 75.32 109.9 173.091 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 528' ' ' THR . . . . . 0.447 ' OG1' ' HA2' ' A' ' 503' ' ' GLY . 8.8 t -87.82 164.26 16.01 Favored 'General case' 0 N--CA 1.411 -2.38 0 CA-C-N 115.079 -0.964 . . . . 75.14 110.208 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 13.3 t -63.21 -42.75 99.34 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 115.262 -0.881 . . . . 70.21 108.712 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -100.78 67.4 0.49 Allowed Glycine 0 N--CA 1.434 -1.47 0 N-CA-C 110.764 -0.934 . . . . 73.55 110.764 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -78.89 80.45 5.24 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.261 0.553 . . . . 75.44 110.742 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -134.63 138.65 44.68 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 106.306 -1.739 . . . . 75.22 106.306 177.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 533' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 563' ' ' GLN . . . 87.93 173.48 47.75 Favored Glycine 0 C--N 1.302 -1.314 0 C-N-CA 119.883 -1.151 . . . . 74.23 111.156 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 534' ' ' ASN . . . . . 0.402 HD22 ' HG3' ' A' ' 561' ' ' GLU . 2.9 t-20 -105.98 121.27 43.76 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 122.409 -0.465 . . . . 75.3 109.809 -177.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 59.8 t -124.01 126.21 72.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.409 -0.96 . . . . 73.41 108.409 178.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 536' ' ' ILE . . . . . 0.5 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 47.4 mm -99.23 137.28 27.17 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 N-CA-C 108.661 -0.866 . . . . 72.15 108.661 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 57.9 t -122.45 109.82 32.64 Favored Pre-proline 0 C--N 1.307 -1.266 0 CA-C-N 116.417 -0.356 . . . . 74.21 110.805 -179.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -75.25 135.92 19.23 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 122.541 2.161 . . . . 74.21 111.668 176.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 539' ' ' TYR . . . . . 0.455 ' CD1' ' HG ' ' A' ' 560' ' ' LEU . 42.9 p90 -134.12 157.49 46.03 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 109.068 -0.716 . . . . 73.22 109.068 -178.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -156.73 156.85 34.06 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 123.322 0.389 . . . . 74.11 111.048 177.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 1.6 p -91.45 116.85 29.19 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 115.437 -0.801 . . . . 71.14 110.663 174.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.6 mp -87.51 112.27 23.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 106.282 -1.747 . . . . 74.41 106.282 174.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.69 -46.19 74.07 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 114.797 1.406 . . . . 75.01 114.797 -176.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 63.41 -94.54 0.13 Allowed Glycine 0 CA--C 1.523 0.546 0 CA-C-O 121.349 0.416 . . . . 74.43 113.146 177.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 10.2 t -114.09 0.4 14.28 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.293 0.568 . . . . 73.42 110.712 -178.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -104.02 156.7 17.65 Favored 'General case' 0 C--N 1.318 -0.794 0 O-C-N 121.97 -0.457 . . . . 63.43 109.923 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . 0.407 ' HB2' ' HB2' ' A' ' 552' ' ' ASP . 4.6 mpt_? -87.21 125.43 34.18 Favored 'General case' 0 CA--C 1.483 -1.602 0 CA-C-O 121.442 0.639 . . . . 71.22 110.991 -178.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -86.32 179.92 49.47 Favored Glycine 0 C--N 1.279 -2.633 0 CA-C-N 114.245 -1.343 . . . . 73.03 112.083 -177.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 74.18 30.86 60.24 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 114.039 0.376 . . . . 72.44 114.039 177.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 76.08 21.39 76.11 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.259 -0.972 . . . . 62.44 111.919 178.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -91.67 -66.26 0.94 Allowed 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 110.02 -0.363 . . . . 75.15 110.02 -177.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . 0.407 ' HB2' ' HB2' ' A' ' 547' ' ' ARG . 1.8 t70 -101.79 -29.84 11.64 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 106.608 -1.627 . . . . 72.2 106.608 177.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -146.07 160.06 42.41 Favored 'General case' 0 C--O 1.247 0.937 0 CA-C-N 114.963 -1.017 . . . . 73.43 108.374 175.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -91.21 130.09 37.13 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.404 -1.702 . . . . 75.32 106.404 178.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -86.17 117.46 25.01 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 116.511 -0.313 . . . . 64.14 110.579 -174.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 556' ' ' THR . . . . . 0.408 ' CG2' HG23 ' A' ' 573' ' ' VAL . 13.8 t -115.99 122.35 44.98 Favored 'General case' 0 N--CA 1.409 -2.477 0 CA-C-O 122.206 1.003 . . . . 72.32 110.462 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 1.8 p -143.87 128.76 18.42 Favored 'General case' 0 N--CA 1.417 -2.087 0 CA-C-N 114.54 -1.209 . . . . 72.24 108.693 179.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -177.4 -158.42 20.48 Favored Glycine 0 N--CA 1.419 -2.47 0 N-CA-C 110.103 -1.199 . . . . 74.41 110.103 -176.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 559' ' ' GLU . . . . . 0.5 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 38.7 mt-10 -129.97 125.73 36.12 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 120.999 0.428 . . . . 72.55 111.935 -176.273 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . 0.455 ' HG ' ' CD1' ' A' ' 539' ' ' TYR . 94.9 mt -88.91 144.92 25.86 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 109.07 -0.715 . . . . 74.11 109.07 177.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 561' ' ' GLU . . . . . 0.402 ' HG3' HD22 ' A' ' 534' ' ' ASN . 37.5 tt0 -103.95 122.17 44.64 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 116.418 -0.355 . . . . 75.32 110.475 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -121.24 146.57 46.67 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.445 -0.946 . . . . 75.03 108.445 171.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . 0.436 ' HA ' ' O ' ' A' ' 533' ' ' GLY . 3.6 pt20 -159.14 -173.16 4.08 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 110.324 -0.25 . . . . 73.01 110.324 178.271 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -59.11 -45.41 90.96 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 123.58 0.752 . . . . 72.5 112.24 -177.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -91.95 -41.21 10.7 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 120.17 -0.612 . . . . 55.02 111.748 -178.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -66.94 135.2 53.44 Favored 'General case' 0 C--N 1.317 -0.809 0 O-C-N 123.247 0.342 . . . . 71.0 110.233 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 567' ' ' ILE . . . . . 0.442 ' HA ' ' HD3' ' A' ' 527' ' ' ARG . 31.1 pt -116.94 -172.19 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.412 -2.365 0 N-CA-C 109.057 -0.72 . . . . 73.34 109.057 -178.026 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 2.8 p 5.9 128.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 C-N-CA 129.628 3.171 . . . . 72.32 116.944 172.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 569' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -117.11 153.87 32.01 Favored 'General case' 0 C--N 1.266 -3.024 0 CA-C-N 115.234 -0.894 . . . . 72.21 110.699 177.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 570' ' ' THR . . . . . 0.551 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 8.3 p -126.78 121.2 31.28 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 124.032 0.832 . . . . 75.22 111.998 177.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 571' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 2.5 mp -77.15 118.15 23.33 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 N-CA-C 105.191 -2.151 . . . . 73.34 105.191 172.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 5.7 m -105.93 109.36 21.28 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.894 -0.78 . . . . 63.1 108.894 -176.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 573' ' ' VAL . . . . . 0.408 HG23 ' CG2' ' A' ' 556' ' ' THR . 40.6 t -114.01 135.3 54.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 110.067 -0.346 . . . . 72.01 110.067 -176.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 574' ' ' LYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 519' ' ' GLY . 15.7 tppt? -90.4 123.98 34.58 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.369 -0.832 . . . . 73.22 110.112 178.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 64.3 t -94.59 117.66 38.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 107.724 -1.213 . . . . 72.51 107.724 176.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 36.8 mm -78.96 154.65 4.85 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 N-CA-C 108.347 -0.983 . . . . 74.41 108.347 -176.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -72.36 86.78 1.13 Allowed 'General case' 0 C--O 1.247 0.947 0 CA-C-O 122.061 0.934 . . . . 73.05 110.26 173.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -40.6 130.57 2.4 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 127.681 2.392 . . . . 73.32 113.25 178.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.25 -26.8 60.44 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 114.145 -1.389 . . . . 74.42 114.126 -171.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 580' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 581' ' ' TYR . 0.8 OUTLIER -124.63 178.7 5.3 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 119.549 -0.861 . . . . 75.22 110.67 -174.742 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 581' ' ' TYR . . . . . 0.466 ' O ' ' HG2' ' A' ' 580' ' ' GLU . 7.2 p90 -86.01 151.43 23.73 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 105.451 -2.055 . . . . 75.54 105.451 173.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 582' ' ' GLU . . . . . 0.419 ' OE2' ' HG3' ' A' ' 585' ' ' LYS . 9.5 pt-20 -133.4 172.02 13.27 Favored 'General case' 0 C--N 1.277 -2.549 0 C-N-CA 119.194 -1.002 . . . . 75.31 109.672 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -90.65 -48.87 6.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 N-CA-C 106.812 -1.551 . . . . 75.32 106.812 173.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 1.4 m120 175.22 101.08 0.01 OUTLIER 'General case' 0 C--N 1.259 -3.344 0 CA-C-N 110.822 -2.899 . . . . 71.5 109.476 177.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 585' ' ' LYS . . . . . 0.419 ' HG3' ' OE2' ' A' ' 582' ' ' GLU 0.263 0.1 OUTLIER -89.87 162.02 15.67 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 118.065 -1.454 . . . . 74.22 109.676 172.994 . . . . . . . . 4 4 . 1 . 018 nuclear orig core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 5.2 t -151.36 142.98 23.66 Favored 'General case' 0 N--CA 1.415 -2.216 0 CA-C-O 121.174 0.512 . . . . 65.4 110.186 -176.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -126.09 147.01 49.69 Favored 'General case' 0 N--CA 1.421 -1.898 0 CA-C-N 114.104 -1.407 . . . . 74.34 108.412 176.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 588' ' ' PHE . . . . . 0.429 ' HA ' ' O ' ' A' ' 642' ' ' LEU . 10.5 m-85 -105.92 135.48 47.29 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 116.027 -0.533 . . . . 70.23 109.708 -172.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . 0.431 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.3 OUTLIER -104.27 124.99 50.15 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 106.096 -1.816 . . . . 63.41 106.096 175.786 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -131.38 135.72 47.45 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 109.526 -0.546 . . . . 74.04 109.526 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 591' ' ' ILE . . . . . . . . . . . . . 22.5 pt -99.36 134.71 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.734 0 N-CA-C 107.059 -1.46 . . . . 74.12 107.059 174.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -90.4 -150.66 24.53 Favored Glycine 0 C--N 1.297 -1.6 0 C-N-CA 120.786 -0.721 . . . . 74.02 112.965 -175.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -67.83 118.73 60.8 Favored Pre-proline 0 C--N 1.315 -0.935 0 C-N-CA 122.743 0.417 . . . . 75.22 110.292 179.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -70.51 143.21 46.59 Favored 'Trans proline' 0 N--CA 1.438 -1.772 0 C-N-CA 121.84 1.693 . . . . 72.14 109.78 175.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 595' ' ' ARG . . . . . 0.419 ' HG3' ' HB ' ' A' ' 536' ' ' ILE . 5.5 ptp180 -120.79 122.46 40.38 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 116.402 -0.363 . . . . 75.52 111.056 -174.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.18 122.48 26.32 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 107.735 -1.209 . . . . 75.41 107.735 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 17.1 t . . . . . 0 C--N 1.303 -1.435 0 CA-C-O 121.676 0.751 . . . . 73.33 110.111 -178.31 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 55.4 mtt180 . . . . . 0 C--O 1.218 -0.561 0 N-CA-C 112.088 0.403 . . . . 75.32 112.088 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -89.54 168.21 4.98 Favored 'Trans proline' 0 N--CA 1.441 -1.57 0 C-N-CA 122.661 2.24 . . . . 74.42 111.293 174.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.1 pp -144.06 178.54 1.72 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 113.416 0.895 . . . . 72.04 113.416 -175.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -82.67 148.16 28.1 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 108.775 -0.824 . . . . 74.42 108.775 178.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . 0.415 ' HA3' ' HB ' ' A' ' 506' ' ' THR . . . -90.77 -128.55 3.96 Favored Glycine 0 C--N 1.294 -1.79 0 C-N-CA 120.736 -0.745 . . . . 63.51 114.46 -176.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -72.1 -56.67 5.19 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.379 -0.41 . . . . 71.12 111.448 -175.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 20.3 p80 -145.38 109.69 4.93 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.833 0.825 . . . . 72.52 111.684 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 37.9 p -101.35 90.25 4.04 Favored 'General case' 0 N--CA 1.398 -3.034 0 N-CA-C 107.849 -1.167 . . . . 74.41 107.849 174.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -178.32 125.74 0.11 Allowed 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 105.01 -2.219 . . . . 64.2 105.01 -177.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 642' ' ' LEU . . . . . 0.521 ' CD2' HG23 ' A' ' 523' ' ' VAL . 38.0 tp -124.72 111.07 15.13 Favored 'General case' 0 C--N 1.28 -2.435 0 N-CA-C 108.17 -1.048 . . . . 74.14 108.17 174.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -93.62 101.44 13.6 Favored 'General case' 0 C--N 1.272 -2.767 0 N-CA-C 107.484 -1.302 . . . . 75.31 107.484 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 39.4 t -93.04 108.52 20.49 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 108.906 -0.775 . . . . 75.53 108.906 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 4.2 mp -94.05 121.82 45.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 107.944 -1.132 . . . . 72.32 107.944 176.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 646' ' ' ILE . . . . . 0.503 ' N ' HD12 ' A' ' 646' ' ' ILE . 2.9 mp -100.19 134.09 40.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 107.091 -1.448 . . . . 75.11 107.091 -176.063 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -118.02 145.23 44.93 Favored 'General case' 0 N--CA 1.419 -2.023 0 C-N-CA 120.229 -0.589 . . . . 75.15 109.855 -178.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -60.31 137.56 58.11 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 107.019 -1.474 . . . . 74.44 107.019 176.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 17.0 t . . . . . 0 N--CA 1.434 -1.253 0 CA-C-O 122.177 0.989 . . . . 74.03 112.881 -173.12 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . 0.65 ' HA2' ' OG1' ' A' ' 528' ' ' THR . . . . . . . . 1 N--CA 1.395 -4.061 0 N-CA-C 110.952 -0.859 . . . . 73.03 110.952 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 2.7 mp -105.54 101.01 11.76 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 N-CA-C 106.763 -1.569 . . . . 72.41 106.763 176.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -114.71 122.87 47.74 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 109.457 -0.571 . . . . 73.04 109.457 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 11.2 t -148.64 163.99 35.62 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.483 -0.932 . . . . 73.11 108.483 -176.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -92.51 161.98 14.4 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 107.306 -1.368 . . . . 74.5 107.306 172.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -96.91 -26.3 15.11 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.322 -1.362 . . . . 74.4 107.322 173.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -97.32 120.57 60.72 Favored Pre-proline 0 N--CA 1.419 -1.989 0 CA-C-N 114.618 -1.174 . . . . 74.22 110.587 176.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -82.16 -19.09 7.02 Favored 'Trans proline' 0 N--CA 1.429 -2.28 0 N-CA-C 108.065 -1.552 . . . . 74.2 108.065 168.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 93.7 t -147.89 139.69 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 C-N-CA 126.005 1.722 . . . . 71.24 107.897 -177.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 14.4 t -137.05 119.47 15.82 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 108.051 -1.092 . . . . 72.21 108.051 173.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -88.41 128.61 35.52 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 122.085 -0.384 . . . . 74.42 110.225 175.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 26.8 m -126.25 161.52 31.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-N 115.657 -0.701 . . . . 75.12 109.717 -178.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 56.9 m -88.21 167.8 13.28 Favored 'General case' 0 N--CA 1.403 -2.807 0 CA-C-N 115.079 -0.964 . . . . 73.51 109.99 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -94.32 -23.63 17.74 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.497 0.665 . . . . 72.33 110.608 176.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 14.2 m -85.31 20.77 1.89 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.932 0.873 . . . . 73.21 110.406 -176.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 15.3 tt -108.3 155.83 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.133 0 N-CA-C 107.554 -1.276 . . . . 74.52 107.554 -176.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -96.65 -59.85 1.0 Allowed Glycine 0 C--N 1.293 -1.848 0 C-N-CA 120.175 -1.012 . . . . 65.21 111.297 179.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 41.9 mm -121.48 136.22 59.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 109.402 -0.592 . . . . 75.52 109.402 -178.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 521' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.35 132.68 56.54 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 106.368 -1.716 . . . . 74.33 106.368 171.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 522' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 9.4 mp0 -109.17 149.29 29.58 Favored 'General case' 0 N--CA 1.428 -1.563 0 C-N-CA 120.509 -0.476 . . . . 71.04 109.852 -178.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . 0.627 ' O ' ' HA ' ' A' ' 570' ' ' THR . 40.0 t -126.12 121.05 58.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 109.722 -0.473 . . . . 64.34 109.722 178.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . 0.438 ' HD2' HG22 ' A' ' 568' ' ' VAL . 28.0 mmtp -82.09 118.9 23.39 Favored 'General case' 0 C--N 1.313 -1.021 0 O-C-N 124.095 0.872 . . . . 75.55 110.453 178.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 21.7 t -98.87 139.18 21.28 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 CA-C-N 114.563 -1.199 . . . . 71.23 108.982 -178.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -79.7 146.36 32.46 Favored 'General case' 0 C--N 1.31 -1.12 0 O-C-N 123.635 0.585 . . . . 74.33 109.566 -179.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . 0.404 ' HG2' ' N ' ' A' ' 528' ' ' THR . 31.8 ttp180 -87.64 160.16 18.26 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.384 -0.969 . . . . 73.43 108.384 -179.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 528' ' ' THR . . . . . 0.65 ' OG1' ' HA2' ' A' ' 503' ' ' GLY . 4.6 t -61.82 150.76 36.25 Favored 'General case' 0 N--CA 1.421 -1.916 0 CA-C-O 121.362 0.601 . . . . 64.25 110.71 174.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 42.2 t -69.99 -22.17 63.16 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 114.83 -1.077 . . . . 74.25 109.754 179.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -129.0 89.71 0.31 Allowed Glycine 0 N--CA 1.435 -1.377 0 N-CA-C 109.907 -1.277 . . . . 65.12 109.907 178.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -86.87 85.93 7.3 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 121.382 0.611 . . . . 64.34 111.291 -176.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -123.54 101.78 7.51 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.634 -0.712 . . . . 75.15 110.772 177.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 119.07 -148.79 18.26 Favored Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 110.969 -0.852 . . . . 75.44 110.969 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 534' ' ' ASN . . . . . 0.46 HD22 ' CG ' ' A' ' 561' ' ' GLU . 2.9 t-20 -138.2 131.62 30.58 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 106.288 -1.745 . . . . 63.44 106.288 178.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 67.7 t -127.44 137.6 57.25 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 118.189 0.45 . . . . 70.41 111.416 -174.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 536' ' ' ILE . . . . . . . . . . . . . 27.9 mm -102.91 126.04 57.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 108.889 -0.782 . . . . 75.15 108.889 174.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 31.7 t -117.1 106.83 46.68 Favored Pre-proline 0 C--N 1.298 -1.652 0 N-CA-C 108.543 -0.91 . . . . 75.15 108.543 178.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -75.61 137.81 20.86 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.102 1.868 . . . . 74.52 111.364 177.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -130.68 160.42 34.33 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.535 -0.543 . . . . 73.52 109.535 179.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.33 146.91 18.83 Favored 'General case' 0 C--N 1.314 -0.972 0 O-C-N 123.67 0.606 . . . . 74.45 110.679 175.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 7.9 p -86.77 122.33 30.52 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.053 -0.521 . . . . 74.23 110.38 176.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.4 mp -82.49 122.47 37.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 105.753 -1.943 . . . . 74.21 105.753 172.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -63.75 -48.69 75.98 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 123.464 0.478 . . . . 73.12 109.928 -178.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 67.24 -93.5 0.23 Allowed Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 115.858 -0.61 . . . . 73.44 112.215 177.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 15.1 t -113.74 -0.61 14.2 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.494 -0.558 . . . . 65.1 109.494 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -97.34 176.49 5.87 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-N 115.646 -0.706 . . . . 71.2 111.592 -177.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -127.31 111.97 14.52 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 109.25 -0.648 . . . . 72.42 109.25 -179.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -78.43 -160.9 17.29 Favored Glycine 0 C--N 1.315 -0.606 0 C-N-CA 121.57 -0.348 . . . . 72.21 112.602 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 67.37 17.68 68.71 Favored Glycine 0 C--N 1.314 -0.656 0 CA-C-O 120.908 0.171 . . . . 53.14 113.191 -177.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 77.42 11.58 85.36 Favored Glycine 0 C--O 1.211 -1.29 0 N-CA-C 111.041 -0.824 . . . . 73.1 111.041 -178.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -78.76 -42.44 28.02 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 122.469 0.308 . . . . 70.12 111.291 -175.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -135.89 -20.67 1.49 Allowed 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 107.822 -1.177 . . . . 74.54 107.822 173.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -155.79 163.51 39.74 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 107.181 -1.414 . . . . 75.13 107.181 169.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -98.09 109.19 21.99 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 106.761 -1.57 . . . . 63.15 106.761 -178.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -77.54 147.25 35.86 Favored 'General case' 0 CA--C 1.499 -0.993 0 C-N-CA 120.761 -0.375 . . . . 75.35 110.439 -175.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 8.3 t -139.59 142.22 37.13 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-O 121.605 0.717 . . . . 73.21 111.778 -174.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 7.6 p -145.46 149.6 34.97 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.214 -1.402 . . . . 73.31 107.214 176.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 173.47 -167.21 39.8 Favored Glycine 0 N--CA 1.418 -2.543 0 N-CA-C 110.346 -1.101 . . . . 33.41 110.346 -178.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -126.73 124.63 40.22 Favored 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 123.165 0.586 . . . . 75.34 110.169 -176.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 94.3 mt -95.97 142.05 28.66 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.746 -0.835 . . . . 72.05 108.746 177.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 561' ' ' GLU . . . . . 0.46 ' CG ' HD22 ' A' ' 534' ' ' ASN . 31.1 tt0 -115.83 115.9 27.06 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 120.912 0.387 . . . . 70.01 111.143 -176.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -102.05 140.93 35.68 Favored 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 108.982 -0.747 . . . . 74.53 108.982 176.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . 0.403 ' HB2' ' H ' ' A' ' 566' ' ' GLU . 4.6 mt-30 -119.7 -178.23 3.58 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 119.033 -1.067 . . . . 75.43 110.337 179.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -74.43 -34.71 63.3 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.916 0.865 . . . . 64.12 109.001 176.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -94.0 -43.39 8.55 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.437 -1.256 . . . . 60.15 110.901 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 566' ' ' GLU . . . . . 0.403 ' H ' ' HB2' ' A' ' 563' ' ' GLN . 25.5 tt0 -70.99 123.29 21.72 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.064 0.459 . . . . 74.22 111.326 -179.086 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 8.7 pt -104.81 166.01 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.564 0 N-CA-C 108.797 -0.816 . . . . 74.33 108.797 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 568' ' ' VAL . . . . . 0.438 HG22 ' HD2' ' A' ' 524' ' ' LYS . 2.0 p 47.34 159.96 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.58 2.107 0 C-N-CA 127.027 2.131 . . . . 71.34 115.392 179.213 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 569' ' ' LYS . . . . . 0.422 ' HA ' ' HE2' ' A' ' 569' ' ' LYS . 4.3 mmpt? -142.67 166.05 25.73 Favored 'General case' 0 CA--C 1.493 -1.217 0 O-C-N 121.16 -0.962 . . . . 73.11 109.019 172.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 570' ' ' THR . . . . . 0.627 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 1.3 p -138.57 127.16 23.35 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 123.902 0.751 . . . . 74.32 112.897 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 571' ' ' ILE . . . . . 0.413 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 3.3 mp -96.07 122.06 47.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 106.477 -1.675 . . . . 75.2 106.477 170.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 49.2 m -107.36 125.08 50.75 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 108.84 -0.8 . . . . 74.33 108.84 177.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 573' ' ' VAL . . . . . . . . . . . . . 48.1 t -124.68 139.45 50.86 Favored 'Isoleucine or valine' 0 C--O 1.243 0.757 0 N-CA-C 108.458 -0.942 . . . . 72.31 108.458 -178.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -95.7 129.99 42.74 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-O 121.77 0.795 . . . . 75.41 111.786 -178.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 59.2 t -94.13 138.72 19.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 107.044 -1.465 . . . . 65.33 107.044 176.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 45.8 mm -104.62 143.97 15.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 108.659 -0.867 . . . . 74.4 108.659 -176.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -59.18 129.76 43.7 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 108.535 -0.913 . . . . 74.31 108.535 174.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -77.96 117.36 19.22 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 115.02 -0.991 . . . . 74.14 111.911 -167.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.08 -16.81 59.09 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 114.263 1.208 . . . . 74.22 114.263 -177.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 580' ' ' GLU . . . . . 0.547 ' HG2' ' O ' ' A' ' 581' ' ' TYR . 0.0 OUTLIER -141.21 -176.71 4.81 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 106.553 -1.647 . . . . 73.41 106.553 173.257 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 581' ' ' TYR . . . . . 0.547 ' O ' ' HG2' ' A' ' 580' ' ' GLU . 12.4 p90 -87.19 152.21 22.52 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 106.825 -1.546 . . . . 72.42 106.825 174.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 582' ' ' GLU . . . . . 0.694 ' OE1' ' HB3' ' A' ' 585' ' ' LYS . 14.7 pt-20 -132.81 175.84 8.99 Favored 'General case' 0 C--N 1.276 -2.599 0 N-CA-C 108.826 -0.805 . . . . 74.13 108.826 -178.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 583' ' ' LYS . . . . . 0.451 ' O ' ' HG3' ' A' ' 582' ' ' GLU . 56.3 mtpt -100.05 -165.92 1.27 Allowed 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 105.551 -2.018 . . . . 74.44 105.551 169.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -74.73 89.16 2.27 Favored 'General case' 0 C--N 1.281 -2.391 0 C-N-CA 118.82 -1.152 . . . . 75.42 111.853 178.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 585' ' ' LYS . . . . . 0.694 ' HB3' ' OE1' ' A' ' 582' ' ' GLU . 0.0 OUTLIER -79.02 143.81 35.29 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 114.879 -1.055 . . . . 75.44 108.746 -178.964 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 5.9 t -145.14 141.57 28.88 Favored 'General case' 0 N--CA 1.407 -2.604 0 CA-C-O 121.169 0.509 . . . . 70.4 110.517 -176.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -122.16 144.63 48.83 Favored 'General case' 0 N--CA 1.412 -2.342 0 CA-C-N 113.928 -1.487 . . . . 74.53 108.468 175.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 588' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -104.66 128.16 52.62 Favored 'General case' 0 C--N 1.284 -2.239 0 N-CA-C 108.732 -0.84 . . . . 75.43 108.732 -173.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . 0.436 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.7 OUTLIER -98.45 126.08 43.86 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 106.642 -1.614 . . . . 72.03 106.642 177.381 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -128.43 132.75 48.45 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 109.993 -0.373 . . . . 75.4 109.993 179.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 591' ' ' ILE . . . . . . . . . . . . . 16.0 pt -97.32 128.71 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.652 0 N-CA-C 106.256 -1.757 . . . . 74.34 106.256 170.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -87.32 -139.81 6.18 Favored Glycine 0 N--CA 1.435 -1.401 0 CA-C-N 116.104 -0.498 . . . . 73.34 114.18 -172.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -79.9 112.36 29.19 Favored Pre-proline 0 C--N 1.311 -1.071 0 N-CA-C 109.301 -0.629 . . . . 71.53 109.301 -178.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -78.53 149.68 24.25 Favored 'Trans proline' 0 N--CA 1.434 -1.974 0 C-N-CA 122.094 1.863 . . . . 73.23 110.886 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 8.8 ptt-85 -129.23 132.82 47.31 Favored 'General case' 0 C--N 1.28 -2.421 0 CA-C-N 115.912 -0.586 . . . . 74.4 110.402 -175.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -77.06 125.77 29.87 Favored 'General case' 0 N--CA 1.415 -2.181 0 N-CA-C 105.501 -2.037 . . . . 64.15 105.501 178.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 96.6 t . . . . . 0 C--N 1.3 -1.562 0 N-CA-C 108.646 -0.872 . . . . 62.53 108.646 -179.709 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 . . . . . 0 C--O 1.203 -1.367 0 N-CA-C 108.502 -0.925 . . . . 72.52 108.502 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -76.18 153.51 36.36 Favored 'Trans proline' 0 N--CA 1.434 -1.98 0 C-N-CA 121.116 1.211 . . . . 72.03 110.21 176.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.0 pp -138.96 -175.25 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 112.765 0.654 . . . . 74.5 112.765 -175.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.71 146.09 32.58 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 115.425 -0.807 . . . . 74.31 109.327 178.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -83.97 -107.33 0.57 Allowed Glycine 0 C--N 1.291 -1.96 0 CA-C-N 116.105 -0.498 . . . . 63.4 112.474 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -94.66 -65.82 0.96 Allowed 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.238 0.542 . . . . 73.32 110.142 -177.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 17.0 p80 -130.54 114.08 15.04 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.628 0.728 . . . . 64.32 111.011 -177.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 13.7 p -104.78 89.76 3.27 Favored 'General case' 0 N--CA 1.397 -3.124 0 N-CA-C 107.473 -1.306 . . . . 75.12 107.473 173.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -176.46 123.62 0.17 Allowed 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 105.175 -2.158 . . . . 74.55 105.175 -174.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 642' ' ' LEU . . . . . 0.449 ' CD2' HG22 ' A' ' 523' ' ' VAL . 45.1 tp -125.55 106.84 10.06 Favored 'General case' 0 C--N 1.274 -2.681 0 N-CA-C 106.976 -1.49 . . . . 71.05 106.976 177.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -88.8 100.56 13.25 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 108.029 -1.1 . . . . 62.13 108.029 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 23.1 t -91.01 105.61 16.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 108.925 -0.769 . . . . 74.22 108.925 -179.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 4.4 mp -92.36 124.93 45.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 108.426 -0.953 . . . . 74.21 108.426 175.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 646' ' ' ILE . . . . . 0.532 HD11 ' N ' ' A' ' 646' ' ' ILE . 1.9 mp -106.55 108.02 24.13 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.473 0 N-CA-C 106.492 -1.669 . . . . 71.34 106.492 -178.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -104.15 143.7 32.58 Favored 'General case' 0 C--N 1.269 -2.905 0 CA-C-N 114.698 -1.137 . . . . 75.31 109.625 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -57.07 132.48 53.04 Favored 'General case' 0 C--O 1.249 1.068 0 N-CA-C 106.154 -1.795 . . . . 75.24 106.154 175.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 8.6 t . . . . . 0 C--O 1.245 0.826 0 O-C-N 124.18 0.925 . . . . 71.32 112.327 -169.11 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . 0.631 ' HA3' ' OG1' ' A' ' 528' ' ' THR . . . . . . . . 1 N--CA 1.394 -4.11 0 CA-C-O 121.593 0.552 . . . . 52.3 113.505 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 3.1 mp -119.18 126.81 75.68 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 CA-C-N 114.126 -1.037 . . . . 72.02 108.256 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -134.86 103.99 5.82 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 106.803 -1.555 . . . . 75.33 106.803 172.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 14.3 t -143.42 160.46 40.52 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 109.66 -0.496 . . . . 73.43 109.66 -173.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -81.58 153.13 26.88 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 107.171 -1.418 . . . . 74.25 107.171 173.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.02 -50.06 38.19 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.339 -0.985 . . . . 71.12 108.339 176.168 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -116.02 131.87 23.52 Favored Pre-proline 0 C--N 1.303 -1.431 0 CA-C-N 115.7 -0.682 . . . . 74.4 109.195 -178.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -83.81 -13.08 8.28 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.477 2.118 . . . . 71.0 112.127 178.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 511' ' ' VAL . . . . . 0.408 HG22 ' HB3' ' A' ' 643' ' ' GLU . 73.9 t -136.52 132.51 48.71 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.461 0 N-CA-C 107.873 -1.158 . . . . 75.54 107.873 178.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 3.8 t -138.61 140.95 39.15 Favored 'General case' 0 N--CA 1.396 -3.153 0 N-CA-C 107.666 -1.235 . . . . 74.2 107.666 177.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -109.17 137.79 46.52 Favored 'General case' 0 CA--C 1.479 -1.772 0 N-CA-C 107.474 -1.306 . . . . 73.11 107.474 176.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.654 HG12 ' SD ' ' A' ' 521' ' ' MET . 35.0 m -132.28 155.25 41.28 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.309 0 CA-C-O 121.518 0.675 . . . . 74.42 110.32 -176.1 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 19.3 m -68.61 141.27 55.47 Favored 'General case' 0 N--CA 1.393 -3.276 0 CA-C-N 113.665 -1.607 . . . . 74.23 107.877 176.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -73.79 -24.15 59.79 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 119.388 -0.925 . . . . 63.45 109.718 176.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 24.0 t -107.16 75.71 1.05 Allowed 'General case' 0 N--CA 1.415 -2.192 0 N-CA-C 107.876 -1.157 . . . . 74.11 107.876 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 17.1 tt -141.04 161.01 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.26 0 CA-C-N 113.766 -1.561 . . . . 65.2 106.813 176.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -96.15 -69.58 1.02 Allowed Glycine 0 N--CA 1.434 -1.46 0 C-N-CA 119.571 -1.3 . . . . 72.32 111.596 177.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 40.9 mm -116.24 134.57 59.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 109.361 -0.607 . . . . 74.25 109.361 -178.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 521' ' ' MET . . . . . 0.654 ' SD ' HG12 ' A' ' 514' ' ' VAL . 23.8 ptt? -114.29 138.74 50.12 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 106.934 -1.506 . . . . 73.43 106.934 171.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -117.07 132.66 56.63 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 108.837 -0.801 . . . . 74.12 108.837 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 523' ' ' VAL . . . . . 0.677 ' O ' ' HA ' ' A' ' 570' ' ' THR . 24.8 t -114.99 134.11 59.09 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 109.314 -0.625 . . . . 74.43 109.314 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -84.91 128.13 34.48 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 122.027 0.918 . . . . 75.03 113.1 -175.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 3.3 t -113.68 132.84 61.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 106.951 -1.5 . . . . 65.03 106.951 177.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -93.77 151.13 19.83 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 108.959 -0.756 . . . . 74.22 108.959 -177.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 527' ' ' ARG . . . . . 0.531 ' CZ ' HG23 ' A' ' 567' ' ' ILE . 68.9 mtm180 -87.02 179.31 6.71 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-O 122.018 0.913 . . . . 75.52 111.137 -179.068 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 528' ' ' THR . . . . . 0.631 ' OG1' ' HA3' ' A' ' 503' ' ' GLY . 1.0 OUTLIER -78.16 159.71 28.44 Favored 'General case' 0 N--CA 1.408 -2.553 0 CA-C-N 113.796 -1.547 . . . . 74.35 109.766 176.21 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 17.0 t -74.73 -20.04 59.99 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 107.903 -1.147 . . . . 73.15 107.903 177.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -118.14 66.3 0.36 Allowed Glycine 0 N--CA 1.438 -1.199 0 N-CA-C 111.07 -0.812 . . . . 72.13 111.07 175.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 531' ' ' ALA . . . . . 0.409 ' O ' ' HD3' ' A' ' 532' ' ' ARG . . . -76.26 96.13 3.88 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.357 0.599 . . . . 72.31 111.565 -178.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . 0.409 ' HD3' ' O ' ' A' ' 531' ' ' ALA . 60.5 mmt-85 -134.56 127.68 31.77 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.47 -0.786 . . . . 71.32 109.984 178.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 93.77 175.66 39.81 Favored Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 121.087 -0.578 . . . . 74.33 113.642 176.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -95.87 123.22 39.36 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 107.936 -1.135 . . . . 74.45 107.936 177.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 56.4 t -127.96 131.95 69.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.761 0 N-CA-C 108.71 -0.848 . . . . 74.21 108.71 -178.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 536' ' ' ILE . . . . . . . . . . . . . 38.6 mm -103.77 129.28 56.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 108.739 -0.837 . . . . 74.44 108.739 178.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . 0.424 HG21 ' HB3' ' A' ' 594' ' ' PRO . 14.7 t -117.99 111.79 38.72 Favored Pre-proline 0 C--N 1.301 -1.506 0 N-CA-C 109.575 -0.528 . . . . 73.22 109.575 -178.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -73.98 150.87 44.19 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 121.714 1.609 . . . . 73.02 110.244 176.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 539' ' ' TYR . . . . . 0.475 ' CD1' ' HG ' ' A' ' 560' ' ' LEU . 48.3 p90 -150.85 157.71 43.25 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 109.119 -0.697 . . . . 74.44 109.119 179.1 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 540' ' ' LYS . . . . . 0.418 ' O ' ' HD3' ' A' ' 540' ' ' LYS . 0.1 OUTLIER -157.11 145.65 19.65 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 113.3 0.852 . . . . 75.3 113.3 -179.842 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 2.9 p -76.26 134.08 39.9 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.4 -0.818 . . . . 75.34 111.074 171.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.2 mp -99.22 126.65 52.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 105.391 -2.077 . . . . 75.45 105.391 172.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -48.78 -44.82 39.23 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.288 1.035 . . . . 74.22 113.06 -174.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 71.89 -100.28 0.91 Allowed Glycine 0 N--CA 1.437 -1.243 0 N-CA-C 110.036 -1.226 . . . . 55.02 110.036 -178.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 9.0 t -134.12 10.71 3.87 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.926 0.869 . . . . 73.41 109.37 176.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -85.16 168.06 15.15 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.858 -0.61 . . . . 74.33 110.027 177.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -85.91 166.83 15.65 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 107.74 -1.207 . . . . 71.43 107.74 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -57.39 174.75 1.91 Allowed Glycine 0 C--O 1.253 1.306 0 N-CA-C 115.705 1.042 . . . . 64.44 115.705 -176.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . -57.59 117.15 9.28 Favored Glycine 0 N--CA 1.437 -1.255 0 CA-C-N 114.217 -0.992 . . . . 55.32 113.783 -176.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 104.53 -15.06 50.13 Favored Glycine 0 N--CA 1.428 -1.859 0 N-CA-C 111.719 -0.552 . . . . 71.31 111.719 177.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -91.58 -63.65 1.22 Allowed 'General case' 0 CA--C 1.499 -1.009 0 CA-C-O 121.084 0.468 . . . . 75.21 110.422 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -107.39 -43.11 4.63 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.093 -0.958 . . . . 74.34 108.861 -176.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -133.79 155.83 49.1 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 107.313 -1.366 . . . . 75.52 107.313 175.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -85.17 128.98 34.88 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 105.532 -2.025 . . . . 71.14 105.532 177.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -54.78 108.47 0.4 Allowed 'General case' 0 CA--C 1.483 -1.627 0 O-C-N 123.474 0.484 . . . . 73.45 110.167 -177.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 40.8 m -109.96 97.98 7.37 Favored 'General case' 1 N--CA 1.372 -4.326 0 C-N-CA 118.595 -1.242 . . . . 72.41 112.234 -175.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 24.2 p -137.1 134.25 36.26 Favored 'General case' 0 N--CA 1.418 -2.037 0 N-CA-C 107.399 -1.334 . . . . 70.13 107.399 174.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -176.83 -156.91 16.73 Favored Glycine 0 N--CA 1.418 -2.541 0 N-CA-C 110.08 -1.208 . . . . 72.53 110.08 -176.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -135.14 142.96 46.29 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.091 0.472 . . . . 75.31 110.978 -176.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 560' ' ' LEU . . . . . 0.475 ' HG ' ' CD1' ' A' ' 539' ' ' TYR . 93.6 mt -104.22 139.91 38.59 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.273 -0.876 . . . . 72.02 109.275 177.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -106.6 114.03 27.88 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 123.21 0.604 . . . . 72.23 110.784 -177.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 562' ' ' PHE . . . . . 0.555 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 36.3 m-85 -108.64 145.35 35.09 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 120.695 0.283 . . . . 75.23 110.386 173.333 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 563' ' ' GLN . . . . . 0.479 ' HB2' ' HB2' ' A' ' 566' ' ' GLU . 0.2 OUTLIER -131.79 177.27 7.65 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 105.769 -1.938 . . . . 74.2 105.769 175.33 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -75.98 -30.46 58.58 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 121.111 0.481 . . . . 70.31 109.962 178.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -94.03 -22.84 18.28 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.259 0.552 . . . . 63.44 110.996 -179.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 566' ' ' GLU . . . . . 0.479 ' HB2' ' HB2' ' A' ' 563' ' ' GLN . 2.3 tm-20 -84.25 119.52 25.14 Favored 'General case' 0 C--O 1.245 0.84 0 N-CA-C 107.019 -1.475 . . . . 74.45 107.019 -177.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 567' ' ' ILE . . . . . 0.531 HG23 ' CZ ' ' A' ' 527' ' ' ARG . 6.2 pt -108.51 161.97 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.143 0 C-N-CA 120.65 -0.42 . . . . 74.44 111.047 -175.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 568' ' ' VAL . . . . . 0.408 HG23 ' H ' ' A' ' 569' ' ' LYS . 2.4 p 47.68 174.66 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.11 0 C-N-CA 126.421 1.889 . . . . 72.34 113.231 -179.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 569' ' ' LYS . . . . . 0.555 ' HB2' ' CZ ' ' A' ' 562' ' ' PHE . 0.2 OUTLIER -156.25 156.98 35.02 Favored 'General case' 0 C--N 1.289 -2.045 0 O-C-N 120.797 -1.189 . . . . 72.31 107.986 176.057 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 570' ' ' THR . . . . . 0.677 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 4.4 p -134.3 131.74 38.76 Favored 'General case' 0 N--CA 1.412 -2.361 0 O-C-N 123.999 0.812 . . . . 74.51 110.765 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 2.8 mp -91.3 113.39 26.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 106.728 -1.582 . . . . 72.2 106.728 170.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 2.6 p -93.85 120.17 33.75 Favored 'General case' 0 C--N 1.29 -2.021 0 O-C-N 123.677 0.61 . . . . 52.24 109.859 177.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 573' ' ' VAL . . . . . . . . . . . . . 49.1 t -123.38 135.77 62.18 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 108.549 -0.908 . . . . 73.41 108.549 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -93.45 124.05 37.17 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-O 121.403 0.621 . . . . 71.51 109.836 175.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 61.5 t -89.51 141.76 13.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 N-CA-C 106.755 -1.572 . . . . 55.13 106.755 176.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 32.9 mm -105.78 158.21 6.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 107.672 -1.232 . . . . 72.25 107.672 -178.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -67.22 137.46 56.21 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.228 -1.027 . . . . 74.21 108.228 177.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.85 158.97 34.51 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 112.295 0.48 . . . . 73.24 112.295 -172.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.21 -12.73 1.4 Allowed 'General case' 0 CA--C 1.558 1.263 0 N-CA-C 116.141 1.904 . . . . 75.15 116.141 -172.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 580' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 581' ' ' TYR . 0.1 OUTLIER -127.02 -171.02 2.32 Favored 'General case' 0 C--N 1.317 -0.838 0 O-C-N 121.164 -0.96 . . . . 73.12 110.138 -177.167 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 581' ' ' TYR . . . . . 0.489 ' O ' ' HG2' ' A' ' 580' ' ' GLU . 46.2 p90 -63.74 152.51 39.09 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 107.931 -1.136 . . . . 74.54 107.931 174.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -120.89 132.95 55.26 Favored 'General case' 0 C--N 1.288 -2.099 0 C-N-CA 118.824 -1.15 . . . . 72.44 114.076 -174.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -129.38 -165.95 1.59 Allowed 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 105.562 -2.014 . . . . 73.33 105.562 176.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -65.52 105.06 1.11 Allowed 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 106.855 -1.535 . . . . 75.34 106.855 172.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 585' ' ' LYS . . . . . 0.428 ' HD2' HD11 ' A' ' 646' ' ' ILE . 4.2 tmmm? -115.38 117.66 31.06 Favored 'General case' 0 N--CA 1.403 -2.79 0 N-CA-C 107.709 -1.219 . . . . 75.31 107.709 -175.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 3.4 t -142.39 147.2 35.83 Favored 'General case' 0 N--CA 1.404 -2.74 0 CA-C-N 114.688 -1.142 . . . . 65.21 110.029 -176.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -129.25 148.56 51.19 Favored 'General case' 0 N--CA 1.405 -2.687 0 CA-C-N 113.857 -1.52 . . . . 54.03 108.232 176.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 588' ' ' PHE . . . . . 0.513 ' HA ' ' O ' ' A' ' 642' ' ' LEU . 23.0 m-85 -104.8 141.54 36.31 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 109.356 -0.609 . . . . 74.24 109.356 -173.222 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . 0.453 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.5 OUTLIER -110.26 126.07 53.78 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 105.813 -1.921 . . . . 73.55 105.813 174.285 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -134.26 123.09 23.68 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 109.455 -0.572 . . . . 74.41 109.455 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 591' ' ' ILE . . . . . . . . . . . . . 20.9 pt -79.14 149.49 5.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 N-CA-C 108.0 -1.111 . . . . 72.21 108.0 173.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -93.23 -142.76 12.05 Favored Glycine 0 N--CA 1.425 -2.086 0 C-N-CA 121.008 -0.615 . . . . 54.42 112.693 -176.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -93.41 117.88 67.48 Favored Pre-proline 0 C--N 1.3 -1.584 0 N-CA-C 108.636 -0.876 . . . . 75.33 108.636 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 594' ' ' PRO . . . . . 0.608 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 30.2 Cg_endo -65.69 143.75 75.57 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 121.969 1.78 . . . . 71.5 110.714 177.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -123.83 135.86 54.02 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.888 -0.508 . . . . 73.24 110.483 -176.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.58 124.81 28.86 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 107.892 -1.151 . . . . 72.12 107.892 -178.252 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 65.9 t . . . . . 0 C--N 1.305 -1.349 0 N-CA-C 112.574 0.583 . . . . 73.43 112.574 -176.078 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.5 -0.977 0 N-CA-C 106.739 -1.578 . . . . 70.35 106.739 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . 0.608 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 10.9 Cg_endo -76.7 135.66 16.28 Favored 'Trans proline' 0 N--CA 1.419 -2.866 0 N-CA-C 106.936 -1.986 . . . . 75.12 106.936 164.057 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . 0.255 2.3 pp -118.71 170.12 8.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 114.001 1.112 . . . . 74.21 114.001 -178.236 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.07 164.98 25.94 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 114.898 -1.046 . . . . 75.42 112.051 -176.433 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -85.34 -114.68 0.77 Allowed Glycine 0 N--CA 1.441 -1.001 0 CA-C-N 115.284 -0.871 . . . . 72.42 112.942 -177.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -98.37 -68.72 0.79 Allowed 'General case' 0 N--CA 1.42 -1.928 0 C-N-CA 120.576 -0.45 . . . . 75.43 110.611 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 18.7 p80 -113.33 109.2 18.34 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 113.655 0.983 . . . . 73.32 113.655 -173.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 12.5 p -98.8 90.47 4.69 Favored 'General case' 0 N--CA 1.408 -2.54 0 N-CA-C 107.167 -1.42 . . . . 72.43 107.167 172.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -173.26 138.6 0.73 Allowed 'General case' 0 N--CA 1.424 -1.73 0 CA-C-N 114.393 -1.276 . . . . 73.44 107.685 -173.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 642' ' ' LEU . . . . . 0.513 ' O ' ' HA ' ' A' ' 588' ' ' PHE . 42.1 tp -145.12 105.26 4.05 Favored 'General case' 0 C--N 1.274 -2.708 0 N-CA-C 107.494 -1.299 . . . . 74.43 107.494 173.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . 0.408 ' HB3' HG22 ' A' ' 511' ' ' VAL . 28.5 tt0 -92.87 100.5 12.95 Favored 'General case' 0 C--N 1.261 -3.248 0 N-CA-C 107.03 -1.47 . . . . 72.32 107.03 179.577 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 26.3 t -92.73 108.65 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.287 0 CA-C-N 115.792 -0.64 . . . . 61.34 109.396 -177.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 4.0 mp -94.05 118.42 39.94 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 N-CA-C 107.916 -1.142 . . . . 73.31 107.916 177.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 646' ' ' ILE . . . . . 0.5 HD12 ' N ' ' A' ' 646' ' ' ILE . 2.5 mp -104.46 112.17 36.97 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.451 0 N-CA-C 107.098 -1.445 . . . . 75.31 107.098 -175.177 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -115.45 149.35 38.18 Favored 'General case' 0 C--N 1.27 -2.863 0 C-N-CA 120.191 -0.604 . . . . 74.03 112.519 -177.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 23.1 tp10 -54.69 135.51 46.88 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.188 -1.369 . . . . 72.12 109.917 -177.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 C--O 1.237 0.403 0 O-C-N 124.209 0.943 . . . . 74.12 110.768 -176.856 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 12.1 t60 . . . . . 0 N--CA 1.45 -0.474 0 N-CA-C 108.875 -0.787 . . . . 73.23 108.875 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . 0.462 ' HB2' ' HA ' ' A' ' 634' ' ' PRO . . . 170.79 -70.4 0.0 OUTLIER 'General case' 0 CA--C 1.503 -0.839 0 C-N-CA 125.5 1.52 . . . . 75.12 107.635 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . 0.591 ' HA2' ' OG1' ' A' ' 528' ' ' THR . . . -161.3 142.79 8.32 Favored Glycine 0 N--CA 1.401 -3.667 0 CA-C-N 114.978 -1.01 . . . . 64.21 110.804 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 3.7 mp -125.98 102.65 10.39 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 106.363 -1.718 . . . . 74.44 106.363 177.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -123.4 106.1 10.37 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 108.071 -1.085 . . . . 75.13 108.071 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 13.6 t -139.67 159.63 41.73 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 108.188 -1.041 . . . . 75.33 108.188 -176.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -84.64 153.6 23.05 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.429 -0.952 . . . . 71.31 108.429 175.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -77.53 -32.27 53.9 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.353 -0.98 . . . . 74.54 108.353 176.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -133.4 134.76 24.24 Favored Pre-proline 0 C--N 1.314 -0.942 0 N-CA-C 108.873 -0.788 . . . . 70.53 108.873 178.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -81.86 -16.54 8.81 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.401 2.067 . . . . 71.45 111.938 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 69.7 t -136.61 131.96 48.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 107.824 -1.176 . . . . 73.25 107.824 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 6.3 t -133.93 139.61 46.24 Favored 'General case' 0 N--CA 1.406 -2.633 0 N-CA-C 108.501 -0.926 . . . . 75.23 108.501 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -109.46 124.43 51.04 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 109.737 -0.468 . . . . 75.21 109.737 178.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 15.5 m -127.13 157.55 38.58 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 107.905 -1.146 . . . . 74.13 107.905 -178.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 35.5 t -82.13 156.4 24.52 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 109.541 -0.54 . . . . 74.35 109.541 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -83.4 -7.94 59.48 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.26 -1.015 . . . . 63.13 108.26 174.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 14.0 t -98.78 15.71 24.52 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 115.688 -0.687 . . . . 63.23 109.298 -177.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 12.7 tt -99.62 161.47 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 N-CA-C 108.915 -0.772 . . . . 74.12 108.915 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -94.9 -70.69 1.09 Allowed Glycine 0 N--CA 1.43 -1.753 0 N-CA-C 110.554 -1.018 . . . . 71.1 110.554 176.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 36.7 mm -114.73 126.24 72.24 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 C-N-CA 123.006 0.522 . . . . 74.51 109.668 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 521' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.55 140.06 38.54 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.768 -1.197 . . . . 75.41 107.768 173.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -124.73 137.6 54.33 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 123.777 0.673 . . . . 73.4 111.021 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . 0.606 ' O ' ' HA ' ' A' ' 570' ' ' THR . 45.7 t -122.99 137.45 56.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 109.048 -0.723 . . . . 74.24 109.048 -179.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -80.92 131.72 35.37 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.66 0.743 . . . . 75.13 112.927 -177.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 6.7 t -114.76 134.39 57.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 CA-C-N 114.327 -1.306 . . . . 74.51 107.873 177.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -86.94 139.49 30.56 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.238 -1.023 . . . . 75.15 108.238 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . 0.418 ' CZ ' HG22 ' A' ' 567' ' ' ILE . 31.7 ttp180 -93.95 158.59 15.56 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 116.202 -0.454 . . . . 74.21 110.514 -173.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 528' ' ' THR . . . . . 0.591 ' OG1' ' HA2' ' A' ' 503' ' ' GLY . 5.1 t -56.38 145.82 26.12 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.746 -0.661 . . . . 75.4 111.448 176.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 23.8 t -81.61 -12.74 58.62 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 108.79 -0.818 . . . . 75.24 108.79 178.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -109.02 52.94 0.61 Allowed Glycine 0 N--CA 1.429 -1.767 0 N-CA-C 109.592 -1.403 . . . . 72.42 109.592 177.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -82.83 95.49 7.94 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-O 121.591 0.71 . . . . 74.53 109.129 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -133.78 25.02 4.01 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 114.854 -1.066 . . . . 73.43 111.665 -178.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 175.76 -169.5 42.21 Favored Glycine 0 N--CA 1.416 -2.644 0 C-N-CA 120.097 -1.049 . . . . 45.42 111.141 -174.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -102.23 121.85 43.06 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 122.887 0.475 . . . . 62.3 110.822 -176.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 79.6 t -125.53 135.73 63.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 123.403 0.681 . . . . 63.31 109.651 -178.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 536' ' ' ILE . . . . . 0.469 ' O ' ' HA ' ' A' ' 594' ' ' PRO . 22.8 mm -101.18 129.17 52.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 115.881 -0.6 . . . . 73.43 109.874 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . 0.423 HG23 ' HB3' ' A' ' 594' ' ' PRO . 33.2 t -122.15 105.57 36.95 Favored Pre-proline 0 C--N 1.319 -0.751 0 N-CA-C 108.715 -0.846 . . . . 71.35 108.715 176.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -73.01 152.05 50.93 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.068 1.845 . . . . 65.01 110.828 177.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 539' ' ' TYR . . . . . 0.432 ' CD1' ' HG ' ' A' ' 560' ' ' LEU . 50.9 p90 -147.38 157.88 43.75 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.409 -0.589 . . . . 74.24 109.409 178.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -149.52 155.43 40.33 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 120.979 0.419 . . . . 73.42 111.17 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 10.4 p -96.4 113.39 24.97 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.062 -0.972 . . . . 74.41 110.871 176.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.6 mp -83.0 115.62 25.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 105.517 -2.031 . . . . 74.32 105.517 173.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . 0.442 ' HB3' ' O ' ' A' ' 546' ' ' ALA . 47.8 mt-10 -53.5 -49.84 66.66 Favored 'General case' 0 C--N 1.32 -0.686 0 O-C-N 124.156 0.91 . . . . 75.54 112.667 -174.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 70.26 -101.67 0.92 Allowed Glycine 0 N--CA 1.44 -1.098 0 C-N-CA 120.522 -0.847 . . . . 74.12 111.259 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 8.8 t -113.62 0.23 14.55 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.869 0.842 . . . . 62.21 109.295 178.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . 0.442 ' O ' ' HB3' ' A' ' 543' ' ' GLU . . . -95.33 170.98 9.0 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 108.132 -1.062 . . . . 73.24 108.132 175.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . 0.411 ' HD2' ' OE2' ' A' ' 543' ' ' GLU . 9.6 tpt180 -130.46 122.72 28.23 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 118.012 0.369 . . . . 74.5 110.189 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -82.48 -166.4 38.46 Favored Glycine 0 C--N 1.306 -1.135 0 CA-C-N 116.01 -0.541 . . . . 65.34 111.868 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 78.83 13.93 82.58 Favored Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 120.948 -0.644 . . . . 62.13 112.587 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 84.37 13.92 72.45 Favored Glycine 0 N--CA 1.435 -1.373 0 C-N-CA 120.212 -0.994 . . . . 63.23 111.891 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -79.81 -69.92 0.55 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.4 0.619 . . . . 73.52 109.982 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . 0.633 ' OD2' 'CA ' ' A' ' 850' ' ' ' CA' . 8.4 t70 -109.41 -35.05 6.36 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 107.692 -1.225 . . . . 75.33 107.692 -176.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 553' ' ' PHE . . . . . 0.451 ' HA ' HG12 ' A' ' 576' ' ' ILE . 14.7 p90 -145.54 164.06 32.81 Favored 'General case' 0 N--CA 1.423 -1.817 0 CA-C-N 115.096 -0.956 . . . . 75.2 108.544 173.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . 0.42 ' HB3' ' HB3' ' A' ' 574' ' ' LYS . 1.0 OUTLIER -95.45 106.82 18.93 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 105.477 -2.046 . . . . 73.42 105.477 179.082 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -72.62 149.53 43.83 Favored 'General case' 0 CA--C 1.49 -1.333 0 CA-C-N 116.093 -0.503 . . . . 71.15 110.095 -174.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 5.6 t -139.57 131.6 27.9 Favored 'General case' 0 N--CA 1.403 -2.779 0 CA-C-O 121.669 0.747 . . . . 72.21 111.274 -177.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 557' ' ' CYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 539' ' ' TYR . 12.5 p -142.38 104.91 4.49 Favored 'General case' 0 N--CA 1.418 -2.037 0 N-CA-C 107.541 -1.281 . . . . 72.42 107.541 175.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -151.11 -149.33 5.02 Favored Glycine 0 N--CA 1.408 -3.171 0 N-CA-C 109.867 -1.293 . . . . 73.22 109.867 -176.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -136.94 133.44 35.66 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 120.858 0.361 . . . . 73.51 110.715 -173.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . 0.432 ' HG ' ' CD1' ' A' ' 539' ' ' TYR . 92.1 mt -93.45 123.16 36.56 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.979 -1.119 . . . . 74.4 107.979 173.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -97.89 113.53 25.38 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 116.097 -0.501 . . . . 70.1 110.136 -177.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -103.99 144.36 31.64 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 109.639 -0.504 . . . . 63.13 109.639 176.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . 0.4 ' HB2' ' H ' ' A' ' 566' ' ' GLU . 42.7 mt-30 -136.56 179.85 6.11 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.059 -1.089 . . . . 75.23 108.059 -178.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 31.6 t30 -73.73 -34.77 64.93 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.669 -0.863 . . . . 74.2 108.669 176.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -87.64 -36.34 17.52 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 114.969 -1.014 . . . . 75.33 111.397 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . 0.4 ' H ' ' HB2' ' A' ' 563' ' ' GLN . 10.5 tp10 -77.33 117.08 18.48 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.77 -0.826 . . . . 74.22 108.77 178.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 567' ' ' ILE . . . . . 0.418 HG22 ' CZ ' ' A' ' 527' ' ' ARG . 6.5 pt -109.2 163.39 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.143 0 N-CA-C 109.317 -0.623 . . . . 65.02 109.317 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 568' ' ' VAL . . . . . 0.455 HG23 ' H ' ' A' ' 569' ' ' LYS . 2.3 p 44.49 -171.73 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.569 1.699 0 C-N-CA 125.543 1.537 . . . . 72.55 111.821 -177.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 569' ' ' LYS . . . . . 0.493 ' HA ' ' HE2' ' A' ' 569' ' ' LYS . 0.0 OUTLIER -173.3 158.41 3.56 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 107.142 -1.429 . . . . 75.21 107.142 174.78 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 570' ' ' THR . . . . . 0.606 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 24.1 p -134.37 137.73 44.33 Favored 'General case' 0 N--CA 1.423 -1.796 0 O-C-N 123.744 0.652 . . . . 71.34 109.316 175.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 2.9 mp -88.29 114.31 26.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 106.148 -1.797 . . . . 72.52 106.148 171.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 9.4 p -95.81 111.88 23.75 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 123.215 0.322 . . . . 62.24 110.429 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 573' ' ' VAL . . . . . . . . . . . . . 46.9 t -118.82 137.69 51.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.33 -0.618 . . . . 74.52 109.33 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 574' ' ' LYS . . . . . 0.42 ' HB3' ' HB3' ' A' ' 554' ' ' GLU . 38.7 ttmt -95.71 130.65 42.55 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 123.926 0.767 . . . . 74.55 110.218 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 58.9 t -95.76 143.63 11.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 107.852 -1.166 . . . . 73.23 107.852 176.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 576' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' A' ' 553' ' ' PHE . 28.9 mm -112.16 161.12 11.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 108.154 -1.054 . . . . 72.03 108.154 -177.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -77.68 144.43 37.35 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.021 -0.733 . . . . 72.11 109.021 176.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 578' ' ' ASP . . . . . 0.611 ' OD2' 'CA ' ' A' ' 800' ' ' ' CA' . 3.2 m-20 -57.89 136.9 57.09 Favored 'General case' 0 CA--C 1.484 -1.562 0 N-CA-C 115.453 1.649 . . . . 74.24 115.453 -174.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 5.6 pm0 -107.06 -26.01 11.33 Favored 'General case' 0 N--CA 1.421 -1.876 0 CA-C-N 113.413 -1.721 . . . . 63.44 112.38 -176.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 580' ' ' GLU . . . . . 0.406 ' HG2' ' CD2' ' A' ' 581' ' ' TYR . 0.1 OUTLIER -110.38 -69.26 0.88 Allowed 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 112.753 0.649 . . . . 72.33 112.753 -170.002 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 581' ' ' TYR . . . . . 0.406 ' CD2' ' HG2' ' A' ' 580' ' ' GLU . 32.1 p90 -162.35 153.71 18.03 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 104.422 -2.436 . . . . 74.1 104.422 -176.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 582' ' ' GLU . . . . . 0.603 ' OE1' 'CA ' ' A' ' 800' ' ' ' CA' . 20.3 mt-10 -102.98 136.6 42.5 Favored 'General case' 0 C--N 1.274 -2.708 0 C-N-CA 117.604 -1.638 . . . . 74.44 115.23 -172.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 12.8 ptpt -153.62 167.06 30.82 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 113.239 -1.801 . . . . 74.03 106.177 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -86.52 123.4 31.69 Favored 'General case' 0 CA--C 1.488 -1.431 0 N-CA-C 105.656 -1.979 . . . . 72.43 105.656 169.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.66 173.67 7.3 Favored 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 108.691 -0.855 . . . . 73.21 108.691 -171.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 8.6 t -153.61 146.77 24.66 Favored 'General case' 0 N--CA 1.428 -1.531 0 C-N-CA 120.042 -0.663 . . . . 74.43 111.774 -174.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -130.96 149.8 52.41 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-N 114.237 -1.347 . . . . 74.22 109.891 177.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 588' ' ' PHE . . . . . 0.416 ' HA ' ' O ' ' A' ' 642' ' ' LEU . 25.7 m-85 -104.06 133.36 49.13 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.094 -0.706 . . . . 74.11 109.094 -176.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . 0.447 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.4 OUTLIER -106.01 123.77 48.52 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 105.895 -1.891 . . . . 70.43 105.895 175.845 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -130.71 145.66 51.99 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 107.615 -1.254 . . . . 73.13 107.615 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 591' ' ' ILE . . . . . . . . . . . . . 27.5 pt -106.05 152.48 7.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 108.934 -0.765 . . . . 72.15 108.934 178.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -97.97 -150.51 26.37 Favored Glycine 0 N--CA 1.429 -1.802 0 C-N-CA 120.792 -0.718 . . . . 71.31 112.873 -177.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.433 ' CB ' ' HA ' ' A' ' 617' ' ' PRO . 1.4 tm-20 -79.49 121.3 82.55 Favored Pre-proline 0 C--N 1.297 -1.681 0 C-N-CA 123.589 0.756 . . . . 71.4 111.426 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 594' ' ' PRO . . . . . 0.469 ' HA ' ' O ' ' A' ' 536' ' ' ILE . 68.7 Cg_endo -81.33 145.9 15.3 Favored 'Trans proline' 0 N--CA 1.43 -2.231 0 C-N-CA 121.817 1.678 . . . . 74.23 110.083 176.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 595' ' ' ARG . . . . . 0.414 ' HB3' ' OE2' ' A' ' 593' ' ' GLU . 14.2 ptp180 -136.7 143.75 43.53 Favored 'General case' 0 C--N 1.273 -2.733 0 CA-C-N 116.286 -0.416 . . . . 72.42 109.991 -177.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -77.25 126.83 31.57 Favored 'General case' 0 N--CA 1.416 -2.155 0 N-CA-C 106.001 -1.851 . . . . 72.31 106.001 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 43.6 t -71.61 -38.19 66.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 107.855 -1.165 . . . . 64.01 107.855 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -87.13 95.89 10.11 Favored 'General case' 0 N--CA 1.417 -2.104 0 N-CA-C 106.311 -1.737 . . . . 72.24 106.311 174.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 24.0 ptm -71.03 110.71 5.89 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.381 0.61 . . . . 54.21 111.285 -175.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 13.5 m -56.48 123.33 14.39 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 124.421 1.089 . . . . 74.53 111.444 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -85.81 90.6 8.09 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 108.696 -0.853 . . . . 73.4 108.696 177.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -88.69 121.88 31.53 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 106.349 -1.723 . . . . 72.13 106.349 178.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -79.68 86.71 5.26 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.241 0.543 . . . . 75.13 111.767 -173.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -87.76 -37.76 7.82 Favored Glycine 0 N--CA 1.432 -1.6 0 N-CA-C 109.486 -1.446 . . . . 74.2 109.486 175.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 120.03 -178.33 16.48 Favored Glycine 0 N--CA 1.426 -2.015 0 N-CA-C 111.357 -0.697 . . . . 71.1 111.357 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -68.54 122.95 19.54 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 109.97 -0.381 . . . . 73.51 109.97 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 5.8 p -129.53 154.4 47.07 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 115.998 -0.547 . . . . 74.41 109.973 176.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 52.3 mt -78.99 134.48 27.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 108.757 -0.831 . . . . 74.14 108.757 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 11.4 m 67.01 82.1 0.19 Allowed 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 124.463 1.105 . . . . 65.13 111.913 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -118.41 89.32 3.1 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.504 -1.295 . . . . 74.45 107.504 173.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -121.6 -176.56 3.34 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 114.557 -1.201 . . . . 70.44 108.39 -174.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -85.74 81.32 8.65 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 119.571 -0.852 . . . . 74.21 110.77 173.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -103.71 -141.04 0.36 Allowed 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 104.053 -2.573 . . . . 64.43 104.053 174.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 32.8 t70 64.29 20.02 12.01 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 122.416 1.103 . . . . 61.14 110.539 175.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.05 -9.53 58.55 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-N 114.562 -1.199 . . . . 74.13 111.545 -175.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -78.16 140.05 61.16 Favored Pre-proline 0 C--N 1.307 -1.276 0 N-CA-C 109.272 -0.64 . . . . 72.33 109.272 178.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 617' ' ' PRO . . . . . 0.433 ' HA ' ' CB ' ' A' ' 593' ' ' GLU . 44.1 Cg_endo -71.39 -159.64 0.07 OUTLIER 'Trans proline' 0 C--O 1.247 0.968 0 C-N-CA 122.336 2.024 . . . . 72.32 111.175 178.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.425 ' H ' HD22 ' A' ' 618' ' ' LEU . 2.2 mm? -69.55 100.31 1.41 Allowed 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 107.044 -1.465 . . . . 74.24 107.044 178.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 5.4 p -141.57 7.27 1.91 Allowed 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 113.887 1.069 . . . . 74.53 113.887 -171.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 17.1 p -73.48 85.04 1.52 Allowed 'General case' 0 N--CA 1.437 -1.077 0 CA-C-O 122.539 1.161 . . . . 64.1 111.866 -179.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 621' ' ' LYS . . . . . 0.514 ' HB2' ' HZ1' ' A' ' 621' ' ' LYS . 4.7 ttmp? -108.9 -40.77 4.93 Favored 'General case' 0 N--CA 1.426 -1.652 0 CA-C-N 114.407 -1.269 . . . . 73.21 110.044 -174.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -118.84 -25.92 6.19 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.477 0.656 . . . . 62.21 109.58 178.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.57 109.27 18.41 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-N 115.139 -0.937 . . . . 65.51 109.367 176.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -83.27 -27.74 29.63 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 115.58 -0.736 . . . . 72.35 110.635 -176.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -68.31 -30.58 69.61 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 111.952 0.353 . . . . 75.32 111.952 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . 0.405 ' O ' ' HD3' ' A' ' 626' ' ' ARG . 0.0 OUTLIER -70.03 -22.3 63.11 Favored 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 108.175 -1.046 . . . . 71.05 108.175 179.594 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 627' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -65.96 -29.59 70.01 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.146 -0.479 . . . . 75.42 110.413 178.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 86.1 mt -62.21 -45.28 99.11 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 N-CA-C 109.2 -0.667 . . . . 72.44 109.2 177.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 629' ' ' ALA . . . . . 0.633 ' O ' ' HG3' ' A' ' 633' ' ' ARG . . . -66.84 -45.36 78.45 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-N 115.009 -0.996 . . . . 75.15 110.242 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -65.15 -20.37 66.42 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.031 0.443 . . . . 73.21 111.855 -178.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 631' ' ' MET . . . . . . . . . . . . . 45.7 ttm -74.65 -28.47 60.87 Favored 'General case' 0 N--CA 1.427 -1.624 0 C-N-CA 123.362 0.665 . . . . 73.22 109.86 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -96.2 5.98 65.92 Favored Glycine 0 CA--C 1.508 -0.374 0 CA-C-N 115.742 -0.663 . . . . 22.24 111.66 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 633' ' ' ARG . . . . . 0.633 ' HG3' ' O ' ' A' ' 629' ' ' ALA . 6.3 mtp-105 -116.63 163.44 22.32 Favored Pre-proline 0 C--N 1.303 -1.445 0 N-CA-C 107.412 -1.329 . . . . 74.22 107.412 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.462 ' HA ' ' HB2' ' A' ' 502' ' ' ALA . 24.6 Cg_endo -76.1 155.76 37.99 Favored 'Trans proline' 0 N--CA 1.438 -1.776 0 C-N-CA 120.856 1.038 . . . . 73.21 110.07 168.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.68 -173.54 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 107.798 -1.186 . . . . 74.43 107.798 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -87.29 -179.77 6.47 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 123.291 0.37 . . . . 74.43 111.622 -178.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -99.69 -125.18 5.4 Favored Glycine 0 N--CA 1.438 -1.188 0 CA-C-N 116.175 -0.466 . . . . 54.43 113.983 -176.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -84.54 -71.4 0.52 Allowed 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 112.41 0.522 . . . . 75.42 112.41 -177.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -117.67 107.94 14.82 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 122.466 1.127 . . . . 74.41 112.436 -174.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 3.6 p -108.19 92.05 3.9 Favored 'General case' 0 N--CA 1.404 -2.747 0 CA-C-N 114.269 -1.332 . . . . 74.44 109.855 177.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -178.33 129.44 0.13 Allowed 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 104.826 -2.287 . . . . 75.03 104.826 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 642' ' ' LEU . . . . . 0.519 HD21 HG23 ' A' ' 523' ' ' VAL . 42.6 tp -132.37 114.52 14.46 Favored 'General case' 0 C--N 1.274 -2.681 0 N-CA-C 108.692 -0.855 . . . . 74.21 108.692 177.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -99.05 104.81 16.87 Favored 'General case' 0 C--N 1.273 -2.734 0 N-CA-C 107.069 -1.456 . . . . 72.12 107.069 178.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 33.7 t -92.94 105.12 16.42 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 N-CA-C 108.551 -0.907 . . . . 75.4 108.551 -179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 3.9 mp -88.94 115.08 28.16 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 N-CA-C 107.469 -1.308 . . . . 72.24 107.469 175.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 646' ' ' ILE . . . . . 0.457 HD12 ' N ' ' A' ' 646' ' ' ILE . 2.9 mp -95.48 106.43 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.453 0 N-CA-C 105.383 -2.08 . . . . 73.44 105.383 -178.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -97.95 132.15 43.78 Favored 'General case' 0 N--CA 1.399 -3.017 0 CA-C-N 115.249 -0.887 . . . . 73.31 109.275 -178.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . 0.647 ' OE1' 'CA ' ' A' ' 800' ' ' ' CA' . 15.2 tt0 -67.32 144.29 55.94 Favored 'General case' 0 N--CA 1.408 -2.527 0 N-CA-C 107.878 -1.156 . . . . 74.14 107.878 -177.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 23.1 t -49.5 118.73 2.93 Favored 'General case' 0 N--CA 1.444 -0.748 0 O-C-N 124.442 1.089 . . . . 73.11 113.342 -170.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -141.42 -68.35 0.39 Allowed 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 114.14 -1.391 . . . . 74.11 107.509 176.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 173.85 152.93 0.1 Allowed 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 104.569 -2.382 . . . . 73.03 104.569 -178.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -95.95 163.51 13.11 Favored 'General case' 0 C--N 1.265 -3.069 0 N-CA-C 108.923 -0.769 . . . . 71.3 108.923 -174.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt 75.44 6.25 4.06 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.938 1.295 . . . . 73.33 110.739 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 25.3 p -84.39 -43.88 14.27 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 115.335 -0.848 . . . . 73.24 109.608 -178.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 2.3 m -83.86 88.36 7.11 Favored 'General case' 0 N--CA 1.42 -1.955 0 N-CA-C 109.095 -0.705 . . . . 75.12 109.095 178.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 7.5 p -107.73 128.12 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.834 0 CA-C-N 115.468 -0.787 . . . . 73.43 109.726 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 10.0 t70 . . . . . 0 C--O 1.262 1.754 0 CA-C-N 115.621 -0.718 . . . . 65.24 109.804 -179.791 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 800' ' ' ' CA' . . . . . 0.647 'CA ' ' OE1' ' A' ' 648' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 850' ' ' ' CA' . . . . . 0.633 'CA ' ' OD2' ' A' ' 552' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 7.6 t60 . . . . . 0 N--CA 1.446 -0.629 0 N-CA-C 107.575 -1.268 . . . . 72.32 107.575 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -155.93 -39.38 0.08 Allowed 'General case' 0 C--N 1.308 -1.238 0 O-C-N 123.559 0.537 . . . . 54.42 109.79 178.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . 0.652 ' HA2' ' OG1' ' A' ' 528' ' ' THR . . . -174.55 131.84 2.09 Favored Glycine 0 N--CA 1.415 -2.735 0 C-N-CA 120.676 -0.773 . . . . 54.44 111.787 178.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . 0.401 ' H ' ' CB ' ' A' ' 528' ' ' THR . 4.1 mp -119.23 113.97 43.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 107.436 -1.32 . . . . 74.33 107.436 177.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -123.94 119.74 30.47 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 109.228 -0.656 . . . . 74.5 109.228 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 14.8 t -148.54 167.54 25.11 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.78 -0.452 . . . . 74.53 109.78 -174.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -99.66 162.33 13.08 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 107.441 -1.318 . . . . 75.44 107.441 173.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.18 -24.39 13.57 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.203 0.525 . . . . 75.3 111.314 176.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -116.66 122.96 30.98 Favored Pre-proline 0 N--CA 1.436 -1.152 0 N-CA-C 108.382 -0.97 . . . . 74.3 108.382 171.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -80.71 -9.96 13.17 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 121.961 1.774 . . . . 74.31 111.48 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 75.3 t -141.28 135.96 32.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 107.521 -1.289 . . . . 74.44 107.521 -178.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 5.6 t -136.68 146.71 46.22 Favored 'General case' 0 N--CA 1.41 -2.439 0 N-CA-C 108.005 -1.109 . . . . 74.24 108.005 177.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -116.69 131.3 56.99 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.429 -0.582 . . . . 75.11 109.429 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 22.3 m -127.26 160.87 35.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 CA-C-N 115.762 -0.654 . . . . 74.43 109.753 -175.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 71.1 m -75.73 153.03 37.32 Favored 'General case' 0 N--CA 1.403 -2.803 0 CA-C-N 114.72 -1.127 . . . . 75.31 108.083 175.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -88.36 -24.8 23.01 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.054 -1.058 . . . . 72.31 111.121 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 23.3 t -102.6 70.16 1.12 Allowed 'General case' 0 N--CA 1.419 -1.982 0 N-CA-C 107.862 -1.162 . . . . 72.43 107.862 176.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 18.8 tt -135.85 152.47 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.503 0 N-CA-C 106.73 -1.582 . . . . 75.41 106.73 176.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -84.93 -59.21 2.0 Allowed Glycine 0 C--N 1.287 -2.154 0 C-N-CA 120.239 -0.982 . . . . 73.42 111.667 -178.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 36.5 mm -125.98 126.01 69.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 109.486 -0.561 . . . . 73.14 109.486 -178.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 521' ' ' MET . . . . . 0.483 ' HE3' ' CG2' ' A' ' 573' ' ' VAL . 0.0 OUTLIER -101.6 134.88 44.05 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 106.38 -1.711 . . . . 45.32 106.38 171.721 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -121.49 137.54 54.68 Favored 'General case' 0 C--N 1.308 -1.206 0 O-C-N 123.68 0.613 . . . . 73.52 110.523 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . 0.535 ' O ' ' HA ' ' A' ' 570' ' ' THR . 41.7 t -121.1 138.26 52.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 N-CA-C 108.119 -1.067 . . . . 63.33 108.119 179.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . 0.449 ' HD2' HG22 ' A' ' 568' ' ' VAL . 29.1 mmtp -88.16 116.07 26.1 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.867 0.841 . . . . 72.02 111.84 -176.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 22.9 t -97.19 135.62 30.77 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 CA-C-N 114.545 -1.207 . . . . 73.13 109.178 -178.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -79.68 138.86 37.49 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 123.687 0.617 . . . . 65.45 109.804 -178.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . 0.5 ' HG2' ' N ' ' A' ' 528' ' ' THR . 50.5 ttp180 -86.29 160.28 19.18 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.274 -1.01 . . . . 73.24 108.274 178.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 528' ' ' THR . . . . . 0.652 ' OG1' ' HA2' ' A' ' 503' ' ' GLY . 5.3 t -65.43 146.76 54.48 Favored 'General case' 0 N--CA 1.412 -2.347 0 CA-C-N 115.657 -0.701 . . . . 74.32 110.388 172.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 38.0 t -62.37 -46.36 88.99 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-N 114.963 -1.017 . . . . 71.15 109.042 175.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -114.1 117.28 4.09 Favored Glycine 0 N--CA 1.415 -2.743 0 N-CA-C 109.914 -1.274 . . . . 64.42 109.914 -177.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -131.69 119.93 22.06 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 109.372 -0.603 . . . . 74.11 109.372 178.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -114.94 74.96 0.9 Allowed 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.559 -0.534 . . . . 75.54 109.559 175.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 124.92 -143.39 14.54 Favored Glycine 0 N--CA 1.433 -1.528 0 C-N-CA 120.38 -0.915 . . . . 53.11 112.628 177.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 534' ' ' ASN . . . . . 0.423 HD22 ' HG3' ' A' ' 561' ' ' GLU . 2.8 t-20 -114.25 134.01 55.24 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.031 -0.729 . . . . 72.11 109.031 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 59.3 t -126.45 131.45 71.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 109.458 -0.571 . . . . 73.3 109.458 -178.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 536' ' ' ILE . . . . . . . . . . . . . 39.7 mm -98.89 125.92 52.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 109.061 -0.718 . . . . 71.32 109.061 178.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 40.6 t -115.82 107.24 48.66 Favored Pre-proline 0 C--N 1.306 -1.325 0 CA-C-N 115.839 -0.619 . . . . 70.25 109.356 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -73.52 145.95 38.46 Favored 'Trans proline' 0 C--O 1.238 0.484 0 C-N-CA 122.539 2.159 . . . . 74.54 111.951 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -147.96 161.3 41.61 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 109.34 -0.615 . . . . 72.23 109.34 178.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -157.9 153.95 27.12 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 109.237 -0.653 . . . . 73.41 109.237 177.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 2.7 p -90.76 128.75 36.79 Favored 'General case' 0 C--N 1.293 -1.886 0 O-C-N 123.625 0.578 . . . . 72.33 110.152 175.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.7 mp -95.05 117.92 40.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 106.244 -1.762 . . . . 75.2 106.244 174.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . 0.517 ' HB2' ' O ' ' A' ' 546' ' ' ALA 0.289 0.0 OUTLIER -60.89 -51.51 68.98 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 114.685 1.365 . . . . 74.3 114.685 -176.759 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 67.63 -79.95 0.17 Allowed Glycine 0 N--CA 1.448 -0.532 0 O-C-N 123.266 0.354 . . . . 70.31 113.833 175.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 7.9 t -125.64 -1.7 7.37 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 120.956 0.408 . . . . 62.25 110.325 -178.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . 0.517 ' O ' ' HB2' ' A' ' 543' ' ' GLU . . . -111.11 174.54 5.81 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 108.6 -0.889 . . . . 72.54 108.6 177.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . 0.456 ' N ' ' HD2' ' A' ' 547' ' ' ARG . 2.4 mpt_? -112.77 128.78 56.52 Favored 'General case' 0 CA--C 1.487 -1.454 0 CA-C-O 121.548 0.689 . . . . 71.53 112.414 -175.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -84.6 -174.16 50.2 Favored Glycine 0 C--N 1.277 -2.731 0 CA-C-N 114.052 -1.431 . . . . 61.24 112.532 -177.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 69.78 16.33 72.16 Favored Glycine 0 C--O 1.222 -0.644 0 N-CA-C 114.196 0.438 . . . . 55.01 114.196 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 84.5 6.21 86.06 Favored Glycine 0 N--CA 1.438 -1.208 0 C-N-CA 119.989 -1.101 . . . . 64.42 111.297 -177.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -74.12 -43.94 55.65 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 110.542 -0.17 . . . . 72.34 110.542 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . 0.667 ' OD1' 'CA ' ' A' ' 850' ' ' ' CA' . 10.2 t70 -132.27 -28.88 1.65 Allowed 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.577 -0.897 . . . . 54.31 108.577 175.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 553' ' ' PHE . . . . . 0.415 ' HA ' HG12 ' A' ' 576' ' ' ILE . 35.1 p90 -144.12 158.39 43.75 Favored 'General case' 0 C--O 1.249 1.053 0 N-CA-C 107.183 -1.414 . . . . 74.51 107.183 170.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -89.93 119.44 30.29 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 106.974 -1.491 . . . . 74.4 106.974 178.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -75.45 99.03 4.06 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-N 115.966 -0.561 . . . . 74.15 110.738 -176.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 556' ' ' THR . . . . . 0.486 ' CG2' HG23 ' A' ' 573' ' ' VAL . 10.1 t -89.8 97.03 10.96 Favored 'General case' 0 N--CA 1.41 -2.453 0 CA-C-O 123.295 1.521 . . . . 75.53 110.48 -178.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 1.6 p -109.4 106.62 16.47 Favored 'General case' 0 C--N 1.275 -2.65 0 CA-C-N 113.8 -1.545 . . . . 71.22 107.903 175.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -154.92 -157.84 8.42 Favored Glycine 0 N--CA 1.414 -2.804 0 N-CA-C 110.705 -0.958 . . . . 73.25 110.705 -174.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -142.77 131.24 22.33 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 109.584 -0.524 . . . . 63.34 109.584 -175.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 95.1 mt -89.89 138.01 31.86 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.835 -0.62 . . . . 71.24 109.379 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 561' ' ' GLU . . . . . 0.423 ' HG3' HD22 ' A' ' 534' ' ' ASN . 39.9 tt0 -104.46 106.54 17.08 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 109.384 -0.598 . . . . 74.14 109.384 -179.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -100.08 132.22 45.57 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 109.9 -0.407 . . . . 61.24 109.9 177.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -116.43 160.81 20.02 Favored 'General case' 0 C--N 1.289 -2.06 0 C-N-CA 119.635 -0.826 . . . . 74.22 109.617 177.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -69.93 -25.11 63.5 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 122.214 1.007 . . . . 75.23 109.545 176.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -90.85 -6.27 54.46 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.386 -1.279 . . . . 62.22 110.821 -178.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -118.96 154.82 32.41 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.899 -0.778 . . . . 64.44 108.899 -177.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 9.4 pt -124.77 164.2 23.83 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 108.318 -0.993 . . . . 63.12 108.318 170.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 568' ' ' VAL . . . . . 0.449 HG22 ' HD2' ' A' ' 524' ' ' LYS . 1.5 p 49.97 155.5 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.576 1.944 0 C-N-CA 127.072 2.149 . . . . 75.04 115.734 179.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 569' ' ' LYS . . . . . . . . . . . . . 5.8 mmpt? -140.69 166.29 25.15 Favored 'General case' 0 CA--C 1.486 -1.487 0 N-CA-C 107.806 -1.183 . . . . 73.34 107.806 172.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 570' ' ' THR . . . . . 0.535 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 18.2 p -137.49 133.49 34.67 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 123.825 0.703 . . . . 70.52 110.603 175.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 3.1 mp -84.77 122.36 38.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 106.591 -1.633 . . . . 71.2 106.591 172.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 10.2 p -98.2 109.08 21.9 Favored 'General case' 0 N--CA 1.418 -2.074 0 N-CA-C 109.838 -0.43 . . . . 74.25 109.838 178.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 573' ' ' VAL . . . . . 0.486 HG23 ' CG2' ' A' ' 556' ' ' THR . 58.9 t -110.55 123.7 66.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 N-CA-C 109.869 -0.419 . . . . 73.53 109.869 178.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -77.91 113.23 15.6 Favored 'General case' 0 N--CA 1.433 -1.29 0 O-C-N 124.036 0.835 . . . . 74.32 109.067 175.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 57.1 t -87.24 130.32 37.27 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 107.624 -1.25 . . . . 71.44 107.624 177.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 576' ' ' ILE . . . . . 0.415 HG12 ' HA ' ' A' ' 553' ' ' PHE . 37.4 mm -94.98 150.04 4.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 108.312 -0.996 . . . . 74.21 108.312 -175.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -68.51 139.81 55.66 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.329 -0.619 . . . . 73.31 109.329 176.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 578' ' ' ASP . . . . . 0.616 ' OD1' 'CA ' ' A' ' 850' ' ' ' CA' . 0.3 OUTLIER -81.66 -177.74 6.67 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 112.898 0.703 . . . . 73.14 112.898 -173.264 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 579' ' ' GLU . . . . . 0.593 ' OE1' 'CA ' ' A' ' 850' ' ' ' CA' . 0.3 OUTLIER -166.71 -38.19 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.462 0 N-CA-C 114.566 1.321 . . . . 72.31 114.566 -173.19 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 580' ' ' GLU . . . . . 0.534 ' HG2' ' O ' ' A' ' 581' ' ' TYR . 0.1 OUTLIER -99.77 -168.08 1.55 Allowed 'General case' 0 C--O 1.25 1.104 0 C-N-CA 122.71 0.404 . . . . 74.21 111.887 -169.022 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 581' ' ' TYR . . . . . 0.534 ' O ' ' HG2' ' A' ' 580' ' ' GLU . 27.8 p90 -65.48 151.12 47.14 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 106.819 -1.549 . . . . 74.24 106.819 174.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -130.31 154.81 47.25 Favored 'General case' 0 N--CA 1.412 -2.338 0 C-N-CA 118.467 -1.293 . . . . 64.34 113.918 178.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -133.82 -174.51 3.55 Favored 'General case' 0 C--N 1.274 -2.692 0 N-CA-C 103.648 -2.723 . . . . 74.43 103.648 176.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -72.69 107.04 4.95 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.594 -1.261 . . . . 73.11 107.594 173.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 585' ' ' LYS . . . . . . . . . . . . 0.252 0.0 OUTLIER -113.28 143.7 43.97 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 119.921 -0.712 . . . . 75.14 111.351 -179.041 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 586' ' ' THR . . . . . 0.439 ' HG1' ' C ' ' A' ' 644' ' ' VAL . 3.5 t -155.81 148.96 24.52 Favored 'General case' 0 N--CA 1.418 -2.072 0 CA-C-N 115.215 -0.902 . . . . 71.54 109.764 -172.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -120.14 142.15 49.2 Favored 'General case' 0 N--CA 1.414 -2.272 0 CA-C-N 114.576 -1.193 . . . . 74.42 109.665 176.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 588' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -98.92 133.5 43.11 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.561 -0.904 . . . . 74.3 108.561 -175.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . 0.455 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.5 OUTLIER -108.01 127.17 53.53 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 106.323 -1.732 . . . . 62.43 106.323 176.365 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -127.95 126.86 42.24 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 109.242 -0.651 . . . . 74.23 109.242 176.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 591' ' ' ILE . . . . . . . . . . . . . 17.0 pt -94.22 128.66 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 N-CA-C 106.351 -1.722 . . . . 74.52 106.351 171.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -93.35 -144.75 15.7 Favored Glycine 0 N--CA 1.431 -1.674 0 CA-C-N 115.793 -0.64 . . . . 63.11 114.386 -171.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -77.43 116.35 57.13 Favored Pre-proline 0 N--CA 1.435 -1.195 0 CA-C-N 114.635 -0.782 . . . . 71.14 109.155 -178.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -76.3 160.25 35.99 Favored 'Trans proline' 0 N--CA 1.446 -1.31 0 C-N-CA 122.475 2.117 . . . . 74.41 111.283 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 8.3 ptp85 -135.31 139.07 44.04 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 109.046 -0.724 . . . . 75.42 109.046 -178.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 596' ' ' LEU . . . . . 0.444 ' HG ' ' OG ' ' A' ' 600' ' ' SER . 0.0 OUTLIER -83.39 129.19 34.98 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 105.954 -1.869 . . . . 75.45 105.954 179.242 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 69.7 t -71.56 -25.25 24.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-O 121.905 0.859 . . . . 73.44 110.393 -178.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -113.35 159.46 19.39 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.394 -0.965 . . . . 62.22 108.394 175.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 43.3 ttp -84.74 108.85 17.64 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 119.843 -0.743 . . . . 74.42 110.278 -178.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 600' ' ' SER . . . . . 0.444 ' OG ' ' HG ' ' A' ' 596' ' ' LEU . 59.9 m -75.55 112.94 12.42 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-N 116.035 -0.529 . . . . 62.43 112.049 176.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -144.22 142.41 30.48 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 105.504 -2.036 . . . . 72.14 105.504 172.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -119.59 -23.34 6.6 Favored 'General case' 0 C--N 1.289 -2.053 0 O-C-N 123.365 0.415 . . . . 74.31 110.625 -173.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -112.88 -73.3 0.67 Allowed 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 112.469 0.544 . . . . 74.23 112.469 -174.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -159.25 131.07 2.63 Favored Glycine 0 CA--C 1.487 -1.706 0 N-CA-C 110.282 -1.127 . . . . 74.12 110.282 -177.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . -70.65 118.03 7.44 Favored Glycine 0 N--CA 1.43 -1.76 0 O-C-N 123.893 0.408 . . . . 72.23 112.675 -177.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -67.4 -33.6 75.52 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.169 -1.049 . . . . 75.43 108.169 175.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 18.4 p -129.79 159.94 34.97 Favored 'General case' 0 N--CA 1.414 -2.246 0 N-CA-C 105.617 -1.994 . . . . 74.43 105.617 172.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 15.4 mt -84.43 16.94 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.971 0 CA-C-O 122.508 1.147 . . . . 70.41 109.402 -177.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 4.8 t -172.81 122.91 0.42 Allowed 'General case' 0 N--CA 1.428 -1.544 0 CA-C-N 114.989 -1.005 . . . . 73.23 109.666 178.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -119.16 18.89 13.01 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.455 0.645 . . . . 73.34 109.485 174.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -66.57 104.35 1.26 Allowed 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.724 -1.213 . . . . 63.43 107.724 177.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 62.32 67.42 0.73 Allowed 'General case' 0 C--N 1.328 -0.365 0 O-C-N 124.772 1.295 . . . . 75.14 108.125 -175.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 613' ' ' ASP . . . . . 0.489 ' OD1' ' HD3' ' A' ' 633' ' ' ARG . 5.4 p-10 -79.95 -36.66 35.89 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.564 -0.744 . . . . 75.44 110.749 -177.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -132.37 108.97 9.52 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.464 -1.31 . . . . 70.55 107.464 177.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -93.49 77.4 4.41 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 112.616 0.599 . . . . 73.35 112.616 -173.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -135.46 157.74 75.87 Favored Pre-proline 0 C--N 1.295 -1.783 0 N-CA-C 107.302 -1.37 . . . . 75.31 107.302 173.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -62.94 -168.43 0.08 OUTLIER 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.697 2.265 . . . . 73.34 113.242 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -61.26 103.43 0.29 Allowed 'General case' 0 C--O 1.243 0.758 0 CA-C-N 115.676 -0.693 . . . . 75.31 110.506 -177.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 6.3 p -128.46 18.54 6.36 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 115.442 -0.799 . . . . 74.23 112.55 -172.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -100.78 32.89 2.97 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.022 -0.733 . . . . 74.3 109.022 -176.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 7.8 mtmp? -82.23 -54.56 5.16 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.815 0.672 . . . . 72.15 112.815 -171.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -86.48 -54.53 4.36 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 121.636 0.732 . . . . 73.3 111.339 -170.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -89.58 146.1 24.8 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 114.66 -1.154 . . . . 74.4 111.493 -174.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -92.3 -16.43 26.08 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 115.654 -0.703 . . . . 75.32 110.071 178.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -59.72 -33.08 71.16 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-O 121.411 0.624 . . . . 74.41 109.807 178.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -75.84 -33.43 60.04 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 115.296 -0.865 . . . . 74.23 109.886 178.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 627' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -67.05 -22.6 65.86 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.007 -0.542 . . . . 72.52 110.58 -178.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . 0.475 ' O ' ' HG2' ' A' ' 631' ' ' MET . 95.3 mt -64.06 -41.38 92.29 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.653 0 CA-C-N 115.866 -0.606 . . . . 73.4 109.958 175.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -69.12 -36.99 78.1 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-O 122.413 1.101 . . . . 74.24 108.324 177.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.93 12.69 0.64 Allowed 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 113.877 -1.511 . . . . 74.34 114.278 177.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 631' ' ' MET . . . . . 0.475 ' HG2' ' O ' ' A' ' 628' ' ' ILE . 21.3 ptp -80.98 -21.17 40.53 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 106.244 -1.761 . . . . 73.01 106.244 166.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -100.06 -37.05 3.98 Favored Glycine 0 N--CA 1.425 -2.095 0 CA-C-N 114.655 -1.157 . . . . 75.32 110.886 177.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 633' ' ' ARG . . . . . 0.489 ' HD3' ' OD1' ' A' ' 613' ' ' ASP . 0.0 OUTLIER -94.63 128.28 40.48 Favored Pre-proline 0 C--O 1.207 -1.135 0 N-CA-C 109.527 -0.546 . . . . 75.24 109.527 176.753 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -75.6 153.89 39.3 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 121.863 1.709 . . . . 73.24 111.754 178.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.3 pp -130.96 179.78 4.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.798 0.666 . . . . 72.42 112.798 -177.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -76.71 153.4 35.13 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.793 -0.64 . . . . 74.35 109.473 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -83.93 -135.72 2.93 Favored Glycine 0 C--N 1.304 -1.239 0 C-N-CA 120.917 -0.659 . . . . 71.32 114.18 -175.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -70.32 -56.97 5.41 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.168 0.508 . . . . 74.42 110.449 -176.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -148.26 122.53 9.6 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.429 0.633 . . . . 71.41 110.096 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 55.2 p -108.59 91.49 3.67 Favored 'General case' 0 N--CA 1.406 -2.665 0 CA-C-O 121.907 0.86 . . . . 74.24 109.118 178.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -166.39 130.19 2.06 Favored 'General case' 0 CA--C 1.491 -1.295 0 N-CA-C 107.81 -1.181 . . . . 64.41 107.81 -177.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 642' ' ' LEU . . . . . 0.494 HD22 HG22 ' A' ' 523' ' ' VAL . 29.3 tp -137.91 110.53 7.55 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 108.531 -0.914 . . . . 75.35 108.531 176.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -93.92 109.69 21.39 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 107.188 -1.412 . . . . 75.2 107.188 176.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 644' ' ' VAL . . . . . 0.439 ' C ' ' HG1' ' A' ' 586' ' ' THR . 34.7 t -96.59 105.44 17.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 109.982 -0.377 . . . . 75.42 109.982 -177.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 3.7 mp -87.86 120.16 36.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 108.418 -0.956 . . . . 75.51 108.418 178.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 646' ' ' ILE . . . . . 0.433 ' H ' HD11 ' A' ' 646' ' ' ILE . 2.1 mp -101.7 107.47 21.62 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.746 0 N-CA-C 105.938 -1.875 . . . . 64.51 105.938 -177.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -110.53 145.92 36.93 Favored 'General case' 0 N--CA 1.406 -2.627 0 C-N-CA 120.273 -0.571 . . . . 72.54 110.294 -178.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -53.33 132.8 39.82 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.004 -0.998 . . . . 72.04 110.091 -178.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 3.6 m -56.88 124.01 17.06 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 124.444 1.098 . . . . 63.04 111.681 -173.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -151.42 -55.94 0.15 Allowed 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.383 -0.826 . . . . 73.44 110.058 -178.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 651' ' ' GLU . . . . . 0.576 ' HG2' ' H ' ' A' ' 652' ' ' PHE . 21.9 tt0 -164.6 -162.99 0.69 Allowed 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 105.565 -2.013 . . . . 75.44 105.565 -177.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 652' ' ' PHE . . . . . 0.576 ' H ' ' HG2' ' A' ' 651' ' ' GLU . 69.5 t80 -134.95 130.45 35.83 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.694 -1.224 . . . . 74.01 107.694 178.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -113.86 143.84 44.02 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 109.047 -0.723 . . . . 74.2 109.047 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 40.9 m -110.01 99.38 8.49 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 109.59 -0.522 . . . . 71.41 109.59 177.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 32.7 m -71.91 111.77 7.44 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.386 -0.825 . . . . 72.34 111.366 -176.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 35.4 m -98.92 155.16 3.93 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 N-CA-C 108.858 -0.793 . . . . 71.15 108.858 177.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 27.2 t70 . . . . . 0 C--N 1.3 -1.584 0 CA-C-N 116.482 -0.326 . . . . 73.12 110.291 -179.356 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 800' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 850' ' ' ' CA' . . . . . 0.667 'CA ' ' OD1' ' A' ' 552' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 13.8 t60 . . . . . 0 N--CA 1.445 -0.685 0 N-CA-C 108.037 -1.098 . . . . 74.41 108.037 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -150.04 15.89 0.84 Allowed 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.76 0.315 . . . . 73.55 110.975 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 146.72 171.57 16.14 Favored Glycine 0 N--CA 1.419 -2.47 0 C-N-CA 119.912 -1.137 . . . . 72.12 112.624 179.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 4.1 mp -122.75 114.81 43.83 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 108.54 -0.911 . . . . 74.23 108.54 178.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -128.88 98.75 5.06 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 107.753 -1.203 . . . . 74.32 107.753 174.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 15.4 t -134.99 156.83 48.36 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 116.044 -0.526 . . . . 74.42 109.679 -173.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -85.41 154.28 21.95 Favored 'General case' 0 CA--C 1.487 -1.476 0 N-CA-C 108.583 -0.895 . . . . 73.2 108.583 175.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -84.38 -26.92 28.02 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.099 -1.075 . . . . 73.33 108.099 173.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -111.26 121.22 41.03 Favored Pre-proline 0 N--CA 1.436 -1.174 0 CA-C-N 114.636 -1.165 . . . . 74.02 109.98 -178.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -85.7 -18.48 3.77 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 121.206 1.271 . . . . 75.32 109.51 169.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . 0.425 HG23 ' HB3' ' A' ' 643' ' ' GLU . 67.6 t -149.32 131.13 5.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 C-N-CA 125.953 1.701 . . . . 71.1 106.972 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 14.9 t -130.49 143.73 50.95 Favored 'General case' 0 N--CA 1.421 -1.902 0 N-CA-C 107.676 -1.231 . . . . 74.45 107.676 177.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -109.76 131.99 54.56 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 107.504 -1.295 . . . . 73.33 107.504 178.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 24.7 m -130.19 154.89 41.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 CA-C-O 121.312 0.577 . . . . 72.24 110.077 -178.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 65.7 m -77.08 150.0 35.7 Favored 'General case' 0 N--CA 1.397 -3.103 0 CA-C-N 114.493 -1.23 . . . . 74.42 109.955 178.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . 0.627 ' OE2' 'CA ' ' A' ' 800' ' ' ' CA' . 37.9 tt0 -71.69 -29.3 64.43 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.813 0.816 . . . . 65.24 109.659 174.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 39.7 m -107.95 75.07 0.98 Allowed 'General case' 0 N--CA 1.418 -2.033 0 CA-C-O 122.129 0.966 . . . . 73.23 109.462 -177.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 13.3 tt -145.3 161.04 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.214 0 CA-C-N 113.069 -1.878 . . . . 74.42 106.027 176.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . -92.51 -75.71 1.31 Allowed Glycine 0 N--CA 1.434 -1.449 0 C-N-CA 120.002 -1.094 . . . . 42.11 110.894 177.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 34.6 mm -107.68 127.03 63.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 109.866 -0.42 . . . . 75.22 109.866 -178.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 521' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.95 139.99 37.8 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.075 -1.454 . . . . 72.34 107.075 172.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -113.7 155.67 25.15 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 121.419 0.628 . . . . 72.3 111.709 -176.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . 0.675 ' O ' ' HA ' ' A' ' 570' ' ' THR . 12.1 t -135.77 126.07 42.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 115.118 -0.947 . . . . 71.12 108.479 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . 0.446 ' HD2' HG21 ' A' ' 568' ' ' VAL . 31.2 mmtp -79.7 126.08 30.47 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.507 0.67 . . . . 72.12 112.088 -179.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 19.1 t -110.67 122.87 65.95 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 107.367 -1.346 . . . . 73.53 107.367 176.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -78.82 144.93 34.59 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.073 -0.714 . . . . 71.41 109.073 -178.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . 0.473 ' HG2' ' N ' ' A' ' 528' ' ' THR . 40.3 ttp180 -88.23 151.81 22.4 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.451 0.643 . . . . 64.32 110.764 -175.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 528' ' ' THR . . . . . 0.473 ' N ' ' HG2' ' A' ' 527' ' ' ARG . 4.6 t -59.97 139.63 57.29 Favored 'General case' 0 N--CA 1.418 -2.049 0 CA-C-N 114.514 -1.221 . . . . 63.3 110.525 172.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 23.3 t -73.92 -40.65 62.98 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 108.553 -0.906 . . . . 75.32 108.553 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -90.57 56.63 3.46 Favored Glycine 0 N--CA 1.434 -1.459 0 N-CA-C 110.392 -1.083 . . . . 64.11 110.392 177.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -70.14 99.88 1.56 Allowed 'General case' 0 CA--C 1.505 -0.767 0 C-N-CA 122.972 0.509 . . . . 64.1 110.884 -178.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -127.33 100.22 5.96 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 115.708 -0.678 . . . . 73.32 109.899 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 533' ' ' GLY . . . . . 0.52 ' H ' ' HB3' ' A' ' 564' ' ' ASN . . . 102.67 165.23 26.19 Favored Glycine 0 N--CA 1.42 -2.42 0 C-N-CA 120.695 -0.764 . . . . 41.11 113.161 177.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -79.72 123.11 27.38 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.383 -1.34 . . . . 74.44 107.383 176.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 65.7 t -124.32 139.48 50.54 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-N 116.19 -0.459 . . . . 74.03 110.023 -175.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 536' ' ' ILE . . . . . 0.462 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 30.2 mm -104.24 139.18 25.94 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 109.014 -0.736 . . . . 63.33 109.014 178.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 41.9 t -118.4 108.53 41.58 Favored Pre-proline 0 C--N 1.306 -1.3 0 N-CA-C 109.474 -0.565 . . . . 73.23 109.474 177.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -73.93 138.85 26.47 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 122.117 1.878 . . . . 65.35 110.885 177.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -146.46 161.47 40.35 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 120.804 -0.358 . . . . 73.34 110.531 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.31 147.65 23.87 Favored 'General case' 0 C--N 1.317 -0.807 0 O-C-N 123.518 0.511 . . . . 73.33 111.495 177.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 16.7 p -84.8 132.34 34.43 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 116.2 -0.455 . . . . 72.33 110.039 173.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.5 mp -93.63 124.22 46.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 106.271 -1.751 . . . . 72.54 106.271 173.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . 0.402 ' HB3' ' O ' ' A' ' 546' ' ' ALA . 2.7 mp0 -57.12 -52.67 64.36 Favored 'General case' 0 C--O 1.243 0.712 0 O-C-N 123.818 0.699 . . . . 74.42 110.765 -178.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 71.08 -81.91 0.44 Allowed Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 115.45 -0.795 . . . . 62.55 111.946 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 11.1 t -132.9 5.47 3.9 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.677 0.751 . . . . 74.33 109.806 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . 0.402 ' O ' ' HB3' ' A' ' 543' ' ' GLU . . . -106.2 178.83 4.45 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.841 -0.618 . . . . 75.35 109.612 178.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . 0.475 ' HD2' ' CB ' ' A' ' 551' ' ' GLU . 1.7 tmt_? -129.03 124.26 34.46 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 107.677 -1.231 . . . . 74.14 107.677 -175.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -82.9 -151.36 10.16 Favored Glycine 0 C--N 1.321 -0.264 0 C-N-CA 121.321 -0.466 . . . . 72.05 112.715 -177.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 66.6 19.4 69.01 Favored Glycine 0 C--N 1.314 -0.672 0 CA-C-N 116.689 0.244 . . . . 65.31 113.289 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 76.7 32.3 50.87 Favored Glycine 0 N--CA 1.437 -1.289 0 C-N-CA 120.748 -0.739 . . . . 51.22 111.614 -178.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . 0.475 ' CB ' ' HD2' ' A' ' 547' ' ' ARG . 8.1 tp10 -101.41 -65.75 0.96 Allowed 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.865 -0.42 . . . . 71.51 109.865 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -101.38 -34.05 9.76 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 106.526 -1.657 . . . . 73.4 106.526 177.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 553' ' ' PHE . . . . . 0.45 ' HA ' HG12 ' A' ' 576' ' ' ILE . 20.4 p90 -149.46 164.56 34.68 Favored 'General case' 0 N--CA 1.419 -2.023 0 CA-C-N 113.99 -1.459 . . . . 65.42 108.054 175.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . 0.447 ' HG3' ' HE2' ' A' ' 574' ' ' LYS . 0.5 OUTLIER -94.56 112.3 24.06 Favored 'General case' 0 C--N 1.282 -2.368 0 N-CA-C 105.805 -1.924 . . . . 74.52 105.805 176.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -76.94 101.06 5.8 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-O 122.525 1.155 . . . . 62.14 110.736 -175.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 556' ' ' THR . . . . . 0.454 ' CG2' HG22 ' A' ' 573' ' ' VAL . 8.9 t -91.44 121.8 33.47 Favored 'General case' 0 N--CA 1.396 -3.148 0 CA-C-O 122.395 1.093 . . . . 75.14 110.967 -178.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 10.4 p -136.83 119.25 15.79 Favored 'General case' 0 N--CA 1.41 -2.43 0 N-CA-C 106.56 -1.644 . . . . 72.44 106.56 177.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -170.12 -152.91 8.29 Favored Glycine 0 N--CA 1.415 -2.724 0 N-CA-C 110.596 -1.002 . . . . 72.52 110.596 -175.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 559' ' ' GLU . . . . . 0.462 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 34.7 mt-10 -135.03 127.47 30.48 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 122.364 0.265 . . . . 64.42 111.124 -176.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 96.1 mt -88.19 155.6 19.68 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.346 -0.612 . . . . 75.34 109.346 177.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -123.37 119.29 29.64 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-O 121.039 0.447 . . . . 74.22 111.471 -178.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -113.82 148.39 36.69 Favored 'General case' 0 CA--C 1.502 -0.881 0 C-N-CA 123.981 0.912 . . . . 75.33 109.492 176.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -127.87 167.55 16.43 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 120.243 -0.583 . . . . 72.43 109.45 177.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 564' ' ' ASN . . . . . 0.52 ' HB3' ' H ' ' A' ' 533' ' ' GLY . 32.1 p30 -66.87 -24.51 66.13 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.272 0.558 . . . . 72.11 111.142 178.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -102.72 -5.1 24.11 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.577 -0.738 . . . . 72.5 111.0 -177.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -115.35 134.86 54.72 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 116.4 -0.363 . . . . 72.41 110.599 -175.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 567' ' ' ILE . . . . . 0.439 ' HA ' ' HD3' ' A' ' 527' ' ' ARG . 9.5 pt -114.09 164.73 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 C-N-CA 120.969 -0.292 . . . . 73.4 110.267 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 568' ' ' VAL . . . . . 0.446 HG21 ' HD2' ' A' ' 524' ' ' LYS . 1.2 p 49.54 165.82 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.566 1.559 0 C-N-CA 127.301 2.24 . . . . 73.21 114.488 179.266 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 569' ' ' LYS . . . . . 0.432 ' HE3' ' HA ' ' A' ' 569' ' ' LYS . 1.0 OUTLIER -161.0 160.81 31.13 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 106.087 -1.82 . . . . 73.12 106.087 177.289 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 570' ' ' THR . . . . . 0.675 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 19.8 p -133.89 127.58 32.82 Favored 'General case' 0 N--CA 1.427 -1.601 0 O-C-N 123.478 0.486 . . . . 64.53 110.964 177.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 2.9 mp -76.62 125.45 36.4 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 107.016 -1.476 . . . . 70.14 107.016 173.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 24.4 m -99.44 109.37 21.94 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 120.859 0.361 . . . . 72.11 110.342 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 573' ' ' VAL . . . . . 0.454 HG22 ' CG2' ' A' ' 556' ' ' THR . 40.1 t -116.45 120.07 63.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 108.97 -0.752 . . . . 71.13 108.97 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 574' ' ' LYS . . . . . 0.447 ' HE2' ' HG3' ' A' ' 554' ' ' GLU . 38.8 ttpt -82.1 126.6 32.21 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-O 121.457 0.646 . . . . 75.23 110.938 177.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 82.5 t -91.51 134.84 28.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 107.982 -1.118 . . . . 64.12 107.982 178.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 576' ' ' ILE . . . . . 0.45 HG12 ' HA ' ' A' ' 553' ' ' PHE . 21.9 mm -105.69 160.05 5.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 107.475 -1.306 . . . . 74.43 107.475 -177.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -68.77 132.17 46.37 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 116.387 -0.37 . . . . 64.44 110.103 177.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 578' ' ' ASP . . . . . 0.603 ' OD1' 'CA ' ' A' ' 850' ' ' ' CA' . 0.9 OUTLIER -62.36 128.85 37.98 Favored 'General case' 0 CA--C 1.49 -1.342 0 CA-C-O 121.808 0.813 . . . . 72.14 111.405 -178.095 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 579' ' ' GLU . . . . . 0.602 ' OE2' 'CA ' ' A' ' 850' ' ' ' CA' . 0.0 OUTLIER -100.18 -0.82 38.04 Favored 'General case' 0 C--N 1.275 -2.642 0 CA-C-N 114.02 -1.445 . . . . 73.11 113.335 -175.231 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 580' ' ' GLU . . . . . 0.532 ' HG2' ' O ' ' A' ' 581' ' ' TYR . 0.5 OUTLIER -137.29 -174.93 3.89 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.93 -0.481 . . . . 72.31 110.706 -176.63 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 581' ' ' TYR . . . . . 0.532 ' O ' ' HG2' ' A' ' 580' ' ' GLU . 28.5 p90 -65.63 154.32 39.13 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 108.706 -0.85 . . . . 71.23 108.706 174.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -86.0 152.26 23.06 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 114.988 1.477 . . . . 74.03 114.988 -176.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -157.71 172.74 17.97 Favored 'General case' 0 N--CA 1.433 -1.283 0 C-N-CA 126.77 2.028 . . . . 75.34 105.611 176.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -80.77 97.68 7.43 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.075 -1.454 . . . . 75.13 107.075 176.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.68 136.0 53.32 Favored 'General case' 0 N--CA 1.416 -2.152 0 CA-C-N 115.365 -0.834 . . . . 74.14 110.363 -175.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 586' ' ' THR . . . . . 0.435 ' HG1' ' C ' ' A' ' 644' ' ' VAL . 3.9 t -151.33 146.97 26.38 Favored 'General case' 0 N--CA 1.421 -1.917 0 CA-C-N 115.137 -0.938 . . . . 75.41 110.483 -174.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -122.18 155.62 35.4 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 114.6 -1.182 . . . . 71.42 109.628 177.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 588' ' ' PHE . . . . . 0.512 ' HA ' ' O ' ' A' ' 642' ' ' LEU . 34.9 m-85 -110.71 145.73 37.51 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.721 -0.474 . . . . 74.04 109.721 -174.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -116.25 119.62 36.32 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 106.491 -1.67 . . . . 73.33 106.491 176.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -125.5 138.78 53.99 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 108.847 -0.797 . . . . 61.34 108.847 -178.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 591' ' ' ILE . . . . . . . . . . . . . 27.3 pt -103.73 151.03 6.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 108.502 -0.925 . . . . 73.13 108.502 176.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -93.72 -150.09 26.26 Favored Glycine 0 N--CA 1.427 -1.918 0 N-CA-C 110.855 -0.898 . . . . 64.14 110.855 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -86.3 119.63 71.7 Favored Pre-proline 0 C--N 1.301 -1.53 0 N-CA-C 108.552 -0.907 . . . . 73.53 108.552 178.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 594' ' ' PRO . . . . . 0.465 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 12.9 Cg_endo -57.47 149.13 68.09 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 122.37 2.047 . . . . 74.42 111.175 177.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -128.66 132.84 48.1 Favored 'General case' 0 C--N 1.291 -1.959 0 O-C-N 121.996 -0.44 . . . . 74.32 110.306 -173.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -77.43 128.12 33.7 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.671 -1.233 . . . . 71.44 107.671 -177.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 597' ' ' VAL . . . . . 0.428 ' CG2' HG12 ' A' ' 536' ' ' ILE . 52.2 t -76.25 -41.72 36.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-O 121.869 0.842 . . . . 73.41 109.373 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -85.49 129.33 34.84 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 114.671 -1.15 . . . . 75.14 110.321 -176.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 18.3 ptm -67.7 121.61 16.31 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-O 122.183 0.992 . . . . 71.41 110.731 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 8.8 p -118.51 88.94 3.02 Favored 'General case' 0 C--N 1.269 -2.908 0 CA-C-N 114.326 -1.307 . . . . 71.35 110.339 176.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -77.48 91.76 3.95 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-O 122.195 0.998 . . . . 72.32 108.332 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . 0.442 ' HG3' ' CD1' ' A' ' 606' ' ' PHE . 7.3 ptpp? -85.03 78.59 9.87 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-O 123.334 1.54 . . . . 73.25 112.132 -173.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 603' ' ' LYS . . . . . 0.574 ' HZ3' ' HB3' ' A' ' 603' ' ' LYS . 0.7 OUTLIER -79.36 157.58 27.61 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 112.683 -2.053 . . . . 72.14 111.327 -178.093 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 109.12 -54.6 0.54 Allowed Glycine 0 N--CA 1.428 -1.89 0 N-CA-C 108.113 -1.995 . . . . 73.41 108.113 -175.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . -92.56 -41.37 4.79 Favored Glycine 0 N--CA 1.428 -1.844 0 N-CA-C 109.721 -1.352 . . . . 72.0 109.721 174.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 606' ' ' PHE . . . . . 0.442 ' CD1' ' HG3' ' A' ' 602' ' ' LYS . 89.4 m-85 -97.16 153.65 17.85 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.313 -0.625 . . . . 73.25 109.313 175.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 11.8 p -85.93 -178.44 6.57 Favored 'General case' 0 C--N 1.292 -1.907 0 C-N-CA 123.658 0.783 . . . . 71.41 111.998 -175.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 23.1 mm -91.7 63.07 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 N-CA-C 105.343 -2.095 . . . . 64.44 105.343 175.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 52.3 m -150.34 137.81 19.71 Favored 'General case' 0 C--N 1.279 -2.472 0 CA-C-N 115.216 -0.902 . . . . 62.43 109.121 -173.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -102.65 80.78 1.95 Allowed 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 109.004 -0.739 . . . . 73.04 109.004 -177.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -136.56 154.21 50.76 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 116.345 -0.388 . . . . 72.01 110.122 -177.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 65.56 27.59 11.52 Favored 'General case' 0 CA--C 1.511 -0.551 0 O-C-N 124.407 1.067 . . . . 72.04 113.047 174.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -117.0 127.48 54.22 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 114.5 -1.227 . . . . 73.13 108.104 173.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -168.62 173.03 7.62 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 105.556 -2.016 . . . . 71.32 105.556 -177.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -85.24 72.19 10.77 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 119.221 0.918 . . . . 75.42 109.087 175.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -93.24 155.45 41.03 Favored Pre-proline 0 N--CA 1.433 -1.285 0 CA-C-N 114.631 -1.168 . . . . 72.02 109.673 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -79.35 -168.68 0.66 Allowed 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 122.171 1.914 . . . . 70.33 109.368 172.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -69.44 105.56 2.65 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 107.649 -1.241 . . . . 73.13 107.649 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 2.2 p -139.09 68.53 1.38 Allowed 'General case' 0 N--CA 1.435 -1.203 0 CA-C-O 121.451 0.643 . . . . 62.12 112.415 -172.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 620' ' ' SER . . . . . 0.45 ' OG ' ' HG3' ' A' ' 630' ' ' GLU . 2.0 m -88.04 -21.21 24.9 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.819 -0.628 . . . . 72.23 110.94 -175.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt 67.26 -65.09 0.24 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.891 1.276 . . . . 71.31 112.751 178.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 171.7 -40.15 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.941 1.296 . . . . 74.14 107.514 -176.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -47.85 127.07 11.4 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 113.381 -1.736 . . . . 64.35 111.72 -178.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -62.86 -39.78 95.47 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-N 116.171 -0.468 . . . . 65.3 110.05 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -56.73 -40.07 75.06 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 123.968 0.792 . . . . 70.33 109.105 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . 0.65 ' O ' ' HG2' ' A' ' 630' ' ' GLU . 1.9 tpp180 -72.62 -47.09 50.62 Favored 'General case' 0 C--O 1.193 -1.874 0 CA-C-N 115.371 -0.831 . . . . 74.33 109.307 -179.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 627' ' ' ARG . . . . . . . . . . . . . 39.4 mtm180 -53.66 -40.63 66.05 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.413 0.524 . . . . 73.24 112.413 178.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 98.2 mt -64.65 -41.76 93.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 120.873 0.368 . . . . 74.21 110.466 176.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -69.42 -36.19 76.46 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.263 -0.426 . . . . 72.43 111.214 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 630' ' ' GLU . . . . . 0.65 ' HG2' ' O ' ' A' ' 626' ' ' ARG . 20.3 mm-40 -61.99 -35.31 78.11 Favored 'General case' 0 C--O 1.212 -0.918 0 C-N-CA 123.191 0.596 . . . . 74.24 110.077 177.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 631' ' ' MET . . . . . . . . . . . . . 24.3 ptt? -89.69 7.1 38.41 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.678 0.751 . . . . 75.12 109.869 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -78.76 -21.38 68.89 Favored Glycine 0 N--CA 1.437 -1.3 0 N-CA-C 108.316 -1.914 . . . . 71.14 108.316 173.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 633' ' ' ARG . . . . . 0.403 ' CZ ' ' HA ' ' A' ' 630' ' ' GLU . 0.2 OUTLIER -110.13 151.34 42.47 Favored Pre-proline 0 N--CA 1.43 -1.442 0 N-CA-C 105.894 -1.891 . . . . 75.22 105.894 174.217 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.465 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 18.2 Cg_endo -63.17 144.81 92.88 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 121.203 1.268 . . . . 73.31 110.485 175.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.3 pp -122.48 169.25 14.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 113.46 0.911 . . . . 74.41 113.46 -177.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.85 168.34 19.63 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 123.788 0.835 . . . . 62.5 112.106 -176.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -113.18 -157.51 12.72 Favored Glycine 0 N--CA 1.437 -1.282 0 N-CA-C 115.704 1.042 . . . . 72.05 115.704 -174.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -42.65 -59.32 1.96 Allowed 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 128.107 2.563 . . . . 64.33 114.751 -173.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 10.6 p80 -140.06 109.63 6.28 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 122.019 0.914 . . . . 75.51 111.812 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 11.0 p -114.61 91.71 3.71 Favored 'General case' 0 N--CA 1.411 -2.412 0 CA-C-N 115.008 -0.996 . . . . 71.52 111.102 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 641' ' ' LYS . . . . . 0.439 ' HD3' ' N ' ' A' ' 642' ' ' LEU . 1.0 OUTLIER -175.23 137.25 0.39 Allowed 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 105.353 -2.091 . . . . 75.41 105.353 178.779 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 642' ' ' LEU . . . . . 0.512 ' O ' ' HA ' ' A' ' 588' ' ' PHE . 27.6 tp -135.31 114.14 11.94 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 108.775 -0.824 . . . . 74.43 108.775 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . 0.425 ' HB3' HG23 ' A' ' 511' ' ' VAL . 28.6 tt0 -98.31 110.04 22.69 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 107.127 -1.434 . . . . 74.1 107.127 176.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 644' ' ' VAL . . . . . 0.435 ' C ' ' HG1' ' A' ' 586' ' ' THR . 22.0 t -97.46 102.08 13.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 109.77 -0.456 . . . . 75.25 109.77 -177.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 4.0 mp -89.15 120.18 37.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 N-CA-C 107.799 -1.186 . . . . 74.45 107.799 177.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 646' ' ' ILE . . . . . 0.462 ' N ' HD13 ' A' ' 646' ' ' ILE . 2.8 mp -99.83 106.71 19.55 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.505 0 N-CA-C 106.724 -1.584 . . . . 75.23 106.724 -176.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -104.87 155.43 18.93 Favored 'General case' 0 C--N 1.279 -2.497 0 CA-C-O 121.237 0.541 . . . . 73.44 111.565 -177.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . 0.491 ' C ' ' H ' ' A' ' 650' ' ' TYR . 41.6 mm-40 -60.84 162.61 6.6 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.052 -0.976 . . . . 62.54 113.479 -174.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 8.3 t -85.52 40.11 0.82 Allowed 'General case' 0 CA--C 1.557 1.223 0 CA-C-O 123.184 1.469 . . . . 75.42 107.654 177.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 650' ' ' TYR . . . . . 0.491 ' H ' ' C ' ' A' ' 648' ' ' GLU . 1.2 t80 -85.1 -44.21 13.19 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 112.932 -1.94 . . . . 74.14 108.013 178.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -177.82 174.18 1.48 Allowed 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 100.961 -3.718 . . . . 74.5 100.961 -178.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -136.71 116.47 13.07 Favored 'General case' 0 C--N 1.263 -3.175 0 CA-C-N 118.682 0.673 . . . . 74.43 109.886 -175.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.32 174.65 8.8 Favored 'General case' 0 C--N 1.277 -2.55 0 CA-C-N 115.757 -0.656 . . . . 75.44 109.275 -179.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 50.8 m -148.1 76.82 1.39 Allowed 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 107.27 -1.382 . . . . 60.12 107.27 172.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 21.0 m -69.32 106.99 3.1 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 115.186 -0.915 . . . . 74.52 110.978 -176.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . 0.32 11.7 p 46.81 93.18 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.246 0.891 0 C-N-CA 126.455 1.902 . . . . 64.45 114.506 -178.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 . . . . . 0 C--N 1.306 -1.32 0 CA-C-N 114.137 -1.392 . . . . 74.23 109.573 -177.605 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 800' ' ' ' CA' . . . . . 0.627 'CA ' ' OE2' ' A' ' 516' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 850' ' ' ' CA' . . . . . 0.603 'CA ' ' OD1' ' A' ' 578' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . 0.521 ' HA ' ' O ' ' A' ' 631' ' ' MET . 6.2 p-80 . . . . . 0 C--O 1.241 0.608 0 N-CA-C 110.266 -0.272 . . . . 74.34 110.266 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -93.08 -49.07 6.19 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 108.167 -1.049 . . . . 72.32 108.167 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . 0.496 ' HA3' ' OG1' ' A' ' 528' ' ' THR . . . -164.4 -177.36 37.01 Favored Glycine 0 N--CA 1.406 -3.328 0 C-N-CA 119.258 -1.449 . . . . 71.21 114.128 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 4.0 mp -125.61 134.88 65.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 123.879 0.871 . . . . 74.0 108.927 -173.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -131.2 127.62 38.29 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.343 -0.614 . . . . 74.3 109.343 173.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 506' ' ' THR . . . . . 0.432 ' HB ' ' HA3' ' A' ' 637' ' ' GLY . 15.0 t -154.25 164.49 38.48 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 109.443 -0.577 . . . . 72.55 109.443 -177.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -94.8 157.67 15.83 Favored 'General case' 0 CA--C 1.493 -1.242 0 N-CA-C 108.647 -0.871 . . . . 75.21 108.647 175.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -93.75 -33.81 13.46 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 106.882 -1.525 . . . . 72.42 106.882 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -95.61 120.9 62.75 Favored Pre-proline 0 CA--C 1.49 -1.362 0 CA-C-N 114.285 -1.325 . . . . 60.34 110.097 175.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 641' ' ' LYS . 2.7 Cg_exo -80.88 -20.88 7.33 Favored 'Trans proline' 0 N--CA 1.44 -1.643 0 N-CA-C 108.251 -1.48 . . . . 72.41 108.251 165.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 99.2 t -145.06 138.73 22.16 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 C-N-CA 124.876 1.27 . . . . 75.43 109.061 -178.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 10.1 t -137.02 138.99 41.08 Favored 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 107.025 -1.472 . . . . 74.22 107.025 175.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 75.7 m-70 -109.99 116.13 31.04 Favored 'General case' 0 CA--C 1.488 -1.414 0 N-CA-C 109.064 -0.717 . . . . 73.42 109.064 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.622 HG12 ' SD ' ' A' ' 521' ' ' MET . 33.4 m -109.18 155.58 10.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 CA-C-O 122.024 0.916 . . . . 73.24 112.226 -174.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 515' ' ' SER . . . . . 0.477 ' O ' HG23 ' A' ' 518' ' ' ILE . 51.0 m -77.89 156.88 30.07 Favored 'General case' 0 N--CA 1.389 -3.502 0 CA-C-N 113.597 -1.638 . . . . 73.34 110.286 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . 0.415 ' HB2' ' O ' ' A' ' 647' ' ' GLU . 20.8 tp10 -87.7 -18.68 28.95 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 107.847 -1.168 . . . . 73.32 107.847 177.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 30.4 m -96.66 18.37 14.43 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.601 -0.727 . . . . 71.41 110.739 -176.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 518' ' ' ILE . . . . . 0.477 HG23 ' O ' ' A' ' 515' ' ' SER . 13.9 tt -102.81 152.22 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.631 0 N-CA-C 108.388 -0.968 . . . . 75.41 108.388 -177.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -92.89 -70.05 1.14 Allowed Glycine 0 N--CA 1.424 -2.133 0 C-N-CA 119.832 -1.175 . . . . 71.03 110.777 176.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 42.6 mm -117.34 125.21 73.87 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 N-CA-C 108.657 -0.868 . . . . 75.31 108.657 -176.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 521' ' ' MET . . . . . 0.622 ' SD ' HG12 ' A' ' 514' ' ' VAL . 22.6 ptt? -95.96 136.55 36.25 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 107.322 -1.362 . . . . 74.12 107.322 172.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 29.3 mp0 -115.79 107.56 15.2 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 108.191 -1.04 . . . . 74.43 108.191 177.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 570' ' ' THR . 35.0 t -98.03 128.05 49.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 109.582 -0.525 . . . . 75.03 109.582 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -73.87 156.61 37.53 Favored 'General case' 0 C--N 1.317 -0.837 0 O-C-N 123.71 0.631 . . . . 74.11 111.141 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 27.2 t -127.74 144.4 37.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 N-CA-C 107.067 -1.457 . . . . 61.42 107.067 176.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -75.74 140.0 42.17 Favored 'General case' 0 CA--C 1.493 -1.237 0 N-CA-C 109.363 -0.606 . . . . 74.41 109.363 177.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . 0.463 ' CZ ' HG23 ' A' ' 567' ' ' ILE . 35.8 ttt180 -91.03 147.22 23.23 Favored 'General case' 0 N--CA 1.414 -2.24 0 CA-C-N 115.238 -0.892 . . . . 73.55 109.246 -176.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 528' ' ' THR . . . . . 0.496 ' OG1' ' HA3' ' A' ' 503' ' ' GLY . 4.2 t -59.54 146.48 40.46 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 114.737 -1.12 . . . . 71.4 112.122 177.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 15.7 t -79.54 -15.6 57.41 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 108.128 -1.064 . . . . 72.15 108.128 176.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -118.75 93.76 0.57 Allowed Glycine 0 N--CA 1.432 -1.598 0 N-CA-C 109.396 -1.481 . . . . 72.25 109.396 176.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -102.17 93.37 5.19 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.393 0.616 . . . . 72.25 110.572 -177.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -116.52 115.03 25.01 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.738 -0.664 . . . . 74.34 111.698 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 77.64 -121.17 5.72 Favored Glycine 0 N--CA 1.435 -1.372 0 CA-C-N 115.208 -0.905 . . . . 73.2 113.275 173.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 534' ' ' ASN . . . . . 0.515 HD22 ' HG3' ' A' ' 561' ' ' GLU . 2.6 t-20 -139.44 127.6 22.5 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.262 -1.014 . . . . 73.34 108.262 -178.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 54.8 t -123.52 124.57 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.742 0 N-CA-C 109.496 -0.557 . . . . 73.02 109.496 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 536' ' ' ILE . . . . . 0.439 HG23 ' HB3' ' A' ' 559' ' ' GLU . 29.9 mm -93.66 120.53 43.21 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 CA-C-N 114.966 -1.015 . . . . 71.13 109.135 178.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 21.9 t -113.84 104.57 55.06 Favored Pre-proline 0 C--N 1.303 -1.451 0 N-CA-C 109.242 -0.651 . . . . 74.34 109.242 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -70.79 153.05 64.39 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 121.961 1.774 . . . . 75.41 110.978 177.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 539' ' ' TYR . . . . . 0.404 ' CD1' ' HG ' ' A' ' 560' ' ' LEU . 52.7 p90 -150.97 159.93 44.25 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.021 -0.733 . . . . 73.2 109.021 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -155.15 154.98 33.14 Favored 'General case' 0 C--N 1.316 -0.851 0 O-C-N 123.721 0.638 . . . . 75.42 110.605 177.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 18.0 p -93.4 116.11 28.66 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.853 -0.612 . . . . 73.32 109.369 174.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.5 mp -83.35 122.29 37.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 105.608 -1.997 . . . . 72.44 105.608 174.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -51.86 -39.45 58.93 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.115 0.783 . . . . 74.42 113.115 -175.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 74.74 -86.68 0.75 Allowed Glycine 0 N--CA 1.437 -1.273 0 N-CA-C 110.521 -1.032 . . . . 65.23 110.521 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 11.3 t -143.17 14.07 1.84 Allowed 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 122.488 1.137 . . . . 73.3 108.899 177.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -96.74 -167.64 1.59 Allowed 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 114.714 -1.13 . . . . 73.03 109.512 177.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . 0.469 ' HG3' ' OE2' ' A' ' 551' ' ' GLU . 0.0 OUTLIER -136.23 122.79 20.88 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 106.97 -1.493 . . . . 75.31 106.97 -178.944 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -78.7 -153.97 7.42 Favored Glycine 0 C--N 1.303 -1.261 0 O-C-N 123.587 0.554 . . . . 70.44 112.802 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 63.92 10.5 39.59 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 114.909 0.723 . . . . 63.01 114.909 177.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 86.18 14.19 67.13 Favored Glycine 0 N--CA 1.433 -1.561 0 C-N-CA 120.285 -0.96 . . . . 50.54 112.02 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . 0.469 ' OE2' ' HG3' ' A' ' 547' ' ' ARG . 31.8 tt0 -84.59 -61.45 1.79 Allowed 'General case' 0 C--O 1.236 0.393 0 N-CA-C 109.574 -0.528 . . . . 74.32 109.574 178.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . 0.666 ' OD2' 'CA ' ' A' ' 850' ' ' ' CA' . 17.4 t70 -105.71 -36.95 6.9 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.628 -0.879 . . . . 74.54 108.628 177.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 553' ' ' PHE . . . . . 0.471 ' HA ' HG12 ' A' ' 576' ' ' ILE . 14.0 p90 -147.97 162.61 38.98 Favored 'General case' 0 N--CA 1.428 -1.525 0 N-CA-C 108.37 -0.974 . . . . 75.3 108.37 173.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -93.9 111.42 23.12 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 105.898 -1.89 . . . . 72.33 105.898 178.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -81.68 123.53 28.8 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-O 121.873 0.844 . . . . 74.23 110.419 -175.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 10.2 t -119.89 140.97 50.03 Favored 'General case' 0 N--CA 1.412 -2.338 0 CA-C-O 121.84 0.829 . . . . 63.3 110.664 -174.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 5.9 p -144.85 134.08 22.9 Favored 'General case' 0 N--CA 1.413 -2.324 0 N-CA-C 106.638 -1.615 . . . . 74.22 106.638 177.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -167.82 -153.87 8.34 Favored Glycine 0 N--CA 1.412 -2.954 0 C-N-CA 119.715 -1.231 . . . . 75.11 110.83 -175.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 559' ' ' GLU . . . . . 0.439 ' HB3' HG23 ' A' ' 536' ' ' ILE . 35.7 mt-10 -140.86 124.89 17.25 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 122.961 0.504 . . . . 74.03 109.828 -174.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . 0.404 ' HG ' ' CD1' ' A' ' 539' ' ' TYR . 95.4 mt -90.36 134.81 34.08 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 110.113 -0.329 . . . . 64.14 110.113 178.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 561' ' ' GLU . . . . . 0.515 ' HG3' HD22 ' A' ' 534' ' ' ASN . 43.7 tt0 -102.47 100.89 11.04 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.461 -0.791 . . . . 72.44 111.208 -176.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -99.62 144.63 28.49 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 109.202 -0.666 . . . . 72.03 109.202 174.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -138.78 171.28 14.57 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 109.82 -0.437 . . . . 73.03 109.82 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 19.4 p30 -64.72 -27.53 68.97 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 116.098 -0.501 . . . . 73.34 111.26 176.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -100.97 -23.88 14.44 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 116.159 -0.473 . . . . 62.51 111.783 177.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -85.38 128.56 34.76 Favored 'General case' 0 C--O 1.248 0.974 0 N-CA-C 110.227 -0.286 . . . . 75.21 110.227 -178.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 567' ' ' ILE . . . . . 0.463 HG23 ' CZ ' ' A' ' 527' ' ' ARG . 1.5 pp -116.42 138.49 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.024 0 N-CA-C 109.028 -0.73 . . . . 74.34 109.028 -179.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 568' ' ' VAL . . . . . 0.438 HG13 ' O ' ' A' ' 567' ' ' ILE . 1.4 p 58.66 153.75 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.153 0 C-N-CA 126.554 1.942 . . . . 73.43 113.88 177.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 569' ' ' LYS . . . . . 0.533 ' HA ' ' HE2' ' A' ' 569' ' ' LYS . 7.2 mmpt? -141.1 165.93 26.18 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.92 -0.77 . . . . 74.34 108.92 175.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 570' ' ' THR . . . . . 0.539 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 7.2 p -134.48 141.81 46.87 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 124.202 0.939 . . . . 73.21 110.886 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 2.7 mp -95.4 120.88 45.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 106.656 -1.609 . . . . 71.24 106.656 173.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 8.5 p -97.39 121.81 39.71 Favored 'General case' 0 N--CA 1.427 -1.618 0 O-C-N 123.683 0.615 . . . . 75.05 110.193 178.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 573' ' ' VAL . . . . . . . . . . . . . 52.1 t -130.51 134.72 61.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 N-CA-C 109.032 -0.729 . . . . 71.0 109.032 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -89.8 120.0 30.67 Favored 'General case' 0 C--O 1.248 0.985 0 O-C-N 123.705 0.628 . . . . 74.2 110.458 177.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 99.5 t -84.57 125.43 40.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 107.74 -1.207 . . . . 72.33 107.74 175.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 576' ' ' ILE . . . . . 0.471 HG12 ' HA ' ' A' ' 553' ' ' PHE . 31.1 mm -96.44 147.5 6.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 106.899 -1.519 . . . . 75.23 106.899 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -64.76 125.48 24.94 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 123.533 0.521 . . . . 53.33 110.387 -178.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 578' ' ' ASP . . . . . 0.631 ' OD1' 'CA ' ' A' ' 850' ' ' ' CA' . 3.1 m-20 -52.25 115.32 1.68 Allowed 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 114.636 1.347 . . . . 74.43 114.636 176.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 579' ' ' GLU . . . . . 0.648 ' OE1' 'CA ' ' A' ' 850' ' ' ' CA' . 0.0 OUTLIER -73.03 -38.16 66.63 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 112.633 -2.076 . . . . 74.32 109.035 176.07 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 580' ' ' GLU . . . . . 0.648 ' OE1' 'CA ' ' A' ' 850' ' ' ' CA' . 0.0 OUTLIER -124.98 -176.35 3.53 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 114.963 -1.017 . . . . 74.02 113.169 -176.818 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -52.74 153.71 3.1 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 126.159 1.784 . . . . 73.35 109.972 175.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 582' ' ' GLU . . . . . 0.499 ' OE2' ' HB ' ' A' ' 646' ' ' ILE . 33.1 tt0 -130.2 113.81 14.91 Favored 'General case' 0 C--N 1.287 -2.118 0 C-N-CA 119.05 -1.06 . . . . 73.42 111.988 178.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -89.26 -157.73 0.47 Allowed 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 106.285 -1.746 . . . . 74.52 106.285 173.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -75.19 76.69 2.33 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.392 -1.336 . . . . 73.41 107.392 171.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -104.42 128.96 52.41 Favored 'General case' 0 N--CA 1.402 -2.838 0 N-CA-C 107.715 -1.217 . . . . 73.31 107.715 -179.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 586' ' ' THR . . . . . 0.456 ' HG1' ' C ' ' A' ' 644' ' ' VAL . 2.9 t -151.92 153.63 34.5 Favored 'General case' 0 N--CA 1.393 -3.276 0 CA-C-N 114.845 -1.07 . . . . 75.42 110.093 -172.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 587' ' ' PHE . . . . . 0.521 ' CE2' HD12 ' A' ' 646' ' ' ILE . 0.8 OUTLIER -119.92 148.77 43.1 Favored 'General case' 0 N--CA 1.422 -1.858 0 O-C-N 124.668 1.23 . . . . 75.13 108.648 175.365 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 588' ' ' PHE . . . . . 0.4 ' CD1' ' HE3' ' A' ' 641' ' ' LYS . 13.8 m-85 -107.26 133.18 52.2 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.769 -0.456 . . . . 72.42 109.769 -172.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -102.91 130.42 49.95 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 106.054 -1.832 . . . . 74.21 106.054 173.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -139.33 151.18 46.19 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 107.149 -1.426 . . . . 71.5 107.149 178.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 591' ' ' ILE . . . . . . . . . . . . . 23.4 pt -107.24 152.14 8.91 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 O-C-N 123.234 0.334 . . . . 74.31 110.18 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -95.7 -164.42 34.26 Favored Glycine 0 N--CA 1.435 -1.38 0 N-CA-C 111.648 -0.581 . . . . 71.23 111.648 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -68.74 114.77 24.75 Favored Pre-proline 0 C--O 1.248 1.011 0 C-N-CA 122.572 0.349 . . . . 74.53 110.067 -177.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 594' ' ' PRO . . . . . 0.556 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 39.3 Cg_endo -69.39 134.08 27.86 Favored 'Trans proline' 0 N--CA 1.439 -1.725 0 C-N-CA 121.816 1.677 . . . . 73.52 109.774 177.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -122.89 127.08 48.49 Favored 'General case' 0 C--N 1.282 -2.349 0 CA-C-O 121.218 0.532 . . . . 75.22 111.651 -172.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -75.31 125.79 29.68 Favored 'General case' 0 N--CA 1.428 -1.525 0 N-CA-C 106.82 -1.548 . . . . 74.03 106.82 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 94.7 t -72.42 -30.32 34.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 N-CA-C 112.38 0.511 . . . . 75.25 112.38 -176.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -76.67 92.05 3.49 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 122.245 1.022 . . . . 73.42 113.341 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 91.6 mmm 60.64 78.68 0.27 Allowed 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 115.652 1.723 . . . . 74.53 115.652 174.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 21.1 m -82.4 98.38 8.83 Favored 'General case' 0 N--CA 1.419 -1.988 0 CA-C-O 122.308 1.052 . . . . 75.25 108.814 171.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -89.67 8.6 30.71 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.154 -1.385 . . . . 70.21 112.851 -172.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . 0.424 ' HB2' ' NZ ' ' A' ' 602' ' ' LYS . 0.1 OUTLIER 59.15 68.88 0.77 Allowed 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 109.054 -0.721 . . . . 74.55 109.054 -173.481 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.75 62.85 7.2 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.474 -0.785 . . . . 75.42 112.1 -174.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . 0.51 ' HA3' ' O ' ' A' ' 613' ' ' ASP . . . -130.57 55.81 0.76 Allowed Glycine 0 N--CA 1.423 -2.228 0 CA-C-N 115.322 -0.854 . . . . 44.21 111.083 -178.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 155.11 -151.32 22.95 Favored Glycine 0 N--CA 1.424 -2.107 0 N-CA-C 110.846 -0.901 . . . . 73.44 110.846 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -121.33 163.52 18.51 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 106.76 -1.57 . . . . 74.24 106.76 178.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 1.9 p -83.51 147.04 28.03 Favored 'General case' 0 N--CA 1.416 -2.174 0 N-CA-C 113.302 0.853 . . . . 72.31 113.302 -178.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 49.5 mt 72.56 79.32 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 C-N-CA 125.892 1.677 . . . . 74.12 109.392 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 10.9 t 178.77 -175.15 0.2 Allowed 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 105.541 -2.022 . . . . 60.21 105.541 -178.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -107.5 -6.45 17.03 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 109.367 -0.605 . . . . 73.52 109.367 176.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -90.97 93.55 9.25 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.828 -0.624 . . . . 71.5 112.053 -174.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -133.17 93.56 3.19 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 107.516 -1.29 . . . . 75.11 107.516 175.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 613' ' ' ASP . . . . . 0.51 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 24.5 t70 -101.57 109.55 21.38 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.634 0.73 . . . . 72.31 112.004 -176.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 614' ' ' ASP . . . . . 0.42 ' OD2' ' HG2' ' A' ' 615' ' ' LYS . 18.1 t70 -151.85 172.39 16.26 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 104.922 -2.251 . . . . 74.21 104.922 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 615' ' ' LYS . . . . . 0.469 ' HE3' ' HA ' ' A' ' 615' ' ' LYS . 0.0 OUTLIER 72.47 14.23 5.32 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 123.925 0.89 . . . . 74.31 112.047 176.772 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -90.65 161.03 37.5 Favored Pre-proline 0 N--CA 1.43 -1.438 0 N-CA-C 107.703 -1.221 . . . . 72.2 107.703 172.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -56.24 174.73 0.31 Allowed 'Trans proline' 0 CA--C 1.546 1.115 0 C-N-CA 122.508 2.139 . . . . 74.0 111.748 172.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.433 ' HG ' ' HB2' ' A' ' 636' ' ' LEU . 3.1 mm? -66.49 163.4 18.6 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 116.415 -0.357 . . . . 74.24 111.639 -176.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 619' ' ' THR . . . . . . . . . . . . 0.399 32.3 p 72.33 131.93 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 125.855 1.662 . . . . 71.52 112.747 -175.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 620' ' ' SER . . . . . 0.474 ' OG ' ' HB3' ' A' ' 626' ' ' ARG . 2.3 t -73.28 -7.74 52.82 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 115.45 1.648 . . . . 63.15 115.45 -165.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 59.07 29.55 19.14 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 118.07 0.395 . . . . 74.44 111.496 175.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 74.93 -7.24 1.79 Allowed 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.997 1.319 . . . . 75.04 112.553 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -80.46 132.32 35.7 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 109.51 -0.552 . . . . 74.35 109.51 -179.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -88.57 -17.2 30.7 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 116.529 -0.305 . . . . 71.11 111.568 -176.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -70.0 -40.52 75.25 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.667 -1.234 . . . . 74.03 107.667 173.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . 0.474 ' HB3' ' OG ' ' A' ' 620' ' ' SER . 0.0 OUTLIER -64.13 -31.25 72.38 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.372 -1.285 . . . . 75.14 108.001 179.904 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 627' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -63.34 -31.11 72.18 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 116.145 -0.48 . . . . 73.21 112.087 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 82.6 mt -63.28 -43.74 98.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 108.299 -1.0 . . . . 65.33 108.299 177.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -67.5 -39.82 85.17 Favored 'General case' 0 C--O 1.192 -1.941 0 CA-C-N 114.741 -1.118 . . . . 55.24 110.078 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -58.56 -30.12 66.9 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.061 0.458 . . . . 72.3 111.374 178.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 631' ' ' MET . . . . . 0.521 ' O ' ' HA ' ' A' ' 501' ' ' HIS . 66.9 mtm -91.72 -27.04 18.31 Favored 'General case' 0 CA--C 1.491 -1.314 0 CA-C-O 121.313 0.577 . . . . 73.03 110.69 -179.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -85.84 -29.33 26.51 Favored Glycine 0 N--CA 1.407 -3.266 0 C-N-CA 119.834 -1.174 . . . . 73.1 112.525 -177.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.48 160.15 59.88 Favored Pre-proline 0 C--N 1.307 -1.244 0 C-N-CA 124.642 1.177 . . . . 74.42 111.69 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.556 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 8.0 Cg_endo -70.25 143.13 47.56 Favored 'Trans proline' 0 N--CA 1.432 -2.112 0 N-CA-C 105.815 -2.417 . . . . 74.21 105.815 162.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.0 pp -129.43 -178.28 2.41 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 N-CA-C 115.54 1.681 . . . . 74.23 115.54 -174.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . 0.433 ' HB2' ' HG ' ' A' ' 618' ' ' LEU . 2.5 tp -70.79 148.22 48.12 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 113.635 -1.62 . . . . 74.2 109.959 -178.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . 0.432 ' HA3' ' HB ' ' A' ' 506' ' ' THR . . . -89.39 -133.04 4.78 Favored Glycine 0 N--CA 1.423 -2.219 0 C-N-CA 120.631 -0.795 . . . . 73.54 111.698 174.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -98.09 -54.2 3.15 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 122.638 -0.331 . . . . 75.23 111.555 -175.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -124.58 93.98 4.06 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 122.285 1.04 . . . . 74.43 112.904 -178.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 3.1 p -100.7 91.21 4.53 Favored 'General case' 0 N--CA 1.404 -2.75 0 CA-C-N 114.545 -1.207 . . . . 73.22 108.992 174.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 641' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 510' ' ' PRO . 21.0 tptm -169.76 130.44 1.03 Allowed 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 106.992 -1.484 . . . . 74.43 106.992 -175.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 642' ' ' LEU . . . . . 0.458 HD22 HG23 ' A' ' 523' ' ' VAL . 41.5 tp -132.57 103.45 6.16 Favored 'General case' 0 C--N 1.272 -2.778 0 N-CA-C 107.225 -1.398 . . . . 74.42 107.225 175.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -91.4 104.91 17.37 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 107.196 -1.409 . . . . 72.04 107.196 178.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 644' ' ' VAL . . . . . 0.461 HG23 ' HE1' ' A' ' 521' ' ' MET . 21.6 t -92.4 99.03 9.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-N 115.904 -0.589 . . . . 74.11 110.085 -176.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 3.5 mp -87.6 127.12 41.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 107.928 -1.138 . . . . 74.31 107.928 177.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 646' ' ' ILE . . . . . 0.521 HD12 ' CE2' ' A' ' 587' ' ' PHE . 1.7 mp -101.58 141.62 17.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 106.691 -1.596 . . . . 75.54 106.691 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . 0.478 ' OE2' ' HB3' ' A' ' 650' ' ' TYR . 2.0 pt-20 -135.43 159.65 40.92 Favored 'General case' 0 C--N 1.264 -3.144 0 N-CA-C 107.38 -1.341 . . . . 74.53 107.38 178.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . 0.618 ' OE2' 'CA ' ' A' ' 800' ' ' ' CA' . 3.0 mp0 -72.62 77.1 1.09 Allowed 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 121.829 0.823 . . . . 73.32 110.296 174.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 4.3 t 28.56 85.93 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 129.372 3.069 . . . . 71.35 115.886 177.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 650' ' ' TYR . . . . . 0.478 ' HB3' ' OE2' ' A' ' 647' ' ' GLU . 32.1 t80 -96.18 -72.09 0.65 Allowed 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 107.65 -1.241 . . . . 70.52 107.65 169.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -175.55 164.5 3.08 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 107.905 -1.146 . . . . 71.42 107.905 -178.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -79.84 127.89 32.78 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 116.015 -0.539 . . . . 73.31 111.232 -177.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -141.57 150.7 42.41 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 123.828 0.851 . . . . 75.44 110.524 176.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 34.1 t -152.7 91.44 1.56 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 106.839 -1.541 . . . . 75.31 106.839 173.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 28.4 m -96.95 96.6 8.62 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.356 0.598 . . . . 70.53 110.197 -177.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 46.8 t -112.54 143.89 21.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 108.04 -1.096 . . . . 75.1 108.04 178.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 . . . . . 0 C--N 1.301 -1.533 0 N-CA-C 109.189 -0.671 . . . . 75.43 109.189 179.707 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 800' ' ' ' CA' . . . . . 0.63 'CA ' ' OD2' ' A' ' 578' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 850' ' ' ' CA' . . . . . 0.666 'CA ' ' OD2' ' A' ' 552' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 8.6 p-80 . . . . . 0 N--CA 1.451 -0.394 0 N-CA-C 108.596 -0.89 . . . . 74.43 108.596 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -136.44 6.72 3.03 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 109.322 -0.622 . . . . 71.24 109.322 174.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . 0.619 ' HA2' ' OG1' ' A' ' 528' ' ' THR . . . -160.46 148.11 15.91 Favored Glycine 0 N--CA 1.414 -2.825 0 C-N-CA 117.953 -2.07 . . . . 72.23 114.979 -178.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 4.0 mp -138.58 96.3 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 N-CA-C 105.624 -1.991 . . . . 73.21 105.624 171.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -120.86 108.32 13.78 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 108.869 -0.789 . . . . 75.15 108.869 178.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 11.4 t -139.26 160.81 38.93 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 108.02 -1.104 . . . . 72.15 108.02 -176.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -85.68 148.9 25.66 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.675 -0.491 . . . . 75.04 109.675 175.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -73.51 -31.23 63.59 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.435 -0.95 . . . . 73.32 108.435 177.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -138.72 135.89 18.23 Favored Pre-proline 0 N--CA 1.44 -0.964 0 N-CA-C 109.431 -0.581 . . . . 75.01 109.431 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -82.2 -13.04 10.28 Favored 'Trans proline' 0 C--O 1.218 -0.485 0 C-N-CA 122.671 2.247 . . . . 72.44 112.08 178.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . 0.414 HG23 ' HB3' ' A' ' 643' ' ' GLU . 70.6 t -140.63 137.66 35.79 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.858 0 N-CA-C 108.365 -0.976 . . . . 72.14 108.365 -178.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 4.9 t -143.6 137.06 28.07 Favored 'General case' 0 N--CA 1.419 -1.993 0 N-CA-C 107.925 -1.139 . . . . 75.32 107.925 177.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -106.82 126.49 52.37 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 109.106 -0.702 . . . . 75.32 109.106 176.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 29.1 m -126.92 161.47 33.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 115.751 -0.659 . . . . 70.24 109.373 -175.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 33.8 t -85.54 161.86 19.15 Favored 'General case' 0 N--CA 1.424 -1.759 0 N-CA-C 108.527 -0.916 . . . . 73.33 108.527 178.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -99.3 -11.83 20.89 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-O 121.376 0.608 . . . . 73.01 109.366 177.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 48.8 m -91.41 8.94 33.84 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.637 0.732 . . . . 70.13 109.885 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 13.6 tt -90.29 157.16 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 N-CA-C 108.122 -1.066 . . . . 74.14 108.122 -178.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -88.48 -57.07 1.91 Allowed Glycine 0 N--CA 1.438 -1.199 0 C-N-CA 120.201 -1.0 . . . . 61.34 111.282 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . 0.404 HD12 ' HA ' ' A' ' 574' ' ' LYS . 44.9 mm -127.39 136.65 60.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 108.778 -0.823 . . . . 74.43 108.778 -178.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 521' ' ' MET . . . . . 0.432 ' HE3' HG13 ' A' ' 644' ' ' VAL . 0.0 OUTLIER -111.03 133.28 53.54 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.077 -1.453 . . . . 72.1 107.077 171.103 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 -117.38 128.78 55.37 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 109.294 -0.632 . . . . 74.11 109.294 -176.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . 0.604 ' O ' ' HA ' ' A' ' 570' ' ' THR . 20.5 t -119.81 134.87 61.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 N-CA-C 109.746 -0.464 . . . . 70.11 109.746 179.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -80.39 129.45 34.51 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 113.792 1.034 . . . . 72.52 113.792 -177.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 3.3 t -112.46 133.5 58.02 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 N-CA-C 106.644 -1.613 . . . . 74.44 106.644 177.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -86.76 139.67 30.49 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 120.477 -0.489 . . . . 72.35 109.723 -178.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . 0.463 ' HG2' ' N ' ' A' ' 528' ' ' THR . 37.6 ttp180 -86.96 157.73 19.42 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.103 0.478 . . . . 65.04 111.176 -176.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 528' ' ' THR . . . . . 0.619 ' OG1' ' HA2' ' A' ' 503' ' ' GLY . 4.2 t -58.36 158.48 7.29 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 125.006 1.323 . . . . 71.21 111.674 173.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 32.8 t -87.94 -7.37 57.22 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 115.021 -0.99 . . . . 72.04 109.406 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -132.13 110.39 0.94 Allowed Glycine 0 N--CA 1.436 -1.324 0 N-CA-C 109.409 -1.476 . . . . 72.34 109.409 178.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -155.35 92.85 1.45 Allowed 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 109.3 -0.63 . . . . 65.22 109.3 -175.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.54 23.8 13.88 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 115.318 -0.856 . . . . 75.03 111.085 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . -177.26 -168.26 36.8 Favored Glycine 0 N--CA 1.42 -2.392 0 N-CA-C 110.461 -1.056 . . . . 65.11 110.461 -174.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 534' ' ' ASN . . . . . 0.45 HD22 ' HG3' ' A' ' 561' ' ' GLU . 2.9 t-20 -85.37 132.82 34.17 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 123.482 0.713 . . . . 75.55 110.304 -177.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 58.0 t -128.13 124.74 63.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 108.871 -0.789 . . . . 63.13 108.871 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 536' ' ' ILE . . . . . 0.41 HG21 ' HB3' ' A' ' 559' ' ' GLU . 19.7 mm -97.85 127.8 49.87 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 CA-C-N 115.921 -0.581 . . . . 75.33 109.931 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . 0.49 HG21 ' HB3' ' A' ' 594' ' ' PRO . 41.5 t -117.1 103.74 51.48 Favored Pre-proline 0 C--N 1.309 -1.187 0 N-CA-C 108.684 -0.858 . . . . 74.11 108.684 176.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -71.95 144.47 43.04 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.193 1.929 . . . . 72.35 110.769 178.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 539' ' ' TYR . . . . . 0.449 ' CD2' ' HG ' ' A' ' 560' ' ' LEU . 49.0 p90 -145.75 167.31 23.46 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 109.414 -0.587 . . . . 74.13 109.414 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -158.97 157.14 30.73 Favored 'General case' 0 C--N 1.308 -1.222 0 O-C-N 123.711 0.632 . . . . 74.53 109.781 177.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 3.3 p -93.17 113.6 25.88 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 115.143 -0.935 . . . . 70.31 110.546 175.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.3 mp -78.47 118.01 24.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 N-CA-C 104.781 -2.303 . . . . 74.42 104.781 173.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -53.65 -43.12 68.55 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 124.019 0.825 . . . . 52.14 112.76 -174.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 67.19 -89.71 0.17 Allowed Glycine 0 N--CA 1.451 -0.327 0 O-C-N 123.491 0.494 . . . . 71.51 112.258 176.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 7.4 t -137.2 20.06 2.97 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.3 0.571 . . . . 74.04 110.166 178.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -119.37 166.41 13.08 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.465 -0.939 . . . . 74.14 108.465 175.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.72 114.04 25.74 Favored 'General case' 0 CA--C 1.488 -1.438 0 C-N-CA 120.012 -0.675 . . . . 71.23 112.643 176.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -94.77 108.81 3.74 Favored Glycine 0 C--N 1.291 -1.928 0 N-CA-C 110.061 -1.216 . . . . 74.52 110.061 178.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 154.43 8.76 0.08 OUTLIER Glycine 0 C--N 1.295 -1.735 0 C-N-CA 119.341 -1.409 . . . . 62.22 112.703 -178.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 109.3 5.18 30.42 Favored Glycine 0 N--CA 1.431 -1.649 0 C-N-CA 119.234 -1.46 . . . . 71.2 113.585 178.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -84.29 -70.39 0.58 Allowed 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 117.614 0.707 . . . . 63.24 109.212 177.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . 0.592 ' OD1' 'CA ' ' A' ' 850' ' ' ' CA' . 13.8 m-20 -101.31 -39.56 7.54 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 108.276 -1.009 . . . . 74.23 108.276 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -139.33 160.88 38.8 Favored 'General case' 0 C--O 1.262 1.715 0 CA-C-O 121.238 0.542 . . . . 72.13 109.617 179.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.21 119.28 29.56 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 106.675 -1.602 . . . . 72.4 106.675 179.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -67.06 101.81 0.92 Allowed 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 122.979 0.512 . . . . 73.55 109.671 -178.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 556' ' ' THR . . . . . 0.428 HG21 HG21 ' A' ' 573' ' ' VAL . 12.4 t -100.78 110.75 22.87 Favored 'General case' 0 N--CA 1.413 -2.308 0 CA-C-O 122.689 1.233 . . . . 72.03 110.779 -176.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 1.7 p -133.39 96.69 3.78 Favored 'General case' 0 N--CA 1.413 -2.297 0 CA-C-N 114.234 -1.348 . . . . 74.11 108.66 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -147.03 -153.33 5.88 Favored Glycine 0 N--CA 1.408 -3.167 0 N-CA-C 110.518 -1.033 . . . . 64.4 110.518 -173.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 559' ' ' GLU . . . . . 0.41 ' HB3' HG21 ' A' ' 536' ' ' ILE . 33.3 mt-10 -133.73 124.64 27.02 Favored 'General case' 0 C--N 1.29 -2.001 0 O-C-N 123.605 0.238 . . . . 73.55 111.289 -172.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . 0.449 ' HG ' ' CD2' ' A' ' 539' ' ' TYR . 93.2 mt -80.99 133.03 35.42 Favored 'General case' 0 C--O 1.247 0.929 0 N-CA-C 109.765 -0.457 . . . . 74.1 109.765 177.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 561' ' ' GLU . . . . . 0.45 ' HG3' HD22 ' A' ' 534' ' ' ASN . 43.9 tt0 -96.78 98.19 9.94 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 115.986 -0.552 . . . . 74.32 111.475 -178.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -96.98 150.88 20.27 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 107.004 -1.48 . . . . 72.12 107.004 172.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -156.53 172.7 18.08 Favored 'General case' 0 C--N 1.28 -2.434 0 O-C-N 121.926 -0.484 . . . . 72.23 111.044 -178.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -52.14 -47.15 65.54 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 124.687 1.195 . . . . 73.25 111.012 -177.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -90.15 4.84 49.25 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 114.061 1.134 . . . . 75.21 114.061 -177.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 24.8 tp10 -121.79 126.63 49.27 Favored 'General case' 0 C--N 1.309 -1.189 0 O-C-N 121.76 -0.587 . . . . 74.41 110.555 -178.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 567' ' ' ILE . . . . . 0.434 ' HA ' ' HD3' ' A' ' 527' ' ' ARG . 4.9 pt -111.39 159.72 11.18 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.868 0 N-CA-C 109.266 -0.642 . . . . 72.33 109.266 174.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 568' ' ' VAL . . . . . 0.406 HG11 ' O ' ' A' ' 567' ' ' ILE . 1.4 p 50.14 176.28 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.57 1.748 0 C-N-CA 125.955 1.702 . . . . 73.03 111.487 -176.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 569' ' ' LYS . . . . . 0.5 ' HE3' ' HA ' ' A' ' 569' ' ' LYS . 0.0 OUTLIER -165.72 167.83 16.71 Favored 'General case' 0 C--N 1.313 -1.017 0 O-C-N 120.911 -1.118 . . . . 73.4 108.28 173.941 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 570' ' ' THR . . . . . 0.604 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 7.1 p -132.28 138.66 47.94 Favored 'General case' 0 N--CA 1.421 -1.881 0 O-C-N 123.719 0.637 . . . . 71.4 109.971 179.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 3.3 mp -90.66 117.07 33.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 106.618 -1.623 . . . . 74.23 106.618 170.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 15.7 p -95.29 110.8 22.75 Favored 'General case' 0 N--CA 1.426 -1.646 0 CA-C-O 121.059 0.457 . . . . 74.03 109.892 177.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 573' ' ' VAL . . . . . 0.428 HG21 HG21 ' A' ' 556' ' ' THR . 48.6 t -108.73 132.29 57.08 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 N-CA-C 109.113 -0.699 . . . . 61.22 109.113 -179.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 574' ' ' LYS . . . . . 0.404 ' HA ' HD12 ' A' ' 520' ' ' ILE . 22.3 tptm -86.91 119.74 27.45 Favored 'General case' 0 N--CA 1.434 -1.262 0 O-C-N 123.569 0.543 . . . . 75.14 110.463 179.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 56.3 t -89.91 132.87 33.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 106.674 -1.602 . . . . 71.11 106.674 175.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 39.5 mm -94.32 153.36 3.45 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 N-CA-C 109.16 -0.682 . . . . 65.13 109.16 -173.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -61.73 106.36 0.67 Allowed 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.582 -0.896 . . . . 72.51 108.582 172.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 578' ' ' ASP . . . . . 0.658 ' OD2' 'CA ' ' A' ' 800' ' ' ' CA' . 44.1 t0 -62.29 142.18 57.88 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 113.944 -1.48 . . . . 70.31 112.949 -169.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -80.18 -51.91 8.39 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.844 0.83 . . . . 72.21 110.052 -177.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.64 -156.27 0.69 Allowed 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.803 -0.814 . . . . 70.55 108.803 -176.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -113.51 150.28 33.15 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 105.557 -2.016 . . . . 74.15 105.557 172.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 582' ' ' GLU . . . . . 0.645 ' OE1' 'CA ' ' A' ' 800' ' ' ' CA' . 41.1 mp0 -126.68 -174.43 3.13 Favored 'General case' 0 C--N 1.282 -2.365 0 N-CA-C 108.785 -0.82 . . . . 64.23 108.785 176.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -85.64 -158.75 0.41 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 106.633 -1.617 . . . . 75.11 106.633 174.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -85.63 79.81 9.23 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 106.437 -1.69 . . . . 74.1 106.437 173.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.55 168.03 12.92 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 115.411 -0.813 . . . . 74.23 110.131 -172.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 5.0 t -155.29 149.92 26.33 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-O 121.742 0.782 . . . . 74.24 112.873 -173.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -126.55 148.68 49.71 Favored 'General case' 0 N--CA 1.412 -2.33 0 CA-C-N 112.894 -1.957 . . . . 74.21 108.167 174.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 588' ' ' PHE . . . . . 0.505 ' HA ' ' O ' ' A' ' 642' ' ' LEU . 28.3 m-85 -105.61 129.74 53.79 Favored 'General case' 0 C--N 1.292 -1.935 0 N-CA-C 109.177 -0.675 . . . . 74.41 109.177 -175.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.83 121.09 39.34 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 106.034 -1.839 . . . . 75.54 106.034 176.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -125.34 129.89 50.86 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 109.712 -0.477 . . . . 72.24 109.712 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 591' ' ' ILE . . . . . 0.406 HG21 ' HB3' ' A' ' 539' ' ' TYR . 22.8 pt -98.44 138.4 23.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 107.229 -1.397 . . . . 73.51 107.229 174.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -91.06 -144.95 13.29 Favored Glycine 0 N--CA 1.431 -1.642 0 C-N-CA 121.0 -0.619 . . . . 71.32 112.897 -176.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -83.33 119.28 73.73 Favored Pre-proline 0 C--N 1.301 -1.516 0 N-CA-C 109.451 -0.574 . . . . 73.12 109.451 -178.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 594' ' ' PRO . . . . . 0.49 ' HB3' HG21 ' A' ' 537' ' ' VAL . 30.2 Cg_endo -67.15 152.7 79.36 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 121.966 1.777 . . . . 73.54 111.016 176.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -137.21 133.42 35.12 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 110.051 -0.351 . . . . 74.42 110.051 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.01 130.91 36.04 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 106.643 -1.614 . . . . 63.34 106.643 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 16.8 t -91.2 16.97 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 CA-C-O 122.071 0.939 . . . . 74.25 109.954 -177.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -78.15 85.7 4.32 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-O 122.857 1.313 . . . . 71.25 110.626 176.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 83.0 mmm -99.39 82.36 2.66 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 114.644 -1.162 . . . . 71.5 108.624 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 25.8 t -93.73 -33.94 13.42 Favored 'General case' 0 N--CA 1.417 -2.116 0 CA-C-N 114.029 -1.441 . . . . 73.32 108.619 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 59.38 92.59 0.04 OUTLIER 'General case' 0 C--O 1.242 0.682 0 C-N-CA 124.363 1.065 . . . . 71.11 108.76 -176.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -99.79 147.93 24.95 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 115.072 -0.967 . . . . 74.51 112.863 -168.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 1.7 tmmm? -132.99 75.56 1.63 Allowed 'General case' 0 N--CA 1.423 -1.79 0 N-CA-C 106.104 -1.813 . . . . 75.53 106.104 175.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -86.26 -26.95 32.0 Favored Glycine 0 CA--C 1.491 -1.415 0 N-CA-C 109.227 -1.549 . . . . 75.11 109.227 178.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 176.68 178.66 46.62 Favored Glycine 0 N--CA 1.412 -2.946 0 N-CA-C 107.267 -2.333 . . . . 63.31 107.267 178.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -93.96 85.46 4.76 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 107.734 -1.21 . . . . 72.43 107.734 177.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 28.9 p -78.52 121.99 25.3 Favored 'General case' 0 N--CA 1.418 -2.066 0 CA-C-N 114.603 -1.18 . . . . 71.4 111.962 -174.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 57.3 mt -89.02 96.4 6.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 106.078 -1.823 . . . . 73.44 106.078 175.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 12.8 t -156.16 146.92 21.95 Favored 'General case' 0 C--N 1.286 -2.186 0 CA-C-N 115.536 -0.756 . . . . 75.44 109.802 -173.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -93.57 93.25 7.97 Favored 'General case' 0 N--CA 1.418 -2.046 0 CA-C-N 115.567 -0.742 . . . . 71.1 109.072 174.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -131.53 67.25 1.52 Allowed 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 105.92 -1.882 . . . . 71.41 105.92 172.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -107.35 134.92 49.7 Favored 'General case' 0 N--CA 1.404 -2.759 0 CA-C-N 113.904 -1.498 . . . . 74.25 108.857 -174.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -72.91 90.03 1.44 Allowed 'General case' 0 CA--C 1.498 -1.041 0 CA-C-O 121.666 0.746 . . . . 64.24 109.088 175.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -85.47 101.98 13.09 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 107.909 -1.145 . . . . 74.23 107.909 176.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -74.87 83.2 2.18 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 122.526 1.155 . . . . 75.23 112.837 -173.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -135.21 166.87 25.7 Favored Pre-proline 0 C--N 1.296 -1.747 0 CA-C-N 113.026 -1.897 . . . . 74.32 106.912 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -62.4 167.74 10.78 Favored 'Trans proline' 0 C--O 1.253 1.263 0 C-N-CA 121.418 1.412 . . . . 71.52 109.824 172.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -67.27 99.55 0.72 Allowed 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.809 0.814 . . . . 74.21 111.457 -175.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 5.6 p -140.72 145.86 37.03 Favored 'General case' 0 N--CA 1.42 -1.962 0 CA-C-N 114.074 -1.421 . . . . 71.33 107.686 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 5.7 p -107.48 -20.96 13.09 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-O 120.599 0.238 . . . . 75.01 110.38 177.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm 62.99 11.43 5.11 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.307 1.043 . . . . 74.51 111.339 175.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 68.6 -3.82 1.29 Allowed 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 124.96 1.304 . . . . 75.33 111.007 -174.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -76.54 128.38 34.65 Favored 'General case' 0 N--CA 1.432 -1.342 0 C-N-CA 124.278 1.031 . . . . 73.05 109.087 -175.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -69.63 -33.4 72.58 Favored 'General case' 0 C--O 1.201 -1.495 0 C-N-CA 120.246 -0.581 . . . . 75.32 110.263 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 16.2 mp0 -56.94 -40.42 76.38 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 123.383 0.427 . . . . 73.41 110.954 178.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . 0.642 ' O ' ' HG2' ' A' ' 630' ' ' GLU . 11.4 tpt180 -70.75 -47.04 61.74 Favored 'General case' 0 C--O 1.204 -1.293 0 N-CA-C 108.705 -0.85 . . . . 75.01 108.705 176.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 627' ' ' ARG . . . . . . . . . . . . . 70.4 mtm180 -59.67 -39.6 85.0 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 113.103 0.779 . . . . 73.41 113.103 -177.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . 0.401 ' O ' ' HG2' ' A' ' 631' ' ' MET . 96.8 mt -64.74 -36.04 76.54 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 CA-C-O 121.301 0.572 . . . . 73.01 110.015 177.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -69.52 -39.21 77.66 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.842 -0.617 . . . . 75.44 109.995 177.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 630' ' ' GLU . . . . . 0.642 ' HG2' ' O ' ' A' ' 626' ' ' ARG . 3.7 mm-40 -72.88 -1.14 15.65 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 112.527 0.566 . . . . 74.25 112.527 -176.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 631' ' ' MET . . . . . 0.401 ' HG2' ' O ' ' A' ' 628' ' ' ILE . 26.1 ptt? -102.58 -13.23 17.25 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 119.838 -0.745 . . . . 73.02 110.539 173.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -100.12 -27.87 7.56 Favored Glycine 0 C--N 1.319 -0.388 0 N-CA-C 108.844 -1.703 . . . . 75.43 108.844 174.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 15.2 mtp85 -98.72 139.91 21.41 Favored Pre-proline 0 C--N 1.297 -1.717 0 C-N-CA 124.968 1.307 . . . . 71.32 108.412 176.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.489 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 51.0 Cg_endo -73.08 139.58 29.93 Favored 'Trans proline' 0 N--CA 1.441 -1.578 0 C-N-CA 121.545 1.497 . . . . 75.21 110.697 176.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.4 pp -126.68 -175.96 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 111.904 0.335 . . . . 72.13 111.904 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -77.61 178.29 7.41 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.228 0.537 . . . . 75.32 111.29 -174.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -96.58 -85.18 1.74 Allowed Glycine 0 N--CA 1.421 -2.343 0 C-N-CA 120.554 -0.831 . . . . 51.23 111.606 178.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -127.53 -66.78 0.86 Allowed 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 115.509 -0.346 . . . . 72.31 110.08 -175.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 13.3 p80 -123.14 119.05 29.11 Favored 'General case' 0 C--O 1.246 0.9 0 CA-C-O 121.627 0.727 . . . . 61.03 111.51 -177.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 6.3 p -109.12 90.98 3.46 Favored 'General case' 0 N--CA 1.412 -2.356 0 CA-C-N 115.145 -0.934 . . . . 73.32 108.747 175.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -177.49 132.1 0.16 Allowed 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 106.49 -1.67 . . . . 74.04 106.49 -176.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 642' ' ' LEU . . . . . 0.508 HD23 HG21 ' A' ' 523' ' ' VAL . 41.8 tp -138.24 111.83 8.2 Favored 'General case' 0 C--N 1.29 -2.007 0 O-C-N 123.705 0.628 . . . . 74.24 109.61 177.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . 0.414 ' HB3' HG23 ' A' ' 511' ' ' VAL . 35.7 tt0 -90.74 104.01 16.64 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 107.392 -1.336 . . . . 75.31 107.392 177.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 644' ' ' VAL . . . . . 0.432 HG13 ' HE3' ' A' ' 521' ' ' MET . 39.8 t -95.01 110.07 23.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.804 -0.813 . . . . 71.01 108.804 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 3.9 mp -91.82 117.74 35.76 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 N-CA-C 108.013 -1.106 . . . . 64.11 108.013 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 646' ' ' ILE . . . . . 0.451 HD11 ' N ' ' A' ' 646' ' ' ILE . 1.5 mp -107.13 109.54 28.53 Favored 'Isoleucine or valine' 0 CA--C 1.473 -2.018 0 N-CA-C 106.115 -1.809 . . . . 62.42 106.115 -176.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -111.33 150.35 29.83 Favored 'General case' 0 C--N 1.249 -3.787 0 C-N-CA 120.417 -0.513 . . . . 73.55 111.401 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -63.3 133.9 54.92 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 105.552 -2.018 . . . . 72.52 105.552 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 8.2 t -60.98 107.46 0.72 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.827 0.822 . . . . 74.4 112.05 -169.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -132.87 -60.63 0.86 Allowed 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 114.579 -1.191 . . . . 74.3 110.158 -178.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 179.96 160.22 0.85 Allowed 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 106.255 -1.758 . . . . 73.2 106.255 -176.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -130.0 104.77 7.55 Favored 'General case' 0 N--CA 1.409 -2.483 0 CA-C-O 121.279 0.561 . . . . 74.1 111.714 -173.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -111.22 117.48 33.3 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.376 -1.342 . . . . 74.22 107.376 175.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 30.4 t -71.36 113.56 8.53 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.35 0.595 . . . . 74.32 112.068 -173.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 9.0 t -143.28 79.29 1.63 Allowed 'General case' 0 N--CA 1.417 -2.117 0 CA-C-O 122.921 1.343 . . . . 74.14 107.848 174.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 6.5 p -83.52 110.48 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.244 0 CA-C-N 114.505 -1.225 . . . . 75.25 111.318 -176.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 16.5 t70 . . . . . 0 C--N 1.303 -1.444 0 CA-C-N 115.151 -0.931 . . . . 73.11 111.009 -179.344 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 800' ' ' ' CA' . . . . . 0.658 'CA ' ' OD2' ' A' ' 578' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 850' ' ' ' CA' . . . . . 0.625 'CA ' ' OD1' ' A' ' 578' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 . . . . . 0 N--CA 1.443 -0.782 0 N-CA-C 108.972 -0.751 . . . . 74.43 108.972 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . 0.42 ' HB1' ' HA ' ' A' ' 634' ' ' PRO . . . -130.62 -52.13 1.07 Allowed 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 107.606 -1.257 . . . . 73.12 107.606 174.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . 0.497 ' HA2' ' OG1' ' A' ' 528' ' ' THR . . . -147.83 146.17 15.56 Favored Glycine 0 N--CA 1.398 -3.838 0 CA-C-N 114.311 -1.313 . . . . 64.22 110.938 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 2.9 mp -123.58 105.81 16.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 108.096 -1.076 . . . . 75.42 108.096 -178.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . 0.415 ' CE1' ' HB ' ' A' ' 528' ' ' THR . 93.1 m-85 -114.9 121.49 43.37 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.178 0.513 . . . . 75.1 110.59 178.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 13.8 t -147.21 163.01 37.71 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.022 -1.103 . . . . 74.03 108.022 -177.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -85.61 148.32 25.97 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 120.844 0.354 . . . . 75.3 110.961 176.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -84.44 -20.5 31.68 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 107.264 -1.384 . . . . 75.04 107.264 176.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . 0.409 ' HG3' ' O ' ' A' ' 511' ' ' VAL . 1.9 tp10 -129.01 120.58 20.34 Favored Pre-proline 0 N--CA 1.431 -1.389 0 CA-C-N 114.734 -1.121 . . . . 63.43 108.169 -178.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -80.38 -24.3 5.51 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 120.908 1.072 . . . . 75.54 110.147 173.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . 0.417 HG22 ' HB3' ' A' ' 643' ' ' GLU . 76.4 t -142.93 129.02 17.13 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 C-N-CA 124.561 1.145 . . . . 75.02 108.722 -178.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 14.6 t -128.2 142.94 51.03 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 108.284 -1.006 . . . . 74.14 108.284 177.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 52.6 m80 -108.42 120.85 43.6 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.861 -0.792 . . . . 74.04 108.861 175.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 23.1 m -118.13 150.15 20.36 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.394 0 N-CA-C 107.919 -1.141 . . . . 74.24 107.919 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 2.7 t -83.95 152.71 24.33 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 108.74 -0.837 . . . . 74.34 108.74 -178.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . 0.659 ' OE2' 'CA ' ' A' ' 800' ' ' ' CA' . 38.8 tt0 -70.33 -21.08 62.95 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 120.934 0.397 . . . . 73.03 110.928 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 45.2 m -90.35 12.21 19.04 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-O 121.226 0.536 . . . . 74.41 110.709 -175.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 12.7 tt -86.57 153.46 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.877 0 N-CA-C 108.871 -0.788 . . . . 74.41 108.871 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -90.98 -63.92 1.2 Allowed Glycine 0 N--CA 1.432 -1.596 0 C-N-CA 119.959 -1.115 . . . . 71.24 110.568 178.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 37.1 mm -120.25 121.44 65.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 107.905 -1.146 . . . . 72.41 107.905 178.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 521' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.92 136.37 35.32 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 106.907 -1.516 . . . . 73.32 106.907 174.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 522' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 48.9 mt-10 -124.41 138.26 54.38 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 124.093 0.871 . . . . 71.11 109.949 -178.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . 0.594 ' O ' ' HA ' ' A' ' 570' ' ' THR . 39.7 t -129.23 140.87 48.06 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 N-CA-C 109.055 -0.72 . . . . 74.15 109.055 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . 0.553 ' HD2' ' CG2' ' A' ' 568' ' ' VAL . 34.1 mmtp -85.34 134.35 34.1 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 122.243 1.02 . . . . 75.51 113.18 -178.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 4.2 t -110.57 146.94 15.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-N 113.926 -1.488 . . . . 65.2 107.349 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -87.3 135.58 33.26 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 109.567 -0.531 . . . . 75.41 109.567 177.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . 0.516 ' HD3' ' HA ' ' A' ' 567' ' ' ILE . 39.2 ttp180 -83.27 150.38 26.2 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-N 115.6 -0.727 . . . . 75.21 110.468 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 528' ' ' THR . . . . . 0.497 ' OG1' ' HA2' ' A' ' 503' ' ' GLY . 1.8 t -50.12 147.36 4.15 Favored 'General case' 0 N--CA 1.435 -1.198 0 C-N-CA 125.866 1.667 . . . . 73.42 113.2 174.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 19.2 m -65.07 -38.05 89.53 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 114.4 -1.273 . . . . 71.41 110.035 176.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -107.45 103.24 1.92 Allowed Glycine 0 N--CA 1.419 -2.451 0 N-CA-C 108.994 -1.642 . . . . 63.12 108.994 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -122.13 65.76 0.92 Allowed 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.046 0.45 . . . . 71.43 111.281 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -117.1 90.76 3.4 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.101 -1.444 . . . . 74.21 107.101 175.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 142.4 -138.31 8.38 Favored Glycine 0 N--CA 1.419 -2.464 0 N-CA-C 110.153 -1.179 . . . . 74.41 110.153 -175.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 534' ' ' ASN . . . . . 0.428 HD22 ' HG3' ' A' ' 561' ' ' GLU . 2.8 t-20 -146.14 131.34 18.42 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.841 -1.17 . . . . 75.53 107.841 -178.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 59.2 t -131.01 132.7 63.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.156 -0.683 . . . . 75.21 109.156 -177.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 536' ' ' ILE . . . . . . . . . . . . . 44.0 mm -105.35 131.04 55.64 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 109.665 -0.495 . . . . 64.32 109.665 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . 0.421 HG21 ' HB3' ' A' ' 594' ' ' PRO . 20.1 t -118.12 102.36 50.83 Favored Pre-proline 0 C--N 1.311 -1.089 0 O-C-N 123.307 0.38 . . . . 74.11 110.09 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -73.78 138.64 26.56 Favored 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 122.372 2.048 . . . . 72.32 111.604 178.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 539' ' ' TYR . . . . . 0.418 ' CE2' HG21 ' A' ' 571' ' ' ILE . 51.5 p90 -142.72 160.6 40.0 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 110.353 -0.24 . . . . 74.11 110.353 -177.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.67 160.03 41.14 Favored 'General case' 0 C--O 1.247 0.938 0 O-C-N 123.595 0.56 . . . . 72.12 111.432 176.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 31.6 p -96.67 127.03 42.26 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.665 -0.698 . . . . 71.53 111.495 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.8 mp -93.72 111.52 25.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 106.142 -1.799 . . . . 74.41 106.142 172.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -51.88 -53.34 41.85 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 124.348 1.059 . . . . 70.54 111.693 -176.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 68.95 -98.06 0.53 Allowed Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 121.1 -0.571 . . . . 72.33 111.969 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 8.8 t -111.29 -1.91 15.88 Favored 'General case' 0 CA--C 1.553 1.058 0 CA-C-O 121.969 0.89 . . . . 73.31 109.589 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -93.8 171.12 9.07 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 108.067 -1.086 . . . . 73.25 108.067 174.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -126.67 121.55 32.44 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.009 -0.737 . . . . 75.54 109.009 -176.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -79.53 -164.58 28.85 Favored Glycine 0 CA--C 1.518 0.223 0 CA-C-N 116.234 -0.439 . . . . 75.24 112.892 -177.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 77.58 15.95 80.79 Favored Glycine 0 C--N 1.307 -1.058 0 N-CA-C 112.372 -0.291 . . . . 70.42 112.372 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 69.97 32.9 69.77 Favored Glycine 0 N--CA 1.431 -1.671 0 N-CA-C 110.5 -1.04 . . . . 74.12 110.5 -176.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -96.81 -64.58 1.03 Allowed 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 109.025 -0.731 . . . . 73.23 109.025 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . 0.636 ' OD2' 'CA ' ' A' ' 850' ' ' ' CA' . 12.2 t70 -102.6 -36.62 8.28 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 106.807 -1.553 . . . . 74.11 106.807 177.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 553' ' ' PHE . . . . . 0.419 ' HA ' HG12 ' A' ' 576' ' ' ILE . 11.7 p90 -146.59 163.68 35.03 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 114.735 -1.121 . . . . 74.14 108.565 174.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -91.79 105.43 17.71 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 107.022 -1.473 . . . . 71.22 107.022 177.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -71.19 139.38 50.14 Favored 'General case' 0 CA--C 1.486 -1.488 0 N-CA-C 108.343 -0.984 . . . . 75.01 108.343 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 11.0 t -138.16 138.43 38.61 Favored 'General case' 0 N--CA 1.396 -3.149 0 C-N-CA 118.842 -1.143 . . . . 74.33 111.989 -175.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 23.2 p -131.04 119.75 22.45 Favored 'General case' 0 N--CA 1.415 -2.216 0 N-CA-C 106.255 -1.757 . . . . 61.04 106.255 173.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -147.83 -170.67 16.1 Favored Glycine 0 N--CA 1.41 -3.057 0 C-N-CA 120.136 -1.031 . . . . 70.45 111.236 -172.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -139.09 106.6 5.57 Favored 'General case' 0 C--N 1.293 -1.885 0 C-N-CA 122.75 0.42 . . . . 73.43 109.869 -175.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 91.3 mt -73.71 136.79 43.75 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-N 116.043 -0.526 . . . . 72.43 110.198 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 561' ' ' GLU . . . . . 0.428 ' HG3' HD22 ' A' ' 534' ' ' ASN . 44.6 tt0 -105.62 114.71 29.04 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 116.102 -0.499 . . . . 71.31 111.235 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -111.17 148.74 32.1 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.656 -0.868 . . . . 75.43 108.656 174.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . 0.407 ' H ' ' HB3' ' A' ' 566' ' ' GLU . 4.2 pt20 -159.51 -178.16 6.92 Favored 'General case' 0 C--N 1.285 -2.225 0 N-CA-C 108.713 -0.847 . . . . 75.11 108.713 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -69.08 -29.98 68.2 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 121.712 0.768 . . . . 51.14 110.728 -178.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -82.74 -0.98 50.13 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.749 0.785 . . . . 73.54 110.798 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . 0.407 ' HB3' ' H ' ' A' ' 563' ' ' GLN . 8.2 tp10 -120.74 142.66 49.33 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.704 -0.623 . . . . 74.12 110.542 -175.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 567' ' ' ILE . . . . . 0.516 ' HA ' ' HD3' ' A' ' 527' ' ' ARG . 2.4 pt -133.58 150.78 32.31 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.273 0 N-CA-C 106.035 -1.839 . . . . 75.03 106.035 170.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 568' ' ' VAL . . . . . 0.553 ' CG2' ' HD2' ' A' ' 524' ' ' LYS . 1.2 p 49.77 -177.71 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.59 2.497 0 C-N-CA 124.7 1.2 . . . . 75.33 111.78 -175.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 569' ' ' LYS . . . . . 0.526 ' HE3' ' HA ' ' A' ' 569' ' ' LYS . 0.2 OUTLIER -173.94 164.55 4.21 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 107.979 -1.119 . . . . 75.23 107.979 176.032 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 570' ' ' THR . . . . . 0.594 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 36.3 p -127.1 142.85 51.42 Favored 'General case' 0 N--CA 1.436 -1.174 0 O-C-N 123.477 0.486 . . . . 70.34 110.907 177.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 571' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 2.5 mp -91.78 122.48 43.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 N-CA-C 105.849 -1.908 . . . . 73.44 105.849 170.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 9.7 m -97.25 109.86 22.53 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 109.966 -0.383 . . . . 53.23 109.966 -179.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 573' ' ' VAL . . . . . . . . . . . . . 62.2 t -120.94 130.85 74.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 109.305 -0.628 . . . . 74.3 109.305 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -91.36 132.25 36.31 Favored 'General case' 0 C--N 1.312 -1.052 0 O-C-N 123.509 0.506 . . . . 71.43 111.064 179.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 64.0 t -97.66 137.99 23.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 108.063 -1.088 . . . . 72.31 108.063 177.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 576' ' ' ILE . . . . . 0.419 HG12 ' HA ' ' A' ' 553' ' ' PHE . 30.4 mm -103.11 160.49 4.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 107.369 -1.345 . . . . 72.34 107.369 -177.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -69.99 133.69 47.52 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 109.502 -0.555 . . . . 74.33 109.502 177.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 578' ' ' ASP . . . . . 0.602 ' OD1' 'CA ' ' A' ' 850' ' ' ' CA' . 0.8 OUTLIER -66.33 137.84 57.2 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.352 0.596 . . . . 71.03 111.033 -174.355 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.78 -35.89 3.8 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 115.925 1.824 . . . . 75.0 115.925 -171.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 580' ' ' GLU . . . . . 0.495 ' HG2' ' CD2' ' A' ' 581' ' ' TYR . 0.0 OUTLIER -93.63 -60.38 1.78 Allowed 'General case' 0 C--N 1.313 -1.01 0 O-C-N 121.482 -0.761 . . . . 75.21 112.75 -170.52 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 581' ' ' TYR . . . . . 0.495 ' CD2' ' HG2' ' A' ' 580' ' ' GLU . 31.4 p90 -164.38 153.97 13.9 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 106.561 -1.644 . . . . 72.13 106.561 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 582' ' ' GLU . . . . . 0.641 ' OE1' 'CA ' ' A' ' 800' ' ' ' CA' . 43.1 mm-40 -89.87 143.81 26.48 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 119.618 -0.833 . . . . 73.34 112.218 -177.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -169.74 168.8 8.81 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 107.472 -1.307 . . . . 74.51 107.472 175.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -88.39 78.47 7.93 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 107.988 -1.115 . . . . 74.42 107.988 174.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.02 166.66 22.09 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 108.243 -1.021 . . . . 72.34 108.243 -177.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 6.9 t -154.06 144.36 22.16 Favored 'General case' 0 N--CA 1.415 -2.213 0 C-N-CA 120.258 -0.577 . . . . 73.43 111.178 -173.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 587' ' ' PHE . . . . . 0.452 ' CE2' HD12 ' A' ' 646' ' ' ILE . 3.6 p90 -126.02 148.54 49.28 Favored 'General case' 0 N--CA 1.418 -2.072 0 CA-C-N 113.799 -1.546 . . . . 73.2 109.407 176.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 588' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -104.77 130.99 52.77 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 108.791 -0.818 . . . . 70.33 108.791 -174.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . 0.452 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.4 OUTLIER -99.83 124.98 45.69 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 106.308 -1.738 . . . . 75.43 106.308 176.922 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -124.44 132.12 53.5 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-O 121.013 0.435 . . . . 75.42 110.11 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 591' ' ' ILE . . . . . . . . . . . . . 24.8 pt -101.33 143.86 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.085 0 N-CA-C 107.224 -1.398 . . . . 75.12 107.224 174.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -89.41 -148.84 19.69 Favored Glycine 0 C--N 1.292 -1.905 0 N-CA-C 110.47 -1.052 . . . . 55.51 110.47 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.424 ' CD ' HH21 ' A' ' 633' ' ' ARG . 23.4 tt0 -82.09 128.49 67.83 Favored Pre-proline 0 C--N 1.29 -2.013 0 N-CA-C 108.997 -0.742 . . . . 64.11 108.997 177.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 594' ' ' PRO . . . . . 0.421 ' HB3' HG21 ' A' ' 537' ' ' VAL . 55.0 Cg_endo -71.55 146.36 49.33 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 121.965 1.777 . . . . 74.14 109.944 173.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 16.0 ptt-85 -126.93 138.19 53.25 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.593 -0.692 . . . . 74.11 110.003 -175.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -81.8 129.15 34.64 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 106.938 -1.505 . . . . 73.34 106.938 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 89.6 t -75.58 -27.67 19.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-O 121.245 0.545 . . . . 62.23 110.073 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -128.72 95.95 4.25 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 122.061 0.934 . . . . 74.32 111.453 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.41 7.47 5.86 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.579 -0.737 . . . . 63.43 112.182 -177.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 16.6 m -91.99 132.57 36.43 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 120.676 -0.41 . . . . 73.31 111.639 -175.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 58.02 77.07 0.3 Allowed 'General case' 0 C--O 1.237 0.434 0 C-N-CA 125.196 1.398 . . . . 74.11 114.491 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 48.3 pttt -99.51 173.57 6.68 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.259 -1.385 . . . . 72.35 107.259 172.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 603' ' ' LYS . . . . . 0.517 ' HZ1' ' HB3' ' A' ' 603' ' ' LYS . 0.5 OUTLIER -92.06 103.35 15.87 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.547 0.689 . . . . 73.42 110.143 175.648 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 134.8 146.84 5.45 Favored Glycine 0 N--CA 1.435 -1.427 0 N-CA-C 110.216 -1.154 . . . . 74.21 110.216 -177.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . -144.09 98.31 0.2 Allowed Glycine 0 N--CA 1.431 -1.685 0 C-N-CA 120.03 -1.081 . . . . 72.31 112.734 -177.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -104.74 173.4 6.32 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.525 -0.917 . . . . 75.4 108.525 176.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 10.5 p -72.52 110.95 7.27 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 121.892 0.853 . . . . 73.21 113.221 -176.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 7.5 mt -80.06 166.81 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.565 0 N-CA-C 106.612 -1.625 . . . . 74.22 106.612 177.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 7.3 t -93.08 10.04 33.25 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-O 122.006 0.908 . . . . 71.32 109.804 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 60.11 -1.99 0.17 Allowed 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 116.005 1.854 . . . . 71.54 116.005 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -75.7 90.31 2.84 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 106.055 -1.832 . . . . 75.44 106.055 171.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -101.09 129.9 47.05 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 115.268 -0.878 . . . . 74.21 109.351 -174.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 11.9 t70 74.87 -55.02 0.66 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.823 1.249 . . . . 72.12 112.71 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -45.88 114.14 0.73 Allowed 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 125.392 1.477 . . . . 75.42 113.415 -176.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 22.5 pttm -85.13 97.78 10.08 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 114.605 -1.179 . . . . 70.22 111.518 -178.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -104.82 167.81 9.35 Favored Pre-proline 0 C--N 1.291 -1.971 0 CA-C-N 115.52 -0.764 . . . . 63.33 110.245 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -67.49 172.21 10.66 Favored 'Trans proline' 0 C--O 1.255 1.366 0 C-N-CA 121.748 1.632 . . . . 73.22 110.868 174.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -70.7 104.43 2.85 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.641 0.734 . . . . 74.42 110.462 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -106.94 6.58 29.33 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 114.403 -1.271 . . . . 71.21 113.308 -173.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 1.7 p -82.56 108.53 16.02 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 121.453 0.644 . . . . 64.45 111.782 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 621' ' ' LYS . . . . . 0.464 ' HB2' ' HZ1' ' A' ' 621' ' ' LYS . 5.1 ttmp? -136.9 -62.85 0.63 Allowed 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 115.448 -0.796 . . . . 65.4 108.885 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -113.73 -35.22 5.24 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.128 -0.487 . . . . 75.02 111.76 -179.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . 0.519 ' HG3' ' H ' ' A' ' 626' ' ' ARG . 9.2 tp10 -65.38 126.18 27.43 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 120.888 0.375 . . . . 74.42 110.178 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -92.24 -24.41 19.02 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.543 -0.54 . . . . 73.11 109.543 -179.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -56.77 -44.12 81.48 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.834 0.825 . . . . 73.2 108.937 177.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . 0.611 ' O ' ' HG3' ' A' ' 630' ' ' GLU . 14.4 tpt180 -59.87 -48.27 82.35 Favored 'General case' 0 C--O 1.209 -1.032 0 CA-C-N 114.604 -1.18 . . . . 65.55 109.542 175.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 627' ' ' ARG . . . . . 0.406 ' HA ' ' OE1' ' A' ' 630' ' ' GLU . 64.7 mtm180 -64.31 -34.39 78.02 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 113.073 0.768 . . . . 74.33 113.073 -176.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . 0.667 ' O ' ' HG2' ' A' ' 631' ' ' MET . 98.0 mt -69.25 -38.98 78.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 109.42 -0.585 . . . . 72.45 109.42 175.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -68.85 -18.39 64.14 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.169 0.509 . . . . 74.53 110.594 176.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 630' ' ' GLU . . . . . 0.611 ' HG3' ' O ' ' A' ' 626' ' ' ARG . 77.6 mt-10 -82.19 9.79 8.03 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.905 -0.589 . . . . 74.02 111.288 178.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 631' ' ' MET . . . . . 0.667 ' HG2' ' O ' ' A' ' 628' ' ' ILE . 20.8 ptp -82.31 -22.39 35.64 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 106.729 -1.582 . . . . 75.54 106.729 167.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -100.87 -43.74 2.2 Favored Glycine 0 N--CA 1.44 -1.067 0 CA-C-N 115.099 -0.955 . . . . 73.14 110.86 177.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 633' ' ' ARG . . . . . 0.424 HH21 ' CD ' ' A' ' 593' ' ' GLU . 20.7 mtp180 -87.29 120.95 71.51 Favored Pre-proline 0 C--N 1.32 -0.694 0 N-CA-C 109.81 -0.441 . . . . 74.55 109.81 178.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.42 ' HA ' ' HB1' ' A' ' 502' ' ' ALA . 36.7 Cg_endo -68.42 147.47 71.37 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.268 1.979 . . . . 74.32 110.475 177.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 635' ' ' ILE . . . . . 0.421 HG22 ' OE2' ' A' ' 630' ' ' GLU . 2.3 pp -135.1 -175.06 1.26 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.753 0 N-CA-C 114.623 1.342 . . . . 71.42 114.623 -173.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -78.01 154.87 31.08 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.195 -0.911 . . . . 71.34 110.641 -177.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -96.48 -107.74 2.41 Favored Glycine 0 C--N 1.297 -1.621 0 C-N-CA 120.664 -0.779 . . . . 73.02 112.685 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -89.53 -65.4 1.02 Allowed 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 121.494 0.664 . . . . 73.11 110.953 -176.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -133.81 116.51 15.78 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 115.381 -0.827 . . . . 71.32 111.645 -174.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 22.1 p -104.42 90.89 3.68 Favored 'General case' 0 N--CA 1.396 -3.161 0 N-CA-C 107.887 -1.153 . . . . 73.22 107.887 175.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 21.5 tptm -175.71 135.36 0.3 Allowed 'General case' 0 N--CA 1.425 -1.701 0 CA-C-N 113.758 -1.564 . . . . 73.44 107.204 -175.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 642' ' ' LEU . . . . . 0.511 HD23 HG21 ' A' ' 523' ' ' VAL . 41.5 tp -138.22 110.1 7.19 Favored 'General case' 0 C--N 1.276 -2.606 0 N-CA-C 107.611 -1.255 . . . . 63.42 107.611 173.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . 0.417 ' HB3' HG22 ' A' ' 511' ' ' VAL . 21.4 tt0 -93.59 106.98 18.9 Favored 'General case' 0 C--N 1.275 -2.644 0 N-CA-C 107.475 -1.306 . . . . 72.25 107.475 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 25.6 t -96.81 105.6 17.33 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 109.346 -0.613 . . . . 72.31 109.346 -176.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 3.5 mp -91.54 120.42 40.56 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 107.521 -1.289 . . . . 75.1 107.521 176.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 646' ' ' ILE . . . . . 0.492 HD11 ' N ' ' A' ' 646' ' ' ILE . 2.7 mp -97.74 109.28 23.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 105.928 -1.879 . . . . 73.23 105.928 -177.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -93.3 148.49 22.0 Favored 'General case' 0 N--CA 1.399 -3.007 0 CA-C-N 115.518 -0.764 . . . . 75.21 110.889 -174.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -73.0 69.46 0.98 Allowed 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 124.416 1.086 . . . . 74.02 110.993 -178.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 14.4 m 28.14 74.46 0.04 OUTLIER 'General case' 0 C--O 1.243 0.755 0 C-N-CA 128.422 2.689 . . . . 74.53 115.525 177.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -128.75 -63.33 0.98 Allowed 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.37 -0.832 . . . . 74.12 111.609 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -159.9 -174.25 4.49 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 121.625 0.726 . . . . 75.14 111.945 -175.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -132.96 101.9 5.41 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 115.009 -0.996 . . . . 75.3 110.287 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -140.47 113.38 8.26 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 114.428 -1.26 . . . . 71.34 108.098 175.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 48.8 m -108.0 110.69 22.46 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 120.97 0.414 . . . . 63.24 111.517 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 25.3 m -83.87 102.2 12.21 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 108.881 -0.785 . . . . 74.45 108.881 176.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 21.1 m -131.25 -174.76 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 C-N-CA 123.151 0.58 . . . . 74.22 109.481 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 . . . . . 0 C--N 1.311 -1.076 0 N-CA-C 110.462 -0.199 . . . . 63.44 110.462 179.652 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 800' ' ' ' CA' . . . . . 0.659 'CA ' ' OE2' ' A' ' 516' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 850' ' ' ' CA' . . . . . 0.636 'CA ' ' OD2' ' A' ' 552' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . 0.618 ' HA ' ' O ' ' A' ' 631' ' ' MET . 15.5 t-160 . . . . . 0 N--CA 1.448 -0.561 0 N-CA-C 109.017 -0.735 . . . . 73.51 109.017 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -80.69 -52.49 7.49 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 109.321 -0.622 . . . . 72.15 109.321 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . 0.682 ' HA3' ' OG1' ' A' ' 528' ' ' THR . . . 140.35 -167.99 25.3 Favored Glycine 0 N--CA 1.412 -2.921 0 C-N-CA 118.18 -1.962 . . . . 72.04 116.751 170.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . 0.477 HG23 ' CA ' ' A' ' 637' ' ' GLY . 3.5 mp -111.35 136.25 48.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 125.521 1.529 . . . . 75.22 111.471 -168.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -132.6 123.58 26.7 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.898 -0.779 . . . . 72.52 108.898 170.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 506' ' ' THR . . . . . 0.417 ' HB ' ' HA3' ' A' ' 637' ' ' GLY . 14.7 t -150.52 163.15 39.15 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.233 -0.654 . . . . 74.54 109.233 -176.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -84.35 159.74 20.81 Favored 'General case' 0 CA--C 1.495 -1.145 0 N-CA-C 108.486 -0.931 . . . . 75.33 108.486 173.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -81.34 -44.29 17.83 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.385 -0.968 . . . . 72.15 108.385 176.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . 0.545 ' HB3' ' O ' ' A' ' 655' ' ' THR . 10.6 pt-20 -124.93 137.06 28.9 Favored Pre-proline 0 C--N 1.313 -0.993 0 N-CA-C 109.076 -0.713 . . . . 75.2 109.076 177.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . 0.525 ' HA ' ' O ' ' A' ' 641' ' ' LYS . 94.6 Cg_endo -90.66 -6.72 4.19 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.0 1.8 . . . . 75.2 112.734 178.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 74.3 t -143.04 132.99 21.9 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.318 0 N-CA-C 107.02 -1.474 . . . . 74.33 107.02 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 4.1 t -141.42 143.63 34.02 Favored 'General case' 0 N--CA 1.411 -2.4 0 N-CA-C 106.697 -1.594 . . . . 75.15 106.697 178.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 513' ' ' HIS . . . . . 0.458 ' HB2' ' HB2' ' A' ' 653' ' ' LYS . 28.7 m-70 -114.52 127.85 56.02 Favored 'General case' 0 CA--C 1.484 -1.595 0 N-CA-C 107.471 -1.307 . . . . 72.43 107.471 177.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.618 HG11 ' SD ' ' A' ' 521' ' ' MET . 33.7 m -113.19 164.43 9.12 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.355 0 C-N-CA 120.271 -0.572 . . . . 74.32 110.853 -173.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 35.4 t -87.5 145.01 26.43 Favored 'General case' 0 N--CA 1.406 -2.657 0 N-CA-C 107.255 -1.387 . . . . 73.42 107.255 176.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . 0.628 ' OE1' 'CA ' ' A' ' 800' ' ' ' CA' . 32.6 tt0 -79.38 -9.98 59.71 Favored 'General case' 0 C--N 1.279 -2.495 0 CA-C-O 121.604 0.716 . . . . 72.51 109.801 177.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 39.3 m -97.62 17.06 18.65 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.508 0.67 . . . . 75.31 109.874 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 10.8 tt -96.38 158.25 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.366 0 N-CA-C 108.724 -0.843 . . . . 75.32 108.724 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -102.89 -59.35 0.74 Allowed Glycine 0 N--CA 1.43 -1.738 0 N-CA-C 111.018 -0.833 . . . . 75.15 111.018 178.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 36.1 mm -123.36 126.85 73.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 109.224 -0.658 . . . . 72.5 109.224 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 521' ' ' MET . . . . . 0.618 ' SD ' HG11 ' A' ' 514' ' ' VAL . 25.3 ptt? -104.03 139.34 39.28 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.132 -1.062 . . . . 75.01 108.132 173.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -120.25 120.13 35.22 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 123.882 0.739 . . . . 74.31 110.72 177.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . 0.6 ' O ' ' HA ' ' A' ' 570' ' ' THR . 40.4 t -106.33 130.78 57.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 CA-C-N 115.56 -0.746 . . . . 74.34 109.831 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -77.93 131.84 37.63 Favored 'General case' 0 C--O 1.246 0.894 0 CA-C-O 121.784 0.802 . . . . 72.34 113.114 -177.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 11.4 t -114.7 135.22 55.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 107.42 -1.326 . . . . 65.42 107.42 177.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -82.55 151.22 26.52 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.416 0.626 . . . . 75.52 111.408 -175.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . 0.42 ' HD2' ' HA ' ' A' ' 567' ' ' ILE . 43.7 ttt-85 -98.47 143.55 28.78 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 114.658 -1.155 . . . . 63.55 110.447 -174.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 528' ' ' THR . . . . . 0.682 ' OG1' ' HA3' ' A' ' 503' ' ' GLY . 4.6 t -58.9 151.29 22.05 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.539 -0.755 . . . . 75.24 112.441 177.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 35.6 t -77.89 -17.94 56.75 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 115.224 -0.898 . . . . 72.22 108.736 176.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -109.87 52.52 0.63 Allowed Glycine 0 N--CA 1.442 -0.912 0 N-CA-C 111.232 -0.747 . . . . 63.15 111.232 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -82.36 92.61 7.02 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-O 121.543 0.687 . . . . 75.25 109.665 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 2.6 ppt_? -133.5 20.36 3.95 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 114.771 -1.104 . . . . 72.41 112.038 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . -177.16 -179.38 47.47 Favored Glycine 0 N--CA 1.427 -1.959 0 N-CA-C 109.524 -1.431 . . . . 63.03 109.524 -177.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 534' ' ' ASN . . . . . 0.413 HD22 ' HG3' ' A' ' 561' ' ' GLU . 2.5 t-20 -90.41 125.02 35.42 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.047 0.451 . . . . 74.15 110.082 -179.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 60.1 t -123.95 128.39 74.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 107.533 -1.284 . . . . 75.54 107.533 176.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 536' ' ' ILE . . . . . 0.535 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 46.5 mm -99.57 135.82 33.36 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.238 0 N-CA-C 109.425 -0.583 . . . . 74.43 109.425 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 42.5 t -120.15 109.38 37.24 Favored Pre-proline 0 C--N 1.307 -1.268 0 CA-C-N 116.06 -0.518 . . . . 73.11 109.608 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -74.07 143.69 32.8 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.16 1.906 . . . . 73.54 111.64 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 539' ' ' TYR . . . . . 0.408 ' CD1' ' HG ' ' A' ' 560' ' ' LEU . 45.1 p90 -144.35 160.66 40.66 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.598 -0.519 . . . . 74.11 109.598 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -160.48 160.58 32.22 Favored 'General case' 0 C--O 1.243 0.721 0 O-C-N 123.788 0.68 . . . . 73.31 110.543 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 2.6 p -100.22 108.14 20.16 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 123.676 0.61 . . . . 71.43 111.53 176.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.5 mp -81.7 128.24 38.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 107.378 -1.341 . . . . 74.21 107.378 178.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -63.61 -62.94 1.33 Allowed 'General case' 0 C--O 1.237 0.413 0 O-C-N 123.585 0.553 . . . . 72.51 111.212 -178.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 72.71 -72.48 1.04 Allowed Glycine 0 C--O 1.227 -0.292 0 CA-C-N 116.256 -0.429 . . . . 75.4 112.205 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 545' ' ' THR . . . . . 0.437 HG22 ' H ' ' A' ' 586' ' ' THR . 6.0 t -138.59 -2.11 1.8 Allowed 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.056 0.455 . . . . 71.1 110.233 178.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -96.1 171.03 8.86 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 108.969 -0.752 . . . . 70.21 108.969 174.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . 0.445 ' HG3' ' HG3' ' A' ' 551' ' ' GLU . 2.3 tpt180 -115.65 112.46 22.14 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.902 -0.777 . . . . 73.32 108.902 -178.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -95.95 166.92 25.05 Favored Glycine 0 CA--C 1.499 -0.962 0 C-N-CA 121.408 -0.425 . . . . 52.35 113.409 -176.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 100.52 23.44 10.21 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 111.526 -0.63 . . . . 62.23 111.526 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 91.07 6.45 66.82 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.833 -0.698 . . . . 62.23 111.396 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . 0.445 ' HG3' ' HG3' ' A' ' 547' ' ' ARG . 12.3 mm-40 -76.18 -71.23 0.4 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.553 -0.536 . . . . 75.31 109.553 -178.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -111.4 -27.65 8.54 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.197 -1.409 . . . . 62.33 107.197 178.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -141.68 156.68 45.63 Favored 'General case' 0 C--O 1.256 1.415 0 CA-C-N 115.031 -0.986 . . . . 75.02 109.063 174.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.45 126.77 36.01 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 106.261 -1.755 . . . . 74.21 106.261 178.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -79.02 112.04 15.83 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.77 0.319 . . . . 74.23 111.784 -173.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 556' ' ' THR . . . . . 0.411 HG22 HG23 ' A' ' 573' ' ' VAL . 11.1 t -109.51 122.88 48.41 Favored 'General case' 0 N--CA 1.418 -2.026 0 CA-C-O 122.269 1.033 . . . . 75.44 110.052 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 1.7 p -142.07 133.04 25.93 Favored 'General case' 0 C--N 1.277 -2.572 0 CA-C-N 114.475 -1.239 . . . . 73.51 107.894 178.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 179.9 -148.98 8.28 Favored Glycine 0 N--CA 1.422 -2.289 0 N-CA-C 110.34 -1.104 . . . . 74.42 110.34 -176.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 559' ' ' GLU . . . . . 0.535 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 47.5 mt-10 -143.54 133.62 24.28 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 122.964 0.506 . . . . 73.52 110.706 -176.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . 0.408 ' HG ' ' CD1' ' A' ' 539' ' ' TYR . 87.4 mt -94.21 146.17 24.19 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 123.319 0.648 . . . . 74.3 110.117 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 561' ' ' GLU . . . . . 0.413 ' HG3' HD22 ' A' ' 534' ' ' ASN . 44.0 tt0 -105.67 112.85 26.09 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-O 121.075 0.464 . . . . 70.51 111.752 -178.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -109.66 144.07 38.53 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.59 -0.892 . . . . 74.42 108.59 171.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -145.99 -171.42 3.7 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.459 -0.941 . . . . 74.23 108.459 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 31.9 t30 -78.87 -39.15 35.98 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 107.24 -1.393 . . . . 75.22 107.24 172.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -88.45 -2.48 58.62 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.731 -1.122 . . . . 65.14 110.978 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -116.83 123.87 48.14 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.964 -0.754 . . . . 74.54 108.964 -178.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 567' ' ' ILE . . . . . 0.42 ' HA ' ' HD2' ' A' ' 527' ' ' ARG . 1.5 pp -119.13 139.91 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.73 0 N-CA-C 108.6 -0.889 . . . . 73.41 108.6 -178.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 568' ' ' VAL . . . . . 0.411 HG11 ' O ' ' A' ' 567' ' ' ILE . 1.2 p 56.11 160.18 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 C-N-CA 126.625 1.97 . . . . 71.22 113.462 179.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 569' ' ' LYS . . . . . 0.463 ' HE3' ' HA ' ' A' ' 569' ' ' LYS . 0.0 OUTLIER -148.03 162.89 38.44 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.511 -0.743 . . . . 72.15 109.089 175.444 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 570' ' ' THR . . . . . 0.6 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 11.7 p -135.1 134.3 40.13 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 123.921 0.763 . . . . 71.2 110.942 178.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 3.1 mp -85.51 118.37 32.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 106.62 -1.622 . . . . 62.32 106.62 172.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 19.1 m -98.73 120.62 39.47 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 108.709 -0.848 . . . . 73.42 108.709 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 573' ' ' VAL . . . . . 0.411 HG23 HG22 ' A' ' 556' ' ' THR . 33.2 t -123.67 134.52 66.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 N-CA-C 109.15 -0.685 . . . . 70.11 109.15 -178.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 57.9 tptt -88.25 116.26 26.32 Favored 'General case' 0 N--CA 1.435 -1.193 0 O-C-N 123.815 0.697 . . . . 74.22 109.221 177.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 59.1 t -87.03 133.8 29.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 107.72 -1.215 . . . . 72.45 107.72 178.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 42.8 mm -96.66 158.22 3.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 107.984 -1.117 . . . . 73.12 107.984 -177.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -67.78 119.48 12.55 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.645 -0.872 . . . . 73.32 108.645 176.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 578' ' ' ASP . . . . . 0.617 ' OD1' 'CA ' ' A' ' 850' ' ' ' CA' . 25.9 t0 -67.32 122.65 18.35 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 114.822 -1.081 . . . . 72.05 111.628 -173.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 579' ' ' GLU . . . . . 0.613 ' OE1' 'CA ' ' A' ' 850' ' ' ' CA' . 0.2 OUTLIER -87.57 -23.75 24.23 Favored 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 125.502 1.521 . . . . 71.43 113.557 -172.871 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 580' ' ' GLU . . . . . 0.622 ' OE2' 'CA ' ' A' ' 850' ' ' ' CA' . 0.1 OUTLIER -117.67 176.84 5.0 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 118.648 -1.221 . . . . 73.35 111.283 -177.057 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -60.59 154.37 21.29 Favored 'General case' 0 C--O 1.253 1.283 0 N-CA-C 108.256 -1.016 . . . . 61.51 108.256 174.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 582' ' ' GLU . . . . . 0.62 ' OE1' 'CA ' ' A' ' 800' ' ' ' CA' . 21.0 tp10 -84.25 101.55 11.99 Favored 'General case' 0 N--CA 1.414 -2.229 0 C-N-CA 118.049 -1.46 . . . . 63.55 114.091 -175.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -97.22 134.07 41.02 Favored 'General case' 0 N--CA 1.406 -2.665 0 N-CA-C 101.961 -3.348 . . . . 70.41 101.961 160.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -76.11 77.89 2.94 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-O 121.733 0.778 . . . . 73.22 112.391 -174.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.67 167.22 18.45 Favored 'General case' 0 N--CA 1.412 -2.357 0 N-CA-C 106.519 -1.66 . . . . 64.53 106.519 176.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 586' ' ' THR . . . . . 0.437 ' H ' HG22 ' A' ' 545' ' ' THR . 3.5 t -155.93 144.92 20.53 Favored 'General case' 0 N--CA 1.404 -2.741 0 C-N-CA 120.402 -0.519 . . . . 74.01 110.736 -176.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 587' ' ' PHE . . . . . 0.438 ' CE2' HD13 ' A' ' 646' ' ' ILE . 2.5 p90 -112.34 149.54 32.3 Favored 'General case' 0 N--CA 1.418 -2.028 0 CA-C-N 114.198 -1.364 . . . . 75.15 108.865 177.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 588' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -106.47 131.31 53.8 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 116.052 -0.522 . . . . 75.23 109.735 -173.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . 0.476 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.4 OUTLIER -102.77 118.44 36.83 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 105.016 -2.216 . . . . 73.1 105.016 173.231 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -129.82 144.51 51.34 Favored 'General case' 0 C--N 1.273 -2.728 0 N-CA-C 108.306 -0.998 . . . . 75.14 108.306 -178.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 591' ' ' ILE . . . . . . . . . . . . . 27.0 pt -106.27 152.76 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.853 0 N-CA-C 108.748 -0.834 . . . . 74.34 108.748 178.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -99.14 -163.74 29.75 Favored Glycine 0 N--CA 1.419 -2.46 0 N-CA-C 111.362 -0.695 . . . . 74.45 111.362 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -66.75 121.18 76.4 Favored Pre-proline 0 C--N 1.298 -1.645 0 C-N-CA 123.211 0.604 . . . . 75.43 110.612 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 594' ' ' PRO . . . . . 0.415 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 18.9 Cg_endo -67.25 140.84 54.73 Favored 'Trans proline' 0 N--CA 1.437 -1.819 0 C-N-CA 121.856 1.704 . . . . 62.5 110.461 176.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -121.88 122.29 39.08 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 115.696 -0.683 . . . . 74.11 110.101 -173.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -75.51 123.9 26.25 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 107.858 -1.164 . . . . 73.35 107.858 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 21.8 t -89.85 70.62 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-O 122.418 1.104 . . . . 71.55 109.348 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -148.84 149.45 31.31 Favored 'General case' 0 C--N 1.261 -3.255 0 CA-C-N 113.915 -1.493 . . . . 54.13 108.146 174.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 599' ' ' MET . . . . . 0.456 ' HG3' ' O ' ' A' ' 599' ' ' MET . 14.6 ptm -84.99 113.91 21.78 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.575 -0.898 . . . . 71.43 108.575 176.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 49.3 m -123.17 102.48 7.98 Favored 'General case' 0 C--N 1.276 -2.602 0 CA-C-O 121.257 0.551 . . . . 55.34 110.746 177.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -150.02 124.13 9.43 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.28 -0.873 . . . . 73.23 109.897 178.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . 0.491 ' HE2' ' HA ' ' A' ' 602' ' ' LYS . 0.3 OUTLIER -126.26 96.84 4.84 Favored 'General case' 0 N--CA 1.416 -2.163 0 N-CA-C 106.767 -1.568 . . . . 73.42 106.767 175.95 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 603' ' ' LYS . . . . . 0.452 ' O ' ' HD3' ' A' ' 603' ' ' LYS . 0.0 OUTLIER -131.37 139.6 49.51 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.447 -0.797 . . . . 74.13 111.817 -178.196 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -112.27 -45.74 0.78 Allowed Glycine 0 C--N 1.288 -2.111 0 N-CA-C 110.096 -1.202 . . . . 55.51 110.096 177.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 153.09 -102.85 0.23 Allowed Glycine 0 N--CA 1.425 -2.067 0 C-N-CA 120.772 -0.728 . . . . 73.31 111.827 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -62.51 94.42 0.06 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.844 0.831 . . . . 74.11 112.786 -177.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 1.3 p -145.95 135.64 23.3 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.367 -0.833 . . . . 71.33 111.115 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 62.6 mt -103.06 112.29 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.814 0 N-CA-C 107.496 -1.298 . . . . 73.51 107.496 176.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 15.4 t -176.36 159.5 2.0 Allowed 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.107 -1.442 . . . . 74.25 107.107 -177.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -115.08 80.94 1.49 Allowed 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.441 0.639 . . . . 74.2 109.437 174.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -84.39 100.56 11.38 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 114.884 -1.053 . . . . 72.12 109.829 178.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -86.6 134.46 33.63 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.479 -0.782 . . . . 75.12 111.665 -175.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -117.41 11.45 13.92 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 106.76 -1.57 . . . . 73.55 106.76 171.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -57.21 128.46 37.09 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 113.219 -1.81 . . . . 72.25 111.494 -179.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 615' ' ' LYS . . . . . 0.471 ' HZ3' ' HB3' ' A' ' 615' ' ' LYS . 0.3 OUTLIER -87.42 94.86 9.82 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.869 0.842 . . . . 75.43 111.572 -178.26 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -101.13 164.04 16.81 Favored Pre-proline 0 C--N 1.302 -1.462 0 CA-C-N 114.992 -1.004 . . . . 75.41 109.041 178.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -70.31 -177.17 1.92 Allowed 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 121.517 1.478 . . . . 73.43 109.552 173.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -75.87 103.77 6.1 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 121.824 0.821 . . . . 73.51 110.719 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 9.9 t -162.65 167.55 22.99 Favored 'General case' 0 N--CA 1.416 -2.161 0 N-CA-C 106.639 -1.615 . . . . 73.54 106.639 -177.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 11.2 t -120.39 -13.06 8.89 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.161 -1.051 . . . . 73.32 108.161 173.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 621' ' ' LYS . . . . . 0.447 ' HA ' ' HE3' ' A' ' 621' ' ' LYS . 0.0 OUTLIER 58.5 18.49 5.74 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 123.68 0.792 . . . . 61.14 111.994 179.637 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 57.99 30.01 18.55 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 124.633 1.173 . . . . 71.21 111.68 -177.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -105.55 135.5 46.83 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 116.256 -0.429 . . . . 72.51 110.804 -178.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -61.82 -37.6 85.04 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.755 -0.832 . . . . 74.23 108.755 175.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -58.45 -35.44 72.14 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.57 -1.196 . . . . 74.33 110.254 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . 0.438 ' O ' ' HG3' ' A' ' 630' ' ' GLU . 14.3 tpp180 -77.93 -29.26 49.92 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 120.511 -0.476 . . . . 74.42 109.816 -175.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 627' ' ' ARG . . . . . . . . . . . . . 21.7 mmm180 -60.92 -38.51 86.0 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 122.083 0.944 . . . . 74.23 109.729 178.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 77.2 mt -66.6 -41.64 88.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 CA-C-N 113.874 -1.512 . . . . 63.01 110.296 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -68.69 -40.74 79.94 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.705 -0.68 . . . . 74.13 110.274 177.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 630' ' ' GLU . . . . . 0.438 ' HG3' ' O ' ' A' ' 626' ' ' ARG . 45.4 mt-10 -66.36 -19.71 65.88 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 121.375 0.607 . . . . 71.43 111.243 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 631' ' ' MET . . . . . 0.618 ' O ' ' HA ' ' A' ' 501' ' ' HIS . 56.9 ttp -76.85 -30.15 56.17 Favored 'General case' 0 N--CA 1.414 -2.261 0 CA-C-N 115.828 -0.624 . . . . 74.2 110.194 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -99.96 -27.23 7.96 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.329 -0.939 . . . . 71.03 112.39 -178.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 67.9 mtt-85 -102.34 149.62 36.81 Favored Pre-proline 0 C--N 1.305 -1.344 0 N-CA-C 109.347 -0.612 . . . . 74.13 109.347 -177.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.415 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 39.7 Cg_endo -74.83 142.68 28.75 Favored 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 121.635 1.556 . . . . 72.13 110.548 177.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -131.97 -170.77 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 CA-C-O 121.126 0.489 . . . . 75.22 109.899 -177.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.78 160.53 21.2 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 115.791 -0.641 . . . . 74.34 111.196 -178.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . 0.477 ' CA ' HG23 ' A' ' 504' ' ' ILE . . . -85.81 -98.53 0.74 Allowed Glycine 0 CA--C 1.483 -1.928 0 CA-C-N 115.337 -0.847 . . . . 75.14 111.771 177.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -114.52 -49.29 2.83 Favored 'General case' 0 C--N 1.281 -2.392 0 C-N-CA 119.752 -0.779 . . . . 73.54 110.151 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -131.4 119.15 21.24 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.958 0.885 . . . . 64.03 113.099 -176.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 23.8 p -115.27 91.15 3.52 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 107.385 -1.339 . . . . 75.0 107.385 173.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 641' ' ' LYS . . . . . 0.525 ' O ' ' HA ' ' A' ' 510' ' ' PRO . 22.6 tptm -175.27 137.04 0.38 Allowed 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 106.434 -1.691 . . . . 72.43 106.434 -174.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 642' ' ' LEU . . . . . 0.476 ' HB3' ' HB3' ' A' ' 589' ' ' LEU . 38.7 tp -140.69 105.07 4.85 Favored 'General case' 0 C--N 1.277 -2.55 0 N-CA-C 107.961 -1.125 . . . . 75.02 107.961 172.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -94.35 105.05 17.03 Favored 'General case' 0 C--N 1.276 -2.625 0 N-CA-C 106.646 -1.613 . . . . 70.13 106.646 178.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 644' ' ' VAL . . . . . 0.451 HG23 ' HE3' ' A' ' 521' ' ' MET . 32.5 t -94.28 106.15 17.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-N 115.765 -0.652 . . . . 72.01 109.571 -177.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 3.7 mp -89.36 126.32 42.33 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 N-CA-C 108.026 -1.101 . . . . 74.41 108.026 179.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 646' ' ' ILE . . . . . 0.438 HD13 ' CE2' ' A' ' 587' ' ' PHE . 1.7 mp -104.54 140.29 23.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 107.866 -1.161 . . . . 74.43 107.866 -177.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -158.4 140.05 13.63 Favored 'General case' 0 N--CA 1.429 -1.508 0 O-C-N 123.722 0.638 . . . . 74.41 110.822 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -41.62 136.5 1.86 Allowed 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.138 1.375 . . . . 74.42 110.561 176.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 34.9 t -33.31 104.93 0.03 OUTLIER 'General case' 0 C--O 1.243 0.72 0 C-N-CA 126.518 1.927 . . . . 63.01 114.238 -171.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -120.77 -63.93 1.3 Allowed 'General case' 0 N--CA 1.426 -1.668 0 CA-C-N 113.423 -1.717 . . . . 74.34 107.808 175.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -176.25 168.5 2.82 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 105.781 -1.933 . . . . 74.13 105.781 -177.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -104.09 127.13 51.65 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 108.182 -1.044 . . . . 74.25 108.182 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 653' ' ' LYS . . . . . 0.458 ' HB2' ' HB2' ' A' ' 513' ' ' HIS . 31.9 mmmt -110.36 93.88 4.72 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 116.486 -0.324 . . . . 73.11 111.421 -176.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 34.9 t -100.12 115.01 28.81 Favored 'General case' 0 N--CA 1.423 -1.805 0 N-CA-C 104.447 -2.427 . . . . 70.34 104.447 170.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 655' ' ' THR . . . . . 0.545 ' O ' ' HB3' ' A' ' 509' ' ' GLU . 8.9 t -107.71 131.79 54.04 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-O 121.453 0.645 . . . . 75.1 110.936 -176.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 7.7 p -83.18 131.93 32.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.12 -1.067 . . . . 74.55 108.12 176.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 14.6 t70 . . . . . 0 C--N 1.307 -1.27 0 CA-C-N 116.527 -0.306 . . . . 61.1 111.06 -177.456 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 800' ' ' ' CA' . . . . . 0.628 'CA ' ' OE1' ' A' ' 516' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 850' ' ' ' CA' . . . . . 0.622 'CA ' ' OE2' ' A' ' 580' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 8.1 p80 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 121.861 0.839 . . . . 62.22 108.874 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -162.8 -49.85 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 107.078 -1.453 . . . . 74.22 107.078 -177.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 108.53 145.74 11.65 Favored Glycine 0 N--CA 1.433 -1.543 0 CA-C-N 115.029 -0.987 . . . . 72.34 113.758 174.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 1.7 mp -107.24 130.31 59.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 N-CA-C 107.956 -1.127 . . . . 62.41 107.956 177.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . 0.415 ' HA ' ' O ' ' A' ' 526' ' ' LEU . 97.9 m-85 -116.21 121.39 41.91 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.115 0.483 . . . . 74.15 111.071 -178.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 11.8 t -139.39 156.19 47.15 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.037 -1.098 . . . . 70.2 108.037 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -82.65 154.41 24.92 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.526 -0.916 . . . . 73.41 108.526 174.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -77.29 -27.71 53.12 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 109.301 -0.629 . . . . 65.04 109.301 176.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -140.51 135.99 16.29 Favored Pre-proline 0 C--N 1.315 -0.897 0 N-CA-C 108.878 -0.786 . . . . 73.43 108.878 177.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -85.13 -13.84 6.26 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 121.765 1.643 . . . . 72.21 111.654 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 71.7 t -139.0 133.85 41.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 107.693 -1.225 . . . . 63.14 107.693 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 5.4 t -134.05 136.21 43.86 Favored 'General case' 0 N--CA 1.402 -2.834 0 N-CA-C 108.077 -1.083 . . . . 72.03 108.077 178.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 32.6 m-70 -108.37 114.75 28.85 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.541 -0.911 . . . . 73.43 108.541 177.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 16.7 m -118.93 162.49 17.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 CA-C-N 115.935 -0.575 . . . . 60.42 110.093 -174.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 515' ' ' SER . . . . . 0.414 ' O ' HG21 ' A' ' 518' ' ' ILE . 62.2 m -81.2 148.92 29.3 Favored 'General case' 0 N--CA 1.392 -3.37 0 N-CA-C 108.096 -1.075 . . . . 72.41 108.096 178.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -85.55 -22.35 28.15 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 118.719 -1.192 . . . . 73.34 110.632 176.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 16.0 m -90.12 30.39 1.1 Allowed 'General case' 0 C--N 1.293 -1.874 0 CA-C-O 121.605 0.717 . . . . 74.25 110.023 -176.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 518' ' ' ILE . . . . . 0.414 HG21 ' O ' ' A' ' 515' ' ' SER . 13.7 tt -112.81 150.87 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.015 0 N-CA-C 107.342 -1.355 . . . . 75.02 107.342 -178.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . 0.535 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . -81.83 -61.93 1.99 Allowed Glycine 0 N--CA 1.426 -1.975 0 C-N-CA 120.098 -1.049 . . . . 72.1 111.06 178.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 35.8 mm -120.82 133.45 67.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 CA-C-N 115.482 -0.359 . . . . 74.22 110.199 -177.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 521' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.28 141.23 48.42 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.147 -1.427 . . . . 75.1 107.147 171.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 522' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 44.9 mt-10 -126.38 145.28 50.52 Favored 'General case' 0 C--N 1.316 -0.89 0 O-C-N 123.584 0.552 . . . . 72.41 111.445 -178.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . 0.618 ' O ' ' HA ' ' A' ' 570' ' ' THR . 30.2 t -132.58 138.99 50.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 108.512 -0.921 . . . . 65.34 108.512 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -84.0 133.17 34.69 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 113.043 0.757 . . . . 74.21 113.043 -177.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . 0.598 ' O ' ' HA ' ' A' ' 568' ' ' VAL . 10.7 t -113.46 125.49 70.74 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 N-CA-C 106.725 -1.583 . . . . 75.13 106.725 177.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' A' ' 505' ' ' PHE . 2.1 mm? -91.3 140.81 29.43 Favored 'General case' 0 C--N 1.28 -2.427 0 CA-C-O 120.794 0.331 . . . . 74.32 110.397 -176.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . 0.426 ' HG3' HH11 ' A' ' 527' ' ' ARG . 27.9 ttt85 -114.24 93.78 4.51 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 105.06 -2.2 . . . . 64.32 105.06 173.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 1.4 p -121.55 -168.68 1.73 Allowed 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 114.712 -1.131 . . . . 70.23 111.967 -173.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 39.6 m 35.01 32.62 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 126.419 1.888 . . . . 74.35 114.134 -172.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . 129.43 151.95 7.47 Favored Glycine 0 N--CA 1.418 -2.53 0 N-CA-C 111.67 -0.572 . . . . 71.2 111.67 178.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -127.75 -125.44 0.23 Allowed 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 107.798 -1.186 . . . . 64.35 107.798 176.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 69.37 127.29 0.03 OUTLIER 'General case' 0 C--O 1.244 0.77 0 C-N-CA 124.516 1.126 . . . . 74.44 113.593 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 533' ' ' GLY . . . . . 0.401 ' H ' ' HB3' ' A' ' 564' ' ' ASN . . . 86.81 162.36 37.32 Favored Glycine 0 N--CA 1.437 -1.278 0 CA-C-N 115.125 -0.943 . . . . 75.53 113.316 175.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -90.81 122.96 33.98 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.271 -1.381 . . . . 75.5 107.271 176.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 62.4 t -125.31 125.67 69.45 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 N-CA-C 109.58 -0.526 . . . . 71.22 109.58 -178.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 536' ' ' ILE . . . . . 0.437 ' O ' ' HG2' ' A' ' 595' ' ' ARG . 40.1 mm -100.25 125.37 54.02 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 N-CA-C 108.396 -0.964 . . . . 72.32 108.396 177.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . 0.429 HG21 ' HB3' ' A' ' 594' ' ' PRO . 38.6 t -113.54 107.54 53.03 Favored Pre-proline 0 C--N 1.296 -1.757 0 CA-C-N 116.368 -0.378 . . . . 73.51 110.391 -177.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -74.59 147.19 35.48 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.408 2.072 . . . . 74.02 111.308 178.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -147.85 156.9 43.21 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 108.255 -1.017 . . . . 75.23 108.255 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.96 150.9 28.8 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 123.399 0.437 . . . . 72.23 111.42 178.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 1.1 p -87.54 118.17 26.84 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 123.684 0.794 . . . . 74.52 112.075 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.7 mp -84.83 123.66 39.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 107.545 -1.28 . . . . 75.0 107.545 176.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -54.3 -54.02 45.87 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 124.225 1.01 . . . . 75.35 113.059 -175.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 72.18 -90.37 0.51 Allowed Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.898 -0.668 . . . . 71.22 112.203 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 8.9 t -124.84 -0.78 7.93 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 121.935 0.874 . . . . 73.35 109.299 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -94.9 175.79 6.51 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.586 -0.734 . . . . 71.43 109.926 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . 0.511 ' N ' ' HD2' ' A' ' 547' ' ' ARG . 4.5 mpt_? -101.58 173.05 6.6 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.716 -0.22 . . . . 74.41 111.296 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -62.54 -175.42 2.52 Favored Glycine 0 C--O 1.252 1.23 0 N-CA-C 116.116 1.206 . . . . 72.24 116.116 -174.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . -58.9 119.93 20.16 Favored Glycine 0 N--CA 1.439 -1.113 0 CA-C-N 114.087 -1.056 . . . . 61.23 114.362 -175.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 83.89 4.98 88.33 Favored Glycine 0 N--CA 1.438 -1.189 0 CA-C-N 115.287 -0.456 . . . . 72.24 112.028 176.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -103.04 -67.22 0.89 Allowed 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 108.408 -0.96 . . . . 71.51 108.408 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . 0.643 ' OD2' 'CA ' ' A' ' 850' ' ' ' CA' . 12.8 t70 -104.54 -38.33 6.81 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.764 0.793 . . . . 75.4 109.125 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -138.17 160.77 38.56 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 108.276 -1.009 . . . . 75.12 108.276 176.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -86.42 110.34 19.66 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 105.411 -2.07 . . . . 74.42 105.411 176.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -67.61 100.83 0.93 Allowed 'General case' 0 CA--C 1.485 -1.54 0 CA-C-N 115.551 -0.749 . . . . 74.45 110.587 -174.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 556' ' ' THR . . . . . 0.446 HG22 HG21 ' A' ' 573' ' ' VAL . 9.6 t -97.98 95.88 7.78 Favored 'General case' 0 N--CA 1.393 -3.298 0 CA-C-O 123.31 1.529 . . . . 74.11 110.019 -177.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 1.9 p -115.44 97.76 6.35 Favored 'General case' 0 N--CA 1.399 -2.976 0 CA-C-N 113.015 -1.902 . . . . 75.11 106.93 176.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -152.79 -156.21 7.45 Favored Glycine 0 N--CA 1.402 -3.586 0 N-CA-C 110.612 -0.995 . . . . 63.14 110.612 -172.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 559' ' ' GLU . . . . . 0.428 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 41.5 mt-10 -137.11 135.82 37.77 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-O 120.717 0.294 . . . . 74.35 110.885 -171.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . 0.402 ' HB3' ' HG2' ' A' ' 569' ' ' LYS . 80.2 mt -93.92 138.11 32.41 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 109.284 -0.636 . . . . 71.4 109.284 175.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -103.39 106.32 16.8 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.77 -0.65 . . . . 74.23 111.385 -175.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 562' ' ' PHE . . . . . 0.558 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 88.7 m-85 -109.15 143.57 38.37 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 116.088 -0.506 . . . . 75.31 109.8 176.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -119.24 -167.88 1.48 Allowed 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 108.154 -1.054 . . . . 75.41 108.154 -178.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 564' ' ' ASN . . . . . 0.401 ' HB3' ' H ' ' A' ' 533' ' ' GLY . 27.6 p-10 -78.33 -42.15 31.5 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 109.636 -0.505 . . . . 72.42 109.636 178.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -89.35 -29.69 18.94 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.575 -0.738 . . . . 72.12 110.684 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -79.37 108.19 12.7 Favored 'General case' 0 C--O 1.248 1.012 0 CA-C-N 115.878 -0.601 . . . . 74.14 110.17 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 567' ' ' ILE . . . . . 0.432 ' O ' HG12 ' A' ' 568' ' ' VAL . 6.1 pt -110.17 166.19 5.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 108.049 -1.093 . . . . 71.5 108.049 174.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 568' ' ' VAL . . . . . 0.598 ' HA ' ' O ' ' A' ' 525' ' ' VAL . 0.9 OUTLIER 58.77 155.83 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.56 1.336 0 C-N-CA 125.681 1.592 . . . . 74.03 112.564 -178.814 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 569' ' ' LYS . . . . . 0.558 ' HB2' ' CZ ' ' A' ' 562' ' ' PHE . 0.0 OUTLIER -161.94 166.62 25.87 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 106.985 -1.487 . . . . 74.42 106.985 179.492 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 570' ' ' THR . . . . . 0.618 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 7.0 p -127.52 138.68 52.98 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 123.427 0.454 . . . . 65.01 111.363 175.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 571' ' ' ILE . . . . . 0.457 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 3.2 mp -88.61 115.18 28.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 106.763 -1.569 . . . . 72.31 106.763 171.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 24.2 p -92.82 109.49 20.92 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 109.365 -0.606 . . . . 75.12 109.365 178.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 573' ' ' VAL . . . . . 0.446 HG21 HG22 ' A' ' 556' ' ' THR . 43.6 t -112.69 129.94 67.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 N-CA-C 109.328 -0.619 . . . . 75.15 109.328 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 574' ' ' LYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 519' ' ' GLY . 86.9 tttt -89.09 124.12 34.02 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 123.814 0.696 . . . . 74.21 110.156 176.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 46.5 t -91.07 131.61 37.78 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 N-CA-C 108.312 -0.996 . . . . 74.45 108.312 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 30.1 mm -101.03 160.65 3.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 107.784 -1.191 . . . . 75.12 107.784 -177.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -76.91 147.73 36.82 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 110.061 -0.348 . . . . 60.15 110.061 177.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 578' ' ' ASP . . . . . 0.637 ' OD2' 'CA ' ' A' ' 800' ' ' ' CA' . 5.5 m-20 -69.98 132.4 45.87 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 114.55 1.315 . . . . 72.21 114.55 -175.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 579' ' ' GLU . . . . . 0.631 ' OE2' 'CA ' ' A' ' 850' ' ' ' CA' . 0.0 OUTLIER -96.59 -26.27 15.3 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 112.533 -2.121 . . . . 74.12 111.394 179.599 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 580' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 581' ' ' TYR . 0.1 OUTLIER -105.11 -174.97 2.66 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 107.192 -1.41 . . . . 74.25 107.192 178.813 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 581' ' ' TYR . . . . . 0.426 ' O ' ' HG2' ' A' ' 580' ' ' GLU . 24.6 p90 -69.25 145.14 53.38 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 106.31 -1.737 . . . . 75.42 106.31 176.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 582' ' ' GLU . . . . . 0.604 ' OE1' 'CA ' ' A' ' 800' ' ' ' CA' 0.528 18.6 pt-20 -93.79 121.03 34.81 Favored 'General case' 0 N--CA 1.408 -2.56 0 N-CA-C 117.673 2.472 . . . . 73.44 117.673 -175.133 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.19 170.94 11.88 Favored 'General case' 0 N--CA 1.417 -2.108 0 CA-C-N 111.407 -2.633 . . . . 73.1 106.476 178.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -67.71 119.31 12.24 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.36 0.6 . . . . 64.31 109.468 -177.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 585' ' ' LYS . . . . . 0.434 ' HD2' HD11 ' A' ' 646' ' ' ILE . 1.6 tmmm? -122.58 142.51 50.55 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-N 115.003 -0.999 . . . . 74.43 109.911 -171.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 6.8 t -148.22 142.99 26.7 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-O 121.14 0.495 . . . . 73.3 110.698 -175.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -129.64 148.23 51.51 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-N 114.113 -1.403 . . . . 75.33 109.802 177.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 588' ' ' PHE . . . . . 0.532 ' HA ' ' O ' ' A' ' 642' ' ' LEU . 27.2 m-85 -104.14 138.3 40.83 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.978 -0.556 . . . . 74.42 109.672 -176.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . 0.492 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.5 OUTLIER -113.01 115.24 28.08 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 105.642 -1.985 . . . . 73.4 105.642 175.573 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -125.59 133.37 52.3 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 109.148 -0.686 . . . . 64.33 109.148 178.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 591' ' ' ILE . . . . . . . . . . . . . 22.0 pt -85.58 146.96 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-N 115.808 -0.633 . . . . 74.21 109.412 178.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -93.54 -148.43 23.6 Favored Glycine 0 N--CA 1.427 -1.905 0 C-N-CA 120.911 -0.662 . . . . 71.33 111.496 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -75.56 117.04 60.42 Favored Pre-proline 0 C--N 1.295 -1.786 0 N-CA-C 108.866 -0.79 . . . . 71.3 108.866 178.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 594' ' ' PRO . . . . . 0.429 ' HB3' HG21 ' A' ' 537' ' ' VAL . 57.8 Cg_endo -72.81 134.34 21.68 Favored 'Trans proline' 0 N--CA 1.433 -2.045 0 C-N-CA 121.573 1.515 . . . . 61.11 109.408 176.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 595' ' ' ARG . . . . . 0.437 ' HG2' ' O ' ' A' ' 536' ' ' ILE . 14.2 ptm180 -108.29 121.15 44.31 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-O 121.028 0.442 . . . . 74.35 111.057 -172.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -76.7 118.44 19.33 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 105.786 -1.931 . . . . 75.14 105.786 176.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 21.4 t -83.49 72.8 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 CA-C-O 121.905 0.859 . . . . 73.04 109.46 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -124.64 -27.32 3.7 Favored 'General case' 0 C--N 1.276 -2.62 0 CA-C-N 114.003 -1.453 . . . . 73.1 110.218 172.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 58.7 mtm 61.57 31.92 18.74 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.178 0.991 . . . . 74.33 111.119 175.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 29.1 t -113.96 142.54 46.01 Favored 'General case' 0 N--CA 1.423 -1.803 0 CA-C-N 115.841 -0.618 . . . . 75.13 110.522 -175.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.57 97.55 6.96 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-N 115.4 -0.818 . . . . 74.52 109.147 177.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 65.4 tttp -141.86 148.87 39.49 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.194 -0.669 . . . . 74.32 109.194 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? 73.24 -46.88 0.65 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.454 1.502 . . . . 74.45 112.174 178.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . 0.405 ' HA3' ' HA ' ' A' ' 629' ' ' ALA . . . -84.05 -69.05 1.39 Allowed Glycine 0 N--CA 1.436 -1.304 0 N-CA-C 111.167 -0.773 . . . . 63.52 111.167 178.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . -61.06 110.0 2.79 Favored Glycine 0 N--CA 1.442 -0.91 0 O-C-N 123.844 0.379 . . . . 75.22 113.194 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -89.53 -25.96 21.12 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.625 -0.88 . . . . 73.1 108.625 176.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 5.4 p -76.29 151.26 36.8 Favored 'General case' 0 N--CA 1.416 -2.139 0 CA-C-N 114.827 -1.079 . . . . 72.54 110.455 178.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 23.5 mt -86.9 16.26 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 CA-C-O 123.265 1.507 . . . . 72.5 108.9 -176.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 92.5 m -152.72 131.57 12.47 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 107.099 -1.445 . . . . 73.21 107.099 179.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -78.77 83.75 4.89 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 108.38 -0.97 . . . . 71.0 108.38 176.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.31 136.17 34.46 Favored 'General case' 0 N--CA 1.421 -1.893 0 CA-C-N 115.737 -0.665 . . . . 73.52 112.403 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 59.43 66.16 1.06 Allowed 'General case' 0 C--O 1.243 0.728 0 C-N-CA 125.016 1.326 . . . . 74.31 112.327 -176.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -98.59 100.32 11.54 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 122.205 1.003 . . . . 74.54 109.239 177.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -120.21 118.65 31.03 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.404 -0.816 . . . . 63.22 109.107 -178.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -77.73 106.82 9.79 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 122.185 0.993 . . . . 60.14 111.539 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -117.42 176.63 1.51 Allowed Pre-proline 0 C--N 1.288 -2.099 0 CA-C-N 113.394 -1.73 . . . . 73.33 107.315 -176.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -67.01 167.34 20.12 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 N-CA-C 108.037 -1.563 . . . . 74.54 108.037 169.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -62.2 104.36 0.47 Allowed 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.346 0.593 . . . . 74.42 111.824 -176.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 7.3 p -135.33 143.6 46.24 Favored 'General case' 0 N--CA 1.423 -1.806 0 CA-C-N 114.864 -1.062 . . . . 75.05 109.231 -178.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 50.6 m -129.74 -5.09 4.62 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 120.489 -0.485 . . . . 71.43 111.785 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 621' ' ' LYS . . . . . 0.425 ' HA ' ' HE3' ' A' ' 621' ' ' LYS . 1.1 tpmt? 60.96 16.01 6.6 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.614 0.766 . . . . 73.15 110.599 176.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 66.27 7.58 4.99 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.921 1.289 . . . . 71.24 112.068 -174.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -79.7 121.9 25.9 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 109.334 -0.617 . . . . 75.11 109.334 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 624' ' ' GLU . . . . . 0.435 ' O ' HG13 ' A' ' 628' ' ' ILE . 45.7 mt-10 -61.96 -37.9 86.49 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.597 -0.274 . . . . 64.22 111.695 -179.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -71.38 -22.02 61.94 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.239 0.543 . . . . 72.3 111.547 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . . . . . . . . . 24.2 tpt180 -80.82 -36.37 31.71 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 107.437 -1.32 . . . . 75.41 107.437 174.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 627' ' ' ARG . . . . . . . . . . . . . 84.8 mtt180 -61.99 -38.92 90.4 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.893 -0.594 . . . . 64.03 110.258 175.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . 0.454 ' O ' ' HB3' ' A' ' 631' ' ' MET . 98.8 mt -65.14 -36.61 78.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 123.078 0.551 . . . . 74.22 110.932 176.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 629' ' ' ALA . . . . . 0.405 ' HA ' ' HA3' ' A' ' 604' ' ' GLY . . . -69.98 -44.57 69.17 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 109.662 -0.496 . . . . 61.11 109.662 177.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -79.43 4.59 15.03 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.463 -0.789 . . . . 74.1 111.119 -178.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 631' ' ' MET . . . . . 0.454 ' HB3' ' O ' ' A' ' 628' ' ' ILE . 46.0 ttm -79.05 -27.57 43.14 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 108.542 -0.91 . . . . 65.35 108.542 174.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -84.51 -9.93 80.6 Favored Glycine 0 CA--C 1.503 -0.658 0 N-CA-C 110.458 -1.057 . . . . 62.14 110.458 177.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -91.7 148.1 36.51 Favored Pre-proline 0 C--N 1.305 -1.359 0 CA-C-N 114.394 -0.903 . . . . 74.31 108.919 178.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.413 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 4.9 Cg_endo -75.5 154.52 40.22 Favored 'Trans proline' 0 N--CA 1.44 -1.645 0 N-CA-C 107.073 -1.933 . . . . 72.02 107.073 166.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.6 pp -135.48 173.66 13.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 C-N-CA 118.804 -1.158 . . . . 75.41 113.928 -175.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -75.67 146.99 39.8 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.969 -1.014 . . . . 73.34 110.232 -179.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -94.04 -132.16 6.39 Favored Glycine 0 C--N 1.289 -2.044 0 CA-C-N 115.604 -0.725 . . . . 75.12 113.821 -176.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -69.68 -56.48 7.12 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 111.955 0.354 . . . . 71.44 111.955 -175.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -137.07 114.62 11.08 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.889 0.852 . . . . 75.05 112.274 -178.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 17.5 p -119.68 91.84 3.64 Favored 'General case' 0 N--CA 1.416 -2.158 0 CA-C-N 115.219 -0.9 . . . . 74.03 110.568 177.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -178.71 126.0 0.1 Allowed 'General case' 0 CA--C 1.482 -1.642 0 N-CA-C 103.988 -2.597 . . . . 74.0 103.988 176.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 642' ' ' LEU . . . . . 0.532 ' O ' ' HA ' ' A' ' 588' ' ' PHE . 51.7 tp -115.82 112.99 22.77 Favored 'General case' 0 C--N 1.263 -3.189 0 N-CA-C 108.653 -0.869 . . . . 73.35 108.653 177.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -97.55 103.47 15.41 Favored 'General case' 0 C--N 1.273 -2.734 0 N-CA-C 107.204 -1.406 . . . . 65.53 107.204 178.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 21.8 t -91.95 106.74 18.05 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.289 0 N-CA-C 108.15 -1.056 . . . . 74.1 108.15 -178.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 4.0 mp -90.99 115.87 31.05 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.293 0 N-CA-C 107.019 -1.475 . . . . 74.55 107.019 173.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 646' ' ' ILE . . . . . 0.496 HD12 ' N ' ' A' ' 646' ' ' ILE . 3.2 mp -101.9 112.05 33.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 107.606 -1.257 . . . . 74.54 107.606 -175.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -111.2 138.2 47.94 Favored 'General case' 0 C--N 1.275 -2.671 0 CA-C-N 115.629 -0.714 . . . . 74.32 110.889 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . 0.635 ' OE2' 'CA ' ' A' ' 800' ' ' ' CA' . 9.5 mp0 -48.75 136.17 14.01 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.888 -1.051 . . . . 74.01 110.811 178.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 8.6 t -86.67 81.71 8.13 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 122.191 0.995 . . . . 63.1 109.987 -175.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -105.46 -49.3 3.47 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 113.769 -1.56 . . . . 72.32 107.813 173.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 651' ' ' GLU . . . . . 0.572 ' HG3' ' H ' ' A' ' 652' ' ' PHE . 9.3 tp10 -157.99 -161.14 0.98 Allowed 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 103.179 -2.897 . . . . 73.31 103.179 -178.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 652' ' ' PHE . . . . . 0.572 ' H ' ' HG3' ' A' ' 651' ' ' GLU . 11.1 t80 -148.03 162.37 39.5 Favored 'General case' 0 C--N 1.276 -2.595 0 N-CA-C 105.37 -2.085 . . . . 74.54 105.37 177.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.83 -74.93 0.59 Allowed 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 120.545 -0.462 . . . . 73.34 110.69 -179.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 44.4 p 55.25 18.16 2.36 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 124.547 1.139 . . . . 72.31 112.483 -176.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 7.5 p -86.21 125.29 33.44 Favored 'General case' 0 N--CA 1.423 -1.79 0 CA-C-N 115.409 -0.814 . . . . 63.55 110.668 -177.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 7.2 p -98.4 125.15 51.81 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.082 0 N-CA-C 108.182 -1.044 . . . . 72.43 108.182 178.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 13.6 t70 . . . . . 0 C--N 1.299 -1.607 0 C-N-CA 119.732 -0.787 . . . . 74.15 110.391 -176.008 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 800' ' ' ' CA' . . . . . 0.637 'CA ' ' OD2' ' A' ' 578' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 850' ' ' ' CA' . . . . . 0.643 'CA ' ' OD2' ' A' ' 552' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.469 0.49 0 CA-C-O 121.743 0.783 . . . . 74.32 110.087 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -178.61 -169.37 0.17 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 104.75 -2.315 . . . . 64.03 104.75 -177.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . 0.448 ' HA2' ' OG1' ' A' ' 528' ' ' THR . . . -164.08 130.64 2.25 Favored Glycine 0 N--CA 1.406 -3.314 0 C-N-CA 118.015 -2.04 . . . . 74.12 113.486 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 2.8 mp -81.84 102.03 7.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 107.483 -1.303 . . . . 65.53 107.483 174.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . 0.413 ' O ' ' HA3' ' A' ' 637' ' ' GLY . 42.9 m-85 -115.5 124.02 50.03 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.043 -1.095 . . . . 73.3 108.043 178.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 11.6 t -155.71 168.75 26.17 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.343 -0.984 . . . . 74.33 108.343 -174.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -87.43 151.4 23.09 Favored 'General case' 0 CA--C 1.494 -1.19 0 N-CA-C 107.639 -1.245 . . . . 74.12 107.639 175.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -87.0 -39.49 15.62 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 109.367 -0.605 . . . . 72.43 109.367 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -110.08 128.63 25.04 Favored Pre-proline 0 N--CA 1.437 -1.084 0 N-CA-C 108.469 -0.937 . . . . 73.33 108.469 176.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -79.42 -14.65 12.93 Favored 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 121.93 1.753 . . . . 73.21 112.373 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . 0.448 HG23 ' HB3' ' A' ' 643' ' ' GLU . 73.6 t -138.99 135.76 42.57 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.854 0 N-CA-C 108.755 -0.832 . . . . 63.44 108.755 -178.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 3.5 t -137.76 138.47 39.3 Favored 'General case' 0 N--CA 1.408 -2.536 0 N-CA-C 107.8 -1.185 . . . . 73.11 107.8 177.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 513' ' ' HIS . . . . . 0.537 ' CE1' ' HA ' ' A' ' 654' ' ' SER . 23.4 m-70 -108.57 124.53 50.61 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 108.366 -0.976 . . . . 71.04 108.366 178.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 32.1 m -123.2 159.49 27.29 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.383 0 CA-C-O 121.433 0.635 . . . . 64.34 111.777 -173.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 41.2 m -75.58 152.33 37.73 Favored 'General case' 0 N--CA 1.399 -3.002 0 CA-C-N 114.012 -1.449 . . . . 74.32 109.961 -179.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . 0.673 ' OE2' 'CA ' ' A' ' 800' ' ' ' CA' . 21.7 tt0 -78.08 -48.38 16.19 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 121.408 0.623 . . . . 62.21 111.889 178.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 29.7 m -90.3 38.61 0.94 Allowed 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 122.157 0.979 . . . . 63.42 110.12 -171.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 17.4 tt -105.79 155.83 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.433 0 N-CA-C 105.855 -1.906 . . . . 75.13 105.855 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . 0.446 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . -89.93 -57.08 1.75 Allowed Glycine 0 C--N 1.289 -2.063 0 C-N-CA 119.108 -1.52 . . . . 75.22 111.185 178.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 34.3 mm -126.29 136.41 60.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 CA-C-N 115.27 -0.465 . . . . 71.12 109.847 -176.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 521' ' ' MET . . . . . 0.416 ' HE1' HG13 ' A' ' 644' ' ' VAL . 0.0 OUTLIER -114.19 130.74 56.61 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 106.419 -1.697 . . . . 74.13 106.419 170.161 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -113.07 122.84 48.78 Favored 'General case' 0 C--N 1.313 -1.019 0 O-C-N 123.379 0.425 . . . . 72.42 110.265 -176.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . 0.617 ' O ' ' HA ' ' A' ' 570' ' ' THR . 43.4 t -103.32 126.76 57.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 CA-C-N 116.246 -0.433 . . . . 71.44 110.521 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 27.8 mmtp -78.22 134.96 37.51 Favored 'General case' 0 C--N 1.317 -0.843 0 O-C-N 123.853 0.721 . . . . 74.3 111.801 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 21.5 t -115.0 142.12 29.06 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 N-CA-C 108.656 -0.868 . . . . 73.25 108.656 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -69.57 167.47 16.78 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-O 122.305 1.05 . . . . 74.32 113.448 -178.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 3.4 tpm_? -106.88 158.81 16.73 Favored 'General case' 0 N--CA 1.426 -1.668 0 CA-C-N 114.027 -1.442 . . . . 73.43 109.574 -175.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 528' ' ' THR . . . . . 0.448 ' OG1' ' HA2' ' A' ' 503' ' ' GLY . 3.3 t -73.03 160.5 31.97 Favored 'General case' 0 N--CA 1.432 -1.374 0 C-N-CA 124.003 0.921 . . . . 72.3 110.215 176.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 22.2 t -85.2 -11.67 54.41 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 108.575 -0.898 . . . . 65.54 108.575 178.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -146.51 100.74 0.23 Allowed Glycine 0 N--CA 1.438 -1.194 0 N-CA-C 109.943 -1.263 . . . . 72.03 109.943 177.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -90.36 88.55 7.24 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.115 0.483 . . . . 71.15 111.754 -176.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 -137.76 100.23 4.13 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.373 -0.973 . . . . 75.34 108.373 174.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 123.17 154.63 9.07 Favored Glycine 0 N--CA 1.429 -1.825 0 C-N-CA 120.117 -1.039 . . . . 71.43 112.365 178.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 534' ' ' ASN . . . . . 0.431 ' HA ' ' HA ' ' A' ' 563' ' ' GLN . 2.6 t-20 -98.54 119.94 38.11 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-O 121.375 0.607 . . . . 74.32 109.557 176.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 89.9 t -122.45 135.59 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-N 115.124 -0.944 . . . . 64.11 109.202 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 536' ' ' ILE . . . . . 0.579 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 43.3 mm -102.81 133.4 46.66 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.062 0 N-CA-C 108.961 -0.755 . . . . 74.33 108.961 178.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 63.6 t -119.55 110.36 37.31 Favored Pre-proline 0 C--N 1.297 -1.683 0 N-CA-C 109.772 -0.455 . . . . 75.3 109.772 178.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -74.11 152.73 45.94 Favored 'Trans proline' 0 C--O 1.24 0.592 0 C-N-CA 122.644 2.229 . . . . 74.23 111.93 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 539' ' ' TYR . . . . . 0.428 ' CE1' ' HG ' ' A' ' 560' ' ' LEU . 53.7 p90 -152.61 159.5 43.23 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.676 -0.861 . . . . 73.43 108.676 -178.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.35 150.96 16.72 Favored 'General case' 0 C--N 1.309 -1.16 0 O-C-N 123.613 0.57 . . . . 74.42 110.23 179.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 7.3 p -82.17 121.93 27.24 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 114.98 -1.009 . . . . 74.23 110.858 173.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.5 mp -93.17 118.49 39.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 105.259 -2.126 . . . . 71.11 105.259 171.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -48.15 -55.36 10.54 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 124.316 1.046 . . . . 73.22 112.406 -175.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 72.47 -102.3 1.17 Allowed Glycine 0 N--CA 1.442 -0.939 0 N-CA-C 110.702 -0.959 . . . . 54.45 110.702 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 11.4 t -118.68 -0.36 11.32 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 122.334 1.064 . . . . 73.04 109.359 177.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -88.62 143.61 26.83 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 108.342 -0.984 . . . . 61.11 108.342 173.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . 0.422 ' HG3' ' HG3' ' A' ' 551' ' ' GLU . 27.6 tpt180 -90.19 119.13 30.25 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.826 -0.805 . . . . 75.34 108.826 179.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -86.45 174.29 46.69 Favored Glycine 0 C--N 1.306 -1.13 0 C-N-CA 120.503 -0.856 . . . . 71.12 113.15 -176.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 86.0 36.2 10.38 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 121.148 -0.549 . . . . 75.54 113.416 176.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 87.87 10.8 68.95 Favored Glycine 0 N--CA 1.44 -1.055 0 C-N-CA 120.261 -0.971 . . . . 73.32 112.82 176.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . 0.422 ' HG3' ' HG3' ' A' ' 547' ' ' ARG . 7.8 mm-40 -92.72 -71.83 0.63 Allowed 'General case' 0 C--O 1.213 -0.862 0 N-CA-C 109.412 -0.588 . . . . 74.31 109.412 179.032 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . 0.606 ' OD1' 'CA ' ' A' ' 850' ' ' ' CA' . 56.5 m-20 -97.55 -30.05 13.09 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 108.626 -0.879 . . . . 74.22 108.626 176.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 553' ' ' PHE . . . . . 0.486 ' HB3' ' CE2' ' A' ' 587' ' ' PHE . 46.4 p90 -149.76 155.24 39.81 Favored 'General case' 0 N--CA 1.419 -1.989 0 CA-C-N 115.312 -0.858 . . . . 65.14 110.198 178.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -82.54 123.2 28.97 Favored 'General case' 0 C--N 1.276 -2.6 0 N-CA-C 104.48 -2.415 . . . . 74.44 104.48 175.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -60.77 121.11 11.47 Favored 'General case' 0 CA--C 1.488 -1.423 0 CA-C-O 122.237 1.017 . . . . 60.32 111.575 -175.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 98.4 m -120.22 112.64 19.32 Favored 'General case' 0 N--CA 1.388 -3.555 0 CA-C-N 114.5 -1.227 . . . . 71.1 111.806 -171.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 20.7 p -145.63 128.97 16.83 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.846 -1.168 . . . . 73.54 107.846 176.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -165.86 -155.61 8.84 Favored Glycine 0 N--CA 1.422 -2.295 0 C-N-CA 120.462 -0.875 . . . . 73.14 111.139 -176.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 559' ' ' GLU . . . . . 0.579 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 42.1 mt-10 -143.09 125.63 15.8 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 123.06 0.544 . . . . 65.42 110.269 -176.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . 0.428 ' HG ' ' CE1' ' A' ' 539' ' ' TYR . 87.7 mt -88.7 135.79 33.33 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 122.723 0.409 . . . . 75.14 110.776 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 561' ' ' GLU . . . . . 0.423 ' HG3' HD22 ' A' ' 534' ' ' ASN . 45.4 tt0 -96.38 108.57 21.11 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.601 -0.727 . . . . 73.32 110.593 179.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 562' ' ' PHE . . . . . 0.404 ' CE1' ' HG2' ' A' ' 569' ' ' LYS . 8.0 m-85 -107.74 116.92 32.82 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.234 -0.654 . . . . 74.42 109.234 173.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . 0.431 ' HA ' ' HA ' ' A' ' 534' ' ' ASN . 3.5 pt20 -119.56 -175.26 2.91 Favored 'General case' 0 C--N 1.29 -1.995 0 C-N-CA 119.068 -1.053 . . . . 73.12 112.023 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -59.06 -47.53 84.9 Favored 'General case' 0 C--N 1.318 -0.774 0 O-C-N 123.86 0.725 . . . . 75.21 109.667 177.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -77.74 -67.19 0.75 Allowed 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.278 -0.873 . . . . 75.45 111.233 -178.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . 0.431 ' H ' ' HG3' ' A' ' 563' ' ' GLN . 15.3 tt0 -56.27 113.86 1.74 Allowed 'General case' 0 C--O 1.247 0.922 0 O-C-N 123.783 0.677 . . . . 72.21 112.629 -178.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 10.4 pt -102.36 169.14 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.407 -2.591 0 N-CA-C 106.64 -1.615 . . . . 74.41 106.64 173.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 1.7 p 40.55 124.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.559 1.306 0 C-N-CA 127.069 2.147 . . . . 65.41 116.628 177.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 569' ' ' LYS . . . . . 0.404 ' HG2' ' CE1' ' A' ' 562' ' ' PHE . 32.8 mmmt -116.85 157.43 25.63 Favored 'General case' 0 C--N 1.265 -3.103 0 CA-C-N 114.921 -1.036 . . . . 72.44 110.16 178.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 570' ' ' THR . . . . . 0.617 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 1.8 p -129.88 125.27 35.2 Favored 'General case' 0 C--N 1.278 -2.538 0 CA-C-N 114.784 -1.098 . . . . 63.13 111.307 179.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 3.6 mp -84.52 111.12 19.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 106.277 -1.749 . . . . 71.14 106.277 173.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 3.1 p -95.66 109.45 21.72 Favored 'General case' 0 N--CA 1.417 -2.093 0 O-C-N 123.87 0.731 . . . . 73.4 109.918 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 573' ' ' VAL . . . . . . . . . . . . . 59.9 t -111.82 133.68 56.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 108.916 -0.772 . . . . 73.32 108.916 -178.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 574' ' ' LYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 519' ' ' GLY . 41.4 ttmt -84.81 117.14 23.68 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-O 121.444 0.64 . . . . 75.31 109.676 177.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 60.2 t -89.44 143.74 10.56 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 N-CA-C 107.08 -1.452 . . . . 75.04 107.08 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 576' ' ' ILE . . . . . 0.41 HG12 ' HA ' ' A' ' 553' ' ' PHE . 26.0 mm -111.81 132.3 60.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 C-N-CA 119.975 -0.69 . . . . 72.55 109.196 -177.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -59.65 137.53 58.01 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.301 -0.863 . . . . 73.03 108.873 178.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 578' ' ' ASP . . . . . 0.596 ' OD2' 'CA ' ' A' ' 800' ' ' ' CA' 0.413 15.9 m-20 -59.31 119.65 7.81 Favored 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 117.144 2.276 . . . . 75.23 117.144 -171.968 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 6.1 pm0 -97.07 -14.07 21.81 Favored 'General case' 0 N--CA 1.401 -2.888 0 CA-C-N 110.483 -3.053 . . . . 73.24 112.948 -172.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 580' ' ' GLU . . . . . 0.62 ' HG2' ' O ' ' A' ' 581' ' ' TYR . 2.4 pm0 -128.5 -167.23 1.74 Allowed 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 122.897 0.479 . . . . 71.33 110.016 -173.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 581' ' ' TYR . . . . . 0.62 ' O ' ' HG2' ' A' ' 580' ' ' GLU . 52.5 p90 -58.3 153.41 15.44 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 107.709 -1.219 . . . . 71.44 107.709 170.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -93.34 134.44 35.55 Favored 'General case' 0 C--N 1.275 -2.668 0 C-N-CA 116.654 -2.019 . . . . 72.33 113.36 -176.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.93 130.79 18.12 Favored 'General case' 0 N--CA 1.412 -2.331 0 N-CA-C 104.584 -2.376 . . . . 74.45 104.584 171.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -66.3 123.72 20.72 Favored 'General case' 0 CA--C 1.488 -1.434 0 N-CA-C 107.364 -1.347 . . . . 74.22 107.364 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.87 166.71 18.56 Favored 'General case' 0 C--N 1.285 -2.216 0 CA-C-N 115.604 -0.725 . . . . 73.14 109.902 -168.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 6.5 t -156.22 145.41 20.59 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-O 120.797 0.332 . . . . 64.14 110.866 -173.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 587' ' ' PHE . . . . . 0.486 ' CE2' ' HB3' ' A' ' 553' ' ' PHE . 3.4 p90 -125.33 147.76 49.01 Favored 'General case' 0 N--CA 1.42 -1.965 0 O-C-N 125.068 1.48 . . . . 74.31 109.644 176.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 588' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -100.95 127.4 47.46 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.393 -0.966 . . . . 74.22 108.393 -176.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . 0.45 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.5 OUTLIER -100.96 117.19 34.53 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 104.898 -2.26 . . . . 74.04 104.898 175.707 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -126.13 125.9 43.28 Favored 'General case' 0 C--N 1.281 -2.372 0 C-N-CA 120.233 -0.587 . . . . 72.43 109.708 -177.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 591' ' ' ILE . . . . . 0.419 HG21 ' HB3' ' A' ' 539' ' ' TYR . 14.8 pt -87.44 138.67 18.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 N-CA-C 107.828 -1.175 . . . . 74.11 107.828 173.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -98.88 -136.91 9.54 Favored Glycine 0 N--CA 1.429 -1.819 0 C-N-CA 120.381 -0.914 . . . . 64.44 114.023 -173.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.53 ' OE1' ' HA ' ' A' ' 617' ' ' PRO . 23.5 tt0 -84.64 118.36 70.86 Favored Pre-proline 0 C--N 1.294 -1.842 0 C-N-CA 124.555 1.142 . . . . 74.15 110.133 -176.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.11 150.82 72.61 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.354 2.036 . . . . 72.3 111.488 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -132.57 132.11 42.21 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 109.429 -0.582 . . . . 75.21 109.429 -177.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 596' ' ' LEU . . . . . 0.4 ' HB2' ' HD3' ' A' ' 634' ' ' PRO . 0.0 OUTLIER -80.09 134.61 36.2 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.336 -1.357 . . . . 74.43 107.336 -178.605 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 58.1 t -81.78 -49.05 18.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-O 121.868 0.842 . . . . 73.14 109.098 178.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -89.34 99.69 12.64 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 114.619 -1.173 . . . . 61.11 108.69 -177.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 599' ' ' MET . . . . . 0.441 ' HE2' ' HA ' ' A' ' 599' ' ' MET . 4.5 tpt -81.31 86.18 6.29 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 121.194 0.521 . . . . 70.2 109.835 -177.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 30.6 m -141.72 156.52 45.6 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.846 -0.798 . . . . 75.42 108.846 178.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -104.82 142.65 34.34 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 120.857 0.361 . . . . 72.14 110.252 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -140.68 127.23 20.13 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 106.918 -1.512 . . . . 74.51 106.918 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 4.4 mmpt? 64.65 23.17 12.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 123.465 0.478 . . . . 72.11 111.497 -178.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -102.25 -127.02 5.98 Favored Glycine 0 N--CA 1.42 -2.374 0 C-N-CA 120.795 -0.717 . . . . 73.45 111.501 -176.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 149.47 -137.01 6.02 Favored Glycine 0 N--CA 1.416 -2.695 0 N-CA-C 107.803 -2.119 . . . . 71.12 107.803 -176.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -149.09 107.38 3.76 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 117.595 0.698 . . . . 75.04 110.775 176.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 22.0 p -84.85 127.19 34.03 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 107.029 -1.471 . . . . 74.34 107.029 171.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 41.4 mt -73.9 99.0 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 109.047 -0.723 . . . . 74.11 109.047 -177.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 8.9 t -143.89 167.99 21.01 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 114.935 -1.029 . . . . 74.2 108.813 -176.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -97.16 4.72 51.04 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.004 0.43 . . . . 74.11 110.082 -177.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -70.24 83.78 0.55 Allowed 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 113.666 0.987 . . . . 65.11 113.666 -177.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -104.22 84.83 2.27 Favored 'General case' 0 CA--C 1.475 -1.931 0 N-CA-C 107.7 -1.222 . . . . 74.21 107.7 171.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -81.3 108.78 15.21 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 114.299 -1.319 . . . . 72.4 109.238 -176.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -97.21 92.7 6.14 Favored 'General case' 0 C--N 1.28 -2.438 0 C-N-CA 119.447 -0.901 . . . . 65.01 109.37 175.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 22.2 pttm 42.21 47.88 4.14 Favored 'General case' 0 C--N 1.319 -0.737 0 O-C-N 125.356 1.66 . . . . 71.41 114.329 177.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -78.67 162.88 63.81 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 108.749 -0.834 . . . . 74.23 108.749 176.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 617' ' ' PRO . . . . . 0.53 ' HA ' ' OE1' ' A' ' 593' ' ' GLU . 32.4 Cg_exo -63.47 -165.1 0.05 OUTLIER 'Trans proline' 0 C--O 1.25 1.084 0 C-N-CA 122.703 2.269 . . . . 63.43 112.664 176.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -55.57 116.22 2.77 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.78 0.8 . . . . 73.32 109.889 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 1.2 p -129.32 -173.82 3.11 Favored 'General case' 0 C--N 1.287 -2.118 0 CA-C-N 114.77 -1.104 . . . . 73.3 109.751 -174.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 620' ' ' SER . . . . . 0.443 ' OG ' ' HB3' ' A' ' 626' ' ' ARG . 30.0 t 72.23 24.59 3.05 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 123.833 0.708 . . . . 74.23 112.629 174.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.68 -8.09 58.41 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.141 -0.623 . . . . 72.32 110.782 178.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -115.41 -59.48 2.0 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.246 0.546 . . . . 73.43 110.874 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -73.92 125.14 27.54 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.748 -0.66 . . . . 74.44 111.485 -176.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -76.15 -33.59 59.38 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.528 -0.76 . . . . 74.42 108.966 178.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -66.54 -23.69 66.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.634 -0.712 . . . . 62.43 110.367 177.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . 0.483 ' O ' ' HG2' ' A' ' 630' ' ' GLU . 0.5 OUTLIER -66.86 -41.21 87.71 Favored 'General case' 0 C--O 1.205 -1.258 0 CA-C-N 115.306 -0.861 . . . . 75.44 109.38 176.617 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 627' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -61.89 -24.08 66.72 Favored 'General case' 0 C--O 1.22 -0.494 0 CA-C-N 116.048 -0.524 . . . . 73.55 111.543 -178.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 74.5 mt -71.05 -43.9 75.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 121.652 0.739 . . . . 75.44 109.341 176.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -72.02 -38.26 69.6 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.377 -0.829 . . . . 64.11 109.603 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 630' ' ' GLU . . . . . 0.483 ' HG2' ' O ' ' A' ' 626' ' ' ARG . 24.0 mm-40 -74.61 -4.11 35.19 Favored 'General case' 0 C--O 1.211 -0.969 0 CA-C-N 115.627 -0.715 . . . . 73.22 110.972 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 631' ' ' MET . . . . . . . . . . . . . 44.4 ttm -81.52 -11.24 59.25 Favored 'General case' 0 N--CA 1.422 -1.839 0 N-CA-C 108.757 -0.831 . . . . 74.3 108.757 177.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -93.85 5.34 72.73 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 108.789 -1.724 . . . . 75.33 108.789 172.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 80.7 mtt180 -125.26 174.17 4.17 Favored Pre-proline 0 N--CA 1.428 -1.557 0 C-N-CA 125.632 1.573 . . . . 74.3 107.963 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.4 ' HD3' ' HB2' ' A' ' 596' ' ' LEU . 74.5 Cg_endo -94.26 151.47 2.05 Favored 'Trans proline' 0 N--CA 1.428 -2.336 0 C-N-CA 121.504 1.47 . . . . 74.1 110.816 173.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.2 pp -112.91 173.37 2.81 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 CA-C-N 116.375 -0.375 . . . . 71.13 111.451 -178.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 14.0 tp -78.91 158.37 28.07 Favored 'General case' 0 N--CA 1.433 -1.296 0 O-C-N 123.182 0.301 . . . . 73.34 110.432 -177.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' A' ' 505' ' ' PHE . . . -76.44 -107.04 0.13 Allowed Glycine 0 N--CA 1.435 -1.424 0 N-CA-C 115.032 0.773 . . . . 73.03 115.032 -177.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -127.5 -70.66 0.7 Allowed 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.033 -0.729 . . . . 65.54 109.033 -175.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 12.8 p80 -132.84 114.76 14.46 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 109.059 -0.719 . . . . 75.3 109.059 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 30.8 p -98.46 91.3 5.12 Favored 'General case' 0 N--CA 1.407 -2.622 0 CA-C-O 121.626 0.727 . . . . 71.41 109.885 -178.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -170.96 129.9 0.77 Allowed 'General case' 0 CA--C 1.498 -1.036 0 CA-C-N 115.437 -0.801 . . . . 75.23 109.311 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 642' ' ' LEU . . . . . 0.461 ' CD2' HG23 ' A' ' 523' ' ' VAL . 27.8 tp -137.08 109.88 7.59 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 107.45 -1.315 . . . . 74.44 107.45 172.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . 0.448 ' HB3' HG23 ' A' ' 511' ' ' VAL . 19.3 tt0 -94.34 104.1 16.09 Favored 'General case' 0 C--N 1.273 -2.741 0 N-CA-C 107.12 -1.437 . . . . 70.32 107.12 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 644' ' ' VAL . . . . . 0.416 HG13 ' HE1' ' A' ' 521' ' ' MET . 25.4 t -95.56 108.01 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.194 0 N-CA-C 109.559 -0.534 . . . . 75.42 109.559 -177.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 3.5 mp -94.84 124.81 47.49 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 107.233 -1.395 . . . . 73.22 107.233 177.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 646' ' ' ILE . . . . . 0.51 ' N ' HD13 ' A' ' 646' ' ' ILE . 2.8 mp -104.35 115.68 46.72 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.438 0 N-CA-C 107.601 -1.259 . . . . 75.43 107.601 -174.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -121.16 168.92 11.05 Favored 'General case' 0 N--CA 1.419 -2.007 0 O-C-N 123.608 0.568 . . . . 60.24 109.585 -175.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -69.95 157.9 36.61 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 112.766 0.654 . . . . 65.43 112.766 -172.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 20.2 t -75.94 85.37 2.86 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 106.573 -1.64 . . . . 74.45 106.573 175.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -163.33 -66.9 0.04 OUTLIER 'General case' 0 N--CA 1.433 -1.315 0 C-N-CA 124.977 1.311 . . . . 74.42 108.077 -174.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -161.81 -174.11 4.03 Favored 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 106.4 -1.704 . . . . 74.34 106.4 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -126.6 154.52 43.83 Favored 'General case' 0 N--CA 1.397 -3.082 0 N-CA-C 108.164 -1.05 . . . . 65.42 108.164 178.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -115.44 67.43 0.7 Allowed 'General case' 0 C--N 1.271 -2.808 0 N-CA-C 105.782 -1.933 . . . . 73.02 105.782 177.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 654' ' ' SER . . . . . 0.537 ' HA ' ' CE1' ' A' ' 513' ' ' HIS . 41.0 m -61.79 94.43 0.05 OUTLIER 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 114.88 -1.055 . . . . 75.24 110.342 -177.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 4.2 t -94.98 80.22 3.64 Favored 'General case' 0 N--CA 1.405 -2.712 0 CA-C-O 121.977 0.894 . . . . 64.01 111.794 -177.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 5.1 p -90.76 82.33 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.081 0 N-CA-C 106.397 -1.705 . . . . 74.51 106.397 172.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 9.3 t70 . . . . . 0 C--N 1.289 -2.053 0 CA-C-N 112.739 -2.028 . . . . 73.21 109.844 -169.565 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 800' ' ' ' CA' . . . . . 0.673 'CA ' ' OE2' ' A' ' 516' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 850' ' ' ' CA' . . . . . 0.606 'CA ' ' OD1' ' A' ' 552' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 17.2 t-160 . . . . . 0 N--CA 1.454 -0.269 0 CA-C-O 120.917 0.389 . . . . 72.34 111.714 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -115.07 -40.18 3.52 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.533 -0.914 . . . . 73.34 108.533 171.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . 0.614 ' HA2' ' OG1' ' A' ' 528' ' ' THR . . . -171.14 139.67 5.54 Favored Glycine 0 N--CA 1.415 -2.738 0 C-N-CA 119.214 -1.47 . . . . 72.43 113.063 179.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 3.7 mp -116.31 112.39 39.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 107.1 -1.444 . . . . 74.23 107.1 175.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -119.7 125.56 48.98 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.57 -0.9 . . . . 72.22 108.57 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 506' ' ' THR . . . . . 0.413 ' HB ' ' HA3' ' A' ' 637' ' ' GLY . 15.1 t -155.44 169.44 24.25 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 109.77 -0.456 . . . . 74.23 109.77 -174.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -98.81 161.15 13.8 Favored 'General case' 0 C--O 1.249 1.063 0 N-CA-C 106.243 -1.762 . . . . 71.52 106.243 172.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . 0.43 ' HG2' HD21 ' A' ' 526' ' ' LEU . 3.4 pt-20 -99.17 -27.93 13.58 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 120.387 -0.525 . . . . 75.41 110.734 176.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -114.26 119.16 40.85 Favored Pre-proline 0 N--CA 1.43 -1.463 0 N-CA-C 107.647 -1.242 . . . . 74.25 107.647 174.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -83.39 -4.28 10.92 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 121.902 1.735 . . . . 71.01 111.951 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 88.3 t -143.27 134.9 23.66 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.069 0 N-CA-C 108.036 -1.098 . . . . 72.41 108.036 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 4.7 t -139.5 151.49 46.19 Favored 'General case' 0 N--CA 1.404 -2.766 0 N-CA-C 108.099 -1.075 . . . . 62.44 108.099 176.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 513' ' ' HIS . . . . . 0.456 ' CD2' ' HB ' ' A' ' 645' ' ' ILE . 47.0 m80 -117.3 116.86 28.05 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 109.168 -0.678 . . . . 72.21 109.168 179.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.683 HG13 ' SD ' ' A' ' 521' ' ' MET . 31.0 m -111.6 153.13 13.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 C-N-CA 120.469 -0.492 . . . . 75.52 110.909 -177.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 515' ' ' SER . . . . . 0.501 ' HA ' ' OE2' ' A' ' 647' ' ' GLU . 40.5 t -76.59 143.88 39.97 Favored 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 114.945 -1.025 . . . . 64.31 109.715 -178.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . 0.639 ' OE2' 'CA ' ' A' ' 800' ' ' ' CA' . 35.4 tt0 -68.71 -10.24 55.22 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.449 0.643 . . . . 74.43 111.195 178.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 20.5 t -115.49 21.93 13.61 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 109.317 -0.623 . . . . 65.21 109.317 -177.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 518' ' ' ILE . . . . . 0.426 HG21 ' O ' ' A' ' 515' ' ' SER . 15.1 tt -90.29 151.0 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 N-CA-C 108.847 -0.797 . . . . 75.23 108.847 178.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -96.35 -63.94 0.94 Allowed Glycine 0 N--CA 1.429 -1.822 0 C-N-CA 120.05 -1.071 . . . . 70.22 111.517 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 30.3 mm -119.04 118.18 56.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 109.635 -0.505 . . . . 75.45 109.635 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 521' ' ' MET . . . . . 0.683 ' SD ' HG13 ' A' ' 514' ' ' VAL . 25.1 ptt? -99.91 129.48 46.0 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 107.153 -1.425 . . . . 74.02 107.153 173.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 522' ' ' GLU . . . . . 0.555 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 30.9 mt-10 -117.43 130.18 56.3 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.849 -0.614 . . . . 72.15 109.95 175.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 570' ' ' THR . 29.3 t -113.52 130.08 68.18 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 CA-C-N 115.207 -0.906 . . . . 75.22 109.117 -178.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . 0.427 ' HD2' HG22 ' A' ' 568' ' ' VAL . 32.3 mmtp -75.42 126.81 31.77 Favored 'General case' 0 C--N 1.31 -1.122 0 O-C-N 124.045 0.841 . . . . 74.34 112.4 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 8.9 t -105.16 140.27 23.69 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 N-CA-C 107.188 -1.412 . . . . 74.52 107.188 177.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . 0.43 HD21 ' HG2' ' A' ' 508' ' ' GLU . 2.4 mm? -90.3 139.39 30.71 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 120.804 -0.359 . . . . 71.52 110.033 -178.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . 0.464 ' HG2' ' N ' ' A' ' 528' ' ' THR . 39.0 ttp180 -76.26 158.45 31.56 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 115.349 -0.842 . . . . 73.11 109.186 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 528' ' ' THR . . . . . 0.614 ' OG1' ' HA2' ' A' ' 503' ' ' GLY . 3.2 t -61.87 160.75 11.51 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 123.855 0.862 . . . . 72.22 111.03 173.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 23.1 t -78.81 -26.49 44.29 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 108.673 -0.862 . . . . 72.31 108.673 178.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -121.14 104.52 0.96 Allowed Glycine 0 N--CA 1.442 -0.941 0 N-CA-C 109.579 -1.408 . . . . 62.42 109.579 178.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -100.8 98.47 8.98 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 120.848 0.356 . . . . 64.22 111.539 -176.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -130.85 119.82 22.77 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.862 -0.608 . . . . 71.45 110.08 178.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 86.6 -177.85 48.6 Favored Glycine 0 N--CA 1.438 -1.207 0 C-N-CA 120.693 -0.765 . . . . 74.52 112.433 176.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 534' ' ' ASN . . . . . 0.492 HD22 ' HG3' ' A' ' 561' ' ' GLU . 2.8 t-20 -99.07 130.58 45.41 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.15 -1.055 . . . . 73.34 108.15 178.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 58.7 t -127.6 131.37 70.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-O 120.84 0.352 . . . . 73.15 110.095 -176.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 536' ' ' ILE . . . . . 0.459 HG21 ' HB3' ' A' ' 559' ' ' GLU . 33.1 mm -98.41 129.76 48.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 N-CA-C 109.266 -0.642 . . . . 74.13 109.266 177.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . 0.405 HG23 ' HB3' ' A' ' 594' ' ' PRO . 21.6 t -118.56 101.54 50.72 Favored Pre-proline 0 C--N 1.314 -0.978 0 N-CA-C 109.156 -0.683 . . . . 73.24 109.156 179.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.21 151.12 54.48 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.943 2.428 . . . . 72.33 112.131 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 539' ' ' TYR . . . . . 0.432 ' CD1' ' HG ' ' A' ' 560' ' ' LEU . 45.4 p90 -149.45 162.43 40.13 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 109.385 -0.598 . . . . 72.12 109.385 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -157.59 156.27 31.6 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 123.797 0.686 . . . . 74.11 109.919 177.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 3.2 p -91.12 122.22 33.58 Favored 'General case' 0 N--CA 1.423 -1.816 0 O-C-N 123.636 0.585 . . . . 73.33 109.78 173.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.7 mp -92.7 118.63 38.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 105.915 -1.884 . . . . 73.41 105.915 174.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -50.25 -46.05 54.62 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 124.361 1.038 . . . . 74.12 111.656 -176.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 67.34 -106.24 1.61 Allowed Glycine 0 N--CA 1.426 -1.971 0 N-CA-C 110.616 -0.994 . . . . 73.44 110.616 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 11.5 t -118.81 6.64 11.49 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-O 121.615 0.722 . . . . 74.41 109.973 -178.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -86.06 170.32 12.35 Favored 'General case' 0 N--CA 1.442 -0.874 0 O-C-N 122.029 -0.419 . . . . 54.24 110.468 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . 0.448 ' HB2' ' HB2' ' A' ' 552' ' ' ASP . 29.8 mmt180 -69.76 174.05 5.57 Favored 'General case' 0 CA--C 1.502 -0.886 0 CA-C-N 116.007 -0.542 . . . . 73.32 110.964 176.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -68.46 172.89 34.19 Favored Glycine 0 C--N 1.295 -1.731 0 CA-C-N 114.954 -1.021 . . . . 65.43 114.157 -176.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . -62.37 123.35 30.73 Favored Glycine 0 N--CA 1.435 -1.386 0 CA-C-N 115.131 -0.535 . . . . 62.33 111.797 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 95.94 -17.75 58.71 Favored Glycine 0 N--CA 1.437 -1.295 0 N-CA-C 111.553 -0.619 . . . . 72.43 111.553 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -84.72 -66.61 0.87 Allowed 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 109.123 -0.695 . . . . 73.22 109.123 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . 0.63 ' OD1' 'CA ' ' A' ' 850' ' ' ' CA' . 1.2 m-20 -107.47 -22.37 12.57 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.664 -0.414 . . . . 72.22 111.728 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -151.87 151.94 31.94 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 108.849 -0.797 . . . . 74.23 108.849 177.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.49 122.06 30.74 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 106.048 -1.834 . . . . 75.13 106.048 177.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -74.38 105.99 5.79 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.128 0.489 . . . . 71.03 111.231 -175.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 13.5 t -104.08 119.99 40.13 Favored 'General case' 0 N--CA 1.414 -2.271 0 CA-C-O 122.324 1.059 . . . . 74.13 109.917 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 1.2 p -136.96 105.01 5.63 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-N 114.608 -1.178 . . . . 74.12 108.728 178.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -151.34 -152.3 5.83 Favored Glycine 0 N--CA 1.416 -2.663 0 N-CA-C 110.743 -0.943 . . . . 64.14 110.743 -174.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 559' ' ' GLU . . . . . 0.459 ' HB3' HG21 ' A' ' 536' ' ' ILE . 52.2 mt-10 -142.47 129.28 20.53 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.163 0.506 . . . . 74.12 110.952 -175.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . 0.432 ' HG ' ' CD1' ' A' ' 539' ' ' TYR . 92.8 mt -91.17 139.47 30.72 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.527 -0.761 . . . . 73.11 109.678 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 561' ' ' GLU . . . . . 0.492 ' HG3' HD22 ' A' ' 534' ' ' ASN . 28.2 tt0 -100.26 115.68 30.49 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.517 0.675 . . . . 75.32 111.474 178.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -109.37 158.82 17.54 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 107.355 -1.35 . . . . 73.03 107.355 171.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . 0.407 ' HB3' HD21 ' A' ' 534' ' ' ASN . 10.6 pt20 -165.87 179.24 6.0 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 109.803 -0.443 . . . . 75.13 109.803 177.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -59.47 -32.31 70.13 Favored 'General case' 0 C--N 1.322 -0.612 0 O-C-N 124.083 0.864 . . . . 73.3 110.468 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -88.85 -12.41 41.98 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.406 -0.816 . . . . 72.43 111.249 -177.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -100.96 132.79 46.2 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 113.244 0.831 . . . . 74.14 113.244 -176.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 3.9 pt -120.27 156.11 23.25 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.065 0 N-CA-C 105.823 -1.917 . . . . 72.44 105.823 170.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 568' ' ' VAL . . . . . 0.427 HG22 ' HD2' ' A' ' 524' ' ' LYS . 1.0 OUTLIER 48.11 178.34 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.578 2.03 0 C-N-CA 125.708 1.603 . . . . 70.02 113.003 -177.403 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 569' ' ' LYS . . . . . 0.402 ' HG2' HD12 ' A' ' 560' ' ' LEU . 1.4 tpmt? -172.01 163.59 6.12 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 106.067 -1.827 . . . . 73.03 106.067 175.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 570' ' ' THR . . . . . 0.55 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 11.5 p -135.58 141.26 45.13 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 123.45 0.469 . . . . 62.23 110.779 176.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 571' ' ' ILE . . . . . 0.555 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 3.5 mp -97.28 122.13 48.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 N-CA-C 106.166 -1.79 . . . . 62.45 106.166 169.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 40.4 p -99.96 118.69 36.9 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 109.329 -0.619 . . . . 72.35 109.329 177.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 573' ' ' VAL . . . . . . . . . . . . . 45.2 t -117.48 126.64 74.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 108.887 -0.783 . . . . 74.41 108.887 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -77.89 106.73 9.93 Favored 'General case' 0 N--CA 1.421 -1.907 0 N-CA-C 108.608 -0.886 . . . . 72.42 108.608 174.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 62.1 t -84.19 119.81 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.378 0 N-CA-C 105.757 -1.942 . . . . 75.33 105.757 175.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 39.4 mm -76.87 131.09 35.49 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 106.776 -1.565 . . . . 73.14 106.776 -177.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -60.29 99.16 0.07 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 122.092 0.949 . . . . 71.34 109.773 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 578' ' ' ASP . . . . . 0.616 ' OD1' 'CA ' ' A' ' 850' ' ' ' CA' . 19.1 t70 -61.64 133.77 56.01 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 114.346 -1.297 . . . . 63.42 113.93 -172.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 579' ' ' GLU . . . . . 0.59 ' OE2' 'CA ' ' A' ' 850' ' ' ' CA' . 0.6 OUTLIER -96.36 -13.83 22.96 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 113.599 -1.637 . . . . 74.14 113.883 -173.973 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -124.99 166.76 15.76 Favored 'General case' 0 C--O 1.264 1.826 0 C-N-CA 117.936 -1.506 . . . . 73.5 113.491 -176.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -71.86 153.37 41.94 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 107.664 -1.235 . . . . 74.33 107.664 178.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 582' ' ' GLU . . . . . 0.61 ' OE1' 'CA ' ' A' ' 800' ' ' ' CA' . 6.1 pt-20 -148.79 166.1 29.48 Favored 'General case' 0 C--N 1.278 -2.531 0 N-CA-C 108.619 -0.882 . . . . 73.44 108.619 176.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . 0.451 ' O ' ' HB2' ' A' ' 584' ' ' ASN . 34.1 mmtp -106.59 30.22 6.23 Favored 'General case' 0 C--N 1.286 -2.186 0 CA-C-O 122.814 1.293 . . . . 74.21 107.825 176.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 584' ' ' ASN . . . . . 0.517 ' ND2' ' HA ' ' A' ' 647' ' ' GLU . 19.9 m120 80.26 96.12 0.05 Allowed 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 110.902 -2.863 . . . . 72.4 111.491 178.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.14 163.0 19.02 Favored 'General case' 0 N--CA 1.434 -1.267 0 C-N-CA 119.434 -0.906 . . . . 73.44 109.955 176.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 6.0 t -148.49 143.77 26.92 Favored 'General case' 0 N--CA 1.415 -2.188 0 CA-C-O 120.97 0.415 . . . . 65.5 110.059 -177.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 587' ' ' PHE . . . . . 0.408 ' CZ ' HD13 ' A' ' 646' ' ' ILE . 3.1 p90 -129.38 149.62 51.08 Favored 'General case' 0 N--CA 1.418 -2.042 0 CA-C-N 114.305 -1.316 . . . . 75.43 108.711 177.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 588' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -106.81 136.25 46.96 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 116.41 -0.359 . . . . 75.33 110.086 -172.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . 0.432 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.4 OUTLIER -105.87 122.97 47.2 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 105.466 -2.05 . . . . 74.43 105.466 174.87 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -130.67 135.38 47.78 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 109.627 -0.508 . . . . 73.33 109.627 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 591' ' ' ILE . . . . . 0.402 HG22 ' HB3' ' A' ' 539' ' ' TYR . 19.6 pt -96.93 141.06 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.552 0 N-CA-C 106.839 -1.541 . . . . 71.44 106.839 173.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -95.9 -134.13 7.77 Favored Glycine 0 C--N 1.295 -1.729 0 C-N-CA 120.604 -0.808 . . . . 44.43 113.026 -175.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -85.19 116.05 63.82 Favored Pre-proline 0 C--N 1.303 -1.438 0 C-N-CA 122.958 0.503 . . . . 63.02 110.667 -177.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 594' ' ' PRO . . . . . 0.437 ' HA ' ' O ' ' A' ' 536' ' ' ILE . 59.8 Cg_endo -75.16 137.07 20.9 Favored 'Trans proline' 0 N--CA 1.431 -2.191 0 C-N-CA 121.316 1.344 . . . . 74.51 109.377 173.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -129.96 137.9 50.56 Favored 'General case' 0 C--N 1.285 -2.213 0 O-C-N 121.876 -0.515 . . . . 75.04 111.548 -175.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -77.18 124.81 28.35 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 107.905 -1.146 . . . . 73.54 107.905 -176.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 23.1 t -86.31 -45.74 16.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 CA-C-O 121.301 0.572 . . . . 74.1 109.667 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -83.47 141.99 31.26 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.688 -0.687 . . . . 74.01 110.863 -176.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 17.9 ptm -96.48 100.26 11.87 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-O 121.977 0.894 . . . . 75.01 109.964 178.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 33.5 t -144.42 120.8 10.95 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 107.431 -1.322 . . . . 70.34 107.431 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 60.79 27.3 17.09 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.299 1.039 . . . . 75.21 109.904 -177.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . 0.473 ' HE2' ' HA ' ' A' ' 602' ' ' LYS . 0.5 OUTLIER -88.73 96.15 10.55 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-N 114.509 -1.223 . . . . 74.12 108.426 -175.855 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -139.99 151.07 45.2 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.239 0.542 . . . . 74.42 112.048 -179.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -116.51 77.88 0.28 Allowed Glycine 0 C--N 1.303 -1.298 0 N-CA-C 108.87 -1.692 . . . . 64.41 108.87 175.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . -71.59 104.16 1.4 Allowed Glycine 0 N--CA 1.428 -1.859 0 CA-C-N 115.264 -0.468 . . . . 72.03 113.091 -175.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 60.78 32.43 20.16 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.581 1.153 . . . . 72.14 111.971 174.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 2.0 p -72.7 127.5 32.74 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-O 121.07 0.462 . . . . 74.14 111.23 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 36.6 mm -92.94 79.38 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 N-CA-C 108.577 -0.897 . . . . 73.31 108.577 -177.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 11.5 t 176.54 169.68 0.47 Allowed 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 114.901 -1.045 . . . . 73.12 108.554 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -111.25 -3.79 15.22 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 107.97 -1.122 . . . . 74.11 107.97 171.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 611' ' ' GLU . . . . . 0.444 ' HB3' ' HB3' ' A' ' 614' ' ' ASP . 23.4 mm-40 -82.52 52.67 2.13 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 115.0 -1.0 . . . . 74.34 110.033 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 612' ' ' TYR . . . . . 0.463 ' OH ' ' HG3' ' A' ' 602' ' ' LYS . 73.3 t80 -75.98 119.01 19.35 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 108.013 -1.106 . . . . 73.42 108.013 177.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 613' ' ' ASP . . . . . 0.437 ' CG ' ' HZ3' ' A' ' 602' ' ' LYS . 0.9 OUTLIER 51.96 43.86 29.94 Favored 'General case' 0 CA--C 1.512 -0.494 0 O-C-N 124.24 0.962 . . . . 64.4 109.92 -177.541 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 614' ' ' ASP . . . . . 0.444 ' HB3' ' HB3' ' A' ' 611' ' ' GLU . 3.8 p30 -55.31 167.83 0.42 Allowed 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 125.419 1.488 . . . . 74.13 114.762 -174.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -112.1 24.21 12.86 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 114.22 -1.355 . . . . 74.53 110.963 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -75.37 148.43 83.41 Favored Pre-proline 0 C--O 1.249 1.072 0 N-CA-C 106.312 -1.736 . . . . 74.11 106.312 175.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -57.41 164.48 7.01 Favored 'Trans proline' 0 C--O 1.245 0.874 0 C-N-CA 121.235 1.29 . . . . 74.32 110.64 175.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -57.49 112.54 1.45 Allowed 'General case' 0 C--N 1.319 -0.742 0 O-C-N 123.312 0.382 . . . . 73.1 111.494 -174.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 15.3 t -149.37 161.91 41.13 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 108.967 -0.753 . . . . 64.12 108.967 -178.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 620' ' ' SER . . . . . 0.485 ' HA ' ' HG3' ' A' ' 626' ' ' ARG . 12.0 p -150.1 -36.67 0.15 Allowed 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 123.345 0.658 . . . . 74.53 110.142 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 66.5 mttm 61.75 20.95 11.81 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.87 0.868 . . . . 74.35 111.732 173.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 55.97 24.46 7.71 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.559 1.144 . . . . 74.42 111.154 -174.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . 0.504 ' O ' ' HB3' ' A' ' 626' ' ' ARG . 32.8 tt0 -75.24 139.45 42.57 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 109.081 -0.711 . . . . 70.33 109.081 -179.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.81 -53.66 30.54 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.496 -0.928 . . . . 54.52 108.496 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -54.0 -29.8 44.71 Favored 'General case' 0 C--O 1.249 1.068 0 C-N-CA 123.894 0.878 . . . . 75.44 113.346 -179.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . 0.504 ' HB3' ' O ' ' A' ' 623' ' ' GLU . 0.0 OUTLIER -47.79 -35.04 9.38 Favored 'General case' 0 N--CA 1.435 -1.209 0 C-N-CA 124.511 1.124 . . . . 75.22 113.351 174.921 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 627' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -63.14 -26.59 68.88 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.367 0.877 . . . . 75.42 113.367 -177.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 95.7 mt -67.58 -38.27 80.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 N-CA-C 108.981 -0.748 . . . . 73.33 108.981 176.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -73.32 -32.54 64.64 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.444 -0.798 . . . . 61.02 110.382 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 630' ' ' GLU . . . . . 0.457 ' HG2' ' O ' ' A' ' 626' ' ' ARG . 13.7 mm-40 -66.09 -24.53 66.72 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.167 0.587 . . . . 70.31 111.407 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 631' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -95.22 -7.15 39.87 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 119.927 -0.709 . . . . 73.21 110.57 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -97.58 -44.24 2.75 Favored Glycine 0 N--CA 1.43 -1.705 0 N-CA-C 110.019 -1.233 . . . . 52.33 110.019 177.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -101.75 126.64 33.4 Favored Pre-proline 0 C--N 1.306 -1.323 0 N-CA-C 107.734 -1.21 . . . . 75.0 107.734 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -66.17 142.05 65.74 Favored 'Trans proline' 0 N--CA 1.437 -1.82 0 N-CA-C 108.204 -1.499 . . . . 75.14 108.204 171.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.3 pp -122.88 176.26 4.99 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 N-CA-C 113.677 0.992 . . . . 73.23 113.677 -173.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.91 152.21 28.2 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 114.881 -1.054 . . . . 73.22 108.5 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . 0.413 ' HA3' ' HB ' ' A' ' 506' ' ' THR . . . -80.74 -135.96 1.69 Allowed Glycine 0 C--N 1.293 -1.851 0 C-N-CA 120.864 -0.684 . . . . 73.21 113.668 -176.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -83.56 -58.67 2.72 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 120.125 -0.63 . . . . 74.14 109.969 -177.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -125.75 94.38 4.1 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 121.85 0.834 . . . . 72.35 111.905 -178.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 17.8 p -96.03 90.67 5.64 Favored 'General case' 0 N--CA 1.407 -2.595 0 N-CA-C 107.878 -1.156 . . . . 74.34 107.878 174.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -172.5 134.4 0.66 Allowed 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 105.583 -2.006 . . . . 73.43 105.583 -175.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 642' ' ' LEU . . . . . 0.486 ' CD2' HG21 ' A' ' 523' ' ' VAL . 37.1 tp -134.93 106.34 6.8 Favored 'General case' 0 C--N 1.277 -2.583 0 N-CA-C 108.02 -1.104 . . . . 72.43 108.02 177.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -87.66 104.25 16.35 Favored 'General case' 0 C--N 1.277 -2.565 0 N-CA-C 106.748 -1.575 . . . . 74.31 106.748 178.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 644' ' ' VAL . . . . . 0.406 HG23 ' HE3' ' A' ' 521' ' ' MET . 40.1 t -94.06 106.02 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.155 0 N-CA-C 108.372 -0.973 . . . . 73.33 108.372 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 645' ' ' ILE . . . . . 0.456 ' HB ' ' CD2' ' A' ' 513' ' ' HIS . 3.8 mp -93.38 126.89 45.75 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 106.615 -1.624 . . . . 74.43 106.615 176.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 646' ' ' ILE . . . . . 0.531 HD12 ' N ' ' A' ' 646' ' ' ILE . 2.4 mp -99.11 124.02 52.12 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.249 0 N-CA-C 106.626 -1.62 . . . . 64.04 106.626 -177.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . 0.517 ' HA ' ' ND2' ' A' ' 584' ' ' ASN . 0.0 OUTLIER -109.07 152.44 25.04 Favored 'General case' 0 C--N 1.266 -3.024 0 CA-C-N 115.598 -0.728 . . . . 73.43 109.518 -178.599 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . 0.43 ' CD ' ' HG2' ' A' ' 582' ' ' GLU . 25.5 mt-10 -83.79 75.31 10.1 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-O 122.327 1.061 . . . . 72.55 110.788 -176.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 18.2 m 30.88 82.5 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 129.024 2.93 . . . . 74.41 115.31 -176.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -114.83 -65.06 1.23 Allowed 'General case' 0 N--CA 1.431 -1.388 0 CA-C-N 114.83 -1.077 . . . . 74.24 108.728 174.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 178.02 167.33 0.75 Allowed 'General case' 0 CA--C 1.552 1.02 0 O-C-N 123.677 0.61 . . . . 74.4 109.371 -176.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -86.32 127.43 34.79 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 123.607 0.763 . . . . 74.22 108.98 -177.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -126.5 115.01 18.89 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 116.246 -0.434 . . . . 74.0 112.006 -177.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 25.6 m -95.18 96.4 9.18 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.284 0.564 . . . . 74.33 109.746 176.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 51.8 m -145.5 107.31 4.28 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 109.435 -0.58 . . . . 75.44 109.435 179.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 56.5 t -107.78 119.26 57.08 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-N 115.976 -0.556 . . . . 72.44 109.87 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 . . . . . 0 C--N 1.307 -1.272 0 N-CA-C 109.212 -0.662 . . . . 71.04 109.212 176.79 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 800' ' ' ' CA' . . . . . 0.639 'CA ' ' OE2' ' A' ' 516' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 850' ' ' ' CA' . . . . . 0.63 'CA ' ' OD1' ' A' ' 552' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 4.4 t60 . . . . . 0 N--CA 1.446 -0.652 0 N-CA-C 108.711 -0.848 . . . . 72.11 108.711 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . 0.492 ' HB1' ' H ' ' A' ' 635' ' ' ILE . . . -138.15 -165.48 1.8 Allowed 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 107.136 -1.431 . . . . 74.24 107.136 177.114 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -129.5 173.62 19.57 Favored Glycine 0 N--CA 1.41 -3.074 0 C-N-CA 118.328 -1.891 . . . . 73.21 113.803 -175.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . 0.442 ' H ' ' CB ' ' A' ' 528' ' ' THR . 3.6 mp -119.57 96.48 4.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 107.463 -1.31 . . . . 75.54 107.463 173.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -108.71 115.04 29.34 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 106.135 -1.802 . . . . 74.32 106.135 178.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 506' ' ' THR . . . . . 0.44 ' HB ' ' H ' ' A' ' 638' ' ' GLU . 15.0 t -147.71 164.33 33.91 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 120.232 -0.587 . . . . 73.04 109.478 -173.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -94.35 160.24 14.76 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 107.658 -1.238 . . . . 73.32 107.658 173.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -91.04 -33.46 15.5 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 107.445 -1.317 . . . . 74.51 107.445 -179.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -124.16 134.95 25.84 Favored Pre-proline 0 N--CA 1.414 -2.241 0 CA-C-N 114.369 -1.287 . . . . 75.31 109.538 179.087 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . 0.606 ' HA ' ' O ' ' A' ' 641' ' ' LYS . 81.9 Cg_endo -85.76 -4.64 9.02 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 121.82 1.68 . . . . 74.23 111.416 174.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . 0.447 ' HB ' HG12 ' A' ' 656' ' ' VAL . 81.9 t -143.64 134.71 22.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 C-N-CA 123.882 0.873 . . . . 72.32 108.672 -178.214 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 14.6 t -134.06 132.12 39.62 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 107.265 -1.383 . . . . 74.4 107.265 175.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 28.5 m-70 -100.52 121.63 41.89 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.485 -0.931 . . . . 65.22 108.485 177.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.649 HG13 ' SD ' ' A' ' 521' ' ' MET . 33.0 m -115.02 156.66 15.93 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 CA-C-N 116.27 -0.423 . . . . 73.44 109.983 -177.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 22.9 t -82.89 133.12 35.13 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 107.822 -1.177 . . . . 74.24 107.822 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -68.31 -7.52 31.74 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 112.07 0.396 . . . . 75.45 112.07 -177.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 45.6 p -103.09 8.02 38.78 Favored 'General case' 0 C--N 1.313 -0.992 0 O-C-N 121.63 -0.669 . . . . 71.11 110.655 179.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 12.4 tt -80.23 152.02 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 N-CA-C 109.536 -0.542 . . . . 74.14 109.536 -177.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -91.23 -61.45 1.26 Allowed Glycine 0 N--CA 1.426 -1.982 0 C-N-CA 120.253 -0.975 . . . . 73.02 110.996 177.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 28.3 mm -121.18 128.42 76.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-O 121.068 0.461 . . . . 60.04 110.849 -177.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 521' ' ' MET . . . . . 0.649 ' SD ' HG13 ' A' ' 514' ' ' VAL . 24.0 ptt? -107.95 140.71 40.68 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 107.3 -1.37 . . . . 73.44 107.3 171.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -119.61 113.0 20.03 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-O 121.185 0.517 . . . . 71.43 109.957 -178.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . 0.643 ' O ' ' HA ' ' A' ' 570' ' ' THR . 47.3 t -93.04 126.45 45.47 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.31 0 CA-C-N 115.258 -0.883 . . . . 71.21 109.769 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . 0.409 ' HD2' HG21 ' A' ' 568' ' ' VAL . 31.4 mmtp -87.47 142.6 27.74 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 124.329 1.018 . . . . 73.41 111.427 -178.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 26.8 t -120.0 132.8 68.69 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 N-CA-C 107.016 -1.476 . . . . 73.54 107.016 176.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -71.84 139.01 48.7 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-O 121.322 0.582 . . . . 75.44 110.902 -179.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . 0.482 ' HD3' ' CZ ' ' A' ' 562' ' ' PHE . 13.6 tpt85 -79.37 127.4 32.04 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 114.839 -1.073 . . . . 75.25 110.001 179.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 528' ' ' THR . . . . . 0.442 ' CB ' ' H ' ' A' ' 504' ' ' ILE . 2.6 t -60.67 146.65 44.86 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 113.979 -1.464 . . . . 73.15 111.561 175.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 32.6 t -61.58 -35.58 78.24 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 115.143 -0.935 . . . . 75.33 109.239 176.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -120.6 110.01 1.67 Allowed Glycine 0 N--CA 1.423 -2.185 0 N-CA-C 110.489 -1.044 . . . . 64.23 110.489 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -127.14 112.29 14.99 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.326 -0.99 . . . . 74.13 108.326 176.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -119.01 102.61 8.88 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 120.891 0.377 . . . . 73.54 111.192 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 93.54 -153.72 21.42 Favored Glycine 0 N--CA 1.43 -1.724 0 CA-C-N 115.534 -0.757 . . . . 61.43 112.261 175.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 534' ' ' ASN . . . . . 0.503 HD22 ' HG3' ' A' ' 561' ' ' GLU . 2.4 t-20 -104.24 126.16 51.12 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.183 -0.673 . . . . 73.54 109.183 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 55.6 t -121.16 136.42 58.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 123.284 0.634 . . . . 73.21 109.529 -177.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 536' ' ' ILE . . . . . 0.507 HG21 ' HB3' ' A' ' 559' ' ' GLU . 18.7 mm -101.65 129.26 53.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-N 116.321 -0.4 . . . . 74.41 110.18 178.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . 0.429 HG23 ' HB3' ' A' ' 594' ' ' PRO . 39.1 t -118.84 108.85 40.33 Favored Pre-proline 0 C--N 1.317 -0.844 0 N-CA-C 108.812 -0.81 . . . . 75.55 108.812 177.107 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -72.34 143.07 38.4 Favored 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 122.033 1.822 . . . . 74.44 111.177 178.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 539' ' ' TYR . . . . . 0.509 ' CE1' ' HG ' ' A' ' 560' ' ' LEU . 35.3 p90 -152.13 155.5 37.97 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 109.865 -0.42 . . . . 63.11 109.865 -179.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -153.36 154.9 35.41 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 116.208 -0.451 . . . . 73.42 109.979 176.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 16.8 p -93.71 110.29 21.92 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 115.603 -0.726 . . . . 73.12 109.264 176.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.6 mp -77.57 118.87 25.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 105.69 -1.967 . . . . 73.2 105.69 176.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -54.83 -36.64 65.23 Favored 'General case' 0 C--N 1.319 -0.728 0 O-C-N 124.28 0.987 . . . . 74.45 113.578 -173.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 69.93 -97.81 0.59 Allowed Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 111.636 -0.586 . . . . 65.43 111.636 177.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 6.9 t -122.95 -0.27 9.02 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.472 0.653 . . . . 63.23 110.553 177.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -99.07 -170.26 1.89 Allowed 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 107.6 -1.259 . . . . 72.11 107.6 177.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . 0.435 ' HD3' ' N ' ' A' ' 548' ' ' GLY . 0.0 OUTLIER -138.12 130.14 28.59 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.34 -0.985 . . . . 74.43 108.34 -178.767 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 548' ' ' GLY . . . . . 0.435 ' N ' ' HD3' ' A' ' 547' ' ' ARG . . . -76.89 -146.15 2.12 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 111.346 -0.702 . . . . 72.54 111.346 177.087 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 64.44 15.69 59.58 Favored Glycine 0 C--N 1.314 -0.671 0 CA-C-N 117.077 0.438 . . . . 53.23 113.404 178.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 77.49 18.64 77.52 Favored Glycine 0 N--CA 1.431 -1.65 0 C-N-CA 121.172 -0.537 . . . . 74.11 112.166 -178.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -84.33 -70.62 0.56 Allowed 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 121.359 0.6 . . . . 65.31 109.491 178.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . 0.648 ' OD2' 'CA ' ' A' ' 850' ' ' ' CA' . 9.3 t70 -100.63 -39.11 8.04 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 107.331 -1.359 . . . . 72.52 107.331 -178.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 553' ' ' PHE . . . . . 0.451 ' HA ' HG12 ' A' ' 576' ' ' ILE . 25.1 p90 -144.72 166.27 25.7 Favored 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 108.109 -1.071 . . . . 72.44 108.109 173.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -98.56 109.12 21.93 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 106.409 -1.7 . . . . 64.42 106.409 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -75.83 122.62 24.37 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-O 121.693 0.759 . . . . 71.42 111.038 -175.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 7.3 t -111.14 112.63 24.57 Favored 'General case' 0 N--CA 1.409 -2.514 0 CA-C-O 122.081 0.943 . . . . 61.1 109.957 -177.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 4.4 p -126.17 116.66 21.67 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 114.724 -1.125 . . . . 74.54 108.773 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -170.71 -156.27 11.26 Favored Glycine 0 N--CA 1.403 -3.547 0 C-N-CA 120.09 -1.053 . . . . 74.31 110.945 -176.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 559' ' ' GLU . . . . . 0.507 ' HB3' HG21 ' A' ' 536' ' ' ILE . 49.1 mt-10 -133.11 126.5 31.88 Favored 'General case' 0 C--N 1.284 -2.269 0 C-N-CA 122.368 0.267 . . . . 74.24 110.37 -176.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . 0.509 ' HG ' ' CE1' ' A' ' 539' ' ' TYR . 74.9 mt -82.42 136.26 34.98 Favored 'General case' 0 CA--C 1.5 -0.948 0 CA-C-N 116.064 -0.516 . . . . 74.22 110.88 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 561' ' ' GLU . . . . . 0.503 ' HG3' HD22 ' A' ' 534' ' ' ASN . 43.1 tt0 -98.32 102.33 14.04 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.096 -0.956 . . . . 75.33 108.9 178.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 562' ' ' PHE . . . . . 0.482 ' CZ ' ' HD3' ' A' ' 527' ' ' ARG . 1.3 t80 -111.37 147.95 34.05 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 106.559 -1.645 . . . . 72.14 106.559 -179.155 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -141.68 179.13 7.01 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 121.559 -0.713 . . . . 73.31 111.065 -173.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -77.63 -35.48 52.62 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 109.314 -0.624 . . . . 74.23 109.314 175.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -84.09 5.04 27.57 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 122.123 0.963 . . . . 74.41 109.599 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -121.56 146.51 46.88 Favored 'General case' 0 N--CA 1.422 -1.869 0 CA-C-N 115.09 -0.959 . . . . 72.4 108.874 -179.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 3.3 pt -135.27 155.92 38.17 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.629 0 N-CA-C 106.707 -1.59 . . . . 71.32 106.707 173.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 568' ' ' VAL . . . . . 0.409 HG21 ' HD2' ' A' ' 524' ' ' LYS . 0.9 OUTLIER 51.01 170.13 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.624 0 C-N-CA 125.52 1.528 . . . . 75.22 112.048 -174.824 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 569' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -159.27 149.58 19.25 Favored 'General case' 0 C--N 1.283 -2.303 0 O-C-N 120.394 -1.441 . . . . 73.32 107.653 176.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 570' ' ' THR . . . . . 0.643 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 9.4 p -124.4 123.8 40.96 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 113.162 0.801 . . . . 61.44 113.162 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 2.8 mp -85.83 114.29 25.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 104.857 -2.275 . . . . 74.22 104.857 171.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 572' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 521' ' ' MET . 24.9 m -102.55 109.2 20.75 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.191 0.52 . . . . 70.4 110.106 -177.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 573' ' ' VAL . . . . . . . . . . . . . 25.5 t -111.53 137.06 45.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 115.735 -0.666 . . . . 70.42 109.687 -176.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -95.05 123.87 38.77 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 124.021 0.826 . . . . 71.34 110.087 178.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 57.9 t -94.33 133.47 35.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 107.03 -1.47 . . . . 71.12 107.03 175.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 576' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' A' ' 553' ' ' PHE . 25.9 mm -98.55 160.3 3.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 109.261 -0.644 . . . . 73.22 109.261 -175.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -64.7 109.51 2.05 Favored 'General case' 0 C--O 1.247 0.94 0 C-N-CA 123.096 0.559 . . . . 74.42 110.054 177.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 578' ' ' ASP . . . . . 0.596 ' OD1' 'CA ' ' A' ' 850' ' ' ' CA' . 11.1 t0 -55.93 127.7 31.62 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 124.211 0.944 . . . . 71.52 110.913 -172.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 579' ' ' GLU . . . . . 0.599 ' OE1' 'CA ' ' A' ' 850' ' ' ' CA' . 1.3 pm0 -110.32 -30.5 7.67 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 115.752 1.76 . . . . 75.54 115.752 -167.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 580' ' ' GLU . . . . . 0.421 ' HG2' ' CD2' ' A' ' 581' ' ' TYR . 0.0 OUTLIER -103.81 -72.26 0.71 Allowed 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 115.009 1.485 . . . . 75.53 115.009 -162.493 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 581' ' ' TYR . . . . . 0.421 ' CD2' ' HG2' ' A' ' 580' ' ' GLU . 6.3 p90 -141.47 154.03 45.3 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 107.572 -1.27 . . . . 74.25 107.572 -174.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -109.87 108.14 18.34 Favored 'General case' 0 C--N 1.27 -2.854 0 C-N-CA 119.137 -1.025 . . . . 74.43 109.809 -177.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 9.9 mmmm -139.03 169.38 17.89 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 105.73 -1.952 . . . . 73.14 105.73 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -74.94 98.72 3.64 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 108.008 -1.108 . . . . 74.11 108.008 175.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.09 147.21 30.28 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-O 121.202 0.525 . . . . 72.24 111.196 -178.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 4.1 t -152.41 152.12 31.64 Favored 'General case' 0 N--CA 1.422 -1.858 0 CA-C-N 115.372 -0.831 . . . . 75.42 109.643 -175.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -133.83 160.02 38.89 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-N 114.695 -1.139 . . . . 75.4 109.68 177.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 588' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -116.33 138.38 51.38 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 120.625 0.25 . . . . 73.31 110.379 -171.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . 0.462 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.6 OUTLIER -106.28 122.26 45.88 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 105.447 -2.057 . . . . 74.4 105.447 173.161 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -129.6 130.78 46.1 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 107.343 -1.354 . . . . 75.21 107.343 178.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 591' ' ' ILE . . . . . 0.416 HG23 ' HB3' ' A' ' 539' ' ' TYR . 27.4 pt -103.75 147.82 9.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.495 -0.928 . . . . 74.55 108.495 179.027 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -94.29 -168.45 37.33 Favored Glycine 0 N--CA 1.425 -2.1 0 N-CA-C 111.621 -0.591 . . . . 52.23 111.621 -178.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.49 ' CD ' HD12 ' A' ' 618' ' ' LEU . 5.5 tp10 -77.67 127.18 83.06 Favored Pre-proline 0 N--CA 1.428 -1.556 0 N-CA-C 107.881 -1.155 . . . . 74.5 107.881 -178.155 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 594' ' ' PRO . . . . . 0.604 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 72.0 Cg_endo -71.77 171.17 17.02 Favored 'Trans proline' 0 C--N 1.324 -0.715 0 C-N-CA 123.384 2.722 . . . . 74.3 112.934 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 595' ' ' ARG . . . . . 0.41 ' NH2' ' HG3' ' A' ' 615' ' ' LYS . 7.9 ptp85 -150.22 151.41 32.99 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 107.076 -1.453 . . . . 72.34 107.076 177.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -81.04 131.49 35.31 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 104.879 -2.267 . . . . 63.51 104.879 178.144 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 597' ' ' VAL . . . . . 0.493 ' CG2' HG12 ' A' ' 536' ' ' ILE . 99.3 t -66.99 -28.75 43.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-O 122.435 1.112 . . . . 62.34 108.584 178.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -107.37 86.28 2.28 Favored 'General case' 0 N--CA 1.406 -2.647 0 CA-C-N 114.144 -1.389 . . . . 74.21 108.594 177.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 86.7 mmm -85.25 88.86 7.53 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.584 -0.735 . . . . 75.24 110.741 -178.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 20.9 m -89.97 122.67 33.2 Favored 'General case' 0 N--CA 1.426 -1.643 0 CA-C-N 115.298 -0.864 . . . . 71.51 109.539 178.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 601' ' ' GLU . . . . . 0.427 ' HB3' ' HB2' ' A' ' 610' ' ' GLU . 12.0 pt-20 -74.79 153.53 38.72 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 109.873 -0.417 . . . . 75.4 109.873 177.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 2.7 tmtp? -76.22 81.73 3.02 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 122.198 0.999 . . . . 75.11 109.71 -176.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -75.9 130.8 39.07 Favored 'General case' 0 N--CA 1.42 -1.937 0 CA-C-N 114.023 -1.444 . . . . 74.01 109.357 178.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 94.62 21.53 26.25 Favored Glycine 0 C--N 1.302 -1.306 0 N-CA-C 109.959 -1.256 . . . . 73.53 109.959 -176.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . -137.21 -139.56 3.93 Favored Glycine 0 N--CA 1.429 -1.82 0 N-CA-C 110.54 -1.024 . . . . 75.22 110.54 178.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -92.36 -28.71 16.74 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 120.813 0.339 . . . . 74.43 111.257 -178.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 8.2 p -86.25 130.1 34.63 Favored 'General case' 0 N--CA 1.421 -1.893 0 N-CA-C 115.133 1.531 . . . . 61.53 115.133 -173.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 54.7 mt -128.42 132.32 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.85 0 N-CA-C 106.052 -1.833 . . . . 73.32 106.052 174.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 24.3 m 67.84 73.11 0.31 Allowed 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 123.985 0.914 . . . . 75.35 111.342 179.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 610' ' ' GLU . . . . . 0.427 ' HB2' ' HB3' ' A' ' 601' ' ' GLU . 42.1 mt-10 -102.34 95.23 6.15 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 107.415 -1.328 . . . . 71.55 107.415 174.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -126.56 -160.57 1.0 Allowed 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 114.953 -1.021 . . . . 71.03 109.667 -178.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 73.54 54.91 0.11 Allowed 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 125.043 1.337 . . . . 74.22 111.249 -177.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -94.75 130.38 41.31 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 114.035 -1.439 . . . . 63.34 108.873 176.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -167.94 -166.08 0.7 Allowed 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 106.531 -1.655 . . . . 73.25 106.531 -178.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 615' ' ' LYS . . . . . 0.443 ' N ' ' HD3' ' A' ' 615' ' ' LYS . 0.1 OUTLIER -78.45 96.9 5.5 Favored 'General case' 0 N--CA 1.426 -1.651 0 N-CA-C 107.335 -1.357 . . . . 74.24 107.335 177.298 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -83.14 148.57 56.7 Favored Pre-proline 0 C--N 1.299 -1.588 0 CA-C-N 115.506 -0.77 . . . . 73.12 111.871 -175.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -80.94 174.21 11.18 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 C-N-CA 122.19 1.927 . . . . 73.25 108.417 170.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.49 HD12 ' CD ' ' A' ' 593' ' ' GLU . 4.0 mm? -69.12 100.77 1.31 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 113.011 0.745 . . . . 72.03 113.011 -177.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 8.0 p 25.32 -91.27 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 127.623 2.369 . . . . 70.13 115.348 -177.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 620' ' ' SER . . . . . 0.584 ' OG ' ' HB3' ' A' ' 623' ' ' GLU . 1.8 t -158.45 120.75 3.65 Favored 'General case' 0 N--CA 1.397 -3.086 0 N-CA-C 103.732 -2.692 . . . . 64.52 103.732 178.232 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 621' ' ' LYS . . . . . 0.463 ' HZ1' ' HB3' ' A' ' 621' ' ' LYS . 7.7 mtpm? -66.33 -72.41 0.16 Allowed 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 113.105 0.78 . . . . 72.32 113.105 -171.088 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -93.84 -24.9 17.58 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.832 0.825 . . . . 73.23 109.196 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . 0.584 ' HB3' ' OG ' ' A' ' 620' ' ' SER . 2.8 tm-20 -80.52 147.36 30.87 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 107.788 -1.19 . . . . 75.31 107.788 -176.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -104.92 -28.73 10.93 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 113.793 1.034 . . . . 71.52 113.793 -174.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -70.74 -33.0 70.35 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 113.166 0.802 . . . . 72.52 113.166 -170.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . 0.436 ' CB ' ' HB2' ' A' ' 620' ' ' SER . 11.5 mmt180 -67.74 -27.32 66.7 Favored 'General case' 0 C--O 1.19 -2.036 0 C-N-CA 119.572 -0.851 . . . . 75.23 111.042 172.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 627' ' ' ARG . . . . . . . . . . . . . 82.1 mtt180 -67.73 -45.71 74.25 Favored 'General case' 0 C--O 1.213 -0.846 0 N-CA-C 107.805 -1.183 . . . . 70.24 107.805 176.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . 0.56 ' O ' ' HG2' ' A' ' 631' ' ' MET . 69.2 mt -57.24 -44.01 82.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 115.465 -0.789 . . . . 64.53 110.198 177.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -71.24 -38.44 71.95 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.082 -0.508 . . . . 74.12 111.703 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -87.4 -2.82 58.89 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 113.129 0.789 . . . . 73.15 113.129 -175.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 631' ' ' MET . . . . . 0.56 ' HG2' ' O ' ' A' ' 628' ' ' ILE . 25.7 ptt? -72.46 -7.86 52.04 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 120.46 -0.496 . . . . 74.1 111.684 -178.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -72.3 -21.75 79.19 Favored Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 109.954 -1.258 . . . . 64.44 109.954 173.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -91.18 153.35 44.65 Favored Pre-proline 0 N--CA 1.442 -0.874 0 N-CA-C 106.862 -1.533 . . . . 74.33 106.862 176.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.604 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 11.9 Cg_endo -64.94 132.7 33.16 Favored 'Trans proline' 0 N--CA 1.441 -1.588 0 N-CA-C 107.562 -1.745 . . . . 74.43 107.562 167.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 635' ' ' ILE . . . . . 0.492 ' H ' ' HB1' ' A' ' 502' ' ' ALA . 2.5 pp -112.69 161.28 11.69 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.371 0 C-N-CA 120.194 -0.603 . . . . 70.0 111.442 -178.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 10.0 tt -63.1 154.57 30.55 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 124.34 1.056 . . . . 72.44 112.184 -178.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -79.77 -125.41 0.53 Allowed Glycine 0 N--CA 1.431 -1.664 0 N-CA-C 116.298 1.279 . . . . 71.4 116.298 -173.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . 0.44 ' H ' ' HB ' ' A' ' 506' ' ' THR . 34.6 tt0 -90.75 -72.96 0.55 Allowed 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.699 -0.751 . . . . 72.54 112.668 -169.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -130.84 127.93 39.61 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.113 0.483 . . . . 62.12 110.191 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 17.1 p -129.51 92.78 3.41 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-O 121.92 0.867 . . . . 73.22 112.743 -175.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 641' ' ' LYS . . . . . 0.606 ' O ' ' HA ' ' A' ' 510' ' ' PRO . 20.5 tptm -156.12 139.15 15.43 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 106.147 -1.798 . . . . 73.44 106.147 178.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 642' ' ' LEU . . . . . 0.462 ' HB3' ' HB3' ' A' ' 589' ' ' LEU . 21.8 tp -138.21 103.64 4.98 Favored 'General case' 0 N--CA 1.409 -2.491 0 N-CA-C 108.154 -1.054 . . . . 71.3 108.154 173.378 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -93.11 107.63 19.39 Favored 'General case' 0 C--N 1.274 -2.681 0 N-CA-C 106.847 -1.538 . . . . 74.14 106.847 176.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 644' ' ' VAL . . . . . 0.451 HG23 ' HE1' ' A' ' 521' ' ' MET . 24.0 t -93.24 104.89 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.004 0 N-CA-C 109.057 -0.72 . . . . 73.44 109.057 -177.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 4.0 mp -91.22 118.99 37.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 107.281 -1.377 . . . . 73.55 107.281 176.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 646' ' ' ILE . . . . . 0.451 HD12 ' N ' ' A' ' 646' ' ' ILE . 2.5 mp -100.15 108.0 22.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 106.607 -1.627 . . . . 74.25 106.607 -176.078 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -114.23 152.39 31.34 Favored 'General case' 0 C--N 1.281 -2.405 0 O-C-N 123.371 0.42 . . . . 75.24 111.241 -175.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . 0.598 ' OE2' 'CA ' ' A' ' 800' ' ' ' CA' . 5.2 mp0 -58.1 133.55 55.67 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.321 -0.854 . . . . 71.22 110.09 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 33.5 t -58.42 108.52 0.63 Allowed 'General case' 0 N--CA 1.436 -1.151 0 O-C-N 124.218 0.949 . . . . 63.4 112.383 -174.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -134.21 -68.41 0.55 Allowed 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 115.099 -0.955 . . . . 74.23 108.641 174.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -136.06 -163.12 1.35 Allowed 'General case' 0 C--O 1.246 0.905 0 N-CA-C 108.4 -0.963 . . . . 72.43 108.4 -178.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -134.55 90.0 2.61 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-O 121.276 0.56 . . . . 74.4 112.451 178.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -114.95 101.46 9.05 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 115.071 -0.968 . . . . 75.31 108.583 174.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 9.5 t -141.07 90.24 2.31 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 106.605 -1.628 . . . . 75.03 106.605 179.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 4.1 t -138.63 112.66 8.54 Favored 'General case' 0 N--CA 1.426 -1.628 0 CA-C-N 115.638 -0.71 . . . . 63.51 110.673 -174.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.447 HG12 ' HB ' ' A' ' 511' ' ' VAL . 12.9 m -136.38 -177.81 2.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.892 -0.595 . . . . 74.3 109.656 179.013 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 . . . . . 0 C--N 1.299 -1.59 0 N-CA-C 109.807 -0.442 . . . . 75.45 109.807 179.257 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 800' ' ' ' CA' . . . . . 0.598 'CA ' ' OE2' ' A' ' 648' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 850' ' ' ' CA' . . . . . 0.648 'CA ' ' OD2' ' A' ' 552' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 16.2 p-80 . . . . . 0 C--O 1.236 0.39 0 N-CA-C 110.147 -0.316 . . . . 61.23 110.147 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . 0.452 ' HB3' ' HA ' ' A' ' 634' ' ' PRO . . . -99.57 -48.23 4.83 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.446 -0.946 . . . . 62.21 108.446 177.049 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . 0.513 ' HA2' ' OG1' ' A' ' 528' ' ' THR . . . 178.57 153.0 10.87 Favored Glycine 0 N--CA 1.414 -2.812 0 C-N-CA 120.317 -0.944 . . . . 63.34 112.352 177.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 3.8 mp -123.26 104.95 15.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 N-CA-C 107.756 -1.202 . . . . 75.4 107.756 175.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -118.62 112.42 19.82 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.775 -1.194 . . . . 75.51 107.775 176.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 14.9 t -141.62 155.22 45.74 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 120.392 -0.523 . . . . 75.51 110.25 -174.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -81.19 144.81 31.36 Favored 'General case' 0 CA--C 1.489 -1.372 0 N-CA-C 107.559 -1.274 . . . . 74.51 107.559 175.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -65.28 -43.71 90.3 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 123.88 0.737 . . . . 72.31 109.757 178.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -123.93 125.71 25.8 Favored Pre-proline 0 N--CA 1.425 -1.675 0 CA-C-N 115.625 -0.716 . . . . 75.42 109.257 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 641' ' ' LYS . 58.4 Cg_endo -73.52 -16.61 24.16 Favored 'Trans proline' 0 CA--C 1.53 0.298 0 C-N-CA 122.163 1.909 . . . . 74.33 111.708 176.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 83.1 t -133.82 131.78 56.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 109.013 -0.736 . . . . 63.23 109.013 178.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 6.0 t -132.84 143.37 49.49 Favored 'General case' 0 N--CA 1.406 -2.65 0 N-CA-C 107.568 -1.271 . . . . 75.03 107.568 178.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 513' ' ' HIS . . . . . 0.499 ' CD2' ' HA ' ' A' ' 654' ' ' SER . 36.1 m-70 -114.59 127.72 55.94 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.379 -0.971 . . . . 62.3 108.379 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.535 HG13 ' SD ' ' A' ' 521' ' ' MET . 34.1 m -124.86 158.94 32.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-O 121.015 0.436 . . . . 74.51 111.128 -174.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 515' ' ' SER . . . . . 0.68 ' HA ' ' CZ ' ' A' ' 652' ' ' PHE . 34.9 t -77.74 148.91 34.64 Favored 'General case' 0 N--CA 1.414 -2.227 0 CA-C-N 115.22 -0.9 . . . . 72.51 110.787 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . 0.659 ' OE2' 'CA ' ' A' ' 800' ' ' ' CA' . 29.6 tt0 -68.45 -17.67 64.25 Favored 'General case' 0 N--CA 1.422 -1.844 0 CA-C-N 114.827 -1.079 . . . . 75.0 108.512 172.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 43.6 m -108.75 22.06 16.43 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 116.056 -0.52 . . . . 73.42 111.375 -176.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 518' ' ' ILE . . . . . 0.401 HG23 ' O ' ' A' ' 515' ' ' SER . 16.1 tt -92.36 159.68 2.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 109.317 -0.623 . . . . 73.2 109.317 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . -106.22 -67.08 0.67 Allowed Glycine 0 N--CA 1.417 -2.621 0 C-N-CA 120.281 -0.962 . . . . 74.42 111.179 177.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 33.5 mm -120.66 124.2 71.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 109.604 -0.517 . . . . 61.41 109.604 -177.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 521' ' ' MET . . . . . 0.535 ' SD ' HG13 ' A' ' 514' ' ' VAL . 24.6 ptt? -103.86 137.73 41.45 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 107.109 -1.441 . . . . 74.12 107.109 172.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 15.8 mp0 -114.16 97.37 6.31 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 108.788 -0.819 . . . . 72.03 108.788 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . 0.573 ' O ' ' HA ' ' A' ' 570' ' ' THR . 26.5 t -84.26 131.72 33.27 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 CA-C-N 116.1 -0.5 . . . . 62.2 110.308 -177.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -85.27 128.14 34.58 Favored 'General case' 0 C--O 1.247 0.966 0 N-CA-C 113.211 0.819 . . . . 74.34 113.211 -176.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 21.6 t -117.35 123.84 72.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 CA-C-N 114.251 -1.341 . . . . 75.25 107.773 177.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -81.69 141.71 33.36 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 109.487 -0.56 . . . . 74.44 109.487 -176.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . 0.459 ' HG2' ' N ' ' A' ' 528' ' ' THR . 39.3 ttp180 -86.77 161.06 18.58 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.498 -0.774 . . . . 71.31 110.851 -175.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 528' ' ' THR . . . . . 0.513 ' OG1' ' HA2' ' A' ' 503' ' ' GLY . 5.7 t -67.68 142.53 56.32 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-N 115.11 -0.95 . . . . 71.12 110.478 173.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 21.9 t -63.85 -38.85 92.64 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 115.216 -0.902 . . . . 73.32 108.924 176.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -100.37 80.14 0.47 Allowed Glycine 0 N--CA 1.431 -1.679 0 N-CA-C 110.329 -1.108 . . . . 51.34 110.329 177.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -93.68 107.8 19.62 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 109.279 -0.637 . . . . 72.52 109.279 178.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 19.4 mmt180 -119.49 111.06 17.64 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 120.889 0.376 . . . . 72.32 110.723 -179.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 89.33 -126.45 8.24 Favored Glycine 0 N--CA 1.426 -2.022 0 C-N-CA 120.111 -1.042 . . . . 74.42 113.504 175.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 534' ' ' ASN . . . . . 0.495 HD22 ' HG3' ' A' ' 561' ' ' GLU . 2.6 t-20 -135.85 124.16 23.27 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.278 -1.008 . . . . 74.41 108.278 -177.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 72.1 t -125.04 125.42 69.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 109.326 -0.62 . . . . 75.41 109.326 -178.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 536' ' ' ILE . . . . . 0.414 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 36.6 mm -100.57 125.03 54.48 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.134 0 CA-C-N 115.447 -0.797 . . . . 72.53 109.103 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 30.0 t -116.82 112.41 40.53 Favored Pre-proline 0 C--N 1.312 -1.031 0 CA-C-N 116.202 -0.454 . . . . 64.52 110.682 -176.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -74.28 140.62 27.83 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.481 2.121 . . . . 74.31 112.227 177.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 539' ' ' TYR . . . . . 0.489 ' CD1' ' HG ' ' A' ' 560' ' ' LEU . 48.5 p90 -140.99 156.18 46.09 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.004 -1.11 . . . . 73.54 108.004 -179.39 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -154.99 157.82 38.24 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 123.28 0.362 . . . . 73.12 110.659 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 1.6 p -95.09 124.6 39.22 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 115.1 -0.954 . . . . 75.5 108.812 174.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.5 mp -93.35 128.35 44.85 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 106.275 -1.75 . . . . 74.05 106.275 175.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -57.9 -50.23 74.03 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 123.782 0.677 . . . . 72.3 111.377 -176.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 69.4 -101.59 0.85 Allowed Glycine 0 N--CA 1.434 -1.477 0 CA-C-N 115.652 -0.703 . . . . 63.43 111.973 178.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 10.0 t -125.89 14.72 8.0 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 122.323 1.058 . . . . 72.01 109.26 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -116.94 152.92 33.53 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.114 -1.069 . . . . 64.45 108.114 176.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . 0.455 ' HG2' ' HG3' ' A' ' 551' ' ' GLU . 31.8 ttp180 -89.47 130.1 35.86 Favored 'General case' 0 N--CA 1.422 -1.841 0 CA-C-O 121.101 0.477 . . . . 74.34 111.116 -178.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -96.49 -176.92 35.73 Favored Glycine 0 C--N 1.301 -1.402 0 C-N-CA 120.884 -0.674 . . . . 73.24 112.774 -175.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 80.72 26.63 53.39 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.927 -0.654 . . . . 71.45 113.002 177.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 92.08 11.29 60.21 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.743 -0.742 . . . . 74.34 112.953 177.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . 0.455 ' HG3' ' HG2' ' A' ' 547' ' ' ARG . 5.8 mm-40 -88.99 -70.51 0.65 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 117.273 0.537 . . . . 54.4 110.287 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . 0.652 ' OD1' 'CA ' ' A' ' 850' ' ' ' CA' . 23.5 m-20 -98.86 -27.02 14.1 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.575 -0.898 . . . . 74.23 108.575 174.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 553' ' ' PHE . . . . . 0.627 ' HB3' ' CE2' ' A' ' 587' ' ' PHE . 40.8 p90 -151.46 154.2 36.11 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.569 -0.741 . . . . 75.25 110.055 176.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.99 129.6 34.81 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 104.948 -2.241 . . . . 75.0 104.948 174.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -86.19 113.48 22.25 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.212 0.529 . . . . 71.3 111.112 -172.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 11.3 t -111.51 104.85 13.3 Favored 'General case' 0 N--CA 1.415 -2.206 0 CA-C-O 122.443 1.116 . . . . 74.54 110.587 -176.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 1.6 p -123.8 110.94 15.53 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 114.778 -1.101 . . . . 74.21 109.295 176.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -163.01 -153.91 7.42 Favored Glycine 0 N--CA 1.418 -2.547 0 N-CA-C 110.296 -1.122 . . . . 54.33 110.296 -175.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 559' ' ' GLU . . . . . 0.414 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 39.0 mt-10 -137.99 136.34 36.83 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 120.77 0.319 . . . . 75.04 111.084 -176.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . 0.489 ' HG ' ' CD1' ' A' ' 539' ' ' TYR . 82.7 mt -93.85 147.82 22.72 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.375 -0.83 . . . . 74.43 109.866 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 561' ' ' GLU . . . . . 0.495 ' HG3' HD22 ' A' ' 534' ' ' ASN . 40.4 tt0 -104.82 107.73 18.84 Favored 'General case' 0 N--CA 1.424 -1.754 0 CA-C-O 121.213 0.53 . . . . 74.55 112.152 -178.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -101.74 146.86 27.17 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.443 -0.947 . . . . 72.21 108.443 172.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . 0.4 ' HB2' ' H ' ' A' ' 566' ' ' GLU . 51.7 mt-30 -144.2 -176.66 5.1 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 108.171 -1.048 . . . . 73.25 108.171 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -74.77 -31.58 61.81 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 107.76 -1.2 . . . . 75.32 107.76 174.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -78.87 -49.47 12.82 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.796 -1.093 . . . . 74.11 110.384 177.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . 0.4 ' H ' ' HB2' ' A' ' 563' ' ' GLN . 59.6 mm-40 -65.53 139.41 58.47 Favored 'General case' 0 CA--C 1.503 -0.838 0 CA-C-N 115.725 -0.67 . . . . 71.23 112.276 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 567' ' ' ILE . . . . . 0.451 ' HA ' ' HD3' ' A' ' 527' ' ' ARG . 21.6 pt -115.8 -170.67 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.412 -2.372 0 N-CA-C 105.649 -1.982 . . . . 74.33 105.649 172.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 3.1 p 0.55 127.71 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.07 0 C-N-CA 128.027 2.531 . . . . 74.21 116.682 173.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 569' ' ' LYS . . . . . 0.461 ' HA ' ' HE2' ' A' ' 569' ' ' LYS . 8.8 mmpt? -105.74 164.69 11.73 Favored 'General case' 0 C--N 1.271 -2.835 0 CA-C-N 114.683 -1.144 . . . . 74.24 109.605 178.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 570' ' ' THR . . . . . 0.573 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 5.1 p -137.58 119.3 15.08 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.068 -0.969 . . . . 52.35 110.781 178.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 3.4 mp -86.92 106.4 15.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 107.291 -1.374 . . . . 74.21 107.291 176.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 4.1 p -84.27 109.13 17.55 Favored 'General case' 0 N--CA 1.415 -2.204 0 O-C-N 123.976 0.798 . . . . 65.31 109.685 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 573' ' ' VAL . . . . . . . . . . . . . 44.0 t -113.89 128.44 70.81 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 N-CA-C 108.75 -0.833 . . . . 74.5 108.75 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 574' ' ' LYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 519' ' ' GLY . 58.8 tptt -83.4 103.49 12.8 Favored 'General case' 0 N--CA 1.417 -2.116 0 O-C-N 124.087 0.867 . . . . 75.41 108.827 177.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 71.5 t -78.75 135.1 26.56 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 105.995 -1.854 . . . . 65.53 105.995 176.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 32.3 mm -98.64 139.88 19.59 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 N-CA-C 108.715 -0.846 . . . . 72.12 108.715 -176.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -53.43 117.44 3.08 Favored 'General case' 0 C--O 1.244 0.783 0 O-C-N 124.302 1.001 . . . . 73.51 108.558 175.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 578' ' ' ASP . . . . . 0.646 ' OD1' 'CA ' ' A' ' 850' ' ' ' CA' . 25.3 t70 -62.29 120.28 10.69 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.265 -0.879 . . . . 55.31 112.462 -173.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 579' ' ' GLU . . . . . 0.636 ' OE1' 'CA ' ' A' ' 850' ' ' ' CA' . 1.7 pm0 -81.78 -19.13 41.9 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 114.55 1.315 . . . . 75.51 114.55 -172.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 580' ' ' GLU . . . . . 0.67 ' OE2' 'CA ' ' A' ' 850' ' ' ' CA' . 0.4 OUTLIER -131.38 -164.02 1.39 Allowed 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 119.668 -0.813 . . . . 75.22 110.703 -177.357 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -62.74 152.36 35.93 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 107.444 -1.317 . . . . 73.43 107.444 173.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 582' ' ' GLU . . . . . 0.647 ' OE1' 'CA ' ' A' ' 800' ' ' ' CA' . 42.5 tt0 -122.2 110.47 15.77 Favored 'General case' 0 N--CA 1.411 -2.39 0 C-N-CA 118.298 -1.361 . . . . 74.24 113.256 -172.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -79.54 -179.72 7.0 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 113.79 -1.55 . . . . 74.33 107.333 173.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -77.47 84.17 3.87 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 106.455 -1.683 . . . . 74.42 106.455 172.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 585' ' ' LYS . . . . . . . . . . . . 0.262 0.0 OUTLIER -108.61 145.06 35.49 Favored 'General case' 0 N--CA 1.414 -2.262 0 CA-C-N 115.512 -0.767 . . . . 73.33 111.426 178.329 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 586' ' ' THR . . . . . 0.408 ' HG1' ' C ' ' A' ' 644' ' ' VAL . 2.9 t -151.39 149.35 29.21 Favored 'General case' 0 N--CA 1.397 -3.094 0 CA-C-N 114.93 -1.032 . . . . 74.45 110.232 -174.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 587' ' ' PHE . . . . . 0.627 ' CE2' ' HB3' ' A' ' 553' ' ' PHE . 2.2 p90 -117.97 146.77 43.76 Favored 'General case' 0 N--CA 1.416 -2.171 0 CA-C-N 114.097 -1.411 . . . . 74.14 107.789 176.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 588' ' ' PHE . . . . . 0.519 ' HA ' ' O ' ' A' ' 642' ' ' LEU . 17.1 m-85 -107.36 142.87 36.48 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 120.707 -0.397 . . . . 73.42 110.218 -171.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.17 125.6 54.3 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 106.424 -1.695 . . . . 73.23 106.424 175.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -133.75 149.22 51.46 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 109.087 -0.708 . . . . 70.35 109.087 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 591' ' ' ILE . . . . . . . . . . . . . 27.5 pt -109.16 147.97 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.348 0 N-CA-C 108.485 -0.931 . . . . 74.43 108.485 176.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -102.38 -140.3 10.96 Favored Glycine 0 C--N 1.302 -1.344 0 C-N-CA 120.631 -0.795 . . . . 52.42 112.529 -177.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -77.8 115.06 47.01 Favored Pre-proline 0 C--N 1.315 -0.934 0 C-N-CA 122.623 0.369 . . . . 73.44 110.041 179.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.93 146.15 29.13 Favored 'Trans proline' 0 N--CA 1.444 -1.434 0 C-N-CA 121.577 1.518 . . . . 72.1 109.182 176.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 3.2 ptp180 -123.03 138.26 54.73 Favored 'General case' 0 C--N 1.297 -1.674 0 C-N-CA 119.561 -0.856 . . . . 75.04 110.527 -174.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -86.69 118.23 25.96 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 107.42 -1.326 . . . . 54.41 107.42 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 59.2 t -78.3 -35.42 19.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 108.534 -0.914 . . . . 72.43 108.534 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -86.19 -168.79 2.36 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 106.95 -1.5 . . . . 75.01 106.95 175.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 599' ' ' MET . . . . . 0.417 ' HE2' ' HA ' ' A' ' 599' ' ' MET . 1.0 OUTLIER 64.62 47.86 2.75 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.656 0.741 . . . . 74.44 109.692 -179.644 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 17.1 m -73.59 -40.1 64.12 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.19 -0.914 . . . . 70.32 109.701 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -89.93 95.24 10.14 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 115.423 -0.808 . . . . 71.53 110.34 -177.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 57.7 tttp -157.15 135.87 11.55 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 104.766 -2.309 . . . . 73.13 104.766 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 603' ' ' LYS . . . . . 0.407 ' HD2' ' O ' ' A' ' 603' ' ' LYS 0.309 0.0 OUTLIER -73.51 108.62 6.47 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 114.546 1.313 . . . . 60.0 114.546 -175.431 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -86.58 78.7 1.89 Allowed Glycine 0 N--CA 1.426 -1.969 0 N-CA-C 109.546 -1.422 . . . . 60.43 109.546 176.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 160.43 62.69 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.733 0 N-CA-C 110.281 -1.128 . . . . 64.32 110.281 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -90.54 -46.49 8.28 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 120.887 0.375 . . . . 74.23 111.122 -178.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 21.3 p -130.0 129.91 44.33 Favored 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 108.992 -0.744 . . . . 74.42 108.992 175.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 13.3 mt 60.88 16.27 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 C-N-CA 124.646 1.178 . . . . 74.43 111.451 175.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 6.3 m 67.0 29.03 8.25 Favored 'General case' 0 CA--C 1.562 1.441 0 C-N-CA 124.466 1.107 . . . . 72.43 110.758 -177.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -64.07 108.11 1.45 Allowed 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.937 -0.574 . . . . 74.33 110.079 174.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -117.3 33.82 5.43 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.482 -0.933 . . . . 74.41 108.482 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 612' ' ' TYR . . . . . 0.439 ' CE1' ' HG3' ' A' ' 633' ' ' ARG . 89.6 m-85 73.84 68.14 0.1 Allowed 'General case' 0 CA--C 1.494 -1.194 0 CA-C-N 113.769 -1.56 . . . . 53.44 107.907 -171.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -95.35 65.92 2.8 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 113.582 -1.645 . . . . 63.23 110.18 -176.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -161.8 178.23 9.15 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-N 114.284 -1.325 . . . . 71.43 107.456 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -147.8 31.98 0.86 Allowed 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.635 -0.876 . . . . 74.1 108.635 173.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -108.66 166.89 10.02 Favored Pre-proline 0 C--N 1.31 -1.136 0 CA-C-N 115.281 -0.872 . . . . 74.04 109.665 -176.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -62.54 -167.91 0.07 OUTLIER 'Trans proline' 0 C--N 1.362 1.274 0 C-N-CA 122.735 2.29 . . . . 75.51 112.944 177.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -63.97 113.7 3.64 Favored 'General case' 0 C--O 1.245 0.843 0 N-CA-C 109.484 -0.561 . . . . 72.42 109.484 -177.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 1.4 p -135.11 131.17 36.58 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 113.371 0.878 . . . . 75.45 113.371 -172.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 48.2 m -163.97 132.73 3.73 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 106.227 -1.768 . . . . 63.44 106.227 175.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -120.6 -71.19 0.75 Allowed 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 120.83 -0.348 . . . . 75.1 111.225 175.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -118.89 -1.65 10.99 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.645 0.736 . . . . 74.34 109.601 178.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -84.7 107.61 16.98 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 115.044 -0.98 . . . . 72.14 110.463 -171.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.76 -35.2 72.51 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.271 -0.64 . . . . 75.01 109.271 176.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -59.13 -37.56 77.54 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.908 -0.587 . . . . 70.34 110.048 174.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . 0.514 ' O ' ' HG2' ' A' ' 630' ' ' GLU . 11.4 tpt180 -68.16 -39.3 82.65 Favored 'General case' 0 C--O 1.2 -1.537 0 N-CA-C 109.32 -0.622 . . . . 72.33 109.32 -178.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 627' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -60.26 -31.46 70.24 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.393 0.616 . . . . 74.04 111.522 176.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 98.2 mt -72.41 -40.63 64.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-N 115.371 -0.832 . . . . 73.11 110.022 177.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -65.85 -38.43 88.84 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 109.339 -0.615 . . . . 63.13 109.339 175.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 630' ' ' GLU . . . . . 0.514 ' HG2' ' O ' ' A' ' 626' ' ' ARG . 6.5 mm-40 -73.96 -0.94 17.76 Favored 'General case' 0 C--O 1.217 -0.658 0 C-N-CA 123.785 0.834 . . . . 75.35 112.272 -179.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 631' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -107.53 0.51 22.75 Favored 'General case' 0 CA--C 1.507 -0.68 0 C-N-CA 119.728 -0.789 . . . . 75.3 109.814 172.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -88.34 -35.8 8.52 Favored Glycine 0 CA--C 1.497 -1.09 0 N-CA-C 106.324 -2.711 . . . . 74.43 106.324 169.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 633' ' ' ARG . . . . . 0.473 ' HD2' ' OE1' ' A' ' 630' ' ' GLU . 91.0 mtt180 -80.38 147.65 64.68 Favored Pre-proline 0 N--CA 1.427 -1.579 0 N-CA-C 107.239 -1.393 . . . . 74.14 107.239 169.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.452 ' HA ' ' HB3' ' A' ' 502' ' ' ALA . 27.7 Cg_endo -79.28 153.31 24.28 Favored 'Trans proline' 0 N--CA 1.429 -2.267 0 N-CA-C 107.937 -1.601 . . . . 70.11 107.937 166.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 635' ' ' ILE . . . . . 0.41 HG12 ' HB1' ' A' ' 502' ' ' ALA . 8.8 pt -122.86 -178.99 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 C-N-CA 119.7 -0.8 . . . . 72.11 109.98 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.55 -176.67 4.16 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 115.835 -0.621 . . . . 71.22 109.631 -178.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -83.54 -125.16 1.07 Allowed Glycine 0 N--CA 1.429 -1.811 0 C-N-CA 120.694 -0.765 . . . . 62.42 113.263 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -114.5 -59.94 1.95 Allowed 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 115.121 -0.54 . . . . 74.24 110.243 -176.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -107.52 93.82 4.75 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 122.068 0.937 . . . . 75.42 111.445 -178.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 23.7 p -109.46 91.27 3.58 Favored 'General case' 0 N--CA 1.41 -2.453 0 CA-C-N 115.389 -0.823 . . . . 73.5 109.788 178.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 641' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 510' ' ' PRO . 0.3 OUTLIER -168.92 129.26 1.13 Allowed 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 104.305 -2.48 . . . . 73.01 104.305 -178.021 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 642' ' ' LEU . . . . . 0.519 ' O ' ' HA ' ' A' ' 588' ' ' PHE . 37.0 tp -125.4 112.78 16.7 Favored 'General case' 0 C--N 1.276 -2.588 0 N-CA-C 108.094 -1.076 . . . . 71.14 108.094 175.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . 0.406 ' HB2' ' HE2' ' A' ' 641' ' ' LYS . 23.6 tt0 -98.07 107.2 19.63 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 107.175 -1.417 . . . . 74.45 107.175 177.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 644' ' ' VAL . . . . . 0.46 HG23 ' HE3' ' A' ' 521' ' ' MET . 26.6 t -95.05 103.18 14.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 N-CA-C 109.193 -0.669 . . . . 71.24 109.193 -178.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 3.9 mp -89.79 120.93 39.39 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 N-CA-C 108.401 -0.963 . . . . 74.43 108.401 178.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 646' ' ' ILE . . . . . 0.48 HD11 ' CE2' ' A' ' 587' ' ' PHE . 1.5 mp -104.83 128.64 58.38 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.764 0 N-CA-C 104.982 -2.229 . . . . 74.15 104.982 -178.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -147.22 170.66 16.77 Favored 'General case' 0 C--N 1.282 -2.356 0 O-C-N 123.551 0.532 . . . . 75.22 112.078 -176.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . 0.643 ' OE2' 'CA ' ' A' ' 800' ' ' ' CA' . 14.6 mm-40 -52.77 137.45 31.57 Favored 'General case' 0 C--O 1.249 1.037 0 CA-C-N 114.738 -1.119 . . . . 74.32 109.692 178.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 649' ' ' SER . . . . . 0.441 ' HA ' ' CZ ' ' A' ' 652' ' ' PHE . 9.4 t -79.15 86.01 4.99 Favored 'General case' 0 N--CA 1.422 -1.842 0 CA-C-O 121.945 0.879 . . . . 74.24 111.897 -174.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -109.2 -58.27 2.05 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 107.299 -1.371 . . . . 75.04 107.299 173.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -179.84 160.05 0.88 Allowed 'General case' 0 N--CA 1.422 -1.87 0 N-CA-C 101.941 -3.355 . . . . 70.44 101.941 175.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 652' ' ' PHE . . . . . 0.68 ' CZ ' ' HA ' ' A' ' 515' ' ' SER . 60.0 m-85 -121.0 99.74 6.67 Favored 'General case' 0 N--CA 1.397 -3.095 0 N-CA-C 109.192 -0.67 . . . . 75.42 109.192 -174.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 27.6 mmmt -78.78 92.23 4.8 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.541 -1.281 . . . . 54.42 107.541 -178.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 654' ' ' SER . . . . . 0.499 ' HA ' ' CD2' ' A' ' 513' ' ' HIS . 21.8 t -62.18 125.45 23.92 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.847 -1.07 . . . . 73.43 111.838 -172.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 90.7 m -75.26 92.82 2.78 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 107.999 -1.112 . . . . 70.25 107.999 174.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 56.7 t -75.69 116.39 18.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 N-CA-C 109.517 -0.549 . . . . 75.35 109.517 -178.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 13.9 t70 . . . . . 0 C--N 1.299 -1.617 0 N-CA-C 109.313 -0.625 . . . . 74.04 109.313 -179.355 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 800' ' ' ' CA' . . . . . 0.659 'CA ' ' OE2' ' A' ' 516' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 850' ' ' ' CA' . . . . . 0.67 'CA ' ' OE2' ' A' ' 580' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 23.5 t-160 . . . . . 0 N--CA 1.447 -0.594 0 CA-C-O 121.061 0.458 . . . . 73.11 110.015 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' A' ' 630' ' ' GLU . . . -151.81 -59.64 0.16 Allowed 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 107.299 -1.371 . . . . 53.44 107.299 175.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . 0.646 ' HA2' ' OG1' ' A' ' 528' ' ' THR . . . -155.29 113.15 0.56 Allowed Glycine 0 N--CA 1.403 -3.505 0 CA-C-N 114.642 -1.163 . . . . 74.34 110.585 177.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 3.1 mp -90.38 103.61 14.47 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.475 0 N-CA-C 108.783 -0.821 . . . . 62.13 108.783 177.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -117.15 109.37 16.83 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 106.728 -1.582 . . . . 75.34 106.728 175.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 12.5 t -150.62 164.39 36.17 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 109.196 -0.668 . . . . 73.42 109.196 -175.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -96.53 165.2 12.28 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.075 -1.083 . . . . 73.12 108.075 175.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.1 -30.97 9.89 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 120.781 -0.367 . . . . 74.42 111.919 175.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -107.85 123.7 37.04 Favored Pre-proline 0 C--N 1.311 -1.091 0 N-CA-C 108.714 -0.847 . . . . 75.22 108.714 173.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -82.43 -13.11 9.97 Favored 'Trans proline' 0 CA--C 1.532 0.381 0 C-N-CA 121.926 1.75 . . . . 75.11 111.549 177.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . 0.412 HG21 ' HB3' ' A' ' 643' ' ' GLU . 75.2 t -138.74 133.19 41.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 108.524 -0.917 . . . . 71.33 108.524 -179.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 5.4 t -136.45 145.86 45.7 Favored 'General case' 0 N--CA 1.41 -2.45 0 N-CA-C 108.613 -0.884 . . . . 71.3 108.613 176.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 27.8 m-70 -110.46 137.82 47.66 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.935 -0.765 . . . . 65.51 108.935 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.574 HG12 ' SD ' ' A' ' 521' ' ' MET . 27.7 m -126.74 151.53 33.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-O 121.197 0.522 . . . . 73.24 110.432 179.15 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 515' ' ' SER . . . . . 0.402 ' O ' HG21 ' A' ' 518' ' ' ILE . 43.5 t -76.32 146.95 38.49 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 107.849 -1.167 . . . . 74.24 107.849 176.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . 0.684 ' HB2' ' O ' ' A' ' 647' ' ' GLU . 33.4 tt0 -74.98 -7.4 53.52 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-O 121.905 0.86 . . . . 74.25 109.683 176.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 10.7 t -110.28 22.72 15.18 Favored 'General case' 0 N--CA 1.415 -2.207 0 N-CA-C 108.382 -0.97 . . . . 75.03 108.382 -177.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 518' ' ' ILE . . . . . 0.402 HG21 ' O ' ' A' ' 515' ' ' SER . 15.0 tt -94.02 155.61 3.18 Favored 'Isoleucine or valine' 0 C--O 1.247 0.948 0 N-CA-C 109.087 -0.708 . . . . 74.34 109.087 178.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -101.42 -70.45 0.89 Allowed Glycine 0 N--CA 1.419 -2.457 0 N-CA-C 110.66 -0.976 . . . . 65.33 110.66 177.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 32.3 mm -116.81 114.04 44.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 CA-C-O 120.689 0.28 . . . . 62.11 111.029 -177.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 521' ' ' MET . . . . . 0.574 ' SD ' HG12 ' A' ' 514' ' ' VAL . 24.7 ptt? -92.98 137.65 32.17 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.755 -1.202 . . . . 75.15 107.755 173.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -123.76 114.64 20.19 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 121.4 0.619 . . . . 75.23 110.794 178.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . 0.541 ' O ' ' HA ' ' A' ' 570' ' ' THR . 20.5 t -103.54 138.09 29.35 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 CA-C-N 114.639 -1.164 . . . . 75.23 108.414 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp -85.13 145.89 27.4 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.664 0.745 . . . . 73.34 112.329 -177.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 7.9 t -123.13 131.49 73.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 106.49 -1.67 . . . . 72.01 106.49 175.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -77.54 140.6 39.76 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.064 -0.717 . . . . 75.24 109.064 -178.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . 0.469 ' HG3' ' HA ' ' A' ' 567' ' ' ILE . 2.7 tmm_? -96.12 135.29 38.1 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 109.202 -0.666 . . . . 70.34 109.202 -176.1 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 528' ' ' THR . . . . . 0.646 ' OG1' ' HA2' ' A' ' 503' ' ' GLY . 6.0 t -50.85 147.04 5.26 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 125.083 1.353 . . . . 73.14 114.557 -177.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 35.2 t -63.21 -55.11 27.72 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 114.55 -1.204 . . . . 51.31 107.811 173.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -85.95 95.5 2.02 Favored Glycine 0 N--CA 1.423 -2.171 0 N-CA-C 109.5 -1.44 . . . . 64.03 109.5 178.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -111.64 98.93 7.77 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 121.092 0.472 . . . . 64.44 110.24 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -125.01 131.78 53.35 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 109.299 -0.63 . . . . 75.44 109.299 177.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 81.07 -144.54 24.94 Favored Glycine 0 N--CA 1.422 -2.286 0 C-N-CA 120.828 -0.701 . . . . 60.34 113.254 175.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -140.2 121.74 15.18 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 107.858 -1.164 . . . . 72.02 107.858 179.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 58.1 t -126.75 131.74 70.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 108.803 -0.814 . . . . 75.02 108.803 -178.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 536' ' ' ILE . . . . . 0.606 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 42.5 mm -94.92 129.63 44.81 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 108.888 -0.782 . . . . 74.12 108.888 178.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 67.9 t -111.97 110.73 54.04 Favored Pre-proline 0 C--N 1.295 -1.783 0 N-CA-C 109.37 -0.604 . . . . 75.54 109.37 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -73.96 155.95 47.88 Favored 'Trans proline' 0 CA--C 1.512 -0.625 0 C-N-CA 122.513 2.142 . . . . 72.2 111.495 178.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 539' ' ' TYR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 591' ' ' ILE . 48.2 p90 -150.41 156.34 41.3 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.295 -1.002 . . . . 74.43 108.295 177.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -152.44 147.9 26.81 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 112.188 0.44 . . . . 74.55 112.188 176.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 3.5 p -84.34 120.92 26.82 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-N 115.474 -0.785 . . . . 72.55 110.94 176.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.8 mp -88.84 119.92 36.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 N-CA-C 105.728 -1.953 . . . . 71.05 105.728 173.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -52.47 -41.01 62.97 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 124.479 1.112 . . . . 75.43 112.716 -174.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 72.34 -92.05 0.57 Allowed Glycine 0 N--CA 1.435 -1.369 0 N-CA-C 110.825 -0.91 . . . . 73.41 110.825 178.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 10.2 t -146.14 18.13 1.39 Allowed 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 121.382 0.611 . . . . 72.3 109.812 177.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -101.08 161.03 13.89 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.619 -1.252 . . . . 64.42 107.619 176.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 18.5 mmm180 -63.86 173.23 1.88 Allowed 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 113.75 1.019 . . . . 74.24 113.75 -179.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -71.34 -178.47 28.7 Favored Glycine 0 C--O 1.254 1.355 0 CA-C-N 114.254 -1.339 . . . . 62.11 114.281 -175.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . -59.87 119.38 18.09 Favored Glycine 0 N--CA 1.441 -1.005 0 CA-C-N 114.737 -0.731 . . . . 74.51 113.287 -176.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 95.28 -10.41 69.51 Favored Glycine 0 N--CA 1.435 -1.399 0 N-CA-C 111.712 -0.555 . . . . 63.42 111.712 178.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -98.51 -68.36 0.81 Allowed 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.782 -0.822 . . . . 71.35 108.782 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -94.22 -38.29 11.13 Favored 'General case' 0 CA--C 1.492 -1.264 0 C-N-CA 118.862 -1.135 . . . . 74.22 111.414 175.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 553' ' ' PHE . . . . . 0.407 ' HB3' ' CE2' ' A' ' 587' ' ' PHE . 48.0 p90 -145.04 155.63 43.47 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 108.316 -0.994 . . . . 71.52 108.316 -179.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -83.56 119.24 24.48 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 105.329 -2.1 . . . . 75.02 105.329 174.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -73.53 104.23 4.42 Favored 'General case' 0 CA--C 1.498 -1.035 0 CA-C-O 121.267 0.556 . . . . 61.33 110.043 -175.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 556' ' ' THR . . . . . 0.423 HG22 HG21 ' A' ' 573' ' ' VAL . 11.5 t -103.36 100.8 10.69 Favored 'General case' 0 N--CA 1.395 -3.175 0 CA-C-O 122.793 1.282 . . . . 64.52 110.978 -176.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 1.8 p -116.61 94.45 4.62 Favored 'General case' 0 N--CA 1.409 -2.502 0 CA-C-N 114.085 -1.416 . . . . 71.41 108.47 174.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -142.34 -157.54 7.19 Favored Glycine 0 N--CA 1.407 -3.291 0 N-CA-C 110.029 -1.228 . . . . 71.0 110.029 -174.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 559' ' ' GLU . . . . . 0.606 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 49.3 mt-10 -142.23 137.09 30.48 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 120.647 0.26 . . . . 63.14 111.315 -173.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 95.5 mt -96.82 144.94 26.31 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 123.415 0.686 . . . . 72.24 109.681 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -102.88 113.25 26.54 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 120.923 0.392 . . . . 74.52 110.665 -178.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -109.08 132.51 54.04 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 110.076 -0.342 . . . . 70.21 110.076 175.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -121.96 174.22 7.04 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.457 -0.897 . . . . 75.43 111.343 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -64.68 -38.03 89.59 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 114.122 -1.399 . . . . 65.34 110.222 176.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -94.34 -33.89 13.01 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.529 -0.76 . . . . 62.13 112.269 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -78.19 132.15 37.47 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.51 -0.313 . . . . 71.13 111.681 -177.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 567' ' ' ILE . . . . . 0.469 ' HA ' ' HG3' ' A' ' 527' ' ' ARG . 7.8 pt -109.94 163.29 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.617 0 N-CA-C 109.732 -0.47 . . . . 75.44 109.732 178.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 568' ' ' VAL . . . . . 0.504 ' O ' ' HG2' ' A' ' 569' ' ' LYS . 1.4 p 45.53 171.93 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.574 1.882 0 C-N-CA 127.278 2.231 . . . . 72.54 114.553 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 569' ' ' LYS . . . . . 0.504 ' HG2' ' O ' ' A' ' 568' ' ' VAL . 0.0 OUTLIER -158.98 163.98 35.97 Favored 'General case' 0 CA--C 1.497 -1.095 0 C-N-CA 124.39 1.076 . . . . 73.31 108.235 173.698 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 570' ' ' THR . . . . . 0.541 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 4.7 p -135.4 133.96 39.22 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 124.112 0.883 . . . . 74.44 110.352 177.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 3.3 mp -93.03 106.26 17.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 106.618 -1.623 . . . . 74.5 106.618 172.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 572' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' A' ' 521' ' ' MET . 13.0 p -88.14 112.02 22.24 Favored 'General case' 0 N--CA 1.424 -1.733 0 O-C-N 123.575 0.547 . . . . 74.44 109.797 178.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 573' ' ' VAL . . . . . 0.423 HG21 HG22 ' A' ' 556' ' ' THR . 42.4 t -115.54 131.22 68.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 109.148 -0.686 . . . . 75.23 109.148 -178.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -88.01 112.69 22.88 Favored 'General case' 0 N--CA 1.423 -1.784 0 O-C-N 123.929 0.768 . . . . 74.33 109.516 176.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 62.9 t -85.88 133.61 29.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 N-CA-C 106.42 -1.696 . . . . 73.24 106.42 176.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 25.8 mm -97.78 159.9 3.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 107.914 -1.143 . . . . 74.42 107.914 -174.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -71.35 114.22 9.19 Favored 'General case' 0 C--O 1.25 1.13 0 N-CA-C 110.007 -0.368 . . . . 74.22 110.007 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -56.82 142.71 39.91 Favored 'General case' 0 C--O 1.246 0.921 0 C-N-CA 124.614 1.166 . . . . 72.42 110.969 -176.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 579' ' ' GLU . . . . . 0.655 ' OE1' 'CA ' ' A' ' 850' ' ' ' CA' . 0.0 OUTLIER -124.88 -28.35 3.5 Favored 'General case' 0 C--N 1.289 -2.055 0 C-N-CA 125.115 1.366 . . . . 75.32 112.31 -170.439 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 580' ' ' GLU . . . . . 0.624 ' OE2' 'CA ' ' A' ' 850' ' ' ' CA' 0.3 0.0 OUTLIER -111.49 174.07 6.04 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 114.647 1.351 . . . . 71.32 114.647 -172.653 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 31.7 p90 -48.8 148.02 2.38 Favored 'General case' 0 CA--C 1.522 -0.122 0 O-C-N 124.778 1.298 . . . . 71.33 110.287 -178.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -122.99 106.5 10.9 Favored 'General case' 0 N--CA 1.408 -2.573 0 C-N-CA 118.265 -1.374 . . . . 75.34 114.177 -173.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -98.45 -158.48 0.67 Allowed 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 104.902 -2.258 . . . . 74.01 104.902 169.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -83.05 88.34 6.87 Favored 'General case' 0 C--N 1.282 -2.353 0 C-N-CA 118.903 -1.119 . . . . 73.03 108.4 174.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 585' ' ' LYS . . . . . . . . . . . . 0.315 0.5 OUTLIER -100.85 138.36 38.0 Favored 'General case' 0 N--CA 1.425 -1.684 0 C-N-CA 119.429 -0.908 . . . . 75.22 111.81 -179.014 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 4.1 t -152.42 150.21 29.41 Favored 'General case' 0 N--CA 1.405 -2.681 0 CA-C-N 114.699 -1.137 . . . . 74.44 109.79 -175.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 587' ' ' PHE . . . . . 0.407 ' CE2' ' HB3' ' A' ' 553' ' ' PHE . 4.1 p90 -124.35 151.23 44.59 Favored 'General case' 0 N--CA 1.411 -2.395 0 CA-C-N 114.221 -1.354 . . . . 71.13 108.335 176.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 588' ' ' PHE . . . . . 0.494 ' HA ' ' O ' ' A' ' 642' ' ' LEU . 16.5 m-85 -113.35 142.04 46.33 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 116.471 -0.331 . . . . 64.42 110.281 -171.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.71 131.7 54.14 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 106.481 -1.674 . . . . 75.1 106.481 175.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -141.77 144.4 33.95 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.396 -0.964 . . . . 64.14 108.396 -179.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 591' ' ' ILE . . . . . 0.544 HG12 ' OG1' ' A' ' 640' ' ' THR . 20.0 pt -96.37 168.01 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 O-C-N 123.699 0.624 . . . . 74.33 109.691 177.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -118.03 -154.27 9.76 Favored Glycine 0 C--N 1.303 -1.288 0 C-N-CA 120.444 -0.884 . . . . 71.23 113.675 -177.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -76.93 118.24 70.47 Favored Pre-proline 0 C--N 1.319 -0.751 0 N-CA-C 108.664 -0.865 . . . . 73.02 108.664 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -66.72 138.19 48.28 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 122.398 2.065 . . . . 73.32 112.071 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 595' ' ' ARG . . . . . 0.535 ' CG ' ' HB ' ' A' ' 536' ' ' ILE . 7.2 ptm180 -116.03 119.48 36.02 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.69 -0.686 . . . . 75.13 109.822 -174.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 596' ' ' LEU . . . . . 0.424 ' C ' ' H ' ' A' ' 598' ' ' GLU . 0.0 OUTLIER -69.96 129.0 38.31 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 107.92 -1.141 . . . . 73.15 107.92 179.216 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 597' ' ' VAL . . . . . 0.476 ' CG2' HG12 ' A' ' 536' ' ' ILE . 11.6 t -91.0 36.7 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 122.696 1.236 . . . . 70.24 108.286 178.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 598' ' ' GLU . . . . . 0.424 ' H ' ' C ' ' A' ' 596' ' ' LEU . 44.3 mt-10 70.14 -39.95 0.45 Allowed 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 126.292 1.837 . . . . 73.41 115.922 177.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 62.6 ttp -53.5 109.61 0.46 Allowed 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 112.578 0.585 . . . . 74.44 112.578 -174.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 32.8 t 178.48 116.3 0.04 OUTLIER 'General case' 0 N--CA 1.421 -1.903 0 N-CA-C 103.807 -2.664 . . . . 74.53 103.807 179.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -122.19 131.65 54.05 Favored 'General case' 0 C--N 1.284 -2.281 0 C-N-CA 119.411 -0.915 . . . . 73.44 112.819 -173.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -90.42 129.0 36.66 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 104.821 -2.289 . . . . 72.51 104.821 167.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -75.36 7.22 3.69 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.463 0.649 . . . . 65.22 111.302 -174.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -90.63 20.36 38.92 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 116.237 -0.438 . . . . 52.42 112.142 178.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 85.91 42.08 6.9 Favored Glycine 0 N--CA 1.438 -1.189 0 C-N-CA 120.913 -0.66 . . . . 65.44 113.217 176.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -160.57 126.88 4.09 Favored 'General case' 0 C--O 1.245 0.817 0 CA-C-N 117.142 0.471 . . . . 74.53 110.643 178.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 15.3 p -97.53 135.33 39.53 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-N 116.141 -0.482 . . . . 75.42 109.962 176.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 49.7 mm -74.58 152.29 6.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 C-N-CA 122.881 0.472 . . . . 71.23 110.413 -174.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 7.6 t -153.33 75.18 1.05 Allowed 'General case' 0 N--CA 1.405 -2.69 0 CA-C-O 122.766 1.269 . . . . 75.55 111.295 176.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -86.62 84.2 7.45 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 106.979 -1.489 . . . . 75.3 106.979 176.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -88.21 92.24 9.08 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-O 121.997 0.903 . . . . 73.25 113.382 -175.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -118.21 84.89 2.25 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 105.767 -1.938 . . . . 74.11 105.767 170.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -126.75 22.37 6.86 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 112.709 -2.042 . . . . 75.03 107.834 -169.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -94.52 2.99 55.68 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.8 -1.091 . . . . 72.41 111.915 -172.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp 51.5 72.44 0.37 Allowed 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 114.064 -1.425 . . . . 75.11 112.35 -179.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 80.1 mm-40 -108.31 170.93 4.97 Favored Pre-proline 0 C--N 1.282 -2.362 0 CA-C-N 114.704 -1.135 . . . . 75.34 108.609 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -65.82 162.64 33.97 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 121.096 1.197 . . . . 74.35 109.3 171.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -60.54 137.36 58.17 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 121.555 0.693 . . . . 74.21 111.329 -178.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 619' ' ' THR . . . . . 0.439 ' O ' ' HG2' ' A' ' 626' ' ' ARG . 19.4 p -66.34 -9.34 32.3 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 116.502 2.038 . . . . 72.41 116.502 -167.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 7.6 p -74.08 78.23 1.73 Allowed 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 114.496 1.295 . . . . 74.31 114.496 -175.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 44.1 tttm -86.32 -49.44 7.67 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 114.677 -1.147 . . . . 73.5 108.166 174.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 25.8 mp0 -103.71 148.53 25.95 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 107.01 -1.478 . . . . 73.23 107.01 175.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -93.02 -33.57 14.07 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 107.668 -1.234 . . . . 75.32 107.668 171.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -58.97 -67.34 0.38 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.751 -1.113 . . . . 71.11 112.534 -178.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -87.31 -33.63 19.15 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 113.556 0.947 . . . . 64.44 113.556 -173.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . 0.444 ' O ' ' HG3' ' A' ' 630' ' ' GLU . 6.4 tpp180 -66.61 -37.5 84.99 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 112.704 0.631 . . . . 75.04 112.704 -171.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 627' ' ' ARG . . . . . . . . . . . . . 81.6 mtm180 -55.6 -28.59 56.03 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 112.81 0.67 . . . . 72.55 112.81 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . 0.432 ' O ' ' HG2' ' A' ' 631' ' ' MET . 93.7 mt -64.56 -36.99 78.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-N 115.441 -0.8 . . . . 64.23 110.362 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -86.22 -30.57 22.28 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.933 -0.576 . . . . 74.24 109.569 178.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 630' ' ' GLU . . . . . 0.486 ' O ' ' HB2' ' A' ' 502' ' ' ALA . 50.4 mt-10 -80.45 2.54 24.71 Favored 'General case' 0 C--O 1.216 -0.679 0 CA-C-N 115.671 -0.695 . . . . 61.52 112.36 -177.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 631' ' ' MET . . . . . 0.432 ' HG2' ' O ' ' A' ' 628' ' ' ILE . 19.4 ptp -85.58 -30.81 23.04 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 119.176 -1.01 . . . . 74.31 109.208 174.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -92.57 -40.76 4.94 Favored Glycine 0 N--CA 1.431 -1.66 0 N-CA-C 110.979 -0.848 . . . . 72.23 110.979 177.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -88.97 138.82 29.05 Favored Pre-proline 0 C--N 1.314 -0.954 0 N-CA-C 108.773 -0.825 . . . . 74.41 108.773 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -74.31 154.17 45.89 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.39 2.06 . . . . 70.41 113.188 -175.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 1.9 pp -144.09 -169.81 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.31 -0.859 . . . . 75.43 110.775 -176.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.61 164.1 19.94 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 123.082 0.239 . . . . 73.32 110.621 -179.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -81.16 -85.29 0.7 Allowed Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 121.317 -0.468 . . . . 71.45 113.78 -177.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -143.02 -63.58 0.41 Allowed 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 120.465 -0.494 . . . . 74.44 110.425 -178.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 10.7 p80 -127.68 114.77 17.77 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-O 121.913 0.864 . . . . 75.43 111.598 178.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 640' ' ' THR . . . . . 0.544 ' OG1' HG12 ' A' ' 591' ' ' ILE . 0.7 OUTLIER -111.4 92.28 3.98 Favored 'General case' 0 N--CA 1.416 -2.131 0 CA-C-N 114.811 -1.086 . . . . 62.33 109.674 177.361 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -169.88 125.44 0.81 Allowed 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 106.503 -1.666 . . . . 63.45 106.503 178.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 642' ' ' LEU . . . . . 0.494 ' O ' ' HA ' ' A' ' 588' ' ' PHE . 31.3 tp -130.43 110.09 11.21 Favored 'General case' 0 C--N 1.277 -2.553 0 N-CA-C 108.312 -0.996 . . . . 72.54 108.312 177.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . 0.412 ' HB3' HG21 ' A' ' 511' ' ' VAL . 43.1 tt0 -92.31 107.22 19.05 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.062 -1.088 . . . . 73.53 108.062 178.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 644' ' ' VAL . . . . . 0.457 HG22 ' HE3' ' A' ' 521' ' ' MET . 24.3 t -97.73 104.56 16.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 109.248 -0.649 . . . . 74.22 109.248 -179.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 4.5 mp -86.69 128.21 39.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 108.903 -0.777 . . . . 73.32 108.903 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 646' ' ' ILE . . . . . 0.448 ' N ' HD13 ' A' ' 646' ' ' ILE . 1.2 mp -110.81 106.94 21.73 Favored 'Isoleucine or valine' 0 C--O 1.255 1.377 0 N-CA-C 108.158 -1.053 . . . . 73.34 108.158 -177.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . 0.684 ' O ' ' HB2' ' A' ' 516' ' ' GLU . 8.0 pt-20 -109.19 -161.4 0.76 Allowed 'General case' 0 C--N 1.268 -2.958 0 CA-C-N 113.718 -1.583 . . . . 75.31 107.864 -178.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . 0.656 ' OE1' 'CA ' ' A' ' 800' ' ' ' CA' . 7.8 mm-40 -81.5 -173.1 4.19 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.3 -0.63 . . . . 74.1 109.3 177.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 23.1 t -79.76 80.41 6.15 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.213 -1.032 . . . . 64.3 108.213 175.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 650' ' ' TYR . . . . . 0.412 ' O ' ' HB2' ' A' ' 651' ' ' GLU . 81.6 t80 -143.52 -61.96 0.4 Allowed 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 114.557 -1.201 . . . . 74.11 108.516 -177.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 651' ' ' GLU . . . . . 0.412 ' HB2' ' O ' ' A' ' 650' ' ' TYR . 35.1 mt-10 71.86 121.09 0.04 OUTLIER 'General case' 0 C--O 1.247 0.966 0 C-N-CA 126.199 1.8 . . . . 73.31 111.425 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -122.81 164.66 17.96 Favored 'General case' 0 C--N 1.27 -2.865 0 N-CA-C 106.884 -1.524 . . . . 73.53 106.884 -179.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -118.03 98.91 6.56 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 120.802 0.334 . . . . 75.3 110.777 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 23.4 t -135.65 79.28 1.77 Allowed 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 108.722 -0.844 . . . . 72.54 108.722 176.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 15.0 m -95.84 100.96 12.59 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 115.252 -0.886 . . . . 75.02 109.337 -178.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 31.5 m -91.15 164.76 2.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 CA-C-N 115.78 -0.645 . . . . 71.33 110.343 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 . . . . . 0 C--O 1.253 1.286 0 N-CA-C 110.058 -0.349 . . . . 72.13 110.058 -179.546 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 800' ' ' ' CA' . . . . . 0.675 'CA ' ' OE1' ' A' ' 516' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 850' ' ' ' CA' . . . . . 0.655 'CA ' ' OE1' ' A' ' 579' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 9.7 t-160 . . . . . 0 CA--C 1.515 -0.395 0 CA-C-O 121.669 0.747 . . . . 71.3 111.764 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . 0.411 ' HB2' ' HA ' ' A' ' 634' ' ' PRO . . . -145.82 -64.07 0.32 Allowed 'General case' 0 C--N 1.279 -2.459 0 N-CA-C 106.302 -1.74 . . . . 73.24 106.302 173.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . 0.457 ' HA2' ' OG1' ' A' ' 528' ' ' THR . . . 137.38 125.82 2.44 Favored Glycine 0 N--CA 1.409 -3.113 0 C-N-CA 120.31 -0.948 . . . . 71.22 112.248 176.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . 0.425 ' H ' ' CB ' ' A' ' 528' ' ' THR . 3.1 mp -93.57 98.46 8.28 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 N-CA-C 107.826 -1.176 . . . . 74.34 107.826 174.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -113.9 114.73 26.63 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.922 -1.14 . . . . 72.5 107.922 176.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 506' ' ' THR . . . . . 0.424 ' HB ' ' HA3' ' A' ' 637' ' ' GLY . 15.0 t -149.02 162.66 39.49 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.876 -0.787 . . . . 74.23 108.876 -176.183 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -81.71 152.19 27.17 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 108.023 -1.103 . . . . 74.12 108.023 176.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -76.14 -24.85 54.9 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.551 0.691 . . . . 71.34 109.691 178.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . 0.432 ' OE1' ' HB ' ' A' ' 655' ' ' THR . 24.2 pt-20 -139.45 132.78 15.58 Favored Pre-proline 0 N--CA 1.424 -1.765 0 CA-C-N 115.144 -0.935 . . . . 72.2 108.683 -179.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 641' ' ' LYS . 84.5 Cg_endo -84.33 0.33 9.19 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 122.122 1.881 . . . . 72.33 112.202 176.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . 0.443 HG23 ' HB3' ' A' ' 643' ' ' GLU . 69.3 t -145.57 135.33 18.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 124.193 0.997 . . . . 73.34 108.413 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 6.2 t -142.03 140.79 32.73 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.198 -1.408 . . . . 64.25 107.198 177.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -110.79 133.55 53.25 Favored 'General case' 0 CA--C 1.492 -1.258 0 N-CA-C 108.325 -0.991 . . . . 73.3 108.325 178.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.655 HG13 ' SD ' ' A' ' 521' ' ' MET . 34.0 m -129.62 159.89 41.18 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 CA-C-N 116.209 -0.451 . . . . 73.24 110.288 -174.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 515' ' ' SER . . . . . 0.401 ' HB3' ' HB ' ' A' ' 518' ' ' ILE . 47.3 t -77.7 150.48 34.47 Favored 'General case' 0 N--CA 1.415 -2.216 0 N-CA-C 107.564 -1.273 . . . . 75.45 107.564 177.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -88.43 -7.06 57.22 Favored 'General case' 0 C--N 1.286 -2.156 0 CA-C-O 122.315 1.055 . . . . 70.24 108.946 178.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 33.0 t -100.29 2.43 42.62 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 114.97 -1.014 . . . . 75.21 109.16 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 518' ' ' ILE . . . . . 0.401 ' HB ' ' HB3' ' A' ' 515' ' ' SER . 15.0 tt -78.52 151.99 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-N 115.979 -0.555 . . . . 71.33 110.039 -176.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -87.52 -70.78 1.29 Allowed Glycine 0 N--CA 1.43 -1.719 0 N-CA-C 110.094 -1.202 . . . . 73.41 110.094 176.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 31.7 mm -112.54 126.31 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 CA-C-O 120.935 0.398 . . . . 62.35 110.178 179.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 521' ' ' MET . . . . . 0.655 ' SD ' HG13 ' A' ' 514' ' ' VAL . 23.1 ptt? -105.46 142.96 34.3 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 107.167 -1.42 . . . . 74.34 107.167 173.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -121.03 151.61 39.58 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 121.395 0.617 . . . . 73.31 111.555 178.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . 0.629 ' O ' ' HA ' ' A' ' 570' ' ' THR . 33.0 t -130.83 137.17 56.59 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 107.832 -1.173 . . . . 71.33 107.832 -179.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -90.43 127.33 36.18 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 113.024 0.75 . . . . 74.54 113.024 -176.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 22.9 t -112.57 121.95 65.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 107.291 -1.374 . . . . 72.52 107.291 176.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -75.42 145.08 41.83 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.893 0.854 . . . . 75.04 112.687 -174.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . 0.411 ' HG3' ' O ' ' A' ' 528' ' ' THR . 11.2 tpp85 -75.62 133.08 40.98 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 114.073 -1.422 . . . . 71.5 109.202 173.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 528' ' ' THR . . . . . 0.457 ' OG1' ' HA2' ' A' ' 503' ' ' GLY . 3.0 t -57.64 159.85 4.81 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 114.56 -1.2 . . . . 75.32 111.965 174.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 35.7 t -62.04 -37.87 86.57 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.73 0.812 . . . . 43.12 109.126 178.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -137.63 122.78 2.57 Favored Glycine 0 N--CA 1.425 -2.099 0 N-CA-C 109.961 -1.256 . . . . 74.42 109.961 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . 0.401 ' HB2' ' CG2' ' A' ' 528' ' ' THR . . . -130.25 114.01 15.12 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.332 -0.988 . . . . 75.13 108.332 176.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -120.79 90.09 3.25 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.696 -0.853 . . . . 74.33 108.696 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 533' ' ' GLY . . . . . 0.476 ' H ' ' HB3' ' A' ' 564' ' ' ASN . . . 122.57 -178.86 16.3 Favored Glycine 0 N--CA 1.437 -1.256 0 N-CA-C 110.96 -0.856 . . . . 75.4 110.96 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 534' ' ' ASN . . . . . 0.506 HD21 ' N ' ' A' ' 535' ' ' VAL . 0.2 OUTLIER -91.92 131.1 37.49 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.27 -1.011 . . . . 74.22 108.27 179.223 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 535' ' ' VAL . . . . . 0.506 ' N ' HD21 ' A' ' 534' ' ' ASN . 89.8 t -119.1 139.03 47.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-O 121.059 0.457 . . . . 73.24 110.143 179.2 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 536' ' ' ILE . . . . . . . . . . . . . 42.1 mm -105.44 125.01 60.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 108.949 -0.76 . . . . 75.53 108.949 178.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 22.0 t -113.49 106.24 54.38 Favored Pre-proline 0 C--N 1.302 -1.482 0 O-C-N 123.35 0.406 . . . . 74.32 109.909 -178.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.9 145.37 25.11 Favored 'Trans proline' 0 CA--C 1.533 0.454 0 C-N-CA 122.369 2.046 . . . . 75.33 111.71 178.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -142.45 163.05 33.89 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 110.212 -0.292 . . . . 73.25 110.212 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -151.76 153.78 34.98 Favored 'General case' 0 C--N 1.308 -1.196 0 O-C-N 123.6 0.563 . . . . 74.34 110.618 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 4.1 p -99.24 125.14 44.78 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.796 -0.638 . . . . 72.04 110.363 173.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.7 mp -96.06 118.52 42.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 105.937 -1.875 . . . . 72.24 105.937 174.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -55.84 -50.56 70.23 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 123.868 0.73 . . . . 75.45 112.273 -176.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 69.51 -103.49 1.11 Allowed Glycine 0 N--CA 1.431 -1.645 0 N-CA-C 111.099 -0.8 . . . . 73.34 111.099 -179.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 9.1 t -109.63 -3.96 16.51 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.337 0.589 . . . . 71.45 110.311 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -96.01 171.54 8.56 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.927 -0.397 . . . . 75.43 109.927 176.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 31.7 tpt180 -115.4 119.51 36.47 Favored 'General case' 0 C--O 1.247 0.968 0 N-CA-C 109.253 -0.647 . . . . 72.34 109.253 179.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -86.75 -154.03 24.8 Favored Glycine 0 C--N 1.311 -0.828 0 C-N-CA 120.874 -0.679 . . . . 73.12 112.37 -179.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 72.07 17.44 77.18 Favored Glycine 0 C--N 1.316 -0.567 0 CA-C-O 120.151 -0.249 . . . . 62.43 113.558 178.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 83.85 27.16 38.94 Favored Glycine 0 N--CA 1.439 -1.145 0 N-CA-C 110.817 -0.913 . . . . 74.41 110.817 -178.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -99.32 -69.75 0.75 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 120.711 0.291 . . . . 73.54 110.333 -178.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . 0.655 ' OD1' 'CA ' ' A' ' 850' ' ' ' CA' . 1.2 t70 -102.99 -27.91 12.33 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 106.879 -1.526 . . . . 75.15 106.879 177.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -146.23 158.2 43.86 Favored 'General case' 0 C--O 1.252 1.213 0 CA-C-N 114.526 -1.216 . . . . 74.31 108.438 174.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -87.81 116.61 26.08 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 106.121 -1.807 . . . . 73.33 106.121 178.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -75.78 132.81 40.68 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.3 -0.63 . . . . 73.41 109.3 -175.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 8.9 t -133.76 117.89 17.44 Favored 'General case' 0 N--CA 1.412 -2.348 0 CA-C-O 122.038 0.923 . . . . 75.13 111.534 -175.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 8.0 p -130.23 100.64 5.47 Favored 'General case' 0 N--CA 1.424 -1.77 0 N-CA-C 107.628 -1.249 . . . . 74.41 107.628 174.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -145.77 -159.71 8.3 Favored Glycine 0 N--CA 1.411 -2.968 0 N-CA-C 109.984 -1.246 . . . . 60.33 109.984 -174.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -136.1 136.77 40.41 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-O 120.678 0.275 . . . . 74.33 110.635 -175.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 89.1 mt -95.16 134.25 38.1 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.642 -0.708 . . . . 73.34 109.415 178.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 561' ' ' GLU . . . . . 0.423 ' HG3' HD22 ' A' ' 534' ' ' ASN . 43.9 tt0 -93.32 97.03 10.33 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.703 -0.851 . . . . 73.54 108.703 176.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -101.88 108.27 19.7 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 106.838 -1.542 . . . . 74.1 106.838 -178.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -97.49 172.4 7.77 Favored 'General case' 0 C--N 1.278 -2.506 0 CA-C-N 116.415 -0.357 . . . . 70.54 110.94 -174.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 564' ' ' ASN . . . . . 0.476 ' HB3' ' H ' ' A' ' 533' ' ' GLY . 2.6 p-10 -79.0 -16.04 57.44 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.98 0.895 . . . . 54.1 109.107 175.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -96.07 -54.79 3.19 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.211 -0.904 . . . . 75.12 109.195 176.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -63.78 138.48 58.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.614 -0.721 . . . . 75.02 109.692 177.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 21.8 pt -106.0 -172.23 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.41 -2.466 0 N-CA-C 108.219 -1.03 . . . . 74.04 108.219 -178.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 3.4 p 3.19 126.47 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 128.832 2.853 . . . . 75.54 116.165 173.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 569' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -110.16 149.07 30.62 Favored 'General case' 0 C--N 1.259 -3.342 0 CA-C-N 115.112 -0.949 . . . . 71.34 110.502 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 570' ' ' THR . . . . . 0.629 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 16.0 p -122.53 128.16 50.43 Favored 'General case' 0 N--CA 1.415 -2.21 0 CA-C-N 115.259 -0.882 . . . . 72.33 110.188 177.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 3.3 mp -84.0 104.21 12.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 107.033 -1.469 . . . . 62.41 107.033 174.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 11.0 p -84.72 111.17 19.34 Favored 'General case' 0 N--CA 1.419 -2.009 0 CA-C-N 115.758 -0.655 . . . . 72.43 110.084 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 573' ' ' VAL . . . . . . . . . . . . . 57.6 t -114.24 136.57 50.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 109.143 -0.688 . . . . 75.34 109.143 -178.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -95.15 125.05 39.53 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 124.123 0.89 . . . . 75.22 111.18 -178.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 81.8 t -93.59 132.84 36.63 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 N-CA-C 107.745 -1.206 . . . . 75.23 107.745 175.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 40.3 mm -91.6 160.44 2.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 109.535 -0.543 . . . . 75.23 109.535 -173.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -52.4 119.1 4.08 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 124.043 0.937 . . . . 72.12 109.671 175.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 578' ' ' ASP . . . . . 0.637 ' OD1' 'CA ' ' A' ' 850' ' ' ' CA' . 35.0 t70 -90.69 151.31 21.3 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.1 0.476 . . . . 75.2 111.952 -175.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 579' ' ' GLU . . . . . 0.616 ' OE1' 'CA ' ' A' ' 850' ' ' ' CA' . 0.0 OUTLIER -127.91 -26.73 2.87 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 114.194 1.183 . . . . 64.11 114.194 -172.363 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 580' ' ' GLU . . . . . 0.4 ' HG2' ' O ' ' A' ' 581' ' ' TYR . 0.0 OUTLIER -112.23 178.21 4.38 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 118.741 -1.184 . . . . 73.45 113.263 -166.943 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 581' ' ' TYR . . . . . 0.4 ' O ' ' HG2' ' A' ' 580' ' ' GLU . 47.8 p90 -61.94 154.34 26.68 Favored 'General case' 0 C--O 1.247 0.969 0 CA-C-N 114.803 -1.09 . . . . 75.22 108.922 175.013 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 582' ' ' GLU . . . . . 0.456 ' HG3' ' O ' ' A' ' 583' ' ' LYS . 5.8 tp10 -94.31 152.78 18.4 Favored 'General case' 0 C--N 1.284 -2.251 0 C-N-CA 119.023 -1.071 . . . . 63.21 110.633 179.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . 0.456 ' O ' ' HG3' ' A' ' 582' ' ' GLU . 18.3 ptpt -137.85 -172.16 3.18 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 103.365 -2.828 . . . . 74.31 103.365 176.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -79.54 91.69 5.2 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.254 -1.758 . . . . 75.34 106.254 170.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 585' ' ' LYS . . . . . 0.442 ' HD2' HD13 ' A' ' 646' ' ' ILE . 4.7 tmmm? -106.67 109.23 21.08 Favored 'General case' 0 N--CA 1.396 -3.165 0 N-CA-C 106.756 -1.572 . . . . 75.31 106.756 -172.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 4.6 t -142.44 145.76 34.11 Favored 'General case' 0 N--CA 1.392 -3.35 0 CA-C-N 113.823 -1.535 . . . . 75.13 109.306 -174.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -128.85 155.57 45.02 Favored 'General case' 0 N--CA 1.412 -2.35 0 CA-C-N 114.408 -1.269 . . . . 73.45 108.858 178.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 588' ' ' PHE . . . . . 0.497 ' HA ' ' O ' ' A' ' 642' ' ' LEU . 23.5 m-85 -109.67 138.13 46.49 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-N 116.36 -0.382 . . . . 74.23 110.23 -171.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . 0.433 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.8 OUTLIER -110.94 125.76 54.02 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 105.777 -1.934 . . . . 73.0 105.777 176.297 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -127.94 131.24 49.34 Favored 'General case' 0 C--N 1.284 -2.248 0 C-N-CA 120.613 -0.435 . . . . 74.44 110.289 179.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 591' ' ' ILE . . . . . . . . . . . . . 15.2 pt -93.66 134.02 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.621 0 N-CA-C 106.758 -1.571 . . . . 63.31 106.758 171.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -86.83 -146.95 10.64 Favored Glycine 0 C--N 1.3 -1.47 0 C-N-CA 120.965 -0.636 . . . . 73.11 111.586 -176.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.568 ' OE1' ' HD3' ' A' ' 633' ' ' ARG . 35.0 tt0 -88.57 123.87 67.11 Favored Pre-proline 0 N--CA 1.425 -1.695 0 N-CA-C 107.967 -1.123 . . . . 75.1 107.967 177.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -68.42 162.13 41.94 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 123.084 2.523 . . . . 75.43 111.428 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 29.9 ptt85 -130.12 143.45 50.8 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.263 -0.643 . . . . 75.21 109.263 178.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -85.37 128.56 34.76 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 106.188 -1.782 . . . . 74.13 106.188 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 87.2 t -68.43 -39.64 81.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-O 121.307 0.575 . . . . 75.43 109.829 -179.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -112.95 151.66 30.28 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.083 -1.081 . . . . 74.02 108.083 176.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 10.2 mmt -82.88 115.86 21.94 Favored 'General case' 0 C--N 1.284 -2.254 0 C-N-CA 118.874 -1.13 . . . . 73.51 112.161 176.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 29.8 m -49.23 113.64 0.85 Allowed 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 113.492 -1.685 . . . . 62.24 110.631 176.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -76.16 75.65 2.99 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-O 121.731 0.777 . . . . 73.21 112.307 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -105.12 124.82 50.19 Favored 'General case' 0 C--N 1.28 -2.432 0 N-CA-C 104.259 -2.497 . . . . 73.33 104.259 172.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -81.92 94.65 7.15 Favored 'General case' 0 N--CA 1.412 -2.328 0 C-N-CA 118.892 -1.123 . . . . 73.23 112.11 -172.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -106.31 -53.77 0.72 Allowed Glycine 0 N--CA 1.418 -2.55 0 N-CA-C 107.366 -2.294 . . . . 74.34 107.366 172.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 66.96 32.99 82.49 Favored Glycine 0 N--CA 1.434 -1.456 0 CA-C-N 114.341 -0.929 . . . . 71.31 112.515 175.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -118.2 160.68 21.17 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.731 -0.84 . . . . 74.54 108.731 -177.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 10.2 p -92.58 179.5 5.49 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 122.66 0.384 . . . . 74.34 111.348 -179.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 608' ' ' ILE . . . . . 0.464 HG21 ' H ' ' A' ' 609' ' ' THR . 18.7 mt -110.39 176.44 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 N-CA-C 105.757 -1.942 . . . . 72.23 105.757 177.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 609' ' ' THR . . . . . 0.464 ' H ' HG21 ' A' ' 608' ' ' ILE . 2.7 m -71.23 23.71 0.04 OUTLIER 'General case' 0 CA--C 1.577 2.01 0 C-N-CA 124.483 1.113 . . . . 73.53 113.733 -175.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 61.06 14.42 5.38 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 114.952 1.464 . . . . 72.03 114.952 177.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.79 178.56 5.54 Favored 'General case' 0 N--CA 1.415 -2.206 0 N-CA-C 110.448 -0.204 . . . . 73.33 110.448 177.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -99.02 133.14 43.71 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 113.619 0.97 . . . . 72.34 113.619 -176.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 613' ' ' ASP . . . . . 0.434 ' O ' ' HG2' ' A' ' 616' ' ' GLN . 14.6 t70 -80.0 -44.42 20.24 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 113.961 -1.472 . . . . 74.24 110.066 178.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 4.2 p30 48.78 22.13 0.51 Allowed 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 127.4 2.28 . . . . 75.03 116.037 176.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 98.3 mttt 61.03 29.53 19.03 Favored 'General case' 0 C--N 1.313 -1.012 0 C-N-CA 124.456 1.103 . . . . 74.42 112.455 177.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 616' ' ' GLN . . . . . 0.434 ' HG2' ' O ' ' A' ' 613' ' ' ASP . 29.4 pt20 -66.0 146.7 99.01 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 108.531 -0.915 . . . . 74.54 108.531 175.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -65.66 -156.64 0.03 OUTLIER 'Trans proline' 0 CA--C 1.549 1.232 0 C-N-CA 123.062 2.508 . . . . 74.53 113.505 -177.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.415 ' H ' HD23 ' A' ' 618' ' ' LEU . 2.9 mm? -58.52 120.23 8.45 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 116.129 -0.487 . . . . 74.14 110.47 -178.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 2.1 t -144.1 -72.81 0.27 Allowed 'General case' 0 N--CA 1.425 -1.686 0 N-CA-C 114.241 1.2 . . . . 73.05 114.241 -179.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 620' ' ' SER . . . . . 0.461 ' HB3' ' HG3' ' A' ' 630' ' ' GLU . 77.7 p 51.31 14.14 0.22 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.261 1.424 . . . . 74.5 112.765 -168.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 6.4 tppt? -97.03 92.46 6.08 Favored 'General case' 0 N--CA 1.421 -1.92 0 CA-C-O 121.463 0.649 . . . . 73.4 109.516 -173.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -167.77 -66.33 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.846 -1.168 . . . . 70.52 107.846 -176.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -168.48 164.1 12.6 Favored 'General case' 0 N--CA 1.422 -1.856 0 N-CA-C 105.247 -2.131 . . . . 75.24 105.247 -177.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 624' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' A' ' 627' ' ' ARG . 9.7 pt-20 -65.61 -21.39 66.57 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 122.507 0.323 . . . . 72.22 111.649 -176.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -64.67 -29.48 70.48 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 116.607 -0.269 . . . . 73.22 111.375 176.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . 0.588 ' O ' ' HG2' ' A' ' 630' ' ' GLU . 12.9 mtp85 -71.02 -34.34 71.21 Favored 'General case' 0 CA--C 1.471 -2.092 0 C-N-CA 119.513 -0.875 . . . . 72.01 111.657 176.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 627' ' ' ARG . . . . . 0.445 ' HB2' ' O ' ' A' ' 624' ' ' GLU . 9.3 mmm180 -46.82 -33.81 4.78 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 123.941 0.776 . . . . 73.33 112.621 177.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . 0.447 ' O ' ' HG2' ' A' ' 631' ' ' MET . 88.1 mt -74.99 -38.28 42.72 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 CA-C-N 115.47 -0.787 . . . . 75.32 110.913 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -73.56 -34.17 65.03 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 121.412 0.625 . . . . 74.43 109.415 176.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 630' ' ' GLU . . . . . 0.588 ' HG2' ' O ' ' A' ' 626' ' ' ARG . 22.0 mm-40 -67.08 -26.72 66.87 Favored 'General case' 0 C--O 1.213 -0.837 0 CA-C-N 115.281 -0.872 . . . . 73.45 110.175 177.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 631' ' ' MET . . . . . 0.447 ' HG2' ' O ' ' A' ' 628' ' ' ILE . 21.1 ptp -90.05 -3.58 57.87 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.664 0.745 . . . . 74.22 109.097 177.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -82.24 -20.35 62.76 Favored Glycine 0 N--CA 1.434 -1.468 0 N-CA-C 108.68 -1.768 . . . . 73.4 108.68 174.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 633' ' ' ARG . . . . . 0.568 ' HD3' ' OE1' ' A' ' 593' ' ' GLU . 95.1 mtt180 -95.85 150.3 37.17 Favored Pre-proline 0 N--CA 1.426 -1.672 0 N-CA-C 106.739 -1.578 . . . . 71.21 106.739 176.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.411 ' HA ' ' HB2' ' A' ' 502' ' ' ALA . 37.2 Cg_endo -76.08 146.79 29.29 Favored 'Trans proline' 0 N--CA 1.429 -2.3 0 N-CA-C 107.348 -1.828 . . . . 72.52 107.348 166.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 1.9 pp -126.57 -173.27 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 114.494 1.294 . . . . 64.21 114.494 -172.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.46 150.6 39.83 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.389 -0.823 . . . . 74.42 109.672 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . 0.424 ' HA3' ' HB ' ' A' ' 506' ' ' THR . . . -76.69 -71.13 1.21 Allowed Glycine 0 C--N 1.297 -1.598 0 C-N-CA 120.763 -0.732 . . . . 73.04 112.58 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -150.36 -59.72 0.19 Allowed 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 120.408 -0.517 . . . . 74.45 110.619 178.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 16.7 p80 -120.43 99.63 6.68 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.735 0.779 . . . . 70.21 111.921 -179.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 36.4 p -98.62 91.26 5.05 Favored 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 109.278 -0.638 . . . . 73.31 109.278 177.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 641' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 510' ' ' PRO . 1.3 tmtp? -177.26 133.14 0.18 Allowed 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 106.159 -1.793 . . . . 71.54 106.159 -178.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 642' ' ' LEU . . . . . 0.497 ' O ' ' HA ' ' A' ' 588' ' ' PHE . 27.9 tp -133.84 118.03 17.51 Favored 'General case' 0 C--N 1.276 -2.602 0 N-CA-C 108.511 -0.922 . . . . 75.01 108.511 177.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . 0.443 ' HB3' HG23 ' A' ' 511' ' ' VAL . 33.6 tt0 -99.25 107.44 19.75 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 107.06 -1.459 . . . . 74.43 107.06 177.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 644' ' ' VAL . . . . . 0.429 HG22 ' HE3' ' A' ' 521' ' ' MET . 38.9 t -95.37 109.84 23.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 108.949 -0.76 . . . . 75.32 108.949 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 3.9 mp -94.86 119.9 43.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 N-CA-C 108.413 -0.958 . . . . 73.51 108.413 177.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 646' ' ' ILE . . . . . 0.515 HD11 ' N ' ' A' ' 646' ' ' ILE . 1.8 mp -107.88 134.51 49.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 105.798 -1.926 . . . . 73.21 105.798 -176.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -136.48 161.48 35.73 Favored 'General case' 0 C--N 1.277 -2.549 0 N-CA-C 112.31 0.485 . . . . 75.44 112.31 -172.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . 0.63 ' OE2' 'CA ' ' A' ' 800' ' ' ' CA' . 31.2 mm-40 -61.17 100.38 0.12 Allowed 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 106.189 -1.782 . . . . 73.43 106.189 172.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 10.5 m -24.72 92.78 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 128.254 2.621 . . . . 71.04 115.871 -169.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -135.03 -51.94 0.78 Allowed 'General case' 0 C--O 1.246 0.886 0 CA-C-N 114.797 -1.092 . . . . 75.13 110.686 175.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -68.99 144.29 54.15 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-N 116.194 -0.457 . . . . 74.3 110.975 -176.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -140.06 124.76 18.23 Favored 'General case' 0 N--CA 1.398 -3.042 0 N-CA-C 107.003 -1.48 . . . . 73.41 107.003 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 653' ' ' LYS . . . . . 0.498 ' HA ' ' HE2' ' A' ' 653' ' ' LYS . 9.8 mmpt? 72.91 8.74 5.48 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.041 1.336 . . . . 72.42 112.202 178.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 69.0 m -66.97 103.76 1.22 Allowed 'General case' 0 N--CA 1.443 -0.811 0 CA-C-O 121.899 0.857 . . . . 72.43 110.415 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 655' ' ' THR . . . . . 0.432 ' HB ' ' OE1' ' A' ' 509' ' ' GLU . 4.5 p -142.38 156.72 45.24 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.736 -1.209 . . . . 75.11 107.736 -176.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 511' ' ' VAL . 34.0 m -104.76 -176.89 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 C-N-CA 119.8 -0.76 . . . . 64.14 112.013 -175.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 . . . . . 0 C--N 1.309 -1.187 0 CA-C-N 115.662 -0.699 . . . . 74.31 110.92 -178.627 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 800' ' ' ' CA' . . . . . 0.63 'CA ' ' OE2' ' A' ' 648' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 850' ' ' ' CA' . . . . . 0.655 'CA ' ' OD1' ' A' ' 552' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 27.0 t60 . . . . . 0 N--CA 1.445 -0.701 0 N-CA-C 108.845 -0.798 . . . . 75.1 108.845 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -138.06 -48.77 0.55 Allowed 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.748 -0.464 . . . . 73.54 109.748 177.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -159.65 -179.0 34.16 Favored Glycine 0 N--CA 1.421 -2.34 0 C-N-CA 120.663 -0.78 . . . . 72.24 111.151 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 3.9 mp -122.27 111.39 30.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 109.255 -0.646 . . . . 74.41 109.255 -178.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -128.35 104.29 7.64 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 106.492 -1.67 . . . . 75.23 106.492 173.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 506' ' ' THR . . . . . 0.411 ' HB ' ' HA3' ' A' ' 637' ' ' GLY . 15.0 t -152.02 162.95 40.28 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.631 -0.878 . . . . 75.35 108.631 -175.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -91.77 168.78 11.22 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.749 -1.204 . . . . 74.43 107.749 172.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . 0.404 ' HB2' HD21 ' A' ' 526' ' ' LEU . 21.5 tt0 -99.74 -35.88 9.65 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 107.944 -1.132 . . . . 74.03 107.944 179.251 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -111.31 134.98 20.99 Favored Pre-proline 0 N--CA 1.419 -2.021 0 CA-C-N 114.377 -1.283 . . . . 64.12 110.239 -178.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -81.19 -18.7 8.49 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.554 1.503 . . . . 75.21 111.095 173.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . 0.402 HG23 ' HB3' ' A' ' 643' ' ' GLU . 93.2 t -138.04 141.5 38.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 123.81 0.844 . . . . 74.44 108.853 -177.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 8.1 t -137.3 140.81 41.78 Favored 'General case' 0 N--CA 1.416 -2.168 0 N-CA-C 107.526 -1.287 . . . . 75.23 107.526 174.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 55.4 m-70 -105.76 130.04 53.84 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.585 -0.895 . . . . 74.14 108.585 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 24.2 m -132.33 156.45 42.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 N-CA-C 108.862 -0.792 . . . . 75.33 108.862 -179.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 40.3 t -82.42 149.16 27.8 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 107.934 -1.136 . . . . 63.01 107.934 178.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -82.3 -7.5 59.63 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.85 0.833 . . . . 75.42 109.062 176.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 9.4 t -95.77 10.01 38.5 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.905 -0.776 . . . . 75.4 108.905 -178.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 12.4 tt -91.68 155.34 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 108.66 -0.867 . . . . 75.51 108.66 -177.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -91.44 -63.44 1.18 Allowed Glycine 0 N--CA 1.43 -1.755 0 N-CA-C 110.47 -1.052 . . . . 74.14 110.47 176.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . 0.407 HD13 ' HA ' ' A' ' 574' ' ' LYS . 34.4 mm -116.51 117.02 54.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 109.92 -0.4 . . . . 73.44 109.92 179.012 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 521' ' ' MET . . . . . 0.414 ' HE1' HG11 ' A' ' 644' ' ' VAL . 0.0 OUTLIER -96.41 128.66 43.53 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 106.609 -1.626 . . . . 73.24 106.609 172.238 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -117.36 138.74 51.59 Favored 'General case' 0 N--CA 1.424 -1.751 0 CA-C-N 115.829 -0.623 . . . . 73.24 111.269 178.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . 0.52 ' O ' ' HA ' ' A' ' 570' ' ' THR . 22.1 t -121.09 134.34 64.8 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.087 0 N-CA-C 106.176 -1.787 . . . . 73.33 106.176 175.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 569' ' ' LYS . 55.2 mttp -91.91 163.04 14.16 Favored 'General case' 0 N--CA 1.416 -2.171 0 C-N-CA 120.325 -0.55 . . . . 74.31 111.904 -178.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 16.0 t -128.5 141.98 45.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-N 115.512 -0.767 . . . . 65.44 109.115 -175.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . 0.404 HD21 ' HB2' ' A' ' 508' ' ' GLU . 2.0 mm? -78.24 139.08 38.92 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 107.554 -1.276 . . . . 74.35 107.554 178.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 48.2 ttp180 -92.79 140.5 29.45 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.729 -0.788 . . . . 73.42 111.199 -175.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 4.2 t -55.17 149.02 13.07 Favored 'General case' 0 N--CA 1.413 -2.28 0 CA-C-N 114.044 -1.434 . . . . 73.41 111.97 174.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 26.1 t -80.62 -15.89 55.46 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.386 -0.824 . . . . 73.51 109.038 177.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -127.54 110.92 1.24 Allowed Glycine 0 N--CA 1.433 -1.517 0 N-CA-C 111.163 -0.775 . . . . 75.42 111.163 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -165.06 76.11 0.27 Allowed 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 123.334 0.653 . . . . 75.45 110.173 177.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -90.36 81.53 6.02 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.751 0.786 . . . . 75.24 110.064 177.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 533' ' ' GLY . . . . . 0.498 ' H ' ' HB2' ' A' ' 564' ' ' ASN . . . 149.37 -118.97 0.99 Allowed Glycine 0 N--CA 1.414 -2.772 0 CA-C-N 114.828 -1.078 . . . . 74.44 112.071 179.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 534' ' ' ASN . . . . . 0.508 ' ND2' ' HG2' ' A' ' 563' ' ' GLN . 2.8 t-20 -145.07 131.3 19.49 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 107.234 -1.395 . . . . 74.12 107.234 -178.099 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 46.8 t -128.36 133.86 65.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 109.387 -0.597 . . . . 74.03 109.387 -178.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 536' ' ' ILE . . . . . 0.469 HG23 ' HB3' ' A' ' 559' ' ' GLU . 28.5 mm -98.28 126.48 51.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 109.217 -0.66 . . . . 73.11 109.217 178.176 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 36.1 t -116.65 103.38 52.59 Favored Pre-proline 0 C--N 1.301 -1.513 0 N-CA-C 108.579 -0.897 . . . . 73.31 108.579 177.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.56 146.93 50.64 Favored 'Trans proline' 0 C--N 1.331 -0.391 0 C-N-CA 122.264 1.976 . . . . 75.3 111.169 179.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 539' ' ' TYR . . . . . 0.528 ' CE1' ' HG ' ' A' ' 560' ' ' LEU . 36.0 p90 -151.14 161.58 42.46 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 109.689 -0.485 . . . . 75.14 109.689 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -155.67 148.6 24.35 Favored 'General case' 0 C--N 1.309 -1.174 0 O-C-N 123.471 0.482 . . . . 73.23 111.933 178.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 2.4 p -85.82 121.09 27.98 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 115.957 -0.565 . . . . 74.44 110.967 175.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.8 mp -86.96 116.99 30.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 105.271 -2.122 . . . . 71.32 105.271 172.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -55.2 -43.43 74.4 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 124.163 0.914 . . . . 73.44 112.146 -174.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 67.96 -94.06 0.29 Allowed Glycine 0 N--CA 1.439 -1.101 0 CA-C-N 115.733 -0.667 . . . . 73.31 111.757 178.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 9.2 t -124.41 -2.07 8.04 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 120.788 0.328 . . . . 70.51 110.488 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -91.19 155.54 18.52 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.71 -0.478 . . . . 74.12 109.71 178.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 22.1 tpt180 -94.55 108.31 20.27 Favored 'General case' 0 C--O 1.25 1.097 0 N-CA-C 109.546 -0.539 . . . . 73.4 109.546 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -89.66 -163.57 39.37 Favored Glycine 0 CA--C 1.507 -0.422 0 C-N-CA 121.124 -0.56 . . . . 73.44 114.046 -175.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 77.75 12.38 84.52 Favored Glycine 0 C--N 1.321 -0.281 0 CA-C-N 115.433 -0.384 . . . . 73.44 113.593 178.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 95.79 4.56 60.32 Favored Glycine 0 N--CA 1.437 -1.251 0 C-N-CA 120.46 -0.876 . . . . 71.13 111.644 -178.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -73.98 -69.86 0.42 Allowed 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.912 -0.773 . . . . 72.01 108.912 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . 0.635 ' OD2' 'CA ' ' A' ' 850' ' ' ' CA' . 5.8 t70 -107.8 -34.12 7.05 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.861 -1.163 . . . . 75.52 107.861 177.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -135.95 157.27 47.25 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 108.464 -0.939 . . . . 74.11 108.464 174.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -88.14 121.02 30.06 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.855 -1.165 . . . . 73.05 107.855 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -78.67 100.96 7.25 Favored 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 109.263 -0.643 . . . . 75.53 109.263 -177.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 13.9 t -98.51 98.51 9.68 Favored 'General case' 0 N--CA 1.396 -3.134 0 CA-C-O 123.439 1.59 . . . . 63.35 111.538 -175.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 1.6 p -110.27 129.86 55.65 Favored 'General case' 0 C--N 1.274 -2.675 0 N-CA-C 106.518 -1.66 . . . . 71.34 106.518 172.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 178.64 -156.66 19.49 Favored Glycine 0 N--CA 1.42 -2.422 0 N-CA-C 110.367 -1.093 . . . . 72.24 110.367 -176.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 559' ' ' GLU . . . . . 0.469 ' HB3' HG23 ' A' ' 536' ' ' ILE . 40.0 mt-10 -135.97 133.92 38.06 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 121.295 0.569 . . . . 75.35 111.683 -175.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . 0.528 ' HG ' ' CE1' ' A' ' 539' ' ' TYR . 55.7 mt -87.84 132.77 34.06 Favored 'General case' 0 CA--C 1.491 -1.312 0 N-CA-C 108.795 -0.817 . . . . 74.34 108.795 174.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -105.84 107.37 18.34 Favored 'General case' 0 C--N 1.274 -2.71 0 N-CA-C 108.451 -0.944 . . . . 74.13 108.451 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 562' ' ' PHE . . . . . 0.402 ' CZ ' ' HG2' ' A' ' 569' ' ' LYS . 0.1 OUTLIER -100.59 132.41 45.99 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 107.744 -1.206 . . . . 62.25 107.744 -179.2 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . 0.508 ' HG2' ' ND2' ' A' ' 534' ' ' ASN . 6.8 mt-30 -119.81 165.05 15.07 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.2 -1.0 . . . . 74.4 110.699 -179.086 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 564' ' ' ASN . . . . . 0.498 ' HB2' ' H ' ' A' ' 533' ' ' GLY . 7.8 t30 -62.57 -33.46 75.01 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.879 -0.6 . . . . 73.32 111.296 179.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -99.27 -3.66 33.64 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.858 0.837 . . . . 53.02 111.145 -177.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -102.98 130.34 50.03 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.725 -0.609 . . . . 75.11 109.406 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 2.0 pp -112.04 145.27 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.728 0 N-CA-C 108.414 -0.958 . . . . 74.42 108.414 179.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 568' ' ' VAL . . . . . 0.408 HG23 ' HD3' ' A' ' 524' ' ' LYS . 1.8 p 58.91 133.78 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 126.482 1.913 . . . . 75.41 114.79 176.288 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 569' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 524' ' ' LYS . 32.6 mmmt -117.82 164.06 15.59 Favored 'General case' 0 C--N 1.284 -2.268 0 O-C-N 121.32 -0.863 . . . . 65.04 109.868 176.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 570' ' ' THR . . . . . 0.52 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 6.3 p -132.72 134.26 44.56 Favored 'General case' 0 C--N 1.279 -2.499 0 O-C-N 124.413 1.071 . . . . 73.34 111.851 177.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 2.2 mp -91.17 103.92 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.836 0 N-CA-C 105.207 -2.145 . . . . 74.21 105.207 170.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 4.5 m -91.93 112.64 24.64 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 108.479 -0.934 . . . . 73.52 108.479 -177.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 573' ' ' VAL . . . . . 0.408 ' CG2' ' HE3' ' A' ' 521' ' ' MET . 61.7 t -116.0 121.88 68.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 109.543 -0.54 . . . . 71.04 109.543 -178.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 574' ' ' LYS . . . . . 0.407 ' HA ' HD13 ' A' ' 520' ' ' ILE . 23.0 tptm -80.09 120.73 24.63 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-N 114.908 -1.042 . . . . 74.35 110.548 178.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 60.0 t -94.32 132.36 38.6 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 N-CA-C 105.953 -1.869 . . . . 74.22 105.953 174.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 34.3 mm -88.84 159.98 2.87 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 107.221 -1.4 . . . . 75.24 107.221 -175.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -71.53 115.34 10.6 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 109.199 -0.667 . . . . 64.22 109.199 178.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 578' ' ' ASP . . . . . 0.66 ' OD2' 'CA ' ' A' ' 800' ' ' ' CA' . 44.9 t0 -61.24 144.44 53.79 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 114.897 -1.047 . . . . 64.33 112.612 -173.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -92.21 -49.06 6.38 Favored 'General case' 0 C--N 1.29 -1.995 0 C-N-CA 124.289 1.036 . . . . 70.14 110.424 -176.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 580' ' ' GLU . . . . . 0.582 ' OE1' 'CA ' ' A' ' 850' ' ' ' CA' . 0.0 OUTLIER -127.09 -152.64 0.53 Allowed 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.396 -0.82 . . . . 73.04 109.1 -174.305 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -111.67 152.12 28.06 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 107.32 -1.363 . . . . 75.32 107.32 176.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 582' ' ' GLU . . . . . 0.62 ' OE1' 'CA ' ' A' ' 800' ' ' ' CA' . 36.4 mp0 -128.98 164.81 22.38 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.501 -0.555 . . . . 72.54 109.501 175.201 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 10.0 mptt -87.59 -152.0 0.19 Allowed 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 105.771 -1.937 . . . . 73.43 105.771 173.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -57.83 113.05 1.68 Allowed 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 109.115 -0.698 . . . . 74.23 109.115 172.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.32 118.73 23.74 Favored 'General case' 0 N--CA 1.409 -2.496 0 N-CA-C 106.362 -1.718 . . . . 74.41 106.362 -174.198 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 3.9 t -150.7 146.86 26.73 Favored 'General case' 0 N--CA 1.418 -2.04 0 CA-C-N 115.487 -0.779 . . . . 74.44 110.795 -172.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -126.58 150.63 48.75 Favored 'General case' 0 N--CA 1.419 -2.011 0 CA-C-N 113.891 -1.504 . . . . 70.33 109.225 177.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 588' ' ' PHE . . . . . 0.417 ' HA ' ' O ' ' A' ' 642' ' ' LEU . 22.3 m-85 -108.37 139.25 43.36 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 109.381 -0.6 . . . . 73.23 109.381 -174.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.93 134.36 50.95 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 107.04 -1.467 . . . . 64.01 107.04 176.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -143.05 136.96 28.89 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.803 -0.814 . . . . 72.14 108.803 -179.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 591' ' ' ILE . . . . . 0.53 HG12 ' OG1' ' A' ' 640' ' ' THR . 22.0 pt -101.95 162.48 3.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 109.206 -0.664 . . . . 73.21 109.206 178.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -111.15 -162.96 17.92 Favored Glycine 0 N--CA 1.43 -1.732 0 C-N-CA 121.259 -0.496 . . . . 74.35 112.103 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -67.88 118.11 54.86 Favored Pre-proline 0 C--N 1.309 -1.195 0 C-N-CA 123.979 0.911 . . . . 72.15 108.803 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 594' ' ' PRO . . . . . 0.454 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 58.1 Cg_endo -73.16 146.56 41.08 Favored 'Trans proline' 0 N--CA 1.437 -1.82 0 C-N-CA 121.916 1.744 . . . . 64.34 110.593 178.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 14.9 ptt180 -128.24 133.71 48.87 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 109.704 -0.48 . . . . 74.04 109.704 -175.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 596' ' ' LEU . . . . . 0.419 ' C ' ' H ' ' A' ' 598' ' ' GLU . 0.0 OUTLIER -73.99 131.82 41.78 Favored 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 104.988 -2.227 . . . . 64.12 104.988 178.367 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 597' ' ' VAL . . . . . 0.42 ' CG2' HG12 ' A' ' 536' ' ' ILE . 23.8 t -81.51 61.42 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-O 121.821 0.819 . . . . 73.12 110.767 -178.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 598' ' ' GLU . . . . . 0.463 ' OE1' ' HG3' ' A' ' 603' ' ' LYS . 32.8 mt-10 58.99 -7.42 0.05 OUTLIER 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 128.491 2.716 . . . . 73.33 117.322 166.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 71.5 mtm 67.09 19.12 10.5 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 124.762 1.225 . . . . 70.02 109.145 -174.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 600' ' ' SER . . . . . 0.404 ' O ' ' HB2' ' A' ' 598' ' ' GLU . 22.6 t -166.46 149.38 6.96 Favored 'General case' 0 N--CA 1.405 -2.689 0 N-CA-C 101.762 -3.422 . . . . 73.34 101.762 -178.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -69.11 -28.2 66.27 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 119.228 0.922 . . . . 74.04 110.514 -176.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -145.63 146.91 31.52 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 106.625 -1.62 . . . . 75.5 106.625 173.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 603' ' ' LYS . . . . . 0.463 ' HG3' ' OE1' ' A' ' 598' ' ' GLU . 38.4 mtmm -82.66 84.92 7.13 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-O 121.614 0.721 . . . . 75.13 110.171 175.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -102.08 11.34 57.22 Favored Glycine 0 N--CA 1.434 -1.454 0 CA-C-N 114.736 -1.12 . . . . 50.24 111.743 -178.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . -83.51 -54.97 2.97 Favored Glycine 0 N--CA 1.434 -1.445 0 N-CA-C 109.749 -1.34 . . . . 73.34 109.749 176.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -173.82 158.0 3.15 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 106.363 -1.717 . . . . 73.43 106.363 176.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 28.1 p -74.88 134.83 41.57 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 120.323 -0.551 . . . . 75.14 110.901 177.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 24.9 mm -97.85 160.46 3.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 106.384 -1.709 . . . . 74.34 106.384 -179.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 609' ' ' THR . . . . . 0.417 HG22 ' HG3' ' A' ' 611' ' ' GLU . 20.1 m -74.17 88.46 1.96 Allowed 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 106.433 -1.692 . . . . 54.21 106.433 172.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -88.07 -20.16 26.11 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.549 -0.75 . . . . 73.0 111.213 -175.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 611' ' ' GLU . . . . . 0.417 ' HG3' HG22 ' A' ' 609' ' ' THR . 33.1 mt-10 52.66 44.79 29.73 Favored 'General case' 0 C--O 1.247 0.936 0 O-C-N 124.436 1.085 . . . . 71.3 110.964 178.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 66.88 84.31 0.16 Allowed 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.886 1.274 . . . . 74.42 112.02 -176.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 613' ' ' ASP . . . . . 0.452 ' HA ' ' NH2' ' A' ' 633' ' ' ARG . 28.0 t70 -89.58 117.29 28.36 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.78 -1.1 . . . . 63.01 109.906 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -137.48 -164.38 1.59 Allowed 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 108.491 -0.929 . . . . 63.24 108.491 -174.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 615' ' ' LYS . . . . . 0.435 ' HZ2' ' CD ' ' A' ' 559' ' ' GLU . 48.3 pttt -133.01 85.67 2.24 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 122.815 1.293 . . . . 63.15 108.0 -178.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -96.53 -170.8 0.23 Allowed Pre-proline 0 C--N 1.292 -1.91 0 CA-C-N 114.494 -1.23 . . . . 74.31 108.716 -170.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -86.62 160.81 9.33 Favored 'Trans proline' 0 N--CA 1.443 -1.473 0 N-CA-C 108.979 -1.201 . . . . 71.42 108.979 163.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . 0.421 ' HG ' ' HB2' ' A' ' 636' ' ' LEU . 3.5 mm? -74.22 99.73 3.51 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.54 -0.911 . . . . 73.24 108.54 177.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 1.8 p -135.62 103.33 5.4 Favored 'General case' 0 N--CA 1.42 -1.957 0 CA-C-N 115.185 -0.916 . . . . 70.11 112.021 -173.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 620' ' ' SER . . . . . 0.447 ' HB3' ' HG2' ' A' ' 623' ' ' GLU . 16.2 m -109.6 109.98 20.91 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.525 -0.917 . . . . 55.3 108.525 176.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 11.2 tmtt? -92.5 -71.86 0.62 Allowed 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.024 -0.732 . . . . 73.5 109.024 -176.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -76.25 -25.64 55.19 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.095 -0.705 . . . . 64.1 109.095 178.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . 0.447 ' HG2' ' HB3' ' A' ' 620' ' ' SER . 47.4 mt-10 74.41 -40.1 0.44 Allowed 'General case' 0 C--O 1.213 -0.849 0 C-N-CA 125.526 1.53 . . . . 74.35 115.035 177.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -53.03 -61.87 2.02 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.947 1.092 . . . . 75.21 113.947 -176.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -76.14 -25.93 55.82 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.071 0.462 . . . . 71.14 110.806 -178.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -67.07 -34.36 77.49 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.903 -0.589 . . . . 74.21 110.048 178.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 627' ' ' ARG . . . . . . . . . . . . . 46.7 ttp180 -56.73 -29.06 62.13 Favored 'General case' 0 N--CA 1.424 -1.728 0 C-N-CA 125.111 1.364 . . . . 64.1 111.425 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 88.2 mt -71.89 -39.62 67.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 121.695 0.76 . . . . 72.23 109.821 177.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -70.11 -40.83 74.68 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.658 -0.701 . . . . 64.13 109.639 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -68.04 -17.71 64.48 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 115.392 -0.822 . . . . 72.21 110.569 178.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 631' ' ' MET . . . . . . . . . . . . . 42.6 ttm -83.6 -36.99 23.49 Favored 'General case' 0 N--CA 1.425 -1.68 0 C-N-CA 123.277 0.631 . . . . 74.32 110.579 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -86.19 -37.27 9.19 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.715 -0.755 . . . . 62.12 112.282 -178.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 633' ' ' ARG . . . . . 0.452 ' NH2' ' HA ' ' A' ' 613' ' ' ASP . 98.3 mtt180 -93.35 146.12 31.27 Favored Pre-proline 0 C--N 1.302 -1.475 0 N-CA-C 109.46 -0.57 . . . . 72.21 109.46 -177.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.454 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 10.1 Cg_endo -60.86 145.01 99.66 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.591 1.527 . . . . 72.32 109.527 172.153 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.3 pp -123.42 175.96 5.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 114.054 1.131 . . . . 74.53 114.054 -176.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . 0.455 ' HG ' ' N ' ' A' ' 637' ' ' GLY . 33.3 tp -68.93 158.65 34.19 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 124.8 1.24 . . . . 75.35 112.716 -176.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . 0.455 ' N ' ' HG ' ' A' ' 636' ' ' LEU . . . -83.06 -100.02 0.52 Allowed Glycine 0 N--CA 1.427 -1.91 0 N-CA-C 109.642 -1.383 . . . . 65.45 109.642 172.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -126.22 -73.13 0.63 Allowed 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 119.801 -0.76 . . . . 73.45 111.632 177.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -107.02 114.26 28.23 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 118.715 -1.194 . . . . 63.11 113.122 -174.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 640' ' ' THR . . . . . 0.53 ' OG1' HG12 ' A' ' 591' ' ' ILE . 1.1 t -107.08 91.53 3.7 Favored 'General case' 0 N--CA 1.41 -2.437 0 N-CA-C 108.367 -0.975 . . . . 75.1 108.367 169.364 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -172.17 121.83 0.46 Allowed 'General case' 0 C--N 1.279 -2.466 0 N-CA-C 105.726 -1.953 . . . . 73.14 105.726 178.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 642' ' ' LEU . . . . . 0.509 HD22 HG22 ' A' ' 523' ' ' VAL . 35.9 tp -129.91 113.13 14.24 Favored 'General case' 0 C--N 1.271 -2.829 0 N-CA-C 108.077 -1.083 . . . . 71.44 108.077 178.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . 0.402 ' HB3' HG23 ' A' ' 511' ' ' VAL . 30.0 tt0 -95.11 104.77 16.65 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 107.469 -1.308 . . . . 72.21 107.469 179.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 644' ' ' VAL . . . . . 0.414 HG11 ' HE1' ' A' ' 521' ' ' MET . 30.9 t -94.98 106.66 18.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 109.483 -0.562 . . . . 73.11 109.483 -177.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 3.9 mp -88.78 118.29 33.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 108.444 -0.947 . . . . 72.21 108.444 175.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 646' ' ' ILE . . . . . 0.461 HD12 ' N ' ' A' ' 646' ' ' ILE . 2.8 mp -100.73 107.21 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 N-CA-C 106.63 -1.618 . . . . 73.23 106.63 -177.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -103.69 136.42 43.43 Favored 'General case' 0 C--N 1.279 -2.48 0 CA-C-N 115.671 -0.695 . . . . 74.14 110.832 -176.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . 0.625 ' OE2' 'CA ' ' A' ' 800' ' ' ' CA' . 14.6 mt-10 -67.47 142.03 56.76 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.626 -0.879 . . . . 73.12 108.626 -177.128 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 21.2 t -74.95 81.33 2.18 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 114.072 1.138 . . . . 74.21 114.072 -169.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -93.95 -44.78 7.91 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 106.675 -1.602 . . . . 72.21 106.675 168.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 651' ' ' GLU . . . . . 0.531 ' HG2' ' H ' ' A' ' 652' ' ' PHE . 23.1 tt0 -163.84 -160.33 0.56 Allowed 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 102.663 -3.088 . . . . 75.14 102.663 179.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 652' ' ' PHE . . . . . 0.531 ' H ' ' HG2' ' A' ' 651' ' ' GLU . 48.3 t80 -157.2 144.51 18.68 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 105.635 -1.987 . . . . 73.45 105.635 178.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 653' ' ' LYS . . . . . 0.462 ' HG3' ' CD2' ' A' ' 652' ' ' PHE . 53.7 mtmt 69.0 22.13 7.12 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.704 0.802 . . . . 75.5 112.269 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 50.3 m -72.16 -37.66 69.31 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-O 121.257 0.551 . . . . 73.23 109.71 178.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 88.7 m -159.27 135.77 9.21 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 108.413 -0.958 . . . . 74.24 108.413 178.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 33.2 m -90.58 153.15 3.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 108.498 -0.927 . . . . 74.42 108.498 175.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 16.4 t70 . . . . . 0 C--N 1.299 -1.624 0 N-CA-C 108.847 -0.797 . . . . 74.55 108.847 -177.339 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 800' ' ' ' CA' . . . . . 0.66 'CA ' ' OD2' ' A' ' 578' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 850' ' ' ' CA' . . . . . 0.635 'CA ' ' OD2' ' A' ' 552' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . 0.426 ' N ' ' HA ' ' A' ' 631' ' ' MET . 4.5 t60 . . . . . 0 N--CA 1.445 -0.719 0 N-CA-C 109.644 -0.502 . . . . 75.12 109.644 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . 0.526 ' O ' ' HA3' ' A' ' 530' ' ' GLY . . . -124.55 -74.03 0.62 Allowed 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 107.71 -1.218 . . . . 74.44 107.71 172.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -136.6 134.29 7.04 Favored Glycine 0 N--CA 1.419 -2.448 0 N-CA-C 109.71 -1.356 . . . . 75.51 109.71 177.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . 0.635 ' O ' ' HB ' ' A' ' 528' ' ' THR . 3.6 mp -108.87 97.77 6.15 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.263 0 C-N-CA 126.04 1.736 . . . . 74.43 109.235 -176.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -103.16 124.85 49.36 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 122.035 -0.415 . . . . 74.3 110.087 -178.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 15.3 t -145.89 159.54 43.07 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.378 -0.601 . . . . 73.21 109.378 -178.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -89.21 155.85 19.14 Favored 'General case' 0 CA--C 1.485 -1.549 0 N-CA-C 108.372 -0.973 . . . . 73.14 108.372 174.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -89.98 -34.57 15.95 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 106.84 -1.541 . . . . 75.1 106.84 175.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -96.61 118.84 64.86 Favored Pre-proline 0 N--CA 1.436 -1.137 0 CA-C-N 114.549 -1.205 . . . . 72.43 110.847 176.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . 0.584 ' HA ' ' O ' ' A' ' 641' ' ' LYS . 1.2 Cg_endo -83.22 -16.96 6.87 Favored 'Trans proline' 0 N--CA 1.443 -1.456 0 N-CA-C 108.72 -1.3 . . . . 75.15 108.72 166.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 78.7 t -144.63 139.56 23.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 C-N-CA 125.575 1.55 . . . . 65.14 107.268 -179.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 11.4 t -138.63 148.01 43.57 Favored 'General case' 0 N--CA 1.414 -2.234 0 N-CA-C 107.66 -1.237 . . . . 61.14 107.66 174.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -115.87 127.48 55.05 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 109.024 -0.732 . . . . 74.14 109.024 177.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 18.2 m -130.24 154.2 40.11 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 N-CA-C 109.103 -0.703 . . . . 73.13 109.103 -176.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 34.2 t -78.03 154.81 31.1 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.782 -1.192 . . . . 72.35 107.782 177.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -89.06 -6.83 56.84 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 122.195 0.998 . . . . 71.13 109.019 173.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 34.0 m -92.26 17.3 9.9 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-O 122.314 1.054 . . . . 73.4 108.744 177.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 9.5 tt -100.99 154.43 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.06 0 N-CA-C 107.064 -1.458 . . . . 74.41 107.064 177.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -95.71 -63.61 0.97 Allowed Glycine 0 N--CA 1.427 -1.946 0 C-N-CA 119.745 -1.217 . . . . 71.21 110.348 176.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 29.0 mm -116.41 127.73 73.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 114.725 -0.737 . . . . 70.4 109.865 -178.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 521' ' ' MET . . . . . 0.401 ' HE1' ' HB ' ' A' ' 573' ' ' VAL . 0.0 OUTLIER -109.99 135.88 50.14 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.76 -1.2 . . . . 72.32 107.76 172.888 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 522' ' ' GLU . . . . . 0.527 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 36.8 mt-10 -121.15 135.26 55.2 Favored 'General case' 0 CA--C 1.493 -1.25 0 O-C-N 123.947 0.779 . . . . 75.12 110.711 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . 0.52 ' O ' ' HA ' ' A' ' 570' ' ' THR . 18.9 t -123.03 140.47 46.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.91 -0.774 . . . . 65.54 108.91 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -85.35 141.53 29.96 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.912 0.863 . . . . 72.13 112.603 -178.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 21.3 t -111.88 119.49 60.12 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 N-CA-C 105.154 -2.165 . . . . 74.22 105.154 172.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -62.16 136.05 57.77 Favored 'General case' 0 CA--C 1.504 -0.804 0 O-C-N 123.522 0.514 . . . . 75.42 110.625 -174.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 14.2 ttp180 -84.73 138.7 32.47 Favored 'General case' 0 N--CA 1.423 -1.782 0 N-CA-C 108.612 -0.884 . . . . 75.5 108.612 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 528' ' ' THR . . . . . 0.635 ' HB ' ' O ' ' A' ' 504' ' ' ILE . 10.3 t -94.41 169.59 10.1 Favored 'General case' 0 N--CA 1.397 -3.096 0 N-CA-C 114.81 1.411 . . . . 71.22 114.81 -171.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . 0.309 5.7 m -49.9 -34.06 19.16 Favored 'General case' 0 N--CA 1.417 -2.124 0 C-N-CA 130.658 3.583 . . . . 70.14 111.35 171.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . 0.526 ' HA3' ' O ' ' A' ' 502' ' ' ALA . . . -121.3 68.41 0.42 Allowed Glycine 0 N--CA 1.428 -1.856 0 C-N-CA 120.722 -0.752 . . . . 75.22 113.203 -177.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -87.88 83.41 7.1 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 106.704 -1.591 . . . . 73.24 106.704 173.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -121.05 137.3 54.72 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 115.744 -0.662 . . . . 74.02 112.321 -174.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 533' ' ' GLY . . . . . 0.464 ' N ' ' HB3' ' A' ' 564' ' ' ASN . . . 69.27 -121.32 11.28 Favored Glycine 0 N--CA 1.438 -1.173 0 CA-C-N 114.741 -1.118 . . . . 45.0 111.966 176.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -136.47 124.15 22.41 Favored 'General case' 0 C--N 1.286 -2.175 0 N-CA-C 106.079 -1.823 . . . . 45.12 106.079 177.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 57.5 t -126.57 122.97 62.15 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-O 121.398 0.618 . . . . 74.2 109.494 -175.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 536' ' ' ILE . . . . . 0.446 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 40.2 mm -97.57 127.21 50.1 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.451 0 CA-C-N 115.444 -0.798 . . . . 72.34 109.968 -178.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . 0.426 HG22 ' HB3' ' A' ' 594' ' ' PRO . 86.1 t -113.0 102.31 54.6 Favored Pre-proline 0 C--N 1.308 -1.22 0 CA-C-N 115.448 -0.797 . . . . 72.44 110.18 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -74.74 150.31 39.31 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.667 2.245 . . . . 75.04 111.635 178.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 539' ' ' TYR . . . . . 0.496 ' CE1' ' HG ' ' A' ' 560' ' ' LEU . 17.4 p90 -154.9 165.95 35.08 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 110.246 -0.279 . . . . 73.53 110.246 -178.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -157.86 157.47 33.28 Favored 'General case' 0 C--N 1.316 -0.864 0 O-C-N 123.659 0.599 . . . . 72.43 110.142 177.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 2.1 p -96.46 112.17 24.01 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 123.337 0.655 . . . . 72.11 109.775 173.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.5 mp -81.01 122.96 37.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 107.917 -1.142 . . . . 73.41 107.917 177.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -55.31 -52.73 62.5 Favored 'General case' 0 C--O 1.242 0.704 0 O-C-N 124.223 0.952 . . . . 65.12 110.851 -178.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 71.53 -80.11 0.54 Allowed Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.837 -0.619 . . . . 65.04 113.179 175.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 12.8 t -134.43 -7.47 2.55 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.452 0.644 . . . . 72.31 110.04 -179.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -80.36 -176.37 5.62 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 121.181 0.515 . . . . 54.2 111.723 -179.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . 0.623 ' HB3' ' OE1' ' A' ' 551' ' ' GLU . 56.9 mmt-85 -85.58 177.29 7.78 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.652 -0.703 . . . . 63.4 110.917 177.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -64.38 174.57 13.22 Favored Glycine 0 CA--C 1.538 1.521 0 CA-C-N 115.166 -0.925 . . . . 53.15 114.354 -177.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . -67.63 122.84 18.26 Favored Glycine 0 N--CA 1.441 -0.997 0 CA-C-N 115.259 -0.471 . . . . 70.14 112.46 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 82.98 2.94 90.68 Favored Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 110.634 -0.987 . . . . 74.55 110.634 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . 0.623 ' OE1' ' HB3' ' A' ' 547' ' ' ARG . 38.2 tt0 -96.53 -69.99 0.73 Allowed 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 108.958 -0.756 . . . . 64.51 108.958 -178.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . 0.652 ' OD2' 'CA ' ' A' ' 850' ' ' ' CA' . 17.4 t70 -106.63 -25.57 11.73 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-O 122.004 0.907 . . . . 71.43 109.006 177.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -142.84 152.68 42.42 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 106.65 -1.611 . . . . 74.42 106.65 174.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -87.48 122.7 31.55 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 107.06 -1.459 . . . . 65.0 107.06 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -79.54 123.14 27.31 Favored 'General case' 0 CA--C 1.491 -1.298 0 CA-C-O 120.888 0.375 . . . . 65.13 110.725 -174.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 12.1 t -123.98 107.32 11.2 Favored 'General case' 0 N--CA 1.404 -2.762 0 CA-C-O 122.531 1.158 . . . . 73.34 110.773 -178.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 3.6 p -129.09 130.07 46.02 Favored 'General case' 0 N--CA 1.42 -1.968 0 CA-C-N 114.622 -1.172 . . . . 73.51 108.679 177.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 174.66 -151.39 12.46 Favored Glycine 0 N--CA 1.41 -3.073 0 N-CA-C 109.81 -1.316 . . . . 61.14 109.81 -177.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 559' ' ' GLU . . . . . 0.446 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 70.5 mt-10 -129.71 126.66 38.78 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-O 120.933 0.397 . . . . 64.54 111.533 -175.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . 0.496 ' HG ' ' CE1' ' A' ' 539' ' ' TYR . 83.7 mt -79.67 122.76 26.95 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.787 -0.82 . . . . 74.41 108.787 175.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -93.22 110.01 21.53 Favored 'General case' 0 N--CA 1.419 -1.976 0 N-CA-C 109.194 -0.669 . . . . 71.33 109.194 -178.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -129.26 150.52 50.6 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.054 -0.976 . . . . 71.0 108.373 -179.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . 0.484 ' H ' ' HB3' ' A' ' 566' ' ' GLU . 7.3 pt20 -148.88 178.53 8.6 Favored 'General case' 0 C--N 1.288 -2.07 0 O-C-N 121.882 -0.511 . . . . 73.13 110.746 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 564' ' ' ASN . . . . . 0.464 ' HB3' ' N ' ' A' ' 533' ' ' GLY . 3.7 p-10 -61.89 -33.1 73.61 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 124.347 1.059 . . . . 60.13 111.447 -176.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -91.46 -6.55 52.5 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.864 0.84 . . . . 74.44 110.425 -176.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . 0.484 ' HB3' ' H ' ' A' ' 563' ' ' GLN . 9.6 tp10 -98.94 155.54 17.36 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.497 -1.298 . . . . 72.42 107.497 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 1.7 pp -126.75 140.58 48.53 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.625 0 C-N-CA 119.654 -0.818 . . . . 75.41 109.263 177.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 1.1 p 53.51 176.58 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.524 0 C-N-CA 126.14 1.776 . . . . 75.34 113.649 177.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 569' ' ' LYS . . . . . 0.513 ' HA ' ' HE2' ' A' ' 569' ' ' LYS . 6.7 mmpt? -146.63 153.9 40.86 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 109.119 -0.697 . . . . 71.32 109.119 173.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 570' ' ' THR . . . . . 0.52 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 12.0 p -136.72 133.11 35.75 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 124.13 0.894 . . . . 74.31 110.5 178.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 571' ' ' ILE . . . . . 0.527 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 2.4 mp -95.66 117.8 40.51 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 107.129 -1.434 . . . . 74.4 107.129 174.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 4.1 p -102.1 109.47 21.19 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 123.698 0.624 . . . . 74.43 110.498 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 573' ' ' VAL . . . . . 0.401 ' HB ' ' HE1' ' A' ' 521' ' ' MET . 48.0 t -112.32 136.66 47.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 N-CA-C 109.467 -0.568 . . . . 64.1 109.467 -178.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 58.8 tttp -92.72 126.08 37.64 Favored 'General case' 0 C--N 1.309 -1.159 0 O-C-N 124.046 0.841 . . . . 74.52 109.849 178.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 47.6 t -94.12 132.42 38.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 107.482 -1.303 . . . . 75.1 107.482 177.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 30.5 mm -97.43 146.35 7.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 C-N-CA 120.605 -0.438 . . . . 75.25 109.989 -174.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -61.95 145.14 53.8 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.4 0.68 . . . . 64.35 110.561 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 578' ' ' ASP . . . . . 0.658 ' OD1' 'CA ' ' A' ' 850' ' ' ' CA' . 1.9 m-20 -70.61 134.35 47.51 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 116.032 1.864 . . . . 74.14 116.032 -175.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 579' ' ' GLU . . . . . 0.646 ' OE1' 'CA ' ' A' ' 850' ' ' ' CA' . 0.1 OUTLIER -110.94 -24.82 10.16 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 112.882 -1.963 . . . . 73.22 109.431 177.824 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 580' ' ' GLU . . . . . 0.654 ' OE1' 'CA ' ' A' ' 850' ' ' ' CA' . 0.0 OUTLIER -133.14 178.72 6.68 Favored 'General case' 0 C--O 1.249 1.052 0 N-CA-C 113.232 0.827 . . . . 73.42 113.232 -179.063 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -66.49 152.67 44.72 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.644 -1.162 . . . . 75.22 107.889 177.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 582' ' ' GLU . . . . . 0.616 ' OE1' 'CA ' ' A' ' 800' ' ' ' CA' . 31.4 tt0 -126.29 138.38 53.59 Favored 'General case' 0 C--N 1.293 -1.849 0 C-N-CA 117.385 -1.726 . . . . 72.53 113.011 -176.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -97.21 -158.35 0.66 Allowed 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 106.819 -1.549 . . . . 74.12 106.819 176.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 -79.15 93.54 5.21 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 106.072 -1.825 . . . . 74.44 106.072 170.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 3.8 tmmm? -98.91 121.9 41.47 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 108.364 -0.976 . . . . 71.21 108.364 -172.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 4.9 t -147.01 144.51 29.2 Favored 'General case' 0 N--CA 1.414 -2.226 0 CA-C-N 114.9 -1.046 . . . . 71.14 109.291 -177.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 587' ' ' PHE . . . . . 0.44 ' CE2' HD12 ' A' ' 646' ' ' ILE . 2.5 p90 -125.9 146.68 49.74 Favored 'General case' 0 N--CA 1.419 -2.016 0 CA-C-N 114.542 -1.208 . . . . 70.33 109.235 176.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 588' ' ' PHE . . . . . 0.42 ' HA ' ' O ' ' A' ' 642' ' ' LEU . 30.2 m-85 -102.53 128.52 49.14 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 109.294 -0.632 . . . . 75.11 109.294 -175.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . 0.466 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.5 OUTLIER -101.36 125.72 48.04 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 104.59 -2.374 . . . . 72.24 104.59 173.506 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -137.9 134.29 34.83 Favored 'General case' 0 C--N 1.273 -2.743 0 N-CA-C 108.92 -0.77 . . . . 74.0 108.92 -178.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 591' ' ' ILE . . . . . 0.414 HG21 ' HB3' ' A' ' 539' ' ' TYR . 28.8 pt -96.64 145.56 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.651 0 N-CA-C 108.158 -1.053 . . . . 75.43 108.158 178.255 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -89.62 -151.52 24.96 Favored Glycine 0 C--N 1.292 -1.879 0 N-CA-C 111.09 -0.804 . . . . 75.51 111.09 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -80.88 125.85 79.06 Favored Pre-proline 0 C--N 1.297 -1.68 0 N-CA-C 108.964 -0.754 . . . . 74.2 108.964 178.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 594' ' ' PRO . . . . . 0.426 ' HB3' HG22 ' A' ' 537' ' ' VAL . 38.4 Cg_endo -69.71 153.07 69.62 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 121.878 1.719 . . . . 75.4 110.841 176.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -129.79 132.38 46.51 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.844 -0.535 . . . . 73.41 111.488 -177.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 596' ' ' LEU . . . . . 0.438 ' HB2' ' HD3' ' A' ' 634' ' ' PRO . 0.0 OUTLIER -87.13 125.9 34.44 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 108.221 -1.029 . . . . 74.23 108.221 -179.567 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 21.4 t -91.77 20.93 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.55 0 CA-C-O 121.949 0.88 . . . . 72.55 109.802 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -57.44 -42.17 81.95 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.616 -0.72 . . . . 71.11 111.43 179.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 31.4 ttp -103.51 98.72 8.57 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 106.919 -1.512 . . . . 75.13 106.919 174.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 12.6 m -77.01 151.71 35.48 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 108.671 -0.863 . . . . 71.3 108.671 178.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -70.61 92.64 0.86 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.572 0.701 . . . . 74.12 109.195 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -177.39 -33.37 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 125.579 1.552 . . . . 72.32 106.934 -174.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.66 -179.37 3.72 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 114.554 -1.203 . . . . 73.02 109.164 177.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -166.95 -43.34 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.705 0 N-CA-C 110.004 -1.238 . . . . 71.33 110.004 177.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 97.16 -114.19 4.91 Favored Glycine 0 N--CA 1.437 -1.296 0 N-CA-C 110.485 -1.046 . . . . 74.52 110.485 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -115.55 97.4 6.13 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.677 -1.231 . . . . 72.34 107.677 176.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 607' ' ' THR . . . . . 0.513 ' HB ' ' O ' ' A' ' 609' ' ' THR . 18.8 p -131.52 130.47 42.39 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 115.802 -0.636 . . . . 70.45 110.699 -177.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 3.2 mp -65.52 -43.69 94.25 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.867 0 CA-C-O 123.438 1.589 . . . . 73.33 107.235 174.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 609' ' ' THR . . . . . 0.513 ' O ' ' HB ' ' A' ' 607' ' ' THR . 13.8 p -139.82 152.09 46.24 Favored 'General case' 0 C--N 1.246 -3.931 0 CA-C-N 111.167 -2.742 . . . . 74.34 105.532 175.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -98.32 9.32 43.33 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.555 -0.858 . . . . 74.01 110.345 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -77.05 76.49 3.6 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 114.046 1.128 . . . . 74.43 114.046 -177.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -98.79 72.32 1.96 Allowed 'General case' 0 C--N 1.281 -2.385 0 N-CA-C 104.937 -2.246 . . . . 74.32 104.937 167.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -84.27 62.85 7.41 Favored 'General case' 0 N--CA 1.427 -1.62 0 CA-C-N 112.134 -2.303 . . . . 65.54 109.804 -170.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -80.9 79.55 7.54 Favored 'General case' 0 CA--C 1.483 -1.623 0 CA-C-O 122.571 1.176 . . . . 61.24 109.364 176.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -124.29 20.27 8.9 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 105.941 -1.874 . . . . 75.54 105.941 177.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -96.32 170.92 6.83 Favored Pre-proline 0 N--CA 1.433 -1.321 0 CA-C-N 112.485 -2.143 . . . . 73.13 108.61 -176.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -75.43 177.67 8.35 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 121.656 1.571 . . . . 74.24 109.278 169.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -67.42 117.71 9.76 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.133 0.492 . . . . 72.33 111.581 -177.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 36.0 p -109.64 28.13 8.87 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.397 -0.82 . . . . 71.3 108.993 178.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 2.4 m -61.76 -35.66 78.77 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 124.365 1.066 . . . . 75.35 113.214 -172.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -103.64 5.44 36.45 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.465 0.65 . . . . 61.23 110.212 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -93.46 -51.13 5.11 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 107.859 -1.163 . . . . 65.05 107.859 179.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . 0.464 ' O ' ' HB2' ' A' ' 626' ' ' ARG . 39.2 mt-10 -98.9 123.47 43.2 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 106.883 -1.525 . . . . 74.23 106.883 177.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -78.77 -12.54 60.03 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 119.883 -0.727 . . . . 74.51 112.016 -176.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -87.52 -16.66 34.06 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 123.13 0.572 . . . . 73.31 110.989 174.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . 0.593 ' O ' ' HG3' ' A' ' 630' ' ' GLU . 0.0 OUTLIER -51.03 -44.05 61.0 Favored 'General case' 0 C--O 1.2 -1.501 0 N-CA-C 113.163 0.801 . . . . 73.42 113.163 -173.367 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 627' ' ' ARG . . . . . . . . . . . . . 78.0 mtt180 -71.29 -24.42 62.14 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 118.585 0.63 . . . . 74.32 112.535 -175.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . 0.419 ' O ' ' HB3' ' A' ' 631' ' ' MET . 96.4 mt -70.41 -36.93 68.77 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 N-CA-C 108.306 -0.998 . . . . 74.34 108.306 172.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -72.02 -30.39 65.15 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 109.138 -0.69 . . . . 75.41 109.138 175.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 630' ' ' GLU . . . . . 0.593 ' HG3' ' O ' ' A' ' 626' ' ' ARG . 76.3 mt-10 -77.76 10.31 2.84 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.606 0.762 . . . . 74.14 111.014 177.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 631' ' ' MET . . . . . 0.426 ' HA ' ' N ' ' A' ' 501' ' ' HIS . 43.3 ttp -84.84 -29.19 25.52 Favored 'General case' 0 N--CA 1.409 -2.501 0 N-CA-C 106.819 -1.549 . . . . 71.3 106.819 170.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -100.95 -17.7 22.23 Favored Glycine 0 N--CA 1.438 -1.18 0 CA-C-N 115.102 -0.954 . . . . 64.1 111.805 175.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -109.89 134.85 20.54 Favored Pre-proline 0 C--N 1.313 -1.021 0 N-CA-C 108.589 -0.893 . . . . 72.45 108.589 -179.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.438 ' HD3' ' HB2' ' A' ' 596' ' ' LEU . 70.8 Cg_endo -75.77 157.19 39.64 Favored 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 121.924 1.749 . . . . 72.33 111.196 178.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 29.7 pt -132.03 178.21 5.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 CA-C-O 121.655 0.74 . . . . 74.53 111.048 -173.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -94.05 152.47 18.76 Favored 'General case' 0 N--CA 1.423 -1.805 0 N-CA-C 106.768 -1.568 . . . . 75.21 106.768 171.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -81.26 -126.04 0.75 Allowed Glycine 0 C--N 1.29 -2.014 0 C-N-CA 120.871 -0.68 . . . . 62.53 113.445 -176.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -87.5 -50.27 6.65 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 112.072 0.397 . . . . 64.12 112.072 -175.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -132.99 110.6 10.36 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.999 0.904 . . . . 73.15 112.939 -177.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 22.3 p -120.32 92.47 3.78 Favored 'General case' 0 N--CA 1.422 -1.861 0 CA-C-N 115.423 -0.808 . . . . 74.32 110.698 176.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 641' ' ' LYS . . . . . 0.584 ' O ' ' HA ' ' A' ' 510' ' ' PRO . 0.2 OUTLIER -170.51 127.55 0.79 Allowed 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 104.564 -2.384 . . . . 74.15 104.564 178.204 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 642' ' ' LEU . . . . . 0.472 ' CD2' HG22 ' A' ' 523' ' ' VAL . 43.8 tp -117.23 107.06 13.97 Favored 'General case' 0 C--N 1.274 -2.713 0 N-CA-C 108.386 -0.968 . . . . 73.23 108.386 177.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -90.71 100.97 13.72 Favored 'General case' 0 C--N 1.275 -2.64 0 N-CA-C 107.306 -1.368 . . . . 73.53 107.306 178.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 19.3 t -91.74 103.55 14.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 109.181 -0.674 . . . . 73.12 109.181 -177.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 3.8 mp -93.42 123.97 45.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 105.704 -1.962 . . . . 74.33 105.704 174.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 646' ' ' ILE . . . . . 0.444 HD11 ' N ' ' A' ' 646' ' ' ILE . 2.8 mp -97.76 129.15 48.35 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 N-CA-C 108.447 -0.946 . . . . 72.13 108.447 -173.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -92.38 117.31 29.79 Favored 'General case' 0 N--CA 1.403 -2.787 0 CA-C-N 115.69 -0.686 . . . . 73.42 110.744 -179.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . 0.642 ' OE1' 'CA ' ' A' ' 800' ' ' ' CA' . 33.0 tp10 -61.58 141.37 57.81 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 114.257 -1.338 . . . . 74.3 107.763 178.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 6.5 t -55.99 113.74 1.64 Allowed 'General case' 0 C--O 1.241 0.623 0 C-N-CA 123.245 0.618 . . . . 71.24 109.654 -176.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -168.68 -63.08 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.508 -0.769 . . . . 74.13 109.629 -175.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 651' ' ' GLU . . . . . 0.405 ' OE2' ' HD3' ' A' ' 653' ' ' LYS . 35.2 tt0 -175.37 174.34 2.36 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 104.214 -2.513 . . . . 74.22 104.214 -175.218 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -100.04 110.37 22.68 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.41 -1.33 . . . . 75.11 107.41 -178.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 653' ' ' LYS . . . . . 0.405 ' HD3' ' OE2' ' A' ' 651' ' ' GLU . 14.3 mmmm -135.75 49.67 2.14 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 124.027 0.931 . . . . 75.44 109.356 -173.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 15.2 m -50.86 110.12 0.39 Allowed 'General case' 0 C--O 1.243 0.72 0 C-N-CA 124.209 1.004 . . . . 72.23 111.303 179.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 4.0 t -82.56 80.52 8.67 Favored 'General case' 0 N--CA 1.418 -2.038 0 CA-C-O 122.467 1.127 . . . . 73.51 111.092 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 46.2 t -125.99 95.48 3.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 N-CA-C 107.289 -1.375 . . . . 74.15 107.289 177.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 . . . . . 0 C--N 1.285 -2.238 0 CA-C-N 114.588 -1.187 . . . . 74.22 109.218 -176.327 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 800' ' ' ' CA' . . . . . 0.642 'CA ' ' OE1' ' A' ' 648' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 850' ' ' ' CA' . . . . . 0.658 'CA ' ' OD1' ' A' ' 578' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 4.7 p-80 . . . . . 0 N--CA 1.448 -0.549 0 CA-C-O 120.642 0.258 . . . . 74.22 110.707 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -127.18 -47.73 1.47 Allowed 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 108.924 -0.769 . . . . 71.42 108.924 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . 0.516 ' HA2' ' OG1' ' A' ' 528' ' ' THR . . . -100.95 147.41 17.84 Favored Glycine 0 N--CA 1.41 -3.077 0 C-N-CA 119.912 -1.137 . . . . 61.51 114.868 -172.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . 0.404 ' H ' ' HA ' ' A' ' 528' ' ' THR . 3.5 mp -129.32 90.53 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 N-CA-C 106.036 -1.839 . . . . 74.14 106.036 174.07 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . 0.498 ' CZ ' ' HB ' ' A' ' 528' ' ' THR . 89.3 m-85 -112.11 110.52 20.85 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 109.176 -0.676 . . . . 72.04 109.176 179.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 506' ' ' THR . . . . . 0.47 ' HB ' ' HA3' ' A' ' 637' ' ' GLY . 11.7 t -149.25 167.61 25.55 Favored 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 107.229 -1.397 . . . . 74.12 107.229 -177.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -94.75 155.0 17.02 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.565 -1.642 . . . . 73.03 106.565 173.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -90.92 -29.74 17.29 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 107.426 -1.324 . . . . 64.14 107.426 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -112.5 130.9 22.94 Favored Pre-proline 0 N--CA 1.425 -1.711 0 CA-C-N 114.964 -1.016 . . . . 75.12 109.454 174.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -84.59 -10.17 8.73 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.203 1.935 . . . . 63.04 111.193 176.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 94.3 t -141.29 135.52 31.88 Favored 'Isoleucine or valine' 0 C--O 1.244 0.813 0 C-N-CA 123.929 0.892 . . . . 72.25 109.645 -177.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 7.3 t -139.22 138.35 36.77 Favored 'General case' 0 N--CA 1.413 -2.317 0 N-CA-C 107.066 -1.457 . . . . 75.03 107.066 174.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 25.1 m-70 -107.64 132.87 52.85 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 106.643 -1.614 . . . . 74.02 106.643 177.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.68 HG11 ' SD ' ' A' ' 521' ' ' MET . 34.6 m -120.27 159.04 22.0 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 CA-C-O 121.826 0.822 . . . . 75.15 111.534 -174.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 515' ' ' SER . . . . . 0.537 ' O ' HG23 ' A' ' 518' ' ' ILE . 51.6 m -82.02 142.08 32.67 Favored 'General case' 0 N--CA 1.387 -3.592 0 CA-C-N 114.13 -1.395 . . . . 61.23 107.971 178.132 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . 0.647 ' OE2' 'CA ' ' A' ' 800' ' ' ' CA' . 39.3 tt0 -80.12 -20.84 44.09 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 120.066 -0.653 . . . . 70.44 110.792 179.013 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 47.8 m -94.73 22.7 6.07 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.705 0.764 . . . . 52.55 110.613 -177.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 518' ' ' ILE . . . . . 0.537 HG23 ' O ' ' A' ' 515' ' ' SER . 16.2 tt -97.09 149.71 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.756 0 N-CA-C 108.367 -0.975 . . . . 75.32 108.367 -179.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -83.49 -54.58 3.08 Favored Glycine 0 N--CA 1.43 -1.764 0 C-N-CA 120.359 -0.924 . . . . 73.01 111.39 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . 0.418 HD13 ' HA ' ' A' ' 574' ' ' LYS . 34.2 mm -132.72 125.4 52.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.85 -0.796 . . . . 74.14 108.85 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 521' ' ' MET . . . . . 0.68 ' SD ' HG11 ' A' ' 514' ' ' VAL . 23.7 ptt? -94.23 137.75 33.04 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.833 -1.543 . . . . 74.02 106.833 172.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -125.35 140.43 52.82 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 123.387 0.429 . . . . 61.23 110.947 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . 0.589 ' O ' ' HA ' ' A' ' 570' ' ' THR . 39.7 t -124.32 126.09 71.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 108.716 -0.846 . . . . 64.54 108.716 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -77.77 117.42 19.13 Favored 'General case' 0 C--N 1.311 -1.105 0 O-C-N 123.784 0.678 . . . . 74.35 110.933 -178.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 25.5 t -98.8 140.17 19.03 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.289 0 CA-C-N 115.241 -0.89 . . . . 72.42 110.858 -175.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -68.7 144.62 54.36 Favored 'General case' 0 C--O 1.238 0.457 0 O-C-N 123.956 0.785 . . . . 70.33 109.187 177.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . 0.405 ' HG2' ' N ' ' A' ' 528' ' ' THR . 27.1 ttp180 -99.16 157.77 16.14 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.343 0.592 . . . . 73.32 110.926 -173.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 528' ' ' THR . . . . . 0.516 ' OG1' ' HA2' ' A' ' 503' ' ' GLY . 5.1 t -65.9 135.03 54.24 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 115.547 -0.751 . . . . 72.35 110.179 173.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 22.6 t -81.87 -37.35 27.07 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.515 -0.92 . . . . 74.23 108.515 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -87.34 98.03 2.34 Favored Glycine 0 N--CA 1.418 -2.512 0 N-CA-C 108.168 -1.973 . . . . 51.53 108.168 175.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . 0.442 ' HB3' HG22 ' A' ' 528' ' ' THR . . . -149.38 100.66 3.04 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 120.854 0.359 . . . . 73.42 110.282 -177.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . 0.408 ' HD2' ' N ' ' A' ' 532' ' ' ARG . 7.5 mpt_? -119.82 12.8 12.21 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 108.4 -0.963 . . . . 74.33 108.4 172.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . -155.22 -166.16 15.11 Favored Glycine 0 N--CA 1.437 -1.291 0 CA-C-N 115.006 -0.997 . . . . 71.32 111.013 -172.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -97.8 134.54 40.82 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 122.926 0.49 . . . . 70.43 109.982 -178.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 535' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 595' ' ' ARG . 61.3 t -133.06 131.45 58.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 123.025 0.53 . . . . 73.4 109.856 -178.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 536' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 594' ' ' PRO . 35.1 mm -103.82 138.17 29.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 110.033 -0.358 . . . . 75.22 110.033 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 48.8 t -126.28 110.19 23.81 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 110.086 -0.338 . . . . 75.03 110.086 178.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.04 154.41 37.67 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.369 2.046 . . . . 75.52 111.754 178.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -147.23 161.66 40.48 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.243 -0.651 . . . . 72.03 109.243 177.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -152.5 157.57 41.32 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 123.724 0.64 . . . . 75.32 109.782 178.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 2.7 p -99.93 122.66 43.18 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 123.469 0.481 . . . . 71.42 110.649 174.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.4 mp -91.08 112.52 25.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 106.242 -1.762 . . . . 73.34 106.242 174.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -52.13 -50.68 61.22 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 124.246 0.966 . . . . 71.23 111.823 -178.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 67.18 -94.68 0.26 Allowed Glycine 0 N--CA 1.442 -0.903 0 CA-C-N 116.058 -0.519 . . . . 71.42 112.24 176.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 8.0 t -119.19 9.39 11.73 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 120.759 0.314 . . . . 73.13 110.575 -178.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . 0.43 ' HB2' ' HD3' ' A' ' 585' ' ' LYS . . . -98.78 166.31 11.37 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.847 -0.427 . . . . 64.51 109.847 178.065 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 2.8 tpp180 -75.55 167.33 22.1 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 108.024 -1.102 . . . . 73.23 108.024 178.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -65.02 177.25 10.64 Favored Glycine 0 C--O 1.254 1.393 0 CA-C-O 121.513 0.507 . . . . 55.24 114.36 -178.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . -57.03 127.55 45.13 Favored Glycine 0 N--CA 1.439 -1.141 0 CA-C-N 114.718 -0.741 . . . . 71.03 114.115 -177.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 94.95 -10.23 70.24 Favored Glycine 0 N--CA 1.434 -1.459 0 CA-C-N 115.311 -0.444 . . . . 75.15 112.565 176.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -91.08 -70.84 0.66 Allowed 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 120.405 -0.518 . . . . 75.31 109.754 -179.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . 0.657 ' OD1' 'CA ' ' A' ' 850' ' ' ' CA' . 71.1 m-20 -96.03 -37.9 10.44 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-O 121.572 0.701 . . . . 64.23 109.97 175.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -142.46 156.82 45.21 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 108.115 -1.069 . . . . 72.33 108.115 -177.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -87.42 117.41 26.19 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 106.519 -1.66 . . . . 71.15 106.519 178.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -72.38 107.15 4.81 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.75 -0.659 . . . . 72.2 109.791 -176.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 9.6 t -106.58 126.66 52.55 Favored 'General case' 0 N--CA 1.413 -2.32 0 CA-C-O 122.123 0.963 . . . . 64.52 111.565 -173.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 20.5 p -136.99 109.77 7.57 Favored 'General case' 0 N--CA 1.414 -2.244 0 N-CA-C 107.367 -1.346 . . . . 73.22 107.367 175.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -152.92 -161.69 10.46 Favored Glycine 0 N--CA 1.418 -2.505 0 N-CA-C 110.607 -0.997 . . . . 73.41 110.607 -174.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -139.18 131.25 27.98 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 122.983 0.513 . . . . 71.04 110.454 -176.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 87.7 mt -92.99 143.73 25.95 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 123.725 0.81 . . . . 74.4 109.123 179.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -102.62 123.59 46.61 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-O 121.414 0.626 . . . . 71.5 110.618 178.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -121.35 157.49 30.32 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 108.26 -1.015 . . . . 71.23 108.26 173.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -162.92 -178.93 6.41 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 109.769 -0.456 . . . . 74.34 109.769 176.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 -63.74 -36.36 83.6 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 124.108 0.88 . . . . 75.34 111.587 178.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -90.11 -17.26 28.01 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.399 -0.819 . . . . 74.51 112.309 -176.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -109.58 128.65 55.36 Favored 'General case' 0 C--N 1.31 -1.123 0 O-C-N 121.844 -0.535 . . . . 73.24 111.081 -174.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 4.7 pt -109.43 159.45 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.125 0 N-CA-C 108.735 -0.839 . . . . 72.23 108.735 176.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 1.3 p 49.25 160.89 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.573 1.855 0 C-N-CA 127.081 2.152 . . . . 71.54 115.182 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 569' ' ' LYS . . . . . 0.473 ' HE3' ' HA ' ' A' ' 569' ' ' LYS . 0.0 OUTLIER -153.23 162.54 41.19 Favored 'General case' 0 CA--C 1.484 -1.578 0 N-CA-C 107.463 -1.31 . . . . 74.42 107.463 173.114 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 570' ' ' THR . . . . . 0.589 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 4.9 p -136.87 127.96 27.79 Favored 'General case' 0 C--N 1.291 -1.938 0 O-C-N 124.169 0.918 . . . . 71.04 110.815 178.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 3.3 mp -79.38 106.93 11.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 107.432 -1.321 . . . . 75.44 107.432 174.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 7.3 p -86.42 111.95 21.02 Favored 'General case' 0 N--CA 1.415 -2.2 0 O-C-N 123.645 0.591 . . . . 61.21 110.419 179.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 573' ' ' VAL . . . . . . . . . . . . . 42.3 t -114.39 130.7 68.23 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 N-CA-C 109.089 -0.708 . . . . 74.52 109.089 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 574' ' ' LYS . . . . . 0.418 ' HA ' HD13 ' A' ' 520' ' ' ILE . 86.1 tttt -86.87 121.88 29.97 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 115.476 -0.784 . . . . 75.13 110.292 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 56.5 t -90.06 139.37 17.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 107.015 -1.476 . . . . 74.54 107.015 176.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 31.3 mm -103.52 158.31 5.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 107.842 -1.17 . . . . 74.02 107.842 -175.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -67.31 126.56 29.65 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.019 -0.734 . . . . 55.42 109.019 178.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 578' ' ' ASP . . . . . 0.641 ' OD1' 'CA ' ' A' ' 850' ' ' ' CA' . 26.8 t0 -76.23 130.43 38.18 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.818 -0.628 . . . . 75.33 110.45 -171.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 579' ' ' GLU . . . . . 0.634 ' OE1' 'CA ' ' A' ' 850' ' ' ' CA' . 0.6 OUTLIER -92.29 -35.34 13.82 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 113.842 1.053 . . . . 74.11 113.842 -175.718 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 580' ' ' GLU . . . . . 0.656 ' OE1' 'CA ' ' A' ' 850' ' ' ' CA' . 0.0 OUTLIER -117.58 -178.99 3.6 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 120.251 -0.58 . . . . 74.14 111.009 -174.573 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -71.48 152.43 43.05 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 106.419 -1.697 . . . . 75.3 106.419 175.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 582' ' ' GLU . . . . . 0.658 ' OE1' 'CA ' ' A' ' 800' ' ' ' CA' . 40.7 tt0 -145.14 141.81 29.07 Favored 'General case' 0 N--CA 1.409 -2.495 0 C-N-CA 118.517 -1.273 . . . . 74.04 111.597 -174.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . 0.448 ' O ' ' HG2' ' A' ' 582' ' ' GLU . 97.3 mttt -94.57 -179.29 4.84 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 106.555 -1.646 . . . . 74.42 106.555 174.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -74.78 94.49 2.75 Favored 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 119.819 -0.753 . . . . 73.24 109.125 178.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 585' ' ' LYS . . . . . 0.43 ' HD3' ' HB2' ' A' ' 546' ' ' ALA . 0.0 OUTLIER -102.73 170.43 8.01 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 115.828 -0.624 . . . . 74.04 109.319 -179.56 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 2.8 t -151.79 148.96 28.48 Favored 'General case' 0 N--CA 1.418 -2.043 0 CA-C-O 121.486 0.66 . . . . 70.33 111.502 -177.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -128.84 150.09 50.47 Favored 'General case' 0 N--CA 1.411 -2.409 0 CA-C-N 113.537 -1.665 . . . . 70.3 107.321 174.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 588' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -108.51 135.98 48.88 Favored 'General case' 0 C--N 1.29 -1.993 0 C-N-CA 120.555 -0.458 . . . . 74.15 110.5 -169.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . 0.416 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.3 OUTLIER -102.85 129.58 49.57 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 105.8 -1.926 . . . . 72.11 105.8 175.712 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -132.97 127.08 33.42 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 109.392 -0.595 . . . . 72.54 109.392 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 591' ' ' ILE . . . . . . . . . . . . . 16.3 pt -94.17 138.43 20.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 107.945 -1.132 . . . . 73.01 107.945 174.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -97.64 -145.3 18.75 Favored Glycine 0 N--CA 1.43 -1.746 0 N-CA-C 115.049 0.779 . . . . 65.11 115.049 -172.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -84.99 119.67 72.82 Favored Pre-proline 0 C--N 1.302 -1.462 0 CA-C-N 114.081 -1.059 . . . . 63.24 109.827 -174.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 594' ' ' PRO . . . . . 0.409 ' HA ' ' O ' ' A' ' 536' ' ' ILE . 43.9 Cg_endo -72.5 156.01 54.51 Favored 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 123.082 2.521 . . . . 73.3 114.202 -177.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 595' ' ' ARG . . . . . 0.509 ' O ' ' HA ' ' A' ' 535' ' ' VAL . 5.7 mmp_? -115.37 118.15 32.43 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 123.713 0.805 . . . . 73.24 109.284 -175.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -82.5 117.99 22.92 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 104.793 -2.299 . . . . 72.24 104.793 169.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 17.0 t -83.68 59.63 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-O 121.776 0.798 . . . . 75.44 112.787 -172.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 63.67 -32.54 0.12 Allowed 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 118.082 2.623 . . . . 75.34 118.082 167.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 44.5 tpp -47.78 -64.62 0.74 Allowed 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 114.345 1.239 . . . . 74.25 114.345 -174.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 17.4 p -137.67 173.15 11.96 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 109.706 -0.479 . . . . 71.22 109.706 -175.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 61.02 26.76 16.69 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 124.185 0.928 . . . . 75.5 112.102 173.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.51 32.5 1.37 Allowed 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.968 0.89 . . . . 75.44 111.475 -176.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 603' ' ' LYS . . . . . 0.436 ' HZ2' ' HB3' ' A' ' 603' ' ' LYS . 9.3 mtpm? -88.96 81.7 6.83 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.927 -1.033 . . . . 71.25 110.432 179.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -151.11 -51.71 0.01 OUTLIER Glycine 0 C--N 1.307 -1.081 0 N-CA-C 109.583 -1.407 . . . . 54.04 109.583 177.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . -117.62 76.95 0.29 Allowed Glycine 0 N--CA 1.432 -1.623 0 N-CA-C 109.206 -1.558 . . . . 64.1 109.206 174.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -71.33 -26.14 62.7 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 122.827 0.451 . . . . 72.51 111.43 -175.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -67.57 129.16 39.02 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 123.535 0.734 . . . . 64.44 112.689 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 39.1 mm -77.16 77.63 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-O 122.55 1.167 . . . . 74.4 112.337 -175.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 8.9 t -146.56 11.58 1.13 Allowed 'General case' 0 C--N 1.273 -2.738 0 CA-C-N 114.51 -1.223 . . . . 51.33 108.044 176.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 42.95 76.67 0.07 Allowed 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 114.109 -1.405 . . . . 73.23 111.924 -171.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -95.27 26.51 3.74 Favored 'General case' 0 C--N 1.286 -2.18 0 CA-C-O 122.364 1.078 . . . . 73.31 112.711 -178.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -87.9 82.12 7.36 Favored 'General case' 0 N--CA 1.414 -2.227 0 CA-C-N 114.08 -1.418 . . . . 74.04 107.667 171.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 17.4 p-10 -90.44 3.02 55.05 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 111.799 -2.455 . . . . 51.04 110.96 -173.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -73.66 98.81 2.95 Favored 'General case' 0 C--N 1.287 -2.119 0 C-N-CA 123.199 0.6 . . . . 74.5 112.179 -177.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -147.97 19.03 1.12 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 107.814 -1.18 . . . . 74.24 107.814 172.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 616' ' ' GLN . . . . . 0.435 ' HB3' ' HD2' ' A' ' 617' ' ' PRO . 1.2 mp0 -109.13 173.46 2.95 Favored Pre-proline 0 C--N 1.313 -1.004 0 C-N-CA 123.752 0.821 . . . . 74.3 110.174 -174.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 617' ' ' PRO . . . . . 0.435 ' HD2' ' HB3' ' A' ' 616' ' ' GLN . 33.3 Cg_endo -69.62 168.87 20.13 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 121.702 1.602 . . . . 71.23 110.139 170.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -77.96 105.57 9.24 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 120.844 0.354 . . . . 72.43 111.783 -175.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 8.8 t -163.96 159.0 20.33 Favored 'General case' 0 N--CA 1.426 -1.641 0 N-CA-C 109.129 -0.693 . . . . 75.24 109.129 176.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 620' ' ' SER . . . . . 0.663 ' HB3' ' NE ' ' A' ' 626' ' ' ARG . 14.9 p -144.96 -8.95 0.61 Allowed 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 115.691 -0.686 . . . . 73.15 111.153 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm 64.38 21.45 12.49 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 107.881 -1.155 . . . . 74.5 107.881 -170.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 65.41 21.88 11.91 Favored 'General case' 0 CA--C 1.558 1.277 0 C-N-CA 126.634 1.974 . . . . 65.0 110.577 -175.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -71.18 124.03 23.53 Favored 'General case' 0 C--O 1.258 1.517 0 CA-C-O 121.719 0.771 . . . . 61.33 110.488 176.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -61.83 -39.35 91.5 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-N 113.984 -1.462 . . . . 72.03 112.05 -177.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . 0.272 1.7 pp20? -64.6 -28.46 69.64 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 119.378 -0.929 . . . . 71.53 112.521 -178.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . 0.663 ' NE ' ' HB3' ' A' ' 620' ' ' SER . 1.9 tmm_? -70.75 -42.62 70.24 Favored 'General case' 0 C--O 1.202 -1.421 0 N-CA-C 106.759 -1.571 . . . . 73.35 106.759 175.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 627' ' ' ARG . . . . . . . . . . . . . 72.9 mtp180 -63.72 -34.67 78.4 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 116.144 -0.48 . . . . 72.23 110.924 -178.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 96.2 mt -64.76 -37.56 80.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 121.316 0.579 . . . . 73.53 110.479 175.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -69.0 -31.29 70.01 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.523 0.678 . . . . 74.53 110.028 178.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 630' ' ' GLU . . . . . 0.619 ' HG2' ' O ' ' A' ' 626' ' ' ARG . 4.5 mm-40 -81.0 2.96 24.69 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.249 -0.887 . . . . 74.4 110.436 -179.052 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 631' ' ' MET . . . . . . . . . . . . . 44.6 ttm -78.27 -27.43 47.43 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 107.647 -1.242 . . . . 71.24 107.647 175.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -96.87 -44.94 2.75 Favored Glycine 0 N--CA 1.427 -1.958 0 N-CA-C 110.289 -1.124 . . . . 74.43 110.289 177.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 21.8 mtm180 -70.37 152.69 95.48 Favored Pre-proline 0 N--CA 1.443 -0.79 0 CA-C-O 121.187 0.518 . . . . 74.41 112.32 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.454 ' HA ' ' H ' ' A' ' 503' ' ' GLY . 61.3 Cg_endo -77.16 148.82 27.69 Favored 'Trans proline' 0 N--CA 1.437 -1.834 0 C-N-CA 121.795 1.663 . . . . 75.14 109.532 173.193 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 11.6 pt -137.33 -171.74 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-O 120.956 0.408 . . . . 74.24 110.351 -178.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.48 164.42 14.83 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 115.482 -0.781 . . . . 75.23 110.227 177.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . 0.47 ' HA3' ' HB ' ' A' ' 506' ' ' THR . . . -82.35 -106.51 0.43 Allowed Glycine 0 N--CA 1.435 -1.428 0 CA-C-N 115.917 -0.583 . . . . 50.22 112.99 -176.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -107.99 -54.16 2.53 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 119.889 -0.724 . . . . 73.04 111.003 -176.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 14.5 p80 -133.84 116.16 15.34 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 121.79 0.805 . . . . 75.51 111.423 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 16.2 p -104.3 91.24 3.83 Favored 'General case' 0 N--CA 1.408 -2.552 0 N-CA-C 109.091 -0.707 . . . . 73.44 109.091 174.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -171.65 126.25 0.61 Allowed 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 105.898 -1.89 . . . . 73.34 105.898 -178.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 642' ' ' LEU . . . . . 0.494 ' CD2' HG21 ' A' ' 523' ' ' VAL . 42.6 tp -126.28 110.97 14.01 Favored 'General case' 0 C--N 1.281 -2.398 0 N-CA-C 108.086 -1.079 . . . . 73.51 108.086 176.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -90.9 102.97 15.73 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 107.569 -1.271 . . . . 72.31 107.569 178.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 41.2 t -93.2 110.9 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 N-CA-C 109.333 -0.618 . . . . 71.33 109.333 -179.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 3.5 mp -93.07 125.6 45.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 108.425 -0.954 . . . . 74.12 108.425 176.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 646' ' ' ILE . . . . . 0.514 ' N ' HD13 ' A' ' 646' ' ' ILE . 2.1 mp -110.72 131.14 62.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 N-CA-C 107.424 -1.324 . . . . 74.33 107.424 -176.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -131.22 157.35 43.48 Favored 'General case' 0 C--N 1.28 -2.448 0 N-CA-C 108.511 -0.922 . . . . 75.43 108.511 178.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . 0.656 ' OE2' 'CA ' ' A' ' 800' ' ' ' CA' . 6.5 mp0 -56.5 117.97 4.36 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 106.307 -1.738 . . . . 72.11 106.307 170.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 2.9 t -45.95 97.74 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.028 0 O-C-N 125.802 1.939 . . . . 74.01 113.784 -165.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -138.7 -60.34 0.6 Allowed 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 115.382 -0.826 . . . . 74.5 110.472 174.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -102.5 160.39 14.6 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-O 121.572 0.701 . . . . 74.44 110.576 -173.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -133.3 125.13 28.58 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 114.817 -1.083 . . . . 74.4 109.18 179.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -148.71 166.4 28.48 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 123.375 0.67 . . . . 73.13 109.795 -178.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 14.4 t -165.38 86.23 0.39 Allowed 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 106.321 -1.733 . . . . 64.14 106.321 172.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 14.1 t -80.22 131.46 35.7 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-N 115.497 -0.774 . . . . 73.04 111.152 -174.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 17.3 m -94.48 160.36 2.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-N 115.144 -0.934 . . . . 74.43 109.005 177.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 20.1 t70 . . . . . 0 C--N 1.313 -1.006 0 CA-C-O 119.417 -0.325 . . . . 73.13 110.369 -174.709 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 800' ' ' ' CA' . . . . . 0.658 'CA ' ' OE1' ' A' ' 582' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 850' ' ' ' CA' . . . . . 0.657 'CA ' ' OD1' ' A' ' 552' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 . . . . . 0 CA--C 1.516 -0.34 0 N-CA-C 109.717 -0.475 . . . . 73.44 109.717 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -129.29 151.13 50.28 Favored 'General case' 0 CA--C 1.465 -2.298 0 N-CA-C 106.402 -1.703 . . . . 52.5 106.402 176.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . 0.447 ' HA2' ' OG1' ' A' ' 528' ' ' THR . . . -86.55 124.48 6.96 Favored Glycine 0 N--CA 1.403 -3.564 0 C-N-CA 119.021 -1.561 . . . . 74.22 110.08 175.033 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 4.1 mp -91.82 119.34 39.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 108.712 -0.847 . . . . 75.4 108.712 178.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -123.48 126.04 46.0 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 109.627 -0.508 . . . . 71.3 109.627 177.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 506' ' ' THR . . . . . 0.415 ' HB ' ' HA3' ' A' ' 637' ' ' GLY . 8.8 t -153.41 165.18 36.62 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.522 -0.918 . . . . 74.1 108.522 -177.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -89.31 162.65 15.72 Favored 'General case' 0 C--O 1.251 1.136 0 N-CA-C 107.228 -1.397 . . . . 73.45 107.228 173.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -88.42 -44.43 10.75 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 106.293 -1.743 . . . . 75.32 106.293 178.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -105.36 133.73 20.02 Favored Pre-proline 0 N--CA 1.42 -1.93 0 CA-C-N 114.502 -1.226 . . . . 74.42 109.495 176.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -87.21 -10.63 5.59 Favored 'Trans proline' 0 C--O 1.219 -0.469 0 C-N-CA 121.956 1.77 . . . . 71.53 110.824 175.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 81.5 t -142.42 138.89 29.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 C-N-CA 124.378 1.071 . . . . 74.02 108.441 -176.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 11.3 t -142.09 141.71 32.75 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 107.726 -1.213 . . . . 74.13 107.726 174.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 35.5 m-70 -108.94 130.4 55.45 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.486 -0.561 . . . . 70.24 109.486 178.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 26.4 m -128.71 162.47 35.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 CA-C-O 120.937 0.398 . . . . 73.4 110.221 -176.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 45.9 t -84.24 156.68 21.89 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 108.412 -0.959 . . . . 71.14 108.412 175.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -88.91 -6.77 57.06 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-O 122.089 0.947 . . . . 75.25 109.659 174.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 8.7 t -96.99 6.34 48.8 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 108.707 -0.849 . . . . 75.51 108.707 179.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 12.5 tt -85.11 151.03 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.623 0 N-CA-C 108.69 -0.856 . . . . 73.44 108.69 -178.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . 0.452 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . -89.61 -63.38 1.29 Allowed Glycine 0 N--CA 1.426 -2.023 0 C-N-CA 120.366 -0.921 . . . . 75.4 111.098 179.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 32.1 mm -123.64 124.26 69.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 109.458 -0.571 . . . . 74.02 109.458 -179.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 521' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.6 135.51 44.12 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.597 -1.26 . . . . 64.1 107.597 172.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 522' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 42.7 mt-10 -120.93 132.29 54.86 Favored 'General case' 0 CA--C 1.494 -1.206 0 O-C-N 123.522 0.514 . . . . 71.23 110.713 -177.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 570' ' ' THR . 29.4 t -112.67 123.46 68.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-N 115.37 -0.832 . . . . 71.22 108.888 178.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp -79.78 122.77 27.02 Favored 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 123.468 0.707 . . . . 71.54 110.408 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 21.9 t -101.21 150.97 5.59 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 CA-C-N 115.405 -0.816 . . . . 72.11 109.126 -178.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -95.43 153.53 17.65 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 108.974 -0.75 . . . . 75.42 108.974 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . 0.442 ' HD3' ' HA ' ' A' ' 567' ' ' ILE . 67.1 mtm180 -94.21 176.81 6.18 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.201 0.524 . . . . 75.32 109.9 173.091 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 528' ' ' THR . . . . . 0.447 ' OG1' ' HA2' ' A' ' 503' ' ' GLY . 8.8 t -87.82 164.26 16.01 Favored 'General case' 0 N--CA 1.411 -2.38 0 CA-C-N 115.079 -0.964 . . . . 75.14 110.208 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 13.3 t -63.21 -42.75 99.34 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 115.262 -0.881 . . . . 70.21 108.712 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -100.78 67.4 0.49 Allowed Glycine 0 N--CA 1.434 -1.47 0 N-CA-C 110.764 -0.934 . . . . 73.55 110.764 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -78.89 80.45 5.24 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.261 0.553 . . . . 75.44 110.742 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -134.63 138.65 44.68 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 106.306 -1.739 . . . . 75.22 106.306 177.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 533' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 563' ' ' GLN . . . 87.93 173.48 47.75 Favored Glycine 0 C--N 1.302 -1.314 0 C-N-CA 119.883 -1.151 . . . . 74.23 111.156 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 534' ' ' ASN . . . . . 0.402 HD22 ' HG3' ' A' ' 561' ' ' GLU . 2.9 t-20 -105.98 121.27 43.76 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 122.409 -0.465 . . . . 75.3 109.809 -177.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 59.8 t -124.01 126.21 72.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.409 -0.96 . . . . 73.41 108.409 178.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 536' ' ' ILE . . . . . 0.5 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 47.4 mm -99.23 137.28 27.17 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 N-CA-C 108.661 -0.866 . . . . 72.15 108.661 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 57.9 t -122.45 109.82 32.64 Favored Pre-proline 0 C--N 1.307 -1.266 0 CA-C-N 116.417 -0.356 . . . . 74.21 110.805 -179.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -75.25 135.92 19.23 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 122.541 2.161 . . . . 74.21 111.668 176.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 539' ' ' TYR . . . . . 0.455 ' CD1' ' HG ' ' A' ' 560' ' ' LEU . 42.9 p90 -134.12 157.49 46.03 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 109.068 -0.716 . . . . 73.22 109.068 -178.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -156.73 156.85 34.06 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 123.322 0.389 . . . . 74.11 111.048 177.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 1.6 p -91.45 116.85 29.19 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 115.437 -0.801 . . . . 71.14 110.663 174.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.6 mp -87.51 112.27 23.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 106.282 -1.747 . . . . 74.41 106.282 174.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.69 -46.19 74.07 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 114.797 1.406 . . . . 75.01 114.797 -176.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 63.41 -94.54 0.13 Allowed Glycine 0 CA--C 1.523 0.546 0 CA-C-O 121.349 0.416 . . . . 74.43 113.146 177.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 10.2 t -114.09 0.4 14.28 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.293 0.568 . . . . 73.42 110.712 -178.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -104.02 156.7 17.65 Favored 'General case' 0 C--N 1.318 -0.794 0 O-C-N 121.97 -0.457 . . . . 63.43 109.923 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . 0.407 ' HB2' ' HB2' ' A' ' 552' ' ' ASP . 4.6 mpt_? -87.21 125.43 34.18 Favored 'General case' 0 CA--C 1.483 -1.602 0 CA-C-O 121.442 0.639 . . . . 71.22 110.991 -178.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -86.32 179.92 49.47 Favored Glycine 0 C--N 1.279 -2.633 0 CA-C-N 114.245 -1.343 . . . . 73.03 112.083 -177.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 74.18 30.86 60.24 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 114.039 0.376 . . . . 72.44 114.039 177.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 76.08 21.39 76.11 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.259 -0.972 . . . . 62.44 111.919 178.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -91.67 -66.26 0.94 Allowed 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 110.02 -0.363 . . . . 75.15 110.02 -177.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . 0.407 ' HB2' ' HB2' ' A' ' 547' ' ' ARG . 1.8 t70 -101.79 -29.84 11.64 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 106.608 -1.627 . . . . 72.2 106.608 177.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -146.07 160.06 42.41 Favored 'General case' 0 C--O 1.247 0.937 0 CA-C-N 114.963 -1.017 . . . . 73.43 108.374 175.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -91.21 130.09 37.13 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.404 -1.702 . . . . 75.32 106.404 178.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -86.17 117.46 25.01 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 116.511 -0.313 . . . . 64.14 110.579 -174.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 556' ' ' THR . . . . . 0.408 ' CG2' HG23 ' A' ' 573' ' ' VAL . 13.8 t -115.99 122.35 44.98 Favored 'General case' 0 N--CA 1.409 -2.477 0 CA-C-O 122.206 1.003 . . . . 72.32 110.462 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 1.8 p -143.87 128.76 18.42 Favored 'General case' 0 N--CA 1.417 -2.087 0 CA-C-N 114.54 -1.209 . . . . 72.24 108.693 179.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -177.4 -158.42 20.48 Favored Glycine 0 N--CA 1.419 -2.47 0 N-CA-C 110.103 -1.199 . . . . 74.41 110.103 -176.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 559' ' ' GLU . . . . . 0.5 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 38.7 mt-10 -129.97 125.73 36.12 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 120.999 0.428 . . . . 72.55 111.935 -176.273 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . 0.455 ' HG ' ' CD1' ' A' ' 539' ' ' TYR . 94.9 mt -88.91 144.92 25.86 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 109.07 -0.715 . . . . 74.11 109.07 177.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 561' ' ' GLU . . . . . 0.402 ' HG3' HD22 ' A' ' 534' ' ' ASN . 37.5 tt0 -103.95 122.17 44.64 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 116.418 -0.355 . . . . 75.32 110.475 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -121.24 146.57 46.67 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.445 -0.946 . . . . 75.03 108.445 171.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . 0.436 ' HA ' ' O ' ' A' ' 533' ' ' GLY . 3.6 pt20 -159.14 -173.16 4.08 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 110.324 -0.25 . . . . 73.01 110.324 178.271 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -59.11 -45.41 90.96 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 123.58 0.752 . . . . 72.5 112.24 -177.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -91.95 -41.21 10.7 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 120.17 -0.612 . . . . 55.02 111.748 -178.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -66.94 135.2 53.44 Favored 'General case' 0 C--N 1.317 -0.809 0 O-C-N 123.247 0.342 . . . . 71.0 110.233 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 567' ' ' ILE . . . . . 0.442 ' HA ' ' HD3' ' A' ' 527' ' ' ARG . 31.1 pt -116.94 -172.19 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.412 -2.365 0 N-CA-C 109.057 -0.72 . . . . 73.34 109.057 -178.026 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 2.8 p 5.9 128.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 C-N-CA 129.628 3.171 . . . . 72.32 116.944 172.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 569' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -117.11 153.87 32.01 Favored 'General case' 0 C--N 1.266 -3.024 0 CA-C-N 115.234 -0.894 . . . . 72.21 110.699 177.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 570' ' ' THR . . . . . 0.551 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 8.3 p -126.78 121.2 31.28 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 124.032 0.832 . . . . 75.22 111.998 177.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 571' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 2.5 mp -77.15 118.15 23.33 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 N-CA-C 105.191 -2.151 . . . . 73.34 105.191 172.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 5.7 m -105.93 109.36 21.28 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.894 -0.78 . . . . 63.1 108.894 -176.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 573' ' ' VAL . . . . . 0.408 HG23 ' CG2' ' A' ' 556' ' ' THR . 40.6 t -114.01 135.3 54.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 110.067 -0.346 . . . . 72.01 110.067 -176.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 574' ' ' LYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 519' ' ' GLY . 15.7 tppt? -90.4 123.98 34.58 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.369 -0.832 . . . . 73.22 110.112 178.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 64.3 t -94.59 117.66 38.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 107.724 -1.213 . . . . 72.51 107.724 176.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 36.8 mm -78.96 154.65 4.85 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 N-CA-C 108.347 -0.983 . . . . 74.41 108.347 -176.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -72.36 86.78 1.13 Allowed 'General case' 0 C--O 1.247 0.947 0 CA-C-O 122.061 0.934 . . . . 73.05 110.26 173.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 578' ' ' ASP . . . . . 0.625 ' OD1' 'CA ' ' A' ' 850' ' ' ' CA' . 4.4 t0 -40.6 130.57 2.4 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 127.681 2.392 . . . . 73.32 113.25 178.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.25 -26.8 60.44 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 114.145 -1.389 . . . . 74.42 114.126 -171.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 580' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 581' ' ' TYR . 0.8 OUTLIER -124.63 178.7 5.3 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 119.549 -0.861 . . . . 75.22 110.67 -174.742 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 581' ' ' TYR . . . . . 0.466 ' O ' ' HG2' ' A' ' 580' ' ' GLU . 7.2 p90 -86.01 151.43 23.73 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 105.451 -2.055 . . . . 75.54 105.451 173.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 582' ' ' GLU . . . . . 0.611 ' OE1' 'CA ' ' A' ' 800' ' ' ' CA' . 9.5 pt-20 -133.4 172.02 13.27 Favored 'General case' 0 C--N 1.277 -2.549 0 C-N-CA 119.194 -1.002 . . . . 75.31 109.672 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -90.65 -48.87 6.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 N-CA-C 106.812 -1.551 . . . . 75.32 106.812 173.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 1.4 m120 175.22 101.08 0.01 OUTLIER 'General case' 0 C--N 1.259 -3.344 0 CA-C-N 110.822 -2.899 . . . . 71.5 109.476 177.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 585' ' ' LYS . . . . . 0.419 ' HG3' ' OE2' ' A' ' 582' ' ' GLU 0.263 0.1 OUTLIER -89.87 162.02 15.67 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 118.065 -1.454 . . . . 74.22 109.676 172.994 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 5.2 t -151.36 142.98 23.66 Favored 'General case' 0 N--CA 1.415 -2.216 0 CA-C-O 121.174 0.512 . . . . 65.4 110.186 -176.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -126.09 147.01 49.69 Favored 'General case' 0 N--CA 1.421 -1.898 0 CA-C-N 114.104 -1.407 . . . . 74.34 108.412 176.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 588' ' ' PHE . . . . . 0.429 ' HA ' ' O ' ' A' ' 642' ' ' LEU . 10.5 m-85 -105.92 135.48 47.29 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 116.027 -0.533 . . . . 70.23 109.708 -172.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . 0.431 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.3 OUTLIER -104.27 124.99 50.15 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 106.096 -1.816 . . . . 63.41 106.096 175.786 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -131.38 135.72 47.45 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 109.526 -0.546 . . . . 74.04 109.526 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 591' ' ' ILE . . . . . . . . . . . . . 22.5 pt -99.36 134.71 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.734 0 N-CA-C 107.059 -1.46 . . . . 74.12 107.059 174.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -90.4 -150.66 24.53 Favored Glycine 0 C--N 1.297 -1.6 0 C-N-CA 120.786 -0.721 . . . . 74.02 112.965 -175.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -67.83 118.73 60.8 Favored Pre-proline 0 C--N 1.315 -0.935 0 C-N-CA 122.743 0.417 . . . . 75.22 110.292 179.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -70.51 143.21 46.59 Favored 'Trans proline' 0 N--CA 1.438 -1.772 0 C-N-CA 121.84 1.693 . . . . 72.14 109.78 175.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 595' ' ' ARG . . . . . 0.419 ' HG3' ' HB ' ' A' ' 536' ' ' ILE . 5.5 ptp180 -120.79 122.46 40.38 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 116.402 -0.363 . . . . 75.52 111.056 -174.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.18 122.48 26.32 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 107.735 -1.209 . . . . 75.41 107.735 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 17.1 t -93.28 -42.68 13.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-O 121.676 0.751 . . . . 73.33 110.111 -178.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -166.39 155.95 11.57 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.109 -0.95 . . . . 73.41 108.898 -174.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 22.4 ptt? -174.74 -36.98 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.675 0 O-C-N 123.851 0.72 . . . . 73.14 110.948 -173.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 25.5 m -142.33 84.39 1.86 Allowed 'General case' 0 N--CA 1.433 -1.284 0 CA-C-O 121.717 0.77 . . . . 74.02 111.261 -178.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -91.5 148.29 22.4 Favored 'General case' 0 C--N 1.283 -2.311 0 CA-C-N 114.698 -1.137 . . . . 73.45 107.96 179.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 95.4 mttt 79.35 -12.88 1.02 Allowed 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.95 1.3 . . . . 72.14 113.649 174.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.94 26.22 2.74 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-O 122.155 0.978 . . . . 74.12 110.347 176.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -96.98 -2.23 59.49 Favored Glycine 0 N--CA 1.439 -1.166 0 CA-C-N 114.757 -1.11 . . . . 73.3 110.986 177.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 94.35 178.13 38.62 Favored Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 111.728 -0.549 . . . . 54.42 111.728 178.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -89.75 -6.21 56.22 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.626 0.727 . . . . 65.2 110.368 179.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 8.9 p -76.56 129.08 35.93 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 108.841 -0.799 . . . . 73.35 108.841 174.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 18.7 mm -73.2 152.11 7.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 107.888 -1.153 . . . . 74.13 107.888 -175.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 18.7 m -59.17 124.94 21.65 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 106.628 -1.619 . . . . 74.43 106.628 175.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 610' ' ' GLU . . . . . 0.44 ' HG3' ' NH2' ' A' ' 633' ' ' ARG . 11.0 pt-20 -63.65 -7.19 6.71 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 113.814 1.042 . . . . 73.0 113.814 -175.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.3 110.33 15.63 Favored 'General case' 0 C--O 1.246 0.917 0 N-CA-C 109.065 -0.717 . . . . 74.23 109.065 169.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -114.81 69.65 0.72 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.577 -1.268 . . . . 73.34 107.577 178.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 33.6 t70 55.71 72.17 0.5 Allowed 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 114.788 -1.096 . . . . 74.15 108.617 -171.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -107.21 141.77 37.98 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 115.292 -0.867 . . . . 75.34 112.936 -174.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 615' ' ' LYS . . . . . 0.513 ' N ' ' HD3' ' A' ' 615' ' ' LYS . 0.0 OUTLIER -137.66 82.46 1.92 Allowed 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 113.876 -1.511 . . . . 73.13 107.385 179.758 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -117.84 173.27 3.36 Favored Pre-proline 0 C--N 1.289 -2.039 0 CA-C-N 114.32 -1.309 . . . . 73.15 109.587 -173.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -71.36 171.13 16.75 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 121.639 1.559 . . . . 63.41 108.823 168.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -67.03 129.04 38.62 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.069 0.462 . . . . 63.05 110.813 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 9.0 t -65.46 -16.86 64.07 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 115.015 -0.993 . . . . 64.15 112.601 -175.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 6.1 p -77.61 76.89 4.13 Favored 'General case' 0 N--CA 1.423 -1.787 0 CA-C-O 121.617 0.722 . . . . 63.53 111.94 -178.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -129.24 -160.22 1.02 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.424 -0.807 . . . . 75.4 110.277 -178.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -58.54 -34.19 70.72 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 114.545 1.313 . . . . 71.41 114.545 -174.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -70.93 112.85 7.42 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 119.836 -0.745 . . . . 74.21 110.976 178.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.68 -10.65 38.33 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 124.848 1.259 . . . . 74.0 114.108 -173.121 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -61.39 -18.31 58.2 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.608 0.718 . . . . 74.21 109.272 174.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . . . . . . . . . 14.3 ptt180 -52.0 -30.95 27.38 Favored 'General case' 0 C--O 1.184 -2.358 0 CA-C-N 115.256 -0.884 . . . . 72.54 111.998 176.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 627' ' ' ARG . . . . . . . . . . . . . 58.6 mtp180 -58.9 -35.23 72.68 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.081 0.467 . . . . 75.43 110.407 178.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 95.1 mt -76.55 -43.08 35.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 108.586 -0.894 . . . . 74.45 108.586 176.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -59.5 -46.02 90.01 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.955 -1.02 . . . . 74.31 111.311 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -69.84 -9.4 54.63 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 124.632 1.173 . . . . 75.32 112.295 -177.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 631' ' ' MET . . . . . . . . . . . . . 49.3 ttp -82.99 -27.64 30.28 Favored 'General case' 0 N--CA 1.419 -2.005 0 CA-C-O 121.337 0.589 . . . . 74.12 109.441 179.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -101.85 -45.66 1.74 Allowed Glycine 0 N--CA 1.442 -0.93 0 CA-C-N 115.489 -0.778 . . . . 64.01 112.181 175.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 633' ' ' ARG . . . . . 0.44 ' NH2' ' HG3' ' A' ' 610' ' ' GLU . 55.4 mtt180 -87.38 153.56 53.57 Favored Pre-proline 0 C--N 1.311 -1.103 0 C-N-CA 123.984 0.914 . . . . 75.32 112.088 -174.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -89.54 168.21 4.98 Favored 'Trans proline' 0 N--CA 1.441 -1.57 0 C-N-CA 122.661 2.24 . . . . 74.42 111.293 174.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.1 pp -144.06 178.54 1.72 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 113.416 0.895 . . . . 72.04 113.416 -175.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -82.67 148.16 28.1 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 108.775 -0.824 . . . . 74.42 108.775 178.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . 0.415 ' HA3' ' HB ' ' A' ' 506' ' ' THR . . . -90.77 -128.55 3.96 Favored Glycine 0 C--N 1.294 -1.79 0 C-N-CA 120.736 -0.745 . . . . 63.51 114.46 -176.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -72.1 -56.67 5.19 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.379 -0.41 . . . . 71.12 111.448 -175.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 20.3 p80 -145.38 109.69 4.93 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.833 0.825 . . . . 72.52 111.684 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 37.9 p -101.35 90.25 4.04 Favored 'General case' 0 N--CA 1.398 -3.034 0 N-CA-C 107.849 -1.167 . . . . 74.41 107.849 174.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -178.32 125.74 0.11 Allowed 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 105.01 -2.219 . . . . 64.2 105.01 -177.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 642' ' ' LEU . . . . . 0.521 ' CD2' HG23 ' A' ' 523' ' ' VAL . 38.0 tp -124.72 111.07 15.13 Favored 'General case' 0 C--N 1.28 -2.435 0 N-CA-C 108.17 -1.048 . . . . 74.14 108.17 174.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -93.62 101.44 13.6 Favored 'General case' 0 C--N 1.272 -2.767 0 N-CA-C 107.484 -1.302 . . . . 75.31 107.484 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 39.4 t -93.04 108.52 20.49 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 108.906 -0.775 . . . . 75.53 108.906 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 4.2 mp -94.05 121.82 45.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 107.944 -1.132 . . . . 72.32 107.944 176.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 646' ' ' ILE . . . . . 0.503 HD12 ' N ' ' A' ' 646' ' ' ILE . 2.9 mp -100.19 134.09 40.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 107.091 -1.448 . . . . 75.11 107.091 -176.063 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -118.02 145.23 44.93 Favored 'General case' 0 N--CA 1.419 -2.023 0 C-N-CA 120.229 -0.589 . . . . 75.15 109.855 -178.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . 0.63 ' OE1' 'CA ' ' A' ' 800' ' ' ' CA' . 5.8 mm-40 -60.31 137.56 58.11 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 107.019 -1.474 . . . . 74.44 107.019 176.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 17.0 t -64.79 123.19 18.71 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-O 122.177 0.989 . . . . 74.03 112.881 -173.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 650' ' ' TYR . . . . . 0.487 ' O ' ' HG2' ' A' ' 651' ' ' GLU . 48.5 t80 -147.42 -75.35 0.19 Allowed 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 105.934 -1.876 . . . . 72.42 105.934 173.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 651' ' ' GLU . . . . . 0.487 ' HG2' ' O ' ' A' ' 650' ' ' TYR . 12.4 mm-40 -176.59 176.08 1.62 Allowed 'General case' 0 CA--C 1.501 -0.917 0 C-N-CA 127.618 2.367 . . . . 73.32 105.878 -178.289 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -100.0 111.87 24.17 Favored 'General case' 0 C--N 1.296 -1.717 0 N-CA-C 108.807 -0.812 . . . . 74.04 108.807 -179.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -118.72 167.94 11.2 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-N 115.202 -0.908 . . . . 74.33 108.898 -176.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 22.2 t -156.65 -68.51 0.11 Allowed 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.831 -0.803 . . . . 71.33 108.831 177.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 22.1 m -115.28 101.71 9.2 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.314 -0.624 . . . . 74.52 109.314 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 92.5 t -80.97 117.49 27.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 109.687 -0.486 . . . . 75.41 109.687 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 23.2 t70 . . . . . 0 C--N 1.313 -0.982 0 CA-C-N 115.659 -0.7 . . . . 74.31 110.394 -177.831 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 800' ' ' ' CA' . . . . . 0.63 'CA ' ' OE1' ' A' ' 648' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 850' ' ' ' CA' . . . . . 0.625 'CA ' ' OD1' ' A' ' 578' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 . . . . . 0 N--CA 1.447 -0.618 0 CA-C-O 121.084 0.469 . . . . 73.34 110.644 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -123.56 -62.2 1.33 Allowed 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.014 -1.106 . . . . 74.5 108.014 172.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . 0.65 ' HA2' ' OG1' ' A' ' 528' ' ' THR . . . -140.34 120.52 1.79 Allowed Glycine 1 N--CA 1.395 -4.061 0 C-N-CA 119.985 -1.103 . . . . 73.03 110.952 179.476 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 2.7 mp -105.54 101.01 11.76 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 N-CA-C 106.763 -1.569 . . . . 72.41 106.763 176.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -114.71 122.87 47.74 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 109.457 -0.571 . . . . 73.04 109.457 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 11.2 t -148.64 163.99 35.62 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.483 -0.932 . . . . 73.11 108.483 -176.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -92.51 161.98 14.4 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 107.306 -1.368 . . . . 74.5 107.306 172.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -96.91 -26.3 15.11 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.322 -1.362 . . . . 74.4 107.322 173.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -97.32 120.57 60.72 Favored Pre-proline 0 N--CA 1.419 -1.989 0 CA-C-N 114.618 -1.174 . . . . 74.22 110.587 176.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -82.16 -19.09 7.02 Favored 'Trans proline' 0 N--CA 1.429 -2.28 0 N-CA-C 108.065 -1.552 . . . . 74.2 108.065 168.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 93.7 t -147.89 139.69 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 C-N-CA 126.005 1.722 . . . . 71.24 107.897 -177.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 14.4 t -137.05 119.47 15.82 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 108.051 -1.092 . . . . 72.21 108.051 173.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -88.41 128.61 35.52 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 122.085 -0.384 . . . . 74.42 110.225 175.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 26.8 m -126.25 161.52 31.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-N 115.657 -0.701 . . . . 75.12 109.717 -178.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 56.9 m -88.21 167.8 13.28 Favored 'General case' 0 N--CA 1.403 -2.807 0 CA-C-N 115.079 -0.964 . . . . 73.51 109.99 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . 0.65 ' OE2' 'CA ' ' A' ' 800' ' ' ' CA' . 38.2 tt0 -94.32 -23.63 17.74 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.497 0.665 . . . . 72.33 110.608 176.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 14.2 m -85.31 20.77 1.89 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.932 0.873 . . . . 73.21 110.406 -176.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 15.3 tt -108.3 155.83 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.133 0 N-CA-C 107.554 -1.276 . . . . 74.52 107.554 -176.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -96.65 -59.85 1.0 Allowed Glycine 0 C--N 1.293 -1.848 0 C-N-CA 120.175 -1.012 . . . . 65.21 111.297 179.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 41.9 mm -121.48 136.22 59.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 109.402 -0.592 . . . . 75.52 109.402 -178.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 521' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.35 132.68 56.54 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 106.368 -1.716 . . . . 74.33 106.368 171.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 522' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 9.4 mp0 -109.17 149.29 29.58 Favored 'General case' 0 N--CA 1.428 -1.563 0 C-N-CA 120.509 -0.476 . . . . 71.04 109.852 -178.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . 0.627 ' O ' ' HA ' ' A' ' 570' ' ' THR . 40.0 t -126.12 121.05 58.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 109.722 -0.473 . . . . 64.34 109.722 178.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . 0.438 ' HD2' HG22 ' A' ' 568' ' ' VAL . 28.0 mmtp -82.09 118.9 23.39 Favored 'General case' 0 C--N 1.313 -1.021 0 O-C-N 124.095 0.872 . . . . 75.55 110.453 178.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 21.7 t -98.87 139.18 21.28 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 CA-C-N 114.563 -1.199 . . . . 71.23 108.982 -178.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -79.7 146.36 32.46 Favored 'General case' 0 C--N 1.31 -1.12 0 O-C-N 123.635 0.585 . . . . 74.33 109.566 -179.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . 0.404 ' HG2' ' N ' ' A' ' 528' ' ' THR . 31.8 ttp180 -87.64 160.16 18.26 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.384 -0.969 . . . . 73.43 108.384 -179.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 528' ' ' THR . . . . . 0.65 ' OG1' ' HA2' ' A' ' 503' ' ' GLY . 4.6 t -61.82 150.76 36.25 Favored 'General case' 0 N--CA 1.421 -1.916 0 CA-C-O 121.362 0.601 . . . . 64.25 110.71 174.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 42.2 t -69.99 -22.17 63.16 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 114.83 -1.077 . . . . 74.25 109.754 179.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -129.0 89.71 0.31 Allowed Glycine 0 N--CA 1.435 -1.377 0 N-CA-C 109.907 -1.277 . . . . 65.12 109.907 178.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -86.87 85.93 7.3 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 121.382 0.611 . . . . 64.34 111.291 -176.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -123.54 101.78 7.51 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.634 -0.712 . . . . 75.15 110.772 177.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 119.07 -148.79 18.26 Favored Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 110.969 -0.852 . . . . 75.44 110.969 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 534' ' ' ASN . . . . . 0.46 HD22 ' CG ' ' A' ' 561' ' ' GLU . 2.9 t-20 -138.2 131.62 30.58 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 106.288 -1.745 . . . . 63.44 106.288 178.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 67.7 t -127.44 137.6 57.25 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 118.189 0.45 . . . . 70.41 111.416 -174.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 536' ' ' ILE . . . . . . . . . . . . . 27.9 mm -102.91 126.04 57.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 108.889 -0.782 . . . . 75.15 108.889 174.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 31.7 t -117.1 106.83 46.68 Favored Pre-proline 0 C--N 1.298 -1.652 0 N-CA-C 108.543 -0.91 . . . . 75.15 108.543 178.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -75.61 137.81 20.86 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.102 1.868 . . . . 74.52 111.364 177.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -130.68 160.42 34.33 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.535 -0.543 . . . . 73.52 109.535 179.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.33 146.91 18.83 Favored 'General case' 0 C--N 1.314 -0.972 0 O-C-N 123.67 0.606 . . . . 74.45 110.679 175.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 7.9 p -86.77 122.33 30.52 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.053 -0.521 . . . . 74.23 110.38 176.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.4 mp -82.49 122.47 37.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 105.753 -1.943 . . . . 74.21 105.753 172.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -63.75 -48.69 75.98 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 123.464 0.478 . . . . 73.12 109.928 -178.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 67.24 -93.5 0.23 Allowed Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 115.858 -0.61 . . . . 73.44 112.215 177.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 15.1 t -113.74 -0.61 14.2 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.494 -0.558 . . . . 65.1 109.494 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -97.34 176.49 5.87 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-N 115.646 -0.706 . . . . 71.2 111.592 -177.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -127.31 111.97 14.52 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 109.25 -0.648 . . . . 72.42 109.25 -179.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -78.43 -160.9 17.29 Favored Glycine 0 C--N 1.315 -0.606 0 C-N-CA 121.57 -0.348 . . . . 72.21 112.602 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 67.37 17.68 68.71 Favored Glycine 0 C--N 1.314 -0.656 0 CA-C-O 120.908 0.171 . . . . 53.14 113.191 -177.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 77.42 11.58 85.36 Favored Glycine 0 C--O 1.211 -1.29 0 N-CA-C 111.041 -0.824 . . . . 73.1 111.041 -178.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -78.76 -42.44 28.02 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 122.469 0.308 . . . . 70.12 111.291 -175.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . 0.654 ' OD1' 'CA ' ' A' ' 850' ' ' ' CA' . 15.0 t70 -135.89 -20.67 1.49 Allowed 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 107.822 -1.177 . . . . 74.54 107.822 173.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -155.79 163.51 39.74 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 107.181 -1.414 . . . . 75.13 107.181 169.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -98.09 109.19 21.99 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 106.761 -1.57 . . . . 63.15 106.761 -178.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -77.54 147.25 35.86 Favored 'General case' 0 CA--C 1.499 -0.993 0 C-N-CA 120.761 -0.375 . . . . 75.35 110.439 -175.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 8.3 t -139.59 142.22 37.13 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-O 121.605 0.717 . . . . 73.21 111.778 -174.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 7.6 p -145.46 149.6 34.97 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.214 -1.402 . . . . 73.31 107.214 176.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 173.47 -167.21 39.8 Favored Glycine 0 N--CA 1.418 -2.543 0 N-CA-C 110.346 -1.101 . . . . 33.41 110.346 -178.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -126.73 124.63 40.22 Favored 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 123.165 0.586 . . . . 75.34 110.169 -176.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 94.3 mt -95.97 142.05 28.66 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.746 -0.835 . . . . 72.05 108.746 177.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 561' ' ' GLU . . . . . 0.46 ' CG ' HD22 ' A' ' 534' ' ' ASN . 31.1 tt0 -115.83 115.9 27.06 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 120.912 0.387 . . . . 70.01 111.143 -176.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -102.05 140.93 35.68 Favored 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 108.982 -0.747 . . . . 74.53 108.982 176.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . 0.403 ' HB2' ' H ' ' A' ' 566' ' ' GLU . 4.6 mt-30 -119.7 -178.23 3.58 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 119.033 -1.067 . . . . 75.43 110.337 179.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -74.43 -34.71 63.3 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.916 0.865 . . . . 64.12 109.001 176.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -94.0 -43.39 8.55 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.437 -1.256 . . . . 60.15 110.901 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . 0.403 ' H ' ' HB2' ' A' ' 563' ' ' GLN . 25.5 tt0 -70.99 123.29 21.72 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.064 0.459 . . . . 74.22 111.326 -179.086 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 8.7 pt -104.81 166.01 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.564 0 N-CA-C 108.797 -0.816 . . . . 74.33 108.797 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 568' ' ' VAL . . . . . 0.438 HG22 ' HD2' ' A' ' 524' ' ' LYS . 2.0 p 47.34 159.96 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.58 2.107 0 C-N-CA 127.027 2.131 . . . . 71.34 115.392 179.213 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 569' ' ' LYS . . . . . 0.422 ' HA ' ' HE2' ' A' ' 569' ' ' LYS . 4.3 mmpt? -142.67 166.05 25.73 Favored 'General case' 0 CA--C 1.493 -1.217 0 O-C-N 121.16 -0.962 . . . . 73.11 109.019 172.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 570' ' ' THR . . . . . 0.627 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 1.3 p -138.57 127.16 23.35 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 123.902 0.751 . . . . 74.32 112.897 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 571' ' ' ILE . . . . . 0.413 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 3.3 mp -96.07 122.06 47.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 106.477 -1.675 . . . . 75.2 106.477 170.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 49.2 m -107.36 125.08 50.75 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 108.84 -0.8 . . . . 74.33 108.84 177.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 573' ' ' VAL . . . . . . . . . . . . . 48.1 t -124.68 139.45 50.86 Favored 'Isoleucine or valine' 0 C--O 1.243 0.757 0 N-CA-C 108.458 -0.942 . . . . 72.31 108.458 -178.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -95.7 129.99 42.74 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-O 121.77 0.795 . . . . 75.41 111.786 -178.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 59.2 t -94.13 138.72 19.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 107.044 -1.465 . . . . 65.33 107.044 176.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 45.8 mm -104.62 143.97 15.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 108.659 -0.867 . . . . 74.4 108.659 -176.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -59.18 129.76 43.7 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 108.535 -0.913 . . . . 74.31 108.535 174.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 578' ' ' ASP . . . . . 0.621 ' OD1' 'CA ' ' A' ' 850' ' ' ' CA' . 15.4 t0 -77.96 117.36 19.22 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 115.02 -0.991 . . . . 74.14 111.911 -167.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 579' ' ' GLU . . . . . 0.64 ' OE2' 'CA ' ' A' ' 850' ' ' ' CA' . 0.0 OUTLIER -77.08 -16.81 59.09 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 114.263 1.208 . . . . 74.22 114.263 -177.705 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 580' ' ' GLU . . . . . 0.64 ' OE1' 'CA ' ' A' ' 850' ' ' ' CA' . 0.0 OUTLIER -141.21 -176.71 4.81 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 106.553 -1.647 . . . . 73.41 106.553 173.257 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 581' ' ' TYR . . . . . 0.547 ' O ' ' HG2' ' A' ' 580' ' ' GLU . 12.4 p90 -87.19 152.21 22.52 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 106.825 -1.546 . . . . 72.42 106.825 174.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 582' ' ' GLU . . . . . 0.694 ' OE1' ' HB3' ' A' ' 585' ' ' LYS . 14.7 pt-20 -132.81 175.84 8.99 Favored 'General case' 0 C--N 1.276 -2.599 0 N-CA-C 108.826 -0.805 . . . . 74.13 108.826 -178.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . 0.451 ' O ' ' HG3' ' A' ' 582' ' ' GLU . 56.3 mtpt -100.05 -165.92 1.27 Allowed 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 105.551 -2.018 . . . . 74.44 105.551 169.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -74.73 89.16 2.27 Favored 'General case' 0 C--N 1.281 -2.391 0 C-N-CA 118.82 -1.152 . . . . 75.42 111.853 178.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 585' ' ' LYS . . . . . 0.694 ' HB3' ' OE1' ' A' ' 582' ' ' GLU . 0.0 OUTLIER -79.02 143.81 35.29 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 114.879 -1.055 . . . . 75.44 108.746 -178.964 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 5.9 t -145.14 141.57 28.88 Favored 'General case' 0 N--CA 1.407 -2.604 0 CA-C-O 121.169 0.509 . . . . 70.4 110.517 -176.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -122.16 144.63 48.83 Favored 'General case' 0 N--CA 1.412 -2.342 0 CA-C-N 113.928 -1.487 . . . . 74.53 108.468 175.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 588' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -104.66 128.16 52.62 Favored 'General case' 0 C--N 1.284 -2.239 0 N-CA-C 108.732 -0.84 . . . . 75.43 108.732 -173.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . 0.436 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.7 OUTLIER -98.45 126.08 43.86 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 106.642 -1.614 . . . . 72.03 106.642 177.381 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -128.43 132.75 48.45 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 109.993 -0.373 . . . . 75.4 109.993 179.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 591' ' ' ILE . . . . . . . . . . . . . 16.0 pt -97.32 128.71 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.652 0 N-CA-C 106.256 -1.757 . . . . 74.34 106.256 170.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -87.32 -139.81 6.18 Favored Glycine 0 N--CA 1.435 -1.401 0 CA-C-N 116.104 -0.498 . . . . 73.34 114.18 -172.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -79.9 112.36 29.19 Favored Pre-proline 0 C--N 1.311 -1.071 0 N-CA-C 109.301 -0.629 . . . . 71.53 109.301 -178.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -78.53 149.68 24.25 Favored 'Trans proline' 0 N--CA 1.434 -1.974 0 C-N-CA 122.094 1.863 . . . . 73.23 110.886 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 8.8 ptt-85 -129.23 132.82 47.31 Favored 'General case' 0 C--N 1.28 -2.421 0 CA-C-N 115.912 -0.586 . . . . 74.4 110.402 -175.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -77.06 125.77 29.87 Favored 'General case' 0 N--CA 1.415 -2.181 0 N-CA-C 105.501 -2.037 . . . . 64.15 105.501 178.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 96.6 t -71.03 -31.62 45.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 108.646 -0.872 . . . . 62.53 108.646 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -90.38 155.4 18.97 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 114.068 -1.424 . . . . 75.05 107.926 178.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 42.3 mtm -87.72 -20.87 25.63 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.719 -0.845 . . . . 74.2 108.719 178.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 10.2 m -50.36 118.09 2.8 Favored 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 125.289 1.436 . . . . 74.1 112.274 -176.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 601' ' ' GLU . . . . . 0.408 ' OE1' ' HA3' ' A' ' 632' ' ' GLY . 17.0 pt-20 -141.68 144.29 34.03 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 108.436 -0.95 . . . . 72.52 108.436 177.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 21.9 ttmm -88.4 89.59 8.05 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 105.63 -1.989 . . . . 75.2 105.63 173.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -54.44 158.05 2.58 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.179 -1.373 . . . . 75.24 114.324 -173.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -87.9 58.82 4.3 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.024 -0.989 . . . . 75.1 112.089 177.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 84.07 -71.92 2.9 Favored Glycine 0 C--O 1.244 0.764 0 N-CA-C 110.881 -0.888 . . . . 62.2 110.881 -179.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -155.21 132.52 11.03 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.312 -0.995 . . . . 75.12 108.312 178.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 10.2 p -107.82 123.28 48.33 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 109.051 -0.722 . . . . 71.22 109.051 175.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 56.4 mt -78.32 -28.19 14.7 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.891 0 CA-C-O 123.53 1.634 . . . . 74.31 108.166 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 8.1 m -96.11 91.73 6.08 Favored 'General case' 0 C--N 1.248 -3.806 0 CA-C-N 112.466 -2.152 . . . . 60.11 109.862 -178.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -84.23 -5.87 59.32 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 107.799 -1.185 . . . . 65.45 107.799 173.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -74.47 89.27 2.14 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 114.498 -1.228 . . . . 75.53 109.864 178.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -93.51 83.3 4.5 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 107.517 -1.29 . . . . 74.53 107.517 174.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -116.21 71.27 0.78 Allowed 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 106.642 -1.614 . . . . 73.31 106.642 -177.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -138.9 93.52 2.71 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 114.917 -1.038 . . . . 61.02 111.196 -176.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 2.4 mmmp? -121.31 82.66 1.96 Allowed 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 104.882 -2.266 . . . . 71.41 104.882 169.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -139.3 173.54 5.05 Favored Pre-proline 0 C--N 1.3 -1.57 0 CA-C-N 113.609 -1.632 . . . . 74.03 107.152 -171.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -66.42 171.34 10.68 Favored 'Trans proline' 0 N--CA 1.442 -1.503 0 N-CA-C 109.374 -1.049 . . . . 75.33 109.374 169.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -72.65 121.2 19.38 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 109.745 -0.465 . . . . 74.25 109.745 -176.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 9.8 t -155.44 141.12 17.99 Favored 'General case' 0 N--CA 1.425 -1.71 0 CA-C-O 121.502 0.668 . . . . 72.42 111.459 -176.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 3.1 p -146.64 113.31 6.02 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.538 -1.282 . . . . 74.11 107.538 176.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 621' ' ' LYS . . . . . 0.435 ' N ' ' HD2' ' A' ' 621' ' ' LYS . 0.1 OUTLIER -86.25 -71.26 0.55 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.398 0.618 . . . . 73.43 110.382 -173.273 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -92.55 -7.69 46.51 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.704 -1.221 . . . . 74.22 107.704 177.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . 0.296 10.7 pt-20 60.18 -39.71 0.09 Allowed 'General case' 0 C--O 1.186 -2.256 0 C-N-CA 129.314 3.046 . . . . 71.12 116.894 176.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -39.63 -68.76 0.15 Allowed 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 124.356 1.063 . . . . 74.14 113.819 -174.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -67.78 -37.18 81.7 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.466 -0.334 . . . . 72.5 110.505 -176.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . 0.653 ' O ' ' HG2' ' A' ' 630' ' ' GLU . 0.0 OUTLIER -63.4 -47.56 81.51 Favored 'General case' 0 C--O 1.202 -1.425 0 N-CA-C 109.434 -0.58 . . . . 73.43 109.434 -178.199 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 627' ' ' ARG . . . . . . . . . . . . . 51.0 ttp180 -60.71 -29.78 69.56 Favored 'General case' 0 N--CA 1.424 -1.748 0 C-N-CA 125.693 1.597 . . . . 63.55 111.991 -176.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 97.5 mt -65.67 -36.84 78.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-O 121.615 0.722 . . . . 70.25 109.578 175.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -78.07 -29.34 49.11 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.602 -0.727 . . . . 71.22 109.369 176.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 630' ' ' GLU . . . . . 0.653 ' HG2' ' O ' ' A' ' 626' ' ' ARG . 4.4 mm-40 -76.84 -3.04 36.4 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 123.975 0.91 . . . . 63.41 109.717 177.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 631' ' ' MET . . . . . . . . . . . . . 48.1 ttp -95.05 -15.89 23.11 Favored 'General case' 0 N--CA 1.402 -2.83 0 N-CA-C 108.031 -1.099 . . . . 74.33 108.031 175.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 632' ' ' GLY . . . . . 0.408 ' HA3' ' OE1' ' A' ' 601' ' ' GLU . . . -100.51 -39.08 3.3 Favored Glycine 0 N--CA 1.439 -1.119 0 N-CA-C 110.365 -1.094 . . . . 64.13 110.365 175.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 -92.82 144.02 27.88 Favored Pre-proline 0 C--O 1.203 -1.367 0 N-CA-C 108.502 -0.925 . . . . 72.52 108.502 173.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -76.18 153.51 36.36 Favored 'Trans proline' 0 N--CA 1.434 -1.98 0 C-N-CA 121.116 1.211 . . . . 72.03 110.21 176.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.0 pp -138.96 -175.25 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 112.765 0.654 . . . . 74.5 112.765 -175.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.71 146.09 32.58 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 115.425 -0.807 . . . . 74.31 109.327 178.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -83.97 -107.33 0.57 Allowed Glycine 0 C--N 1.291 -1.96 0 CA-C-N 116.105 -0.498 . . . . 63.4 112.474 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -94.66 -65.82 0.96 Allowed 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.238 0.542 . . . . 73.32 110.142 -177.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 17.0 p80 -130.54 114.08 15.04 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.628 0.728 . . . . 64.32 111.011 -177.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 13.7 p -104.78 89.76 3.27 Favored 'General case' 0 N--CA 1.397 -3.124 0 N-CA-C 107.473 -1.306 . . . . 75.12 107.473 173.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -176.46 123.62 0.17 Allowed 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 105.175 -2.158 . . . . 74.55 105.175 -174.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 642' ' ' LEU . . . . . 0.449 ' CD2' HG22 ' A' ' 523' ' ' VAL . 45.1 tp -125.55 106.84 10.06 Favored 'General case' 0 C--N 1.274 -2.681 0 N-CA-C 106.976 -1.49 . . . . 71.05 106.976 177.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -88.8 100.56 13.25 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 108.029 -1.1 . . . . 62.13 108.029 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 23.1 t -91.01 105.61 16.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 108.925 -0.769 . . . . 74.22 108.925 -179.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 4.4 mp -92.36 124.93 45.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 108.426 -0.953 . . . . 74.21 108.426 175.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 646' ' ' ILE . . . . . 0.532 HD11 ' N ' ' A' ' 646' ' ' ILE . 1.9 mp -106.55 108.02 24.13 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.473 0 N-CA-C 106.492 -1.669 . . . . 71.34 106.492 -178.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -104.15 143.7 32.58 Favored 'General case' 0 C--N 1.269 -2.905 0 CA-C-N 114.698 -1.137 . . . . 75.31 109.625 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -57.07 132.48 53.04 Favored 'General case' 0 C--O 1.249 1.068 0 N-CA-C 106.154 -1.795 . . . . 75.24 106.154 175.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 8.6 t -52.36 123.4 10.75 Favored 'General case' 0 C--O 1.245 0.826 0 O-C-N 124.18 0.925 . . . . 71.32 112.327 -169.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -135.63 -65.12 0.61 Allowed 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 113.281 -1.781 . . . . 75.32 107.161 -177.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -152.26 -166.6 2.53 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 124.832 1.253 . . . . 55.24 107.813 177.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -140.73 90.18 2.32 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-O 121.949 0.881 . . . . 72.24 109.625 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -126.25 121.16 31.88 Favored 'General case' 0 C--N 1.277 -2.548 0 CA-C-N 114.411 -1.268 . . . . 71.32 108.813 176.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 16.9 p -87.57 82.77 7.36 Favored 'General case' 0 N--CA 1.424 -1.738 0 C-N-CA 120.518 -0.473 . . . . 63.34 110.838 -178.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 9.2 t -70.06 128.41 36.2 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 108.358 -0.979 . . . . 70.44 108.358 177.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 46.4 t 67.1 82.16 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-O 122.448 1.118 . . . . 64.12 107.99 -171.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 . . . . . 0 C--N 1.293 -1.861 0 CA-C-N 113.858 -1.519 . . . . 73.24 110.221 -176.19 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 800' ' ' ' CA' . . . . . 0.65 'CA ' ' OE2' ' A' ' 516' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 850' ' ' ' CA' . . . . . 0.654 'CA ' ' OD1' ' A' ' 552' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 16.5 t60 . . . . . 0 N--CA 1.449 -0.497 0 N-CA-C 105.908 -1.886 . . . . 73.41 105.908 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 502' ' ' ALA . . . . . 0.426 ' CB ' ' HA ' ' A' ' 634' ' ' PRO . . . -131.54 -149.9 0.4 Allowed 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 106.914 -1.513 . . . . 71.51 106.914 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . 0.631 ' HA3' ' OG1' ' A' ' 528' ' ' THR . . . 153.16 -136.33 5.27 Favored Glycine 1 N--CA 1.394 -4.11 0 C-N-CA 117.608 -2.234 . . . . 52.3 113.505 178.284 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 3.1 mp -119.18 126.81 75.68 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 CA-C-N 114.126 -1.037 . . . . 72.02 108.256 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -134.86 103.99 5.82 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 106.803 -1.555 . . . . 75.33 106.803 172.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 14.3 t -143.42 160.46 40.52 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 109.66 -0.496 . . . . 73.43 109.66 -173.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -81.58 153.13 26.88 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 107.171 -1.418 . . . . 74.25 107.171 173.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.02 -50.06 38.19 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.339 -0.985 . . . . 71.12 108.339 176.168 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -116.02 131.87 23.52 Favored Pre-proline 0 C--N 1.303 -1.431 0 CA-C-N 115.7 -0.682 . . . . 74.4 109.195 -178.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -83.81 -13.08 8.28 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.477 2.118 . . . . 71.0 112.127 178.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 511' ' ' VAL . . . . . 0.408 HG22 ' HB3' ' A' ' 643' ' ' GLU . 73.9 t -136.52 132.51 48.71 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.461 0 N-CA-C 107.873 -1.158 . . . . 75.54 107.873 178.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 3.8 t -138.61 140.95 39.15 Favored 'General case' 0 N--CA 1.396 -3.153 0 N-CA-C 107.666 -1.235 . . . . 74.2 107.666 177.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 513' ' ' HIS . . . . . 0.48 ' CD2' ' HG1' ' A' ' 655' ' ' THR . 17.9 m-70 -109.17 137.79 46.52 Favored 'General case' 0 CA--C 1.479 -1.772 0 N-CA-C 107.474 -1.306 . . . . 73.11 107.474 176.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.654 HG12 ' SD ' ' A' ' 521' ' ' MET . 35.0 m -132.28 155.25 41.28 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.309 0 CA-C-O 121.518 0.675 . . . . 74.42 110.32 -176.1 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 19.3 m -68.61 141.27 55.47 Favored 'General case' 0 N--CA 1.393 -3.276 0 CA-C-N 113.665 -1.607 . . . . 74.23 107.877 176.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -73.79 -24.15 59.79 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 119.388 -0.925 . . . . 63.45 109.718 176.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 24.0 t -107.16 75.71 1.05 Allowed 'General case' 0 N--CA 1.415 -2.192 0 N-CA-C 107.876 -1.157 . . . . 74.11 107.876 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 17.1 tt -141.04 161.01 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.26 0 CA-C-N 113.766 -1.561 . . . . 65.2 106.813 176.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -96.15 -69.58 1.02 Allowed Glycine 0 N--CA 1.434 -1.46 0 C-N-CA 119.571 -1.3 . . . . 72.32 111.596 177.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 40.9 mm -116.24 134.57 59.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 109.361 -0.607 . . . . 74.25 109.361 -178.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 521' ' ' MET . . . . . 0.654 ' SD ' HG12 ' A' ' 514' ' ' VAL . 23.8 ptt? -114.29 138.74 50.12 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 106.934 -1.506 . . . . 73.43 106.934 171.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -117.07 132.66 56.63 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 108.837 -0.801 . . . . 74.12 108.837 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . 0.677 ' O ' ' HA ' ' A' ' 570' ' ' THR . 24.8 t -114.99 134.11 59.09 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 109.314 -0.625 . . . . 74.43 109.314 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -84.91 128.13 34.48 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 122.027 0.918 . . . . 75.03 113.1 -175.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 3.3 t -113.68 132.84 61.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 106.951 -1.5 . . . . 65.03 106.951 177.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -93.77 151.13 19.83 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 108.959 -0.756 . . . . 74.22 108.959 -177.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 527' ' ' ARG . . . . . 0.531 ' CZ ' HG23 ' A' ' 567' ' ' ILE . 68.9 mtm180 -87.02 179.31 6.71 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-O 122.018 0.913 . . . . 75.52 111.137 -179.068 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 528' ' ' THR . . . . . 0.631 ' OG1' ' HA3' ' A' ' 503' ' ' GLY . 1.0 OUTLIER -78.16 159.71 28.44 Favored 'General case' 0 N--CA 1.408 -2.553 0 CA-C-N 113.796 -1.547 . . . . 74.35 109.766 176.21 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 17.0 t -74.73 -20.04 59.99 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 107.903 -1.147 . . . . 73.15 107.903 177.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -118.14 66.3 0.36 Allowed Glycine 0 N--CA 1.438 -1.199 0 N-CA-C 111.07 -0.812 . . . . 72.13 111.07 175.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 531' ' ' ALA . . . . . 0.409 ' O ' ' HD3' ' A' ' 532' ' ' ARG . . . -76.26 96.13 3.88 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.357 0.599 . . . . 72.31 111.565 -178.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . 0.409 ' HD3' ' O ' ' A' ' 531' ' ' ALA . 60.5 mmt-85 -134.56 127.68 31.77 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.47 -0.786 . . . . 71.32 109.984 178.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 93.77 175.66 39.81 Favored Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 121.087 -0.578 . . . . 74.33 113.642 176.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -95.87 123.22 39.36 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 107.936 -1.135 . . . . 74.45 107.936 177.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 56.4 t -127.96 131.95 69.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.761 0 N-CA-C 108.71 -0.848 . . . . 74.21 108.71 -178.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 536' ' ' ILE . . . . . . . . . . . . . 38.6 mm -103.77 129.28 56.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 108.739 -0.837 . . . . 74.44 108.739 178.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . 0.424 HG21 ' HB3' ' A' ' 594' ' ' PRO . 14.7 t -117.99 111.79 38.72 Favored Pre-proline 0 C--N 1.301 -1.506 0 N-CA-C 109.575 -0.528 . . . . 73.22 109.575 -178.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -73.98 150.87 44.19 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 121.714 1.609 . . . . 73.02 110.244 176.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 539' ' ' TYR . . . . . 0.475 ' CD1' ' HG ' ' A' ' 560' ' ' LEU . 48.3 p90 -150.85 157.71 43.25 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 109.119 -0.697 . . . . 74.44 109.119 179.1 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 540' ' ' LYS . . . . . 0.418 ' O ' ' HD3' ' A' ' 540' ' ' LYS . 0.1 OUTLIER -157.11 145.65 19.65 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 113.3 0.852 . . . . 75.3 113.3 -179.842 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 2.9 p -76.26 134.08 39.9 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.4 -0.818 . . . . 75.34 111.074 171.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.2 mp -99.22 126.65 52.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 105.391 -2.077 . . . . 75.45 105.391 172.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -48.78 -44.82 39.23 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.288 1.035 . . . . 74.22 113.06 -174.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 71.89 -100.28 0.91 Allowed Glycine 0 N--CA 1.437 -1.243 0 N-CA-C 110.036 -1.226 . . . . 55.02 110.036 -178.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 9.0 t -134.12 10.71 3.87 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.926 0.869 . . . . 73.41 109.37 176.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -85.16 168.06 15.15 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.858 -0.61 . . . . 74.33 110.027 177.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -85.91 166.83 15.65 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 107.74 -1.207 . . . . 71.43 107.74 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -57.39 174.75 1.91 Allowed Glycine 0 C--O 1.253 1.306 0 N-CA-C 115.705 1.042 . . . . 64.44 115.705 -176.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . -57.59 117.15 9.28 Favored Glycine 0 N--CA 1.437 -1.255 0 CA-C-N 114.217 -0.992 . . . . 55.32 113.783 -176.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 104.53 -15.06 50.13 Favored Glycine 0 N--CA 1.428 -1.859 0 N-CA-C 111.719 -0.552 . . . . 71.31 111.719 177.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -91.58 -63.65 1.22 Allowed 'General case' 0 CA--C 1.499 -1.009 0 CA-C-O 121.084 0.468 . . . . 75.21 110.422 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . 0.645 ' OD2' 'CA ' ' A' ' 850' ' ' ' CA' . 5.0 t70 -107.39 -43.11 4.63 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.093 -0.958 . . . . 74.34 108.861 -176.286 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -133.79 155.83 49.1 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 107.313 -1.366 . . . . 75.52 107.313 175.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -85.17 128.98 34.88 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 105.532 -2.025 . . . . 71.14 105.532 177.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -54.78 108.47 0.4 Allowed 'General case' 0 CA--C 1.483 -1.627 0 O-C-N 123.474 0.484 . . . . 73.45 110.167 -177.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 40.8 m -109.96 97.98 7.37 Favored 'General case' 1 N--CA 1.372 -4.326 0 C-N-CA 118.595 -1.242 . . . . 72.41 112.234 -175.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 24.2 p -137.1 134.25 36.26 Favored 'General case' 0 N--CA 1.418 -2.037 0 N-CA-C 107.399 -1.334 . . . . 70.13 107.399 174.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -176.83 -156.91 16.73 Favored Glycine 0 N--CA 1.418 -2.541 0 N-CA-C 110.08 -1.208 . . . . 72.53 110.08 -176.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -135.14 142.96 46.29 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.091 0.472 . . . . 75.31 110.978 -176.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 560' ' ' LEU . . . . . 0.475 ' HG ' ' CD1' ' A' ' 539' ' ' TYR . 93.6 mt -104.22 139.91 38.59 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.273 -0.876 . . . . 72.02 109.275 177.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -106.6 114.03 27.88 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 123.21 0.604 . . . . 72.23 110.784 -177.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 562' ' ' PHE . . . . . 0.555 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 36.3 m-85 -108.64 145.35 35.09 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 120.695 0.283 . . . . 75.23 110.386 173.333 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 563' ' ' GLN . . . . . 0.479 ' HB2' ' HB2' ' A' ' 566' ' ' GLU . 0.2 OUTLIER -131.79 177.27 7.65 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 105.769 -1.938 . . . . 74.2 105.769 175.33 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -75.98 -30.46 58.58 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 121.111 0.481 . . . . 70.31 109.962 178.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -94.03 -22.84 18.28 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.259 0.552 . . . . 63.44 110.996 -179.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 566' ' ' GLU . . . . . 0.479 ' HB2' ' HB2' ' A' ' 563' ' ' GLN . 2.3 tm-20 -84.25 119.52 25.14 Favored 'General case' 0 C--O 1.245 0.84 0 N-CA-C 107.019 -1.475 . . . . 74.45 107.019 -177.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 567' ' ' ILE . . . . . 0.531 HG23 ' CZ ' ' A' ' 527' ' ' ARG . 6.2 pt -108.51 161.97 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.143 0 C-N-CA 120.65 -0.42 . . . . 74.44 111.047 -175.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 568' ' ' VAL . . . . . 0.408 HG23 ' H ' ' A' ' 569' ' ' LYS . 2.4 p 47.68 174.66 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.11 0 C-N-CA 126.421 1.889 . . . . 72.34 113.231 -179.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 569' ' ' LYS . . . . . 0.555 ' HB2' ' CZ ' ' A' ' 562' ' ' PHE . 0.2 OUTLIER -156.25 156.98 35.02 Favored 'General case' 0 C--N 1.289 -2.045 0 O-C-N 120.797 -1.189 . . . . 72.31 107.986 176.057 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 570' ' ' THR . . . . . 0.677 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 4.4 p -134.3 131.74 38.76 Favored 'General case' 0 N--CA 1.412 -2.361 0 O-C-N 123.999 0.812 . . . . 74.51 110.765 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 2.8 mp -91.3 113.39 26.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 106.728 -1.582 . . . . 72.2 106.728 170.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 2.6 p -93.85 120.17 33.75 Favored 'General case' 0 C--N 1.29 -2.021 0 O-C-N 123.677 0.61 . . . . 52.24 109.859 177.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 573' ' ' VAL . . . . . . . . . . . . . 49.1 t -123.38 135.77 62.18 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 108.549 -0.908 . . . . 73.41 108.549 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -93.45 124.05 37.17 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-O 121.403 0.621 . . . . 71.51 109.836 175.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 61.5 t -89.51 141.76 13.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 N-CA-C 106.755 -1.572 . . . . 55.13 106.755 176.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 32.9 mm -105.78 158.21 6.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 107.672 -1.232 . . . . 72.25 107.672 -178.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -67.22 137.46 56.21 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.228 -1.027 . . . . 74.21 108.228 177.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 578' ' ' ASP . . . . . 0.61 ' OD1' 'CA ' ' A' ' 850' ' ' ' CA' . 0.5 OUTLIER -69.85 158.97 34.51 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 112.295 0.48 . . . . 73.24 112.295 -172.857 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 579' ' ' GLU . . . . . 0.638 ' OE1' 'CA ' ' A' ' 850' ' ' ' CA' . 0.0 OUTLIER -138.21 -12.73 1.4 Allowed 'General case' 0 CA--C 1.558 1.263 0 N-CA-C 116.141 1.904 . . . . 75.15 116.141 -172.479 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 580' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 581' ' ' TYR . 0.1 OUTLIER -127.02 -171.02 2.32 Favored 'General case' 0 C--N 1.317 -0.838 0 O-C-N 121.164 -0.96 . . . . 73.12 110.138 -177.167 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 581' ' ' TYR . . . . . 0.489 ' O ' ' HG2' ' A' ' 580' ' ' GLU . 46.2 p90 -63.74 152.51 39.09 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 107.931 -1.136 . . . . 74.54 107.931 174.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -120.89 132.95 55.26 Favored 'General case' 0 C--N 1.288 -2.099 0 C-N-CA 118.824 -1.15 . . . . 72.44 114.076 -174.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -129.38 -165.95 1.59 Allowed 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 105.562 -2.014 . . . . 73.33 105.562 176.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -65.52 105.06 1.11 Allowed 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 106.855 -1.535 . . . . 75.34 106.855 172.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 585' ' ' LYS . . . . . 0.428 ' HD2' HD11 ' A' ' 646' ' ' ILE . 4.2 tmmm? -115.38 117.66 31.06 Favored 'General case' 0 N--CA 1.403 -2.79 0 N-CA-C 107.709 -1.219 . . . . 75.31 107.709 -175.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 3.4 t -142.39 147.2 35.83 Favored 'General case' 0 N--CA 1.404 -2.74 0 CA-C-N 114.688 -1.142 . . . . 65.21 110.029 -176.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -129.25 148.56 51.19 Favored 'General case' 0 N--CA 1.405 -2.687 0 CA-C-N 113.857 -1.52 . . . . 54.03 108.232 176.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 588' ' ' PHE . . . . . 0.513 ' HA ' ' O ' ' A' ' 642' ' ' LEU . 23.0 m-85 -104.8 141.54 36.31 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 109.356 -0.609 . . . . 74.24 109.356 -173.222 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . 0.453 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.5 OUTLIER -110.26 126.07 53.78 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 105.813 -1.921 . . . . 73.55 105.813 174.285 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -134.26 123.09 23.68 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 109.455 -0.572 . . . . 74.41 109.455 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 591' ' ' ILE . . . . . . . . . . . . . 20.9 pt -79.14 149.49 5.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 N-CA-C 108.0 -1.111 . . . . 72.21 108.0 173.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -93.23 -142.76 12.05 Favored Glycine 0 N--CA 1.425 -2.086 0 C-N-CA 121.008 -0.615 . . . . 54.42 112.693 -176.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -93.41 117.88 67.48 Favored Pre-proline 0 C--N 1.3 -1.584 0 N-CA-C 108.636 -0.876 . . . . 75.33 108.636 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 594' ' ' PRO . . . . . 0.608 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 30.2 Cg_endo -65.69 143.75 75.57 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 121.969 1.78 . . . . 71.5 110.714 177.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -123.83 135.86 54.02 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.888 -0.508 . . . . 73.24 110.483 -176.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.58 124.81 28.86 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 107.892 -1.151 . . . . 72.12 107.892 -178.252 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 65.9 t -75.5 -39.59 40.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 112.574 0.583 . . . . 73.43 112.574 -176.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -76.27 158.21 31.8 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 112.541 0.571 . . . . 74.12 112.541 -178.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 27.4 ptt? -89.73 23.34 2.72 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 123.831 0.852 . . . . 74.3 111.857 -172.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 32.0 t -74.35 99.11 3.41 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.117 0.484 . . . . 64.33 110.8 -178.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -91.6 131.86 36.72 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 108.789 -0.819 . . . . 75.4 108.789 177.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . 0.417 ' HD2' ' N ' ' A' ' 602' ' ' LYS . 3.6 mptp? -94.08 139.46 30.95 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 108.151 -1.055 . . . . 75.43 108.151 177.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -135.28 177.08 8.09 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 121.482 0.658 . . . . 73.42 112.386 -173.064 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -116.72 -166.0 14.15 Favored Glycine 0 N--CA 1.428 -1.843 0 N-CA-C 108.696 -1.762 . . . . 75.11 108.696 174.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . -101.9 -63.74 0.75 Allowed Glycine 0 C--N 1.293 -1.81 0 C-N-CA 120.274 -0.965 . . . . 74.5 111.177 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -93.33 -3.71 52.95 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.413 0.625 . . . . 75.34 110.38 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 3.7 p -104.82 171.62 7.23 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 115.859 -0.609 . . . . 65.34 112.132 -177.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 12.6 pt -139.92 160.01 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.594 0 CA-C-N 114.745 -1.116 . . . . 72.35 109.441 177.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 609' ' ' THR . . . . . 0.446 HG22 ' HB2' ' A' ' 611' ' ' GLU . 4.4 m -94.19 117.15 29.69 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.986 -1.116 . . . . 74.4 107.986 177.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -81.43 14.75 2.33 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 121.708 0.766 . . . . 74.53 111.479 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 611' ' ' GLU . . . . . 0.446 ' HB2' HG22 ' A' ' 609' ' ' THR . 2.3 tm-20 -88.88 174.93 7.67 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.601 -0.889 . . . . 73.43 108.601 178.133 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -125.22 10.62 8.08 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.513 -1.291 . . . . 75.12 107.513 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 11.0 t70 53.39 31.64 12.37 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 112.883 -1.962 . . . . 75.45 108.16 -172.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -76.86 135.55 38.86 Favored 'General case' 0 CA--C 1.488 -1.404 0 CA-C-N 114.05 -1.432 . . . . 70.51 110.511 -173.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -77.4 101.09 6.21 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-O 122.273 1.035 . . . . 72.31 108.959 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -98.04 174.45 3.17 Favored Pre-proline 0 C--N 1.286 -2.162 0 CA-C-N 113.527 -1.669 . . . . 74.23 110.705 -172.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -86.23 161.15 9.91 Favored 'Trans proline' 0 N--CA 1.438 -1.768 0 N-CA-C 108.267 -1.474 . . . . 64.33 108.267 162.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.29 110.01 1.76 Allowed 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 120.6 -0.44 . . . . 75.31 110.691 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 9.3 t -136.15 139.6 43.02 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 116.134 -0.484 . . . . 61.31 109.829 -179.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 13.3 p -134.69 124.37 25.18 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.581 0.705 . . . . 73.53 111.785 -178.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 54.5 mttm -90.37 0.14 57.4 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.249 -0.887 . . . . 74.21 109.536 178.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 73.93 -46.77 0.63 Allowed 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 125.918 1.687 . . . . 71.21 110.986 -174.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -51.43 149.28 4.32 Favored 'General case' 0 C--O 1.251 1.159 0 C-N-CA 124.159 0.983 . . . . 71.43 110.628 177.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 624' ' ' GLU . . . . . 0.415 ' O ' HG13 ' A' ' 628' ' ' ILE . 16.3 pt-20 -62.66 -15.19 51.01 Favored 'General case' 0 C--O 1.211 -0.932 0 N-CA-C 113.672 0.99 . . . . 72.33 113.672 -174.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -61.53 -34.35 75.4 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 118.118 0.417 . . . . 75.33 110.485 174.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . 0.523 ' O ' ' HG2' ' A' ' 630' ' ' GLU . 0.2 OUTLIER -64.22 -38.36 90.77 Favored 'General case' 0 C--O 1.193 -1.883 0 N-CA-C 108.626 -0.879 . . . . 74.24 108.626 173.838 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 627' ' ' ARG . . . . . . . . . . . . . 62.6 mtt-85 -74.89 -29.68 61.07 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 116.052 -0.522 . . . . 72.32 110.182 -176.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . 0.573 ' O ' ' HG2' ' A' ' 631' ' ' MET . 97.8 mt -68.52 -44.99 82.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.257 -0.646 . . . . 73.32 109.257 173.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -63.64 -45.41 90.36 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.94 -0.573 . . . . 73.34 110.561 179.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 630' ' ' GLU . . . . . 0.523 ' HG2' ' O ' ' A' ' 626' ' ' ARG . 8.7 mm-40 -79.59 2.3 22.86 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 113.476 0.917 . . . . 63.53 113.476 -174.433 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 631' ' ' MET . . . . . 0.573 ' HG2' ' O ' ' A' ' 628' ' ' ILE . 27.6 ptt? -93.39 -12.94 28.71 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 118.686 -1.206 . . . . 73.12 107.951 172.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -85.3 -23.56 47.48 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 110.167 -1.173 . . . . 74.13 110.167 176.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.91 151.84 37.71 Favored Pre-proline 0 CA--C 1.5 -0.977 0 N-CA-C 106.739 -1.578 . . . . 70.35 106.739 174.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.608 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 10.9 Cg_endo -76.7 135.66 16.28 Favored 'Trans proline' 0 N--CA 1.419 -2.866 0 N-CA-C 106.936 -1.986 . . . . 75.12 106.936 164.057 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . 0.255 2.3 pp -118.71 170.12 8.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 114.001 1.112 . . . . 74.21 114.001 -178.236 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.07 164.98 25.94 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 114.898 -1.046 . . . . 75.42 112.051 -176.433 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -85.34 -114.68 0.77 Allowed Glycine 0 N--CA 1.441 -1.001 0 CA-C-N 115.284 -0.871 . . . . 72.42 112.942 -177.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -98.37 -68.72 0.79 Allowed 'General case' 0 N--CA 1.42 -1.928 0 C-N-CA 120.576 -0.45 . . . . 75.43 110.611 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 18.7 p80 -113.33 109.2 18.34 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 113.655 0.983 . . . . 73.32 113.655 -173.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 12.5 p -98.8 90.47 4.69 Favored 'General case' 0 N--CA 1.408 -2.54 0 N-CA-C 107.167 -1.42 . . . . 72.43 107.167 172.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -173.26 138.6 0.73 Allowed 'General case' 0 N--CA 1.424 -1.73 0 CA-C-N 114.393 -1.276 . . . . 73.44 107.685 -173.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 642' ' ' LEU . . . . . 0.513 ' O ' ' HA ' ' A' ' 588' ' ' PHE . 42.1 tp -145.12 105.26 4.05 Favored 'General case' 0 C--N 1.274 -2.708 0 N-CA-C 107.494 -1.299 . . . . 74.43 107.494 173.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . 0.408 ' HB3' HG22 ' A' ' 511' ' ' VAL . 28.5 tt0 -92.87 100.5 12.95 Favored 'General case' 0 C--N 1.261 -3.248 0 N-CA-C 107.03 -1.47 . . . . 72.32 107.03 179.577 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 644' ' ' VAL . . . . . . . . . . . . . 26.3 t -92.73 108.65 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.287 0 CA-C-N 115.792 -0.64 . . . . 61.34 109.396 -177.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 4.0 mp -94.05 118.42 39.94 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 N-CA-C 107.916 -1.142 . . . . 73.31 107.916 177.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 646' ' ' ILE . . . . . 0.5 HD12 ' N ' ' A' ' 646' ' ' ILE . 2.5 mp -104.46 112.17 36.97 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.451 0 N-CA-C 107.098 -1.445 . . . . 75.31 107.098 -175.177 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . 0.592 ' OE1' ' HG3' ' A' ' 653' ' ' LYS . 6.7 pt-20 -115.45 149.35 38.18 Favored 'General case' 0 C--N 1.27 -2.863 0 C-N-CA 120.191 -0.604 . . . . 74.03 112.519 -177.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . 0.622 ' OE1' 'CA ' ' A' ' 800' ' ' ' CA' . 23.1 tp10 -54.69 135.51 46.88 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.188 -1.369 . . . . 72.12 109.917 -177.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 22.9 t -51.4 119.67 4.33 Favored 'General case' 0 C--O 1.237 0.403 0 O-C-N 124.209 0.943 . . . . 74.12 110.768 -176.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -152.05 -62.06 0.17 Allowed 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.704 -1.134 . . . . 62.32 109.058 -174.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -151.25 -175.49 5.19 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 106.317 -1.734 . . . . 60.43 106.317 177.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -98.87 121.29 40.63 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 108.626 -0.879 . . . . 73.14 108.626 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 653' ' ' LYS . . . . . 0.592 ' HG3' ' OE1' ' A' ' 647' ' ' GLU . 9.2 mmmm -111.1 136.72 49.72 Favored 'General case' 0 C--N 1.281 -2.394 0 CA-C-N 115.229 -0.896 . . . . 71.53 109.829 -177.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 33.3 p -153.18 128.2 9.66 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 109.305 -0.628 . . . . 72.41 109.305 177.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 655' ' ' THR . . . . . 0.48 ' HG1' ' CD2' ' A' ' 513' ' ' HIS . 98.9 m -94.11 104.51 16.53 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.458 -0.571 . . . . 72.3 109.458 178.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 27.9 m -81.58 161.34 3.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 116.079 -0.509 . . . . 74.23 110.758 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 27.0 t70 . . . . . 0 C--N 1.305 -1.334 0 CA-C-N 116.127 -0.488 . . . . 75.15 110.757 -176.405 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 800' ' ' ' CA' . . . . . 0.622 'CA ' ' OE1' ' A' ' 648' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 850' ' ' ' CA' . . . . . 0.645 'CA ' ' OD2' ' A' ' 552' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 503' ' ' GLY . . . . . 0.607 ' HA2' ' OG1' ' A' ' 528' ' ' THR . . . . . . . . 0 N--CA 1.401 -3.667 0 N-CA-C 110.804 -0.919 . . . . 62.25 110.804 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 504' ' ' ILE . . . . . 0.412 ' H ' ' HA ' ' A' ' 528' ' ' THR . 3.7 mp -125.98 102.65 10.39 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 106.363 -1.718 . . . . 72.51 106.363 177.327 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -123.4 106.1 10.37 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 108.071 -1.085 . . . . 72.03 108.071 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 13.6 t -139.67 159.63 41.73 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 108.188 -1.041 . . . . 75.33 108.188 -176.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -84.64 153.6 23.05 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.429 -0.952 . . . . 63.23 108.429 175.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -77.53 -32.27 53.9 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.353 -0.98 . . . . 74.54 108.353 176.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -133.4 134.76 24.24 Favored Pre-proline 0 C--N 1.314 -0.942 0 N-CA-C 108.873 -0.788 . . . . 70.53 108.873 178.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -81.86 -16.54 8.81 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.401 2.067 . . . . 71.45 111.938 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 511' ' ' VAL . . . . . 0.461 HG22 ' HB3' ' A' ' 643' ' ' GLU . 69.7 t -136.61 131.96 48.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 107.824 -1.176 . . . . 64.33 107.824 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 6.3 t -133.93 139.61 46.24 Favored 'General case' 0 N--CA 1.406 -2.633 0 N-CA-C 108.501 -0.926 . . . . 75.23 108.501 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -109.46 124.43 51.04 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 109.737 -0.468 . . . . 75.21 109.737 178.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 15.5 m -127.13 157.55 38.58 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 107.905 -1.146 . . . . 62.04 107.905 -178.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 35.5 t -82.13 156.4 24.52 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 109.541 -0.54 . . . . 74.35 109.541 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -83.4 -7.94 59.48 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.26 -1.015 . . . . 63.13 108.26 174.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 14.0 t -98.78 15.71 24.52 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 115.688 -0.687 . . . . 63.23 109.298 -177.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 12.7 tt -99.62 161.47 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 N-CA-C 108.915 -0.772 . . . . 74.12 108.915 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 519' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . -94.9 -70.69 1.09 Allowed Glycine 0 N--CA 1.43 -1.753 0 N-CA-C 110.554 -1.018 . . . . 71.1 110.554 176.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 36.7 mm -114.73 126.24 72.24 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 C-N-CA 123.006 0.522 . . . . 74.51 109.668 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 521' ' ' MET . . . . . 0.701 ' HE2' HG21 ' A' ' 644' ' ' VAL . 0.0 OUTLIER -104.55 140.06 38.54 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.768 -1.197 . . . . 75.41 107.768 173.431 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -124.73 137.6 54.33 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 123.777 0.673 . . . . 73.4 111.021 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 523' ' ' VAL . . . . . 0.72 HG21 HD21 ' A' ' 642' ' ' LEU . 45.7 t -122.99 137.45 56.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 109.048 -0.723 . . . . 44.35 109.048 -179.068 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -80.92 131.72 35.37 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.66 0.743 . . . . 74.44 112.927 -177.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 6.7 t -114.76 134.39 57.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 CA-C-N 114.327 -1.306 . . . . 71.45 107.873 177.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -86.94 139.49 30.56 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.238 -1.023 . . . . 73.12 108.238 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 527' ' ' ARG . . . . . 0.417 ' CZ ' HG22 ' A' ' 567' ' ' ILE . 31.7 ttp180 -93.95 158.59 15.56 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 116.202 -0.454 . . . . 73.32 110.514 -173.294 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 528' ' ' THR . . . . . 0.607 ' OG1' ' HA2' ' A' ' 503' ' ' GLY . 5.1 t -56.38 145.82 26.12 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.746 -0.661 . . . . 71.32 111.448 176.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 23.8 t -81.61 -12.74 58.62 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 108.79 -0.818 . . . . 75.24 108.79 178.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -109.02 52.94 0.61 Allowed Glycine 0 N--CA 1.429 -1.767 0 N-CA-C 109.592 -1.403 . . . . 72.42 109.592 177.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -82.83 95.49 7.94 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-O 121.591 0.71 . . . . 74.42 109.129 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -133.78 25.02 4.01 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 114.854 -1.066 . . . . 73.43 111.665 -178.162 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 175.76 -169.5 42.21 Favored Glycine 0 N--CA 1.416 -2.644 0 C-N-CA 120.097 -1.049 . . . . 41.32 111.141 -174.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -102.23 121.85 43.06 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 122.887 0.475 . . . . 61.2 110.822 -176.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 535' ' ' VAL . . . . . 0.437 HG22 HD22 ' A' ' 596' ' ' LEU . 79.6 t -125.53 135.73 63.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 123.403 0.681 . . . . 63.31 109.651 -178.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 536' ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' A' ' 594' ' ' PRO . 22.8 mm -101.18 129.17 52.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 115.881 -0.6 . . . . 70.02 109.874 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 537' ' ' VAL . . . . . 0.473 HG22 ' HB3' ' A' ' 594' ' ' PRO . 33.2 t -122.15 105.57 36.95 Favored Pre-proline 0 C--N 1.319 -0.751 0 N-CA-C 108.715 -0.846 . . . . 64.51 108.715 176.411 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 538' ' ' PRO . . . . . 0.409 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 55.8 Cg_endo -73.01 152.05 50.93 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.068 1.845 . . . . 62.22 110.828 177.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 539' ' ' TYR . . . . . 0.455 ' O ' ' HA ' ' A' ' 557' ' ' CYS . 50.9 p90 -147.38 157.88 43.75 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.409 -0.589 . . . . 65.04 109.409 178.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -149.52 155.43 40.33 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 120.979 0.419 . . . . 62.22 111.17 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 10.4 p -96.4 113.39 24.97 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.062 -0.972 . . . . 63.24 110.871 176.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.403 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 3.6 mp -83.0 115.62 25.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 105.517 -2.031 . . . . 72.31 105.517 173.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 543' ' ' GLU . . . . . 0.453 ' HB3' ' O ' ' A' ' 546' ' ' ALA . 47.8 mt-10 -53.5 -49.84 66.66 Favored 'General case' 0 C--N 1.32 -0.686 0 O-C-N 124.156 0.91 . . . . 75.54 112.667 -174.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 70.26 -101.67 0.92 Allowed Glycine 0 N--CA 1.44 -1.098 0 C-N-CA 120.522 -0.847 . . . . 70.52 111.259 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 545' ' ' THR . . . . . 0.422 HG23 ' HB2' ' A' ' 585' ' ' LYS . 8.8 t -113.62 0.23 14.55 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.869 0.842 . . . . 62.21 109.295 178.422 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 546' ' ' ALA . . . . . 0.503 ' HB2' ' HG2' ' A' ' 585' ' ' LYS . . . -95.33 170.98 9.0 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 108.132 -1.062 . . . . 73.24 108.132 175.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 547' ' ' ARG . . . . . 0.483 ' H ' ' HB3' ' A' ' 552' ' ' ASP . 9.6 tpt180 -130.46 122.72 28.23 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 118.012 0.369 . . . . 64.1 110.189 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 548' ' ' GLY . . . . . 0.419 ' HA3' ' HB3' ' A' ' 555' ' ' ASP . . . -82.48 -166.4 38.46 Favored Glycine 0 C--N 1.306 -1.135 0 CA-C-N 116.01 -0.541 . . . . 61.44 111.868 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 78.83 13.93 82.58 Favored Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 120.948 -0.644 . . . . 62.13 112.587 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 84.37 13.92 72.45 Favored Glycine 0 N--CA 1.435 -1.373 0 C-N-CA 120.212 -0.994 . . . . 63.23 111.891 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -79.81 -69.92 0.55 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.4 0.619 . . . . 73.52 109.982 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 552' ' ' ASP . . . . . 0.483 ' HB3' ' H ' ' A' ' 547' ' ' ARG . 8.4 t70 -109.41 -35.05 6.36 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 107.692 -1.225 . . . . 70.44 107.692 -176.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 553' ' ' PHE . . . . . 0.439 ' HA ' HG12 ' A' ' 576' ' ' ILE . 14.7 p90 -145.54 164.06 32.81 Favored 'General case' 0 N--CA 1.423 -1.817 0 CA-C-N 115.096 -0.956 . . . . 75.03 108.544 173.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 554' ' ' GLU . . . . . 0.463 ' HB3' ' HB3' ' A' ' 574' ' ' LYS . 1.0 OUTLIER -95.45 106.82 18.93 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 105.477 -2.046 . . . . 63.43 105.477 179.082 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 555' ' ' ASP . . . . . 0.419 ' HB3' ' HA3' ' A' ' 548' ' ' GLY . 3.4 p-10 -72.62 149.53 43.83 Favored 'General case' 0 CA--C 1.49 -1.333 0 CA-C-N 116.093 -0.503 . . . . 71.15 110.095 -174.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 5.6 t -139.57 131.6 27.9 Favored 'General case' 0 N--CA 1.403 -2.779 0 CA-C-O 121.669 0.747 . . . . 63.43 111.274 -177.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 557' ' ' CYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 539' ' ' TYR . 12.5 p -142.38 104.91 4.49 Favored 'General case' 0 N--CA 1.418 -2.037 0 N-CA-C 107.541 -1.281 . . . . 72.42 107.541 175.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -151.11 -149.33 5.02 Favored Glycine 0 N--CA 1.408 -3.171 0 N-CA-C 109.867 -1.293 . . . . 73.22 109.867 -176.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 559' ' ' GLU . . . . . 0.442 ' HB3' HG23 ' A' ' 536' ' ' ILE . 52.2 mt-10 -136.94 133.44 35.66 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 120.858 0.361 . . . . 73.51 110.715 -173.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 560' ' ' LEU . . . . . 0.455 HD22 ' CG ' ' A' ' 569' ' ' LYS . 92.1 mt -93.45 123.16 36.56 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.979 -1.119 . . . . 74.4 107.979 173.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -97.89 113.53 25.38 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 116.097 -0.501 . . . . 51.41 110.136 -177.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -103.99 144.36 31.64 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 109.639 -0.504 . . . . 61.43 109.639 176.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 563' ' ' GLN . . . . . 0.499 ' HB2' ' H ' ' A' ' 566' ' ' GLU . 42.7 mt-30 -136.56 179.85 6.11 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.059 -1.089 . . . . 74.33 108.059 -178.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 31.6 t30 -73.73 -34.77 64.93 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.669 -0.863 . . . . 64.01 108.669 176.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -87.64 -36.34 17.52 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 114.969 -1.014 . . . . 71.22 111.397 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 566' ' ' GLU . . . . . 0.499 ' H ' ' HB2' ' A' ' 563' ' ' GLN . 10.5 tp10 -77.33 117.08 18.48 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.77 -0.826 . . . . 74.22 108.77 178.237 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 567' ' ' ILE . . . . . 0.417 HG22 ' CZ ' ' A' ' 527' ' ' ARG . 6.5 pt -109.2 163.39 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.143 0 N-CA-C 109.317 -0.623 . . . . 63.22 109.317 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 568' ' ' VAL . . . . . 0.488 HG22 ' H ' ' A' ' 569' ' ' LYS . 2.3 p 44.49 -171.73 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.569 1.699 0 C-N-CA 125.543 1.537 . . . . 72.55 111.821 -177.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 569' ' ' LYS . . . . . 0.534 ' HA ' ' HE2' ' A' ' 569' ' ' LYS . 0.0 OUTLIER -173.3 158.41 3.56 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 107.142 -1.429 . . . . 75.21 107.142 174.78 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 570' ' ' THR . . . . . 0.604 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 24.1 p -134.37 137.73 44.33 Favored 'General case' 0 N--CA 1.423 -1.796 0 O-C-N 123.744 0.652 . . . . 71.34 109.316 175.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 571' ' ' ILE . . . . . 0.464 HG22 HG23 ' A' ' 573' ' ' VAL . 2.9 mp -88.29 114.31 26.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 106.148 -1.797 . . . . 72.52 106.148 171.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 9.4 p -95.81 111.88 23.75 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 123.215 0.322 . . . . 52.44 110.429 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 573' ' ' VAL . . . . . 0.464 HG23 HG22 ' A' ' 571' ' ' ILE . 46.9 t -118.82 137.69 51.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.33 -0.618 . . . . 74.52 109.33 -178.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 574' ' ' LYS . . . . . 0.463 ' HB3' ' HB3' ' A' ' 554' ' ' GLU . 38.7 ttmt -95.71 130.65 42.55 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 123.926 0.767 . . . . 72.24 110.218 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 58.9 t -95.76 143.63 11.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 107.852 -1.166 . . . . 73.14 107.852 176.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 576' ' ' ILE . . . . . 0.439 HG12 ' HA ' ' A' ' 553' ' ' PHE . 28.9 mm -112.16 161.12 11.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 108.154 -1.054 . . . . 72.03 108.154 -177.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -77.68 144.43 37.35 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.021 -0.733 . . . . 55.4 109.021 176.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -57.89 136.9 57.09 Favored 'General case' 0 CA--C 1.484 -1.562 0 N-CA-C 115.453 1.649 . . . . 74.24 115.453 -174.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 5.6 pm0 -107.06 -26.01 11.33 Favored 'General case' 0 N--CA 1.421 -1.876 0 CA-C-N 113.413 -1.721 . . . . 63.44 112.38 -176.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 580' ' ' GLU . . . . . 0.425 ' HG2' ' CD2' ' A' ' 581' ' ' TYR . 0.1 OUTLIER -110.38 -69.26 0.88 Allowed 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 112.753 0.649 . . . . 72.33 112.753 -170.002 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 581' ' ' TYR . . . . . 0.425 ' CD2' ' HG2' ' A' ' 580' ' ' GLU . 32.1 p90 -162.35 153.71 18.03 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 104.422 -2.436 . . . . 74.1 104.422 -176.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 582' ' ' GLU . . . . . 0.442 ' HB3' ' OE1' ' A' ' 648' ' ' GLU . 20.3 mt-10 -102.98 136.6 42.5 Favored 'General case' 0 C--N 1.274 -2.708 0 C-N-CA 117.604 -1.638 . . . . 73.11 115.23 -172.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 12.8 ptpt -153.62 167.06 30.82 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 113.239 -1.801 . . . . 74.03 106.177 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -86.52 123.4 31.69 Favored 'General case' 0 CA--C 1.488 -1.431 0 N-CA-C 105.656 -1.979 . . . . 71.04 105.656 169.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 585' ' ' LYS . . . . . 0.503 ' HG2' ' HB2' ' A' ' 546' ' ' ALA . 0.0 OUTLIER -121.66 173.67 7.3 Favored 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 108.691 -0.855 . . . . 72.54 108.691 -171.592 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 8.6 t -153.61 146.77 24.66 Favored 'General case' 0 N--CA 1.428 -1.531 0 C-N-CA 120.042 -0.663 . . . . 63.3 111.774 -174.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -130.96 149.8 52.41 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-N 114.237 -1.347 . . . . 73.1 109.891 177.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 588' ' ' PHE . . . . . 0.404 ' HA ' ' O ' ' A' ' 642' ' ' LEU . 25.7 m-85 -104.06 133.36 49.13 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.094 -0.706 . . . . 74.11 109.094 -176.057 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 589' ' ' LEU . . . . . 0.506 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.4 OUTLIER -106.01 123.77 48.52 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 105.895 -1.891 . . . . 70.43 105.895 175.845 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -130.71 145.66 51.99 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 107.615 -1.254 . . . . 73.13 107.615 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 591' ' ' ILE . . . . . 0.412 HG22 ' HB3' ' A' ' 539' ' ' TYR . 27.5 pt -106.05 152.48 7.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 108.934 -0.765 . . . . 71.23 108.934 178.627 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -97.97 -150.51 26.37 Favored Glycine 0 N--CA 1.429 -1.802 0 C-N-CA 120.792 -0.718 . . . . 64.15 112.873 -177.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.416 ' OE2' ' HB3' ' A' ' 595' ' ' ARG . 1.4 tm-20 -79.49 121.3 82.55 Favored Pre-proline 0 C--N 1.297 -1.681 0 C-N-CA 123.589 0.756 . . . . 71.4 111.426 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 594' ' ' PRO . . . . . 0.496 ' HA ' ' O ' ' A' ' 536' ' ' ILE . 68.7 Cg_endo -81.33 145.9 15.3 Favored 'Trans proline' 0 N--CA 1.43 -2.231 0 C-N-CA 121.817 1.678 . . . . 71.44 110.083 176.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 595' ' ' ARG . . . . . 0.416 ' HB3' ' OE2' ' A' ' 593' ' ' GLU . 14.2 ptp180 -136.7 143.75 43.53 Favored 'General case' 0 C--N 1.273 -2.733 0 CA-C-N 116.286 -0.416 . . . . 72.42 109.991 -177.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 596' ' ' LEU . . . . . 0.437 HD22 HG22 ' A' ' 535' ' ' VAL . 0.0 OUTLIER -77.25 126.83 31.57 Favored 'General case' 0 N--CA 1.416 -2.155 0 N-CA-C 106.001 -1.851 . . . . 72.31 106.001 179.469 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 43.6 t . . . . . 0 C--N 1.311 -1.067 0 N-CA-C 107.855 -1.165 . . . . 64.01 107.855 179.995 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 6.3 mtp-105 . . . . . 0 N--CA 1.441 -0.91 0 N-CA-C 107.412 -1.329 . . . . 73.2 107.412 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -76.1 155.76 37.99 Favored 'Trans proline' 0 N--CA 1.438 -1.776 0 C-N-CA 120.856 1.038 . . . . 64.32 110.07 168.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 635' ' ' ILE . . . . . 0.464 HD13 ' H ' ' A' ' 635' ' ' ILE . 0.2 OUTLIER -136.68 -173.54 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 107.798 -1.186 . . . . 53.0 107.798 179.438 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 636' ' ' LEU . . . . . 0.552 HD13 ' H ' ' A' ' 636' ' ' LEU . 0.0 OUTLIER -87.29 -179.77 6.47 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 123.291 0.37 . . . . 65.32 111.622 -178.93 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -99.69 -125.18 5.4 Favored Glycine 0 N--CA 1.438 -1.188 0 CA-C-N 116.175 -0.466 . . . . 23.32 113.983 -176.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -84.54 -71.4 0.52 Allowed 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 112.41 0.522 . . . . 75.42 112.41 -177.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -117.67 107.94 14.82 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 122.466 1.127 . . . . 64.33 112.436 -174.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 640' ' ' THR . . . . . 0.404 HG21 ' HB2' ' A' ' 636' ' ' LEU . 3.6 p -108.19 92.05 3.9 Favored 'General case' 0 N--CA 1.404 -2.747 0 CA-C-N 114.269 -1.332 . . . . 65.2 109.855 177.244 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 641' ' ' LYS . . . . . 0.454 ' HE2' ' HB2' ' A' ' 643' ' ' GLU . 1.2 tmtp? -178.33 129.44 0.13 Allowed 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 104.826 -2.287 . . . . 75.03 104.826 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 642' ' ' LEU . . . . . 0.72 HD21 HG21 ' A' ' 523' ' ' VAL . 42.6 tp -132.37 114.52 14.46 Favored 'General case' 0 C--N 1.274 -2.681 0 N-CA-C 108.692 -0.855 . . . . 71.55 108.692 177.206 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 643' ' ' GLU . . . . . 0.461 ' HB3' HG22 ' A' ' 511' ' ' VAL . 22.5 tt0 -99.05 104.81 16.87 Favored 'General case' 0 C--N 1.273 -2.734 0 N-CA-C 107.069 -1.456 . . . . 63.13 107.069 178.297 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 644' ' ' VAL . . . . . 0.701 HG21 ' HE2' ' A' ' 521' ' ' MET . 33.7 t -92.94 105.12 16.42 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 N-CA-C 108.551 -0.907 . . . . 75.4 108.551 -179.149 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 3.9 mp -88.94 115.08 28.16 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 N-CA-C 107.469 -1.308 . . . . 71.24 107.469 175.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 646' ' ' ILE . . . . . 0.468 HD12 ' N ' ' A' ' 646' ' ' ILE . 2.9 mp -95.48 106.43 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.453 0 N-CA-C 105.383 -2.08 . . . . 64.43 105.383 -178.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -97.95 132.15 43.78 Favored 'General case' 0 N--CA 1.399 -3.017 0 CA-C-N 115.249 -0.887 . . . . 64.33 109.275 -178.213 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 648' ' ' GLU . . . . . 0.442 ' OE1' ' HB3' ' A' ' 582' ' ' GLU . 15.2 tt0 -67.32 144.29 55.94 Favored 'General case' 0 N--CA 1.408 -2.527 0 N-CA-C 107.878 -1.156 . . . . 74.14 107.878 -177.354 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 23.1 t . . . . . 0 N--CA 1.444 -0.748 0 O-C-N 124.442 1.089 . . . . 73.11 113.342 -170.165 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 503' ' ' GLY . . . . . 0.662 ' HA2' ' OG1' ' A' ' 528' ' ' THR . . . . . . . . 0 N--CA 1.415 -2.735 0 N-CA-C 111.787 -0.525 . . . . 54.44 111.787 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 504' ' ' ILE . . . . . 0.413 ' H ' ' CB ' ' A' ' 528' ' ' THR . 4.1 mp -119.23 113.97 43.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 107.436 -1.32 . . . . 74.33 107.436 177.526 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -123.94 119.74 30.47 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 109.228 -0.656 . . . . 64.1 109.228 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 14.8 t -148.54 167.54 25.11 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.78 -0.452 . . . . 74.53 109.78 -174.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -99.66 162.33 13.08 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 107.441 -1.318 . . . . 75.44 107.441 173.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 508' ' ' GLU . . . . . 0.436 ' HG3' HD21 ' A' ' 526' ' ' LEU . 0.0 OUTLIER -103.18 -24.39 13.57 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.203 0.525 . . . . 75.3 111.314 176.245 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -116.66 122.96 30.98 Favored Pre-proline 0 N--CA 1.436 -1.152 0 N-CA-C 108.382 -0.97 . . . . 74.0 108.382 171.159 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -80.71 -9.96 13.17 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 121.961 1.774 . . . . 74.31 111.48 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 511' ' ' VAL . . . . . 0.435 HG22 ' HB3' ' A' ' 643' ' ' GLU . 75.3 t -141.28 135.96 32.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 107.521 -1.289 . . . . 74.44 107.521 -178.494 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 5.6 t -136.68 146.71 46.22 Favored 'General case' 0 N--CA 1.41 -2.439 0 N-CA-C 108.005 -1.109 . . . . 74.24 108.005 177.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -116.69 131.3 56.99 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.429 -0.582 . . . . 75.11 109.429 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 22.3 m -127.26 160.87 35.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 CA-C-N 115.762 -0.654 . . . . 73.13 109.753 -175.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 71.1 m -75.73 153.03 37.32 Favored 'General case' 0 N--CA 1.403 -2.803 0 CA-C-N 114.72 -1.127 . . . . 71.24 108.083 175.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -88.36 -24.8 23.01 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.054 -1.058 . . . . 63.35 111.121 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 23.3 t -102.6 70.16 1.12 Allowed 'General case' 0 N--CA 1.419 -1.982 0 N-CA-C 107.862 -1.162 . . . . 72.43 107.862 176.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 18.8 tt -135.85 152.47 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.503 0 N-CA-C 106.73 -1.582 . . . . 73.14 106.73 176.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -84.93 -59.21 2.0 Allowed Glycine 0 C--N 1.287 -2.154 0 C-N-CA 120.239 -0.982 . . . . 71.31 111.667 -178.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 36.5 mm -125.98 126.01 69.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 109.486 -0.561 . . . . 73.14 109.486 -178.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 521' ' ' MET . . . . . 0.741 ' HE1' HG21 ' A' ' 644' ' ' VAL . 0.0 OUTLIER -101.6 134.88 44.05 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 106.38 -1.711 . . . . 43.24 106.38 171.721 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -121.49 137.54 54.68 Favored 'General case' 0 C--N 1.308 -1.206 0 O-C-N 123.68 0.613 . . . . 72.14 110.523 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 523' ' ' VAL . . . . . 0.679 HG21 HD21 ' A' ' 642' ' ' LEU . 41.7 t -121.1 138.26 52.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 N-CA-C 108.119 -1.067 . . . . 63.3 108.119 179.177 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 524' ' ' LYS . . . . . 0.571 ' HD2' HG21 ' A' ' 568' ' ' VAL . 29.1 mmtp -88.16 116.07 26.1 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.867 0.841 . . . . 72.02 111.84 -176.144 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 22.9 t -97.19 135.62 30.77 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 CA-C-N 114.545 -1.207 . . . . 73.13 109.178 -178.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 526' ' ' LEU . . . . . 0.436 HD21 ' HG3' ' A' ' 508' ' ' GLU . 2.5 mm? -79.68 138.86 37.49 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 123.687 0.617 . . . . 63.43 109.804 -178.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 527' ' ' ARG . . . . . 0.508 ' HG2' ' N ' ' A' ' 528' ' ' THR . 50.5 ttp180 -86.29 160.28 19.18 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.274 -1.01 . . . . 72.21 108.274 178.292 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 528' ' ' THR . . . . . 0.662 ' OG1' ' HA2' ' A' ' 503' ' ' GLY . 5.3 t -65.43 146.76 54.48 Favored 'General case' 0 N--CA 1.412 -2.347 0 CA-C-N 115.657 -0.701 . . . . 74.25 110.388 172.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 38.0 t -62.37 -46.36 88.99 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-N 114.963 -1.017 . . . . 71.15 109.042 175.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -114.1 117.28 4.09 Favored Glycine 0 N--CA 1.415 -2.743 0 N-CA-C 109.914 -1.274 . . . . 64.42 109.914 -177.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 531' ' ' ALA . . . . . 0.432 ' HB2' HG23 ' A' ' 528' ' ' THR . . . -131.69 119.93 22.06 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 109.372 -0.603 . . . . 70.52 109.372 178.612 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -114.94 74.96 0.9 Allowed 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.559 -0.534 . . . . 75.54 109.559 175.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 533' ' ' GLY . . . . . 0.446 ' H ' ' HB3' ' A' ' 564' ' ' ASN . . . 124.92 -143.39 14.54 Favored Glycine 0 N--CA 1.433 -1.528 0 C-N-CA 120.38 -0.915 . . . . 52.12 112.628 177.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -114.25 134.01 55.24 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.031 -0.729 . . . . 72.11 109.031 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 535' ' ' VAL . . . . . 0.528 HG22 HD22 ' A' ' 596' ' ' LEU . 59.3 t -126.45 131.45 71.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 109.458 -0.571 . . . . 65.12 109.458 -178.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 536' ' ' ILE . . . . . . . . . . . . . 39.7 mm -98.89 125.92 52.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 109.061 -0.718 . . . . 61.31 109.061 178.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 537' ' ' VAL . . . . . 0.438 HG22 ' HB3' ' A' ' 594' ' ' PRO . 40.6 t -115.82 107.24 48.66 Favored Pre-proline 0 C--N 1.306 -1.325 0 CA-C-N 115.839 -0.619 . . . . 61.21 109.356 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -73.52 145.95 38.46 Favored 'Trans proline' 0 C--O 1.238 0.484 0 C-N-CA 122.539 2.159 . . . . 74.54 111.951 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 539' ' ' TYR . . . . . 0.492 ' HB3' HG22 ' A' ' 591' ' ' ILE . 43.7 p90 -147.96 161.3 41.61 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 109.34 -0.615 . . . . 72.23 109.34 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -157.9 153.95 27.12 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 109.237 -0.653 . . . . 73.41 109.237 177.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 2.7 p -90.76 128.75 36.79 Favored 'General case' 0 C--N 1.293 -1.886 0 O-C-N 123.625 0.578 . . . . 72.33 110.152 175.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.428 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 3.7 mp -95.05 117.92 40.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 106.244 -1.762 . . . . 75.2 106.244 174.16 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 543' ' ' GLU . . . . . 0.538 ' HB2' ' O ' ' A' ' 546' ' ' ALA 0.289 0.0 OUTLIER -60.89 -51.51 68.98 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 114.685 1.365 . . . . 64.32 114.685 -176.759 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 67.63 -79.95 0.17 Allowed Glycine 0 N--CA 1.448 -0.532 0 O-C-N 123.266 0.354 . . . . 70.31 113.833 175.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 7.9 t -125.64 -1.7 7.37 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 120.956 0.408 . . . . 44.12 110.325 -178.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 546' ' ' ALA . . . . . 0.538 ' O ' ' HB2' ' A' ' 543' ' ' GLU . . . -111.11 174.54 5.81 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 108.6 -0.889 . . . . 72.54 108.6 177.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 547' ' ' ARG . . . . . 0.483 ' H ' ' HB3' ' A' ' 552' ' ' ASP . 2.4 mpt_? -112.77 128.78 56.52 Favored 'General case' 0 CA--C 1.487 -1.454 0 CA-C-O 121.548 0.689 . . . . 71.53 112.414 -175.197 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -84.6 -174.16 50.2 Favored Glycine 0 C--N 1.277 -2.731 0 CA-C-N 114.052 -1.431 . . . . 61.24 112.532 -177.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 69.78 16.33 72.16 Favored Glycine 0 C--O 1.222 -0.644 0 N-CA-C 114.196 0.438 . . . . 55.01 114.196 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 84.5 6.21 86.06 Favored Glycine 0 N--CA 1.438 -1.208 0 C-N-CA 119.989 -1.101 . . . . 64.04 111.297 -177.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -74.12 -43.94 55.65 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 110.542 -0.17 . . . . 64.52 110.542 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 552' ' ' ASP . . . . . 0.483 ' HB3' ' H ' ' A' ' 547' ' ' ARG . 10.2 t70 -132.27 -28.88 1.65 Allowed 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.577 -0.897 . . . . 54.31 108.577 175.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 553' ' ' PHE . . . . . 0.411 ' HA ' HG12 ' A' ' 576' ' ' ILE . 35.1 p90 -144.12 158.39 43.75 Favored 'General case' 0 C--O 1.249 1.053 0 N-CA-C 107.183 -1.414 . . . . 74.51 107.183 170.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -89.93 119.44 30.29 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 106.974 -1.491 . . . . 74.4 106.974 178.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -75.45 99.03 4.06 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-N 115.966 -0.561 . . . . 72.21 110.738 -176.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 556' ' ' THR . . . . . 0.485 ' CG2' HG22 ' A' ' 573' ' ' VAL . 10.1 t -89.8 97.03 10.96 Favored 'General case' 0 N--CA 1.41 -2.453 0 CA-C-O 123.295 1.521 . . . . 74.23 110.48 -178.504 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 1.6 p -109.4 106.62 16.47 Favored 'General case' 0 C--N 1.275 -2.65 0 CA-C-N 113.8 -1.545 . . . . 71.22 107.903 175.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -154.92 -157.84 8.42 Favored Glycine 0 N--CA 1.414 -2.804 0 N-CA-C 110.705 -0.958 . . . . 73.25 110.705 -174.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -142.77 131.24 22.33 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 109.584 -0.524 . . . . 55.42 109.584 -175.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 560' ' ' LEU . . . . . 0.403 ' HG ' ' CD1' ' A' ' 539' ' ' TYR . 95.1 mt -89.89 138.01 31.86 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.835 -0.62 . . . . 71.24 109.379 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -104.46 106.54 17.08 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 109.384 -0.598 . . . . 74.14 109.384 -179.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -100.08 132.22 45.57 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 109.9 -0.407 . . . . 60.04 109.9 177.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -116.43 160.81 20.02 Favored 'General case' 0 C--N 1.289 -2.06 0 C-N-CA 119.635 -0.826 . . . . 63.44 109.617 177.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 564' ' ' ASN . . . . . 0.446 ' HB3' ' H ' ' A' ' 533' ' ' GLY . 4.6 p-10 -69.93 -25.11 63.5 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 122.214 1.007 . . . . 73.4 109.545 176.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -90.85 -6.27 54.46 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.386 -1.279 . . . . 61.1 110.821 -178.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -118.96 154.82 32.41 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.899 -0.778 . . . . 22.22 108.899 -177.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 567' ' ' ILE . . . . . 0.416 ' HA ' ' HD3' ' A' ' 527' ' ' ARG . 9.4 pt -124.77 164.2 23.83 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 108.318 -0.993 . . . . 63.12 108.318 170.319 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 568' ' ' VAL . . . . . 0.571 HG21 ' HD2' ' A' ' 524' ' ' LYS . 1.5 p 49.97 155.5 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.576 1.944 0 C-N-CA 127.072 2.149 . . . . 75.04 115.734 179.025 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 569' ' ' LYS . . . . . . . . . . . . . 5.8 mmpt? -140.69 166.29 25.15 Favored 'General case' 0 CA--C 1.486 -1.487 0 N-CA-C 107.806 -1.183 . . . . 64.34 107.806 172.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 570' ' ' THR . . . . . 0.542 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 18.2 p -137.49 133.49 34.67 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 123.825 0.703 . . . . 70.52 110.603 175.371 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 3.1 mp -84.77 122.36 38.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 106.591 -1.633 . . . . 64.31 106.591 172.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 10.2 p -98.2 109.08 21.9 Favored 'General case' 0 N--CA 1.418 -2.074 0 N-CA-C 109.838 -0.43 . . . . 74.25 109.838 178.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 573' ' ' VAL . . . . . 0.485 HG22 ' CG2' ' A' ' 556' ' ' THR . 58.9 t -110.55 123.7 66.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 N-CA-C 109.869 -0.419 . . . . 73.53 109.869 178.505 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -77.91 113.23 15.6 Favored 'General case' 0 N--CA 1.433 -1.29 0 O-C-N 124.036 0.835 . . . . 74.32 109.067 175.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 57.1 t -87.24 130.32 37.27 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 107.624 -1.25 . . . . 60.2 107.624 177.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 576' ' ' ILE . . . . . 0.411 HG12 ' HA ' ' A' ' 553' ' ' PHE . 37.4 mm -94.98 150.04 4.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 108.312 -0.996 . . . . 74.21 108.312 -175.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -68.51 139.81 55.66 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.329 -0.619 . . . . 73.31 109.329 176.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.66 -177.74 6.67 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 112.898 0.703 . . . . 73.14 112.898 -173.264 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -166.71 -38.19 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.462 0 N-CA-C 114.566 1.321 . . . . 72.31 114.566 -173.19 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 580' ' ' GLU . . . . . 0.541 ' HG2' ' O ' ' A' ' 581' ' ' TYR . 0.1 OUTLIER -99.77 -168.08 1.55 Allowed 'General case' 0 C--O 1.25 1.104 0 C-N-CA 122.71 0.404 . . . . 74.21 111.887 -169.022 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 581' ' ' TYR . . . . . 0.541 ' O ' ' HG2' ' A' ' 580' ' ' GLU . 27.8 p90 -65.48 151.12 47.14 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 106.819 -1.549 . . . . 74.24 106.819 174.083 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -130.31 154.81 47.25 Favored 'General case' 0 N--CA 1.412 -2.338 0 C-N-CA 118.467 -1.293 . . . . 64.34 113.918 178.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -133.82 -174.51 3.55 Favored 'General case' 0 C--N 1.274 -2.692 0 N-CA-C 103.648 -2.723 . . . . 62.05 103.648 176.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -72.69 107.04 4.95 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.594 -1.261 . . . . 71.44 107.594 173.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . 0.252 0.0 OUTLIER -113.28 143.7 43.97 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 119.921 -0.712 . . . . 73.02 111.351 -179.041 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 3.5 t -155.81 148.96 24.52 Favored 'General case' 0 N--CA 1.418 -2.072 0 CA-C-N 115.215 -0.902 . . . . 71.54 109.764 -172.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -120.14 142.15 49.2 Favored 'General case' 0 N--CA 1.414 -2.272 0 CA-C-N 114.576 -1.193 . . . . 74.42 109.665 176.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 588' ' ' PHE . . . . . 0.428 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 25.8 m-85 -98.92 133.5 43.11 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.561 -0.904 . . . . 65.33 108.561 -175.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 589' ' ' LEU . . . . . 0.522 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.5 OUTLIER -108.01 127.17 53.53 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 106.323 -1.732 . . . . 53.01 106.323 176.365 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -127.95 126.86 42.24 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 109.242 -0.651 . . . . 54.53 109.242 176.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 591' ' ' ILE . . . . . 0.492 HG22 ' HB3' ' A' ' 539' ' ' TYR . 17.0 pt -94.22 128.66 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 N-CA-C 106.351 -1.722 . . . . 74.52 106.351 171.257 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -93.35 -144.75 15.7 Favored Glycine 0 N--CA 1.431 -1.674 0 CA-C-N 115.793 -0.64 . . . . 63.11 114.386 -171.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -77.43 116.35 57.13 Favored Pre-proline 0 N--CA 1.435 -1.195 0 CA-C-N 114.635 -0.782 . . . . 71.14 109.155 -178.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 594' ' ' PRO . . . . . 0.438 ' HB3' HG22 ' A' ' 537' ' ' VAL . 78.1 Cg_endo -76.3 160.25 35.99 Favored 'Trans proline' 0 N--CA 1.446 -1.31 0 C-N-CA 122.475 2.117 . . . . 71.42 111.283 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 8.3 ptp85 -135.31 139.07 44.04 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 109.046 -0.724 . . . . 75.42 109.046 -178.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 596' ' ' LEU . . . . . 0.528 HD22 HG22 ' A' ' 535' ' ' VAL . 0.0 OUTLIER -83.39 129.19 34.98 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 105.954 -1.869 . . . . 75.45 105.954 179.242 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 69.7 t . . . . . 0 C--N 1.312 -1.043 0 CA-C-O 121.905 0.859 . . . . 73.44 110.393 -178.672 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.207 -1.135 0 N-CA-C 109.527 -0.546 . . . . 74.51 109.527 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -75.6 153.89 39.3 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 121.863 1.709 . . . . 54.11 111.754 178.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.3 pp -130.96 179.78 4.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.798 0.666 . . . . 64.43 112.798 -177.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 636' ' ' LEU . . . . . 0.401 HD22 ' O ' ' A' ' 637' ' ' GLY . 0.0 OUTLIER -76.71 153.4 35.13 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.793 -0.64 . . . . 74.35 109.473 -179.734 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 637' ' ' GLY . . . . . 0.401 ' O ' HD22 ' A' ' 636' ' ' LEU . . . -83.93 -135.72 2.93 Favored Glycine 0 C--N 1.304 -1.239 0 C-N-CA 120.917 -0.659 . . . . 71.32 114.18 -175.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -70.32 -56.97 5.41 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.168 0.508 . . . . 74.42 110.449 -176.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -148.26 122.53 9.6 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.429 0.633 . . . . 71.41 110.096 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 55.2 p -108.59 91.49 3.67 Favored 'General case' 0 N--CA 1.406 -2.665 0 CA-C-O 121.907 0.86 . . . . 62.43 109.118 178.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -166.39 130.19 2.06 Favored 'General case' 0 CA--C 1.491 -1.295 0 N-CA-C 107.81 -1.181 . . . . 64.41 107.81 -177.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 642' ' ' LEU . . . . . 0.679 HD21 HG21 ' A' ' 523' ' ' VAL . 29.3 tp -137.91 110.53 7.55 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 108.531 -0.914 . . . . 74.51 108.531 176.103 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 643' ' ' GLU . . . . . 0.435 ' HB3' HG22 ' A' ' 511' ' ' VAL . 36.8 tt0 -93.92 109.69 21.39 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 107.188 -1.412 . . . . 75.2 107.188 176.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 644' ' ' VAL . . . . . 0.741 HG21 ' HE1' ' A' ' 521' ' ' MET . 34.7 t -96.59 105.44 17.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 109.982 -0.377 . . . . 75.42 109.982 -177.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 3.7 mp -87.86 120.16 36.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 108.418 -0.956 . . . . 75.51 108.418 178.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 646' ' ' ILE . . . . . 0.493 HD12 ' H ' ' A' ' 646' ' ' ILE . 2.1 mp -101.7 107.47 21.62 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.746 0 N-CA-C 105.938 -1.875 . . . . 64.51 105.938 -177.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -110.53 145.92 36.93 Favored 'General case' 0 N--CA 1.406 -2.627 0 C-N-CA 120.273 -0.571 . . . . 70.24 110.294 -178.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -53.33 132.8 39.82 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.004 -0.998 . . . . 72.04 110.091 -178.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 3.6 m . . . . . 0 C--N 1.298 -1.661 0 C-N-CA 124.444 1.098 . . . . 63.04 111.681 -173.549 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.419 -2.47 0 N-CA-C 112.624 -0.19 . . . . 35.24 112.624 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 504' ' ' ILE . . . . . 0.4 ' H ' ' CB ' ' A' ' 528' ' ' THR . 4.1 mp -122.75 114.81 43.83 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 108.54 -0.911 . . . . 74.23 108.54 178.222 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -128.88 98.75 5.06 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 107.753 -1.203 . . . . 74.32 107.753 174.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 15.4 t -134.99 156.83 48.36 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 116.044 -0.526 . . . . 73.43 109.679 -173.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -85.41 154.28 21.95 Favored 'General case' 0 CA--C 1.487 -1.476 0 N-CA-C 108.583 -0.895 . . . . 73.2 108.583 175.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -84.38 -26.92 28.02 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.099 -1.075 . . . . 73.33 108.099 173.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -111.26 121.22 41.03 Favored Pre-proline 0 N--CA 1.436 -1.174 0 CA-C-N 114.636 -1.165 . . . . 74.02 109.98 -178.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 510' ' ' PRO . . . . . 0.435 ' HA ' ' O ' ' A' ' 641' ' ' LYS . 56.2 Cg_endo -85.7 -18.48 3.77 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 121.206 1.271 . . . . 42.21 109.51 169.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 511' ' ' VAL . . . . . 0.542 HG22 ' HB3' ' A' ' 643' ' ' GLU . 67.6 t -149.32 131.13 5.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 C-N-CA 125.953 1.701 . . . . 61.45 106.972 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 14.9 t -130.49 143.73 50.95 Favored 'General case' 0 N--CA 1.421 -1.902 0 N-CA-C 107.676 -1.231 . . . . 73.25 107.676 177.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -109.76 131.99 54.56 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 107.504 -1.295 . . . . 63.54 107.504 178.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 24.7 m -130.19 154.89 41.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 CA-C-O 121.312 0.577 . . . . 72.24 110.077 -178.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 65.7 m -77.08 150.0 35.7 Favored 'General case' 0 N--CA 1.397 -3.103 0 CA-C-N 114.493 -1.23 . . . . 74.42 109.955 178.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -71.69 -29.3 64.43 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.813 0.816 . . . . 64.21 109.659 174.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 39.7 m -107.95 75.07 0.98 Allowed 'General case' 0 N--CA 1.418 -2.033 0 CA-C-O 122.129 0.966 . . . . 73.23 109.462 -177.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 13.3 tt -145.3 161.04 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.214 0 CA-C-N 113.069 -1.878 . . . . 71.42 106.027 176.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 519' ' ' GLY . . . . . 0.46 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . -92.51 -75.71 1.31 Allowed Glycine 0 N--CA 1.434 -1.449 0 C-N-CA 120.002 -1.094 . . . . 42.11 110.894 177.32 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 34.6 mm -107.68 127.03 63.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 109.866 -0.42 . . . . 75.22 109.866 -178.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 521' ' ' MET . . . . . 0.582 ' HE2' HG21 ' A' ' 644' ' ' VAL . 0.0 OUTLIER -102.95 139.99 37.8 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.075 -1.454 . . . . 72.34 107.075 172.103 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -113.7 155.67 25.15 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 121.419 0.628 . . . . 72.3 111.709 -176.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 523' ' ' VAL . . . . . 0.678 ' O ' ' HA ' ' A' ' 570' ' ' THR . 12.1 t -135.77 126.07 42.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 115.118 -0.947 . . . . 71.12 108.479 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 524' ' ' LYS . . . . . 0.54 ' HD2' HG21 ' A' ' 568' ' ' VAL . 31.2 mmtp -79.7 126.08 30.47 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.507 0.67 . . . . 54.53 112.088 -179.156 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 19.1 t -110.67 122.87 65.95 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 107.367 -1.346 . . . . 61.12 107.367 176.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -78.82 144.93 34.59 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.073 -0.714 . . . . 61.25 109.073 -178.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 527' ' ' ARG . . . . . 0.504 ' HD3' ' HA ' ' A' ' 567' ' ' ILE . 40.3 ttp180 -88.23 151.81 22.4 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.451 0.643 . . . . 64.32 110.764 -175.244 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 528' ' ' THR . . . . . 0.481 ' N ' ' HG2' ' A' ' 527' ' ' ARG . 4.6 t -59.97 139.63 57.29 Favored 'General case' 0 N--CA 1.418 -2.049 0 CA-C-N 114.514 -1.221 . . . . 62.45 110.525 172.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 23.3 t -73.92 -40.65 62.98 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 108.553 -0.906 . . . . 75.32 108.553 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -90.57 56.63 3.46 Favored Glycine 0 N--CA 1.434 -1.459 0 N-CA-C 110.392 -1.083 . . . . 64.11 110.392 177.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -70.14 99.88 1.56 Allowed 'General case' 0 CA--C 1.505 -0.767 0 C-N-CA 122.972 0.509 . . . . 64.01 110.884 -178.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -127.33 100.22 5.96 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 115.708 -0.678 . . . . 73.32 109.899 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 533' ' ' GLY . . . . . 0.561 ' H ' ' HB3' ' A' ' 564' ' ' ASN . . . 102.67 165.23 26.19 Favored Glycine 0 N--CA 1.42 -2.42 0 C-N-CA 120.695 -0.764 . . . . 41.11 113.161 177.255 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -79.72 123.11 27.38 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.383 -1.34 . . . . 74.41 107.383 176.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 535' ' ' VAL . . . . . 0.509 HG22 HD22 ' A' ' 596' ' ' LEU . 65.7 t -124.32 139.48 50.54 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-N 116.19 -0.459 . . . . 74.03 110.023 -175.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 536' ' ' ILE . . . . . 0.503 HG23 ' HB3' ' A' ' 559' ' ' GLU . 30.2 mm -104.24 139.18 25.94 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 109.014 -0.736 . . . . 63.33 109.014 178.064 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 41.9 t -118.4 108.53 41.58 Favored Pre-proline 0 C--N 1.306 -1.3 0 N-CA-C 109.474 -0.565 . . . . 73.23 109.474 177.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -73.93 138.85 26.47 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 122.117 1.878 . . . . 65.35 110.885 177.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 539' ' ' TYR . . . . . 0.443 ' HB3' HG22 ' A' ' 591' ' ' ILE . 46.0 p90 -146.46 161.47 40.35 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 120.804 -0.358 . . . . 73.34 110.531 -178.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 540' ' ' LYS . . . . . 0.41 ' HD2' ' O ' ' A' ' 540' ' ' LYS . 0.0 OUTLIER -155.31 147.65 23.87 Favored 'General case' 0 C--N 1.317 -0.807 0 O-C-N 123.518 0.511 . . . . 73.33 111.495 177.416 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 16.7 p -84.8 132.34 34.43 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 116.2 -0.455 . . . . 72.33 110.039 173.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.5 mp -93.63 124.22 46.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 106.271 -1.751 . . . . 72.54 106.271 173.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 543' ' ' GLU . . . . . 0.413 ' HB3' ' O ' ' A' ' 546' ' ' ALA . 2.7 mp0 -57.12 -52.67 64.36 Favored 'General case' 0 C--O 1.243 0.712 0 O-C-N 123.818 0.699 . . . . 73.5 110.765 -178.597 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 71.08 -81.91 0.44 Allowed Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 115.45 -0.795 . . . . 62.55 111.946 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 11.1 t -132.9 5.47 3.9 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.677 0.751 . . . . 74.33 109.806 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 546' ' ' ALA . . . . . 0.413 ' O ' ' HB3' ' A' ' 543' ' ' GLU . . . -106.2 178.83 4.45 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.841 -0.618 . . . . 33.35 109.612 178.469 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 547' ' ' ARG . . . . . 0.491 ' HD2' ' HB3' ' A' ' 551' ' ' GLU . 1.7 tmt_? -129.03 124.26 34.46 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 107.677 -1.231 . . . . 72.3 107.677 -175.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -82.9 -151.36 10.16 Favored Glycine 0 C--N 1.321 -0.264 0 C-N-CA 121.321 -0.466 . . . . 44.23 112.715 -177.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 66.6 19.4 69.01 Favored Glycine 0 C--N 1.314 -0.672 0 CA-C-N 116.689 0.244 . . . . 61.24 113.289 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 76.7 32.3 50.87 Favored Glycine 0 N--CA 1.437 -1.289 0 C-N-CA 120.748 -0.739 . . . . 50.33 111.614 -178.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 551' ' ' GLU . . . . . 0.491 ' HB3' ' HD2' ' A' ' 547' ' ' ARG . 8.1 tp10 -101.41 -65.75 0.96 Allowed 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.865 -0.42 . . . . 71.51 109.865 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -101.38 -34.05 9.76 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 106.526 -1.657 . . . . 73.4 106.526 177.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 553' ' ' PHE . . . . . 0.473 ' HA ' HG12 ' A' ' 576' ' ' ILE . 20.4 p90 -149.46 164.56 34.68 Favored 'General case' 0 N--CA 1.419 -2.023 0 CA-C-N 113.99 -1.459 . . . . 65.42 108.054 175.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 554' ' ' GLU . . . . . 0.515 ' HG3' ' HE2' ' A' ' 574' ' ' LYS . 0.5 OUTLIER -94.56 112.3 24.06 Favored 'General case' 0 C--N 1.282 -2.368 0 N-CA-C 105.805 -1.924 . . . . 73.31 105.805 176.983 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -76.94 101.06 5.8 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-O 122.525 1.155 . . . . 62.14 110.736 -175.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 556' ' ' THR . . . . . 0.47 ' CG2' HG22 ' A' ' 573' ' ' VAL . 8.9 t -91.44 121.8 33.47 Favored 'General case' 0 N--CA 1.396 -3.148 0 CA-C-O 122.395 1.093 . . . . 71.1 110.967 -178.067 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 10.4 p -136.83 119.25 15.79 Favored 'General case' 0 N--CA 1.41 -2.43 0 N-CA-C 106.56 -1.644 . . . . 72.44 106.56 177.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -170.12 -152.91 8.29 Favored Glycine 0 N--CA 1.415 -2.724 0 N-CA-C 110.596 -1.002 . . . . 72.52 110.596 -175.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 559' ' ' GLU . . . . . 0.503 ' HB3' HG23 ' A' ' 536' ' ' ILE . 34.7 mt-10 -135.03 127.47 30.48 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 122.364 0.265 . . . . 64.42 111.124 -176.145 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 96.1 mt -88.19 155.6 19.68 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.346 -0.612 . . . . 61.35 109.346 177.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -123.37 119.29 29.64 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-O 121.039 0.447 . . . . 74.22 111.471 -178.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -113.82 148.39 36.69 Favored 'General case' 0 CA--C 1.502 -0.881 0 C-N-CA 123.981 0.912 . . . . 75.33 109.492 176.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -127.87 167.55 16.43 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 120.243 -0.583 . . . . 72.43 109.45 177.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 564' ' ' ASN . . . . . 0.561 ' HB3' ' H ' ' A' ' 533' ' ' GLY . 32.1 p30 -66.87 -24.51 66.13 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.272 0.558 . . . . 22.45 111.142 178.491 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -102.72 -5.1 24.11 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.577 -0.738 . . . . 72.5 111.0 -177.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -115.35 134.86 54.72 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 116.4 -0.363 . . . . 72.41 110.599 -175.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 567' ' ' ILE . . . . . 0.504 ' HA ' ' HD3' ' A' ' 527' ' ' ARG . 9.5 pt -114.09 164.73 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 C-N-CA 120.969 -0.292 . . . . 51.11 110.267 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 568' ' ' VAL . . . . . 0.54 HG21 ' HD2' ' A' ' 524' ' ' LYS . 1.2 p 49.54 165.82 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.566 1.559 0 C-N-CA 127.301 2.24 . . . . 73.21 114.488 179.266 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 569' ' ' LYS . . . . . 0.512 ' HE3' ' HA ' ' A' ' 569' ' ' LYS . 1.0 OUTLIER -161.0 160.81 31.13 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 106.087 -1.82 . . . . 73.12 106.087 177.289 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 570' ' ' THR . . . . . 0.678 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 19.8 p -133.89 127.58 32.82 Favored 'General case' 0 N--CA 1.427 -1.601 0 O-C-N 123.478 0.486 . . . . 64.53 110.964 177.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 2.9 mp -76.62 125.45 36.4 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 107.016 -1.476 . . . . 70.14 107.016 173.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 24.4 m -99.44 109.37 21.94 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 120.859 0.361 . . . . 72.11 110.342 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 573' ' ' VAL . . . . . 0.47 HG22 ' CG2' ' A' ' 556' ' ' THR . 40.1 t -116.45 120.07 63.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 108.97 -0.752 . . . . 71.13 108.97 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 574' ' ' LYS . . . . . 0.515 ' HE2' ' HG3' ' A' ' 554' ' ' GLU . 38.8 ttpt -82.1 126.6 32.21 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-O 121.457 0.646 . . . . 75.23 110.938 177.321 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 82.5 t -91.51 134.84 28.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 107.982 -1.118 . . . . 55.0 107.982 178.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 576' ' ' ILE . . . . . 0.473 HG12 ' HA ' ' A' ' 553' ' ' PHE . 21.9 mm -105.69 160.05 5.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 107.475 -1.306 . . . . 72.13 107.475 -177.091 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -68.77 132.17 46.37 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 116.387 -0.37 . . . . 64.44 110.103 177.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.36 128.85 37.98 Favored 'General case' 0 CA--C 1.49 -1.342 0 CA-C-O 121.808 0.813 . . . . 64.24 111.405 -178.095 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 579' ' ' GLU . . . . . 0.442 ' H ' ' CD ' ' A' ' 579' ' ' GLU . 0.0 OUTLIER -100.18 -0.82 38.04 Favored 'General case' 0 C--N 1.275 -2.642 0 CA-C-N 114.02 -1.445 . . . . 73.11 113.335 -175.231 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 580' ' ' GLU . . . . . 0.542 ' HG2' ' O ' ' A' ' 581' ' ' TYR . 0.5 OUTLIER -137.29 -174.93 3.89 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.93 -0.481 . . . . 64.41 110.706 -176.63 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 581' ' ' TYR . . . . . 0.542 ' O ' ' HG2' ' A' ' 580' ' ' GLU . 28.5 p90 -65.63 154.32 39.13 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 108.706 -0.85 . . . . 71.23 108.706 174.147 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -86.0 152.26 23.06 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 114.988 1.477 . . . . 74.03 114.988 -176.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -157.71 172.74 17.97 Favored 'General case' 0 N--CA 1.433 -1.283 0 C-N-CA 126.77 2.028 . . . . 75.34 105.611 176.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -80.77 97.68 7.43 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.075 -1.454 . . . . 75.13 107.075 176.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 585' ' ' LYS . . . . . 0.474 ' HD2' HD13 ' A' ' 646' ' ' ILE . 0.0 OUTLIER -113.68 136.0 53.32 Favored 'General case' 0 N--CA 1.416 -2.152 0 CA-C-N 115.365 -0.834 . . . . 71.12 110.363 -175.652 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 3.9 t -151.33 146.97 26.38 Favored 'General case' 0 N--CA 1.421 -1.917 0 CA-C-N 115.137 -0.938 . . . . 75.41 110.483 -174.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 587' ' ' PHE . . . . . 0.4 ' CE2' HD11 ' A' ' 646' ' ' ILE . 2.5 p90 -122.18 155.62 35.4 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 114.6 -1.182 . . . . 64.13 109.628 177.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 588' ' ' PHE . . . . . 0.514 ' HA ' ' O ' ' A' ' 642' ' ' LEU . 34.9 m-85 -110.71 145.73 37.51 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.721 -0.474 . . . . 71.34 109.721 -174.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -116.25 119.62 36.32 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 106.491 -1.67 . . . . 73.33 106.491 176.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -125.5 138.78 53.99 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 108.847 -0.797 . . . . 60.33 108.847 -178.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 591' ' ' ILE . . . . . 0.443 HG22 ' HB3' ' A' ' 539' ' ' TYR . 27.3 pt -103.73 151.03 6.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 108.502 -0.925 . . . . 71.03 108.502 176.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -93.72 -150.09 26.26 Favored Glycine 0 N--CA 1.427 -1.918 0 N-CA-C 110.855 -0.898 . . . . 64.14 110.855 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -86.3 119.63 71.7 Favored Pre-proline 0 C--N 1.301 -1.53 0 N-CA-C 108.552 -0.907 . . . . 73.53 108.552 178.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 594' ' ' PRO . . . . . 0.456 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 12.9 Cg_endo -57.47 149.13 68.09 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 122.37 2.047 . . . . 73.44 111.175 177.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -128.66 132.84 48.1 Favored 'General case' 0 C--N 1.291 -1.959 0 O-C-N 121.996 -0.44 . . . . 72.05 110.306 -173.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 596' ' ' LEU . . . . . 0.509 HD22 HG22 ' A' ' 535' ' ' VAL . 0.0 OUTLIER -77.43 128.12 33.7 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.671 -1.233 . . . . 71.15 107.671 -177.337 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 597' ' ' VAL . . . . . 0.459 ' CG2' HG12 ' A' ' 536' ' ' ILE . 52.2 t . . . . . 0 C--N 1.315 -0.92 0 CA-C-O 121.869 0.842 . . . . 73.41 109.373 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.43 -1.442 0 N-CA-C 105.894 -1.891 . . . . 75.22 105.894 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 634' ' ' PRO . . . . . 0.456 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 18.2 Cg_endo -63.17 144.81 92.88 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 121.203 1.268 . . . . 72.54 110.485 175.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.3 pp -122.48 169.25 14.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 113.46 0.911 . . . . 73.34 113.46 -177.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 636' ' ' LEU . . . . . 0.445 ' HB2' HG21 ' A' ' 640' ' ' THR . 0.0 OUTLIER -73.85 168.34 19.63 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 123.788 0.835 . . . . 62.5 112.106 -176.967 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -113.18 -157.51 12.72 Favored Glycine 0 N--CA 1.437 -1.282 0 N-CA-C 115.704 1.042 . . . . 72.05 115.704 -174.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -42.65 -59.32 1.96 Allowed 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 128.107 2.563 . . . . 64.33 114.751 -173.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 10.6 p80 -140.06 109.63 6.28 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 122.019 0.914 . . . . 63.34 111.812 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 640' ' ' THR . . . . . 0.445 HG21 ' HB2' ' A' ' 636' ' ' LEU . 11.0 p -114.61 91.71 3.71 Favored 'General case' 0 N--CA 1.411 -2.412 0 CA-C-N 115.008 -0.996 . . . . 71.52 111.102 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 641' ' ' LYS . . . . . 0.451 ' HE2' ' HB2' ' A' ' 643' ' ' GLU . 1.0 OUTLIER -175.23 137.25 0.39 Allowed 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 105.353 -2.091 . . . . 75.34 105.353 178.779 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 642' ' ' LEU . . . . . 0.514 ' O ' ' HA ' ' A' ' 588' ' ' PHE . 27.6 tp -135.31 114.14 11.94 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 108.775 -0.824 . . . . 74.43 108.775 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 643' ' ' GLU . . . . . 0.542 ' HB3' HG22 ' A' ' 511' ' ' VAL . 28.6 tt0 -98.31 110.04 22.69 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 107.127 -1.434 . . . . 74.1 107.127 176.248 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 644' ' ' VAL . . . . . 0.582 HG21 ' HE2' ' A' ' 521' ' ' MET . 22.0 t -97.46 102.08 13.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 109.77 -0.456 . . . . 63.23 109.77 -177.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 4.0 mp -89.15 120.18 37.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 N-CA-C 107.799 -1.186 . . . . 74.45 107.799 177.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 646' ' ' ILE . . . . . 0.474 HD13 ' HD2' ' A' ' 585' ' ' LYS . 2.8 mp -99.83 106.71 19.55 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.505 0 N-CA-C 106.724 -1.584 . . . . 74.54 106.724 -176.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -104.87 155.43 18.93 Favored 'General case' 0 C--N 1.279 -2.497 0 CA-C-O 121.237 0.541 . . . . 63.43 111.565 -177.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -60.84 162.61 6.6 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.052 -0.976 . . . . 62.54 113.479 -174.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 CA--C 1.557 1.223 0 CA-C-O 123.184 1.469 . . . . 75.42 107.654 177.939 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 503' ' ' GLY . . . . . 0.447 ' HA3' ' OG1' ' A' ' 528' ' ' THR . . . . . . . . 0 N--CA 1.406 -3.328 0 N-CA-C 114.128 0.411 . . . . 71.21 114.128 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 4.0 mp -125.61 134.88 65.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 123.879 0.871 . . . . 74.0 108.927 -173.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -131.2 127.62 38.29 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.343 -0.614 . . . . 74.24 109.343 173.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 506' ' ' THR . . . . . 0.453 ' HB ' ' HA3' ' A' ' 637' ' ' GLY . 15.0 t -154.25 164.49 38.48 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 109.443 -0.577 . . . . 53.44 109.443 -177.334 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -94.8 157.67 15.83 Favored 'General case' 0 CA--C 1.493 -1.242 0 N-CA-C 108.647 -0.871 . . . . 74.14 108.647 175.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -93.75 -33.81 13.46 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 106.882 -1.525 . . . . 72.42 106.882 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -95.61 120.9 62.75 Favored Pre-proline 0 CA--C 1.49 -1.362 0 CA-C-N 114.285 -1.325 . . . . 60.34 110.097 175.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 510' ' ' PRO . . . . . 0.489 ' HA ' ' O ' ' A' ' 641' ' ' LYS . 2.7 Cg_exo -80.88 -20.88 7.33 Favored 'Trans proline' 0 N--CA 1.44 -1.643 0 N-CA-C 108.251 -1.48 . . . . 72.41 108.251 165.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 99.2 t -145.06 138.73 22.16 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 C-N-CA 124.876 1.27 . . . . 75.43 109.061 -178.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 10.1 t -137.02 138.99 41.08 Favored 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 107.025 -1.472 . . . . 62.2 107.025 175.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 75.7 m-70 -109.99 116.13 31.04 Favored 'General case' 0 CA--C 1.488 -1.414 0 N-CA-C 109.064 -0.717 . . . . 72.23 109.064 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.627 HG11 ' SD ' ' A' ' 521' ' ' MET . 33.4 m -109.18 155.58 10.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 CA-C-O 122.024 0.916 . . . . 55.11 112.226 -174.158 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 515' ' ' SER . . . . . 0.465 ' O ' HG22 ' A' ' 518' ' ' ILE . 51.0 m -77.89 156.88 30.07 Favored 'General case' 0 N--CA 1.389 -3.502 0 CA-C-N 113.597 -1.638 . . . . 72.42 110.286 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 516' ' ' GLU . . . . . 0.43 ' HB2' ' O ' ' A' ' 647' ' ' GLU . 20.8 tp10 -87.7 -18.68 28.95 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 107.847 -1.168 . . . . 73.32 107.847 177.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 30.4 m -96.66 18.37 14.43 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.601 -0.727 . . . . 71.41 110.739 -176.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 518' ' ' ILE . . . . . 0.465 HG22 ' O ' ' A' ' 515' ' ' SER . 13.9 tt -102.81 152.22 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.631 0 N-CA-C 108.388 -0.968 . . . . 75.41 108.388 -177.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -92.89 -70.05 1.14 Allowed Glycine 0 N--CA 1.424 -2.133 0 C-N-CA 119.832 -1.175 . . . . 42.01 110.777 176.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 42.6 mm -117.34 125.21 73.87 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 N-CA-C 108.657 -0.868 . . . . 75.31 108.657 -176.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 521' ' ' MET . . . . . 0.672 ' HE1' HG21 ' A' ' 644' ' ' VAL . 22.6 ptt? -95.96 136.55 36.25 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 107.322 -1.362 . . . . 74.12 107.322 172.18 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 29.3 mp0 -115.79 107.56 15.2 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 108.191 -1.04 . . . . 74.43 108.191 177.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 523' ' ' VAL . . . . . 0.543 HG21 HD21 ' A' ' 642' ' ' LEU . 35.0 t -98.03 128.05 49.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 109.582 -0.525 . . . . 70.13 109.582 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -73.87 156.61 37.53 Favored 'General case' 0 C--N 1.317 -0.837 0 O-C-N 123.71 0.631 . . . . 74.11 111.141 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 27.2 t -127.74 144.4 37.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 N-CA-C 107.067 -1.457 . . . . 54.04 107.067 176.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -75.74 140.0 42.17 Favored 'General case' 0 CA--C 1.493 -1.237 0 N-CA-C 109.363 -0.606 . . . . 73.32 109.363 177.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 527' ' ' ARG . . . . . 0.475 ' CZ ' HG22 ' A' ' 567' ' ' ILE . 35.8 ttt180 -91.03 147.22 23.23 Favored 'General case' 0 N--CA 1.414 -2.24 0 CA-C-N 115.238 -0.892 . . . . 73.14 109.246 -176.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 528' ' ' THR . . . . . 0.447 ' OG1' ' HA3' ' A' ' 503' ' ' GLY . 4.2 t -59.54 146.48 40.46 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 114.737 -1.12 . . . . 71.4 112.122 177.461 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 15.7 t -79.54 -15.6 57.41 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 108.128 -1.064 . . . . 72.15 108.128 176.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -118.75 93.76 0.57 Allowed Glycine 0 N--CA 1.432 -1.598 0 N-CA-C 109.396 -1.481 . . . . 72.25 109.396 176.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -102.17 93.37 5.19 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.393 0.616 . . . . 63.53 110.572 -177.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -116.52 115.03 25.01 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.738 -0.664 . . . . 74.05 111.698 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 77.64 -121.17 5.72 Favored Glycine 0 N--CA 1.435 -1.372 0 CA-C-N 115.208 -0.905 . . . . 73.2 113.275 173.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 534' ' ' ASN . . . . . 0.425 ' ND2' HG21 ' A' ' 597' ' ' VAL . 34.7 t30 -139.44 127.6 22.5 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.262 -1.014 . . . . 73.34 108.262 -178.275 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 535' ' ' VAL . . . . . 0.529 HG22 HD22 ' A' ' 596' ' ' LEU . 54.8 t -123.52 124.57 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.742 0 N-CA-C 109.496 -0.557 . . . . 63.53 109.496 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 536' ' ' ILE . . . . . 0.504 HG23 ' HB3' ' A' ' 559' ' ' GLU . 29.9 mm -93.66 120.53 43.21 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 CA-C-N 114.966 -1.015 . . . . 64.42 109.135 178.149 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 537' ' ' VAL . . . . . 0.436 HG22 ' HB3' ' A' ' 594' ' ' PRO . 21.9 t -113.84 104.57 55.06 Favored Pre-proline 0 C--N 1.303 -1.451 0 N-CA-C 109.242 -0.651 . . . . 74.34 109.242 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -70.79 153.05 64.39 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 121.961 1.774 . . . . 72.43 110.978 177.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 539' ' ' TYR . . . . . 0.407 ' CD1' ' HG ' ' A' ' 560' ' ' LEU . 52.7 p90 -150.97 159.93 44.25 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.021 -0.733 . . . . 72.43 109.021 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -155.15 154.98 33.14 Favored 'General case' 0 C--N 1.316 -0.851 0 O-C-N 123.721 0.638 . . . . 75.42 110.605 177.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 18.0 p -93.4 116.11 28.66 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.853 -0.612 . . . . 73.32 109.369 174.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.5 mp -83.35 122.29 37.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 105.608 -1.997 . . . . 72.44 105.608 174.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -51.86 -39.45 58.93 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.115 0.783 . . . . 71.42 113.115 -175.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 74.74 -86.68 0.75 Allowed Glycine 0 N--CA 1.437 -1.273 0 N-CA-C 110.521 -1.032 . . . . 65.23 110.521 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 11.3 t -143.17 14.07 1.84 Allowed 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 122.488 1.137 . . . . 70.03 108.899 177.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 546' ' ' ALA . . . . . 0.456 ' HB2' ' HD3' ' A' ' 585' ' ' LYS . . . -96.74 -167.64 1.59 Allowed 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 114.714 -1.13 . . . . 65.14 109.512 177.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 547' ' ' ARG . . . . . 0.489 ' H ' ' HB3' ' A' ' 552' ' ' ASP . 0.0 OUTLIER -136.23 122.79 20.88 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 106.97 -1.493 . . . . 74.14 106.97 -178.944 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -78.7 -153.97 7.42 Favored Glycine 0 C--N 1.303 -1.261 0 O-C-N 123.587 0.554 . . . . 41.2 112.802 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 63.92 10.5 39.59 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 114.909 0.723 . . . . 63.01 114.909 177.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 86.18 14.19 67.13 Favored Glycine 0 N--CA 1.433 -1.561 0 C-N-CA 120.285 -0.96 . . . . 50.54 112.02 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 551' ' ' GLU . . . . . 0.481 ' OE2' ' HG3' ' A' ' 547' ' ' ARG . 31.8 tt0 -84.59 -61.45 1.79 Allowed 'General case' 0 C--O 1.236 0.393 0 N-CA-C 109.574 -0.528 . . . . 74.32 109.574 178.391 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 552' ' ' ASP . . . . . 0.489 ' HB3' ' H ' ' A' ' 547' ' ' ARG . 17.4 t70 -105.71 -36.95 6.9 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.628 -0.879 . . . . 74.54 108.628 177.355 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 553' ' ' PHE . . . . . 0.515 ' HA ' HG12 ' A' ' 576' ' ' ILE . 14.0 p90 -147.97 162.61 38.98 Favored 'General case' 0 N--CA 1.428 -1.525 0 N-CA-C 108.37 -0.974 . . . . 64.21 108.37 173.251 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -93.9 111.42 23.12 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 105.898 -1.89 . . . . 72.33 105.898 178.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -81.68 123.53 28.8 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-O 121.873 0.844 . . . . 71.42 110.419 -175.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 10.2 t -119.89 140.97 50.03 Favored 'General case' 0 N--CA 1.412 -2.338 0 CA-C-O 121.84 0.829 . . . . 63.3 110.664 -174.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 5.9 p -144.85 134.08 22.9 Favored 'General case' 0 N--CA 1.413 -2.324 0 N-CA-C 106.638 -1.615 . . . . 74.22 106.638 177.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -167.82 -153.87 8.34 Favored Glycine 0 N--CA 1.412 -2.954 0 C-N-CA 119.715 -1.231 . . . . 75.11 110.83 -175.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 559' ' ' GLU . . . . . 0.504 ' HB3' HG23 ' A' ' 536' ' ' ILE . 35.7 mt-10 -140.86 124.89 17.25 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 122.961 0.504 . . . . 74.03 109.828 -174.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 560' ' ' LEU . . . . . 0.407 ' HG ' ' CD1' ' A' ' 539' ' ' TYR . 95.4 mt -90.36 134.81 34.08 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 110.113 -0.329 . . . . 54.02 110.113 178.113 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -102.47 100.89 11.04 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.461 -0.791 . . . . 72.44 111.208 -176.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -99.62 144.63 28.49 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 109.202 -0.666 . . . . 72.03 109.202 174.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -138.78 171.28 14.57 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 109.82 -0.437 . . . . 73.03 109.82 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 19.4 p30 -64.72 -27.53 68.97 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 116.098 -0.501 . . . . 61.1 111.26 176.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -100.97 -23.88 14.44 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 116.159 -0.473 . . . . 62.51 111.783 177.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -85.38 128.56 34.76 Favored 'General case' 0 C--O 1.248 0.974 0 N-CA-C 110.227 -0.286 . . . . 75.21 110.227 -178.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 567' ' ' ILE . . . . . 0.475 HG22 ' CZ ' ' A' ' 527' ' ' ARG . 1.5 pp -116.42 138.49 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.024 0 N-CA-C 109.028 -0.73 . . . . 73.15 109.028 -179.143 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 568' ' ' VAL . . . . . 0.424 HG12 ' O ' ' A' ' 567' ' ' ILE . 1.4 p 58.66 153.75 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.153 0 C-N-CA 126.554 1.942 . . . . 62.34 113.88 177.172 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 569' ' ' LYS . . . . . 0.638 ' HA ' ' HE2' ' A' ' 569' ' ' LYS . 7.2 mmpt? -141.1 165.93 26.18 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.92 -0.77 . . . . 74.34 108.92 175.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 570' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 7.2 p -134.48 141.81 46.87 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 124.202 0.939 . . . . 73.21 110.886 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 2.7 mp -95.4 120.88 45.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 106.656 -1.609 . . . . 70.32 106.656 173.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 8.5 p -97.39 121.81 39.71 Favored 'General case' 0 N--CA 1.427 -1.618 0 O-C-N 123.683 0.615 . . . . 75.05 110.193 178.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 573' ' ' VAL . . . . . . . . . . . . . 52.1 t -130.51 134.72 61.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 N-CA-C 109.032 -0.729 . . . . 45.42 109.032 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -89.8 120.0 30.67 Favored 'General case' 0 C--O 1.248 0.985 0 O-C-N 123.705 0.628 . . . . 74.2 110.458 177.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 99.5 t -84.57 125.43 40.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 107.74 -1.207 . . . . 71.42 107.74 175.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 576' ' ' ILE . . . . . 0.515 HG12 ' HA ' ' A' ' 553' ' ' PHE . 31.1 mm -96.44 147.5 6.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 106.899 -1.519 . . . . 74.21 106.899 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -64.76 125.48 24.94 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 123.533 0.521 . . . . 53.33 110.387 -178.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -52.25 115.32 1.68 Allowed 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 114.636 1.347 . . . . 74.43 114.636 176.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.03 -38.16 66.63 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 112.633 -2.076 . . . . 74.32 109.035 176.07 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.98 -176.35 3.53 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 114.963 -1.017 . . . . 64.05 113.169 -176.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -52.74 153.71 3.1 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 126.159 1.784 . . . . 73.35 109.972 175.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 582' ' ' GLU . . . . . 0.507 ' OE2' ' HB ' ' A' ' 646' ' ' ILE . 33.1 tt0 -130.2 113.81 14.91 Favored 'General case' 0 C--N 1.287 -2.118 0 C-N-CA 119.05 -1.06 . . . . 73.42 111.988 178.508 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -89.26 -157.73 0.47 Allowed 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 106.285 -1.746 . . . . 71.34 106.285 173.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -75.19 76.69 2.33 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.392 -1.336 . . . . 65.41 107.392 171.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 585' ' ' LYS . . . . . 0.456 ' HD3' ' HB2' ' A' ' 546' ' ' ALA . 0.7 OUTLIER -104.42 128.96 52.41 Favored 'General case' 0 N--CA 1.402 -2.838 0 N-CA-C 107.715 -1.217 . . . . 73.31 107.715 -179.237 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 2.9 t -151.92 153.63 34.5 Favored 'General case' 0 N--CA 1.393 -3.276 0 CA-C-N 114.845 -1.07 . . . . 75.42 110.093 -172.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 587' ' ' PHE . . . . . 0.522 ' CE2' HD11 ' A' ' 646' ' ' ILE . 0.8 OUTLIER -119.92 148.77 43.1 Favored 'General case' 0 N--CA 1.422 -1.858 0 O-C-N 124.668 1.23 . . . . 75.13 108.648 175.365 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 588' ' ' PHE . . . . . 0.421 ' CD1' ' HE3' ' A' ' 641' ' ' LYS . 13.8 m-85 -107.26 133.18 52.2 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.769 -0.456 . . . . 72.42 109.769 -172.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 589' ' ' LEU . . . . . 0.469 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.3 OUTLIER -102.91 130.42 49.95 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 106.054 -1.832 . . . . 64.43 106.054 173.638 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -139.33 151.18 46.19 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 107.149 -1.426 . . . . 71.5 107.149 178.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 591' ' ' ILE . . . . . . . . . . . . . 23.4 pt -107.24 152.14 8.91 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 O-C-N 123.234 0.334 . . . . 73.12 110.18 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -95.7 -164.42 34.26 Favored Glycine 0 N--CA 1.435 -1.38 0 N-CA-C 111.648 -0.581 . . . . 64.34 111.648 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -68.74 114.77 24.75 Favored Pre-proline 0 C--O 1.248 1.011 0 C-N-CA 122.572 0.349 . . . . 71.41 110.067 -177.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 594' ' ' PRO . . . . . 0.579 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 39.3 Cg_endo -69.39 134.08 27.86 Favored 'Trans proline' 0 N--CA 1.439 -1.725 0 C-N-CA 121.816 1.677 . . . . 73.52 109.774 177.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -122.89 127.08 48.49 Favored 'General case' 0 C--N 1.282 -2.349 0 CA-C-O 121.218 0.532 . . . . 62.51 111.651 -172.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 596' ' ' LEU . . . . . 0.529 HD22 HG22 ' A' ' 535' ' ' VAL . 0.0 OUTLIER -75.31 125.79 29.68 Favored 'General case' 0 N--CA 1.428 -1.525 0 N-CA-C 106.82 -1.548 . . . . 72.42 106.82 -179.686 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 597' ' ' VAL . . . . . 0.425 HG21 ' ND2' ' A' ' 534' ' ' ASN . 94.7 t . . . . . 0 C--N 1.297 -1.712 0 N-CA-C 112.38 0.511 . . . . 75.25 112.38 -176.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.888 0 CA-C-O 121.347 0.594 . . . . 70.11 111.69 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 634' ' ' PRO . . . . . 0.579 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 8.0 Cg_endo -70.25 143.13 47.56 Favored 'Trans proline' 0 N--CA 1.432 -2.112 0 N-CA-C 105.815 -2.417 . . . . 73.22 105.815 162.091 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.0 pp -129.43 -178.28 2.41 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 N-CA-C 115.54 1.681 . . . . 73.03 115.54 -174.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 2.5 tp -70.79 148.22 48.12 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 113.635 -1.62 . . . . 71.04 109.959 -178.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 637' ' ' GLY . . . . . 0.453 ' HA3' ' HB ' ' A' ' 506' ' ' THR . . . -89.39 -133.04 4.78 Favored Glycine 0 N--CA 1.423 -2.219 0 C-N-CA 120.631 -0.795 . . . . 52.12 111.698 174.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -98.09 -54.2 3.15 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 122.638 -0.331 . . . . 75.23 111.555 -175.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -124.58 93.98 4.06 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 122.285 1.04 . . . . 74.43 112.904 -178.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 3.1 p -100.7 91.21 4.53 Favored 'General case' 0 N--CA 1.404 -2.75 0 CA-C-N 114.545 -1.207 . . . . 73.22 108.992 174.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 641' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 510' ' ' PRO . 21.0 tptm -169.76 130.44 1.03 Allowed 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 106.992 -1.484 . . . . 74.43 106.992 -175.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 642' ' ' LEU . . . . . 0.543 HD21 HG21 ' A' ' 523' ' ' VAL . 41.5 tp -132.57 103.45 6.16 Favored 'General case' 0 C--N 1.272 -2.778 0 N-CA-C 107.225 -1.398 . . . . 74.42 107.225 175.231 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 643' ' ' GLU . . . . . 0.429 ' HB2' ' HE2' ' A' ' 641' ' ' LYS . 22.0 tt0 -91.4 104.91 17.37 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 107.196 -1.409 . . . . 71.31 107.196 178.486 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 644' ' ' VAL . . . . . 0.672 HG21 ' HE1' ' A' ' 521' ' ' MET . 21.6 t -92.4 99.03 9.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-N 115.904 -0.589 . . . . 64.12 110.085 -176.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 3.5 mp -87.6 127.12 41.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 107.928 -1.138 . . . . 74.31 107.928 177.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 646' ' ' ILE . . . . . 0.522 HD11 ' CE2' ' A' ' 587' ' ' PHE . 1.7 mp -101.58 141.62 17.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 106.691 -1.596 . . . . 72.3 106.691 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 647' ' ' GLU . . . . . 0.43 ' O ' ' HB2' ' A' ' 516' ' ' GLU . 2.0 pt-20 -135.43 159.65 40.92 Favored 'General case' 0 C--N 1.264 -3.144 0 N-CA-C 107.38 -1.341 . . . . 74.43 107.38 178.379 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -72.62 77.1 1.09 Allowed 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 121.829 0.823 . . . . 61.12 110.296 174.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 4.3 t . . . . . 0 C--N 1.317 -0.844 0 C-N-CA 129.372 3.069 . . . . 65.32 115.886 177.326 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 503' ' ' GLY . . . . . 0.598 ' HA2' ' OG1' ' A' ' 528' ' ' THR . . . . . . . . 0 N--CA 1.414 -2.825 0 N-CA-C 114.979 0.751 . . . . 43.53 114.979 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 4.0 mp -138.58 96.3 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 N-CA-C 105.624 -1.991 . . . . 51.03 105.624 171.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -120.86 108.32 13.78 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 108.869 -0.789 . . . . 71.03 108.869 178.085 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 11.4 t -139.26 160.81 38.93 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 108.02 -1.104 . . . . 72.15 108.02 -176.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -85.68 148.9 25.66 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.675 -0.491 . . . . 70.34 109.675 175.347 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -73.51 -31.23 63.59 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.435 -0.95 . . . . 73.32 108.435 177.169 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -138.72 135.89 18.23 Favored Pre-proline 0 N--CA 1.44 -0.964 0 N-CA-C 109.431 -0.581 . . . . 75.01 109.431 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -82.2 -13.04 10.28 Favored 'Trans proline' 0 C--O 1.218 -0.485 0 C-N-CA 122.671 2.247 . . . . 33.41 112.08 178.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 511' ' ' VAL . . . . . 0.545 HG22 ' HB3' ' A' ' 643' ' ' GLU . 70.6 t -140.63 137.66 35.79 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.858 0 N-CA-C 108.365 -0.976 . . . . 63.41 108.365 -178.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 4.9 t -143.6 137.06 28.07 Favored 'General case' 0 N--CA 1.419 -1.993 0 N-CA-C 107.925 -1.139 . . . . 73.25 107.925 177.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -106.82 126.49 52.37 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 109.106 -0.702 . . . . 75.12 109.106 176.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 29.1 m -126.92 161.47 33.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 115.751 -0.659 . . . . 64.21 109.373 -175.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 33.8 t -85.54 161.86 19.15 Favored 'General case' 0 N--CA 1.424 -1.759 0 N-CA-C 108.527 -0.916 . . . . 73.33 108.527 178.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -99.3 -11.83 20.89 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-O 121.376 0.608 . . . . 73.01 109.366 177.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 48.8 m -91.41 8.94 33.84 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.637 0.732 . . . . 70.13 109.885 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 13.6 tt -90.29 157.16 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 N-CA-C 108.122 -1.066 . . . . 65.01 108.122 -178.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -88.48 -57.07 1.91 Allowed Glycine 0 N--CA 1.438 -1.199 0 C-N-CA 120.201 -1.0 . . . . 61.34 111.282 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 520' ' ' ILE . . . . . 0.456 HD13 ' HA ' ' A' ' 574' ' ' LYS . 44.9 mm -127.39 136.65 60.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 108.778 -0.823 . . . . 43.33 108.778 -178.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 521' ' ' MET . . . . . 0.587 ' HE2' HG21 ' A' ' 644' ' ' VAL . 0.0 OUTLIER -111.03 133.28 53.54 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.077 -1.453 . . . . 72.1 107.077 171.103 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 -117.38 128.78 55.37 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 109.294 -0.632 . . . . 72.52 109.294 -176.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 523' ' ' VAL . . . . . 0.64 HG21 HD21 ' A' ' 642' ' ' LEU . 20.5 t -119.81 134.87 61.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 N-CA-C 109.746 -0.464 . . . . 65.05 109.746 179.101 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 524' ' ' LYS . . . . . 0.419 ' HD2' HG21 ' A' ' 568' ' ' VAL . 29.3 mmtp -80.39 129.45 34.51 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 113.792 1.034 . . . . 62.21 113.792 -177.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 3.3 t -112.46 133.5 58.02 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 N-CA-C 106.644 -1.613 . . . . 55.32 106.644 177.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -86.76 139.67 30.49 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 120.477 -0.489 . . . . 72.21 109.723 -178.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 527' ' ' ARG . . . . . 0.472 ' HG2' ' N ' ' A' ' 528' ' ' THR . 37.6 ttp180 -86.96 157.73 19.42 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.103 0.478 . . . . 65.04 111.176 -176.378 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 528' ' ' THR . . . . . 0.598 ' OG1' ' HA2' ' A' ' 503' ' ' GLY . 4.2 t -58.36 158.48 7.29 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 125.006 1.323 . . . . 71.21 111.674 173.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 32.8 t -87.94 -7.37 57.22 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 115.021 -0.99 . . . . 70.31 109.406 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -132.13 110.39 0.94 Allowed Glycine 0 N--CA 1.436 -1.324 0 N-CA-C 109.409 -1.476 . . . . 60.12 109.409 178.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 531' ' ' ALA . . . . . 0.408 ' HB2' HG23 ' A' ' 528' ' ' THR . . . -155.35 92.85 1.45 Allowed 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 109.3 -0.63 . . . . 65.22 109.3 -175.282 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.54 23.8 13.88 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 115.318 -0.856 . . . . 75.03 111.085 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . -177.26 -168.26 36.8 Favored Glycine 0 N--CA 1.42 -2.392 0 N-CA-C 110.461 -1.056 . . . . 64.12 110.461 -174.071 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 534' ' ' ASN . . . . . 0.406 ' HA ' ' HA ' ' A' ' 563' ' ' GLN . 51.1 t30 -85.37 132.82 34.17 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 123.482 0.713 . . . . 75.55 110.304 -177.153 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 535' ' ' VAL . . . . . 0.513 HG22 HD22 ' A' ' 596' ' ' LEU . 58.0 t -128.13 124.74 63.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 108.871 -0.789 . . . . 50.3 108.871 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 536' ' ' ILE . . . . . 0.506 HG23 ' HB3' ' A' ' 559' ' ' GLU . 19.7 mm -97.85 127.8 49.87 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 CA-C-N 115.921 -0.581 . . . . 62.04 109.931 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 537' ' ' VAL . . . . . 0.521 HG22 ' HB3' ' A' ' 594' ' ' PRO . 41.5 t -117.1 103.74 51.48 Favored Pre-proline 0 C--N 1.309 -1.187 0 N-CA-C 108.684 -0.858 . . . . 73.42 108.684 176.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -71.95 144.47 43.04 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.193 1.929 . . . . 63.12 110.769 178.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 539' ' ' TYR . . . . . 0.487 ' HB3' HG22 ' A' ' 591' ' ' ILE . 49.0 p90 -145.75 167.31 23.46 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 109.414 -0.587 . . . . 73.0 109.414 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -158.97 157.14 30.73 Favored 'General case' 0 C--N 1.308 -1.222 0 O-C-N 123.711 0.632 . . . . 74.53 109.781 177.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 3.3 p -93.17 113.6 25.88 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 115.143 -0.935 . . . . 55.31 110.546 175.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.3 mp -78.47 118.01 24.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 N-CA-C 104.781 -2.303 . . . . 70.04 104.781 173.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -53.65 -43.12 68.55 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 124.019 0.825 . . . . 52.14 112.76 -174.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 67.19 -89.71 0.17 Allowed Glycine 0 N--CA 1.451 -0.327 0 O-C-N 123.491 0.494 . . . . 71.51 112.258 176.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 7.4 t -137.2 20.06 2.97 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.3 0.571 . . . . 74.04 110.166 178.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 546' ' ' ALA . . . . . 0.434 ' HB2' ' HG2' ' A' ' 585' ' ' LYS . . . -119.37 166.41 13.08 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.465 -0.939 . . . . 74.14 108.465 175.43 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 547' ' ' ARG . . . . . 0.444 ' HB2' ' HB2' ' A' ' 551' ' ' GLU . 0.0 OUTLIER -95.72 114.04 25.74 Favored 'General case' 0 CA--C 1.488 -1.438 0 C-N-CA 120.012 -0.675 . . . . 71.23 112.643 176.872 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -94.77 108.81 3.74 Favored Glycine 0 C--N 1.291 -1.928 0 N-CA-C 110.061 -1.216 . . . . 74.52 110.061 178.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 154.43 8.76 0.08 OUTLIER Glycine 0 C--N 1.295 -1.735 0 C-N-CA 119.341 -1.409 . . . . 53.32 112.703 -178.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 109.3 5.18 30.42 Favored Glycine 0 N--CA 1.431 -1.649 0 C-N-CA 119.234 -1.46 . . . . 71.2 113.585 178.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 551' ' ' GLU . . . . . 0.444 ' HB2' ' HB2' ' A' ' 547' ' ' ARG . 15.2 mm-40 -84.29 -70.39 0.58 Allowed 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 117.614 0.707 . . . . 63.24 109.212 177.26 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -101.31 -39.56 7.54 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 108.276 -1.009 . . . . 62.12 108.276 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -139.33 160.88 38.8 Favored 'General case' 0 C--O 1.262 1.715 0 CA-C-O 121.238 0.542 . . . . 71.12 109.617 179.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.21 119.28 29.56 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 106.675 -1.602 . . . . 72.4 106.675 179.265 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -67.06 101.81 0.92 Allowed 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 122.979 0.512 . . . . 73.55 109.671 -178.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 556' ' ' THR . . . . . 0.509 HG21 HG22 ' A' ' 573' ' ' VAL . 12.4 t -100.78 110.75 22.87 Favored 'General case' 0 N--CA 1.413 -2.308 0 CA-C-O 122.689 1.233 . . . . 72.03 110.779 -176.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 1.7 p -133.39 96.69 3.78 Favored 'General case' 0 N--CA 1.413 -2.297 0 CA-C-N 114.234 -1.348 . . . . 62.33 108.66 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -147.03 -153.33 5.88 Favored Glycine 0 N--CA 1.408 -3.167 0 N-CA-C 110.518 -1.033 . . . . 61.04 110.518 -173.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 559' ' ' GLU . . . . . 0.506 ' HB3' HG23 ' A' ' 536' ' ' ILE . 33.3 mt-10 -133.73 124.64 27.02 Favored 'General case' 0 C--N 1.29 -2.001 0 O-C-N 123.605 0.238 . . . . 61.04 111.289 -172.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 560' ' ' LEU . . . . . 0.455 ' HG ' ' CD2' ' A' ' 539' ' ' TYR . 93.2 mt -80.99 133.03 35.42 Favored 'General case' 0 C--O 1.247 0.929 0 N-CA-C 109.765 -0.457 . . . . 64.0 109.765 177.109 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -96.78 98.19 9.94 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 115.986 -0.552 . . . . 74.32 111.475 -178.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -96.98 150.88 20.27 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 107.004 -1.48 . . . . 71.55 107.004 172.199 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 563' ' ' GLN . . . . . 0.406 ' HA ' ' HA ' ' A' ' 534' ' ' ASN . 1.9 pt20 -156.53 172.7 18.08 Favored 'General case' 0 C--N 1.28 -2.434 0 O-C-N 121.926 -0.484 . . . . 72.11 111.044 -178.205 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -52.14 -47.15 65.54 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 124.687 1.195 . . . . 62.02 111.012 -177.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -90.15 4.84 49.25 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 114.061 1.134 . . . . 75.21 114.061 -177.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 24.8 tp10 -121.79 126.63 49.27 Favored 'General case' 0 C--N 1.309 -1.189 0 O-C-N 121.76 -0.587 . . . . 74.41 110.555 -178.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 567' ' ' ILE . . . . . 0.456 ' HA ' ' HD3' ' A' ' 527' ' ' ARG . 4.9 pt -111.39 159.72 11.18 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.868 0 N-CA-C 109.266 -0.642 . . . . 72.32 109.266 174.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 568' ' ' VAL . . . . . 0.419 HG21 ' HD2' ' A' ' 524' ' ' LYS . 1.4 p 50.14 176.28 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.57 1.748 0 C-N-CA 125.955 1.702 . . . . 73.03 111.487 -176.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 569' ' ' LYS . . . . . 0.575 ' HE3' ' HA ' ' A' ' 569' ' ' LYS . 0.0 OUTLIER -165.72 167.83 16.71 Favored 'General case' 0 C--N 1.313 -1.017 0 O-C-N 120.911 -1.118 . . . . 73.4 108.28 173.941 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 570' ' ' THR . . . . . 0.612 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 7.1 p -132.28 138.66 47.94 Favored 'General case' 0 N--CA 1.421 -1.881 0 O-C-N 123.719 0.637 . . . . 71.4 109.971 179.003 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 571' ' ' ILE . . . . . 0.407 HG21 HD21 ' A' ' 589' ' ' LEU . 3.3 mp -90.66 117.07 33.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 106.618 -1.623 . . . . 74.23 106.618 170.332 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 15.7 p -95.29 110.8 22.75 Favored 'General case' 0 N--CA 1.426 -1.646 0 CA-C-O 121.059 0.457 . . . . 74.03 109.892 177.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 573' ' ' VAL . . . . . 0.509 HG22 HG21 ' A' ' 556' ' ' THR . 48.6 t -108.73 132.29 57.08 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 N-CA-C 109.113 -0.699 . . . . 54.12 109.113 -179.324 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 574' ' ' LYS . . . . . 0.456 ' HA ' HD13 ' A' ' 520' ' ' ILE . 22.3 tptm -86.91 119.74 27.45 Favored 'General case' 0 N--CA 1.434 -1.262 0 O-C-N 123.569 0.543 . . . . 75.14 110.463 179.03 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 56.3 t -89.91 132.87 33.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 106.674 -1.602 . . . . 71.11 106.674 175.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 39.5 mm -94.32 153.36 3.45 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 N-CA-C 109.16 -0.682 . . . . 64.11 109.16 -173.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -61.73 106.36 0.67 Allowed 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.582 -0.896 . . . . 72.51 108.582 172.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -62.29 142.18 57.88 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 113.944 -1.48 . . . . 70.31 112.949 -169.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -80.18 -51.91 8.39 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.844 0.83 . . . . 72.21 110.052 -177.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.64 -156.27 0.69 Allowed 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.803 -0.814 . . . . 70.55 108.803 -176.24 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -113.51 150.28 33.15 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 105.557 -2.016 . . . . 73.01 105.557 172.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 41.1 mp0 -126.68 -174.43 3.13 Favored 'General case' 0 C--N 1.282 -2.365 0 N-CA-C 108.785 -0.82 . . . . 64.23 108.785 176.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -85.64 -158.75 0.41 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 106.633 -1.617 . . . . 54.33 106.633 174.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -85.63 79.81 9.23 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 106.437 -1.69 . . . . 71.03 106.437 173.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 585' ' ' LYS . . . . . 0.434 ' HG2' ' HB2' ' A' ' 546' ' ' ALA . 0.0 OUTLIER -88.55 168.03 12.92 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 115.411 -0.813 . . . . 64.44 110.131 -172.86 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 5.0 t -155.29 149.92 26.33 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-O 121.742 0.782 . . . . 74.24 112.873 -173.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -126.55 148.68 49.71 Favored 'General case' 0 N--CA 1.412 -2.33 0 CA-C-N 112.894 -1.957 . . . . 74.21 108.167 174.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 588' ' ' PHE . . . . . 0.515 ' HA ' ' O ' ' A' ' 642' ' ' LEU . 28.3 m-85 -105.61 129.74 53.79 Favored 'General case' 0 C--N 1.292 -1.935 0 N-CA-C 109.177 -0.675 . . . . 63.24 109.177 -175.302 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 589' ' ' LEU . . . . . 0.407 HD21 HG21 ' A' ' 571' ' ' ILE . 0.3 OUTLIER -97.83 121.09 39.34 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 106.034 -1.839 . . . . 72.52 106.034 176.814 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -125.34 129.89 50.86 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 109.712 -0.477 . . . . 72.24 109.712 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 591' ' ' ILE . . . . . 0.487 HG22 ' HB3' ' A' ' 539' ' ' TYR . 22.8 pt -98.44 138.4 23.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 107.229 -1.397 . . . . 73.51 107.229 174.214 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -91.06 -144.95 13.29 Favored Glycine 0 N--CA 1.431 -1.642 0 C-N-CA 121.0 -0.619 . . . . 71.32 112.897 -176.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -83.33 119.28 73.73 Favored Pre-proline 0 C--N 1.301 -1.516 0 N-CA-C 109.451 -0.574 . . . . 73.12 109.451 -178.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 594' ' ' PRO . . . . . 0.521 ' HB3' HG22 ' A' ' 537' ' ' VAL . 30.2 Cg_endo -67.15 152.7 79.36 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 121.966 1.777 . . . . 62.14 111.016 176.14 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -137.21 133.42 35.12 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 110.051 -0.351 . . . . 74.42 110.051 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 596' ' ' LEU . . . . . 0.513 HD22 HG22 ' A' ' 535' ' ' VAL . 0.0 OUTLIER -79.01 130.91 36.04 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 106.643 -1.614 . . . . 63.34 106.643 179.832 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 16.8 t . . . . . 0 C--N 1.293 -1.884 0 CA-C-O 122.071 0.939 . . . . 73.32 109.954 -177.457 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 15.2 mtp85 . . . . . 0 N--CA 1.431 -1.401 0 N-CA-C 108.412 -0.958 . . . . 71.32 108.412 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 634' ' ' PRO . . . . . 0.493 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 51.0 Cg_endo -73.08 139.58 29.93 Favored 'Trans proline' 0 N--CA 1.441 -1.578 0 C-N-CA 121.545 1.497 . . . . 75.21 110.697 176.49 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.4 pp -126.68 -175.96 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 111.904 0.335 . . . . 71.34 111.904 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -77.61 178.29 7.41 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.228 0.537 . . . . 75.32 111.29 -174.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -96.58 -85.18 1.74 Allowed Glycine 0 N--CA 1.421 -2.343 0 C-N-CA 120.554 -0.831 . . . . 43.11 111.606 178.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -127.53 -66.78 0.86 Allowed 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 115.509 -0.346 . . . . 72.31 110.08 -175.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 13.3 p80 -123.14 119.05 29.11 Favored 'General case' 0 C--O 1.246 0.9 0 CA-C-O 121.627 0.727 . . . . 61.03 111.51 -177.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 6.3 p -109.12 90.98 3.46 Favored 'General case' 0 N--CA 1.412 -2.356 0 CA-C-N 115.145 -0.934 . . . . 73.32 108.747 175.243 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -177.49 132.1 0.16 Allowed 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 106.49 -1.67 . . . . 72.03 106.49 -176.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 642' ' ' LEU . . . . . 0.64 HD21 HG21 ' A' ' 523' ' ' VAL . 41.8 tp -138.24 111.83 8.2 Favored 'General case' 0 C--N 1.29 -2.007 0 O-C-N 123.705 0.628 . . . . 73.04 109.61 177.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 643' ' ' GLU . . . . . 0.545 ' HB3' HG22 ' A' ' 511' ' ' VAL . 35.7 tt0 -90.74 104.01 16.64 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 107.392 -1.336 . . . . 53.11 107.392 177.14 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 644' ' ' VAL . . . . . 0.587 HG21 ' HE2' ' A' ' 521' ' ' MET . 39.8 t -95.01 110.07 23.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.804 -0.813 . . . . 71.01 108.804 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 3.9 mp -91.82 117.74 35.76 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 N-CA-C 108.013 -1.106 . . . . 64.11 108.013 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 646' ' ' ILE . . . . . 0.494 HD12 ' H ' ' A' ' 646' ' ' ILE . 1.5 mp -107.13 109.54 28.53 Favored 'Isoleucine or valine' 0 CA--C 1.473 -2.018 0 N-CA-C 106.115 -1.809 . . . . 62.42 106.115 -176.081 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -111.33 150.35 29.83 Favored 'General case' 0 C--N 1.249 -3.787 0 C-N-CA 120.417 -0.513 . . . . 73.55 111.401 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -63.3 133.9 54.92 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 105.552 -2.018 . . . . 72.52 105.552 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 8.2 t . . . . . 0 C--N 1.318 -0.763 0 CA-C-O 121.827 0.822 . . . . 34.35 112.05 -169.175 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 503' ' ' GLY . . . . . 0.553 ' HA2' ' OG1' ' A' ' 528' ' ' THR . . . . . . . . 0 N--CA 1.398 -3.838 0 N-CA-C 110.938 -0.865 . . . . 64.22 110.938 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 2.9 mp -123.58 105.81 16.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 108.096 -1.076 . . . . 44.22 108.096 -178.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 505' ' ' PHE . . . . . 0.428 ' CE1' ' HB ' ' A' ' 528' ' ' THR . 93.1 m-85 -114.9 121.49 43.37 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.178 0.513 . . . . 52.12 110.59 178.438 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 506' ' ' THR . . . . . 0.433 HG23 HD23 ' A' ' 526' ' ' LEU . 13.8 t -147.21 163.01 37.71 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.022 -1.103 . . . . 74.03 108.022 -177.367 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -85.61 148.32 25.97 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 120.844 0.354 . . . . 75.02 110.961 176.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -84.44 -20.5 31.68 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 107.264 -1.384 . . . . 71.52 107.264 176.492 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 509' ' ' GLU . . . . . 0.432 ' HG3' ' O ' ' A' ' 511' ' ' VAL . 1.9 tp10 -129.01 120.58 20.34 Favored Pre-proline 0 N--CA 1.431 -1.389 0 CA-C-N 114.734 -1.121 . . . . 62.4 108.169 -178.291 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -80.38 -24.3 5.51 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 120.908 1.072 . . . . 74.41 110.147 173.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 511' ' ' VAL . . . . . 0.521 HG22 ' HB3' ' A' ' 643' ' ' GLU . 76.4 t -142.93 129.02 17.13 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 C-N-CA 124.561 1.145 . . . . 44.14 108.722 -178.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 14.6 t -128.2 142.94 51.03 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 108.284 -1.006 . . . . 70.22 108.284 177.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 68.5 m-70 -108.42 120.85 43.6 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.861 -0.792 . . . . 61.31 108.861 175.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 23.1 m -118.13 150.15 20.36 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.394 0 N-CA-C 107.919 -1.141 . . . . 71.12 107.919 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 515' ' ' SER . . . . . 0.406 ' HG ' ' HA ' ' A' ' 649' ' ' SER . 2.7 t -83.95 152.71 24.33 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 108.74 -0.837 . . . . 54.44 108.74 -178.289 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -70.33 -21.08 62.95 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 120.934 0.397 . . . . 70.34 110.928 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 45.2 m -90.35 12.21 19.04 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-O 121.226 0.536 . . . . 61.21 110.709 -175.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 12.7 tt -86.57 153.46 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.877 0 N-CA-C 108.871 -0.788 . . . . 74.25 108.871 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -90.98 -63.92 1.2 Allowed Glycine 0 N--CA 1.432 -1.596 0 C-N-CA 119.959 -1.115 . . . . 71.24 110.568 178.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 37.1 mm -120.25 121.44 65.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 107.905 -1.146 . . . . 72.41 107.905 178.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 521' ' ' MET . . . . . 0.574 ' HE1' HG21 ' A' ' 644' ' ' VAL . 0.0 OUTLIER -94.92 136.37 35.32 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 106.907 -1.516 . . . . 73.32 106.907 174.312 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 522' ' ' GLU . . . . . 0.46 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 48.9 mt-10 -124.41 138.26 54.38 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 124.093 0.871 . . . . 71.11 109.949 -178.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 523' ' ' VAL . . . . . 0.797 HG21 HD21 ' A' ' 642' ' ' LEU . 39.7 t -129.23 140.87 48.06 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 N-CA-C 109.055 -0.72 . . . . 74.15 109.055 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 524' ' ' LYS . . . . . 0.576 ' HD2' ' CG2' ' A' ' 568' ' ' VAL . 34.1 mmtp -85.34 134.35 34.1 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 122.243 1.02 . . . . 75.11 113.18 -178.106 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 4.2 t -110.57 146.94 15.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-N 113.926 -1.488 . . . . 65.2 107.349 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 526' ' ' LEU . . . . . 0.433 HD23 HG23 ' A' ' 506' ' ' THR . 2.8 mm? -87.3 135.58 33.26 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 109.567 -0.531 . . . . 75.41 109.567 177.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 527' ' ' ARG . . . . . 0.534 ' HD3' ' HA ' ' A' ' 567' ' ' ILE . 39.2 ttp180 -83.27 150.38 26.2 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-N 115.6 -0.727 . . . . 75.21 110.468 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 528' ' ' THR . . . . . 0.553 ' OG1' ' HA2' ' A' ' 503' ' ' GLY . 1.8 t -50.12 147.36 4.15 Favored 'General case' 0 N--CA 1.435 -1.198 0 C-N-CA 125.866 1.667 . . . . 73.42 113.2 174.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 19.2 m -65.07 -38.05 89.53 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 114.4 -1.273 . . . . 71.41 110.035 176.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -107.45 103.24 1.92 Allowed Glycine 0 N--CA 1.419 -2.451 0 N-CA-C 108.994 -1.642 . . . . 63.12 108.994 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 531' ' ' ALA . . . . . 0.475 ' HB2' HG23 ' A' ' 528' ' ' THR . . . -122.13 65.76 0.92 Allowed 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.046 0.45 . . . . 64.12 111.281 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -117.1 90.76 3.4 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.101 -1.444 . . . . 64.35 107.101 175.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 142.4 -138.31 8.38 Favored Glycine 0 N--CA 1.419 -2.464 0 N-CA-C 110.153 -1.179 . . . . 74.41 110.153 -175.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -146.14 131.34 18.42 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.841 -1.17 . . . . 64.14 107.841 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 535' ' ' VAL . . . . . 0.452 HG22 HD22 ' A' ' 596' ' ' LEU . 59.2 t -131.01 132.7 63.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.156 -0.683 . . . . 74.44 109.156 -177.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 536' ' ' ILE . . . . . . . . . . . . . 44.0 mm -105.35 131.04 55.64 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 109.665 -0.495 . . . . 64.24 109.665 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 537' ' ' VAL . . . . . 0.484 HG22 ' HB3' ' A' ' 594' ' ' PRO . 20.1 t -118.12 102.36 50.83 Favored Pre-proline 0 C--N 1.311 -1.089 0 O-C-N 123.307 0.38 . . . . 41.55 110.09 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -73.78 138.64 26.56 Favored 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 122.372 2.048 . . . . 61.55 111.604 178.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 539' ' ' TYR . . . . . 0.47 ' HB3' HG22 ' A' ' 591' ' ' ILE . 51.5 p90 -142.72 160.6 40.0 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 110.353 -0.24 . . . . 73.32 110.353 -177.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 540' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 556' ' ' THR . 0.0 OUTLIER -154.67 160.03 41.14 Favored 'General case' 0 C--O 1.247 0.938 0 O-C-N 123.595 0.56 . . . . 72.12 111.432 176.656 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 31.6 p -96.67 127.03 42.26 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.665 -0.698 . . . . 53.5 111.495 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.8 mp -93.72 111.52 25.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 106.142 -1.799 . . . . 71.4 106.142 172.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 543' ' ' GLU . . . . . 0.414 ' H ' ' CD ' ' A' ' 543' ' ' GLU . 1.5 mp0 -51.88 -53.34 41.85 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 124.348 1.059 . . . . 70.54 111.693 -176.145 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 68.95 -98.06 0.53 Allowed Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 121.1 -0.571 . . . . 72.33 111.969 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 545' ' ' THR . . . . . 0.436 HG23 ' H ' ' A' ' 586' ' ' THR . 8.8 t -111.29 -1.91 15.88 Favored 'General case' 0 CA--C 1.553 1.058 0 CA-C-O 121.969 0.89 . . . . 73.31 109.589 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 546' ' ' ALA . . . . . 0.42 ' HB2' ' HG2' ' A' ' 585' ' ' LYS . . . -93.8 171.12 9.07 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 108.067 -1.086 . . . . 55.24 108.067 174.518 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 547' ' ' ARG . . . . . 0.481 ' H ' ' HB3' ' A' ' 552' ' ' ASP . 1.4 tmt_? -126.67 121.55 32.44 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.009 -0.737 . . . . 75.54 109.009 -176.258 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -79.53 -164.58 28.85 Favored Glycine 0 CA--C 1.518 0.223 0 CA-C-N 116.234 -0.439 . . . . 71.22 112.892 -177.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 77.58 15.95 80.79 Favored Glycine 0 C--N 1.307 -1.058 0 N-CA-C 112.372 -0.291 . . . . 54.11 112.372 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 69.97 32.9 69.77 Favored Glycine 0 N--CA 1.431 -1.671 0 N-CA-C 110.5 -1.04 . . . . 74.12 110.5 -176.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -96.81 -64.58 1.03 Allowed 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 109.025 -0.731 . . . . 73.23 109.025 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 552' ' ' ASP . . . . . 0.481 ' HB3' ' H ' ' A' ' 547' ' ' ARG . 12.2 t70 -102.6 -36.62 8.28 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 106.807 -1.553 . . . . 61.5 106.807 177.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 553' ' ' PHE . . . . . 0.416 ' HA ' HG12 ' A' ' 576' ' ' ILE . 11.7 p90 -146.59 163.68 35.03 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 114.735 -1.121 . . . . 74.14 108.565 174.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -91.79 105.43 17.71 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 107.022 -1.473 . . . . 71.22 107.022 177.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -71.19 139.38 50.14 Favored 'General case' 0 CA--C 1.486 -1.488 0 N-CA-C 108.343 -0.984 . . . . 75.01 108.343 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 556' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 540' ' ' LYS . 11.0 t -138.16 138.43 38.61 Favored 'General case' 0 N--CA 1.396 -3.149 0 C-N-CA 118.842 -1.143 . . . . 74.33 111.989 -175.188 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 23.2 p -131.04 119.75 22.45 Favored 'General case' 0 N--CA 1.415 -2.216 0 N-CA-C 106.255 -1.757 . . . . 61.04 106.255 173.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -147.83 -170.67 16.1 Favored Glycine 0 N--CA 1.41 -3.057 0 C-N-CA 120.136 -1.031 . . . . 70.45 111.236 -172.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -139.09 106.6 5.57 Favored 'General case' 0 C--N 1.293 -1.885 0 C-N-CA 122.75 0.42 . . . . 53.5 109.869 -175.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 91.3 mt -73.71 136.79 43.75 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-N 116.043 -0.526 . . . . 72.43 110.198 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -105.62 114.71 29.04 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 116.102 -0.499 . . . . 63.12 111.235 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -111.17 148.74 32.1 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.656 -0.868 . . . . 75.43 108.656 174.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 563' ' ' GLN . . . . . 0.466 ' H ' ' HB3' ' A' ' 566' ' ' GLU . 26.9 pt20 -159.51 -178.16 6.92 Favored 'General case' 0 C--N 1.285 -2.225 0 N-CA-C 108.713 -0.847 . . . . 73.13 108.713 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -69.08 -29.98 68.2 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 121.712 0.768 . . . . 51.14 110.728 -178.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -82.74 -0.98 50.13 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.749 0.785 . . . . 73.54 110.798 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 566' ' ' GLU . . . . . 0.466 ' HB3' ' H ' ' A' ' 563' ' ' GLN . 8.2 tp10 -120.74 142.66 49.33 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.704 -0.623 . . . . 64.13 110.542 -175.578 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 567' ' ' ILE . . . . . 0.534 ' HA ' ' HD3' ' A' ' 527' ' ' ARG . 2.4 pt -133.58 150.78 32.31 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.273 0 N-CA-C 106.035 -1.839 . . . . 75.03 106.035 170.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 568' ' ' VAL . . . . . 0.576 ' CG2' ' HD2' ' A' ' 524' ' ' LYS . 1.2 p 49.77 -177.71 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.59 2.497 0 C-N-CA 124.7 1.2 . . . . 63.52 111.78 -175.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 569' ' ' LYS . . . . . 0.596 ' HE3' ' HA ' ' A' ' 569' ' ' LYS . 0.2 OUTLIER -173.94 164.55 4.21 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 107.979 -1.119 . . . . 75.23 107.979 176.032 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 570' ' ' THR . . . . . 0.592 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 36.3 p -127.1 142.85 51.42 Favored 'General case' 0 N--CA 1.436 -1.174 0 O-C-N 123.477 0.486 . . . . 51.11 110.907 177.469 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 571' ' ' ILE . . . . . 0.494 HG22 HG23 ' A' ' 573' ' ' VAL . 2.5 mp -91.78 122.48 43.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 N-CA-C 105.849 -1.908 . . . . 71.41 105.849 170.051 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 9.7 m -97.25 109.86 22.53 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 109.966 -0.383 . . . . 53.23 109.966 -179.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 573' ' ' VAL . . . . . 0.494 HG23 HG22 ' A' ' 571' ' ' ILE . 62.2 t -120.94 130.85 74.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 109.305 -0.628 . . . . 74.3 109.305 178.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -91.36 132.25 36.31 Favored 'General case' 0 C--N 1.312 -1.052 0 O-C-N 123.509 0.506 . . . . 64.3 111.064 179.139 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 64.0 t -97.66 137.99 23.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 108.063 -1.088 . . . . 72.31 108.063 177.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 576' ' ' ILE . . . . . 0.416 HG12 ' HA ' ' A' ' 553' ' ' PHE . 30.4 mm -103.11 160.49 4.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 107.369 -1.345 . . . . 72.34 107.369 -177.359 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -69.99 133.69 47.52 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 109.502 -0.555 . . . . 74.33 109.502 177.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.33 137.84 57.2 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.352 0.596 . . . . 71.03 111.033 -174.355 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.78 -35.89 3.8 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 115.925 1.824 . . . . 75.0 115.925 -171.43 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 580' ' ' GLU . . . . . 0.517 ' HG2' ' CD2' ' A' ' 581' ' ' TYR . 0.0 OUTLIER -93.63 -60.38 1.78 Allowed 'General case' 0 C--N 1.313 -1.01 0 O-C-N 121.482 -0.761 . . . . 70.12 112.75 -170.52 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 581' ' ' TYR . . . . . 0.517 ' CD2' ' HG2' ' A' ' 580' ' ' GLU . 31.4 p90 -164.38 153.97 13.9 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 106.561 -1.644 . . . . 54.4 106.561 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -89.87 143.81 26.48 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 119.618 -0.833 . . . . 64.24 112.218 -177.395 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -169.74 168.8 8.81 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 107.472 -1.307 . . . . 64.42 107.472 175.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -88.39 78.47 7.93 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 107.988 -1.115 . . . . 74.42 107.988 174.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 585' ' ' LYS . . . . . 0.42 ' HG2' ' HB2' ' A' ' 546' ' ' ALA . 0.0 OUTLIER -79.02 166.66 22.09 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 108.243 -1.021 . . . . 72.34 108.243 -177.417 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 586' ' ' THR . . . . . 0.436 ' H ' HG23 ' A' ' 545' ' ' THR . 6.9 t -154.06 144.36 22.16 Favored 'General case' 0 N--CA 1.415 -2.213 0 C-N-CA 120.258 -0.577 . . . . 73.43 111.178 -173.234 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 587' ' ' PHE . . . . . 0.437 ' CE2' HD11 ' A' ' 646' ' ' ILE . 3.6 p90 -126.02 148.54 49.28 Favored 'General case' 0 N--CA 1.418 -2.072 0 CA-C-N 113.799 -1.546 . . . . 62.32 109.407 176.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 588' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -104.77 130.99 52.77 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 108.791 -0.818 . . . . 70.33 108.791 -174.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 589' ' ' LEU . . . . . 0.521 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.4 OUTLIER -99.83 124.98 45.69 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 106.308 -1.738 . . . . 75.43 106.308 176.922 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -124.44 132.12 53.5 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-O 121.013 0.435 . . . . 74.44 110.11 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 591' ' ' ILE . . . . . 0.47 HG22 ' HB3' ' A' ' 539' ' ' TYR . 24.8 pt -101.33 143.86 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.085 0 N-CA-C 107.224 -1.398 . . . . 75.12 107.224 174.394 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -89.41 -148.84 19.69 Favored Glycine 0 C--N 1.292 -1.905 0 N-CA-C 110.47 -1.052 . . . . 31.14 110.47 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.424 ' CD ' HH21 ' A' ' 633' ' ' ARG . 23.4 tt0 -82.09 128.49 67.83 Favored Pre-proline 0 C--N 1.29 -2.013 0 N-CA-C 108.997 -0.742 . . . . 64.11 108.997 177.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 594' ' ' PRO . . . . . 0.484 ' HB3' HG22 ' A' ' 537' ' ' VAL . 55.0 Cg_endo -71.55 146.36 49.33 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 121.965 1.777 . . . . 53.35 109.944 173.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 16.0 ptt-85 -126.93 138.19 53.25 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.593 -0.692 . . . . 61.44 110.003 -175.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 596' ' ' LEU . . . . . 0.452 HD22 HG22 ' A' ' 535' ' ' VAL . 0.0 OUTLIER -81.8 129.15 34.64 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 106.938 -1.505 . . . . 51.21 106.938 179.753 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 89.6 t . . . . . 0 C--N 1.307 -1.277 0 CA-C-O 121.245 0.545 . . . . 61.22 110.073 179.256 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 633' ' ' ARG . . . . . 0.424 HH21 ' CD ' ' A' ' 593' ' ' GLU . 20.7 mtp180 . . . . . 0 N--CA 1.447 -0.582 0 N-CA-C 109.81 -0.441 . . . . 71.42 109.81 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -68.42 147.47 71.37 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.268 1.979 . . . . 74.32 110.475 177.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.3 pp -135.1 -175.06 1.26 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.753 0 N-CA-C 114.623 1.342 . . . . 71.2 114.623 -173.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -78.01 154.87 31.08 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.195 -0.911 . . . . 65.43 110.641 -177.015 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 637' ' ' GLY . . . . . 0.407 ' HA3' ' HB ' ' A' ' 506' ' ' THR . . . -96.48 -107.74 2.41 Favored Glycine 0 C--N 1.297 -1.621 0 C-N-CA 120.664 -0.779 . . . . 73.02 112.685 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -89.53 -65.4 1.02 Allowed 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 121.494 0.664 . . . . 73.11 110.953 -176.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -133.81 116.51 15.78 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 115.381 -0.827 . . . . 62.52 111.645 -174.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 22.1 p -104.42 90.89 3.68 Favored 'General case' 0 N--CA 1.396 -3.161 0 N-CA-C 107.887 -1.153 . . . . 73.22 107.887 175.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 21.5 tptm -175.71 135.36 0.3 Allowed 'General case' 0 N--CA 1.425 -1.701 0 CA-C-N 113.758 -1.564 . . . . 72.21 107.204 -175.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 642' ' ' LEU . . . . . 0.797 HD21 HG21 ' A' ' 523' ' ' VAL . 41.5 tp -138.22 110.1 7.19 Favored 'General case' 0 C--N 1.276 -2.606 0 N-CA-C 107.611 -1.255 . . . . 63.42 107.611 173.163 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 643' ' ' GLU . . . . . 0.521 ' HB3' HG22 ' A' ' 511' ' ' VAL . 21.4 tt0 -93.59 106.98 18.9 Favored 'General case' 0 C--N 1.275 -2.644 0 N-CA-C 107.475 -1.306 . . . . 72.25 107.475 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 644' ' ' VAL . . . . . 0.574 HG21 ' HE1' ' A' ' 521' ' ' MET . 25.6 t -96.81 105.6 17.33 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 109.346 -0.613 . . . . 72.31 109.346 -176.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 3.5 mp -91.54 120.42 40.56 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 107.521 -1.289 . . . . 75.1 107.521 176.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 646' ' ' ILE . . . . . 0.508 HD12 ' N ' ' A' ' 646' ' ' ILE . 2.7 mp -97.74 109.28 23.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 105.928 -1.879 . . . . 72.14 105.928 -177.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 647' ' ' GLU . . . . . 0.401 ' OE2' ' HA ' ' A' ' 515' ' ' SER . 1.5 pp20? -93.3 148.49 22.0 Favored 'General case' 0 N--CA 1.399 -3.007 0 CA-C-N 115.518 -0.764 . . . . 75.21 110.889 -174.367 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -73.0 69.46 0.98 Allowed 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 124.416 1.086 . . . . 74.02 110.993 -178.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 649' ' ' SER . . . . . 0.406 ' HA ' ' HG ' ' A' ' 515' ' ' SER . 14.4 m . . . . . 0 C--O 1.243 0.755 0 C-N-CA 128.422 2.689 . . . . 51.13 115.525 177.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 503' ' ' GLY . . . . . 0.708 ' HA3' ' OG1' ' A' ' 528' ' ' THR . . . . . . . . 0 N--CA 1.412 -2.921 0 N-CA-C 116.751 1.46 . . . . 72.04 116.751 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 504' ' ' ILE . . . . . 0.51 HG23 ' CA ' ' A' ' 637' ' ' GLY . 3.5 mp -111.35 136.25 48.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 125.521 1.529 . . . . 73.11 111.471 -168.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -132.6 123.58 26.7 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.898 -0.779 . . . . 71.23 108.898 170.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 506' ' ' THR . . . . . 0.438 ' HB ' ' HA3' ' A' ' 637' ' ' GLY . 14.7 t -150.52 163.15 39.15 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.233 -0.654 . . . . 64.04 109.233 -176.093 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -84.35 159.74 20.81 Favored 'General case' 0 CA--C 1.495 -1.145 0 N-CA-C 108.486 -0.931 . . . . 73.01 108.486 173.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -81.34 -44.29 17.83 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.385 -0.968 . . . . 71.21 108.385 176.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -124.93 137.06 28.9 Favored Pre-proline 0 C--N 1.313 -0.993 0 N-CA-C 109.076 -0.713 . . . . 75.2 109.076 177.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 510' ' ' PRO . . . . . 0.511 ' HA ' ' O ' ' A' ' 641' ' ' LYS . 94.6 Cg_endo -90.66 -6.72 4.19 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.0 1.8 . . . . 75.2 112.734 178.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 74.3 t -143.04 132.99 21.9 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.318 0 N-CA-C 107.02 -1.474 . . . . 74.33 107.02 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 4.1 t -141.42 143.63 34.02 Favored 'General case' 0 N--CA 1.411 -2.4 0 N-CA-C 106.697 -1.594 . . . . 75.15 106.697 178.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 28.7 m-70 -114.52 127.85 56.02 Favored 'General case' 0 CA--C 1.484 -1.595 0 N-CA-C 107.471 -1.307 . . . . 70.02 107.471 177.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.625 HG11 ' SD ' ' A' ' 521' ' ' MET . 33.7 m -113.19 164.43 9.12 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.355 0 C-N-CA 120.271 -0.572 . . . . 52.43 110.853 -173.373 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 35.4 t -87.5 145.01 26.43 Favored 'General case' 0 N--CA 1.406 -2.657 0 N-CA-C 107.255 -1.387 . . . . 73.42 107.255 176.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -79.38 -9.98 59.71 Favored 'General case' 0 C--N 1.279 -2.495 0 CA-C-O 121.604 0.716 . . . . 72.14 109.801 177.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 39.3 m -97.62 17.06 18.65 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.508 0.67 . . . . 75.31 109.874 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 10.8 tt -96.38 158.25 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.366 0 N-CA-C 108.724 -0.843 . . . . 75.32 108.724 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -102.89 -59.35 0.74 Allowed Glycine 0 N--CA 1.43 -1.738 0 N-CA-C 111.018 -0.833 . . . . 75.15 111.018 178.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 520' ' ' ILE . . . . . 0.406 HD13 ' HA ' ' A' ' 574' ' ' LYS . 36.1 mm -123.36 126.85 73.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 109.224 -0.658 . . . . 61.53 109.224 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 521' ' ' MET . . . . . 0.625 ' SD ' HG11 ' A' ' 514' ' ' VAL . 25.3 ptt? -104.03 139.34 39.28 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.132 -1.062 . . . . 71.32 108.132 173.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -120.25 120.13 35.22 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 123.882 0.739 . . . . 74.31 110.72 177.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 523' ' ' VAL . . . . . 0.598 ' O ' ' HA ' ' A' ' 570' ' ' THR . 40.4 t -106.33 130.78 57.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 CA-C-N 115.56 -0.746 . . . . 74.34 109.831 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -77.93 131.84 37.63 Favored 'General case' 0 C--O 1.246 0.894 0 CA-C-O 121.784 0.802 . . . . 72.34 113.114 -177.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 11.4 t -114.7 135.22 55.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 107.42 -1.326 . . . . 65.42 107.42 177.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -82.55 151.22 26.52 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.416 0.626 . . . . 61.11 111.408 -175.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 527' ' ' ARG . . . . . 0.488 ' HD2' ' HA ' ' A' ' 567' ' ' ILE . 43.7 ttt-85 -98.47 143.55 28.78 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 114.658 -1.155 . . . . 63.55 110.447 -174.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 528' ' ' THR . . . . . 0.708 ' OG1' ' HA3' ' A' ' 503' ' ' GLY . 4.6 t -58.9 151.29 22.05 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.539 -0.755 . . . . 75.24 112.441 177.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 35.6 t -77.89 -17.94 56.75 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 115.224 -0.898 . . . . 62.12 108.736 176.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -109.87 52.52 0.63 Allowed Glycine 0 N--CA 1.442 -0.912 0 N-CA-C 111.232 -0.747 . . . . 63.15 111.232 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -82.36 92.61 7.02 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-O 121.543 0.687 . . . . 73.24 109.665 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 2.6 ppt_? -133.5 20.36 3.95 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 114.771 -1.104 . . . . 65.0 112.038 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . -177.16 -179.38 47.47 Favored Glycine 0 N--CA 1.427 -1.959 0 N-CA-C 109.524 -1.431 . . . . 63.03 109.524 -177.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 534' ' ' ASN . . . . . 0.509 HD21 ' HG3' ' A' ' 561' ' ' GLU . 2.5 t-20 -90.41 125.02 35.42 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.047 0.451 . . . . 74.15 110.082 -179.278 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 535' ' ' VAL . . . . . 0.467 HG22 HD22 ' A' ' 596' ' ' LEU . 60.1 t -123.95 128.39 74.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 107.533 -1.284 . . . . 72.22 107.533 176.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 536' ' ' ILE . . . . . 0.547 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 46.5 mm -99.57 135.82 33.36 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.238 0 N-CA-C 109.425 -0.583 . . . . 72.21 109.425 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 42.5 t -120.15 109.38 37.24 Favored Pre-proline 0 C--N 1.307 -1.268 0 CA-C-N 116.06 -0.518 . . . . 72.3 109.608 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -74.07 143.69 32.8 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.16 1.906 . . . . 72.0 111.64 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 539' ' ' TYR . . . . . 0.434 ' HB3' HG22 ' A' ' 591' ' ' ILE . 45.1 p90 -144.35 160.66 40.66 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.598 -0.519 . . . . 74.11 109.598 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -160.48 160.58 32.22 Favored 'General case' 0 C--O 1.243 0.721 0 O-C-N 123.788 0.68 . . . . 70.42 110.543 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 2.6 p -100.22 108.14 20.16 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 123.676 0.61 . . . . 71.43 111.53 176.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.5 mp -81.7 128.24 38.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 107.378 -1.341 . . . . 74.21 107.378 178.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -63.61 -62.94 1.33 Allowed 'General case' 0 C--O 1.237 0.413 0 O-C-N 123.585 0.553 . . . . 72.51 111.212 -178.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 72.71 -72.48 1.04 Allowed Glycine 0 C--O 1.227 -0.292 0 CA-C-N 116.256 -0.429 . . . . 75.4 112.205 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 545' ' ' THR . . . . . 0.472 HG23 ' H ' ' A' ' 586' ' ' THR . 6.0 t -138.59 -2.11 1.8 Allowed 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.056 0.455 . . . . 71.1 110.233 178.352 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -96.1 171.03 8.86 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 108.969 -0.752 . . . . 70.21 108.969 174.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 547' ' ' ARG . . . . . 0.473 ' HG3' ' HG3' ' A' ' 551' ' ' GLU . 2.3 tpt180 -115.65 112.46 22.14 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.902 -0.777 . . . . 73.32 108.902 -178.043 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -95.95 166.92 25.05 Favored Glycine 0 CA--C 1.499 -0.962 0 C-N-CA 121.408 -0.425 . . . . 52.35 113.409 -176.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 100.52 23.44 10.21 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 111.526 -0.63 . . . . 50.32 111.526 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 91.07 6.45 66.82 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.833 -0.698 . . . . 62.13 111.396 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 551' ' ' GLU . . . . . 0.473 ' HG3' ' HG3' ' A' ' 547' ' ' ARG . 12.3 mm-40 -76.18 -71.23 0.4 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.553 -0.536 . . . . 75.31 109.553 -178.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -111.4 -27.65 8.54 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.197 -1.409 . . . . 62.33 107.197 178.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -141.68 156.68 45.63 Favored 'General case' 0 C--O 1.256 1.415 0 CA-C-N 115.031 -0.986 . . . . 72.32 109.063 174.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 554' ' ' GLU . . . . . 0.413 ' HB3' ' HB3' ' A' ' 574' ' ' LYS . 0.4 OUTLIER -90.45 126.77 36.01 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 106.261 -1.755 . . . . 74.21 106.261 178.393 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -79.02 112.04 15.83 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.77 0.319 . . . . 74.23 111.784 -173.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 556' ' ' THR . . . . . 0.478 HG21 HG22 ' A' ' 573' ' ' VAL . 11.1 t -109.51 122.88 48.41 Favored 'General case' 0 N--CA 1.418 -2.026 0 CA-C-O 122.269 1.033 . . . . 75.44 110.052 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 1.7 p -142.07 133.04 25.93 Favored 'General case' 0 C--N 1.277 -2.572 0 CA-C-N 114.475 -1.239 . . . . 73.5 107.894 178.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 179.9 -148.98 8.28 Favored Glycine 0 N--CA 1.422 -2.289 0 N-CA-C 110.34 -1.104 . . . . 74.42 110.34 -176.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 559' ' ' GLU . . . . . 0.547 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 47.5 mt-10 -143.54 133.62 24.28 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 122.964 0.506 . . . . 73.52 110.706 -176.06 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 560' ' ' LEU . . . . . 0.408 ' HG ' ' CD1' ' A' ' 539' ' ' TYR . 87.4 mt -94.21 146.17 24.19 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 123.319 0.648 . . . . 74.3 110.117 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 561' ' ' GLU . . . . . 0.509 ' HG3' HD21 ' A' ' 534' ' ' ASN . 44.0 tt0 -105.67 112.85 26.09 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-O 121.075 0.464 . . . . 50.43 111.752 -178.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -109.66 144.07 38.53 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.59 -0.892 . . . . 73.32 108.59 171.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -145.99 -171.42 3.7 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.459 -0.941 . . . . 74.23 108.459 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 31.9 t30 -78.87 -39.15 35.98 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 107.24 -1.393 . . . . 74.54 107.24 172.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -88.45 -2.48 58.62 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.731 -1.122 . . . . 65.14 110.978 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -116.83 123.87 48.14 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.964 -0.754 . . . . 74.54 108.964 -178.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 567' ' ' ILE . . . . . 0.488 ' HA ' ' HD2' ' A' ' 527' ' ' ARG . 1.5 pp -119.13 139.91 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.73 0 N-CA-C 108.6 -0.889 . . . . 72.1 108.6 -178.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 1.2 p 56.11 160.18 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 C-N-CA 126.625 1.97 . . . . 61.21 113.462 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 569' ' ' LYS . . . . . 0.53 ' HE3' ' HA ' ' A' ' 569' ' ' LYS . 0.0 OUTLIER -148.03 162.89 38.44 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.511 -0.743 . . . . 70.32 109.089 175.444 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 570' ' ' THR . . . . . 0.598 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 11.7 p -135.1 134.3 40.13 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 123.921 0.763 . . . . 71.2 110.942 178.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 571' ' ' ILE . . . . . 0.476 HG12 HD11 ' A' ' 589' ' ' LEU . 3.1 mp -85.51 118.37 32.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 106.62 -1.622 . . . . 62.31 106.62 172.173 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 19.1 m -98.73 120.62 39.47 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 108.709 -0.848 . . . . 73.42 108.709 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 573' ' ' VAL . . . . . 0.478 HG22 HG21 ' A' ' 556' ' ' THR . 33.2 t -123.67 134.52 66.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 N-CA-C 109.15 -0.685 . . . . 63.14 109.15 -178.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 574' ' ' LYS . . . . . 0.413 ' HB3' ' HB3' ' A' ' 554' ' ' GLU . 57.9 tptt -88.25 116.26 26.32 Favored 'General case' 0 N--CA 1.435 -1.193 0 O-C-N 123.815 0.697 . . . . 74.22 109.221 177.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 59.1 t -87.03 133.8 29.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 107.72 -1.215 . . . . 70.21 107.72 178.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 42.8 mm -96.66 158.22 3.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 107.984 -1.117 . . . . 71.14 107.984 -177.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -67.78 119.48 12.55 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.645 -0.872 . . . . 73.32 108.645 176.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -67.32 122.65 18.35 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 114.822 -1.081 . . . . 70.43 111.628 -173.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 579' ' ' GLU . . . . . 0.407 ' H ' ' CD ' ' A' ' 579' ' ' GLU . 0.2 OUTLIER -87.57 -23.75 24.23 Favored 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 125.502 1.521 . . . . 71.43 113.557 -172.871 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -117.67 176.84 5.0 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 118.648 -1.221 . . . . 73.23 111.283 -177.057 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -60.59 154.37 21.29 Favored 'General case' 0 C--O 1.253 1.283 0 N-CA-C 108.256 -1.016 . . . . 61.33 108.256 174.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 21.0 tp10 -84.25 101.55 11.99 Favored 'General case' 0 N--CA 1.414 -2.229 0 C-N-CA 118.049 -1.46 . . . . 50.13 114.091 -175.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -97.22 134.07 41.02 Favored 'General case' 0 N--CA 1.406 -2.665 0 N-CA-C 101.961 -3.348 . . . . 70.41 101.961 160.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -76.11 77.89 2.94 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-O 121.733 0.778 . . . . 73.22 112.391 -174.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.67 167.22 18.45 Favored 'General case' 0 N--CA 1.412 -2.357 0 N-CA-C 106.519 -1.66 . . . . 64.53 106.519 176.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 586' ' ' THR . . . . . 0.472 ' H ' HG23 ' A' ' 545' ' ' THR . 3.5 t -155.93 144.92 20.53 Favored 'General case' 0 N--CA 1.404 -2.741 0 C-N-CA 120.402 -0.519 . . . . 70.31 110.736 -176.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 587' ' ' PHE . . . . . 0.426 ' CE2' HD11 ' A' ' 646' ' ' ILE . 2.5 p90 -112.34 149.54 32.3 Favored 'General case' 0 N--CA 1.418 -2.028 0 CA-C-N 114.198 -1.364 . . . . 75.15 108.865 177.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 588' ' ' PHE . . . . . 0.412 ' CD1' ' HE3' ' A' ' 641' ' ' LYS . 17.5 m-85 -106.47 131.31 53.8 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 116.052 -0.522 . . . . 65.21 109.735 -173.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 589' ' ' LEU . . . . . 0.56 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.4 OUTLIER -102.77 118.44 36.83 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 105.016 -2.216 . . . . 73.1 105.016 173.231 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -129.82 144.51 51.34 Favored 'General case' 0 C--N 1.273 -2.728 0 N-CA-C 108.306 -0.998 . . . . 75.14 108.306 -178.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 591' ' ' ILE . . . . . 0.434 HG22 ' HB3' ' A' ' 539' ' ' TYR . 27.0 pt -106.27 152.76 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.853 0 N-CA-C 108.748 -0.834 . . . . 74.13 108.748 178.278 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -99.14 -163.74 29.75 Favored Glycine 0 N--CA 1.419 -2.46 0 N-CA-C 111.362 -0.695 . . . . 71.42 111.362 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -66.75 121.18 76.4 Favored Pre-proline 0 C--N 1.298 -1.645 0 C-N-CA 123.211 0.604 . . . . 75.43 110.612 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 594' ' ' PRO . . . . . 0.422 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 18.9 Cg_endo -67.25 140.84 54.73 Favored 'Trans proline' 0 N--CA 1.437 -1.819 0 C-N-CA 121.856 1.704 . . . . 62.5 110.461 176.032 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 595' ' ' ARG . . . . . 0.448 ' HG3' ' HB ' ' A' ' 536' ' ' ILE . 9.4 ptm180 -121.88 122.29 39.08 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 115.696 -0.683 . . . . 71.31 110.101 -173.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 596' ' ' LEU . . . . . 0.467 HD22 HG22 ' A' ' 535' ' ' VAL . 0.0 OUTLIER -75.51 123.9 26.25 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 107.858 -1.164 . . . . 55.14 107.858 179.282 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 21.8 t . . . . . 0 C--N 1.298 -1.645 0 CA-C-O 122.418 1.104 . . . . 71.55 109.348 179.703 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 67.9 mtt-85 . . . . . 0 CA--C 1.508 -0.641 0 N-CA-C 109.347 -0.612 . . . . 71.21 109.347 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 634' ' ' PRO . . . . . 0.422 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 39.7 Cg_endo -74.83 142.68 28.75 Favored 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 121.635 1.556 . . . . 55.13 110.548 177.322 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 635' ' ' ILE . . . . . 0.48 HD13 ' H ' ' A' ' 635' ' ' ILE . 0.1 OUTLIER -131.97 -170.77 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 CA-C-O 121.126 0.489 . . . . 75.22 109.899 -177.911 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.78 160.53 21.2 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 115.791 -0.641 . . . . 74.34 111.196 -178.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 637' ' ' GLY . . . . . 0.51 ' CA ' HG23 ' A' ' 504' ' ' ILE . . . -85.81 -98.53 0.74 Allowed Glycine 0 CA--C 1.483 -1.928 0 CA-C-N 115.337 -0.847 . . . . 64.42 111.771 177.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -114.52 -49.29 2.83 Favored 'General case' 0 C--N 1.281 -2.392 0 C-N-CA 119.752 -0.779 . . . . 73.54 110.151 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -131.4 119.15 21.24 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.958 0.885 . . . . 61.11 113.099 -176.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 23.8 p -115.27 91.15 3.52 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 107.385 -1.339 . . . . 65.14 107.385 173.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 641' ' ' LYS . . . . . 0.511 ' O ' ' HA ' ' A' ' 510' ' ' PRO . 22.6 tptm -175.27 137.04 0.38 Allowed 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 106.434 -1.691 . . . . 71.52 106.434 -174.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 642' ' ' LEU . . . . . 0.573 HD21 HG21 ' A' ' 523' ' ' VAL . 38.7 tp -140.69 105.07 4.85 Favored 'General case' 0 C--N 1.277 -2.55 0 N-CA-C 107.961 -1.125 . . . . 73.13 107.961 172.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -94.35 105.05 17.03 Favored 'General case' 0 C--N 1.276 -2.625 0 N-CA-C 106.646 -1.613 . . . . 70.13 106.646 178.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 644' ' ' VAL . . . . . 0.547 HG21 ' HE1' ' A' ' 521' ' ' MET . 32.5 t -94.28 106.15 17.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-N 115.765 -0.652 . . . . 45.24 109.571 -177.252 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 3.7 mp -89.36 126.32 42.33 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 N-CA-C 108.026 -1.101 . . . . 72.22 108.026 179.131 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 646' ' ' ILE . . . . . 0.446 HD12 ' H ' ' A' ' 646' ' ' ILE . 1.7 mp -104.54 140.29 23.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 107.866 -1.161 . . . . 74.24 107.866 -177.142 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -158.4 140.05 13.63 Favored 'General case' 0 N--CA 1.429 -1.508 0 O-C-N 123.722 0.638 . . . . 74.41 110.822 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -41.62 136.5 1.86 Allowed 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.138 1.375 . . . . 73.55 110.561 176.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 34.9 t . . . . . 0 C--O 1.243 0.72 0 C-N-CA 126.518 1.927 . . . . 63.01 114.238 -171.623 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 503' ' ' GLY . . . . . 0.428 ' HA2' ' O ' ' A' ' 530' ' ' GLY . . . . . . . . 0 N--CA 1.433 -1.543 0 CA-C-O 121.44 0.467 . . . . 72.34 113.758 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 1.7 mp -107.24 130.31 59.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 N-CA-C 107.956 -1.127 . . . . 53.02 107.956 177.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 505' ' ' PHE . . . . . 0.429 ' HA ' ' O ' ' A' ' 526' ' ' LEU . 97.9 m-85 -116.21 121.39 41.91 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.115 0.483 . . . . 65.14 111.071 -178.224 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 11.8 t -139.39 156.19 47.15 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.037 -1.098 . . . . 52.25 108.037 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -82.65 154.41 24.92 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.526 -0.916 . . . . 71.33 108.526 174.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -77.29 -27.71 53.12 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 109.301 -0.629 . . . . 65.04 109.301 176.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -140.51 135.99 16.29 Favored Pre-proline 0 C--N 1.315 -0.897 0 N-CA-C 108.878 -0.786 . . . . 73.43 108.878 177.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 510' ' ' PRO . . . . . 0.4 ' HA ' ' O ' ' A' ' 641' ' ' LYS . 73.5 Cg_endo -85.13 -13.84 6.26 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 121.765 1.643 . . . . 72.21 111.654 178.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 511' ' ' VAL . . . . . 0.447 HG22 ' HB3' ' A' ' 643' ' ' GLU . 71.7 t -139.0 133.85 41.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 107.693 -1.225 . . . . 63.14 107.693 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 5.4 t -134.05 136.21 43.86 Favored 'General case' 0 N--CA 1.402 -2.834 0 N-CA-C 108.077 -1.083 . . . . 72.03 108.077 178.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 32.6 m-70 -108.37 114.75 28.85 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.541 -0.911 . . . . 73.43 108.541 177.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 16.7 m -118.93 162.49 17.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 CA-C-N 115.935 -0.575 . . . . 55.2 110.093 -174.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 62.2 m -81.2 148.92 29.3 Favored 'General case' 0 N--CA 1.392 -3.37 0 N-CA-C 108.096 -1.075 . . . . 71.4 108.096 178.056 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -85.55 -22.35 28.15 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 118.719 -1.192 . . . . 73.34 110.632 176.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 16.0 m -90.12 30.39 1.1 Allowed 'General case' 0 C--N 1.293 -1.874 0 CA-C-O 121.605 0.717 . . . . 74.25 110.023 -176.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 13.7 tt -112.81 150.87 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.015 0 N-CA-C 107.342 -1.355 . . . . 65.42 107.342 -178.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 519' ' ' GLY . . . . . 0.55 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . -81.83 -61.93 1.99 Allowed Glycine 0 N--CA 1.426 -1.975 0 C-N-CA 120.098 -1.049 . . . . 45.24 111.06 178.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 35.8 mm -120.82 133.45 67.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 CA-C-N 115.482 -0.359 . . . . 74.22 110.199 -177.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 521' ' ' MET . . . . . 0.494 ' HE2' HG21 ' A' ' 644' ' ' VAL . 0.0 OUTLIER -116.28 141.23 48.42 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.147 -1.427 . . . . 75.1 107.147 171.302 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 522' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 44.9 mt-10 -126.38 145.28 50.52 Favored 'General case' 0 C--N 1.316 -0.89 0 O-C-N 123.584 0.552 . . . . 72.41 111.445 -178.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 523' ' ' VAL . . . . . 0.677 HG21 HD21 ' A' ' 642' ' ' LEU . 30.2 t -132.58 138.99 50.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 108.512 -0.921 . . . . 65.34 108.512 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -84.0 133.17 34.69 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 113.043 0.757 . . . . 74.21 113.043 -177.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 525' ' ' VAL . . . . . 0.613 ' O ' ' HA ' ' A' ' 568' ' ' VAL . 10.7 t -113.46 125.49 70.74 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 N-CA-C 106.725 -1.583 . . . . 61.14 106.725 177.117 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 526' ' ' LEU . . . . . 0.429 ' O ' ' HA ' ' A' ' 505' ' ' PHE . 2.1 mm? -91.3 140.81 29.43 Favored 'General case' 0 C--N 1.28 -2.427 0 CA-C-O 120.794 0.331 . . . . 60.32 110.397 -176.043 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 527' ' ' ARG . . . . . 0.479 ' HG3' HH11 ' A' ' 527' ' ' ARG . 27.9 ttt85 -114.24 93.78 4.51 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 105.06 -2.2 . . . . 62.01 105.06 173.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 1.4 p -121.55 -168.68 1.73 Allowed 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 114.712 -1.131 . . . . 70.23 111.967 -173.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 39.6 m 35.01 32.62 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 126.419 1.888 . . . . 70.03 114.134 -172.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 530' ' ' GLY . . . . . 0.428 ' O ' ' HA2' ' A' ' 503' ' ' GLY . . . 129.43 151.95 7.47 Favored Glycine 0 N--CA 1.418 -2.53 0 N-CA-C 111.67 -0.572 . . . . 71.2 111.67 178.013 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -127.75 -125.44 0.23 Allowed 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 107.798 -1.186 . . . . 53.13 107.798 176.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 69.37 127.29 0.03 OUTLIER 'General case' 0 C--O 1.244 0.77 0 C-N-CA 124.516 1.126 . . . . 73.33 113.593 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 533' ' ' GLY . . . . . 0.453 ' H ' ' HB3' ' A' ' 564' ' ' ASN . . . 86.81 162.36 37.32 Favored Glycine 0 N--CA 1.437 -1.278 0 CA-C-N 115.125 -0.943 . . . . 53.21 113.316 175.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -90.81 122.96 33.98 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.271 -1.381 . . . . 74.11 107.271 176.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 62.4 t -125.31 125.67 69.45 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 N-CA-C 109.58 -0.526 . . . . 71.22 109.58 -178.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 536' ' ' ILE . . . . . 0.449 ' O ' ' HG2' ' A' ' 595' ' ' ARG . 40.1 mm -100.25 125.37 54.02 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 N-CA-C 108.396 -0.964 . . . . 61.31 108.396 177.207 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 537' ' ' VAL . . . . . 0.504 HG22 ' HB3' ' A' ' 594' ' ' PRO . 38.6 t -113.54 107.54 53.03 Favored Pre-proline 0 C--N 1.296 -1.757 0 CA-C-N 116.368 -0.378 . . . . 73.51 110.391 -177.559 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -74.59 147.19 35.48 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.408 2.072 . . . . 74.02 111.308 178.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 539' ' ' TYR . . . . . 0.4 ' CD2' ' HG ' ' A' ' 560' ' ' LEU . 50.6 p90 -147.85 156.9 43.21 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 108.255 -1.017 . . . . 75.23 108.255 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.96 150.9 28.8 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 123.399 0.437 . . . . 72.23 111.42 178.161 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 1.1 p -87.54 118.17 26.84 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 123.684 0.794 . . . . 74.34 112.075 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.419 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 3.7 mp -84.83 123.66 39.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 107.545 -1.28 . . . . 74.25 107.545 176.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -54.3 -54.02 45.87 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 124.225 1.01 . . . . 71.4 113.059 -175.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 72.18 -90.37 0.51 Allowed Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.898 -0.668 . . . . 63.45 112.203 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 8.9 t -124.84 -0.78 7.93 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 121.935 0.874 . . . . 73.25 109.299 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -94.9 175.79 6.51 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.586 -0.734 . . . . 54.14 109.926 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 547' ' ' ARG . . . . . 0.495 ' N ' ' HD2' ' A' ' 547' ' ' ARG . 4.5 mpt_? -101.58 173.05 6.6 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.716 -0.22 . . . . 74.2 111.296 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -62.54 -175.42 2.52 Favored Glycine 0 C--O 1.252 1.23 0 N-CA-C 116.116 1.206 . . . . 72.24 116.116 -174.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . -58.9 119.93 20.16 Favored Glycine 0 N--CA 1.439 -1.113 0 CA-C-N 114.087 -1.056 . . . . 61.23 114.362 -175.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 83.89 4.98 88.33 Favored Glycine 0 N--CA 1.438 -1.189 0 CA-C-N 115.287 -0.456 . . . . 72.24 112.028 176.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -103.04 -67.22 0.89 Allowed 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 108.408 -0.96 . . . . 54.32 108.408 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 552' ' ' ASP . . . . . 0.435 ' CB ' ' H ' ' A' ' 547' ' ' ARG . 12.8 t70 -104.54 -38.33 6.81 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.764 0.793 . . . . 75.4 109.125 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -138.17 160.77 38.56 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 108.276 -1.009 . . . . 73.12 108.276 176.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -86.42 110.34 19.66 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 105.411 -2.07 . . . . 74.42 105.411 176.323 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -67.61 100.83 0.93 Allowed 'General case' 0 CA--C 1.485 -1.54 0 CA-C-N 115.551 -0.749 . . . . 74.45 110.587 -174.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 556' ' ' THR . . . . . 0.524 HG21 HG22 ' A' ' 573' ' ' VAL . 9.6 t -97.98 95.88 7.78 Favored 'General case' 0 N--CA 1.393 -3.298 0 CA-C-O 123.31 1.529 . . . . 74.11 110.019 -177.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 1.9 p -115.44 97.76 6.35 Favored 'General case' 0 N--CA 1.399 -2.976 0 CA-C-N 113.015 -1.902 . . . . 61.3 106.93 176.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -152.79 -156.21 7.45 Favored Glycine 0 N--CA 1.402 -3.586 0 N-CA-C 110.612 -0.995 . . . . 63.14 110.612 -172.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 559' ' ' GLU . . . . . 0.441 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 41.5 mt-10 -137.11 135.82 37.77 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-O 120.717 0.294 . . . . 74.35 110.885 -171.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 560' ' ' LEU . . . . . 0.434 ' HB3' ' HG2' ' A' ' 569' ' ' LYS . 80.2 mt -93.92 138.11 32.41 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 109.284 -0.636 . . . . 71.4 109.284 175.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -103.39 106.32 16.8 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.77 -0.65 . . . . 74.23 111.385 -175.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 562' ' ' PHE . . . . . 0.569 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 88.7 m-85 -109.15 143.57 38.37 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 116.088 -0.506 . . . . 75.31 109.8 176.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -119.24 -167.88 1.48 Allowed 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 108.154 -1.054 . . . . 75.41 108.154 -178.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 564' ' ' ASN . . . . . 0.453 ' HB3' ' H ' ' A' ' 533' ' ' GLY . 27.6 p-10 -78.33 -42.15 31.5 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 109.636 -0.505 . . . . 72.42 109.636 178.139 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -89.35 -29.69 18.94 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.575 -0.738 . . . . 72.12 110.684 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -79.37 108.19 12.7 Favored 'General case' 0 C--O 1.248 1.012 0 CA-C-N 115.878 -0.601 . . . . 74.14 110.17 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 567' ' ' ILE . . . . . 0.43 ' O ' HG12 ' A' ' 568' ' ' VAL . 6.1 pt -110.17 166.19 5.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 108.049 -1.093 . . . . 71.04 108.049 174.094 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 568' ' ' VAL . . . . . 0.613 ' HA ' ' O ' ' A' ' 525' ' ' VAL . 0.9 OUTLIER 58.77 155.83 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.56 1.336 0 C-N-CA 125.681 1.592 . . . . 73.45 112.564 -178.814 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 569' ' ' LYS . . . . . 0.569 ' HB2' ' CZ ' ' A' ' 562' ' ' PHE . 0.0 OUTLIER -161.94 166.62 25.87 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 106.985 -1.487 . . . . 64.44 106.985 179.492 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 570' ' ' THR . . . . . 0.616 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 7.0 p -127.52 138.68 52.98 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 123.427 0.454 . . . . 65.01 111.363 175.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 571' ' ' ILE . . . . . 0.466 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 3.2 mp -88.61 115.18 28.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 106.763 -1.569 . . . . 72.31 106.763 171.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 24.2 p -92.82 109.49 20.92 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 109.365 -0.606 . . . . 73.04 109.365 178.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 573' ' ' VAL . . . . . 0.524 HG22 HG21 ' A' ' 556' ' ' THR . 43.6 t -112.69 129.94 67.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 N-CA-C 109.328 -0.619 . . . . 75.15 109.328 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 574' ' ' LYS . . . . . 0.55 ' HA ' ' O ' ' A' ' 519' ' ' GLY . 86.9 tttt -89.09 124.12 34.02 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 123.814 0.696 . . . . 61.43 110.156 176.373 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 46.5 t -91.07 131.61 37.78 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 N-CA-C 108.312 -0.996 . . . . 74.45 108.312 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 576' ' ' ILE . . . . . 0.411 ' HB ' ' O ' ' A' ' 552' ' ' ASP . 30.1 mm -101.03 160.65 3.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 107.784 -1.191 . . . . 74.41 107.784 -177.513 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -76.91 147.73 36.82 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 110.061 -0.348 . . . . 60.15 110.061 177.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -69.98 132.4 45.87 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 114.55 1.315 . . . . 72.21 114.55 -175.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 579' ' ' GLU . . . . . 0.486 ' H ' ' CD ' ' A' ' 579' ' ' GLU . 0.0 OUTLIER -96.59 -26.27 15.3 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 112.533 -2.121 . . . . 74.12 111.394 179.599 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 580' ' ' GLU . . . . . 0.435 ' HG2' ' O ' ' A' ' 581' ' ' TYR . 0.1 OUTLIER -105.11 -174.97 2.66 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 107.192 -1.41 . . . . 70.23 107.192 178.813 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 581' ' ' TYR . . . . . 0.435 ' O ' ' HG2' ' A' ' 580' ' ' GLU . 24.6 p90 -69.25 145.14 53.38 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 106.31 -1.737 . . . . 75.42 106.31 176.131 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 582' ' ' GLU . . . . . . . . . . . . 0.528 18.6 pt-20 -93.79 121.03 34.81 Favored 'General case' 0 N--CA 1.408 -2.56 0 N-CA-C 117.673 2.472 . . . . 73.44 117.673 -175.133 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.19 170.94 11.88 Favored 'General case' 0 N--CA 1.417 -2.108 0 CA-C-N 111.407 -2.633 . . . . 72.55 106.476 178.051 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -67.71 119.31 12.24 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.36 0.6 . . . . 61.31 109.468 -177.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 585' ' ' LYS . . . . . 0.498 ' HD2' HD13 ' A' ' 646' ' ' ILE . 1.6 tmmm? -122.58 142.51 50.55 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-N 115.003 -0.999 . . . . 74.43 109.911 -171.171 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 6.8 t -148.22 142.99 26.7 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-O 121.14 0.495 . . . . 53.32 110.698 -175.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -129.64 148.23 51.51 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-N 114.113 -1.403 . . . . 75.33 109.802 177.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 588' ' ' PHE . . . . . 0.507 ' HA ' ' O ' ' A' ' 642' ' ' LEU . 27.2 m-85 -104.14 138.3 40.83 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.978 -0.556 . . . . 74.42 109.672 -176.036 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 589' ' ' LEU . . . . . 0.583 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.5 OUTLIER -113.01 115.24 28.08 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 105.642 -1.985 . . . . 73.4 105.642 175.573 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -125.59 133.37 52.3 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 109.148 -0.686 . . . . 64.33 109.148 178.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 591' ' ' ILE . . . . . . . . . . . . . 22.0 pt -85.58 146.96 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-N 115.808 -0.633 . . . . 71.13 109.412 178.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -93.54 -148.43 23.6 Favored Glycine 0 N--CA 1.427 -1.905 0 C-N-CA 120.911 -0.662 . . . . 71.33 111.496 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -75.56 117.04 60.42 Favored Pre-proline 0 C--N 1.295 -1.786 0 N-CA-C 108.866 -0.79 . . . . 71.3 108.866 178.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 594' ' ' PRO . . . . . 0.504 ' HB3' HG22 ' A' ' 537' ' ' VAL . 57.8 Cg_endo -72.81 134.34 21.68 Favored 'Trans proline' 0 N--CA 1.433 -2.045 0 C-N-CA 121.573 1.515 . . . . 61.11 109.408 176.242 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 595' ' ' ARG . . . . . 0.449 ' HG2' ' O ' ' A' ' 536' ' ' ILE . 14.2 ptm180 -108.29 121.15 44.31 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-O 121.028 0.442 . . . . 73.02 111.057 -172.336 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -76.7 118.44 19.33 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 105.786 -1.931 . . . . 71.03 105.786 176.165 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--N 1.29 -2.001 0 CA-C-O 121.905 0.859 . . . . 73.04 109.46 -178.113 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? . . . . . 0 N--CA 1.435 -1.209 0 N-CA-C 108.919 -0.771 . . . . 73.01 108.919 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 634' ' ' PRO . . . . . 0.441 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 4.9 Cg_endo -75.5 154.52 40.22 Favored 'Trans proline' 0 N--CA 1.44 -1.645 0 N-CA-C 107.073 -1.933 . . . . 72.02 107.073 166.511 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.6 pp -135.48 173.66 13.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 C-N-CA 118.804 -1.158 . . . . 72.33 113.928 -175.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 636' ' ' LEU . . . . . 0.422 ' HB2' HG21 ' A' ' 640' ' ' THR . 0.0 OUTLIER -75.67 146.99 39.8 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.969 -1.014 . . . . 73.34 110.232 -179.149 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -94.04 -132.16 6.39 Favored Glycine 0 C--N 1.289 -2.044 0 CA-C-N 115.604 -0.725 . . . . 75.12 113.821 -176.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -69.68 -56.48 7.12 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 111.955 0.354 . . . . 61.3 111.955 -175.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -137.07 114.62 11.08 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.889 0.852 . . . . 72.15 112.274 -178.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 640' ' ' THR . . . . . 0.422 HG21 ' HB2' ' A' ' 636' ' ' LEU . 17.5 p -119.68 91.84 3.64 Favored 'General case' 0 N--CA 1.416 -2.158 0 CA-C-N 115.219 -0.9 . . . . 74.03 110.568 177.391 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 641' ' ' LYS . . . . . 0.439 ' HE3' ' HB2' ' A' ' 643' ' ' GLU . 0.3 OUTLIER -178.71 126.0 0.1 Allowed 'General case' 0 CA--C 1.482 -1.642 0 N-CA-C 103.988 -2.597 . . . . 74.0 103.988 176.49 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 642' ' ' LEU . . . . . 0.677 HD21 HG21 ' A' ' 523' ' ' VAL . 51.7 tp -115.82 112.99 22.77 Favored 'General case' 0 C--N 1.263 -3.189 0 N-CA-C 108.653 -0.869 . . . . 73.35 108.653 177.27 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 643' ' ' GLU . . . . . 0.447 ' HB3' HG22 ' A' ' 511' ' ' VAL . 19.3 tt0 -97.55 103.47 15.41 Favored 'General case' 0 C--N 1.273 -2.734 0 N-CA-C 107.204 -1.406 . . . . 62.11 107.204 178.042 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 644' ' ' VAL . . . . . 0.494 HG21 ' HE2' ' A' ' 521' ' ' MET . 21.8 t -91.95 106.74 18.05 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.289 0 N-CA-C 108.15 -1.056 . . . . 63.2 108.15 -178.488 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 4.0 mp -90.99 115.87 31.05 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.293 0 N-CA-C 107.019 -1.475 . . . . 74.41 107.019 173.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 646' ' ' ILE . . . . . 0.498 HD13 ' HD2' ' A' ' 585' ' ' LYS . 3.2 mp -101.9 112.05 33.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 107.606 -1.257 . . . . 74.54 107.606 -175.363 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -111.2 138.2 47.94 Favored 'General case' 0 C--N 1.275 -2.671 0 CA-C-N 115.629 -0.714 . . . . 73.31 110.889 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -48.75 136.17 14.01 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.888 -1.051 . . . . 74.01 110.811 178.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 8.6 t . . . . . 0 N--CA 1.426 -1.667 0 CA-C-O 122.191 0.995 . . . . 61.34 109.987 -175.338 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 503' ' ' GLY . . . . . 0.461 ' HA2' ' OG1' ' A' ' 528' ' ' THR . . . . . . . . 0 N--CA 1.406 -3.314 0 N-CA-C 113.486 0.154 . . . . 74.12 113.486 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 2.8 mp -81.84 102.03 7.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 107.483 -1.303 . . . . 64.2 107.483 174.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 505' ' ' PHE . . . . . 0.413 ' O ' ' HA3' ' A' ' 637' ' ' GLY . 42.9 m-85 -115.5 124.02 50.03 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.043 -1.095 . . . . 73.3 108.043 178.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 11.6 t -155.71 168.75 26.17 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.343 -0.984 . . . . 74.33 108.343 -174.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -87.43 151.4 23.09 Favored 'General case' 0 CA--C 1.494 -1.19 0 N-CA-C 107.639 -1.245 . . . . 72.14 107.639 175.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -87.0 -39.49 15.62 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 109.367 -0.605 . . . . 72.43 109.367 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -110.08 128.63 25.04 Favored Pre-proline 0 N--CA 1.437 -1.084 0 N-CA-C 108.469 -0.937 . . . . 73.33 108.469 176.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -79.42 -14.65 12.93 Favored 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 121.93 1.753 . . . . 64.34 112.373 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 511' ' ' VAL . . . . . 0.553 HG22 ' HB3' ' A' ' 643' ' ' GLU . 73.6 t -138.99 135.76 42.57 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.854 0 N-CA-C 108.755 -0.832 . . . . 63.44 108.755 -178.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 3.5 t -137.76 138.47 39.3 Favored 'General case' 0 N--CA 1.408 -2.536 0 N-CA-C 107.8 -1.185 . . . . 73.11 107.8 177.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 23.4 m-70 -108.57 124.53 50.61 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 108.366 -0.976 . . . . 71.04 108.366 178.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 32.1 m -123.2 159.49 27.29 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.383 0 CA-C-O 121.433 0.635 . . . . 62.42 111.777 -173.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 41.2 m -75.58 152.33 37.73 Favored 'General case' 0 N--CA 1.399 -3.002 0 CA-C-N 114.012 -1.449 . . . . 71.41 109.961 -179.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -78.08 -48.38 16.19 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 121.408 0.623 . . . . 62.21 111.889 178.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 29.7 m -90.3 38.61 0.94 Allowed 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 122.157 0.979 . . . . 63.42 110.12 -171.007 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 17.4 tt -105.79 155.83 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.433 0 N-CA-C 105.855 -1.906 . . . . 65.02 105.855 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 519' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . -89.93 -57.08 1.75 Allowed Glycine 0 C--N 1.289 -2.063 0 C-N-CA 119.108 -1.52 . . . . 75.22 111.185 178.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 34.3 mm -126.29 136.41 60.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 CA-C-N 115.27 -0.465 . . . . 71.12 109.847 -176.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 521' ' ' MET . . . . . 0.637 ' HE2' HG21 ' A' ' 644' ' ' VAL . 0.0 OUTLIER -114.19 130.74 56.61 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 106.419 -1.697 . . . . 71.32 106.419 170.161 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -113.07 122.84 48.78 Favored 'General case' 0 C--N 1.313 -1.019 0 O-C-N 123.379 0.425 . . . . 72.42 110.265 -176.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 523' ' ' VAL . . . . . 0.62 ' O ' ' HA ' ' A' ' 570' ' ' THR . 43.4 t -103.32 126.76 57.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 CA-C-N 116.246 -0.433 . . . . 43.45 110.521 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 27.8 mmtp -78.22 134.96 37.51 Favored 'General case' 0 C--N 1.317 -0.843 0 O-C-N 123.853 0.721 . . . . 73.51 111.801 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 21.5 t -115.0 142.12 29.06 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 N-CA-C 108.656 -0.868 . . . . 53.55 108.656 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -69.57 167.47 16.78 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-O 122.305 1.05 . . . . 73.14 113.448 -178.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 527' ' ' ARG . . . . . 0.432 HH11 ' HD3' ' A' ' 527' ' ' ARG . 3.4 tpm_? -106.88 158.81 16.73 Favored 'General case' 0 N--CA 1.426 -1.668 0 CA-C-N 114.027 -1.442 . . . . 73.43 109.574 -175.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 528' ' ' THR . . . . . 0.461 ' OG1' ' HA2' ' A' ' 503' ' ' GLY . 3.3 t -73.03 160.5 31.97 Favored 'General case' 0 N--CA 1.432 -1.374 0 C-N-CA 124.003 0.921 . . . . 50.44 110.215 176.438 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 22.2 t -85.2 -11.67 54.41 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 108.575 -0.898 . . . . 62.52 108.575 178.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -146.51 100.74 0.23 Allowed Glycine 0 N--CA 1.438 -1.194 0 N-CA-C 109.943 -1.263 . . . . 72.03 109.943 177.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -90.36 88.55 7.24 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.115 0.483 . . . . 60.0 111.754 -176.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 -137.76 100.23 4.13 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.373 -0.973 . . . . 74.43 108.373 174.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 123.17 154.63 9.07 Favored Glycine 0 N--CA 1.429 -1.825 0 C-N-CA 120.117 -1.039 . . . . 71.43 112.365 178.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 534' ' ' ASN . . . . . 0.471 ' HA ' ' HA ' ' A' ' 563' ' ' GLN . 46.7 t30 -98.54 119.94 38.11 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-O 121.375 0.607 . . . . 74.32 109.557 176.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 535' ' ' VAL . . . . . 0.528 HG22 HD22 ' A' ' 596' ' ' LEU . 89.9 t -122.45 135.59 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-N 115.124 -0.944 . . . . 64.11 109.202 -179.227 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 536' ' ' ILE . . . . . 0.593 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 43.3 mm -102.81 133.4 46.66 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.062 0 N-CA-C 108.961 -0.755 . . . . 74.32 108.961 178.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 63.6 t -119.55 110.36 37.31 Favored Pre-proline 0 C--N 1.297 -1.683 0 N-CA-C 109.772 -0.455 . . . . 74.12 109.772 178.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -74.11 152.73 45.94 Favored 'Trans proline' 0 C--O 1.24 0.592 0 C-N-CA 122.644 2.229 . . . . 74.23 111.93 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 539' ' ' TYR . . . . . 0.534 ' HB3' HG22 ' A' ' 591' ' ' ILE . 53.7 p90 -152.61 159.5 43.23 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.676 -0.861 . . . . 71.22 108.676 -178.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 540' ' ' LYS . . . . . 0.414 ' HE3' HD11 ' A' ' 542' ' ' ILE . 0.1 OUTLIER -161.35 150.96 16.72 Favored 'General case' 0 C--N 1.309 -1.16 0 O-C-N 123.613 0.57 . . . . 70.41 110.23 179.025 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 7.3 p -82.17 121.93 27.24 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 114.98 -1.009 . . . . 74.23 110.858 173.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.426 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 3.5 mp -93.17 118.49 39.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 105.259 -2.126 . . . . 71.11 105.259 171.373 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 543' ' ' GLU . . . . . 0.452 ' CD ' ' H ' ' A' ' 543' ' ' GLU . 1.6 mp0 -48.15 -55.36 10.54 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 124.316 1.046 . . . . 73.22 112.406 -175.093 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 72.47 -102.3 1.17 Allowed Glycine 0 N--CA 1.442 -0.939 0 N-CA-C 110.702 -0.959 . . . . 54.45 110.702 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 11.4 t -118.68 -0.36 11.32 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 122.334 1.064 . . . . 73.04 109.359 177.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -88.62 143.61 26.83 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 108.342 -0.984 . . . . 61.11 108.342 173.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 547' ' ' ARG . . . . . 0.483 ' HG3' ' HG3' ' A' ' 551' ' ' GLU . 27.6 tpt180 -90.19 119.13 30.25 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.826 -0.805 . . . . 75.25 108.826 179.039 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -86.45 174.29 46.69 Favored Glycine 0 C--N 1.306 -1.13 0 C-N-CA 120.503 -0.856 . . . . 71.12 113.15 -176.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 86.0 36.2 10.38 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 121.148 -0.549 . . . . 75.54 113.416 176.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 87.87 10.8 68.95 Favored Glycine 0 N--CA 1.44 -1.055 0 C-N-CA 120.261 -0.971 . . . . 42.45 112.82 176.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 551' ' ' GLU . . . . . 0.483 ' HG3' ' HG3' ' A' ' 547' ' ' ARG . 7.8 mm-40 -92.72 -71.83 0.63 Allowed 'General case' 0 C--O 1.213 -0.862 0 N-CA-C 109.412 -0.588 . . . . 74.31 109.412 179.032 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -97.55 -30.05 13.09 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 108.626 -0.879 . . . . 74.22 108.626 176.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 553' ' ' PHE . . . . . 0.504 ' HB3' ' CE2' ' A' ' 587' ' ' PHE . 46.4 p90 -149.76 155.24 39.81 Favored 'General case' 0 N--CA 1.419 -1.989 0 CA-C-N 115.312 -0.858 . . . . 65.14 110.198 178.357 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -82.54 123.2 28.97 Favored 'General case' 0 C--N 1.276 -2.6 0 N-CA-C 104.48 -2.415 . . . . 74.44 104.48 175.058 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -60.77 121.11 11.47 Favored 'General case' 0 CA--C 1.488 -1.423 0 CA-C-O 122.237 1.017 . . . . 60.32 111.575 -175.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 556' ' ' THR . . . . . 0.44 HG21 HG22 ' A' ' 573' ' ' VAL . 98.4 m -120.22 112.64 19.32 Favored 'General case' 0 N--CA 1.388 -3.555 0 CA-C-N 114.5 -1.227 . . . . 51.04 111.806 -171.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 20.7 p -145.63 128.97 16.83 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.846 -1.168 . . . . 73.54 107.846 176.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -165.86 -155.61 8.84 Favored Glycine 0 N--CA 1.422 -2.295 0 C-N-CA 120.462 -0.875 . . . . 61.33 111.139 -176.276 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 559' ' ' GLU . . . . . 0.593 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 42.1 mt-10 -143.09 125.63 15.8 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 123.06 0.544 . . . . 65.42 110.269 -176.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 560' ' ' LEU . . . . . 0.441 ' HG ' ' CE1' ' A' ' 539' ' ' TYR . 87.7 mt -88.7 135.79 33.33 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 122.723 0.409 . . . . 75.14 110.776 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 561' ' ' GLU . . . . . 0.433 ' HA ' HD13 ' A' ' 536' ' ' ILE . 45.4 tt0 -96.38 108.57 21.11 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.601 -0.727 . . . . 73.32 110.593 179.179 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 562' ' ' PHE . . . . . 0.423 ' CE1' ' HG2' ' A' ' 569' ' ' LYS . 8.0 m-85 -107.74 116.92 32.82 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.234 -0.654 . . . . 74.42 109.234 173.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 563' ' ' GLN . . . . . 0.509 ' HG3' ' H ' ' A' ' 566' ' ' GLU . 9.3 pt20 -119.56 -175.26 2.91 Favored 'General case' 0 C--N 1.29 -1.995 0 C-N-CA 119.068 -1.053 . . . . 73.12 112.023 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -59.06 -47.53 84.9 Favored 'General case' 0 C--N 1.318 -0.774 0 O-C-N 123.86 0.725 . . . . 75.21 109.667 177.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -77.74 -67.19 0.75 Allowed 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.278 -0.873 . . . . 63.03 111.233 -178.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 566' ' ' GLU . . . . . 0.509 ' H ' ' HG3' ' A' ' 563' ' ' GLN . 15.3 tt0 -56.27 113.86 1.74 Allowed 'General case' 0 C--O 1.247 0.922 0 O-C-N 123.783 0.677 . . . . 72.21 112.629 -178.387 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 10.4 pt -102.36 169.14 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.407 -2.591 0 N-CA-C 106.64 -1.615 . . . . 71.41 106.64 173.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 1.7 p 40.55 124.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.559 1.306 0 C-N-CA 127.069 2.147 . . . . 54.33 116.628 177.277 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 569' ' ' LYS . . . . . 0.426 ' HD2' ' HA ' ' A' ' 569' ' ' LYS . 32.8 mmmt -116.85 157.43 25.63 Favored 'General case' 0 C--N 1.265 -3.103 0 CA-C-N 114.921 -1.036 . . . . 71.12 110.16 178.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 570' ' ' THR . . . . . 0.62 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 1.8 p -129.88 125.27 35.2 Favored 'General case' 0 C--N 1.278 -2.538 0 CA-C-N 114.784 -1.098 . . . . 44.05 111.307 179.049 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 3.6 mp -84.52 111.12 19.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 106.277 -1.749 . . . . 71.14 106.277 173.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 3.1 p -95.66 109.45 21.72 Favored 'General case' 0 N--CA 1.417 -2.093 0 O-C-N 123.87 0.731 . . . . 73.4 109.918 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 573' ' ' VAL . . . . . 0.44 HG22 HG21 ' A' ' 556' ' ' THR . 59.9 t -111.82 133.68 56.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 108.916 -0.772 . . . . 64.14 108.916 -178.532 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 574' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 519' ' ' GLY . 41.4 ttmt -84.81 117.14 23.68 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-O 121.444 0.64 . . . . 75.31 109.676 177.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 60.2 t -89.44 143.74 10.56 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 N-CA-C 107.08 -1.452 . . . . 71.11 107.08 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 576' ' ' ILE . . . . . 0.435 HG12 ' HA ' ' A' ' 553' ' ' PHE . 26.0 mm -111.81 132.3 60.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 C-N-CA 119.975 -0.69 . . . . 72.55 109.196 -177.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -59.65 137.53 58.01 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.301 -0.863 . . . . 73.03 108.873 178.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 578' ' ' ASP . . . . . . . . . . . . 0.413 15.9 m-20 -59.31 119.65 7.81 Favored 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 117.144 2.276 . . . . 70.23 117.144 -171.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 579' ' ' GLU . . . . . 0.437 ' H ' ' CD ' ' A' ' 579' ' ' GLU . 6.1 pm0 -97.07 -14.07 21.81 Favored 'General case' 0 N--CA 1.401 -2.888 0 CA-C-N 110.483 -3.053 . . . . 62.43 112.948 -172.374 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 580' ' ' GLU . . . . . 0.621 ' HG2' ' O ' ' A' ' 581' ' ' TYR . 2.4 pm0 -128.5 -167.23 1.74 Allowed 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 122.897 0.479 . . . . 71.33 110.016 -173.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 581' ' ' TYR . . . . . 0.621 ' O ' ' HG2' ' A' ' 580' ' ' GLU . 52.5 p90 -58.3 153.41 15.44 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 107.709 -1.219 . . . . 71.44 107.709 170.195 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -93.34 134.44 35.55 Favored 'General case' 0 C--N 1.275 -2.668 0 C-N-CA 116.654 -2.019 . . . . 65.13 113.36 -176.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 583' ' ' LYS . . . . . 0.407 ' HE2' ' HB3' ' A' ' 585' ' ' LYS . 0.0 OUTLIER -145.93 130.79 18.12 Favored 'General case' 0 N--CA 1.412 -2.331 0 N-CA-C 104.584 -2.376 . . . . 70.33 104.584 171.253 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -66.3 123.72 20.72 Favored 'General case' 0 CA--C 1.488 -1.434 0 N-CA-C 107.364 -1.347 . . . . 72.13 107.364 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 585' ' ' LYS . . . . . 0.407 ' HB3' ' HE2' ' A' ' 583' ' ' LYS . 0.0 OUTLIER -128.87 166.71 18.56 Favored 'General case' 0 C--N 1.285 -2.216 0 CA-C-N 115.604 -0.725 . . . . 71.14 109.902 -168.527 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 6.5 t -156.22 145.41 20.59 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-O 120.797 0.332 . . . . 61.52 110.866 -173.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 587' ' ' PHE . . . . . 0.504 ' CE2' ' HB3' ' A' ' 553' ' ' PHE . 3.4 p90 -125.33 147.76 49.01 Favored 'General case' 0 N--CA 1.42 -1.965 0 O-C-N 125.068 1.48 . . . . 64.32 109.644 176.575 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 588' ' ' PHE . . . . . 0.426 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 20.7 m-85 -100.95 127.4 47.46 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.393 -0.966 . . . . 63.45 108.393 -176.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 589' ' ' LEU . . . . . 0.498 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.5 OUTLIER -100.96 117.19 34.53 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 104.898 -2.26 . . . . 62.12 104.898 175.707 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -126.13 125.9 43.28 Favored 'General case' 0 C--N 1.281 -2.372 0 C-N-CA 120.233 -0.587 . . . . 72.43 109.708 -177.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 591' ' ' ILE . . . . . 0.534 HG22 ' HB3' ' A' ' 539' ' ' TYR . 14.8 pt -87.44 138.67 18.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 N-CA-C 107.828 -1.175 . . . . 52.22 107.828 173.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -98.88 -136.91 9.54 Favored Glycine 0 N--CA 1.429 -1.819 0 C-N-CA 120.381 -0.914 . . . . 64.24 114.023 -173.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -84.64 118.36 70.86 Favored Pre-proline 0 C--N 1.294 -1.842 0 C-N-CA 124.555 1.142 . . . . 61.14 110.133 -176.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.11 150.82 72.61 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.354 2.036 . . . . 72.3 111.488 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 595' ' ' ARG . . . . . 0.4 ' CG ' ' HB ' ' A' ' 536' ' ' ILE . 10.8 ptm180 -132.57 132.11 42.21 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 109.429 -0.582 . . . . 72.4 109.429 -177.102 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 596' ' ' LEU . . . . . 0.528 HD22 HG22 ' A' ' 535' ' ' VAL . 0.0 OUTLIER -80.09 134.61 36.2 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.336 -1.357 . . . . 74.43 107.336 -178.605 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 597' ' ' VAL . . . . . 0.466 HG21 ' ND2' ' A' ' 534' ' ' ASN . 58.1 t . . . . . 0 C--N 1.303 -1.42 0 CA-C-O 121.868 0.842 . . . . 65.53 109.098 178.086 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 80.7 mtt180 . . . . . 0 N--CA 1.428 -1.557 0 N-CA-C 107.963 -1.125 . . . . 74.3 107.963 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -94.26 151.47 2.05 Favored 'Trans proline' 0 N--CA 1.428 -2.336 0 C-N-CA 121.504 1.47 . . . . 74.05 110.816 173.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.2 pp -112.91 173.37 2.81 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 CA-C-N 116.375 -0.375 . . . . 63.15 111.451 -178.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 636' ' ' LEU . . . . . 0.448 HD11 HG21 ' A' ' 640' ' ' THR . 14.0 tp -78.91 158.37 28.07 Favored 'General case' 0 N--CA 1.433 -1.296 0 O-C-N 123.182 0.301 . . . . 73.34 110.432 -177.422 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 637' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' A' ' 505' ' ' PHE . . . -76.44 -107.04 0.13 Allowed Glycine 0 N--CA 1.435 -1.424 0 N-CA-C 115.032 0.773 . . . . 25.14 115.032 -177.316 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -127.5 -70.66 0.7 Allowed 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.033 -0.729 . . . . 65.54 109.033 -175.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 12.8 p80 -132.84 114.76 14.46 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 109.059 -0.719 . . . . 75.3 109.059 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 640' ' ' THR . . . . . 0.448 HG21 HD11 ' A' ' 636' ' ' LEU . 30.8 p -98.46 91.3 5.12 Favored 'General case' 0 N--CA 1.407 -2.622 0 CA-C-O 121.626 0.727 . . . . 65.01 109.885 -178.136 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 641' ' ' LYS . . . . . 0.418 ' HE3' ' CD1' ' A' ' 588' ' ' PHE . 23.4 tptm -170.96 129.9 0.77 Allowed 'General case' 0 CA--C 1.498 -1.036 0 CA-C-N 115.437 -0.801 . . . . 75.23 109.311 -179.047 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 642' ' ' LEU . . . . . 0.569 HD21 HG21 ' A' ' 523' ' ' VAL . 27.8 tp -137.08 109.88 7.59 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 107.45 -1.315 . . . . 64.31 107.45 172.535 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 643' ' ' GLU . . . . . 0.553 ' HB3' HG22 ' A' ' 511' ' ' VAL . 19.3 tt0 -94.34 104.1 16.09 Favored 'General case' 0 C--N 1.273 -2.741 0 N-CA-C 107.12 -1.437 . . . . 70.32 107.12 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 644' ' ' VAL . . . . . 0.637 HG21 ' HE2' ' A' ' 521' ' ' MET . 25.4 t -95.56 108.01 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.194 0 N-CA-C 109.559 -0.534 . . . . 74.41 109.559 -177.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 3.5 mp -94.84 124.81 47.49 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 107.233 -1.395 . . . . 52.11 107.233 177.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 646' ' ' ILE . . . . . 0.519 HD12 ' N ' ' A' ' 646' ' ' ILE . 2.8 mp -104.35 115.68 46.72 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.438 0 N-CA-C 107.601 -1.259 . . . . 75.43 107.601 -174.245 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -121.16 168.92 11.05 Favored 'General case' 0 N--CA 1.419 -2.007 0 O-C-N 123.608 0.568 . . . . 55.45 109.585 -175.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -69.95 157.9 36.61 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 112.766 0.654 . . . . 65.43 112.766 -172.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 20.2 t . . . . . 0 N--CA 1.439 -0.994 0 N-CA-C 106.573 -1.64 . . . . 64.02 106.573 175.335 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 503' ' ' GLY . . . . . 0.64 ' HA2' ' OG1' ' A' ' 528' ' ' THR . . . . . . . . 0 N--CA 1.415 -2.738 0 CA-C-O 119.947 -0.363 . . . . 64.23 113.063 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 3.7 mp -116.31 112.39 39.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 107.1 -1.444 . . . . 55.14 107.1 175.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -119.7 125.56 48.98 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.57 -0.9 . . . . 65.05 108.57 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 506' ' ' THR . . . . . 0.439 ' HB ' ' HA3' ' A' ' 637' ' ' GLY . 15.1 t -155.44 169.44 24.25 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 109.77 -0.456 . . . . 74.14 109.77 -174.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -98.81 161.15 13.8 Favored 'General case' 0 C--O 1.249 1.063 0 N-CA-C 106.243 -1.762 . . . . 71.52 106.243 172.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 508' ' ' GLU . . . . . 0.427 ' HG2' HD21 ' A' ' 526' ' ' LEU . 3.4 pt-20 -99.17 -27.93 13.58 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 120.387 -0.525 . . . . 75.41 110.734 176.546 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -114.26 119.16 40.85 Favored Pre-proline 0 N--CA 1.43 -1.463 0 N-CA-C 107.647 -1.242 . . . . 74.25 107.647 174.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -83.39 -4.28 10.92 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 121.902 1.735 . . . . 65.41 111.951 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 511' ' ' VAL . . . . . 0.429 HG13 ' CD1' ' A' ' 645' ' ' ILE . 88.3 t -143.27 134.9 23.66 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.069 0 N-CA-C 108.036 -1.098 . . . . 63.23 108.036 -179.113 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 4.7 t -139.5 151.49 46.19 Favored 'General case' 0 N--CA 1.404 -2.766 0 N-CA-C 108.099 -1.075 . . . . 50.15 108.099 176.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 78.1 m-70 -117.3 116.86 28.05 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 109.168 -0.678 . . . . 71.33 109.168 179.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.673 HG11 ' SD ' ' A' ' 521' ' ' MET . 31.0 m -111.6 153.13 13.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 C-N-CA 120.469 -0.492 . . . . 73.4 110.909 -177.566 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 515' ' ' SER . . . . . 0.502 ' HA ' ' OE2' ' A' ' 647' ' ' GLU . 40.5 t -76.59 143.88 39.97 Favored 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 114.945 -1.025 . . . . 64.31 109.715 -178.384 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 516' ' ' GLU . . . . . 0.466 ' HG3' ' HB3' ' A' ' 578' ' ' ASP . 35.4 tt0 -68.71 -10.24 55.22 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.449 0.643 . . . . 51.11 111.195 178.023 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 20.5 t -115.49 21.93 13.61 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 109.317 -0.623 . . . . 65.01 109.317 -177.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 518' ' ' ILE . . . . . 0.428 HG22 ' O ' ' A' ' 515' ' ' SER . 15.1 tt -90.29 151.0 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 N-CA-C 108.847 -0.797 . . . . 71.53 108.847 178.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -96.35 -63.94 0.94 Allowed Glycine 0 N--CA 1.429 -1.822 0 C-N-CA 120.05 -1.071 . . . . 62.22 111.517 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 30.3 mm -119.04 118.18 56.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 109.635 -0.505 . . . . 73.45 109.635 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 521' ' ' MET . . . . . 0.673 ' SD ' HG11 ' A' ' 514' ' ' VAL . 25.1 ptt? -99.91 129.48 46.0 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 107.153 -1.425 . . . . 74.02 107.153 173.081 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 522' ' ' GLU . . . . . 0.565 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 30.9 mt-10 -117.43 130.18 56.3 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.849 -0.614 . . . . 72.15 109.95 175.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 523' ' ' VAL . . . . . 0.565 HG21 HD21 ' A' ' 642' ' ' LEU . 29.3 t -113.52 130.08 68.18 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 CA-C-N 115.207 -0.906 . . . . 75.22 109.117 -178.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 524' ' ' LYS . . . . . 0.523 ' HD2' HG21 ' A' ' 568' ' ' VAL . 32.3 mmtp -75.42 126.81 31.77 Favored 'General case' 0 C--N 1.31 -1.122 0 O-C-N 124.045 0.841 . . . . 73.15 112.4 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 8.9 t -105.16 140.27 23.69 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 N-CA-C 107.188 -1.412 . . . . 73.05 107.188 177.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 526' ' ' LEU . . . . . 0.429 HD22 ' N ' ' A' ' 526' ' ' LEU . 2.4 mm? -90.3 139.39 30.71 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 120.804 -0.359 . . . . 71.25 110.033 -178.121 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 527' ' ' ARG . . . . . 0.462 ' HG2' ' N ' ' A' ' 528' ' ' THR . 39.0 ttp180 -76.26 158.45 31.56 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 115.349 -0.842 . . . . 71.41 109.186 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 528' ' ' THR . . . . . 0.64 ' OG1' ' HA2' ' A' ' 503' ' ' GLY . 3.2 t -61.87 160.75 11.51 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 123.855 0.862 . . . . 72.22 111.03 173.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 23.1 t -78.81 -26.49 44.29 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 108.673 -0.862 . . . . 72.31 108.673 178.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -121.14 104.52 0.96 Allowed Glycine 0 N--CA 1.442 -0.941 0 N-CA-C 109.579 -1.408 . . . . 62.42 109.579 178.043 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -100.8 98.47 8.98 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 120.848 0.356 . . . . 63.4 111.539 -176.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -130.85 119.82 22.77 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.862 -0.608 . . . . 71.45 110.08 178.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 86.6 -177.85 48.6 Favored Glycine 0 N--CA 1.438 -1.207 0 C-N-CA 120.693 -0.765 . . . . 74.52 112.433 176.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -99.07 130.58 45.41 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.15 -1.055 . . . . 65.31 108.15 178.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 535' ' ' VAL . . . . . 0.438 HG22 HD22 ' A' ' 596' ' ' LEU . 58.7 t -127.6 131.37 70.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-O 120.84 0.352 . . . . 73.15 110.095 -176.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 536' ' ' ILE . . . . . 0.529 HG23 ' HB3' ' A' ' 559' ' ' GLU . 33.1 mm -98.41 129.76 48.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 N-CA-C 109.266 -0.642 . . . . 72.14 109.266 177.252 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 537' ' ' VAL . . . . . 0.468 HG22 ' HB3' ' A' ' 594' ' ' PRO . 21.6 t -118.56 101.54 50.72 Favored Pre-proline 0 C--N 1.314 -0.978 0 N-CA-C 109.156 -0.683 . . . . 72.35 109.156 179.01 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 538' ' ' PRO . . . . . 0.429 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 58.1 Cg_endo -72.21 151.12 54.48 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.943 2.428 . . . . 72.33 112.131 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 539' ' ' TYR . . . . . 0.48 ' HB3' HG22 ' A' ' 591' ' ' ILE . 45.4 p90 -149.45 162.43 40.13 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 109.385 -0.598 . . . . 72.11 109.385 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -157.59 156.27 31.6 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 123.797 0.686 . . . . 62.13 109.919 177.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 3.2 p -91.12 122.22 33.58 Favored 'General case' 0 N--CA 1.423 -1.816 0 O-C-N 123.636 0.585 . . . . 44.45 109.78 173.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.7 mp -92.7 118.63 38.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 105.915 -1.884 . . . . 73.41 105.915 174.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -50.25 -46.05 54.62 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 124.361 1.038 . . . . 74.12 111.656 -176.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 67.34 -106.24 1.61 Allowed Glycine 0 N--CA 1.426 -1.971 0 N-CA-C 110.616 -0.994 . . . . 73.22 110.616 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 11.5 t -118.81 6.64 11.49 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-O 121.615 0.722 . . . . 64.53 109.973 -178.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -86.06 170.32 12.35 Favored 'General case' 0 N--CA 1.442 -0.874 0 O-C-N 122.029 -0.419 . . . . 54.24 110.468 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 547' ' ' ARG . . . . . 0.512 ' HB2' ' HB2' ' A' ' 552' ' ' ASP . 29.8 mmt180 -69.76 174.05 5.57 Favored 'General case' 0 CA--C 1.502 -0.886 0 CA-C-N 116.007 -0.542 . . . . 73.32 110.964 176.082 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -68.46 172.89 34.19 Favored Glycine 0 C--N 1.295 -1.731 0 CA-C-N 114.954 -1.021 . . . . 64.51 114.157 -176.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . -62.37 123.35 30.73 Favored Glycine 0 N--CA 1.435 -1.386 0 CA-C-N 115.131 -0.535 . . . . 62.33 111.797 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 95.94 -17.75 58.71 Favored Glycine 0 N--CA 1.437 -1.295 0 N-CA-C 111.553 -0.619 . . . . 72.43 111.553 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -84.72 -66.61 0.87 Allowed 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 109.123 -0.695 . . . . 73.22 109.123 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 552' ' ' ASP . . . . . 0.512 ' HB2' ' HB2' ' A' ' 547' ' ' ARG . 1.2 m-20 -107.47 -22.37 12.57 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.664 -0.414 . . . . 72.22 111.728 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 553' ' ' PHE . . . . . 0.408 ' HB3' ' CE2' ' A' ' 587' ' ' PHE . 35.9 p90 -151.87 151.94 31.94 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 108.849 -0.797 . . . . 63.33 108.849 177.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.49 122.06 30.74 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 106.048 -1.834 . . . . 73.2 106.048 177.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -74.38 105.99 5.79 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.128 0.489 . . . . 71.03 111.231 -175.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 13.5 t -104.08 119.99 40.13 Favored 'General case' 0 N--CA 1.414 -2.271 0 CA-C-O 122.324 1.059 . . . . 74.13 109.917 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 1.2 p -136.96 105.01 5.63 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-N 114.608 -1.178 . . . . 63.45 108.728 178.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -151.34 -152.3 5.83 Favored Glycine 0 N--CA 1.416 -2.663 0 N-CA-C 110.743 -0.943 . . . . 64.14 110.743 -174.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 559' ' ' GLU . . . . . 0.529 ' HB3' HG23 ' A' ' 536' ' ' ILE . 52.2 mt-10 -142.47 129.28 20.53 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.163 0.506 . . . . 74.12 110.952 -175.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 560' ' ' LEU . . . . . 0.465 HD13 ' HG2' ' A' ' 569' ' ' LYS . 92.8 mt -91.17 139.47 30.72 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.527 -0.761 . . . . 73.11 109.678 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -100.26 115.68 30.49 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.517 0.675 . . . . 71.55 111.474 178.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -109.37 158.82 17.54 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 107.355 -1.35 . . . . 73.03 107.355 171.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 563' ' ' GLN . . . . . 0.449 ' H ' ' HB2' ' A' ' 566' ' ' GLU . 10.6 pt20 -165.87 179.24 6.0 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 109.803 -0.443 . . . . 74.03 109.803 177.25 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -59.47 -32.31 70.13 Favored 'General case' 0 C--N 1.322 -0.612 0 O-C-N 124.083 0.864 . . . . 72.24 110.468 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -88.85 -12.41 41.98 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.406 -0.816 . . . . 54.11 111.249 -177.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 566' ' ' GLU . . . . . 0.449 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 26.0 mm-40 -100.96 132.79 46.2 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 113.244 0.831 . . . . 71.33 113.244 -176.132 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 3.9 pt -120.27 156.11 23.25 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.065 0 N-CA-C 105.823 -1.917 . . . . 51.41 105.823 170.063 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 568' ' ' VAL . . . . . 0.523 HG21 ' HD2' ' A' ' 524' ' ' LYS . 1.0 OUTLIER 48.11 178.34 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.578 2.03 0 C-N-CA 125.708 1.603 . . . . 61.23 113.003 -177.403 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 569' ' ' LYS . . . . . 0.465 ' HG2' HD13 ' A' ' 560' ' ' LEU . 1.4 tpmt? -172.01 163.59 6.12 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 106.067 -1.827 . . . . 70.3 106.067 175.259 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 570' ' ' THR . . . . . 0.551 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 11.5 p -135.58 141.26 45.13 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 123.45 0.469 . . . . 62.23 110.779 176.049 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 571' ' ' ILE . . . . . 0.565 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 3.5 mp -97.28 122.13 48.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 N-CA-C 106.166 -1.79 . . . . 62.45 106.166 169.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 40.4 p -99.96 118.69 36.9 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 109.329 -0.619 . . . . 72.35 109.329 177.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 573' ' ' VAL . . . . . . . . . . . . . 45.2 t -117.48 126.64 74.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 108.887 -0.783 . . . . 74.41 108.887 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -77.89 106.73 9.93 Favored 'General case' 0 N--CA 1.421 -1.907 0 N-CA-C 108.608 -0.886 . . . . 63.42 108.608 174.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 62.1 t -84.19 119.81 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.378 0 N-CA-C 105.757 -1.942 . . . . 75.33 105.757 175.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 39.4 mm -76.87 131.09 35.49 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 106.776 -1.565 . . . . 61.11 106.776 -177.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -60.29 99.16 0.07 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 122.092 0.949 . . . . 71.34 109.773 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 578' ' ' ASP . . . . . 0.466 ' HB3' ' HG3' ' A' ' 516' ' ' GLU . 19.1 t70 -61.64 133.77 56.01 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 114.346 -1.297 . . . . 62.43 113.93 -172.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 579' ' ' GLU . . . . . 0.513 ' H ' ' CD ' ' A' ' 579' ' ' GLU . 0.6 OUTLIER -96.36 -13.83 22.96 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 113.599 -1.637 . . . . 74.14 113.883 -173.973 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -124.99 166.76 15.76 Favored 'General case' 0 C--O 1.264 1.826 0 C-N-CA 117.936 -1.506 . . . . 70.31 113.491 -176.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -71.86 153.37 41.94 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 107.664 -1.235 . . . . 64.33 107.664 178.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 582' ' ' GLU . . . . . 0.459 ' HG3' ' H ' ' A' ' 584' ' ' ASN . 6.1 pt-20 -148.79 166.1 29.48 Favored 'General case' 0 C--N 1.278 -2.531 0 N-CA-C 108.619 -0.882 . . . . 73.44 108.619 176.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 583' ' ' LYS . . . . . 0.412 ' HD3' ' HA ' ' A' ' 583' ' ' LYS . 34.1 mmtp -106.59 30.22 6.23 Favored 'General case' 0 C--N 1.286 -2.186 0 CA-C-O 122.814 1.293 . . . . 74.21 107.825 176.027 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 584' ' ' ASN . . . . . 0.459 ' H ' ' HG3' ' A' ' 582' ' ' GLU . 52.7 m-80 80.26 96.12 0.05 Allowed 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 110.902 -2.863 . . . . 72.33 111.491 178.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.14 163.0 19.02 Favored 'General case' 0 N--CA 1.434 -1.267 0 C-N-CA 119.434 -0.906 . . . . 65.3 109.955 176.311 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 6.0 t -148.49 143.77 26.92 Favored 'General case' 0 N--CA 1.415 -2.188 0 CA-C-O 120.97 0.415 . . . . 65.5 110.059 -177.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 587' ' ' PHE . . . . . 0.41 ' CZ ' HD11 ' A' ' 646' ' ' ILE . 3.1 p90 -129.38 149.62 51.08 Favored 'General case' 0 N--CA 1.418 -2.042 0 CA-C-N 114.305 -1.316 . . . . 75.43 108.711 177.06 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 588' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -106.81 136.25 46.96 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 116.41 -0.359 . . . . 75.25 110.086 -172.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 589' ' ' LEU . . . . . 0.493 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.4 OUTLIER -105.87 122.97 47.2 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 105.466 -2.05 . . . . 44.4 105.466 174.87 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -130.67 135.38 47.78 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 109.627 -0.508 . . . . 73.33 109.627 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 591' ' ' ILE . . . . . 0.48 HG22 ' HB3' ' A' ' 539' ' ' TYR . 19.6 pt -96.93 141.06 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.552 0 N-CA-C 106.839 -1.541 . . . . 71.44 106.839 173.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -95.9 -134.13 7.77 Favored Glycine 0 C--N 1.295 -1.729 0 C-N-CA 120.604 -0.808 . . . . 44.43 113.026 -175.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -85.19 116.05 63.82 Favored Pre-proline 0 C--N 1.303 -1.438 0 C-N-CA 122.958 0.503 . . . . 63.02 110.667 -177.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 594' ' ' PRO . . . . . 0.478 ' HA ' ' O ' ' A' ' 536' ' ' ILE . 59.8 Cg_endo -75.16 137.07 20.9 Favored 'Trans proline' 0 N--CA 1.431 -2.191 0 C-N-CA 121.316 1.344 . . . . 74.51 109.377 173.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -129.96 137.9 50.56 Favored 'General case' 0 C--N 1.285 -2.213 0 O-C-N 121.876 -0.515 . . . . 74.52 111.548 -175.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 596' ' ' LEU . . . . . 0.438 HD22 HG22 ' A' ' 535' ' ' VAL . 0.0 OUTLIER -77.18 124.81 28.35 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 107.905 -1.146 . . . . 64.3 107.905 -176.434 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 597' ' ' VAL . . . . . 0.418 ' CG2' HG12 ' A' ' 536' ' ' ILE . 23.1 t . . . . . 0 C--N 1.298 -1.644 0 CA-C-O 121.301 0.572 . . . . 61.14 109.667 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 . . . . . 0 CA--C 1.494 -1.199 0 N-CA-C 107.734 -1.21 . . . . 75.0 107.734 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -66.17 142.05 65.74 Favored 'Trans proline' 0 N--CA 1.437 -1.82 0 N-CA-C 108.204 -1.499 . . . . 71.24 108.204 171.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.3 pp -122.88 176.26 4.99 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 N-CA-C 113.677 0.992 . . . . 73.23 113.677 -173.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 636' ' ' LEU . . . . . 0.488 ' HB2' HG21 ' A' ' 640' ' ' THR . 0.0 OUTLIER -80.91 152.21 28.2 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 114.881 -1.054 . . . . 73.22 108.5 -179.344 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 637' ' ' GLY . . . . . 0.439 ' HA3' ' HB ' ' A' ' 506' ' ' THR . . . -80.74 -135.96 1.69 Allowed Glycine 0 C--N 1.293 -1.851 0 C-N-CA 120.864 -0.684 . . . . 73.21 113.668 -176.488 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -83.56 -58.67 2.72 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 120.125 -0.63 . . . . 72.45 109.969 -177.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -125.75 94.38 4.1 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 121.85 0.834 . . . . 62.15 111.905 -178.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 640' ' ' THR . . . . . 0.488 HG21 ' HB2' ' A' ' 636' ' ' LEU . 17.8 p -96.03 90.67 5.64 Favored 'General case' 0 N--CA 1.407 -2.595 0 N-CA-C 107.878 -1.156 . . . . 74.34 107.878 174.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 641' ' ' LYS . . . . . 0.446 ' HE2' ' HB2' ' A' ' 643' ' ' GLU . 1.2 tmtp? -172.5 134.4 0.66 Allowed 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 105.583 -2.006 . . . . 71.23 105.583 -175.186 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 642' ' ' LEU . . . . . 0.565 HD21 HG21 ' A' ' 523' ' ' VAL . 37.1 tp -134.93 106.34 6.8 Favored 'General case' 0 C--N 1.277 -2.583 0 N-CA-C 108.02 -1.104 . . . . 72.43 108.02 177.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 643' ' ' GLU . . . . . 0.446 ' HB2' ' HE2' ' A' ' 641' ' ' LYS . 27.2 tt0 -87.66 104.25 16.35 Favored 'General case' 0 C--N 1.277 -2.565 0 N-CA-C 106.748 -1.575 . . . . 74.31 106.748 178.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 644' ' ' VAL . . . . . 0.459 HG21 ' HE1' ' A' ' 521' ' ' MET . 40.1 t -94.06 106.02 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.155 0 N-CA-C 108.372 -0.973 . . . . 73.33 108.372 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 645' ' ' ILE . . . . . 0.429 ' CD1' HG13 ' A' ' 511' ' ' VAL . 3.8 mp -93.38 126.89 45.75 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 106.615 -1.624 . . . . 72.34 106.615 176.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 646' ' ' ILE . . . . . 0.539 HD12 ' N ' ' A' ' 646' ' ' ILE . 2.4 mp -99.11 124.02 52.12 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.249 0 N-CA-C 106.626 -1.62 . . . . 64.04 106.626 -177.373 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 647' ' ' GLU . . . . . 0.502 ' OE2' ' HA ' ' A' ' 515' ' ' SER . 0.0 OUTLIER -109.07 152.44 25.04 Favored 'General case' 0 C--N 1.266 -3.024 0 CA-C-N 115.598 -0.728 . . . . 63.23 109.518 -178.599 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 648' ' ' GLU . . . . . 0.432 ' CD ' ' HG2' ' A' ' 582' ' ' GLU . 25.5 mt-10 -83.79 75.31 10.1 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-O 122.327 1.061 . . . . 70.1 110.788 -176.407 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 18.2 m . . . . . 0 N--CA 1.446 -0.675 0 C-N-CA 129.024 2.93 . . . . 74.41 115.31 -176.987 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.41 -3.074 0 N-CA-C 113.803 0.281 . . . . 73.21 113.803 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 504' ' ' ILE . . . . . 0.483 ' H ' ' CB ' ' A' ' 528' ' ' THR . 3.6 mp -119.57 96.48 4.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 107.463 -1.31 . . . . 63.15 107.463 173.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -108.71 115.04 29.34 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 106.135 -1.802 . . . . 74.32 106.135 178.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 506' ' ' THR . . . . . 0.461 ' HB ' ' H ' ' A' ' 638' ' ' GLU . 15.0 t -147.71 164.33 33.91 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 120.232 -0.587 . . . . 73.04 109.478 -173.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -94.35 160.24 14.76 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 107.658 -1.238 . . . . 62.25 107.658 173.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 508' ' ' GLU . . . . . 0.434 ' HB2' HD21 ' A' ' 526' ' ' LEU . 24.2 tt0 -91.04 -33.46 15.5 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 107.445 -1.317 . . . . 53.11 107.445 -179.015 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -124.16 134.95 25.84 Favored Pre-proline 0 N--CA 1.414 -2.241 0 CA-C-N 114.369 -1.287 . . . . 70.31 109.538 179.087 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 510' ' ' PRO . . . . . 0.632 ' HA ' ' O ' ' A' ' 641' ' ' LYS . 81.9 Cg_endo -85.76 -4.64 9.02 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 121.82 1.68 . . . . 63.05 111.416 174.687 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 511' ' ' VAL . . . . . 0.405 HG22 ' HB3' ' A' ' 643' ' ' GLU . 81.9 t -143.64 134.71 22.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 C-N-CA 123.882 0.873 . . . . 72.13 108.672 -178.214 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 14.6 t -134.06 132.12 39.62 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 107.265 -1.383 . . . . 71.22 107.265 175.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 28.5 m-70 -100.52 121.63 41.89 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.485 -0.931 . . . . 64.24 108.485 177.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.648 HG11 ' SD ' ' A' ' 521' ' ' MET . 33.0 m -115.02 156.66 15.93 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 CA-C-N 116.27 -0.423 . . . . 72.12 109.983 -177.437 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 22.9 t -82.89 133.12 35.13 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 107.822 -1.177 . . . . 72.33 107.822 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -68.31 -7.52 31.74 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 112.07 0.396 . . . . 74.34 112.07 -177.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 45.6 p -103.09 8.02 38.78 Favored 'General case' 0 C--N 1.313 -0.992 0 O-C-N 121.63 -0.669 . . . . 71.11 110.655 179.064 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 12.4 tt -80.23 152.02 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 N-CA-C 109.536 -0.542 . . . . 74.14 109.536 -177.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 519' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . -91.23 -61.45 1.26 Allowed Glycine 0 N--CA 1.426 -1.982 0 C-N-CA 120.253 -0.975 . . . . 55.31 110.996 177.237 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 28.3 mm -121.18 128.42 76.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-O 121.068 0.461 . . . . 43.54 110.849 -177.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 521' ' ' MET . . . . . 0.667 ' HE1' HG21 ' A' ' 644' ' ' VAL . 24.0 ptt? -107.95 140.71 40.68 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 107.3 -1.37 . . . . 73.44 107.3 171.47 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -119.61 113.0 20.03 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-O 121.185 0.517 . . . . 70.11 109.957 -178.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 523' ' ' VAL . . . . . 0.646 ' O ' ' HA ' ' A' ' 570' ' ' THR . 47.3 t -93.04 126.45 45.47 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.31 0 CA-C-N 115.258 -0.883 . . . . 51.13 109.769 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 524' ' ' LYS . . . . . 0.495 ' HD2' HG21 ' A' ' 568' ' ' VAL . 31.4 mmtp -87.47 142.6 27.74 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 124.329 1.018 . . . . 51.13 111.427 -178.635 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 26.8 t -120.0 132.8 68.69 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 N-CA-C 107.016 -1.476 . . . . 73.54 107.016 176.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 526' ' ' LEU . . . . . 0.434 HD21 ' HB2' ' A' ' 508' ' ' GLU . 3.1 mm? -71.84 139.01 48.7 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-O 121.322 0.582 . . . . 73.42 110.902 -179.108 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 527' ' ' ARG . . . . . 0.507 ' HD3' ' CZ ' ' A' ' 562' ' ' PHE . 13.6 tpt85 -79.37 127.4 32.04 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 114.839 -1.073 . . . . 75.25 110.001 179.185 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 528' ' ' THR . . . . . 0.483 ' CB ' ' H ' ' A' ' 504' ' ' ILE . 2.6 t -60.67 146.65 44.86 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 113.979 -1.464 . . . . 62.03 111.561 175.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 32.6 t -61.58 -35.58 78.24 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 115.143 -0.935 . . . . 75.33 109.239 176.383 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -120.6 110.01 1.67 Allowed Glycine 0 N--CA 1.423 -2.185 0 N-CA-C 110.489 -1.044 . . . . 62.11 110.489 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 531' ' ' ALA . . . . . 0.445 ' HB2' HG23 ' A' ' 528' ' ' THR . . . -127.14 112.29 14.99 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.326 -0.99 . . . . 71.23 108.326 176.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -119.01 102.61 8.88 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 120.891 0.377 . . . . 73.54 111.192 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 93.54 -153.72 21.42 Favored Glycine 0 N--CA 1.43 -1.724 0 CA-C-N 115.534 -0.757 . . . . 61.43 112.261 175.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -104.24 126.16 51.12 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.183 -0.673 . . . . 71.5 109.183 179.493 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 535' ' ' VAL . . . . . 0.471 HG22 HD22 ' A' ' 596' ' ' LEU . 55.6 t -121.16 136.42 58.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 123.284 0.634 . . . . 73.21 109.529 -177.13 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 536' ' ' ILE . . . . . 0.614 HG23 ' HB3' ' A' ' 559' ' ' GLU . 18.7 mm -101.65 129.26 53.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-N 116.321 -0.4 . . . . 64.14 110.18 178.665 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 537' ' ' VAL . . . . . 0.461 HG22 ' HB3' ' A' ' 594' ' ' PRO . 39.1 t -118.84 108.85 40.33 Favored Pre-proline 0 C--N 1.317 -0.844 0 N-CA-C 108.812 -0.81 . . . . 75.55 108.812 177.107 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -72.34 143.07 38.4 Favored 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 122.033 1.822 . . . . 63.12 111.177 178.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 539' ' ' TYR . . . . . 0.514 ' CE1' ' HG ' ' A' ' 560' ' ' LEU . 35.3 p90 -152.13 155.5 37.97 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 109.865 -0.42 . . . . 50.4 109.865 -179.398 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -153.36 154.9 35.41 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 116.208 -0.451 . . . . 73.42 109.979 176.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 16.8 p -93.71 110.29 21.92 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 115.603 -0.726 . . . . 31.34 109.264 176.016 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.6 mp -77.57 118.87 25.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 105.69 -1.967 . . . . 65.42 105.69 176.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -54.83 -36.64 65.23 Favored 'General case' 0 C--N 1.319 -0.728 0 O-C-N 124.28 0.987 . . . . 74.45 113.578 -173.163 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 69.93 -97.81 0.59 Allowed Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 111.636 -0.586 . . . . 65.33 111.636 177.27 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 6.9 t -122.95 -0.27 9.02 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.472 0.653 . . . . 53.12 110.553 177.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -99.07 -170.26 1.89 Allowed 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 107.6 -1.259 . . . . 44.23 107.6 177.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 547' ' ' ARG . . . . . 0.446 ' HD3' ' N ' ' A' ' 548' ' ' GLY . 0.0 OUTLIER -138.12 130.14 28.59 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.34 -0.985 . . . . 65.12 108.34 -178.767 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 548' ' ' GLY . . . . . 0.446 ' N ' ' HD3' ' A' ' 547' ' ' ARG . . . -76.89 -146.15 2.12 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 111.346 -0.702 . . . . 72.54 111.346 177.087 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 64.44 15.69 59.58 Favored Glycine 0 C--N 1.314 -0.671 0 CA-C-N 117.077 0.438 . . . . 53.23 113.404 178.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 77.49 18.64 77.52 Favored Glycine 0 N--CA 1.431 -1.65 0 C-N-CA 121.172 -0.537 . . . . 74.11 112.166 -178.089 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -84.33 -70.62 0.56 Allowed 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 121.359 0.6 . . . . 65.31 109.491 178.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -100.63 -39.11 8.04 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 107.331 -1.359 . . . . 72.52 107.331 -178.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 553' ' ' PHE . . . . . 0.45 ' HA ' HG12 ' A' ' 576' ' ' ILE . 25.1 p90 -144.72 166.27 25.7 Favored 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 108.109 -1.071 . . . . 72.34 108.109 173.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 554' ' ' GLU . . . . . 0.411 ' HB3' ' HB3' ' A' ' 574' ' ' LYS . 0.6 OUTLIER -98.56 109.12 21.93 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 106.409 -1.7 . . . . 64.42 106.409 179.184 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -75.83 122.62 24.37 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-O 121.693 0.759 . . . . 71.42 111.038 -175.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 7.3 t -111.14 112.63 24.57 Favored 'General case' 0 N--CA 1.409 -2.514 0 CA-C-O 122.081 0.943 . . . . 44.31 109.957 -177.489 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 4.4 p -126.17 116.66 21.67 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 114.724 -1.125 . . . . 62.44 108.773 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -170.71 -156.27 11.26 Favored Glycine 0 N--CA 1.403 -3.547 0 C-N-CA 120.09 -1.053 . . . . 74.31 110.945 -176.267 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 559' ' ' GLU . . . . . 0.614 ' HB3' HG23 ' A' ' 536' ' ' ILE . 49.1 mt-10 -133.11 126.5 31.88 Favored 'General case' 0 C--N 1.284 -2.269 0 C-N-CA 122.368 0.267 . . . . 74.24 110.37 -176.441 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 560' ' ' LEU . . . . . 0.514 ' HG ' ' CE1' ' A' ' 539' ' ' TYR . 74.9 mt -82.42 136.26 34.98 Favored 'General case' 0 CA--C 1.5 -0.948 0 CA-C-N 116.064 -0.516 . . . . 65.41 110.88 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -98.32 102.33 14.04 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.096 -0.956 . . . . 75.33 108.9 178.342 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 562' ' ' PHE . . . . . 0.507 ' CZ ' ' HD3' ' A' ' 527' ' ' ARG . 1.3 t80 -111.37 147.95 34.05 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 106.559 -1.645 . . . . 71.53 106.559 -179.155 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 563' ' ' GLN . . . . . 0.426 ' H ' ' HB3' ' A' ' 566' ' ' GLU . 46.3 mt-30 -141.68 179.13 7.01 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 121.559 -0.713 . . . . 73.31 111.065 -173.212 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -77.63 -35.48 52.62 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 109.314 -0.624 . . . . 74.23 109.314 175.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -84.09 5.04 27.57 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 122.123 0.963 . . . . 74.41 109.599 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 566' ' ' GLU . . . . . 0.426 ' HB3' ' H ' ' A' ' 563' ' ' GLN . 6.7 tp10 -121.56 146.51 46.88 Favored 'General case' 0 N--CA 1.422 -1.869 0 CA-C-N 115.09 -0.959 . . . . 70.33 108.874 -179.226 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 3.3 pt -135.27 155.92 38.17 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.629 0 N-CA-C 106.707 -1.59 . . . . 71.32 106.707 173.351 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 568' ' ' VAL . . . . . 0.495 HG21 ' HD2' ' A' ' 524' ' ' LYS . 0.9 OUTLIER 51.01 170.13 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.624 0 C-N-CA 125.52 1.528 . . . . 75.22 112.048 -174.824 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 569' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -159.27 149.58 19.25 Favored 'General case' 0 C--N 1.283 -2.303 0 O-C-N 120.394 -1.441 . . . . 54.23 107.653 176.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 570' ' ' THR . . . . . 0.646 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 9.4 p -124.4 123.8 40.96 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 113.162 0.801 . . . . 50.31 113.162 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 2.8 mp -85.83 114.29 25.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 104.857 -2.275 . . . . 72.24 104.857 171.204 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 572' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 521' ' ' MET . 24.9 m -102.55 109.2 20.75 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.191 0.52 . . . . 70.4 110.106 -177.246 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 573' ' ' VAL . . . . . . . . . . . . . 25.5 t -111.53 137.06 45.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 115.735 -0.666 . . . . 70.42 109.687 -176.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 574' ' ' LYS . . . . . 0.411 ' HB3' ' HB3' ' A' ' 554' ' ' GLU . 5.0 tppp? -95.05 123.87 38.77 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 124.021 0.826 . . . . 62.13 110.087 178.245 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 57.9 t -94.33 133.47 35.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 107.03 -1.47 . . . . 71.12 107.03 175.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 576' ' ' ILE . . . . . 0.45 HG12 ' HA ' ' A' ' 553' ' ' PHE . 25.9 mm -98.55 160.3 3.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 109.261 -0.644 . . . . 62.1 109.261 -175.224 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -64.7 109.51 2.05 Favored 'General case' 0 C--O 1.247 0.94 0 C-N-CA 123.096 0.559 . . . . 71.44 110.054 177.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -55.93 127.7 31.62 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 124.211 0.944 . . . . 64.51 110.913 -172.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -110.32 -30.5 7.67 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 115.752 1.76 . . . . 53.15 115.752 -167.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 580' ' ' GLU . . . . . 0.448 ' HG2' ' CD2' ' A' ' 581' ' ' TYR . 0.0 OUTLIER -103.81 -72.26 0.71 Allowed 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 115.009 1.485 . . . . 75.53 115.009 -162.493 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 581' ' ' TYR . . . . . 0.448 ' CD2' ' HG2' ' A' ' 580' ' ' GLU . 6.3 p90 -141.47 154.03 45.3 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 107.572 -1.27 . . . . 72.45 107.572 -174.619 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -109.87 108.14 18.34 Favored 'General case' 0 C--N 1.27 -2.854 0 C-N-CA 119.137 -1.025 . . . . 72.52 109.809 -177.164 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 9.9 mmmm -139.03 169.38 17.89 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 105.73 -1.952 . . . . 73.14 105.73 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -74.94 98.72 3.64 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 108.008 -1.108 . . . . 74.11 108.008 175.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.09 147.21 30.28 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-O 121.202 0.525 . . . . 62.22 111.196 -178.46 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 4.1 t -152.41 152.12 31.64 Favored 'General case' 0 N--CA 1.422 -1.858 0 CA-C-N 115.372 -0.831 . . . . 72.14 109.643 -175.417 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -133.83 160.02 38.89 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-N 114.695 -1.139 . . . . 75.4 109.68 177.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 588' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -116.33 138.38 51.38 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 120.625 0.25 . . . . 73.31 110.379 -171.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 589' ' ' LEU . . . . . 0.572 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.6 OUTLIER -106.28 122.26 45.88 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 105.447 -2.057 . . . . 22.03 105.447 173.161 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -129.6 130.78 46.1 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 107.343 -1.354 . . . . 75.21 107.343 178.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 591' ' ' ILE . . . . . 0.491 HG22 ' HB3' ' A' ' 539' ' ' TYR . 27.4 pt -103.75 147.82 9.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.495 -0.928 . . . . 74.22 108.495 179.027 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -94.29 -168.45 37.33 Favored Glycine 0 N--CA 1.425 -2.1 0 N-CA-C 111.621 -0.591 . . . . 43.31 111.621 -178.031 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -77.67 127.18 83.06 Favored Pre-proline 0 N--CA 1.428 -1.556 0 N-CA-C 107.881 -1.155 . . . . 74.22 107.881 -178.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 594' ' ' PRO . . . . . 0.607 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 72.0 Cg_endo -71.77 171.17 17.02 Favored 'Trans proline' 0 C--N 1.324 -0.715 0 C-N-CA 123.384 2.722 . . . . 74.3 112.934 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 7.9 ptp85 -150.22 151.41 32.99 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 107.076 -1.453 . . . . 72.34 107.076 177.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 596' ' ' LEU . . . . . 0.471 HD22 HG22 ' A' ' 535' ' ' VAL . 0.0 OUTLIER -81.04 131.49 35.31 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 104.879 -2.267 . . . . 63.51 104.879 178.144 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 597' ' ' VAL . . . . . 0.52 ' CG2' HG12 ' A' ' 536' ' ' ILE . 99.3 t . . . . . 0 C--N 1.31 -1.133 0 CA-C-O 122.435 1.112 . . . . 61.51 108.584 178.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? . . . . . 0 N--CA 1.442 -0.874 0 N-CA-C 106.862 -1.533 . . . . 74.33 106.862 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 634' ' ' PRO . . . . . 0.607 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 11.9 Cg_endo -64.94 132.7 33.16 Favored 'Trans proline' 0 N--CA 1.441 -1.588 0 N-CA-C 107.562 -1.745 . . . . 44.25 107.562 167.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.5 pp -112.69 161.28 11.69 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.371 0 C-N-CA 120.194 -0.603 . . . . 63.42 111.442 -178.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 10.0 tt -63.1 154.57 30.55 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 124.34 1.056 . . . . 65.33 112.184 -178.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -79.77 -125.41 0.53 Allowed Glycine 0 N--CA 1.431 -1.664 0 N-CA-C 116.298 1.279 . . . . 64.24 116.298 -173.298 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 638' ' ' GLU . . . . . 0.461 ' H ' ' HB ' ' A' ' 506' ' ' THR . 34.6 tt0 -90.75 -72.96 0.55 Allowed 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.699 -0.751 . . . . 64.51 112.668 -169.522 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -130.84 127.93 39.61 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.113 0.483 . . . . 62.12 110.191 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 17.1 p -129.51 92.78 3.41 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-O 121.92 0.867 . . . . 73.22 112.743 -175.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 641' ' ' LYS . . . . . 0.632 ' O ' ' HA ' ' A' ' 510' ' ' PRO . 20.5 tptm -156.12 139.15 15.43 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 106.147 -1.798 . . . . 71.53 106.147 178.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 642' ' ' LEU . . . . . 0.572 ' HB3' ' HB3' ' A' ' 589' ' ' LEU . 21.8 tp -138.21 103.64 4.98 Favored 'General case' 0 N--CA 1.409 -2.491 0 N-CA-C 108.154 -1.054 . . . . 60.11 108.154 173.378 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 643' ' ' GLU . . . . . 0.405 ' HB3' HG22 ' A' ' 511' ' ' VAL . 24.9 tt0 -93.11 107.63 19.39 Favored 'General case' 0 C--N 1.274 -2.681 0 N-CA-C 106.847 -1.538 . . . . 72.42 106.847 176.723 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 644' ' ' VAL . . . . . 0.667 HG21 ' HE1' ' A' ' 521' ' ' MET . 24.0 t -93.24 104.89 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.004 0 N-CA-C 109.057 -0.72 . . . . 73.44 109.057 -177.405 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 4.0 mp -91.22 118.99 37.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 107.281 -1.377 . . . . 73.44 107.281 176.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 646' ' ' ILE . . . . . 0.458 HD12 ' N ' ' A' ' 646' ' ' ILE . 2.5 mp -100.15 108.0 22.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 106.607 -1.627 . . . . 64.41 106.607 -176.078 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -114.23 152.39 31.34 Favored 'General case' 0 C--N 1.281 -2.405 0 O-C-N 123.371 0.42 . . . . 63.52 111.241 -175.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -58.1 133.55 55.67 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.321 -0.854 . . . . 53.2 110.09 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 33.5 t . . . . . 0 N--CA 1.436 -1.151 0 O-C-N 124.218 0.949 . . . . 55.23 112.383 -174.148 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 503' ' ' GLY . . . . . 0.561 ' HA2' ' OG1' ' A' ' 528' ' ' THR . . . . . . . . 0 N--CA 1.414 -2.812 0 N-CA-C 112.352 -0.299 . . . . 61.01 112.352 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 3.8 mp -123.26 104.95 15.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 N-CA-C 107.756 -1.202 . . . . 75.4 107.756 175.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -118.62 112.42 19.82 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.775 -1.194 . . . . 75.51 107.775 176.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 14.9 t -141.62 155.22 45.74 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 120.392 -0.523 . . . . 75.51 110.25 -174.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -81.19 144.81 31.36 Favored 'General case' 0 CA--C 1.489 -1.372 0 N-CA-C 107.559 -1.274 . . . . 74.51 107.559 175.087 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -65.28 -43.71 90.3 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 123.88 0.737 . . . . 63.1 109.757 178.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -123.93 125.71 25.8 Favored Pre-proline 0 N--CA 1.425 -1.675 0 CA-C-N 115.625 -0.716 . . . . 75.42 109.257 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 510' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 641' ' ' LYS . 58.4 Cg_endo -73.52 -16.61 24.16 Favored 'Trans proline' 0 CA--C 1.53 0.298 0 C-N-CA 122.163 1.909 . . . . 74.22 111.708 176.554 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 83.1 t -133.82 131.78 56.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 109.013 -0.736 . . . . 63.23 109.013 178.191 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 6.0 t -132.84 143.37 49.49 Favored 'General case' 0 N--CA 1.406 -2.65 0 N-CA-C 107.568 -1.271 . . . . 75.03 107.568 178.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 36.1 m-70 -114.59 127.72 55.94 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.379 -0.971 . . . . 62.3 108.379 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.538 HG11 ' SD ' ' A' ' 521' ' ' MET . 34.1 m -124.86 158.94 32.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-O 121.015 0.436 . . . . 53.35 111.128 -174.357 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 515' ' ' SER . . . . . 0.413 ' O ' HG22 ' A' ' 518' ' ' ILE . 34.9 t -77.74 148.91 34.64 Favored 'General case' 0 N--CA 1.414 -2.227 0 CA-C-N 115.22 -0.9 . . . . 72.51 110.787 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -68.45 -17.67 64.25 Favored 'General case' 0 N--CA 1.422 -1.844 0 CA-C-N 114.827 -1.079 . . . . 75.0 108.512 172.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 43.6 m -108.75 22.06 16.43 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 116.056 -0.52 . . . . 73.42 111.375 -176.337 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 518' ' ' ILE . . . . . 0.413 HG22 ' O ' ' A' ' 515' ' ' SER . 16.1 tt -92.36 159.68 2.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 109.317 -0.623 . . . . 73.2 109.317 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 519' ' ' GLY . . . . . 0.481 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . -106.22 -67.08 0.67 Allowed Glycine 0 N--CA 1.417 -2.621 0 C-N-CA 120.281 -0.962 . . . . 74.42 111.179 177.069 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 33.5 mm -120.66 124.2 71.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 109.604 -0.517 . . . . 51.22 109.604 -177.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 521' ' ' MET . . . . . 0.72 ' HE1' HG21 ' A' ' 644' ' ' VAL . 24.6 ptt? -103.86 137.73 41.45 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 107.109 -1.441 . . . . 61.11 107.109 172.725 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 15.8 mp0 -114.16 97.37 6.31 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 108.788 -0.819 . . . . 72.03 108.788 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 523' ' ' VAL . . . . . 0.579 ' O ' ' HA ' ' A' ' 570' ' ' THR . 26.5 t -84.26 131.72 33.27 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 CA-C-N 116.1 -0.5 . . . . 52.53 110.308 -177.48 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 524' ' ' LYS . . . . . 0.458 ' HD2' HG21 ' A' ' 568' ' ' VAL . 32.3 mmtp -85.27 128.14 34.58 Favored 'General case' 0 C--O 1.247 0.966 0 N-CA-C 113.211 0.819 . . . . 73.52 113.211 -176.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 21.6 t -117.35 123.84 72.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 CA-C-N 114.251 -1.341 . . . . 75.22 107.773 177.487 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -81.69 141.71 33.36 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 109.487 -0.56 . . . . 74.44 109.487 -176.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 527' ' ' ARG . . . . . 0.472 ' HG2' ' N ' ' A' ' 528' ' ' THR . 39.3 ttp180 -86.77 161.06 18.58 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.498 -0.774 . . . . 51.32 110.851 -175.652 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 528' ' ' THR . . . . . 0.561 ' OG1' ' HA2' ' A' ' 503' ' ' GLY . 5.7 t -67.68 142.53 56.32 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-N 115.11 -0.95 . . . . 33.41 110.478 173.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 21.9 t -63.85 -38.85 92.64 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 115.216 -0.902 . . . . 73.32 108.924 176.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -100.37 80.14 0.47 Allowed Glycine 0 N--CA 1.431 -1.679 0 N-CA-C 110.329 -1.108 . . . . 51.34 110.329 177.077 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -93.68 107.8 19.62 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 109.279 -0.637 . . . . 72.52 109.279 178.391 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 19.4 mmt180 -119.49 111.06 17.64 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 120.889 0.376 . . . . 72.32 110.723 -179.04 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 89.33 -126.45 8.24 Favored Glycine 0 N--CA 1.426 -2.022 0 C-N-CA 120.111 -1.042 . . . . 74.42 113.504 175.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -135.85 124.16 23.27 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.278 -1.008 . . . . 63.43 108.278 -177.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 535' ' ' VAL . . . . . 0.446 HG22 HD22 ' A' ' 596' ' ' LEU . 72.1 t -125.04 125.42 69.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 109.326 -0.62 . . . . 75.41 109.326 -178.719 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 536' ' ' ILE . . . . . 0.429 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 36.6 mm -100.57 125.03 54.48 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.134 0 CA-C-N 115.447 -0.797 . . . . 54.22 109.103 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 537' ' ' VAL . . . . . 0.457 HG22 ' HB3' ' A' ' 594' ' ' PRO . 30.0 t -116.82 112.41 40.53 Favored Pre-proline 0 C--N 1.312 -1.031 0 CA-C-N 116.202 -0.454 . . . . 61.24 110.682 -176.142 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -74.28 140.62 27.83 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.481 2.121 . . . . 74.31 112.227 177.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 539' ' ' TYR . . . . . 0.494 ' CD1' ' HG ' ' A' ' 560' ' ' LEU . 48.5 p90 -140.99 156.18 46.09 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.004 -1.11 . . . . 62.1 108.004 -179.39 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -154.99 157.82 38.24 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 123.28 0.362 . . . . 63.21 110.659 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 1.6 p -95.09 124.6 39.22 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 115.1 -0.954 . . . . 74.11 108.812 174.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.5 mp -93.35 128.35 44.85 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 106.275 -1.75 . . . . 65.3 106.275 175.227 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -57.9 -50.23 74.03 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 123.782 0.677 . . . . 63.32 111.377 -176.227 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 69.4 -101.59 0.85 Allowed Glycine 0 N--CA 1.434 -1.477 0 CA-C-N 115.652 -0.703 . . . . 63.43 111.973 178.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 10.0 t -125.89 14.72 8.0 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 122.323 1.058 . . . . 61.1 109.26 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -116.94 152.92 33.53 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.114 -1.069 . . . . 42.43 108.114 176.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 547' ' ' ARG . . . . . 0.471 ' HG2' ' HG3' ' A' ' 551' ' ' GLU . 31.8 ttp180 -89.47 130.1 35.86 Favored 'General case' 0 N--CA 1.422 -1.841 0 CA-C-O 121.101 0.477 . . . . 73.22 111.116 -178.422 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -96.49 -176.92 35.73 Favored Glycine 0 C--N 1.301 -1.402 0 C-N-CA 120.884 -0.674 . . . . 73.24 112.774 -175.263 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 80.72 26.63 53.39 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.927 -0.654 . . . . 64.45 113.002 177.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 92.08 11.29 60.21 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.743 -0.742 . . . . 74.34 112.953 177.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 551' ' ' GLU . . . . . 0.471 ' HG3' ' HG2' ' A' ' 547' ' ' ARG . 5.8 mm-40 -88.99 -70.51 0.65 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 117.273 0.537 . . . . 54.4 110.287 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -98.86 -27.02 14.1 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.575 -0.898 . . . . 74.23 108.575 174.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 553' ' ' PHE . . . . . 0.638 ' HB3' ' CE2' ' A' ' 587' ' ' PHE . 40.8 p90 -151.46 154.2 36.11 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.569 -0.741 . . . . 35.5 110.055 176.331 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.99 129.6 34.81 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 104.948 -2.241 . . . . 75.0 104.948 174.514 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -86.19 113.48 22.25 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.212 0.529 . . . . 71.3 111.112 -172.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 556' ' ' THR . . . . . 0.428 HG21 HG22 ' A' ' 573' ' ' VAL . 11.3 t -111.51 104.85 13.3 Favored 'General case' 0 N--CA 1.415 -2.206 0 CA-C-O 122.443 1.116 . . . . 74.54 110.587 -176.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 1.6 p -123.8 110.94 15.53 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 114.778 -1.101 . . . . 74.21 109.295 176.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -163.01 -153.91 7.42 Favored Glycine 0 N--CA 1.418 -2.547 0 N-CA-C 110.296 -1.122 . . . . 54.33 110.296 -175.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 559' ' ' GLU . . . . . 0.429 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 39.0 mt-10 -137.99 136.34 36.83 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 120.77 0.319 . . . . 75.04 111.084 -176.4 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 560' ' ' LEU . . . . . 0.494 ' HG ' ' CD1' ' A' ' 539' ' ' TYR . 82.7 mt -93.85 147.82 22.72 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.375 -0.83 . . . . 74.43 109.866 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -104.82 107.73 18.84 Favored 'General case' 0 N--CA 1.424 -1.754 0 CA-C-O 121.213 0.53 . . . . 74.55 112.152 -178.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -101.74 146.86 27.17 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.443 -0.947 . . . . 72.21 108.443 172.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 563' ' ' GLN . . . . . 0.485 ' HB2' ' H ' ' A' ' 566' ' ' GLU . 51.7 mt-30 -144.2 -176.66 5.1 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 108.171 -1.048 . . . . 52.33 108.171 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -74.77 -31.58 61.81 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 107.76 -1.2 . . . . 75.04 107.76 174.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -78.87 -49.47 12.82 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.796 -1.093 . . . . 63.21 110.384 177.322 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 566' ' ' GLU . . . . . 0.485 ' H ' ' HB2' ' A' ' 563' ' ' GLN . 59.6 mm-40 -65.53 139.41 58.47 Favored 'General case' 0 CA--C 1.503 -0.838 0 CA-C-N 115.725 -0.67 . . . . 54.42 112.276 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 567' ' ' ILE . . . . . 0.451 ' HA ' ' HD3' ' A' ' 527' ' ' ARG . 21.6 pt -115.8 -170.67 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.412 -2.372 0 N-CA-C 105.649 -1.982 . . . . 64.54 105.649 172.487 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 568' ' ' VAL . . . . . 0.458 HG21 ' HD2' ' A' ' 524' ' ' LYS . 3.1 p 0.55 127.71 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.07 0 C-N-CA 128.027 2.531 . . . . 74.21 116.682 173.225 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 569' ' ' LYS . . . . . 0.539 ' HA ' ' HE2' ' A' ' 569' ' ' LYS . 8.8 mmpt? -105.74 164.69 11.73 Favored 'General case' 0 C--N 1.271 -2.835 0 CA-C-N 114.683 -1.144 . . . . 74.24 109.605 178.545 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 570' ' ' THR . . . . . 0.579 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 5.1 p -137.58 119.3 15.08 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.068 -0.969 . . . . 52.35 110.781 178.474 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 3.4 mp -86.92 106.4 15.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 107.291 -1.374 . . . . 65.41 107.291 176.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 4.1 p -84.27 109.13 17.55 Favored 'General case' 0 N--CA 1.415 -2.204 0 O-C-N 123.976 0.798 . . . . 65.31 109.685 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 573' ' ' VAL . . . . . 0.428 HG22 HG21 ' A' ' 556' ' ' THR . 44.0 t -113.89 128.44 70.81 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 N-CA-C 108.75 -0.833 . . . . 74.5 108.75 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 574' ' ' LYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 519' ' ' GLY . 58.8 tptt -83.4 103.49 12.8 Favored 'General case' 0 N--CA 1.417 -2.116 0 O-C-N 124.087 0.867 . . . . 75.41 108.827 177.029 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 71.5 t -78.75 135.1 26.56 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 105.995 -1.854 . . . . 61.22 105.995 176.249 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 32.3 mm -98.64 139.88 19.59 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 N-CA-C 108.715 -0.846 . . . . 65.21 108.715 -176.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -53.43 117.44 3.08 Favored 'General case' 0 C--O 1.244 0.783 0 O-C-N 124.302 1.001 . . . . 64.5 108.558 175.337 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 578' ' ' ASP . . . . . 0.44 ' OD2' ' HB2' ' A' ' 582' ' ' GLU . 25.3 t70 -62.29 120.28 10.69 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.265 -0.879 . . . . 55.31 112.462 -173.36 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -81.78 -19.13 41.9 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 114.55 1.315 . . . . 65.22 114.55 -172.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -131.38 -164.02 1.39 Allowed 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 119.668 -0.813 . . . . 74.52 110.703 -177.357 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -62.74 152.36 35.93 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 107.444 -1.317 . . . . 72.52 107.444 173.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 582' ' ' GLU . . . . . 0.44 ' HB2' ' OD2' ' A' ' 578' ' ' ASP . 42.5 tt0 -122.2 110.47 15.77 Favored 'General case' 0 N--CA 1.411 -2.39 0 C-N-CA 118.298 -1.361 . . . . 70.2 113.256 -172.178 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -79.54 -179.72 7.0 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 113.79 -1.55 . . . . 74.33 107.333 173.431 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -77.47 84.17 3.87 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 106.455 -1.683 . . . . 74.42 106.455 172.159 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . 0.262 0.0 OUTLIER -108.61 145.06 35.49 Favored 'General case' 0 N--CA 1.414 -2.262 0 CA-C-N 115.512 -0.767 . . . . 73.33 111.426 178.329 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 2.9 t -151.39 149.35 29.21 Favored 'General case' 0 N--CA 1.397 -3.094 0 CA-C-N 114.93 -1.032 . . . . 74.45 110.232 -174.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 587' ' ' PHE . . . . . 0.638 ' CE2' ' HB3' ' A' ' 553' ' ' PHE . 2.2 p90 -117.97 146.77 43.76 Favored 'General case' 0 N--CA 1.416 -2.171 0 CA-C-N 114.097 -1.411 . . . . 64.23 107.789 176.228 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 588' ' ' PHE . . . . . 0.526 ' HA ' ' O ' ' A' ' 642' ' ' LEU . 17.1 m-85 -107.36 142.87 36.48 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 120.707 -0.397 . . . . 73.35 110.218 -171.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 589' ' ' LEU . . . . . 0.439 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.3 OUTLIER -112.17 125.6 54.3 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 106.424 -1.695 . . . . 71.35 106.424 175.531 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -133.75 149.22 51.46 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 109.087 -0.708 . . . . 64.3 109.087 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 591' ' ' ILE . . . . . . . . . . . . . 27.5 pt -109.16 147.97 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.348 0 N-CA-C 108.485 -0.931 . . . . 74.43 108.485 176.18 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -102.38 -140.3 10.96 Favored Glycine 0 C--N 1.302 -1.344 0 C-N-CA 120.631 -0.795 . . . . 52.42 112.529 -177.075 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -77.8 115.06 47.01 Favored Pre-proline 0 C--N 1.315 -0.934 0 C-N-CA 122.623 0.369 . . . . 73.44 110.041 179.274 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 594' ' ' PRO . . . . . 0.457 ' HB3' HG22 ' A' ' 537' ' ' VAL . 73.4 Cg_endo -75.93 146.15 29.13 Favored 'Trans proline' 0 N--CA 1.444 -1.434 0 C-N-CA 121.577 1.518 . . . . 72.1 109.182 176.323 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 3.2 ptp180 -123.03 138.26 54.73 Favored 'General case' 0 C--N 1.297 -1.674 0 C-N-CA 119.561 -0.856 . . . . 74.21 110.527 -174.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 596' ' ' LEU . . . . . 0.446 HD22 HG22 ' A' ' 535' ' ' VAL . 0.0 OUTLIER -86.69 118.23 25.96 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 107.42 -1.326 . . . . 44.3 107.42 179.576 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 59.2 t . . . . . 0 C--N 1.304 -1.411 0 N-CA-C 108.534 -0.914 . . . . 71.1 108.534 -179.346 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 . . . . . 0 N--CA 1.427 -1.579 0 N-CA-C 107.239 -1.393 . . . . 52.32 107.239 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 634' ' ' PRO . . . . . 0.404 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 27.7 Cg_endo -79.28 153.31 24.28 Favored 'Trans proline' 0 N--CA 1.429 -2.267 0 N-CA-C 107.937 -1.601 . . . . 70.11 107.937 166.485 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 8.8 pt -122.86 -178.99 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 C-N-CA 119.7 -0.8 . . . . 72.11 109.98 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.55 -176.67 4.16 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 115.835 -0.621 . . . . 71.22 109.631 -178.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -83.54 -125.16 1.07 Allowed Glycine 0 N--CA 1.429 -1.811 0 C-N-CA 120.694 -0.765 . . . . 62.42 113.263 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -114.5 -59.94 1.95 Allowed 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 115.121 -0.54 . . . . 74.24 110.243 -176.349 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -107.52 93.82 4.75 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 122.068 0.937 . . . . 71.54 111.445 -178.069 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 23.7 p -109.46 91.27 3.58 Favored 'General case' 0 N--CA 1.41 -2.453 0 CA-C-N 115.389 -0.823 . . . . 72.43 109.788 178.133 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 641' ' ' LYS . . . . . 0.472 ' HE2' ' HB2' ' A' ' 643' ' ' GLU . 0.3 OUTLIER -168.92 129.26 1.13 Allowed 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 104.305 -2.48 . . . . 73.01 104.305 -178.021 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 642' ' ' LEU . . . . . 0.526 ' O ' ' HA ' ' A' ' 588' ' ' PHE . 37.0 tp -125.4 112.78 16.7 Favored 'General case' 0 C--N 1.276 -2.588 0 N-CA-C 108.094 -1.076 . . . . 61.1 108.094 175.547 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 643' ' ' GLU . . . . . 0.472 ' HB2' ' HE2' ' A' ' 641' ' ' LYS . 23.6 tt0 -98.07 107.2 19.63 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 107.175 -1.417 . . . . 74.45 107.175 177.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 644' ' ' VAL . . . . . 0.72 HG21 ' HE1' ' A' ' 521' ' ' MET . 26.6 t -95.05 103.18 14.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 N-CA-C 109.193 -0.669 . . . . 62.21 109.193 -178.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 3.9 mp -89.79 120.93 39.39 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 N-CA-C 108.401 -0.963 . . . . 74.43 108.401 178.453 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 646' ' ' ILE . . . . . 0.496 HD12 ' H ' ' A' ' 646' ' ' ILE . 1.5 mp -104.83 128.64 58.38 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.764 0 N-CA-C 104.982 -2.229 . . . . 72.15 104.982 -178.578 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -147.22 170.66 16.77 Favored 'General case' 0 C--N 1.282 -2.356 0 O-C-N 123.551 0.532 . . . . 54.31 112.078 -176.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -52.77 137.45 31.57 Favored 'General case' 0 C--O 1.249 1.037 0 CA-C-N 114.738 -1.119 . . . . 65.14 109.692 178.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 9.4 t . . . . . 0 N--CA 1.422 -1.842 0 CA-C-O 121.945 0.879 . . . . 64.2 111.897 -174.29 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 503' ' ' GLY . . . . . 0.642 ' HA2' ' OG1' ' A' ' 528' ' ' THR . . . . . . . . 0 N--CA 1.403 -3.505 0 N-CA-C 110.585 -1.006 . . . . 74.34 110.585 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 504' ' ' ILE . . . . . 0.416 ' HA ' ' HA2' ' A' ' 637' ' ' GLY . 3.1 mp -90.38 103.61 14.47 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.475 0 N-CA-C 108.783 -0.821 . . . . 61.54 108.783 177.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -117.15 109.37 16.83 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 106.728 -1.582 . . . . 75.34 106.728 175.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 12.5 t -150.62 164.39 36.17 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 109.196 -0.668 . . . . 51.31 109.196 -175.101 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -96.53 165.2 12.28 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.075 -1.083 . . . . 73.12 108.075 175.136 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.1 -30.97 9.89 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 120.781 -0.367 . . . . 74.42 111.919 175.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -107.85 123.7 37.04 Favored Pre-proline 0 C--N 1.311 -1.091 0 N-CA-C 108.714 -0.847 . . . . 75.22 108.714 173.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -82.43 -13.11 9.97 Favored 'Trans proline' 0 CA--C 1.532 0.381 0 C-N-CA 121.926 1.75 . . . . 70.44 111.549 177.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 511' ' ' VAL . . . . . 0.488 HG22 ' HB3' ' A' ' 643' ' ' GLU . 75.2 t -138.74 133.19 41.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 108.524 -0.917 . . . . 71.33 108.524 -179.349 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 5.4 t -136.45 145.86 45.7 Favored 'General case' 0 N--CA 1.41 -2.45 0 N-CA-C 108.613 -0.884 . . . . 53.13 108.613 176.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 27.8 m-70 -110.46 137.82 47.66 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.935 -0.765 . . . . 65.51 108.935 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.566 HG11 ' SD ' ' A' ' 521' ' ' MET . 27.7 m -126.74 151.53 33.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-O 121.197 0.522 . . . . 73.22 110.432 179.15 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 43.5 t -76.32 146.95 38.49 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 107.849 -1.167 . . . . 64.33 107.849 176.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 516' ' ' GLU . . . . . 0.692 ' HB2' ' O ' ' A' ' 647' ' ' GLU . 33.4 tt0 -74.98 -7.4 53.52 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-O 121.905 0.86 . . . . 71.31 109.683 176.524 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 10.7 t -110.28 22.72 15.18 Favored 'General case' 0 N--CA 1.415 -2.207 0 N-CA-C 108.382 -0.97 . . . . 53.13 108.382 -177.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 15.0 tt -94.02 155.61 3.18 Favored 'Isoleucine or valine' 0 C--O 1.247 0.948 0 N-CA-C 109.087 -0.708 . . . . 74.34 109.087 178.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -101.42 -70.45 0.89 Allowed Glycine 0 N--CA 1.419 -2.457 0 N-CA-C 110.66 -0.976 . . . . 63.21 110.66 177.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 32.3 mm -116.81 114.04 44.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 CA-C-O 120.689 0.28 . . . . 62.11 111.029 -177.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 521' ' ' MET . . . . . 0.57 ' HE1' HG21 ' A' ' 644' ' ' VAL . 24.7 ptt? -92.98 137.65 32.17 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.755 -1.202 . . . . 75.03 107.755 173.566 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -123.76 114.64 20.19 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 121.4 0.619 . . . . 74.24 110.794 178.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 523' ' ' VAL . . . . . 0.559 HG21 HD21 ' A' ' 642' ' ' LEU . 20.5 t -103.54 138.09 29.35 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 CA-C-N 114.639 -1.164 . . . . 71.2 108.414 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 524' ' ' LYS . . . . . 0.413 ' HD2' ' CG2' ' A' ' 568' ' ' VAL . 30.8 mmtp -85.13 145.89 27.4 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.664 0.745 . . . . 72.4 112.329 -177.416 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 7.9 t -123.13 131.49 73.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 106.49 -1.67 . . . . 72.01 106.49 175.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -77.54 140.6 39.76 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.064 -0.717 . . . . 72.4 109.064 -178.183 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 527' ' ' ARG . . . . . 0.499 ' HG3' ' HA ' ' A' ' 567' ' ' ILE . 2.7 tmm_? -96.12 135.29 38.1 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 109.202 -0.666 . . . . 70.34 109.202 -176.1 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 528' ' ' THR . . . . . 0.642 ' OG1' ' HA2' ' A' ' 503' ' ' GLY . 6.0 t -50.85 147.04 5.26 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 125.083 1.353 . . . . 71.13 114.557 -177.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 35.2 t -63.21 -55.11 27.72 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 114.55 -1.204 . . . . 45.31 107.811 173.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -85.95 95.5 2.02 Favored Glycine 0 N--CA 1.423 -2.171 0 N-CA-C 109.5 -1.44 . . . . 64.03 109.5 178.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -111.64 98.93 7.77 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 121.092 0.472 . . . . 64.44 110.24 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -125.01 131.78 53.35 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 109.299 -0.63 . . . . 73.42 109.299 177.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 81.07 -144.54 24.94 Favored Glycine 0 N--CA 1.422 -2.286 0 C-N-CA 120.828 -0.701 . . . . 45.4 113.254 175.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -140.2 121.74 15.18 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 107.858 -1.164 . . . . 72.02 107.858 179.233 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 535' ' ' VAL . . . . . 0.438 HG22 HD22 ' A' ' 596' ' ' LEU . 58.1 t -126.75 131.74 70.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 108.803 -0.814 . . . . 54.54 108.803 -178.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 536' ' ' ILE . . . . . 0.62 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 42.5 mm -94.92 129.63 44.81 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 108.888 -0.782 . . . . 74.12 108.888 178.503 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 67.9 t -111.97 110.73 54.04 Favored Pre-proline 0 C--N 1.295 -1.783 0 N-CA-C 109.37 -0.604 . . . . 74.4 109.37 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -73.96 155.95 47.88 Favored 'Trans proline' 0 CA--C 1.512 -0.625 0 C-N-CA 122.513 2.142 . . . . 43.34 111.495 178.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 539' ' ' TYR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 591' ' ' ILE . 48.2 p90 -150.41 156.34 41.3 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.295 -1.002 . . . . 73.54 108.295 177.051 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -152.44 147.9 26.81 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 112.188 0.44 . . . . 73.5 112.188 176.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 3.5 p -84.34 120.92 26.82 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-N 115.474 -0.785 . . . . 70.21 110.94 176.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.8 mp -88.84 119.92 36.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 N-CA-C 105.728 -1.953 . . . . 64.1 105.728 173.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -52.47 -41.01 62.97 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 124.479 1.112 . . . . 73.42 112.716 -174.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 72.34 -92.05 0.57 Allowed Glycine 0 N--CA 1.435 -1.369 0 N-CA-C 110.825 -0.91 . . . . 71.51 110.825 178.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 10.2 t -146.14 18.13 1.39 Allowed 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 121.382 0.611 . . . . 64.13 109.812 177.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -101.08 161.03 13.89 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.619 -1.252 . . . . 64.42 107.619 176.025 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 18.5 mmm180 -63.86 173.23 1.88 Allowed 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 113.75 1.019 . . . . 72.24 113.75 -179.316 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -71.34 -178.47 28.7 Favored Glycine 0 C--O 1.254 1.355 0 CA-C-N 114.254 -1.339 . . . . 62.11 114.281 -175.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . -59.87 119.38 18.09 Favored Glycine 0 N--CA 1.441 -1.005 0 CA-C-N 114.737 -0.731 . . . . 74.51 113.287 -176.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 95.28 -10.41 69.51 Favored Glycine 0 N--CA 1.435 -1.399 0 N-CA-C 111.712 -0.555 . . . . 45.52 111.712 178.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -98.51 -68.36 0.81 Allowed 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.782 -0.822 . . . . 61.4 108.782 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -94.22 -38.29 11.13 Favored 'General case' 0 CA--C 1.492 -1.264 0 C-N-CA 118.862 -1.135 . . . . 74.22 111.414 175.056 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 553' ' ' PHE . . . . . 0.426 ' HB3' ' CE2' ' A' ' 587' ' ' PHE . 48.0 p90 -145.04 155.63 43.47 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 108.316 -0.994 . . . . 71.52 108.316 -179.538 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -83.56 119.24 24.48 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 105.329 -2.1 . . . . 75.02 105.329 174.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -73.53 104.23 4.42 Favored 'General case' 0 CA--C 1.498 -1.035 0 CA-C-O 121.267 0.556 . . . . 61.33 110.043 -175.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 556' ' ' THR . . . . . 0.489 HG21 HG22 ' A' ' 573' ' ' VAL . 11.5 t -103.36 100.8 10.69 Favored 'General case' 0 N--CA 1.395 -3.175 0 CA-C-O 122.793 1.282 . . . . 52.45 110.978 -176.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 1.8 p -116.61 94.45 4.62 Favored 'General case' 0 N--CA 1.409 -2.502 0 CA-C-N 114.085 -1.416 . . . . 71.41 108.47 174.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -142.34 -157.54 7.19 Favored Glycine 0 N--CA 1.407 -3.291 0 N-CA-C 110.029 -1.228 . . . . 71.0 110.029 -174.007 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 559' ' ' GLU . . . . . 0.62 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 49.3 mt-10 -142.23 137.09 30.48 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 120.647 0.26 . . . . 61.12 111.315 -173.719 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 95.5 mt -96.82 144.94 26.31 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 123.415 0.686 . . . . 70.12 109.681 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -102.88 113.25 26.54 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 120.923 0.392 . . . . 72.13 110.665 -178.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -109.08 132.51 54.04 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 110.076 -0.342 . . . . 62.34 110.076 175.344 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -121.96 174.22 7.04 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.457 -0.897 . . . . 74.34 111.343 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -64.68 -38.03 89.59 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 114.122 -1.399 . . . . 65.0 110.222 176.14 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -94.34 -33.89 13.01 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.529 -0.76 . . . . 54.54 112.269 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -78.19 132.15 37.47 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.51 -0.313 . . . . 71.13 111.681 -177.167 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 567' ' ' ILE . . . . . 0.499 ' HA ' ' HG3' ' A' ' 527' ' ' ARG . 7.8 pt -109.94 163.29 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.617 0 N-CA-C 109.732 -0.47 . . . . 72.21 109.732 178.611 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 568' ' ' VAL . . . . . 0.498 ' O ' ' HG2' ' A' ' 569' ' ' LYS . 1.4 p 45.53 171.93 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.574 1.882 0 C-N-CA 127.278 2.231 . . . . 64.53 114.553 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 569' ' ' LYS . . . . . 0.566 ' HE3' ' HA ' ' A' ' 569' ' ' LYS . 0.0 OUTLIER -158.98 163.98 35.97 Favored 'General case' 0 CA--C 1.497 -1.095 0 C-N-CA 124.39 1.076 . . . . 73.31 108.235 173.698 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 570' ' ' THR . . . . . 0.537 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 4.7 p -135.4 133.96 39.22 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 124.112 0.883 . . . . 73.13 110.352 177.298 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 3.3 mp -93.03 106.26 17.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 106.618 -1.623 . . . . 63.21 106.618 172.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 572' ' ' SER . . . . . 0.424 ' HA ' ' O ' ' A' ' 521' ' ' MET . 13.0 p -88.14 112.02 22.24 Favored 'General case' 0 N--CA 1.424 -1.733 0 O-C-N 123.575 0.547 . . . . 74.44 109.797 178.315 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 573' ' ' VAL . . . . . 0.489 HG22 HG21 ' A' ' 556' ' ' THR . 42.4 t -115.54 131.22 68.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 109.148 -0.686 . . . . 64.15 109.148 -178.25 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -88.01 112.69 22.88 Favored 'General case' 0 N--CA 1.423 -1.784 0 O-C-N 123.929 0.768 . . . . 63.52 109.516 176.223 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 62.9 t -85.88 133.61 29.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 N-CA-C 106.42 -1.696 . . . . 70.31 106.42 176.142 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 25.8 mm -97.78 159.9 3.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 107.914 -1.143 . . . . 72.22 107.914 -174.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -71.35 114.22 9.19 Favored 'General case' 0 C--O 1.25 1.13 0 N-CA-C 110.007 -0.368 . . . . 74.22 110.007 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -56.82 142.71 39.91 Favored 'General case' 0 C--O 1.246 0.921 0 C-N-CA 124.614 1.166 . . . . 72.42 110.969 -176.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 579' ' ' GLU . . . . . 0.441 ' OE1' ' HG3' ' A' ' 580' ' ' GLU . 0.0 OUTLIER -124.88 -28.35 3.5 Favored 'General case' 0 C--N 1.289 -2.055 0 C-N-CA 125.115 1.366 . . . . 71.14 112.31 -170.439 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 580' ' ' GLU . . . . . 0.441 ' HG3' ' OE1' ' A' ' 579' ' ' GLU 0.3 0.0 OUTLIER -111.49 174.07 6.04 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 114.647 1.351 . . . . 43.14 114.647 -172.653 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 31.7 p90 -48.8 148.02 2.38 Favored 'General case' 0 CA--C 1.522 -0.122 0 O-C-N 124.778 1.298 . . . . 71.33 110.287 -178.182 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -122.99 106.5 10.9 Favored 'General case' 0 N--CA 1.408 -2.573 0 C-N-CA 118.265 -1.374 . . . . 75.34 114.177 -173.081 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -98.45 -158.48 0.67 Allowed 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 104.902 -2.258 . . . . 72.22 104.902 169.45 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -83.05 88.34 6.87 Favored 'General case' 0 C--N 1.282 -2.353 0 C-N-CA 118.903 -1.119 . . . . 72.33 108.4 174.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . 0.315 0.5 OUTLIER -100.85 138.36 38.0 Favored 'General case' 0 N--CA 1.425 -1.684 0 C-N-CA 119.429 -0.908 . . . . 53.03 111.81 -179.014 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 4.1 t -152.42 150.21 29.41 Favored 'General case' 0 N--CA 1.405 -2.681 0 CA-C-N 114.699 -1.137 . . . . 74.33 109.79 -175.355 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 587' ' ' PHE . . . . . 0.426 ' CE2' ' HB3' ' A' ' 553' ' ' PHE . 4.1 p90 -124.35 151.23 44.59 Favored 'General case' 0 N--CA 1.411 -2.395 0 CA-C-N 114.221 -1.354 . . . . 63.13 108.335 176.19 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 588' ' ' PHE . . . . . 0.5 ' HA ' ' O ' ' A' ' 642' ' ' LEU . 16.5 m-85 -113.35 142.04 46.33 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 116.471 -0.331 . . . . 64.42 110.281 -171.147 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 589' ' ' LEU . . . . . 0.442 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.4 OUTLIER -107.71 131.7 54.14 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 106.481 -1.674 . . . . 75.1 106.481 175.988 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -141.77 144.4 33.95 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.396 -0.964 . . . . 64.14 108.396 -179.282 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 591' ' ' ILE . . . . . 0.567 HG12 ' OG1' ' A' ' 640' ' ' THR . 20.0 pt -96.37 168.01 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 O-C-N 123.699 0.624 . . . . 73.04 109.691 177.332 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -118.03 -154.27 9.76 Favored Glycine 0 C--N 1.303 -1.288 0 C-N-CA 120.444 -0.884 . . . . 62.33 113.675 -177.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -76.93 118.24 70.47 Favored Pre-proline 0 C--N 1.319 -0.751 0 N-CA-C 108.664 -0.865 . . . . 73.02 108.664 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -66.72 138.19 48.28 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 122.398 2.065 . . . . 73.32 112.071 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 595' ' ' ARG . . . . . 0.55 ' CG ' ' HB ' ' A' ' 536' ' ' ILE . 7.2 ptm180 -116.03 119.48 36.02 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.69 -0.686 . . . . 62.15 109.822 -174.324 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 596' ' ' LEU . . . . . 0.438 HD22 HG22 ' A' ' 535' ' ' VAL . 0.0 OUTLIER -69.96 129.0 38.31 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 107.92 -1.141 . . . . 72.31 107.92 179.216 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 597' ' ' VAL . . . . . 0.498 ' CG2' HG12 ' A' ' 536' ' ' ILE . 11.6 t . . . . . 0 C--N 1.317 -0.842 0 CA-C-O 122.696 1.236 . . . . 54.24 108.286 178.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 . . . . . 0 C--O 1.218 -0.57 0 N-CA-C 108.773 -0.825 . . . . 72.04 108.773 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -74.31 154.17 45.89 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.39 2.06 . . . . 60.3 113.188 -175.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 1.9 pp -144.09 -169.81 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.31 -0.859 . . . . 75.43 110.775 -176.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.61 164.1 19.94 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 123.082 0.239 . . . . 73.32 110.621 -179.176 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 637' ' ' GLY . . . . . 0.416 ' HA2' ' HA ' ' A' ' 504' ' ' ILE . . . -81.16 -85.29 0.7 Allowed Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 121.317 -0.468 . . . . 71.45 113.78 -177.586 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -143.02 -63.58 0.41 Allowed 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 120.465 -0.494 . . . . 74.44 110.425 -178.304 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 10.7 p80 -127.68 114.77 17.77 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-O 121.913 0.864 . . . . 75.43 111.598 178.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 640' ' ' THR . . . . . 0.567 ' OG1' HG12 ' A' ' 591' ' ' ILE . 0.7 OUTLIER -111.4 92.28 3.98 Favored 'General case' 0 N--CA 1.416 -2.131 0 CA-C-N 114.811 -1.086 . . . . 53.32 109.674 177.361 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -169.88 125.44 0.81 Allowed 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 106.503 -1.666 . . . . 63.14 106.503 178.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 642' ' ' LEU . . . . . 0.559 HD21 HG21 ' A' ' 523' ' ' VAL . 31.3 tp -130.43 110.09 11.21 Favored 'General case' 0 C--N 1.277 -2.553 0 N-CA-C 108.312 -0.996 . . . . 72.54 108.312 177.609 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 643' ' ' GLU . . . . . 0.488 ' HB3' HG22 ' A' ' 511' ' ' VAL . 43.1 tt0 -92.31 107.22 19.05 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.062 -1.088 . . . . 71.25 108.062 178.21 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 644' ' ' VAL . . . . . 0.57 HG21 ' HE1' ' A' ' 521' ' ' MET . 24.3 t -97.73 104.56 16.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 109.248 -0.649 . . . . 74.22 109.248 -179.293 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 4.5 mp -86.69 128.21 39.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 108.903 -0.777 . . . . 73.32 108.903 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 646' ' ' ILE . . . . . 0.443 HD12 ' N ' ' A' ' 646' ' ' ILE . 1.2 mp -110.81 106.94 21.73 Favored 'Isoleucine or valine' 0 C--O 1.255 1.377 0 N-CA-C 108.158 -1.053 . . . . 73.34 108.158 -177.462 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 647' ' ' GLU . . . . . 0.692 ' O ' ' HB2' ' A' ' 516' ' ' GLU . 8.0 pt-20 -109.19 -161.4 0.76 Allowed 'General case' 0 C--N 1.268 -2.958 0 CA-C-N 113.718 -1.583 . . . . 75.31 107.864 -178.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -81.5 -173.1 4.19 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.3 -0.63 . . . . 74.1 109.3 177.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 23.1 t . . . . . 0 C--N 1.299 -1.59 0 N-CA-C 108.213 -1.032 . . . . 62.44 108.213 175.965 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 503' ' ' GLY . . . . . 0.457 ' HA2' ' OG1' ' A' ' 528' ' ' THR . . . . . . . . 0 N--CA 1.409 -3.113 0 N-CA-C 112.248 -0.341 . . . . 65.32 112.248 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 504' ' ' ILE . . . . . 0.443 ' H ' ' CB ' ' A' ' 528' ' ' THR . 3.1 mp -93.57 98.46 8.28 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 N-CA-C 107.826 -1.176 . . . . 74.34 107.826 174.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -113.9 114.73 26.63 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.922 -1.14 . . . . 71.21 107.922 176.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 506' ' ' THR . . . . . 0.463 ' HB ' ' HA3' ' A' ' 637' ' ' GLY . 15.0 t -149.02 162.66 39.49 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.876 -0.787 . . . . 74.23 108.876 -176.183 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -81.71 152.19 27.17 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 108.023 -1.103 . . . . 74.12 108.023 176.193 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -76.14 -24.85 54.9 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.551 0.691 . . . . 65.24 109.691 178.021 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -139.45 132.78 15.58 Favored Pre-proline 0 N--CA 1.424 -1.765 0 CA-C-N 115.144 -0.935 . . . . 70.33 108.683 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -84.33 0.33 9.19 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 122.122 1.881 . . . . 62.53 112.202 176.16 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 511' ' ' VAL . . . . . 0.52 HG22 ' HB3' ' A' ' 643' ' ' GLU . 69.3 t -145.57 135.33 18.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 124.193 0.997 . . . . 73.34 108.413 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 6.2 t -142.03 140.79 32.73 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.198 -1.408 . . . . 63.03 107.198 177.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -110.79 133.55 53.25 Favored 'General case' 0 CA--C 1.492 -1.258 0 N-CA-C 108.325 -0.991 . . . . 73.3 108.325 178.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.641 HG11 ' SD ' ' A' ' 521' ' ' MET . 34.0 m -129.62 159.89 41.18 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 CA-C-N 116.209 -0.451 . . . . 62.42 110.288 -174.357 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 515' ' ' SER . . . . . 0.424 ' HB3' ' HB ' ' A' ' 518' ' ' ILE . 47.3 t -77.7 150.48 34.47 Favored 'General case' 0 N--CA 1.415 -2.216 0 N-CA-C 107.564 -1.273 . . . . 75.45 107.564 177.378 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -88.43 -7.06 57.22 Favored 'General case' 0 C--N 1.286 -2.156 0 CA-C-O 122.315 1.055 . . . . 54.01 108.946 178.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 33.0 t -100.29 2.43 42.62 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 114.97 -1.014 . . . . 74.3 109.16 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 518' ' ' ILE . . . . . 0.424 ' HB ' ' HB3' ' A' ' 515' ' ' SER . 15.0 tt -78.52 151.99 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-N 115.979 -0.555 . . . . 71.33 110.039 -176.524 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -87.52 -70.78 1.29 Allowed Glycine 0 N--CA 1.43 -1.719 0 N-CA-C 110.094 -1.202 . . . . 73.41 110.094 176.049 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 31.7 mm -112.54 126.31 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 CA-C-O 120.935 0.398 . . . . 62.35 110.178 179.106 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 521' ' ' MET . . . . . 0.67 ' HE1' HG21 ' A' ' 644' ' ' VAL . 23.1 ptt? -105.46 142.96 34.3 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 107.167 -1.42 . . . . 62.04 107.167 173.312 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -121.03 151.61 39.58 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 121.395 0.617 . . . . 55.31 111.555 178.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 523' ' ' VAL . . . . . 0.641 ' O ' ' HA ' ' A' ' 570' ' ' THR . 33.0 t -130.83 137.17 56.59 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 107.832 -1.173 . . . . 71.33 107.832 -179.042 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -90.43 127.33 36.18 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 113.024 0.75 . . . . 61.24 113.024 -176.373 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 22.9 t -112.57 121.95 65.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 107.291 -1.374 . . . . 72.52 107.291 176.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -75.42 145.08 41.83 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.893 0.854 . . . . 74.22 112.687 -174.373 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 527' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' A' ' 528' ' ' THR . 11.2 tpp85 -75.62 133.08 40.98 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 114.073 -1.422 . . . . 65.12 109.202 173.358 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 528' ' ' THR . . . . . 0.457 ' OG1' ' HA2' ' A' ' 503' ' ' GLY . 3.0 t -57.64 159.85 4.81 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 114.56 -1.2 . . . . 75.32 111.965 174.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 35.7 t -62.04 -37.87 86.57 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.73 0.812 . . . . 35.13 109.126 178.152 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -137.63 122.78 2.57 Favored Glycine 0 N--CA 1.425 -2.099 0 N-CA-C 109.961 -1.256 . . . . 74.42 109.961 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 531' ' ' ALA . . . . . 0.414 ' HB2' ' CG2' ' A' ' 528' ' ' THR . . . -130.25 114.01 15.12 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.332 -0.988 . . . . 75.13 108.332 176.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -120.79 90.09 3.25 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.696 -0.853 . . . . 71.13 108.696 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 533' ' ' GLY . . . . . 0.529 ' H ' ' HB3' ' A' ' 564' ' ' ASN . . . 122.57 -178.86 16.3 Favored Glycine 0 N--CA 1.437 -1.256 0 N-CA-C 110.96 -0.856 . . . . 75.4 110.96 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 534' ' ' ASN . . . . . 0.424 ' HA ' ' HA ' ' A' ' 563' ' ' GLN . 48.4 t-20 -91.92 131.1 37.49 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.27 -1.011 . . . . 74.22 108.27 179.223 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 535' ' ' VAL . . . . . 0.489 HG22 HD22 ' A' ' 596' ' ' LEU . 89.8 t -119.1 139.03 47.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-O 121.059 0.457 . . . . 73.24 110.143 179.2 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 536' ' ' ILE . . . . . . . . . . . . . 42.1 mm -105.44 125.01 60.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 108.949 -0.76 . . . . 62.02 108.949 178.124 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 22.0 t -113.49 106.24 54.38 Favored Pre-proline 0 C--N 1.302 -1.482 0 O-C-N 123.35 0.406 . . . . 74.32 109.909 -178.201 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.9 145.37 25.11 Favored 'Trans proline' 0 CA--C 1.533 0.454 0 C-N-CA 122.369 2.046 . . . . 75.33 111.71 178.541 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 539' ' ' TYR . . . . . 0.482 ' HB3' HG22 ' A' ' 591' ' ' ILE . 53.8 p90 -142.45 163.05 33.89 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 110.212 -0.292 . . . . 73.25 110.212 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -151.76 153.78 34.98 Favored 'General case' 0 C--N 1.308 -1.196 0 O-C-N 123.6 0.563 . . . . 65.22 110.618 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 4.1 p -99.24 125.14 44.78 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.796 -0.638 . . . . 72.04 110.363 173.206 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.417 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 3.7 mp -96.06 118.52 42.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 105.937 -1.875 . . . . 53.24 105.937 174.49 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -55.84 -50.56 70.23 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 123.868 0.73 . . . . 75.45 112.273 -176.002 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 69.51 -103.49 1.11 Allowed Glycine 0 N--CA 1.431 -1.645 0 N-CA-C 111.099 -0.8 . . . . 40.14 111.099 -179.309 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 545' ' ' THR . . . . . 0.453 HG23 ' HA ' ' A' ' 585' ' ' LYS . 9.1 t -109.63 -3.96 16.51 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.337 0.589 . . . . 71.45 110.311 -179.25 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -96.01 171.54 8.56 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.927 -0.397 . . . . 53.43 109.927 176.252 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 31.7 tpt180 -115.4 119.51 36.47 Favored 'General case' 0 C--O 1.247 0.968 0 N-CA-C 109.253 -0.647 . . . . 61.23 109.253 179.061 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -86.75 -154.03 24.8 Favored Glycine 0 C--N 1.311 -0.828 0 C-N-CA 120.874 -0.679 . . . . 65.44 112.37 -179.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 549' ' ' GLY . . . . . 0.441 ' H ' ' HB2' ' A' ' 555' ' ' ASP . . . 72.07 17.44 77.18 Favored Glycine 0 C--N 1.316 -0.567 0 CA-C-O 120.151 -0.249 . . . . 54.43 113.558 178.714 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 83.85 27.16 38.94 Favored Glycine 0 N--CA 1.439 -1.145 0 N-CA-C 110.817 -0.913 . . . . 74.41 110.817 -178.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -99.32 -69.75 0.75 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 120.711 0.291 . . . . 73.54 110.333 -178.379 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -102.99 -27.91 12.33 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 106.879 -1.526 . . . . 75.15 106.879 177.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -146.23 158.2 43.86 Favored 'General case' 0 C--O 1.252 1.213 0 CA-C-N 114.526 -1.216 . . . . 74.31 108.438 174.095 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -87.81 116.61 26.08 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 106.121 -1.807 . . . . 73.33 106.121 178.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 555' ' ' ASP . . . . . 0.441 ' HB2' ' H ' ' A' ' 549' ' ' GLY . 14.4 t70 -75.78 132.81 40.68 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.3 -0.63 . . . . 73.41 109.3 -175.356 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 556' ' ' THR . . . . . 0.455 HG21 HG22 ' A' ' 573' ' ' VAL . 8.9 t -133.76 117.89 17.44 Favored 'General case' 0 N--CA 1.412 -2.348 0 CA-C-O 122.038 0.923 . . . . 75.13 111.534 -175.396 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 8.0 p -130.23 100.64 5.47 Favored 'General case' 0 N--CA 1.424 -1.77 0 N-CA-C 107.628 -1.249 . . . . 74.41 107.628 174.092 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -145.77 -159.71 8.3 Favored Glycine 0 N--CA 1.411 -2.968 0 N-CA-C 109.984 -1.246 . . . . 41.42 109.984 -174.2 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -136.1 136.77 40.41 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-O 120.678 0.275 . . . . 74.33 110.635 -175.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 89.1 mt -95.16 134.25 38.1 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.642 -0.708 . . . . 73.34 109.415 178.063 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -93.32 97.03 10.33 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.703 -0.851 . . . . 70.13 108.703 176.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -101.88 108.27 19.7 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 106.838 -1.542 . . . . 74.1 106.838 -178.394 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 563' ' ' GLN . . . . . 0.496 ' HB2' ' H ' ' A' ' 566' ' ' GLU . 42.9 mt-30 -97.49 172.4 7.77 Favored 'General case' 0 C--N 1.278 -2.506 0 CA-C-N 116.415 -0.357 . . . . 70.54 110.94 -174.085 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 564' ' ' ASN . . . . . 0.529 ' HB3' ' H ' ' A' ' 533' ' ' GLY . 2.6 p-10 -79.0 -16.04 57.44 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.98 0.895 . . . . 54.1 109.107 175.283 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -96.07 -54.79 3.19 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.211 -0.904 . . . . 75.12 109.195 176.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 566' ' ' GLU . . . . . 0.496 ' H ' ' HB2' ' A' ' 563' ' ' GLN . 9.7 tp10 -63.78 138.48 58.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.614 -0.721 . . . . 71.05 109.692 177.042 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 21.8 pt -106.0 -172.23 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.41 -2.466 0 N-CA-C 108.219 -1.03 . . . . 74.04 108.219 -178.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 3.4 p 3.19 126.47 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 128.832 2.853 . . . . 62.22 116.165 173.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 569' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -110.16 149.07 30.62 Favored 'General case' 0 C--N 1.259 -3.342 0 CA-C-N 115.112 -0.949 . . . . 63.23 110.502 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 570' ' ' THR . . . . . 0.641 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 16.0 p -122.53 128.16 50.43 Favored 'General case' 0 N--CA 1.415 -2.21 0 CA-C-N 115.259 -0.882 . . . . 72.33 110.188 177.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 3.3 mp -84.0 104.21 12.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 107.033 -1.469 . . . . 62.23 107.033 174.196 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 11.0 p -84.72 111.17 19.34 Favored 'General case' 0 N--CA 1.419 -2.009 0 CA-C-N 115.758 -0.655 . . . . 72.43 110.084 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 573' ' ' VAL . . . . . 0.455 HG22 HG21 ' A' ' 556' ' ' THR . 57.6 t -114.24 136.57 50.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 109.143 -0.688 . . . . 44.34 109.143 -178.278 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -95.15 125.05 39.53 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 124.123 0.89 . . . . 75.22 111.18 -178.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 81.8 t -93.59 132.84 36.63 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 N-CA-C 107.745 -1.206 . . . . 74.33 107.745 175.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 40.3 mm -91.6 160.44 2.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 109.535 -0.543 . . . . 75.23 109.535 -173.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -52.4 119.1 4.08 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 124.043 0.937 . . . . 72.12 109.671 175.275 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -90.69 151.31 21.3 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.1 0.476 . . . . 75.2 111.952 -175.076 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.91 -26.73 2.87 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 114.194 1.183 . . . . 64.11 114.194 -172.363 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 580' ' ' GLU . . . . . 0.408 ' HG2' ' O ' ' A' ' 581' ' ' TYR . 0.0 OUTLIER -112.23 178.21 4.38 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 118.741 -1.184 . . . . 62.42 113.263 -166.943 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 581' ' ' TYR . . . . . 0.408 ' O ' ' HG2' ' A' ' 580' ' ' GLU . 47.8 p90 -61.94 154.34 26.68 Favored 'General case' 0 C--O 1.247 0.969 0 CA-C-N 114.803 -1.09 . . . . 75.22 108.922 175.013 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 582' ' ' GLU . . . . . 0.498 ' HB2' ' HG2' ' A' ' 648' ' ' GLU . 5.8 tp10 -94.31 152.78 18.4 Favored 'General case' 0 C--N 1.284 -2.251 0 C-N-CA 119.023 -1.071 . . . . 63.21 110.633 179.442 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 583' ' ' LYS . . . . . 0.467 ' O ' ' HG3' ' A' ' 582' ' ' GLU . 18.3 ptpt -137.85 -172.16 3.18 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 103.365 -2.828 . . . . 74.24 103.365 176.389 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -79.54 91.69 5.2 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.254 -1.758 . . . . 75.34 106.254 170.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 585' ' ' LYS . . . . . 0.502 ' HD2' HD13 ' A' ' 646' ' ' ILE . 4.7 tmmm? -106.67 109.23 21.08 Favored 'General case' 0 N--CA 1.396 -3.165 0 N-CA-C 106.756 -1.572 . . . . 73.43 106.756 -172.337 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 4.6 t -142.44 145.76 34.11 Favored 'General case' 0 N--CA 1.392 -3.35 0 CA-C-N 113.823 -1.535 . . . . 54.03 109.306 -174.389 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -128.85 155.57 45.02 Favored 'General case' 0 N--CA 1.412 -2.35 0 CA-C-N 114.408 -1.269 . . . . 73.1 108.858 178.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 588' ' ' PHE . . . . . 0.505 ' HA ' ' O ' ' A' ' 642' ' ' LEU . 23.5 m-85 -109.67 138.13 46.49 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-N 116.36 -0.382 . . . . 71.22 110.23 -171.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 589' ' ' LEU . . . . . 0.487 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.8 OUTLIER -110.94 125.76 54.02 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 105.777 -1.934 . . . . 73.0 105.777 176.297 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -127.94 131.24 49.34 Favored 'General case' 0 C--N 1.284 -2.248 0 C-N-CA 120.613 -0.435 . . . . 74.44 110.289 179.162 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 591' ' ' ILE . . . . . 0.482 HG22 ' HB3' ' A' ' 539' ' ' TYR . 15.2 pt -93.66 134.02 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.621 0 N-CA-C 106.758 -1.571 . . . . 63.31 106.758 171.082 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -86.83 -146.95 10.64 Favored Glycine 0 C--N 1.3 -1.47 0 C-N-CA 120.965 -0.636 . . . . 72.05 111.586 -176.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.575 ' OE1' ' HD3' ' A' ' 633' ' ' ARG . 35.0 tt0 -88.57 123.87 67.11 Favored Pre-proline 0 N--CA 1.425 -1.695 0 N-CA-C 107.967 -1.123 . . . . 75.1 107.967 177.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -68.42 162.13 41.94 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 123.084 2.523 . . . . 75.43 111.428 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 29.9 ptt85 -130.12 143.45 50.8 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.263 -0.643 . . . . 75.21 109.263 178.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 596' ' ' LEU . . . . . 0.489 HD22 HG22 ' A' ' 535' ' ' VAL . 0.0 OUTLIER -85.37 128.56 34.76 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 106.188 -1.782 . . . . 71.55 106.188 179.207 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 87.2 t . . . . . 0 C--N 1.312 -1.026 0 CA-C-O 121.307 0.575 . . . . 75.43 109.829 -179.579 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 633' ' ' ARG . . . . . 0.575 ' HD3' ' OE1' ' A' ' 593' ' ' GLU . 95.1 mtt180 . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 106.739 -1.578 . . . . 64.22 106.739 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -76.08 146.79 29.29 Favored 'Trans proline' 0 N--CA 1.429 -2.3 0 N-CA-C 107.348 -1.828 . . . . 72.52 107.348 166.224 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 1.9 pp -126.57 -173.27 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 114.494 1.294 . . . . 61.43 114.494 -172.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.46 150.6 39.83 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.389 -0.823 . . . . 52.34 109.672 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 637' ' ' GLY . . . . . 0.463 ' HA3' ' HB ' ' A' ' 506' ' ' THR . . . -76.69 -71.13 1.21 Allowed Glycine 0 C--N 1.297 -1.598 0 C-N-CA 120.763 -0.732 . . . . 73.04 112.58 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -150.36 -59.72 0.19 Allowed 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 120.408 -0.517 . . . . 74.45 110.619 178.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 16.7 p80 -120.43 99.63 6.68 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.735 0.779 . . . . 70.21 111.921 -179.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 36.4 p -98.62 91.26 5.05 Favored 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 109.278 -0.638 . . . . 73.21 109.278 177.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -177.26 133.14 0.18 Allowed 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 106.159 -1.793 . . . . 71.21 106.159 -178.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 642' ' ' LEU . . . . . 0.505 ' O ' ' HA ' ' A' ' 588' ' ' PHE . 27.9 tp -133.84 118.03 17.51 Favored 'General case' 0 C--N 1.276 -2.602 0 N-CA-C 108.511 -0.922 . . . . 60.23 108.511 177.423 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 643' ' ' GLU . . . . . 0.52 ' HB3' HG22 ' A' ' 511' ' ' VAL . 33.6 tt0 -99.25 107.44 19.75 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 107.06 -1.459 . . . . 61.44 107.06 177.019 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 644' ' ' VAL . . . . . 0.67 HG21 ' HE1' ' A' ' 521' ' ' MET . 38.9 t -95.37 109.84 23.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 108.949 -0.76 . . . . 63.23 108.949 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 3.9 mp -94.86 119.9 43.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 N-CA-C 108.413 -0.958 . . . . 71.3 108.413 177.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 646' ' ' ILE . . . . . 0.514 HD12 ' N ' ' A' ' 646' ' ' ILE . 1.8 mp -107.88 134.51 49.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 105.798 -1.926 . . . . 35.01 105.798 -176.448 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -136.48 161.48 35.73 Favored 'General case' 0 C--N 1.277 -2.549 0 N-CA-C 112.31 0.485 . . . . 75.44 112.31 -172.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 648' ' ' GLU . . . . . 0.498 ' HG2' ' HB2' ' A' ' 582' ' ' GLU . 31.2 mm-40 -61.17 100.38 0.12 Allowed 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 106.189 -1.782 . . . . 73.21 106.189 172.323 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 10.5 m . . . . . 0 C--N 1.307 -1.265 0 C-N-CA 128.254 2.621 . . . . 71.04 115.871 -169.95 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.421 -2.34 0 N-CA-C 111.151 -0.779 . . . . 72.24 111.151 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 3.9 mp -122.27 111.39 30.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 109.255 -0.646 . . . . 74.03 109.255 -178.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -128.35 104.29 7.64 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 106.492 -1.67 . . . . 75.23 106.492 173.358 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 15.0 t -152.02 162.95 40.28 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.631 -0.878 . . . . 75.35 108.631 -175.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -91.77 168.78 11.22 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.749 -1.204 . . . . 73.34 107.749 172.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 508' ' ' GLU . . . . . 0.491 ' HB2' HD21 ' A' ' 526' ' ' LEU . 21.5 tt0 -99.74 -35.88 9.65 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 107.944 -1.132 . . . . 73.42 107.944 179.251 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -111.31 134.98 20.99 Favored Pre-proline 0 N--CA 1.419 -2.021 0 CA-C-N 114.377 -1.283 . . . . 64.12 110.239 -178.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -81.19 -18.7 8.49 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.554 1.503 . . . . 75.21 111.095 173.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 511' ' ' VAL . . . . . 0.47 HG22 ' HB3' ' A' ' 643' ' ' GLU . 93.2 t -138.04 141.5 38.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 123.81 0.844 . . . . 73.41 108.853 -177.655 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 8.1 t -137.3 140.81 41.78 Favored 'General case' 0 N--CA 1.416 -2.168 0 N-CA-C 107.526 -1.287 . . . . 75.23 107.526 174.202 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 55.4 m-70 -105.76 130.04 53.84 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.585 -0.895 . . . . 64.1 108.585 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 24.2 m -132.33 156.45 42.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 N-CA-C 108.862 -0.792 . . . . 73.22 108.862 -179.042 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 40.3 t -82.42 149.16 27.8 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 107.934 -1.136 . . . . 63.01 107.934 178.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -82.3 -7.5 59.63 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.85 0.833 . . . . 75.42 109.062 176.279 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 9.4 t -95.77 10.01 38.5 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.905 -0.776 . . . . 73.35 108.905 -178.15 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 12.4 tt -91.68 155.34 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 108.66 -0.867 . . . . 75.51 108.66 -177.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -91.44 -63.44 1.18 Allowed Glycine 0 N--CA 1.43 -1.755 0 N-CA-C 110.47 -1.052 . . . . 74.14 110.47 176.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 520' ' ' ILE . . . . . 0.414 HD13 ' HA ' ' A' ' 574' ' ' LYS . 34.4 mm -116.51 117.02 54.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 109.92 -0.4 . . . . 73.44 109.92 179.012 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 521' ' ' MET . . . . . 0.69 ' HE2' HG21 ' A' ' 644' ' ' VAL . 0.0 OUTLIER -96.41 128.66 43.53 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 106.609 -1.626 . . . . 73.24 106.609 172.238 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -117.36 138.74 51.59 Favored 'General case' 0 N--CA 1.424 -1.751 0 CA-C-N 115.829 -0.623 . . . . 72.41 111.269 178.153 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 523' ' ' VAL . . . . . 0.713 HG21 HD21 ' A' ' 642' ' ' LEU . 22.1 t -121.09 134.34 64.8 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.087 0 N-CA-C 106.176 -1.787 . . . . 70.23 106.176 175.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 524' ' ' LYS . . . . . 0.563 ' HD3' HG21 ' A' ' 568' ' ' VAL . 55.2 mttp -91.91 163.04 14.16 Favored 'General case' 0 N--CA 1.416 -2.171 0 C-N-CA 120.325 -0.55 . . . . 74.31 111.904 -178.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 16.0 t -128.5 141.98 45.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-N 115.512 -0.767 . . . . 62.01 109.115 -175.248 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 526' ' ' LEU . . . . . 0.491 HD21 ' HB2' ' A' ' 508' ' ' GLU . 2.0 mm? -78.24 139.08 38.92 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 107.554 -1.276 . . . . 74.35 107.554 178.244 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 48.2 ttp180 -92.79 140.5 29.45 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.729 -0.788 . . . . 73.42 111.199 -175.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 4.2 t -55.17 149.02 13.07 Favored 'General case' 0 N--CA 1.413 -2.28 0 CA-C-N 114.044 -1.434 . . . . 73.41 111.97 174.1 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 26.1 t -80.62 -15.89 55.46 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.386 -0.824 . . . . 60.13 109.038 177.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -127.54 110.92 1.24 Allowed Glycine 0 N--CA 1.433 -1.517 0 N-CA-C 111.163 -0.775 . . . . 62.0 111.163 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -165.06 76.11 0.27 Allowed 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 123.334 0.653 . . . . 75.45 110.173 177.268 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -90.36 81.53 6.02 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.751 0.786 . . . . 75.24 110.064 177.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 533' ' ' GLY . . . . . 0.575 ' H ' ' HB2' ' A' ' 564' ' ' ASN . . . 149.37 -118.97 0.99 Allowed Glycine 0 N--CA 1.414 -2.772 0 CA-C-N 114.828 -1.078 . . . . 64.13 112.071 179.06 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -145.07 131.3 19.49 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 107.234 -1.395 . . . . 72.0 107.234 -178.099 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 535' ' ' VAL . . . . . 0.428 HG22 HD22 ' A' ' 596' ' ' LEU . 46.8 t -128.36 133.86 65.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 109.387 -0.597 . . . . 65.53 109.387 -178.327 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 536' ' ' ILE . . . . . 0.54 HG23 ' HB3' ' A' ' 559' ' ' GLU . 28.5 mm -98.28 126.48 51.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 109.217 -0.66 . . . . 73.11 109.217 178.176 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 36.1 t -116.65 103.38 52.59 Favored Pre-proline 0 C--N 1.301 -1.513 0 N-CA-C 108.579 -0.897 . . . . 73.31 108.579 177.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.56 146.93 50.64 Favored 'Trans proline' 0 C--N 1.331 -0.391 0 C-N-CA 122.264 1.976 . . . . 75.3 111.169 179.39 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 539' ' ' TYR . . . . . 0.539 ' CE1' ' HG ' ' A' ' 560' ' ' LEU . 36.0 p90 -151.14 161.58 42.46 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 109.689 -0.485 . . . . 75.14 109.689 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -155.67 148.6 24.35 Favored 'General case' 0 C--N 1.309 -1.174 0 O-C-N 123.471 0.482 . . . . 61.21 111.933 178.507 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 2.4 p -85.82 121.09 27.98 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 115.957 -0.565 . . . . 70.25 110.967 175.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.8 mp -86.96 116.99 30.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 105.271 -2.122 . . . . 65.03 105.271 172.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -55.2 -43.43 74.4 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 124.163 0.914 . . . . 72.33 112.146 -174.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 67.96 -94.06 0.29 Allowed Glycine 0 N--CA 1.439 -1.101 0 CA-C-N 115.733 -0.667 . . . . 65.23 111.757 178.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 545' ' ' THR . . . . . 0.476 HG23 ' HA ' ' A' ' 585' ' ' LYS . 9.2 t -124.41 -2.07 8.04 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 120.788 0.328 . . . . 53.11 110.488 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -91.19 155.54 18.52 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.71 -0.478 . . . . 74.03 109.71 178.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 22.1 tpt180 -94.55 108.31 20.27 Favored 'General case' 0 C--O 1.25 1.097 0 N-CA-C 109.546 -0.539 . . . . 62.21 109.546 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -89.66 -163.57 39.37 Favored Glycine 0 CA--C 1.507 -0.422 0 C-N-CA 121.124 -0.56 . . . . 73.04 114.046 -175.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 77.75 12.38 84.52 Favored Glycine 0 C--N 1.321 -0.281 0 CA-C-N 115.433 -0.384 . . . . 73.44 113.593 178.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 95.79 4.56 60.32 Favored Glycine 0 N--CA 1.437 -1.251 0 C-N-CA 120.46 -0.876 . . . . 71.13 111.644 -178.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -73.98 -69.86 0.42 Allowed 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.912 -0.773 . . . . 71.41 108.912 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -107.8 -34.12 7.05 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.861 -1.163 . . . . 75.52 107.861 177.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -135.95 157.27 47.25 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 108.464 -0.939 . . . . 74.11 108.464 174.18 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -88.14 121.02 30.06 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.855 -1.165 . . . . 64.21 107.855 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -78.67 100.96 7.25 Favored 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 109.263 -0.643 . . . . 65.42 109.263 -177.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 13.9 t -98.51 98.51 9.68 Favored 'General case' 0 N--CA 1.396 -3.134 0 CA-C-O 123.439 1.59 . . . . 53.13 111.538 -175.058 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 1.6 p -110.27 129.86 55.65 Favored 'General case' 0 C--N 1.274 -2.675 0 N-CA-C 106.518 -1.66 . . . . 71.34 106.518 172.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 178.64 -156.66 19.49 Favored Glycine 0 N--CA 1.42 -2.422 0 N-CA-C 110.367 -1.093 . . . . 72.24 110.367 -176.482 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 559' ' ' GLU . . . . . 0.54 ' HB3' HG23 ' A' ' 536' ' ' ILE . 40.0 mt-10 -135.97 133.92 38.06 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 121.295 0.569 . . . . 75.35 111.683 -175.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 560' ' ' LEU . . . . . 0.539 ' HG ' ' CE1' ' A' ' 539' ' ' TYR . 55.7 mt -87.84 132.77 34.06 Favored 'General case' 0 CA--C 1.491 -1.312 0 N-CA-C 108.795 -0.817 . . . . 72.12 108.795 174.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -105.84 107.37 18.34 Favored 'General case' 0 C--N 1.274 -2.71 0 N-CA-C 108.451 -0.944 . . . . 71.34 108.451 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 562' ' ' PHE . . . . . 0.419 ' CZ ' ' HG2' ' A' ' 569' ' ' LYS . 0.1 OUTLIER -100.59 132.41 45.99 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 107.744 -1.206 . . . . 60.3 107.744 -179.2 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -119.81 165.05 15.07 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.2 -1.0 . . . . 41.51 110.699 -179.086 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 564' ' ' ASN . . . . . 0.575 ' HB2' ' H ' ' A' ' 533' ' ' GLY . 7.8 t30 -62.57 -33.46 75.01 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.879 -0.6 . . . . 73.32 111.296 179.229 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -99.27 -3.66 33.64 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.858 0.837 . . . . 53.02 111.145 -177.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -102.98 130.34 50.03 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.725 -0.609 . . . . 73.1 109.406 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 2.0 pp -112.04 145.27 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.728 0 N-CA-C 108.414 -0.958 . . . . 72.35 108.414 179.003 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 568' ' ' VAL . . . . . 0.563 HG21 ' HD3' ' A' ' 524' ' ' LYS . 1.8 p 58.91 133.78 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 126.482 1.913 . . . . 75.41 114.79 176.288 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 569' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 524' ' ' LYS . 32.6 mmmt -117.82 164.06 15.59 Favored 'General case' 0 C--N 1.284 -2.268 0 O-C-N 121.32 -0.863 . . . . 65.04 109.868 176.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 570' ' ' THR . . . . . 0.509 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 6.3 p -132.72 134.26 44.56 Favored 'General case' 0 C--N 1.279 -2.499 0 O-C-N 124.413 1.071 . . . . 63.12 111.851 177.46 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 2.2 mp -91.17 103.92 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.836 0 N-CA-C 105.207 -2.145 . . . . 64.01 105.207 170.203 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 4.5 m -91.93 112.64 24.64 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 108.479 -0.934 . . . . 60.42 108.479 -177.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 573' ' ' VAL . . . . . . . . . . . . . 61.7 t -116.0 121.88 68.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 109.543 -0.54 . . . . 71.04 109.543 -178.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 574' ' ' LYS . . . . . 0.414 ' HA ' HD13 ' A' ' 520' ' ' ILE . 23.0 tptm -80.09 120.73 24.63 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-N 114.908 -1.042 . . . . 72.21 110.548 178.578 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 60.0 t -94.32 132.36 38.6 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 N-CA-C 105.953 -1.869 . . . . 74.22 105.953 174.115 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 34.3 mm -88.84 159.98 2.87 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 107.221 -1.4 . . . . 75.24 107.221 -175.409 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -71.53 115.34 10.6 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 109.199 -0.667 . . . . 64.22 109.199 178.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -61.24 144.44 53.79 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 114.897 -1.047 . . . . 63.54 112.612 -173.165 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -92.21 -49.06 6.38 Favored 'General case' 0 C--N 1.29 -1.995 0 C-N-CA 124.289 1.036 . . . . 70.14 110.424 -176.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.09 -152.64 0.53 Allowed 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.396 -0.82 . . . . 73.04 109.1 -174.305 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -111.67 152.12 28.06 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 107.32 -1.363 . . . . 64.35 107.32 176.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 36.4 mp0 -128.98 164.81 22.38 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.501 -0.555 . . . . 72.43 109.501 175.201 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 10.0 mptt -87.59 -152.0 0.19 Allowed 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 105.771 -1.937 . . . . 73.43 105.771 173.256 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -57.83 113.05 1.68 Allowed 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 109.115 -0.698 . . . . 72.31 109.115 172.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 585' ' ' LYS . . . . . 0.476 ' HA ' HG23 ' A' ' 545' ' ' THR . 0.1 OUTLIER -128.32 118.73 23.74 Favored 'General case' 0 N--CA 1.409 -2.496 0 N-CA-C 106.362 -1.718 . . . . 34.42 106.362 -174.198 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 3.9 t -150.7 146.86 26.73 Favored 'General case' 0 N--CA 1.418 -2.04 0 CA-C-N 115.487 -0.779 . . . . 74.44 110.795 -172.387 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -126.58 150.63 48.75 Favored 'General case' 0 N--CA 1.419 -2.011 0 CA-C-N 113.891 -1.504 . . . . 70.33 109.225 177.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 588' ' ' PHE . . . . . 0.421 ' HA ' ' O ' ' A' ' 642' ' ' LEU . 22.3 m-85 -108.37 139.25 43.36 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 109.381 -0.6 . . . . 73.23 109.381 -174.325 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 589' ' ' LEU . . . . . 0.46 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.3 OUTLIER -107.93 134.36 50.95 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 107.04 -1.467 . . . . 61.24 107.04 176.83 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -143.05 136.96 28.89 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.803 -0.814 . . . . 72.14 108.803 -179.034 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 591' ' ' ILE . . . . . 0.541 HG12 ' OG1' ' A' ' 640' ' ' THR . 22.0 pt -101.95 162.48 3.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 109.206 -0.664 . . . . 63.42 109.206 178.841 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -111.15 -162.96 17.92 Favored Glycine 0 N--CA 1.43 -1.732 0 C-N-CA 121.259 -0.496 . . . . 63.24 112.103 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -67.88 118.11 54.86 Favored Pre-proline 0 C--N 1.309 -1.195 0 C-N-CA 123.979 0.911 . . . . 72.15 108.803 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 594' ' ' PRO . . . . . 0.46 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 58.1 Cg_endo -73.16 146.56 41.08 Favored 'Trans proline' 0 N--CA 1.437 -1.82 0 C-N-CA 121.916 1.744 . . . . 61.33 110.593 178.47 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 14.9 ptt180 -128.24 133.71 48.87 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 109.704 -0.48 . . . . 74.04 109.704 -175.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 596' ' ' LEU . . . . . 0.428 HD22 HG22 ' A' ' 535' ' ' VAL . 0.0 OUTLIER -73.99 131.82 41.78 Favored 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 104.988 -2.227 . . . . 62.24 104.988 178.367 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 597' ' ' VAL . . . . . 0.442 ' CG2' HG12 ' A' ' 536' ' ' ILE . 23.8 t . . . . . 0 C--N 1.308 -1.233 0 CA-C-O 121.821 0.819 . . . . 73.12 110.767 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 . . . . . 0 N--CA 1.447 -0.612 0 N-CA-C 109.46 -0.57 . . . . 72.21 109.46 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 634' ' ' PRO . . . . . 0.46 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 10.1 Cg_endo -60.86 145.01 99.66 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.591 1.527 . . . . 62.41 109.527 172.153 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.3 pp -123.42 175.96 5.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 114.054 1.131 . . . . 74.43 114.054 -176.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 636' ' ' LEU . . . . . 0.454 ' HG ' ' N ' ' A' ' 637' ' ' GLY . 33.3 tp -68.93 158.65 34.19 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 124.8 1.24 . . . . 75.35 112.716 -176.526 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 637' ' ' GLY . . . . . 0.454 ' N ' ' HG ' ' A' ' 636' ' ' LEU . . . -83.06 -100.02 0.52 Allowed Glycine 0 N--CA 1.427 -1.91 0 N-CA-C 109.642 -1.383 . . . . 65.45 109.642 172.476 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -126.22 -73.13 0.63 Allowed 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 119.801 -0.76 . . . . 73.45 111.632 177.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -107.02 114.26 28.23 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 118.715 -1.194 . . . . 63.11 113.122 -174.093 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 640' ' ' THR . . . . . 0.541 ' OG1' HG12 ' A' ' 591' ' ' ILE . 1.1 t -107.08 91.53 3.7 Favored 'General case' 0 N--CA 1.41 -2.437 0 N-CA-C 108.367 -0.975 . . . . 75.1 108.367 169.364 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -172.17 121.83 0.46 Allowed 'General case' 0 C--N 1.279 -2.466 0 N-CA-C 105.726 -1.953 . . . . 73.14 105.726 178.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 642' ' ' LEU . . . . . 0.713 HD21 HG21 ' A' ' 523' ' ' VAL . 35.9 tp -129.91 113.13 14.24 Favored 'General case' 0 C--N 1.271 -2.829 0 N-CA-C 108.077 -1.083 . . . . 54.15 108.077 178.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 643' ' ' GLU . . . . . 0.47 ' HB3' HG22 ' A' ' 511' ' ' VAL . 30.0 tt0 -95.11 104.77 16.65 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 107.469 -1.308 . . . . 61.12 107.469 179.207 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 644' ' ' VAL . . . . . 0.69 HG21 ' HE2' ' A' ' 521' ' ' MET . 30.9 t -94.98 106.66 18.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 109.483 -0.562 . . . . 62.21 109.483 -177.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 3.9 mp -88.78 118.29 33.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 108.444 -0.947 . . . . 72.21 108.444 175.337 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 646' ' ' ILE . . . . . 0.467 HD12 ' N ' ' A' ' 646' ' ' ILE . 2.8 mp -100.73 107.21 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 N-CA-C 106.63 -1.618 . . . . 73.0 106.63 -177.027 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -103.69 136.42 43.43 Favored 'General case' 0 C--N 1.279 -2.48 0 CA-C-N 115.671 -0.695 . . . . 74.14 110.832 -176.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -67.47 142.03 56.76 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.626 -0.879 . . . . 73.12 108.626 -177.128 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 21.2 t . . . . . 0 N--CA 1.431 -1.39 0 N-CA-C 114.072 1.138 . . . . 74.21 114.072 -169.558 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.419 -2.448 0 N-CA-C 109.71 -1.356 . . . . 75.51 109.71 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 504' ' ' ILE . . . . . 0.642 ' O ' ' HB ' ' A' ' 528' ' ' THR . 3.6 mp -108.87 97.77 6.15 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.263 0 C-N-CA 126.04 1.736 . . . . 63.41 109.235 -176.539 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -103.16 124.85 49.36 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 122.035 -0.415 . . . . 74.3 110.087 -178.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 506' ' ' THR . . . . . 0.404 ' HB ' ' HA3' ' A' ' 637' ' ' GLY . 15.3 t -145.89 159.54 43.07 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.378 -0.601 . . . . 73.21 109.378 -178.154 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -89.21 155.85 19.14 Favored 'General case' 0 CA--C 1.485 -1.549 0 N-CA-C 108.372 -0.973 . . . . 73.14 108.372 174.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 508' ' ' GLU . . . . . 0.418 ' HB2' HD21 ' A' ' 526' ' ' LEU . 24.1 tt0 -89.98 -34.57 15.95 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 106.84 -1.541 . . . . 72.31 106.84 175.611 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -96.61 118.84 64.86 Favored Pre-proline 0 N--CA 1.436 -1.137 0 CA-C-N 114.549 -1.205 . . . . 72.43 110.847 176.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 510' ' ' PRO . . . . . 0.612 ' HA ' ' O ' ' A' ' 641' ' ' LYS . 1.2 Cg_endo -83.22 -16.96 6.87 Favored 'Trans proline' 0 N--CA 1.443 -1.456 0 N-CA-C 108.72 -1.3 . . . . 75.15 108.72 166.399 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 511' ' ' VAL . . . . . 0.487 HG22 ' HB3' ' A' ' 643' ' ' GLU . 78.7 t -144.63 139.56 23.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 C-N-CA 125.575 1.55 . . . . 51.31 107.268 -179.169 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 11.4 t -138.63 148.01 43.57 Favored 'General case' 0 N--CA 1.414 -2.234 0 N-CA-C 107.66 -1.237 . . . . 61.14 107.66 174.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -115.87 127.48 55.05 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 109.024 -0.732 . . . . 74.14 109.024 177.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 18.2 m -130.24 154.2 40.11 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 N-CA-C 109.103 -0.703 . . . . 43.23 109.103 -176.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 34.2 t -78.03 154.81 31.1 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.782 -1.192 . . . . 72.35 107.782 177.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -89.06 -6.83 56.84 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 122.195 0.998 . . . . 71.13 109.019 173.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 34.0 m -92.26 17.3 9.9 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-O 122.314 1.054 . . . . 73.4 108.744 177.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 9.5 tt -100.99 154.43 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.06 0 N-CA-C 107.064 -1.458 . . . . 74.41 107.064 177.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 519' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . -95.71 -63.61 0.97 Allowed Glycine 0 N--CA 1.427 -1.946 0 C-N-CA 119.745 -1.217 . . . . 71.21 110.348 176.275 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 29.0 mm -116.41 127.73 73.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 114.725 -0.737 . . . . 70.4 109.865 -178.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 521' ' ' MET . . . . . 0.614 ' HE2' HG21 ' A' ' 644' ' ' VAL . 0.0 OUTLIER -109.99 135.88 50.14 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.76 -1.2 . . . . 72.32 107.76 172.888 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 522' ' ' GLU . . . . . 0.535 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 36.8 mt-10 -121.15 135.26 55.2 Favored 'General case' 0 CA--C 1.493 -1.25 0 O-C-N 123.947 0.779 . . . . 75.12 110.711 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 523' ' ' VAL . . . . . 0.667 HG21 HD21 ' A' ' 642' ' ' LEU . 18.9 t -123.03 140.47 46.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.91 -0.774 . . . . 65.54 108.91 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 524' ' ' LYS . . . . . 0.47 ' HD2' HG21 ' A' ' 568' ' ' VAL . 46.2 mmtm -85.35 141.53 29.96 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.912 0.863 . . . . 61.01 112.603 -178.194 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 21.3 t -111.88 119.49 60.12 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 N-CA-C 105.154 -2.165 . . . . 74.22 105.154 172.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 526' ' ' LEU . . . . . 0.425 HD22 ' H ' ' A' ' 526' ' ' LEU . 2.6 mm? -62.16 136.05 57.77 Favored 'General case' 0 CA--C 1.504 -0.804 0 O-C-N 123.522 0.514 . . . . 74.24 110.625 -174.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 14.2 ttp180 -84.73 138.7 32.47 Favored 'General case' 0 N--CA 1.423 -1.782 0 N-CA-C 108.612 -0.884 . . . . 75.5 108.612 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 528' ' ' THR . . . . . 0.642 ' HB ' ' O ' ' A' ' 504' ' ' ILE . 10.3 t -94.41 169.59 10.1 Favored 'General case' 0 N--CA 1.397 -3.096 0 N-CA-C 114.81 1.411 . . . . 71.22 114.81 -171.687 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . 0.309 5.7 m -49.9 -34.06 19.16 Favored 'General case' 0 N--CA 1.417 -2.124 0 C-N-CA 130.658 3.583 . . . . 70.14 111.35 171.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -121.3 68.41 0.42 Allowed Glycine 0 N--CA 1.428 -1.856 0 C-N-CA 120.722 -0.752 . . . . 61.24 113.203 -177.188 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -87.88 83.41 7.1 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 106.704 -1.591 . . . . 65.22 106.704 173.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -121.05 137.3 54.72 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 115.744 -0.662 . . . . 74.02 112.321 -174.149 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 533' ' ' GLY . . . . . 0.477 ' N ' ' HB3' ' A' ' 564' ' ' ASN . . . 69.27 -121.32 11.28 Favored Glycine 0 N--CA 1.438 -1.173 0 CA-C-N 114.741 -1.118 . . . . 33.22 111.966 176.518 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -136.47 124.15 22.41 Favored 'General case' 0 C--N 1.286 -2.175 0 N-CA-C 106.079 -1.823 . . . . 43.25 106.079 177.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 535' ' ' VAL . . . . . 0.482 HG22 HD22 ' A' ' 596' ' ' LEU . 57.5 t -126.57 122.97 62.15 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-O 121.398 0.618 . . . . 71.31 109.494 -175.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 536' ' ' ILE . . . . . 0.459 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 40.2 mm -97.57 127.21 50.1 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.451 0 CA-C-N 115.444 -0.798 . . . . 72.34 109.968 -178.166 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 537' ' ' VAL . . . . . 0.45 HG22 ' HB3' ' A' ' 594' ' ' PRO . 86.1 t -113.0 102.31 54.6 Favored Pre-proline 0 C--N 1.308 -1.22 0 CA-C-N 115.448 -0.797 . . . . 62.04 110.18 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 538' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 63.9 Cg_endo -74.74 150.31 39.31 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.667 2.245 . . . . 62.14 111.635 178.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 539' ' ' TYR . . . . . 0.498 ' CE1' ' HG ' ' A' ' 560' ' ' LEU . 17.4 p90 -154.9 165.95 35.08 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 110.246 -0.279 . . . . 61.34 110.246 -178.38 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -157.86 157.47 33.28 Favored 'General case' 0 C--N 1.316 -0.864 0 O-C-N 123.659 0.599 . . . . 64.31 110.142 177.087 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 2.1 p -96.46 112.17 24.01 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 123.337 0.655 . . . . 72.11 109.775 173.317 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.428 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 3.5 mp -81.01 122.96 37.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 107.917 -1.142 . . . . 72.32 107.917 177.458 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -55.31 -52.73 62.5 Favored 'General case' 0 C--O 1.242 0.704 0 O-C-N 124.223 0.952 . . . . 65.12 110.851 -178.343 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 71.53 -80.11 0.54 Allowed Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.837 -0.619 . . . . 65.04 113.179 175.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 12.8 t -134.43 -7.47 2.55 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.452 0.644 . . . . 70.14 110.04 -179.222 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -80.36 -176.37 5.62 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 121.181 0.515 . . . . 52.41 111.723 -179.131 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 547' ' ' ARG . . . . . 0.627 ' HB3' ' OE1' ' A' ' 551' ' ' GLU . 56.9 mmt-85 -85.58 177.29 7.78 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.652 -0.703 . . . . 63.22 110.917 177.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -64.38 174.57 13.22 Favored Glycine 0 CA--C 1.538 1.521 0 CA-C-N 115.166 -0.925 . . . . 22.33 114.354 -177.172 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . -67.63 122.84 18.26 Favored Glycine 0 N--CA 1.441 -0.997 0 CA-C-N 115.259 -0.471 . . . . 70.14 112.46 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 82.98 2.94 90.68 Favored Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 110.634 -0.987 . . . . 74.55 110.634 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 551' ' ' GLU . . . . . 0.627 ' OE1' ' HB3' ' A' ' 547' ' ' ARG . 38.2 tt0 -96.53 -69.99 0.73 Allowed 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 108.958 -0.756 . . . . 64.51 108.958 -178.449 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 552' ' ' ASP . . . . . 0.545 ' CB ' ' HB2' ' A' ' 547' ' ' ARG . 17.4 t70 -106.63 -25.57 11.73 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-O 122.004 0.907 . . . . 42.33 109.006 177.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -142.84 152.68 42.42 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 106.65 -1.611 . . . . 74.42 106.65 174.172 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 554' ' ' GLU . . . . . 0.407 ' CB ' ' HB3' ' A' ' 574' ' ' LYS . 1.0 OUTLIER -87.48 122.7 31.55 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 107.06 -1.459 . . . . 64.42 107.06 -179.584 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -79.54 123.14 27.31 Favored 'General case' 0 CA--C 1.491 -1.298 0 CA-C-O 120.888 0.375 . . . . 64.43 110.725 -174.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 12.1 t -123.98 107.32 11.2 Favored 'General case' 0 N--CA 1.404 -2.762 0 CA-C-O 122.531 1.158 . . . . 73.34 110.773 -178.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 3.6 p -129.09 130.07 46.02 Favored 'General case' 0 N--CA 1.42 -1.968 0 CA-C-N 114.622 -1.172 . . . . 41.24 108.679 177.241 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 174.66 -151.39 12.46 Favored Glycine 0 N--CA 1.41 -3.073 0 N-CA-C 109.81 -1.316 . . . . 55.14 109.81 -177.269 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 559' ' ' GLU . . . . . 0.459 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 70.5 mt-10 -129.71 126.66 38.78 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-O 120.933 0.397 . . . . 62.14 111.533 -175.624 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 560' ' ' LEU . . . . . 0.498 ' HG ' ' CE1' ' A' ' 539' ' ' TYR . 83.7 mt -79.67 122.76 26.95 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.787 -0.82 . . . . 64.32 108.787 175.434 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -93.22 110.01 21.53 Favored 'General case' 0 N--CA 1.419 -1.976 0 N-CA-C 109.194 -0.669 . . . . 71.33 109.194 -178.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -129.26 150.52 50.6 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.054 -0.976 . . . . 71.0 108.373 -179.179 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 563' ' ' GLN . . . . . 0.57 ' H ' ' HB3' ' A' ' 566' ' ' GLU . 7.3 pt20 -148.88 178.53 8.6 Favored 'General case' 0 C--N 1.288 -2.07 0 O-C-N 121.882 -0.511 . . . . 65.23 110.746 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 564' ' ' ASN . . . . . 0.477 ' HB3' ' N ' ' A' ' 533' ' ' GLY . 3.7 p-10 -61.89 -33.1 73.61 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 124.347 1.059 . . . . 50.12 111.447 -176.51 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -91.46 -6.55 52.5 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.864 0.84 . . . . 74.44 110.425 -176.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 566' ' ' GLU . . . . . 0.57 ' HB3' ' H ' ' A' ' 563' ' ' GLN . 9.6 tp10 -98.94 155.54 17.36 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.497 -1.298 . . . . 72.42 107.497 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 1.7 pp -126.75 140.58 48.53 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.625 0 C-N-CA 119.654 -0.818 . . . . 72.25 109.263 177.093 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 568' ' ' VAL . . . . . 0.47 HG21 ' HD2' ' A' ' 524' ' ' LYS . 1.1 p 53.51 176.58 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.524 0 C-N-CA 126.14 1.776 . . . . 75.34 113.649 177.016 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 569' ' ' LYS . . . . . 0.603 ' HA ' ' HE2' ' A' ' 569' ' ' LYS . 6.7 mmpt? -146.63 153.9 40.86 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 109.119 -0.697 . . . . 62.34 109.119 173.562 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 570' ' ' THR . . . . . 0.519 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 12.0 p -136.72 133.11 35.75 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 124.13 0.894 . . . . 64.32 110.5 178.547 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 571' ' ' ILE . . . . . 0.535 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 2.4 mp -95.66 117.8 40.51 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 107.129 -1.434 . . . . 62.11 107.129 174.556 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 572' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 521' ' ' MET . 4.1 p -102.1 109.47 21.19 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 123.698 0.624 . . . . 71.41 110.498 179.476 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 573' ' ' VAL . . . . . . . . . . . . . 48.0 t -112.32 136.66 47.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 N-CA-C 109.467 -0.568 . . . . 55.33 109.467 -178.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 574' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 519' ' ' GLY . 58.8 tttp -92.72 126.08 37.64 Favored 'General case' 0 C--N 1.309 -1.159 0 O-C-N 124.046 0.841 . . . . 71.14 109.849 178.587 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 47.6 t -94.12 132.42 38.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 107.482 -1.303 . . . . 71.31 107.482 177.544 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 30.5 mm -97.43 146.35 7.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 C-N-CA 120.605 -0.438 . . . . 62.03 109.989 -174.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -61.95 145.14 53.8 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.4 0.68 . . . . 64.35 110.561 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -70.61 134.35 47.51 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 116.032 1.864 . . . . 62.02 116.032 -175.2 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 579' ' ' GLU . . . . . 0.502 ' HG2' ' HG3' ' A' ' 580' ' ' GLU . 0.1 OUTLIER -110.94 -24.82 10.16 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 112.882 -1.963 . . . . 73.22 109.431 177.824 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 580' ' ' GLU . . . . . 0.502 ' HG3' ' HG2' ' A' ' 579' ' ' GLU . 0.0 OUTLIER -133.14 178.72 6.68 Favored 'General case' 0 C--O 1.249 1.052 0 N-CA-C 113.232 0.827 . . . . 73.42 113.232 -179.063 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -66.49 152.67 44.72 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.644 -1.162 . . . . 75.22 107.889 177.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -126.29 138.38 53.59 Favored 'General case' 0 C--N 1.293 -1.849 0 C-N-CA 117.385 -1.726 . . . . 72.53 113.011 -176.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -97.21 -158.35 0.66 Allowed 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 106.819 -1.549 . . . . 65.01 106.819 176.142 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 -79.15 93.54 5.21 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 106.072 -1.825 . . . . 74.44 106.072 170.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 585' ' ' LYS . . . . . 0.455 ' HD2' HD13 ' A' ' 646' ' ' ILE . 3.8 tmmm? -98.91 121.9 41.47 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 108.364 -0.976 . . . . 65.23 108.364 -172.074 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 4.9 t -147.01 144.51 29.2 Favored 'General case' 0 N--CA 1.414 -2.226 0 CA-C-N 114.9 -1.046 . . . . 52.53 109.291 -177.171 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -125.9 146.68 49.74 Favored 'General case' 0 N--CA 1.419 -2.016 0 CA-C-N 114.542 -1.208 . . . . 70.33 109.235 176.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 588' ' ' PHE . . . . . 0.428 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 30.2 m-85 -102.53 128.52 49.14 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 109.294 -0.632 . . . . 52.34 109.294 -175.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 589' ' ' LEU . . . . . 0.554 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.5 OUTLIER -101.36 125.72 48.04 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 104.59 -2.374 . . . . 72.24 104.59 173.506 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -137.9 134.29 34.83 Favored 'General case' 0 C--N 1.273 -2.743 0 N-CA-C 108.92 -0.77 . . . . 74.0 108.92 -178.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 591' ' ' ILE . . . . . 0.481 HG22 ' HB3' ' A' ' 539' ' ' TYR . 28.8 pt -96.64 145.56 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.651 0 N-CA-C 108.158 -1.053 . . . . 70.25 108.158 178.255 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -89.62 -151.52 24.96 Favored Glycine 0 C--N 1.292 -1.879 0 N-CA-C 111.09 -0.804 . . . . 75.51 111.09 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -80.88 125.85 79.06 Favored Pre-proline 0 C--N 1.297 -1.68 0 N-CA-C 108.964 -0.754 . . . . 54.31 108.964 178.541 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 594' ' ' PRO . . . . . 0.45 ' HB3' HG22 ' A' ' 537' ' ' VAL . 38.4 Cg_endo -69.71 153.07 69.62 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 121.878 1.719 . . . . 75.4 110.841 176.063 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -129.79 132.38 46.51 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.844 -0.535 . . . . 71.1 111.488 -177.599 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 596' ' ' LEU . . . . . 0.489 ' HB2' ' HD3' ' A' ' 634' ' ' PRO . 0.0 OUTLIER -87.13 125.9 34.44 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 108.221 -1.029 . . . . 71.03 108.221 -179.567 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 CA--C 1.565 1.55 0 CA-C-O 121.949 0.88 . . . . 61.24 109.802 -179.452 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 . . . . . 0 C--O 1.215 -0.719 0 N-CA-C 108.589 -0.893 . . . . 70.42 108.589 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 634' ' ' PRO . . . . . 0.489 ' HD3' ' HB2' ' A' ' 596' ' ' LEU . 70.8 Cg_endo -75.77 157.19 39.64 Favored 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 121.924 1.749 . . . . 61.2 111.196 178.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 29.7 pt -132.03 178.21 5.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 CA-C-O 121.655 0.74 . . . . 55.24 111.048 -173.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 636' ' ' LEU . . . . . 0.403 HD22 ' O ' ' A' ' 637' ' ' GLY . 0.0 OUTLIER -94.05 152.47 18.76 Favored 'General case' 0 N--CA 1.423 -1.805 0 N-CA-C 106.768 -1.568 . . . . 75.21 106.768 171.766 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 637' ' ' GLY . . . . . 0.404 ' HA3' ' HB ' ' A' ' 506' ' ' THR . . . -81.26 -126.04 0.75 Allowed Glycine 0 C--N 1.29 -2.014 0 C-N-CA 120.871 -0.68 . . . . 62.53 113.445 -176.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -87.5 -50.27 6.65 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 112.072 0.397 . . . . 64.12 112.072 -175.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -132.99 110.6 10.36 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.999 0.904 . . . . 73.15 112.939 -177.234 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 22.3 p -120.32 92.47 3.78 Favored 'General case' 0 N--CA 1.422 -1.861 0 CA-C-N 115.423 -0.808 . . . . 61.35 110.698 176.191 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 641' ' ' LYS . . . . . 0.612 ' O ' ' HA ' ' A' ' 510' ' ' PRO . 0.2 OUTLIER -170.51 127.55 0.79 Allowed 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 104.564 -2.384 . . . . 72.43 104.564 178.204 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 642' ' ' LEU . . . . . 0.667 HD21 HG21 ' A' ' 523' ' ' VAL . 43.8 tp -117.23 107.06 13.97 Favored 'General case' 0 C--N 1.274 -2.713 0 N-CA-C 108.386 -0.968 . . . . 72.03 108.386 177.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 643' ' ' GLU . . . . . 0.487 ' HB3' HG22 ' A' ' 511' ' ' VAL . 22.8 tt0 -90.71 100.97 13.72 Favored 'General case' 0 C--N 1.275 -2.64 0 N-CA-C 107.306 -1.368 . . . . 64.01 107.306 178.684 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 644' ' ' VAL . . . . . 0.614 HG21 ' HE2' ' A' ' 521' ' ' MET . 19.3 t -91.74 103.55 14.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 109.181 -0.674 . . . . 73.12 109.181 -177.666 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 645' ' ' ILE . . . . . 0.4 ' CD1' HG13 ' A' ' 511' ' ' VAL . 3.8 mp -93.42 123.97 45.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 105.704 -1.962 . . . . 72.23 105.704 174.597 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 646' ' ' ILE . . . . . 0.523 HD12 ' N ' ' A' ' 646' ' ' ILE . 2.8 mp -97.76 129.15 48.35 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 N-CA-C 108.447 -0.946 . . . . 72.13 108.447 -173.416 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -92.38 117.31 29.79 Favored 'General case' 0 N--CA 1.403 -2.787 0 CA-C-N 115.69 -0.686 . . . . 44.03 110.744 -179.152 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 33.0 tp10 -61.58 141.37 57.81 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 114.257 -1.338 . . . . 71.34 107.763 178.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 6.5 t . . . . . 0 C--O 1.241 0.623 0 C-N-CA 123.245 0.618 . . . . 71.24 109.654 -176.816 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 503' ' ' GLY . . . . . 0.544 ' HA2' ' OG1' ' A' ' 528' ' ' THR . . . . . . . . 0 N--CA 1.41 -3.077 0 N-CA-C 114.868 0.707 . . . . 42.05 114.868 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 504' ' ' ILE . . . . . 0.47 ' H ' ' HA ' ' A' ' 528' ' ' THR . 3.5 mp -129.32 90.53 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 N-CA-C 106.036 -1.839 . . . . 73.02 106.036 174.07 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 505' ' ' PHE . . . . . 0.524 ' CZ ' ' HB ' ' A' ' 528' ' ' THR . 89.3 m-85 -112.11 110.52 20.85 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 109.176 -0.676 . . . . 71.04 109.176 179.33 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 506' ' ' THR . . . . . 0.507 ' HB ' ' HA3' ' A' ' 637' ' ' GLY . 11.7 t -149.25 167.61 25.55 Favored 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 107.229 -1.397 . . . . 73.02 107.229 -177.473 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -94.75 155.0 17.02 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.565 -1.642 . . . . 73.03 106.565 173.13 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -90.92 -29.74 17.29 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 107.426 -1.324 . . . . 64.14 107.426 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -112.5 130.9 22.94 Favored Pre-proline 0 N--CA 1.425 -1.711 0 CA-C-N 114.964 -1.016 . . . . 75.12 109.454 174.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -84.59 -10.17 8.73 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.203 1.935 . . . . 63.04 111.193 176.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 511' ' ' VAL . . . . . 0.414 HG22 ' HB3' ' A' ' 643' ' ' GLU . 94.3 t -141.29 135.52 31.88 Favored 'Isoleucine or valine' 0 C--O 1.244 0.813 0 C-N-CA 123.929 0.892 . . . . 63.11 109.645 -177.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 7.3 t -139.22 138.35 36.77 Favored 'General case' 0 N--CA 1.413 -2.317 0 N-CA-C 107.066 -1.457 . . . . 35.33 107.066 174.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 25.1 m-70 -107.64 132.87 52.85 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 106.643 -1.614 . . . . 74.02 106.643 177.183 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.679 HG11 ' SD ' ' A' ' 521' ' ' MET . 34.6 m -120.27 159.04 22.0 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 CA-C-O 121.826 0.822 . . . . 70.23 111.534 -174.615 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 515' ' ' SER . . . . . 0.473 ' O ' HG22 ' A' ' 518' ' ' ILE . 51.6 m -82.02 142.08 32.67 Favored 'General case' 0 N--CA 1.387 -3.592 0 CA-C-N 114.13 -1.395 . . . . 61.23 107.971 178.132 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 516' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 647' ' ' GLU . 39.3 tt0 -80.12 -20.84 44.09 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 120.066 -0.653 . . . . 54.21 110.792 179.013 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 47.8 m -94.73 22.7 6.07 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.705 0.764 . . . . 51.43 110.613 -177.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 518' ' ' ILE . . . . . 0.473 HG22 ' O ' ' A' ' 515' ' ' SER . 16.2 tt -97.09 149.71 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.756 0 N-CA-C 108.367 -0.975 . . . . 71.22 108.367 -179.415 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -83.49 -54.58 3.08 Favored Glycine 0 N--CA 1.43 -1.764 0 C-N-CA 120.359 -0.924 . . . . 73.01 111.39 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 520' ' ' ILE . . . . . 0.446 HD13 ' HA ' ' A' ' 574' ' ' LYS . 34.2 mm -132.72 125.4 52.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.85 -0.796 . . . . 74.14 108.85 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 521' ' ' MET . . . . . 0.679 ' SD ' HG11 ' A' ' 514' ' ' VAL . 23.7 ptt? -94.23 137.75 33.04 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.833 -1.543 . . . . 74.02 106.833 172.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -125.35 140.43 52.82 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 123.387 0.429 . . . . 61.23 110.947 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 523' ' ' VAL . . . . . 0.591 ' O ' ' HA ' ' A' ' 570' ' ' THR . 39.7 t -124.32 126.09 71.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 108.716 -0.846 . . . . 64.54 108.716 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 524' ' ' LYS . . . . . 0.446 ' HD2' HG21 ' A' ' 568' ' ' VAL . 28.2 mmtp -77.77 117.42 19.13 Favored 'General case' 0 C--N 1.311 -1.105 0 O-C-N 123.784 0.678 . . . . 71.31 110.933 -178.422 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 25.5 t -98.8 140.17 19.03 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.289 0 CA-C-N 115.241 -0.89 . . . . 63.1 110.858 -175.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -68.7 144.62 54.36 Favored 'General case' 0 C--O 1.238 0.457 0 O-C-N 123.956 0.785 . . . . 70.33 109.187 177.378 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 527' ' ' ARG . . . . . 0.416 ' HG2' ' N ' ' A' ' 528' ' ' THR . 27.1 ttp180 -99.16 157.77 16.14 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.343 0.592 . . . . 73.24 110.926 -173.545 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 528' ' ' THR . . . . . 0.648 HG23 ' HB2' ' A' ' 531' ' ' ALA . 5.1 t -65.9 135.03 54.24 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 115.547 -0.751 . . . . 72.35 110.179 173.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 22.6 t -81.87 -37.35 27.07 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.515 -0.92 . . . . 64.1 108.515 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -87.34 98.03 2.34 Favored Glycine 0 N--CA 1.418 -2.512 0 N-CA-C 108.168 -1.973 . . . . 41.31 108.168 175.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 531' ' ' ALA . . . . . 0.648 ' HB2' HG23 ' A' ' 528' ' ' THR . . . -149.38 100.66 3.04 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 120.854 0.359 . . . . 52.12 110.282 -177.648 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 532' ' ' ARG . . . . . 0.415 ' HD2' ' N ' ' A' ' 532' ' ' ARG . 7.5 mpt_? -119.82 12.8 12.21 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 108.4 -0.963 . . . . 73.13 108.4 172.483 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . -155.22 -166.16 15.11 Favored Glycine 0 N--CA 1.437 -1.291 0 CA-C-N 115.006 -0.997 . . . . 71.32 111.013 -172.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -97.8 134.54 40.82 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 122.926 0.49 . . . . 70.43 109.982 -178.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 535' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' A' ' 595' ' ' ARG . 61.3 t -133.06 131.45 58.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 123.025 0.53 . . . . 73.4 109.856 -178.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 536' ' ' ILE . . . . . 0.425 ' HB ' ' HB2' ' A' ' 595' ' ' ARG . 35.1 mm -103.82 138.17 29.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 110.033 -0.358 . . . . 75.22 110.033 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 537' ' ' VAL . . . . . 0.409 HG22 ' HB3' ' A' ' 594' ' ' PRO . 48.8 t -126.28 110.19 23.81 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 110.086 -0.338 . . . . 75.03 110.086 178.222 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.04 154.41 37.67 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.369 2.046 . . . . 75.52 111.754 178.116 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 539' ' ' TYR . . . . . 0.443 ' HB3' HG22 ' A' ' 591' ' ' ILE . 52.8 p90 -147.23 161.66 40.48 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.243 -0.651 . . . . 72.03 109.243 177.496 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -152.5 157.57 41.32 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 123.724 0.64 . . . . 72.41 109.782 178.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 2.7 p -99.93 122.66 43.18 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 123.469 0.481 . . . . 70.44 110.649 174.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.4 mp -91.08 112.52 25.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 106.242 -1.762 . . . . 62.31 106.242 174.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -52.13 -50.68 61.22 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 124.246 0.966 . . . . 61.44 111.823 -178.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 67.18 -94.68 0.26 Allowed Glycine 0 N--CA 1.442 -0.903 0 CA-C-N 116.058 -0.519 . . . . 71.42 112.24 176.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 545' ' ' THR . . . . . 0.514 HG23 ' HB2' ' A' ' 585' ' ' LYS . 8.0 t -119.19 9.39 11.73 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 120.759 0.314 . . . . 73.13 110.575 -178.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 546' ' ' ALA . . . . . 0.435 ' HB2' ' HD3' ' A' ' 585' ' ' LYS . . . -98.78 166.31 11.37 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.847 -0.427 . . . . 64.51 109.847 178.065 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 547' ' ' ARG . . . . . 0.426 ' HB3' ' HB2' ' A' ' 551' ' ' GLU . 2.8 tpp180 -75.55 167.33 22.1 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 108.024 -1.102 . . . . 72.52 108.024 178.807 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -65.02 177.25 10.64 Favored Glycine 0 C--O 1.254 1.393 0 CA-C-O 121.513 0.507 . . . . 55.24 114.36 -178.414 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . -57.03 127.55 45.13 Favored Glycine 0 N--CA 1.439 -1.141 0 CA-C-N 114.718 -0.741 . . . . 44.1 114.115 -177.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 94.95 -10.23 70.24 Favored Glycine 0 N--CA 1.434 -1.459 0 CA-C-N 115.311 -0.444 . . . . 75.15 112.565 176.593 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 551' ' ' GLU . . . . . 0.426 ' HB2' ' HB3' ' A' ' 547' ' ' ARG . 61.8 mm-40 -91.08 -70.84 0.66 Allowed 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 120.405 -0.518 . . . . 75.31 109.754 -179.253 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -96.03 -37.9 10.44 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-O 121.572 0.701 . . . . 63.25 109.97 175.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -142.46 156.82 45.21 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 108.115 -1.069 . . . . 72.33 108.115 -177.108 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -87.42 117.41 26.19 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 106.519 -1.66 . . . . 61.24 106.519 178.477 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -72.38 107.15 4.81 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.75 -0.659 . . . . 72.2 109.791 -176.085 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 556' ' ' THR . . . . . 0.47 HG21 HG22 ' A' ' 573' ' ' VAL . 9.6 t -106.58 126.66 52.55 Favored 'General case' 0 N--CA 1.413 -2.32 0 CA-C-O 122.123 0.963 . . . . 64.52 111.565 -173.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 20.5 p -136.99 109.77 7.57 Favored 'General case' 0 N--CA 1.414 -2.244 0 N-CA-C 107.367 -1.346 . . . . 72.42 107.367 175.104 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -152.92 -161.69 10.46 Favored Glycine 0 N--CA 1.418 -2.505 0 N-CA-C 110.607 -0.997 . . . . 70.32 110.607 -174.072 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -139.18 131.25 27.98 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 122.983 0.513 . . . . 71.04 110.454 -176.164 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 87.7 mt -92.99 143.73 25.95 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 123.725 0.81 . . . . 72.43 109.123 179.26 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -102.62 123.59 46.61 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-O 121.414 0.626 . . . . 71.5 110.618 178.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -121.35 157.49 30.32 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 108.26 -1.015 . . . . 71.23 108.26 173.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 563' ' ' GLN . . . . . 0.401 ' HG3' ' H ' ' A' ' 566' ' ' GLU . 3.6 pt20 -162.92 -178.93 6.41 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 109.769 -0.456 . . . . 70.24 109.769 176.595 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 -63.74 -36.36 83.6 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 124.108 0.88 . . . . 72.52 111.587 178.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -90.11 -17.26 28.01 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.399 -0.819 . . . . 74.51 112.309 -176.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 566' ' ' GLU . . . . . 0.401 ' H ' ' HG3' ' A' ' 563' ' ' GLN . 6.7 tp10 -109.58 128.65 55.36 Favored 'General case' 0 C--N 1.31 -1.123 0 O-C-N 121.844 -0.535 . . . . 73.24 111.081 -174.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 4.7 pt -109.43 159.45 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.125 0 N-CA-C 108.735 -0.839 . . . . 72.23 108.735 176.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 568' ' ' VAL . . . . . 0.446 HG21 ' HD2' ' A' ' 524' ' ' LYS . 1.3 p 49.25 160.89 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.573 1.855 0 C-N-CA 127.081 2.152 . . . . 71.54 115.182 -179.517 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 569' ' ' LYS . . . . . 0.543 ' HE3' ' HA ' ' A' ' 569' ' ' LYS . 0.0 OUTLIER -153.23 162.54 41.19 Favored 'General case' 0 CA--C 1.484 -1.578 0 N-CA-C 107.463 -1.31 . . . . 74.21 107.463 173.114 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 570' ' ' THR . . . . . 0.591 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 4.9 p -136.87 127.96 27.79 Favored 'General case' 0 C--N 1.291 -1.938 0 O-C-N 124.169 0.918 . . . . 71.04 110.815 178.47 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 571' ' ' ILE . . . . . 0.45 HG21 HD21 ' A' ' 589' ' ' LEU . 3.3 mp -79.38 106.93 11.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 107.432 -1.321 . . . . 75.44 107.432 174.351 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 7.3 p -86.42 111.95 21.02 Favored 'General case' 0 N--CA 1.415 -2.2 0 O-C-N 123.645 0.591 . . . . 61.21 110.419 179.33 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 573' ' ' VAL . . . . . 0.47 HG22 HG21 ' A' ' 556' ' ' THR . 42.3 t -114.39 130.7 68.23 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 N-CA-C 109.089 -0.708 . . . . 64.42 109.089 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 574' ' ' LYS . . . . . 0.446 ' HA ' HD13 ' A' ' 520' ' ' ILE . 86.1 tttt -86.87 121.88 29.97 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 115.476 -0.784 . . . . 64.3 110.292 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 56.5 t -90.06 139.37 17.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 107.015 -1.476 . . . . 73.12 107.015 176.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 31.3 mm -103.52 158.31 5.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 107.842 -1.17 . . . . 73.53 107.842 -175.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -67.31 126.56 29.65 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.019 -0.734 . . . . 55.42 109.019 178.201 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -76.23 130.43 38.18 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.818 -0.628 . . . . 61.31 110.45 -171.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -92.29 -35.34 13.82 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 113.842 1.053 . . . . 35.05 113.842 -175.718 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.58 -178.99 3.6 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 120.251 -0.58 . . . . 74.14 111.009 -174.573 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -71.48 152.43 43.05 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 106.419 -1.697 . . . . 75.3 106.419 175.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 582' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 583' ' ' LYS . 40.7 tt0 -145.14 141.81 29.07 Favored 'General case' 0 N--CA 1.409 -2.495 0 C-N-CA 118.517 -1.273 . . . . 74.04 111.597 -174.647 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 583' ' ' LYS . . . . . 0.465 ' O ' ' HG2' ' A' ' 582' ' ' GLU . 97.3 mttt -94.57 -179.29 4.84 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 106.555 -1.646 . . . . 61.25 106.555 174.532 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -74.78 94.49 2.75 Favored 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 119.819 -0.753 . . . . 73.11 109.125 178.193 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 585' ' ' LYS . . . . . 0.514 ' HB2' HG23 ' A' ' 545' ' ' THR . 0.0 OUTLIER -102.73 170.43 8.01 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 115.828 -0.624 . . . . 65.02 109.319 -179.56 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 2.8 t -151.79 148.96 28.48 Favored 'General case' 0 N--CA 1.418 -2.043 0 CA-C-O 121.486 0.66 . . . . 62.01 111.502 -177.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -128.84 150.09 50.47 Favored 'General case' 0 N--CA 1.411 -2.409 0 CA-C-N 113.537 -1.665 . . . . 70.3 107.321 174.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 588' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -108.51 135.98 48.88 Favored 'General case' 0 C--N 1.29 -1.993 0 C-N-CA 120.555 -0.458 . . . . 74.15 110.5 -169.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 589' ' ' LEU . . . . . 0.473 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.3 OUTLIER -102.85 129.58 49.57 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 105.8 -1.926 . . . . 72.11 105.8 175.712 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -132.97 127.08 33.42 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 109.392 -0.595 . . . . 72.33 109.392 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 591' ' ' ILE . . . . . 0.443 HG22 ' HB3' ' A' ' 539' ' ' TYR . 16.3 pt -94.17 138.43 20.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 107.945 -1.132 . . . . 72.14 107.945 174.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -97.64 -145.3 18.75 Favored Glycine 0 N--CA 1.43 -1.746 0 N-CA-C 115.049 0.779 . . . . 65.11 115.049 -172.115 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -84.99 119.67 72.82 Favored Pre-proline 0 C--N 1.302 -1.462 0 CA-C-N 114.081 -1.059 . . . . 63.21 109.827 -174.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 594' ' ' PRO . . . . . 0.415 ' HA ' ' O ' ' A' ' 536' ' ' ILE . 43.9 Cg_endo -72.5 156.01 54.51 Favored 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 123.082 2.521 . . . . 52.23 114.202 -177.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 595' ' ' ARG . . . . . 0.51 ' O ' ' HA ' ' A' ' 535' ' ' VAL . 5.7 mmp_? -115.37 118.15 32.43 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 123.713 0.805 . . . . 54.24 109.284 -175.727 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 596' ' ' LEU . . . . . 0.421 HD22 HG22 ' A' ' 535' ' ' VAL . 0.0 OUTLIER -82.5 117.99 22.92 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 104.793 -2.299 . . . . 72.21 104.793 169.586 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 17.0 t . . . . . 0 C--N 1.304 -1.396 0 CA-C-O 121.776 0.798 . . . . 73.22 112.787 -172.833 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 21.8 mtm180 . . . . . 0 N--CA 1.443 -0.79 0 CA-C-O 121.187 0.518 . . . . 74.41 112.32 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -77.16 148.82 27.69 Favored 'Trans proline' 0 N--CA 1.437 -1.834 0 C-N-CA 121.795 1.663 . . . . 72.21 109.532 173.193 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 11.6 pt -137.33 -171.74 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-O 120.956 0.408 . . . . 74.24 110.351 -178.372 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.48 164.42 14.83 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 115.482 -0.781 . . . . 63.03 110.227 177.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 637' ' ' GLY . . . . . 0.507 ' HA3' ' HB ' ' A' ' 506' ' ' THR . . . -82.35 -106.51 0.43 Allowed Glycine 0 N--CA 1.435 -1.428 0 CA-C-N 115.917 -0.583 . . . . 50.22 112.99 -176.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -107.99 -54.16 2.53 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 119.889 -0.724 . . . . 73.04 111.003 -176.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 14.5 p80 -133.84 116.16 15.34 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 121.79 0.805 . . . . 75.51 111.423 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 16.2 p -104.3 91.24 3.83 Favored 'General case' 0 N--CA 1.408 -2.552 0 N-CA-C 109.091 -0.707 . . . . 71.23 109.091 174.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -171.65 126.25 0.61 Allowed 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 105.898 -1.89 . . . . 73.25 105.898 -178.267 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 642' ' ' LEU . . . . . 0.553 HD21 HG21 ' A' ' 523' ' ' VAL . 42.6 tp -126.28 110.97 14.01 Favored 'General case' 0 C--N 1.281 -2.398 0 N-CA-C 108.086 -1.079 . . . . 73.51 108.086 176.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 643' ' ' GLU . . . . . 0.414 ' HB3' HG22 ' A' ' 511' ' ' VAL . 30.6 tt0 -90.9 102.97 15.73 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 107.569 -1.271 . . . . 65.24 107.569 178.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 644' ' ' VAL . . . . . 0.489 HG21 ' HE1' ' A' ' 521' ' ' MET . 41.2 t -93.2 110.9 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 N-CA-C 109.333 -0.618 . . . . 71.33 109.333 -179.174 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 3.5 mp -93.07 125.6 45.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 108.425 -0.954 . . . . 72.34 108.425 176.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 646' ' ' ILE . . . . . 0.514 HD12 ' N ' ' A' ' 646' ' ' ILE . 2.1 mp -110.72 131.14 62.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 N-CA-C 107.424 -1.324 . . . . 61.05 107.424 -176.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 647' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' A' ' 516' ' ' GLU . 2.2 pt-20 -131.22 157.35 43.48 Favored 'General case' 0 C--N 1.28 -2.448 0 N-CA-C 108.511 -0.922 . . . . 75.43 108.511 178.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -56.5 117.97 4.36 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 106.307 -1.738 . . . . 72.11 106.307 170.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 2.9 t . . . . . 0 C--N 1.312 -1.028 0 O-C-N 125.802 1.939 . . . . 74.01 113.784 -165.258 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 503' ' ' GLY . . . . . 0.474 ' HA2' ' OG1' ' A' ' 528' ' ' THR . . . . . . . . 0 N--CA 1.403 -3.564 0 N-CA-C 110.08 -1.208 . . . . 34.05 110.08 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 4.1 mp -91.82 119.34 39.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 108.712 -0.847 . . . . 75.4 108.712 178.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -123.48 126.04 46.0 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 109.627 -0.508 . . . . 64.41 109.627 177.29 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 506' ' ' THR . . . . . 0.453 ' HB ' ' HA3' ' A' ' 637' ' ' GLY . 8.8 t -153.41 165.18 36.62 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.522 -0.918 . . . . 71.31 108.522 -177.371 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -89.31 162.65 15.72 Favored 'General case' 0 C--O 1.251 1.136 0 N-CA-C 107.228 -1.397 . . . . 73.45 107.228 173.175 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -88.42 -44.43 10.75 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 106.293 -1.743 . . . . 75.32 106.293 178.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -105.36 133.73 20.02 Favored Pre-proline 0 N--CA 1.42 -1.93 0 CA-C-N 114.502 -1.226 . . . . 65.54 109.495 176.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -87.21 -10.63 5.59 Favored 'Trans proline' 0 C--O 1.219 -0.469 0 C-N-CA 121.956 1.77 . . . . 71.53 110.824 175.352 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 511' ' ' VAL . . . . . 0.454 HG22 ' HB3' ' A' ' 643' ' ' GLU . 81.5 t -142.42 138.89 29.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 C-N-CA 124.378 1.071 . . . . 62.14 108.441 -176.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 11.3 t -142.09 141.71 32.75 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 107.726 -1.213 . . . . 74.13 107.726 174.357 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 35.5 m-70 -108.94 130.4 55.45 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.486 -0.561 . . . . 70.24 109.486 178.028 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 26.4 m -128.71 162.47 35.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 CA-C-O 120.937 0.398 . . . . 70.24 110.221 -176.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 45.9 t -84.24 156.68 21.89 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 108.412 -0.959 . . . . 71.14 108.412 175.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -88.91 -6.77 57.06 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-O 122.089 0.947 . . . . 65.42 109.659 174.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 8.7 t -96.99 6.34 48.8 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 108.707 -0.849 . . . . 75.51 108.707 179.447 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 12.5 tt -85.11 151.03 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.623 0 N-CA-C 108.69 -0.856 . . . . 55.03 108.69 -178.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 519' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . -89.61 -63.38 1.29 Allowed Glycine 0 N--CA 1.426 -2.023 0 C-N-CA 120.366 -0.921 . . . . 75.4 111.098 179.492 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 32.1 mm -123.64 124.26 69.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 109.458 -0.571 . . . . 44.11 109.458 -179.099 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 521' ' ' MET . . . . . 0.638 ' HE2' HG21 ' A' ' 644' ' ' VAL . 0.0 OUTLIER -102.6 135.51 44.12 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.597 -1.26 . . . . 64.1 107.597 172.625 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 522' ' ' GLU . . . . . 0.423 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 42.7 mt-10 -120.93 132.29 54.86 Favored 'General case' 0 CA--C 1.494 -1.206 0 O-C-N 123.522 0.514 . . . . 54.45 110.713 -177.66 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 523' ' ' VAL . . . . . 0.566 HG21 ' CD2' ' A' ' 642' ' ' LEU . 29.4 t -112.67 123.46 68.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-N 115.37 -0.832 . . . . 71.21 108.888 178.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 524' ' ' LYS . . . . . 0.416 ' HD2' HG21 ' A' ' 568' ' ' VAL . 28.6 mmtp -79.78 122.77 27.02 Favored 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 123.468 0.707 . . . . 65.41 110.408 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 21.9 t -101.21 150.97 5.59 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 CA-C-N 115.405 -0.816 . . . . 72.11 109.126 -178.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -95.43 153.53 17.65 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 108.974 -0.75 . . . . 71.12 108.974 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 527' ' ' ARG . . . . . 0.472 ' HD3' ' HA ' ' A' ' 567' ' ' ILE . 67.1 mtm180 -94.21 176.81 6.18 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.201 0.524 . . . . 73.34 109.9 173.091 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 528' ' ' THR . . . . . 0.474 ' OG1' ' HA2' ' A' ' 503' ' ' GLY . 8.8 t -87.82 164.26 16.01 Favored 'General case' 0 N--CA 1.411 -2.38 0 CA-C-N 115.079 -0.964 . . . . 75.14 110.208 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 13.3 t -63.21 -42.75 99.34 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 115.262 -0.881 . . . . 70.21 108.712 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -100.78 67.4 0.49 Allowed Glycine 0 N--CA 1.434 -1.47 0 N-CA-C 110.764 -0.934 . . . . 41.25 110.764 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -78.89 80.45 5.24 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.261 0.553 . . . . 75.42 110.742 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -134.63 138.65 44.68 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 106.306 -1.739 . . . . 73.41 106.306 177.461 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 533' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' A' ' 563' ' ' GLN . . . 87.93 173.48 47.75 Favored Glycine 0 C--N 1.302 -1.314 0 C-N-CA 119.883 -1.151 . . . . 74.23 111.156 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -105.98 121.27 43.76 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 122.409 -0.465 . . . . 62.12 109.809 -177.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 535' ' ' VAL . . . . . 0.445 HG22 HD22 ' A' ' 596' ' ' LEU . 59.8 t -124.01 126.21 72.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.409 -0.96 . . . . 62.12 108.409 178.147 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 536' ' ' ILE . . . . . 0.51 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 47.4 mm -99.23 137.28 27.17 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 N-CA-C 108.661 -0.866 . . . . 63.24 108.661 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 57.9 t -122.45 109.82 32.64 Favored Pre-proline 0 C--N 1.307 -1.266 0 CA-C-N 116.417 -0.356 . . . . 74.21 110.805 -179.193 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -75.25 135.92 19.23 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 122.541 2.161 . . . . 64.11 111.668 176.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 539' ' ' TYR . . . . . 0.455 ' CD1' ' HG ' ' A' ' 560' ' ' LEU . 42.9 p90 -134.12 157.49 46.03 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 109.068 -0.716 . . . . 73.01 109.068 -178.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -156.73 156.85 34.06 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 123.322 0.389 . . . . 74.11 111.048 177.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 1.6 p -91.45 116.85 29.19 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 115.437 -0.801 . . . . 71.14 110.663 174.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.6 mp -87.51 112.27 23.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 106.282 -1.747 . . . . 74.41 106.282 174.465 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.69 -46.19 74.07 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 114.797 1.406 . . . . 63.4 114.797 -176.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 63.41 -94.54 0.13 Allowed Glycine 0 CA--C 1.523 0.546 0 CA-C-O 121.349 0.416 . . . . 74.43 113.146 177.407 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 10.2 t -114.09 0.4 14.28 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.293 0.568 . . . . 71.13 110.712 -178.458 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -104.02 156.7 17.65 Favored 'General case' 0 C--N 1.318 -0.794 0 O-C-N 121.97 -0.457 . . . . 63.43 109.923 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 547' ' ' ARG . . . . . 0.463 ' HB2' ' HB2' ' A' ' 552' ' ' ASP . 4.6 mpt_? -87.21 125.43 34.18 Favored 'General case' 0 CA--C 1.483 -1.602 0 CA-C-O 121.442 0.639 . . . . 71.22 110.991 -178.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -86.32 179.92 49.47 Favored Glycine 0 C--N 1.279 -2.633 0 CA-C-N 114.245 -1.343 . . . . 73.03 112.083 -177.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 74.18 30.86 60.24 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 114.039 0.376 . . . . 72.44 114.039 177.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 76.08 21.39 76.11 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.259 -0.972 . . . . 52.04 111.919 178.472 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -91.67 -66.26 0.94 Allowed 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 110.02 -0.363 . . . . 75.15 110.02 -177.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 552' ' ' ASP . . . . . 0.463 ' HB2' ' HB2' ' A' ' 547' ' ' ARG . 1.8 t70 -101.79 -29.84 11.64 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 106.608 -1.627 . . . . 51.44 106.608 177.512 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -146.07 160.06 42.41 Favored 'General case' 0 C--O 1.247 0.937 0 CA-C-N 114.963 -1.017 . . . . 73.43 108.374 175.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -91.21 130.09 37.13 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.404 -1.702 . . . . 75.32 106.404 178.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -86.17 117.46 25.01 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 116.511 -0.313 . . . . 64.14 110.579 -174.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 556' ' ' THR . . . . . 0.43 ' CG2' HG22 ' A' ' 573' ' ' VAL . 13.8 t -115.99 122.35 44.98 Favored 'General case' 0 N--CA 1.409 -2.477 0 CA-C-O 122.206 1.003 . . . . 65.23 110.462 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 1.8 p -143.87 128.76 18.42 Favored 'General case' 0 N--CA 1.417 -2.087 0 CA-C-N 114.54 -1.209 . . . . 72.24 108.693 179.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -177.4 -158.42 20.48 Favored Glycine 0 N--CA 1.419 -2.47 0 N-CA-C 110.103 -1.199 . . . . 73.44 110.103 -176.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 559' ' ' GLU . . . . . 0.51 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 38.7 mt-10 -129.97 125.73 36.12 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 120.999 0.428 . . . . 65.43 111.935 -176.273 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 560' ' ' LEU . . . . . 0.455 ' HG ' ' CD1' ' A' ' 539' ' ' TYR . 94.9 mt -88.91 144.92 25.86 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 109.07 -0.715 . . . . 74.11 109.07 177.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -103.95 122.17 44.64 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 116.418 -0.355 . . . . 74.44 110.475 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 562' ' ' PHE . . . . . 0.421 ' CE1' ' HG2' ' A' ' 569' ' ' LYS . 70.0 m-85 -121.24 146.57 46.67 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.445 -0.946 . . . . 73.24 108.445 171.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 563' ' ' GLN . . . . . 0.483 ' HA ' ' O ' ' A' ' 533' ' ' GLY . 10.0 pt20 -159.14 -173.16 4.08 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 110.324 -0.25 . . . . 72.41 110.324 178.271 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -59.11 -45.41 90.96 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 123.58 0.752 . . . . 72.5 112.24 -177.379 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -91.95 -41.21 10.7 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 120.17 -0.612 . . . . 54.32 111.748 -178.136 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 566' ' ' GLU . . . . . 0.406 ' H ' ' HG3' ' A' ' 563' ' ' GLN . 8.2 tp10 -66.94 135.2 53.44 Favored 'General case' 0 C--N 1.317 -0.809 0 O-C-N 123.247 0.342 . . . . 71.0 110.233 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 567' ' ' ILE . . . . . 0.472 ' HA ' ' HD3' ' A' ' 527' ' ' ARG . 31.1 pt -116.94 -172.19 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.412 -2.365 0 N-CA-C 109.057 -0.72 . . . . 73.21 109.057 -178.026 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 568' ' ' VAL . . . . . 0.416 HG21 ' HD2' ' A' ' 524' ' ' LYS . 2.8 p 5.9 128.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 C-N-CA 129.628 3.171 . . . . 54.02 116.944 172.576 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 569' ' ' LYS . . . . . 0.421 ' HG2' ' CE1' ' A' ' 562' ' ' PHE . 27.7 mmmt -117.11 153.87 32.01 Favored 'General case' 0 C--N 1.266 -3.024 0 CA-C-N 115.234 -0.894 . . . . 72.21 110.699 177.61 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 570' ' ' THR . . . . . 0.551 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 8.3 p -126.78 121.2 31.28 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 124.032 0.832 . . . . 63.33 111.998 177.124 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 571' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 2.5 mp -77.15 118.15 23.33 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 N-CA-C 105.191 -2.151 . . . . 64.43 105.191 172.706 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 5.7 m -105.93 109.36 21.28 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.894 -0.78 . . . . 63.1 108.894 -176.272 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 573' ' ' VAL . . . . . 0.43 HG22 ' CG2' ' A' ' 556' ' ' THR . 40.6 t -114.01 135.3 54.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 110.067 -0.346 . . . . 61.22 110.067 -176.644 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 574' ' ' LYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 519' ' ' GLY . 15.7 tppt? -90.4 123.98 34.58 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.369 -0.832 . . . . 73.22 110.112 178.418 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 64.3 t -94.59 117.66 38.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 107.724 -1.213 . . . . 71.33 107.724 176.586 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 36.8 mm -78.96 154.65 4.85 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 N-CA-C 108.347 -0.983 . . . . 74.41 108.347 -176.324 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -72.36 86.78 1.13 Allowed 'General case' 0 C--O 1.247 0.947 0 CA-C-O 122.061 0.934 . . . . 43.3 110.26 173.173 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -40.6 130.57 2.4 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 127.681 2.392 . . . . 73.32 113.25 178.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.25 -26.8 60.44 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 114.145 -1.389 . . . . 74.42 114.126 -171.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 580' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' A' ' 581' ' ' TYR . 0.8 OUTLIER -124.63 178.7 5.3 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 119.549 -0.861 . . . . 73.2 110.67 -174.742 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 581' ' ' TYR . . . . . 0.477 ' O ' ' HG2' ' A' ' 580' ' ' GLU . 7.2 p90 -86.01 151.43 23.73 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 105.451 -2.055 . . . . 75.54 105.451 173.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 582' ' ' GLU . . . . . 0.418 ' OE2' ' HG3' ' A' ' 585' ' ' LYS . 9.5 pt-20 -133.4 172.02 13.27 Favored 'General case' 0 C--N 1.277 -2.549 0 C-N-CA 119.194 -1.002 . . . . 75.31 109.672 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -90.65 -48.87 6.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 N-CA-C 106.812 -1.551 . . . . 72.2 106.812 173.06 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 28.2 m-20 175.22 101.08 0.01 OUTLIER 'General case' 0 C--N 1.259 -3.344 0 CA-C-N 110.822 -2.899 . . . . 71.5 109.476 177.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 585' ' ' LYS . . . . . 0.418 ' HG3' ' OE2' ' A' ' 582' ' ' GLU 0.263 0.1 OUTLIER -89.87 162.02 15.67 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 118.065 -1.454 . . . . 74.22 109.676 172.994 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 5.2 t -151.36 142.98 23.66 Favored 'General case' 0 N--CA 1.415 -2.216 0 CA-C-O 121.174 0.512 . . . . 65.4 110.186 -176.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -126.09 147.01 49.69 Favored 'General case' 0 N--CA 1.421 -1.898 0 CA-C-N 114.104 -1.407 . . . . 74.34 108.412 176.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 588' ' ' PHE . . . . . 0.437 ' HA ' ' O ' ' A' ' 642' ' ' LEU . 10.5 m-85 -105.92 135.48 47.29 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 116.027 -0.533 . . . . 70.23 109.708 -172.451 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 589' ' ' LEU . . . . . 0.501 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.3 OUTLIER -104.27 124.99 50.15 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 106.096 -1.816 . . . . 63.41 106.096 175.786 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -131.38 135.72 47.45 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 109.526 -0.546 . . . . 70.14 109.526 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 591' ' ' ILE . . . . . . . . . . . . . 22.5 pt -99.36 134.71 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.734 0 N-CA-C 107.059 -1.46 . . . . 72.12 107.059 174.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -90.4 -150.66 24.53 Favored Glycine 0 C--N 1.297 -1.6 0 C-N-CA 120.786 -0.721 . . . . 74.02 112.965 -175.242 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -67.83 118.73 60.8 Favored Pre-proline 0 C--N 1.315 -0.935 0 C-N-CA 122.743 0.417 . . . . 74.23 110.292 179.212 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -70.51 143.21 46.59 Favored 'Trans proline' 0 N--CA 1.438 -1.772 0 C-N-CA 121.84 1.693 . . . . 71.23 109.78 175.369 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 595' ' ' ARG . . . . . 0.493 ' HG3' ' HB ' ' A' ' 536' ' ' ILE . 5.5 ptp180 -120.79 122.46 40.38 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 116.402 -0.363 . . . . 73.34 111.056 -174.578 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 596' ' ' LEU . . . . . 0.445 HD22 HG22 ' A' ' 535' ' ' VAL . 0.0 OUTLIER -79.18 122.48 26.32 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 107.735 -1.209 . . . . 55.32 107.735 179.904 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 17.1 t . . . . . 0 C--N 1.303 -1.435 0 CA-C-O 121.676 0.751 . . . . 73.32 110.111 -178.31 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 55.4 mtt180 . . . . . 0 C--O 1.218 -0.561 0 N-CA-C 112.088 0.403 . . . . 70.52 112.088 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -89.54 168.21 4.98 Favored 'Trans proline' 0 N--CA 1.441 -1.57 0 C-N-CA 122.661 2.24 . . . . 70.02 111.293 174.468 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.1 pp -144.06 178.54 1.72 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 113.416 0.895 . . . . 62.34 113.416 -175.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -82.67 148.16 28.1 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 108.775 -0.824 . . . . 45.22 108.775 178.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 637' ' ' GLY . . . . . 0.453 ' HA3' ' HB ' ' A' ' 506' ' ' THR . . . -90.77 -128.55 3.96 Favored Glycine 0 C--N 1.294 -1.79 0 C-N-CA 120.736 -0.745 . . . . 35.44 114.46 -176.32 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -72.1 -56.67 5.19 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.379 -0.41 . . . . 71.12 111.448 -175.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 20.3 p80 -145.38 109.69 4.93 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.833 0.825 . . . . 72.52 111.684 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 37.9 p -101.35 90.25 4.04 Favored 'General case' 0 N--CA 1.398 -3.034 0 N-CA-C 107.849 -1.167 . . . . 73.34 107.849 174.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -178.32 125.74 0.11 Allowed 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 105.01 -2.219 . . . . 64.2 105.01 -177.477 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 642' ' ' LEU . . . . . 0.566 ' CD2' HG21 ' A' ' 523' ' ' VAL . 38.0 tp -124.72 111.07 15.13 Favored 'General case' 0 C--N 1.28 -2.435 0 N-CA-C 108.17 -1.048 . . . . 74.14 108.17 174.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 643' ' ' GLU . . . . . 0.454 ' HB3' HG22 ' A' ' 511' ' ' VAL . 26.1 tt0 -93.62 101.44 13.6 Favored 'General case' 0 C--N 1.272 -2.767 0 N-CA-C 107.484 -1.302 . . . . 75.31 107.484 -179.385 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 644' ' ' VAL . . . . . 0.638 HG21 ' HE2' ' A' ' 521' ' ' MET . 39.4 t -93.04 108.52 20.49 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 108.906 -0.775 . . . . 75.41 108.906 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 4.2 mp -94.05 121.82 45.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 107.944 -1.132 . . . . 72.32 107.944 176.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 646' ' ' ILE . . . . . 0.514 HD12 ' N ' ' A' ' 646' ' ' ILE . 2.9 mp -100.19 134.09 40.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 107.091 -1.448 . . . . 75.11 107.091 -176.063 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -118.02 145.23 44.93 Favored 'General case' 0 N--CA 1.419 -2.023 0 C-N-CA 120.229 -0.589 . . . . 75.13 109.855 -178.083 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -60.31 137.56 58.11 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 107.019 -1.474 . . . . 73.11 107.019 176.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 17.0 t . . . . . 0 N--CA 1.434 -1.253 0 CA-C-O 122.177 0.989 . . . . 74.03 112.881 -173.12 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 503' ' ' GLY . . . . . 0.638 ' HA2' ' OG1' ' A' ' 528' ' ' THR . . . . . . . . 1 N--CA 1.395 -4.061 0 N-CA-C 110.952 -0.859 . . . . 73.03 110.952 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 2.7 mp -105.54 101.01 11.76 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 N-CA-C 106.763 -1.569 . . . . 72.41 106.763 176.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -114.71 122.87 47.74 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 109.457 -0.571 . . . . 72.23 109.457 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 11.2 t -148.64 163.99 35.62 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.483 -0.932 . . . . 71.13 108.483 -176.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -92.51 161.98 14.4 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 107.306 -1.368 . . . . 74.5 107.306 172.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -96.91 -26.3 15.11 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.322 -1.362 . . . . 71.1 107.322 173.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -97.32 120.57 60.72 Favored Pre-proline 0 N--CA 1.419 -1.989 0 CA-C-N 114.618 -1.174 . . . . 65.4 110.587 176.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -82.16 -19.09 7.02 Favored 'Trans proline' 0 N--CA 1.429 -2.28 0 N-CA-C 108.065 -1.552 . . . . 74.2 108.065 168.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 511' ' ' VAL . . . . . 0.426 HG22 ' HB3' ' A' ' 643' ' ' GLU . 93.7 t -147.89 139.69 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 C-N-CA 126.005 1.722 . . . . 71.24 107.897 -177.281 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 14.4 t -137.05 119.47 15.82 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 108.051 -1.092 . . . . 72.21 108.051 173.114 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -88.41 128.61 35.52 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 122.085 -0.384 . . . . 73.21 110.225 175.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 26.8 m -126.25 161.52 31.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-N 115.657 -0.701 . . . . 75.12 109.717 -178.446 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 56.9 m -88.21 167.8 13.28 Favored 'General case' 0 N--CA 1.403 -2.807 0 CA-C-N 115.079 -0.964 . . . . 73.51 109.99 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -94.32 -23.63 17.74 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.497 0.665 . . . . 72.33 110.608 176.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 14.2 m -85.31 20.77 1.89 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.932 0.873 . . . . 73.21 110.406 -176.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 15.3 tt -108.3 155.83 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.133 0 N-CA-C 107.554 -1.276 . . . . 74.52 107.554 -176.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -96.65 -59.85 1.0 Allowed Glycine 0 C--N 1.293 -1.848 0 C-N-CA 120.175 -1.012 . . . . 65.21 111.297 179.36 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 41.9 mm -121.48 136.22 59.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 109.402 -0.592 . . . . 75.52 109.402 -178.177 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 521' ' ' MET . . . . . 0.594 ' HE1' HG21 ' A' ' 644' ' ' VAL . 0.0 OUTLIER -115.35 132.68 56.54 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 106.368 -1.716 . . . . 72.12 106.368 171.764 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -109.17 149.29 29.58 Favored 'General case' 0 N--CA 1.428 -1.563 0 C-N-CA 120.509 -0.476 . . . . 65.32 109.852 -178.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 523' ' ' VAL . . . . . 0.631 ' O ' ' HA ' ' A' ' 570' ' ' THR . 40.0 t -126.12 121.05 58.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 109.722 -0.473 . . . . 63.32 109.722 178.729 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 524' ' ' LYS . . . . . 0.509 ' HD2' HG21 ' A' ' 568' ' ' VAL . 28.0 mmtp -82.09 118.9 23.39 Favored 'General case' 0 C--N 1.313 -1.021 0 O-C-N 124.095 0.872 . . . . 75.14 110.453 178.471 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 21.7 t -98.87 139.18 21.28 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 CA-C-N 114.563 -1.199 . . . . 63.21 108.982 -178.41 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -79.7 146.36 32.46 Favored 'General case' 0 C--N 1.31 -1.12 0 O-C-N 123.635 0.585 . . . . 74.33 109.566 -179.179 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 527' ' ' ARG . . . . . 0.406 ' HG2' ' N ' ' A' ' 528' ' ' THR . 31.8 ttp180 -87.64 160.16 18.26 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.384 -0.969 . . . . 71.45 108.384 -179.018 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 528' ' ' THR . . . . . 0.638 ' OG1' ' HA2' ' A' ' 503' ' ' GLY . 4.6 t -61.82 150.76 36.25 Favored 'General case' 0 N--CA 1.421 -1.916 0 CA-C-O 121.362 0.601 . . . . 62.02 110.71 174.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 42.2 t -69.99 -22.17 63.16 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 114.83 -1.077 . . . . 74.25 109.754 179.056 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -129.0 89.71 0.31 Allowed Glycine 0 N--CA 1.435 -1.377 0 N-CA-C 109.907 -1.277 . . . . 65.12 109.907 178.007 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -86.87 85.93 7.3 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 121.382 0.611 . . . . 64.34 111.291 -176.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 532' ' ' ARG . . . . . 0.419 ' HD3' ' HA ' ' A' ' 532' ' ' ARG . 37.5 mmt180 -123.54 101.78 7.51 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.634 -0.712 . . . . 75.15 110.772 177.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 533' ' ' GLY . . . . . 0.409 ' H ' ' HB3' ' A' ' 564' ' ' ASN . . . 119.07 -148.79 18.26 Favored Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 110.969 -0.852 . . . . 71.23 110.969 179.465 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -138.2 131.62 30.58 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 106.288 -1.745 . . . . 25.24 106.288 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 535' ' ' VAL . . . . . 0.448 HG22 HD22 ' A' ' 596' ' ' LEU . 67.7 t -127.44 137.6 57.25 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 118.189 0.45 . . . . 62.1 111.416 -174.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 536' ' ' ILE . . . . . 0.427 HG23 ' HB3' ' A' ' 559' ' ' GLU . 27.9 mm -102.91 126.04 57.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 108.889 -0.782 . . . . 75.15 108.889 174.423 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 31.7 t -117.1 106.83 46.68 Favored Pre-proline 0 C--N 1.298 -1.652 0 N-CA-C 108.543 -0.91 . . . . 75.15 108.543 178.37 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -75.61 137.81 20.86 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.102 1.868 . . . . 74.52 111.364 177.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -130.68 160.42 34.33 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.535 -0.543 . . . . 73.52 109.535 179.294 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.33 146.91 18.83 Favored 'General case' 0 C--N 1.314 -0.972 0 O-C-N 123.67 0.606 . . . . 73.33 110.679 175.622 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 7.9 p -86.77 122.33 30.52 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.053 -0.521 . . . . 53.4 110.38 176.315 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.4 mp -82.49 122.47 37.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 105.753 -1.943 . . . . 74.21 105.753 172.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -63.75 -48.69 75.98 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 123.464 0.478 . . . . 73.12 109.928 -178.213 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 67.24 -93.5 0.23 Allowed Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 115.858 -0.61 . . . . 73.44 112.215 177.446 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 15.1 t -113.74 -0.61 14.2 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.494 -0.558 . . . . 63.11 109.494 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -97.34 176.49 5.87 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-N 115.646 -0.706 . . . . 71.2 111.592 -177.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -127.31 111.97 14.52 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 109.25 -0.648 . . . . 71.41 109.25 -179.318 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -78.43 -160.9 17.29 Favored Glycine 0 C--N 1.315 -0.606 0 C-N-CA 121.57 -0.348 . . . . 64.21 112.602 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 67.37 17.68 68.71 Favored Glycine 0 C--N 1.314 -0.656 0 CA-C-O 120.908 0.171 . . . . 53.14 113.191 -177.123 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 77.42 11.58 85.36 Favored Glycine 0 C--O 1.211 -1.29 0 N-CA-C 111.041 -0.824 . . . . 73.1 111.041 -178.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -78.76 -42.44 28.02 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 122.469 0.308 . . . . 62.41 111.291 -175.147 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -135.89 -20.67 1.49 Allowed 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 107.822 -1.177 . . . . 71.14 107.822 173.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -155.79 163.51 39.74 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 107.181 -1.414 . . . . 75.13 107.181 169.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 554' ' ' GLU . . . . . 0.421 ' HB3' ' HB3' ' A' ' 574' ' ' LYS . 0.7 OUTLIER -98.09 109.19 21.99 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 106.761 -1.57 . . . . 52.33 106.761 -178.855 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -77.54 147.25 35.86 Favored 'General case' 0 CA--C 1.499 -0.993 0 C-N-CA 120.761 -0.375 . . . . 75.35 110.439 -175.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 8.3 t -139.59 142.22 37.13 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-O 121.605 0.717 . . . . 33.01 111.778 -174.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 7.6 p -145.46 149.6 34.97 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.214 -1.402 . . . . 70.42 107.214 176.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 173.47 -167.21 39.8 Favored Glycine 0 N--CA 1.418 -2.543 0 N-CA-C 110.346 -1.101 . . . . 31.43 110.346 -178.369 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 559' ' ' GLU . . . . . 0.427 ' HB3' HG23 ' A' ' 536' ' ' ILE . 42.2 mt-10 -126.73 124.63 40.22 Favored 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 123.165 0.586 . . . . 75.34 110.169 -176.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 94.3 mt -95.97 142.05 28.66 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.746 -0.835 . . . . 62.22 108.746 177.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -115.83 115.9 27.06 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 120.912 0.387 . . . . 70.01 111.143 -176.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -102.05 140.93 35.68 Favored 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 108.982 -0.747 . . . . 74.53 108.982 176.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 563' ' ' GLN . . . . . 0.496 ' HB2' ' H ' ' A' ' 566' ' ' GLU . 29.7 mt-30 -119.7 -178.23 3.58 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 119.033 -1.067 . . . . 75.43 110.337 179.231 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 564' ' ' ASN . . . . . 0.409 ' HB3' ' H ' ' A' ' 533' ' ' GLY . 28.0 p-10 -74.43 -34.71 63.3 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.916 0.865 . . . . 64.12 109.001 176.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -94.0 -43.39 8.55 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.437 -1.256 . . . . 60.15 110.901 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 566' ' ' GLU . . . . . 0.496 ' H ' ' HB2' ' A' ' 563' ' ' GLN . 25.5 tt0 -70.99 123.29 21.72 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.064 0.459 . . . . 74.22 111.326 -179.086 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 8.7 pt -104.81 166.01 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.564 0 N-CA-C 108.797 -0.816 . . . . 72.02 108.797 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 568' ' ' VAL . . . . . 0.509 HG21 ' HD2' ' A' ' 524' ' ' LYS . 2.0 p 47.34 159.96 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.58 2.107 0 C-N-CA 127.027 2.131 . . . . 71.34 115.392 179.213 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 569' ' ' LYS . . . . . 0.508 ' HA ' ' HE2' ' A' ' 569' ' ' LYS . 4.3 mmpt? -142.67 166.05 25.73 Favored 'General case' 0 CA--C 1.493 -1.217 0 O-C-N 121.16 -0.962 . . . . 73.11 109.019 172.445 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 570' ' ' THR . . . . . 0.631 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 1.3 p -138.57 127.16 23.35 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 123.902 0.751 . . . . 74.32 112.897 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 571' ' ' ILE . . . . . 0.429 HG21 HD21 ' A' ' 589' ' ' LEU . 3.3 mp -96.07 122.06 47.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 106.477 -1.675 . . . . 73.42 106.477 170.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 49.2 m -107.36 125.08 50.75 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 108.84 -0.8 . . . . 61.44 108.84 177.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 573' ' ' VAL . . . . . . . . . . . . . 48.1 t -124.68 139.45 50.86 Favored 'Isoleucine or valine' 0 C--O 1.243 0.757 0 N-CA-C 108.458 -0.942 . . . . 63.42 108.458 -178.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 574' ' ' LYS . . . . . 0.421 ' HB3' ' HB3' ' A' ' 554' ' ' GLU . 87.0 tttt -95.7 129.99 42.74 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-O 121.77 0.795 . . . . 75.41 111.786 -178.352 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 59.2 t -94.13 138.72 19.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 107.044 -1.465 . . . . 65.33 107.044 176.172 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 45.8 mm -104.62 143.97 15.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 108.659 -0.867 . . . . 74.4 108.659 -176.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -59.18 129.76 43.7 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 108.535 -0.913 . . . . 74.31 108.535 174.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -77.96 117.36 19.22 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 115.02 -0.991 . . . . 74.14 111.911 -167.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.08 -16.81 59.09 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 114.263 1.208 . . . . 73.04 114.263 -177.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 580' ' ' GLU . . . . . 0.557 ' HG2' ' O ' ' A' ' 581' ' ' TYR . 0.0 OUTLIER -141.21 -176.71 4.81 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 106.553 -1.647 . . . . 61.05 106.553 173.257 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 581' ' ' TYR . . . . . 0.557 ' O ' ' HG2' ' A' ' 580' ' ' GLU . 12.4 p90 -87.19 152.21 22.52 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 106.825 -1.546 . . . . 72.23 106.825 174.242 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 582' ' ' GLU . . . . . 0.701 ' OE1' ' HB3' ' A' ' 585' ' ' LYS . 14.7 pt-20 -132.81 175.84 8.99 Favored 'General case' 0 C--N 1.276 -2.599 0 N-CA-C 108.826 -0.805 . . . . 72.01 108.826 -178.757 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 583' ' ' LYS . . . . . 0.446 ' O ' ' HG3' ' A' ' 582' ' ' GLU . 56.3 mtpt -100.05 -165.92 1.27 Allowed 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 105.551 -2.018 . . . . 72.54 105.551 169.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -74.73 89.16 2.27 Favored 'General case' 0 C--N 1.281 -2.391 0 C-N-CA 118.82 -1.152 . . . . 53.0 111.853 178.455 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 585' ' ' LYS . . . . . 0.701 ' HB3' ' OE1' ' A' ' 582' ' ' GLU . 0.0 OUTLIER -79.02 143.81 35.29 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 114.879 -1.055 . . . . 74.32 108.746 -178.964 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 5.9 t -145.14 141.57 28.88 Favored 'General case' 0 N--CA 1.407 -2.604 0 CA-C-O 121.169 0.509 . . . . 70.4 110.517 -176.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -122.16 144.63 48.83 Favored 'General case' 0 N--CA 1.412 -2.342 0 CA-C-N 113.928 -1.487 . . . . 70.32 108.468 175.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 588' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -104.66 128.16 52.62 Favored 'General case' 0 C--N 1.284 -2.239 0 N-CA-C 108.732 -0.84 . . . . 75.43 108.732 -173.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 589' ' ' LEU . . . . . 0.501 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.7 OUTLIER -98.45 126.08 43.86 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 106.642 -1.614 . . . . 72.03 106.642 177.381 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -128.43 132.75 48.45 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 109.993 -0.373 . . . . 75.4 109.993 179.123 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 591' ' ' ILE . . . . . . . . . . . . . 16.0 pt -97.32 128.71 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.652 0 N-CA-C 106.256 -1.757 . . . . 64.04 106.256 170.299 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -87.32 -139.81 6.18 Favored Glycine 0 N--CA 1.435 -1.401 0 CA-C-N 116.104 -0.498 . . . . 42.22 114.18 -172.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -79.9 112.36 29.19 Favored Pre-proline 0 C--N 1.311 -1.071 0 N-CA-C 109.301 -0.629 . . . . 71.53 109.301 -178.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -78.53 149.68 24.25 Favored 'Trans proline' 0 N--CA 1.434 -1.974 0 C-N-CA 122.094 1.863 . . . . 73.23 110.886 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 8.8 ptt-85 -129.23 132.82 47.31 Favored 'General case' 0 C--N 1.28 -2.421 0 CA-C-N 115.912 -0.586 . . . . 61.22 110.402 -175.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 596' ' ' LEU . . . . . 0.448 HD22 HG22 ' A' ' 535' ' ' VAL . 0.0 OUTLIER -77.06 125.77 29.87 Favored 'General case' 0 N--CA 1.415 -2.181 0 N-CA-C 105.501 -2.037 . . . . 64.15 105.501 178.703 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 96.6 t . . . . . 0 C--N 1.3 -1.562 0 N-CA-C 108.646 -0.872 . . . . 51.34 108.646 -179.709 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 . . . . . 0 C--O 1.203 -1.367 0 N-CA-C 108.502 -0.925 . . . . 72.03 108.502 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -76.18 153.51 36.36 Favored 'Trans proline' 0 N--CA 1.434 -1.98 0 C-N-CA 121.116 1.211 . . . . 64.22 110.21 176.276 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.0 pp -138.96 -175.25 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 112.765 0.654 . . . . 74.5 112.765 -175.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.71 146.09 32.58 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 115.425 -0.807 . . . . 74.31 109.327 178.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -83.97 -107.33 0.57 Allowed Glycine 0 C--N 1.291 -1.96 0 CA-C-N 116.105 -0.498 . . . . 63.4 112.474 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -94.66 -65.82 0.96 Allowed 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.238 0.542 . . . . 54.12 110.142 -177.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 17.0 p80 -130.54 114.08 15.04 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.628 0.728 . . . . 64.32 111.011 -177.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 13.7 p -104.78 89.76 3.27 Favored 'General case' 0 N--CA 1.397 -3.124 0 N-CA-C 107.473 -1.306 . . . . 75.12 107.473 173.582 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -176.46 123.62 0.17 Allowed 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 105.175 -2.158 . . . . 72.01 105.175 -174.383 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 642' ' ' LEU . . . . . 0.532 ' CD2' HG21 ' A' ' 523' ' ' VAL . 45.1 tp -125.55 106.84 10.06 Favored 'General case' 0 C--N 1.274 -2.681 0 N-CA-C 106.976 -1.49 . . . . 71.05 106.976 177.545 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 643' ' ' GLU . . . . . 0.426 ' HB3' HG22 ' A' ' 511' ' ' VAL . 26.9 tt0 -88.8 100.56 13.25 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 108.029 -1.1 . . . . 53.43 108.029 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 644' ' ' VAL . . . . . 0.594 HG21 ' HE1' ' A' ' 521' ' ' MET . 23.1 t -91.01 105.61 16.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 108.925 -0.769 . . . . 73.41 108.925 -179.357 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 4.4 mp -92.36 124.93 45.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 108.426 -0.953 . . . . 74.03 108.426 175.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 646' ' ' ILE . . . . . 0.567 HD12 ' N ' ' A' ' 646' ' ' ILE . 1.9 mp -106.55 108.02 24.13 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.473 0 N-CA-C 106.492 -1.669 . . . . 71.34 106.492 -178.176 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -104.15 143.7 32.58 Favored 'General case' 0 C--N 1.269 -2.905 0 CA-C-N 114.698 -1.137 . . . . 74.13 109.625 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -57.07 132.48 53.04 Favored 'General case' 0 C--O 1.249 1.068 0 N-CA-C 106.154 -1.795 . . . . 75.24 106.154 175.183 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 8.6 t . . . . . 0 C--O 1.245 0.826 0 O-C-N 124.18 0.925 . . . . 45.11 112.327 -169.11 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 503' ' ' GLY . . . . . 0.704 ' HA3' ' OG1' ' A' ' 528' ' ' THR . . . . . . . . 1 N--CA 1.394 -4.11 0 CA-C-O 121.593 0.552 . . . . 52.3 113.505 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 3.1 mp -119.18 126.81 75.68 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 CA-C-N 114.126 -1.037 . . . . 72.02 108.256 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -134.86 103.99 5.82 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 106.803 -1.555 . . . . 75.33 106.803 172.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 14.3 t -143.42 160.46 40.52 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 109.66 -0.496 . . . . 73.43 109.66 -173.216 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -81.58 153.13 26.88 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 107.171 -1.418 . . . . 74.25 107.171 173.236 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.02 -50.06 38.19 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.339 -0.985 . . . . 61.31 108.339 176.168 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -116.02 131.87 23.52 Favored Pre-proline 0 C--N 1.303 -1.431 0 CA-C-N 115.7 -0.682 . . . . 74.4 109.195 -178.338 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -83.81 -13.08 8.28 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.477 2.118 . . . . 63.43 112.127 178.64 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 511' ' ' VAL . . . . . 0.517 HG22 ' HB3' ' A' ' 643' ' ' GLU . 73.9 t -136.52 132.51 48.71 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.461 0 N-CA-C 107.873 -1.158 . . . . 54.43 107.873 178.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 3.8 t -138.61 140.95 39.15 Favored 'General case' 0 N--CA 1.396 -3.153 0 N-CA-C 107.666 -1.235 . . . . 63.12 107.666 177.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -109.17 137.79 46.52 Favored 'General case' 0 CA--C 1.479 -1.772 0 N-CA-C 107.474 -1.306 . . . . 73.11 107.474 176.606 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.649 HG11 ' SD ' ' A' ' 521' ' ' MET . 35.0 m -132.28 155.25 41.28 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.309 0 CA-C-O 121.518 0.675 . . . . 65.53 110.32 -176.1 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 515' ' ' SER . . . . . 0.425 ' HB2' ' HB ' ' A' ' 518' ' ' ILE . 19.3 m -68.61 141.27 55.47 Favored 'General case' 0 N--CA 1.393 -3.276 0 CA-C-N 113.665 -1.607 . . . . 74.23 107.877 176.689 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -73.79 -24.15 59.79 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 119.388 -0.925 . . . . 63.45 109.718 176.315 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 24.0 t -107.16 75.71 1.05 Allowed 'General case' 0 N--CA 1.415 -2.192 0 N-CA-C 107.876 -1.157 . . . . 73.2 107.876 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 518' ' ' ILE . . . . . 0.425 ' HB ' ' HB2' ' A' ' 515' ' ' SER . 17.1 tt -141.04 161.01 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.26 0 CA-C-N 113.766 -1.561 . . . . 62.14 106.813 176.59 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -96.15 -69.58 1.02 Allowed Glycine 0 N--CA 1.434 -1.46 0 C-N-CA 119.571 -1.3 . . . . 72.32 111.596 177.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 40.9 mm -116.24 134.57 59.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 109.361 -0.607 . . . . 74.21 109.361 -178.105 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 521' ' ' MET . . . . . 0.649 ' SD ' HG11 ' A' ' 514' ' ' VAL . 23.8 ptt? -114.29 138.74 50.12 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 106.934 -1.506 . . . . 73.43 106.934 171.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -117.07 132.66 56.63 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 108.837 -0.801 . . . . 64.5 108.837 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 523' ' ' VAL . . . . . 0.688 ' O ' ' HA ' ' A' ' 570' ' ' THR . 24.8 t -114.99 134.11 59.09 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 109.314 -0.625 . . . . 62.22 109.314 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 524' ' ' LYS . . . . . 0.43 ' HD2' HG21 ' A' ' 568' ' ' VAL . 33.0 mmtp -84.91 128.13 34.48 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 122.027 0.918 . . . . 75.03 113.1 -175.49 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 3.3 t -113.68 132.84 61.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 106.951 -1.5 . . . . 61.53 106.951 177.658 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -93.77 151.13 19.83 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 108.959 -0.756 . . . . 64.31 108.959 -177.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 527' ' ' ARG . . . . . 0.536 ' CZ ' HG22 ' A' ' 567' ' ' ILE . 68.9 mtm180 -87.02 179.31 6.71 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-O 122.018 0.913 . . . . 75.52 111.137 -179.068 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 528' ' ' THR . . . . . 0.704 ' OG1' ' HA3' ' A' ' 503' ' ' GLY . 1.0 OUTLIER -78.16 159.71 28.44 Favored 'General case' 0 N--CA 1.408 -2.553 0 CA-C-N 113.796 -1.547 . . . . 62.34 109.766 176.21 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 17.0 t -74.73 -20.04 59.99 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 107.903 -1.147 . . . . 73.15 107.903 177.027 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -118.14 66.3 0.36 Allowed Glycine 0 N--CA 1.438 -1.199 0 N-CA-C 111.07 -0.812 . . . . 72.13 111.07 175.13 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 531' ' ' ALA . . . . . 0.403 ' O ' ' HD3' ' A' ' 532' ' ' ARG . . . -76.26 96.13 3.88 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.357 0.599 . . . . 72.31 111.565 -178.2 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 532' ' ' ARG . . . . . 0.403 ' HD3' ' O ' ' A' ' 531' ' ' ALA . 60.5 mmt-85 -134.56 127.68 31.77 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.47 -0.786 . . . . 71.32 109.984 178.765 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 93.77 175.66 39.81 Favored Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 121.087 -0.578 . . . . 74.33 113.642 176.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -95.87 123.22 39.36 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 107.936 -1.135 . . . . 74.45 107.936 177.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 56.4 t -127.96 131.95 69.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.761 0 N-CA-C 108.71 -0.848 . . . . 74.21 108.71 -178.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 536' ' ' ILE . . . . . . . . . . . . . 38.6 mm -103.77 129.28 56.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 108.739 -0.837 . . . . 50.15 108.739 178.324 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 537' ' ' VAL . . . . . 0.502 HG22 ' HB3' ' A' ' 594' ' ' PRO . 14.7 t -117.99 111.79 38.72 Favored Pre-proline 0 C--N 1.301 -1.506 0 N-CA-C 109.575 -0.528 . . . . 44.03 109.575 -178.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -73.98 150.87 44.19 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 121.714 1.609 . . . . 73.02 110.244 176.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 539' ' ' TYR . . . . . 0.476 ' CD1' ' HG ' ' A' ' 560' ' ' LEU . 48.3 p90 -150.85 157.71 43.25 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 109.119 -0.697 . . . . 74.44 109.119 179.1 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 540' ' ' LYS . . . . . 0.416 ' O ' ' HD3' ' A' ' 540' ' ' LYS . 0.1 OUTLIER -157.11 145.65 19.65 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 113.3 0.852 . . . . 72.23 113.3 -179.842 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 541' ' ' THR . . . . . 0.44 HG23 ' HB ' ' A' ' 556' ' ' THR . 2.9 p -76.26 134.08 39.9 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.4 -0.818 . . . . 75.34 111.074 171.485 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.2 mp -99.22 126.65 52.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 105.391 -2.077 . . . . 74.42 105.391 172.579 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 543' ' ' GLU . . . . . 0.417 ' H ' ' CD ' ' A' ' 543' ' ' GLU . 1.4 mp0 -48.78 -44.82 39.23 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.288 1.035 . . . . 70.45 113.06 -174.572 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 71.89 -100.28 0.91 Allowed Glycine 0 N--CA 1.437 -1.243 0 N-CA-C 110.036 -1.226 . . . . 50.34 110.036 -178.623 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 9.0 t -134.12 10.71 3.87 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.926 0.869 . . . . 73.41 109.37 176.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -85.16 168.06 15.15 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.858 -0.61 . . . . 74.33 110.027 177.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -85.91 166.83 15.65 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 107.74 -1.207 . . . . 63.44 107.74 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -57.39 174.75 1.91 Allowed Glycine 0 C--O 1.253 1.306 0 N-CA-C 115.705 1.042 . . . . 64.44 115.705 -176.404 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . -57.59 117.15 9.28 Favored Glycine 0 N--CA 1.437 -1.255 0 CA-C-N 114.217 -0.992 . . . . 55.32 113.783 -176.745 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 104.53 -15.06 50.13 Favored Glycine 0 N--CA 1.428 -1.859 0 N-CA-C 111.719 -0.552 . . . . 41.12 111.719 177.302 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -91.58 -63.65 1.22 Allowed 'General case' 0 CA--C 1.499 -1.009 0 CA-C-O 121.084 0.468 . . . . 74.52 110.422 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -107.39 -43.11 4.63 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.093 -0.958 . . . . 74.34 108.861 -176.286 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -133.79 155.83 49.1 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 107.313 -1.366 . . . . 75.52 107.313 175.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -85.17 128.98 34.88 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 105.532 -2.025 . . . . 71.14 105.532 177.395 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -54.78 108.47 0.4 Allowed 'General case' 0 CA--C 1.483 -1.627 0 O-C-N 123.474 0.484 . . . . 73.45 110.167 -177.617 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 556' ' ' THR . . . . . 0.44 ' HB ' HG23 ' A' ' 541' ' ' THR . 40.8 m -109.96 97.98 7.37 Favored 'General case' 1 N--CA 1.372 -4.326 0 C-N-CA 118.595 -1.242 . . . . 61.51 112.234 -175.453 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 24.2 p -137.1 134.25 36.26 Favored 'General case' 0 N--CA 1.418 -2.037 0 N-CA-C 107.399 -1.334 . . . . 70.13 107.399 174.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -176.83 -156.91 16.73 Favored Glycine 0 N--CA 1.418 -2.541 0 N-CA-C 110.08 -1.208 . . . . 72.53 110.08 -176.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -135.14 142.96 46.29 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.091 0.472 . . . . 75.31 110.978 -176.07 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 560' ' ' LEU . . . . . 0.516 HD13 ' HG2' ' A' ' 569' ' ' LYS . 93.6 mt -104.22 139.91 38.59 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.273 -0.876 . . . . 72.02 109.275 177.288 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -106.6 114.03 27.88 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 123.21 0.604 . . . . 71.43 110.784 -177.072 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 562' ' ' PHE . . . . . 0.554 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 36.3 m-85 -108.64 145.35 35.09 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 120.695 0.283 . . . . 75.23 110.386 173.333 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 563' ' ' GLN . . . . . 0.587 ' HB2' ' HB2' ' A' ' 566' ' ' GLU . 13.3 mm-40 -131.79 177.27 7.65 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 105.769 -1.938 . . . . 71.44 105.769 175.33 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -75.98 -30.46 58.58 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 121.111 0.481 . . . . 50.24 109.962 178.488 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -94.03 -22.84 18.28 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.259 0.552 . . . . 62.22 110.996 -179.29 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 566' ' ' GLU . . . . . 0.587 ' HB2' ' HB2' ' A' ' 563' ' ' GLN . 2.3 tm-20 -84.25 119.52 25.14 Favored 'General case' 0 C--O 1.245 0.84 0 N-CA-C 107.019 -1.475 . . . . 74.45 107.019 -177.665 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 567' ' ' ILE . . . . . 0.536 HG22 ' CZ ' ' A' ' 527' ' ' ARG . 6.2 pt -108.51 161.97 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.143 0 C-N-CA 120.65 -0.42 . . . . 74.44 111.047 -175.415 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 568' ' ' VAL . . . . . 0.445 HG22 ' H ' ' A' ' 569' ' ' LYS . 2.4 p 47.68 174.66 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.11 0 C-N-CA 126.421 1.889 . . . . 72.34 113.231 -179.161 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 569' ' ' LYS . . . . . 0.644 ' HE3' ' HA ' ' A' ' 569' ' ' LYS . 0.2 OUTLIER -156.25 156.98 35.02 Favored 'General case' 0 C--N 1.289 -2.045 0 O-C-N 120.797 -1.189 . . . . 64.43 107.986 176.057 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 570' ' ' THR . . . . . 0.688 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 4.4 p -134.3 131.74 38.76 Favored 'General case' 0 N--CA 1.412 -2.361 0 O-C-N 123.999 0.812 . . . . 63.02 110.765 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 2.8 mp -91.3 113.39 26.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 106.728 -1.582 . . . . 72.2 106.728 170.372 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 2.6 p -93.85 120.17 33.75 Favored 'General case' 0 C--N 1.29 -2.021 0 O-C-N 123.677 0.61 . . . . 52.24 109.859 177.404 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 573' ' ' VAL . . . . . . . . . . . . . 49.1 t -123.38 135.77 62.18 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 108.549 -0.908 . . . . 55.44 108.549 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -93.45 124.05 37.17 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-O 121.403 0.621 . . . . 71.51 109.836 175.372 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 61.5 t -89.51 141.76 13.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 N-CA-C 106.755 -1.572 . . . . 54.51 106.755 176.306 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 32.9 mm -105.78 158.21 6.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 107.672 -1.232 . . . . 63.12 107.672 -178.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -67.22 137.46 56.21 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.228 -1.027 . . . . 74.21 108.228 177.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.85 158.97 34.51 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 112.295 0.48 . . . . 63.13 112.295 -172.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.21 -12.73 1.4 Allowed 'General case' 0 CA--C 1.558 1.263 0 N-CA-C 116.141 1.904 . . . . 72.34 116.141 -172.479 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 580' ' ' GLU . . . . . 0.491 ' HG2' ' O ' ' A' ' 581' ' ' TYR . 0.1 OUTLIER -127.02 -171.02 2.32 Favored 'General case' 0 C--N 1.317 -0.838 0 O-C-N 121.164 -0.96 . . . . 73.12 110.138 -177.167 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 581' ' ' TYR . . . . . 0.491 ' O ' ' HG2' ' A' ' 580' ' ' GLU . 46.2 p90 -63.74 152.51 39.09 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 107.931 -1.136 . . . . 73.54 107.931 174.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -120.89 132.95 55.26 Favored 'General case' 0 C--N 1.288 -2.099 0 C-N-CA 118.824 -1.15 . . . . 72.44 114.076 -174.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -129.38 -165.95 1.59 Allowed 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 105.562 -2.014 . . . . 73.33 105.562 176.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -65.52 105.06 1.11 Allowed 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 106.855 -1.535 . . . . 75.34 106.855 172.589 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 585' ' ' LYS . . . . . 0.481 ' HD2' HD13 ' A' ' 646' ' ' ILE . 4.2 tmmm? -115.38 117.66 31.06 Favored 'General case' 0 N--CA 1.403 -2.79 0 N-CA-C 107.709 -1.219 . . . . 75.31 107.709 -175.55 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 3.4 t -142.39 147.2 35.83 Favored 'General case' 0 N--CA 1.404 -2.74 0 CA-C-N 114.688 -1.142 . . . . 63.05 110.029 -176.228 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -129.25 148.56 51.19 Favored 'General case' 0 N--CA 1.405 -2.687 0 CA-C-N 113.857 -1.52 . . . . 51.35 108.232 176.324 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 588' ' ' PHE . . . . . 0.512 ' HA ' ' O ' ' A' ' 642' ' ' LEU . 23.0 m-85 -104.8 141.54 36.31 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 109.356 -0.609 . . . . 73.31 109.356 -173.222 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 589' ' ' LEU . . . . . 0.527 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.5 OUTLIER -110.26 126.07 53.78 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 105.813 -1.921 . . . . 54.35 105.813 174.285 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -134.26 123.09 23.68 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 109.455 -0.572 . . . . 74.41 109.455 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 591' ' ' ILE . . . . . 0.431 HG22 ' HB3' ' A' ' 539' ' ' TYR . 20.9 pt -79.14 149.49 5.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 N-CA-C 108.0 -1.111 . . . . 71.54 108.0 173.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -93.23 -142.76 12.05 Favored Glycine 0 N--CA 1.425 -2.086 0 C-N-CA 121.008 -0.615 . . . . 53.33 112.693 -176.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -93.41 117.88 67.48 Favored Pre-proline 0 C--N 1.3 -1.584 0 N-CA-C 108.636 -0.876 . . . . 70.51 108.636 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 594' ' ' PRO . . . . . 0.603 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 30.2 Cg_endo -65.69 143.75 75.57 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 121.969 1.78 . . . . 53.54 110.714 177.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -123.83 135.86 54.02 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.888 -0.508 . . . . 52.21 110.483 -176.138 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.58 124.81 28.86 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 107.892 -1.151 . . . . 70.5 107.892 -178.252 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 65.9 t . . . . . 0 C--N 1.305 -1.349 0 N-CA-C 112.574 0.583 . . . . 64.33 112.574 -176.078 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.5 -0.977 0 N-CA-C 106.739 -1.578 . . . . 70.33 106.739 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 634' ' ' PRO . . . . . 0.603 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 10.9 Cg_endo -76.7 135.66 16.28 Favored 'Trans proline' 0 N--CA 1.419 -2.866 0 N-CA-C 106.936 -1.986 . . . . 75.12 106.936 164.057 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . 0.255 2.3 pp -118.71 170.12 8.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 114.001 1.112 . . . . 65.15 114.001 -178.236 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.07 164.98 25.94 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 114.898 -1.046 . . . . 53.43 112.051 -176.433 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -85.34 -114.68 0.77 Allowed Glycine 0 N--CA 1.441 -1.001 0 CA-C-N 115.284 -0.871 . . . . 72.42 112.942 -177.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -98.37 -68.72 0.79 Allowed 'General case' 0 N--CA 1.42 -1.928 0 C-N-CA 120.576 -0.45 . . . . 75.43 110.611 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 18.7 p80 -113.33 109.2 18.34 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 113.655 0.983 . . . . 73.32 113.655 -173.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 12.5 p -98.8 90.47 4.69 Favored 'General case' 0 N--CA 1.408 -2.54 0 N-CA-C 107.167 -1.42 . . . . 72.43 107.167 172.149 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -173.26 138.6 0.73 Allowed 'General case' 0 N--CA 1.424 -1.73 0 CA-C-N 114.393 -1.276 . . . . 73.44 107.685 -173.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 642' ' ' LEU . . . . . 0.549 ' CD2' HG21 ' A' ' 523' ' ' VAL . 42.1 tp -145.12 105.26 4.05 Favored 'General case' 0 C--N 1.274 -2.708 0 N-CA-C 107.494 -1.299 . . . . 61.13 107.494 173.516 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 643' ' ' GLU . . . . . 0.517 ' HB3' HG22 ' A' ' 511' ' ' VAL . 28.5 tt0 -92.87 100.5 12.95 Favored 'General case' 0 C--N 1.261 -3.248 0 N-CA-C 107.03 -1.47 . . . . 72.32 107.03 179.577 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 644' ' ' VAL . . . . . 0.531 HG21 ' HE1' ' A' ' 521' ' ' MET . 26.3 t -92.73 108.65 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.287 0 CA-C-N 115.792 -0.64 . . . . 60.12 109.396 -177.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 4.0 mp -94.05 118.42 39.94 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 N-CA-C 107.916 -1.142 . . . . 72.34 107.916 177.252 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 646' ' ' ILE . . . . . 0.488 HD12 ' N ' ' A' ' 646' ' ' ILE . 2.5 mp -104.46 112.17 36.97 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.451 0 N-CA-C 107.098 -1.445 . . . . 54.52 107.098 -175.177 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -115.45 149.35 38.18 Favored 'General case' 0 C--N 1.27 -2.863 0 C-N-CA 120.191 -0.604 . . . . 74.03 112.519 -177.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 23.1 tp10 -54.69 135.51 46.88 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.188 -1.369 . . . . 72.12 109.917 -177.46 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 C--O 1.237 0.403 0 O-C-N 124.209 0.943 . . . . 71.01 110.768 -176.856 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 12.1 t60 . . . . . 0 N--CA 1.45 -0.474 0 N-CA-C 108.875 -0.787 . . . . 72.11 108.875 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 502' ' ' ALA . . . . . 0.529 ' HB1' ' HA ' ' A' ' 634' ' ' PRO . . . 170.79 -70.4 0.0 OUTLIER 'General case' 0 CA--C 1.503 -0.839 0 C-N-CA 125.5 1.52 . . . . 74.01 107.635 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 503' ' ' GLY . . . . . 0.607 ' HA2' ' OG1' ' A' ' 528' ' ' THR . . . -161.3 142.79 8.32 Favored Glycine 0 N--CA 1.401 -3.667 0 CA-C-N 114.978 -1.01 . . . . 62.25 110.804 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 504' ' ' ILE . . . . . 0.412 ' H ' ' HA ' ' A' ' 528' ' ' THR . 3.7 mp -125.98 102.65 10.39 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 106.363 -1.718 . . . . 72.51 106.363 177.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -123.4 106.1 10.37 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 108.071 -1.085 . . . . 72.03 108.071 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 13.6 t -139.67 159.63 41.73 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 108.188 -1.041 . . . . 75.33 108.188 -176.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -84.64 153.6 23.05 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.429 -0.952 . . . . 63.23 108.429 175.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -77.53 -32.27 53.9 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.353 -0.98 . . . . 74.54 108.353 176.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -133.4 134.76 24.24 Favored Pre-proline 0 C--N 1.314 -0.942 0 N-CA-C 108.873 -0.788 . . . . 70.53 108.873 178.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -81.86 -16.54 8.81 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.401 2.067 . . . . 71.45 111.938 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 511' ' ' VAL . . . . . 0.461 HG22 ' HB3' ' A' ' 643' ' ' GLU . 69.7 t -136.61 131.96 48.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 107.824 -1.176 . . . . 64.33 107.824 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 6.3 t -133.93 139.61 46.24 Favored 'General case' 0 N--CA 1.406 -2.633 0 N-CA-C 108.501 -0.926 . . . . 75.23 108.501 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -109.46 124.43 51.04 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 109.737 -0.468 . . . . 75.21 109.737 178.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 15.5 m -127.13 157.55 38.58 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 107.905 -1.146 . . . . 62.04 107.905 -178.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 35.5 t -82.13 156.4 24.52 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 109.541 -0.54 . . . . 74.35 109.541 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -83.4 -7.94 59.48 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.26 -1.015 . . . . 63.13 108.26 174.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 14.0 t -98.78 15.71 24.52 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 115.688 -0.687 . . . . 63.23 109.298 -177.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 12.7 tt -99.62 161.47 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 N-CA-C 108.915 -0.772 . . . . 74.12 108.915 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 519' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . -94.9 -70.69 1.09 Allowed Glycine 0 N--CA 1.43 -1.753 0 N-CA-C 110.554 -1.018 . . . . 71.1 110.554 176.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 36.7 mm -114.73 126.24 72.24 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 C-N-CA 123.006 0.522 . . . . 74.51 109.668 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 521' ' ' MET . . . . . 0.701 ' HE2' HG21 ' A' ' 644' ' ' VAL . 0.0 OUTLIER -104.55 140.06 38.54 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.768 -1.197 . . . . 75.41 107.768 173.431 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -124.73 137.6 54.33 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 123.777 0.673 . . . . 73.4 111.021 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 523' ' ' VAL . . . . . 0.72 HG21 HD21 ' A' ' 642' ' ' LEU . 45.7 t -122.99 137.45 56.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 109.048 -0.723 . . . . 44.35 109.048 -179.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -80.92 131.72 35.37 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.66 0.743 . . . . 74.44 112.927 -177.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 6.7 t -114.76 134.39 57.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 CA-C-N 114.327 -1.306 . . . . 71.45 107.873 177.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -86.94 139.49 30.56 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.238 -1.023 . . . . 73.12 108.238 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 527' ' ' ARG . . . . . 0.417 ' CZ ' HG22 ' A' ' 567' ' ' ILE . 31.7 ttp180 -93.95 158.59 15.56 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 116.202 -0.454 . . . . 73.32 110.514 -173.294 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 528' ' ' THR . . . . . 0.607 ' OG1' ' HA2' ' A' ' 503' ' ' GLY . 5.1 t -56.38 145.82 26.12 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.746 -0.661 . . . . 71.32 111.448 176.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 23.8 t -81.61 -12.74 58.62 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 108.79 -0.818 . . . . 75.24 108.79 178.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -109.02 52.94 0.61 Allowed Glycine 0 N--CA 1.429 -1.767 0 N-CA-C 109.592 -1.403 . . . . 72.42 109.592 177.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -82.83 95.49 7.94 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-O 121.591 0.71 . . . . 74.42 109.129 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -133.78 25.02 4.01 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 114.854 -1.066 . . . . 73.43 111.665 -178.162 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 175.76 -169.5 42.21 Favored Glycine 0 N--CA 1.416 -2.644 0 C-N-CA 120.097 -1.049 . . . . 41.32 111.141 -174.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -102.23 121.85 43.06 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 122.887 0.475 . . . . 61.2 110.822 -176.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 535' ' ' VAL . . . . . 0.437 HG22 HD22 ' A' ' 596' ' ' LEU . 79.6 t -125.53 135.73 63.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 123.403 0.681 . . . . 63.31 109.651 -178.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 536' ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' A' ' 594' ' ' PRO . 22.8 mm -101.18 129.17 52.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 115.881 -0.6 . . . . 70.02 109.874 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 537' ' ' VAL . . . . . 0.473 HG22 ' HB3' ' A' ' 594' ' ' PRO . 33.2 t -122.15 105.57 36.95 Favored Pre-proline 0 C--N 1.319 -0.751 0 N-CA-C 108.715 -0.846 . . . . 64.51 108.715 176.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 538' ' ' PRO . . . . . 0.409 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 55.8 Cg_endo -73.01 152.05 50.93 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.068 1.845 . . . . 62.22 110.828 177.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 539' ' ' TYR . . . . . 0.455 ' O ' ' HA ' ' A' ' 557' ' ' CYS . 50.9 p90 -147.38 157.88 43.75 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.409 -0.589 . . . . 65.04 109.409 178.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -149.52 155.43 40.33 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 120.979 0.419 . . . . 62.22 111.17 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 10.4 p -96.4 113.39 24.97 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.062 -0.972 . . . . 63.24 110.871 176.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.403 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 3.6 mp -83.0 115.62 25.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 105.517 -2.031 . . . . 72.31 105.517 173.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 543' ' ' GLU . . . . . 0.453 ' HB3' ' O ' ' A' ' 546' ' ' ALA . 47.8 mt-10 -53.5 -49.84 66.66 Favored 'General case' 0 C--N 1.32 -0.686 0 O-C-N 124.156 0.91 . . . . 75.54 112.667 -174.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 70.26 -101.67 0.92 Allowed Glycine 0 N--CA 1.44 -1.098 0 C-N-CA 120.522 -0.847 . . . . 70.52 111.259 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 545' ' ' THR . . . . . 0.422 HG23 ' HB2' ' A' ' 585' ' ' LYS . 8.8 t -113.62 0.23 14.55 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.869 0.842 . . . . 62.21 109.295 178.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 546' ' ' ALA . . . . . 0.503 ' HB2' ' HG2' ' A' ' 585' ' ' LYS . . . -95.33 170.98 9.0 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 108.132 -1.062 . . . . 73.24 108.132 175.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 547' ' ' ARG . . . . . 0.483 ' H ' ' HB3' ' A' ' 552' ' ' ASP . 9.6 tpt180 -130.46 122.72 28.23 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 118.012 0.369 . . . . 64.1 110.189 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 548' ' ' GLY . . . . . 0.419 ' HA3' ' HB3' ' A' ' 555' ' ' ASP . . . -82.48 -166.4 38.46 Favored Glycine 0 C--N 1.306 -1.135 0 CA-C-N 116.01 -0.541 . . . . 61.44 111.868 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 78.83 13.93 82.58 Favored Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 120.948 -0.644 . . . . 62.13 112.587 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 84.37 13.92 72.45 Favored Glycine 0 N--CA 1.435 -1.373 0 C-N-CA 120.212 -0.994 . . . . 63.23 111.891 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -79.81 -69.92 0.55 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.4 0.619 . . . . 73.52 109.982 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 552' ' ' ASP . . . . . 0.633 ' OD2' 'CA ' ' A' ' 850' ' ' ' CA' . 8.4 t70 -109.41 -35.05 6.36 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 107.692 -1.225 . . . . 70.44 107.692 -176.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 553' ' ' PHE . . . . . 0.439 ' HA ' HG12 ' A' ' 576' ' ' ILE . 14.7 p90 -145.54 164.06 32.81 Favored 'General case' 0 N--CA 1.423 -1.817 0 CA-C-N 115.096 -0.956 . . . . 75.03 108.544 173.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 554' ' ' GLU . . . . . 0.463 ' HB3' ' HB3' ' A' ' 574' ' ' LYS . 1.0 OUTLIER -95.45 106.82 18.93 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 105.477 -2.046 . . . . 63.43 105.477 179.082 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 555' ' ' ASP . . . . . 0.419 ' HB3' ' HA3' ' A' ' 548' ' ' GLY . 3.4 p-10 -72.62 149.53 43.83 Favored 'General case' 0 CA--C 1.49 -1.333 0 CA-C-N 116.093 -0.503 . . . . 71.15 110.095 -174.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 5.6 t -139.57 131.6 27.9 Favored 'General case' 0 N--CA 1.403 -2.779 0 CA-C-O 121.669 0.747 . . . . 63.43 111.274 -177.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 557' ' ' CYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 539' ' ' TYR . 12.5 p -142.38 104.91 4.49 Favored 'General case' 0 N--CA 1.418 -2.037 0 N-CA-C 107.541 -1.281 . . . . 72.42 107.541 175.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -151.11 -149.33 5.02 Favored Glycine 0 N--CA 1.408 -3.171 0 N-CA-C 109.867 -1.293 . . . . 73.22 109.867 -176.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 559' ' ' GLU . . . . . 0.442 ' HB3' HG23 ' A' ' 536' ' ' ILE . 52.2 mt-10 -136.94 133.44 35.66 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 120.858 0.361 . . . . 73.51 110.715 -173.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 560' ' ' LEU . . . . . 0.455 HD22 ' CG ' ' A' ' 569' ' ' LYS . 92.1 mt -93.45 123.16 36.56 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.979 -1.119 . . . . 74.4 107.979 173.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -97.89 113.53 25.38 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 116.097 -0.501 . . . . 51.41 110.136 -177.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -103.99 144.36 31.64 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 109.639 -0.504 . . . . 61.43 109.639 176.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 563' ' ' GLN . . . . . 0.499 ' HB2' ' H ' ' A' ' 566' ' ' GLU . 42.7 mt-30 -136.56 179.85 6.11 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.059 -1.089 . . . . 74.33 108.059 -178.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 31.6 t30 -73.73 -34.77 64.93 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.669 -0.863 . . . . 64.01 108.669 176.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -87.64 -36.34 17.52 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 114.969 -1.014 . . . . 71.22 111.397 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 566' ' ' GLU . . . . . 0.499 ' H ' ' HB2' ' A' ' 563' ' ' GLN . 10.5 tp10 -77.33 117.08 18.48 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.77 -0.826 . . . . 74.22 108.77 178.237 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 567' ' ' ILE . . . . . 0.417 HG22 ' CZ ' ' A' ' 527' ' ' ARG . 6.5 pt -109.2 163.39 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.143 0 N-CA-C 109.317 -0.623 . . . . 63.22 109.317 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 568' ' ' VAL . . . . . 0.488 HG22 ' H ' ' A' ' 569' ' ' LYS . 2.3 p 44.49 -171.73 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.569 1.699 0 C-N-CA 125.543 1.537 . . . . 72.55 111.821 -177.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 569' ' ' LYS . . . . . 0.534 ' HA ' ' HE2' ' A' ' 569' ' ' LYS . 0.0 OUTLIER -173.3 158.41 3.56 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 107.142 -1.429 . . . . 75.21 107.142 174.78 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 570' ' ' THR . . . . . 0.604 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 24.1 p -134.37 137.73 44.33 Favored 'General case' 0 N--CA 1.423 -1.796 0 O-C-N 123.744 0.652 . . . . 71.34 109.316 175.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 571' ' ' ILE . . . . . 0.464 HG22 HG23 ' A' ' 573' ' ' VAL . 2.9 mp -88.29 114.31 26.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 106.148 -1.797 . . . . 72.52 106.148 171.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 9.4 p -95.81 111.88 23.75 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 123.215 0.322 . . . . 52.44 110.429 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 573' ' ' VAL . . . . . 0.464 HG23 HG22 ' A' ' 571' ' ' ILE . 46.9 t -118.82 137.69 51.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.33 -0.618 . . . . 74.52 109.33 -178.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 574' ' ' LYS . . . . . 0.463 ' HB3' ' HB3' ' A' ' 554' ' ' GLU . 38.7 ttmt -95.71 130.65 42.55 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 123.926 0.767 . . . . 72.24 110.218 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 58.9 t -95.76 143.63 11.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 107.852 -1.166 . . . . 73.14 107.852 176.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 576' ' ' ILE . . . . . 0.439 HG12 ' HA ' ' A' ' 553' ' ' PHE . 28.9 mm -112.16 161.12 11.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 108.154 -1.054 . . . . 72.03 108.154 -177.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -77.68 144.43 37.35 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.021 -0.733 . . . . 55.4 109.021 176.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 578' ' ' ASP . . . . . 0.611 ' OD2' 'CA ' ' A' ' 800' ' ' ' CA' . 3.2 m-20 -57.89 136.9 57.09 Favored 'General case' 0 CA--C 1.484 -1.562 0 N-CA-C 115.453 1.649 . . . . 74.24 115.453 -174.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 5.6 pm0 -107.06 -26.01 11.33 Favored 'General case' 0 N--CA 1.421 -1.876 0 CA-C-N 113.413 -1.721 . . . . 63.44 112.38 -176.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 580' ' ' GLU . . . . . 0.425 ' HG2' ' CD2' ' A' ' 581' ' ' TYR . 0.1 OUTLIER -110.38 -69.26 0.88 Allowed 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 112.753 0.649 . . . . 72.33 112.753 -170.002 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 581' ' ' TYR . . . . . 0.425 ' CD2' ' HG2' ' A' ' 580' ' ' GLU . 32.1 p90 -162.35 153.71 18.03 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 104.422 -2.436 . . . . 74.1 104.422 -176.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 582' ' ' GLU . . . . . 0.603 ' OE1' 'CA ' ' A' ' 800' ' ' ' CA' . 20.3 mt-10 -102.98 136.6 42.5 Favored 'General case' 0 C--N 1.274 -2.708 0 C-N-CA 117.604 -1.638 . . . . 73.11 115.23 -172.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 12.8 ptpt -153.62 167.06 30.82 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 113.239 -1.801 . . . . 74.03 106.177 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -86.52 123.4 31.69 Favored 'General case' 0 CA--C 1.488 -1.431 0 N-CA-C 105.656 -1.979 . . . . 71.04 105.656 169.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 585' ' ' LYS . . . . . 0.503 ' HG2' ' HB2' ' A' ' 546' ' ' ALA . 0.0 OUTLIER -121.66 173.67 7.3 Favored 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 108.691 -0.855 . . . . 72.54 108.691 -171.592 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 8.6 t -153.61 146.77 24.66 Favored 'General case' 0 N--CA 1.428 -1.531 0 C-N-CA 120.042 -0.663 . . . . 63.3 111.774 -174.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -130.96 149.8 52.41 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-N 114.237 -1.347 . . . . 73.1 109.891 177.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 588' ' ' PHE . . . . . 0.404 ' HA ' ' O ' ' A' ' 642' ' ' LEU . 25.7 m-85 -104.06 133.36 49.13 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.094 -0.706 . . . . 74.11 109.094 -176.057 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 589' ' ' LEU . . . . . 0.506 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.4 OUTLIER -106.01 123.77 48.52 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 105.895 -1.891 . . . . 70.43 105.895 175.845 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -130.71 145.66 51.99 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 107.615 -1.254 . . . . 73.13 107.615 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 591' ' ' ILE . . . . . 0.412 HG22 ' HB3' ' A' ' 539' ' ' TYR . 27.5 pt -106.05 152.48 7.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 108.934 -0.765 . . . . 71.23 108.934 178.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -97.97 -150.51 26.37 Favored Glycine 0 N--CA 1.429 -1.802 0 C-N-CA 120.792 -0.718 . . . . 64.15 112.873 -177.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.448 ' CB ' ' HA ' ' A' ' 617' ' ' PRO . 1.4 tm-20 -79.49 121.3 82.55 Favored Pre-proline 0 C--N 1.297 -1.681 0 C-N-CA 123.589 0.756 . . . . 71.4 111.426 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 594' ' ' PRO . . . . . 0.496 ' HA ' ' O ' ' A' ' 536' ' ' ILE . 68.7 Cg_endo -81.33 145.9 15.3 Favored 'Trans proline' 0 N--CA 1.43 -2.231 0 C-N-CA 121.817 1.678 . . . . 71.44 110.083 176.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 595' ' ' ARG . . . . . 0.416 ' HB3' ' OE2' ' A' ' 593' ' ' GLU . 14.2 ptp180 -136.7 143.75 43.53 Favored 'General case' 0 C--N 1.273 -2.733 0 CA-C-N 116.286 -0.416 . . . . 72.42 109.991 -177.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 596' ' ' LEU . . . . . 0.437 HD22 HG22 ' A' ' 535' ' ' VAL . 0.0 OUTLIER -77.25 126.83 31.57 Favored 'General case' 0 N--CA 1.416 -2.155 0 N-CA-C 106.001 -1.851 . . . . 72.31 106.001 179.469 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 43.6 t -71.61 -38.19 66.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 107.855 -1.165 . . . . 64.01 107.855 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -87.13 95.89 10.11 Favored 'General case' 0 N--CA 1.417 -2.104 0 N-CA-C 106.311 -1.737 . . . . 65.44 106.311 174.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 24.0 ptm -71.03 110.71 5.89 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.381 0.61 . . . . 54.21 111.285 -175.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 13.5 m -56.48 123.33 14.39 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 124.421 1.089 . . . . 62.21 111.444 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -85.81 90.6 8.09 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 108.696 -0.853 . . . . 73.23 108.696 177.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -88.69 121.88 31.53 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 106.349 -1.723 . . . . 72.13 106.349 178.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -79.68 86.71 5.26 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.241 0.543 . . . . 74.41 111.767 -173.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -87.76 -37.76 7.82 Favored Glycine 0 N--CA 1.432 -1.6 0 N-CA-C 109.486 -1.446 . . . . 42.44 109.486 175.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 120.03 -178.33 16.48 Favored Glycine 0 N--CA 1.426 -2.015 0 N-CA-C 111.357 -0.697 . . . . 63.04 111.357 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -68.54 122.95 19.54 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 109.97 -0.381 . . . . 73.51 109.97 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 5.8 p -129.53 154.4 47.07 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 115.998 -0.547 . . . . 74.41 109.973 176.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 52.3 mt -78.99 134.48 27.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 108.757 -0.831 . . . . 73.53 108.757 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 11.4 m 67.01 82.1 0.19 Allowed 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 124.463 1.105 . . . . 62.14 111.913 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -118.41 89.32 3.1 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.504 -1.295 . . . . 74.45 107.504 173.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -121.6 -176.56 3.34 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 114.557 -1.201 . . . . 70.44 108.39 -174.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -85.74 81.32 8.65 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 119.571 -0.852 . . . . 74.21 110.77 173.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -103.71 -141.04 0.36 Allowed 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 104.053 -2.573 . . . . 52.0 104.053 174.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 32.8 t70 64.29 20.02 12.01 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 122.416 1.103 . . . . 50.03 110.539 175.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 615' ' ' LYS . . . . . 0.456 ' HD3' ' H ' ' A' ' 615' ' ' LYS . 0.0 OUTLIER -84.05 -9.53 58.55 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-N 114.562 -1.199 . . . . 74.13 111.545 -175.074 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -78.16 140.05 61.16 Favored Pre-proline 0 C--N 1.307 -1.276 0 N-CA-C 109.272 -0.64 . . . . 52.51 109.272 178.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 617' ' ' PRO . . . . . 0.448 ' HA ' ' CB ' ' A' ' 593' ' ' GLU . 44.1 Cg_endo -71.39 -159.64 0.07 OUTLIER 'Trans proline' 0 C--O 1.247 0.968 0 C-N-CA 122.336 2.024 . . . . 70.53 111.175 178.217 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.462 ' H ' HD22 ' A' ' 618' ' ' LEU . 2.2 mm? -69.55 100.31 1.41 Allowed 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 107.044 -1.465 . . . . 65.13 107.044 178.084 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 5.4 p -141.57 7.27 1.91 Allowed 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 113.887 1.069 . . . . 74.53 113.887 -171.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 620' ' ' SER . . . . . 0.442 ' HB3' ' HB3' ' A' ' 626' ' ' ARG . 17.1 p -73.48 85.04 1.52 Allowed 'General case' 0 N--CA 1.437 -1.077 0 CA-C-O 122.539 1.161 . . . . 61.03 111.866 -179.247 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 621' ' ' LYS . . . . . 0.418 ' HB2' ' NZ ' ' A' ' 621' ' ' LYS . 4.7 ttmp? -108.9 -40.77 4.93 Favored 'General case' 0 N--CA 1.426 -1.652 0 CA-C-N 114.407 -1.269 . . . . 73.11 110.044 -174.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -118.84 -25.92 6.19 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.477 0.656 . . . . 62.21 109.58 178.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 623' ' ' GLU . . . . . 0.426 ' H ' ' CD ' ' A' ' 623' ' ' GLU . 0.7 OUTLIER -85.57 109.27 18.41 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-N 115.139 -0.937 . . . . 65.51 109.367 176.792 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -83.27 -27.74 29.63 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 115.58 -0.736 . . . . 64.24 110.635 -176.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -68.31 -30.58 69.61 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 111.952 0.353 . . . . 75.32 111.952 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 626' ' ' ARG . . . . . 0.442 ' HB3' ' HB3' ' A' ' 620' ' ' SER . 0.0 OUTLIER -70.03 -22.3 63.11 Favored 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 108.175 -1.046 . . . . 71.05 108.175 179.594 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 627' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -65.96 -29.59 70.01 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.146 -0.479 . . . . 62.12 110.413 178.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 86.1 mt -62.21 -45.28 99.11 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 N-CA-C 109.2 -0.667 . . . . 72.44 109.2 177.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 629' ' ' ALA . . . . . 0.635 ' O ' ' HG3' ' A' ' 633' ' ' ARG . . . -66.84 -45.36 78.45 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-N 115.009 -0.996 . . . . 73.11 110.242 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -65.15 -20.37 66.42 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.031 0.443 . . . . 73.21 111.855 -178.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 631' ' ' MET . . . . . . . . . . . . . 45.7 ttm -74.65 -28.47 60.87 Favored 'General case' 0 N--CA 1.427 -1.624 0 C-N-CA 123.362 0.665 . . . . 73.22 109.86 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -96.2 5.98 65.92 Favored Glycine 0 CA--C 1.508 -0.374 0 CA-C-N 115.742 -0.663 . . . . 21.25 111.66 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 633' ' ' ARG . . . . . 0.635 ' HG3' ' O ' ' A' ' 629' ' ' ALA . 6.3 mtp-105 -116.63 163.44 22.32 Favored Pre-proline 0 C--N 1.303 -1.445 0 N-CA-C 107.412 -1.329 . . . . 73.2 107.412 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.529 ' HA ' ' HB1' ' A' ' 502' ' ' ALA . 24.6 Cg_endo -76.1 155.76 37.99 Favored 'Trans proline' 0 N--CA 1.438 -1.776 0 C-N-CA 120.856 1.038 . . . . 64.32 110.07 168.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 635' ' ' ILE . . . . . 0.464 HD13 ' H ' ' A' ' 635' ' ' ILE . 0.2 OUTLIER -136.68 -173.54 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 107.798 -1.186 . . . . 53.0 107.798 179.438 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 636' ' ' LEU . . . . . 0.552 HD13 ' H ' ' A' ' 636' ' ' LEU . 0.0 OUTLIER -87.29 -179.77 6.47 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 123.291 0.37 . . . . 65.32 111.622 -178.93 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -99.69 -125.18 5.4 Favored Glycine 0 N--CA 1.438 -1.188 0 CA-C-N 116.175 -0.466 . . . . 23.32 113.983 -176.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -84.54 -71.4 0.52 Allowed 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 112.41 0.522 . . . . 75.42 112.41 -177.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -117.67 107.94 14.82 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 122.466 1.127 . . . . 64.33 112.436 -174.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 640' ' ' THR . . . . . 0.404 HG21 ' HB2' ' A' ' 636' ' ' LEU . 3.6 p -108.19 92.05 3.9 Favored 'General case' 0 N--CA 1.404 -2.747 0 CA-C-N 114.269 -1.332 . . . . 65.2 109.855 177.244 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 641' ' ' LYS . . . . . 0.454 ' HE2' ' HB2' ' A' ' 643' ' ' GLU . 1.2 tmtp? -178.33 129.44 0.13 Allowed 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 104.826 -2.287 . . . . 75.03 104.826 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 642' ' ' LEU . . . . . 0.72 HD21 HG21 ' A' ' 523' ' ' VAL . 42.6 tp -132.37 114.52 14.46 Favored 'General case' 0 C--N 1.274 -2.681 0 N-CA-C 108.692 -0.855 . . . . 71.55 108.692 177.206 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 643' ' ' GLU . . . . . 0.461 ' HB3' HG22 ' A' ' 511' ' ' VAL . 22.5 tt0 -99.05 104.81 16.87 Favored 'General case' 0 C--N 1.273 -2.734 0 N-CA-C 107.069 -1.456 . . . . 63.13 107.069 178.297 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 644' ' ' VAL . . . . . 0.701 HG21 ' HE2' ' A' ' 521' ' ' MET . 33.7 t -92.94 105.12 16.42 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 N-CA-C 108.551 -0.907 . . . . 75.4 108.551 -179.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 3.9 mp -88.94 115.08 28.16 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 N-CA-C 107.469 -1.308 . . . . 71.24 107.469 175.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 646' ' ' ILE . . . . . 0.468 HD12 ' N ' ' A' ' 646' ' ' ILE . 2.9 mp -95.48 106.43 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.453 0 N-CA-C 105.383 -2.08 . . . . 64.43 105.383 -178.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -97.95 132.15 43.78 Favored 'General case' 0 N--CA 1.399 -3.017 0 CA-C-N 115.249 -0.887 . . . . 64.33 109.275 -178.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 648' ' ' GLU . . . . . 0.647 ' OE1' 'CA ' ' A' ' 800' ' ' ' CA' . 15.2 tt0 -67.32 144.29 55.94 Favored 'General case' 0 N--CA 1.408 -2.527 0 N-CA-C 107.878 -1.156 . . . . 74.14 107.878 -177.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 23.1 t -49.5 118.73 2.93 Favored 'General case' 0 N--CA 1.444 -0.748 0 O-C-N 124.442 1.089 . . . . 73.11 113.342 -170.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -141.42 -68.35 0.39 Allowed 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 114.14 -1.391 . . . . 72.1 107.509 176.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 173.85 152.93 0.1 Allowed 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 104.569 -2.382 . . . . 73.03 104.569 -178.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -95.95 163.51 13.11 Favored 'General case' 0 C--N 1.265 -3.069 0 N-CA-C 108.923 -0.769 . . . . 71.3 108.923 -174.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt 75.44 6.25 4.06 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.938 1.295 . . . . 73.11 110.739 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 25.3 p -84.39 -43.88 14.27 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 115.335 -0.848 . . . . 65.33 109.608 -178.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 2.3 m -83.86 88.36 7.11 Favored 'General case' 0 N--CA 1.42 -1.955 0 N-CA-C 109.095 -0.705 . . . . 73.11 109.095 178.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 7.5 p -107.73 128.12 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.834 0 CA-C-N 115.468 -0.787 . . . . 73.43 109.726 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 10.0 t70 . . . . . 0 C--O 1.262 1.754 0 CA-C-N 115.621 -0.718 . . . . 63.43 109.804 -179.791 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 800' ' ' ' CA' . . . . . 0.647 'CA ' ' OE1' ' A' ' 648' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 850' ' ' ' CA' . . . . . 0.633 'CA ' ' OD2' ' A' ' 552' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 7.6 t60 . . . . . 0 N--CA 1.446 -0.629 0 N-CA-C 107.575 -1.268 . . . . 61.54 107.575 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -155.93 -39.38 0.08 Allowed 'General case' 0 C--N 1.308 -1.238 0 O-C-N 123.559 0.537 . . . . 41.13 109.79 178.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 503' ' ' GLY . . . . . 0.662 ' HA2' ' OG1' ' A' ' 528' ' ' THR . . . -174.55 131.84 2.09 Favored Glycine 0 N--CA 1.415 -2.735 0 C-N-CA 120.676 -0.773 . . . . 54.44 111.787 178.205 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 504' ' ' ILE . . . . . 0.413 ' H ' ' CB ' ' A' ' 528' ' ' THR . 4.1 mp -119.23 113.97 43.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 107.436 -1.32 . . . . 74.33 107.436 177.526 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -123.94 119.74 30.47 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 109.228 -0.656 . . . . 64.1 109.228 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 14.8 t -148.54 167.54 25.11 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.78 -0.452 . . . . 74.53 109.78 -174.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -99.66 162.33 13.08 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 107.441 -1.318 . . . . 75.44 107.441 173.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 508' ' ' GLU . . . . . 0.436 ' HG3' HD21 ' A' ' 526' ' ' LEU . 0.0 OUTLIER -103.18 -24.39 13.57 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.203 0.525 . . . . 75.3 111.314 176.245 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -116.66 122.96 30.98 Favored Pre-proline 0 N--CA 1.436 -1.152 0 N-CA-C 108.382 -0.97 . . . . 74.0 108.382 171.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -80.71 -9.96 13.17 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 121.961 1.774 . . . . 74.31 111.48 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 511' ' ' VAL . . . . . 0.435 HG22 ' HB3' ' A' ' 643' ' ' GLU . 75.3 t -141.28 135.96 32.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 107.521 -1.289 . . . . 74.44 107.521 -178.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 5.6 t -136.68 146.71 46.22 Favored 'General case' 0 N--CA 1.41 -2.439 0 N-CA-C 108.005 -1.109 . . . . 74.24 108.005 177.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -116.69 131.3 56.99 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.429 -0.582 . . . . 75.11 109.429 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 22.3 m -127.26 160.87 35.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 CA-C-N 115.762 -0.654 . . . . 73.13 109.753 -175.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 71.1 m -75.73 153.03 37.32 Favored 'General case' 0 N--CA 1.403 -2.803 0 CA-C-N 114.72 -1.127 . . . . 71.24 108.083 175.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -88.36 -24.8 23.01 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.054 -1.058 . . . . 63.35 111.121 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 23.3 t -102.6 70.16 1.12 Allowed 'General case' 0 N--CA 1.419 -1.982 0 N-CA-C 107.862 -1.162 . . . . 72.43 107.862 176.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 18.8 tt -135.85 152.47 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.503 0 N-CA-C 106.73 -1.582 . . . . 73.14 106.73 176.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -84.93 -59.21 2.0 Allowed Glycine 0 C--N 1.287 -2.154 0 C-N-CA 120.239 -0.982 . . . . 71.31 111.667 -178.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 36.5 mm -125.98 126.01 69.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 109.486 -0.561 . . . . 73.14 109.486 -178.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 521' ' ' MET . . . . . 0.741 ' HE1' HG21 ' A' ' 644' ' ' VAL . 0.0 OUTLIER -101.6 134.88 44.05 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 106.38 -1.711 . . . . 43.24 106.38 171.721 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -121.49 137.54 54.68 Favored 'General case' 0 C--N 1.308 -1.206 0 O-C-N 123.68 0.613 . . . . 72.14 110.523 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 523' ' ' VAL . . . . . 0.679 HG21 HD21 ' A' ' 642' ' ' LEU . 41.7 t -121.1 138.26 52.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 N-CA-C 108.119 -1.067 . . . . 63.3 108.119 179.177 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 524' ' ' LYS . . . . . 0.571 ' HD2' HG21 ' A' ' 568' ' ' VAL . 29.1 mmtp -88.16 116.07 26.1 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.867 0.841 . . . . 72.02 111.84 -176.144 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 22.9 t -97.19 135.62 30.77 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 CA-C-N 114.545 -1.207 . . . . 73.13 109.178 -178.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 526' ' ' LEU . . . . . 0.436 HD21 ' HG3' ' A' ' 508' ' ' GLU . 2.5 mm? -79.68 138.86 37.49 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 123.687 0.617 . . . . 63.43 109.804 -178.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 527' ' ' ARG . . . . . 0.508 ' HG2' ' N ' ' A' ' 528' ' ' THR . 50.5 ttp180 -86.29 160.28 19.18 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.274 -1.01 . . . . 72.21 108.274 178.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 528' ' ' THR . . . . . 0.662 ' OG1' ' HA2' ' A' ' 503' ' ' GLY . 5.3 t -65.43 146.76 54.48 Favored 'General case' 0 N--CA 1.412 -2.347 0 CA-C-N 115.657 -0.701 . . . . 74.25 110.388 172.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 38.0 t -62.37 -46.36 88.99 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-N 114.963 -1.017 . . . . 71.15 109.042 175.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -114.1 117.28 4.09 Favored Glycine 0 N--CA 1.415 -2.743 0 N-CA-C 109.914 -1.274 . . . . 64.42 109.914 -177.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 531' ' ' ALA . . . . . 0.432 ' HB2' HG23 ' A' ' 528' ' ' THR . . . -131.69 119.93 22.06 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 109.372 -0.603 . . . . 70.52 109.372 178.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -114.94 74.96 0.9 Allowed 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.559 -0.534 . . . . 75.54 109.559 175.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 533' ' ' GLY . . . . . 0.446 ' H ' ' HB3' ' A' ' 564' ' ' ASN . . . 124.92 -143.39 14.54 Favored Glycine 0 N--CA 1.433 -1.528 0 C-N-CA 120.38 -0.915 . . . . 52.12 112.628 177.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -114.25 134.01 55.24 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.031 -0.729 . . . . 72.11 109.031 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 535' ' ' VAL . . . . . 0.528 HG22 HD22 ' A' ' 596' ' ' LEU . 59.3 t -126.45 131.45 71.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 109.458 -0.571 . . . . 65.12 109.458 -178.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 536' ' ' ILE . . . . . . . . . . . . . 39.7 mm -98.89 125.92 52.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 109.061 -0.718 . . . . 61.31 109.061 178.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 537' ' ' VAL . . . . . 0.438 HG22 ' HB3' ' A' ' 594' ' ' PRO . 40.6 t -115.82 107.24 48.66 Favored Pre-proline 0 C--N 1.306 -1.325 0 CA-C-N 115.839 -0.619 . . . . 61.21 109.356 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -73.52 145.95 38.46 Favored 'Trans proline' 0 C--O 1.238 0.484 0 C-N-CA 122.539 2.159 . . . . 74.54 111.951 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 539' ' ' TYR . . . . . 0.492 ' HB3' HG22 ' A' ' 591' ' ' ILE . 43.7 p90 -147.96 161.3 41.61 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 109.34 -0.615 . . . . 72.23 109.34 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -157.9 153.95 27.12 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 109.237 -0.653 . . . . 73.41 109.237 177.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 2.7 p -90.76 128.75 36.79 Favored 'General case' 0 C--N 1.293 -1.886 0 O-C-N 123.625 0.578 . . . . 72.33 110.152 175.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.428 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 3.7 mp -95.05 117.92 40.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 106.244 -1.762 . . . . 75.2 106.244 174.16 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 543' ' ' GLU . . . . . 0.538 ' HB2' ' O ' ' A' ' 546' ' ' ALA 0.289 0.0 OUTLIER -60.89 -51.51 68.98 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 114.685 1.365 . . . . 64.32 114.685 -176.759 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 67.63 -79.95 0.17 Allowed Glycine 0 N--CA 1.448 -0.532 0 O-C-N 123.266 0.354 . . . . 70.31 113.833 175.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 7.9 t -125.64 -1.7 7.37 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 120.956 0.408 . . . . 44.12 110.325 -178.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 546' ' ' ALA . . . . . 0.538 ' O ' ' HB2' ' A' ' 543' ' ' GLU . . . -111.11 174.54 5.81 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 108.6 -0.889 . . . . 72.54 108.6 177.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 547' ' ' ARG . . . . . 0.483 ' H ' ' HB3' ' A' ' 552' ' ' ASP . 2.4 mpt_? -112.77 128.78 56.52 Favored 'General case' 0 CA--C 1.487 -1.454 0 CA-C-O 121.548 0.689 . . . . 71.53 112.414 -175.197 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -84.6 -174.16 50.2 Favored Glycine 0 C--N 1.277 -2.731 0 CA-C-N 114.052 -1.431 . . . . 61.24 112.532 -177.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 69.78 16.33 72.16 Favored Glycine 0 C--O 1.222 -0.644 0 N-CA-C 114.196 0.438 . . . . 55.01 114.196 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 84.5 6.21 86.06 Favored Glycine 0 N--CA 1.438 -1.208 0 C-N-CA 119.989 -1.101 . . . . 64.04 111.297 -177.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -74.12 -43.94 55.65 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 110.542 -0.17 . . . . 64.52 110.542 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 552' ' ' ASP . . . . . 0.667 ' OD1' 'CA ' ' A' ' 850' ' ' ' CA' . 10.2 t70 -132.27 -28.88 1.65 Allowed 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.577 -0.897 . . . . 54.31 108.577 175.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 553' ' ' PHE . . . . . 0.411 ' HA ' HG12 ' A' ' 576' ' ' ILE . 35.1 p90 -144.12 158.39 43.75 Favored 'General case' 0 C--O 1.249 1.053 0 N-CA-C 107.183 -1.414 . . . . 74.51 107.183 170.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -89.93 119.44 30.29 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 106.974 -1.491 . . . . 74.4 106.974 178.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -75.45 99.03 4.06 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-N 115.966 -0.561 . . . . 72.21 110.738 -176.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 556' ' ' THR . . . . . 0.485 ' CG2' HG22 ' A' ' 573' ' ' VAL . 10.1 t -89.8 97.03 10.96 Favored 'General case' 0 N--CA 1.41 -2.453 0 CA-C-O 123.295 1.521 . . . . 74.23 110.48 -178.504 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 1.6 p -109.4 106.62 16.47 Favored 'General case' 0 C--N 1.275 -2.65 0 CA-C-N 113.8 -1.545 . . . . 71.22 107.903 175.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -154.92 -157.84 8.42 Favored Glycine 0 N--CA 1.414 -2.804 0 N-CA-C 110.705 -0.958 . . . . 73.25 110.705 -174.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -142.77 131.24 22.33 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 109.584 -0.524 . . . . 55.42 109.584 -175.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 560' ' ' LEU . . . . . 0.403 ' HG ' ' CD1' ' A' ' 539' ' ' TYR . 95.1 mt -89.89 138.01 31.86 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.835 -0.62 . . . . 71.24 109.379 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -104.46 106.54 17.08 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 109.384 -0.598 . . . . 74.14 109.384 -179.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -100.08 132.22 45.57 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 109.9 -0.407 . . . . 60.04 109.9 177.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -116.43 160.81 20.02 Favored 'General case' 0 C--N 1.289 -2.06 0 C-N-CA 119.635 -0.826 . . . . 63.44 109.617 177.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 564' ' ' ASN . . . . . 0.446 ' HB3' ' H ' ' A' ' 533' ' ' GLY . 4.6 p-10 -69.93 -25.11 63.5 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 122.214 1.007 . . . . 73.4 109.545 176.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -90.85 -6.27 54.46 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.386 -1.279 . . . . 61.1 110.821 -178.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -118.96 154.82 32.41 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.899 -0.778 . . . . 22.22 108.899 -177.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 567' ' ' ILE . . . . . 0.416 ' HA ' ' HD3' ' A' ' 527' ' ' ARG . 9.4 pt -124.77 164.2 23.83 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 108.318 -0.993 . . . . 63.12 108.318 170.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 568' ' ' VAL . . . . . 0.571 HG21 ' HD2' ' A' ' 524' ' ' LYS . 1.5 p 49.97 155.5 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.576 1.944 0 C-N-CA 127.072 2.149 . . . . 75.04 115.734 179.025 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 569' ' ' LYS . . . . . . . . . . . . . 5.8 mmpt? -140.69 166.29 25.15 Favored 'General case' 0 CA--C 1.486 -1.487 0 N-CA-C 107.806 -1.183 . . . . 64.34 107.806 172.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 570' ' ' THR . . . . . 0.542 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 18.2 p -137.49 133.49 34.67 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 123.825 0.703 . . . . 70.52 110.603 175.371 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 3.1 mp -84.77 122.36 38.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 106.591 -1.633 . . . . 64.31 106.591 172.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 10.2 p -98.2 109.08 21.9 Favored 'General case' 0 N--CA 1.418 -2.074 0 N-CA-C 109.838 -0.43 . . . . 74.25 109.838 178.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 573' ' ' VAL . . . . . 0.485 HG22 ' CG2' ' A' ' 556' ' ' THR . 58.9 t -110.55 123.7 66.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 N-CA-C 109.869 -0.419 . . . . 73.53 109.869 178.505 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -77.91 113.23 15.6 Favored 'General case' 0 N--CA 1.433 -1.29 0 O-C-N 124.036 0.835 . . . . 74.32 109.067 175.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 57.1 t -87.24 130.32 37.27 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 107.624 -1.25 . . . . 60.2 107.624 177.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 576' ' ' ILE . . . . . 0.411 HG12 ' HA ' ' A' ' 553' ' ' PHE . 37.4 mm -94.98 150.04 4.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 108.312 -0.996 . . . . 74.21 108.312 -175.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -68.51 139.81 55.66 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.329 -0.619 . . . . 73.31 109.329 176.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 578' ' ' ASP . . . . . 0.616 ' OD1' 'CA ' ' A' ' 850' ' ' ' CA' . 0.3 OUTLIER -81.66 -177.74 6.67 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 112.898 0.703 . . . . 73.14 112.898 -173.264 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 579' ' ' GLU . . . . . 0.593 ' OE1' 'CA ' ' A' ' 850' ' ' ' CA' . 0.3 OUTLIER -166.71 -38.19 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.462 0 N-CA-C 114.566 1.321 . . . . 72.31 114.566 -173.19 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 580' ' ' GLU . . . . . 0.541 ' HG2' ' O ' ' A' ' 581' ' ' TYR . 0.1 OUTLIER -99.77 -168.08 1.55 Allowed 'General case' 0 C--O 1.25 1.104 0 C-N-CA 122.71 0.404 . . . . 74.21 111.887 -169.022 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 581' ' ' TYR . . . . . 0.541 ' O ' ' HG2' ' A' ' 580' ' ' GLU . 27.8 p90 -65.48 151.12 47.14 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 106.819 -1.549 . . . . 74.24 106.819 174.083 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -130.31 154.81 47.25 Favored 'General case' 0 N--CA 1.412 -2.338 0 C-N-CA 118.467 -1.293 . . . . 64.34 113.918 178.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -133.82 -174.51 3.55 Favored 'General case' 0 C--N 1.274 -2.692 0 N-CA-C 103.648 -2.723 . . . . 62.05 103.648 176.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -72.69 107.04 4.95 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.594 -1.261 . . . . 71.44 107.594 173.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 585' ' ' LYS . . . . . . . . . . . . 0.252 0.0 OUTLIER -113.28 143.7 43.97 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 119.921 -0.712 . . . . 73.02 111.351 -179.041 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 3.5 t -155.81 148.96 24.52 Favored 'General case' 0 N--CA 1.418 -2.072 0 CA-C-N 115.215 -0.902 . . . . 71.54 109.764 -172.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -120.14 142.15 49.2 Favored 'General case' 0 N--CA 1.414 -2.272 0 CA-C-N 114.576 -1.193 . . . . 74.42 109.665 176.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 588' ' ' PHE . . . . . 0.428 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 25.8 m-85 -98.92 133.5 43.11 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.561 -0.904 . . . . 65.33 108.561 -175.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 589' ' ' LEU . . . . . 0.522 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.5 OUTLIER -108.01 127.17 53.53 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 106.323 -1.732 . . . . 53.01 106.323 176.365 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -127.95 126.86 42.24 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 109.242 -0.651 . . . . 54.53 109.242 176.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 591' ' ' ILE . . . . . 0.492 HG22 ' HB3' ' A' ' 539' ' ' TYR . 17.0 pt -94.22 128.66 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 N-CA-C 106.351 -1.722 . . . . 74.52 106.351 171.257 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -93.35 -144.75 15.7 Favored Glycine 0 N--CA 1.431 -1.674 0 CA-C-N 115.793 -0.64 . . . . 63.11 114.386 -171.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -77.43 116.35 57.13 Favored Pre-proline 0 N--CA 1.435 -1.195 0 CA-C-N 114.635 -0.782 . . . . 71.14 109.155 -178.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 594' ' ' PRO . . . . . 0.438 ' HB3' HG22 ' A' ' 537' ' ' VAL . 78.1 Cg_endo -76.3 160.25 35.99 Favored 'Trans proline' 0 N--CA 1.446 -1.31 0 C-N-CA 122.475 2.117 . . . . 71.42 111.283 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 8.3 ptp85 -135.31 139.07 44.04 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 109.046 -0.724 . . . . 75.42 109.046 -178.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 596' ' ' LEU . . . . . 0.528 HD22 HG22 ' A' ' 535' ' ' VAL . 0.0 OUTLIER -83.39 129.19 34.98 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 105.954 -1.869 . . . . 75.45 105.954 179.242 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 69.7 t -71.56 -25.25 24.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-O 121.905 0.859 . . . . 73.44 110.393 -178.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -113.35 159.46 19.39 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.394 -0.965 . . . . 61.12 108.394 175.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 43.3 ttp -84.74 108.85 17.64 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 119.843 -0.743 . . . . 74.42 110.278 -178.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 600' ' ' SER . . . . . 0.452 ' OG ' ' HG ' ' A' ' 596' ' ' LEU . 59.9 m -75.55 112.94 12.42 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-N 116.035 -0.529 . . . . 60.4 112.049 176.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -144.22 142.41 30.48 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 105.504 -2.036 . . . . 71.24 105.504 172.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -119.59 -23.34 6.6 Favored 'General case' 0 C--N 1.289 -2.053 0 O-C-N 123.365 0.415 . . . . 53.24 110.625 -173.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -112.88 -73.3 0.67 Allowed 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 112.469 0.544 . . . . 73.11 112.469 -174.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -159.25 131.07 2.63 Favored Glycine 0 CA--C 1.487 -1.706 0 N-CA-C 110.282 -1.127 . . . . 71.33 110.282 -177.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . -70.65 118.03 7.44 Favored Glycine 0 N--CA 1.43 -1.76 0 O-C-N 123.893 0.408 . . . . 72.23 112.675 -177.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -67.4 -33.6 75.52 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.169 -1.049 . . . . 75.43 108.169 175.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 18.4 p -129.79 159.94 34.97 Favored 'General case' 0 N--CA 1.414 -2.246 0 N-CA-C 105.617 -1.994 . . . . 74.43 105.617 172.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 15.4 mt -84.43 16.94 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.971 0 CA-C-O 122.508 1.147 . . . . 70.41 109.402 -177.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 4.8 t -172.81 122.91 0.42 Allowed 'General case' 0 N--CA 1.428 -1.544 0 CA-C-N 114.989 -1.005 . . . . 73.23 109.666 178.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 610' ' ' GLU . . . . . 0.421 ' CD ' HH12 ' A' ' 633' ' ' ARG . 28.1 mt-10 -119.16 18.89 13.01 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.455 0.645 . . . . 71.45 109.485 174.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -66.57 104.35 1.26 Allowed 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.724 -1.213 . . . . 62.21 107.724 177.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 62.32 67.42 0.73 Allowed 'General case' 0 C--N 1.328 -0.365 0 O-C-N 124.772 1.295 . . . . 75.14 108.125 -175.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 613' ' ' ASP . . . . . 0.503 ' OD1' ' HD3' ' A' ' 633' ' ' ARG . 5.4 p-10 -79.95 -36.66 35.89 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.564 -0.744 . . . . 63.14 110.749 -177.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -132.37 108.97 9.52 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.464 -1.31 . . . . 70.43 107.464 177.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -93.49 77.4 4.41 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 112.616 0.599 . . . . 73.35 112.616 -173.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -135.46 157.74 75.87 Favored Pre-proline 0 C--N 1.295 -1.783 0 N-CA-C 107.302 -1.37 . . . . 75.31 107.302 173.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -62.94 -168.43 0.08 OUTLIER 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.697 2.265 . . . . 73.34 113.242 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -61.26 103.43 0.29 Allowed 'General case' 0 C--O 1.243 0.758 0 CA-C-N 115.676 -0.693 . . . . 74.43 110.506 -177.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 6.3 p -128.46 18.54 6.36 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 115.442 -0.799 . . . . 72.12 112.55 -172.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -100.78 32.89 2.97 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.022 -0.733 . . . . 74.3 109.022 -176.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 7.8 mtmp? -82.23 -54.56 5.16 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.815 0.672 . . . . 72.15 112.815 -171.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -86.48 -54.53 4.36 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 121.636 0.732 . . . . 73.3 111.339 -170.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 623' ' ' GLU . . . . . 0.422 ' H ' ' CD ' ' A' ' 623' ' ' GLU . 0.7 OUTLIER -89.58 146.1 24.8 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 114.66 -1.154 . . . . 64.54 111.493 -174.029 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -92.3 -16.43 26.08 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 115.654 -0.703 . . . . 75.32 110.071 178.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 625' ' ' GLU . . . . . 0.415 ' HG2' ' HB2' ' A' ' 623' ' ' GLU . 12.3 pt-20 -59.72 -33.08 71.16 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-O 121.411 0.624 . . . . 74.41 109.807 178.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 626' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -75.84 -33.43 60.04 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 115.296 -0.865 . . . . 74.23 109.886 178.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 627' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -67.05 -22.6 65.86 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.007 -0.542 . . . . 72.52 110.58 -178.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 628' ' ' ILE . . . . . 0.465 ' O ' ' HG2' ' A' ' 631' ' ' MET . 95.3 mt -64.06 -41.38 92.29 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.653 0 CA-C-N 115.866 -0.606 . . . . 73.4 109.958 175.303 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -69.12 -36.99 78.1 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-O 122.413 1.101 . . . . 74.24 108.324 177.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.93 12.69 0.64 Allowed 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 113.877 -1.511 . . . . 73.1 114.278 177.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 631' ' ' MET . . . . . 0.465 ' HG2' ' O ' ' A' ' 628' ' ' ILE . 21.3 ptp -80.98 -21.17 40.53 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 106.244 -1.761 . . . . 54.14 106.244 166.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -100.06 -37.05 3.98 Favored Glycine 0 N--CA 1.425 -2.095 0 CA-C-N 114.655 -1.157 . . . . 75.32 110.886 177.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 633' ' ' ARG . . . . . 0.503 ' HD3' ' OD1' ' A' ' 613' ' ' ASP . 0.0 OUTLIER -94.63 128.28 40.48 Favored Pre-proline 0 C--O 1.207 -1.135 0 N-CA-C 109.527 -0.546 . . . . 74.51 109.527 176.753 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -75.6 153.89 39.3 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 121.863 1.709 . . . . 54.11 111.754 178.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.3 pp -130.96 179.78 4.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.798 0.666 . . . . 64.43 112.798 -177.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 636' ' ' LEU . . . . . 0.401 HD22 ' O ' ' A' ' 637' ' ' GLY . 0.0 OUTLIER -76.71 153.4 35.13 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.793 -0.64 . . . . 74.35 109.473 -179.734 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 637' ' ' GLY . . . . . 0.401 ' O ' HD22 ' A' ' 636' ' ' LEU . . . -83.93 -135.72 2.93 Favored Glycine 0 C--N 1.304 -1.239 0 C-N-CA 120.917 -0.659 . . . . 71.32 114.18 -175.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -70.32 -56.97 5.41 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.168 0.508 . . . . 74.42 110.449 -176.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -148.26 122.53 9.6 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.429 0.633 . . . . 71.41 110.096 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 55.2 p -108.59 91.49 3.67 Favored 'General case' 0 N--CA 1.406 -2.665 0 CA-C-O 121.907 0.86 . . . . 62.43 109.118 178.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -166.39 130.19 2.06 Favored 'General case' 0 CA--C 1.491 -1.295 0 N-CA-C 107.81 -1.181 . . . . 64.41 107.81 -177.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 642' ' ' LEU . . . . . 0.679 HD21 HG21 ' A' ' 523' ' ' VAL . 29.3 tp -137.91 110.53 7.55 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 108.531 -0.914 . . . . 74.51 108.531 176.103 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 643' ' ' GLU . . . . . 0.435 ' HB3' HG22 ' A' ' 511' ' ' VAL . 36.8 tt0 -93.92 109.69 21.39 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 107.188 -1.412 . . . . 75.2 107.188 176.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 644' ' ' VAL . . . . . 0.741 HG21 ' HE1' ' A' ' 521' ' ' MET . 34.7 t -96.59 105.44 17.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 109.982 -0.377 . . . . 75.42 109.982 -177.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 3.7 mp -87.86 120.16 36.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 108.418 -0.956 . . . . 75.51 108.418 178.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 646' ' ' ILE . . . . . 0.493 HD12 ' H ' ' A' ' 646' ' ' ILE . 2.1 mp -101.7 107.47 21.62 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.746 0 N-CA-C 105.938 -1.875 . . . . 64.51 105.938 -177.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -110.53 145.92 36.93 Favored 'General case' 0 N--CA 1.406 -2.627 0 C-N-CA 120.273 -0.571 . . . . 70.24 110.294 -178.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -53.33 132.8 39.82 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.004 -0.998 . . . . 72.04 110.091 -178.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 3.6 m -56.88 124.01 17.06 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 124.444 1.098 . . . . 63.04 111.681 -173.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -151.42 -55.94 0.15 Allowed 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.383 -0.826 . . . . 73.44 110.058 -178.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 651' ' ' GLU . . . . . 0.614 ' HG2' ' H ' ' A' ' 652' ' ' PHE . 21.9 tt0 -164.6 -162.99 0.69 Allowed 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 105.565 -2.013 . . . . 75.44 105.565 -177.027 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 652' ' ' PHE . . . . . 0.614 ' H ' ' HG2' ' A' ' 651' ' ' GLU . 69.5 t80 -134.95 130.45 35.83 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.694 -1.224 . . . . 65.43 107.694 178.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -113.86 143.84 44.02 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 109.047 -0.723 . . . . 74.2 109.047 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 40.9 m -110.01 99.38 8.49 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 109.59 -0.522 . . . . 71.41 109.59 177.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 32.7 m -71.91 111.77 7.44 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.386 -0.825 . . . . 62.01 111.366 -176.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 35.4 m -98.92 155.16 3.93 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 N-CA-C 108.858 -0.793 . . . . 54.23 108.858 177.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 27.2 t70 . . . . . 0 C--N 1.3 -1.584 0 CA-C-N 116.482 -0.326 . . . . 73.12 110.291 -179.356 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 800' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 850' ' ' ' CA' . . . . . 0.667 'CA ' ' OD1' ' A' ' 552' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 50.2 t-80 . . . . . 0 N--CA 1.445 -0.685 0 N-CA-C 108.037 -1.098 . . . . 74.41 108.037 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -150.04 15.89 0.84 Allowed 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.76 0.315 . . . . 73.55 110.975 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 146.72 171.57 16.14 Favored Glycine 0 N--CA 1.419 -2.47 0 C-N-CA 119.912 -1.137 . . . . 35.24 112.624 179.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 504' ' ' ILE . . . . . 0.4 ' H ' ' CB ' ' A' ' 528' ' ' THR . 4.1 mp -122.75 114.81 43.83 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 108.54 -0.911 . . . . 74.23 108.54 178.222 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -128.88 98.75 5.06 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 107.753 -1.203 . . . . 74.32 107.753 174.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 15.4 t -134.99 156.83 48.36 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 116.044 -0.526 . . . . 73.43 109.679 -173.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -85.41 154.28 21.95 Favored 'General case' 0 CA--C 1.487 -1.476 0 N-CA-C 108.583 -0.895 . . . . 73.2 108.583 175.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -84.38 -26.92 28.02 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.099 -1.075 . . . . 73.33 108.099 173.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -111.26 121.22 41.03 Favored Pre-proline 0 N--CA 1.436 -1.174 0 CA-C-N 114.636 -1.165 . . . . 74.02 109.98 -178.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 510' ' ' PRO . . . . . 0.435 ' HA ' ' O ' ' A' ' 641' ' ' LYS . 56.2 Cg_endo -85.7 -18.48 3.77 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 121.206 1.271 . . . . 42.21 109.51 169.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 511' ' ' VAL . . . . . 0.542 HG22 ' HB3' ' A' ' 643' ' ' GLU . 67.6 t -149.32 131.13 5.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 C-N-CA 125.953 1.701 . . . . 61.45 106.972 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 14.9 t -130.49 143.73 50.95 Favored 'General case' 0 N--CA 1.421 -1.902 0 N-CA-C 107.676 -1.231 . . . . 73.25 107.676 177.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -109.76 131.99 54.56 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 107.504 -1.295 . . . . 63.54 107.504 178.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 24.7 m -130.19 154.89 41.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 CA-C-O 121.312 0.577 . . . . 72.24 110.077 -178.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 65.7 m -77.08 150.0 35.7 Favored 'General case' 0 N--CA 1.397 -3.103 0 CA-C-N 114.493 -1.23 . . . . 74.42 109.955 178.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 516' ' ' GLU . . . . . 0.627 ' OE2' 'CA ' ' A' ' 800' ' ' ' CA' . 37.9 tt0 -71.69 -29.3 64.43 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.813 0.816 . . . . 64.21 109.659 174.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 39.7 m -107.95 75.07 0.98 Allowed 'General case' 0 N--CA 1.418 -2.033 0 CA-C-O 122.129 0.966 . . . . 73.23 109.462 -177.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 13.3 tt -145.3 161.04 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.214 0 CA-C-N 113.069 -1.878 . . . . 71.42 106.027 176.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 519' ' ' GLY . . . . . 0.46 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . -92.51 -75.71 1.31 Allowed Glycine 0 N--CA 1.434 -1.449 0 C-N-CA 120.002 -1.094 . . . . 42.11 110.894 177.32 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 34.6 mm -107.68 127.03 63.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 109.866 -0.42 . . . . 75.22 109.866 -178.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 521' ' ' MET . . . . . 0.582 ' HE2' HG21 ' A' ' 644' ' ' VAL . 0.0 OUTLIER -102.95 139.99 37.8 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.075 -1.454 . . . . 72.34 107.075 172.103 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -113.7 155.67 25.15 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 121.419 0.628 . . . . 72.3 111.709 -176.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 523' ' ' VAL . . . . . 0.678 ' O ' ' HA ' ' A' ' 570' ' ' THR . 12.1 t -135.77 126.07 42.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 115.118 -0.947 . . . . 71.12 108.479 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 524' ' ' LYS . . . . . 0.54 ' HD2' HG21 ' A' ' 568' ' ' VAL . 31.2 mmtp -79.7 126.08 30.47 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.507 0.67 . . . . 54.53 112.088 -179.156 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 19.1 t -110.67 122.87 65.95 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 107.367 -1.346 . . . . 61.12 107.367 176.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -78.82 144.93 34.59 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.073 -0.714 . . . . 61.25 109.073 -178.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 527' ' ' ARG . . . . . 0.504 ' HD3' ' HA ' ' A' ' 567' ' ' ILE . 40.3 ttp180 -88.23 151.81 22.4 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.451 0.643 . . . . 64.32 110.764 -175.244 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 528' ' ' THR . . . . . 0.481 ' N ' ' HG2' ' A' ' 527' ' ' ARG . 4.6 t -59.97 139.63 57.29 Favored 'General case' 0 N--CA 1.418 -2.049 0 CA-C-N 114.514 -1.221 . . . . 62.45 110.525 172.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 23.3 t -73.92 -40.65 62.98 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 108.553 -0.906 . . . . 75.32 108.553 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -90.57 56.63 3.46 Favored Glycine 0 N--CA 1.434 -1.459 0 N-CA-C 110.392 -1.083 . . . . 64.11 110.392 177.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -70.14 99.88 1.56 Allowed 'General case' 0 CA--C 1.505 -0.767 0 C-N-CA 122.972 0.509 . . . . 64.01 110.884 -178.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -127.33 100.22 5.96 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 115.708 -0.678 . . . . 73.32 109.899 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 533' ' ' GLY . . . . . 0.561 ' H ' ' HB3' ' A' ' 564' ' ' ASN . . . 102.67 165.23 26.19 Favored Glycine 0 N--CA 1.42 -2.42 0 C-N-CA 120.695 -0.764 . . . . 41.11 113.161 177.255 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -79.72 123.11 27.38 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.383 -1.34 . . . . 74.41 107.383 176.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 535' ' ' VAL . . . . . 0.509 HG22 HD22 ' A' ' 596' ' ' LEU . 65.7 t -124.32 139.48 50.54 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-N 116.19 -0.459 . . . . 74.03 110.023 -175.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 536' ' ' ILE . . . . . 0.503 HG23 ' HB3' ' A' ' 559' ' ' GLU . 30.2 mm -104.24 139.18 25.94 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 109.014 -0.736 . . . . 63.33 109.014 178.064 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 41.9 t -118.4 108.53 41.58 Favored Pre-proline 0 C--N 1.306 -1.3 0 N-CA-C 109.474 -0.565 . . . . 73.23 109.474 177.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -73.93 138.85 26.47 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 122.117 1.878 . . . . 65.35 110.885 177.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 539' ' ' TYR . . . . . 0.443 ' HB3' HG22 ' A' ' 591' ' ' ILE . 46.0 p90 -146.46 161.47 40.35 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 120.804 -0.358 . . . . 73.34 110.531 -178.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 540' ' ' LYS . . . . . 0.41 ' HD2' ' O ' ' A' ' 540' ' ' LYS . 0.0 OUTLIER -155.31 147.65 23.87 Favored 'General case' 0 C--N 1.317 -0.807 0 O-C-N 123.518 0.511 . . . . 73.33 111.495 177.416 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 16.7 p -84.8 132.34 34.43 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 116.2 -0.455 . . . . 72.33 110.039 173.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.5 mp -93.63 124.22 46.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 106.271 -1.751 . . . . 72.54 106.271 173.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 543' ' ' GLU . . . . . 0.413 ' HB3' ' O ' ' A' ' 546' ' ' ALA . 2.7 mp0 -57.12 -52.67 64.36 Favored 'General case' 0 C--O 1.243 0.712 0 O-C-N 123.818 0.699 . . . . 73.5 110.765 -178.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 71.08 -81.91 0.44 Allowed Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 115.45 -0.795 . . . . 62.55 111.946 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 11.1 t -132.9 5.47 3.9 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.677 0.751 . . . . 74.33 109.806 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 546' ' ' ALA . . . . . 0.413 ' O ' ' HB3' ' A' ' 543' ' ' GLU . . . -106.2 178.83 4.45 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.841 -0.618 . . . . 33.35 109.612 178.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 547' ' ' ARG . . . . . 0.491 ' HD2' ' HB3' ' A' ' 551' ' ' GLU . 1.7 tmt_? -129.03 124.26 34.46 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 107.677 -1.231 . . . . 72.3 107.677 -175.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -82.9 -151.36 10.16 Favored Glycine 0 C--N 1.321 -0.264 0 C-N-CA 121.321 -0.466 . . . . 44.23 112.715 -177.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 66.6 19.4 69.01 Favored Glycine 0 C--N 1.314 -0.672 0 CA-C-N 116.689 0.244 . . . . 61.24 113.289 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 76.7 32.3 50.87 Favored Glycine 0 N--CA 1.437 -1.289 0 C-N-CA 120.748 -0.739 . . . . 50.33 111.614 -178.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 551' ' ' GLU . . . . . 0.491 ' HB3' ' HD2' ' A' ' 547' ' ' ARG . 8.1 tp10 -101.41 -65.75 0.96 Allowed 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.865 -0.42 . . . . 71.51 109.865 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -101.38 -34.05 9.76 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 106.526 -1.657 . . . . 73.4 106.526 177.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 553' ' ' PHE . . . . . 0.473 ' HA ' HG12 ' A' ' 576' ' ' ILE . 20.4 p90 -149.46 164.56 34.68 Favored 'General case' 0 N--CA 1.419 -2.023 0 CA-C-N 113.99 -1.459 . . . . 65.42 108.054 175.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 554' ' ' GLU . . . . . 0.515 ' HG3' ' HE2' ' A' ' 574' ' ' LYS . 0.5 OUTLIER -94.56 112.3 24.06 Favored 'General case' 0 C--N 1.282 -2.368 0 N-CA-C 105.805 -1.924 . . . . 73.31 105.805 176.983 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -76.94 101.06 5.8 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-O 122.525 1.155 . . . . 62.14 110.736 -175.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 556' ' ' THR . . . . . 0.47 ' CG2' HG22 ' A' ' 573' ' ' VAL . 8.9 t -91.44 121.8 33.47 Favored 'General case' 0 N--CA 1.396 -3.148 0 CA-C-O 122.395 1.093 . . . . 71.1 110.967 -178.067 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 10.4 p -136.83 119.25 15.79 Favored 'General case' 0 N--CA 1.41 -2.43 0 N-CA-C 106.56 -1.644 . . . . 72.44 106.56 177.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -170.12 -152.91 8.29 Favored Glycine 0 N--CA 1.415 -2.724 0 N-CA-C 110.596 -1.002 . . . . 72.52 110.596 -175.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 559' ' ' GLU . . . . . 0.503 ' HB3' HG23 ' A' ' 536' ' ' ILE . 34.7 mt-10 -135.03 127.47 30.48 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 122.364 0.265 . . . . 64.42 111.124 -176.145 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 96.1 mt -88.19 155.6 19.68 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.346 -0.612 . . . . 61.35 109.346 177.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -123.37 119.29 29.64 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-O 121.039 0.447 . . . . 74.22 111.471 -178.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -113.82 148.39 36.69 Favored 'General case' 0 CA--C 1.502 -0.881 0 C-N-CA 123.981 0.912 . . . . 75.33 109.492 176.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -127.87 167.55 16.43 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 120.243 -0.583 . . . . 72.43 109.45 177.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 564' ' ' ASN . . . . . 0.561 ' HB3' ' H ' ' A' ' 533' ' ' GLY . 32.1 p30 -66.87 -24.51 66.13 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.272 0.558 . . . . 22.45 111.142 178.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -102.72 -5.1 24.11 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.577 -0.738 . . . . 72.5 111.0 -177.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -115.35 134.86 54.72 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 116.4 -0.363 . . . . 72.41 110.599 -175.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 567' ' ' ILE . . . . . 0.504 ' HA ' ' HD3' ' A' ' 527' ' ' ARG . 9.5 pt -114.09 164.73 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 C-N-CA 120.969 -0.292 . . . . 51.11 110.267 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 568' ' ' VAL . . . . . 0.54 HG21 ' HD2' ' A' ' 524' ' ' LYS . 1.2 p 49.54 165.82 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.566 1.559 0 C-N-CA 127.301 2.24 . . . . 73.21 114.488 179.266 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 569' ' ' LYS . . . . . 0.512 ' HE3' ' HA ' ' A' ' 569' ' ' LYS . 1.0 OUTLIER -161.0 160.81 31.13 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 106.087 -1.82 . . . . 73.12 106.087 177.289 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 570' ' ' THR . . . . . 0.678 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 19.8 p -133.89 127.58 32.82 Favored 'General case' 0 N--CA 1.427 -1.601 0 O-C-N 123.478 0.486 . . . . 64.53 110.964 177.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 2.9 mp -76.62 125.45 36.4 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 107.016 -1.476 . . . . 70.14 107.016 173.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 24.4 m -99.44 109.37 21.94 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 120.859 0.361 . . . . 72.11 110.342 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 573' ' ' VAL . . . . . 0.47 HG22 ' CG2' ' A' ' 556' ' ' THR . 40.1 t -116.45 120.07 63.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 108.97 -0.752 . . . . 71.13 108.97 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 574' ' ' LYS . . . . . 0.515 ' HE2' ' HG3' ' A' ' 554' ' ' GLU . 38.8 ttpt -82.1 126.6 32.21 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-O 121.457 0.646 . . . . 75.23 110.938 177.321 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 82.5 t -91.51 134.84 28.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 107.982 -1.118 . . . . 55.0 107.982 178.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 576' ' ' ILE . . . . . 0.473 HG12 ' HA ' ' A' ' 553' ' ' PHE . 21.9 mm -105.69 160.05 5.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 107.475 -1.306 . . . . 72.13 107.475 -177.091 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -68.77 132.17 46.37 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 116.387 -0.37 . . . . 64.44 110.103 177.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 578' ' ' ASP . . . . . 0.603 ' OD1' 'CA ' ' A' ' 850' ' ' ' CA' . 0.9 OUTLIER -62.36 128.85 37.98 Favored 'General case' 0 CA--C 1.49 -1.342 0 CA-C-O 121.808 0.813 . . . . 64.24 111.405 -178.095 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 579' ' ' GLU . . . . . 0.602 ' OE2' 'CA ' ' A' ' 850' ' ' ' CA' . 0.0 OUTLIER -100.18 -0.82 38.04 Favored 'General case' 0 C--N 1.275 -2.642 0 CA-C-N 114.02 -1.445 . . . . 73.11 113.335 -175.231 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 580' ' ' GLU . . . . . 0.542 ' HG2' ' O ' ' A' ' 581' ' ' TYR . 0.5 OUTLIER -137.29 -174.93 3.89 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.93 -0.481 . . . . 64.41 110.706 -176.63 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 581' ' ' TYR . . . . . 0.542 ' O ' ' HG2' ' A' ' 580' ' ' GLU . 28.5 p90 -65.63 154.32 39.13 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 108.706 -0.85 . . . . 71.23 108.706 174.147 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -86.0 152.26 23.06 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 114.988 1.477 . . . . 74.03 114.988 -176.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -157.71 172.74 17.97 Favored 'General case' 0 N--CA 1.433 -1.283 0 C-N-CA 126.77 2.028 . . . . 75.34 105.611 176.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -80.77 97.68 7.43 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.075 -1.454 . . . . 75.13 107.075 176.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 585' ' ' LYS . . . . . 0.474 ' HD2' HD13 ' A' ' 646' ' ' ILE . 0.0 OUTLIER -113.68 136.0 53.32 Favored 'General case' 0 N--CA 1.416 -2.152 0 CA-C-N 115.365 -0.834 . . . . 71.12 110.363 -175.652 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 3.9 t -151.33 146.97 26.38 Favored 'General case' 0 N--CA 1.421 -1.917 0 CA-C-N 115.137 -0.938 . . . . 75.41 110.483 -174.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 587' ' ' PHE . . . . . 0.4 ' CE2' HD11 ' A' ' 646' ' ' ILE . 2.5 p90 -122.18 155.62 35.4 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 114.6 -1.182 . . . . 64.13 109.628 177.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 588' ' ' PHE . . . . . 0.514 ' HA ' ' O ' ' A' ' 642' ' ' LEU . 34.9 m-85 -110.71 145.73 37.51 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.721 -0.474 . . . . 71.34 109.721 -174.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -116.25 119.62 36.32 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 106.491 -1.67 . . . . 73.33 106.491 176.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -125.5 138.78 53.99 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 108.847 -0.797 . . . . 60.33 108.847 -178.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 591' ' ' ILE . . . . . 0.443 HG22 ' HB3' ' A' ' 539' ' ' TYR . 27.3 pt -103.73 151.03 6.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 108.502 -0.925 . . . . 71.03 108.502 176.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -93.72 -150.09 26.26 Favored Glycine 0 N--CA 1.427 -1.918 0 N-CA-C 110.855 -0.898 . . . . 64.14 110.855 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -86.3 119.63 71.7 Favored Pre-proline 0 C--N 1.301 -1.53 0 N-CA-C 108.552 -0.907 . . . . 73.53 108.552 178.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 594' ' ' PRO . . . . . 0.456 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 12.9 Cg_endo -57.47 149.13 68.09 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 122.37 2.047 . . . . 73.44 111.175 177.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -128.66 132.84 48.1 Favored 'General case' 0 C--N 1.291 -1.959 0 O-C-N 121.996 -0.44 . . . . 72.05 110.306 -173.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 596' ' ' LEU . . . . . 0.509 HD22 HG22 ' A' ' 535' ' ' VAL . 0.0 OUTLIER -77.43 128.12 33.7 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.671 -1.233 . . . . 71.15 107.671 -177.337 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 597' ' ' VAL . . . . . 0.459 ' CG2' HG12 ' A' ' 536' ' ' ILE . 52.2 t -76.25 -41.72 36.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-O 121.869 0.842 . . . . 73.41 109.373 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -85.49 129.33 34.84 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 114.671 -1.15 . . . . 72.22 110.321 -176.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 18.3 ptm -67.7 121.61 16.31 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-O 122.183 0.992 . . . . 71.41 110.731 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 8.8 p -118.51 88.94 3.02 Favored 'General case' 0 C--N 1.269 -2.908 0 CA-C-N 114.326 -1.307 . . . . 71.35 110.339 176.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -77.48 91.76 3.95 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-O 122.195 0.998 . . . . 72.32 108.332 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 602' ' ' LYS . . . . . 0.45 ' HG3' ' CD1' ' A' ' 606' ' ' PHE . 7.3 ptpp? -85.03 78.59 9.87 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-O 123.334 1.54 . . . . 63.2 112.132 -173.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 603' ' ' LYS . . . . . 0.432 ' HZ2' ' HB3' ' A' ' 603' ' ' LYS . 0.7 OUTLIER -79.36 157.58 27.61 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 112.683 -2.053 . . . . 72.14 111.327 -178.093 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 109.12 -54.6 0.54 Allowed Glycine 0 N--CA 1.428 -1.89 0 N-CA-C 108.113 -1.995 . . . . 72.51 108.113 -175.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . -92.56 -41.37 4.79 Favored Glycine 0 N--CA 1.428 -1.844 0 N-CA-C 109.721 -1.352 . . . . 72.0 109.721 174.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 606' ' ' PHE . . . . . 0.45 ' CD1' ' HG3' ' A' ' 602' ' ' LYS . 89.4 m-85 -97.16 153.65 17.85 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.313 -0.625 . . . . 73.25 109.313 175.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 11.8 p -85.93 -178.44 6.57 Favored 'General case' 0 C--N 1.292 -1.907 0 C-N-CA 123.658 0.783 . . . . 71.41 111.998 -175.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 23.1 mm -91.7 63.07 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 N-CA-C 105.343 -2.095 . . . . 62.44 105.343 175.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 609' ' ' THR . . . . . 0.429 HG22 ' HG2' ' A' ' 611' ' ' GLU . 52.3 m -150.34 137.81 19.71 Favored 'General case' 0 C--N 1.279 -2.472 0 CA-C-N 115.216 -0.902 . . . . 62.43 109.121 -173.114 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -102.65 80.78 1.95 Allowed 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 109.004 -0.739 . . . . 63.11 109.004 -177.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 611' ' ' GLU . . . . . 0.429 ' HG2' HG22 ' A' ' 609' ' ' THR . 72.7 mm-40 -136.56 154.21 50.76 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 116.345 -0.388 . . . . 71.05 110.122 -177.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 65.56 27.59 11.52 Favored 'General case' 0 CA--C 1.511 -0.551 0 O-C-N 124.407 1.067 . . . . 72.04 113.047 174.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -117.0 127.48 54.22 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 114.5 -1.227 . . . . 73.13 108.104 173.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -168.62 173.03 7.62 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 105.556 -2.016 . . . . 71.32 105.556 -177.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -85.24 72.19 10.77 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 119.221 0.918 . . . . 72.24 109.087 175.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -93.24 155.45 41.03 Favored Pre-proline 0 N--CA 1.433 -1.285 0 CA-C-N 114.631 -1.168 . . . . 72.02 109.673 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -79.35 -168.68 0.66 Allowed 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 122.171 1.914 . . . . 64.33 109.368 172.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -69.44 105.56 2.65 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 107.649 -1.241 . . . . 73.13 107.649 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 2.2 p -139.09 68.53 1.38 Allowed 'General case' 0 N--CA 1.435 -1.203 0 CA-C-O 121.451 0.643 . . . . 62.12 112.415 -172.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 620' ' ' SER . . . . . 0.459 ' OG ' ' HG3' ' A' ' 630' ' ' GLU . 2.0 m -88.04 -21.21 24.9 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.819 -0.628 . . . . 72.23 110.94 -175.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt 67.26 -65.09 0.24 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.891 1.276 . . . . 71.31 112.751 178.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 171.7 -40.15 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.941 1.296 . . . . 70.43 107.514 -176.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -47.85 127.07 11.4 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 113.381 -1.736 . . . . 64.35 111.72 -178.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -62.86 -39.78 95.47 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-N 116.171 -0.468 . . . . 65.3 110.05 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -56.73 -40.07 75.06 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 123.968 0.792 . . . . 64.13 109.105 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 626' ' ' ARG . . . . . 0.656 ' O ' ' HG2' ' A' ' 630' ' ' GLU . 1.9 tpp180 -72.62 -47.09 50.62 Favored 'General case' 0 C--O 1.193 -1.874 0 CA-C-N 115.371 -0.831 . . . . 74.33 109.307 -179.086 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 627' ' ' ARG . . . . . . . . . . . . . 39.4 mtm180 -53.66 -40.63 66.05 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.413 0.524 . . . . 73.2 112.413 178.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 98.2 mt -64.65 -41.76 93.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 120.873 0.368 . . . . 74.13 110.466 176.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -69.42 -36.19 76.46 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.263 -0.426 . . . . 72.43 111.214 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 630' ' ' GLU . . . . . 0.656 ' HG2' ' O ' ' A' ' 626' ' ' ARG . 20.3 mm-40 -61.99 -35.31 78.11 Favored 'General case' 0 C--O 1.212 -0.918 0 C-N-CA 123.191 0.596 . . . . 74.24 110.077 177.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 631' ' ' MET . . . . . . . . . . . . . 24.3 ptt? -89.69 7.1 38.41 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.678 0.751 . . . . 64.12 109.869 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -78.76 -21.38 68.89 Favored Glycine 0 N--CA 1.437 -1.3 0 N-CA-C 108.316 -1.914 . . . . 71.14 108.316 173.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 633' ' ' ARG . . . . . 0.41 ' CZ ' ' HA ' ' A' ' 630' ' ' GLU . 0.2 OUTLIER -110.13 151.34 42.47 Favored Pre-proline 0 N--CA 1.43 -1.442 0 N-CA-C 105.894 -1.891 . . . . 75.22 105.894 174.217 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.456 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 18.2 Cg_endo -63.17 144.81 92.88 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 121.203 1.268 . . . . 72.54 110.485 175.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.3 pp -122.48 169.25 14.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 113.46 0.911 . . . . 73.34 113.46 -177.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 636' ' ' LEU . . . . . 0.445 ' HB2' HG21 ' A' ' 640' ' ' THR . 0.0 OUTLIER -73.85 168.34 19.63 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 123.788 0.835 . . . . 62.5 112.106 -176.967 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -113.18 -157.51 12.72 Favored Glycine 0 N--CA 1.437 -1.282 0 N-CA-C 115.704 1.042 . . . . 72.05 115.704 -174.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -42.65 -59.32 1.96 Allowed 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 128.107 2.563 . . . . 64.33 114.751 -173.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 10.6 p80 -140.06 109.63 6.28 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 122.019 0.914 . . . . 63.34 111.812 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 640' ' ' THR . . . . . 0.445 HG21 ' HB2' ' A' ' 636' ' ' LEU . 11.0 p -114.61 91.71 3.71 Favored 'General case' 0 N--CA 1.411 -2.412 0 CA-C-N 115.008 -0.996 . . . . 71.52 111.102 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 641' ' ' LYS . . . . . 0.451 ' HE2' ' HB2' ' A' ' 643' ' ' GLU . 1.0 OUTLIER -175.23 137.25 0.39 Allowed 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 105.353 -2.091 . . . . 75.34 105.353 178.779 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 642' ' ' LEU . . . . . 0.514 ' O ' ' HA ' ' A' ' 588' ' ' PHE . 27.6 tp -135.31 114.14 11.94 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 108.775 -0.824 . . . . 74.43 108.775 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 643' ' ' GLU . . . . . 0.542 ' HB3' HG22 ' A' ' 511' ' ' VAL . 28.6 tt0 -98.31 110.04 22.69 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 107.127 -1.434 . . . . 74.1 107.127 176.248 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 644' ' ' VAL . . . . . 0.582 HG21 ' HE2' ' A' ' 521' ' ' MET . 22.0 t -97.46 102.08 13.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 109.77 -0.456 . . . . 63.23 109.77 -177.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 4.0 mp -89.15 120.18 37.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 N-CA-C 107.799 -1.186 . . . . 74.45 107.799 177.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 646' ' ' ILE . . . . . 0.474 HD13 ' HD2' ' A' ' 585' ' ' LYS . 2.8 mp -99.83 106.71 19.55 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.505 0 N-CA-C 106.724 -1.584 . . . . 74.54 106.724 -176.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -104.87 155.43 18.93 Favored 'General case' 0 C--N 1.279 -2.497 0 CA-C-O 121.237 0.541 . . . . 63.43 111.565 -177.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 648' ' ' GLU . . . . . 0.462 ' C ' ' H ' ' A' ' 650' ' ' TYR . 41.6 mm-40 -60.84 162.61 6.6 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.052 -0.976 . . . . 62.54 113.479 -174.224 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 8.3 t -85.52 40.11 0.82 Allowed 'General case' 0 CA--C 1.557 1.223 0 CA-C-O 123.184 1.469 . . . . 75.42 107.654 177.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 650' ' ' TYR . . . . . 0.462 ' H ' ' C ' ' A' ' 648' ' ' GLU . 1.2 t80 -85.1 -44.21 13.19 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 112.932 -1.94 . . . . 74.14 108.013 178.299 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -177.82 174.18 1.48 Allowed 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 100.961 -3.718 . . . . 74.04 100.961 -178.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -136.71 116.47 13.07 Favored 'General case' 0 C--N 1.263 -3.175 0 CA-C-N 118.682 0.673 . . . . 64.4 109.886 -175.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.32 174.65 8.8 Favored 'General case' 0 C--N 1.277 -2.55 0 CA-C-N 115.757 -0.656 . . . . 75.44 109.275 -179.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 50.8 m -148.1 76.82 1.39 Allowed 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 107.27 -1.382 . . . . 60.12 107.27 172.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 21.0 m -69.32 106.99 3.1 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 115.186 -0.915 . . . . 53.2 110.978 -176.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . 0.32 11.7 p 46.81 93.18 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.246 0.891 0 C-N-CA 126.455 1.902 . . . . 64.13 114.506 -178.312 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 . . . . . 0 C--N 1.306 -1.32 0 CA-C-N 114.137 -1.392 . . . . 70.4 109.573 -177.605 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 800' ' ' ' CA' . . . . . 0.627 'CA ' ' OE2' ' A' ' 516' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 850' ' ' ' CA' . . . . . 0.603 'CA ' ' OD1' ' A' ' 578' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 501' ' ' HIS . . . . . 0.511 ' HA ' ' O ' ' A' ' 631' ' ' MET . 6.2 p-80 . . . . . 0 C--O 1.241 0.608 0 N-CA-C 110.266 -0.272 . . . . 64.43 110.266 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -93.08 -49.07 6.19 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 108.167 -1.049 . . . . 72.32 108.167 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 503' ' ' GLY . . . . . 0.45 ' H ' ' HA ' ' A' ' 634' ' ' PRO . . . -164.4 -177.36 37.01 Favored Glycine 0 N--CA 1.406 -3.328 0 C-N-CA 119.258 -1.449 . . . . 71.21 114.128 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 4.0 mp -125.61 134.88 65.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 123.879 0.871 . . . . 74.0 108.927 -173.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -131.2 127.62 38.29 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.343 -0.614 . . . . 74.24 109.343 173.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 506' ' ' THR . . . . . 0.453 ' HB ' ' HA3' ' A' ' 637' ' ' GLY . 15.0 t -154.25 164.49 38.48 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 109.443 -0.577 . . . . 53.44 109.443 -177.334 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -94.8 157.67 15.83 Favored 'General case' 0 CA--C 1.493 -1.242 0 N-CA-C 108.647 -0.871 . . . . 74.14 108.647 175.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -93.75 -33.81 13.46 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 106.882 -1.525 . . . . 72.42 106.882 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -95.61 120.9 62.75 Favored Pre-proline 0 CA--C 1.49 -1.362 0 CA-C-N 114.285 -1.325 . . . . 60.34 110.097 175.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 510' ' ' PRO . . . . . 0.489 ' HA ' ' O ' ' A' ' 641' ' ' LYS . 2.7 Cg_exo -80.88 -20.88 7.33 Favored 'Trans proline' 0 N--CA 1.44 -1.643 0 N-CA-C 108.251 -1.48 . . . . 72.41 108.251 165.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 99.2 t -145.06 138.73 22.16 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 C-N-CA 124.876 1.27 . . . . 75.43 109.061 -178.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 10.1 t -137.02 138.99 41.08 Favored 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 107.025 -1.472 . . . . 62.2 107.025 175.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 75.7 m-70 -109.99 116.13 31.04 Favored 'General case' 0 CA--C 1.488 -1.414 0 N-CA-C 109.064 -0.717 . . . . 72.23 109.064 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.627 HG11 ' SD ' ' A' ' 521' ' ' MET . 33.4 m -109.18 155.58 10.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 CA-C-O 122.024 0.916 . . . . 55.11 112.226 -174.158 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 515' ' ' SER . . . . . 0.465 ' O ' HG22 ' A' ' 518' ' ' ILE . 51.0 m -77.89 156.88 30.07 Favored 'General case' 0 N--CA 1.389 -3.502 0 CA-C-N 113.597 -1.638 . . . . 72.42 110.286 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 516' ' ' GLU . . . . . 0.43 ' HB2' ' O ' ' A' ' 647' ' ' GLU . 20.8 tp10 -87.7 -18.68 28.95 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 107.847 -1.168 . . . . 73.32 107.847 177.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 30.4 m -96.66 18.37 14.43 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.601 -0.727 . . . . 71.41 110.739 -176.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 518' ' ' ILE . . . . . 0.465 HG22 ' O ' ' A' ' 515' ' ' SER . 13.9 tt -102.81 152.22 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.631 0 N-CA-C 108.388 -0.968 . . . . 75.41 108.388 -177.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -92.89 -70.05 1.14 Allowed Glycine 0 N--CA 1.424 -2.133 0 C-N-CA 119.832 -1.175 . . . . 42.01 110.777 176.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 42.6 mm -117.34 125.21 73.87 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 N-CA-C 108.657 -0.868 . . . . 75.31 108.657 -176.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 521' ' ' MET . . . . . 0.672 ' HE1' HG21 ' A' ' 644' ' ' VAL . 22.6 ptt? -95.96 136.55 36.25 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 107.322 -1.362 . . . . 74.12 107.322 172.18 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 29.3 mp0 -115.79 107.56 15.2 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 108.191 -1.04 . . . . 74.43 108.191 177.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 523' ' ' VAL . . . . . 0.543 HG21 HD21 ' A' ' 642' ' ' LEU . 35.0 t -98.03 128.05 49.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 109.582 -0.525 . . . . 70.13 109.582 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -73.87 156.61 37.53 Favored 'General case' 0 C--N 1.317 -0.837 0 O-C-N 123.71 0.631 . . . . 74.11 111.141 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 27.2 t -127.74 144.4 37.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 N-CA-C 107.067 -1.457 . . . . 54.04 107.067 176.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -75.74 140.0 42.17 Favored 'General case' 0 CA--C 1.493 -1.237 0 N-CA-C 109.363 -0.606 . . . . 73.32 109.363 177.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 527' ' ' ARG . . . . . 0.475 ' CZ ' HG22 ' A' ' 567' ' ' ILE . 35.8 ttt180 -91.03 147.22 23.23 Favored 'General case' 0 N--CA 1.414 -2.24 0 CA-C-N 115.238 -0.892 . . . . 73.14 109.246 -176.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 528' ' ' THR . . . . . 0.447 ' OG1' ' HA3' ' A' ' 503' ' ' GLY . 4.2 t -59.54 146.48 40.46 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 114.737 -1.12 . . . . 71.4 112.122 177.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 15.7 t -79.54 -15.6 57.41 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 108.128 -1.064 . . . . 72.15 108.128 176.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -118.75 93.76 0.57 Allowed Glycine 0 N--CA 1.432 -1.598 0 N-CA-C 109.396 -1.481 . . . . 72.25 109.396 176.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -102.17 93.37 5.19 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.393 0.616 . . . . 63.53 110.572 -177.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -116.52 115.03 25.01 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.738 -0.664 . . . . 74.05 111.698 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 77.64 -121.17 5.72 Favored Glycine 0 N--CA 1.435 -1.372 0 CA-C-N 115.208 -0.905 . . . . 73.2 113.275 173.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 534' ' ' ASN . . . . . 0.425 ' ND2' HG21 ' A' ' 597' ' ' VAL . 34.7 t30 -139.44 127.6 22.5 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.262 -1.014 . . . . 73.34 108.262 -178.275 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 535' ' ' VAL . . . . . 0.529 HG22 HD22 ' A' ' 596' ' ' LEU . 54.8 t -123.52 124.57 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.742 0 N-CA-C 109.496 -0.557 . . . . 63.53 109.496 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 536' ' ' ILE . . . . . 0.504 HG23 ' HB3' ' A' ' 559' ' ' GLU . 29.9 mm -93.66 120.53 43.21 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 CA-C-N 114.966 -1.015 . . . . 64.42 109.135 178.149 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 537' ' ' VAL . . . . . 0.436 HG22 ' HB3' ' A' ' 594' ' ' PRO . 21.9 t -113.84 104.57 55.06 Favored Pre-proline 0 C--N 1.303 -1.451 0 N-CA-C 109.242 -0.651 . . . . 74.34 109.242 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -70.79 153.05 64.39 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 121.961 1.774 . . . . 72.43 110.978 177.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 539' ' ' TYR . . . . . 0.407 ' CD1' ' HG ' ' A' ' 560' ' ' LEU . 52.7 p90 -150.97 159.93 44.25 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.021 -0.733 . . . . 72.43 109.021 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -155.15 154.98 33.14 Favored 'General case' 0 C--N 1.316 -0.851 0 O-C-N 123.721 0.638 . . . . 75.42 110.605 177.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 18.0 p -93.4 116.11 28.66 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.853 -0.612 . . . . 73.32 109.369 174.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.5 mp -83.35 122.29 37.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 105.608 -1.997 . . . . 72.44 105.608 174.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -51.86 -39.45 58.93 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.115 0.783 . . . . 71.42 113.115 -175.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 74.74 -86.68 0.75 Allowed Glycine 0 N--CA 1.437 -1.273 0 N-CA-C 110.521 -1.032 . . . . 65.23 110.521 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 11.3 t -143.17 14.07 1.84 Allowed 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 122.488 1.137 . . . . 70.03 108.899 177.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 546' ' ' ALA . . . . . 0.456 ' HB2' ' HD3' ' A' ' 585' ' ' LYS . . . -96.74 -167.64 1.59 Allowed 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 114.714 -1.13 . . . . 65.14 109.512 177.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 547' ' ' ARG . . . . . 0.489 ' H ' ' HB3' ' A' ' 552' ' ' ASP . 0.0 OUTLIER -136.23 122.79 20.88 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 106.97 -1.493 . . . . 74.14 106.97 -178.944 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -78.7 -153.97 7.42 Favored Glycine 0 C--N 1.303 -1.261 0 O-C-N 123.587 0.554 . . . . 41.2 112.802 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 63.92 10.5 39.59 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 114.909 0.723 . . . . 63.01 114.909 177.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 86.18 14.19 67.13 Favored Glycine 0 N--CA 1.433 -1.561 0 C-N-CA 120.285 -0.96 . . . . 50.54 112.02 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 551' ' ' GLU . . . . . 0.481 ' OE2' ' HG3' ' A' ' 547' ' ' ARG . 31.8 tt0 -84.59 -61.45 1.79 Allowed 'General case' 0 C--O 1.236 0.393 0 N-CA-C 109.574 -0.528 . . . . 74.32 109.574 178.391 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 552' ' ' ASP . . . . . 0.666 ' OD2' 'CA ' ' A' ' 850' ' ' ' CA' . 17.4 t70 -105.71 -36.95 6.9 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.628 -0.879 . . . . 74.54 108.628 177.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 553' ' ' PHE . . . . . 0.515 ' HA ' HG12 ' A' ' 576' ' ' ILE . 14.0 p90 -147.97 162.61 38.98 Favored 'General case' 0 N--CA 1.428 -1.525 0 N-CA-C 108.37 -0.974 . . . . 64.21 108.37 173.251 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -93.9 111.42 23.12 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 105.898 -1.89 . . . . 72.33 105.898 178.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -81.68 123.53 28.8 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-O 121.873 0.844 . . . . 71.42 110.419 -175.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 10.2 t -119.89 140.97 50.03 Favored 'General case' 0 N--CA 1.412 -2.338 0 CA-C-O 121.84 0.829 . . . . 63.3 110.664 -174.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 5.9 p -144.85 134.08 22.9 Favored 'General case' 0 N--CA 1.413 -2.324 0 N-CA-C 106.638 -1.615 . . . . 74.22 106.638 177.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -167.82 -153.87 8.34 Favored Glycine 0 N--CA 1.412 -2.954 0 C-N-CA 119.715 -1.231 . . . . 75.11 110.83 -175.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 559' ' ' GLU . . . . . 0.504 ' HB3' HG23 ' A' ' 536' ' ' ILE . 35.7 mt-10 -140.86 124.89 17.25 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 122.961 0.504 . . . . 74.03 109.828 -174.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 560' ' ' LEU . . . . . 0.407 ' HG ' ' CD1' ' A' ' 539' ' ' TYR . 95.4 mt -90.36 134.81 34.08 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 110.113 -0.329 . . . . 54.02 110.113 178.113 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -102.47 100.89 11.04 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.461 -0.791 . . . . 72.44 111.208 -176.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -99.62 144.63 28.49 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 109.202 -0.666 . . . . 72.03 109.202 174.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -138.78 171.28 14.57 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 109.82 -0.437 . . . . 73.03 109.82 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 19.4 p30 -64.72 -27.53 68.97 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 116.098 -0.501 . . . . 61.1 111.26 176.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -100.97 -23.88 14.44 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 116.159 -0.473 . . . . 62.51 111.783 177.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -85.38 128.56 34.76 Favored 'General case' 0 C--O 1.248 0.974 0 N-CA-C 110.227 -0.286 . . . . 75.21 110.227 -178.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 567' ' ' ILE . . . . . 0.475 HG22 ' CZ ' ' A' ' 527' ' ' ARG . 1.5 pp -116.42 138.49 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.024 0 N-CA-C 109.028 -0.73 . . . . 73.15 109.028 -179.143 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 568' ' ' VAL . . . . . 0.424 HG12 ' O ' ' A' ' 567' ' ' ILE . 1.4 p 58.66 153.75 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.153 0 C-N-CA 126.554 1.942 . . . . 62.34 113.88 177.172 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 569' ' ' LYS . . . . . 0.638 ' HA ' ' HE2' ' A' ' 569' ' ' LYS . 7.2 mmpt? -141.1 165.93 26.18 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.92 -0.77 . . . . 74.34 108.92 175.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 570' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 7.2 p -134.48 141.81 46.87 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 124.202 0.939 . . . . 73.21 110.886 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 2.7 mp -95.4 120.88 45.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 106.656 -1.609 . . . . 70.32 106.656 173.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 8.5 p -97.39 121.81 39.71 Favored 'General case' 0 N--CA 1.427 -1.618 0 O-C-N 123.683 0.615 . . . . 75.05 110.193 178.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 573' ' ' VAL . . . . . . . . . . . . . 52.1 t -130.51 134.72 61.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 N-CA-C 109.032 -0.729 . . . . 45.42 109.032 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -89.8 120.0 30.67 Favored 'General case' 0 C--O 1.248 0.985 0 O-C-N 123.705 0.628 . . . . 74.2 110.458 177.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 99.5 t -84.57 125.43 40.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 107.74 -1.207 . . . . 71.42 107.74 175.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 576' ' ' ILE . . . . . 0.515 HG12 ' HA ' ' A' ' 553' ' ' PHE . 31.1 mm -96.44 147.5 6.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 106.899 -1.519 . . . . 74.21 106.899 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -64.76 125.48 24.94 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 123.533 0.521 . . . . 53.33 110.387 -178.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 578' ' ' ASP . . . . . 0.631 ' OD1' 'CA ' ' A' ' 850' ' ' ' CA' . 3.1 m-20 -52.25 115.32 1.68 Allowed 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 114.636 1.347 . . . . 74.43 114.636 176.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 579' ' ' GLU . . . . . 0.648 ' OE1' 'CA ' ' A' ' 850' ' ' ' CA' . 0.0 OUTLIER -73.03 -38.16 66.63 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 112.633 -2.076 . . . . 74.32 109.035 176.07 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 580' ' ' GLU . . . . . 0.648 ' OE1' 'CA ' ' A' ' 850' ' ' ' CA' . 0.0 OUTLIER -124.98 -176.35 3.53 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 114.963 -1.017 . . . . 64.05 113.169 -176.818 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -52.74 153.71 3.1 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 126.159 1.784 . . . . 73.35 109.972 175.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 582' ' ' GLU . . . . . 0.507 ' OE2' ' HB ' ' A' ' 646' ' ' ILE . 33.1 tt0 -130.2 113.81 14.91 Favored 'General case' 0 C--N 1.287 -2.118 0 C-N-CA 119.05 -1.06 . . . . 73.42 111.988 178.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -89.26 -157.73 0.47 Allowed 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 106.285 -1.746 . . . . 71.34 106.285 173.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -75.19 76.69 2.33 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.392 -1.336 . . . . 65.41 107.392 171.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 585' ' ' LYS . . . . . 0.456 ' HD3' ' HB2' ' A' ' 546' ' ' ALA . 0.7 OUTLIER -104.42 128.96 52.41 Favored 'General case' 0 N--CA 1.402 -2.838 0 N-CA-C 107.715 -1.217 . . . . 73.31 107.715 -179.237 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 2.9 t -151.92 153.63 34.5 Favored 'General case' 0 N--CA 1.393 -3.276 0 CA-C-N 114.845 -1.07 . . . . 75.42 110.093 -172.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 587' ' ' PHE . . . . . 0.522 ' CE2' HD11 ' A' ' 646' ' ' ILE . 0.8 OUTLIER -119.92 148.77 43.1 Favored 'General case' 0 N--CA 1.422 -1.858 0 O-C-N 124.668 1.23 . . . . 75.13 108.648 175.365 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 588' ' ' PHE . . . . . 0.421 ' CD1' ' HE3' ' A' ' 641' ' ' LYS . 13.8 m-85 -107.26 133.18 52.2 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.769 -0.456 . . . . 72.42 109.769 -172.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 589' ' ' LEU . . . . . 0.469 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.3 OUTLIER -102.91 130.42 49.95 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 106.054 -1.832 . . . . 64.43 106.054 173.638 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -139.33 151.18 46.19 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 107.149 -1.426 . . . . 71.5 107.149 178.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 591' ' ' ILE . . . . . . . . . . . . . 23.4 pt -107.24 152.14 8.91 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 O-C-N 123.234 0.334 . . . . 73.12 110.18 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -95.7 -164.42 34.26 Favored Glycine 0 N--CA 1.435 -1.38 0 N-CA-C 111.648 -0.581 . . . . 64.34 111.648 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -68.74 114.77 24.75 Favored Pre-proline 0 C--O 1.248 1.011 0 C-N-CA 122.572 0.349 . . . . 71.41 110.067 -177.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 594' ' ' PRO . . . . . 0.579 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 39.3 Cg_endo -69.39 134.08 27.86 Favored 'Trans proline' 0 N--CA 1.439 -1.725 0 C-N-CA 121.816 1.677 . . . . 73.52 109.774 177.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -122.89 127.08 48.49 Favored 'General case' 0 C--N 1.282 -2.349 0 CA-C-O 121.218 0.532 . . . . 62.51 111.651 -172.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 596' ' ' LEU . . . . . 0.529 HD22 HG22 ' A' ' 535' ' ' VAL . 0.0 OUTLIER -75.31 125.79 29.68 Favored 'General case' 0 N--CA 1.428 -1.525 0 N-CA-C 106.82 -1.548 . . . . 72.42 106.82 -179.686 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 597' ' ' VAL . . . . . 0.425 HG21 ' ND2' ' A' ' 534' ' ' ASN . 94.7 t -72.42 -30.32 34.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 N-CA-C 112.38 0.511 . . . . 75.25 112.38 -176.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 598' ' ' GLU . . . . . 0.51 ' HG2' HD12 ' A' ' 596' ' ' LEU . 9.4 pt-20 -76.67 92.05 3.49 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 122.245 1.022 . . . . 73.42 113.341 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 91.6 mmm 60.64 78.68 0.27 Allowed 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 115.652 1.723 . . . . 73.34 115.652 174.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 21.1 m -82.4 98.38 8.83 Favored 'General case' 0 N--CA 1.419 -1.988 0 CA-C-O 122.308 1.052 . . . . 75.25 108.814 171.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -89.67 8.6 30.71 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.154 -1.385 . . . . 70.21 112.851 -172.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 602' ' ' LYS . . . . . 0.423 ' N ' ' HD3' ' A' ' 602' ' ' LYS . 0.1 OUTLIER 59.15 68.88 0.77 Allowed 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 109.054 -0.721 . . . . 74.55 109.054 -173.481 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 603' ' ' LYS . . . . . 0.413 ' HZ3' ' HB3' ' A' ' 603' ' ' LYS . 0.7 OUTLIER -87.75 62.85 7.2 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.474 -0.785 . . . . 64.14 112.1 -174.211 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 604' ' ' GLY . . . . . 0.524 ' HA3' ' O ' ' A' ' 613' ' ' ASP . . . -130.57 55.81 0.76 Allowed Glycine 0 N--CA 1.423 -2.228 0 CA-C-N 115.322 -0.854 . . . . 44.21 111.083 -178.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 155.11 -151.32 22.95 Favored Glycine 0 N--CA 1.424 -2.107 0 N-CA-C 110.846 -0.901 . . . . 64.45 110.846 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -121.33 163.52 18.51 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 106.76 -1.57 . . . . 74.24 106.76 178.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 1.9 p -83.51 147.04 28.03 Favored 'General case' 0 N--CA 1.416 -2.174 0 N-CA-C 113.302 0.853 . . . . 35.51 113.302 -178.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 49.5 mt 72.56 79.32 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 C-N-CA 125.892 1.677 . . . . 74.12 109.392 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 10.9 t 178.77 -175.15 0.2 Allowed 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 105.541 -2.022 . . . . 60.21 105.541 -178.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -107.5 -6.45 17.03 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 109.367 -0.605 . . . . 73.52 109.367 176.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -90.97 93.55 9.25 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.828 -0.624 . . . . 71.42 112.053 -174.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -133.17 93.56 3.19 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 107.516 -1.29 . . . . 73.11 107.516 175.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 613' ' ' ASP . . . . . 0.524 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 24.5 t70 -101.57 109.55 21.38 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.634 0.73 . . . . 71.44 112.004 -176.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 614' ' ' ASP . . . . . 0.417 ' OD2' ' HG2' ' A' ' 615' ' ' LYS . 18.1 t70 -151.85 172.39 16.26 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 104.922 -2.251 . . . . 61.55 104.922 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 615' ' ' LYS . . . . . 0.524 ' HE3' ' HA ' ' A' ' 615' ' ' LYS . 0.0 OUTLIER 72.47 14.23 5.32 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 123.925 0.89 . . . . 74.31 112.047 176.772 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -90.65 161.03 37.5 Favored Pre-proline 0 N--CA 1.43 -1.438 0 N-CA-C 107.703 -1.221 . . . . 64.5 107.703 172.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -56.24 174.73 0.31 Allowed 'Trans proline' 0 CA--C 1.546 1.115 0 C-N-CA 122.508 2.139 . . . . 55.43 111.748 172.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.472 ' HG ' ' HB2' ' A' ' 636' ' ' LEU . 3.1 mm? -66.49 163.4 18.6 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 116.415 -0.357 . . . . 63.42 111.639 -176.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 619' ' ' THR . . . . . . . . . . . . 0.399 32.3 p 72.33 131.93 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 125.855 1.662 . . . . 71.52 112.747 -175.055 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 620' ' ' SER . . . . . 0.489 ' OG ' ' HB3' ' A' ' 626' ' ' ARG . 2.3 t -73.28 -7.74 52.82 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 115.45 1.648 . . . . 63.15 115.45 -165.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 59.07 29.55 19.14 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 118.07 0.395 . . . . 74.44 111.496 175.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 74.93 -7.24 1.79 Allowed 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.997 1.319 . . . . 75.04 112.553 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -80.46 132.32 35.7 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 109.51 -0.552 . . . . 74.35 109.51 -179.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -88.57 -17.2 30.7 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 116.529 -0.305 . . . . 71.11 111.568 -176.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -70.0 -40.52 75.25 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.667 -1.234 . . . . 72.43 107.667 173.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 626' ' ' ARG . . . . . 0.489 ' HB3' ' OG ' ' A' ' 620' ' ' SER . 0.0 OUTLIER -64.13 -31.25 72.38 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.372 -1.285 . . . . 62.34 108.001 179.904 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 627' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -63.34 -31.11 72.18 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 116.145 -0.48 . . . . 72.22 112.087 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 82.6 mt -63.28 -43.74 98.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 108.299 -1.0 . . . . 55.01 108.299 177.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -67.5 -39.82 85.17 Favored 'General case' 0 C--O 1.192 -1.941 0 CA-C-N 114.741 -1.118 . . . . 54.23 110.078 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -58.56 -30.12 66.9 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.061 0.458 . . . . 64.35 111.374 178.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 631' ' ' MET . . . . . 0.511 ' O ' ' HA ' ' A' ' 501' ' ' HIS . 66.9 mtm -91.72 -27.04 18.31 Favored 'General case' 0 CA--C 1.491 -1.314 0 CA-C-O 121.313 0.577 . . . . 73.03 110.69 -179.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -85.84 -29.33 26.51 Favored Glycine 0 N--CA 1.407 -3.266 0 C-N-CA 119.834 -1.174 . . . . 73.1 112.525 -177.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.48 160.15 59.88 Favored Pre-proline 0 C--N 1.307 -1.244 0 C-N-CA 124.642 1.177 . . . . 70.11 111.69 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.579 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 8.0 Cg_endo -70.25 143.13 47.56 Favored 'Trans proline' 0 N--CA 1.432 -2.112 0 N-CA-C 105.815 -2.417 . . . . 73.22 105.815 162.091 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.0 pp -129.43 -178.28 2.41 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 N-CA-C 115.54 1.681 . . . . 73.03 115.54 -174.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 636' ' ' LEU . . . . . 0.472 ' HB2' ' HG ' ' A' ' 618' ' ' LEU . 2.5 tp -70.79 148.22 48.12 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 113.635 -1.62 . . . . 71.04 109.959 -178.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 637' ' ' GLY . . . . . 0.453 ' HA3' ' HB ' ' A' ' 506' ' ' THR . . . -89.39 -133.04 4.78 Favored Glycine 0 N--CA 1.423 -2.219 0 C-N-CA 120.631 -0.795 . . . . 52.12 111.698 174.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -98.09 -54.2 3.15 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 122.638 -0.331 . . . . 75.23 111.555 -175.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -124.58 93.98 4.06 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 122.285 1.04 . . . . 74.43 112.904 -178.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 3.1 p -100.7 91.21 4.53 Favored 'General case' 0 N--CA 1.404 -2.75 0 CA-C-N 114.545 -1.207 . . . . 73.22 108.992 174.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 641' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 510' ' ' PRO . 21.0 tptm -169.76 130.44 1.03 Allowed 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 106.992 -1.484 . . . . 74.43 106.992 -175.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 642' ' ' LEU . . . . . 0.543 HD21 HG21 ' A' ' 523' ' ' VAL . 41.5 tp -132.57 103.45 6.16 Favored 'General case' 0 C--N 1.272 -2.778 0 N-CA-C 107.225 -1.398 . . . . 74.42 107.225 175.231 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 643' ' ' GLU . . . . . 0.429 ' HB2' ' HE2' ' A' ' 641' ' ' LYS . 22.0 tt0 -91.4 104.91 17.37 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 107.196 -1.409 . . . . 71.31 107.196 178.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 644' ' ' VAL . . . . . 0.672 HG21 ' HE1' ' A' ' 521' ' ' MET . 21.6 t -92.4 99.03 9.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-N 115.904 -0.589 . . . . 64.12 110.085 -176.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 3.5 mp -87.6 127.12 41.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 107.928 -1.138 . . . . 74.31 107.928 177.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 646' ' ' ILE . . . . . 0.522 HD11 ' CE2' ' A' ' 587' ' ' PHE . 1.7 mp -101.58 141.62 17.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 106.691 -1.596 . . . . 72.3 106.691 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 647' ' ' GLU . . . . . 0.49 ' OE2' ' HB3' ' A' ' 650' ' ' TYR . 2.0 pt-20 -135.43 159.65 40.92 Favored 'General case' 0 C--N 1.264 -3.144 0 N-CA-C 107.38 -1.341 . . . . 74.43 107.38 178.379 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 648' ' ' GLU . . . . . 0.618 ' OE2' 'CA ' ' A' ' 800' ' ' ' CA' . 3.0 mp0 -72.62 77.1 1.09 Allowed 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 121.829 0.823 . . . . 61.12 110.296 174.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 4.3 t 28.56 85.93 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 129.372 3.069 . . . . 65.32 115.886 177.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 650' ' ' TYR . . . . . 0.49 ' HB3' ' OE2' ' A' ' 647' ' ' GLU . 32.1 t80 -96.18 -72.09 0.65 Allowed 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 107.65 -1.241 . . . . 65.04 107.65 169.116 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -175.55 164.5 3.08 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 107.905 -1.146 . . . . 65.22 107.905 -178.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -79.84 127.89 32.78 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 116.015 -0.539 . . . . 73.31 111.232 -177.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -141.57 150.7 42.41 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 123.828 0.851 . . . . 61.11 110.524 176.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 34.1 t -152.7 91.44 1.56 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 106.839 -1.541 . . . . 71.23 106.839 173.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 28.4 m -96.95 96.6 8.62 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.356 0.598 . . . . 70.53 110.197 -177.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 46.8 t -112.54 143.89 21.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 108.04 -1.096 . . . . 72.22 108.04 178.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 . . . . . 0 C--N 1.301 -1.533 0 N-CA-C 109.189 -0.671 . . . . 75.43 109.189 179.707 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 800' ' ' ' CA' . . . . . 0.63 'CA ' ' OD2' ' A' ' 578' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 850' ' ' ' CA' . . . . . 0.666 'CA ' ' OD2' ' A' ' 552' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 8.6 p-80 . . . . . 0 N--CA 1.451 -0.394 0 N-CA-C 108.596 -0.89 . . . . 74.43 108.596 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -136.44 6.72 3.03 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 109.322 -0.622 . . . . 54.44 109.322 174.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 503' ' ' GLY . . . . . 0.598 ' HA2' ' OG1' ' A' ' 528' ' ' THR . . . -160.46 148.11 15.91 Favored Glycine 0 N--CA 1.414 -2.825 0 C-N-CA 117.953 -2.07 . . . . 43.53 114.979 -178.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 4.0 mp -138.58 96.3 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 N-CA-C 105.624 -1.991 . . . . 51.03 105.624 171.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -120.86 108.32 13.78 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 108.869 -0.789 . . . . 71.03 108.869 178.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 11.4 t -139.26 160.81 38.93 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 108.02 -1.104 . . . . 72.15 108.02 -176.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -85.68 148.9 25.66 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.675 -0.491 . . . . 70.34 109.675 175.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -73.51 -31.23 63.59 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.435 -0.95 . . . . 73.32 108.435 177.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -138.72 135.89 18.23 Favored Pre-proline 0 N--CA 1.44 -0.964 0 N-CA-C 109.431 -0.581 . . . . 75.01 109.431 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -82.2 -13.04 10.28 Favored 'Trans proline' 0 C--O 1.218 -0.485 0 C-N-CA 122.671 2.247 . . . . 33.41 112.08 178.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 511' ' ' VAL . . . . . 0.545 HG22 ' HB3' ' A' ' 643' ' ' GLU . 70.6 t -140.63 137.66 35.79 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.858 0 N-CA-C 108.365 -0.976 . . . . 63.41 108.365 -178.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 4.9 t -143.6 137.06 28.07 Favored 'General case' 0 N--CA 1.419 -1.993 0 N-CA-C 107.925 -1.139 . . . . 73.25 107.925 177.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -106.82 126.49 52.37 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 109.106 -0.702 . . . . 75.12 109.106 176.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 29.1 m -126.92 161.47 33.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 115.751 -0.659 . . . . 64.21 109.373 -175.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 33.8 t -85.54 161.86 19.15 Favored 'General case' 0 N--CA 1.424 -1.759 0 N-CA-C 108.527 -0.916 . . . . 73.33 108.527 178.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -99.3 -11.83 20.89 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-O 121.376 0.608 . . . . 73.01 109.366 177.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 48.8 m -91.41 8.94 33.84 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.637 0.732 . . . . 70.13 109.885 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 13.6 tt -90.29 157.16 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 N-CA-C 108.122 -1.066 . . . . 65.01 108.122 -178.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -88.48 -57.07 1.91 Allowed Glycine 0 N--CA 1.438 -1.199 0 C-N-CA 120.201 -1.0 . . . . 61.34 111.282 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 520' ' ' ILE . . . . . 0.456 HD13 ' HA ' ' A' ' 574' ' ' LYS . 44.9 mm -127.39 136.65 60.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 108.778 -0.823 . . . . 43.33 108.778 -178.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 521' ' ' MET . . . . . 0.587 ' HE2' HG21 ' A' ' 644' ' ' VAL . 0.0 OUTLIER -111.03 133.28 53.54 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.077 -1.453 . . . . 72.1 107.077 171.103 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 -117.38 128.78 55.37 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 109.294 -0.632 . . . . 72.52 109.294 -176.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 523' ' ' VAL . . . . . 0.64 HG21 HD21 ' A' ' 642' ' ' LEU . 20.5 t -119.81 134.87 61.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 N-CA-C 109.746 -0.464 . . . . 65.05 109.746 179.101 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 524' ' ' LYS . . . . . 0.419 ' HD2' HG21 ' A' ' 568' ' ' VAL . 29.3 mmtp -80.39 129.45 34.51 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 113.792 1.034 . . . . 62.21 113.792 -177.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 3.3 t -112.46 133.5 58.02 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 N-CA-C 106.644 -1.613 . . . . 55.32 106.644 177.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -86.76 139.67 30.49 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 120.477 -0.489 . . . . 72.21 109.723 -178.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 527' ' ' ARG . . . . . 0.472 ' HG2' ' N ' ' A' ' 528' ' ' THR . 37.6 ttp180 -86.96 157.73 19.42 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.103 0.478 . . . . 65.04 111.176 -176.378 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 528' ' ' THR . . . . . 0.598 ' OG1' ' HA2' ' A' ' 503' ' ' GLY . 4.2 t -58.36 158.48 7.29 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 125.006 1.323 . . . . 71.21 111.674 173.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 32.8 t -87.94 -7.37 57.22 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 115.021 -0.99 . . . . 70.31 109.406 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -132.13 110.39 0.94 Allowed Glycine 0 N--CA 1.436 -1.324 0 N-CA-C 109.409 -1.476 . . . . 60.12 109.409 178.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 531' ' ' ALA . . . . . 0.408 ' HB2' HG23 ' A' ' 528' ' ' THR . . . -155.35 92.85 1.45 Allowed 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 109.3 -0.63 . . . . 65.22 109.3 -175.282 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.54 23.8 13.88 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 115.318 -0.856 . . . . 75.03 111.085 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . -177.26 -168.26 36.8 Favored Glycine 0 N--CA 1.42 -2.392 0 N-CA-C 110.461 -1.056 . . . . 64.12 110.461 -174.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 534' ' ' ASN . . . . . 0.406 ' HA ' ' HA ' ' A' ' 563' ' ' GLN . 51.1 t30 -85.37 132.82 34.17 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 123.482 0.713 . . . . 75.55 110.304 -177.153 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 535' ' ' VAL . . . . . 0.513 HG22 HD22 ' A' ' 596' ' ' LEU . 58.0 t -128.13 124.74 63.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 108.871 -0.789 . . . . 50.3 108.871 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 536' ' ' ILE . . . . . 0.506 HG23 ' HB3' ' A' ' 559' ' ' GLU . 19.7 mm -97.85 127.8 49.87 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 CA-C-N 115.921 -0.581 . . . . 62.04 109.931 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 537' ' ' VAL . . . . . 0.521 HG22 ' HB3' ' A' ' 594' ' ' PRO . 41.5 t -117.1 103.74 51.48 Favored Pre-proline 0 C--N 1.309 -1.187 0 N-CA-C 108.684 -0.858 . . . . 73.42 108.684 176.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -71.95 144.47 43.04 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.193 1.929 . . . . 63.12 110.769 178.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 539' ' ' TYR . . . . . 0.487 ' HB3' HG22 ' A' ' 591' ' ' ILE . 49.0 p90 -145.75 167.31 23.46 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 109.414 -0.587 . . . . 73.0 109.414 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -158.97 157.14 30.73 Favored 'General case' 0 C--N 1.308 -1.222 0 O-C-N 123.711 0.632 . . . . 74.53 109.781 177.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 3.3 p -93.17 113.6 25.88 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 115.143 -0.935 . . . . 55.31 110.546 175.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.3 mp -78.47 118.01 24.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 N-CA-C 104.781 -2.303 . . . . 70.04 104.781 173.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -53.65 -43.12 68.55 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 124.019 0.825 . . . . 52.14 112.76 -174.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 67.19 -89.71 0.17 Allowed Glycine 0 N--CA 1.451 -0.327 0 O-C-N 123.491 0.494 . . . . 71.51 112.258 176.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 7.4 t -137.2 20.06 2.97 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.3 0.571 . . . . 74.04 110.166 178.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 546' ' ' ALA . . . . . 0.434 ' HB2' ' HG2' ' A' ' 585' ' ' LYS . . . -119.37 166.41 13.08 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.465 -0.939 . . . . 74.14 108.465 175.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 547' ' ' ARG . . . . . 0.444 ' HB2' ' HB2' ' A' ' 551' ' ' GLU . 0.0 OUTLIER -95.72 114.04 25.74 Favored 'General case' 0 CA--C 1.488 -1.438 0 C-N-CA 120.012 -0.675 . . . . 71.23 112.643 176.872 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -94.77 108.81 3.74 Favored Glycine 0 C--N 1.291 -1.928 0 N-CA-C 110.061 -1.216 . . . . 74.52 110.061 178.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 154.43 8.76 0.08 OUTLIER Glycine 0 C--N 1.295 -1.735 0 C-N-CA 119.341 -1.409 . . . . 53.32 112.703 -178.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 109.3 5.18 30.42 Favored Glycine 0 N--CA 1.431 -1.649 0 C-N-CA 119.234 -1.46 . . . . 71.2 113.585 178.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 551' ' ' GLU . . . . . 0.444 ' HB2' ' HB2' ' A' ' 547' ' ' ARG . 15.2 mm-40 -84.29 -70.39 0.58 Allowed 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 117.614 0.707 . . . . 63.24 109.212 177.26 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 552' ' ' ASP . . . . . 0.592 ' OD1' 'CA ' ' A' ' 850' ' ' ' CA' . 13.8 m-20 -101.31 -39.56 7.54 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 108.276 -1.009 . . . . 62.12 108.276 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -139.33 160.88 38.8 Favored 'General case' 0 C--O 1.262 1.715 0 CA-C-O 121.238 0.542 . . . . 71.12 109.617 179.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.21 119.28 29.56 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 106.675 -1.602 . . . . 72.4 106.675 179.265 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -67.06 101.81 0.92 Allowed 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 122.979 0.512 . . . . 73.55 109.671 -178.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 556' ' ' THR . . . . . 0.509 HG21 HG22 ' A' ' 573' ' ' VAL . 12.4 t -100.78 110.75 22.87 Favored 'General case' 0 N--CA 1.413 -2.308 0 CA-C-O 122.689 1.233 . . . . 72.03 110.779 -176.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 1.7 p -133.39 96.69 3.78 Favored 'General case' 0 N--CA 1.413 -2.297 0 CA-C-N 114.234 -1.348 . . . . 62.33 108.66 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -147.03 -153.33 5.88 Favored Glycine 0 N--CA 1.408 -3.167 0 N-CA-C 110.518 -1.033 . . . . 61.04 110.518 -173.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 559' ' ' GLU . . . . . 0.506 ' HB3' HG23 ' A' ' 536' ' ' ILE . 33.3 mt-10 -133.73 124.64 27.02 Favored 'General case' 0 C--N 1.29 -2.001 0 O-C-N 123.605 0.238 . . . . 61.04 111.289 -172.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 560' ' ' LEU . . . . . 0.455 ' HG ' ' CD2' ' A' ' 539' ' ' TYR . 93.2 mt -80.99 133.03 35.42 Favored 'General case' 0 C--O 1.247 0.929 0 N-CA-C 109.765 -0.457 . . . . 64.0 109.765 177.109 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -96.78 98.19 9.94 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 115.986 -0.552 . . . . 74.32 111.475 -178.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -96.98 150.88 20.27 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 107.004 -1.48 . . . . 71.55 107.004 172.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 563' ' ' GLN . . . . . 0.406 ' HA ' ' HA ' ' A' ' 534' ' ' ASN . 1.9 pt20 -156.53 172.7 18.08 Favored 'General case' 0 C--N 1.28 -2.434 0 O-C-N 121.926 -0.484 . . . . 72.11 111.044 -178.205 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -52.14 -47.15 65.54 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 124.687 1.195 . . . . 62.02 111.012 -177.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -90.15 4.84 49.25 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 114.061 1.134 . . . . 75.21 114.061 -177.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 24.8 tp10 -121.79 126.63 49.27 Favored 'General case' 0 C--N 1.309 -1.189 0 O-C-N 121.76 -0.587 . . . . 74.41 110.555 -178.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 567' ' ' ILE . . . . . 0.456 ' HA ' ' HD3' ' A' ' 527' ' ' ARG . 4.9 pt -111.39 159.72 11.18 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.868 0 N-CA-C 109.266 -0.642 . . . . 72.32 109.266 174.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 568' ' ' VAL . . . . . 0.419 HG21 ' HD2' ' A' ' 524' ' ' LYS . 1.4 p 50.14 176.28 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.57 1.748 0 C-N-CA 125.955 1.702 . . . . 73.03 111.487 -176.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 569' ' ' LYS . . . . . 0.575 ' HE3' ' HA ' ' A' ' 569' ' ' LYS . 0.0 OUTLIER -165.72 167.83 16.71 Favored 'General case' 0 C--N 1.313 -1.017 0 O-C-N 120.911 -1.118 . . . . 73.4 108.28 173.941 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 570' ' ' THR . . . . . 0.612 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 7.1 p -132.28 138.66 47.94 Favored 'General case' 0 N--CA 1.421 -1.881 0 O-C-N 123.719 0.637 . . . . 71.4 109.971 179.003 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 571' ' ' ILE . . . . . 0.407 HG21 HD21 ' A' ' 589' ' ' LEU . 3.3 mp -90.66 117.07 33.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 106.618 -1.623 . . . . 74.23 106.618 170.332 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 15.7 p -95.29 110.8 22.75 Favored 'General case' 0 N--CA 1.426 -1.646 0 CA-C-O 121.059 0.457 . . . . 74.03 109.892 177.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 573' ' ' VAL . . . . . 0.509 HG22 HG21 ' A' ' 556' ' ' THR . 48.6 t -108.73 132.29 57.08 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 N-CA-C 109.113 -0.699 . . . . 54.12 109.113 -179.324 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 574' ' ' LYS . . . . . 0.456 ' HA ' HD13 ' A' ' 520' ' ' ILE . 22.3 tptm -86.91 119.74 27.45 Favored 'General case' 0 N--CA 1.434 -1.262 0 O-C-N 123.569 0.543 . . . . 75.14 110.463 179.03 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 56.3 t -89.91 132.87 33.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 106.674 -1.602 . . . . 71.11 106.674 175.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 39.5 mm -94.32 153.36 3.45 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 N-CA-C 109.16 -0.682 . . . . 64.11 109.16 -173.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -61.73 106.36 0.67 Allowed 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.582 -0.896 . . . . 72.51 108.582 172.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 578' ' ' ASP . . . . . 0.658 ' OD2' 'CA ' ' A' ' 800' ' ' ' CA' . 44.1 t0 -62.29 142.18 57.88 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 113.944 -1.48 . . . . 70.31 112.949 -169.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -80.18 -51.91 8.39 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.844 0.83 . . . . 72.21 110.052 -177.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.64 -156.27 0.69 Allowed 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.803 -0.814 . . . . 70.55 108.803 -176.24 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -113.51 150.28 33.15 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 105.557 -2.016 . . . . 73.01 105.557 172.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 582' ' ' GLU . . . . . 0.645 ' OE1' 'CA ' ' A' ' 800' ' ' ' CA' . 41.1 mp0 -126.68 -174.43 3.13 Favored 'General case' 0 C--N 1.282 -2.365 0 N-CA-C 108.785 -0.82 . . . . 64.23 108.785 176.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -85.64 -158.75 0.41 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 106.633 -1.617 . . . . 54.33 106.633 174.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -85.63 79.81 9.23 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 106.437 -1.69 . . . . 71.03 106.437 173.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 585' ' ' LYS . . . . . 0.434 ' HG2' ' HB2' ' A' ' 546' ' ' ALA . 0.0 OUTLIER -88.55 168.03 12.92 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 115.411 -0.813 . . . . 64.44 110.131 -172.86 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 5.0 t -155.29 149.92 26.33 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-O 121.742 0.782 . . . . 74.24 112.873 -173.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -126.55 148.68 49.71 Favored 'General case' 0 N--CA 1.412 -2.33 0 CA-C-N 112.894 -1.957 . . . . 74.21 108.167 174.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 588' ' ' PHE . . . . . 0.515 ' HA ' ' O ' ' A' ' 642' ' ' LEU . 28.3 m-85 -105.61 129.74 53.79 Favored 'General case' 0 C--N 1.292 -1.935 0 N-CA-C 109.177 -0.675 . . . . 63.24 109.177 -175.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 589' ' ' LEU . . . . . 0.407 HD21 HG21 ' A' ' 571' ' ' ILE . 0.3 OUTLIER -97.83 121.09 39.34 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 106.034 -1.839 . . . . 72.52 106.034 176.814 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -125.34 129.89 50.86 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 109.712 -0.477 . . . . 72.24 109.712 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 591' ' ' ILE . . . . . 0.487 HG22 ' HB3' ' A' ' 539' ' ' TYR . 22.8 pt -98.44 138.4 23.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 107.229 -1.397 . . . . 73.51 107.229 174.214 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -91.06 -144.95 13.29 Favored Glycine 0 N--CA 1.431 -1.642 0 C-N-CA 121.0 -0.619 . . . . 71.32 112.897 -176.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -83.33 119.28 73.73 Favored Pre-proline 0 C--N 1.301 -1.516 0 N-CA-C 109.451 -0.574 . . . . 73.12 109.451 -178.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 594' ' ' PRO . . . . . 0.521 ' HB3' HG22 ' A' ' 537' ' ' VAL . 30.2 Cg_endo -67.15 152.7 79.36 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 121.966 1.777 . . . . 62.14 111.016 176.14 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -137.21 133.42 35.12 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 110.051 -0.351 . . . . 74.42 110.051 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 596' ' ' LEU . . . . . 0.513 HD22 HG22 ' A' ' 535' ' ' VAL . 0.0 OUTLIER -79.01 130.91 36.04 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 106.643 -1.614 . . . . 63.34 106.643 179.832 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 16.8 t -91.2 16.97 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 CA-C-O 122.071 0.939 . . . . 73.32 109.954 -177.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -78.15 85.7 4.32 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-O 122.857 1.313 . . . . 71.25 110.626 176.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 83.0 mmm -99.39 82.36 2.66 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 114.644 -1.162 . . . . 71.5 108.624 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 25.8 t -93.73 -33.94 13.42 Favored 'General case' 0 N--CA 1.417 -2.116 0 CA-C-N 114.029 -1.441 . . . . 72.4 108.619 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 59.38 92.59 0.04 OUTLIER 'General case' 0 C--O 1.242 0.682 0 C-N-CA 124.363 1.065 . . . . 71.11 108.76 -176.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -99.79 147.93 24.95 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 115.072 -0.967 . . . . 72.24 112.863 -168.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 1.7 tmmm? -132.99 75.56 1.63 Allowed 'General case' 0 N--CA 1.423 -1.79 0 N-CA-C 106.104 -1.813 . . . . 64.2 106.104 175.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -86.26 -26.95 32.0 Favored Glycine 0 CA--C 1.491 -1.415 0 N-CA-C 109.227 -1.549 . . . . 75.11 109.227 178.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 176.68 178.66 46.62 Favored Glycine 0 N--CA 1.412 -2.946 0 N-CA-C 107.267 -2.333 . . . . 63.31 107.267 178.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -93.96 85.46 4.76 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 107.734 -1.21 . . . . 71.33 107.734 177.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 28.9 p -78.52 121.99 25.3 Favored 'General case' 0 N--CA 1.418 -2.066 0 CA-C-N 114.603 -1.18 . . . . 53.15 111.962 -174.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 57.3 mt -89.02 96.4 6.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 106.078 -1.823 . . . . 64.3 106.078 175.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 12.8 t -156.16 146.92 21.95 Favored 'General case' 0 C--N 1.286 -2.186 0 CA-C-N 115.536 -0.756 . . . . 63.1 109.802 -173.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -93.57 93.25 7.97 Favored 'General case' 0 N--CA 1.418 -2.046 0 CA-C-N 115.567 -0.742 . . . . 71.1 109.072 174.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -131.53 67.25 1.52 Allowed 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 105.92 -1.882 . . . . 53.44 105.92 172.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -107.35 134.92 49.7 Favored 'General case' 0 N--CA 1.404 -2.759 0 CA-C-N 113.904 -1.498 . . . . 74.25 108.857 -174.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -72.91 90.03 1.44 Allowed 'General case' 0 CA--C 1.498 -1.041 0 CA-C-O 121.666 0.746 . . . . 63.24 109.088 175.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -85.47 101.98 13.09 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 107.909 -1.145 . . . . 55.31 107.909 176.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -74.87 83.2 2.18 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 122.526 1.155 . . . . 71.14 112.837 -173.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -135.21 166.87 25.7 Favored Pre-proline 0 C--N 1.296 -1.747 0 CA-C-N 113.026 -1.897 . . . . 53.31 106.912 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -62.4 167.74 10.78 Favored 'Trans proline' 0 C--O 1.253 1.263 0 C-N-CA 121.418 1.412 . . . . 71.52 109.824 172.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -67.27 99.55 0.72 Allowed 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.809 0.814 . . . . 74.21 111.457 -175.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 5.6 p -140.72 145.86 37.03 Favored 'General case' 0 N--CA 1.42 -1.962 0 CA-C-N 114.074 -1.421 . . . . 71.24 107.686 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 5.7 p -107.48 -20.96 13.09 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-O 120.599 0.238 . . . . 52.51 110.38 177.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm 62.99 11.43 5.11 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.307 1.043 . . . . 74.51 111.339 175.051 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 68.6 -3.82 1.29 Allowed 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 124.96 1.304 . . . . 75.33 111.007 -174.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -76.54 128.38 34.65 Favored 'General case' 0 N--CA 1.432 -1.342 0 C-N-CA 124.278 1.031 . . . . 73.05 109.087 -175.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -69.63 -33.4 72.58 Favored 'General case' 0 C--O 1.201 -1.495 0 C-N-CA 120.246 -0.581 . . . . 75.32 110.263 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 16.2 mp0 -56.94 -40.42 76.38 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 123.383 0.427 . . . . 73.41 110.954 178.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 626' ' ' ARG . . . . . 0.647 ' O ' ' HG2' ' A' ' 630' ' ' GLU . 11.4 tpt180 -70.75 -47.04 61.74 Favored 'General case' 0 C--O 1.204 -1.293 0 N-CA-C 108.705 -0.85 . . . . 75.01 108.705 176.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 627' ' ' ARG . . . . . . . . . . . . . 70.4 mtm180 -59.67 -39.6 85.0 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 113.103 0.779 . . . . 71.45 113.103 -177.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 628' ' ' ILE . . . . . 0.418 ' O ' ' HG2' ' A' ' 631' ' ' MET . 96.8 mt -64.74 -36.04 76.54 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 CA-C-O 121.301 0.572 . . . . 51.23 110.015 177.169 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -69.52 -39.21 77.66 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.842 -0.617 . . . . 64.44 109.995 177.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 630' ' ' GLU . . . . . 0.647 ' HG2' ' O ' ' A' ' 626' ' ' ARG . 3.7 mm-40 -72.88 -1.14 15.65 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 112.527 0.566 . . . . 74.25 112.527 -176.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 631' ' ' MET . . . . . 0.418 ' HG2' ' O ' ' A' ' 628' ' ' ILE . 26.1 ptt? -102.58 -13.23 17.25 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 119.838 -0.745 . . . . 73.02 110.539 173.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -100.12 -27.87 7.56 Favored Glycine 0 C--N 1.319 -0.388 0 N-CA-C 108.844 -1.703 . . . . 75.43 108.844 174.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 15.2 mtp85 -98.72 139.91 21.41 Favored Pre-proline 0 C--N 1.297 -1.717 0 C-N-CA 124.968 1.307 . . . . 71.32 108.412 176.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.493 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 51.0 Cg_endo -73.08 139.58 29.93 Favored 'Trans proline' 0 N--CA 1.441 -1.578 0 C-N-CA 121.545 1.497 . . . . 75.21 110.697 176.49 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.4 pp -126.68 -175.96 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 111.904 0.335 . . . . 71.34 111.904 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -77.61 178.29 7.41 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.228 0.537 . . . . 75.32 111.29 -174.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -96.58 -85.18 1.74 Allowed Glycine 0 N--CA 1.421 -2.343 0 C-N-CA 120.554 -0.831 . . . . 43.11 111.606 178.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -127.53 -66.78 0.86 Allowed 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 115.509 -0.346 . . . . 72.31 110.08 -175.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 13.3 p80 -123.14 119.05 29.11 Favored 'General case' 0 C--O 1.246 0.9 0 CA-C-O 121.627 0.727 . . . . 61.03 111.51 -177.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 6.3 p -109.12 90.98 3.46 Favored 'General case' 0 N--CA 1.412 -2.356 0 CA-C-N 115.145 -0.934 . . . . 73.32 108.747 175.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -177.49 132.1 0.16 Allowed 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 106.49 -1.67 . . . . 72.03 106.49 -176.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 642' ' ' LEU . . . . . 0.64 HD21 HG21 ' A' ' 523' ' ' VAL . 41.8 tp -138.24 111.83 8.2 Favored 'General case' 0 C--N 1.29 -2.007 0 O-C-N 123.705 0.628 . . . . 73.04 109.61 177.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 643' ' ' GLU . . . . . 0.545 ' HB3' HG22 ' A' ' 511' ' ' VAL . 35.7 tt0 -90.74 104.01 16.64 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 107.392 -1.336 . . . . 53.11 107.392 177.14 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 644' ' ' VAL . . . . . 0.587 HG21 ' HE2' ' A' ' 521' ' ' MET . 39.8 t -95.01 110.07 23.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.804 -0.813 . . . . 71.01 108.804 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 3.9 mp -91.82 117.74 35.76 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 N-CA-C 108.013 -1.106 . . . . 64.11 108.013 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 646' ' ' ILE . . . . . 0.494 HD12 ' H ' ' A' ' 646' ' ' ILE . 1.5 mp -107.13 109.54 28.53 Favored 'Isoleucine or valine' 0 CA--C 1.473 -2.018 0 N-CA-C 106.115 -1.809 . . . . 62.42 106.115 -176.081 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -111.33 150.35 29.83 Favored 'General case' 0 C--N 1.249 -3.787 0 C-N-CA 120.417 -0.513 . . . . 73.55 111.401 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -63.3 133.9 54.92 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 105.552 -2.018 . . . . 72.52 105.552 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 8.2 t -60.98 107.46 0.72 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.827 0.822 . . . . 34.35 112.05 -169.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -132.87 -60.63 0.86 Allowed 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 114.579 -1.191 . . . . 74.3 110.158 -178.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 179.96 160.22 0.85 Allowed 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 106.255 -1.758 . . . . 60.42 106.255 -176.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -130.0 104.77 7.55 Favored 'General case' 0 N--CA 1.409 -2.483 0 CA-C-O 121.279 0.561 . . . . 72.24 111.714 -173.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -111.22 117.48 33.3 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.376 -1.342 . . . . 74.22 107.376 175.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 30.4 t -71.36 113.56 8.53 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.35 0.595 . . . . 74.32 112.068 -173.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 9.0 t -143.28 79.29 1.63 Allowed 'General case' 0 N--CA 1.417 -2.117 0 CA-C-O 122.921 1.343 . . . . 74.14 107.848 174.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 6.5 p -83.52 110.48 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.244 0 CA-C-N 114.505 -1.225 . . . . 64.25 111.318 -176.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 16.5 t70 . . . . . 0 C--N 1.303 -1.444 0 CA-C-N 115.151 -0.931 . . . . 73.11 111.009 -179.344 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 800' ' ' ' CA' . . . . . 0.658 'CA ' ' OD2' ' A' ' 578' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 850' ' ' ' CA' . . . . . 0.625 'CA ' ' OD1' ' A' ' 578' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 . . . . . 0 N--CA 1.443 -0.782 0 N-CA-C 108.972 -0.751 . . . . 73.12 108.972 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 502' ' ' ALA . . . . . 0.421 ' HB3' ' HA ' ' A' ' 634' ' ' PRO . . . -130.62 -52.13 1.07 Allowed 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 107.606 -1.257 . . . . 72.01 107.606 174.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 503' ' ' GLY . . . . . 0.553 ' HA2' ' OG1' ' A' ' 528' ' ' THR . . . -147.83 146.17 15.56 Favored Glycine 0 N--CA 1.398 -3.838 0 CA-C-N 114.311 -1.313 . . . . 64.22 110.938 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 2.9 mp -123.58 105.81 16.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 108.096 -1.076 . . . . 44.22 108.096 -178.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 505' ' ' PHE . . . . . 0.428 ' CE1' ' HB ' ' A' ' 528' ' ' THR . 93.1 m-85 -114.9 121.49 43.37 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.178 0.513 . . . . 52.12 110.59 178.438 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 506' ' ' THR . . . . . 0.433 HG23 HD23 ' A' ' 526' ' ' LEU . 13.8 t -147.21 163.01 37.71 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.022 -1.103 . . . . 74.03 108.022 -177.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -85.61 148.32 25.97 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 120.844 0.354 . . . . 75.02 110.961 176.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -84.44 -20.5 31.68 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 107.264 -1.384 . . . . 71.52 107.264 176.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 509' ' ' GLU . . . . . 0.432 ' HG3' ' O ' ' A' ' 511' ' ' VAL . 1.9 tp10 -129.01 120.58 20.34 Favored Pre-proline 0 N--CA 1.431 -1.389 0 CA-C-N 114.734 -1.121 . . . . 62.4 108.169 -178.291 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -80.38 -24.3 5.51 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 120.908 1.072 . . . . 74.41 110.147 173.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 511' ' ' VAL . . . . . 0.521 HG22 ' HB3' ' A' ' 643' ' ' GLU . 76.4 t -142.93 129.02 17.13 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 C-N-CA 124.561 1.145 . . . . 44.14 108.722 -178.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 14.6 t -128.2 142.94 51.03 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 108.284 -1.006 . . . . 70.22 108.284 177.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 52.6 m80 -108.42 120.85 43.6 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.861 -0.792 . . . . 61.31 108.861 175.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 23.1 m -118.13 150.15 20.36 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.394 0 N-CA-C 107.919 -1.141 . . . . 71.12 107.919 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 515' ' ' SER . . . . . 0.406 ' HG ' ' HA ' ' A' ' 649' ' ' SER . 2.7 t -83.95 152.71 24.33 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 108.74 -0.837 . . . . 54.44 108.74 -178.289 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 516' ' ' GLU . . . . . 0.659 ' OE2' 'CA ' ' A' ' 800' ' ' ' CA' . 38.8 tt0 -70.33 -21.08 62.95 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 120.934 0.397 . . . . 70.34 110.928 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 45.2 m -90.35 12.21 19.04 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-O 121.226 0.536 . . . . 61.21 110.709 -175.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 12.7 tt -86.57 153.46 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.877 0 N-CA-C 108.871 -0.788 . . . . 74.25 108.871 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -90.98 -63.92 1.2 Allowed Glycine 0 N--CA 1.432 -1.596 0 C-N-CA 119.959 -1.115 . . . . 71.24 110.568 178.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 37.1 mm -120.25 121.44 65.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 107.905 -1.146 . . . . 72.41 107.905 178.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 521' ' ' MET . . . . . 0.574 ' HE1' HG21 ' A' ' 644' ' ' VAL . 0.0 OUTLIER -94.92 136.37 35.32 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 106.907 -1.516 . . . . 73.32 106.907 174.312 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 522' ' ' GLU . . . . . 0.46 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 48.9 mt-10 -124.41 138.26 54.38 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 124.093 0.871 . . . . 71.11 109.949 -178.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 523' ' ' VAL . . . . . 0.797 HG21 HD21 ' A' ' 642' ' ' LEU . 39.7 t -129.23 140.87 48.06 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 N-CA-C 109.055 -0.72 . . . . 74.15 109.055 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 524' ' ' LYS . . . . . 0.576 ' HD2' ' CG2' ' A' ' 568' ' ' VAL . 34.1 mmtp -85.34 134.35 34.1 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 122.243 1.02 . . . . 75.11 113.18 -178.106 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 4.2 t -110.57 146.94 15.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-N 113.926 -1.488 . . . . 65.2 107.349 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 526' ' ' LEU . . . . . 0.433 HD23 HG23 ' A' ' 506' ' ' THR . 2.8 mm? -87.3 135.58 33.26 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 109.567 -0.531 . . . . 75.41 109.567 177.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 527' ' ' ARG . . . . . 0.534 ' HD3' ' HA ' ' A' ' 567' ' ' ILE . 39.2 ttp180 -83.27 150.38 26.2 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-N 115.6 -0.727 . . . . 75.21 110.468 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 528' ' ' THR . . . . . 0.553 ' OG1' ' HA2' ' A' ' 503' ' ' GLY . 1.8 t -50.12 147.36 4.15 Favored 'General case' 0 N--CA 1.435 -1.198 0 C-N-CA 125.866 1.667 . . . . 73.42 113.2 174.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 19.2 m -65.07 -38.05 89.53 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 114.4 -1.273 . . . . 71.41 110.035 176.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -107.45 103.24 1.92 Allowed Glycine 0 N--CA 1.419 -2.451 0 N-CA-C 108.994 -1.642 . . . . 63.12 108.994 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 531' ' ' ALA . . . . . 0.475 ' HB2' HG23 ' A' ' 528' ' ' THR . . . -122.13 65.76 0.92 Allowed 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.046 0.45 . . . . 64.12 111.281 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -117.1 90.76 3.4 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.101 -1.444 . . . . 64.35 107.101 175.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 142.4 -138.31 8.38 Favored Glycine 0 N--CA 1.419 -2.464 0 N-CA-C 110.153 -1.179 . . . . 74.41 110.153 -175.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -146.14 131.34 18.42 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.841 -1.17 . . . . 64.14 107.841 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 535' ' ' VAL . . . . . 0.452 HG22 HD22 ' A' ' 596' ' ' LEU . 59.2 t -131.01 132.7 63.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.156 -0.683 . . . . 74.44 109.156 -177.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 536' ' ' ILE . . . . . . . . . . . . . 44.0 mm -105.35 131.04 55.64 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 109.665 -0.495 . . . . 64.24 109.665 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 537' ' ' VAL . . . . . 0.484 HG22 ' HB3' ' A' ' 594' ' ' PRO . 20.1 t -118.12 102.36 50.83 Favored Pre-proline 0 C--N 1.311 -1.089 0 O-C-N 123.307 0.38 . . . . 41.55 110.09 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -73.78 138.64 26.56 Favored 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 122.372 2.048 . . . . 61.55 111.604 178.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 539' ' ' TYR . . . . . 0.47 ' HB3' HG22 ' A' ' 591' ' ' ILE . 51.5 p90 -142.72 160.6 40.0 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 110.353 -0.24 . . . . 73.32 110.353 -177.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 540' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 556' ' ' THR . 0.0 OUTLIER -154.67 160.03 41.14 Favored 'General case' 0 C--O 1.247 0.938 0 O-C-N 123.595 0.56 . . . . 72.12 111.432 176.656 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 31.6 p -96.67 127.03 42.26 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.665 -0.698 . . . . 53.5 111.495 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.8 mp -93.72 111.52 25.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 106.142 -1.799 . . . . 71.4 106.142 172.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 543' ' ' GLU . . . . . 0.414 ' H ' ' CD ' ' A' ' 543' ' ' GLU . 1.5 mp0 -51.88 -53.34 41.85 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 124.348 1.059 . . . . 70.54 111.693 -176.145 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 68.95 -98.06 0.53 Allowed Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 121.1 -0.571 . . . . 72.33 111.969 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 545' ' ' THR . . . . . 0.436 HG23 ' H ' ' A' ' 586' ' ' THR . 8.8 t -111.29 -1.91 15.88 Favored 'General case' 0 CA--C 1.553 1.058 0 CA-C-O 121.969 0.89 . . . . 73.31 109.589 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 546' ' ' ALA . . . . . 0.42 ' HB2' ' HG2' ' A' ' 585' ' ' LYS . . . -93.8 171.12 9.07 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 108.067 -1.086 . . . . 55.24 108.067 174.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 547' ' ' ARG . . . . . 0.481 ' H ' ' HB3' ' A' ' 552' ' ' ASP . 1.4 tmt_? -126.67 121.55 32.44 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.009 -0.737 . . . . 75.54 109.009 -176.258 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -79.53 -164.58 28.85 Favored Glycine 0 CA--C 1.518 0.223 0 CA-C-N 116.234 -0.439 . . . . 71.22 112.892 -177.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 77.58 15.95 80.79 Favored Glycine 0 C--N 1.307 -1.058 0 N-CA-C 112.372 -0.291 . . . . 54.11 112.372 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 69.97 32.9 69.77 Favored Glycine 0 N--CA 1.431 -1.671 0 N-CA-C 110.5 -1.04 . . . . 74.12 110.5 -176.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -96.81 -64.58 1.03 Allowed 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 109.025 -0.731 . . . . 73.23 109.025 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 552' ' ' ASP . . . . . 0.636 ' OD2' 'CA ' ' A' ' 850' ' ' ' CA' . 12.2 t70 -102.6 -36.62 8.28 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 106.807 -1.553 . . . . 61.5 106.807 177.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 553' ' ' PHE . . . . . 0.416 ' HA ' HG12 ' A' ' 576' ' ' ILE . 11.7 p90 -146.59 163.68 35.03 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 114.735 -1.121 . . . . 74.14 108.565 174.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -91.79 105.43 17.71 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 107.022 -1.473 . . . . 71.22 107.022 177.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -71.19 139.38 50.14 Favored 'General case' 0 CA--C 1.486 -1.488 0 N-CA-C 108.343 -0.984 . . . . 75.01 108.343 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 556' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 540' ' ' LYS . 11.0 t -138.16 138.43 38.61 Favored 'General case' 0 N--CA 1.396 -3.149 0 C-N-CA 118.842 -1.143 . . . . 74.33 111.989 -175.188 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 23.2 p -131.04 119.75 22.45 Favored 'General case' 0 N--CA 1.415 -2.216 0 N-CA-C 106.255 -1.757 . . . . 61.04 106.255 173.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -147.83 -170.67 16.1 Favored Glycine 0 N--CA 1.41 -3.057 0 C-N-CA 120.136 -1.031 . . . . 70.45 111.236 -172.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -139.09 106.6 5.57 Favored 'General case' 0 C--N 1.293 -1.885 0 C-N-CA 122.75 0.42 . . . . 53.5 109.869 -175.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 91.3 mt -73.71 136.79 43.75 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-N 116.043 -0.526 . . . . 72.43 110.198 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -105.62 114.71 29.04 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 116.102 -0.499 . . . . 63.12 111.235 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -111.17 148.74 32.1 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.656 -0.868 . . . . 75.43 108.656 174.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 563' ' ' GLN . . . . . 0.466 ' H ' ' HB3' ' A' ' 566' ' ' GLU . 26.9 pt20 -159.51 -178.16 6.92 Favored 'General case' 0 C--N 1.285 -2.225 0 N-CA-C 108.713 -0.847 . . . . 73.13 108.713 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -69.08 -29.98 68.2 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 121.712 0.768 . . . . 51.14 110.728 -178.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -82.74 -0.98 50.13 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.749 0.785 . . . . 73.54 110.798 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 566' ' ' GLU . . . . . 0.466 ' HB3' ' H ' ' A' ' 563' ' ' GLN . 8.2 tp10 -120.74 142.66 49.33 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.704 -0.623 . . . . 64.13 110.542 -175.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 567' ' ' ILE . . . . . 0.534 ' HA ' ' HD3' ' A' ' 527' ' ' ARG . 2.4 pt -133.58 150.78 32.31 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.273 0 N-CA-C 106.035 -1.839 . . . . 75.03 106.035 170.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 568' ' ' VAL . . . . . 0.576 ' CG2' ' HD2' ' A' ' 524' ' ' LYS . 1.2 p 49.77 -177.71 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.59 2.497 0 C-N-CA 124.7 1.2 . . . . 63.52 111.78 -175.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 569' ' ' LYS . . . . . 0.596 ' HE3' ' HA ' ' A' ' 569' ' ' LYS . 0.2 OUTLIER -173.94 164.55 4.21 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 107.979 -1.119 . . . . 75.23 107.979 176.032 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 570' ' ' THR . . . . . 0.592 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 36.3 p -127.1 142.85 51.42 Favored 'General case' 0 N--CA 1.436 -1.174 0 O-C-N 123.477 0.486 . . . . 51.11 110.907 177.469 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 571' ' ' ILE . . . . . 0.494 HG22 HG23 ' A' ' 573' ' ' VAL . 2.5 mp -91.78 122.48 43.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 N-CA-C 105.849 -1.908 . . . . 71.41 105.849 170.051 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 9.7 m -97.25 109.86 22.53 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 109.966 -0.383 . . . . 53.23 109.966 -179.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 573' ' ' VAL . . . . . 0.494 HG23 HG22 ' A' ' 571' ' ' ILE . 62.2 t -120.94 130.85 74.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 109.305 -0.628 . . . . 74.3 109.305 178.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -91.36 132.25 36.31 Favored 'General case' 0 C--N 1.312 -1.052 0 O-C-N 123.509 0.506 . . . . 64.3 111.064 179.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 64.0 t -97.66 137.99 23.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 108.063 -1.088 . . . . 72.31 108.063 177.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 576' ' ' ILE . . . . . 0.416 HG12 ' HA ' ' A' ' 553' ' ' PHE . 30.4 mm -103.11 160.49 4.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 107.369 -1.345 . . . . 72.34 107.369 -177.359 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -69.99 133.69 47.52 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 109.502 -0.555 . . . . 74.33 109.502 177.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 578' ' ' ASP . . . . . 0.602 ' OD1' 'CA ' ' A' ' 850' ' ' ' CA' . 0.8 OUTLIER -66.33 137.84 57.2 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.352 0.596 . . . . 71.03 111.033 -174.355 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.78 -35.89 3.8 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 115.925 1.824 . . . . 75.0 115.925 -171.43 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 580' ' ' GLU . . . . . 0.517 ' HG2' ' CD2' ' A' ' 581' ' ' TYR . 0.0 OUTLIER -93.63 -60.38 1.78 Allowed 'General case' 0 C--N 1.313 -1.01 0 O-C-N 121.482 -0.761 . . . . 70.12 112.75 -170.52 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 581' ' ' TYR . . . . . 0.517 ' CD2' ' HG2' ' A' ' 580' ' ' GLU . 31.4 p90 -164.38 153.97 13.9 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 106.561 -1.644 . . . . 54.4 106.561 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 582' ' ' GLU . . . . . 0.641 ' OE1' 'CA ' ' A' ' 800' ' ' ' CA' . 43.1 mm-40 -89.87 143.81 26.48 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 119.618 -0.833 . . . . 64.24 112.218 -177.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -169.74 168.8 8.81 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 107.472 -1.307 . . . . 64.42 107.472 175.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -88.39 78.47 7.93 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 107.988 -1.115 . . . . 74.42 107.988 174.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 585' ' ' LYS . . . . . 0.42 ' HG2' ' HB2' ' A' ' 546' ' ' ALA . 0.0 OUTLIER -79.02 166.66 22.09 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 108.243 -1.021 . . . . 72.34 108.243 -177.417 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 586' ' ' THR . . . . . 0.436 ' H ' HG23 ' A' ' 545' ' ' THR . 6.9 t -154.06 144.36 22.16 Favored 'General case' 0 N--CA 1.415 -2.213 0 C-N-CA 120.258 -0.577 . . . . 73.43 111.178 -173.234 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 587' ' ' PHE . . . . . 0.437 ' CE2' HD11 ' A' ' 646' ' ' ILE . 3.6 p90 -126.02 148.54 49.28 Favored 'General case' 0 N--CA 1.418 -2.072 0 CA-C-N 113.799 -1.546 . . . . 62.32 109.407 176.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 588' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -104.77 130.99 52.77 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 108.791 -0.818 . . . . 70.33 108.791 -174.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 589' ' ' LEU . . . . . 0.521 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.4 OUTLIER -99.83 124.98 45.69 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 106.308 -1.738 . . . . 75.43 106.308 176.922 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -124.44 132.12 53.5 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-O 121.013 0.435 . . . . 74.44 110.11 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 591' ' ' ILE . . . . . 0.47 HG22 ' HB3' ' A' ' 539' ' ' TYR . 24.8 pt -101.33 143.86 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.085 0 N-CA-C 107.224 -1.398 . . . . 75.12 107.224 174.394 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -89.41 -148.84 19.69 Favored Glycine 0 C--N 1.292 -1.905 0 N-CA-C 110.47 -1.052 . . . . 31.14 110.47 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.424 ' CD ' HH21 ' A' ' 633' ' ' ARG . 23.4 tt0 -82.09 128.49 67.83 Favored Pre-proline 0 C--N 1.29 -2.013 0 N-CA-C 108.997 -0.742 . . . . 64.11 108.997 177.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 594' ' ' PRO . . . . . 0.484 ' HB3' HG22 ' A' ' 537' ' ' VAL . 55.0 Cg_endo -71.55 146.36 49.33 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 121.965 1.777 . . . . 53.35 109.944 173.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 16.0 ptt-85 -126.93 138.19 53.25 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.593 -0.692 . . . . 61.44 110.003 -175.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 596' ' ' LEU . . . . . 0.452 HD22 HG22 ' A' ' 535' ' ' VAL . 0.0 OUTLIER -81.8 129.15 34.64 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 106.938 -1.505 . . . . 51.21 106.938 179.753 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 89.6 t -75.58 -27.67 19.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-O 121.245 0.545 . . . . 61.22 110.073 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 598' ' ' GLU . . . . . 0.449 ' H ' HD12 ' A' ' 596' ' ' LEU . 10.9 pt-20 -128.72 95.95 4.25 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 122.061 0.934 . . . . 74.32 111.453 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.41 7.47 5.86 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.579 -0.737 . . . . 63.43 112.182 -177.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 16.6 m -91.99 132.57 36.43 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 120.676 -0.41 . . . . 73.31 111.639 -175.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 58.02 77.07 0.3 Allowed 'General case' 0 C--O 1.237 0.434 0 C-N-CA 125.196 1.398 . . . . 74.11 114.491 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 48.3 pttt -99.51 173.57 6.68 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.259 -1.385 . . . . 71.4 107.259 172.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -92.06 103.35 15.87 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.547 0.689 . . . . 73.42 110.143 175.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 134.8 146.84 5.45 Favored Glycine 0 N--CA 1.435 -1.427 0 N-CA-C 110.216 -1.154 . . . . 72.23 110.216 -177.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . -144.09 98.31 0.2 Allowed Glycine 0 N--CA 1.431 -1.685 0 C-N-CA 120.03 -1.081 . . . . 64.13 112.734 -177.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -104.74 173.4 6.32 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.525 -0.917 . . . . 75.4 108.525 176.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 10.5 p -72.52 110.95 7.27 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 121.892 0.853 . . . . 73.21 113.221 -176.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 7.5 mt -80.06 166.81 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.565 0 N-CA-C 106.612 -1.625 . . . . 74.22 106.612 177.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 7.3 t -93.08 10.04 33.25 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-O 122.006 0.908 . . . . 62.03 109.804 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 60.11 -1.99 0.17 Allowed 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 116.005 1.854 . . . . 71.54 116.005 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -75.7 90.31 2.84 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 106.055 -1.832 . . . . 70.24 106.055 171.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -101.09 129.9 47.05 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 115.268 -0.878 . . . . 74.21 109.351 -174.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 11.9 t70 74.87 -55.02 0.66 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.823 1.249 . . . . 71.25 112.71 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -45.88 114.14 0.73 Allowed 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 125.392 1.477 . . . . 72.15 113.415 -176.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 615' ' ' LYS . . . . . 0.412 ' H ' ' HG2' ' A' ' 615' ' ' LYS . 22.5 pttm -85.13 97.78 10.08 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 114.605 -1.179 . . . . 62.34 111.518 -178.409 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -104.82 167.81 9.35 Favored Pre-proline 0 C--N 1.291 -1.971 0 CA-C-N 115.52 -0.764 . . . . 63.15 110.245 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -67.49 172.21 10.66 Favored 'Trans proline' 0 C--O 1.255 1.366 0 C-N-CA 121.748 1.632 . . . . 62.11 110.868 174.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -70.7 104.43 2.85 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.641 0.734 . . . . 72.0 110.462 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -106.94 6.58 29.33 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 114.403 -1.271 . . . . 64.54 113.308 -173.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 1.7 p -82.56 108.53 16.02 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 121.453 0.644 . . . . 64.45 111.782 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 5.1 ttmp? -136.9 -62.85 0.63 Allowed 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 115.448 -0.796 . . . . 55.22 108.885 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -113.73 -35.22 5.24 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.128 -0.487 . . . . 74.35 111.76 -179.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 623' ' ' GLU . . . . . 0.589 ' HG3' ' H ' ' A' ' 626' ' ' ARG . 9.2 tp10 -65.38 126.18 27.43 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 120.888 0.375 . . . . 54.34 110.178 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -92.24 -24.41 19.02 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.543 -0.54 . . . . 73.11 109.543 -179.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -56.77 -44.12 81.48 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.834 0.825 . . . . 73.2 108.937 177.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 626' ' ' ARG . . . . . 0.615 ' O ' ' HG3' ' A' ' 630' ' ' GLU . 14.4 tpt180 -59.87 -48.27 82.35 Favored 'General case' 0 C--O 1.209 -1.032 0 CA-C-N 114.604 -1.18 . . . . 53.12 109.542 175.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 627' ' ' ARG . . . . . 0.406 ' HA ' ' OE1' ' A' ' 630' ' ' GLU . 64.7 mtm180 -64.31 -34.39 78.02 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 113.073 0.768 . . . . 74.33 113.073 -176.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 628' ' ' ILE . . . . . 0.651 ' O ' ' HG2' ' A' ' 631' ' ' MET . 98.0 mt -69.25 -38.98 78.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 109.42 -0.585 . . . . 72.42 109.42 175.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -68.85 -18.39 64.14 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.169 0.509 . . . . 64.41 110.594 176.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 630' ' ' GLU . . . . . 0.615 ' HG3' ' O ' ' A' ' 626' ' ' ARG . 77.6 mt-10 -82.19 9.79 8.03 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.905 -0.589 . . . . 74.02 111.288 178.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 631' ' ' MET . . . . . 0.651 ' HG2' ' O ' ' A' ' 628' ' ' ILE . 20.8 ptp -82.31 -22.39 35.64 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 106.729 -1.582 . . . . 73.55 106.729 167.178 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -100.87 -43.74 2.2 Favored Glycine 0 N--CA 1.44 -1.067 0 CA-C-N 115.099 -0.955 . . . . 41.31 110.86 177.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 633' ' ' ARG . . . . . 0.424 HH21 ' CD ' ' A' ' 593' ' ' GLU . 20.7 mtp180 -87.29 120.95 71.51 Favored Pre-proline 0 C--N 1.32 -0.694 0 N-CA-C 109.81 -0.441 . . . . 71.42 109.81 178.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.421 ' HA ' ' HB3' ' A' ' 502' ' ' ALA . 36.7 Cg_endo -68.42 147.47 71.37 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.268 1.979 . . . . 74.32 110.475 177.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 635' ' ' ILE . . . . . 0.43 HG21 ' OE2' ' A' ' 630' ' ' GLU . 2.3 pp -135.1 -175.06 1.26 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.753 0 N-CA-C 114.623 1.342 . . . . 71.2 114.623 -173.337 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -78.01 154.87 31.08 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.195 -0.911 . . . . 65.43 110.641 -177.015 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 637' ' ' GLY . . . . . 0.407 ' HA3' ' HB ' ' A' ' 506' ' ' THR . . . -96.48 -107.74 2.41 Favored Glycine 0 C--N 1.297 -1.621 0 C-N-CA 120.664 -0.779 . . . . 73.02 112.685 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -89.53 -65.4 1.02 Allowed 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 121.494 0.664 . . . . 73.11 110.953 -176.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -133.81 116.51 15.78 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 115.381 -0.827 . . . . 62.52 111.645 -174.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 22.1 p -104.42 90.89 3.68 Favored 'General case' 0 N--CA 1.396 -3.161 0 N-CA-C 107.887 -1.153 . . . . 73.22 107.887 175.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 21.5 tptm -175.71 135.36 0.3 Allowed 'General case' 0 N--CA 1.425 -1.701 0 CA-C-N 113.758 -1.564 . . . . 72.21 107.204 -175.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 642' ' ' LEU . . . . . 0.797 HD21 HG21 ' A' ' 523' ' ' VAL . 41.5 tp -138.22 110.1 7.19 Favored 'General case' 0 C--N 1.276 -2.606 0 N-CA-C 107.611 -1.255 . . . . 63.42 107.611 173.163 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 643' ' ' GLU . . . . . 0.521 ' HB3' HG22 ' A' ' 511' ' ' VAL . 21.4 tt0 -93.59 106.98 18.9 Favored 'General case' 0 C--N 1.275 -2.644 0 N-CA-C 107.475 -1.306 . . . . 72.25 107.475 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 644' ' ' VAL . . . . . 0.574 HG21 ' HE1' ' A' ' 521' ' ' MET . 25.6 t -96.81 105.6 17.33 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 109.346 -0.613 . . . . 72.31 109.346 -176.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 3.5 mp -91.54 120.42 40.56 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 107.521 -1.289 . . . . 75.1 107.521 176.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 646' ' ' ILE . . . . . 0.508 HD12 ' N ' ' A' ' 646' ' ' ILE . 2.7 mp -97.74 109.28 23.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 105.928 -1.879 . . . . 72.14 105.928 -177.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 647' ' ' GLU . . . . . 0.401 ' OE2' ' HA ' ' A' ' 515' ' ' SER . 1.5 pp20? -93.3 148.49 22.0 Favored 'General case' 0 N--CA 1.399 -3.007 0 CA-C-N 115.518 -0.764 . . . . 75.21 110.889 -174.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -73.0 69.46 0.98 Allowed 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 124.416 1.086 . . . . 74.02 110.993 -178.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 649' ' ' SER . . . . . 0.406 ' HA ' ' HG ' ' A' ' 515' ' ' SER . 14.4 m 28.14 74.46 0.04 OUTLIER 'General case' 0 C--O 1.243 0.755 0 C-N-CA 128.422 2.689 . . . . 51.13 115.525 177.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -128.75 -63.33 0.98 Allowed 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.37 -0.832 . . . . 74.12 111.609 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -159.9 -174.25 4.49 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 121.625 0.726 . . . . 75.14 111.945 -175.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -132.96 101.9 5.41 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 115.009 -0.996 . . . . 74.31 110.287 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -140.47 113.38 8.26 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 114.428 -1.26 . . . . 70.2 108.098 175.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 48.8 m -108.0 110.69 22.46 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 120.97 0.414 . . . . 51.12 111.517 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 25.3 m -83.87 102.2 12.21 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 108.881 -0.785 . . . . 74.45 108.881 176.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 21.1 m -131.25 -174.76 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 C-N-CA 123.151 0.58 . . . . 65.12 109.481 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 . . . . . 0 C--N 1.311 -1.076 0 N-CA-C 110.462 -0.199 . . . . 63.44 110.462 179.652 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 800' ' ' ' CA' . . . . . 0.659 'CA ' ' OE2' ' A' ' 516' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 850' ' ' ' CA' . . . . . 0.636 'CA ' ' OD2' ' A' ' 552' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 501' ' ' HIS . . . . . 0.614 ' HA ' ' O ' ' A' ' 631' ' ' MET . 15.5 t-160 . . . . . 0 N--CA 1.448 -0.561 0 N-CA-C 109.017 -0.735 . . . . 73.51 109.017 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -80.69 -52.49 7.49 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 109.321 -0.622 . . . . 62.43 109.321 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 503' ' ' GLY . . . . . 0.708 ' HA3' ' OG1' ' A' ' 528' ' ' THR . . . 140.35 -167.99 25.3 Favored Glycine 0 N--CA 1.412 -2.921 0 C-N-CA 118.18 -1.962 . . . . 72.04 116.751 170.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 504' ' ' ILE . . . . . 0.51 HG23 ' CA ' ' A' ' 637' ' ' GLY . 3.5 mp -111.35 136.25 48.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 125.521 1.529 . . . . 73.11 111.471 -168.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -132.6 123.58 26.7 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.898 -0.779 . . . . 71.23 108.898 170.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 506' ' ' THR . . . . . 0.438 ' HB ' ' HA3' ' A' ' 637' ' ' GLY . 14.7 t -150.52 163.15 39.15 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.233 -0.654 . . . . 64.04 109.233 -176.093 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -84.35 159.74 20.81 Favored 'General case' 0 CA--C 1.495 -1.145 0 N-CA-C 108.486 -0.931 . . . . 73.01 108.486 173.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -81.34 -44.29 17.83 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.385 -0.968 . . . . 71.21 108.385 176.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 509' ' ' GLU . . . . . 0.553 ' HB3' ' O ' ' A' ' 655' ' ' THR . 10.6 pt-20 -124.93 137.06 28.9 Favored Pre-proline 0 C--N 1.313 -0.993 0 N-CA-C 109.076 -0.713 . . . . 75.2 109.076 177.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 510' ' ' PRO . . . . . 0.511 ' HA ' ' O ' ' A' ' 641' ' ' LYS . 94.6 Cg_endo -90.66 -6.72 4.19 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.0 1.8 . . . . 75.2 112.734 178.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 74.3 t -143.04 132.99 21.9 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.318 0 N-CA-C 107.02 -1.474 . . . . 74.33 107.02 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 4.1 t -141.42 143.63 34.02 Favored 'General case' 0 N--CA 1.411 -2.4 0 N-CA-C 106.697 -1.594 . . . . 75.15 106.697 178.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 513' ' ' HIS . . . . . 0.523 ' HB2' ' HB2' ' A' ' 653' ' ' LYS . 28.7 m-70 -114.52 127.85 56.02 Favored 'General case' 0 CA--C 1.484 -1.595 0 N-CA-C 107.471 -1.307 . . . . 70.02 107.471 177.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.625 HG11 ' SD ' ' A' ' 521' ' ' MET . 33.7 m -113.19 164.43 9.12 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.355 0 C-N-CA 120.271 -0.572 . . . . 52.43 110.853 -173.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 35.4 t -87.5 145.01 26.43 Favored 'General case' 0 N--CA 1.406 -2.657 0 N-CA-C 107.255 -1.387 . . . . 73.42 107.255 176.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 516' ' ' GLU . . . . . 0.628 ' OE1' 'CA ' ' A' ' 800' ' ' ' CA' . 32.6 tt0 -79.38 -9.98 59.71 Favored 'General case' 0 C--N 1.279 -2.495 0 CA-C-O 121.604 0.716 . . . . 72.14 109.801 177.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 39.3 m -97.62 17.06 18.65 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.508 0.67 . . . . 75.31 109.874 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 10.8 tt -96.38 158.25 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.366 0 N-CA-C 108.724 -0.843 . . . . 75.32 108.724 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -102.89 -59.35 0.74 Allowed Glycine 0 N--CA 1.43 -1.738 0 N-CA-C 111.018 -0.833 . . . . 75.15 111.018 178.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 520' ' ' ILE . . . . . 0.406 HD13 ' HA ' ' A' ' 574' ' ' LYS . 36.1 mm -123.36 126.85 73.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 109.224 -0.658 . . . . 61.53 109.224 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 521' ' ' MET . . . . . 0.625 ' SD ' HG11 ' A' ' 514' ' ' VAL . 25.3 ptt? -104.03 139.34 39.28 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.132 -1.062 . . . . 71.32 108.132 173.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -120.25 120.13 35.22 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 123.882 0.739 . . . . 74.31 110.72 177.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 523' ' ' VAL . . . . . 0.598 ' O ' ' HA ' ' A' ' 570' ' ' THR . 40.4 t -106.33 130.78 57.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 CA-C-N 115.56 -0.746 . . . . 74.34 109.831 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -77.93 131.84 37.63 Favored 'General case' 0 C--O 1.246 0.894 0 CA-C-O 121.784 0.802 . . . . 72.34 113.114 -177.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 11.4 t -114.7 135.22 55.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 107.42 -1.326 . . . . 65.42 107.42 177.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -82.55 151.22 26.52 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.416 0.626 . . . . 61.11 111.408 -175.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 527' ' ' ARG . . . . . 0.488 ' HD2' ' HA ' ' A' ' 567' ' ' ILE . 43.7 ttt-85 -98.47 143.55 28.78 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 114.658 -1.155 . . . . 63.55 110.447 -174.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 528' ' ' THR . . . . . 0.708 ' OG1' ' HA3' ' A' ' 503' ' ' GLY . 4.6 t -58.9 151.29 22.05 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.539 -0.755 . . . . 75.24 112.441 177.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 35.6 t -77.89 -17.94 56.75 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 115.224 -0.898 . . . . 62.12 108.736 176.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -109.87 52.52 0.63 Allowed Glycine 0 N--CA 1.442 -0.912 0 N-CA-C 111.232 -0.747 . . . . 63.15 111.232 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -82.36 92.61 7.02 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-O 121.543 0.687 . . . . 73.24 109.665 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 2.6 ppt_? -133.5 20.36 3.95 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 114.771 -1.104 . . . . 65.0 112.038 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . -177.16 -179.38 47.47 Favored Glycine 0 N--CA 1.427 -1.959 0 N-CA-C 109.524 -1.431 . . . . 63.03 109.524 -177.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 534' ' ' ASN . . . . . 0.509 HD21 ' HG3' ' A' ' 561' ' ' GLU . 2.5 t-20 -90.41 125.02 35.42 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.047 0.451 . . . . 74.15 110.082 -179.278 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 535' ' ' VAL . . . . . 0.467 HG22 HD22 ' A' ' 596' ' ' LEU . 60.1 t -123.95 128.39 74.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 107.533 -1.284 . . . . 72.22 107.533 176.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 536' ' ' ILE . . . . . 0.547 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 46.5 mm -99.57 135.82 33.36 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.238 0 N-CA-C 109.425 -0.583 . . . . 72.21 109.425 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 42.5 t -120.15 109.38 37.24 Favored Pre-proline 0 C--N 1.307 -1.268 0 CA-C-N 116.06 -0.518 . . . . 72.3 109.608 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -74.07 143.69 32.8 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.16 1.906 . . . . 72.0 111.64 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 539' ' ' TYR . . . . . 0.434 ' HB3' HG22 ' A' ' 591' ' ' ILE . 45.1 p90 -144.35 160.66 40.66 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.598 -0.519 . . . . 74.11 109.598 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -160.48 160.58 32.22 Favored 'General case' 0 C--O 1.243 0.721 0 O-C-N 123.788 0.68 . . . . 70.42 110.543 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 2.6 p -100.22 108.14 20.16 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 123.676 0.61 . . . . 71.43 111.53 176.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.5 mp -81.7 128.24 38.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 107.378 -1.341 . . . . 74.21 107.378 178.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -63.61 -62.94 1.33 Allowed 'General case' 0 C--O 1.237 0.413 0 O-C-N 123.585 0.553 . . . . 72.51 111.212 -178.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 72.71 -72.48 1.04 Allowed Glycine 0 C--O 1.227 -0.292 0 CA-C-N 116.256 -0.429 . . . . 75.4 112.205 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 545' ' ' THR . . . . . 0.472 HG23 ' H ' ' A' ' 586' ' ' THR . 6.0 t -138.59 -2.11 1.8 Allowed 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.056 0.455 . . . . 71.1 110.233 178.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -96.1 171.03 8.86 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 108.969 -0.752 . . . . 70.21 108.969 174.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 547' ' ' ARG . . . . . 0.473 ' HG3' ' HG3' ' A' ' 551' ' ' GLU . 2.3 tpt180 -115.65 112.46 22.14 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.902 -0.777 . . . . 73.32 108.902 -178.043 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -95.95 166.92 25.05 Favored Glycine 0 CA--C 1.499 -0.962 0 C-N-CA 121.408 -0.425 . . . . 52.35 113.409 -176.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 100.52 23.44 10.21 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 111.526 -0.63 . . . . 50.32 111.526 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 91.07 6.45 66.82 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.833 -0.698 . . . . 62.13 111.396 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 551' ' ' GLU . . . . . 0.473 ' HG3' ' HG3' ' A' ' 547' ' ' ARG . 12.3 mm-40 -76.18 -71.23 0.4 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.553 -0.536 . . . . 75.31 109.553 -178.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -111.4 -27.65 8.54 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.197 -1.409 . . . . 62.33 107.197 178.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -141.68 156.68 45.63 Favored 'General case' 0 C--O 1.256 1.415 0 CA-C-N 115.031 -0.986 . . . . 72.32 109.063 174.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 554' ' ' GLU . . . . . 0.413 ' HB3' ' HB3' ' A' ' 574' ' ' LYS . 0.4 OUTLIER -90.45 126.77 36.01 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 106.261 -1.755 . . . . 74.21 106.261 178.393 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -79.02 112.04 15.83 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.77 0.319 . . . . 74.23 111.784 -173.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 556' ' ' THR . . . . . 0.478 HG21 HG22 ' A' ' 573' ' ' VAL . 11.1 t -109.51 122.88 48.41 Favored 'General case' 0 N--CA 1.418 -2.026 0 CA-C-O 122.269 1.033 . . . . 75.44 110.052 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 1.7 p -142.07 133.04 25.93 Favored 'General case' 0 C--N 1.277 -2.572 0 CA-C-N 114.475 -1.239 . . . . 73.5 107.894 178.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 179.9 -148.98 8.28 Favored Glycine 0 N--CA 1.422 -2.289 0 N-CA-C 110.34 -1.104 . . . . 74.42 110.34 -176.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 559' ' ' GLU . . . . . 0.547 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 47.5 mt-10 -143.54 133.62 24.28 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 122.964 0.506 . . . . 73.52 110.706 -176.06 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 560' ' ' LEU . . . . . 0.408 ' HG ' ' CD1' ' A' ' 539' ' ' TYR . 87.4 mt -94.21 146.17 24.19 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 123.319 0.648 . . . . 74.3 110.117 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 561' ' ' GLU . . . . . 0.509 ' HG3' HD21 ' A' ' 534' ' ' ASN . 44.0 tt0 -105.67 112.85 26.09 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-O 121.075 0.464 . . . . 50.43 111.752 -178.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -109.66 144.07 38.53 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.59 -0.892 . . . . 73.32 108.59 171.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -145.99 -171.42 3.7 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.459 -0.941 . . . . 74.23 108.459 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 31.9 t30 -78.87 -39.15 35.98 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 107.24 -1.393 . . . . 74.54 107.24 172.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -88.45 -2.48 58.62 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.731 -1.122 . . . . 65.14 110.978 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -116.83 123.87 48.14 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.964 -0.754 . . . . 74.54 108.964 -178.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 567' ' ' ILE . . . . . 0.488 ' HA ' ' HD2' ' A' ' 527' ' ' ARG . 1.5 pp -119.13 139.91 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.73 0 N-CA-C 108.6 -0.889 . . . . 72.1 108.6 -178.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 1.2 p 56.11 160.18 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 C-N-CA 126.625 1.97 . . . . 61.21 113.462 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 569' ' ' LYS . . . . . 0.53 ' HE3' ' HA ' ' A' ' 569' ' ' LYS . 0.0 OUTLIER -148.03 162.89 38.44 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.511 -0.743 . . . . 70.32 109.089 175.444 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 570' ' ' THR . . . . . 0.598 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 11.7 p -135.1 134.3 40.13 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 123.921 0.763 . . . . 71.2 110.942 178.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 571' ' ' ILE . . . . . 0.476 HG12 HD11 ' A' ' 589' ' ' LEU . 3.1 mp -85.51 118.37 32.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 106.62 -1.622 . . . . 62.31 106.62 172.173 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 19.1 m -98.73 120.62 39.47 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 108.709 -0.848 . . . . 73.42 108.709 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 573' ' ' VAL . . . . . 0.478 HG22 HG21 ' A' ' 556' ' ' THR . 33.2 t -123.67 134.52 66.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 N-CA-C 109.15 -0.685 . . . . 63.14 109.15 -178.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 574' ' ' LYS . . . . . 0.413 ' HB3' ' HB3' ' A' ' 554' ' ' GLU . 57.9 tptt -88.25 116.26 26.32 Favored 'General case' 0 N--CA 1.435 -1.193 0 O-C-N 123.815 0.697 . . . . 74.22 109.221 177.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 59.1 t -87.03 133.8 29.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 107.72 -1.215 . . . . 70.21 107.72 178.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 42.8 mm -96.66 158.22 3.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 107.984 -1.117 . . . . 71.14 107.984 -177.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -67.78 119.48 12.55 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.645 -0.872 . . . . 73.32 108.645 176.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 578' ' ' ASP . . . . . 0.617 ' OD1' 'CA ' ' A' ' 850' ' ' ' CA' . 25.9 t0 -67.32 122.65 18.35 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 114.822 -1.081 . . . . 70.43 111.628 -173.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 579' ' ' GLU . . . . . 0.613 ' OE1' 'CA ' ' A' ' 850' ' ' ' CA' . 0.2 OUTLIER -87.57 -23.75 24.23 Favored 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 125.502 1.521 . . . . 71.43 113.557 -172.871 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 580' ' ' GLU . . . . . 0.622 ' OE2' 'CA ' ' A' ' 850' ' ' ' CA' . 0.1 OUTLIER -117.67 176.84 5.0 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 118.648 -1.221 . . . . 73.23 111.283 -177.057 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -60.59 154.37 21.29 Favored 'General case' 0 C--O 1.253 1.283 0 N-CA-C 108.256 -1.016 . . . . 61.33 108.256 174.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 582' ' ' GLU . . . . . 0.62 ' OE1' 'CA ' ' A' ' 800' ' ' ' CA' . 21.0 tp10 -84.25 101.55 11.99 Favored 'General case' 0 N--CA 1.414 -2.229 0 C-N-CA 118.049 -1.46 . . . . 50.13 114.091 -175.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -97.22 134.07 41.02 Favored 'General case' 0 N--CA 1.406 -2.665 0 N-CA-C 101.961 -3.348 . . . . 70.41 101.961 160.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -76.11 77.89 2.94 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-O 121.733 0.778 . . . . 73.22 112.391 -174.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.67 167.22 18.45 Favored 'General case' 0 N--CA 1.412 -2.357 0 N-CA-C 106.519 -1.66 . . . . 64.53 106.519 176.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 586' ' ' THR . . . . . 0.472 ' H ' HG23 ' A' ' 545' ' ' THR . 3.5 t -155.93 144.92 20.53 Favored 'General case' 0 N--CA 1.404 -2.741 0 C-N-CA 120.402 -0.519 . . . . 70.31 110.736 -176.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 587' ' ' PHE . . . . . 0.426 ' CE2' HD11 ' A' ' 646' ' ' ILE . 2.5 p90 -112.34 149.54 32.3 Favored 'General case' 0 N--CA 1.418 -2.028 0 CA-C-N 114.198 -1.364 . . . . 75.15 108.865 177.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 588' ' ' PHE . . . . . 0.412 ' CD1' ' HE3' ' A' ' 641' ' ' LYS . 17.5 m-85 -106.47 131.31 53.8 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 116.052 -0.522 . . . . 65.21 109.735 -173.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 589' ' ' LEU . . . . . 0.56 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.4 OUTLIER -102.77 118.44 36.83 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 105.016 -2.216 . . . . 73.1 105.016 173.231 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -129.82 144.51 51.34 Favored 'General case' 0 C--N 1.273 -2.728 0 N-CA-C 108.306 -0.998 . . . . 75.14 108.306 -178.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 591' ' ' ILE . . . . . 0.434 HG22 ' HB3' ' A' ' 539' ' ' TYR . 27.0 pt -106.27 152.76 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.853 0 N-CA-C 108.748 -0.834 . . . . 74.13 108.748 178.278 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -99.14 -163.74 29.75 Favored Glycine 0 N--CA 1.419 -2.46 0 N-CA-C 111.362 -0.695 . . . . 71.42 111.362 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -66.75 121.18 76.4 Favored Pre-proline 0 C--N 1.298 -1.645 0 C-N-CA 123.211 0.604 . . . . 75.43 110.612 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 594' ' ' PRO . . . . . 0.422 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 18.9 Cg_endo -67.25 140.84 54.73 Favored 'Trans proline' 0 N--CA 1.437 -1.819 0 C-N-CA 121.856 1.704 . . . . 62.5 110.461 176.032 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 595' ' ' ARG . . . . . 0.448 ' HG3' ' HB ' ' A' ' 536' ' ' ILE . 9.4 ptm180 -121.88 122.29 39.08 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 115.696 -0.683 . . . . 71.31 110.101 -173.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 596' ' ' LEU . . . . . 0.467 HD22 HG22 ' A' ' 535' ' ' VAL . 0.0 OUTLIER -75.51 123.9 26.25 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 107.858 -1.164 . . . . 55.14 107.858 179.282 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 21.8 t -89.85 70.62 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-O 122.418 1.104 . . . . 71.55 109.348 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -148.84 149.45 31.31 Favored 'General case' 0 C--N 1.261 -3.255 0 CA-C-N 113.915 -1.493 . . . . 54.13 108.146 174.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 599' ' ' MET . . . . . 0.456 ' HG3' ' O ' ' A' ' 599' ' ' MET . 14.6 ptm -84.99 113.91 21.78 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.575 -0.898 . . . . 63.24 108.575 176.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 49.3 m -123.17 102.48 7.98 Favored 'General case' 0 C--N 1.276 -2.602 0 CA-C-O 121.257 0.551 . . . . 34.54 110.746 177.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -150.02 124.13 9.43 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.28 -0.873 . . . . 70.3 109.897 178.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 602' ' ' LYS . . . . . 0.609 ' HE2' ' HA ' ' A' ' 602' ' ' LYS . 0.3 OUTLIER -126.26 96.84 4.84 Favored 'General case' 0 N--CA 1.416 -2.163 0 N-CA-C 106.767 -1.568 . . . . 72.51 106.767 175.95 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 603' ' ' LYS . . . . . 0.44 ' O ' ' HD3' ' A' ' 603' ' ' LYS . 0.0 OUTLIER -131.37 139.6 49.51 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.447 -0.797 . . . . 74.13 111.817 -178.196 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -112.27 -45.74 0.78 Allowed Glycine 0 C--N 1.288 -2.111 0 N-CA-C 110.096 -1.202 . . . . 55.51 110.096 177.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 153.09 -102.85 0.23 Allowed Glycine 0 N--CA 1.425 -2.067 0 C-N-CA 120.772 -0.728 . . . . 71.41 111.827 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -62.51 94.42 0.06 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.844 0.831 . . . . 74.11 112.786 -177.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 1.3 p -145.95 135.64 23.3 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.367 -0.833 . . . . 62.51 111.115 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 62.6 mt -103.06 112.29 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.814 0 N-CA-C 107.496 -1.298 . . . . 73.51 107.496 176.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 15.4 t -176.36 159.5 2.0 Allowed 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.107 -1.442 . . . . 74.25 107.107 -177.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -115.08 80.94 1.49 Allowed 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.441 0.639 . . . . 73.33 109.437 174.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -84.39 100.56 11.38 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 114.884 -1.053 . . . . 63.12 109.829 178.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -86.6 134.46 33.63 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.479 -0.782 . . . . 75.12 111.665 -175.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 613' ' ' ASP . . . . . 0.434 ' HA ' ' NH2' ' A' ' 633' ' ' ARG . 23.6 m-20 -117.41 11.45 13.92 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 106.76 -1.57 . . . . 73.55 106.76 171.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -57.21 128.46 37.09 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 113.219 -1.81 . . . . 72.25 111.494 -179.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -87.42 94.86 9.82 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.869 0.842 . . . . 71.12 111.572 -178.26 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -101.13 164.04 16.81 Favored Pre-proline 0 C--N 1.302 -1.462 0 CA-C-N 114.992 -1.004 . . . . 75.41 109.041 178.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -70.31 -177.17 1.92 Allowed 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 121.517 1.478 . . . . 73.43 109.552 173.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.403 ' HG ' ' HB3' ' A' ' 636' ' ' LEU . 3.4 mm? -75.87 103.77 6.1 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 121.824 0.821 . . . . 53.54 110.719 -179.231 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 9.9 t -162.65 167.55 22.99 Favored 'General case' 0 N--CA 1.416 -2.161 0 N-CA-C 106.639 -1.615 . . . . 72.01 106.639 -177.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 11.2 t -120.39 -13.06 8.89 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.161 -1.051 . . . . 61.41 108.161 173.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 621' ' ' LYS . . . . . 0.503 ' HA ' ' HE3' ' A' ' 621' ' ' LYS . 0.0 OUTLIER 58.5 18.49 5.74 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 123.68 0.792 . . . . 61.14 111.994 179.637 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 57.99 30.01 18.55 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 124.633 1.173 . . . . 64.24 111.68 -177.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -105.55 135.5 46.83 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 116.256 -0.429 . . . . 72.51 110.804 -178.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -61.82 -37.6 85.04 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.755 -0.832 . . . . 61.33 108.755 175.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -58.45 -35.44 72.14 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.57 -1.196 . . . . 74.33 110.254 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 626' ' ' ARG . . . . . 0.431 ' O ' ' HG3' ' A' ' 630' ' ' GLU . 14.3 tpp180 -77.93 -29.26 49.92 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 120.511 -0.476 . . . . 74.42 109.816 -175.415 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 627' ' ' ARG . . . . . . . . . . . . . 21.7 mmm180 -60.92 -38.51 86.0 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 122.083 0.944 . . . . 73.33 109.729 178.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 77.2 mt -66.6 -41.64 88.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 CA-C-N 113.874 -1.512 . . . . 63.01 110.296 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -68.69 -40.74 79.94 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.705 -0.68 . . . . 54.33 110.274 177.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 630' ' ' GLU . . . . . 0.431 ' HG3' ' O ' ' A' ' 626' ' ' ARG . 45.4 mt-10 -66.36 -19.71 65.88 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 121.375 0.607 . . . . 61.0 111.243 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 631' ' ' MET . . . . . 0.614 ' O ' ' HA ' ' A' ' 501' ' ' HIS . 56.9 ttp -76.85 -30.15 56.17 Favored 'General case' 0 N--CA 1.414 -2.261 0 CA-C-N 115.828 -0.624 . . . . 74.2 110.194 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -99.96 -27.23 7.96 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.329 -0.939 . . . . 71.03 112.39 -178.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 633' ' ' ARG . . . . . 0.434 ' NH2' ' HA ' ' A' ' 613' ' ' ASP . 67.9 mtt-85 -102.34 149.62 36.81 Favored Pre-proline 0 C--N 1.305 -1.344 0 N-CA-C 109.347 -0.612 . . . . 71.21 109.347 -177.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.422 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 39.7 Cg_endo -74.83 142.68 28.75 Favored 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 121.635 1.556 . . . . 55.13 110.548 177.322 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 635' ' ' ILE . . . . . 0.48 HD13 ' H ' ' A' ' 635' ' ' ILE . 0.1 OUTLIER -131.97 -170.77 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 CA-C-O 121.126 0.489 . . . . 75.22 109.899 -177.911 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 636' ' ' LEU . . . . . 0.403 ' HB3' ' HG ' ' A' ' 618' ' ' LEU . 0.0 OUTLIER -83.78 160.53 21.2 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 115.791 -0.641 . . . . 74.34 111.196 -178.827 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 637' ' ' GLY . . . . . 0.51 ' CA ' HG23 ' A' ' 504' ' ' ILE . . . -85.81 -98.53 0.74 Allowed Glycine 0 CA--C 1.483 -1.928 0 CA-C-N 115.337 -0.847 . . . . 64.42 111.771 177.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -114.52 -49.29 2.83 Favored 'General case' 0 C--N 1.281 -2.392 0 C-N-CA 119.752 -0.779 . . . . 73.54 110.151 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -131.4 119.15 21.24 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.958 0.885 . . . . 61.11 113.099 -176.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 23.8 p -115.27 91.15 3.52 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 107.385 -1.339 . . . . 65.14 107.385 173.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 641' ' ' LYS . . . . . 0.511 ' O ' ' HA ' ' A' ' 510' ' ' PRO . 22.6 tptm -175.27 137.04 0.38 Allowed 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 106.434 -1.691 . . . . 71.52 106.434 -174.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 642' ' ' LEU . . . . . 0.573 HD21 HG21 ' A' ' 523' ' ' VAL . 38.7 tp -140.69 105.07 4.85 Favored 'General case' 0 C--N 1.277 -2.55 0 N-CA-C 107.961 -1.125 . . . . 73.13 107.961 172.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -94.35 105.05 17.03 Favored 'General case' 0 C--N 1.276 -2.625 0 N-CA-C 106.646 -1.613 . . . . 70.13 106.646 178.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 644' ' ' VAL . . . . . 0.547 HG21 ' HE1' ' A' ' 521' ' ' MET . 32.5 t -94.28 106.15 17.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-N 115.765 -0.652 . . . . 45.24 109.571 -177.252 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 3.7 mp -89.36 126.32 42.33 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 N-CA-C 108.026 -1.101 . . . . 72.22 108.026 179.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 646' ' ' ILE . . . . . 0.446 HD12 ' H ' ' A' ' 646' ' ' ILE . 1.7 mp -104.54 140.29 23.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 107.866 -1.161 . . . . 74.24 107.866 -177.142 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -158.4 140.05 13.63 Favored 'General case' 0 N--CA 1.429 -1.508 0 O-C-N 123.722 0.638 . . . . 74.41 110.822 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -41.62 136.5 1.86 Allowed 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.138 1.375 . . . . 73.55 110.561 176.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 34.9 t -33.31 104.93 0.03 OUTLIER 'General case' 0 C--O 1.243 0.72 0 C-N-CA 126.518 1.927 . . . . 63.01 114.238 -171.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -120.77 -63.93 1.3 Allowed 'General case' 0 N--CA 1.426 -1.668 0 CA-C-N 113.423 -1.717 . . . . 74.34 107.808 175.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -176.25 168.5 2.82 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 105.781 -1.933 . . . . 73.31 105.781 -177.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -104.09 127.13 51.65 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 108.182 -1.044 . . . . 74.25 108.182 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 653' ' ' LYS . . . . . 0.523 ' HB2' ' HB2' ' A' ' 513' ' ' HIS . 31.9 mmmt -110.36 93.88 4.72 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 116.486 -0.324 . . . . 63.32 111.421 -176.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 34.9 t -100.12 115.01 28.81 Favored 'General case' 0 N--CA 1.423 -1.805 0 N-CA-C 104.447 -2.427 . . . . 70.34 104.447 170.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 655' ' ' THR . . . . . 0.553 ' O ' ' HB3' ' A' ' 509' ' ' GLU . 8.9 t -107.71 131.79 54.04 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-O 121.453 0.645 . . . . 75.1 110.936 -176.173 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 7.7 p -83.18 131.93 32.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.12 -1.067 . . . . 74.55 108.12 176.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 14.6 t70 . . . . . 0 C--N 1.307 -1.27 0 CA-C-N 116.527 -0.306 . . . . 61.1 111.06 -177.456 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 800' ' ' ' CA' . . . . . 0.628 'CA ' ' OE1' ' A' ' 516' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 850' ' ' ' CA' . . . . . 0.622 'CA ' ' OE2' ' A' ' 580' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 8.1 p80 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 121.861 0.839 . . . . 62.22 108.874 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -162.8 -49.85 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 107.078 -1.453 . . . . 74.22 107.078 -177.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 503' ' ' GLY . . . . . 0.428 ' HA2' ' O ' ' A' ' 530' ' ' GLY . . . 108.53 145.74 11.65 Favored Glycine 0 N--CA 1.433 -1.543 0 CA-C-N 115.029 -0.987 . . . . 72.34 113.758 174.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 1.7 mp -107.24 130.31 59.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 N-CA-C 107.956 -1.127 . . . . 53.02 107.956 177.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 505' ' ' PHE . . . . . 0.429 ' HA ' ' O ' ' A' ' 526' ' ' LEU . 97.9 m-85 -116.21 121.39 41.91 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.115 0.483 . . . . 65.14 111.071 -178.224 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 11.8 t -139.39 156.19 47.15 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.037 -1.098 . . . . 52.25 108.037 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -82.65 154.41 24.92 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.526 -0.916 . . . . 71.33 108.526 174.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -77.29 -27.71 53.12 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 109.301 -0.629 . . . . 65.04 109.301 176.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -140.51 135.99 16.29 Favored Pre-proline 0 C--N 1.315 -0.897 0 N-CA-C 108.878 -0.786 . . . . 73.43 108.878 177.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 510' ' ' PRO . . . . . 0.4 ' HA ' ' O ' ' A' ' 641' ' ' LYS . 73.5 Cg_endo -85.13 -13.84 6.26 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 121.765 1.643 . . . . 72.21 111.654 178.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 511' ' ' VAL . . . . . 0.447 HG22 ' HB3' ' A' ' 643' ' ' GLU . 71.7 t -139.0 133.85 41.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 107.693 -1.225 . . . . 63.14 107.693 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 5.4 t -134.05 136.21 43.86 Favored 'General case' 0 N--CA 1.402 -2.834 0 N-CA-C 108.077 -1.083 . . . . 72.03 108.077 178.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 32.6 m-70 -108.37 114.75 28.85 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.541 -0.911 . . . . 73.43 108.541 177.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 16.7 m -118.93 162.49 17.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 CA-C-N 115.935 -0.575 . . . . 55.2 110.093 -174.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 62.2 m -81.2 148.92 29.3 Favored 'General case' 0 N--CA 1.392 -3.37 0 N-CA-C 108.096 -1.075 . . . . 71.4 108.096 178.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -85.55 -22.35 28.15 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 118.719 -1.192 . . . . 73.34 110.632 176.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 16.0 m -90.12 30.39 1.1 Allowed 'General case' 0 C--N 1.293 -1.874 0 CA-C-O 121.605 0.717 . . . . 74.25 110.023 -176.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 13.7 tt -112.81 150.87 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.015 0 N-CA-C 107.342 -1.355 . . . . 65.42 107.342 -178.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 519' ' ' GLY . . . . . 0.55 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . -81.83 -61.93 1.99 Allowed Glycine 0 N--CA 1.426 -1.975 0 C-N-CA 120.098 -1.049 . . . . 45.24 111.06 178.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 35.8 mm -120.82 133.45 67.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 CA-C-N 115.482 -0.359 . . . . 74.22 110.199 -177.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 521' ' ' MET . . . . . 0.494 ' HE2' HG21 ' A' ' 644' ' ' VAL . 0.0 OUTLIER -116.28 141.23 48.42 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.147 -1.427 . . . . 75.1 107.147 171.302 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 522' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 44.9 mt-10 -126.38 145.28 50.52 Favored 'General case' 0 C--N 1.316 -0.89 0 O-C-N 123.584 0.552 . . . . 72.41 111.445 -178.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 523' ' ' VAL . . . . . 0.677 HG21 HD21 ' A' ' 642' ' ' LEU . 30.2 t -132.58 138.99 50.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 108.512 -0.921 . . . . 65.34 108.512 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -84.0 133.17 34.69 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 113.043 0.757 . . . . 74.21 113.043 -177.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 525' ' ' VAL . . . . . 0.613 ' O ' ' HA ' ' A' ' 568' ' ' VAL . 10.7 t -113.46 125.49 70.74 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 N-CA-C 106.725 -1.583 . . . . 61.14 106.725 177.117 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 526' ' ' LEU . . . . . 0.429 ' O ' ' HA ' ' A' ' 505' ' ' PHE . 2.1 mm? -91.3 140.81 29.43 Favored 'General case' 0 C--N 1.28 -2.427 0 CA-C-O 120.794 0.331 . . . . 60.32 110.397 -176.043 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 527' ' ' ARG . . . . . 0.479 ' HG3' HH11 ' A' ' 527' ' ' ARG . 27.9 ttt85 -114.24 93.78 4.51 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 105.06 -2.2 . . . . 62.01 105.06 173.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 1.4 p -121.55 -168.68 1.73 Allowed 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 114.712 -1.131 . . . . 70.23 111.967 -173.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 39.6 m 35.01 32.62 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 126.419 1.888 . . . . 70.03 114.134 -172.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 530' ' ' GLY . . . . . 0.428 ' O ' ' HA2' ' A' ' 503' ' ' GLY . . . 129.43 151.95 7.47 Favored Glycine 0 N--CA 1.418 -2.53 0 N-CA-C 111.67 -0.572 . . . . 71.2 111.67 178.013 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -127.75 -125.44 0.23 Allowed 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 107.798 -1.186 . . . . 53.13 107.798 176.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 69.37 127.29 0.03 OUTLIER 'General case' 0 C--O 1.244 0.77 0 C-N-CA 124.516 1.126 . . . . 73.33 113.593 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 533' ' ' GLY . . . . . 0.453 ' H ' ' HB3' ' A' ' 564' ' ' ASN . . . 86.81 162.36 37.32 Favored Glycine 0 N--CA 1.437 -1.278 0 CA-C-N 115.125 -0.943 . . . . 53.21 113.316 175.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -90.81 122.96 33.98 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.271 -1.381 . . . . 74.11 107.271 176.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 62.4 t -125.31 125.67 69.45 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 N-CA-C 109.58 -0.526 . . . . 71.22 109.58 -178.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 536' ' ' ILE . . . . . 0.449 ' O ' ' HG2' ' A' ' 595' ' ' ARG . 40.1 mm -100.25 125.37 54.02 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 N-CA-C 108.396 -0.964 . . . . 61.31 108.396 177.207 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 537' ' ' VAL . . . . . 0.504 HG22 ' HB3' ' A' ' 594' ' ' PRO . 38.6 t -113.54 107.54 53.03 Favored Pre-proline 0 C--N 1.296 -1.757 0 CA-C-N 116.368 -0.378 . . . . 73.51 110.391 -177.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -74.59 147.19 35.48 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.408 2.072 . . . . 74.02 111.308 178.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 539' ' ' TYR . . . . . 0.4 ' CD2' ' HG ' ' A' ' 560' ' ' LEU . 50.6 p90 -147.85 156.9 43.21 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 108.255 -1.017 . . . . 75.23 108.255 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.96 150.9 28.8 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 123.399 0.437 . . . . 72.23 111.42 178.161 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 1.1 p -87.54 118.17 26.84 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 123.684 0.794 . . . . 74.34 112.075 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.419 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 3.7 mp -84.83 123.66 39.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 107.545 -1.28 . . . . 74.25 107.545 176.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -54.3 -54.02 45.87 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 124.225 1.01 . . . . 71.4 113.059 -175.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 72.18 -90.37 0.51 Allowed Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.898 -0.668 . . . . 63.45 112.203 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 8.9 t -124.84 -0.78 7.93 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 121.935 0.874 . . . . 73.25 109.299 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -94.9 175.79 6.51 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.586 -0.734 . . . . 54.14 109.926 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 547' ' ' ARG . . . . . 0.495 ' N ' ' HD2' ' A' ' 547' ' ' ARG . 4.5 mpt_? -101.58 173.05 6.6 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.716 -0.22 . . . . 74.2 111.296 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -62.54 -175.42 2.52 Favored Glycine 0 C--O 1.252 1.23 0 N-CA-C 116.116 1.206 . . . . 72.24 116.116 -174.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . -58.9 119.93 20.16 Favored Glycine 0 N--CA 1.439 -1.113 0 CA-C-N 114.087 -1.056 . . . . 61.23 114.362 -175.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 83.89 4.98 88.33 Favored Glycine 0 N--CA 1.438 -1.189 0 CA-C-N 115.287 -0.456 . . . . 72.24 112.028 176.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -103.04 -67.22 0.89 Allowed 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 108.408 -0.96 . . . . 54.32 108.408 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 552' ' ' ASP . . . . . 0.643 ' OD2' 'CA ' ' A' ' 850' ' ' ' CA' . 12.8 t70 -104.54 -38.33 6.81 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.764 0.793 . . . . 75.4 109.125 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -138.17 160.77 38.56 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 108.276 -1.009 . . . . 73.12 108.276 176.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -86.42 110.34 19.66 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 105.411 -2.07 . . . . 74.42 105.411 176.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -67.61 100.83 0.93 Allowed 'General case' 0 CA--C 1.485 -1.54 0 CA-C-N 115.551 -0.749 . . . . 74.45 110.587 -174.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 556' ' ' THR . . . . . 0.524 HG21 HG22 ' A' ' 573' ' ' VAL . 9.6 t -97.98 95.88 7.78 Favored 'General case' 0 N--CA 1.393 -3.298 0 CA-C-O 123.31 1.529 . . . . 74.11 110.019 -177.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 1.9 p -115.44 97.76 6.35 Favored 'General case' 0 N--CA 1.399 -2.976 0 CA-C-N 113.015 -1.902 . . . . 61.3 106.93 176.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -152.79 -156.21 7.45 Favored Glycine 0 N--CA 1.402 -3.586 0 N-CA-C 110.612 -0.995 . . . . 63.14 110.612 -172.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 559' ' ' GLU . . . . . 0.441 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 41.5 mt-10 -137.11 135.82 37.77 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-O 120.717 0.294 . . . . 74.35 110.885 -171.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 560' ' ' LEU . . . . . 0.434 ' HB3' ' HG2' ' A' ' 569' ' ' LYS . 80.2 mt -93.92 138.11 32.41 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 109.284 -0.636 . . . . 71.4 109.284 175.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -103.39 106.32 16.8 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.77 -0.65 . . . . 74.23 111.385 -175.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 562' ' ' PHE . . . . . 0.569 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 88.7 m-85 -109.15 143.57 38.37 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 116.088 -0.506 . . . . 75.31 109.8 176.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -119.24 -167.88 1.48 Allowed 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 108.154 -1.054 . . . . 75.41 108.154 -178.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 564' ' ' ASN . . . . . 0.453 ' HB3' ' H ' ' A' ' 533' ' ' GLY . 27.6 p-10 -78.33 -42.15 31.5 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 109.636 -0.505 . . . . 72.42 109.636 178.139 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -89.35 -29.69 18.94 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.575 -0.738 . . . . 72.12 110.684 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -79.37 108.19 12.7 Favored 'General case' 0 C--O 1.248 1.012 0 CA-C-N 115.878 -0.601 . . . . 74.14 110.17 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 567' ' ' ILE . . . . . 0.43 ' O ' HG12 ' A' ' 568' ' ' VAL . 6.1 pt -110.17 166.19 5.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 108.049 -1.093 . . . . 71.04 108.049 174.094 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 568' ' ' VAL . . . . . 0.613 ' HA ' ' O ' ' A' ' 525' ' ' VAL . 0.9 OUTLIER 58.77 155.83 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.56 1.336 0 C-N-CA 125.681 1.592 . . . . 73.45 112.564 -178.814 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 569' ' ' LYS . . . . . 0.569 ' HB2' ' CZ ' ' A' ' 562' ' ' PHE . 0.0 OUTLIER -161.94 166.62 25.87 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 106.985 -1.487 . . . . 64.44 106.985 179.492 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 570' ' ' THR . . . . . 0.616 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 7.0 p -127.52 138.68 52.98 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 123.427 0.454 . . . . 65.01 111.363 175.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 571' ' ' ILE . . . . . 0.466 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 3.2 mp -88.61 115.18 28.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 106.763 -1.569 . . . . 72.31 106.763 171.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 24.2 p -92.82 109.49 20.92 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 109.365 -0.606 . . . . 73.04 109.365 178.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 573' ' ' VAL . . . . . 0.524 HG22 HG21 ' A' ' 556' ' ' THR . 43.6 t -112.69 129.94 67.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 N-CA-C 109.328 -0.619 . . . . 75.15 109.328 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 574' ' ' LYS . . . . . 0.55 ' HA ' ' O ' ' A' ' 519' ' ' GLY . 86.9 tttt -89.09 124.12 34.02 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 123.814 0.696 . . . . 61.43 110.156 176.373 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 46.5 t -91.07 131.61 37.78 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 N-CA-C 108.312 -0.996 . . . . 74.45 108.312 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 576' ' ' ILE . . . . . 0.411 ' HB ' ' O ' ' A' ' 552' ' ' ASP . 30.1 mm -101.03 160.65 3.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 107.784 -1.191 . . . . 74.41 107.784 -177.513 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -76.91 147.73 36.82 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 110.061 -0.348 . . . . 60.15 110.061 177.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 578' ' ' ASP . . . . . 0.637 ' OD2' 'CA ' ' A' ' 800' ' ' ' CA' . 5.5 m-20 -69.98 132.4 45.87 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 114.55 1.315 . . . . 72.21 114.55 -175.066 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 579' ' ' GLU . . . . . 0.631 ' OE2' 'CA ' ' A' ' 850' ' ' ' CA' . 0.0 OUTLIER -96.59 -26.27 15.3 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 112.533 -2.121 . . . . 74.12 111.394 179.599 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 580' ' ' GLU . . . . . 0.435 ' HG2' ' O ' ' A' ' 581' ' ' TYR . 0.1 OUTLIER -105.11 -174.97 2.66 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 107.192 -1.41 . . . . 70.23 107.192 178.813 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 581' ' ' TYR . . . . . 0.435 ' O ' ' HG2' ' A' ' 580' ' ' GLU . 24.6 p90 -69.25 145.14 53.38 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 106.31 -1.737 . . . . 75.42 106.31 176.131 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 582' ' ' GLU . . . . . 0.604 ' OE1' 'CA ' ' A' ' 800' ' ' ' CA' 0.528 18.6 pt-20 -93.79 121.03 34.81 Favored 'General case' 0 N--CA 1.408 -2.56 0 N-CA-C 117.673 2.472 . . . . 73.44 117.673 -175.133 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.19 170.94 11.88 Favored 'General case' 0 N--CA 1.417 -2.108 0 CA-C-N 111.407 -2.633 . . . . 72.55 106.476 178.051 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -67.71 119.31 12.24 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.36 0.6 . . . . 61.31 109.468 -177.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 585' ' ' LYS . . . . . 0.498 ' HD2' HD13 ' A' ' 646' ' ' ILE . 1.6 tmmm? -122.58 142.51 50.55 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-N 115.003 -0.999 . . . . 74.43 109.911 -171.171 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 6.8 t -148.22 142.99 26.7 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-O 121.14 0.495 . . . . 53.32 110.698 -175.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -129.64 148.23 51.51 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-N 114.113 -1.403 . . . . 75.33 109.802 177.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 588' ' ' PHE . . . . . 0.507 ' HA ' ' O ' ' A' ' 642' ' ' LEU . 27.2 m-85 -104.14 138.3 40.83 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.978 -0.556 . . . . 74.42 109.672 -176.036 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 589' ' ' LEU . . . . . 0.583 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.5 OUTLIER -113.01 115.24 28.08 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 105.642 -1.985 . . . . 73.4 105.642 175.573 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -125.59 133.37 52.3 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 109.148 -0.686 . . . . 64.33 109.148 178.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 591' ' ' ILE . . . . . . . . . . . . . 22.0 pt -85.58 146.96 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-N 115.808 -0.633 . . . . 71.13 109.412 178.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -93.54 -148.43 23.6 Favored Glycine 0 N--CA 1.427 -1.905 0 C-N-CA 120.911 -0.662 . . . . 71.33 111.496 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -75.56 117.04 60.42 Favored Pre-proline 0 C--N 1.295 -1.786 0 N-CA-C 108.866 -0.79 . . . . 71.3 108.866 178.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 594' ' ' PRO . . . . . 0.504 ' HB3' HG22 ' A' ' 537' ' ' VAL . 57.8 Cg_endo -72.81 134.34 21.68 Favored 'Trans proline' 0 N--CA 1.433 -2.045 0 C-N-CA 121.573 1.515 . . . . 61.11 109.408 176.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 595' ' ' ARG . . . . . 0.449 ' HG2' ' O ' ' A' ' 536' ' ' ILE . 14.2 ptm180 -108.29 121.15 44.31 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-O 121.028 0.442 . . . . 73.02 111.057 -172.336 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -76.7 118.44 19.33 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 105.786 -1.931 . . . . 71.03 105.786 176.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 21.4 t -83.49 72.8 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 CA-C-O 121.905 0.859 . . . . 73.04 109.46 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -124.64 -27.32 3.7 Favored 'General case' 0 C--N 1.276 -2.62 0 CA-C-N 114.003 -1.453 . . . . 73.1 110.218 172.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 58.7 mtm 61.57 31.92 18.74 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.178 0.991 . . . . 73.44 111.119 175.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 29.1 t -113.96 142.54 46.01 Favored 'General case' 0 N--CA 1.423 -1.803 0 CA-C-N 115.841 -0.618 . . . . 75.13 110.522 -175.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.57 97.55 6.96 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-N 115.4 -0.818 . . . . 74.52 109.147 177.358 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 65.4 tttp -141.86 148.87 39.49 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.194 -0.669 . . . . 74.32 109.194 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? 73.24 -46.88 0.65 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.454 1.502 . . . . 74.21 112.174 178.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 604' ' ' GLY . . . . . 0.463 ' HA3' ' HA ' ' A' ' 629' ' ' ALA . . . -84.05 -69.05 1.39 Allowed Glycine 0 N--CA 1.436 -1.304 0 N-CA-C 111.167 -0.773 . . . . 63.52 111.167 178.03 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . -61.06 110.0 2.79 Favored Glycine 0 N--CA 1.442 -0.91 0 O-C-N 123.844 0.379 . . . . 75.22 113.194 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -89.53 -25.96 21.12 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.625 -0.88 . . . . 73.1 108.625 176.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 5.4 p -76.29 151.26 36.8 Favored 'General case' 0 N--CA 1.416 -2.139 0 CA-C-N 114.827 -1.079 . . . . 72.54 110.455 178.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 23.5 mt -86.9 16.26 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 CA-C-O 123.265 1.507 . . . . 72.5 108.9 -176.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 92.5 m -152.72 131.57 12.47 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 107.099 -1.445 . . . . 65.03 107.099 179.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -78.77 83.75 4.89 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 108.38 -0.97 . . . . 71.0 108.38 176.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.31 136.17 34.46 Favored 'General case' 0 N--CA 1.421 -1.893 0 CA-C-N 115.737 -0.665 . . . . 73.52 112.403 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 59.43 66.16 1.06 Allowed 'General case' 0 C--O 1.243 0.728 0 C-N-CA 125.016 1.326 . . . . 74.31 112.327 -176.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -98.59 100.32 11.54 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 122.205 1.003 . . . . 74.54 109.239 177.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -120.21 118.65 31.03 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.404 -0.816 . . . . 63.22 109.107 -178.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -77.73 106.82 9.79 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 122.185 0.993 . . . . 60.14 111.539 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -117.42 176.63 1.51 Allowed Pre-proline 0 C--N 1.288 -2.099 0 CA-C-N 113.394 -1.73 . . . . 73.33 107.315 -176.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -67.01 167.34 20.12 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 N-CA-C 108.037 -1.563 . . . . 74.44 108.037 169.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -62.2 104.36 0.47 Allowed 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.346 0.593 . . . . 74.1 111.824 -176.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 7.3 p -135.33 143.6 46.24 Favored 'General case' 0 N--CA 1.423 -1.806 0 CA-C-N 114.864 -1.062 . . . . 70.25 109.231 -178.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 50.6 m -129.74 -5.09 4.62 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 120.489 -0.485 . . . . 71.43 111.785 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 621' ' ' LYS . . . . . 0.493 ' HA ' ' HE3' ' A' ' 621' ' ' LYS . 1.1 tpmt? 60.96 16.01 6.6 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.614 0.766 . . . . 73.15 110.599 176.149 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 66.27 7.58 4.99 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.921 1.289 . . . . 71.24 112.068 -174.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -79.7 121.9 25.9 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 109.334 -0.617 . . . . 75.11 109.334 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 624' ' ' GLU . . . . . 0.436 ' O ' HG13 ' A' ' 628' ' ' ILE . 45.7 mt-10 -61.96 -37.9 86.49 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.597 -0.274 . . . . 64.22 111.695 -179.014 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -71.38 -22.02 61.94 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.239 0.543 . . . . 72.3 111.547 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 626' ' ' ARG . . . . . . . . . . . . . 24.2 tpt180 -80.82 -36.37 31.71 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 107.437 -1.32 . . . . 75.41 107.437 174.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 627' ' ' ARG . . . . . . . . . . . . . 84.8 mtt180 -61.99 -38.92 90.4 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.893 -0.594 . . . . 63.13 110.258 175.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 628' ' ' ILE . . . . . 0.462 ' O ' ' HB3' ' A' ' 631' ' ' MET . 98.8 mt -65.14 -36.61 78.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 123.078 0.551 . . . . 72.45 110.932 176.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 629' ' ' ALA . . . . . 0.463 ' HA ' ' HA3' ' A' ' 604' ' ' GLY . . . -69.98 -44.57 69.17 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 109.662 -0.496 . . . . 52.14 109.662 177.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -79.43 4.59 15.03 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.463 -0.789 . . . . 74.1 111.119 -178.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 631' ' ' MET . . . . . 0.462 ' HB3' ' O ' ' A' ' 628' ' ' ILE . 46.0 ttm -79.05 -27.57 43.14 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 108.542 -0.91 . . . . 65.35 108.542 174.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -84.51 -9.93 80.6 Favored Glycine 0 CA--C 1.503 -0.658 0 N-CA-C 110.458 -1.057 . . . . 53.42 110.458 177.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -91.7 148.1 36.51 Favored Pre-proline 0 C--N 1.305 -1.359 0 CA-C-N 114.394 -0.903 . . . . 73.01 108.919 178.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.441 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 4.9 Cg_endo -75.5 154.52 40.22 Favored 'Trans proline' 0 N--CA 1.44 -1.645 0 N-CA-C 107.073 -1.933 . . . . 72.02 107.073 166.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.6 pp -135.48 173.66 13.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 C-N-CA 118.804 -1.158 . . . . 72.33 113.928 -175.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 636' ' ' LEU . . . . . 0.422 ' HB2' HG21 ' A' ' 640' ' ' THR . 0.0 OUTLIER -75.67 146.99 39.8 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.969 -1.014 . . . . 73.34 110.232 -179.149 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -94.04 -132.16 6.39 Favored Glycine 0 C--N 1.289 -2.044 0 CA-C-N 115.604 -0.725 . . . . 75.12 113.821 -176.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -69.68 -56.48 7.12 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 111.955 0.354 . . . . 61.3 111.955 -175.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -137.07 114.62 11.08 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.889 0.852 . . . . 72.15 112.274 -178.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 640' ' ' THR . . . . . 0.422 HG21 ' HB2' ' A' ' 636' ' ' LEU . 17.5 p -119.68 91.84 3.64 Favored 'General case' 0 N--CA 1.416 -2.158 0 CA-C-N 115.219 -0.9 . . . . 74.03 110.568 177.391 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 641' ' ' LYS . . . . . 0.439 ' HE3' ' HB2' ' A' ' 643' ' ' GLU . 0.3 OUTLIER -178.71 126.0 0.1 Allowed 'General case' 0 CA--C 1.482 -1.642 0 N-CA-C 103.988 -2.597 . . . . 74.0 103.988 176.49 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 642' ' ' LEU . . . . . 0.677 HD21 HG21 ' A' ' 523' ' ' VAL . 51.7 tp -115.82 112.99 22.77 Favored 'General case' 0 C--N 1.263 -3.189 0 N-CA-C 108.653 -0.869 . . . . 73.35 108.653 177.27 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 643' ' ' GLU . . . . . 0.447 ' HB3' HG22 ' A' ' 511' ' ' VAL . 19.3 tt0 -97.55 103.47 15.41 Favored 'General case' 0 C--N 1.273 -2.734 0 N-CA-C 107.204 -1.406 . . . . 62.11 107.204 178.042 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 644' ' ' VAL . . . . . 0.494 HG21 ' HE2' ' A' ' 521' ' ' MET . 21.8 t -91.95 106.74 18.05 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.289 0 N-CA-C 108.15 -1.056 . . . . 63.2 108.15 -178.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 4.0 mp -90.99 115.87 31.05 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.293 0 N-CA-C 107.019 -1.475 . . . . 74.41 107.019 173.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 646' ' ' ILE . . . . . 0.498 HD13 ' HD2' ' A' ' 585' ' ' LYS . 3.2 mp -101.9 112.05 33.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 107.606 -1.257 . . . . 74.54 107.606 -175.363 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -111.2 138.2 47.94 Favored 'General case' 0 C--N 1.275 -2.671 0 CA-C-N 115.629 -0.714 . . . . 73.31 110.889 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 648' ' ' GLU . . . . . 0.635 ' OE2' 'CA ' ' A' ' 800' ' ' ' CA' . 9.5 mp0 -48.75 136.17 14.01 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.888 -1.051 . . . . 74.01 110.811 178.336 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 8.6 t -86.67 81.71 8.13 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 122.191 0.995 . . . . 61.34 109.987 -175.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -105.46 -49.3 3.47 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 113.769 -1.56 . . . . 72.32 107.813 173.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 651' ' ' GLU . . . . . 0.637 ' HG3' ' H ' ' A' ' 652' ' ' PHE . 9.3 tp10 -157.99 -161.14 0.98 Allowed 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 103.179 -2.897 . . . . 73.31 103.179 -178.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 652' ' ' PHE . . . . . 0.637 ' H ' ' HG3' ' A' ' 651' ' ' GLU . 11.1 t80 -148.03 162.37 39.5 Favored 'General case' 0 C--N 1.276 -2.595 0 N-CA-C 105.37 -2.085 . . . . 72.21 105.37 177.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.83 -74.93 0.59 Allowed 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 120.545 -0.462 . . . . 71.13 110.69 -179.056 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 44.4 p 55.25 18.16 2.36 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 124.547 1.139 . . . . 72.31 112.483 -176.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 7.5 p -86.21 125.29 33.44 Favored 'General case' 0 N--CA 1.423 -1.79 0 CA-C-N 115.409 -0.814 . . . . 53.24 110.668 -177.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 7.2 p -98.4 125.15 51.81 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.082 0 N-CA-C 108.182 -1.044 . . . . 70.54 108.182 178.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 13.6 t70 . . . . . 0 C--N 1.299 -1.607 0 C-N-CA 119.732 -0.787 . . . . 73.35 110.391 -176.008 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 800' ' ' ' CA' . . . . . 0.637 'CA ' ' OD2' ' A' ' 578' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 850' ' ' ' CA' . . . . . 0.643 'CA ' ' OD2' ' A' ' 552' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.469 0.49 0 CA-C-O 121.743 0.783 . . . . 74.32 110.087 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -178.61 -169.37 0.17 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 104.75 -2.315 . . . . 42.22 104.75 -177.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 503' ' ' GLY . . . . . 0.461 ' HA2' ' OG1' ' A' ' 528' ' ' THR . . . -164.08 130.64 2.25 Favored Glycine 0 N--CA 1.406 -3.314 0 C-N-CA 118.015 -2.04 . . . . 74.12 113.486 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 2.8 mp -81.84 102.03 7.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 107.483 -1.303 . . . . 64.2 107.483 174.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 505' ' ' PHE . . . . . 0.413 ' O ' ' HA3' ' A' ' 637' ' ' GLY . 42.9 m-85 -115.5 124.02 50.03 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.043 -1.095 . . . . 73.3 108.043 178.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 11.6 t -155.71 168.75 26.17 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.343 -0.984 . . . . 74.33 108.343 -174.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -87.43 151.4 23.09 Favored 'General case' 0 CA--C 1.494 -1.19 0 N-CA-C 107.639 -1.245 . . . . 72.14 107.639 175.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -87.0 -39.49 15.62 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 109.367 -0.605 . . . . 72.43 109.367 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -110.08 128.63 25.04 Favored Pre-proline 0 N--CA 1.437 -1.084 0 N-CA-C 108.469 -0.937 . . . . 73.33 108.469 176.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -79.42 -14.65 12.93 Favored 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 121.93 1.753 . . . . 64.34 112.373 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 511' ' ' VAL . . . . . 0.553 HG22 ' HB3' ' A' ' 643' ' ' GLU . 73.6 t -138.99 135.76 42.57 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.854 0 N-CA-C 108.755 -0.832 . . . . 63.44 108.755 -178.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 3.5 t -137.76 138.47 39.3 Favored 'General case' 0 N--CA 1.408 -2.536 0 N-CA-C 107.8 -1.185 . . . . 73.11 107.8 177.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 513' ' ' HIS . . . . . 0.536 ' CE1' ' HA ' ' A' ' 654' ' ' SER . 23.4 m-70 -108.57 124.53 50.61 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 108.366 -0.976 . . . . 71.04 108.366 178.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 32.1 m -123.2 159.49 27.29 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.383 0 CA-C-O 121.433 0.635 . . . . 62.42 111.777 -173.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 41.2 m -75.58 152.33 37.73 Favored 'General case' 0 N--CA 1.399 -3.002 0 CA-C-N 114.012 -1.449 . . . . 71.41 109.961 -179.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 516' ' ' GLU . . . . . 0.673 ' OE2' 'CA ' ' A' ' 800' ' ' ' CA' . 21.7 tt0 -78.08 -48.38 16.19 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 121.408 0.623 . . . . 62.21 111.889 178.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 29.7 m -90.3 38.61 0.94 Allowed 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 122.157 0.979 . . . . 63.42 110.12 -171.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 17.4 tt -105.79 155.83 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.433 0 N-CA-C 105.855 -1.906 . . . . 65.02 105.855 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 519' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . -89.93 -57.08 1.75 Allowed Glycine 0 C--N 1.289 -2.063 0 C-N-CA 119.108 -1.52 . . . . 75.22 111.185 178.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 34.3 mm -126.29 136.41 60.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 CA-C-N 115.27 -0.465 . . . . 71.12 109.847 -176.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 521' ' ' MET . . . . . 0.637 ' HE2' HG21 ' A' ' 644' ' ' VAL . 0.0 OUTLIER -114.19 130.74 56.61 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 106.419 -1.697 . . . . 71.32 106.419 170.161 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -113.07 122.84 48.78 Favored 'General case' 0 C--N 1.313 -1.019 0 O-C-N 123.379 0.425 . . . . 72.42 110.265 -176.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 523' ' ' VAL . . . . . 0.62 ' O ' ' HA ' ' A' ' 570' ' ' THR . 43.4 t -103.32 126.76 57.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 CA-C-N 116.246 -0.433 . . . . 43.45 110.521 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 27.8 mmtp -78.22 134.96 37.51 Favored 'General case' 0 C--N 1.317 -0.843 0 O-C-N 123.853 0.721 . . . . 73.51 111.801 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 21.5 t -115.0 142.12 29.06 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 N-CA-C 108.656 -0.868 . . . . 53.55 108.656 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -69.57 167.47 16.78 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-O 122.305 1.05 . . . . 73.14 113.448 -178.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 527' ' ' ARG . . . . . 0.432 HH11 ' HD3' ' A' ' 527' ' ' ARG . 3.4 tpm_? -106.88 158.81 16.73 Favored 'General case' 0 N--CA 1.426 -1.668 0 CA-C-N 114.027 -1.442 . . . . 73.43 109.574 -175.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 528' ' ' THR . . . . . 0.461 ' OG1' ' HA2' ' A' ' 503' ' ' GLY . 3.3 t -73.03 160.5 31.97 Favored 'General case' 0 N--CA 1.432 -1.374 0 C-N-CA 124.003 0.921 . . . . 50.44 110.215 176.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 22.2 t -85.2 -11.67 54.41 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 108.575 -0.898 . . . . 62.52 108.575 178.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -146.51 100.74 0.23 Allowed Glycine 0 N--CA 1.438 -1.194 0 N-CA-C 109.943 -1.263 . . . . 72.03 109.943 177.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -90.36 88.55 7.24 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.115 0.483 . . . . 60.0 111.754 -176.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 -137.76 100.23 4.13 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.373 -0.973 . . . . 74.43 108.373 174.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 123.17 154.63 9.07 Favored Glycine 0 N--CA 1.429 -1.825 0 C-N-CA 120.117 -1.039 . . . . 71.43 112.365 178.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 534' ' ' ASN . . . . . 0.471 ' HA ' ' HA ' ' A' ' 563' ' ' GLN . 46.7 t30 -98.54 119.94 38.11 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-O 121.375 0.607 . . . . 74.32 109.557 176.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 535' ' ' VAL . . . . . 0.528 HG22 HD22 ' A' ' 596' ' ' LEU . 89.9 t -122.45 135.59 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-N 115.124 -0.944 . . . . 64.11 109.202 -179.227 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 536' ' ' ILE . . . . . 0.593 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 43.3 mm -102.81 133.4 46.66 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.062 0 N-CA-C 108.961 -0.755 . . . . 74.32 108.961 178.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 63.6 t -119.55 110.36 37.31 Favored Pre-proline 0 C--N 1.297 -1.683 0 N-CA-C 109.772 -0.455 . . . . 74.12 109.772 178.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -74.11 152.73 45.94 Favored 'Trans proline' 0 C--O 1.24 0.592 0 C-N-CA 122.644 2.229 . . . . 74.23 111.93 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 539' ' ' TYR . . . . . 0.534 ' HB3' HG22 ' A' ' 591' ' ' ILE . 53.7 p90 -152.61 159.5 43.23 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.676 -0.861 . . . . 71.22 108.676 -178.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 540' ' ' LYS . . . . . 0.414 ' HE3' HD11 ' A' ' 542' ' ' ILE . 0.1 OUTLIER -161.35 150.96 16.72 Favored 'General case' 0 C--N 1.309 -1.16 0 O-C-N 123.613 0.57 . . . . 70.41 110.23 179.025 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 7.3 p -82.17 121.93 27.24 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 114.98 -1.009 . . . . 74.23 110.858 173.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.426 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 3.5 mp -93.17 118.49 39.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 105.259 -2.126 . . . . 71.11 105.259 171.373 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 543' ' ' GLU . . . . . 0.452 ' CD ' ' H ' ' A' ' 543' ' ' GLU . 1.6 mp0 -48.15 -55.36 10.54 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 124.316 1.046 . . . . 73.22 112.406 -175.093 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 72.47 -102.3 1.17 Allowed Glycine 0 N--CA 1.442 -0.939 0 N-CA-C 110.702 -0.959 . . . . 54.45 110.702 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 11.4 t -118.68 -0.36 11.32 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 122.334 1.064 . . . . 73.04 109.359 177.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -88.62 143.61 26.83 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 108.342 -0.984 . . . . 61.11 108.342 173.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 547' ' ' ARG . . . . . 0.483 ' HG3' ' HG3' ' A' ' 551' ' ' GLU . 27.6 tpt180 -90.19 119.13 30.25 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.826 -0.805 . . . . 75.25 108.826 179.039 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -86.45 174.29 46.69 Favored Glycine 0 C--N 1.306 -1.13 0 C-N-CA 120.503 -0.856 . . . . 71.12 113.15 -176.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 86.0 36.2 10.38 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 121.148 -0.549 . . . . 75.54 113.416 176.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 87.87 10.8 68.95 Favored Glycine 0 N--CA 1.44 -1.055 0 C-N-CA 120.261 -0.971 . . . . 42.45 112.82 176.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 551' ' ' GLU . . . . . 0.483 ' HG3' ' HG3' ' A' ' 547' ' ' ARG . 7.8 mm-40 -92.72 -71.83 0.63 Allowed 'General case' 0 C--O 1.213 -0.862 0 N-CA-C 109.412 -0.588 . . . . 74.31 109.412 179.032 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 552' ' ' ASP . . . . . 0.606 ' OD1' 'CA ' ' A' ' 850' ' ' ' CA' . 56.5 m-20 -97.55 -30.05 13.09 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 108.626 -0.879 . . . . 74.22 108.626 176.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 553' ' ' PHE . . . . . 0.504 ' HB3' ' CE2' ' A' ' 587' ' ' PHE . 46.4 p90 -149.76 155.24 39.81 Favored 'General case' 0 N--CA 1.419 -1.989 0 CA-C-N 115.312 -0.858 . . . . 65.14 110.198 178.357 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -82.54 123.2 28.97 Favored 'General case' 0 C--N 1.276 -2.6 0 N-CA-C 104.48 -2.415 . . . . 74.44 104.48 175.058 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -60.77 121.11 11.47 Favored 'General case' 0 CA--C 1.488 -1.423 0 CA-C-O 122.237 1.017 . . . . 60.32 111.575 -175.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 556' ' ' THR . . . . . 0.44 HG21 HG22 ' A' ' 573' ' ' VAL . 98.4 m -120.22 112.64 19.32 Favored 'General case' 0 N--CA 1.388 -3.555 0 CA-C-N 114.5 -1.227 . . . . 51.04 111.806 -171.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 20.7 p -145.63 128.97 16.83 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.846 -1.168 . . . . 73.54 107.846 176.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -165.86 -155.61 8.84 Favored Glycine 0 N--CA 1.422 -2.295 0 C-N-CA 120.462 -0.875 . . . . 61.33 111.139 -176.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 559' ' ' GLU . . . . . 0.593 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 42.1 mt-10 -143.09 125.63 15.8 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 123.06 0.544 . . . . 65.42 110.269 -176.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 560' ' ' LEU . . . . . 0.441 ' HG ' ' CE1' ' A' ' 539' ' ' TYR . 87.7 mt -88.7 135.79 33.33 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 122.723 0.409 . . . . 75.14 110.776 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 561' ' ' GLU . . . . . 0.433 ' HA ' HD13 ' A' ' 536' ' ' ILE . 45.4 tt0 -96.38 108.57 21.11 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.601 -0.727 . . . . 73.32 110.593 179.179 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 562' ' ' PHE . . . . . 0.423 ' CE1' ' HG2' ' A' ' 569' ' ' LYS . 8.0 m-85 -107.74 116.92 32.82 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.234 -0.654 . . . . 74.42 109.234 173.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 563' ' ' GLN . . . . . 0.509 ' HG3' ' H ' ' A' ' 566' ' ' GLU . 9.3 pt20 -119.56 -175.26 2.91 Favored 'General case' 0 C--N 1.29 -1.995 0 C-N-CA 119.068 -1.053 . . . . 73.12 112.023 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -59.06 -47.53 84.9 Favored 'General case' 0 C--N 1.318 -0.774 0 O-C-N 123.86 0.725 . . . . 75.21 109.667 177.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -77.74 -67.19 0.75 Allowed 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.278 -0.873 . . . . 63.03 111.233 -178.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 566' ' ' GLU . . . . . 0.509 ' H ' ' HG3' ' A' ' 563' ' ' GLN . 15.3 tt0 -56.27 113.86 1.74 Allowed 'General case' 0 C--O 1.247 0.922 0 O-C-N 123.783 0.677 . . . . 72.21 112.629 -178.387 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 10.4 pt -102.36 169.14 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.407 -2.591 0 N-CA-C 106.64 -1.615 . . . . 71.41 106.64 173.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 1.7 p 40.55 124.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.559 1.306 0 C-N-CA 127.069 2.147 . . . . 54.33 116.628 177.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 569' ' ' LYS . . . . . 0.426 ' HD2' ' HA ' ' A' ' 569' ' ' LYS . 32.8 mmmt -116.85 157.43 25.63 Favored 'General case' 0 C--N 1.265 -3.103 0 CA-C-N 114.921 -1.036 . . . . 71.12 110.16 178.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 570' ' ' THR . . . . . 0.62 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 1.8 p -129.88 125.27 35.2 Favored 'General case' 0 C--N 1.278 -2.538 0 CA-C-N 114.784 -1.098 . . . . 44.05 111.307 179.049 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 3.6 mp -84.52 111.12 19.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 106.277 -1.749 . . . . 71.14 106.277 173.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 3.1 p -95.66 109.45 21.72 Favored 'General case' 0 N--CA 1.417 -2.093 0 O-C-N 123.87 0.731 . . . . 73.4 109.918 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 573' ' ' VAL . . . . . 0.44 HG22 HG21 ' A' ' 556' ' ' THR . 59.9 t -111.82 133.68 56.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 108.916 -0.772 . . . . 64.14 108.916 -178.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 574' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 519' ' ' GLY . 41.4 ttmt -84.81 117.14 23.68 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-O 121.444 0.64 . . . . 75.31 109.676 177.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 60.2 t -89.44 143.74 10.56 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 N-CA-C 107.08 -1.452 . . . . 71.11 107.08 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 576' ' ' ILE . . . . . 0.435 HG12 ' HA ' ' A' ' 553' ' ' PHE . 26.0 mm -111.81 132.3 60.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 C-N-CA 119.975 -0.69 . . . . 72.55 109.196 -177.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -59.65 137.53 58.01 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.301 -0.863 . . . . 73.03 108.873 178.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 578' ' ' ASP . . . . . 0.596 ' OD2' 'CA ' ' A' ' 800' ' ' ' CA' 0.413 15.9 m-20 -59.31 119.65 7.81 Favored 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 117.144 2.276 . . . . 70.23 117.144 -171.968 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 579' ' ' GLU . . . . . 0.437 ' H ' ' CD ' ' A' ' 579' ' ' GLU . 6.1 pm0 -97.07 -14.07 21.81 Favored 'General case' 0 N--CA 1.401 -2.888 0 CA-C-N 110.483 -3.053 . . . . 62.43 112.948 -172.374 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 580' ' ' GLU . . . . . 0.621 ' HG2' ' O ' ' A' ' 581' ' ' TYR . 2.4 pm0 -128.5 -167.23 1.74 Allowed 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 122.897 0.479 . . . . 71.33 110.016 -173.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 581' ' ' TYR . . . . . 0.621 ' O ' ' HG2' ' A' ' 580' ' ' GLU . 52.5 p90 -58.3 153.41 15.44 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 107.709 -1.219 . . . . 71.44 107.709 170.195 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -93.34 134.44 35.55 Favored 'General case' 0 C--N 1.275 -2.668 0 C-N-CA 116.654 -2.019 . . . . 65.13 113.36 -176.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 583' ' ' LYS . . . . . 0.407 ' HE2' ' HB3' ' A' ' 585' ' ' LYS . 0.0 OUTLIER -145.93 130.79 18.12 Favored 'General case' 0 N--CA 1.412 -2.331 0 N-CA-C 104.584 -2.376 . . . . 70.33 104.584 171.253 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -66.3 123.72 20.72 Favored 'General case' 0 CA--C 1.488 -1.434 0 N-CA-C 107.364 -1.347 . . . . 72.13 107.364 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 585' ' ' LYS . . . . . 0.407 ' HB3' ' HE2' ' A' ' 583' ' ' LYS . 0.0 OUTLIER -128.87 166.71 18.56 Favored 'General case' 0 C--N 1.285 -2.216 0 CA-C-N 115.604 -0.725 . . . . 71.14 109.902 -168.527 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 6.5 t -156.22 145.41 20.59 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-O 120.797 0.332 . . . . 61.52 110.866 -173.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 587' ' ' PHE . . . . . 0.504 ' CE2' ' HB3' ' A' ' 553' ' ' PHE . 3.4 p90 -125.33 147.76 49.01 Favored 'General case' 0 N--CA 1.42 -1.965 0 O-C-N 125.068 1.48 . . . . 64.32 109.644 176.575 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 588' ' ' PHE . . . . . 0.426 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 20.7 m-85 -100.95 127.4 47.46 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.393 -0.966 . . . . 63.45 108.393 -176.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 589' ' ' LEU . . . . . 0.498 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.5 OUTLIER -100.96 117.19 34.53 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 104.898 -2.26 . . . . 62.12 104.898 175.707 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -126.13 125.9 43.28 Favored 'General case' 0 C--N 1.281 -2.372 0 C-N-CA 120.233 -0.587 . . . . 72.43 109.708 -177.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 591' ' ' ILE . . . . . 0.534 HG22 ' HB3' ' A' ' 539' ' ' TYR . 14.8 pt -87.44 138.67 18.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 N-CA-C 107.828 -1.175 . . . . 52.22 107.828 173.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -98.88 -136.91 9.54 Favored Glycine 0 N--CA 1.429 -1.819 0 C-N-CA 120.381 -0.914 . . . . 64.24 114.023 -173.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.577 ' OE1' ' HA ' ' A' ' 617' ' ' PRO . 23.5 tt0 -84.64 118.36 70.86 Favored Pre-proline 0 C--N 1.294 -1.842 0 C-N-CA 124.555 1.142 . . . . 61.14 110.133 -176.261 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.11 150.82 72.61 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.354 2.036 . . . . 72.3 111.488 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 595' ' ' ARG . . . . . 0.4 ' CG ' ' HB ' ' A' ' 536' ' ' ILE . 10.8 ptm180 -132.57 132.11 42.21 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 109.429 -0.582 . . . . 72.4 109.429 -177.102 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 596' ' ' LEU . . . . . 0.528 HD22 HG22 ' A' ' 535' ' ' VAL . 0.0 OUTLIER -80.09 134.61 36.2 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.336 -1.357 . . . . 74.43 107.336 -178.605 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 597' ' ' VAL . . . . . 0.466 HG21 ' ND2' ' A' ' 534' ' ' ASN . 58.1 t -81.78 -49.05 18.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-O 121.868 0.842 . . . . 65.53 109.098 178.086 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -89.34 99.69 12.64 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 114.619 -1.173 . . . . 60.23 108.69 -177.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 4.5 tpt -81.31 86.18 6.29 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 121.194 0.521 . . . . 70.2 109.835 -177.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 30.6 m -141.72 156.52 45.6 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.846 -0.798 . . . . 75.42 108.846 178.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -104.82 142.65 34.34 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 120.857 0.361 . . . . 70.15 110.252 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -140.68 127.23 20.13 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 106.918 -1.512 . . . . 74.13 106.918 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 603' ' ' LYS . . . . . 0.411 ' HE2' ' HA ' ' A' ' 603' ' ' LYS . 4.4 mmpt? 64.65 23.17 12.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 123.465 0.478 . . . . 71.43 111.497 -178.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -102.25 -127.02 5.98 Favored Glycine 0 N--CA 1.42 -2.374 0 C-N-CA 120.795 -0.717 . . . . 73.45 111.501 -176.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 149.47 -137.01 6.02 Favored Glycine 0 N--CA 1.416 -2.695 0 N-CA-C 107.803 -2.119 . . . . 71.12 107.803 -176.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -149.09 107.38 3.76 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 117.595 0.698 . . . . 75.04 110.775 176.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 22.0 p -84.85 127.19 34.03 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 107.029 -1.471 . . . . 74.34 107.029 171.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 41.4 mt -73.9 99.0 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 109.047 -0.723 . . . . 74.11 109.047 -177.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 8.9 t -143.89 167.99 21.01 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 114.935 -1.029 . . . . 74.2 108.813 -176.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -97.16 4.72 51.04 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.004 0.43 . . . . 71.33 110.082 -177.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -70.24 83.78 0.55 Allowed 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 113.666 0.987 . . . . 62.03 113.666 -177.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -104.22 84.83 2.27 Favored 'General case' 0 CA--C 1.475 -1.931 0 N-CA-C 107.7 -1.222 . . . . 74.21 107.7 171.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -81.3 108.78 15.21 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 114.299 -1.319 . . . . 72.4 109.238 -176.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -97.21 92.7 6.14 Favored 'General case' 0 C--N 1.28 -2.438 0 C-N-CA 119.447 -0.901 . . . . 65.01 109.37 175.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 22.2 pttm 42.21 47.88 4.14 Favored 'General case' 0 C--N 1.319 -0.737 0 O-C-N 125.356 1.66 . . . . 71.41 114.329 177.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -78.67 162.88 63.81 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 108.749 -0.834 . . . . 74.23 108.749 176.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 617' ' ' PRO . . . . . 0.577 ' HA ' ' OE1' ' A' ' 593' ' ' GLU . 32.4 Cg_exo -63.47 -165.1 0.05 OUTLIER 'Trans proline' 0 C--O 1.25 1.084 0 C-N-CA 122.703 2.269 . . . . 62.53 112.664 176.402 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -55.57 116.22 2.77 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.78 0.8 . . . . 72.21 109.889 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 1.2 p -129.32 -173.82 3.11 Favored 'General case' 0 C--N 1.287 -2.118 0 CA-C-N 114.77 -1.104 . . . . 73.3 109.751 -174.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 620' ' ' SER . . . . . 0.456 ' OG ' ' HB3' ' A' ' 626' ' ' ARG . 30.0 t 72.23 24.59 3.05 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 123.833 0.708 . . . . 74.23 112.629 174.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.68 -8.09 58.41 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.141 -0.623 . . . . 71.3 110.782 178.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -115.41 -59.48 2.0 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.246 0.546 . . . . 71.33 110.874 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 623' ' ' GLU . . . . . 0.432 ' HB2' ' HB2' ' A' ' 626' ' ' ARG . 9.0 mm-40 -73.92 125.14 27.54 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.748 -0.66 . . . . 74.44 111.485 -176.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -76.15 -33.59 59.38 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.528 -0.76 . . . . 74.42 108.966 178.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -66.54 -23.69 66.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.634 -0.712 . . . . 54.32 110.367 177.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 626' ' ' ARG . . . . . 0.492 ' O ' ' HG2' ' A' ' 630' ' ' GLU . 0.5 OUTLIER -66.86 -41.21 87.71 Favored 'General case' 0 C--O 1.205 -1.258 0 CA-C-N 115.306 -0.861 . . . . 75.44 109.38 176.617 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 627' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -61.89 -24.08 66.72 Favored 'General case' 0 C--O 1.22 -0.494 0 CA-C-N 116.048 -0.524 . . . . 65.21 111.543 -178.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 74.5 mt -71.05 -43.9 75.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 121.652 0.739 . . . . 75.44 109.341 176.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -72.02 -38.26 69.6 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.377 -0.829 . . . . 61.54 109.603 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 630' ' ' GLU . . . . . 0.492 ' HG2' ' O ' ' A' ' 626' ' ' ARG . 24.0 mm-40 -74.61 -4.11 35.19 Favored 'General case' 0 C--O 1.211 -0.969 0 CA-C-N 115.627 -0.715 . . . . 64.43 110.972 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 631' ' ' MET . . . . . . . . . . . . . 44.4 ttm -81.52 -11.24 59.25 Favored 'General case' 0 N--CA 1.422 -1.839 0 N-CA-C 108.757 -0.831 . . . . 72.21 108.757 177.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -93.85 5.34 72.73 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 108.789 -1.724 . . . . 62.12 108.789 172.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 80.7 mtt180 -125.26 174.17 4.17 Favored Pre-proline 0 N--CA 1.428 -1.557 0 C-N-CA 125.632 1.573 . . . . 74.3 107.963 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -94.26 151.47 2.05 Favored 'Trans proline' 0 N--CA 1.428 -2.336 0 C-N-CA 121.504 1.47 . . . . 74.05 110.816 173.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.2 pp -112.91 173.37 2.81 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 CA-C-N 116.375 -0.375 . . . . 63.15 111.451 -178.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 636' ' ' LEU . . . . . 0.448 HD11 HG21 ' A' ' 640' ' ' THR . 14.0 tp -78.91 158.37 28.07 Favored 'General case' 0 N--CA 1.433 -1.296 0 O-C-N 123.182 0.301 . . . . 73.34 110.432 -177.422 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 637' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' A' ' 505' ' ' PHE . . . -76.44 -107.04 0.13 Allowed Glycine 0 N--CA 1.435 -1.424 0 N-CA-C 115.032 0.773 . . . . 25.14 115.032 -177.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -127.5 -70.66 0.7 Allowed 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.033 -0.729 . . . . 65.54 109.033 -175.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 12.8 p80 -132.84 114.76 14.46 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 109.059 -0.719 . . . . 75.3 109.059 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 640' ' ' THR . . . . . 0.448 HG21 HD11 ' A' ' 636' ' ' LEU . 30.8 p -98.46 91.3 5.12 Favored 'General case' 0 N--CA 1.407 -2.622 0 CA-C-O 121.626 0.727 . . . . 65.01 109.885 -178.136 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 641' ' ' LYS . . . . . 0.418 ' HE3' ' CD1' ' A' ' 588' ' ' PHE . 23.4 tptm -170.96 129.9 0.77 Allowed 'General case' 0 CA--C 1.498 -1.036 0 CA-C-N 115.437 -0.801 . . . . 75.23 109.311 -179.047 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 642' ' ' LEU . . . . . 0.569 HD21 HG21 ' A' ' 523' ' ' VAL . 27.8 tp -137.08 109.88 7.59 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 107.45 -1.315 . . . . 64.31 107.45 172.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 643' ' ' GLU . . . . . 0.553 ' HB3' HG22 ' A' ' 511' ' ' VAL . 19.3 tt0 -94.34 104.1 16.09 Favored 'General case' 0 C--N 1.273 -2.741 0 N-CA-C 107.12 -1.437 . . . . 70.32 107.12 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 644' ' ' VAL . . . . . 0.637 HG21 ' HE2' ' A' ' 521' ' ' MET . 25.4 t -95.56 108.01 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.194 0 N-CA-C 109.559 -0.534 . . . . 74.41 109.559 -177.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 3.5 mp -94.84 124.81 47.49 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 107.233 -1.395 . . . . 52.11 107.233 177.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 646' ' ' ILE . . . . . 0.519 HD12 ' N ' ' A' ' 646' ' ' ILE . 2.8 mp -104.35 115.68 46.72 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.438 0 N-CA-C 107.601 -1.259 . . . . 75.43 107.601 -174.245 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -121.16 168.92 11.05 Favored 'General case' 0 N--CA 1.419 -2.007 0 O-C-N 123.608 0.568 . . . . 55.45 109.585 -175.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -69.95 157.9 36.61 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 112.766 0.654 . . . . 65.43 112.766 -172.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 20.2 t -75.94 85.37 2.86 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 106.573 -1.64 . . . . 64.02 106.573 175.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -163.33 -66.9 0.04 OUTLIER 'General case' 0 N--CA 1.433 -1.315 0 C-N-CA 124.977 1.311 . . . . 74.42 108.077 -174.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -161.81 -174.11 4.03 Favored 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 106.4 -1.704 . . . . 74.34 106.4 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -126.6 154.52 43.83 Favored 'General case' 0 N--CA 1.397 -3.082 0 N-CA-C 108.164 -1.05 . . . . 54.4 108.164 178.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -115.44 67.43 0.7 Allowed 'General case' 0 C--N 1.271 -2.808 0 N-CA-C 105.782 -1.933 . . . . 72.33 105.782 177.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 654' ' ' SER . . . . . 0.536 ' HA ' ' CE1' ' A' ' 513' ' ' HIS . 41.0 m -61.79 94.43 0.05 OUTLIER 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 114.88 -1.055 . . . . 75.24 110.342 -177.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 4.2 t -94.98 80.22 3.64 Favored 'General case' 0 N--CA 1.405 -2.712 0 CA-C-O 121.977 0.894 . . . . 42.23 111.794 -177.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 5.1 p -90.76 82.33 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.081 0 N-CA-C 106.397 -1.705 . . . . 51.24 106.397 172.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 9.3 t70 . . . . . 0 C--N 1.289 -2.053 0 CA-C-N 112.739 -2.028 . . . . 73.21 109.844 -169.565 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 800' ' ' ' CA' . . . . . 0.673 'CA ' ' OE2' ' A' ' 516' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 850' ' ' ' CA' . . . . . 0.606 'CA ' ' OD1' ' A' ' 552' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 17.2 t-160 . . . . . 0 N--CA 1.454 -0.269 0 CA-C-O 120.917 0.389 . . . . 72.34 111.714 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 502' ' ' ALA . . . . . 0.401 ' HB3' ' HA ' ' A' ' 634' ' ' PRO . . . -115.07 -40.18 3.52 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.533 -0.914 . . . . 31.32 108.533 171.335 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 503' ' ' GLY . . . . . 0.64 ' HA2' ' OG1' ' A' ' 528' ' ' THR . . . -171.14 139.67 5.54 Favored Glycine 0 N--CA 1.415 -2.738 0 C-N-CA 119.214 -1.47 . . . . 64.23 113.063 179.219 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 3.7 mp -116.31 112.39 39.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 107.1 -1.444 . . . . 55.14 107.1 175.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -119.7 125.56 48.98 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.57 -0.9 . . . . 65.05 108.57 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 506' ' ' THR . . . . . 0.439 ' HB ' ' HA3' ' A' ' 637' ' ' GLY . 15.1 t -155.44 169.44 24.25 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 109.77 -0.456 . . . . 74.14 109.77 -174.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -98.81 161.15 13.8 Favored 'General case' 0 C--O 1.249 1.063 0 N-CA-C 106.243 -1.762 . . . . 71.52 106.243 172.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 508' ' ' GLU . . . . . 0.427 ' HG2' HD21 ' A' ' 526' ' ' LEU . 3.4 pt-20 -99.17 -27.93 13.58 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 120.387 -0.525 . . . . 75.41 110.734 176.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -114.26 119.16 40.85 Favored Pre-proline 0 N--CA 1.43 -1.463 0 N-CA-C 107.647 -1.242 . . . . 74.25 107.647 174.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -83.39 -4.28 10.92 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 121.902 1.735 . . . . 65.41 111.951 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 511' ' ' VAL . . . . . 0.429 HG13 ' CD1' ' A' ' 645' ' ' ILE . 88.3 t -143.27 134.9 23.66 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.069 0 N-CA-C 108.036 -1.098 . . . . 63.23 108.036 -179.113 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 4.7 t -139.5 151.49 46.19 Favored 'General case' 0 N--CA 1.404 -2.766 0 N-CA-C 108.099 -1.075 . . . . 50.15 108.099 176.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 513' ' ' HIS . . . . . 0.441 ' CD2' ' HB ' ' A' ' 645' ' ' ILE . 47.0 m80 -117.3 116.86 28.05 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 109.168 -0.678 . . . . 71.33 109.168 179.146 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.673 HG11 ' SD ' ' A' ' 521' ' ' MET . 31.0 m -111.6 153.13 13.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 C-N-CA 120.469 -0.492 . . . . 73.4 110.909 -177.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 515' ' ' SER . . . . . 0.502 ' HA ' ' OE2' ' A' ' 647' ' ' GLU . 40.5 t -76.59 143.88 39.97 Favored 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 114.945 -1.025 . . . . 64.31 109.715 -178.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 516' ' ' GLU . . . . . 0.639 ' OE2' 'CA ' ' A' ' 800' ' ' ' CA' . 35.4 tt0 -68.71 -10.24 55.22 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.449 0.643 . . . . 51.11 111.195 178.023 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 20.5 t -115.49 21.93 13.61 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 109.317 -0.623 . . . . 65.01 109.317 -177.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 518' ' ' ILE . . . . . 0.428 HG22 ' O ' ' A' ' 515' ' ' SER . 15.1 tt -90.29 151.0 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 N-CA-C 108.847 -0.797 . . . . 71.53 108.847 178.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -96.35 -63.94 0.94 Allowed Glycine 0 N--CA 1.429 -1.822 0 C-N-CA 120.05 -1.071 . . . . 62.22 111.517 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 30.3 mm -119.04 118.18 56.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 109.635 -0.505 . . . . 73.45 109.635 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 521' ' ' MET . . . . . 0.673 ' SD ' HG11 ' A' ' 514' ' ' VAL . 25.1 ptt? -99.91 129.48 46.0 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 107.153 -1.425 . . . . 74.02 107.153 173.081 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 522' ' ' GLU . . . . . 0.565 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 30.9 mt-10 -117.43 130.18 56.3 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.849 -0.614 . . . . 72.15 109.95 175.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 523' ' ' VAL . . . . . 0.565 HG21 HD21 ' A' ' 642' ' ' LEU . 29.3 t -113.52 130.08 68.18 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 CA-C-N 115.207 -0.906 . . . . 75.22 109.117 -178.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 524' ' ' LYS . . . . . 0.523 ' HD2' HG21 ' A' ' 568' ' ' VAL . 32.3 mmtp -75.42 126.81 31.77 Favored 'General case' 0 C--N 1.31 -1.122 0 O-C-N 124.045 0.841 . . . . 73.15 112.4 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 8.9 t -105.16 140.27 23.69 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 N-CA-C 107.188 -1.412 . . . . 73.05 107.188 177.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 526' ' ' LEU . . . . . 0.429 HD22 ' N ' ' A' ' 526' ' ' LEU . 2.4 mm? -90.3 139.39 30.71 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 120.804 -0.359 . . . . 71.25 110.033 -178.121 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 527' ' ' ARG . . . . . 0.462 ' HG2' ' N ' ' A' ' 528' ' ' THR . 39.0 ttp180 -76.26 158.45 31.56 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 115.349 -0.842 . . . . 71.41 109.186 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 528' ' ' THR . . . . . 0.64 ' OG1' ' HA2' ' A' ' 503' ' ' GLY . 3.2 t -61.87 160.75 11.51 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 123.855 0.862 . . . . 72.22 111.03 173.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 23.1 t -78.81 -26.49 44.29 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 108.673 -0.862 . . . . 72.31 108.673 178.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -121.14 104.52 0.96 Allowed Glycine 0 N--CA 1.442 -0.941 0 N-CA-C 109.579 -1.408 . . . . 62.42 109.579 178.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -100.8 98.47 8.98 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 120.848 0.356 . . . . 63.4 111.539 -176.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -130.85 119.82 22.77 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.862 -0.608 . . . . 71.45 110.08 178.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 86.6 -177.85 48.6 Favored Glycine 0 N--CA 1.438 -1.207 0 C-N-CA 120.693 -0.765 . . . . 74.52 112.433 176.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -99.07 130.58 45.41 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.15 -1.055 . . . . 65.31 108.15 178.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 535' ' ' VAL . . . . . 0.438 HG22 HD22 ' A' ' 596' ' ' LEU . 58.7 t -127.6 131.37 70.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-O 120.84 0.352 . . . . 73.15 110.095 -176.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 536' ' ' ILE . . . . . 0.529 HG23 ' HB3' ' A' ' 559' ' ' GLU . 33.1 mm -98.41 129.76 48.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 N-CA-C 109.266 -0.642 . . . . 72.14 109.266 177.252 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 537' ' ' VAL . . . . . 0.468 HG22 ' HB3' ' A' ' 594' ' ' PRO . 21.6 t -118.56 101.54 50.72 Favored Pre-proline 0 C--N 1.314 -0.978 0 N-CA-C 109.156 -0.683 . . . . 72.35 109.156 179.01 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 538' ' ' PRO . . . . . 0.429 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 58.1 Cg_endo -72.21 151.12 54.48 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.943 2.428 . . . . 72.33 112.131 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 539' ' ' TYR . . . . . 0.48 ' HB3' HG22 ' A' ' 591' ' ' ILE . 45.4 p90 -149.45 162.43 40.13 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 109.385 -0.598 . . . . 72.11 109.385 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -157.59 156.27 31.6 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 123.797 0.686 . . . . 62.13 109.919 177.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 3.2 p -91.12 122.22 33.58 Favored 'General case' 0 N--CA 1.423 -1.816 0 O-C-N 123.636 0.585 . . . . 44.45 109.78 173.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.7 mp -92.7 118.63 38.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 105.915 -1.884 . . . . 73.41 105.915 174.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -50.25 -46.05 54.62 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 124.361 1.038 . . . . 74.12 111.656 -176.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 67.34 -106.24 1.61 Allowed Glycine 0 N--CA 1.426 -1.971 0 N-CA-C 110.616 -0.994 . . . . 73.22 110.616 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 11.5 t -118.81 6.64 11.49 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-O 121.615 0.722 . . . . 64.53 109.973 -178.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -86.06 170.32 12.35 Favored 'General case' 0 N--CA 1.442 -0.874 0 O-C-N 122.029 -0.419 . . . . 54.24 110.468 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 547' ' ' ARG . . . . . 0.512 ' HB2' ' HB2' ' A' ' 552' ' ' ASP . 29.8 mmt180 -69.76 174.05 5.57 Favored 'General case' 0 CA--C 1.502 -0.886 0 CA-C-N 116.007 -0.542 . . . . 73.32 110.964 176.082 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -68.46 172.89 34.19 Favored Glycine 0 C--N 1.295 -1.731 0 CA-C-N 114.954 -1.021 . . . . 64.51 114.157 -176.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . -62.37 123.35 30.73 Favored Glycine 0 N--CA 1.435 -1.386 0 CA-C-N 115.131 -0.535 . . . . 62.33 111.797 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 95.94 -17.75 58.71 Favored Glycine 0 N--CA 1.437 -1.295 0 N-CA-C 111.553 -0.619 . . . . 72.43 111.553 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -84.72 -66.61 0.87 Allowed 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 109.123 -0.695 . . . . 73.22 109.123 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 552' ' ' ASP . . . . . 0.63 ' OD1' 'CA ' ' A' ' 850' ' ' ' CA' . 1.2 m-20 -107.47 -22.37 12.57 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.664 -0.414 . . . . 72.22 111.728 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 553' ' ' PHE . . . . . 0.408 ' HB3' ' CE2' ' A' ' 587' ' ' PHE . 35.9 p90 -151.87 151.94 31.94 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 108.849 -0.797 . . . . 63.33 108.849 177.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.49 122.06 30.74 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 106.048 -1.834 . . . . 73.2 106.048 177.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -74.38 105.99 5.79 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.128 0.489 . . . . 71.03 111.231 -175.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 13.5 t -104.08 119.99 40.13 Favored 'General case' 0 N--CA 1.414 -2.271 0 CA-C-O 122.324 1.059 . . . . 74.13 109.917 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 1.2 p -136.96 105.01 5.63 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-N 114.608 -1.178 . . . . 63.45 108.728 178.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -151.34 -152.3 5.83 Favored Glycine 0 N--CA 1.416 -2.663 0 N-CA-C 110.743 -0.943 . . . . 64.14 110.743 -174.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 559' ' ' GLU . . . . . 0.529 ' HB3' HG23 ' A' ' 536' ' ' ILE . 52.2 mt-10 -142.47 129.28 20.53 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.163 0.506 . . . . 74.12 110.952 -175.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 560' ' ' LEU . . . . . 0.465 HD13 ' HG2' ' A' ' 569' ' ' LYS . 92.8 mt -91.17 139.47 30.72 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.527 -0.761 . . . . 73.11 109.678 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -100.26 115.68 30.49 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.517 0.675 . . . . 71.55 111.474 178.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -109.37 158.82 17.54 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 107.355 -1.35 . . . . 73.03 107.355 171.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 563' ' ' GLN . . . . . 0.449 ' H ' ' HB2' ' A' ' 566' ' ' GLU . 10.6 pt20 -165.87 179.24 6.0 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 109.803 -0.443 . . . . 74.03 109.803 177.25 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -59.47 -32.31 70.13 Favored 'General case' 0 C--N 1.322 -0.612 0 O-C-N 124.083 0.864 . . . . 72.24 110.468 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -88.85 -12.41 41.98 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.406 -0.816 . . . . 54.11 111.249 -177.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 566' ' ' GLU . . . . . 0.449 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 26.0 mm-40 -100.96 132.79 46.2 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 113.244 0.831 . . . . 71.33 113.244 -176.132 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 3.9 pt -120.27 156.11 23.25 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.065 0 N-CA-C 105.823 -1.917 . . . . 51.41 105.823 170.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 568' ' ' VAL . . . . . 0.523 HG21 ' HD2' ' A' ' 524' ' ' LYS . 1.0 OUTLIER 48.11 178.34 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.578 2.03 0 C-N-CA 125.708 1.603 . . . . 61.23 113.003 -177.403 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 569' ' ' LYS . . . . . 0.465 ' HG2' HD13 ' A' ' 560' ' ' LEU . 1.4 tpmt? -172.01 163.59 6.12 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 106.067 -1.827 . . . . 70.3 106.067 175.259 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 570' ' ' THR . . . . . 0.551 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 11.5 p -135.58 141.26 45.13 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 123.45 0.469 . . . . 62.23 110.779 176.049 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 571' ' ' ILE . . . . . 0.565 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 3.5 mp -97.28 122.13 48.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 N-CA-C 106.166 -1.79 . . . . 62.45 106.166 169.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 40.4 p -99.96 118.69 36.9 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 109.329 -0.619 . . . . 72.35 109.329 177.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 573' ' ' VAL . . . . . . . . . . . . . 45.2 t -117.48 126.64 74.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 108.887 -0.783 . . . . 74.41 108.887 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -77.89 106.73 9.93 Favored 'General case' 0 N--CA 1.421 -1.907 0 N-CA-C 108.608 -0.886 . . . . 63.42 108.608 174.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 62.1 t -84.19 119.81 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.378 0 N-CA-C 105.757 -1.942 . . . . 75.33 105.757 175.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 39.4 mm -76.87 131.09 35.49 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 106.776 -1.565 . . . . 61.11 106.776 -177.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -60.29 99.16 0.07 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 122.092 0.949 . . . . 71.34 109.773 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 578' ' ' ASP . . . . . 0.616 ' OD1' 'CA ' ' A' ' 850' ' ' ' CA' . 19.1 t70 -61.64 133.77 56.01 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 114.346 -1.297 . . . . 62.43 113.93 -172.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 579' ' ' GLU . . . . . 0.59 ' OE2' 'CA ' ' A' ' 850' ' ' ' CA' . 0.6 OUTLIER -96.36 -13.83 22.96 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 113.599 -1.637 . . . . 74.14 113.883 -173.973 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -124.99 166.76 15.76 Favored 'General case' 0 C--O 1.264 1.826 0 C-N-CA 117.936 -1.506 . . . . 70.31 113.491 -176.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -71.86 153.37 41.94 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 107.664 -1.235 . . . . 64.33 107.664 178.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 582' ' ' GLU . . . . . 0.61 ' OE1' 'CA ' ' A' ' 800' ' ' ' CA' . 6.1 pt-20 -148.79 166.1 29.48 Favored 'General case' 0 C--N 1.278 -2.531 0 N-CA-C 108.619 -0.882 . . . . 73.44 108.619 176.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 583' ' ' LYS . . . . . 0.412 ' HD3' ' HA ' ' A' ' 583' ' ' LYS . 34.1 mmtp -106.59 30.22 6.23 Favored 'General case' 0 C--N 1.286 -2.186 0 CA-C-O 122.814 1.293 . . . . 74.21 107.825 176.027 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 584' ' ' ASN . . . . . 0.459 ' H ' ' HG3' ' A' ' 582' ' ' GLU . 52.7 m-80 80.26 96.12 0.05 Allowed 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 110.902 -2.863 . . . . 72.33 111.491 178.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.14 163.0 19.02 Favored 'General case' 0 N--CA 1.434 -1.267 0 C-N-CA 119.434 -0.906 . . . . 65.3 109.955 176.311 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 6.0 t -148.49 143.77 26.92 Favored 'General case' 0 N--CA 1.415 -2.188 0 CA-C-O 120.97 0.415 . . . . 65.5 110.059 -177.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 587' ' ' PHE . . . . . 0.41 ' CZ ' HD11 ' A' ' 646' ' ' ILE . 3.1 p90 -129.38 149.62 51.08 Favored 'General case' 0 N--CA 1.418 -2.042 0 CA-C-N 114.305 -1.316 . . . . 75.43 108.711 177.06 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 588' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -106.81 136.25 46.96 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 116.41 -0.359 . . . . 75.25 110.086 -172.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 589' ' ' LEU . . . . . 0.493 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.4 OUTLIER -105.87 122.97 47.2 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 105.466 -2.05 . . . . 44.4 105.466 174.87 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -130.67 135.38 47.78 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 109.627 -0.508 . . . . 73.33 109.627 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 591' ' ' ILE . . . . . 0.48 HG22 ' HB3' ' A' ' 539' ' ' TYR . 19.6 pt -96.93 141.06 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.552 0 N-CA-C 106.839 -1.541 . . . . 71.44 106.839 173.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -95.9 -134.13 7.77 Favored Glycine 0 C--N 1.295 -1.729 0 C-N-CA 120.604 -0.808 . . . . 44.43 113.026 -175.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -85.19 116.05 63.82 Favored Pre-proline 0 C--N 1.303 -1.438 0 C-N-CA 122.958 0.503 . . . . 63.02 110.667 -177.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 594' ' ' PRO . . . . . 0.478 ' HA ' ' O ' ' A' ' 536' ' ' ILE . 59.8 Cg_endo -75.16 137.07 20.9 Favored 'Trans proline' 0 N--CA 1.431 -2.191 0 C-N-CA 121.316 1.344 . . . . 74.51 109.377 173.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -129.96 137.9 50.56 Favored 'General case' 0 C--N 1.285 -2.213 0 O-C-N 121.876 -0.515 . . . . 74.52 111.548 -175.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 596' ' ' LEU . . . . . 0.438 HD22 HG22 ' A' ' 535' ' ' VAL . 0.0 OUTLIER -77.18 124.81 28.35 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 107.905 -1.146 . . . . 64.3 107.905 -176.434 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 597' ' ' VAL . . . . . 0.418 ' CG2' HG12 ' A' ' 536' ' ' ILE . 23.1 t -86.31 -45.74 16.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 CA-C-O 121.301 0.572 . . . . 61.14 109.667 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -83.47 141.99 31.26 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.688 -0.687 . . . . 73.42 110.863 -176.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 17.9 ptm -96.48 100.26 11.87 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-O 121.977 0.894 . . . . 75.01 109.964 178.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 33.5 t -144.42 120.8 10.95 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 107.431 -1.322 . . . . 55.51 107.431 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 60.79 27.3 17.09 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.299 1.039 . . . . 70.23 109.904 -177.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 602' ' ' LYS . . . . . 0.535 ' HE2' ' HA ' ' A' ' 602' ' ' LYS . 0.5 OUTLIER -88.73 96.15 10.55 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-N 114.509 -1.223 . . . . 74.12 108.426 -175.855 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -139.99 151.07 45.2 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.239 0.542 . . . . 73.11 112.048 -179.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -116.51 77.88 0.28 Allowed Glycine 0 C--N 1.303 -1.298 0 N-CA-C 108.87 -1.692 . . . . 64.41 108.87 175.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . -71.59 104.16 1.4 Allowed Glycine 0 N--CA 1.428 -1.859 0 CA-C-N 115.264 -0.468 . . . . 71.12 113.091 -175.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 60.78 32.43 20.16 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.581 1.153 . . . . 72.14 111.971 174.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 2.0 p -72.7 127.5 32.74 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-O 121.07 0.462 . . . . 74.14 111.23 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 608' ' ' ILE . . . . . 0.402 ' O ' ' HB ' ' A' ' 609' ' ' THR . 36.6 mm -92.94 79.38 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 N-CA-C 108.577 -0.897 . . . . 73.31 108.577 -177.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 609' ' ' THR . . . . . 0.402 ' HB ' ' O ' ' A' ' 608' ' ' ILE . 11.5 t 176.54 169.68 0.47 Allowed 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 114.901 -1.045 . . . . 72.14 108.554 -179.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -111.25 -3.79 15.22 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 107.97 -1.122 . . . . 74.11 107.97 171.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 611' ' ' GLU . . . . . 0.513 ' HB3' ' HB3' ' A' ' 614' ' ' ASP . 23.4 mm-40 -82.52 52.67 2.13 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 115.0 -1.0 . . . . 72.24 110.033 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 612' ' ' TYR . . . . . 0.471 ' OH ' ' HG3' ' A' ' 602' ' ' LYS . 73.3 t80 -75.98 119.01 19.35 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 108.013 -1.106 . . . . 73.42 108.013 177.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 613' ' ' ASP . . . . . 0.404 ' CG ' ' HZ2' ' A' ' 602' ' ' LYS . 0.9 OUTLIER 51.96 43.86 29.94 Favored 'General case' 0 CA--C 1.512 -0.494 0 O-C-N 124.24 0.962 . . . . 63.05 109.92 -177.541 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 614' ' ' ASP . . . . . 0.513 ' HB3' ' HB3' ' A' ' 611' ' ' GLU . 3.8 p30 -55.31 167.83 0.42 Allowed 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 125.419 1.488 . . . . 74.13 114.762 -174.117 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -112.1 24.21 12.86 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 114.22 -1.355 . . . . 73.12 110.963 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -75.37 148.43 83.41 Favored Pre-proline 0 C--O 1.249 1.072 0 N-CA-C 106.312 -1.736 . . . . 74.11 106.312 175.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -57.41 164.48 7.01 Favored 'Trans proline' 0 C--O 1.245 0.874 0 C-N-CA 121.235 1.29 . . . . 61.15 110.64 175.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -57.49 112.54 1.45 Allowed 'General case' 0 C--N 1.319 -0.742 0 O-C-N 123.312 0.382 . . . . 70.33 111.494 -174.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 15.3 t -149.37 161.91 41.13 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 108.967 -0.753 . . . . 64.12 108.967 -178.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 620' ' ' SER . . . . . 0.532 ' HA ' ' HG3' ' A' ' 626' ' ' ARG . 12.0 p -150.1 -36.67 0.15 Allowed 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 123.345 0.658 . . . . 73.33 110.142 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 66.5 mttm 61.75 20.95 11.81 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.87 0.868 . . . . 72.15 111.732 173.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 55.97 24.46 7.71 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.559 1.144 . . . . 74.42 111.154 -174.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 623' ' ' GLU . . . . . 0.516 ' O ' ' HB3' ' A' ' 626' ' ' ARG . 32.8 tt0 -75.24 139.45 42.57 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 109.081 -0.711 . . . . 70.33 109.081 -179.113 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.81 -53.66 30.54 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.496 -0.928 . . . . 54.52 108.496 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -54.0 -29.8 44.71 Favored 'General case' 0 C--O 1.249 1.068 0 C-N-CA 123.894 0.878 . . . . 75.32 113.346 -179.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 626' ' ' ARG . . . . . 0.532 ' HG3' ' HA ' ' A' ' 620' ' ' SER . 0.0 OUTLIER -47.79 -35.04 9.38 Favored 'General case' 0 N--CA 1.435 -1.209 0 C-N-CA 124.511 1.124 . . . . 75.22 113.351 174.921 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 627' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -63.14 -26.59 68.88 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.367 0.877 . . . . 73.44 113.367 -177.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 95.7 mt -67.58 -38.27 80.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 N-CA-C 108.981 -0.748 . . . . 73.33 108.981 176.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -73.32 -32.54 64.64 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.444 -0.798 . . . . 61.02 110.382 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 630' ' ' GLU . . . . . 0.474 ' HG2' ' O ' ' A' ' 626' ' ' ARG . 13.7 mm-40 -66.09 -24.53 66.72 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.167 0.587 . . . . 70.31 111.407 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 631' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -95.22 -7.15 39.87 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 119.927 -0.709 . . . . 62.13 110.57 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -97.58 -44.24 2.75 Favored Glycine 0 N--CA 1.43 -1.705 0 N-CA-C 110.019 -1.233 . . . . 52.33 110.019 177.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -101.75 126.64 33.4 Favored Pre-proline 0 C--N 1.306 -1.323 0 N-CA-C 107.734 -1.21 . . . . 75.0 107.734 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.401 ' HA ' ' HB3' ' A' ' 502' ' ' ALA . 13.4 Cg_endo -66.17 142.05 65.74 Favored 'Trans proline' 0 N--CA 1.437 -1.82 0 N-CA-C 108.204 -1.499 . . . . 71.24 108.204 171.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.3 pp -122.88 176.26 4.99 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 N-CA-C 113.677 0.992 . . . . 73.23 113.677 -173.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 636' ' ' LEU . . . . . 0.488 ' HB2' HG21 ' A' ' 640' ' ' THR . 0.0 OUTLIER -80.91 152.21 28.2 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 114.881 -1.054 . . . . 73.22 108.5 -179.344 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 637' ' ' GLY . . . . . 0.439 ' HA3' ' HB ' ' A' ' 506' ' ' THR . . . -80.74 -135.96 1.69 Allowed Glycine 0 C--N 1.293 -1.851 0 C-N-CA 120.864 -0.684 . . . . 73.21 113.668 -176.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -83.56 -58.67 2.72 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 120.125 -0.63 . . . . 72.45 109.969 -177.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -125.75 94.38 4.1 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 121.85 0.834 . . . . 62.15 111.905 -178.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 640' ' ' THR . . . . . 0.488 HG21 ' HB2' ' A' ' 636' ' ' LEU . 17.8 p -96.03 90.67 5.64 Favored 'General case' 0 N--CA 1.407 -2.595 0 N-CA-C 107.878 -1.156 . . . . 74.34 107.878 174.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 641' ' ' LYS . . . . . 0.446 ' HE2' ' HB2' ' A' ' 643' ' ' GLU . 1.2 tmtp? -172.5 134.4 0.66 Allowed 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 105.583 -2.006 . . . . 71.23 105.583 -175.186 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 642' ' ' LEU . . . . . 0.565 HD21 HG21 ' A' ' 523' ' ' VAL . 37.1 tp -134.93 106.34 6.8 Favored 'General case' 0 C--N 1.277 -2.583 0 N-CA-C 108.02 -1.104 . . . . 72.43 108.02 177.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 643' ' ' GLU . . . . . 0.446 ' HB2' ' HE2' ' A' ' 641' ' ' LYS . 27.2 tt0 -87.66 104.25 16.35 Favored 'General case' 0 C--N 1.277 -2.565 0 N-CA-C 106.748 -1.575 . . . . 74.31 106.748 178.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 644' ' ' VAL . . . . . 0.459 HG21 ' HE1' ' A' ' 521' ' ' MET . 40.1 t -94.06 106.02 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.155 0 N-CA-C 108.372 -0.973 . . . . 73.33 108.372 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 645' ' ' ILE . . . . . 0.441 ' HB ' ' CD2' ' A' ' 513' ' ' HIS . 3.8 mp -93.38 126.89 45.75 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 106.615 -1.624 . . . . 72.34 106.615 176.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 646' ' ' ILE . . . . . 0.539 HD12 ' N ' ' A' ' 646' ' ' ILE . 2.4 mp -99.11 124.02 52.12 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.249 0 N-CA-C 106.626 -1.62 . . . . 64.04 106.626 -177.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 647' ' ' GLU . . . . . 0.502 ' OE2' ' HA ' ' A' ' 515' ' ' SER . 0.0 OUTLIER -109.07 152.44 25.04 Favored 'General case' 0 C--N 1.266 -3.024 0 CA-C-N 115.598 -0.728 . . . . 63.23 109.518 -178.599 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 648' ' ' GLU . . . . . 0.432 ' CD ' ' HG2' ' A' ' 582' ' ' GLU . 25.5 mt-10 -83.79 75.31 10.1 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-O 122.327 1.061 . . . . 70.1 110.788 -176.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 18.2 m 30.88 82.5 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 129.024 2.93 . . . . 74.41 115.31 -176.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -114.83 -65.06 1.23 Allowed 'General case' 0 N--CA 1.431 -1.388 0 CA-C-N 114.83 -1.077 . . . . 74.24 108.728 174.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 178.02 167.33 0.75 Allowed 'General case' 0 CA--C 1.552 1.02 0 O-C-N 123.677 0.61 . . . . 74.4 109.371 -176.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -86.32 127.43 34.79 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 123.607 0.763 . . . . 74.22 108.98 -177.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -126.5 115.01 18.89 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 116.246 -0.434 . . . . 73.33 112.006 -177.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 25.6 m -95.18 96.4 9.18 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.284 0.564 . . . . 74.2 109.746 176.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 51.8 m -145.5 107.31 4.28 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 109.435 -0.58 . . . . 65.32 109.435 179.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.424 HG22 ' HB ' ' A' ' 511' ' ' VAL . 56.5 t -107.78 119.26 57.08 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-N 115.976 -0.556 . . . . 72.44 109.87 -179.007 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 . . . . . 0 C--N 1.307 -1.272 0 N-CA-C 109.212 -0.662 . . . . 71.04 109.212 176.79 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 800' ' ' ' CA' . . . . . 0.639 'CA ' ' OE2' ' A' ' 516' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 850' ' ' ' CA' . . . . . 0.63 'CA ' ' OD1' ' A' ' 552' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 4.4 t60 . . . . . 0 N--CA 1.446 -0.652 0 N-CA-C 108.711 -0.848 . . . . 65.22 108.711 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 502' ' ' ALA . . . . . 0.546 ' HB1' ' H ' ' A' ' 635' ' ' ILE . . . -138.15 -165.48 1.8 Allowed 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 107.136 -1.431 . . . . 74.24 107.136 177.114 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -129.5 173.62 19.57 Favored Glycine 0 N--CA 1.41 -3.074 0 C-N-CA 118.328 -1.891 . . . . 73.21 113.803 -175.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 504' ' ' ILE . . . . . 0.483 ' H ' ' CB ' ' A' ' 528' ' ' THR . 3.6 mp -119.57 96.48 4.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 107.463 -1.31 . . . . 63.15 107.463 173.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -108.71 115.04 29.34 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 106.135 -1.802 . . . . 74.32 106.135 178.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 506' ' ' THR . . . . . 0.461 ' HB ' ' H ' ' A' ' 638' ' ' GLU . 15.0 t -147.71 164.33 33.91 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 120.232 -0.587 . . . . 73.04 109.478 -173.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -94.35 160.24 14.76 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 107.658 -1.238 . . . . 62.25 107.658 173.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 508' ' ' GLU . . . . . 0.434 ' HB2' HD21 ' A' ' 526' ' ' LEU . 24.2 tt0 -91.04 -33.46 15.5 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 107.445 -1.317 . . . . 53.11 107.445 -179.015 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -124.16 134.95 25.84 Favored Pre-proline 0 N--CA 1.414 -2.241 0 CA-C-N 114.369 -1.287 . . . . 70.31 109.538 179.087 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 510' ' ' PRO . . . . . 0.632 ' HA ' ' O ' ' A' ' 641' ' ' LYS . 81.9 Cg_endo -85.76 -4.64 9.02 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 121.82 1.68 . . . . 63.05 111.416 174.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 511' ' ' VAL . . . . . 0.564 ' HB ' HG11 ' A' ' 656' ' ' VAL . 81.9 t -143.64 134.71 22.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 C-N-CA 123.882 0.873 . . . . 72.13 108.672 -178.214 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 14.6 t -134.06 132.12 39.62 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 107.265 -1.383 . . . . 71.22 107.265 175.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 28.5 m-70 -100.52 121.63 41.89 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.485 -0.931 . . . . 64.24 108.485 177.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.648 HG11 ' SD ' ' A' ' 521' ' ' MET . 33.0 m -115.02 156.66 15.93 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 CA-C-N 116.27 -0.423 . . . . 72.12 109.983 -177.437 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 22.9 t -82.89 133.12 35.13 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 107.822 -1.177 . . . . 72.33 107.822 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -68.31 -7.52 31.74 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 112.07 0.396 . . . . 74.34 112.07 -177.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 45.6 p -103.09 8.02 38.78 Favored 'General case' 0 C--N 1.313 -0.992 0 O-C-N 121.63 -0.669 . . . . 71.11 110.655 179.064 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 12.4 tt -80.23 152.02 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 N-CA-C 109.536 -0.542 . . . . 74.14 109.536 -177.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 519' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . -91.23 -61.45 1.26 Allowed Glycine 0 N--CA 1.426 -1.982 0 C-N-CA 120.253 -0.975 . . . . 55.31 110.996 177.237 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 28.3 mm -121.18 128.42 76.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-O 121.068 0.461 . . . . 43.54 110.849 -177.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 521' ' ' MET . . . . . 0.667 ' HE1' HG21 ' A' ' 644' ' ' VAL . 24.0 ptt? -107.95 140.71 40.68 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 107.3 -1.37 . . . . 73.44 107.3 171.47 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -119.61 113.0 20.03 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-O 121.185 0.517 . . . . 70.11 109.957 -178.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 523' ' ' VAL . . . . . 0.646 ' O ' ' HA ' ' A' ' 570' ' ' THR . 47.3 t -93.04 126.45 45.47 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.31 0 CA-C-N 115.258 -0.883 . . . . 51.13 109.769 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 524' ' ' LYS . . . . . 0.495 ' HD2' HG21 ' A' ' 568' ' ' VAL . 31.4 mmtp -87.47 142.6 27.74 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 124.329 1.018 . . . . 51.13 111.427 -178.635 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 26.8 t -120.0 132.8 68.69 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 N-CA-C 107.016 -1.476 . . . . 73.54 107.016 176.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 526' ' ' LEU . . . . . 0.434 HD21 ' HB2' ' A' ' 508' ' ' GLU . 3.1 mm? -71.84 139.01 48.7 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-O 121.322 0.582 . . . . 73.42 110.902 -179.108 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 527' ' ' ARG . . . . . 0.507 ' HD3' ' CZ ' ' A' ' 562' ' ' PHE . 13.6 tpt85 -79.37 127.4 32.04 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 114.839 -1.073 . . . . 75.25 110.001 179.185 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 528' ' ' THR . . . . . 0.483 ' CB ' ' H ' ' A' ' 504' ' ' ILE . 2.6 t -60.67 146.65 44.86 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 113.979 -1.464 . . . . 62.03 111.561 175.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 32.6 t -61.58 -35.58 78.24 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 115.143 -0.935 . . . . 75.33 109.239 176.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -120.6 110.01 1.67 Allowed Glycine 0 N--CA 1.423 -2.185 0 N-CA-C 110.489 -1.044 . . . . 62.11 110.489 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 531' ' ' ALA . . . . . 0.445 ' HB2' HG23 ' A' ' 528' ' ' THR . . . -127.14 112.29 14.99 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.326 -0.99 . . . . 71.23 108.326 176.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -119.01 102.61 8.88 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 120.891 0.377 . . . . 73.54 111.192 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 93.54 -153.72 21.42 Favored Glycine 0 N--CA 1.43 -1.724 0 CA-C-N 115.534 -0.757 . . . . 61.43 112.261 175.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -104.24 126.16 51.12 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.183 -0.673 . . . . 71.5 109.183 179.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 535' ' ' VAL . . . . . 0.471 HG22 HD22 ' A' ' 596' ' ' LEU . 55.6 t -121.16 136.42 58.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 123.284 0.634 . . . . 73.21 109.529 -177.13 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 536' ' ' ILE . . . . . 0.614 HG23 ' HB3' ' A' ' 559' ' ' GLU . 18.7 mm -101.65 129.26 53.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-N 116.321 -0.4 . . . . 64.14 110.18 178.665 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 537' ' ' VAL . . . . . 0.461 HG22 ' HB3' ' A' ' 594' ' ' PRO . 39.1 t -118.84 108.85 40.33 Favored Pre-proline 0 C--N 1.317 -0.844 0 N-CA-C 108.812 -0.81 . . . . 75.55 108.812 177.107 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -72.34 143.07 38.4 Favored 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 122.033 1.822 . . . . 63.12 111.177 178.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 539' ' ' TYR . . . . . 0.514 ' CE1' ' HG ' ' A' ' 560' ' ' LEU . 35.3 p90 -152.13 155.5 37.97 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 109.865 -0.42 . . . . 50.4 109.865 -179.398 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -153.36 154.9 35.41 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 116.208 -0.451 . . . . 73.42 109.979 176.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 16.8 p -93.71 110.29 21.92 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 115.603 -0.726 . . . . 31.34 109.264 176.016 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.6 mp -77.57 118.87 25.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 105.69 -1.967 . . . . 65.42 105.69 176.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -54.83 -36.64 65.23 Favored 'General case' 0 C--N 1.319 -0.728 0 O-C-N 124.28 0.987 . . . . 74.45 113.578 -173.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 69.93 -97.81 0.59 Allowed Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 111.636 -0.586 . . . . 65.33 111.636 177.27 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 6.9 t -122.95 -0.27 9.02 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.472 0.653 . . . . 53.12 110.553 177.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -99.07 -170.26 1.89 Allowed 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 107.6 -1.259 . . . . 44.23 107.6 177.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 547' ' ' ARG . . . . . 0.446 ' HD3' ' N ' ' A' ' 548' ' ' GLY . 0.0 OUTLIER -138.12 130.14 28.59 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.34 -0.985 . . . . 65.12 108.34 -178.767 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 548' ' ' GLY . . . . . 0.446 ' N ' ' HD3' ' A' ' 547' ' ' ARG . . . -76.89 -146.15 2.12 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 111.346 -0.702 . . . . 72.54 111.346 177.087 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 64.44 15.69 59.58 Favored Glycine 0 C--N 1.314 -0.671 0 CA-C-N 117.077 0.438 . . . . 53.23 113.404 178.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 77.49 18.64 77.52 Favored Glycine 0 N--CA 1.431 -1.65 0 C-N-CA 121.172 -0.537 . . . . 74.11 112.166 -178.089 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -84.33 -70.62 0.56 Allowed 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 121.359 0.6 . . . . 65.31 109.491 178.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 552' ' ' ASP . . . . . 0.648 ' OD2' 'CA ' ' A' ' 850' ' ' ' CA' . 9.3 t70 -100.63 -39.11 8.04 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 107.331 -1.359 . . . . 72.52 107.331 -178.454 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 553' ' ' PHE . . . . . 0.45 ' HA ' HG12 ' A' ' 576' ' ' ILE . 25.1 p90 -144.72 166.27 25.7 Favored 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 108.109 -1.071 . . . . 72.34 108.109 173.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 554' ' ' GLU . . . . . 0.411 ' HB3' ' HB3' ' A' ' 574' ' ' LYS . 0.6 OUTLIER -98.56 109.12 21.93 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 106.409 -1.7 . . . . 64.42 106.409 179.184 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -75.83 122.62 24.37 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-O 121.693 0.759 . . . . 71.42 111.038 -175.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 7.3 t -111.14 112.63 24.57 Favored 'General case' 0 N--CA 1.409 -2.514 0 CA-C-O 122.081 0.943 . . . . 44.31 109.957 -177.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 4.4 p -126.17 116.66 21.67 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 114.724 -1.125 . . . . 62.44 108.773 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -170.71 -156.27 11.26 Favored Glycine 0 N--CA 1.403 -3.547 0 C-N-CA 120.09 -1.053 . . . . 74.31 110.945 -176.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 559' ' ' GLU . . . . . 0.614 ' HB3' HG23 ' A' ' 536' ' ' ILE . 49.1 mt-10 -133.11 126.5 31.88 Favored 'General case' 0 C--N 1.284 -2.269 0 C-N-CA 122.368 0.267 . . . . 74.24 110.37 -176.441 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 560' ' ' LEU . . . . . 0.514 ' HG ' ' CE1' ' A' ' 539' ' ' TYR . 74.9 mt -82.42 136.26 34.98 Favored 'General case' 0 CA--C 1.5 -0.948 0 CA-C-N 116.064 -0.516 . . . . 65.41 110.88 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -98.32 102.33 14.04 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.096 -0.956 . . . . 75.33 108.9 178.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 562' ' ' PHE . . . . . 0.507 ' CZ ' ' HD3' ' A' ' 527' ' ' ARG . 1.3 t80 -111.37 147.95 34.05 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 106.559 -1.645 . . . . 71.53 106.559 -179.155 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 563' ' ' GLN . . . . . 0.426 ' H ' ' HB3' ' A' ' 566' ' ' GLU . 46.3 mt-30 -141.68 179.13 7.01 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 121.559 -0.713 . . . . 73.31 111.065 -173.212 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -77.63 -35.48 52.62 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 109.314 -0.624 . . . . 74.23 109.314 175.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -84.09 5.04 27.57 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 122.123 0.963 . . . . 74.41 109.599 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 566' ' ' GLU . . . . . 0.426 ' HB3' ' H ' ' A' ' 563' ' ' GLN . 6.7 tp10 -121.56 146.51 46.88 Favored 'General case' 0 N--CA 1.422 -1.869 0 CA-C-N 115.09 -0.959 . . . . 70.33 108.874 -179.226 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 3.3 pt -135.27 155.92 38.17 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.629 0 N-CA-C 106.707 -1.59 . . . . 71.32 106.707 173.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 568' ' ' VAL . . . . . 0.495 HG21 ' HD2' ' A' ' 524' ' ' LYS . 0.9 OUTLIER 51.01 170.13 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.624 0 C-N-CA 125.52 1.528 . . . . 75.22 112.048 -174.824 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 569' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -159.27 149.58 19.25 Favored 'General case' 0 C--N 1.283 -2.303 0 O-C-N 120.394 -1.441 . . . . 54.23 107.653 176.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 570' ' ' THR . . . . . 0.646 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 9.4 p -124.4 123.8 40.96 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 113.162 0.801 . . . . 50.31 113.162 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 2.8 mp -85.83 114.29 25.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 104.857 -2.275 . . . . 72.24 104.857 171.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 572' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 521' ' ' MET . 24.9 m -102.55 109.2 20.75 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.191 0.52 . . . . 70.4 110.106 -177.246 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 573' ' ' VAL . . . . . . . . . . . . . 25.5 t -111.53 137.06 45.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 115.735 -0.666 . . . . 70.42 109.687 -176.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 574' ' ' LYS . . . . . 0.411 ' HB3' ' HB3' ' A' ' 554' ' ' GLU . 5.0 tppp? -95.05 123.87 38.77 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 124.021 0.826 . . . . 62.13 110.087 178.245 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 57.9 t -94.33 133.47 35.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 107.03 -1.47 . . . . 71.12 107.03 175.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 576' ' ' ILE . . . . . 0.45 HG12 ' HA ' ' A' ' 553' ' ' PHE . 25.9 mm -98.55 160.3 3.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 109.261 -0.644 . . . . 62.1 109.261 -175.224 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -64.7 109.51 2.05 Favored 'General case' 0 C--O 1.247 0.94 0 C-N-CA 123.096 0.559 . . . . 71.44 110.054 177.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 578' ' ' ASP . . . . . 0.596 ' OD1' 'CA ' ' A' ' 850' ' ' ' CA' . 11.1 t0 -55.93 127.7 31.62 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 124.211 0.944 . . . . 64.51 110.913 -172.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 579' ' ' GLU . . . . . 0.599 ' OE1' 'CA ' ' A' ' 850' ' ' ' CA' . 1.3 pm0 -110.32 -30.5 7.67 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 115.752 1.76 . . . . 53.15 115.752 -167.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 580' ' ' GLU . . . . . 0.448 ' HG2' ' CD2' ' A' ' 581' ' ' TYR . 0.0 OUTLIER -103.81 -72.26 0.71 Allowed 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 115.009 1.485 . . . . 75.53 115.009 -162.493 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 581' ' ' TYR . . . . . 0.448 ' CD2' ' HG2' ' A' ' 580' ' ' GLU . 6.3 p90 -141.47 154.03 45.3 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 107.572 -1.27 . . . . 72.45 107.572 -174.619 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -109.87 108.14 18.34 Favored 'General case' 0 C--N 1.27 -2.854 0 C-N-CA 119.137 -1.025 . . . . 72.52 109.809 -177.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 9.9 mmmm -139.03 169.38 17.89 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 105.73 -1.952 . . . . 73.14 105.73 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -74.94 98.72 3.64 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 108.008 -1.108 . . . . 74.11 108.008 175.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.09 147.21 30.28 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-O 121.202 0.525 . . . . 62.22 111.196 -178.46 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 4.1 t -152.41 152.12 31.64 Favored 'General case' 0 N--CA 1.422 -1.858 0 CA-C-N 115.372 -0.831 . . . . 72.14 109.643 -175.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -133.83 160.02 38.89 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-N 114.695 -1.139 . . . . 75.4 109.68 177.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 588' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -116.33 138.38 51.38 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 120.625 0.25 . . . . 73.31 110.379 -171.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 589' ' ' LEU . . . . . 0.572 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.6 OUTLIER -106.28 122.26 45.88 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 105.447 -2.057 . . . . 22.03 105.447 173.161 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -129.6 130.78 46.1 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 107.343 -1.354 . . . . 75.21 107.343 178.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 591' ' ' ILE . . . . . 0.491 HG22 ' HB3' ' A' ' 539' ' ' TYR . 27.4 pt -103.75 147.82 9.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.495 -0.928 . . . . 74.22 108.495 179.027 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -94.29 -168.45 37.33 Favored Glycine 0 N--CA 1.425 -2.1 0 N-CA-C 111.621 -0.591 . . . . 43.31 111.621 -178.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.502 ' HB2' HD22 ' A' ' 618' ' ' LEU . 5.5 tp10 -77.67 127.18 83.06 Favored Pre-proline 0 N--CA 1.428 -1.556 0 N-CA-C 107.881 -1.155 . . . . 74.22 107.881 -178.155 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 594' ' ' PRO . . . . . 0.607 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 72.0 Cg_endo -71.77 171.17 17.02 Favored 'Trans proline' 0 C--N 1.324 -0.715 0 C-N-CA 123.384 2.722 . . . . 74.3 112.934 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 595' ' ' ARG . . . . . 0.409 ' NH2' ' HG3' ' A' ' 615' ' ' LYS . 7.9 ptp85 -150.22 151.41 32.99 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 107.076 -1.453 . . . . 72.34 107.076 177.459 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 596' ' ' LEU . . . . . 0.471 HD22 HG22 ' A' ' 535' ' ' VAL . 0.0 OUTLIER -81.04 131.49 35.31 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 104.879 -2.267 . . . . 63.51 104.879 178.144 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 597' ' ' VAL . . . . . 0.52 ' CG2' HG12 ' A' ' 536' ' ' ILE . 99.3 t -66.99 -28.75 43.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-O 122.435 1.112 . . . . 61.51 108.584 178.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 598' ' ' GLU . . . . . 0.424 ' H ' HD12 ' A' ' 596' ' ' LEU . 31.9 mt-10 -107.37 86.28 2.28 Favored 'General case' 0 N--CA 1.406 -2.647 0 CA-C-N 114.144 -1.389 . . . . 74.21 108.594 177.323 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 86.7 mmm -85.25 88.86 7.53 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.584 -0.735 . . . . 75.24 110.741 -178.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 20.9 m -89.97 122.67 33.2 Favored 'General case' 0 N--CA 1.426 -1.643 0 CA-C-N 115.298 -0.864 . . . . 71.51 109.539 178.002 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 601' ' ' GLU . . . . . 0.481 ' HB3' ' HB2' ' A' ' 610' ' ' GLU . 12.0 pt-20 -74.79 153.53 38.72 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 109.873 -0.417 . . . . 75.4 109.873 177.357 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 2.7 tmtp? -76.22 81.73 3.02 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 122.198 0.999 . . . . 75.11 109.71 -176.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -75.9 130.8 39.07 Favored 'General case' 0 N--CA 1.42 -1.937 0 CA-C-N 114.023 -1.444 . . . . 74.01 109.357 178.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 94.62 21.53 26.25 Favored Glycine 0 C--N 1.302 -1.306 0 N-CA-C 109.959 -1.256 . . . . 32.53 109.959 -176.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . -137.21 -139.56 3.93 Favored Glycine 0 N--CA 1.429 -1.82 0 N-CA-C 110.54 -1.024 . . . . 75.22 110.54 178.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -92.36 -28.71 16.74 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 120.813 0.339 . . . . 74.43 111.257 -178.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 8.2 p -86.25 130.1 34.63 Favored 'General case' 0 N--CA 1.421 -1.893 0 N-CA-C 115.133 1.531 . . . . 61.53 115.133 -173.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 54.7 mt -128.42 132.32 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.85 0 N-CA-C 106.052 -1.833 . . . . 62.21 106.052 174.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 24.3 m 67.84 73.11 0.31 Allowed 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 123.985 0.914 . . . . 23.34 111.342 179.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 610' ' ' GLU . . . . . 0.481 ' HB2' ' HB3' ' A' ' 601' ' ' GLU . 42.1 mt-10 -102.34 95.23 6.15 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 107.415 -1.328 . . . . 53.04 107.415 174.09 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -126.56 -160.57 1.0 Allowed 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 114.953 -1.021 . . . . 61.55 109.667 -178.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 73.54 54.91 0.11 Allowed 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 125.043 1.337 . . . . 74.22 111.249 -177.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -94.75 130.38 41.31 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 114.035 -1.439 . . . . 63.34 108.873 176.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -167.94 -166.08 0.7 Allowed 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 106.531 -1.655 . . . . 73.25 106.531 -178.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 615' ' ' LYS . . . . . 0.439 ' N ' ' HD3' ' A' ' 615' ' ' LYS . 0.1 OUTLIER -78.45 96.9 5.5 Favored 'General case' 0 N--CA 1.426 -1.651 0 N-CA-C 107.335 -1.357 . . . . 62.31 107.335 177.298 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -83.14 148.57 56.7 Favored Pre-proline 0 C--N 1.299 -1.588 0 CA-C-N 115.506 -0.77 . . . . 73.12 111.871 -175.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -80.94 174.21 11.18 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 C-N-CA 122.19 1.927 . . . . 72.02 108.417 170.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.502 HD22 ' HB2' ' A' ' 593' ' ' GLU . 4.0 mm? -69.12 100.77 1.31 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 113.011 0.745 . . . . 71.51 113.011 -177.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 619' ' ' THR . . . . . 0.436 HG22 ' HB2' ' A' ' 630' ' ' GLU . 8.0 p 25.32 -91.27 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 127.623 2.369 . . . . 70.13 115.348 -177.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 620' ' ' SER . . . . . 0.595 ' OG ' ' HB3' ' A' ' 623' ' ' GLU . 1.8 t -158.45 120.75 3.65 Favored 'General case' 0 N--CA 1.397 -3.086 0 N-CA-C 103.732 -2.692 . . . . 64.52 103.732 178.232 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -66.33 -72.41 0.16 Allowed 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 113.105 0.78 . . . . 71.43 113.105 -171.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -93.84 -24.9 17.58 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.832 0.825 . . . . 71.0 109.196 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 623' ' ' GLU . . . . . 0.595 ' HB3' ' OG ' ' A' ' 620' ' ' SER . 2.8 tm-20 -80.52 147.36 30.87 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 107.788 -1.19 . . . . 75.31 107.788 -176.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -104.92 -28.73 10.93 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 113.793 1.034 . . . . 71.52 113.793 -174.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -70.74 -33.0 70.35 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 113.166 0.802 . . . . 55.33 113.166 -170.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 626' ' ' ARG . . . . . 0.445 ' CB ' ' HB2' ' A' ' 620' ' ' SER . 11.5 mmt180 -67.74 -27.32 66.7 Favored 'General case' 0 C--O 1.19 -2.036 0 C-N-CA 119.572 -0.851 . . . . 73.1 111.042 172.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 627' ' ' ARG . . . . . . . . . . . . . 82.1 mtt180 -67.73 -45.71 74.25 Favored 'General case' 0 C--O 1.213 -0.846 0 N-CA-C 107.805 -1.183 . . . . 70.24 107.805 176.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 628' ' ' ILE . . . . . 0.572 ' O ' ' HG2' ' A' ' 631' ' ' MET . 69.2 mt -57.24 -44.01 82.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 115.465 -0.789 . . . . 64.53 110.198 177.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -71.24 -38.44 71.95 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.082 -0.508 . . . . 74.12 111.703 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 630' ' ' GLU . . . . . 0.436 ' HB2' HG22 ' A' ' 619' ' ' THR . 32.0 mm-40 -87.4 -2.82 58.89 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 113.129 0.789 . . . . 52.23 113.129 -175.406 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 631' ' ' MET . . . . . 0.572 ' HG2' ' O ' ' A' ' 628' ' ' ILE . 25.7 ptt? -72.46 -7.86 52.04 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 120.46 -0.496 . . . . 74.1 111.684 -178.029 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -72.3 -21.75 79.19 Favored Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 109.954 -1.258 . . . . 64.44 109.954 173.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -91.18 153.35 44.65 Favored Pre-proline 0 N--CA 1.442 -0.874 0 N-CA-C 106.862 -1.533 . . . . 74.33 106.862 176.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.607 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 11.9 Cg_endo -64.94 132.7 33.16 Favored 'Trans proline' 0 N--CA 1.441 -1.588 0 N-CA-C 107.562 -1.745 . . . . 44.25 107.562 167.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 635' ' ' ILE . . . . . 0.546 ' H ' ' HB1' ' A' ' 502' ' ' ALA . 2.5 pp -112.69 161.28 11.69 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.371 0 C-N-CA 120.194 -0.603 . . . . 63.42 111.442 -178.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 636' ' ' LEU . . . . . 0.429 ' HB3' HD11 ' A' ' 618' ' ' LEU . 10.0 tt -63.1 154.57 30.55 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 124.34 1.056 . . . . 65.33 112.184 -178.486 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -79.77 -125.41 0.53 Allowed Glycine 0 N--CA 1.431 -1.664 0 N-CA-C 116.298 1.279 . . . . 64.24 116.298 -173.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 638' ' ' GLU . . . . . 0.461 ' H ' ' HB ' ' A' ' 506' ' ' THR . 34.6 tt0 -90.75 -72.96 0.55 Allowed 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.699 -0.751 . . . . 64.51 112.668 -169.522 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -130.84 127.93 39.61 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.113 0.483 . . . . 62.12 110.191 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 17.1 p -129.51 92.78 3.41 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-O 121.92 0.867 . . . . 73.22 112.743 -175.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 641' ' ' LYS . . . . . 0.632 ' O ' ' HA ' ' A' ' 510' ' ' PRO . 20.5 tptm -156.12 139.15 15.43 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 106.147 -1.798 . . . . 71.53 106.147 178.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 642' ' ' LEU . . . . . 0.572 ' HB3' ' HB3' ' A' ' 589' ' ' LEU . 21.8 tp -138.21 103.64 4.98 Favored 'General case' 0 N--CA 1.409 -2.491 0 N-CA-C 108.154 -1.054 . . . . 60.11 108.154 173.378 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 643' ' ' GLU . . . . . 0.405 ' HB3' HG22 ' A' ' 511' ' ' VAL . 24.9 tt0 -93.11 107.63 19.39 Favored 'General case' 0 C--N 1.274 -2.681 0 N-CA-C 106.847 -1.538 . . . . 72.42 106.847 176.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 644' ' ' VAL . . . . . 0.667 HG21 ' HE1' ' A' ' 521' ' ' MET . 24.0 t -93.24 104.89 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.004 0 N-CA-C 109.057 -0.72 . . . . 73.44 109.057 -177.405 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 4.0 mp -91.22 118.99 37.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 107.281 -1.377 . . . . 73.44 107.281 176.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 646' ' ' ILE . . . . . 0.458 HD12 ' N ' ' A' ' 646' ' ' ILE . 2.5 mp -100.15 108.0 22.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 106.607 -1.627 . . . . 64.41 106.607 -176.078 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -114.23 152.39 31.34 Favored 'General case' 0 C--N 1.281 -2.405 0 O-C-N 123.371 0.42 . . . . 63.52 111.241 -175.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 648' ' ' GLU . . . . . 0.598 ' OE2' 'CA ' ' A' ' 800' ' ' ' CA' . 5.2 mp0 -58.1 133.55 55.67 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.321 -0.854 . . . . 53.2 110.09 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 33.5 t -58.42 108.52 0.63 Allowed 'General case' 0 N--CA 1.436 -1.151 0 O-C-N 124.218 0.949 . . . . 55.23 112.383 -174.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -134.21 -68.41 0.55 Allowed 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 115.099 -0.955 . . . . 74.23 108.641 174.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -136.06 -163.12 1.35 Allowed 'General case' 0 C--O 1.246 0.905 0 N-CA-C 108.4 -0.963 . . . . 62.53 108.4 -178.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -134.55 90.0 2.61 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-O 121.276 0.56 . . . . 64.22 112.451 178.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -114.95 101.46 9.05 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 115.071 -0.968 . . . . 74.22 108.583 174.243 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 9.5 t -141.07 90.24 2.31 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 106.605 -1.628 . . . . 75.03 106.605 179.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 4.1 t -138.63 112.66 8.54 Favored 'General case' 0 N--CA 1.426 -1.628 0 CA-C-N 115.638 -0.71 . . . . 63.51 110.673 -174.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.564 HG11 ' HB ' ' A' ' 511' ' ' VAL . 12.9 m -136.38 -177.81 2.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.892 -0.595 . . . . 74.03 109.656 179.013 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 . . . . . 0 C--N 1.299 -1.59 0 N-CA-C 109.807 -0.442 . . . . 75.04 109.807 179.257 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 800' ' ' ' CA' . . . . . 0.598 'CA ' ' OE2' ' A' ' 648' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 850' ' ' ' CA' . . . . . 0.648 'CA ' ' OD2' ' A' ' 552' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 16.2 p-80 . . . . . 0 C--O 1.236 0.39 0 N-CA-C 110.147 -0.316 . . . . 54.42 110.147 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 502' ' ' ALA . . . . . 0.478 ' HB1' ' HA ' ' A' ' 634' ' ' PRO . . . -99.57 -48.23 4.83 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.446 -0.946 . . . . 53.4 108.446 177.049 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 503' ' ' GLY . . . . . 0.561 ' HA2' ' OG1' ' A' ' 528' ' ' THR . . . 178.57 153.0 10.87 Favored Glycine 0 N--CA 1.414 -2.812 0 C-N-CA 120.317 -0.944 . . . . 61.01 112.352 177.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 3.8 mp -123.26 104.95 15.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 N-CA-C 107.756 -1.202 . . . . 75.4 107.756 175.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -118.62 112.42 19.82 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.775 -1.194 . . . . 75.51 107.775 176.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 14.9 t -141.62 155.22 45.74 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 120.392 -0.523 . . . . 75.51 110.25 -174.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -81.19 144.81 31.36 Favored 'General case' 0 CA--C 1.489 -1.372 0 N-CA-C 107.559 -1.274 . . . . 74.51 107.559 175.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -65.28 -43.71 90.3 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 123.88 0.737 . . . . 63.1 109.757 178.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -123.93 125.71 25.8 Favored Pre-proline 0 N--CA 1.425 -1.675 0 CA-C-N 115.625 -0.716 . . . . 75.42 109.257 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 510' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 641' ' ' LYS . 58.4 Cg_endo -73.52 -16.61 24.16 Favored 'Trans proline' 0 CA--C 1.53 0.298 0 C-N-CA 122.163 1.909 . . . . 74.22 111.708 176.554 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 83.1 t -133.82 131.78 56.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 109.013 -0.736 . . . . 63.23 109.013 178.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 6.0 t -132.84 143.37 49.49 Favored 'General case' 0 N--CA 1.406 -2.65 0 N-CA-C 107.568 -1.271 . . . . 75.03 107.568 178.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 513' ' ' HIS . . . . . 0.522 ' CD2' ' HA ' ' A' ' 654' ' ' SER . 36.1 m-70 -114.59 127.72 55.94 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.379 -0.971 . . . . 62.3 108.379 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.538 HG11 ' SD ' ' A' ' 521' ' ' MET . 34.1 m -124.86 158.94 32.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-O 121.015 0.436 . . . . 53.35 111.128 -174.357 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 515' ' ' SER . . . . . 0.682 ' HA ' ' CZ ' ' A' ' 652' ' ' PHE . 34.9 t -77.74 148.91 34.64 Favored 'General case' 0 N--CA 1.414 -2.227 0 CA-C-N 115.22 -0.9 . . . . 72.51 110.787 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 516' ' ' GLU . . . . . 0.659 ' OE2' 'CA ' ' A' ' 800' ' ' ' CA' . 29.6 tt0 -68.45 -17.67 64.25 Favored 'General case' 0 N--CA 1.422 -1.844 0 CA-C-N 114.827 -1.079 . . . . 75.0 108.512 172.3 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 43.6 m -108.75 22.06 16.43 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 116.056 -0.52 . . . . 73.42 111.375 -176.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 518' ' ' ILE . . . . . 0.413 HG22 ' O ' ' A' ' 515' ' ' SER . 16.1 tt -92.36 159.68 2.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 109.317 -0.623 . . . . 73.2 109.317 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 519' ' ' GLY . . . . . 0.481 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . -106.22 -67.08 0.67 Allowed Glycine 0 N--CA 1.417 -2.621 0 C-N-CA 120.281 -0.962 . . . . 74.42 111.179 177.069 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 33.5 mm -120.66 124.2 71.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 109.604 -0.517 . . . . 51.22 109.604 -177.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 521' ' ' MET . . . . . 0.72 ' HE1' HG21 ' A' ' 644' ' ' VAL . 24.6 ptt? -103.86 137.73 41.45 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 107.109 -1.441 . . . . 61.11 107.109 172.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 15.8 mp0 -114.16 97.37 6.31 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 108.788 -0.819 . . . . 72.03 108.788 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 523' ' ' VAL . . . . . 0.579 ' O ' ' HA ' ' A' ' 570' ' ' THR . 26.5 t -84.26 131.72 33.27 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 CA-C-N 116.1 -0.5 . . . . 52.53 110.308 -177.48 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 524' ' ' LYS . . . . . 0.458 ' HD2' HG21 ' A' ' 568' ' ' VAL . 32.3 mmtp -85.27 128.14 34.58 Favored 'General case' 0 C--O 1.247 0.966 0 N-CA-C 113.211 0.819 . . . . 73.52 113.211 -176.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 21.6 t -117.35 123.84 72.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 CA-C-N 114.251 -1.341 . . . . 75.22 107.773 177.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -81.69 141.71 33.36 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 109.487 -0.56 . . . . 74.44 109.487 -176.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 527' ' ' ARG . . . . . 0.472 ' HG2' ' N ' ' A' ' 528' ' ' THR . 39.3 ttp180 -86.77 161.06 18.58 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.498 -0.774 . . . . 51.32 110.851 -175.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 528' ' ' THR . . . . . 0.561 ' OG1' ' HA2' ' A' ' 503' ' ' GLY . 5.7 t -67.68 142.53 56.32 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-N 115.11 -0.95 . . . . 33.41 110.478 173.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 21.9 t -63.85 -38.85 92.64 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 115.216 -0.902 . . . . 73.32 108.924 176.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -100.37 80.14 0.47 Allowed Glycine 0 N--CA 1.431 -1.679 0 N-CA-C 110.329 -1.108 . . . . 51.34 110.329 177.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -93.68 107.8 19.62 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 109.279 -0.637 . . . . 72.52 109.279 178.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 19.4 mmt180 -119.49 111.06 17.64 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 120.889 0.376 . . . . 72.32 110.723 -179.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 89.33 -126.45 8.24 Favored Glycine 0 N--CA 1.426 -2.022 0 C-N-CA 120.111 -1.042 . . . . 74.42 113.504 175.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -135.85 124.16 23.27 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.278 -1.008 . . . . 63.43 108.278 -177.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 535' ' ' VAL . . . . . 0.446 HG22 HD22 ' A' ' 596' ' ' LEU . 72.1 t -125.04 125.42 69.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 109.326 -0.62 . . . . 75.41 109.326 -178.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 536' ' ' ILE . . . . . 0.429 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 36.6 mm -100.57 125.03 54.48 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.134 0 CA-C-N 115.447 -0.797 . . . . 54.22 109.103 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 537' ' ' VAL . . . . . 0.457 HG22 ' HB3' ' A' ' 594' ' ' PRO . 30.0 t -116.82 112.41 40.53 Favored Pre-proline 0 C--N 1.312 -1.031 0 CA-C-N 116.202 -0.454 . . . . 61.24 110.682 -176.142 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -74.28 140.62 27.83 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.481 2.121 . . . . 74.31 112.227 177.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 539' ' ' TYR . . . . . 0.494 ' CD1' ' HG ' ' A' ' 560' ' ' LEU . 48.5 p90 -140.99 156.18 46.09 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.004 -1.11 . . . . 62.1 108.004 -179.39 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -154.99 157.82 38.24 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 123.28 0.362 . . . . 63.21 110.659 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 1.6 p -95.09 124.6 39.22 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 115.1 -0.954 . . . . 74.11 108.812 174.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.5 mp -93.35 128.35 44.85 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 106.275 -1.75 . . . . 65.3 106.275 175.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -57.9 -50.23 74.03 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 123.782 0.677 . . . . 63.32 111.377 -176.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 69.4 -101.59 0.85 Allowed Glycine 0 N--CA 1.434 -1.477 0 CA-C-N 115.652 -0.703 . . . . 63.43 111.973 178.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 10.0 t -125.89 14.72 8.0 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 122.323 1.058 . . . . 61.1 109.26 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -116.94 152.92 33.53 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.114 -1.069 . . . . 42.43 108.114 176.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 547' ' ' ARG . . . . . 0.471 ' HG2' ' HG3' ' A' ' 551' ' ' GLU . 31.8 ttp180 -89.47 130.1 35.86 Favored 'General case' 0 N--CA 1.422 -1.841 0 CA-C-O 121.101 0.477 . . . . 73.22 111.116 -178.422 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -96.49 -176.92 35.73 Favored Glycine 0 C--N 1.301 -1.402 0 C-N-CA 120.884 -0.674 . . . . 73.24 112.774 -175.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 80.72 26.63 53.39 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.927 -0.654 . . . . 64.45 113.002 177.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 92.08 11.29 60.21 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.743 -0.742 . . . . 74.34 112.953 177.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 551' ' ' GLU . . . . . 0.471 ' HG3' ' HG2' ' A' ' 547' ' ' ARG . 5.8 mm-40 -88.99 -70.51 0.65 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 117.273 0.537 . . . . 54.4 110.287 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 552' ' ' ASP . . . . . 0.652 ' OD1' 'CA ' ' A' ' 850' ' ' ' CA' . 23.5 m-20 -98.86 -27.02 14.1 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.575 -0.898 . . . . 74.23 108.575 174.556 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 553' ' ' PHE . . . . . 0.638 ' HB3' ' CE2' ' A' ' 587' ' ' PHE . 40.8 p90 -151.46 154.2 36.11 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.569 -0.741 . . . . 35.5 110.055 176.331 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.99 129.6 34.81 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 104.948 -2.241 . . . . 75.0 104.948 174.514 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -86.19 113.48 22.25 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.212 0.529 . . . . 71.3 111.112 -172.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 556' ' ' THR . . . . . 0.428 HG21 HG22 ' A' ' 573' ' ' VAL . 11.3 t -111.51 104.85 13.3 Favored 'General case' 0 N--CA 1.415 -2.206 0 CA-C-O 122.443 1.116 . . . . 74.54 110.587 -176.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 1.6 p -123.8 110.94 15.53 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 114.778 -1.101 . . . . 74.21 109.295 176.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -163.01 -153.91 7.42 Favored Glycine 0 N--CA 1.418 -2.547 0 N-CA-C 110.296 -1.122 . . . . 54.33 110.296 -175.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 559' ' ' GLU . . . . . 0.429 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 39.0 mt-10 -137.99 136.34 36.83 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 120.77 0.319 . . . . 75.04 111.084 -176.4 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 560' ' ' LEU . . . . . 0.494 ' HG ' ' CD1' ' A' ' 539' ' ' TYR . 82.7 mt -93.85 147.82 22.72 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.375 -0.83 . . . . 74.43 109.866 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -104.82 107.73 18.84 Favored 'General case' 0 N--CA 1.424 -1.754 0 CA-C-O 121.213 0.53 . . . . 74.55 112.152 -178.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -101.74 146.86 27.17 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.443 -0.947 . . . . 72.21 108.443 172.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 563' ' ' GLN . . . . . 0.485 ' HB2' ' H ' ' A' ' 566' ' ' GLU . 51.7 mt-30 -144.2 -176.66 5.1 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 108.171 -1.048 . . . . 52.33 108.171 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -74.77 -31.58 61.81 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 107.76 -1.2 . . . . 75.04 107.76 174.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -78.87 -49.47 12.82 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.796 -1.093 . . . . 63.21 110.384 177.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 566' ' ' GLU . . . . . 0.485 ' H ' ' HB2' ' A' ' 563' ' ' GLN . 59.6 mm-40 -65.53 139.41 58.47 Favored 'General case' 0 CA--C 1.503 -0.838 0 CA-C-N 115.725 -0.67 . . . . 54.42 112.276 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 567' ' ' ILE . . . . . 0.451 ' HA ' ' HD3' ' A' ' 527' ' ' ARG . 21.6 pt -115.8 -170.67 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.412 -2.372 0 N-CA-C 105.649 -1.982 . . . . 64.54 105.649 172.487 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 568' ' ' VAL . . . . . 0.458 HG21 ' HD2' ' A' ' 524' ' ' LYS . 3.1 p 0.55 127.71 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.07 0 C-N-CA 128.027 2.531 . . . . 74.21 116.682 173.225 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 569' ' ' LYS . . . . . 0.539 ' HA ' ' HE2' ' A' ' 569' ' ' LYS . 8.8 mmpt? -105.74 164.69 11.73 Favored 'General case' 0 C--N 1.271 -2.835 0 CA-C-N 114.683 -1.144 . . . . 74.24 109.605 178.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 570' ' ' THR . . . . . 0.579 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 5.1 p -137.58 119.3 15.08 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.068 -0.969 . . . . 52.35 110.781 178.474 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 3.4 mp -86.92 106.4 15.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 107.291 -1.374 . . . . 65.41 107.291 176.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 4.1 p -84.27 109.13 17.55 Favored 'General case' 0 N--CA 1.415 -2.204 0 O-C-N 123.976 0.798 . . . . 65.31 109.685 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 573' ' ' VAL . . . . . 0.428 HG22 HG21 ' A' ' 556' ' ' THR . 44.0 t -113.89 128.44 70.81 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 N-CA-C 108.75 -0.833 . . . . 74.5 108.75 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 574' ' ' LYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 519' ' ' GLY . 58.8 tptt -83.4 103.49 12.8 Favored 'General case' 0 N--CA 1.417 -2.116 0 O-C-N 124.087 0.867 . . . . 75.41 108.827 177.029 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 71.5 t -78.75 135.1 26.56 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 105.995 -1.854 . . . . 61.22 105.995 176.249 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 32.3 mm -98.64 139.88 19.59 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 N-CA-C 108.715 -0.846 . . . . 65.21 108.715 -176.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -53.43 117.44 3.08 Favored 'General case' 0 C--O 1.244 0.783 0 O-C-N 124.302 1.001 . . . . 64.5 108.558 175.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 578' ' ' ASP . . . . . 0.646 ' OD1' 'CA ' ' A' ' 850' ' ' ' CA' . 25.3 t70 -62.29 120.28 10.69 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.265 -0.879 . . . . 55.31 112.462 -173.36 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 579' ' ' GLU . . . . . 0.636 ' OE1' 'CA ' ' A' ' 850' ' ' ' CA' . 1.7 pm0 -81.78 -19.13 41.9 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 114.55 1.315 . . . . 65.22 114.55 -172.3 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 580' ' ' GLU . . . . . 0.67 ' OE2' 'CA ' ' A' ' 850' ' ' ' CA' . 0.4 OUTLIER -131.38 -164.02 1.39 Allowed 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 119.668 -0.813 . . . . 74.52 110.703 -177.357 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -62.74 152.36 35.93 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 107.444 -1.317 . . . . 72.52 107.444 173.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 582' ' ' GLU . . . . . 0.647 ' OE1' 'CA ' ' A' ' 800' ' ' ' CA' . 42.5 tt0 -122.2 110.47 15.77 Favored 'General case' 0 N--CA 1.411 -2.39 0 C-N-CA 118.298 -1.361 . . . . 70.2 113.256 -172.178 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -79.54 -179.72 7.0 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 113.79 -1.55 . . . . 74.33 107.333 173.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -77.47 84.17 3.87 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 106.455 -1.683 . . . . 74.42 106.455 172.159 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 585' ' ' LYS . . . . . . . . . . . . 0.262 0.0 OUTLIER -108.61 145.06 35.49 Favored 'General case' 0 N--CA 1.414 -2.262 0 CA-C-N 115.512 -0.767 . . . . 73.33 111.426 178.329 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 2.9 t -151.39 149.35 29.21 Favored 'General case' 0 N--CA 1.397 -3.094 0 CA-C-N 114.93 -1.032 . . . . 74.45 110.232 -174.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 587' ' ' PHE . . . . . 0.638 ' CE2' ' HB3' ' A' ' 553' ' ' PHE . 2.2 p90 -117.97 146.77 43.76 Favored 'General case' 0 N--CA 1.416 -2.171 0 CA-C-N 114.097 -1.411 . . . . 64.23 107.789 176.228 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 588' ' ' PHE . . . . . 0.526 ' HA ' ' O ' ' A' ' 642' ' ' LEU . 17.1 m-85 -107.36 142.87 36.48 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 120.707 -0.397 . . . . 73.35 110.218 -171.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 589' ' ' LEU . . . . . 0.439 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.3 OUTLIER -112.17 125.6 54.3 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 106.424 -1.695 . . . . 71.35 106.424 175.531 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -133.75 149.22 51.46 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 109.087 -0.708 . . . . 64.3 109.087 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 591' ' ' ILE . . . . . . . . . . . . . 27.5 pt -109.16 147.97 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.348 0 N-CA-C 108.485 -0.931 . . . . 74.43 108.485 176.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -102.38 -140.3 10.96 Favored Glycine 0 C--N 1.302 -1.344 0 C-N-CA 120.631 -0.795 . . . . 52.42 112.529 -177.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.443 ' HA ' HD21 ' A' ' 618' ' ' LEU . 14.9 tt0 -77.8 115.06 47.01 Favored Pre-proline 0 C--N 1.315 -0.934 0 C-N-CA 122.623 0.369 . . . . 73.44 110.041 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 594' ' ' PRO . . . . . 0.457 ' HB3' HG22 ' A' ' 537' ' ' VAL . 73.4 Cg_endo -75.93 146.15 29.13 Favored 'Trans proline' 0 N--CA 1.444 -1.434 0 C-N-CA 121.577 1.518 . . . . 72.1 109.182 176.323 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 3.2 ptp180 -123.03 138.26 54.73 Favored 'General case' 0 C--N 1.297 -1.674 0 C-N-CA 119.561 -0.856 . . . . 74.21 110.527 -174.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 596' ' ' LEU . . . . . 0.446 HD22 HG22 ' A' ' 535' ' ' VAL . 0.0 OUTLIER -86.69 118.23 25.96 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 107.42 -1.326 . . . . 44.3 107.42 179.576 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 59.2 t -78.3 -35.42 19.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 108.534 -0.914 . . . . 71.1 108.534 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -86.19 -168.79 2.36 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 106.95 -1.5 . . . . 75.01 106.95 175.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 599' ' ' MET . . . . . 0.422 ' HA ' ' CE ' ' A' ' 599' ' ' MET . 1.0 OUTLIER 64.62 47.86 2.75 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.656 0.741 . . . . 72.41 109.692 -179.644 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 17.1 m -73.59 -40.1 64.12 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.19 -0.914 . . . . 70.32 109.701 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -89.93 95.24 10.14 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 115.423 -0.808 . . . . 61.35 110.34 -177.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 57.7 tttp -157.15 135.87 11.55 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 104.766 -2.309 . . . . 73.13 104.766 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 603' ' ' LYS . . . . . 0.427 ' O ' ' HD2' ' A' ' 603' ' ' LYS 0.309 0.0 OUTLIER -73.51 108.62 6.47 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 114.546 1.313 . . . . 53.04 114.546 -175.431 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -86.58 78.7 1.89 Allowed Glycine 0 N--CA 1.426 -1.969 0 N-CA-C 109.546 -1.422 . . . . 60.43 109.546 176.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 160.43 62.69 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.733 0 N-CA-C 110.281 -1.128 . . . . 64.32 110.281 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -90.54 -46.49 8.28 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 120.887 0.375 . . . . 74.23 111.122 -178.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 21.3 p -130.0 129.91 44.33 Favored 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 108.992 -0.744 . . . . 74.42 108.992 175.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 13.3 mt 60.88 16.27 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 C-N-CA 124.646 1.178 . . . . 60.53 111.451 175.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 6.3 m 67.0 29.03 8.25 Favored 'General case' 0 CA--C 1.562 1.441 0 C-N-CA 124.466 1.107 . . . . 60.34 110.758 -177.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -64.07 108.11 1.45 Allowed 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.937 -0.574 . . . . 74.33 110.079 174.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -117.3 33.82 5.43 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.482 -0.933 . . . . 74.41 108.482 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 612' ' ' TYR . . . . . 0.452 ' CE1' ' HG3' ' A' ' 633' ' ' ARG . 89.6 m-85 73.84 68.14 0.1 Allowed 'General case' 0 CA--C 1.494 -1.194 0 CA-C-N 113.769 -1.56 . . . . 53.22 107.907 -171.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -95.35 65.92 2.8 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 113.582 -1.645 . . . . 63.23 110.18 -176.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -161.8 178.23 9.15 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-N 114.284 -1.325 . . . . 42.24 107.456 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -147.8 31.98 0.86 Allowed 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.635 -0.876 . . . . 74.0 108.635 173.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -108.66 166.89 10.02 Favored Pre-proline 0 C--N 1.31 -1.136 0 CA-C-N 115.281 -0.872 . . . . 74.04 109.665 -176.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -62.54 -167.91 0.07 OUTLIER 'Trans proline' 0 C--N 1.362 1.274 0 C-N-CA 122.735 2.29 . . . . 75.51 112.944 177.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.463 ' H ' HD22 ' A' ' 618' ' ' LEU . 2.5 mm? -63.97 113.7 3.64 Favored 'General case' 0 C--O 1.245 0.843 0 N-CA-C 109.484 -0.561 . . . . 72.42 109.484 -177.068 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 1.4 p -135.11 131.17 36.58 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 113.371 0.878 . . . . 61.33 113.371 -172.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 48.2 m -163.97 132.73 3.73 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 106.227 -1.768 . . . . 44.44 106.227 175.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -120.6 -71.19 0.75 Allowed 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 120.83 -0.348 . . . . 75.02 111.225 175.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -118.89 -1.65 10.99 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.645 0.736 . . . . 71.22 109.601 178.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 623' ' ' GLU . . . . . 0.432 ' HB2' ' CB ' ' A' ' 626' ' ' ARG . 8.2 mp0 -84.7 107.61 16.98 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 115.044 -0.98 . . . . 63.14 110.463 -171.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 624' ' ' GLU . . . . . 0.461 ' H ' ' CD ' ' A' ' 624' ' ' GLU . 0.7 OUTLIER -70.76 -35.2 72.51 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.271 -0.64 . . . . 75.01 109.271 176.678 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -59.13 -37.56 77.54 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.908 -0.587 . . . . 70.34 110.048 174.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 626' ' ' ARG . . . . . 0.526 ' O ' ' HG2' ' A' ' 630' ' ' GLU . 11.4 tpt180 -68.16 -39.3 82.65 Favored 'General case' 0 C--O 1.2 -1.537 0 N-CA-C 109.32 -0.622 . . . . 65.14 109.32 -178.146 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 627' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -60.26 -31.46 70.24 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.393 0.616 . . . . 74.04 111.522 176.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 98.2 mt -72.41 -40.63 64.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-N 115.371 -0.832 . . . . 73.11 110.022 177.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -65.85 -38.43 88.84 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 109.339 -0.615 . . . . 63.13 109.339 175.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 630' ' ' GLU . . . . . 0.526 ' HG2' ' O ' ' A' ' 626' ' ' ARG . 6.5 mm-40 -73.96 -0.94 17.76 Favored 'General case' 0 C--O 1.217 -0.658 0 C-N-CA 123.785 0.834 . . . . 71.42 112.272 -179.506 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 631' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -107.53 0.51 22.75 Favored 'General case' 0 CA--C 1.507 -0.68 0 C-N-CA 119.728 -0.789 . . . . 75.3 109.814 172.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -88.34 -35.8 8.52 Favored Glycine 0 CA--C 1.497 -1.09 0 N-CA-C 106.324 -2.711 . . . . 54.43 106.324 169.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 633' ' ' ARG . . . . . 0.479 ' HD2' ' OE1' ' A' ' 630' ' ' GLU . 91.0 mtt180 -80.38 147.65 64.68 Favored Pre-proline 0 N--CA 1.427 -1.579 0 N-CA-C 107.239 -1.393 . . . . 52.32 107.239 169.319 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.478 ' HA ' ' HB1' ' A' ' 502' ' ' ALA . 27.7 Cg_endo -79.28 153.31 24.28 Favored 'Trans proline' 0 N--CA 1.429 -2.267 0 N-CA-C 107.937 -1.601 . . . . 70.11 107.937 166.485 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 635' ' ' ILE . . . . . 0.447 HG12 ' HB3' ' A' ' 502' ' ' ALA . 8.8 pt -122.86 -178.99 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 C-N-CA 119.7 -0.8 . . . . 72.11 109.98 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.55 -176.67 4.16 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 115.835 -0.621 . . . . 71.22 109.631 -178.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -83.54 -125.16 1.07 Allowed Glycine 0 N--CA 1.429 -1.811 0 C-N-CA 120.694 -0.765 . . . . 62.42 113.263 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -114.5 -59.94 1.95 Allowed 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 115.121 -0.54 . . . . 74.24 110.243 -176.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -107.52 93.82 4.75 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 122.068 0.937 . . . . 71.54 111.445 -178.069 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 23.7 p -109.46 91.27 3.58 Favored 'General case' 0 N--CA 1.41 -2.453 0 CA-C-N 115.389 -0.823 . . . . 72.43 109.788 178.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 641' ' ' LYS . . . . . 0.472 ' HE2' ' HB2' ' A' ' 643' ' ' GLU . 0.3 OUTLIER -168.92 129.26 1.13 Allowed 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 104.305 -2.48 . . . . 73.01 104.305 -178.021 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 642' ' ' LEU . . . . . 0.526 ' O ' ' HA ' ' A' ' 588' ' ' PHE . 37.0 tp -125.4 112.78 16.7 Favored 'General case' 0 C--N 1.276 -2.588 0 N-CA-C 108.094 -1.076 . . . . 61.1 108.094 175.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 643' ' ' GLU . . . . . 0.472 ' HB2' ' HE2' ' A' ' 641' ' ' LYS . 23.6 tt0 -98.07 107.2 19.63 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 107.175 -1.417 . . . . 74.45 107.175 177.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 644' ' ' VAL . . . . . 0.72 HG21 ' HE1' ' A' ' 521' ' ' MET . 26.6 t -95.05 103.18 14.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 N-CA-C 109.193 -0.669 . . . . 62.21 109.193 -178.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 3.9 mp -89.79 120.93 39.39 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 N-CA-C 108.401 -0.963 . . . . 74.43 108.401 178.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 646' ' ' ILE . . . . . 0.496 HD12 ' H ' ' A' ' 646' ' ' ILE . 1.5 mp -104.83 128.64 58.38 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.764 0 N-CA-C 104.982 -2.229 . . . . 72.15 104.982 -178.578 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -147.22 170.66 16.77 Favored 'General case' 0 C--N 1.282 -2.356 0 O-C-N 123.551 0.532 . . . . 54.31 112.078 -176.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 648' ' ' GLU . . . . . 0.643 ' OE2' 'CA ' ' A' ' 800' ' ' ' CA' . 14.6 mm-40 -52.77 137.45 31.57 Favored 'General case' 0 C--O 1.249 1.037 0 CA-C-N 114.738 -1.119 . . . . 65.14 109.692 178.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 649' ' ' SER . . . . . 0.452 ' HA ' ' CZ ' ' A' ' 652' ' ' PHE . 9.4 t -79.15 86.01 4.99 Favored 'General case' 0 N--CA 1.422 -1.842 0 CA-C-O 121.945 0.879 . . . . 64.2 111.897 -174.29 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -109.2 -58.27 2.05 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 107.299 -1.371 . . . . 73.44 107.299 173.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -179.84 160.05 0.88 Allowed 'General case' 0 N--CA 1.422 -1.87 0 N-CA-C 101.941 -3.355 . . . . 70.44 101.941 175.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 652' ' ' PHE . . . . . 0.682 ' CZ ' ' HA ' ' A' ' 515' ' ' SER . 60.0 m-85 -121.0 99.74 6.67 Favored 'General case' 0 N--CA 1.397 -3.095 0 N-CA-C 109.192 -0.67 . . . . 72.23 109.192 -174.265 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 27.6 mmmt -78.78 92.23 4.8 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.541 -1.281 . . . . 54.42 107.541 -178.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 654' ' ' SER . . . . . 0.522 ' HA ' ' CD2' ' A' ' 513' ' ' HIS . 21.8 t -62.18 125.45 23.92 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.847 -1.07 . . . . 73.43 111.838 -172.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 90.7 m -75.26 92.82 2.78 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 107.999 -1.112 . . . . 61.33 107.999 174.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 56.7 t -75.69 116.39 18.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 N-CA-C 109.517 -0.549 . . . . 73.31 109.517 -178.237 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 13.9 t70 . . . . . 0 C--N 1.299 -1.617 0 N-CA-C 109.313 -0.625 . . . . 72.12 109.313 -179.355 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 800' ' ' ' CA' . . . . . 0.659 'CA ' ' OE2' ' A' ' 516' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 850' ' ' ' CA' . . . . . 0.67 'CA ' ' OE2' ' A' ' 580' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 23.5 t-160 . . . . . 0 N--CA 1.447 -0.594 0 CA-C-O 121.061 0.458 . . . . 72.24 110.015 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 502' ' ' ALA . . . . . 0.489 ' HB2' ' O ' ' A' ' 630' ' ' GLU . . . -151.81 -59.64 0.16 Allowed 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 107.299 -1.371 . . . . 51.12 107.299 175.564 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 503' ' ' GLY . . . . . 0.642 ' HA2' ' OG1' ' A' ' 528' ' ' THR . . . -155.29 113.15 0.56 Allowed Glycine 0 N--CA 1.403 -3.505 0 CA-C-N 114.642 -1.163 . . . . 74.34 110.585 177.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 504' ' ' ILE . . . . . 0.416 ' HA ' ' HA2' ' A' ' 637' ' ' GLY . 3.1 mp -90.38 103.61 14.47 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.475 0 N-CA-C 108.783 -0.821 . . . . 61.54 108.783 177.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -117.15 109.37 16.83 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 106.728 -1.582 . . . . 75.34 106.728 175.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 12.5 t -150.62 164.39 36.17 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 109.196 -0.668 . . . . 51.31 109.196 -175.101 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -96.53 165.2 12.28 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.075 -1.083 . . . . 73.12 108.075 175.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.1 -30.97 9.89 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 120.781 -0.367 . . . . 74.42 111.919 175.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -107.85 123.7 37.04 Favored Pre-proline 0 C--N 1.311 -1.091 0 N-CA-C 108.714 -0.847 . . . . 75.22 108.714 173.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -82.43 -13.11 9.97 Favored 'Trans proline' 0 CA--C 1.532 0.381 0 C-N-CA 121.926 1.75 . . . . 70.44 111.549 177.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 511' ' ' VAL . . . . . 0.488 HG22 ' HB3' ' A' ' 643' ' ' GLU . 75.2 t -138.74 133.19 41.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 108.524 -0.917 . . . . 71.33 108.524 -179.349 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 5.4 t -136.45 145.86 45.7 Favored 'General case' 0 N--CA 1.41 -2.45 0 N-CA-C 108.613 -0.884 . . . . 53.13 108.613 176.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 27.8 m-70 -110.46 137.82 47.66 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.935 -0.765 . . . . 65.51 108.935 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.566 HG11 ' SD ' ' A' ' 521' ' ' MET . 27.7 m -126.74 151.53 33.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-O 121.197 0.522 . . . . 73.22 110.432 179.15 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 43.5 t -76.32 146.95 38.49 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 107.849 -1.167 . . . . 64.33 107.849 176.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 516' ' ' GLU . . . . . 0.692 ' HB2' ' O ' ' A' ' 647' ' ' GLU . 33.4 tt0 -74.98 -7.4 53.52 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-O 121.905 0.86 . . . . 71.31 109.683 176.524 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 10.7 t -110.28 22.72 15.18 Favored 'General case' 0 N--CA 1.415 -2.207 0 N-CA-C 108.382 -0.97 . . . . 53.13 108.382 -177.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 15.0 tt -94.02 155.61 3.18 Favored 'Isoleucine or valine' 0 C--O 1.247 0.948 0 N-CA-C 109.087 -0.708 . . . . 74.34 109.087 178.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -101.42 -70.45 0.89 Allowed Glycine 0 N--CA 1.419 -2.457 0 N-CA-C 110.66 -0.976 . . . . 63.21 110.66 177.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 32.3 mm -116.81 114.04 44.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 CA-C-O 120.689 0.28 . . . . 62.11 111.029 -177.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 521' ' ' MET . . . . . 0.57 ' HE1' HG21 ' A' ' 644' ' ' VAL . 24.7 ptt? -92.98 137.65 32.17 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.755 -1.202 . . . . 75.03 107.755 173.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -123.76 114.64 20.19 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 121.4 0.619 . . . . 74.24 110.794 178.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 523' ' ' VAL . . . . . 0.559 HG21 HD21 ' A' ' 642' ' ' LEU . 20.5 t -103.54 138.09 29.35 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 CA-C-N 114.639 -1.164 . . . . 71.2 108.414 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 524' ' ' LYS . . . . . 0.413 ' HD2' ' CG2' ' A' ' 568' ' ' VAL . 30.8 mmtp -85.13 145.89 27.4 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.664 0.745 . . . . 72.4 112.329 -177.416 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 7.9 t -123.13 131.49 73.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 106.49 -1.67 . . . . 72.01 106.49 175.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -77.54 140.6 39.76 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.064 -0.717 . . . . 72.4 109.064 -178.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 527' ' ' ARG . . . . . 0.499 ' HG3' ' HA ' ' A' ' 567' ' ' ILE . 2.7 tmm_? -96.12 135.29 38.1 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 109.202 -0.666 . . . . 70.34 109.202 -176.1 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 528' ' ' THR . . . . . 0.642 ' OG1' ' HA2' ' A' ' 503' ' ' GLY . 6.0 t -50.85 147.04 5.26 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 125.083 1.353 . . . . 71.13 114.557 -177.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 35.2 t -63.21 -55.11 27.72 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 114.55 -1.204 . . . . 45.31 107.811 173.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -85.95 95.5 2.02 Favored Glycine 0 N--CA 1.423 -2.171 0 N-CA-C 109.5 -1.44 . . . . 64.03 109.5 178.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -111.64 98.93 7.77 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 121.092 0.472 . . . . 64.44 110.24 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -125.01 131.78 53.35 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 109.299 -0.63 . . . . 73.42 109.299 177.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 81.07 -144.54 24.94 Favored Glycine 0 N--CA 1.422 -2.286 0 C-N-CA 120.828 -0.701 . . . . 45.4 113.254 175.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -140.2 121.74 15.18 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 107.858 -1.164 . . . . 72.02 107.858 179.233 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 535' ' ' VAL . . . . . 0.438 HG22 HD22 ' A' ' 596' ' ' LEU . 58.1 t -126.75 131.74 70.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 108.803 -0.814 . . . . 54.54 108.803 -178.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 536' ' ' ILE . . . . . 0.62 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 42.5 mm -94.92 129.63 44.81 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 108.888 -0.782 . . . . 74.12 108.888 178.503 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 67.9 t -111.97 110.73 54.04 Favored Pre-proline 0 C--N 1.295 -1.783 0 N-CA-C 109.37 -0.604 . . . . 74.4 109.37 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -73.96 155.95 47.88 Favored 'Trans proline' 0 CA--C 1.512 -0.625 0 C-N-CA 122.513 2.142 . . . . 43.34 111.495 178.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 539' ' ' TYR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 591' ' ' ILE . 48.2 p90 -150.41 156.34 41.3 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.295 -1.002 . . . . 73.54 108.295 177.051 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -152.44 147.9 26.81 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 112.188 0.44 . . . . 73.5 112.188 176.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 3.5 p -84.34 120.92 26.82 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-N 115.474 -0.785 . . . . 70.21 110.94 176.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.8 mp -88.84 119.92 36.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 N-CA-C 105.728 -1.953 . . . . 64.1 105.728 173.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -52.47 -41.01 62.97 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 124.479 1.112 . . . . 73.42 112.716 -174.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 72.34 -92.05 0.57 Allowed Glycine 0 N--CA 1.435 -1.369 0 N-CA-C 110.825 -0.91 . . . . 71.51 110.825 178.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 10.2 t -146.14 18.13 1.39 Allowed 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 121.382 0.611 . . . . 64.13 109.812 177.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -101.08 161.03 13.89 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.619 -1.252 . . . . 64.42 107.619 176.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 18.5 mmm180 -63.86 173.23 1.88 Allowed 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 113.75 1.019 . . . . 72.24 113.75 -179.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -71.34 -178.47 28.7 Favored Glycine 0 C--O 1.254 1.355 0 CA-C-N 114.254 -1.339 . . . . 62.11 114.281 -175.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . -59.87 119.38 18.09 Favored Glycine 0 N--CA 1.441 -1.005 0 CA-C-N 114.737 -0.731 . . . . 74.51 113.287 -176.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 95.28 -10.41 69.51 Favored Glycine 0 N--CA 1.435 -1.399 0 N-CA-C 111.712 -0.555 . . . . 45.52 111.712 178.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -98.51 -68.36 0.81 Allowed 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.782 -0.822 . . . . 61.4 108.782 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -94.22 -38.29 11.13 Favored 'General case' 0 CA--C 1.492 -1.264 0 C-N-CA 118.862 -1.135 . . . . 74.22 111.414 175.056 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 553' ' ' PHE . . . . . 0.426 ' HB3' ' CE2' ' A' ' 587' ' ' PHE . 48.0 p90 -145.04 155.63 43.47 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 108.316 -0.994 . . . . 71.52 108.316 -179.538 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -83.56 119.24 24.48 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 105.329 -2.1 . . . . 75.02 105.329 174.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -73.53 104.23 4.42 Favored 'General case' 0 CA--C 1.498 -1.035 0 CA-C-O 121.267 0.556 . . . . 61.33 110.043 -175.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 556' ' ' THR . . . . . 0.489 HG21 HG22 ' A' ' 573' ' ' VAL . 11.5 t -103.36 100.8 10.69 Favored 'General case' 0 N--CA 1.395 -3.175 0 CA-C-O 122.793 1.282 . . . . 52.45 110.978 -176.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 1.8 p -116.61 94.45 4.62 Favored 'General case' 0 N--CA 1.409 -2.502 0 CA-C-N 114.085 -1.416 . . . . 71.41 108.47 174.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -142.34 -157.54 7.19 Favored Glycine 0 N--CA 1.407 -3.291 0 N-CA-C 110.029 -1.228 . . . . 71.0 110.029 -174.007 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 559' ' ' GLU . . . . . 0.62 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 49.3 mt-10 -142.23 137.09 30.48 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 120.647 0.26 . . . . 61.12 111.315 -173.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 95.5 mt -96.82 144.94 26.31 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 123.415 0.686 . . . . 70.12 109.681 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -102.88 113.25 26.54 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 120.923 0.392 . . . . 72.13 110.665 -178.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -109.08 132.51 54.04 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 110.076 -0.342 . . . . 62.34 110.076 175.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -121.96 174.22 7.04 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.457 -0.897 . . . . 74.34 111.343 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -64.68 -38.03 89.59 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 114.122 -1.399 . . . . 65.0 110.222 176.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -94.34 -33.89 13.01 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.529 -0.76 . . . . 54.54 112.269 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -78.19 132.15 37.47 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.51 -0.313 . . . . 71.13 111.681 -177.167 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 567' ' ' ILE . . . . . 0.499 ' HA ' ' HG3' ' A' ' 527' ' ' ARG . 7.8 pt -109.94 163.29 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.617 0 N-CA-C 109.732 -0.47 . . . . 72.21 109.732 178.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 568' ' ' VAL . . . . . 0.498 ' O ' ' HG2' ' A' ' 569' ' ' LYS . 1.4 p 45.53 171.93 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.574 1.882 0 C-N-CA 127.278 2.231 . . . . 64.53 114.553 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 569' ' ' LYS . . . . . 0.566 ' HE3' ' HA ' ' A' ' 569' ' ' LYS . 0.0 OUTLIER -158.98 163.98 35.97 Favored 'General case' 0 CA--C 1.497 -1.095 0 C-N-CA 124.39 1.076 . . . . 73.31 108.235 173.698 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 570' ' ' THR . . . . . 0.537 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 4.7 p -135.4 133.96 39.22 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 124.112 0.883 . . . . 73.13 110.352 177.298 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 3.3 mp -93.03 106.26 17.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 106.618 -1.623 . . . . 63.21 106.618 172.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 572' ' ' SER . . . . . 0.424 ' HA ' ' O ' ' A' ' 521' ' ' MET . 13.0 p -88.14 112.02 22.24 Favored 'General case' 0 N--CA 1.424 -1.733 0 O-C-N 123.575 0.547 . . . . 74.44 109.797 178.315 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 573' ' ' VAL . . . . . 0.489 HG22 HG21 ' A' ' 556' ' ' THR . 42.4 t -115.54 131.22 68.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 109.148 -0.686 . . . . 64.15 109.148 -178.25 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -88.01 112.69 22.88 Favored 'General case' 0 N--CA 1.423 -1.784 0 O-C-N 123.929 0.768 . . . . 63.52 109.516 176.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 62.9 t -85.88 133.61 29.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 N-CA-C 106.42 -1.696 . . . . 70.31 106.42 176.142 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 25.8 mm -97.78 159.9 3.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 107.914 -1.143 . . . . 72.22 107.914 -174.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -71.35 114.22 9.19 Favored 'General case' 0 C--O 1.25 1.13 0 N-CA-C 110.007 -0.368 . . . . 74.22 110.007 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -56.82 142.71 39.91 Favored 'General case' 0 C--O 1.246 0.921 0 C-N-CA 124.614 1.166 . . . . 72.42 110.969 -176.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 579' ' ' GLU . . . . . 0.655 ' OE1' 'CA ' ' A' ' 850' ' ' ' CA' . 0.0 OUTLIER -124.88 -28.35 3.5 Favored 'General case' 0 C--N 1.289 -2.055 0 C-N-CA 125.115 1.366 . . . . 71.14 112.31 -170.439 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 580' ' ' GLU . . . . . 0.624 ' OE2' 'CA ' ' A' ' 850' ' ' ' CA' 0.3 0.0 OUTLIER -111.49 174.07 6.04 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 114.647 1.351 . . . . 43.14 114.647 -172.653 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 31.7 p90 -48.8 148.02 2.38 Favored 'General case' 0 CA--C 1.522 -0.122 0 O-C-N 124.778 1.298 . . . . 71.33 110.287 -178.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -122.99 106.5 10.9 Favored 'General case' 0 N--CA 1.408 -2.573 0 C-N-CA 118.265 -1.374 . . . . 75.34 114.177 -173.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -98.45 -158.48 0.67 Allowed 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 104.902 -2.258 . . . . 72.22 104.902 169.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -83.05 88.34 6.87 Favored 'General case' 0 C--N 1.282 -2.353 0 C-N-CA 118.903 -1.119 . . . . 72.33 108.4 174.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 585' ' ' LYS . . . . . . . . . . . . 0.315 0.5 OUTLIER -100.85 138.36 38.0 Favored 'General case' 0 N--CA 1.425 -1.684 0 C-N-CA 119.429 -0.908 . . . . 53.03 111.81 -179.014 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 4.1 t -152.42 150.21 29.41 Favored 'General case' 0 N--CA 1.405 -2.681 0 CA-C-N 114.699 -1.137 . . . . 74.33 109.79 -175.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 587' ' ' PHE . . . . . 0.426 ' CE2' ' HB3' ' A' ' 553' ' ' PHE . 4.1 p90 -124.35 151.23 44.59 Favored 'General case' 0 N--CA 1.411 -2.395 0 CA-C-N 114.221 -1.354 . . . . 63.13 108.335 176.19 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 588' ' ' PHE . . . . . 0.5 ' HA ' ' O ' ' A' ' 642' ' ' LEU . 16.5 m-85 -113.35 142.04 46.33 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 116.471 -0.331 . . . . 64.42 110.281 -171.147 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 589' ' ' LEU . . . . . 0.442 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.4 OUTLIER -107.71 131.7 54.14 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 106.481 -1.674 . . . . 75.1 106.481 175.988 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -141.77 144.4 33.95 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.396 -0.964 . . . . 64.14 108.396 -179.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 591' ' ' ILE . . . . . 0.567 HG12 ' OG1' ' A' ' 640' ' ' THR . 20.0 pt -96.37 168.01 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 O-C-N 123.699 0.624 . . . . 73.04 109.691 177.332 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -118.03 -154.27 9.76 Favored Glycine 0 C--N 1.303 -1.288 0 C-N-CA 120.444 -0.884 . . . . 62.33 113.675 -177.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -76.93 118.24 70.47 Favored Pre-proline 0 C--N 1.319 -0.751 0 N-CA-C 108.664 -0.865 . . . . 73.02 108.664 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -66.72 138.19 48.28 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 122.398 2.065 . . . . 73.32 112.071 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 595' ' ' ARG . . . . . 0.55 ' CG ' ' HB ' ' A' ' 536' ' ' ILE . 7.2 ptm180 -116.03 119.48 36.02 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.69 -0.686 . . . . 62.15 109.822 -174.324 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 596' ' ' LEU . . . . . 0.438 HD22 HG22 ' A' ' 535' ' ' VAL . 0.0 OUTLIER -69.96 129.0 38.31 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 107.92 -1.141 . . . . 72.31 107.92 179.216 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 597' ' ' VAL . . . . . 0.498 ' CG2' HG12 ' A' ' 536' ' ' ILE . 11.6 t -91.0 36.7 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 122.696 1.236 . . . . 54.24 108.286 178.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 70.14 -39.95 0.45 Allowed 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 126.292 1.837 . . . . 73.41 115.922 177.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 62.6 ttp -53.5 109.61 0.46 Allowed 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 112.578 0.585 . . . . 61.42 112.578 -174.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 600' ' ' SER . . . . . 0.402 ' HB3' ' HB ' ' A' ' 608' ' ' ILE . 32.8 t 178.48 116.3 0.04 OUTLIER 'General case' 0 N--CA 1.421 -1.903 0 N-CA-C 103.807 -2.664 . . . . 71.53 103.807 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -122.19 131.65 54.05 Favored 'General case' 0 C--N 1.284 -2.281 0 C-N-CA 119.411 -0.915 . . . . 73.44 112.819 -173.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -90.42 129.0 36.66 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 104.821 -2.289 . . . . 70.44 104.821 167.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -75.36 7.22 3.69 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.463 0.649 . . . . 63.11 111.302 -174.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -90.63 20.36 38.92 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 116.237 -0.438 . . . . 42.11 112.142 178.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 85.91 42.08 6.9 Favored Glycine 0 N--CA 1.438 -1.189 0 C-N-CA 120.913 -0.66 . . . . 65.44 113.217 176.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -160.57 126.88 4.09 Favored 'General case' 0 C--O 1.245 0.817 0 CA-C-N 117.142 0.471 . . . . 74.53 110.643 178.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 15.3 p -97.53 135.33 39.53 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-N 116.141 -0.482 . . . . 75.42 109.962 176.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 608' ' ' ILE . . . . . 0.402 ' HB ' ' HB3' ' A' ' 600' ' ' SER . 49.7 mm -74.58 152.29 6.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 C-N-CA 122.881 0.472 . . . . 62.43 110.413 -174.263 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 7.6 t -153.33 75.18 1.05 Allowed 'General case' 0 N--CA 1.405 -2.69 0 CA-C-O 122.766 1.269 . . . . 75.55 111.295 176.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -86.62 84.2 7.45 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 106.979 -1.489 . . . . 74.34 106.979 176.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -88.21 92.24 9.08 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-O 121.997 0.903 . . . . 73.25 113.382 -175.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -118.21 84.89 2.25 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 105.767 -1.938 . . . . 71.04 105.767 170.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -126.75 22.37 6.86 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 112.709 -2.042 . . . . 75.03 107.834 -169.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -94.52 2.99 55.68 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.8 -1.091 . . . . 72.41 111.915 -172.028 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp 51.5 72.44 0.37 Allowed 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 114.064 -1.425 . . . . 74.41 112.35 -179.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 80.1 mm-40 -108.31 170.93 4.97 Favored Pre-proline 0 C--N 1.282 -2.362 0 CA-C-N 114.704 -1.135 . . . . 74.41 108.609 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -65.82 162.64 33.97 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 121.096 1.197 . . . . 71.4 109.3 171.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -60.54 137.36 58.17 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 121.555 0.693 . . . . 72.31 111.329 -178.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 619' ' ' THR . . . . . 0.433 ' O ' ' HG2' ' A' ' 626' ' ' ARG . 19.4 p -66.34 -9.34 32.3 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 116.502 2.038 . . . . 72.41 116.502 -167.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 7.6 p -74.08 78.23 1.73 Allowed 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 114.496 1.295 . . . . 63.34 114.496 -175.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 44.1 tttm -86.32 -49.44 7.67 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 114.677 -1.147 . . . . 71.22 108.166 174.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 25.8 mp0 -103.71 148.53 25.95 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 107.01 -1.478 . . . . 73.23 107.01 175.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -93.02 -33.57 14.07 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 107.668 -1.234 . . . . 75.21 107.668 171.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -58.97 -67.34 0.38 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.751 -1.113 . . . . 64.4 112.534 -178.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -87.31 -33.63 19.15 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 113.556 0.947 . . . . 63.11 113.556 -173.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 626' ' ' ARG . . . . . 0.439 ' O ' ' HG3' ' A' ' 630' ' ' GLU . 6.4 tpp180 -66.61 -37.5 84.99 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 112.704 0.631 . . . . 75.04 112.704 -171.327 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 627' ' ' ARG . . . . . . . . . . . . . 81.6 mtm180 -55.6 -28.59 56.03 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 112.81 0.67 . . . . 72.55 112.81 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 628' ' ' ILE . . . . . 0.446 ' O ' ' HG2' ' A' ' 631' ' ' MET . 93.7 mt -64.56 -36.99 78.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-N 115.441 -0.8 . . . . 64.23 110.362 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -86.22 -30.57 22.28 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.933 -0.576 . . . . 74.24 109.569 178.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 630' ' ' GLU . . . . . 0.489 ' O ' ' HB2' ' A' ' 502' ' ' ALA . 50.4 mt-10 -80.45 2.54 24.71 Favored 'General case' 0 C--O 1.216 -0.679 0 CA-C-N 115.671 -0.695 . . . . 43.04 112.36 -177.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 631' ' ' MET . . . . . 0.446 ' HG2' ' O ' ' A' ' 628' ' ' ILE . 19.4 ptp -85.58 -30.81 23.04 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 119.176 -1.01 . . . . 71.41 109.208 174.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -92.57 -40.76 4.94 Favored Glycine 0 N--CA 1.431 -1.66 0 N-CA-C 110.979 -0.848 . . . . 72.23 110.979 177.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -88.97 138.82 29.05 Favored Pre-proline 0 C--N 1.314 -0.954 0 N-CA-C 108.773 -0.825 . . . . 72.04 108.773 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -74.31 154.17 45.89 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.39 2.06 . . . . 60.3 113.188 -175.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 1.9 pp -144.09 -169.81 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.31 -0.859 . . . . 75.43 110.775 -176.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.61 164.1 19.94 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 123.082 0.239 . . . . 73.32 110.621 -179.176 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 637' ' ' GLY . . . . . 0.416 ' HA2' ' HA ' ' A' ' 504' ' ' ILE . . . -81.16 -85.29 0.7 Allowed Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 121.317 -0.468 . . . . 71.45 113.78 -177.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -143.02 -63.58 0.41 Allowed 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 120.465 -0.494 . . . . 74.44 110.425 -178.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 10.7 p80 -127.68 114.77 17.77 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-O 121.913 0.864 . . . . 75.43 111.598 178.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 640' ' ' THR . . . . . 0.567 ' OG1' HG12 ' A' ' 591' ' ' ILE . 0.7 OUTLIER -111.4 92.28 3.98 Favored 'General case' 0 N--CA 1.416 -2.131 0 CA-C-N 114.811 -1.086 . . . . 53.32 109.674 177.361 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -169.88 125.44 0.81 Allowed 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 106.503 -1.666 . . . . 63.14 106.503 178.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 642' ' ' LEU . . . . . 0.559 HD21 HG21 ' A' ' 523' ' ' VAL . 31.3 tp -130.43 110.09 11.21 Favored 'General case' 0 C--N 1.277 -2.553 0 N-CA-C 108.312 -0.996 . . . . 72.54 108.312 177.609 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 643' ' ' GLU . . . . . 0.488 ' HB3' HG22 ' A' ' 511' ' ' VAL . 43.1 tt0 -92.31 107.22 19.05 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.062 -1.088 . . . . 71.25 108.062 178.21 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 644' ' ' VAL . . . . . 0.57 HG21 ' HE1' ' A' ' 521' ' ' MET . 24.3 t -97.73 104.56 16.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 109.248 -0.649 . . . . 74.22 109.248 -179.293 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 4.5 mp -86.69 128.21 39.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 108.903 -0.777 . . . . 73.32 108.903 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 646' ' ' ILE . . . . . 0.443 HD12 ' N ' ' A' ' 646' ' ' ILE . 1.2 mp -110.81 106.94 21.73 Favored 'Isoleucine or valine' 0 C--O 1.255 1.377 0 N-CA-C 108.158 -1.053 . . . . 73.34 108.158 -177.462 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 647' ' ' GLU . . . . . 0.692 ' O ' ' HB2' ' A' ' 516' ' ' GLU . 8.0 pt-20 -109.19 -161.4 0.76 Allowed 'General case' 0 C--N 1.268 -2.958 0 CA-C-N 113.718 -1.583 . . . . 75.31 107.864 -178.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 648' ' ' GLU . . . . . 0.656 ' OE1' 'CA ' ' A' ' 800' ' ' ' CA' . 7.8 mm-40 -81.5 -173.1 4.19 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.3 -0.63 . . . . 74.1 109.3 177.643 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 23.1 t -79.76 80.41 6.15 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.213 -1.032 . . . . 62.44 108.213 175.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -143.52 -61.96 0.4 Allowed 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 114.557 -1.201 . . . . 74.11 108.516 -177.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 71.86 121.09 0.04 OUTLIER 'General case' 0 C--O 1.247 0.966 0 C-N-CA 126.199 1.8 . . . . 72.11 111.425 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -122.81 164.66 17.96 Favored 'General case' 0 C--N 1.27 -2.865 0 N-CA-C 106.884 -1.524 . . . . 73.14 106.884 -179.2 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -118.03 98.91 6.56 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 120.802 0.334 . . . . 72.43 110.777 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 23.4 t -135.65 79.28 1.77 Allowed 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 108.722 -0.844 . . . . 53.31 108.722 176.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 15.0 m -95.84 100.96 12.59 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 115.252 -0.886 . . . . 55.02 109.337 -178.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 31.5 m -91.15 164.76 2.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 CA-C-N 115.78 -0.645 . . . . 71.33 110.343 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 . . . . . 0 C--O 1.253 1.286 0 N-CA-C 110.058 -0.349 . . . . 62.34 110.058 -179.546 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 800' ' ' ' CA' . . . . . 0.675 'CA ' ' OE1' ' A' ' 516' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 850' ' ' ' CA' . . . . . 0.655 'CA ' ' OE1' ' A' ' 579' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 9.7 t-160 . . . . . 0 CA--C 1.515 -0.395 0 CA-C-O 121.669 0.747 . . . . 71.11 111.764 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 502' ' ' ALA . . . . . 0.406 ' HB1' ' HA ' ' A' ' 634' ' ' PRO . . . -145.82 -64.07 0.32 Allowed 'General case' 0 C--N 1.279 -2.459 0 N-CA-C 106.302 -1.74 . . . . 73.24 106.302 173.145 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 503' ' ' GLY . . . . . 0.457 ' HA2' ' OG1' ' A' ' 528' ' ' THR . . . 137.38 125.82 2.44 Favored Glycine 0 N--CA 1.409 -3.113 0 C-N-CA 120.31 -0.948 . . . . 65.32 112.248 176.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 504' ' ' ILE . . . . . 0.443 ' H ' ' CB ' ' A' ' 528' ' ' THR . 3.1 mp -93.57 98.46 8.28 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 N-CA-C 107.826 -1.176 . . . . 74.34 107.826 174.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -113.9 114.73 26.63 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.922 -1.14 . . . . 71.21 107.922 176.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 506' ' ' THR . . . . . 0.463 ' HB ' ' HA3' ' A' ' 637' ' ' GLY . 15.0 t -149.02 162.66 39.49 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.876 -0.787 . . . . 74.23 108.876 -176.183 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -81.71 152.19 27.17 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 108.023 -1.103 . . . . 74.12 108.023 176.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -76.14 -24.85 54.9 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.551 0.691 . . . . 65.24 109.691 178.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 509' ' ' GLU . . . . . 0.462 ' OE1' ' HB ' ' A' ' 655' ' ' THR . 24.2 pt-20 -139.45 132.78 15.58 Favored Pre-proline 0 N--CA 1.424 -1.765 0 CA-C-N 115.144 -0.935 . . . . 70.33 108.683 -179.542 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -84.33 0.33 9.19 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 122.122 1.881 . . . . 62.53 112.202 176.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 511' ' ' VAL . . . . . 0.52 HG22 ' HB3' ' A' ' 643' ' ' GLU . 69.3 t -145.57 135.33 18.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 124.193 0.997 . . . . 73.34 108.413 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 6.2 t -142.03 140.79 32.73 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.198 -1.408 . . . . 63.03 107.198 177.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 513' ' ' HIS . . . . . 0.414 ' HB2' ' HB2' ' A' ' 654' ' ' SER . 11.8 m170 -110.79 133.55 53.25 Favored 'General case' 0 CA--C 1.492 -1.258 0 N-CA-C 108.325 -0.991 . . . . 73.3 108.325 178.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.641 HG11 ' SD ' ' A' ' 521' ' ' MET . 34.0 m -129.62 159.89 41.18 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 CA-C-N 116.209 -0.451 . . . . 62.42 110.288 -174.357 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 515' ' ' SER . . . . . 0.424 ' HB3' ' HB ' ' A' ' 518' ' ' ILE . 47.3 t -77.7 150.48 34.47 Favored 'General case' 0 N--CA 1.415 -2.216 0 N-CA-C 107.564 -1.273 . . . . 75.45 107.564 177.378 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -88.43 -7.06 57.22 Favored 'General case' 0 C--N 1.286 -2.156 0 CA-C-O 122.315 1.055 . . . . 54.01 108.946 178.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 33.0 t -100.29 2.43 42.62 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 114.97 -1.014 . . . . 74.3 109.16 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 518' ' ' ILE . . . . . 0.424 ' HB ' ' HB3' ' A' ' 515' ' ' SER . 15.0 tt -78.52 151.99 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-N 115.979 -0.555 . . . . 71.33 110.039 -176.524 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -87.52 -70.78 1.29 Allowed Glycine 0 N--CA 1.43 -1.719 0 N-CA-C 110.094 -1.202 . . . . 73.41 110.094 176.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 31.7 mm -112.54 126.31 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 CA-C-O 120.935 0.398 . . . . 62.35 110.178 179.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 521' ' ' MET . . . . . 0.67 ' HE1' HG21 ' A' ' 644' ' ' VAL . 23.1 ptt? -105.46 142.96 34.3 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 107.167 -1.42 . . . . 62.04 107.167 173.312 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -121.03 151.61 39.58 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 121.395 0.617 . . . . 55.31 111.555 178.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 523' ' ' VAL . . . . . 0.641 ' O ' ' HA ' ' A' ' 570' ' ' THR . 33.0 t -130.83 137.17 56.59 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 107.832 -1.173 . . . . 71.33 107.832 -179.042 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -90.43 127.33 36.18 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 113.024 0.75 . . . . 61.24 113.024 -176.373 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 22.9 t -112.57 121.95 65.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 107.291 -1.374 . . . . 72.52 107.291 176.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -75.42 145.08 41.83 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.893 0.854 . . . . 74.22 112.687 -174.373 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 527' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' A' ' 528' ' ' THR . 11.2 tpp85 -75.62 133.08 40.98 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 114.073 -1.422 . . . . 65.12 109.202 173.358 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 528' ' ' THR . . . . . 0.457 ' OG1' ' HA2' ' A' ' 503' ' ' GLY . 3.0 t -57.64 159.85 4.81 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 114.56 -1.2 . . . . 75.32 111.965 174.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 35.7 t -62.04 -37.87 86.57 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.73 0.812 . . . . 35.13 109.126 178.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -137.63 122.78 2.57 Favored Glycine 0 N--CA 1.425 -2.099 0 N-CA-C 109.961 -1.256 . . . . 74.42 109.961 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 531' ' ' ALA . . . . . 0.414 ' HB2' ' CG2' ' A' ' 528' ' ' THR . . . -130.25 114.01 15.12 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.332 -0.988 . . . . 75.13 108.332 176.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -120.79 90.09 3.25 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.696 -0.853 . . . . 71.13 108.696 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 533' ' ' GLY . . . . . 0.529 ' H ' ' HB3' ' A' ' 564' ' ' ASN . . . 122.57 -178.86 16.3 Favored Glycine 0 N--CA 1.437 -1.256 0 N-CA-C 110.96 -0.856 . . . . 75.4 110.96 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 534' ' ' ASN . . . . . 0.424 ' HA ' ' HA ' ' A' ' 563' ' ' GLN . 48.4 t-20 -91.92 131.1 37.49 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.27 -1.011 . . . . 74.22 108.27 179.223 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 535' ' ' VAL . . . . . 0.489 HG22 HD22 ' A' ' 596' ' ' LEU . 89.8 t -119.1 139.03 47.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-O 121.059 0.457 . . . . 73.24 110.143 179.2 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 536' ' ' ILE . . . . . . . . . . . . . 42.1 mm -105.44 125.01 60.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 108.949 -0.76 . . . . 62.02 108.949 178.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 22.0 t -113.49 106.24 54.38 Favored Pre-proline 0 C--N 1.302 -1.482 0 O-C-N 123.35 0.406 . . . . 74.32 109.909 -178.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.9 145.37 25.11 Favored 'Trans proline' 0 CA--C 1.533 0.454 0 C-N-CA 122.369 2.046 . . . . 75.33 111.71 178.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 539' ' ' TYR . . . . . 0.482 ' HB3' HG22 ' A' ' 591' ' ' ILE . 53.8 p90 -142.45 163.05 33.89 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 110.212 -0.292 . . . . 73.25 110.212 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -151.76 153.78 34.98 Favored 'General case' 0 C--N 1.308 -1.196 0 O-C-N 123.6 0.563 . . . . 65.22 110.618 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 4.1 p -99.24 125.14 44.78 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.796 -0.638 . . . . 72.04 110.363 173.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.417 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 3.7 mp -96.06 118.52 42.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 105.937 -1.875 . . . . 53.24 105.937 174.49 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -55.84 -50.56 70.23 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 123.868 0.73 . . . . 75.45 112.273 -176.002 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 69.51 -103.49 1.11 Allowed Glycine 0 N--CA 1.431 -1.645 0 N-CA-C 111.099 -0.8 . . . . 40.14 111.099 -179.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 545' ' ' THR . . . . . 0.453 HG23 ' HA ' ' A' ' 585' ' ' LYS . 9.1 t -109.63 -3.96 16.51 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.337 0.589 . . . . 71.45 110.311 -179.25 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -96.01 171.54 8.56 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.927 -0.397 . . . . 53.43 109.927 176.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 31.7 tpt180 -115.4 119.51 36.47 Favored 'General case' 0 C--O 1.247 0.968 0 N-CA-C 109.253 -0.647 . . . . 61.23 109.253 179.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -86.75 -154.03 24.8 Favored Glycine 0 C--N 1.311 -0.828 0 C-N-CA 120.874 -0.679 . . . . 65.44 112.37 -179.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 549' ' ' GLY . . . . . 0.441 ' H ' ' HB2' ' A' ' 555' ' ' ASP . . . 72.07 17.44 77.18 Favored Glycine 0 C--N 1.316 -0.567 0 CA-C-O 120.151 -0.249 . . . . 54.43 113.558 178.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 83.85 27.16 38.94 Favored Glycine 0 N--CA 1.439 -1.145 0 N-CA-C 110.817 -0.913 . . . . 74.41 110.817 -178.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -99.32 -69.75 0.75 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 120.711 0.291 . . . . 73.54 110.333 -178.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 552' ' ' ASP . . . . . 0.655 ' OD1' 'CA ' ' A' ' 850' ' ' ' CA' . 1.2 t70 -102.99 -27.91 12.33 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 106.879 -1.526 . . . . 75.15 106.879 177.517 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -146.23 158.2 43.86 Favored 'General case' 0 C--O 1.252 1.213 0 CA-C-N 114.526 -1.216 . . . . 74.31 108.438 174.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -87.81 116.61 26.08 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 106.121 -1.807 . . . . 73.33 106.121 178.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 555' ' ' ASP . . . . . 0.441 ' HB2' ' H ' ' A' ' 549' ' ' GLY . 14.4 t70 -75.78 132.81 40.68 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.3 -0.63 . . . . 73.41 109.3 -175.356 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 556' ' ' THR . . . . . 0.455 HG21 HG22 ' A' ' 573' ' ' VAL . 8.9 t -133.76 117.89 17.44 Favored 'General case' 0 N--CA 1.412 -2.348 0 CA-C-O 122.038 0.923 . . . . 75.13 111.534 -175.396 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 8.0 p -130.23 100.64 5.47 Favored 'General case' 0 N--CA 1.424 -1.77 0 N-CA-C 107.628 -1.249 . . . . 74.41 107.628 174.092 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -145.77 -159.71 8.3 Favored Glycine 0 N--CA 1.411 -2.968 0 N-CA-C 109.984 -1.246 . . . . 41.42 109.984 -174.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -136.1 136.77 40.41 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-O 120.678 0.275 . . . . 74.33 110.635 -175.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 89.1 mt -95.16 134.25 38.1 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.642 -0.708 . . . . 73.34 109.415 178.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -93.32 97.03 10.33 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.703 -0.851 . . . . 70.13 108.703 176.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -101.88 108.27 19.7 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 106.838 -1.542 . . . . 74.1 106.838 -178.394 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 563' ' ' GLN . . . . . 0.496 ' HB2' ' H ' ' A' ' 566' ' ' GLU . 42.9 mt-30 -97.49 172.4 7.77 Favored 'General case' 0 C--N 1.278 -2.506 0 CA-C-N 116.415 -0.357 . . . . 70.54 110.94 -174.085 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 564' ' ' ASN . . . . . 0.529 ' HB3' ' H ' ' A' ' 533' ' ' GLY . 2.6 p-10 -79.0 -16.04 57.44 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.98 0.895 . . . . 54.1 109.107 175.283 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -96.07 -54.79 3.19 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.211 -0.904 . . . . 75.12 109.195 176.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 566' ' ' GLU . . . . . 0.496 ' H ' ' HB2' ' A' ' 563' ' ' GLN . 9.7 tp10 -63.78 138.48 58.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.614 -0.721 . . . . 71.05 109.692 177.042 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 21.8 pt -106.0 -172.23 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.41 -2.466 0 N-CA-C 108.219 -1.03 . . . . 74.04 108.219 -178.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 3.4 p 3.19 126.47 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 128.832 2.853 . . . . 62.22 116.165 173.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 569' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -110.16 149.07 30.62 Favored 'General case' 0 C--N 1.259 -3.342 0 CA-C-N 115.112 -0.949 . . . . 63.23 110.502 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 570' ' ' THR . . . . . 0.641 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 16.0 p -122.53 128.16 50.43 Favored 'General case' 0 N--CA 1.415 -2.21 0 CA-C-N 115.259 -0.882 . . . . 72.33 110.188 177.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 3.3 mp -84.0 104.21 12.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 107.033 -1.469 . . . . 62.23 107.033 174.196 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 11.0 p -84.72 111.17 19.34 Favored 'General case' 0 N--CA 1.419 -2.009 0 CA-C-N 115.758 -0.655 . . . . 72.43 110.084 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 573' ' ' VAL . . . . . 0.455 HG22 HG21 ' A' ' 556' ' ' THR . 57.6 t -114.24 136.57 50.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 109.143 -0.688 . . . . 44.34 109.143 -178.278 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -95.15 125.05 39.53 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 124.123 0.89 . . . . 75.22 111.18 -178.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 81.8 t -93.59 132.84 36.63 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 N-CA-C 107.745 -1.206 . . . . 74.33 107.745 175.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 40.3 mm -91.6 160.44 2.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 109.535 -0.543 . . . . 75.23 109.535 -173.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -52.4 119.1 4.08 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 124.043 0.937 . . . . 72.12 109.671 175.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 578' ' ' ASP . . . . . 0.637 ' OD1' 'CA ' ' A' ' 850' ' ' ' CA' . 35.0 t70 -90.69 151.31 21.3 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.1 0.476 . . . . 75.2 111.952 -175.076 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 579' ' ' GLU . . . . . 0.616 ' OE1' 'CA ' ' A' ' 850' ' ' ' CA' . 0.0 OUTLIER -127.91 -26.73 2.87 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 114.194 1.183 . . . . 64.11 114.194 -172.363 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 580' ' ' GLU . . . . . 0.408 ' HG2' ' O ' ' A' ' 581' ' ' TYR . 0.0 OUTLIER -112.23 178.21 4.38 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 118.741 -1.184 . . . . 62.42 113.263 -166.943 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 581' ' ' TYR . . . . . 0.408 ' O ' ' HG2' ' A' ' 580' ' ' GLU . 47.8 p90 -61.94 154.34 26.68 Favored 'General case' 0 C--O 1.247 0.969 0 CA-C-N 114.803 -1.09 . . . . 75.22 108.922 175.013 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 582' ' ' GLU . . . . . 0.498 ' HB2' ' HG2' ' A' ' 648' ' ' GLU . 5.8 tp10 -94.31 152.78 18.4 Favored 'General case' 0 C--N 1.284 -2.251 0 C-N-CA 119.023 -1.071 . . . . 63.21 110.633 179.442 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 583' ' ' LYS . . . . . 0.467 ' O ' ' HG3' ' A' ' 582' ' ' GLU . 18.3 ptpt -137.85 -172.16 3.18 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 103.365 -2.828 . . . . 74.24 103.365 176.389 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -79.54 91.69 5.2 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.254 -1.758 . . . . 75.34 106.254 170.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 585' ' ' LYS . . . . . 0.502 ' HD2' HD13 ' A' ' 646' ' ' ILE . 4.7 tmmm? -106.67 109.23 21.08 Favored 'General case' 0 N--CA 1.396 -3.165 0 N-CA-C 106.756 -1.572 . . . . 73.43 106.756 -172.337 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 4.6 t -142.44 145.76 34.11 Favored 'General case' 0 N--CA 1.392 -3.35 0 CA-C-N 113.823 -1.535 . . . . 54.03 109.306 -174.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -128.85 155.57 45.02 Favored 'General case' 0 N--CA 1.412 -2.35 0 CA-C-N 114.408 -1.269 . . . . 73.1 108.858 178.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 588' ' ' PHE . . . . . 0.505 ' HA ' ' O ' ' A' ' 642' ' ' LEU . 23.5 m-85 -109.67 138.13 46.49 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-N 116.36 -0.382 . . . . 71.22 110.23 -171.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 589' ' ' LEU . . . . . 0.487 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.8 OUTLIER -110.94 125.76 54.02 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 105.777 -1.934 . . . . 73.0 105.777 176.297 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -127.94 131.24 49.34 Favored 'General case' 0 C--N 1.284 -2.248 0 C-N-CA 120.613 -0.435 . . . . 74.44 110.289 179.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 591' ' ' ILE . . . . . 0.482 HG22 ' HB3' ' A' ' 539' ' ' TYR . 15.2 pt -93.66 134.02 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.621 0 N-CA-C 106.758 -1.571 . . . . 63.31 106.758 171.082 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -86.83 -146.95 10.64 Favored Glycine 0 C--N 1.3 -1.47 0 C-N-CA 120.965 -0.636 . . . . 72.05 111.586 -176.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.575 ' OE1' ' HD3' ' A' ' 633' ' ' ARG . 35.0 tt0 -88.57 123.87 67.11 Favored Pre-proline 0 N--CA 1.425 -1.695 0 N-CA-C 107.967 -1.123 . . . . 75.1 107.967 177.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -68.42 162.13 41.94 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 123.084 2.523 . . . . 75.43 111.428 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 29.9 ptt85 -130.12 143.45 50.8 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.263 -0.643 . . . . 75.21 109.263 178.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 596' ' ' LEU . . . . . 0.489 HD22 HG22 ' A' ' 535' ' ' VAL . 0.0 OUTLIER -85.37 128.56 34.76 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 106.188 -1.782 . . . . 71.55 106.188 179.207 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 87.2 t -68.43 -39.64 81.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-O 121.307 0.575 . . . . 75.43 109.829 -179.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -112.95 151.66 30.28 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.083 -1.081 . . . . 74.02 108.083 176.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 10.2 mmt -82.88 115.86 21.94 Favored 'General case' 0 C--N 1.284 -2.254 0 C-N-CA 118.874 -1.13 . . . . 52.34 112.161 176.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 29.8 m -49.23 113.64 0.85 Allowed 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 113.492 -1.685 . . . . 62.24 110.631 176.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -76.16 75.65 2.99 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-O 121.731 0.777 . . . . 73.21 112.307 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -105.12 124.82 50.19 Favored 'General case' 0 C--N 1.28 -2.432 0 N-CA-C 104.259 -2.497 . . . . 42.15 104.259 172.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -81.92 94.65 7.15 Favored 'General case' 0 N--CA 1.412 -2.328 0 C-N-CA 118.892 -1.123 . . . . 73.23 112.11 -172.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -106.31 -53.77 0.72 Allowed Glycine 0 N--CA 1.418 -2.55 0 N-CA-C 107.366 -2.294 . . . . 72.11 107.366 172.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 66.96 32.99 82.49 Favored Glycine 0 N--CA 1.434 -1.456 0 CA-C-N 114.341 -0.929 . . . . 54.14 112.515 175.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -118.2 160.68 21.17 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.731 -0.84 . . . . 74.32 108.731 -177.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 10.2 p -92.58 179.5 5.49 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 122.66 0.384 . . . . 63.24 111.348 -179.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 608' ' ' ILE . . . . . 0.572 HG22 ' H ' ' A' ' 609' ' ' THR . 18.7 mt -110.39 176.44 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 N-CA-C 105.757 -1.942 . . . . 61.4 105.757 177.406 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 609' ' ' THR . . . . . 0.572 ' H ' HG22 ' A' ' 608' ' ' ILE . 2.7 m -71.23 23.71 0.04 OUTLIER 'General case' 0 CA--C 1.577 2.01 0 C-N-CA 124.483 1.113 . . . . 65.22 113.733 -175.086 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 61.06 14.42 5.38 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 114.952 1.464 . . . . 63.04 114.952 177.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.79 178.56 5.54 Favored 'General case' 0 N--CA 1.415 -2.206 0 N-CA-C 110.448 -0.204 . . . . 73.33 110.448 177.215 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -99.02 133.14 43.71 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 113.619 0.97 . . . . 53.32 113.619 -176.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 613' ' ' ASP . . . . . 0.435 ' O ' ' HG2' ' A' ' 616' ' ' GLN . 14.6 t70 -80.0 -44.42 20.24 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 113.961 -1.472 . . . . 72.33 110.066 178.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 4.2 p30 48.78 22.13 0.51 Allowed 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 127.4 2.28 . . . . 75.03 116.037 176.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 98.3 mttt 61.03 29.53 19.03 Favored 'General case' 0 C--N 1.313 -1.012 0 C-N-CA 124.456 1.103 . . . . 62.31 112.455 177.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 616' ' ' GLN . . . . . 0.435 ' HG2' ' O ' ' A' ' 613' ' ' ASP . 29.4 pt20 -66.0 146.7 99.01 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 108.531 -0.915 . . . . 74.11 108.531 175.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -65.66 -156.64 0.03 OUTLIER 'Trans proline' 0 CA--C 1.549 1.232 0 C-N-CA 123.062 2.508 . . . . 74.53 113.505 -177.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.465 ' H ' HD22 ' A' ' 618' ' ' LEU . 2.9 mm? -58.52 120.23 8.45 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 116.129 -0.487 . . . . 74.14 110.47 -178.076 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 619' ' ' THR . . . . . 0.462 HG23 ' H ' ' A' ' 620' ' ' SER . 2.1 t -144.1 -72.81 0.27 Allowed 'General case' 0 N--CA 1.425 -1.686 0 N-CA-C 114.241 1.2 . . . . 61.3 114.241 -179.091 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 620' ' ' SER . . . . . 0.517 ' HB3' ' HG3' ' A' ' 630' ' ' GLU . 77.7 p 51.31 14.14 0.22 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.261 1.424 . . . . 72.51 112.765 -168.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 6.4 tppt? -97.03 92.46 6.08 Favored 'General case' 0 N--CA 1.421 -1.92 0 CA-C-O 121.463 0.649 . . . . 73.4 109.516 -173.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -167.77 -66.33 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.846 -1.168 . . . . 70.52 107.846 -176.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -168.48 164.1 12.6 Favored 'General case' 0 N--CA 1.422 -1.856 0 N-CA-C 105.247 -2.131 . . . . 75.24 105.247 -177.205 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 624' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' A' ' 627' ' ' ARG . 9.7 pt-20 -65.61 -21.39 66.57 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 122.507 0.323 . . . . 72.22 111.649 -176.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -64.67 -29.48 70.48 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 116.607 -0.269 . . . . 73.22 111.375 176.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 626' ' ' ARG . . . . . 0.607 ' O ' ' HG2' ' A' ' 630' ' ' GLU . 12.9 mtp85 -71.02 -34.34 71.21 Favored 'General case' 0 CA--C 1.471 -2.092 0 C-N-CA 119.513 -0.875 . . . . 64.52 111.657 176.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 627' ' ' ARG . . . . . 0.457 ' HB2' ' O ' ' A' ' 624' ' ' GLU . 9.3 mmm180 -46.82 -33.81 4.78 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 123.941 0.776 . . . . 73.33 112.621 177.088 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 628' ' ' ILE . . . . . 0.46 ' O ' ' HG2' ' A' ' 631' ' ' MET . 88.1 mt -74.99 -38.28 42.72 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 CA-C-N 115.47 -0.787 . . . . 75.32 110.913 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -73.56 -34.17 65.03 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 121.412 0.625 . . . . 74.43 109.415 176.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 630' ' ' GLU . . . . . 0.607 ' HG2' ' O ' ' A' ' 626' ' ' ARG . 22.0 mm-40 -67.08 -26.72 66.87 Favored 'General case' 0 C--O 1.213 -0.837 0 CA-C-N 115.281 -0.872 . . . . 73.45 110.175 177.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 631' ' ' MET . . . . . 0.46 ' HG2' ' O ' ' A' ' 628' ' ' ILE . 21.1 ptp -90.05 -3.58 57.87 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.664 0.745 . . . . 53.24 109.097 177.083 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -82.24 -20.35 62.76 Favored Glycine 0 N--CA 1.434 -1.468 0 N-CA-C 108.68 -1.768 . . . . 73.4 108.68 174.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 633' ' ' ARG . . . . . 0.575 ' HD3' ' OE1' ' A' ' 593' ' ' GLU . 95.1 mtt180 -95.85 150.3 37.17 Favored Pre-proline 0 N--CA 1.426 -1.672 0 N-CA-C 106.739 -1.578 . . . . 64.22 106.739 176.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.406 ' HA ' ' HB1' ' A' ' 502' ' ' ALA . 37.2 Cg_endo -76.08 146.79 29.29 Favored 'Trans proline' 0 N--CA 1.429 -2.3 0 N-CA-C 107.348 -1.828 . . . . 72.52 107.348 166.224 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 1.9 pp -126.57 -173.27 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 114.494 1.294 . . . . 61.43 114.494 -172.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.46 150.6 39.83 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.389 -0.823 . . . . 52.34 109.672 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 637' ' ' GLY . . . . . 0.463 ' HA3' ' HB ' ' A' ' 506' ' ' THR . . . -76.69 -71.13 1.21 Allowed Glycine 0 C--N 1.297 -1.598 0 C-N-CA 120.763 -0.732 . . . . 73.04 112.58 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -150.36 -59.72 0.19 Allowed 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 120.408 -0.517 . . . . 74.45 110.619 178.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 16.7 p80 -120.43 99.63 6.68 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.735 0.779 . . . . 70.21 111.921 -179.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 36.4 p -98.62 91.26 5.05 Favored 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 109.278 -0.638 . . . . 73.21 109.278 177.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -177.26 133.14 0.18 Allowed 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 106.159 -1.793 . . . . 71.21 106.159 -178.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 642' ' ' LEU . . . . . 0.505 ' O ' ' HA ' ' A' ' 588' ' ' PHE . 27.9 tp -133.84 118.03 17.51 Favored 'General case' 0 C--N 1.276 -2.602 0 N-CA-C 108.511 -0.922 . . . . 60.23 108.511 177.423 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 643' ' ' GLU . . . . . 0.52 ' HB3' HG22 ' A' ' 511' ' ' VAL . 33.6 tt0 -99.25 107.44 19.75 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 107.06 -1.459 . . . . 61.44 107.06 177.019 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 644' ' ' VAL . . . . . 0.67 HG21 ' HE1' ' A' ' 521' ' ' MET . 38.9 t -95.37 109.84 23.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 108.949 -0.76 . . . . 63.23 108.949 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 3.9 mp -94.86 119.9 43.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 N-CA-C 108.413 -0.958 . . . . 71.3 108.413 177.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 646' ' ' ILE . . . . . 0.514 HD12 ' N ' ' A' ' 646' ' ' ILE . 1.8 mp -107.88 134.51 49.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 105.798 -1.926 . . . . 35.01 105.798 -176.448 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -136.48 161.48 35.73 Favored 'General case' 0 C--N 1.277 -2.549 0 N-CA-C 112.31 0.485 . . . . 75.44 112.31 -172.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 648' ' ' GLU . . . . . 0.63 ' OE2' 'CA ' ' A' ' 800' ' ' ' CA' . 31.2 mm-40 -61.17 100.38 0.12 Allowed 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 106.189 -1.782 . . . . 73.21 106.189 172.323 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 10.5 m -24.72 92.78 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 128.254 2.621 . . . . 71.04 115.871 -169.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -135.03 -51.94 0.78 Allowed 'General case' 0 C--O 1.246 0.886 0 CA-C-N 114.797 -1.092 . . . . 75.13 110.686 175.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -68.99 144.29 54.15 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-N 116.194 -0.457 . . . . 74.3 110.975 -176.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 652' ' ' PHE . . . . . 0.439 ' CD2' ' HG2' ' A' ' 653' ' ' LYS . 55.7 t80 -140.06 124.76 18.23 Favored 'General case' 0 N--CA 1.398 -3.042 0 N-CA-C 107.003 -1.48 . . . . 73.41 107.003 -179.232 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 653' ' ' LYS . . . . . 0.572 ' HA ' ' HE2' ' A' ' 653' ' ' LYS . 9.8 mmpt? 72.91 8.74 5.48 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.041 1.336 . . . . 72.23 112.202 178.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 654' ' ' SER . . . . . 0.414 ' HB2' ' HB2' ' A' ' 513' ' ' HIS . 69.0 m -66.97 103.76 1.22 Allowed 'General case' 0 N--CA 1.443 -0.811 0 CA-C-O 121.899 0.857 . . . . 72.43 110.415 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 655' ' ' THR . . . . . 0.462 ' HB ' ' OE1' ' A' ' 509' ' ' GLU . 4.5 p -142.38 156.72 45.24 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.736 -1.209 . . . . 74.21 107.736 -176.255 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 511' ' ' VAL . 34.0 m -104.76 -176.89 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 C-N-CA 119.8 -0.76 . . . . 62.24 112.013 -175.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 . . . . . 0 C--N 1.309 -1.187 0 CA-C-N 115.662 -0.699 . . . . 74.31 110.92 -178.627 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 800' ' ' ' CA' . . . . . 0.63 'CA ' ' OE2' ' A' ' 648' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 850' ' ' ' CA' . . . . . 0.655 'CA ' ' OD1' ' A' ' 552' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 27.0 t60 . . . . . 0 N--CA 1.445 -0.701 0 N-CA-C 108.845 -0.798 . . . . 72.14 108.845 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 502' ' ' ALA . . . . . 0.461 ' HB3' HG13 ' A' ' 635' ' ' ILE . . . -138.06 -48.77 0.55 Allowed 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.748 -0.464 . . . . 73.54 109.748 177.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -159.65 -179.0 34.16 Favored Glycine 0 N--CA 1.421 -2.34 0 C-N-CA 120.663 -0.78 . . . . 72.24 111.151 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 3.9 mp -122.27 111.39 30.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 109.255 -0.646 . . . . 74.03 109.255 -178.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -128.35 104.29 7.64 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 106.492 -1.67 . . . . 75.23 106.492 173.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 15.0 t -152.02 162.95 40.28 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.631 -0.878 . . . . 75.35 108.631 -175.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -91.77 168.78 11.22 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.749 -1.204 . . . . 73.34 107.749 172.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 508' ' ' GLU . . . . . 0.491 ' HB2' HD21 ' A' ' 526' ' ' LEU . 21.5 tt0 -99.74 -35.88 9.65 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 107.944 -1.132 . . . . 73.42 107.944 179.251 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -111.31 134.98 20.99 Favored Pre-proline 0 N--CA 1.419 -2.021 0 CA-C-N 114.377 -1.283 . . . . 64.12 110.239 -178.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -81.19 -18.7 8.49 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.554 1.503 . . . . 75.21 111.095 173.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 511' ' ' VAL . . . . . 0.47 HG22 ' HB3' ' A' ' 643' ' ' GLU . 93.2 t -138.04 141.5 38.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 123.81 0.844 . . . . 73.41 108.853 -177.655 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 8.1 t -137.3 140.81 41.78 Favored 'General case' 0 N--CA 1.416 -2.168 0 N-CA-C 107.526 -1.287 . . . . 75.23 107.526 174.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 55.4 m-70 -105.76 130.04 53.84 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.585 -0.895 . . . . 64.1 108.585 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 24.2 m -132.33 156.45 42.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 N-CA-C 108.862 -0.792 . . . . 73.22 108.862 -179.042 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 40.3 t -82.42 149.16 27.8 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 107.934 -1.136 . . . . 63.01 107.934 178.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -82.3 -7.5 59.63 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.85 0.833 . . . . 75.42 109.062 176.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 9.4 t -95.77 10.01 38.5 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.905 -0.776 . . . . 73.35 108.905 -178.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 12.4 tt -91.68 155.34 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 108.66 -0.867 . . . . 75.51 108.66 -177.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -91.44 -63.44 1.18 Allowed Glycine 0 N--CA 1.43 -1.755 0 N-CA-C 110.47 -1.052 . . . . 74.14 110.47 176.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 520' ' ' ILE . . . . . 0.414 HD13 ' HA ' ' A' ' 574' ' ' LYS . 34.4 mm -116.51 117.02 54.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 109.92 -0.4 . . . . 73.44 109.92 179.012 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 521' ' ' MET . . . . . 0.69 ' HE2' HG21 ' A' ' 644' ' ' VAL . 0.0 OUTLIER -96.41 128.66 43.53 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 106.609 -1.626 . . . . 73.24 106.609 172.238 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -117.36 138.74 51.59 Favored 'General case' 0 N--CA 1.424 -1.751 0 CA-C-N 115.829 -0.623 . . . . 72.41 111.269 178.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 523' ' ' VAL . . . . . 0.713 HG21 HD21 ' A' ' 642' ' ' LEU . 22.1 t -121.09 134.34 64.8 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.087 0 N-CA-C 106.176 -1.787 . . . . 70.23 106.176 175.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 524' ' ' LYS . . . . . 0.563 ' HD3' HG21 ' A' ' 568' ' ' VAL . 55.2 mttp -91.91 163.04 14.16 Favored 'General case' 0 N--CA 1.416 -2.171 0 C-N-CA 120.325 -0.55 . . . . 74.31 111.904 -178.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 16.0 t -128.5 141.98 45.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-N 115.512 -0.767 . . . . 62.01 109.115 -175.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 526' ' ' LEU . . . . . 0.491 HD21 ' HB2' ' A' ' 508' ' ' GLU . 2.0 mm? -78.24 139.08 38.92 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 107.554 -1.276 . . . . 74.35 107.554 178.244 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 48.2 ttp180 -92.79 140.5 29.45 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.729 -0.788 . . . . 73.42 111.199 -175.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 4.2 t -55.17 149.02 13.07 Favored 'General case' 0 N--CA 1.413 -2.28 0 CA-C-N 114.044 -1.434 . . . . 73.41 111.97 174.1 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 26.1 t -80.62 -15.89 55.46 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.386 -0.824 . . . . 60.13 109.038 177.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -127.54 110.92 1.24 Allowed Glycine 0 N--CA 1.433 -1.517 0 N-CA-C 111.163 -0.775 . . . . 62.0 111.163 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -165.06 76.11 0.27 Allowed 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 123.334 0.653 . . . . 75.45 110.173 177.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -90.36 81.53 6.02 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.751 0.786 . . . . 75.24 110.064 177.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 533' ' ' GLY . . . . . 0.575 ' H ' ' HB2' ' A' ' 564' ' ' ASN . . . 149.37 -118.97 0.99 Allowed Glycine 0 N--CA 1.414 -2.772 0 CA-C-N 114.828 -1.078 . . . . 64.13 112.071 179.06 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -145.07 131.3 19.49 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 107.234 -1.395 . . . . 72.0 107.234 -178.099 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 535' ' ' VAL . . . . . 0.428 HG22 HD22 ' A' ' 596' ' ' LEU . 46.8 t -128.36 133.86 65.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 109.387 -0.597 . . . . 65.53 109.387 -178.327 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 536' ' ' ILE . . . . . 0.54 HG23 ' HB3' ' A' ' 559' ' ' GLU . 28.5 mm -98.28 126.48 51.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 109.217 -0.66 . . . . 73.11 109.217 178.176 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 36.1 t -116.65 103.38 52.59 Favored Pre-proline 0 C--N 1.301 -1.513 0 N-CA-C 108.579 -0.897 . . . . 73.31 108.579 177.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.56 146.93 50.64 Favored 'Trans proline' 0 C--N 1.331 -0.391 0 C-N-CA 122.264 1.976 . . . . 75.3 111.169 179.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 539' ' ' TYR . . . . . 0.539 ' CE1' ' HG ' ' A' ' 560' ' ' LEU . 36.0 p90 -151.14 161.58 42.46 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 109.689 -0.485 . . . . 75.14 109.689 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -155.67 148.6 24.35 Favored 'General case' 0 C--N 1.309 -1.174 0 O-C-N 123.471 0.482 . . . . 61.21 111.933 178.507 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 2.4 p -85.82 121.09 27.98 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 115.957 -0.565 . . . . 70.25 110.967 175.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.8 mp -86.96 116.99 30.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 105.271 -2.122 . . . . 65.03 105.271 172.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -55.2 -43.43 74.4 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 124.163 0.914 . . . . 72.33 112.146 -174.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 67.96 -94.06 0.29 Allowed Glycine 0 N--CA 1.439 -1.101 0 CA-C-N 115.733 -0.667 . . . . 65.23 111.757 178.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 545' ' ' THR . . . . . 0.476 HG23 ' HA ' ' A' ' 585' ' ' LYS . 9.2 t -124.41 -2.07 8.04 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 120.788 0.328 . . . . 53.11 110.488 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -91.19 155.54 18.52 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.71 -0.478 . . . . 74.03 109.71 178.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 22.1 tpt180 -94.55 108.31 20.27 Favored 'General case' 0 C--O 1.25 1.097 0 N-CA-C 109.546 -0.539 . . . . 62.21 109.546 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -89.66 -163.57 39.37 Favored Glycine 0 CA--C 1.507 -0.422 0 C-N-CA 121.124 -0.56 . . . . 73.04 114.046 -175.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 77.75 12.38 84.52 Favored Glycine 0 C--N 1.321 -0.281 0 CA-C-N 115.433 -0.384 . . . . 73.44 113.593 178.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 95.79 4.56 60.32 Favored Glycine 0 N--CA 1.437 -1.251 0 C-N-CA 120.46 -0.876 . . . . 71.13 111.644 -178.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -73.98 -69.86 0.42 Allowed 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.912 -0.773 . . . . 71.41 108.912 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 552' ' ' ASP . . . . . 0.635 ' OD2' 'CA ' ' A' ' 850' ' ' ' CA' . 5.8 t70 -107.8 -34.12 7.05 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.861 -1.163 . . . . 75.52 107.861 177.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -135.95 157.27 47.25 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 108.464 -0.939 . . . . 74.11 108.464 174.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -88.14 121.02 30.06 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.855 -1.165 . . . . 64.21 107.855 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -78.67 100.96 7.25 Favored 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 109.263 -0.643 . . . . 65.42 109.263 -177.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 13.9 t -98.51 98.51 9.68 Favored 'General case' 0 N--CA 1.396 -3.134 0 CA-C-O 123.439 1.59 . . . . 53.13 111.538 -175.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 1.6 p -110.27 129.86 55.65 Favored 'General case' 0 C--N 1.274 -2.675 0 N-CA-C 106.518 -1.66 . . . . 71.34 106.518 172.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 178.64 -156.66 19.49 Favored Glycine 0 N--CA 1.42 -2.422 0 N-CA-C 110.367 -1.093 . . . . 72.24 110.367 -176.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 559' ' ' GLU . . . . . 0.54 ' HB3' HG23 ' A' ' 536' ' ' ILE . 40.0 mt-10 -135.97 133.92 38.06 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 121.295 0.569 . . . . 75.35 111.683 -175.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 560' ' ' LEU . . . . . 0.539 ' HG ' ' CE1' ' A' ' 539' ' ' TYR . 55.7 mt -87.84 132.77 34.06 Favored 'General case' 0 CA--C 1.491 -1.312 0 N-CA-C 108.795 -0.817 . . . . 72.12 108.795 174.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -105.84 107.37 18.34 Favored 'General case' 0 C--N 1.274 -2.71 0 N-CA-C 108.451 -0.944 . . . . 71.34 108.451 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 562' ' ' PHE . . . . . 0.419 ' CZ ' ' HG2' ' A' ' 569' ' ' LYS . 0.1 OUTLIER -100.59 132.41 45.99 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 107.744 -1.206 . . . . 60.3 107.744 -179.2 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -119.81 165.05 15.07 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.2 -1.0 . . . . 41.51 110.699 -179.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 564' ' ' ASN . . . . . 0.575 ' HB2' ' H ' ' A' ' 533' ' ' GLY . 7.8 t30 -62.57 -33.46 75.01 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.879 -0.6 . . . . 73.32 111.296 179.229 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -99.27 -3.66 33.64 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.858 0.837 . . . . 53.02 111.145 -177.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -102.98 130.34 50.03 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.725 -0.609 . . . . 73.1 109.406 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 2.0 pp -112.04 145.27 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.728 0 N-CA-C 108.414 -0.958 . . . . 72.35 108.414 179.003 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 568' ' ' VAL . . . . . 0.563 HG21 ' HD3' ' A' ' 524' ' ' LYS . 1.8 p 58.91 133.78 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 126.482 1.913 . . . . 75.41 114.79 176.288 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 569' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 524' ' ' LYS . 32.6 mmmt -117.82 164.06 15.59 Favored 'General case' 0 C--N 1.284 -2.268 0 O-C-N 121.32 -0.863 . . . . 65.04 109.868 176.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 570' ' ' THR . . . . . 0.509 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 6.3 p -132.72 134.26 44.56 Favored 'General case' 0 C--N 1.279 -2.499 0 O-C-N 124.413 1.071 . . . . 63.12 111.851 177.46 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 2.2 mp -91.17 103.92 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.836 0 N-CA-C 105.207 -2.145 . . . . 64.01 105.207 170.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 4.5 m -91.93 112.64 24.64 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 108.479 -0.934 . . . . 60.42 108.479 -177.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 573' ' ' VAL . . . . . . . . . . . . . 61.7 t -116.0 121.88 68.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 109.543 -0.54 . . . . 71.04 109.543 -178.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 574' ' ' LYS . . . . . 0.414 ' HA ' HD13 ' A' ' 520' ' ' ILE . 23.0 tptm -80.09 120.73 24.63 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-N 114.908 -1.042 . . . . 72.21 110.548 178.578 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 60.0 t -94.32 132.36 38.6 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 N-CA-C 105.953 -1.869 . . . . 74.22 105.953 174.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 34.3 mm -88.84 159.98 2.87 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 107.221 -1.4 . . . . 75.24 107.221 -175.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -71.53 115.34 10.6 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 109.199 -0.667 . . . . 64.22 109.199 178.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 578' ' ' ASP . . . . . 0.66 ' OD2' 'CA ' ' A' ' 800' ' ' ' CA' . 44.9 t0 -61.24 144.44 53.79 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 114.897 -1.047 . . . . 63.54 112.612 -173.165 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -92.21 -49.06 6.38 Favored 'General case' 0 C--N 1.29 -1.995 0 C-N-CA 124.289 1.036 . . . . 70.14 110.424 -176.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 580' ' ' GLU . . . . . 0.582 ' OE1' 'CA ' ' A' ' 850' ' ' ' CA' . 0.0 OUTLIER -127.09 -152.64 0.53 Allowed 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.396 -0.82 . . . . 73.04 109.1 -174.305 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -111.67 152.12 28.06 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 107.32 -1.363 . . . . 64.35 107.32 176.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 582' ' ' GLU . . . . . 0.62 ' OE1' 'CA ' ' A' ' 800' ' ' ' CA' . 36.4 mp0 -128.98 164.81 22.38 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.501 -0.555 . . . . 72.43 109.501 175.201 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 10.0 mptt -87.59 -152.0 0.19 Allowed 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 105.771 -1.937 . . . . 73.43 105.771 173.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -57.83 113.05 1.68 Allowed 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 109.115 -0.698 . . . . 72.31 109.115 172.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 585' ' ' LYS . . . . . 0.476 ' HA ' HG23 ' A' ' 545' ' ' THR . 0.1 OUTLIER -128.32 118.73 23.74 Favored 'General case' 0 N--CA 1.409 -2.496 0 N-CA-C 106.362 -1.718 . . . . 34.42 106.362 -174.198 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 3.9 t -150.7 146.86 26.73 Favored 'General case' 0 N--CA 1.418 -2.04 0 CA-C-N 115.487 -0.779 . . . . 74.44 110.795 -172.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -126.58 150.63 48.75 Favored 'General case' 0 N--CA 1.419 -2.011 0 CA-C-N 113.891 -1.504 . . . . 70.33 109.225 177.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 588' ' ' PHE . . . . . 0.421 ' HA ' ' O ' ' A' ' 642' ' ' LEU . 22.3 m-85 -108.37 139.25 43.36 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 109.381 -0.6 . . . . 73.23 109.381 -174.325 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 589' ' ' LEU . . . . . 0.46 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.3 OUTLIER -107.93 134.36 50.95 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 107.04 -1.467 . . . . 61.24 107.04 176.83 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -143.05 136.96 28.89 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.803 -0.814 . . . . 72.14 108.803 -179.034 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 591' ' ' ILE . . . . . 0.541 HG12 ' OG1' ' A' ' 640' ' ' THR . 22.0 pt -101.95 162.48 3.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 109.206 -0.664 . . . . 63.42 109.206 178.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -111.15 -162.96 17.92 Favored Glycine 0 N--CA 1.43 -1.732 0 C-N-CA 121.259 -0.496 . . . . 63.24 112.103 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -67.88 118.11 54.86 Favored Pre-proline 0 C--N 1.309 -1.195 0 C-N-CA 123.979 0.911 . . . . 72.15 108.803 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 594' ' ' PRO . . . . . 0.46 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 58.1 Cg_endo -73.16 146.56 41.08 Favored 'Trans proline' 0 N--CA 1.437 -1.82 0 C-N-CA 121.916 1.744 . . . . 61.33 110.593 178.47 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 14.9 ptt180 -128.24 133.71 48.87 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 109.704 -0.48 . . . . 74.04 109.704 -175.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 596' ' ' LEU . . . . . 0.428 HD22 HG22 ' A' ' 535' ' ' VAL . 0.0 OUTLIER -73.99 131.82 41.78 Favored 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 104.988 -2.227 . . . . 62.24 104.988 178.367 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 597' ' ' VAL . . . . . 0.442 ' CG2' HG12 ' A' ' 536' ' ' ILE . 23.8 t -81.51 61.42 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-O 121.821 0.819 . . . . 73.12 110.767 -178.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 598' ' ' GLU . . . . . 0.453 ' OE1' ' HG3' ' A' ' 603' ' ' LYS . 32.8 mt-10 58.99 -7.42 0.05 OUTLIER 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 128.491 2.716 . . . . 73.33 117.322 166.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 71.5 mtm 67.09 19.12 10.5 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 124.762 1.225 . . . . 32.12 109.145 -174.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 600' ' ' SER . . . . . 0.416 ' O ' ' HB2' ' A' ' 598' ' ' GLU . 22.6 t -166.46 149.38 6.96 Favored 'General case' 0 N--CA 1.405 -2.689 0 N-CA-C 101.762 -3.422 . . . . 73.34 101.762 -178.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -69.11 -28.2 66.27 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 119.228 0.922 . . . . 60.42 110.514 -176.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -145.63 146.91 31.52 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 106.625 -1.62 . . . . 75.5 106.625 173.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 603' ' ' LYS . . . . . 0.453 ' HG3' ' OE1' ' A' ' 598' ' ' GLU . 38.4 mtmm -82.66 84.92 7.13 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-O 121.614 0.721 . . . . 75.13 110.171 175.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -102.08 11.34 57.22 Favored Glycine 0 N--CA 1.434 -1.454 0 CA-C-N 114.736 -1.12 . . . . 50.24 111.743 -178.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . -83.51 -54.97 2.97 Favored Glycine 0 N--CA 1.434 -1.445 0 N-CA-C 109.749 -1.34 . . . . 70.52 109.749 176.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -173.82 158.0 3.15 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 106.363 -1.717 . . . . 71.45 106.363 176.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 28.1 p -74.88 134.83 41.57 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 120.323 -0.551 . . . . 72.55 110.901 177.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 24.9 mm -97.85 160.46 3.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 106.384 -1.709 . . . . 65.3 106.384 -179.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 609' ' ' THR . . . . . 0.508 HG22 ' HG3' ' A' ' 611' ' ' GLU . 20.1 m -74.17 88.46 1.96 Allowed 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 106.433 -1.692 . . . . 54.21 106.433 172.076 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -88.07 -20.16 26.11 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.549 -0.75 . . . . 72.33 111.213 -175.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 611' ' ' GLU . . . . . 0.508 ' HG3' HG22 ' A' ' 609' ' ' THR . 33.1 mt-10 52.66 44.79 29.73 Favored 'General case' 0 C--O 1.247 0.936 0 O-C-N 124.436 1.085 . . . . 71.3 110.964 178.494 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 66.88 84.31 0.16 Allowed 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.886 1.274 . . . . 74.42 112.02 -176.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 613' ' ' ASP . . . . . 0.455 ' HA ' ' NH2' ' A' ' 633' ' ' ARG . 28.0 t70 -89.58 117.29 28.36 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.78 -1.1 . . . . 63.01 109.906 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -137.48 -164.38 1.59 Allowed 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 108.491 -0.929 . . . . 63.24 108.491 -174.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 48.3 pttt -133.01 85.67 2.24 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 122.815 1.293 . . . . 63.15 108.0 -178.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 616' ' ' GLN . . . . . 0.419 ' HB3' ' HD2' ' A' ' 617' ' ' PRO . 17.9 mt-30 -96.53 -170.8 0.23 Allowed Pre-proline 0 C--N 1.292 -1.91 0 CA-C-N 114.494 -1.23 . . . . 65.53 108.716 -170.622 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 617' ' ' PRO . . . . . 0.419 ' HD2' ' HB3' ' A' ' 616' ' ' GLN . 53.2 Cg_endo -86.62 160.81 9.33 Favored 'Trans proline' 0 N--CA 1.443 -1.473 0 N-CA-C 108.979 -1.201 . . . . 71.42 108.979 163.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.507 ' HG ' ' HB2' ' A' ' 636' ' ' LEU . 3.5 mm? -74.22 99.73 3.51 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.54 -0.911 . . . . 73.24 108.54 177.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 1.8 p -135.62 103.33 5.4 Favored 'General case' 0 N--CA 1.42 -1.957 0 CA-C-N 115.185 -0.916 . . . . 70.11 112.021 -173.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 620' ' ' SER . . . . . 0.559 ' HB3' ' HG2' ' A' ' 623' ' ' GLU . 16.2 m -109.6 109.98 20.91 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.525 -0.917 . . . . 53.45 108.525 176.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 11.2 tmtt? -92.5 -71.86 0.62 Allowed 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.024 -0.732 . . . . 73.5 109.024 -176.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -76.25 -25.64 55.19 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.095 -0.705 . . . . 64.1 109.095 178.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 623' ' ' GLU . . . . . 0.559 ' HG2' ' HB3' ' A' ' 620' ' ' SER . 47.4 mt-10 74.41 -40.1 0.44 Allowed 'General case' 0 C--O 1.213 -0.849 0 C-N-CA 125.526 1.53 . . . . 74.35 115.035 177.209 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -53.03 -61.87 2.02 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.947 1.092 . . . . 75.21 113.947 -176.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -76.14 -25.93 55.82 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.071 0.462 . . . . 70.41 110.806 -178.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 626' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -67.07 -34.36 77.49 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.903 -0.589 . . . . 74.21 110.048 178.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 627' ' ' ARG . . . . . . . . . . . . . 46.7 ttp180 -56.73 -29.06 62.13 Favored 'General case' 0 N--CA 1.424 -1.728 0 C-N-CA 125.111 1.364 . . . . 64.1 111.425 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 88.2 mt -71.89 -39.62 67.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 121.695 0.76 . . . . 72.23 109.821 177.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -70.11 -40.83 74.68 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.658 -0.701 . . . . 62.34 109.639 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -68.04 -17.71 64.48 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 115.392 -0.822 . . . . 72.21 110.569 178.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 631' ' ' MET . . . . . . . . . . . . . 42.6 ttm -83.6 -36.99 23.49 Favored 'General case' 0 N--CA 1.425 -1.68 0 C-N-CA 123.277 0.631 . . . . 70.4 110.579 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -86.19 -37.27 9.19 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.715 -0.755 . . . . 62.12 112.282 -178.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 633' ' ' ARG . . . . . 0.455 ' NH2' ' HA ' ' A' ' 613' ' ' ASP . 98.3 mtt180 -93.35 146.12 31.27 Favored Pre-proline 0 C--N 1.302 -1.475 0 N-CA-C 109.46 -0.57 . . . . 72.21 109.46 -177.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.46 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 10.1 Cg_endo -60.86 145.01 99.66 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.591 1.527 . . . . 62.41 109.527 172.153 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 635' ' ' ILE . . . . . 0.461 HG13 ' HB3' ' A' ' 502' ' ' ALA . 2.3 pp -123.42 175.96 5.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 114.054 1.131 . . . . 74.43 114.054 -176.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 636' ' ' LEU . . . . . 0.507 ' HB2' ' HG ' ' A' ' 618' ' ' LEU . 33.3 tp -68.93 158.65 34.19 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 124.8 1.24 . . . . 75.35 112.716 -176.526 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 637' ' ' GLY . . . . . 0.454 ' N ' ' HG ' ' A' ' 636' ' ' LEU . . . -83.06 -100.02 0.52 Allowed Glycine 0 N--CA 1.427 -1.91 0 N-CA-C 109.642 -1.383 . . . . 65.45 109.642 172.476 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -126.22 -73.13 0.63 Allowed 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 119.801 -0.76 . . . . 73.45 111.632 177.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -107.02 114.26 28.23 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 118.715 -1.194 . . . . 63.11 113.122 -174.093 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 640' ' ' THR . . . . . 0.541 ' OG1' HG12 ' A' ' 591' ' ' ILE . 1.1 t -107.08 91.53 3.7 Favored 'General case' 0 N--CA 1.41 -2.437 0 N-CA-C 108.367 -0.975 . . . . 75.1 108.367 169.364 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -172.17 121.83 0.46 Allowed 'General case' 0 C--N 1.279 -2.466 0 N-CA-C 105.726 -1.953 . . . . 73.14 105.726 178.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 642' ' ' LEU . . . . . 0.713 HD21 HG21 ' A' ' 523' ' ' VAL . 35.9 tp -129.91 113.13 14.24 Favored 'General case' 0 C--N 1.271 -2.829 0 N-CA-C 108.077 -1.083 . . . . 54.15 108.077 178.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 643' ' ' GLU . . . . . 0.47 ' HB3' HG22 ' A' ' 511' ' ' VAL . 30.0 tt0 -95.11 104.77 16.65 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 107.469 -1.308 . . . . 61.12 107.469 179.207 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 644' ' ' VAL . . . . . 0.69 HG21 ' HE2' ' A' ' 521' ' ' MET . 30.9 t -94.98 106.66 18.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 109.483 -0.562 . . . . 62.21 109.483 -177.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 3.9 mp -88.78 118.29 33.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 108.444 -0.947 . . . . 72.21 108.444 175.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 646' ' ' ILE . . . . . 0.467 HD12 ' N ' ' A' ' 646' ' ' ILE . 2.8 mp -100.73 107.21 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 N-CA-C 106.63 -1.618 . . . . 73.0 106.63 -177.027 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -103.69 136.42 43.43 Favored 'General case' 0 C--N 1.279 -2.48 0 CA-C-N 115.671 -0.695 . . . . 74.14 110.832 -176.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 648' ' ' GLU . . . . . 0.625 ' OE2' 'CA ' ' A' ' 800' ' ' ' CA' . 14.6 mt-10 -67.47 142.03 56.76 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.626 -0.879 . . . . 73.12 108.626 -177.128 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 21.2 t -74.95 81.33 2.18 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 114.072 1.138 . . . . 74.21 114.072 -169.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -93.95 -44.78 7.91 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 106.675 -1.602 . . . . 72.21 106.675 168.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 651' ' ' GLU . . . . . 0.574 ' HG2' ' H ' ' A' ' 652' ' ' PHE . 23.1 tt0 -163.84 -160.33 0.56 Allowed 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 102.663 -3.088 . . . . 72.42 102.663 179.042 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 652' ' ' PHE . . . . . 0.574 ' H ' ' HG2' ' A' ' 651' ' ' GLU . 48.3 t80 -157.2 144.51 18.68 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 105.635 -1.987 . . . . 73.45 105.635 178.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 653' ' ' LYS . . . . . 0.495 ' HG3' ' CD2' ' A' ' 652' ' ' PHE . 53.7 mtmt 69.0 22.13 7.12 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.704 0.802 . . . . 73.5 112.269 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 50.3 m -72.16 -37.66 69.31 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-O 121.257 0.551 . . . . 52.21 109.71 178.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 88.7 m -159.27 135.77 9.21 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 108.413 -0.958 . . . . 73.5 108.413 178.139 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 33.2 m -90.58 153.15 3.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 108.498 -0.927 . . . . 71.33 108.498 175.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 16.4 t70 . . . . . 0 C--N 1.299 -1.624 0 N-CA-C 108.847 -0.797 . . . . 73.14 108.847 -177.339 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 800' ' ' ' CA' . . . . . 0.66 'CA ' ' OD2' ' A' ' 578' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 850' ' ' ' CA' . . . . . 0.635 'CA ' ' OD2' ' A' ' 552' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 501' ' ' HIS . . . . . 0.403 ' N ' ' HA ' ' A' ' 631' ' ' MET . 4.5 t60 . . . . . 0 N--CA 1.445 -0.719 0 N-CA-C 109.644 -0.502 . . . . 72.11 109.644 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 502' ' ' ALA . . . . . 0.529 ' O ' ' HA3' ' A' ' 530' ' ' GLY . . . -124.55 -74.03 0.62 Allowed 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 107.71 -1.218 . . . . 74.44 107.71 172.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -136.6 134.29 7.04 Favored Glycine 0 N--CA 1.419 -2.448 0 N-CA-C 109.71 -1.356 . . . . 75.51 109.71 177.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 504' ' ' ILE . . . . . 0.642 ' O ' ' HB ' ' A' ' 528' ' ' THR . 3.6 mp -108.87 97.77 6.15 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.263 0 C-N-CA 126.04 1.736 . . . . 63.41 109.235 -176.539 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -103.16 124.85 49.36 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 122.035 -0.415 . . . . 74.3 110.087 -178.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 506' ' ' THR . . . . . 0.404 ' HB ' ' HA3' ' A' ' 637' ' ' GLY . 15.3 t -145.89 159.54 43.07 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.378 -0.601 . . . . 73.21 109.378 -178.154 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -89.21 155.85 19.14 Favored 'General case' 0 CA--C 1.485 -1.549 0 N-CA-C 108.372 -0.973 . . . . 73.14 108.372 174.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 508' ' ' GLU . . . . . 0.418 ' HB2' HD21 ' A' ' 526' ' ' LEU . 24.1 tt0 -89.98 -34.57 15.95 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 106.84 -1.541 . . . . 72.31 106.84 175.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -96.61 118.84 64.86 Favored Pre-proline 0 N--CA 1.436 -1.137 0 CA-C-N 114.549 -1.205 . . . . 72.43 110.847 176.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 510' ' ' PRO . . . . . 0.612 ' HA ' ' O ' ' A' ' 641' ' ' LYS . 1.2 Cg_endo -83.22 -16.96 6.87 Favored 'Trans proline' 0 N--CA 1.443 -1.456 0 N-CA-C 108.72 -1.3 . . . . 75.15 108.72 166.399 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 511' ' ' VAL . . . . . 0.487 HG22 ' HB3' ' A' ' 643' ' ' GLU . 78.7 t -144.63 139.56 23.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 C-N-CA 125.575 1.55 . . . . 51.31 107.268 -179.169 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 11.4 t -138.63 148.01 43.57 Favored 'General case' 0 N--CA 1.414 -2.234 0 N-CA-C 107.66 -1.237 . . . . 61.14 107.66 174.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -115.87 127.48 55.05 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 109.024 -0.732 . . . . 74.14 109.024 177.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 18.2 m -130.24 154.2 40.11 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 N-CA-C 109.103 -0.703 . . . . 43.23 109.103 -176.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 34.2 t -78.03 154.81 31.1 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.782 -1.192 . . . . 72.35 107.782 177.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -89.06 -6.83 56.84 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 122.195 0.998 . . . . 71.13 109.019 173.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 34.0 m -92.26 17.3 9.9 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-O 122.314 1.054 . . . . 73.4 108.744 177.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 9.5 tt -100.99 154.43 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.06 0 N-CA-C 107.064 -1.458 . . . . 74.41 107.064 177.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 519' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . -95.71 -63.61 0.97 Allowed Glycine 0 N--CA 1.427 -1.946 0 C-N-CA 119.745 -1.217 . . . . 71.21 110.348 176.275 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 29.0 mm -116.41 127.73 73.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 114.725 -0.737 . . . . 70.4 109.865 -178.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 521' ' ' MET . . . . . 0.614 ' HE2' HG21 ' A' ' 644' ' ' VAL . 0.0 OUTLIER -109.99 135.88 50.14 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.76 -1.2 . . . . 72.32 107.76 172.888 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 522' ' ' GLU . . . . . 0.535 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 36.8 mt-10 -121.15 135.26 55.2 Favored 'General case' 0 CA--C 1.493 -1.25 0 O-C-N 123.947 0.779 . . . . 75.12 110.711 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 523' ' ' VAL . . . . . 0.667 HG21 HD21 ' A' ' 642' ' ' LEU . 18.9 t -123.03 140.47 46.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.91 -0.774 . . . . 65.54 108.91 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 524' ' ' LYS . . . . . 0.47 ' HD2' HG21 ' A' ' 568' ' ' VAL . 46.2 mmtm -85.35 141.53 29.96 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.912 0.863 . . . . 61.01 112.603 -178.194 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 21.3 t -111.88 119.49 60.12 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 N-CA-C 105.154 -2.165 . . . . 74.22 105.154 172.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 526' ' ' LEU . . . . . 0.425 HD22 ' H ' ' A' ' 526' ' ' LEU . 2.6 mm? -62.16 136.05 57.77 Favored 'General case' 0 CA--C 1.504 -0.804 0 O-C-N 123.522 0.514 . . . . 74.24 110.625 -174.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 14.2 ttp180 -84.73 138.7 32.47 Favored 'General case' 0 N--CA 1.423 -1.782 0 N-CA-C 108.612 -0.884 . . . . 75.5 108.612 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 528' ' ' THR . . . . . 0.642 ' HB ' ' O ' ' A' ' 504' ' ' ILE . 10.3 t -94.41 169.59 10.1 Favored 'General case' 0 N--CA 1.397 -3.096 0 N-CA-C 114.81 1.411 . . . . 71.22 114.81 -171.687 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . 0.309 5.7 m -49.9 -34.06 19.16 Favored 'General case' 0 N--CA 1.417 -2.124 0 C-N-CA 130.658 3.583 . . . . 70.14 111.35 171.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 530' ' ' GLY . . . . . 0.529 ' HA3' ' O ' ' A' ' 502' ' ' ALA . . . -121.3 68.41 0.42 Allowed Glycine 0 N--CA 1.428 -1.856 0 C-N-CA 120.722 -0.752 . . . . 61.24 113.203 -177.188 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -87.88 83.41 7.1 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 106.704 -1.591 . . . . 65.22 106.704 173.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -121.05 137.3 54.72 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 115.744 -0.662 . . . . 74.02 112.321 -174.149 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 533' ' ' GLY . . . . . 0.477 ' N ' ' HB3' ' A' ' 564' ' ' ASN . . . 69.27 -121.32 11.28 Favored Glycine 0 N--CA 1.438 -1.173 0 CA-C-N 114.741 -1.118 . . . . 33.22 111.966 176.518 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -136.47 124.15 22.41 Favored 'General case' 0 C--N 1.286 -2.175 0 N-CA-C 106.079 -1.823 . . . . 43.25 106.079 177.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 535' ' ' VAL . . . . . 0.482 HG22 HD22 ' A' ' 596' ' ' LEU . 57.5 t -126.57 122.97 62.15 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-O 121.398 0.618 . . . . 71.31 109.494 -175.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 536' ' ' ILE . . . . . 0.459 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 40.2 mm -97.57 127.21 50.1 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.451 0 CA-C-N 115.444 -0.798 . . . . 72.34 109.968 -178.166 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 537' ' ' VAL . . . . . 0.45 HG22 ' HB3' ' A' ' 594' ' ' PRO . 86.1 t -113.0 102.31 54.6 Favored Pre-proline 0 C--N 1.308 -1.22 0 CA-C-N 115.448 -0.797 . . . . 62.04 110.18 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 538' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 63.9 Cg_endo -74.74 150.31 39.31 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.667 2.245 . . . . 62.14 111.635 178.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 539' ' ' TYR . . . . . 0.498 ' CE1' ' HG ' ' A' ' 560' ' ' LEU . 17.4 p90 -154.9 165.95 35.08 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 110.246 -0.279 . . . . 61.34 110.246 -178.38 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -157.86 157.47 33.28 Favored 'General case' 0 C--N 1.316 -0.864 0 O-C-N 123.659 0.599 . . . . 64.31 110.142 177.087 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 2.1 p -96.46 112.17 24.01 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 123.337 0.655 . . . . 72.11 109.775 173.317 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.428 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 3.5 mp -81.01 122.96 37.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 107.917 -1.142 . . . . 72.32 107.917 177.458 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -55.31 -52.73 62.5 Favored 'General case' 0 C--O 1.242 0.704 0 O-C-N 124.223 0.952 . . . . 65.12 110.851 -178.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 71.53 -80.11 0.54 Allowed Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.837 -0.619 . . . . 65.04 113.179 175.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 12.8 t -134.43 -7.47 2.55 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.452 0.644 . . . . 70.14 110.04 -179.222 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -80.36 -176.37 5.62 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 121.181 0.515 . . . . 52.41 111.723 -179.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 547' ' ' ARG . . . . . 0.627 ' HB3' ' OE1' ' A' ' 551' ' ' GLU . 56.9 mmt-85 -85.58 177.29 7.78 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.652 -0.703 . . . . 63.22 110.917 177.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -64.38 174.57 13.22 Favored Glycine 0 CA--C 1.538 1.521 0 CA-C-N 115.166 -0.925 . . . . 22.33 114.354 -177.172 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . -67.63 122.84 18.26 Favored Glycine 0 N--CA 1.441 -0.997 0 CA-C-N 115.259 -0.471 . . . . 70.14 112.46 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 82.98 2.94 90.68 Favored Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 110.634 -0.987 . . . . 74.55 110.634 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 551' ' ' GLU . . . . . 0.627 ' OE1' ' HB3' ' A' ' 547' ' ' ARG . 38.2 tt0 -96.53 -69.99 0.73 Allowed 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 108.958 -0.756 . . . . 64.51 108.958 -178.449 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 552' ' ' ASP . . . . . 0.652 ' OD2' 'CA ' ' A' ' 850' ' ' ' CA' . 17.4 t70 -106.63 -25.57 11.73 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-O 122.004 0.907 . . . . 42.33 109.006 177.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -142.84 152.68 42.42 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 106.65 -1.611 . . . . 74.42 106.65 174.172 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 554' ' ' GLU . . . . . 0.407 ' CB ' ' HB3' ' A' ' 574' ' ' LYS . 1.0 OUTLIER -87.48 122.7 31.55 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 107.06 -1.459 . . . . 64.42 107.06 -179.584 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -79.54 123.14 27.31 Favored 'General case' 0 CA--C 1.491 -1.298 0 CA-C-O 120.888 0.375 . . . . 64.43 110.725 -174.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 12.1 t -123.98 107.32 11.2 Favored 'General case' 0 N--CA 1.404 -2.762 0 CA-C-O 122.531 1.158 . . . . 73.34 110.773 -178.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 3.6 p -129.09 130.07 46.02 Favored 'General case' 0 N--CA 1.42 -1.968 0 CA-C-N 114.622 -1.172 . . . . 41.24 108.679 177.241 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 174.66 -151.39 12.46 Favored Glycine 0 N--CA 1.41 -3.073 0 N-CA-C 109.81 -1.316 . . . . 55.14 109.81 -177.269 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 559' ' ' GLU . . . . . 0.459 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 70.5 mt-10 -129.71 126.66 38.78 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-O 120.933 0.397 . . . . 62.14 111.533 -175.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 560' ' ' LEU . . . . . 0.498 ' HG ' ' CE1' ' A' ' 539' ' ' TYR . 83.7 mt -79.67 122.76 26.95 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.787 -0.82 . . . . 64.32 108.787 175.434 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -93.22 110.01 21.53 Favored 'General case' 0 N--CA 1.419 -1.976 0 N-CA-C 109.194 -0.669 . . . . 71.33 109.194 -178.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -129.26 150.52 50.6 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.054 -0.976 . . . . 71.0 108.373 -179.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 563' ' ' GLN . . . . . 0.57 ' H ' ' HB3' ' A' ' 566' ' ' GLU . 7.3 pt20 -148.88 178.53 8.6 Favored 'General case' 0 C--N 1.288 -2.07 0 O-C-N 121.882 -0.511 . . . . 65.23 110.746 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 564' ' ' ASN . . . . . 0.477 ' HB3' ' N ' ' A' ' 533' ' ' GLY . 3.7 p-10 -61.89 -33.1 73.61 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 124.347 1.059 . . . . 50.12 111.447 -176.51 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -91.46 -6.55 52.5 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.864 0.84 . . . . 74.44 110.425 -176.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 566' ' ' GLU . . . . . 0.57 ' HB3' ' H ' ' A' ' 563' ' ' GLN . 9.6 tp10 -98.94 155.54 17.36 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.497 -1.298 . . . . 72.42 107.497 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 1.7 pp -126.75 140.58 48.53 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.625 0 C-N-CA 119.654 -0.818 . . . . 72.25 109.263 177.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 568' ' ' VAL . . . . . 0.47 HG21 ' HD2' ' A' ' 524' ' ' LYS . 1.1 p 53.51 176.58 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.524 0 C-N-CA 126.14 1.776 . . . . 75.34 113.649 177.016 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 569' ' ' LYS . . . . . 0.603 ' HA ' ' HE2' ' A' ' 569' ' ' LYS . 6.7 mmpt? -146.63 153.9 40.86 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 109.119 -0.697 . . . . 62.34 109.119 173.562 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 570' ' ' THR . . . . . 0.519 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 12.0 p -136.72 133.11 35.75 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 124.13 0.894 . . . . 64.32 110.5 178.547 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 571' ' ' ILE . . . . . 0.535 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 2.4 mp -95.66 117.8 40.51 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 107.129 -1.434 . . . . 62.11 107.129 174.556 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 572' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 521' ' ' MET . 4.1 p -102.1 109.47 21.19 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 123.698 0.624 . . . . 71.41 110.498 179.476 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 573' ' ' VAL . . . . . . . . . . . . . 48.0 t -112.32 136.66 47.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 N-CA-C 109.467 -0.568 . . . . 55.33 109.467 -178.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 574' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 519' ' ' GLY . 58.8 tttp -92.72 126.08 37.64 Favored 'General case' 0 C--N 1.309 -1.159 0 O-C-N 124.046 0.841 . . . . 71.14 109.849 178.587 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 47.6 t -94.12 132.42 38.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 107.482 -1.303 . . . . 71.31 107.482 177.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 30.5 mm -97.43 146.35 7.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 C-N-CA 120.605 -0.438 . . . . 62.03 109.989 -174.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -61.95 145.14 53.8 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.4 0.68 . . . . 64.35 110.561 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 578' ' ' ASP . . . . . 0.658 ' OD1' 'CA ' ' A' ' 850' ' ' ' CA' . 1.9 m-20 -70.61 134.35 47.51 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 116.032 1.864 . . . . 62.02 116.032 -175.2 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 579' ' ' GLU . . . . . 0.646 ' OE1' 'CA ' ' A' ' 850' ' ' ' CA' . 0.1 OUTLIER -110.94 -24.82 10.16 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 112.882 -1.963 . . . . 73.22 109.431 177.824 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 580' ' ' GLU . . . . . 0.654 ' OE1' 'CA ' ' A' ' 850' ' ' ' CA' . 0.0 OUTLIER -133.14 178.72 6.68 Favored 'General case' 0 C--O 1.249 1.052 0 N-CA-C 113.232 0.827 . . . . 73.42 113.232 -179.063 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -66.49 152.67 44.72 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.644 -1.162 . . . . 75.22 107.889 177.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 582' ' ' GLU . . . . . 0.616 ' OE1' 'CA ' ' A' ' 800' ' ' ' CA' . 31.4 tt0 -126.29 138.38 53.59 Favored 'General case' 0 C--N 1.293 -1.849 0 C-N-CA 117.385 -1.726 . . . . 72.53 113.011 -176.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -97.21 -158.35 0.66 Allowed 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 106.819 -1.549 . . . . 65.01 106.819 176.142 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 -79.15 93.54 5.21 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 106.072 -1.825 . . . . 74.44 106.072 170.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 585' ' ' LYS . . . . . 0.455 ' HD2' HD13 ' A' ' 646' ' ' ILE . 3.8 tmmm? -98.91 121.9 41.47 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 108.364 -0.976 . . . . 65.23 108.364 -172.074 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 4.9 t -147.01 144.51 29.2 Favored 'General case' 0 N--CA 1.414 -2.226 0 CA-C-N 114.9 -1.046 . . . . 52.53 109.291 -177.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -125.9 146.68 49.74 Favored 'General case' 0 N--CA 1.419 -2.016 0 CA-C-N 114.542 -1.208 . . . . 70.33 109.235 176.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 588' ' ' PHE . . . . . 0.428 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 30.2 m-85 -102.53 128.52 49.14 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 109.294 -0.632 . . . . 52.34 109.294 -175.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 589' ' ' LEU . . . . . 0.554 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.5 OUTLIER -101.36 125.72 48.04 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 104.59 -2.374 . . . . 72.24 104.59 173.506 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -137.9 134.29 34.83 Favored 'General case' 0 C--N 1.273 -2.743 0 N-CA-C 108.92 -0.77 . . . . 74.0 108.92 -178.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 591' ' ' ILE . . . . . 0.481 HG22 ' HB3' ' A' ' 539' ' ' TYR . 28.8 pt -96.64 145.56 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.651 0 N-CA-C 108.158 -1.053 . . . . 70.25 108.158 178.255 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -89.62 -151.52 24.96 Favored Glycine 0 C--N 1.292 -1.879 0 N-CA-C 111.09 -0.804 . . . . 75.51 111.09 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -80.88 125.85 79.06 Favored Pre-proline 0 C--N 1.297 -1.68 0 N-CA-C 108.964 -0.754 . . . . 54.31 108.964 178.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 594' ' ' PRO . . . . . 0.45 ' HB3' HG22 ' A' ' 537' ' ' VAL . 38.4 Cg_endo -69.71 153.07 69.62 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 121.878 1.719 . . . . 75.4 110.841 176.063 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -129.79 132.38 46.51 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.844 -0.535 . . . . 71.1 111.488 -177.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 596' ' ' LEU . . . . . 0.489 ' HB2' ' HD3' ' A' ' 634' ' ' PRO . 0.0 OUTLIER -87.13 125.9 34.44 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 108.221 -1.029 . . . . 71.03 108.221 -179.567 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 21.4 t -91.77 20.93 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.55 0 CA-C-O 121.949 0.88 . . . . 61.24 109.802 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -57.44 -42.17 81.95 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.616 -0.72 . . . . 71.11 111.43 179.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 31.4 ttp -103.51 98.72 8.57 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 106.919 -1.512 . . . . 71.13 106.919 174.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 12.6 m -77.01 151.71 35.48 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 108.671 -0.863 . . . . 71.3 108.671 178.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -70.61 92.64 0.86 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.572 0.701 . . . . 74.12 109.195 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -177.39 -33.37 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 125.579 1.552 . . . . 35.22 106.934 -174.01 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.66 -179.37 3.72 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 114.554 -1.203 . . . . 62.14 109.164 177.768 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -166.95 -43.34 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.705 0 N-CA-C 110.004 -1.238 . . . . 71.11 110.004 177.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 97.16 -114.19 4.91 Favored Glycine 0 N--CA 1.437 -1.296 0 N-CA-C 110.485 -1.046 . . . . 74.52 110.485 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -115.55 97.4 6.13 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.677 -1.231 . . . . 72.05 107.677 176.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 607' ' ' THR . . . . . 0.533 ' HB ' ' O ' ' A' ' 609' ' ' THR . 18.8 p -131.52 130.47 42.39 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 115.802 -0.636 . . . . 51.33 110.699 -177.464 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 608' ' ' ILE . . . . . 0.412 HD12 ' H ' ' A' ' 608' ' ' ILE . 3.2 mp -65.52 -43.69 94.25 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.867 0 CA-C-O 123.438 1.589 . . . . 73.33 107.235 174.298 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 609' ' ' THR . . . . . 0.533 ' O ' ' HB ' ' A' ' 607' ' ' THR . 13.8 p -139.82 152.09 46.24 Favored 'General case' 0 C--N 1.246 -3.931 0 CA-C-N 111.167 -2.742 . . . . 63.23 105.532 175.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -98.32 9.32 43.33 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.555 -0.858 . . . . 73.33 110.345 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -77.05 76.49 3.6 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 114.046 1.128 . . . . 73.23 114.046 -177.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -98.79 72.32 1.96 Allowed 'General case' 0 C--N 1.281 -2.385 0 N-CA-C 104.937 -2.246 . . . . 74.32 104.937 167.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -84.27 62.85 7.41 Favored 'General case' 0 N--CA 1.427 -1.62 0 CA-C-N 112.134 -2.303 . . . . 62.43 109.804 -170.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -80.9 79.55 7.54 Favored 'General case' 0 CA--C 1.483 -1.623 0 CA-C-O 122.571 1.176 . . . . 53.25 109.364 176.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -124.29 20.27 8.9 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 105.941 -1.874 . . . . 75.32 105.941 177.007 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -96.32 170.92 6.83 Favored Pre-proline 0 N--CA 1.433 -1.321 0 CA-C-N 112.485 -2.143 . . . . 72.24 108.61 -176.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -75.43 177.67 8.35 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 121.656 1.571 . . . . 62.22 109.278 169.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.403 ' HG ' ' CD1' ' A' ' 636' ' ' LEU . 3.6 mm? -67.42 117.71 9.76 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.133 0.492 . . . . 72.33 111.581 -177.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 36.0 p -109.64 28.13 8.87 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.397 -0.82 . . . . 71.3 108.993 178.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 620' ' ' SER . . . . . 0.432 ' HA ' ' HB3' ' A' ' 626' ' ' ARG . 2.4 m -61.76 -35.66 78.77 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 124.365 1.066 . . . . 61.04 113.214 -172.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -103.64 5.44 36.45 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.465 0.65 . . . . 41.15 110.212 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -93.46 -51.13 5.11 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 107.859 -1.163 . . . . 65.05 107.859 179.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 623' ' ' GLU . . . . . 0.471 ' HB2' ' HB2' ' A' ' 626' ' ' ARG . 39.2 mt-10 -98.9 123.47 43.2 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 106.883 -1.525 . . . . 74.23 106.883 177.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -78.77 -12.54 60.03 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 119.883 -0.727 . . . . 51.24 112.016 -176.272 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -87.52 -16.66 34.06 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 123.13 0.572 . . . . 73.31 110.989 174.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 626' ' ' ARG . . . . . 0.6 ' O ' ' HG3' ' A' ' 630' ' ' GLU . 0.0 OUTLIER -51.03 -44.05 61.0 Favored 'General case' 0 C--O 1.2 -1.501 0 N-CA-C 113.163 0.801 . . . . 70.42 113.163 -173.367 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 627' ' ' ARG . . . . . 0.402 ' HA ' ' HB2' ' A' ' 630' ' ' GLU . 78.0 mtt180 -71.29 -24.42 62.14 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 118.585 0.63 . . . . 74.32 112.535 -175.233 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 628' ' ' ILE . . . . . 0.434 ' O ' ' HB3' ' A' ' 631' ' ' MET . 96.4 mt -70.41 -36.93 68.77 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 N-CA-C 108.306 -0.998 . . . . 72.24 108.306 172.678 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -72.02 -30.39 65.15 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 109.138 -0.69 . . . . 75.41 109.138 175.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 630' ' ' GLU . . . . . 0.6 ' HG3' ' O ' ' A' ' 626' ' ' ARG . 76.3 mt-10 -77.76 10.31 2.84 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.606 0.762 . . . . 74.14 111.014 177.48 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 631' ' ' MET . . . . . 0.434 ' HB3' ' O ' ' A' ' 628' ' ' ILE . 43.3 ttp -84.84 -29.19 25.52 Favored 'General case' 0 N--CA 1.409 -2.501 0 N-CA-C 106.819 -1.549 . . . . 71.3 106.819 170.56 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -100.95 -17.7 22.23 Favored Glycine 0 N--CA 1.438 -1.18 0 CA-C-N 115.102 -0.954 . . . . 64.1 111.805 175.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -109.89 134.85 20.54 Favored Pre-proline 0 C--N 1.313 -1.021 0 N-CA-C 108.589 -0.893 . . . . 70.42 108.589 -179.233 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.489 ' HD3' ' HB2' ' A' ' 596' ' ' LEU . 70.8 Cg_endo -75.77 157.19 39.64 Favored 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 121.924 1.749 . . . . 61.2 111.196 178.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 29.7 pt -132.03 178.21 5.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 CA-C-O 121.655 0.74 . . . . 55.24 111.048 -173.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 636' ' ' LEU . . . . . 0.403 ' CD1' ' HG ' ' A' ' 618' ' ' LEU . 0.0 OUTLIER -94.05 152.47 18.76 Favored 'General case' 0 N--CA 1.423 -1.805 0 N-CA-C 106.768 -1.568 . . . . 75.21 106.768 171.766 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 637' ' ' GLY . . . . . 0.404 ' HA3' ' HB ' ' A' ' 506' ' ' THR . . . -81.26 -126.04 0.75 Allowed Glycine 0 C--N 1.29 -2.014 0 C-N-CA 120.871 -0.68 . . . . 62.53 113.445 -176.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -87.5 -50.27 6.65 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 112.072 0.397 . . . . 64.12 112.072 -175.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -132.99 110.6 10.36 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.999 0.904 . . . . 73.15 112.939 -177.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 22.3 p -120.32 92.47 3.78 Favored 'General case' 0 N--CA 1.422 -1.861 0 CA-C-N 115.423 -0.808 . . . . 61.35 110.698 176.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 641' ' ' LYS . . . . . 0.612 ' O ' ' HA ' ' A' ' 510' ' ' PRO . 0.2 OUTLIER -170.51 127.55 0.79 Allowed 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 104.564 -2.384 . . . . 72.43 104.564 178.204 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 642' ' ' LEU . . . . . 0.667 HD21 HG21 ' A' ' 523' ' ' VAL . 43.8 tp -117.23 107.06 13.97 Favored 'General case' 0 C--N 1.274 -2.713 0 N-CA-C 108.386 -0.968 . . . . 72.03 108.386 177.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 643' ' ' GLU . . . . . 0.487 ' HB3' HG22 ' A' ' 511' ' ' VAL . 22.8 tt0 -90.71 100.97 13.72 Favored 'General case' 0 C--N 1.275 -2.64 0 N-CA-C 107.306 -1.368 . . . . 64.01 107.306 178.684 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 644' ' ' VAL . . . . . 0.614 HG21 ' HE2' ' A' ' 521' ' ' MET . 19.3 t -91.74 103.55 14.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 109.181 -0.674 . . . . 73.12 109.181 -177.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 645' ' ' ILE . . . . . 0.4 ' CD1' HG13 ' A' ' 511' ' ' VAL . 3.8 mp -93.42 123.97 45.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 105.704 -1.962 . . . . 72.23 105.704 174.597 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 646' ' ' ILE . . . . . 0.523 HD12 ' N ' ' A' ' 646' ' ' ILE . 2.8 mp -97.76 129.15 48.35 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 N-CA-C 108.447 -0.946 . . . . 72.13 108.447 -173.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -92.38 117.31 29.79 Favored 'General case' 0 N--CA 1.403 -2.787 0 CA-C-N 115.69 -0.686 . . . . 44.03 110.744 -179.152 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 648' ' ' GLU . . . . . 0.642 ' OE1' 'CA ' ' A' ' 800' ' ' ' CA' . 33.0 tp10 -61.58 141.37 57.81 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 114.257 -1.338 . . . . 71.34 107.763 178.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 6.5 t -55.99 113.74 1.64 Allowed 'General case' 0 C--O 1.241 0.623 0 C-N-CA 123.245 0.618 . . . . 71.24 109.654 -176.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -168.68 -63.08 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.508 -0.769 . . . . 73.31 109.629 -175.253 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 651' ' ' GLU . . . . . 0.418 ' OE2' ' HD3' ' A' ' 653' ' ' LYS . 35.2 tt0 -175.37 174.34 2.36 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 104.214 -2.513 . . . . 74.21 104.214 -175.218 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -100.04 110.37 22.68 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.41 -1.33 . . . . 75.11 107.41 -178.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 653' ' ' LYS . . . . . 0.418 ' HD3' ' OE2' ' A' ' 651' ' ' GLU . 14.3 mmmm -135.75 49.67 2.14 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 124.027 0.931 . . . . 65.31 109.356 -173.292 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 15.2 m -50.86 110.12 0.39 Allowed 'General case' 0 C--O 1.243 0.72 0 C-N-CA 124.209 1.004 . . . . 71.43 111.303 179.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 4.0 t -82.56 80.52 8.67 Favored 'General case' 0 N--CA 1.418 -2.038 0 CA-C-O 122.467 1.127 . . . . 73.51 111.092 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 46.2 t -125.99 95.48 3.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 N-CA-C 107.289 -1.375 . . . . 74.15 107.289 177.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 . . . . . 0 C--N 1.285 -2.238 0 CA-C-N 114.588 -1.187 . . . . 74.22 109.218 -176.327 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 800' ' ' ' CA' . . . . . 0.642 'CA ' ' OE1' ' A' ' 648' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 850' ' ' ' CA' . . . . . 0.658 'CA ' ' OD1' ' A' ' 578' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 501' ' ' HIS . . . . . 0.419 ' HA ' ' O ' ' A' ' 630' ' ' GLU . 4.7 p-80 . . . . . 0 N--CA 1.448 -0.549 0 CA-C-O 120.642 0.258 . . . . 64.25 110.707 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -127.18 -47.73 1.47 Allowed 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 108.924 -0.769 . . . . 71.42 108.924 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 503' ' ' GLY . . . . . 0.544 ' HA2' ' OG1' ' A' ' 528' ' ' THR . . . -100.95 147.41 17.84 Favored Glycine 0 N--CA 1.41 -3.077 0 C-N-CA 119.912 -1.137 . . . . 42.05 114.868 -172.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 504' ' ' ILE . . . . . 0.47 ' H ' ' HA ' ' A' ' 528' ' ' THR . 3.5 mp -129.32 90.53 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 N-CA-C 106.036 -1.839 . . . . 73.02 106.036 174.07 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 505' ' ' PHE . . . . . 0.524 ' CZ ' ' HB ' ' A' ' 528' ' ' THR . 89.3 m-85 -112.11 110.52 20.85 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 109.176 -0.676 . . . . 71.04 109.176 179.33 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 506' ' ' THR . . . . . 0.507 ' HB ' ' HA3' ' A' ' 637' ' ' GLY . 11.7 t -149.25 167.61 25.55 Favored 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 107.229 -1.397 . . . . 73.02 107.229 -177.473 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -94.75 155.0 17.02 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.565 -1.642 . . . . 73.03 106.565 173.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -90.92 -29.74 17.29 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 107.426 -1.324 . . . . 64.14 107.426 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -112.5 130.9 22.94 Favored Pre-proline 0 N--CA 1.425 -1.711 0 CA-C-N 114.964 -1.016 . . . . 75.12 109.454 174.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 510' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 656' ' ' VAL . 73.8 Cg_endo -84.59 -10.17 8.73 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.203 1.935 . . . . 63.04 111.193 176.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 511' ' ' VAL . . . . . 0.414 HG22 ' HB3' ' A' ' 643' ' ' GLU . 94.3 t -141.29 135.52 31.88 Favored 'Isoleucine or valine' 0 C--O 1.244 0.813 0 C-N-CA 123.929 0.892 . . . . 63.11 109.645 -177.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 7.3 t -139.22 138.35 36.77 Favored 'General case' 0 N--CA 1.413 -2.317 0 N-CA-C 107.066 -1.457 . . . . 35.33 107.066 174.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 25.1 m-70 -107.64 132.87 52.85 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 106.643 -1.614 . . . . 74.02 106.643 177.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.679 HG11 ' SD ' ' A' ' 521' ' ' MET . 34.6 m -120.27 159.04 22.0 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 CA-C-O 121.826 0.822 . . . . 70.23 111.534 -174.615 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 515' ' ' SER . . . . . 0.473 ' O ' HG22 ' A' ' 518' ' ' ILE . 51.6 m -82.02 142.08 32.67 Favored 'General case' 0 N--CA 1.387 -3.592 0 CA-C-N 114.13 -1.395 . . . . 61.23 107.971 178.132 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 516' ' ' GLU . . . . . 0.647 ' OE2' 'CA ' ' A' ' 800' ' ' ' CA' . 39.3 tt0 -80.12 -20.84 44.09 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 120.066 -0.653 . . . . 54.21 110.792 179.013 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 47.8 m -94.73 22.7 6.07 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.705 0.764 . . . . 51.43 110.613 -177.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 518' ' ' ILE . . . . . 0.473 HG22 ' O ' ' A' ' 515' ' ' SER . 16.2 tt -97.09 149.71 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.756 0 N-CA-C 108.367 -0.975 . . . . 71.22 108.367 -179.415 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -83.49 -54.58 3.08 Favored Glycine 0 N--CA 1.43 -1.764 0 C-N-CA 120.359 -0.924 . . . . 73.01 111.39 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 520' ' ' ILE . . . . . 0.446 HD13 ' HA ' ' A' ' 574' ' ' LYS . 34.2 mm -132.72 125.4 52.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.85 -0.796 . . . . 74.14 108.85 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 521' ' ' MET . . . . . 0.679 ' SD ' HG11 ' A' ' 514' ' ' VAL . 23.7 ptt? -94.23 137.75 33.04 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.833 -1.543 . . . . 74.02 106.833 172.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -125.35 140.43 52.82 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 123.387 0.429 . . . . 61.23 110.947 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 523' ' ' VAL . . . . . 0.591 ' O ' ' HA ' ' A' ' 570' ' ' THR . 39.7 t -124.32 126.09 71.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 108.716 -0.846 . . . . 64.54 108.716 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 524' ' ' LYS . . . . . 0.446 ' HD2' HG21 ' A' ' 568' ' ' VAL . 28.2 mmtp -77.77 117.42 19.13 Favored 'General case' 0 C--N 1.311 -1.105 0 O-C-N 123.784 0.678 . . . . 71.31 110.933 -178.422 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 25.5 t -98.8 140.17 19.03 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.289 0 CA-C-N 115.241 -0.89 . . . . 63.1 110.858 -175.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -68.7 144.62 54.36 Favored 'General case' 0 C--O 1.238 0.457 0 O-C-N 123.956 0.785 . . . . 70.33 109.187 177.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 527' ' ' ARG . . . . . 0.416 ' HG2' ' N ' ' A' ' 528' ' ' THR . 27.1 ttp180 -99.16 157.77 16.14 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.343 0.592 . . . . 73.24 110.926 -173.545 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 528' ' ' THR . . . . . 0.648 HG23 ' HB2' ' A' ' 531' ' ' ALA . 5.1 t -65.9 135.03 54.24 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 115.547 -0.751 . . . . 72.35 110.179 173.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 22.6 t -81.87 -37.35 27.07 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.515 -0.92 . . . . 64.1 108.515 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -87.34 98.03 2.34 Favored Glycine 0 N--CA 1.418 -2.512 0 N-CA-C 108.168 -1.973 . . . . 41.31 108.168 175.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 531' ' ' ALA . . . . . 0.648 ' HB2' HG23 ' A' ' 528' ' ' THR . . . -149.38 100.66 3.04 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 120.854 0.359 . . . . 52.12 110.282 -177.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 532' ' ' ARG . . . . . 0.415 ' HD2' ' N ' ' A' ' 532' ' ' ARG . 7.5 mpt_? -119.82 12.8 12.21 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 108.4 -0.963 . . . . 73.13 108.4 172.483 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . -155.22 -166.16 15.11 Favored Glycine 0 N--CA 1.437 -1.291 0 CA-C-N 115.006 -0.997 . . . . 71.32 111.013 -172.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -97.8 134.54 40.82 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 122.926 0.49 . . . . 70.43 109.982 -178.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 535' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' A' ' 595' ' ' ARG . 61.3 t -133.06 131.45 58.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 123.025 0.53 . . . . 73.4 109.856 -178.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 536' ' ' ILE . . . . . 0.425 ' HB ' ' HB2' ' A' ' 595' ' ' ARG . 35.1 mm -103.82 138.17 29.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 110.033 -0.358 . . . . 75.22 110.033 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 537' ' ' VAL . . . . . 0.409 HG22 ' HB3' ' A' ' 594' ' ' PRO . 48.8 t -126.28 110.19 23.81 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 110.086 -0.338 . . . . 75.03 110.086 178.222 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.04 154.41 37.67 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.369 2.046 . . . . 75.52 111.754 178.116 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 539' ' ' TYR . . . . . 0.443 ' HB3' HG22 ' A' ' 591' ' ' ILE . 52.8 p90 -147.23 161.66 40.48 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.243 -0.651 . . . . 72.03 109.243 177.496 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -152.5 157.57 41.32 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 123.724 0.64 . . . . 72.41 109.782 178.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 2.7 p -99.93 122.66 43.18 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 123.469 0.481 . . . . 70.44 110.649 174.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.4 mp -91.08 112.52 25.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 106.242 -1.762 . . . . 62.31 106.242 174.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -52.13 -50.68 61.22 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 124.246 0.966 . . . . 61.44 111.823 -178.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 67.18 -94.68 0.26 Allowed Glycine 0 N--CA 1.442 -0.903 0 CA-C-N 116.058 -0.519 . . . . 71.42 112.24 176.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 545' ' ' THR . . . . . 0.514 HG23 ' HB2' ' A' ' 585' ' ' LYS . 8.0 t -119.19 9.39 11.73 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 120.759 0.314 . . . . 73.13 110.575 -178.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 546' ' ' ALA . . . . . 0.435 ' HB2' ' HD3' ' A' ' 585' ' ' LYS . . . -98.78 166.31 11.37 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.847 -0.427 . . . . 64.51 109.847 178.065 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 547' ' ' ARG . . . . . 0.426 ' HB3' ' HB2' ' A' ' 551' ' ' GLU . 2.8 tpp180 -75.55 167.33 22.1 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 108.024 -1.102 . . . . 72.52 108.024 178.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -65.02 177.25 10.64 Favored Glycine 0 C--O 1.254 1.393 0 CA-C-O 121.513 0.507 . . . . 55.24 114.36 -178.414 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . -57.03 127.55 45.13 Favored Glycine 0 N--CA 1.439 -1.141 0 CA-C-N 114.718 -0.741 . . . . 44.1 114.115 -177.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 94.95 -10.23 70.24 Favored Glycine 0 N--CA 1.434 -1.459 0 CA-C-N 115.311 -0.444 . . . . 75.15 112.565 176.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 551' ' ' GLU . . . . . 0.426 ' HB2' ' HB3' ' A' ' 547' ' ' ARG . 61.8 mm-40 -91.08 -70.84 0.66 Allowed 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 120.405 -0.518 . . . . 75.31 109.754 -179.253 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 552' ' ' ASP . . . . . 0.657 ' OD1' 'CA ' ' A' ' 850' ' ' ' CA' . 71.1 m-20 -96.03 -37.9 10.44 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-O 121.572 0.701 . . . . 63.25 109.97 175.733 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -142.46 156.82 45.21 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 108.115 -1.069 . . . . 72.33 108.115 -177.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -87.42 117.41 26.19 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 106.519 -1.66 . . . . 61.24 106.519 178.477 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -72.38 107.15 4.81 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.75 -0.659 . . . . 72.2 109.791 -176.085 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 556' ' ' THR . . . . . 0.47 HG21 HG22 ' A' ' 573' ' ' VAL . 9.6 t -106.58 126.66 52.55 Favored 'General case' 0 N--CA 1.413 -2.32 0 CA-C-O 122.123 0.963 . . . . 64.52 111.565 -173.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 20.5 p -136.99 109.77 7.57 Favored 'General case' 0 N--CA 1.414 -2.244 0 N-CA-C 107.367 -1.346 . . . . 72.42 107.367 175.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -152.92 -161.69 10.46 Favored Glycine 0 N--CA 1.418 -2.505 0 N-CA-C 110.607 -0.997 . . . . 70.32 110.607 -174.072 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -139.18 131.25 27.98 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 122.983 0.513 . . . . 71.04 110.454 -176.164 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 87.7 mt -92.99 143.73 25.95 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 123.725 0.81 . . . . 72.43 109.123 179.26 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -102.62 123.59 46.61 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-O 121.414 0.626 . . . . 71.5 110.618 178.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -121.35 157.49 30.32 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 108.26 -1.015 . . . . 71.23 108.26 173.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 563' ' ' GLN . . . . . 0.401 ' HG3' ' H ' ' A' ' 566' ' ' GLU . 3.6 pt20 -162.92 -178.93 6.41 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 109.769 -0.456 . . . . 70.24 109.769 176.595 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 -63.74 -36.36 83.6 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 124.108 0.88 . . . . 72.52 111.587 178.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -90.11 -17.26 28.01 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.399 -0.819 . . . . 74.51 112.309 -176.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 566' ' ' GLU . . . . . 0.401 ' H ' ' HG3' ' A' ' 563' ' ' GLN . 6.7 tp10 -109.58 128.65 55.36 Favored 'General case' 0 C--N 1.31 -1.123 0 O-C-N 121.844 -0.535 . . . . 73.24 111.081 -174.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 4.7 pt -109.43 159.45 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.125 0 N-CA-C 108.735 -0.839 . . . . 72.23 108.735 176.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 568' ' ' VAL . . . . . 0.446 HG21 ' HD2' ' A' ' 524' ' ' LYS . 1.3 p 49.25 160.89 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.573 1.855 0 C-N-CA 127.081 2.152 . . . . 71.54 115.182 -179.517 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 569' ' ' LYS . . . . . 0.543 ' HE3' ' HA ' ' A' ' 569' ' ' LYS . 0.0 OUTLIER -153.23 162.54 41.19 Favored 'General case' 0 CA--C 1.484 -1.578 0 N-CA-C 107.463 -1.31 . . . . 74.21 107.463 173.114 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 570' ' ' THR . . . . . 0.591 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 4.9 p -136.87 127.96 27.79 Favored 'General case' 0 C--N 1.291 -1.938 0 O-C-N 124.169 0.918 . . . . 71.04 110.815 178.47 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 571' ' ' ILE . . . . . 0.45 HG21 HD21 ' A' ' 589' ' ' LEU . 3.3 mp -79.38 106.93 11.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 107.432 -1.321 . . . . 75.44 107.432 174.351 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 7.3 p -86.42 111.95 21.02 Favored 'General case' 0 N--CA 1.415 -2.2 0 O-C-N 123.645 0.591 . . . . 61.21 110.419 179.33 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 573' ' ' VAL . . . . . 0.47 HG22 HG21 ' A' ' 556' ' ' THR . 42.3 t -114.39 130.7 68.23 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 N-CA-C 109.089 -0.708 . . . . 64.42 109.089 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 574' ' ' LYS . . . . . 0.446 ' HA ' HD13 ' A' ' 520' ' ' ILE . 86.1 tttt -86.87 121.88 29.97 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 115.476 -0.784 . . . . 64.3 110.292 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 56.5 t -90.06 139.37 17.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 107.015 -1.476 . . . . 73.12 107.015 176.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 31.3 mm -103.52 158.31 5.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 107.842 -1.17 . . . . 73.53 107.842 -175.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -67.31 126.56 29.65 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.019 -0.734 . . . . 55.42 109.019 178.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 578' ' ' ASP . . . . . 0.641 ' OD1' 'CA ' ' A' ' 850' ' ' ' CA' . 26.8 t0 -76.23 130.43 38.18 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.818 -0.628 . . . . 61.31 110.45 -171.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 579' ' ' GLU . . . . . 0.634 ' OE1' 'CA ' ' A' ' 850' ' ' ' CA' . 0.6 OUTLIER -92.29 -35.34 13.82 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 113.842 1.053 . . . . 35.05 113.842 -175.718 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 580' ' ' GLU . . . . . 0.656 ' OE1' 'CA ' ' A' ' 850' ' ' ' CA' . 0.0 OUTLIER -117.58 -178.99 3.6 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 120.251 -0.58 . . . . 74.14 111.009 -174.573 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -71.48 152.43 43.05 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 106.419 -1.697 . . . . 75.3 106.419 175.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 582' ' ' GLU . . . . . 0.658 ' OE1' 'CA ' ' A' ' 800' ' ' ' CA' . 40.7 tt0 -145.14 141.81 29.07 Favored 'General case' 0 N--CA 1.409 -2.495 0 C-N-CA 118.517 -1.273 . . . . 74.04 111.597 -174.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 583' ' ' LYS . . . . . 0.465 ' O ' ' HG2' ' A' ' 582' ' ' GLU . 97.3 mttt -94.57 -179.29 4.84 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 106.555 -1.646 . . . . 61.25 106.555 174.532 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -74.78 94.49 2.75 Favored 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 119.819 -0.753 . . . . 73.11 109.125 178.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 585' ' ' LYS . . . . . 0.514 ' HB2' HG23 ' A' ' 545' ' ' THR . 0.0 OUTLIER -102.73 170.43 8.01 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 115.828 -0.624 . . . . 65.02 109.319 -179.56 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 2.8 t -151.79 148.96 28.48 Favored 'General case' 0 N--CA 1.418 -2.043 0 CA-C-O 121.486 0.66 . . . . 62.01 111.502 -177.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -128.84 150.09 50.47 Favored 'General case' 0 N--CA 1.411 -2.409 0 CA-C-N 113.537 -1.665 . . . . 70.3 107.321 174.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 588' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -108.51 135.98 48.88 Favored 'General case' 0 C--N 1.29 -1.993 0 C-N-CA 120.555 -0.458 . . . . 74.15 110.5 -169.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 589' ' ' LEU . . . . . 0.473 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.3 OUTLIER -102.85 129.58 49.57 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 105.8 -1.926 . . . . 72.11 105.8 175.712 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -132.97 127.08 33.42 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 109.392 -0.595 . . . . 72.33 109.392 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 591' ' ' ILE . . . . . 0.443 HG22 ' HB3' ' A' ' 539' ' ' TYR . 16.3 pt -94.17 138.43 20.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 107.945 -1.132 . . . . 72.14 107.945 174.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -97.64 -145.3 18.75 Favored Glycine 0 N--CA 1.43 -1.746 0 N-CA-C 115.049 0.779 . . . . 65.11 115.049 -172.115 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -84.99 119.67 72.82 Favored Pre-proline 0 C--N 1.302 -1.462 0 CA-C-N 114.081 -1.059 . . . . 63.21 109.827 -174.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 594' ' ' PRO . . . . . 0.415 ' HA ' ' O ' ' A' ' 536' ' ' ILE . 43.9 Cg_endo -72.5 156.01 54.51 Favored 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 123.082 2.521 . . . . 52.23 114.202 -177.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 595' ' ' ARG . . . . . 0.51 ' O ' ' HA ' ' A' ' 535' ' ' VAL . 5.7 mmp_? -115.37 118.15 32.43 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 123.713 0.805 . . . . 54.24 109.284 -175.727 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 596' ' ' LEU . . . . . 0.421 HD22 HG22 ' A' ' 535' ' ' VAL . 0.0 OUTLIER -82.5 117.99 22.92 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 104.793 -2.299 . . . . 72.21 104.793 169.586 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 17.0 t -83.68 59.63 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-O 121.776 0.798 . . . . 73.22 112.787 -172.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 63.67 -32.54 0.12 Allowed 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 118.082 2.623 . . . . 73.12 118.082 167.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 44.5 tpp -47.78 -64.62 0.74 Allowed 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 114.345 1.239 . . . . 63.13 114.345 -174.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 17.4 p -137.67 173.15 11.96 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 109.706 -0.479 . . . . 71.22 109.706 -175.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 61.02 26.76 16.69 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 124.185 0.928 . . . . 71.42 112.102 173.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.51 32.5 1.37 Allowed 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.968 0.89 . . . . 54.22 111.475 -176.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -88.96 81.7 6.83 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.927 -1.033 . . . . 71.25 110.432 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -151.11 -51.71 0.01 OUTLIER Glycine 0 C--N 1.307 -1.081 0 N-CA-C 109.583 -1.407 . . . . 44.13 109.583 177.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . -117.62 76.95 0.29 Allowed Glycine 0 N--CA 1.432 -1.623 0 N-CA-C 109.206 -1.558 . . . . 25.55 109.206 174.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -71.33 -26.14 62.7 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 122.827 0.451 . . . . 72.51 111.43 -175.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -67.57 129.16 39.02 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 123.535 0.734 . . . . 43.13 112.689 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 39.1 mm -77.16 77.63 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-O 122.55 1.167 . . . . 65.23 112.337 -175.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 8.9 t -146.56 11.58 1.13 Allowed 'General case' 0 C--N 1.273 -2.738 0 CA-C-N 114.51 -1.223 . . . . 51.33 108.044 176.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 42.95 76.67 0.07 Allowed 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 114.109 -1.405 . . . . 73.23 111.924 -171.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -95.27 26.51 3.74 Favored 'General case' 0 C--N 1.286 -2.18 0 CA-C-O 122.364 1.078 . . . . 73.31 112.711 -178.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -87.9 82.12 7.36 Favored 'General case' 0 N--CA 1.414 -2.227 0 CA-C-N 114.08 -1.418 . . . . 74.04 107.667 171.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 17.4 p-10 -90.44 3.02 55.05 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 111.799 -2.455 . . . . 51.04 110.96 -173.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -73.66 98.81 2.95 Favored 'General case' 0 C--N 1.287 -2.119 0 C-N-CA 123.199 0.6 . . . . 74.5 112.179 -177.079 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -147.97 19.03 1.12 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 107.814 -1.18 . . . . 71.43 107.814 172.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 616' ' ' GLN . . . . . 0.49 ' HB3' ' HD2' ' A' ' 617' ' ' PRO . 1.2 mp0 -109.13 173.46 2.95 Favored Pre-proline 0 C--N 1.313 -1.004 0 C-N-CA 123.752 0.821 . . . . 74.3 110.174 -174.724 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 617' ' ' PRO . . . . . 0.49 ' HD2' ' HB3' ' A' ' 616' ' ' GLN . 33.3 Cg_endo -69.62 168.87 20.13 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 121.702 1.602 . . . . 44.24 110.139 170.226 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -77.96 105.57 9.24 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 120.844 0.354 . . . . 72.43 111.783 -175.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 8.8 t -163.96 159.0 20.33 Favored 'General case' 0 N--CA 1.426 -1.641 0 N-CA-C 109.129 -0.693 . . . . 75.24 109.129 176.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 620' ' ' SER . . . . . 0.681 ' HB3' ' NE ' ' A' ' 626' ' ' ARG . 14.9 p -144.96 -8.95 0.61 Allowed 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 115.691 -0.686 . . . . 42.4 111.153 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm 64.38 21.45 12.49 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 107.881 -1.155 . . . . 74.23 107.881 -170.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 65.41 21.88 11.91 Favored 'General case' 0 CA--C 1.558 1.277 0 C-N-CA 126.634 1.974 . . . . 65.0 110.577 -175.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -71.18 124.03 23.53 Favored 'General case' 0 C--O 1.258 1.517 0 CA-C-O 121.719 0.771 . . . . 61.33 110.488 176.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -61.83 -39.35 91.5 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-N 113.984 -1.462 . . . . 63.41 112.05 -177.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . 0.272 1.7 pp20? -64.6 -28.46 69.64 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 119.378 -0.929 . . . . 71.44 112.521 -178.294 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 626' ' ' ARG . . . . . 0.681 ' NE ' ' HB3' ' A' ' 620' ' ' SER . 1.9 tmm_? -70.75 -42.62 70.24 Favored 'General case' 0 C--O 1.202 -1.421 0 N-CA-C 106.759 -1.571 . . . . 73.35 106.759 175.495 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 627' ' ' ARG . . . . . . . . . . . . . 72.9 mtp180 -63.72 -34.67 78.4 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 116.144 -0.48 . . . . 71.51 110.924 -178.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 96.2 mt -64.76 -37.56 80.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 121.316 0.579 . . . . 64.24 110.479 175.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -69.0 -31.29 70.01 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.523 0.678 . . . . 74.53 110.028 178.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 630' ' ' GLU . . . . . 0.62 ' HG2' ' O ' ' A' ' 626' ' ' ARG . 4.5 mm-40 -81.0 2.96 24.69 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.249 -0.887 . . . . 54.31 110.436 -179.052 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 631' ' ' MET . . . . . . . . . . . . . 44.6 ttm -78.27 -27.43 47.43 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 107.647 -1.242 . . . . 65.03 107.647 175.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -96.87 -44.94 2.75 Favored Glycine 0 N--CA 1.427 -1.958 0 N-CA-C 110.289 -1.124 . . . . 51.44 110.289 177.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 21.8 mtm180 -70.37 152.69 95.48 Favored Pre-proline 0 N--CA 1.443 -0.79 0 CA-C-O 121.187 0.518 . . . . 74.41 112.32 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.533 ' HA ' ' H ' ' A' ' 503' ' ' GLY . 61.3 Cg_endo -77.16 148.82 27.69 Favored 'Trans proline' 0 N--CA 1.437 -1.834 0 C-N-CA 121.795 1.663 . . . . 72.21 109.532 173.193 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 635' ' ' ILE . . . . . 0.402 HG12 ' HB2' ' A' ' 501' ' ' HIS . 11.6 pt -137.33 -171.74 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-O 120.956 0.408 . . . . 74.24 110.351 -178.372 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.48 164.42 14.83 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 115.482 -0.781 . . . . 63.03 110.227 177.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 637' ' ' GLY . . . . . 0.507 ' HA3' ' HB ' ' A' ' 506' ' ' THR . . . -82.35 -106.51 0.43 Allowed Glycine 0 N--CA 1.435 -1.428 0 CA-C-N 115.917 -0.583 . . . . 50.22 112.99 -176.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -107.99 -54.16 2.53 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 119.889 -0.724 . . . . 73.04 111.003 -176.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 14.5 p80 -133.84 116.16 15.34 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 121.79 0.805 . . . . 75.51 111.423 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 16.2 p -104.3 91.24 3.83 Favored 'General case' 0 N--CA 1.408 -2.552 0 N-CA-C 109.091 -0.707 . . . . 71.23 109.091 174.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -171.65 126.25 0.61 Allowed 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 105.898 -1.89 . . . . 73.25 105.898 -178.267 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 642' ' ' LEU . . . . . 0.553 HD21 HG21 ' A' ' 523' ' ' VAL . 42.6 tp -126.28 110.97 14.01 Favored 'General case' 0 C--N 1.281 -2.398 0 N-CA-C 108.086 -1.079 . . . . 73.51 108.086 176.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 643' ' ' GLU . . . . . 0.414 ' HB3' HG22 ' A' ' 511' ' ' VAL . 30.6 tt0 -90.9 102.97 15.73 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 107.569 -1.271 . . . . 65.24 107.569 178.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 644' ' ' VAL . . . . . 0.489 HG21 ' HE1' ' A' ' 521' ' ' MET . 41.2 t -93.2 110.9 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 N-CA-C 109.333 -0.618 . . . . 71.33 109.333 -179.174 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 3.5 mp -93.07 125.6 45.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 108.425 -0.954 . . . . 72.34 108.425 176.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 646' ' ' ILE . . . . . 0.514 HD12 ' N ' ' A' ' 646' ' ' ILE . 2.1 mp -110.72 131.14 62.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 N-CA-C 107.424 -1.324 . . . . 61.05 107.424 -176.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 647' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' A' ' 516' ' ' GLU . 2.2 pt-20 -131.22 157.35 43.48 Favored 'General case' 0 C--N 1.28 -2.448 0 N-CA-C 108.511 -0.922 . . . . 75.43 108.511 178.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 648' ' ' GLU . . . . . 0.656 ' OE2' 'CA ' ' A' ' 800' ' ' ' CA' . 6.5 mp0 -56.5 117.97 4.36 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 106.307 -1.738 . . . . 72.11 106.307 170.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 2.9 t -45.95 97.74 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.028 0 O-C-N 125.802 1.939 . . . . 74.01 113.784 -165.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -138.7 -60.34 0.6 Allowed 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 115.382 -0.826 . . . . 74.5 110.472 174.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -102.5 160.39 14.6 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-O 121.572 0.701 . . . . 74.44 110.576 -173.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -133.3 125.13 28.58 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 114.817 -1.083 . . . . 74.4 109.18 179.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -148.71 166.4 28.48 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 123.375 0.67 . . . . 73.13 109.795 -178.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 14.4 t -165.38 86.23 0.39 Allowed 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 106.321 -1.733 . . . . 52.52 106.321 172.009 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 14.1 t -80.22 131.46 35.7 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-N 115.497 -0.774 . . . . 72.42 111.152 -174.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.419 ' HA ' ' HD2' ' A' ' 510' ' ' PRO . 17.3 m -94.48 160.36 2.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-N 115.144 -0.934 . . . . 74.41 109.005 177.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 20.1 t70 . . . . . 0 C--N 1.313 -1.006 0 CA-C-O 119.417 -0.325 . . . . 73.13 110.369 -174.709 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 800' ' ' ' CA' . . . . . 0.658 'CA ' ' OE1' ' A' ' 582' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 850' ' ' ' CA' . . . . . 0.657 'CA ' ' OD1' ' A' ' 552' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 . . . . . 0 CA--C 1.516 -0.34 0 N-CA-C 109.717 -0.475 . . . . 73.44 109.717 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 502' ' ' ALA . . . . . 0.406 ' HB1' ' HA ' ' A' ' 634' ' ' PRO . . . -129.29 151.13 50.28 Favored 'General case' 0 CA--C 1.465 -2.298 0 N-CA-C 106.402 -1.703 . . . . 41.15 106.402 176.084 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 503' ' ' GLY . . . . . 0.474 ' HA2' ' OG1' ' A' ' 528' ' ' THR . . . -86.55 124.48 6.96 Favored Glycine 0 N--CA 1.403 -3.564 0 C-N-CA 119.021 -1.561 . . . . 34.05 110.08 175.033 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 4.1 mp -91.82 119.34 39.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 108.712 -0.847 . . . . 75.4 108.712 178.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -123.48 126.04 46.0 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 109.627 -0.508 . . . . 64.41 109.627 177.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 506' ' ' THR . . . . . 0.453 ' HB ' ' HA3' ' A' ' 637' ' ' GLY . 8.8 t -153.41 165.18 36.62 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.522 -0.918 . . . . 71.31 108.522 -177.371 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -89.31 162.65 15.72 Favored 'General case' 0 C--O 1.251 1.136 0 N-CA-C 107.228 -1.397 . . . . 73.45 107.228 173.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -88.42 -44.43 10.75 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 106.293 -1.743 . . . . 75.32 106.293 178.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -105.36 133.73 20.02 Favored Pre-proline 0 N--CA 1.42 -1.93 0 CA-C-N 114.502 -1.226 . . . . 65.54 109.495 176.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -87.21 -10.63 5.59 Favored 'Trans proline' 0 C--O 1.219 -0.469 0 C-N-CA 121.956 1.77 . . . . 71.53 110.824 175.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 511' ' ' VAL . . . . . 0.454 HG22 ' HB3' ' A' ' 643' ' ' GLU . 81.5 t -142.42 138.89 29.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 C-N-CA 124.378 1.071 . . . . 62.14 108.441 -176.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 11.3 t -142.09 141.71 32.75 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 107.726 -1.213 . . . . 74.13 107.726 174.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 35.5 m-70 -108.94 130.4 55.45 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.486 -0.561 . . . . 70.24 109.486 178.028 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 26.4 m -128.71 162.47 35.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 CA-C-O 120.937 0.398 . . . . 70.24 110.221 -176.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 45.9 t -84.24 156.68 21.89 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 108.412 -0.959 . . . . 71.14 108.412 175.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -88.91 -6.77 57.06 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-O 122.089 0.947 . . . . 65.42 109.659 174.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 8.7 t -96.99 6.34 48.8 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 108.707 -0.849 . . . . 75.51 108.707 179.447 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 12.5 tt -85.11 151.03 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.623 0 N-CA-C 108.69 -0.856 . . . . 55.03 108.69 -178.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 519' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . -89.61 -63.38 1.29 Allowed Glycine 0 N--CA 1.426 -2.023 0 C-N-CA 120.366 -0.921 . . . . 75.4 111.098 179.492 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 32.1 mm -123.64 124.26 69.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 109.458 -0.571 . . . . 44.11 109.458 -179.099 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 521' ' ' MET . . . . . 0.638 ' HE2' HG21 ' A' ' 644' ' ' VAL . 0.0 OUTLIER -102.6 135.51 44.12 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.597 -1.26 . . . . 64.1 107.597 172.625 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 522' ' ' GLU . . . . . 0.423 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 42.7 mt-10 -120.93 132.29 54.86 Favored 'General case' 0 CA--C 1.494 -1.206 0 O-C-N 123.522 0.514 . . . . 54.45 110.713 -177.66 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 523' ' ' VAL . . . . . 0.566 HG21 ' CD2' ' A' ' 642' ' ' LEU . 29.4 t -112.67 123.46 68.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-N 115.37 -0.832 . . . . 71.21 108.888 178.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 524' ' ' LYS . . . . . 0.416 ' HD2' HG21 ' A' ' 568' ' ' VAL . 28.6 mmtp -79.78 122.77 27.02 Favored 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 123.468 0.707 . . . . 65.41 110.408 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 21.9 t -101.21 150.97 5.59 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 CA-C-N 115.405 -0.816 . . . . 72.11 109.126 -178.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -95.43 153.53 17.65 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 108.974 -0.75 . . . . 71.12 108.974 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 527' ' ' ARG . . . . . 0.472 ' HD3' ' HA ' ' A' ' 567' ' ' ILE . 67.1 mtm180 -94.21 176.81 6.18 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.201 0.524 . . . . 73.34 109.9 173.091 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 528' ' ' THR . . . . . 0.474 ' OG1' ' HA2' ' A' ' 503' ' ' GLY . 8.8 t -87.82 164.26 16.01 Favored 'General case' 0 N--CA 1.411 -2.38 0 CA-C-N 115.079 -0.964 . . . . 75.14 110.208 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 13.3 t -63.21 -42.75 99.34 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 115.262 -0.881 . . . . 70.21 108.712 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -100.78 67.4 0.49 Allowed Glycine 0 N--CA 1.434 -1.47 0 N-CA-C 110.764 -0.934 . . . . 41.25 110.764 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -78.89 80.45 5.24 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.261 0.553 . . . . 75.42 110.742 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -134.63 138.65 44.68 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 106.306 -1.739 . . . . 73.41 106.306 177.461 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 533' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' A' ' 563' ' ' GLN . . . 87.93 173.48 47.75 Favored Glycine 0 C--N 1.302 -1.314 0 C-N-CA 119.883 -1.151 . . . . 74.23 111.156 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -105.98 121.27 43.76 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 122.409 -0.465 . . . . 62.12 109.809 -177.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 535' ' ' VAL . . . . . 0.445 HG22 HD22 ' A' ' 596' ' ' LEU . 59.8 t -124.01 126.21 72.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.409 -0.96 . . . . 62.12 108.409 178.147 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 536' ' ' ILE . . . . . 0.51 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 47.4 mm -99.23 137.28 27.17 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 N-CA-C 108.661 -0.866 . . . . 63.24 108.661 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 57.9 t -122.45 109.82 32.64 Favored Pre-proline 0 C--N 1.307 -1.266 0 CA-C-N 116.417 -0.356 . . . . 74.21 110.805 -179.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -75.25 135.92 19.23 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 122.541 2.161 . . . . 64.11 111.668 176.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 539' ' ' TYR . . . . . 0.455 ' CD1' ' HG ' ' A' ' 560' ' ' LEU . 42.9 p90 -134.12 157.49 46.03 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 109.068 -0.716 . . . . 73.01 109.068 -178.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -156.73 156.85 34.06 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 123.322 0.389 . . . . 74.11 111.048 177.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 1.6 p -91.45 116.85 29.19 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 115.437 -0.801 . . . . 71.14 110.663 174.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.6 mp -87.51 112.27 23.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 106.282 -1.747 . . . . 74.41 106.282 174.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.69 -46.19 74.07 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 114.797 1.406 . . . . 63.4 114.797 -176.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 63.41 -94.54 0.13 Allowed Glycine 0 CA--C 1.523 0.546 0 CA-C-O 121.349 0.416 . . . . 74.43 113.146 177.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 10.2 t -114.09 0.4 14.28 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.293 0.568 . . . . 71.13 110.712 -178.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -104.02 156.7 17.65 Favored 'General case' 0 C--N 1.318 -0.794 0 O-C-N 121.97 -0.457 . . . . 63.43 109.923 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 547' ' ' ARG . . . . . 0.463 ' HB2' ' HB2' ' A' ' 552' ' ' ASP . 4.6 mpt_? -87.21 125.43 34.18 Favored 'General case' 0 CA--C 1.483 -1.602 0 CA-C-O 121.442 0.639 . . . . 71.22 110.991 -178.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -86.32 179.92 49.47 Favored Glycine 0 C--N 1.279 -2.633 0 CA-C-N 114.245 -1.343 . . . . 73.03 112.083 -177.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 74.18 30.86 60.24 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 114.039 0.376 . . . . 72.44 114.039 177.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 76.08 21.39 76.11 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.259 -0.972 . . . . 52.04 111.919 178.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -91.67 -66.26 0.94 Allowed 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 110.02 -0.363 . . . . 75.15 110.02 -177.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 552' ' ' ASP . . . . . 0.463 ' HB2' ' HB2' ' A' ' 547' ' ' ARG . 1.8 t70 -101.79 -29.84 11.64 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 106.608 -1.627 . . . . 51.44 106.608 177.512 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -146.07 160.06 42.41 Favored 'General case' 0 C--O 1.247 0.937 0 CA-C-N 114.963 -1.017 . . . . 73.43 108.374 175.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -91.21 130.09 37.13 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.404 -1.702 . . . . 75.32 106.404 178.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -86.17 117.46 25.01 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 116.511 -0.313 . . . . 64.14 110.579 -174.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 556' ' ' THR . . . . . 0.43 ' CG2' HG22 ' A' ' 573' ' ' VAL . 13.8 t -115.99 122.35 44.98 Favored 'General case' 0 N--CA 1.409 -2.477 0 CA-C-O 122.206 1.003 . . . . 65.23 110.462 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 1.8 p -143.87 128.76 18.42 Favored 'General case' 0 N--CA 1.417 -2.087 0 CA-C-N 114.54 -1.209 . . . . 72.24 108.693 179.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -177.4 -158.42 20.48 Favored Glycine 0 N--CA 1.419 -2.47 0 N-CA-C 110.103 -1.199 . . . . 73.44 110.103 -176.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 559' ' ' GLU . . . . . 0.51 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 38.7 mt-10 -129.97 125.73 36.12 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 120.999 0.428 . . . . 65.43 111.935 -176.273 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 560' ' ' LEU . . . . . 0.455 ' HG ' ' CD1' ' A' ' 539' ' ' TYR . 94.9 mt -88.91 144.92 25.86 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 109.07 -0.715 . . . . 74.11 109.07 177.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -103.95 122.17 44.64 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 116.418 -0.355 . . . . 74.44 110.475 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 562' ' ' PHE . . . . . 0.421 ' CE1' ' HG2' ' A' ' 569' ' ' LYS . 70.0 m-85 -121.24 146.57 46.67 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.445 -0.946 . . . . 73.24 108.445 171.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 563' ' ' GLN . . . . . 0.483 ' HA ' ' O ' ' A' ' 533' ' ' GLY . 10.0 pt20 -159.14 -173.16 4.08 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 110.324 -0.25 . . . . 72.41 110.324 178.271 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -59.11 -45.41 90.96 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 123.58 0.752 . . . . 72.5 112.24 -177.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -91.95 -41.21 10.7 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 120.17 -0.612 . . . . 54.32 111.748 -178.136 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 566' ' ' GLU . . . . . 0.406 ' H ' ' HG3' ' A' ' 563' ' ' GLN . 8.2 tp10 -66.94 135.2 53.44 Favored 'General case' 0 C--N 1.317 -0.809 0 O-C-N 123.247 0.342 . . . . 71.0 110.233 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 567' ' ' ILE . . . . . 0.472 ' HA ' ' HD3' ' A' ' 527' ' ' ARG . 31.1 pt -116.94 -172.19 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.412 -2.365 0 N-CA-C 109.057 -0.72 . . . . 73.21 109.057 -178.026 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 568' ' ' VAL . . . . . 0.416 HG21 ' HD2' ' A' ' 524' ' ' LYS . 2.8 p 5.9 128.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 C-N-CA 129.628 3.171 . . . . 54.02 116.944 172.576 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 569' ' ' LYS . . . . . 0.421 ' HG2' ' CE1' ' A' ' 562' ' ' PHE . 27.7 mmmt -117.11 153.87 32.01 Favored 'General case' 0 C--N 1.266 -3.024 0 CA-C-N 115.234 -0.894 . . . . 72.21 110.699 177.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 570' ' ' THR . . . . . 0.551 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 8.3 p -126.78 121.2 31.28 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 124.032 0.832 . . . . 63.33 111.998 177.124 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 571' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 2.5 mp -77.15 118.15 23.33 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 N-CA-C 105.191 -2.151 . . . . 64.43 105.191 172.706 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 5.7 m -105.93 109.36 21.28 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.894 -0.78 . . . . 63.1 108.894 -176.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 573' ' ' VAL . . . . . 0.43 HG22 ' CG2' ' A' ' 556' ' ' THR . 40.6 t -114.01 135.3 54.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 110.067 -0.346 . . . . 61.22 110.067 -176.644 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 574' ' ' LYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 519' ' ' GLY . 15.7 tppt? -90.4 123.98 34.58 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.369 -0.832 . . . . 73.22 110.112 178.418 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 64.3 t -94.59 117.66 38.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 107.724 -1.213 . . . . 71.33 107.724 176.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 36.8 mm -78.96 154.65 4.85 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 N-CA-C 108.347 -0.983 . . . . 74.41 108.347 -176.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -72.36 86.78 1.13 Allowed 'General case' 0 C--O 1.247 0.947 0 CA-C-O 122.061 0.934 . . . . 43.3 110.26 173.173 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 578' ' ' ASP . . . . . 0.625 ' OD1' 'CA ' ' A' ' 850' ' ' ' CA' . 4.4 t0 -40.6 130.57 2.4 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 127.681 2.392 . . . . 73.32 113.25 178.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.25 -26.8 60.44 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 114.145 -1.389 . . . . 74.42 114.126 -171.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 580' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' A' ' 581' ' ' TYR . 0.8 OUTLIER -124.63 178.7 5.3 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 119.549 -0.861 . . . . 73.2 110.67 -174.742 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 581' ' ' TYR . . . . . 0.477 ' O ' ' HG2' ' A' ' 580' ' ' GLU . 7.2 p90 -86.01 151.43 23.73 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 105.451 -2.055 . . . . 75.54 105.451 173.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 582' ' ' GLU . . . . . 0.611 ' OE1' 'CA ' ' A' ' 800' ' ' ' CA' . 9.5 pt-20 -133.4 172.02 13.27 Favored 'General case' 0 C--N 1.277 -2.549 0 C-N-CA 119.194 -1.002 . . . . 75.31 109.672 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -90.65 -48.87 6.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 N-CA-C 106.812 -1.551 . . . . 72.2 106.812 173.06 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 28.2 m-20 175.22 101.08 0.01 OUTLIER 'General case' 0 C--N 1.259 -3.344 0 CA-C-N 110.822 -2.899 . . . . 71.5 109.476 177.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 585' ' ' LYS . . . . . 0.418 ' HG3' ' OE2' ' A' ' 582' ' ' GLU 0.263 0.1 OUTLIER -89.87 162.02 15.67 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 118.065 -1.454 . . . . 74.22 109.676 172.994 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 5.2 t -151.36 142.98 23.66 Favored 'General case' 0 N--CA 1.415 -2.216 0 CA-C-O 121.174 0.512 . . . . 65.4 110.186 -176.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -126.09 147.01 49.69 Favored 'General case' 0 N--CA 1.421 -1.898 0 CA-C-N 114.104 -1.407 . . . . 74.34 108.412 176.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 588' ' ' PHE . . . . . 0.437 ' HA ' ' O ' ' A' ' 642' ' ' LEU . 10.5 m-85 -105.92 135.48 47.29 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 116.027 -0.533 . . . . 70.23 109.708 -172.451 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 589' ' ' LEU . . . . . 0.501 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.3 OUTLIER -104.27 124.99 50.15 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 106.096 -1.816 . . . . 63.41 106.096 175.786 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -131.38 135.72 47.45 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 109.526 -0.546 . . . . 70.14 109.526 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 591' ' ' ILE . . . . . . . . . . . . . 22.5 pt -99.36 134.71 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.734 0 N-CA-C 107.059 -1.46 . . . . 72.12 107.059 174.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -90.4 -150.66 24.53 Favored Glycine 0 C--N 1.297 -1.6 0 C-N-CA 120.786 -0.721 . . . . 74.02 112.965 -175.242 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -67.83 118.73 60.8 Favored Pre-proline 0 C--N 1.315 -0.935 0 C-N-CA 122.743 0.417 . . . . 74.23 110.292 179.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -70.51 143.21 46.59 Favored 'Trans proline' 0 N--CA 1.438 -1.772 0 C-N-CA 121.84 1.693 . . . . 71.23 109.78 175.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 595' ' ' ARG . . . . . 0.493 ' HG3' ' HB ' ' A' ' 536' ' ' ILE . 5.5 ptp180 -120.79 122.46 40.38 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 116.402 -0.363 . . . . 73.34 111.056 -174.578 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 596' ' ' LEU . . . . . 0.445 HD22 HG22 ' A' ' 535' ' ' VAL . 0.0 OUTLIER -79.18 122.48 26.32 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 107.735 -1.209 . . . . 55.32 107.735 179.904 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 17.1 t -93.28 -42.68 13.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-O 121.676 0.751 . . . . 73.32 110.111 -178.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -166.39 155.95 11.57 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.109 -0.95 . . . . 73.41 108.898 -174.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 22.4 ptt? -174.74 -36.98 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.675 0 O-C-N 123.851 0.72 . . . . 73.14 110.948 -173.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 25.5 m -142.33 84.39 1.86 Allowed 'General case' 0 N--CA 1.433 -1.284 0 CA-C-O 121.717 0.77 . . . . 60.13 111.261 -178.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -91.5 148.29 22.4 Favored 'General case' 0 C--N 1.283 -2.311 0 CA-C-N 114.698 -1.137 . . . . 73.45 107.96 179.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 95.4 mttt 79.35 -12.88 1.02 Allowed 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.95 1.3 . . . . 72.14 113.649 174.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.94 26.22 2.74 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-O 122.155 0.978 . . . . 74.12 110.347 176.455 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -96.98 -2.23 59.49 Favored Glycine 0 N--CA 1.439 -1.166 0 CA-C-N 114.757 -1.11 . . . . 73.3 110.986 177.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 94.35 178.13 38.62 Favored Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 111.728 -0.549 . . . . 54.42 111.728 178.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -89.75 -6.21 56.22 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.626 0.727 . . . . 65.2 110.368 179.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 8.9 p -76.56 129.08 35.93 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 108.841 -0.799 . . . . 73.35 108.841 174.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 18.7 mm -73.2 152.11 7.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 107.888 -1.153 . . . . 63.53 107.888 -175.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 18.7 m -59.17 124.94 21.65 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 106.628 -1.619 . . . . 62.21 106.628 175.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 610' ' ' GLU . . . . . 0.436 ' HG3' ' NH2' ' A' ' 633' ' ' ARG . 11.0 pt-20 -63.65 -7.19 6.71 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 113.814 1.042 . . . . 50.4 113.814 -175.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.3 110.33 15.63 Favored 'General case' 0 C--O 1.246 0.917 0 N-CA-C 109.065 -0.717 . . . . 74.23 109.065 169.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -114.81 69.65 0.72 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.577 -1.268 . . . . 73.34 107.577 178.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 33.6 t70 55.71 72.17 0.5 Allowed 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 114.788 -1.096 . . . . 74.15 108.617 -171.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -107.21 141.77 37.98 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 115.292 -0.867 . . . . 74.14 112.936 -174.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 615' ' ' LYS . . . . . 0.515 ' N ' ' HD3' ' A' ' 615' ' ' LYS . 0.0 OUTLIER -137.66 82.46 1.92 Allowed 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 113.876 -1.511 . . . . 73.13 107.385 179.758 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 616' ' ' GLN . . . . . 0.437 ' HB3' ' HD2' ' A' ' 617' ' ' PRO . 17.3 mm-40 -117.84 173.27 3.36 Favored Pre-proline 0 C--N 1.289 -2.039 0 CA-C-N 114.32 -1.309 . . . . 64.42 109.587 -173.113 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 617' ' ' PRO . . . . . 0.437 ' HD2' ' HB3' ' A' ' 616' ' ' GLN . 48.8 Cg_endo -71.36 171.13 16.75 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 121.639 1.559 . . . . 63.21 108.823 168.506 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.434 ' HG ' HD12 ' A' ' 636' ' ' LEU . 3.9 mm? -67.03 129.04 38.62 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.069 0.462 . . . . 62.55 110.813 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 9.0 t -65.46 -16.86 64.07 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 115.015 -0.993 . . . . 62.02 112.601 -175.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 620' ' ' SER . . . . . 0.415 ' HA ' ' CD ' ' A' ' 626' ' ' ARG . 6.1 p -77.61 76.89 4.13 Favored 'General case' 0 N--CA 1.423 -1.787 0 CA-C-O 121.617 0.722 . . . . 63.53 111.94 -178.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -129.24 -160.22 1.02 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.424 -0.807 . . . . 74.15 110.277 -178.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -58.54 -34.19 70.72 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 114.545 1.313 . . . . 64.54 114.545 -174.021 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -70.93 112.85 7.42 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 119.836 -0.745 . . . . 74.21 110.976 178.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 624' ' ' GLU . . . . . 0.439 ' CD ' ' H ' ' A' ' 624' ' ' GLU . 0.5 OUTLIER -65.68 -10.65 38.33 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 124.848 1.259 . . . . 74.0 114.108 -173.121 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -61.39 -18.31 58.2 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.608 0.718 . . . . 74.21 109.272 174.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 626' ' ' ARG . . . . . 0.415 ' CD ' ' HA ' ' A' ' 620' ' ' SER . 14.3 ptt180 -52.0 -30.95 27.38 Favored 'General case' 0 C--O 1.184 -2.358 0 CA-C-N 115.256 -0.884 . . . . 63.22 111.998 176.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 627' ' ' ARG . . . . . . . . . . . . . 58.6 mtp180 -58.9 -35.23 72.68 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.081 0.467 . . . . 75.15 110.407 178.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 95.1 mt -76.55 -43.08 35.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 108.586 -0.894 . . . . 72.32 108.586 176.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -59.5 -46.02 90.01 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.955 -1.02 . . . . 60.42 111.311 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -69.84 -9.4 54.63 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 124.632 1.173 . . . . 75.32 112.295 -177.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 631' ' ' MET . . . . . . . . . . . . . 49.3 ttp -82.99 -27.64 30.28 Favored 'General case' 0 N--CA 1.419 -2.005 0 CA-C-O 121.337 0.589 . . . . 73.13 109.441 179.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -101.85 -45.66 1.74 Allowed Glycine 0 N--CA 1.442 -0.93 0 CA-C-N 115.489 -0.778 . . . . 44.22 112.181 175.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 633' ' ' ARG . . . . . 0.436 ' NH2' ' HG3' ' A' ' 610' ' ' GLU . 55.4 mtt180 -87.38 153.56 53.57 Favored Pre-proline 0 C--N 1.311 -1.103 0 C-N-CA 123.984 0.914 . . . . 70.52 112.088 -174.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.406 ' HA ' ' HB1' ' A' ' 502' ' ' ALA . 67.1 Cg_endo -89.54 168.21 4.98 Favored 'Trans proline' 0 N--CA 1.441 -1.57 0 C-N-CA 122.661 2.24 . . . . 70.02 111.293 174.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.1 pp -144.06 178.54 1.72 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 113.416 0.895 . . . . 62.34 113.416 -175.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 636' ' ' LEU . . . . . 0.434 HD12 ' HG ' ' A' ' 618' ' ' LEU . 0.0 OUTLIER -82.67 148.16 28.1 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 108.775 -0.824 . . . . 45.22 108.775 178.916 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 637' ' ' GLY . . . . . 0.453 ' HA3' ' HB ' ' A' ' 506' ' ' THR . . . -90.77 -128.55 3.96 Favored Glycine 0 C--N 1.294 -1.79 0 C-N-CA 120.736 -0.745 . . . . 35.44 114.46 -176.32 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -72.1 -56.67 5.19 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.379 -0.41 . . . . 71.12 111.448 -175.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 20.3 p80 -145.38 109.69 4.93 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.833 0.825 . . . . 72.52 111.684 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 37.9 p -101.35 90.25 4.04 Favored 'General case' 0 N--CA 1.398 -3.034 0 N-CA-C 107.849 -1.167 . . . . 73.34 107.849 174.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -178.32 125.74 0.11 Allowed 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 105.01 -2.219 . . . . 64.2 105.01 -177.477 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 642' ' ' LEU . . . . . 0.566 ' CD2' HG21 ' A' ' 523' ' ' VAL . 38.0 tp -124.72 111.07 15.13 Favored 'General case' 0 C--N 1.28 -2.435 0 N-CA-C 108.17 -1.048 . . . . 74.14 108.17 174.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 643' ' ' GLU . . . . . 0.454 ' HB3' HG22 ' A' ' 511' ' ' VAL . 26.1 tt0 -93.62 101.44 13.6 Favored 'General case' 0 C--N 1.272 -2.767 0 N-CA-C 107.484 -1.302 . . . . 75.31 107.484 -179.385 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 644' ' ' VAL . . . . . 0.638 HG21 ' HE2' ' A' ' 521' ' ' MET . 39.4 t -93.04 108.52 20.49 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 108.906 -0.775 . . . . 75.41 108.906 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 4.2 mp -94.05 121.82 45.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 107.944 -1.132 . . . . 72.32 107.944 176.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 646' ' ' ILE . . . . . 0.514 HD12 ' N ' ' A' ' 646' ' ' ILE . 2.9 mp -100.19 134.09 40.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 107.091 -1.448 . . . . 75.11 107.091 -176.063 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -118.02 145.23 44.93 Favored 'General case' 0 N--CA 1.419 -2.023 0 C-N-CA 120.229 -0.589 . . . . 75.13 109.855 -178.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 648' ' ' GLU . . . . . 0.63 ' OE1' 'CA ' ' A' ' 800' ' ' ' CA' . 5.8 mm-40 -60.31 137.56 58.11 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 107.019 -1.474 . . . . 73.11 107.019 176.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 17.0 t -64.79 123.19 18.71 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-O 122.177 0.989 . . . . 74.03 112.881 -173.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 650' ' ' TYR . . . . . 0.478 ' O ' ' HG2' ' A' ' 651' ' ' GLU . 48.5 t80 -147.42 -75.35 0.19 Allowed 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 105.934 -1.876 . . . . 72.42 105.934 173.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 651' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 650' ' ' TYR . 12.4 mm-40 -176.59 176.08 1.62 Allowed 'General case' 0 CA--C 1.501 -0.917 0 C-N-CA 127.618 2.367 . . . . 70.41 105.878 -178.289 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -100.0 111.87 24.17 Favored 'General case' 0 C--N 1.296 -1.717 0 N-CA-C 108.807 -0.812 . . . . 62.12 108.807 -179.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -118.72 167.94 11.2 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-N 115.202 -0.908 . . . . 73.51 108.898 -176.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 22.2 t -156.65 -68.51 0.11 Allowed 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.831 -0.803 . . . . 71.33 108.831 177.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 22.1 m -115.28 101.71 9.2 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.314 -0.624 . . . . 74.52 109.314 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 92.5 t -80.97 117.49 27.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 109.687 -0.486 . . . . 75.41 109.687 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 23.2 t70 . . . . . 0 C--N 1.313 -0.982 0 CA-C-N 115.659 -0.7 . . . . 73.14 110.394 -177.831 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 800' ' ' ' CA' . . . . . 0.63 'CA ' ' OE1' ' A' ' 648' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 850' ' ' ' CA' . . . . . 0.625 'CA ' ' OD1' ' A' ' 578' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 . . . . . 0 N--CA 1.447 -0.618 0 CA-C-O 121.084 0.469 . . . . 73.34 110.644 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -123.56 -62.2 1.33 Allowed 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.014 -1.106 . . . . 74.5 108.014 172.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 503' ' ' GLY . . . . . 0.638 ' HA2' ' OG1' ' A' ' 528' ' ' THR . . . -140.34 120.52 1.79 Allowed Glycine 1 N--CA 1.395 -4.061 0 C-N-CA 119.985 -1.103 . . . . 73.03 110.952 179.476 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 2.7 mp -105.54 101.01 11.76 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 N-CA-C 106.763 -1.569 . . . . 72.41 106.763 176.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -114.71 122.87 47.74 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 109.457 -0.571 . . . . 72.23 109.457 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 11.2 t -148.64 163.99 35.62 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.483 -0.932 . . . . 71.13 108.483 -176.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -92.51 161.98 14.4 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 107.306 -1.368 . . . . 74.5 107.306 172.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -96.91 -26.3 15.11 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.322 -1.362 . . . . 71.1 107.322 173.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -97.32 120.57 60.72 Favored Pre-proline 0 N--CA 1.419 -1.989 0 CA-C-N 114.618 -1.174 . . . . 65.4 110.587 176.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -82.16 -19.09 7.02 Favored 'Trans proline' 0 N--CA 1.429 -2.28 0 N-CA-C 108.065 -1.552 . . . . 74.2 108.065 168.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 511' ' ' VAL . . . . . 0.426 HG22 ' HB3' ' A' ' 643' ' ' GLU . 93.7 t -147.89 139.69 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 C-N-CA 126.005 1.722 . . . . 71.24 107.897 -177.281 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 14.4 t -137.05 119.47 15.82 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 108.051 -1.092 . . . . 72.21 108.051 173.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -88.41 128.61 35.52 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 122.085 -0.384 . . . . 73.21 110.225 175.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 26.8 m -126.25 161.52 31.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-N 115.657 -0.701 . . . . 75.12 109.717 -178.446 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 56.9 m -88.21 167.8 13.28 Favored 'General case' 0 N--CA 1.403 -2.807 0 CA-C-N 115.079 -0.964 . . . . 73.51 109.99 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 516' ' ' GLU . . . . . 0.65 ' OE2' 'CA ' ' A' ' 800' ' ' ' CA' . 38.2 tt0 -94.32 -23.63 17.74 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.497 0.665 . . . . 72.33 110.608 176.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 14.2 m -85.31 20.77 1.89 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.932 0.873 . . . . 73.21 110.406 -176.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 15.3 tt -108.3 155.83 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.133 0 N-CA-C 107.554 -1.276 . . . . 74.52 107.554 -176.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -96.65 -59.85 1.0 Allowed Glycine 0 C--N 1.293 -1.848 0 C-N-CA 120.175 -1.012 . . . . 65.21 111.297 179.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 41.9 mm -121.48 136.22 59.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 109.402 -0.592 . . . . 75.52 109.402 -178.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 521' ' ' MET . . . . . 0.594 ' HE1' HG21 ' A' ' 644' ' ' VAL . 0.0 OUTLIER -115.35 132.68 56.54 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 106.368 -1.716 . . . . 72.12 106.368 171.764 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -109.17 149.29 29.58 Favored 'General case' 0 N--CA 1.428 -1.563 0 C-N-CA 120.509 -0.476 . . . . 65.32 109.852 -178.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 523' ' ' VAL . . . . . 0.631 ' O ' ' HA ' ' A' ' 570' ' ' THR . 40.0 t -126.12 121.05 58.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 109.722 -0.473 . . . . 63.32 109.722 178.729 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 524' ' ' LYS . . . . . 0.509 ' HD2' HG21 ' A' ' 568' ' ' VAL . 28.0 mmtp -82.09 118.9 23.39 Favored 'General case' 0 C--N 1.313 -1.021 0 O-C-N 124.095 0.872 . . . . 75.14 110.453 178.471 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 21.7 t -98.87 139.18 21.28 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 CA-C-N 114.563 -1.199 . . . . 63.21 108.982 -178.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -79.7 146.36 32.46 Favored 'General case' 0 C--N 1.31 -1.12 0 O-C-N 123.635 0.585 . . . . 74.33 109.566 -179.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 527' ' ' ARG . . . . . 0.406 ' HG2' ' N ' ' A' ' 528' ' ' THR . 31.8 ttp180 -87.64 160.16 18.26 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.384 -0.969 . . . . 71.45 108.384 -179.018 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 528' ' ' THR . . . . . 0.638 ' OG1' ' HA2' ' A' ' 503' ' ' GLY . 4.6 t -61.82 150.76 36.25 Favored 'General case' 0 N--CA 1.421 -1.916 0 CA-C-O 121.362 0.601 . . . . 62.02 110.71 174.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 42.2 t -69.99 -22.17 63.16 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 114.83 -1.077 . . . . 74.25 109.754 179.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -129.0 89.71 0.31 Allowed Glycine 0 N--CA 1.435 -1.377 0 N-CA-C 109.907 -1.277 . . . . 65.12 109.907 178.007 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -86.87 85.93 7.3 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 121.382 0.611 . . . . 64.34 111.291 -176.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 532' ' ' ARG . . . . . 0.419 ' HD3' ' HA ' ' A' ' 532' ' ' ARG . 37.5 mmt180 -123.54 101.78 7.51 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.634 -0.712 . . . . 75.15 110.772 177.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 533' ' ' GLY . . . . . 0.409 ' H ' ' HB3' ' A' ' 564' ' ' ASN . . . 119.07 -148.79 18.26 Favored Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 110.969 -0.852 . . . . 71.23 110.969 179.465 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -138.2 131.62 30.58 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 106.288 -1.745 . . . . 25.24 106.288 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 535' ' ' VAL . . . . . 0.448 HG22 HD22 ' A' ' 596' ' ' LEU . 67.7 t -127.44 137.6 57.25 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 118.189 0.45 . . . . 62.1 111.416 -174.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 536' ' ' ILE . . . . . 0.427 HG23 ' HB3' ' A' ' 559' ' ' GLU . 27.9 mm -102.91 126.04 57.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 108.889 -0.782 . . . . 75.15 108.889 174.423 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 31.7 t -117.1 106.83 46.68 Favored Pre-proline 0 C--N 1.298 -1.652 0 N-CA-C 108.543 -0.91 . . . . 75.15 108.543 178.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -75.61 137.81 20.86 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.102 1.868 . . . . 74.52 111.364 177.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -130.68 160.42 34.33 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.535 -0.543 . . . . 73.52 109.535 179.294 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.33 146.91 18.83 Favored 'General case' 0 C--N 1.314 -0.972 0 O-C-N 123.67 0.606 . . . . 73.33 110.679 175.622 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 7.9 p -86.77 122.33 30.52 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.053 -0.521 . . . . 53.4 110.38 176.315 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.4 mp -82.49 122.47 37.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 105.753 -1.943 . . . . 74.21 105.753 172.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -63.75 -48.69 75.98 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 123.464 0.478 . . . . 73.12 109.928 -178.213 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 67.24 -93.5 0.23 Allowed Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 115.858 -0.61 . . . . 73.44 112.215 177.446 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 15.1 t -113.74 -0.61 14.2 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.494 -0.558 . . . . 63.11 109.494 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -97.34 176.49 5.87 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-N 115.646 -0.706 . . . . 71.2 111.592 -177.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -127.31 111.97 14.52 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 109.25 -0.648 . . . . 71.41 109.25 -179.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -78.43 -160.9 17.29 Favored Glycine 0 C--N 1.315 -0.606 0 C-N-CA 121.57 -0.348 . . . . 64.21 112.602 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 67.37 17.68 68.71 Favored Glycine 0 C--N 1.314 -0.656 0 CA-C-O 120.908 0.171 . . . . 53.14 113.191 -177.123 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 77.42 11.58 85.36 Favored Glycine 0 C--O 1.211 -1.29 0 N-CA-C 111.041 -0.824 . . . . 73.1 111.041 -178.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -78.76 -42.44 28.02 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 122.469 0.308 . . . . 62.41 111.291 -175.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 552' ' ' ASP . . . . . 0.654 ' OD1' 'CA ' ' A' ' 850' ' ' ' CA' . 15.0 t70 -135.89 -20.67 1.49 Allowed 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 107.822 -1.177 . . . . 71.14 107.822 173.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -155.79 163.51 39.74 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 107.181 -1.414 . . . . 75.13 107.181 169.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 554' ' ' GLU . . . . . 0.421 ' HB3' ' HB3' ' A' ' 574' ' ' LYS . 0.7 OUTLIER -98.09 109.19 21.99 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 106.761 -1.57 . . . . 52.33 106.761 -178.855 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -77.54 147.25 35.86 Favored 'General case' 0 CA--C 1.499 -0.993 0 C-N-CA 120.761 -0.375 . . . . 75.35 110.439 -175.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 8.3 t -139.59 142.22 37.13 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-O 121.605 0.717 . . . . 33.01 111.778 -174.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 7.6 p -145.46 149.6 34.97 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.214 -1.402 . . . . 70.42 107.214 176.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 173.47 -167.21 39.8 Favored Glycine 0 N--CA 1.418 -2.543 0 N-CA-C 110.346 -1.101 . . . . 31.43 110.346 -178.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 559' ' ' GLU . . . . . 0.427 ' HB3' HG23 ' A' ' 536' ' ' ILE . 42.2 mt-10 -126.73 124.63 40.22 Favored 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 123.165 0.586 . . . . 75.34 110.169 -176.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 94.3 mt -95.97 142.05 28.66 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.746 -0.835 . . . . 62.22 108.746 177.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -115.83 115.9 27.06 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 120.912 0.387 . . . . 70.01 111.143 -176.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -102.05 140.93 35.68 Favored 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 108.982 -0.747 . . . . 74.53 108.982 176.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 563' ' ' GLN . . . . . 0.496 ' HB2' ' H ' ' A' ' 566' ' ' GLU . 29.7 mt-30 -119.7 -178.23 3.58 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 119.033 -1.067 . . . . 75.43 110.337 179.231 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 564' ' ' ASN . . . . . 0.409 ' HB3' ' H ' ' A' ' 533' ' ' GLY . 28.0 p-10 -74.43 -34.71 63.3 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.916 0.865 . . . . 64.12 109.001 176.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -94.0 -43.39 8.55 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.437 -1.256 . . . . 60.15 110.901 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 566' ' ' GLU . . . . . 0.496 ' H ' ' HB2' ' A' ' 563' ' ' GLN . 25.5 tt0 -70.99 123.29 21.72 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.064 0.459 . . . . 74.22 111.326 -179.086 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 8.7 pt -104.81 166.01 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.564 0 N-CA-C 108.797 -0.816 . . . . 72.02 108.797 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 568' ' ' VAL . . . . . 0.509 HG21 ' HD2' ' A' ' 524' ' ' LYS . 2.0 p 47.34 159.96 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.58 2.107 0 C-N-CA 127.027 2.131 . . . . 71.34 115.392 179.213 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 569' ' ' LYS . . . . . 0.508 ' HA ' ' HE2' ' A' ' 569' ' ' LYS . 4.3 mmpt? -142.67 166.05 25.73 Favored 'General case' 0 CA--C 1.493 -1.217 0 O-C-N 121.16 -0.962 . . . . 73.11 109.019 172.445 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 570' ' ' THR . . . . . 0.631 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 1.3 p -138.57 127.16 23.35 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 123.902 0.751 . . . . 74.32 112.897 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 571' ' ' ILE . . . . . 0.429 HG21 HD21 ' A' ' 589' ' ' LEU . 3.3 mp -96.07 122.06 47.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 106.477 -1.675 . . . . 73.42 106.477 170.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 49.2 m -107.36 125.08 50.75 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 108.84 -0.8 . . . . 61.44 108.84 177.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 573' ' ' VAL . . . . . . . . . . . . . 48.1 t -124.68 139.45 50.86 Favored 'Isoleucine or valine' 0 C--O 1.243 0.757 0 N-CA-C 108.458 -0.942 . . . . 63.42 108.458 -178.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 574' ' ' LYS . . . . . 0.421 ' HB3' ' HB3' ' A' ' 554' ' ' GLU . 87.0 tttt -95.7 129.99 42.74 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-O 121.77 0.795 . . . . 75.41 111.786 -178.352 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 59.2 t -94.13 138.72 19.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 107.044 -1.465 . . . . 65.33 107.044 176.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 45.8 mm -104.62 143.97 15.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 108.659 -0.867 . . . . 74.4 108.659 -176.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -59.18 129.76 43.7 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 108.535 -0.913 . . . . 74.31 108.535 174.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 578' ' ' ASP . . . . . 0.621 ' OD1' 'CA ' ' A' ' 850' ' ' ' CA' . 15.4 t0 -77.96 117.36 19.22 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 115.02 -0.991 . . . . 74.14 111.911 -167.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 579' ' ' GLU . . . . . 0.64 ' OE2' 'CA ' ' A' ' 850' ' ' ' CA' . 0.0 OUTLIER -77.08 -16.81 59.09 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 114.263 1.208 . . . . 73.04 114.263 -177.705 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 580' ' ' GLU . . . . . 0.64 ' OE1' 'CA ' ' A' ' 850' ' ' ' CA' . 0.0 OUTLIER -141.21 -176.71 4.81 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 106.553 -1.647 . . . . 61.05 106.553 173.257 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 581' ' ' TYR . . . . . 0.557 ' O ' ' HG2' ' A' ' 580' ' ' GLU . 12.4 p90 -87.19 152.21 22.52 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 106.825 -1.546 . . . . 72.23 106.825 174.242 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 582' ' ' GLU . . . . . 0.701 ' OE1' ' HB3' ' A' ' 585' ' ' LYS . 14.7 pt-20 -132.81 175.84 8.99 Favored 'General case' 0 C--N 1.276 -2.599 0 N-CA-C 108.826 -0.805 . . . . 72.01 108.826 -178.757 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 583' ' ' LYS . . . . . 0.446 ' O ' ' HG3' ' A' ' 582' ' ' GLU . 56.3 mtpt -100.05 -165.92 1.27 Allowed 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 105.551 -2.018 . . . . 72.54 105.551 169.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -74.73 89.16 2.27 Favored 'General case' 0 C--N 1.281 -2.391 0 C-N-CA 118.82 -1.152 . . . . 53.0 111.853 178.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 585' ' ' LYS . . . . . 0.701 ' HB3' ' OE1' ' A' ' 582' ' ' GLU . 0.0 OUTLIER -79.02 143.81 35.29 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 114.879 -1.055 . . . . 74.32 108.746 -178.964 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 5.9 t -145.14 141.57 28.88 Favored 'General case' 0 N--CA 1.407 -2.604 0 CA-C-O 121.169 0.509 . . . . 70.4 110.517 -176.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -122.16 144.63 48.83 Favored 'General case' 0 N--CA 1.412 -2.342 0 CA-C-N 113.928 -1.487 . . . . 70.32 108.468 175.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 588' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -104.66 128.16 52.62 Favored 'General case' 0 C--N 1.284 -2.239 0 N-CA-C 108.732 -0.84 . . . . 75.43 108.732 -173.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 589' ' ' LEU . . . . . 0.501 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.7 OUTLIER -98.45 126.08 43.86 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 106.642 -1.614 . . . . 72.03 106.642 177.381 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -128.43 132.75 48.45 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 109.993 -0.373 . . . . 75.4 109.993 179.123 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 591' ' ' ILE . . . . . . . . . . . . . 16.0 pt -97.32 128.71 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.652 0 N-CA-C 106.256 -1.757 . . . . 64.04 106.256 170.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -87.32 -139.81 6.18 Favored Glycine 0 N--CA 1.435 -1.401 0 CA-C-N 116.104 -0.498 . . . . 42.22 114.18 -172.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -79.9 112.36 29.19 Favored Pre-proline 0 C--N 1.311 -1.071 0 N-CA-C 109.301 -0.629 . . . . 71.53 109.301 -178.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -78.53 149.68 24.25 Favored 'Trans proline' 0 N--CA 1.434 -1.974 0 C-N-CA 122.094 1.863 . . . . 73.23 110.886 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 8.8 ptt-85 -129.23 132.82 47.31 Favored 'General case' 0 C--N 1.28 -2.421 0 CA-C-N 115.912 -0.586 . . . . 61.22 110.402 -175.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 596' ' ' LEU . . . . . 0.448 HD22 HG22 ' A' ' 535' ' ' VAL . 0.0 OUTLIER -77.06 125.77 29.87 Favored 'General case' 0 N--CA 1.415 -2.181 0 N-CA-C 105.501 -2.037 . . . . 64.15 105.501 178.703 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 96.6 t -71.03 -31.62 45.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 108.646 -0.872 . . . . 51.34 108.646 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 598' ' ' GLU . . . . . 0.402 ' H ' HD12 ' A' ' 596' ' ' LEU . 7.3 mm-40 -90.38 155.4 18.97 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 114.068 -1.424 . . . . 75.05 107.926 178.175 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 42.3 mtm -87.72 -20.87 25.63 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.719 -0.845 . . . . 73.43 108.719 178.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 10.2 m -50.36 118.09 2.8 Favored 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 125.289 1.436 . . . . 72.31 112.274 -176.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 601' ' ' GLU . . . . . 0.453 ' HB2' ' HA2' ' A' ' 632' ' ' GLY . 17.0 pt-20 -141.68 144.29 34.03 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 108.436 -0.95 . . . . 65.45 108.436 177.25 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 21.9 ttmm -88.4 89.59 8.05 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 105.63 -1.989 . . . . 72.54 105.63 173.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -54.44 158.05 2.58 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.179 -1.373 . . . . 63.54 114.324 -173.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -87.9 58.82 4.3 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.024 -0.989 . . . . 75.1 112.089 177.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 84.07 -71.92 2.9 Favored Glycine 0 C--O 1.244 0.764 0 N-CA-C 110.881 -0.888 . . . . 62.2 110.881 -179.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -155.21 132.52 11.03 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.312 -0.995 . . . . 74.2 108.312 178.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 10.2 p -107.82 123.28 48.33 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 109.051 -0.722 . . . . 71.22 109.051 175.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 56.4 mt -78.32 -28.19 14.7 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.891 0 CA-C-O 123.53 1.634 . . . . 74.31 108.166 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 8.1 m -96.11 91.73 6.08 Favored 'General case' 0 C--N 1.248 -3.806 0 CA-C-N 112.466 -2.152 . . . . 52.55 109.862 -178.123 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -84.23 -5.87 59.32 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 107.799 -1.185 . . . . 65.45 107.799 173.221 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -74.47 89.27 2.14 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 114.498 -1.228 . . . . 75.53 109.864 178.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -93.51 83.3 4.5 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 107.517 -1.29 . . . . 74.53 107.517 174.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -116.21 71.27 0.78 Allowed 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 106.642 -1.614 . . . . 73.31 106.642 -177.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -138.9 93.52 2.71 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 114.917 -1.038 . . . . 52.54 111.196 -176.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 2.4 mmmp? -121.31 82.66 1.96 Allowed 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 104.882 -2.266 . . . . 71.41 104.882 169.095 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -139.3 173.54 5.05 Favored Pre-proline 0 C--N 1.3 -1.57 0 CA-C-N 113.609 -1.632 . . . . 72.24 107.152 -171.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -66.42 171.34 10.68 Favored 'Trans proline' 0 N--CA 1.442 -1.503 0 N-CA-C 109.374 -1.049 . . . . 53.24 109.374 169.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -72.65 121.2 19.38 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 109.745 -0.465 . . . . 74.03 109.745 -176.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 9.8 t -155.44 141.12 17.99 Favored 'General case' 0 N--CA 1.425 -1.71 0 CA-C-O 121.502 0.668 . . . . 51.34 111.459 -176.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 3.1 p -146.64 113.31 6.02 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.538 -1.282 . . . . 72.0 107.538 176.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 621' ' ' LYS . . . . . 0.445 ' N ' ' HD2' ' A' ' 621' ' ' LYS . 0.1 OUTLIER -86.25 -71.26 0.55 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.398 0.618 . . . . 73.43 110.382 -173.273 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -92.55 -7.69 46.51 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.704 -1.221 . . . . 74.22 107.704 177.118 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . 0.296 10.7 pt-20 60.18 -39.71 0.09 Allowed 'General case' 0 C--O 1.186 -2.256 0 C-N-CA 129.314 3.046 . . . . 71.12 116.894 176.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -39.63 -68.76 0.15 Allowed 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 124.356 1.063 . . . . 74.14 113.819 -174.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -67.78 -37.18 81.7 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.466 -0.334 . . . . 72.13 110.505 -176.441 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 626' ' ' ARG . . . . . 0.66 ' O ' ' HG2' ' A' ' 630' ' ' GLU . 0.0 OUTLIER -63.4 -47.56 81.51 Favored 'General case' 0 C--O 1.202 -1.425 0 N-CA-C 109.434 -0.58 . . . . 71.13 109.434 -178.199 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 627' ' ' ARG . . . . . . . . . . . . . 51.0 ttp180 -60.71 -29.78 69.56 Favored 'General case' 0 N--CA 1.424 -1.748 0 C-N-CA 125.693 1.597 . . . . 63.55 111.991 -176.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 97.5 mt -65.67 -36.84 78.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-O 121.615 0.722 . . . . 63.54 109.578 175.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -78.07 -29.34 49.11 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.602 -0.727 . . . . 51.1 109.369 176.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 630' ' ' GLU . . . . . 0.66 ' HG2' ' O ' ' A' ' 626' ' ' ARG . 4.4 mm-40 -76.84 -3.04 36.4 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 123.975 0.91 . . . . 63.41 109.717 177.665 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 631' ' ' MET . . . . . . . . . . . . . 48.1 ttp -95.05 -15.89 23.11 Favored 'General case' 0 N--CA 1.402 -2.83 0 N-CA-C 108.031 -1.099 . . . . 61.41 108.031 175.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 632' ' ' GLY . . . . . 0.453 ' HA2' ' HB2' ' A' ' 601' ' ' GLU . . . -100.51 -39.08 3.3 Favored Glycine 0 N--CA 1.439 -1.119 0 N-CA-C 110.365 -1.094 . . . . 64.13 110.365 175.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 -92.82 144.02 27.88 Favored Pre-proline 0 C--O 1.203 -1.367 0 N-CA-C 108.502 -0.925 . . . . 72.03 108.502 173.326 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -76.18 153.51 36.36 Favored 'Trans proline' 0 N--CA 1.434 -1.98 0 C-N-CA 121.116 1.211 . . . . 64.22 110.21 176.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.0 pp -138.96 -175.25 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 112.765 0.654 . . . . 74.5 112.765 -175.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.71 146.09 32.58 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 115.425 -0.807 . . . . 74.31 109.327 178.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -83.97 -107.33 0.57 Allowed Glycine 0 C--N 1.291 -1.96 0 CA-C-N 116.105 -0.498 . . . . 63.4 112.474 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -94.66 -65.82 0.96 Allowed 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.238 0.542 . . . . 54.12 110.142 -177.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 17.0 p80 -130.54 114.08 15.04 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.628 0.728 . . . . 64.32 111.011 -177.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 13.7 p -104.78 89.76 3.27 Favored 'General case' 0 N--CA 1.397 -3.124 0 N-CA-C 107.473 -1.306 . . . . 75.12 107.473 173.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -176.46 123.62 0.17 Allowed 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 105.175 -2.158 . . . . 72.01 105.175 -174.383 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 642' ' ' LEU . . . . . 0.532 ' CD2' HG21 ' A' ' 523' ' ' VAL . 45.1 tp -125.55 106.84 10.06 Favored 'General case' 0 C--N 1.274 -2.681 0 N-CA-C 106.976 -1.49 . . . . 71.05 106.976 177.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 643' ' ' GLU . . . . . 0.426 ' HB3' HG22 ' A' ' 511' ' ' VAL . 26.9 tt0 -88.8 100.56 13.25 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 108.029 -1.1 . . . . 53.43 108.029 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 644' ' ' VAL . . . . . 0.594 HG21 ' HE1' ' A' ' 521' ' ' MET . 23.1 t -91.01 105.61 16.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 108.925 -0.769 . . . . 73.41 108.925 -179.357 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 4.4 mp -92.36 124.93 45.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 108.426 -0.953 . . . . 74.03 108.426 175.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 646' ' ' ILE . . . . . 0.567 HD12 ' N ' ' A' ' 646' ' ' ILE . 1.9 mp -106.55 108.02 24.13 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.473 0 N-CA-C 106.492 -1.669 . . . . 71.34 106.492 -178.176 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -104.15 143.7 32.58 Favored 'General case' 0 C--N 1.269 -2.905 0 CA-C-N 114.698 -1.137 . . . . 74.13 109.625 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -57.07 132.48 53.04 Favored 'General case' 0 C--O 1.249 1.068 0 N-CA-C 106.154 -1.795 . . . . 75.24 106.154 175.183 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 8.6 t -52.36 123.4 10.75 Favored 'General case' 0 C--O 1.245 0.826 0 O-C-N 124.18 0.925 . . . . 45.11 112.327 -169.11 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -135.63 -65.12 0.61 Allowed 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 113.281 -1.781 . . . . 74.33 107.161 -177.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -152.26 -166.6 2.53 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 124.832 1.253 . . . . 54.32 107.813 177.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -140.73 90.18 2.32 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-O 121.949 0.881 . . . . 72.24 109.625 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -126.25 121.16 31.88 Favored 'General case' 0 C--N 1.277 -2.548 0 CA-C-N 114.411 -1.268 . . . . 70.33 108.813 176.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 16.9 p -87.57 82.77 7.36 Favored 'General case' 0 N--CA 1.424 -1.738 0 C-N-CA 120.518 -0.473 . . . . 63.34 110.838 -178.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 9.2 t -70.06 128.41 36.2 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 108.358 -0.979 . . . . 63.24 108.358 177.054 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 46.4 t 67.1 82.16 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-O 122.448 1.118 . . . . 64.12 107.99 -171.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 . . . . . 0 C--N 1.293 -1.861 0 CA-C-N 113.858 -1.519 . . . . 51.42 110.221 -176.19 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 800' ' ' ' CA' . . . . . 0.65 'CA ' ' OE2' ' A' ' 516' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 850' ' ' ' CA' . . . . . 0.654 'CA ' ' OD1' ' A' ' 552' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 26.5 t-80 . . . . . 0 N--CA 1.449 -0.497 0 N-CA-C 105.908 -1.886 . . . . 63.34 105.908 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 502' ' ' ALA . . . . . 0.438 ' CB ' ' HA ' ' A' ' 634' ' ' PRO . . . -131.54 -149.9 0.4 Allowed 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 106.914 -1.513 . . . . 60.52 106.914 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 503' ' ' GLY . . . . . 0.704 ' HA3' ' OG1' ' A' ' 528' ' ' THR . . . 153.16 -136.33 5.27 Favored Glycine 1 N--CA 1.394 -4.11 0 C-N-CA 117.608 -2.234 . . . . 52.3 113.505 178.284 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 3.1 mp -119.18 126.81 75.68 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 CA-C-N 114.126 -1.037 . . . . 72.02 108.256 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -134.86 103.99 5.82 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 106.803 -1.555 . . . . 75.33 106.803 172.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 14.3 t -143.42 160.46 40.52 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 109.66 -0.496 . . . . 73.43 109.66 -173.216 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -81.58 153.13 26.88 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 107.171 -1.418 . . . . 74.25 107.171 173.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.02 -50.06 38.19 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.339 -0.985 . . . . 61.31 108.339 176.168 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -116.02 131.87 23.52 Favored Pre-proline 0 C--N 1.303 -1.431 0 CA-C-N 115.7 -0.682 . . . . 74.4 109.195 -178.338 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -83.81 -13.08 8.28 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.477 2.118 . . . . 63.43 112.127 178.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 511' ' ' VAL . . . . . 0.517 HG22 ' HB3' ' A' ' 643' ' ' GLU . 73.9 t -136.52 132.51 48.71 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.461 0 N-CA-C 107.873 -1.158 . . . . 54.43 107.873 178.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 3.8 t -138.61 140.95 39.15 Favored 'General case' 0 N--CA 1.396 -3.153 0 N-CA-C 107.666 -1.235 . . . . 63.12 107.666 177.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -109.17 137.79 46.52 Favored 'General case' 0 CA--C 1.479 -1.772 0 N-CA-C 107.474 -1.306 . . . . 73.11 107.474 176.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.649 HG11 ' SD ' ' A' ' 521' ' ' MET . 35.0 m -132.28 155.25 41.28 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.309 0 CA-C-O 121.518 0.675 . . . . 65.53 110.32 -176.1 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 515' ' ' SER . . . . . 0.425 ' HB2' ' HB ' ' A' ' 518' ' ' ILE . 19.3 m -68.61 141.27 55.47 Favored 'General case' 0 N--CA 1.393 -3.276 0 CA-C-N 113.665 -1.607 . . . . 74.23 107.877 176.689 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -73.79 -24.15 59.79 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 119.388 -0.925 . . . . 63.45 109.718 176.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 24.0 t -107.16 75.71 1.05 Allowed 'General case' 0 N--CA 1.415 -2.192 0 N-CA-C 107.876 -1.157 . . . . 73.2 107.876 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 518' ' ' ILE . . . . . 0.425 ' HB ' ' HB2' ' A' ' 515' ' ' SER . 17.1 tt -141.04 161.01 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.26 0 CA-C-N 113.766 -1.561 . . . . 62.14 106.813 176.59 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -96.15 -69.58 1.02 Allowed Glycine 0 N--CA 1.434 -1.46 0 C-N-CA 119.571 -1.3 . . . . 72.32 111.596 177.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 40.9 mm -116.24 134.57 59.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 109.361 -0.607 . . . . 74.21 109.361 -178.105 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 521' ' ' MET . . . . . 0.649 ' SD ' HG11 ' A' ' 514' ' ' VAL . 23.8 ptt? -114.29 138.74 50.12 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 106.934 -1.506 . . . . 73.43 106.934 171.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -117.07 132.66 56.63 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 108.837 -0.801 . . . . 64.5 108.837 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 523' ' ' VAL . . . . . 0.688 ' O ' ' HA ' ' A' ' 570' ' ' THR . 24.8 t -114.99 134.11 59.09 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 109.314 -0.625 . . . . 62.22 109.314 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 524' ' ' LYS . . . . . 0.43 ' HD2' HG21 ' A' ' 568' ' ' VAL . 33.0 mmtp -84.91 128.13 34.48 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 122.027 0.918 . . . . 75.03 113.1 -175.49 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 3.3 t -113.68 132.84 61.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 106.951 -1.5 . . . . 61.53 106.951 177.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -93.77 151.13 19.83 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 108.959 -0.756 . . . . 64.31 108.959 -177.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 527' ' ' ARG . . . . . 0.536 ' CZ ' HG22 ' A' ' 567' ' ' ILE . 68.9 mtm180 -87.02 179.31 6.71 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-O 122.018 0.913 . . . . 75.52 111.137 -179.068 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 528' ' ' THR . . . . . 0.704 ' OG1' ' HA3' ' A' ' 503' ' ' GLY . 1.0 OUTLIER -78.16 159.71 28.44 Favored 'General case' 0 N--CA 1.408 -2.553 0 CA-C-N 113.796 -1.547 . . . . 62.34 109.766 176.21 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 17.0 t -74.73 -20.04 59.99 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 107.903 -1.147 . . . . 73.15 107.903 177.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -118.14 66.3 0.36 Allowed Glycine 0 N--CA 1.438 -1.199 0 N-CA-C 111.07 -0.812 . . . . 72.13 111.07 175.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 531' ' ' ALA . . . . . 0.403 ' O ' ' HD3' ' A' ' 532' ' ' ARG . . . -76.26 96.13 3.88 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.357 0.599 . . . . 72.31 111.565 -178.2 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 532' ' ' ARG . . . . . 0.403 ' HD3' ' O ' ' A' ' 531' ' ' ALA . 60.5 mmt-85 -134.56 127.68 31.77 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.47 -0.786 . . . . 71.32 109.984 178.765 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 93.77 175.66 39.81 Favored Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 121.087 -0.578 . . . . 74.33 113.642 176.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -95.87 123.22 39.36 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 107.936 -1.135 . . . . 74.45 107.936 177.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 56.4 t -127.96 131.95 69.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.761 0 N-CA-C 108.71 -0.848 . . . . 74.21 108.71 -178.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 536' ' ' ILE . . . . . . . . . . . . . 38.6 mm -103.77 129.28 56.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 108.739 -0.837 . . . . 50.15 108.739 178.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 537' ' ' VAL . . . . . 0.502 HG22 ' HB3' ' A' ' 594' ' ' PRO . 14.7 t -117.99 111.79 38.72 Favored Pre-proline 0 C--N 1.301 -1.506 0 N-CA-C 109.575 -0.528 . . . . 44.03 109.575 -178.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -73.98 150.87 44.19 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 121.714 1.609 . . . . 73.02 110.244 176.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 539' ' ' TYR . . . . . 0.476 ' CD1' ' HG ' ' A' ' 560' ' ' LEU . 48.3 p90 -150.85 157.71 43.25 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 109.119 -0.697 . . . . 74.44 109.119 179.1 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 540' ' ' LYS . . . . . 0.416 ' O ' ' HD3' ' A' ' 540' ' ' LYS . 0.1 OUTLIER -157.11 145.65 19.65 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 113.3 0.852 . . . . 72.23 113.3 -179.842 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 541' ' ' THR . . . . . 0.44 HG23 ' HB ' ' A' ' 556' ' ' THR . 2.9 p -76.26 134.08 39.9 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.4 -0.818 . . . . 75.34 111.074 171.485 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.2 mp -99.22 126.65 52.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 105.391 -2.077 . . . . 74.42 105.391 172.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 543' ' ' GLU . . . . . 0.417 ' H ' ' CD ' ' A' ' 543' ' ' GLU . 1.4 mp0 -48.78 -44.82 39.23 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.288 1.035 . . . . 70.45 113.06 -174.572 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 71.89 -100.28 0.91 Allowed Glycine 0 N--CA 1.437 -1.243 0 N-CA-C 110.036 -1.226 . . . . 50.34 110.036 -178.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 9.0 t -134.12 10.71 3.87 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.926 0.869 . . . . 73.41 109.37 176.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -85.16 168.06 15.15 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.858 -0.61 . . . . 74.33 110.027 177.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -85.91 166.83 15.65 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 107.74 -1.207 . . . . 63.44 107.74 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -57.39 174.75 1.91 Allowed Glycine 0 C--O 1.253 1.306 0 N-CA-C 115.705 1.042 . . . . 64.44 115.705 -176.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . -57.59 117.15 9.28 Favored Glycine 0 N--CA 1.437 -1.255 0 CA-C-N 114.217 -0.992 . . . . 55.32 113.783 -176.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 104.53 -15.06 50.13 Favored Glycine 0 N--CA 1.428 -1.859 0 N-CA-C 111.719 -0.552 . . . . 41.12 111.719 177.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -91.58 -63.65 1.22 Allowed 'General case' 0 CA--C 1.499 -1.009 0 CA-C-O 121.084 0.468 . . . . 74.52 110.422 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 552' ' ' ASP . . . . . 0.645 ' OD2' 'CA ' ' A' ' 850' ' ' ' CA' . 5.0 t70 -107.39 -43.11 4.63 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.093 -0.958 . . . . 74.34 108.861 -176.286 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -133.79 155.83 49.1 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 107.313 -1.366 . . . . 75.52 107.313 175.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -85.17 128.98 34.88 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 105.532 -2.025 . . . . 71.14 105.532 177.395 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -54.78 108.47 0.4 Allowed 'General case' 0 CA--C 1.483 -1.627 0 O-C-N 123.474 0.484 . . . . 73.45 110.167 -177.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 556' ' ' THR . . . . . 0.44 ' HB ' HG23 ' A' ' 541' ' ' THR . 40.8 m -109.96 97.98 7.37 Favored 'General case' 1 N--CA 1.372 -4.326 0 C-N-CA 118.595 -1.242 . . . . 61.51 112.234 -175.453 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 24.2 p -137.1 134.25 36.26 Favored 'General case' 0 N--CA 1.418 -2.037 0 N-CA-C 107.399 -1.334 . . . . 70.13 107.399 174.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -176.83 -156.91 16.73 Favored Glycine 0 N--CA 1.418 -2.541 0 N-CA-C 110.08 -1.208 . . . . 72.53 110.08 -176.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -135.14 142.96 46.29 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.091 0.472 . . . . 75.31 110.978 -176.07 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 560' ' ' LEU . . . . . 0.516 HD13 ' HG2' ' A' ' 569' ' ' LYS . 93.6 mt -104.22 139.91 38.59 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.273 -0.876 . . . . 72.02 109.275 177.288 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -106.6 114.03 27.88 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 123.21 0.604 . . . . 71.43 110.784 -177.072 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 562' ' ' PHE . . . . . 0.554 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 36.3 m-85 -108.64 145.35 35.09 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 120.695 0.283 . . . . 75.23 110.386 173.333 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 563' ' ' GLN . . . . . 0.587 ' HB2' ' HB2' ' A' ' 566' ' ' GLU . 13.3 mm-40 -131.79 177.27 7.65 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 105.769 -1.938 . . . . 71.44 105.769 175.33 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -75.98 -30.46 58.58 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 121.111 0.481 . . . . 50.24 109.962 178.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -94.03 -22.84 18.28 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.259 0.552 . . . . 62.22 110.996 -179.29 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 566' ' ' GLU . . . . . 0.587 ' HB2' ' HB2' ' A' ' 563' ' ' GLN . 2.3 tm-20 -84.25 119.52 25.14 Favored 'General case' 0 C--O 1.245 0.84 0 N-CA-C 107.019 -1.475 . . . . 74.45 107.019 -177.665 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 567' ' ' ILE . . . . . 0.536 HG22 ' CZ ' ' A' ' 527' ' ' ARG . 6.2 pt -108.51 161.97 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.143 0 C-N-CA 120.65 -0.42 . . . . 74.44 111.047 -175.415 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 568' ' ' VAL . . . . . 0.445 HG22 ' H ' ' A' ' 569' ' ' LYS . 2.4 p 47.68 174.66 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.11 0 C-N-CA 126.421 1.889 . . . . 72.34 113.231 -179.161 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 569' ' ' LYS . . . . . 0.644 ' HE3' ' HA ' ' A' ' 569' ' ' LYS . 0.2 OUTLIER -156.25 156.98 35.02 Favored 'General case' 0 C--N 1.289 -2.045 0 O-C-N 120.797 -1.189 . . . . 64.43 107.986 176.057 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 570' ' ' THR . . . . . 0.688 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 4.4 p -134.3 131.74 38.76 Favored 'General case' 0 N--CA 1.412 -2.361 0 O-C-N 123.999 0.812 . . . . 63.02 110.765 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 2.8 mp -91.3 113.39 26.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 106.728 -1.582 . . . . 72.2 106.728 170.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 2.6 p -93.85 120.17 33.75 Favored 'General case' 0 C--N 1.29 -2.021 0 O-C-N 123.677 0.61 . . . . 52.24 109.859 177.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 573' ' ' VAL . . . . . . . . . . . . . 49.1 t -123.38 135.77 62.18 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 108.549 -0.908 . . . . 55.44 108.549 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -93.45 124.05 37.17 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-O 121.403 0.621 . . . . 71.51 109.836 175.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 61.5 t -89.51 141.76 13.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 N-CA-C 106.755 -1.572 . . . . 54.51 106.755 176.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 32.9 mm -105.78 158.21 6.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 107.672 -1.232 . . . . 63.12 107.672 -178.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -67.22 137.46 56.21 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.228 -1.027 . . . . 74.21 108.228 177.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 578' ' ' ASP . . . . . 0.61 ' OD1' 'CA ' ' A' ' 850' ' ' ' CA' . 0.5 OUTLIER -69.85 158.97 34.51 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 112.295 0.48 . . . . 63.13 112.295 -172.857 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 579' ' ' GLU . . . . . 0.638 ' OE1' 'CA ' ' A' ' 850' ' ' ' CA' . 0.0 OUTLIER -138.21 -12.73 1.4 Allowed 'General case' 0 CA--C 1.558 1.263 0 N-CA-C 116.141 1.904 . . . . 72.34 116.141 -172.479 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 580' ' ' GLU . . . . . 0.491 ' HG2' ' O ' ' A' ' 581' ' ' TYR . 0.1 OUTLIER -127.02 -171.02 2.32 Favored 'General case' 0 C--N 1.317 -0.838 0 O-C-N 121.164 -0.96 . . . . 73.12 110.138 -177.167 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 581' ' ' TYR . . . . . 0.491 ' O ' ' HG2' ' A' ' 580' ' ' GLU . 46.2 p90 -63.74 152.51 39.09 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 107.931 -1.136 . . . . 73.54 107.931 174.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -120.89 132.95 55.26 Favored 'General case' 0 C--N 1.288 -2.099 0 C-N-CA 118.824 -1.15 . . . . 72.44 114.076 -174.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -129.38 -165.95 1.59 Allowed 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 105.562 -2.014 . . . . 73.33 105.562 176.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -65.52 105.06 1.11 Allowed 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 106.855 -1.535 . . . . 75.34 106.855 172.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 585' ' ' LYS . . . . . 0.481 ' HD2' HD13 ' A' ' 646' ' ' ILE . 4.2 tmmm? -115.38 117.66 31.06 Favored 'General case' 0 N--CA 1.403 -2.79 0 N-CA-C 107.709 -1.219 . . . . 75.31 107.709 -175.55 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 3.4 t -142.39 147.2 35.83 Favored 'General case' 0 N--CA 1.404 -2.74 0 CA-C-N 114.688 -1.142 . . . . 63.05 110.029 -176.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -129.25 148.56 51.19 Favored 'General case' 0 N--CA 1.405 -2.687 0 CA-C-N 113.857 -1.52 . . . . 51.35 108.232 176.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 588' ' ' PHE . . . . . 0.512 ' HA ' ' O ' ' A' ' 642' ' ' LEU . 23.0 m-85 -104.8 141.54 36.31 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 109.356 -0.609 . . . . 73.31 109.356 -173.222 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 589' ' ' LEU . . . . . 0.527 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.5 OUTLIER -110.26 126.07 53.78 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 105.813 -1.921 . . . . 54.35 105.813 174.285 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -134.26 123.09 23.68 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 109.455 -0.572 . . . . 74.41 109.455 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 591' ' ' ILE . . . . . 0.431 HG22 ' HB3' ' A' ' 539' ' ' TYR . 20.9 pt -79.14 149.49 5.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 N-CA-C 108.0 -1.111 . . . . 71.54 108.0 173.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -93.23 -142.76 12.05 Favored Glycine 0 N--CA 1.425 -2.086 0 C-N-CA 121.008 -0.615 . . . . 53.33 112.693 -176.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -93.41 117.88 67.48 Favored Pre-proline 0 C--N 1.3 -1.584 0 N-CA-C 108.636 -0.876 . . . . 70.51 108.636 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 594' ' ' PRO . . . . . 0.603 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 30.2 Cg_endo -65.69 143.75 75.57 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 121.969 1.78 . . . . 53.54 110.714 177.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -123.83 135.86 54.02 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.888 -0.508 . . . . 52.21 110.483 -176.138 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.58 124.81 28.86 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 107.892 -1.151 . . . . 70.5 107.892 -178.252 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 65.9 t -75.5 -39.59 40.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 112.574 0.583 . . . . 64.33 112.574 -176.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -76.27 158.21 31.8 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 112.541 0.571 . . . . 74.12 112.541 -178.268 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 27.4 ptt? -89.73 23.34 2.72 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 123.831 0.852 . . . . 74.3 111.857 -172.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 32.0 t -74.35 99.11 3.41 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.117 0.484 . . . . 64.33 110.8 -178.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -91.6 131.86 36.72 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 108.789 -0.819 . . . . 75.4 108.789 177.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 602' ' ' LYS . . . . . 0.433 ' HD2' ' N ' ' A' ' 602' ' ' LYS . 3.6 mptp? -94.08 139.46 30.95 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 108.151 -1.055 . . . . 75.43 108.151 177.69 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 603' ' ' LYS . . . . . 0.42 ' HD3' ' H ' ' A' ' 603' ' ' LYS . 0.3 OUTLIER -135.28 177.08 8.09 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 121.482 0.658 . . . . 72.21 112.386 -173.064 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -116.72 -166.0 14.15 Favored Glycine 0 N--CA 1.428 -1.843 0 N-CA-C 108.696 -1.762 . . . . 75.11 108.696 174.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . -101.9 -63.74 0.75 Allowed Glycine 0 C--N 1.293 -1.81 0 C-N-CA 120.274 -0.965 . . . . 74.5 111.177 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -93.33 -3.71 52.95 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.413 0.625 . . . . 75.34 110.38 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 3.7 p -104.82 171.62 7.23 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 115.859 -0.609 . . . . 54.23 112.132 -177.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 12.6 pt -139.92 160.01 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.594 0 CA-C-N 114.745 -1.116 . . . . 63.11 109.441 177.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 609' ' ' THR . . . . . 0.57 HG22 ' HB2' ' A' ' 611' ' ' GLU . 4.4 m -94.19 117.15 29.69 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.986 -1.116 . . . . 74.4 107.986 177.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -81.43 14.75 2.33 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 121.708 0.766 . . . . 74.53 111.479 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 611' ' ' GLU . . . . . 0.57 ' HB2' HG22 ' A' ' 609' ' ' THR . 2.3 tm-20 -88.88 174.93 7.67 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.601 -0.889 . . . . 73.31 108.601 178.133 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -125.22 10.62 8.08 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.513 -1.291 . . . . 75.12 107.513 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 11.0 t70 53.39 31.64 12.37 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 112.883 -1.962 . . . . 75.45 108.16 -172.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -76.86 135.55 38.86 Favored 'General case' 0 CA--C 1.488 -1.404 0 CA-C-N 114.05 -1.432 . . . . 70.51 110.511 -173.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -77.4 101.09 6.21 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-O 122.273 1.035 . . . . 72.31 108.959 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -98.04 174.45 3.17 Favored Pre-proline 0 C--N 1.286 -2.162 0 CA-C-N 113.527 -1.669 . . . . 74.23 110.705 -172.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -86.23 161.15 9.91 Favored 'Trans proline' 0 N--CA 1.438 -1.768 0 N-CA-C 108.267 -1.474 . . . . 64.33 108.267 162.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.29 110.01 1.76 Allowed 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 120.6 -0.44 . . . . 75.31 110.691 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 9.3 t -136.15 139.6 43.02 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 116.134 -0.484 . . . . 61.31 109.829 -179.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 620' ' ' SER . . . . . 0.433 ' HA ' ' HD3' ' A' ' 626' ' ' ARG . 13.3 p -134.69 124.37 25.18 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.581 0.705 . . . . 54.12 111.785 -178.244 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 54.5 mttm -90.37 0.14 57.4 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.249 -0.887 . . . . 74.21 109.536 178.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 73.93 -46.77 0.63 Allowed 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 125.918 1.687 . . . . 63.14 110.986 -174.005 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -51.43 149.28 4.32 Favored 'General case' 0 C--O 1.251 1.159 0 C-N-CA 124.159 0.983 . . . . 71.43 110.628 177.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 624' ' ' GLU . . . . . 0.418 ' O ' HG13 ' A' ' 628' ' ' ILE . 16.3 pt-20 -62.66 -15.19 51.01 Favored 'General case' 0 C--O 1.211 -0.932 0 N-CA-C 113.672 0.99 . . . . 72.33 113.672 -174.652 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -61.53 -34.35 75.4 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 118.118 0.417 . . . . 75.33 110.485 174.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 626' ' ' ARG . . . . . 0.535 ' O ' ' HG2' ' A' ' 630' ' ' GLU . 0.2 OUTLIER -64.22 -38.36 90.77 Favored 'General case' 0 C--O 1.193 -1.883 0 N-CA-C 108.626 -0.879 . . . . 62.1 108.626 173.838 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 627' ' ' ARG . . . . . . . . . . . . . 62.6 mtt-85 -74.89 -29.68 61.07 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 116.052 -0.522 . . . . 72.32 110.182 -176.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 628' ' ' ILE . . . . . 0.588 ' O ' ' HG2' ' A' ' 631' ' ' MET . 97.8 mt -68.52 -44.99 82.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.257 -0.646 . . . . 64.33 109.257 173.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -63.64 -45.41 90.36 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.94 -0.573 . . . . 72.23 110.561 179.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 630' ' ' GLU . . . . . 0.535 ' HG2' ' O ' ' A' ' 626' ' ' ARG . 8.7 mm-40 -79.59 2.3 22.86 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 113.476 0.917 . . . . 63.53 113.476 -174.433 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 631' ' ' MET . . . . . 0.588 ' HG2' ' O ' ' A' ' 628' ' ' ILE . 27.6 ptt? -93.39 -12.94 28.71 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 118.686 -1.206 . . . . 73.12 107.951 172.289 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -85.3 -23.56 47.48 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 110.167 -1.173 . . . . 74.13 110.167 176.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.91 151.84 37.71 Favored Pre-proline 0 CA--C 1.5 -0.977 0 N-CA-C 106.739 -1.578 . . . . 70.33 106.739 174.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.603 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 10.9 Cg_endo -76.7 135.66 16.28 Favored 'Trans proline' 0 N--CA 1.419 -2.866 0 N-CA-C 106.936 -1.986 . . . . 75.12 106.936 164.057 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . 0.255 2.3 pp -118.71 170.12 8.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 114.001 1.112 . . . . 65.15 114.001 -178.236 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.07 164.98 25.94 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 114.898 -1.046 . . . . 53.43 112.051 -176.433 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -85.34 -114.68 0.77 Allowed Glycine 0 N--CA 1.441 -1.001 0 CA-C-N 115.284 -0.871 . . . . 72.42 112.942 -177.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -98.37 -68.72 0.79 Allowed 'General case' 0 N--CA 1.42 -1.928 0 C-N-CA 120.576 -0.45 . . . . 75.43 110.611 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 18.7 p80 -113.33 109.2 18.34 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 113.655 0.983 . . . . 73.32 113.655 -173.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 12.5 p -98.8 90.47 4.69 Favored 'General case' 0 N--CA 1.408 -2.54 0 N-CA-C 107.167 -1.42 . . . . 72.43 107.167 172.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -173.26 138.6 0.73 Allowed 'General case' 0 N--CA 1.424 -1.73 0 CA-C-N 114.393 -1.276 . . . . 73.44 107.685 -173.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 642' ' ' LEU . . . . . 0.549 ' CD2' HG21 ' A' ' 523' ' ' VAL . 42.1 tp -145.12 105.26 4.05 Favored 'General case' 0 C--N 1.274 -2.708 0 N-CA-C 107.494 -1.299 . . . . 61.13 107.494 173.516 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 643' ' ' GLU . . . . . 0.517 ' HB3' HG22 ' A' ' 511' ' ' VAL . 28.5 tt0 -92.87 100.5 12.95 Favored 'General case' 0 C--N 1.261 -3.248 0 N-CA-C 107.03 -1.47 . . . . 72.32 107.03 179.577 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 644' ' ' VAL . . . . . 0.531 HG21 ' HE1' ' A' ' 521' ' ' MET . 26.3 t -92.73 108.65 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.287 0 CA-C-N 115.792 -0.64 . . . . 60.12 109.396 -177.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 4.0 mp -94.05 118.42 39.94 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 N-CA-C 107.916 -1.142 . . . . 72.34 107.916 177.252 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 646' ' ' ILE . . . . . 0.488 HD12 ' N ' ' A' ' 646' ' ' ILE . 2.5 mp -104.46 112.17 36.97 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.451 0 N-CA-C 107.098 -1.445 . . . . 54.52 107.098 -175.177 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 647' ' ' GLU . . . . . 0.599 ' OE1' ' HG3' ' A' ' 653' ' ' LYS . 6.7 pt-20 -115.45 149.35 38.18 Favored 'General case' 0 C--N 1.27 -2.863 0 C-N-CA 120.191 -0.604 . . . . 74.03 112.519 -177.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 648' ' ' GLU . . . . . 0.622 ' OE1' 'CA ' ' A' ' 800' ' ' ' CA' . 23.1 tp10 -54.69 135.51 46.88 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.188 -1.369 . . . . 72.12 109.917 -177.46 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 22.9 t -51.4 119.67 4.33 Favored 'General case' 0 C--O 1.237 0.403 0 O-C-N 124.209 0.943 . . . . 71.01 110.768 -176.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -152.05 -62.06 0.17 Allowed 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.704 -1.134 . . . . 62.32 109.058 -174.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -151.25 -175.49 5.19 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 106.317 -1.734 . . . . 60.43 106.317 177.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -98.87 121.29 40.63 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 108.626 -0.879 . . . . 73.14 108.626 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 653' ' ' LYS . . . . . 0.599 ' HG3' ' OE1' ' A' ' 647' ' ' GLU . 9.2 mmmm -111.1 136.72 49.72 Favored 'General case' 0 C--N 1.281 -2.394 0 CA-C-N 115.229 -0.896 . . . . 52.13 109.829 -177.672 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 33.3 p -153.18 128.2 9.66 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 109.305 -0.628 . . . . 72.41 109.305 177.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 98.9 m -94.11 104.51 16.53 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.458 -0.571 . . . . 62.45 109.458 178.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 27.9 m -81.58 161.34 3.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 116.079 -0.509 . . . . 62.32 110.758 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 27.0 t70 . . . . . 0 C--N 1.305 -1.334 0 CA-C-N 116.127 -0.488 . . . . 75.15 110.757 -176.405 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 800' ' ' ' CA' . . . . . 0.622 'CA ' ' OE1' ' A' ' 648' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 850' ' ' ' CA' . . . . . 0.645 'CA ' ' OD2' ' A' ' 552' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . 0.607 ' HA2' ' OG1' ' A' ' 528' ' ' THR . . . . . . . . 0 N--CA 1.401 -3.667 0 N-CA-C 110.804 -0.919 . . . . 62.25 110.804 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . 0.412 ' H ' ' HA ' ' A' ' 528' ' ' THR . 3.7 mp -125.98 102.65 10.39 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 106.363 -1.718 . . . . 72.510000000000005 106.363 177.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -123.4 106.1 10.37 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 108.071 -1.085 . . . . 72.030000000000001 108.071 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 13.6 t -139.67 159.63 41.73 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 108.188 -1.041 . . . . 75.329999999999998 108.188 -176.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -84.64 153.6 23.05 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.429 -0.952 . . . . 63.229999999999997 108.429 175.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -77.53 -32.27 53.9 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.353 -0.98 . . . . 74.540000000000006 108.353 176.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -133.4 134.76 24.24 Favored Pre-proline 0 C--N 1.314 -0.942 0 N-CA-C 108.873 -0.788 . . . . 70.530000000000001 108.873 178.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -81.86 -16.54 8.81 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.401 2.067 . . . . 71.450000000000003 111.938 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . 0.461 HG22 ' HB3' ' A' ' 643' ' ' GLU . 69.7 t -136.61 131.96 48.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 107.824 -1.176 . . . . 64.329999999999998 107.824 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 6.3 t -133.93 139.61 46.24 Favored 'General case' 0 N--CA 1.406 -2.633 0 N-CA-C 108.501 -0.926 . . . . 75.230000000000004 108.501 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -109.46 124.43 51.04 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 109.737 -0.468 . . . . 75.209999999999994 109.737 178.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 15.5 m -127.13 157.55 38.58 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 107.905 -1.146 . . . . 62.039999999999999 107.905 -178.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 35.5 t -82.13 156.4 24.52 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 109.541 -0.54 . . . . 74.349999999999994 109.541 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -83.4 -7.94 59.48 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.26 -1.015 . . . . 63.130000000000003 108.26 174.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 14.0 t -98.78 15.71 24.52 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 115.688 -0.687 . . . . 63.229999999999997 109.298 -177.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 12.7 tt -99.62 161.47 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 N-CA-C 108.915 -0.772 . . . . 74.120000000000005 108.915 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . -94.9 -70.69 1.09 Allowed Glycine 0 N--CA 1.43 -1.753 0 N-CA-C 110.554 -1.018 . . . . 71.099999999999994 110.554 176.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 36.7 mm -114.73 126.24 72.24 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 C-N-CA 123.006 0.522 . . . . 74.510000000000005 109.668 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 521' ' ' MET . . . . . 0.701 ' HE2' HG21 ' A' ' 644' ' ' VAL . 0.0 OUTLIER -104.55 140.06 38.54 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.768 -1.197 . . . . 75.409999999999997 107.768 173.431 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -124.73 137.6 54.33 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 123.777 0.673 . . . . 73.400000000000006 111.021 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . 0.72 HG21 HD21 ' A' ' 642' ' ' LEU . 45.7 t -122.99 137.45 56.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 109.048 -0.723 . . . . 44.350000000000001 109.048 -179.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -80.92 131.72 35.37 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.66 0.743 . . . . 74.439999999999998 112.927 -177.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 6.7 t -114.76 134.39 57.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 CA-C-N 114.327 -1.306 . . . . 71.450000000000003 107.873 177.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -86.94 139.49 30.56 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.238 -1.023 . . . . 73.120000000000005 108.238 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . 0.417 ' CZ ' HG22 ' A' ' 567' ' ' ILE . 31.7 ttp180 -93.95 158.59 15.56 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 116.202 -0.454 . . . . 73.319999999999993 110.514 -173.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . 0.607 ' OG1' ' HA2' ' A' ' 503' ' ' GLY . 5.1 t -56.38 145.82 26.12 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.746 -0.661 . . . . 71.319999999999993 111.448 176.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 23.8 t -81.61 -12.74 58.62 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 108.79 -0.818 . . . . 75.239999999999995 108.79 178.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -109.02 52.94 0.61 Allowed Glycine 0 N--CA 1.429 -1.767 0 N-CA-C 109.592 -1.403 . . . . 72.420000000000002 109.592 177.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -82.83 95.49 7.94 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-O 121.591 0.71 . . . . 74.420000000000002 109.129 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -133.78 25.02 4.01 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 114.854 -1.066 . . . . 73.430000000000007 111.665 -178.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 175.76 -169.5 42.21 Favored Glycine 0 N--CA 1.416 -2.644 0 C-N-CA 120.097 -1.049 . . . . 41.32 111.141 -174.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 534' ' ' ASN . . . . . 0.485 HD21 ' HG3' ' A' ' 561' ' ' GLU . 2.7 t-20 -102.23 121.85 43.06 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 122.887 0.475 . . . . 61.200000000000003 110.822 -176.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 535' ' ' VAL . . . . . 0.437 HG22 HD22 ' A' ' 596' ' ' LEU . 79.6 t -125.53 135.73 63.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 123.403 0.681 . . . . 63.310000000000002 109.651 -178.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 536' ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' A' ' 594' ' ' PRO . 22.8 mm -101.18 129.17 52.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 115.881 -0.6 . . . . 70.019999999999996 109.874 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . 0.473 HG22 ' HB3' ' A' ' 594' ' ' PRO . 33.2 t -122.15 105.57 36.95 Favored Pre-proline 0 C--N 1.319 -0.751 0 N-CA-C 108.715 -0.846 . . . . 64.510000000000005 108.715 176.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . 0.409 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 55.8 Cg_endo -73.01 152.05 50.93 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.068 1.845 . . . . 62.219999999999999 110.828 177.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 539' ' ' TYR . . . . . 0.455 ' O ' ' HA ' ' A' ' 557' ' ' CYS . 50.9 p90 -147.38 157.88 43.75 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.409 -0.589 . . . . 65.040000000000006 109.409 178.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -149.52 155.43 40.33 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 120.979 0.419 . . . . 62.219999999999999 111.17 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 10.4 p -96.4 113.39 24.97 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.062 -0.972 . . . . 63.240000000000002 110.871 176.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.403 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 3.6 mp -83.0 115.62 25.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 105.517 -2.031 . . . . 72.310000000000002 105.517 173.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . 0.453 ' HB3' ' O ' ' A' ' 546' ' ' ALA . 47.8 mt-10 -53.5 -49.84 66.66 Favored 'General case' 0 C--N 1.32 -0.686 0 O-C-N 124.156 0.91 . . . . 75.540000000000006 112.667 -174.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 70.26 -101.67 0.92 Allowed Glycine 0 N--CA 1.44 -1.098 0 C-N-CA 120.522 -0.847 . . . . 70.519999999999996 111.259 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 545' ' ' THR . . . . . 0.422 HG23 ' HB2' ' A' ' 585' ' ' LYS . 8.8 t -113.62 0.23 14.55 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.869 0.842 . . . . 62.210000000000001 109.295 178.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . 0.503 ' HB2' ' HG2' ' A' ' 585' ' ' LYS . . . -95.33 170.98 9.0 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 108.132 -1.062 . . . . 73.239999999999995 108.132 175.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . 0.483 ' H ' ' HB3' ' A' ' 552' ' ' ASP . 9.6 tpt180 -130.46 122.72 28.23 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 118.012 0.369 . . . . 64.099999999999994 110.189 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 548' ' ' GLY . . . . . 0.419 ' HA3' ' HB3' ' A' ' 555' ' ' ASP . . . -82.48 -166.4 38.46 Favored Glycine 0 C--N 1.306 -1.135 0 CA-C-N 116.01 -0.541 . . . . 61.439999999999998 111.868 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 78.83 13.93 82.58 Favored Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 120.948 -0.644 . . . . 62.130000000000003 112.587 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 84.37 13.92 72.45 Favored Glycine 0 N--CA 1.435 -1.373 0 C-N-CA 120.212 -0.994 . . . . 63.229999999999997 111.891 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -79.81 -69.92 0.55 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.4 0.619 . . . . 73.519999999999996 109.982 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . 0.483 ' HB3' ' H ' ' A' ' 547' ' ' ARG . 8.4 t70 -109.41 -35.05 6.36 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 107.692 -1.225 . . . . 70.439999999999998 107.692 -176.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 553' ' ' PHE . . . . . 0.439 ' HA ' HG12 ' A' ' 576' ' ' ILE . 14.7 p90 -145.54 164.06 32.81 Favored 'General case' 0 N--CA 1.423 -1.817 0 CA-C-N 115.096 -0.956 . . . . 75.030000000000001 108.544 173.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . 0.463 ' HB3' ' HB3' ' A' ' 574' ' ' LYS . 1.0 OUTLIER -95.45 106.82 18.93 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 105.477 -2.046 . . . . 63.43 105.477 179.082 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 555' ' ' ASP . . . . . 0.419 ' HB3' ' HA3' ' A' ' 548' ' ' GLY . 3.4 p-10 -72.62 149.53 43.83 Favored 'General case' 0 CA--C 1.49 -1.333 0 CA-C-N 116.093 -0.503 . . . . 71.150000000000006 110.095 -174.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 5.6 t -139.57 131.6 27.9 Favored 'General case' 0 N--CA 1.403 -2.779 0 CA-C-O 121.669 0.747 . . . . 63.43 111.274 -177.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 557' ' ' CYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 539' ' ' TYR . 12.5 p -142.38 104.91 4.49 Favored 'General case' 0 N--CA 1.418 -2.037 0 N-CA-C 107.541 -1.281 . . . . 72.420000000000002 107.541 175.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -151.11 -149.33 5.02 Favored Glycine 0 N--CA 1.408 -3.171 0 N-CA-C 109.867 -1.293 . . . . 73.219999999999999 109.867 -176.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 559' ' ' GLU . . . . . 0.442 ' HB3' HG23 ' A' ' 536' ' ' ILE . 52.2 mt-10 -136.94 133.44 35.66 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 120.858 0.361 . . . . 73.510000000000005 110.715 -173.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . 0.455 HD22 ' CG ' ' A' ' 569' ' ' LYS . 92.1 mt -93.45 123.16 36.56 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.979 -1.119 . . . . 74.400000000000006 107.979 173.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 561' ' ' GLU . . . . . 0.485 ' HG3' HD21 ' A' ' 534' ' ' ASN . 43.1 tt0 -97.89 113.53 25.38 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 116.097 -0.501 . . . . 51.409999999999997 110.136 -177.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -103.99 144.36 31.64 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 109.639 -0.504 . . . . 61.43 109.639 176.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . 0.499 ' HB2' ' H ' ' A' ' 566' ' ' GLU . 42.7 mt-30 -136.56 179.85 6.11 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.059 -1.089 . . . . 74.329999999999998 108.059 -178.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 31.6 t30 -73.73 -34.77 64.93 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.669 -0.863 . . . . 64.010000000000005 108.669 176.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -87.64 -36.34 17.52 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 114.969 -1.014 . . . . 71.219999999999999 111.397 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 566' ' ' GLU . . . . . 0.499 ' H ' ' HB2' ' A' ' 563' ' ' GLN . 10.5 tp10 -77.33 117.08 18.48 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.77 -0.826 . . . . 74.219999999999999 108.77 178.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 567' ' ' ILE . . . . . 0.417 HG22 ' CZ ' ' A' ' 527' ' ' ARG . 6.5 pt -109.2 163.39 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.143 0 N-CA-C 109.317 -0.623 . . . . 63.219999999999999 109.317 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 568' ' ' VAL . . . . . 0.488 HG22 ' H ' ' A' ' 569' ' ' LYS . 2.3 p 44.49 -171.73 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.569 1.699 0 C-N-CA 125.543 1.537 . . . . 72.549999999999997 111.821 -177.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 569' ' ' LYS . . . . . 0.534 ' HA ' ' HE2' ' A' ' 569' ' ' LYS . 0.0 OUTLIER -173.3 158.41 3.56 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 107.142 -1.429 . . . . 75.209999999999994 107.142 174.78 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 570' ' ' THR . . . . . 0.604 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 24.1 p -134.37 137.73 44.33 Favored 'General case' 0 N--CA 1.423 -1.796 0 O-C-N 123.744 0.652 . . . . 71.340000000000003 109.316 175.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 571' ' ' ILE . . . . . 0.464 HG22 HG23 ' A' ' 573' ' ' VAL . 2.9 mp -88.29 114.31 26.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 106.148 -1.797 . . . . 72.519999999999996 106.148 171.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 9.4 p -95.81 111.88 23.75 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 123.215 0.322 . . . . 52.439999999999998 110.429 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 573' ' ' VAL . . . . . 0.464 HG23 HG22 ' A' ' 571' ' ' ILE . 46.9 t -118.82 137.69 51.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.33 -0.618 . . . . 74.519999999999996 109.33 -178.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 574' ' ' LYS . . . . . 0.463 ' HB3' ' HB3' ' A' ' 554' ' ' GLU . 38.7 ttmt -95.71 130.65 42.55 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 123.926 0.767 . . . . 72.239999999999995 110.218 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 58.9 t -95.76 143.63 11.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 107.852 -1.166 . . . . 73.140000000000001 107.852 176.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 576' ' ' ILE . . . . . 0.439 HG12 ' HA ' ' A' ' 553' ' ' PHE . 28.9 mm -112.16 161.12 11.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 108.154 -1.054 . . . . 72.030000000000001 108.154 -177.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -77.68 144.43 37.35 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.021 -0.733 . . . . 55.399999999999999 109.021 176.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -57.89 136.9 57.09 Favored 'General case' 0 CA--C 1.484 -1.562 0 N-CA-C 115.453 1.649 . . . . 74.239999999999995 115.453 -174.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 5.6 pm0 -107.06 -26.01 11.33 Favored 'General case' 0 N--CA 1.421 -1.876 0 CA-C-N 113.413 -1.721 . . . . 63.439999999999998 112.38 -176.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 580' ' ' GLU . . . . . 0.425 ' HG2' ' CD2' ' A' ' 581' ' ' TYR . 0.1 OUTLIER -110.38 -69.26 0.88 Allowed 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 112.753 0.649 . . . . 72.329999999999998 112.753 -170.002 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 581' ' ' TYR . . . . . 0.425 ' CD2' ' HG2' ' A' ' 580' ' ' GLU . 32.1 p90 -162.35 153.71 18.03 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 104.422 -2.436 . . . . 74.099999999999994 104.422 -176.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 582' ' ' GLU . . . . . 0.442 ' HB3' ' OE1' ' A' ' 648' ' ' GLU . 20.3 mt-10 -102.98 136.6 42.5 Favored 'General case' 0 C--N 1.274 -2.708 0 C-N-CA 117.604 -1.638 . . . . 73.109999999999999 115.23 -172.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 12.8 ptpt -153.62 167.06 30.82 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 113.239 -1.801 . . . . 74.030000000000001 106.177 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -86.52 123.4 31.69 Favored 'General case' 0 CA--C 1.488 -1.431 0 N-CA-C 105.656 -1.979 . . . . 71.040000000000006 105.656 169.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 585' ' ' LYS . . . . . 0.503 ' HG2' ' HB2' ' A' ' 546' ' ' ALA . 0.0 OUTLIER -121.66 173.67 7.3 Favored 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 108.691 -0.855 . . . . 72.540000000000006 108.691 -171.592 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 8.6 t -153.61 146.77 24.66 Favored 'General case' 0 N--CA 1.428 -1.531 0 C-N-CA 120.042 -0.663 . . . . 63.299999999999997 111.774 -174.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -130.96 149.8 52.41 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-N 114.237 -1.347 . . . . 73.099999999999994 109.891 177.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 588' ' ' PHE . . . . . 0.404 ' HA ' ' O ' ' A' ' 642' ' ' LEU . 25.7 m-85 -104.06 133.36 49.13 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.094 -0.706 . . . . 74.109999999999999 109.094 -176.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . 0.506 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.4 OUTLIER -106.01 123.77 48.52 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 105.895 -1.891 . . . . 70.430000000000007 105.895 175.845 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -130.71 145.66 51.99 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 107.615 -1.254 . . . . 73.129999999999995 107.615 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 591' ' ' ILE . . . . . 0.412 HG22 ' HB3' ' A' ' 539' ' ' TYR . 27.5 pt -106.05 152.48 7.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 108.934 -0.765 . . . . 71.230000000000004 108.934 178.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -97.97 -150.51 26.37 Favored Glycine 0 N--CA 1.429 -1.802 0 C-N-CA 120.792 -0.718 . . . . 64.150000000000006 112.873 -177.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.416 ' OE2' ' HB3' ' A' ' 595' ' ' ARG . 1.4 tm-20 -79.49 121.3 82.55 Favored Pre-proline 0 C--N 1.297 -1.681 0 C-N-CA 123.589 0.756 . . . . 71.400000000000006 111.426 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 594' ' ' PRO . . . . . 0.496 ' HA ' ' O ' ' A' ' 536' ' ' ILE . 68.7 Cg_endo -81.33 145.9 15.3 Favored 'Trans proline' 0 N--CA 1.43 -2.231 0 C-N-CA 121.817 1.678 . . . . 71.439999999999998 110.083 176.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 595' ' ' ARG . . . . . 0.416 ' HB3' ' OE2' ' A' ' 593' ' ' GLU . 14.2 ptp180 -136.7 143.75 43.53 Favored 'General case' 0 C--N 1.273 -2.733 0 CA-C-N 116.286 -0.416 . . . . 72.420000000000002 109.991 -177.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 596' ' ' LEU . . . . . 0.437 HD22 HG22 ' A' ' 535' ' ' VAL . 0.0 OUTLIER -77.25 126.83 31.57 Favored 'General case' 0 N--CA 1.416 -2.155 0 N-CA-C 106.001 -1.851 . . . . 72.310000000000002 106.001 179.469 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 43.6 t . . . . . 0 C--N 1.311 -1.067 0 N-CA-C 107.855 -1.165 . . . . 64.010000000000005 107.855 179.995 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 6.3 mtp-105 . . . . . 0 N--CA 1.441 -0.91 0 N-CA-C 107.412 -1.329 . . . . 73.200000000000003 107.412 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -76.1 155.76 37.99 Favored 'Trans proline' 0 N--CA 1.438 -1.776 0 C-N-CA 120.856 1.038 . . . . 64.319999999999993 110.07 168.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 635' ' ' ILE . . . . . 0.464 HD13 ' H ' ' A' ' 635' ' ' ILE . 0.2 OUTLIER -136.68 -173.54 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 107.798 -1.186 . . . . 53.0 107.798 179.438 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . 0.552 ' H ' HD13 ' A' ' 636' ' ' LEU . 0.0 OUTLIER -87.29 -179.77 6.47 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 123.291 0.37 . . . . 65.319999999999993 111.622 -178.93 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -99.69 -125.18 5.4 Favored Glycine 0 N--CA 1.438 -1.188 0 CA-C-N 116.175 -0.466 . . . . 23.32 113.983 -176.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -84.54 -71.4 0.52 Allowed 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 112.41 0.522 . . . . 75.420000000000002 112.41 -177.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -117.67 107.94 14.82 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 122.466 1.127 . . . . 64.329999999999998 112.436 -174.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 640' ' ' THR . . . . . 0.404 HG21 ' HB2' ' A' ' 636' ' ' LEU . 3.6 p -108.19 92.05 3.9 Favored 'General case' 0 N--CA 1.404 -2.747 0 CA-C-N 114.269 -1.332 . . . . 65.200000000000003 109.855 177.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 641' ' ' LYS . . . . . 0.454 ' HE2' ' HB2' ' A' ' 643' ' ' GLU . 1.2 tmtp? -178.33 129.44 0.13 Allowed 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 104.826 -2.287 . . . . 75.030000000000001 104.826 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 642' ' ' LEU . . . . . 0.72 HD21 HG21 ' A' ' 523' ' ' VAL . 42.6 tp -132.37 114.52 14.46 Favored 'General case' 0 C--N 1.274 -2.681 0 N-CA-C 108.692 -0.855 . . . . 71.549999999999997 108.692 177.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . 0.461 ' HB3' HG22 ' A' ' 511' ' ' VAL . 22.5 tt0 -99.05 104.81 16.87 Favored 'General case' 0 C--N 1.273 -2.734 0 N-CA-C 107.069 -1.456 . . . . 63.130000000000003 107.069 178.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 644' ' ' VAL . . . . . 0.701 HG21 ' HE2' ' A' ' 521' ' ' MET . 33.7 t -92.94 105.12 16.42 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 N-CA-C 108.551 -0.907 . . . . 75.400000000000006 108.551 -179.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 3.9 mp -88.94 115.08 28.16 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 N-CA-C 107.469 -1.308 . . . . 71.239999999999995 107.469 175.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 646' ' ' ILE . . . . . 0.468 ' N ' HD12 ' A' ' 646' ' ' ILE . 2.9 mp -95.48 106.43 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.453 0 N-CA-C 105.383 -2.08 . . . . 64.430000000000007 105.383 -178.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -97.95 132.15 43.78 Favored 'General case' 0 N--CA 1.399 -3.017 0 CA-C-N 115.249 -0.887 . . . . 64.329999999999998 109.275 -178.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 648' ' ' GLU . . . . . 0.442 ' OE1' ' HB3' ' A' ' 582' ' ' GLU . 15.2 tt0 -67.32 144.29 55.94 Favored 'General case' 0 N--CA 1.408 -2.527 0 N-CA-C 107.878 -1.156 . . . . 74.140000000000001 107.878 -177.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 23.1 t . . . . . 0 N--CA 1.444 -0.748 0 O-C-N 124.442 1.089 . . . . 73.109999999999999 113.342 -170.165 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . 0.662 ' HA2' ' OG1' ' A' ' 528' ' ' THR . . . . . . . . 0 N--CA 1.415 -2.735 0 N-CA-C 111.787 -0.525 . . . . 54.439999999999998 111.787 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . 0.413 ' H ' ' CB ' ' A' ' 528' ' ' THR . 4.1 mp -119.23 113.97 43.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 107.436 -1.32 . . . . 74.329999999999998 107.436 177.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -123.94 119.74 30.47 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 109.228 -0.656 . . . . 64.099999999999994 109.228 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 14.8 t -148.54 167.54 25.11 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.78 -0.452 . . . . 74.530000000000001 109.78 -174.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -99.66 162.33 13.08 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 107.441 -1.318 . . . . 75.439999999999998 107.441 173.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . 0.436 ' HG3' HD21 ' A' ' 526' ' ' LEU . 0.0 OUTLIER -103.18 -24.39 13.57 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.203 0.525 . . . . 75.299999999999997 111.314 176.245 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -116.66 122.96 30.98 Favored Pre-proline 0 N--CA 1.436 -1.152 0 N-CA-C 108.382 -0.97 . . . . 74.0 108.382 171.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -80.71 -9.96 13.17 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 121.961 1.774 . . . . 74.310000000000002 111.48 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . 0.435 HG22 ' HB3' ' A' ' 643' ' ' GLU . 75.3 t -141.28 135.96 32.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 107.521 -1.289 . . . . 74.439999999999998 107.521 -178.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 5.6 t -136.68 146.71 46.22 Favored 'General case' 0 N--CA 1.41 -2.439 0 N-CA-C 108.005 -1.109 . . . . 74.239999999999995 108.005 177.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -116.69 131.3 56.99 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.429 -0.582 . . . . 75.109999999999999 109.429 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 22.3 m -127.26 160.87 35.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 CA-C-N 115.762 -0.654 . . . . 73.129999999999995 109.753 -175.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 71.1 m -75.73 153.03 37.32 Favored 'General case' 0 N--CA 1.403 -2.803 0 CA-C-N 114.72 -1.127 . . . . 71.239999999999995 108.083 175.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -88.36 -24.8 23.01 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.054 -1.058 . . . . 63.350000000000001 111.121 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 23.3 t -102.6 70.16 1.12 Allowed 'General case' 0 N--CA 1.419 -1.982 0 N-CA-C 107.862 -1.162 . . . . 72.430000000000007 107.862 176.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 18.8 tt -135.85 152.47 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.503 0 N-CA-C 106.73 -1.582 . . . . 73.140000000000001 106.73 176.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -84.93 -59.21 2.0 Allowed Glycine 0 C--N 1.287 -2.154 0 C-N-CA 120.239 -0.982 . . . . 71.310000000000002 111.667 -178.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 36.5 mm -125.98 126.01 69.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 109.486 -0.561 . . . . 73.140000000000001 109.486 -178.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 521' ' ' MET . . . . . 0.741 ' HE1' HG21 ' A' ' 644' ' ' VAL . 0.0 OUTLIER -101.6 134.88 44.05 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 106.38 -1.711 . . . . 43.240000000000002 106.38 171.721 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -121.49 137.54 54.68 Favored 'General case' 0 C--N 1.308 -1.206 0 O-C-N 123.68 0.613 . . . . 72.140000000000001 110.523 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . 0.679 HG21 HD21 ' A' ' 642' ' ' LEU . 41.7 t -121.1 138.26 52.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 N-CA-C 108.119 -1.067 . . . . 63.299999999999997 108.119 179.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . 0.571 ' HD2' HG21 ' A' ' 568' ' ' VAL . 29.1 mmtp -88.16 116.07 26.1 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.867 0.841 . . . . 72.019999999999996 111.84 -176.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 22.9 t -97.19 135.62 30.77 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 CA-C-N 114.545 -1.207 . . . . 73.129999999999995 109.178 -178.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . 0.436 HD21 ' HG3' ' A' ' 508' ' ' GLU . 2.5 mm? -79.68 138.86 37.49 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 123.687 0.617 . . . . 63.43 109.804 -178.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . 0.508 ' HG2' ' N ' ' A' ' 528' ' ' THR . 50.5 ttp180 -86.29 160.28 19.18 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.274 -1.01 . . . . 72.209999999999994 108.274 178.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . 0.662 ' OG1' ' HA2' ' A' ' 503' ' ' GLY . 5.3 t -65.43 146.76 54.48 Favored 'General case' 0 N--CA 1.412 -2.347 0 CA-C-N 115.657 -0.701 . . . . 74.25 110.388 172.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 38.0 t -62.37 -46.36 88.99 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-N 114.963 -1.017 . . . . 71.150000000000006 109.042 175.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -114.1 117.28 4.09 Favored Glycine 0 N--CA 1.415 -2.743 0 N-CA-C 109.914 -1.274 . . . . 64.420000000000002 109.914 -177.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . 0.432 ' HB2' HG23 ' A' ' 528' ' ' THR . . . -131.69 119.93 22.06 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 109.372 -0.603 . . . . 70.519999999999996 109.372 178.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -114.94 74.96 0.9 Allowed 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.559 -0.534 . . . . 75.540000000000006 109.559 175.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 533' ' ' GLY . . . . . 0.446 ' H ' ' HB3' ' A' ' 564' ' ' ASN . . . 124.92 -143.39 14.54 Favored Glycine 0 N--CA 1.433 -1.528 0 C-N-CA 120.38 -0.915 . . . . 52.119999999999997 112.628 177.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 534' ' ' ASN . . . . . 0.482 HD21 ' HG3' ' A' ' 561' ' ' GLU . 2.8 t-20 -114.25 134.01 55.24 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.031 -0.729 . . . . 72.109999999999999 109.031 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 535' ' ' VAL . . . . . 0.528 HG22 HD22 ' A' ' 596' ' ' LEU . 59.3 t -126.45 131.45 71.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 109.458 -0.571 . . . . 65.120000000000005 109.458 -178.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 536' ' ' ILE . . . . . . . . . . . . . 39.7 mm -98.89 125.92 52.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 109.061 -0.718 . . . . 61.310000000000002 109.061 178.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . 0.438 HG22 ' HB3' ' A' ' 594' ' ' PRO . 40.6 t -115.82 107.24 48.66 Favored Pre-proline 0 C--N 1.306 -1.325 0 CA-C-N 115.839 -0.619 . . . . 61.210000000000001 109.356 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -73.52 145.95 38.46 Favored 'Trans proline' 0 C--O 1.238 0.484 0 C-N-CA 122.539 2.159 . . . . 74.540000000000006 111.951 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 539' ' ' TYR . . . . . 0.492 ' HB3' HG22 ' A' ' 591' ' ' ILE . 43.7 p90 -147.96 161.3 41.61 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 109.34 -0.615 . . . . 72.230000000000004 109.34 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -157.9 153.95 27.12 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 109.237 -0.653 . . . . 73.409999999999997 109.237 177.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 2.7 p -90.76 128.75 36.79 Favored 'General case' 0 C--N 1.293 -1.886 0 O-C-N 123.625 0.578 . . . . 72.329999999999998 110.152 175.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.428 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 3.7 mp -95.05 117.92 40.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 106.244 -1.762 . . . . 75.200000000000003 106.244 174.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . 0.538 ' HB2' ' O ' ' A' ' 546' ' ' ALA 0.289 0.0 OUTLIER -60.89 -51.51 68.98 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 114.685 1.365 . . . . 64.319999999999993 114.685 -176.759 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 67.63 -79.95 0.17 Allowed Glycine 0 N--CA 1.448 -0.532 0 O-C-N 123.266 0.354 . . . . 70.310000000000002 113.833 175.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 7.9 t -125.64 -1.7 7.37 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 120.956 0.408 . . . . 44.119999999999997 110.325 -178.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . 0.538 ' O ' ' HB2' ' A' ' 543' ' ' GLU . . . -111.11 174.54 5.81 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 108.6 -0.889 . . . . 72.540000000000006 108.6 177.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . 0.483 ' H ' ' HB3' ' A' ' 552' ' ' ASP . 2.4 mpt_? -112.77 128.78 56.52 Favored 'General case' 0 CA--C 1.487 -1.454 0 CA-C-O 121.548 0.689 . . . . 71.530000000000001 112.414 -175.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -84.6 -174.16 50.2 Favored Glycine 0 C--N 1.277 -2.731 0 CA-C-N 114.052 -1.431 . . . . 61.240000000000002 112.532 -177.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 69.78 16.33 72.16 Favored Glycine 0 C--O 1.222 -0.644 0 N-CA-C 114.196 0.438 . . . . 55.009999999999998 114.196 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 84.5 6.21 86.06 Favored Glycine 0 N--CA 1.438 -1.208 0 C-N-CA 119.989 -1.101 . . . . 64.040000000000006 111.297 -177.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -74.12 -43.94 55.65 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 110.542 -0.17 . . . . 64.519999999999996 110.542 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . 0.483 ' HB3' ' H ' ' A' ' 547' ' ' ARG . 10.2 t70 -132.27 -28.88 1.65 Allowed 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.577 -0.897 . . . . 54.310000000000002 108.577 175.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 553' ' ' PHE . . . . . 0.411 ' HA ' HG12 ' A' ' 576' ' ' ILE . 35.1 p90 -144.12 158.39 43.75 Favored 'General case' 0 C--O 1.249 1.053 0 N-CA-C 107.183 -1.414 . . . . 74.510000000000005 107.183 170.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -89.93 119.44 30.29 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 106.974 -1.491 . . . . 74.400000000000006 106.974 178.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -75.45 99.03 4.06 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-N 115.966 -0.561 . . . . 72.209999999999994 110.738 -176.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . 0.485 ' CG2' HG22 ' A' ' 573' ' ' VAL . 10.1 t -89.8 97.03 10.96 Favored 'General case' 0 N--CA 1.41 -2.453 0 CA-C-O 123.295 1.521 . . . . 74.230000000000004 110.48 -178.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 1.6 p -109.4 106.62 16.47 Favored 'General case' 0 C--N 1.275 -2.65 0 CA-C-N 113.8 -1.545 . . . . 71.219999999999999 107.903 175.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -154.92 -157.84 8.42 Favored Glycine 0 N--CA 1.414 -2.804 0 N-CA-C 110.705 -0.958 . . . . 73.25 110.705 -174.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -142.77 131.24 22.33 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 109.584 -0.524 . . . . 55.420000000000002 109.584 -175.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . 0.403 ' HG ' ' CD1' ' A' ' 539' ' ' TYR . 95.1 mt -89.89 138.01 31.86 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.835 -0.62 . . . . 71.239999999999995 109.379 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 561' ' ' GLU . . . . . 0.482 ' HG3' HD21 ' A' ' 534' ' ' ASN . 39.9 tt0 -104.46 106.54 17.08 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 109.384 -0.598 . . . . 74.140000000000001 109.384 -179.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -100.08 132.22 45.57 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 109.9 -0.407 . . . . 60.039999999999999 109.9 177.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -116.43 160.81 20.02 Favored 'General case' 0 C--N 1.289 -2.06 0 C-N-CA 119.635 -0.826 . . . . 63.439999999999998 109.617 177.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 564' ' ' ASN . . . . . 0.446 ' HB3' ' H ' ' A' ' 533' ' ' GLY . 4.6 p-10 -69.93 -25.11 63.5 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 122.214 1.007 . . . . 73.400000000000006 109.545 176.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -90.85 -6.27 54.46 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.386 -1.279 . . . . 61.100000000000001 110.821 -178.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -118.96 154.82 32.41 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.899 -0.778 . . . . 22.219999999999999 108.899 -177.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 567' ' ' ILE . . . . . 0.416 ' HA ' ' HD3' ' A' ' 527' ' ' ARG . 9.4 pt -124.77 164.2 23.83 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 108.318 -0.993 . . . . 63.119999999999997 108.318 170.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 568' ' ' VAL . . . . . 0.571 HG21 ' HD2' ' A' ' 524' ' ' LYS . 1.5 p 49.97 155.5 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.576 1.944 0 C-N-CA 127.072 2.149 . . . . 75.040000000000006 115.734 179.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 569' ' ' LYS . . . . . . . . . . . . . 5.8 mmpt? -140.69 166.29 25.15 Favored 'General case' 0 CA--C 1.486 -1.487 0 N-CA-C 107.806 -1.183 . . . . 64.340000000000003 107.806 172.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 570' ' ' THR . . . . . 0.542 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 18.2 p -137.49 133.49 34.67 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 123.825 0.703 . . . . 70.519999999999996 110.603 175.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 3.1 mp -84.77 122.36 38.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 106.591 -1.633 . . . . 64.310000000000002 106.591 172.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 10.2 p -98.2 109.08 21.9 Favored 'General case' 0 N--CA 1.418 -2.074 0 N-CA-C 109.838 -0.43 . . . . 74.25 109.838 178.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 573' ' ' VAL . . . . . 0.485 HG22 ' CG2' ' A' ' 556' ' ' THR . 58.9 t -110.55 123.7 66.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 N-CA-C 109.869 -0.419 . . . . 73.530000000000001 109.869 178.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -77.91 113.23 15.6 Favored 'General case' 0 N--CA 1.433 -1.29 0 O-C-N 124.036 0.835 . . . . 74.319999999999993 109.067 175.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 57.1 t -87.24 130.32 37.27 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 107.624 -1.25 . . . . 60.200000000000003 107.624 177.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 576' ' ' ILE . . . . . 0.411 HG12 ' HA ' ' A' ' 553' ' ' PHE . 37.4 mm -94.98 150.04 4.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 108.312 -0.996 . . . . 74.209999999999994 108.312 -175.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -68.51 139.81 55.66 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.329 -0.619 . . . . 73.310000000000002 109.329 176.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.66 -177.74 6.67 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 112.898 0.703 . . . . 73.140000000000001 112.898 -173.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -166.71 -38.19 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.462 0 N-CA-C 114.566 1.321 . . . . 72.310000000000002 114.566 -173.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 580' ' ' GLU . . . . . 0.541 ' HG2' ' O ' ' A' ' 581' ' ' TYR . 0.1 OUTLIER -99.77 -168.08 1.55 Allowed 'General case' 0 C--O 1.25 1.104 0 C-N-CA 122.71 0.404 . . . . 74.209999999999994 111.887 -169.022 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 581' ' ' TYR . . . . . 0.541 ' O ' ' HG2' ' A' ' 580' ' ' GLU . 27.8 p90 -65.48 151.12 47.14 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 106.819 -1.549 . . . . 74.239999999999995 106.819 174.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -130.31 154.81 47.25 Favored 'General case' 0 N--CA 1.412 -2.338 0 C-N-CA 118.467 -1.293 . . . . 64.340000000000003 113.918 178.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -133.82 -174.51 3.55 Favored 'General case' 0 C--N 1.274 -2.692 0 N-CA-C 103.648 -2.723 . . . . 62.049999999999997 103.648 176.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -72.69 107.04 4.95 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.594 -1.261 . . . . 71.439999999999998 107.594 173.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . 0.252 0.0 OUTLIER -113.28 143.7 43.97 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 119.921 -0.712 . . . . 73.019999999999996 111.351 -179.041 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 3.5 t -155.81 148.96 24.52 Favored 'General case' 0 N--CA 1.418 -2.072 0 CA-C-N 115.215 -0.902 . . . . 71.540000000000006 109.764 -172.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -120.14 142.15 49.2 Favored 'General case' 0 N--CA 1.414 -2.272 0 CA-C-N 114.576 -1.193 . . . . 74.420000000000002 109.665 176.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 588' ' ' PHE . . . . . 0.428 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 25.8 m-85 -98.92 133.5 43.11 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.561 -0.904 . . . . 65.329999999999998 108.561 -175.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . 0.522 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.5 OUTLIER -108.01 127.17 53.53 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 106.323 -1.732 . . . . 53.009999999999998 106.323 176.365 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -127.95 126.86 42.24 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 109.242 -0.651 . . . . 54.530000000000001 109.242 176.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 591' ' ' ILE . . . . . 0.492 HG22 ' HB3' ' A' ' 539' ' ' TYR . 17.0 pt -94.22 128.66 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 N-CA-C 106.351 -1.722 . . . . 74.519999999999996 106.351 171.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -93.35 -144.75 15.7 Favored Glycine 0 N--CA 1.431 -1.674 0 CA-C-N 115.793 -0.64 . . . . 63.109999999999999 114.386 -171.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -77.43 116.35 57.13 Favored Pre-proline 0 N--CA 1.435 -1.195 0 CA-C-N 114.635 -0.782 . . . . 71.140000000000001 109.155 -178.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 594' ' ' PRO . . . . . 0.438 ' HB3' HG22 ' A' ' 537' ' ' VAL . 78.1 Cg_endo -76.3 160.25 35.99 Favored 'Trans proline' 0 N--CA 1.446 -1.31 0 C-N-CA 122.475 2.117 . . . . 71.420000000000002 111.283 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 8.3 ptp85 -135.31 139.07 44.04 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 109.046 -0.724 . . . . 75.420000000000002 109.046 -178.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 596' ' ' LEU . . . . . 0.528 HD22 HG22 ' A' ' 535' ' ' VAL . 0.0 OUTLIER -83.39 129.19 34.98 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 105.954 -1.869 . . . . 75.450000000000003 105.954 179.242 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 69.7 t . . . . . 0 C--N 1.312 -1.043 0 CA-C-O 121.905 0.859 . . . . 73.439999999999998 110.393 -178.672 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.207 -1.135 0 N-CA-C 109.527 -0.546 . . . . 74.510000000000005 109.527 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -75.6 153.89 39.3 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 121.863 1.709 . . . . 54.109999999999999 111.754 178.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.3 pp -130.96 179.78 4.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.798 0.666 . . . . 64.430000000000007 112.798 -177.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . 0.401 HD22 ' O ' ' A' ' 637' ' ' GLY . 0.0 OUTLIER -76.71 153.4 35.13 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.793 -0.64 . . . . 74.349999999999994 109.473 -179.734 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . 0.401 ' O ' HD22 ' A' ' 636' ' ' LEU . . . -83.93 -135.72 2.93 Favored Glycine 0 C--N 1.304 -1.239 0 C-N-CA 120.917 -0.659 . . . . 71.319999999999993 114.18 -175.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -70.32 -56.97 5.41 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.168 0.508 . . . . 74.420000000000002 110.449 -176.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -148.26 122.53 9.6 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.429 0.633 . . . . 71.409999999999997 110.096 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 55.2 p -108.59 91.49 3.67 Favored 'General case' 0 N--CA 1.406 -2.665 0 CA-C-O 121.907 0.86 . . . . 62.43 109.118 178.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -166.39 130.19 2.06 Favored 'General case' 0 CA--C 1.491 -1.295 0 N-CA-C 107.81 -1.181 . . . . 64.409999999999997 107.81 -177.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 642' ' ' LEU . . . . . 0.679 HD21 HG21 ' A' ' 523' ' ' VAL . 29.3 tp -137.91 110.53 7.55 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 108.531 -0.914 . . . . 74.510000000000005 108.531 176.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . 0.435 ' HB3' HG22 ' A' ' 511' ' ' VAL . 36.8 tt0 -93.92 109.69 21.39 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 107.188 -1.412 . . . . 75.200000000000003 107.188 176.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 644' ' ' VAL . . . . . 0.741 HG21 ' HE1' ' A' ' 521' ' ' MET . 34.7 t -96.59 105.44 17.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 109.982 -0.377 . . . . 75.420000000000002 109.982 -177.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 3.7 mp -87.86 120.16 36.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 108.418 -0.956 . . . . 75.510000000000005 108.418 178.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 646' ' ' ILE . . . . . 0.493 HD12 ' H ' ' A' ' 646' ' ' ILE . 2.1 mp -101.7 107.47 21.62 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.746 0 N-CA-C 105.938 -1.875 . . . . 64.510000000000005 105.938 -177.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -110.53 145.92 36.93 Favored 'General case' 0 N--CA 1.406 -2.627 0 C-N-CA 120.273 -0.571 . . . . 70.239999999999995 110.294 -178.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -53.33 132.8 39.82 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.004 -0.998 . . . . 72.040000000000006 110.091 -178.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 3.6 m . . . . . 0 C--N 1.298 -1.661 0 C-N-CA 124.444 1.098 . . . . 63.039999999999999 111.681 -173.549 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.419 -2.47 0 N-CA-C 112.624 -0.19 . . . . 35.240000000000002 112.624 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . 0.4 ' H ' ' CB ' ' A' ' 528' ' ' THR . 4.1 mp -122.75 114.81 43.83 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 108.54 -0.911 . . . . 74.230000000000004 108.54 178.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -128.88 98.75 5.06 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 107.753 -1.203 . . . . 74.319999999999993 107.753 174.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 15.4 t -134.99 156.83 48.36 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 116.044 -0.526 . . . . 73.430000000000007 109.679 -173.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -85.41 154.28 21.95 Favored 'General case' 0 CA--C 1.487 -1.476 0 N-CA-C 108.583 -0.895 . . . . 73.200000000000003 108.583 175.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -84.38 -26.92 28.02 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.099 -1.075 . . . . 73.329999999999998 108.099 173.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -111.26 121.22 41.03 Favored Pre-proline 0 N--CA 1.436 -1.174 0 CA-C-N 114.636 -1.165 . . . . 74.019999999999996 109.98 -178.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 510' ' ' PRO . . . . . 0.435 ' HA ' ' O ' ' A' ' 641' ' ' LYS . 56.2 Cg_endo -85.7 -18.48 3.77 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 121.206 1.271 . . . . 42.210000000000001 109.51 169.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . 0.542 HG22 ' HB3' ' A' ' 643' ' ' GLU . 67.6 t -149.32 131.13 5.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 C-N-CA 125.953 1.701 . . . . 61.450000000000003 106.972 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 14.9 t -130.49 143.73 50.95 Favored 'General case' 0 N--CA 1.421 -1.902 0 N-CA-C 107.676 -1.231 . . . . 73.25 107.676 177.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -109.76 131.99 54.56 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 107.504 -1.295 . . . . 63.539999999999999 107.504 178.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 24.7 m -130.19 154.89 41.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 CA-C-O 121.312 0.577 . . . . 72.239999999999995 110.077 -178.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 65.7 m -77.08 150.0 35.7 Favored 'General case' 0 N--CA 1.397 -3.103 0 CA-C-N 114.493 -1.23 . . . . 74.420000000000002 109.955 178.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -71.69 -29.3 64.43 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.813 0.816 . . . . 64.209999999999994 109.659 174.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 39.7 m -107.95 75.07 0.98 Allowed 'General case' 0 N--CA 1.418 -2.033 0 CA-C-O 122.129 0.966 . . . . 73.230000000000004 109.462 -177.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 13.3 tt -145.3 161.04 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.214 0 CA-C-N 113.069 -1.878 . . . . 71.420000000000002 106.027 176.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . 0.46 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . -92.51 -75.71 1.31 Allowed Glycine 0 N--CA 1.434 -1.449 0 C-N-CA 120.002 -1.094 . . . . 42.109999999999999 110.894 177.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 34.6 mm -107.68 127.03 63.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 109.866 -0.42 . . . . 75.219999999999999 109.866 -178.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 521' ' ' MET . . . . . 0.582 ' HE2' HG21 ' A' ' 644' ' ' VAL . 0.0 OUTLIER -102.95 139.99 37.8 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.075 -1.454 . . . . 72.340000000000003 107.075 172.103 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -113.7 155.67 25.15 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 121.419 0.628 . . . . 72.299999999999997 111.709 -176.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . 0.678 ' O ' ' HA ' ' A' ' 570' ' ' THR . 12.1 t -135.77 126.07 42.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 115.118 -0.947 . . . . 71.120000000000005 108.479 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . 0.54 ' HD2' HG21 ' A' ' 568' ' ' VAL . 31.2 mmtp -79.7 126.08 30.47 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.507 0.67 . . . . 54.530000000000001 112.088 -179.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 19.1 t -110.67 122.87 65.95 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 107.367 -1.346 . . . . 61.119999999999997 107.367 176.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -78.82 144.93 34.59 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.073 -0.714 . . . . 61.25 109.073 -178.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . 0.504 ' HD3' ' HA ' ' A' ' 567' ' ' ILE . 40.3 ttp180 -88.23 151.81 22.4 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.451 0.643 . . . . 64.319999999999993 110.764 -175.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . 0.481 ' N ' ' HG2' ' A' ' 527' ' ' ARG . 4.6 t -59.97 139.63 57.29 Favored 'General case' 0 N--CA 1.418 -2.049 0 CA-C-N 114.514 -1.221 . . . . 62.450000000000003 110.525 172.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 23.3 t -73.92 -40.65 62.98 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 108.553 -0.906 . . . . 75.319999999999993 108.553 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -90.57 56.63 3.46 Favored Glycine 0 N--CA 1.434 -1.459 0 N-CA-C 110.392 -1.083 . . . . 64.109999999999999 110.392 177.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -70.14 99.88 1.56 Allowed 'General case' 0 CA--C 1.505 -0.767 0 C-N-CA 122.972 0.509 . . . . 64.010000000000005 110.884 -178.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -127.33 100.22 5.96 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 115.708 -0.678 . . . . 73.319999999999993 109.899 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 533' ' ' GLY . . . . . 0.561 ' H ' ' HB3' ' A' ' 564' ' ' ASN . . . 102.67 165.23 26.19 Favored Glycine 0 N--CA 1.42 -2.42 0 C-N-CA 120.695 -0.764 . . . . 41.109999999999999 113.161 177.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 534' ' ' ASN . . . . . 0.424 HD21 ' CG ' ' A' ' 561' ' ' GLU . 2.6 t-20 -79.72 123.11 27.38 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.383 -1.34 . . . . 74.409999999999997 107.383 176.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 535' ' ' VAL . . . . . 0.509 HG22 HD22 ' A' ' 596' ' ' LEU . 65.7 t -124.32 139.48 50.54 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-N 116.19 -0.459 . . . . 74.030000000000001 110.023 -175.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 536' ' ' ILE . . . . . 0.503 HG23 ' HB3' ' A' ' 559' ' ' GLU . 30.2 mm -104.24 139.18 25.94 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 109.014 -0.736 . . . . 63.329999999999998 109.014 178.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 41.9 t -118.4 108.53 41.58 Favored Pre-proline 0 C--N 1.306 -1.3 0 N-CA-C 109.474 -0.565 . . . . 73.230000000000004 109.474 177.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -73.93 138.85 26.47 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 122.117 1.878 . . . . 65.349999999999994 110.885 177.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 539' ' ' TYR . . . . . 0.443 ' HB3' HG22 ' A' ' 591' ' ' ILE . 46.0 p90 -146.46 161.47 40.35 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 120.804 -0.358 . . . . 73.340000000000003 110.531 -178.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 540' ' ' LYS . . . . . 0.41 ' HD2' ' O ' ' A' ' 540' ' ' LYS . 0.0 OUTLIER -155.31 147.65 23.87 Favored 'General case' 0 C--N 1.317 -0.807 0 O-C-N 123.518 0.511 . . . . 73.329999999999998 111.495 177.416 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 16.7 p -84.8 132.34 34.43 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 116.2 -0.455 . . . . 72.329999999999998 110.039 173.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.5 mp -93.63 124.22 46.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 106.271 -1.751 . . . . 72.540000000000006 106.271 173.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . 0.413 ' HB3' ' O ' ' A' ' 546' ' ' ALA . 2.7 mp0 -57.12 -52.67 64.36 Favored 'General case' 0 C--O 1.243 0.712 0 O-C-N 123.818 0.699 . . . . 73.5 110.765 -178.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 71.08 -81.91 0.44 Allowed Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 115.45 -0.795 . . . . 62.549999999999997 111.946 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 11.1 t -132.9 5.47 3.9 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.677 0.751 . . . . 74.329999999999998 109.806 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . 0.413 ' O ' ' HB3' ' A' ' 543' ' ' GLU . . . -106.2 178.83 4.45 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.841 -0.618 . . . . 33.350000000000001 109.612 178.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . 0.491 ' HD2' ' HB3' ' A' ' 551' ' ' GLU . 1.7 tmt_? -129.03 124.26 34.46 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 107.677 -1.231 . . . . 72.299999999999997 107.677 -175.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -82.9 -151.36 10.16 Favored Glycine 0 C--N 1.321 -0.264 0 C-N-CA 121.321 -0.466 . . . . 44.229999999999997 112.715 -177.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 66.6 19.4 69.01 Favored Glycine 0 C--N 1.314 -0.672 0 CA-C-N 116.689 0.244 . . . . 61.240000000000002 113.289 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 76.7 32.3 50.87 Favored Glycine 0 N--CA 1.437 -1.289 0 C-N-CA 120.748 -0.739 . . . . 50.329999999999998 111.614 -178.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . 0.491 ' HB3' ' HD2' ' A' ' 547' ' ' ARG . 8.1 tp10 -101.41 -65.75 0.96 Allowed 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.865 -0.42 . . . . 71.510000000000005 109.865 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -101.38 -34.05 9.76 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 106.526 -1.657 . . . . 73.400000000000006 106.526 177.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 553' ' ' PHE . . . . . 0.473 ' HA ' HG12 ' A' ' 576' ' ' ILE . 20.4 p90 -149.46 164.56 34.68 Favored 'General case' 0 N--CA 1.419 -2.023 0 CA-C-N 113.99 -1.459 . . . . 65.420000000000002 108.054 175.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . 0.515 ' HG3' ' HE2' ' A' ' 574' ' ' LYS . 0.5 OUTLIER -94.56 112.3 24.06 Favored 'General case' 0 C--N 1.282 -2.368 0 N-CA-C 105.805 -1.924 . . . . 73.310000000000002 105.805 176.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -76.94 101.06 5.8 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-O 122.525 1.155 . . . . 62.140000000000001 110.736 -175.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . 0.47 ' CG2' HG22 ' A' ' 573' ' ' VAL . 8.9 t -91.44 121.8 33.47 Favored 'General case' 0 N--CA 1.396 -3.148 0 CA-C-O 122.395 1.093 . . . . 71.099999999999994 110.967 -178.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 10.4 p -136.83 119.25 15.79 Favored 'General case' 0 N--CA 1.41 -2.43 0 N-CA-C 106.56 -1.644 . . . . 72.439999999999998 106.56 177.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -170.12 -152.91 8.29 Favored Glycine 0 N--CA 1.415 -2.724 0 N-CA-C 110.596 -1.002 . . . . 72.519999999999996 110.596 -175.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 559' ' ' GLU . . . . . 0.503 ' HB3' HG23 ' A' ' 536' ' ' ILE . 34.7 mt-10 -135.03 127.47 30.48 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 122.364 0.265 . . . . 64.420000000000002 111.124 -176.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 96.1 mt -88.19 155.6 19.68 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.346 -0.612 . . . . 61.350000000000001 109.346 177.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 561' ' ' GLU . . . . . 0.424 ' CG ' HD21 ' A' ' 534' ' ' ASN . 31.9 tt0 -123.37 119.29 29.64 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-O 121.039 0.447 . . . . 74.219999999999999 111.471 -178.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -113.82 148.39 36.69 Favored 'General case' 0 CA--C 1.502 -0.881 0 C-N-CA 123.981 0.912 . . . . 75.329999999999998 109.492 176.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -127.87 167.55 16.43 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 120.243 -0.583 . . . . 72.430000000000007 109.45 177.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 564' ' ' ASN . . . . . 0.561 ' HB3' ' H ' ' A' ' 533' ' ' GLY . 32.1 p30 -66.87 -24.51 66.13 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.272 0.558 . . . . 22.449999999999999 111.142 178.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -102.72 -5.1 24.11 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.577 -0.738 . . . . 72.5 111.0 -177.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -115.35 134.86 54.72 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 116.4 -0.363 . . . . 72.409999999999997 110.599 -175.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 567' ' ' ILE . . . . . 0.504 ' HA ' ' HD3' ' A' ' 527' ' ' ARG . 9.5 pt -114.09 164.73 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 C-N-CA 120.969 -0.292 . . . . 51.109999999999999 110.267 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 568' ' ' VAL . . . . . 0.54 HG21 ' HD2' ' A' ' 524' ' ' LYS . 1.2 p 49.54 165.82 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.566 1.559 0 C-N-CA 127.301 2.24 . . . . 73.209999999999994 114.488 179.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 569' ' ' LYS . . . . . 0.512 ' HA ' ' HE3' ' A' ' 569' ' ' LYS . 1.0 OUTLIER -161.0 160.81 31.13 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 106.087 -1.82 . . . . 73.120000000000005 106.087 177.289 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 570' ' ' THR . . . . . 0.678 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 19.8 p -133.89 127.58 32.82 Favored 'General case' 0 N--CA 1.427 -1.601 0 O-C-N 123.478 0.486 . . . . 64.530000000000001 110.964 177.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 2.9 mp -76.62 125.45 36.4 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 107.016 -1.476 . . . . 70.140000000000001 107.016 173.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 24.4 m -99.44 109.37 21.94 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 120.859 0.361 . . . . 72.109999999999999 110.342 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 573' ' ' VAL . . . . . 0.47 HG22 ' CG2' ' A' ' 556' ' ' THR . 40.1 t -116.45 120.07 63.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 108.97 -0.752 . . . . 71.129999999999995 108.97 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 574' ' ' LYS . . . . . 0.515 ' HE2' ' HG3' ' A' ' 554' ' ' GLU . 38.8 ttpt -82.1 126.6 32.21 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-O 121.457 0.646 . . . . 75.230000000000004 110.938 177.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 82.5 t -91.51 134.84 28.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 107.982 -1.118 . . . . 55.0 107.982 178.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 576' ' ' ILE . . . . . 0.473 HG12 ' HA ' ' A' ' 553' ' ' PHE . 21.9 mm -105.69 160.05 5.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 107.475 -1.306 . . . . 72.129999999999995 107.475 -177.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -68.77 132.17 46.37 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 116.387 -0.37 . . . . 64.439999999999998 110.103 177.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.36 128.85 37.98 Favored 'General case' 0 CA--C 1.49 -1.342 0 CA-C-O 121.808 0.813 . . . . 64.239999999999995 111.405 -178.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 579' ' ' GLU . . . . . 0.442 ' H ' ' CD ' ' A' ' 579' ' ' GLU . 0.0 OUTLIER -100.18 -0.82 38.04 Favored 'General case' 0 C--N 1.275 -2.642 0 CA-C-N 114.02 -1.445 . . . . 73.109999999999999 113.335 -175.231 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 580' ' ' GLU . . . . . 0.542 ' HG2' ' O ' ' A' ' 581' ' ' TYR . 0.5 OUTLIER -137.29 -174.93 3.89 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.93 -0.481 . . . . 64.409999999999997 110.706 -176.63 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 581' ' ' TYR . . . . . 0.542 ' O ' ' HG2' ' A' ' 580' ' ' GLU . 28.5 p90 -65.63 154.32 39.13 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 108.706 -0.85 . . . . 71.230000000000004 108.706 174.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -86.0 152.26 23.06 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 114.988 1.477 . . . . 74.030000000000001 114.988 -176.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -157.71 172.74 17.97 Favored 'General case' 0 N--CA 1.433 -1.283 0 C-N-CA 126.77 2.028 . . . . 75.340000000000003 105.611 176.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -80.77 97.68 7.43 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.075 -1.454 . . . . 75.129999999999995 107.075 176.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 585' ' ' LYS . . . . . 0.474 ' HD2' HD13 ' A' ' 646' ' ' ILE . 0.0 OUTLIER -113.68 136.0 53.32 Favored 'General case' 0 N--CA 1.416 -2.152 0 CA-C-N 115.365 -0.834 . . . . 71.120000000000005 110.363 -175.652 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 3.9 t -151.33 146.97 26.38 Favored 'General case' 0 N--CA 1.421 -1.917 0 CA-C-N 115.137 -0.938 . . . . 75.409999999999997 110.483 -174.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 587' ' ' PHE . . . . . 0.4 ' CE2' HD11 ' A' ' 646' ' ' ILE . 2.5 p90 -122.18 155.62 35.4 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 114.6 -1.182 . . . . 64.129999999999995 109.628 177.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 588' ' ' PHE . . . . . 0.514 ' HA ' ' O ' ' A' ' 642' ' ' LEU . 34.9 m-85 -110.71 145.73 37.51 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.721 -0.474 . . . . 71.340000000000003 109.721 -174.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -116.25 119.62 36.32 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 106.491 -1.67 . . . . 73.329999999999998 106.491 176.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -125.5 138.78 53.99 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 108.847 -0.797 . . . . 60.329999999999998 108.847 -178.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 591' ' ' ILE . . . . . 0.443 HG22 ' HB3' ' A' ' 539' ' ' TYR . 27.3 pt -103.73 151.03 6.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 108.502 -0.925 . . . . 71.030000000000001 108.502 176.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -93.72 -150.09 26.26 Favored Glycine 0 N--CA 1.427 -1.918 0 N-CA-C 110.855 -0.898 . . . . 64.140000000000001 110.855 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -86.3 119.63 71.7 Favored Pre-proline 0 C--N 1.301 -1.53 0 N-CA-C 108.552 -0.907 . . . . 73.530000000000001 108.552 178.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 594' ' ' PRO . . . . . 0.456 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 12.9 Cg_endo -57.47 149.13 68.09 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 122.37 2.047 . . . . 73.439999999999998 111.175 177.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -128.66 132.84 48.1 Favored 'General case' 0 C--N 1.291 -1.959 0 O-C-N 121.996 -0.44 . . . . 72.049999999999997 110.306 -173.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 596' ' ' LEU . . . . . 0.509 HD22 HG22 ' A' ' 535' ' ' VAL . 0.0 OUTLIER -77.43 128.12 33.7 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.671 -1.233 . . . . 71.150000000000006 107.671 -177.337 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 597' ' ' VAL . . . . . 0.459 ' CG2' HG12 ' A' ' 536' ' ' ILE . 52.2 t . . . . . 0 C--N 1.315 -0.92 0 CA-C-O 121.869 0.842 . . . . 73.409999999999997 109.373 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.43 -1.442 0 N-CA-C 105.894 -1.891 . . . . 75.219999999999999 105.894 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . 0.456 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 18.2 Cg_endo -63.17 144.81 92.88 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 121.203 1.268 . . . . 72.540000000000006 110.485 175.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.3 pp -122.48 169.25 14.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 113.46 0.911 . . . . 73.340000000000003 113.46 -177.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . 0.445 ' HB2' HG21 ' A' ' 640' ' ' THR . 0.0 OUTLIER -73.85 168.34 19.63 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 123.788 0.835 . . . . 62.5 112.106 -176.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -113.18 -157.51 12.72 Favored Glycine 0 N--CA 1.437 -1.282 0 N-CA-C 115.704 1.042 . . . . 72.049999999999997 115.704 -174.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -42.65 -59.32 1.96 Allowed 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 128.107 2.563 . . . . 64.329999999999998 114.751 -173.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 10.6 p80 -140.06 109.63 6.28 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 122.019 0.914 . . . . 63.340000000000003 111.812 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 640' ' ' THR . . . . . 0.445 HG21 ' HB2' ' A' ' 636' ' ' LEU . 11.0 p -114.61 91.71 3.71 Favored 'General case' 0 N--CA 1.411 -2.412 0 CA-C-N 115.008 -0.996 . . . . 71.519999999999996 111.102 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 641' ' ' LYS . . . . . 0.451 ' HE2' ' HB2' ' A' ' 643' ' ' GLU . 1.0 OUTLIER -175.23 137.25 0.39 Allowed 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 105.353 -2.091 . . . . 75.340000000000003 105.353 178.779 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 642' ' ' LEU . . . . . 0.514 ' O ' ' HA ' ' A' ' 588' ' ' PHE . 27.6 tp -135.31 114.14 11.94 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 108.775 -0.824 . . . . 74.430000000000007 108.775 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . 0.542 ' HB3' HG22 ' A' ' 511' ' ' VAL . 28.6 tt0 -98.31 110.04 22.69 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 107.127 -1.434 . . . . 74.099999999999994 107.127 176.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 644' ' ' VAL . . . . . 0.582 HG21 ' HE2' ' A' ' 521' ' ' MET . 22.0 t -97.46 102.08 13.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 109.77 -0.456 . . . . 63.229999999999997 109.77 -177.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 4.0 mp -89.15 120.18 37.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 N-CA-C 107.799 -1.186 . . . . 74.450000000000003 107.799 177.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 646' ' ' ILE . . . . . 0.474 HD13 ' HD2' ' A' ' 585' ' ' LYS . 2.8 mp -99.83 106.71 19.55 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.505 0 N-CA-C 106.724 -1.584 . . . . 74.540000000000006 106.724 -176.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -104.87 155.43 18.93 Favored 'General case' 0 C--N 1.279 -2.497 0 CA-C-O 121.237 0.541 . . . . 63.43 111.565 -177.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -60.84 162.61 6.6 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.052 -0.976 . . . . 62.539999999999999 113.479 -174.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 CA--C 1.557 1.223 0 CA-C-O 123.184 1.469 . . . . 75.420000000000002 107.654 177.939 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . 0.447 ' HA3' ' OG1' ' A' ' 528' ' ' THR . . . . . . . . 0 N--CA 1.406 -3.328 0 N-CA-C 114.128 0.411 . . . . 71.209999999999994 114.128 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 4.0 mp -125.61 134.88 65.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 123.879 0.871 . . . . 74.0 108.927 -173.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -131.2 127.62 38.29 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.343 -0.614 . . . . 74.239999999999995 109.343 173.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . 0.453 ' HB ' ' HA3' ' A' ' 637' ' ' GLY . 15.0 t -154.25 164.49 38.48 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 109.443 -0.577 . . . . 53.439999999999998 109.443 -177.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -94.8 157.67 15.83 Favored 'General case' 0 CA--C 1.493 -1.242 0 N-CA-C 108.647 -0.871 . . . . 74.140000000000001 108.647 175.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -93.75 -33.81 13.46 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 106.882 -1.525 . . . . 72.420000000000002 106.882 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -95.61 120.9 62.75 Favored Pre-proline 0 CA--C 1.49 -1.362 0 CA-C-N 114.285 -1.325 . . . . 60.340000000000003 110.097 175.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 510' ' ' PRO . . . . . 0.489 ' HA ' ' O ' ' A' ' 641' ' ' LYS . 2.7 Cg_exo -80.88 -20.88 7.33 Favored 'Trans proline' 0 N--CA 1.44 -1.643 0 N-CA-C 108.251 -1.48 . . . . 72.409999999999997 108.251 165.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 99.2 t -145.06 138.73 22.16 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 C-N-CA 124.876 1.27 . . . . 75.430000000000007 109.061 -178.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 10.1 t -137.02 138.99 41.08 Favored 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 107.025 -1.472 . . . . 62.200000000000003 107.025 175.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 75.7 m-70 -109.99 116.13 31.04 Favored 'General case' 0 CA--C 1.488 -1.414 0 N-CA-C 109.064 -0.717 . . . . 72.230000000000004 109.064 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.627 HG11 ' SD ' ' A' ' 521' ' ' MET . 33.4 m -109.18 155.58 10.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 CA-C-O 122.024 0.916 . . . . 55.109999999999999 112.226 -174.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . 0.465 ' O ' HG22 ' A' ' 518' ' ' ILE . 51.0 m -77.89 156.88 30.07 Favored 'General case' 0 N--CA 1.389 -3.502 0 CA-C-N 113.597 -1.638 . . . . 72.420000000000002 110.286 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . 0.43 ' HB2' ' O ' ' A' ' 647' ' ' GLU . 20.8 tp10 -87.7 -18.68 28.95 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 107.847 -1.168 . . . . 73.319999999999993 107.847 177.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 30.4 m -96.66 18.37 14.43 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.601 -0.727 . . . . 71.409999999999997 110.739 -176.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 518' ' ' ILE . . . . . 0.465 HG22 ' O ' ' A' ' 515' ' ' SER . 13.9 tt -102.81 152.22 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.631 0 N-CA-C 108.388 -0.968 . . . . 75.409999999999997 108.388 -177.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -92.89 -70.05 1.14 Allowed Glycine 0 N--CA 1.424 -2.133 0 C-N-CA 119.832 -1.175 . . . . 42.009999999999998 110.777 176.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 42.6 mm -117.34 125.21 73.87 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 N-CA-C 108.657 -0.868 . . . . 75.310000000000002 108.657 -176.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 521' ' ' MET . . . . . 0.672 ' HE1' HG21 ' A' ' 644' ' ' VAL . 22.6 ptt? -95.96 136.55 36.25 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 107.322 -1.362 . . . . 74.120000000000005 107.322 172.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 29.3 mp0 -115.79 107.56 15.2 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 108.191 -1.04 . . . . 74.430000000000007 108.191 177.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . 0.543 HG21 HD21 ' A' ' 642' ' ' LEU . 35.0 t -98.03 128.05 49.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 109.582 -0.525 . . . . 70.129999999999995 109.582 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -73.87 156.61 37.53 Favored 'General case' 0 C--N 1.317 -0.837 0 O-C-N 123.71 0.631 . . . . 74.109999999999999 111.141 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 27.2 t -127.74 144.4 37.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 N-CA-C 107.067 -1.457 . . . . 54.039999999999999 107.067 176.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -75.74 140.0 42.17 Favored 'General case' 0 CA--C 1.493 -1.237 0 N-CA-C 109.363 -0.606 . . . . 73.319999999999993 109.363 177.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . 0.475 ' CZ ' HG22 ' A' ' 567' ' ' ILE . 35.8 ttt180 -91.03 147.22 23.23 Favored 'General case' 0 N--CA 1.414 -2.24 0 CA-C-N 115.238 -0.892 . . . . 73.140000000000001 109.246 -176.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . 0.447 ' OG1' ' HA3' ' A' ' 503' ' ' GLY . 4.2 t -59.54 146.48 40.46 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 114.737 -1.12 . . . . 71.400000000000006 112.122 177.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 15.7 t -79.54 -15.6 57.41 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 108.128 -1.064 . . . . 72.150000000000006 108.128 176.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -118.75 93.76 0.57 Allowed Glycine 0 N--CA 1.432 -1.598 0 N-CA-C 109.396 -1.481 . . . . 72.25 109.396 176.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -102.17 93.37 5.19 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.393 0.616 . . . . 63.530000000000001 110.572 -177.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -116.52 115.03 25.01 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.738 -0.664 . . . . 74.049999999999997 111.698 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 77.64 -121.17 5.72 Favored Glycine 0 N--CA 1.435 -1.372 0 CA-C-N 115.208 -0.905 . . . . 73.200000000000003 113.275 173.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 534' ' ' ASN . . . . . 0.608 HD21 ' HG3' ' A' ' 561' ' ' GLU . 2.6 t-20 -139.44 127.6 22.5 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.262 -1.014 . . . . 73.340000000000003 108.262 -178.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 535' ' ' VAL . . . . . 0.529 HG22 HD22 ' A' ' 596' ' ' LEU . 54.8 t -123.52 124.57 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.742 0 N-CA-C 109.496 -0.557 . . . . 63.530000000000001 109.496 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 536' ' ' ILE . . . . . 0.504 HG23 ' HB3' ' A' ' 559' ' ' GLU . 29.9 mm -93.66 120.53 43.21 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 CA-C-N 114.966 -1.015 . . . . 64.420000000000002 109.135 178.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . 0.436 HG22 ' HB3' ' A' ' 594' ' ' PRO . 21.9 t -113.84 104.57 55.06 Favored Pre-proline 0 C--N 1.303 -1.451 0 N-CA-C 109.242 -0.651 . . . . 74.340000000000003 109.242 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -70.79 153.05 64.39 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 121.961 1.774 . . . . 72.430000000000007 110.978 177.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 539' ' ' TYR . . . . . 0.407 ' CD1' ' HG ' ' A' ' 560' ' ' LEU . 52.7 p90 -150.97 159.93 44.25 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.021 -0.733 . . . . 72.430000000000007 109.021 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -155.15 154.98 33.14 Favored 'General case' 0 C--N 1.316 -0.851 0 O-C-N 123.721 0.638 . . . . 75.420000000000002 110.605 177.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 18.0 p -93.4 116.11 28.66 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.853 -0.612 . . . . 73.319999999999993 109.369 174.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.5 mp -83.35 122.29 37.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 105.608 -1.997 . . . . 72.439999999999998 105.608 174.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -51.86 -39.45 58.93 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.115 0.783 . . . . 71.420000000000002 113.115 -175.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 74.74 -86.68 0.75 Allowed Glycine 0 N--CA 1.437 -1.273 0 N-CA-C 110.521 -1.032 . . . . 65.230000000000004 110.521 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 11.3 t -143.17 14.07 1.84 Allowed 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 122.488 1.137 . . . . 70.030000000000001 108.899 177.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . 0.456 ' HB2' ' HD3' ' A' ' 585' ' ' LYS . . . -96.74 -167.64 1.59 Allowed 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 114.714 -1.13 . . . . 65.140000000000001 109.512 177.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . 0.489 ' H ' ' HB3' ' A' ' 552' ' ' ASP . 0.0 OUTLIER -136.23 122.79 20.88 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 106.97 -1.493 . . . . 74.140000000000001 106.97 -178.944 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -78.7 -153.97 7.42 Favored Glycine 0 C--N 1.303 -1.261 0 O-C-N 123.587 0.554 . . . . 41.200000000000003 112.802 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 63.92 10.5 39.59 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 114.909 0.723 . . . . 63.009999999999998 114.909 177.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 86.18 14.19 67.13 Favored Glycine 0 N--CA 1.433 -1.561 0 C-N-CA 120.285 -0.96 . . . . 50.539999999999999 112.02 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . 0.481 ' OE2' ' HG3' ' A' ' 547' ' ' ARG . 31.8 tt0 -84.59 -61.45 1.79 Allowed 'General case' 0 C--O 1.236 0.393 0 N-CA-C 109.574 -0.528 . . . . 74.319999999999993 109.574 178.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . 0.489 ' HB3' ' H ' ' A' ' 547' ' ' ARG . 17.4 t70 -105.71 -36.95 6.9 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.628 -0.879 . . . . 74.540000000000006 108.628 177.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 553' ' ' PHE . . . . . 0.515 ' HA ' HG12 ' A' ' 576' ' ' ILE . 14.0 p90 -147.97 162.61 38.98 Favored 'General case' 0 N--CA 1.428 -1.525 0 N-CA-C 108.37 -0.974 . . . . 64.209999999999994 108.37 173.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -93.9 111.42 23.12 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 105.898 -1.89 . . . . 72.329999999999998 105.898 178.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -81.68 123.53 28.8 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-O 121.873 0.844 . . . . 71.420000000000002 110.419 -175.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 10.2 t -119.89 140.97 50.03 Favored 'General case' 0 N--CA 1.412 -2.338 0 CA-C-O 121.84 0.829 . . . . 63.299999999999997 110.664 -174.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 5.9 p -144.85 134.08 22.9 Favored 'General case' 0 N--CA 1.413 -2.324 0 N-CA-C 106.638 -1.615 . . . . 74.219999999999999 106.638 177.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -167.82 -153.87 8.34 Favored Glycine 0 N--CA 1.412 -2.954 0 C-N-CA 119.715 -1.231 . . . . 75.109999999999999 110.83 -175.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 559' ' ' GLU . . . . . 0.504 ' HB3' HG23 ' A' ' 536' ' ' ILE . 35.7 mt-10 -140.86 124.89 17.25 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 122.961 0.504 . . . . 74.030000000000001 109.828 -174.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . 0.407 ' HG ' ' CD1' ' A' ' 539' ' ' TYR . 95.4 mt -90.36 134.81 34.08 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 110.113 -0.329 . . . . 54.020000000000003 110.113 178.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 561' ' ' GLU . . . . . 0.608 ' HG3' HD21 ' A' ' 534' ' ' ASN . 43.7 tt0 -102.47 100.89 11.04 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.461 -0.791 . . . . 72.439999999999998 111.208 -176.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -99.62 144.63 28.49 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 109.202 -0.666 . . . . 72.030000000000001 109.202 174.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -138.78 171.28 14.57 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 109.82 -0.437 . . . . 73.030000000000001 109.82 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 19.4 p30 -64.72 -27.53 68.97 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 116.098 -0.501 . . . . 61.100000000000001 111.26 176.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -100.97 -23.88 14.44 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 116.159 -0.473 . . . . 62.509999999999998 111.783 177.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -85.38 128.56 34.76 Favored 'General case' 0 C--O 1.248 0.974 0 N-CA-C 110.227 -0.286 . . . . 75.209999999999994 110.227 -178.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 567' ' ' ILE . . . . . 0.475 HG22 ' CZ ' ' A' ' 527' ' ' ARG . 1.5 pp -116.42 138.49 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.024 0 N-CA-C 109.028 -0.73 . . . . 73.150000000000006 109.028 -179.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 568' ' ' VAL . . . . . 0.424 HG12 ' O ' ' A' ' 567' ' ' ILE . 1.4 p 58.66 153.75 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.153 0 C-N-CA 126.554 1.942 . . . . 62.340000000000003 113.88 177.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 569' ' ' LYS . . . . . 0.638 ' HA ' ' HE2' ' A' ' 569' ' ' LYS . 7.2 mmpt? -141.1 165.93 26.18 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.92 -0.77 . . . . 74.340000000000003 108.92 175.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 570' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 7.2 p -134.48 141.81 46.87 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 124.202 0.939 . . . . 73.209999999999994 110.886 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 2.7 mp -95.4 120.88 45.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 106.656 -1.609 . . . . 70.319999999999993 106.656 173.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 8.5 p -97.39 121.81 39.71 Favored 'General case' 0 N--CA 1.427 -1.618 0 O-C-N 123.683 0.615 . . . . 75.049999999999997 110.193 178.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 573' ' ' VAL . . . . . . . . . . . . . 52.1 t -130.51 134.72 61.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 N-CA-C 109.032 -0.729 . . . . 45.420000000000002 109.032 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -89.8 120.0 30.67 Favored 'General case' 0 C--O 1.248 0.985 0 O-C-N 123.705 0.628 . . . . 74.200000000000003 110.458 177.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 99.5 t -84.57 125.43 40.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 107.74 -1.207 . . . . 71.420000000000002 107.74 175.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 576' ' ' ILE . . . . . 0.515 HG12 ' HA ' ' A' ' 553' ' ' PHE . 31.1 mm -96.44 147.5 6.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 106.899 -1.519 . . . . 74.209999999999994 106.899 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -64.76 125.48 24.94 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 123.533 0.521 . . . . 53.329999999999998 110.387 -178.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -52.25 115.32 1.68 Allowed 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 114.636 1.347 . . . . 74.430000000000007 114.636 176.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.03 -38.16 66.63 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 112.633 -2.076 . . . . 74.319999999999993 109.035 176.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.98 -176.35 3.53 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 114.963 -1.017 . . . . 64.049999999999997 113.169 -176.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -52.74 153.71 3.1 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 126.159 1.784 . . . . 73.349999999999994 109.972 175.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 582' ' ' GLU . . . . . 0.507 ' OE2' ' HB ' ' A' ' 646' ' ' ILE . 33.1 tt0 -130.2 113.81 14.91 Favored 'General case' 0 C--N 1.287 -2.118 0 C-N-CA 119.05 -1.06 . . . . 73.420000000000002 111.988 178.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -89.26 -157.73 0.47 Allowed 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 106.285 -1.746 . . . . 71.340000000000003 106.285 173.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -75.19 76.69 2.33 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.392 -1.336 . . . . 65.409999999999997 107.392 171.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 585' ' ' LYS . . . . . 0.456 ' HD3' ' HB2' ' A' ' 546' ' ' ALA . 0.7 OUTLIER -104.42 128.96 52.41 Favored 'General case' 0 N--CA 1.402 -2.838 0 N-CA-C 107.715 -1.217 . . . . 73.310000000000002 107.715 -179.237 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 2.9 t -151.92 153.63 34.5 Favored 'General case' 0 N--CA 1.393 -3.276 0 CA-C-N 114.845 -1.07 . . . . 75.420000000000002 110.093 -172.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 587' ' ' PHE . . . . . 0.522 ' CE2' HD11 ' A' ' 646' ' ' ILE . 0.8 OUTLIER -119.92 148.77 43.1 Favored 'General case' 0 N--CA 1.422 -1.858 0 O-C-N 124.668 1.23 . . . . 75.129999999999995 108.648 175.365 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 588' ' ' PHE . . . . . 0.421 ' CD1' ' HE3' ' A' ' 641' ' ' LYS . 13.8 m-85 -107.26 133.18 52.2 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.769 -0.456 . . . . 72.420000000000002 109.769 -172.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . 0.469 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.3 OUTLIER -102.91 130.42 49.95 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 106.054 -1.832 . . . . 64.430000000000007 106.054 173.638 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -139.33 151.18 46.19 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 107.149 -1.426 . . . . 71.5 107.149 178.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 591' ' ' ILE . . . . . . . . . . . . . 23.4 pt -107.24 152.14 8.91 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 O-C-N 123.234 0.334 . . . . 73.120000000000005 110.18 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -95.7 -164.42 34.26 Favored Glycine 0 N--CA 1.435 -1.38 0 N-CA-C 111.648 -0.581 . . . . 64.340000000000003 111.648 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -68.74 114.77 24.75 Favored Pre-proline 0 C--O 1.248 1.011 0 C-N-CA 122.572 0.349 . . . . 71.409999999999997 110.067 -177.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 594' ' ' PRO . . . . . 0.579 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 39.3 Cg_endo -69.39 134.08 27.86 Favored 'Trans proline' 0 N--CA 1.439 -1.725 0 C-N-CA 121.816 1.677 . . . . 73.519999999999996 109.774 177.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -122.89 127.08 48.49 Favored 'General case' 0 C--N 1.282 -2.349 0 CA-C-O 121.218 0.532 . . . . 62.509999999999998 111.651 -172.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 596' ' ' LEU . . . . . 0.529 HD22 HG22 ' A' ' 535' ' ' VAL . 0.0 OUTLIER -75.31 125.79 29.68 Favored 'General case' 0 N--CA 1.428 -1.525 0 N-CA-C 106.82 -1.548 . . . . 72.420000000000002 106.82 -179.686 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 94.7 t . . . . . 0 C--N 1.297 -1.712 0 N-CA-C 112.38 0.511 . . . . 75.25 112.38 -176.692 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.888 0 CA-C-O 121.347 0.594 . . . . 70.109999999999999 111.69 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . 0.579 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 8.0 Cg_endo -70.25 143.13 47.56 Favored 'Trans proline' 0 N--CA 1.432 -2.112 0 N-CA-C 105.815 -2.417 . . . . 73.219999999999999 105.815 162.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.0 pp -129.43 -178.28 2.41 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 N-CA-C 115.54 1.681 . . . . 73.030000000000001 115.54 -174.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 2.5 tp -70.79 148.22 48.12 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 113.635 -1.62 . . . . 71.040000000000006 109.959 -178.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . 0.453 ' HA3' ' HB ' ' A' ' 506' ' ' THR . . . -89.39 -133.04 4.78 Favored Glycine 0 N--CA 1.423 -2.219 0 C-N-CA 120.631 -0.795 . . . . 52.119999999999997 111.698 174.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -98.09 -54.2 3.15 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 122.638 -0.331 . . . . 75.230000000000004 111.555 -175.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -124.58 93.98 4.06 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 122.285 1.04 . . . . 74.430000000000007 112.904 -178.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 3.1 p -100.7 91.21 4.53 Favored 'General case' 0 N--CA 1.404 -2.75 0 CA-C-N 114.545 -1.207 . . . . 73.219999999999999 108.992 174.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 641' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 510' ' ' PRO . 21.0 tptm -169.76 130.44 1.03 Allowed 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 106.992 -1.484 . . . . 74.430000000000007 106.992 -175.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 642' ' ' LEU . . . . . 0.543 HD21 HG21 ' A' ' 523' ' ' VAL . 41.5 tp -132.57 103.45 6.16 Favored 'General case' 0 C--N 1.272 -2.778 0 N-CA-C 107.225 -1.398 . . . . 74.420000000000002 107.225 175.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . 0.429 ' HB2' ' HE2' ' A' ' 641' ' ' LYS . 22.0 tt0 -91.4 104.91 17.37 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 107.196 -1.409 . . . . 71.310000000000002 107.196 178.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 644' ' ' VAL . . . . . 0.672 HG21 ' HE1' ' A' ' 521' ' ' MET . 21.6 t -92.4 99.03 9.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-N 115.904 -0.589 . . . . 64.120000000000005 110.085 -176.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 3.5 mp -87.6 127.12 41.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 107.928 -1.138 . . . . 74.310000000000002 107.928 177.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 646' ' ' ILE . . . . . 0.522 HD11 ' CE2' ' A' ' 587' ' ' PHE . 1.7 mp -101.58 141.62 17.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 106.691 -1.596 . . . . 72.299999999999997 106.691 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . 0.43 ' O ' ' HB2' ' A' ' 516' ' ' GLU . 2.0 pt-20 -135.43 159.65 40.92 Favored 'General case' 0 C--N 1.264 -3.144 0 N-CA-C 107.38 -1.341 . . . . 74.430000000000007 107.38 178.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -72.62 77.1 1.09 Allowed 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 121.829 0.823 . . . . 61.119999999999997 110.296 174.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 4.3 t . . . . . 0 C--N 1.317 -0.844 0 C-N-CA 129.372 3.069 . . . . 65.319999999999993 115.886 177.326 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . 0.598 ' HA2' ' OG1' ' A' ' 528' ' ' THR . . . . . . . . 0 N--CA 1.414 -2.825 0 N-CA-C 114.979 0.751 . . . . 43.530000000000001 114.979 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 4.0 mp -138.58 96.3 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 N-CA-C 105.624 -1.991 . . . . 51.030000000000001 105.624 171.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -120.86 108.32 13.78 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 108.869 -0.789 . . . . 71.030000000000001 108.869 178.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 11.4 t -139.26 160.81 38.93 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 108.02 -1.104 . . . . 72.150000000000006 108.02 -176.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -85.68 148.9 25.66 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.675 -0.491 . . . . 70.340000000000003 109.675 175.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -73.51 -31.23 63.59 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.435 -0.95 . . . . 73.319999999999993 108.435 177.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -138.72 135.89 18.23 Favored Pre-proline 0 N--CA 1.44 -0.964 0 N-CA-C 109.431 -0.581 . . . . 75.010000000000005 109.431 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -82.2 -13.04 10.28 Favored 'Trans proline' 0 C--O 1.218 -0.485 0 C-N-CA 122.671 2.247 . . . . 33.409999999999997 112.08 178.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . 0.545 HG22 ' HB3' ' A' ' 643' ' ' GLU . 70.6 t -140.63 137.66 35.79 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.858 0 N-CA-C 108.365 -0.976 . . . . 63.409999999999997 108.365 -178.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 4.9 t -143.6 137.06 28.07 Favored 'General case' 0 N--CA 1.419 -1.993 0 N-CA-C 107.925 -1.139 . . . . 73.25 107.925 177.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -106.82 126.49 52.37 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 109.106 -0.702 . . . . 75.120000000000005 109.106 176.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 29.1 m -126.92 161.47 33.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 115.751 -0.659 . . . . 64.209999999999994 109.373 -175.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 33.8 t -85.54 161.86 19.15 Favored 'General case' 0 N--CA 1.424 -1.759 0 N-CA-C 108.527 -0.916 . . . . 73.329999999999998 108.527 178.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -99.3 -11.83 20.89 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-O 121.376 0.608 . . . . 73.010000000000005 109.366 177.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 48.8 m -91.41 8.94 33.84 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.637 0.732 . . . . 70.129999999999995 109.885 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 13.6 tt -90.29 157.16 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 N-CA-C 108.122 -1.066 . . . . 65.010000000000005 108.122 -178.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -88.48 -57.07 1.91 Allowed Glycine 0 N--CA 1.438 -1.199 0 C-N-CA 120.201 -1.0 . . . . 61.340000000000003 111.282 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . 0.456 HD13 ' HA ' ' A' ' 574' ' ' LYS . 44.9 mm -127.39 136.65 60.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 108.778 -0.823 . . . . 43.329999999999998 108.778 -178.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 521' ' ' MET . . . . . 0.587 ' HE2' HG21 ' A' ' 644' ' ' VAL . 0.0 OUTLIER -111.03 133.28 53.54 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.077 -1.453 . . . . 72.099999999999994 107.077 171.103 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 -117.38 128.78 55.37 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 109.294 -0.632 . . . . 72.519999999999996 109.294 -176.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . 0.64 HG21 HD21 ' A' ' 642' ' ' LEU . 20.5 t -119.81 134.87 61.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 N-CA-C 109.746 -0.464 . . . . 65.049999999999997 109.746 179.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . 0.419 ' HD2' HG21 ' A' ' 568' ' ' VAL . 29.3 mmtp -80.39 129.45 34.51 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 113.792 1.034 . . . . 62.210000000000001 113.792 -177.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 3.3 t -112.46 133.5 58.02 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 N-CA-C 106.644 -1.613 . . . . 55.32 106.644 177.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -86.76 139.67 30.49 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 120.477 -0.489 . . . . 72.209999999999994 109.723 -178.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . 0.472 ' HG2' ' N ' ' A' ' 528' ' ' THR . 37.6 ttp180 -86.96 157.73 19.42 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.103 0.478 . . . . 65.040000000000006 111.176 -176.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . 0.598 ' OG1' ' HA2' ' A' ' 503' ' ' GLY . 4.2 t -58.36 158.48 7.29 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 125.006 1.323 . . . . 71.209999999999994 111.674 173.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 32.8 t -87.94 -7.37 57.22 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 115.021 -0.99 . . . . 70.310000000000002 109.406 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -132.13 110.39 0.94 Allowed Glycine 0 N--CA 1.436 -1.324 0 N-CA-C 109.409 -1.476 . . . . 60.119999999999997 109.409 178.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . 0.408 ' HB2' HG23 ' A' ' 528' ' ' THR . . . -155.35 92.85 1.45 Allowed 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 109.3 -0.63 . . . . 65.219999999999999 109.3 -175.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.54 23.8 13.88 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 115.318 -0.856 . . . . 75.030000000000001 111.085 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . -177.26 -168.26 36.8 Favored Glycine 0 N--CA 1.42 -2.392 0 N-CA-C 110.461 -1.056 . . . . 64.120000000000005 110.461 -174.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 534' ' ' ASN . . . . . 0.534 HD21 ' HG3' ' A' ' 561' ' ' GLU . 2.9 t-20 -85.37 132.82 34.17 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 123.482 0.713 . . . . 75.549999999999997 110.304 -177.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 535' ' ' VAL . . . . . 0.513 HG22 HD22 ' A' ' 596' ' ' LEU . 58.0 t -128.13 124.74 63.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 108.871 -0.789 . . . . 50.299999999999997 108.871 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 536' ' ' ILE . . . . . 0.506 HG23 ' HB3' ' A' ' 559' ' ' GLU . 19.7 mm -97.85 127.8 49.87 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 CA-C-N 115.921 -0.581 . . . . 62.039999999999999 109.931 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . 0.521 HG22 ' HB3' ' A' ' 594' ' ' PRO . 41.5 t -117.1 103.74 51.48 Favored Pre-proline 0 C--N 1.309 -1.187 0 N-CA-C 108.684 -0.858 . . . . 73.420000000000002 108.684 176.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -71.95 144.47 43.04 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.193 1.929 . . . . 63.119999999999997 110.769 178.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 539' ' ' TYR . . . . . 0.487 ' HB3' HG22 ' A' ' 591' ' ' ILE . 49.0 p90 -145.75 167.31 23.46 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 109.414 -0.587 . . . . 73.0 109.414 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -158.97 157.14 30.73 Favored 'General case' 0 C--N 1.308 -1.222 0 O-C-N 123.711 0.632 . . . . 74.530000000000001 109.781 177.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 3.3 p -93.17 113.6 25.88 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 115.143 -0.935 . . . . 55.310000000000002 110.546 175.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.3 mp -78.47 118.01 24.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 N-CA-C 104.781 -2.303 . . . . 70.040000000000006 104.781 173.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -53.65 -43.12 68.55 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 124.019 0.825 . . . . 52.140000000000001 112.76 -174.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 67.19 -89.71 0.17 Allowed Glycine 0 N--CA 1.451 -0.327 0 O-C-N 123.491 0.494 . . . . 71.510000000000005 112.258 176.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 7.4 t -137.2 20.06 2.97 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.3 0.571 . . . . 74.040000000000006 110.166 178.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . 0.434 ' HB2' ' HG2' ' A' ' 585' ' ' LYS . . . -119.37 166.41 13.08 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.465 -0.939 . . . . 74.140000000000001 108.465 175.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . 0.444 ' HB2' ' HB2' ' A' ' 551' ' ' GLU . 0.0 OUTLIER -95.72 114.04 25.74 Favored 'General case' 0 CA--C 1.488 -1.438 0 C-N-CA 120.012 -0.675 . . . . 71.230000000000004 112.643 176.872 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -94.77 108.81 3.74 Favored Glycine 0 C--N 1.291 -1.928 0 N-CA-C 110.061 -1.216 . . . . 74.519999999999996 110.061 178.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 154.43 8.76 0.08 OUTLIER Glycine 0 C--N 1.295 -1.735 0 C-N-CA 119.341 -1.409 . . . . 53.32 112.703 -178.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 109.3 5.18 30.42 Favored Glycine 0 N--CA 1.431 -1.649 0 C-N-CA 119.234 -1.46 . . . . 71.200000000000003 113.585 178.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . 0.444 ' HB2' ' HB2' ' A' ' 547' ' ' ARG . 15.2 mm-40 -84.29 -70.39 0.58 Allowed 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 117.614 0.707 . . . . 63.240000000000002 109.212 177.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -101.31 -39.56 7.54 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 108.276 -1.009 . . . . 62.119999999999997 108.276 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -139.33 160.88 38.8 Favored 'General case' 0 C--O 1.262 1.715 0 CA-C-O 121.238 0.542 . . . . 71.120000000000005 109.617 179.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.21 119.28 29.56 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 106.675 -1.602 . . . . 72.400000000000006 106.675 179.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -67.06 101.81 0.92 Allowed 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 122.979 0.512 . . . . 73.549999999999997 109.671 -178.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . 0.509 HG21 HG22 ' A' ' 573' ' ' VAL . 12.4 t -100.78 110.75 22.87 Favored 'General case' 0 N--CA 1.413 -2.308 0 CA-C-O 122.689 1.233 . . . . 72.030000000000001 110.779 -176.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 1.7 p -133.39 96.69 3.78 Favored 'General case' 0 N--CA 1.413 -2.297 0 CA-C-N 114.234 -1.348 . . . . 62.329999999999998 108.66 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -147.03 -153.33 5.88 Favored Glycine 0 N--CA 1.408 -3.167 0 N-CA-C 110.518 -1.033 . . . . 61.039999999999999 110.518 -173.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 559' ' ' GLU . . . . . 0.506 ' HB3' HG23 ' A' ' 536' ' ' ILE . 33.3 mt-10 -133.73 124.64 27.02 Favored 'General case' 0 C--N 1.29 -2.001 0 O-C-N 123.605 0.238 . . . . 61.039999999999999 111.289 -172.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . 0.455 ' HG ' ' CD2' ' A' ' 539' ' ' TYR . 93.2 mt -80.99 133.03 35.42 Favored 'General case' 0 C--O 1.247 0.929 0 N-CA-C 109.765 -0.457 . . . . 64.0 109.765 177.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 561' ' ' GLU . . . . . 0.534 ' HG3' HD21 ' A' ' 534' ' ' ASN . 43.9 tt0 -96.78 98.19 9.94 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 115.986 -0.552 . . . . 74.319999999999993 111.475 -178.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -96.98 150.88 20.27 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 107.004 -1.48 . . . . 71.549999999999997 107.004 172.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . 0.406 ' HA ' ' HA ' ' A' ' 534' ' ' ASN . 1.9 pt20 -156.53 172.7 18.08 Favored 'General case' 0 C--N 1.28 -2.434 0 O-C-N 121.926 -0.484 . . . . 72.109999999999999 111.044 -178.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -52.14 -47.15 65.54 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 124.687 1.195 . . . . 62.020000000000003 111.012 -177.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -90.15 4.84 49.25 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 114.061 1.134 . . . . 75.209999999999994 114.061 -177.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 24.8 tp10 -121.79 126.63 49.27 Favored 'General case' 0 C--N 1.309 -1.189 0 O-C-N 121.76 -0.587 . . . . 74.409999999999997 110.555 -178.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 567' ' ' ILE . . . . . 0.456 ' HA ' ' HD3' ' A' ' 527' ' ' ARG . 4.9 pt -111.39 159.72 11.18 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.868 0 N-CA-C 109.266 -0.642 . . . . 72.319999999999993 109.266 174.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 568' ' ' VAL . . . . . 0.419 HG21 ' HD2' ' A' ' 524' ' ' LYS . 1.4 p 50.14 176.28 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.57 1.748 0 C-N-CA 125.955 1.702 . . . . 73.030000000000001 111.487 -176.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 569' ' ' LYS . . . . . 0.575 ' HA ' ' HE3' ' A' ' 569' ' ' LYS . 0.0 OUTLIER -165.72 167.83 16.71 Favored 'General case' 0 C--N 1.313 -1.017 0 O-C-N 120.911 -1.118 . . . . 73.400000000000006 108.28 173.941 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 570' ' ' THR . . . . . 0.612 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 7.1 p -132.28 138.66 47.94 Favored 'General case' 0 N--CA 1.421 -1.881 0 O-C-N 123.719 0.637 . . . . 71.400000000000006 109.971 179.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 571' ' ' ILE . . . . . 0.407 HG21 HD21 ' A' ' 589' ' ' LEU . 3.3 mp -90.66 117.07 33.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 106.618 -1.623 . . . . 74.230000000000004 106.618 170.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 15.7 p -95.29 110.8 22.75 Favored 'General case' 0 N--CA 1.426 -1.646 0 CA-C-O 121.059 0.457 . . . . 74.030000000000001 109.892 177.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 573' ' ' VAL . . . . . 0.509 HG22 HG21 ' A' ' 556' ' ' THR . 48.6 t -108.73 132.29 57.08 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 N-CA-C 109.113 -0.699 . . . . 54.119999999999997 109.113 -179.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 574' ' ' LYS . . . . . 0.456 ' HA ' HD13 ' A' ' 520' ' ' ILE . 22.3 tptm -86.91 119.74 27.45 Favored 'General case' 0 N--CA 1.434 -1.262 0 O-C-N 123.569 0.543 . . . . 75.140000000000001 110.463 179.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 56.3 t -89.91 132.87 33.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 106.674 -1.602 . . . . 71.109999999999999 106.674 175.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 39.5 mm -94.32 153.36 3.45 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 N-CA-C 109.16 -0.682 . . . . 64.109999999999999 109.16 -173.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -61.73 106.36 0.67 Allowed 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.582 -0.896 . . . . 72.510000000000005 108.582 172.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -62.29 142.18 57.88 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 113.944 -1.48 . . . . 70.310000000000002 112.949 -169.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -80.18 -51.91 8.39 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.844 0.83 . . . . 72.209999999999994 110.052 -177.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.64 -156.27 0.69 Allowed 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.803 -0.814 . . . . 70.549999999999997 108.803 -176.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -113.51 150.28 33.15 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 105.557 -2.016 . . . . 73.010000000000005 105.557 172.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 41.1 mp0 -126.68 -174.43 3.13 Favored 'General case' 0 C--N 1.282 -2.365 0 N-CA-C 108.785 -0.82 . . . . 64.230000000000004 108.785 176.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -85.64 -158.75 0.41 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 106.633 -1.617 . . . . 54.329999999999998 106.633 174.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 584' ' ' ASN . . . . . 0.403 ' ND2' ' HB3' ' A' ' 647' ' ' GLU . 15.0 m120 -85.63 79.81 9.23 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 106.437 -1.69 . . . . 71.030000000000001 106.437 173.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 585' ' ' LYS . . . . . 0.434 ' HG2' ' HB2' ' A' ' 546' ' ' ALA . 0.0 OUTLIER -88.55 168.03 12.92 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 115.411 -0.813 . . . . 64.439999999999998 110.131 -172.86 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 5.0 t -155.29 149.92 26.33 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-O 121.742 0.782 . . . . 74.239999999999995 112.873 -173.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -126.55 148.68 49.71 Favored 'General case' 0 N--CA 1.412 -2.33 0 CA-C-N 112.894 -1.957 . . . . 74.209999999999994 108.167 174.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 588' ' ' PHE . . . . . 0.515 ' HA ' ' O ' ' A' ' 642' ' ' LEU . 28.3 m-85 -105.61 129.74 53.79 Favored 'General case' 0 C--N 1.292 -1.935 0 N-CA-C 109.177 -0.675 . . . . 63.240000000000002 109.177 -175.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . 0.407 HD21 HG21 ' A' ' 571' ' ' ILE . 0.3 OUTLIER -97.83 121.09 39.34 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 106.034 -1.839 . . . . 72.519999999999996 106.034 176.814 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -125.34 129.89 50.86 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 109.712 -0.477 . . . . 72.239999999999995 109.712 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 591' ' ' ILE . . . . . 0.487 HG22 ' HB3' ' A' ' 539' ' ' TYR . 22.8 pt -98.44 138.4 23.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 107.229 -1.397 . . . . 73.510000000000005 107.229 174.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -91.06 -144.95 13.29 Favored Glycine 0 N--CA 1.431 -1.642 0 C-N-CA 121.0 -0.619 . . . . 71.319999999999993 112.897 -176.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -83.33 119.28 73.73 Favored Pre-proline 0 C--N 1.301 -1.516 0 N-CA-C 109.451 -0.574 . . . . 73.120000000000005 109.451 -178.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 594' ' ' PRO . . . . . 0.521 ' HB3' HG22 ' A' ' 537' ' ' VAL . 30.2 Cg_endo -67.15 152.7 79.36 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 121.966 1.777 . . . . 62.140000000000001 111.016 176.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -137.21 133.42 35.12 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 110.051 -0.351 . . . . 74.420000000000002 110.051 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 596' ' ' LEU . . . . . 0.513 HD22 HG22 ' A' ' 535' ' ' VAL . 0.0 OUTLIER -79.01 130.91 36.04 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 106.643 -1.614 . . . . 63.340000000000003 106.643 179.832 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 16.8 t . . . . . 0 C--N 1.293 -1.884 0 CA-C-O 122.071 0.939 . . . . 73.319999999999993 109.954 -177.457 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 15.2 mtp85 . . . . . 0 N--CA 1.431 -1.401 0 N-CA-C 108.412 -0.958 . . . . 71.319999999999993 108.412 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . 0.493 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 51.0 Cg_endo -73.08 139.58 29.93 Favored 'Trans proline' 0 N--CA 1.441 -1.578 0 C-N-CA 121.545 1.497 . . . . 75.209999999999994 110.697 176.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.4 pp -126.68 -175.96 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 111.904 0.335 . . . . 71.340000000000003 111.904 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -77.61 178.29 7.41 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.228 0.537 . . . . 75.319999999999993 111.29 -174.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -96.58 -85.18 1.74 Allowed Glycine 0 N--CA 1.421 -2.343 0 C-N-CA 120.554 -0.831 . . . . 43.109999999999999 111.606 178.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -127.53 -66.78 0.86 Allowed 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 115.509 -0.346 . . . . 72.310000000000002 110.08 -175.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 13.3 p80 -123.14 119.05 29.11 Favored 'General case' 0 C--O 1.246 0.9 0 CA-C-O 121.627 0.727 . . . . 61.030000000000001 111.51 -177.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 6.3 p -109.12 90.98 3.46 Favored 'General case' 0 N--CA 1.412 -2.356 0 CA-C-N 115.145 -0.934 . . . . 73.319999999999993 108.747 175.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -177.49 132.1 0.16 Allowed 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 106.49 -1.67 . . . . 72.030000000000001 106.49 -176.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 642' ' ' LEU . . . . . 0.64 HD21 HG21 ' A' ' 523' ' ' VAL . 41.8 tp -138.24 111.83 8.2 Favored 'General case' 0 C--N 1.29 -2.007 0 O-C-N 123.705 0.628 . . . . 73.040000000000006 109.61 177.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . 0.545 ' HB3' HG22 ' A' ' 511' ' ' VAL . 35.7 tt0 -90.74 104.01 16.64 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 107.392 -1.336 . . . . 53.109999999999999 107.392 177.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 644' ' ' VAL . . . . . 0.587 HG21 ' HE2' ' A' ' 521' ' ' MET . 39.8 t -95.01 110.07 23.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.804 -0.813 . . . . 71.010000000000005 108.804 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 3.9 mp -91.82 117.74 35.76 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 N-CA-C 108.013 -1.106 . . . . 64.109999999999999 108.013 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 646' ' ' ILE . . . . . 0.494 HD12 ' H ' ' A' ' 646' ' ' ILE . 1.5 mp -107.13 109.54 28.53 Favored 'Isoleucine or valine' 0 CA--C 1.473 -2.018 0 N-CA-C 106.115 -1.809 . . . . 62.420000000000002 106.115 -176.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . 0.403 ' HB3' ' ND2' ' A' ' 584' ' ' ASN . 3.8 pt-20 -111.33 150.35 29.83 Favored 'General case' 0 C--N 1.249 -3.787 0 C-N-CA 120.417 -0.513 . . . . 73.549999999999997 111.401 -178.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -63.3 133.9 54.92 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 105.552 -2.018 . . . . 72.519999999999996 105.552 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 8.2 t . . . . . 0 C--N 1.318 -0.763 0 CA-C-O 121.827 0.822 . . . . 34.350000000000001 112.05 -169.175 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . 0.553 ' HA2' ' OG1' ' A' ' 528' ' ' THR . . . . . . . . 0 N--CA 1.398 -3.838 0 N-CA-C 110.938 -0.865 . . . . 64.219999999999999 110.938 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 2.9 mp -123.58 105.81 16.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 108.096 -1.076 . . . . 44.219999999999999 108.096 -178.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . 0.428 ' CE1' ' HB ' ' A' ' 528' ' ' THR . 93.1 m-85 -114.9 121.49 43.37 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.178 0.513 . . . . 52.119999999999997 110.59 178.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . 0.433 HG23 HD23 ' A' ' 526' ' ' LEU . 13.8 t -147.21 163.01 37.71 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.022 -1.103 . . . . 74.030000000000001 108.022 -177.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -85.61 148.32 25.97 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 120.844 0.354 . . . . 75.019999999999996 110.961 176.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -84.44 -20.5 31.68 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 107.264 -1.384 . . . . 71.519999999999996 107.264 176.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 509' ' ' GLU . . . . . 0.432 ' HG3' ' O ' ' A' ' 511' ' ' VAL . 1.9 tp10 -129.01 120.58 20.34 Favored Pre-proline 0 N--CA 1.431 -1.389 0 CA-C-N 114.734 -1.121 . . . . 62.399999999999999 108.169 -178.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -80.38 -24.3 5.51 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 120.908 1.072 . . . . 74.409999999999997 110.147 173.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . 0.521 HG22 ' HB3' ' A' ' 643' ' ' GLU . 76.4 t -142.93 129.02 17.13 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 C-N-CA 124.561 1.145 . . . . 44.140000000000001 108.722 -178.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 14.6 t -128.2 142.94 51.03 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 108.284 -1.006 . . . . 70.219999999999999 108.284 177.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 52.6 m80 -108.42 120.85 43.6 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.861 -0.792 . . . . 61.310000000000002 108.861 175.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 23.1 m -118.13 150.15 20.36 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.394 0 N-CA-C 107.919 -1.141 . . . . 71.120000000000005 107.919 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . 0.406 ' HG ' ' HA ' ' A' ' 649' ' ' SER . 2.7 t -83.95 152.71 24.33 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 108.74 -0.837 . . . . 54.439999999999998 108.74 -178.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -70.33 -21.08 62.95 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 120.934 0.397 . . . . 70.340000000000003 110.928 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 45.2 m -90.35 12.21 19.04 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-O 121.226 0.536 . . . . 61.210000000000001 110.709 -175.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 12.7 tt -86.57 153.46 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.877 0 N-CA-C 108.871 -0.788 . . . . 74.25 108.871 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -90.98 -63.92 1.2 Allowed Glycine 0 N--CA 1.432 -1.596 0 C-N-CA 119.959 -1.115 . . . . 71.239999999999995 110.568 178.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 37.1 mm -120.25 121.44 65.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 107.905 -1.146 . . . . 72.409999999999997 107.905 178.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 521' ' ' MET . . . . . 0.574 ' HE1' HG21 ' A' ' 644' ' ' VAL . 0.0 OUTLIER -94.92 136.37 35.32 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 106.907 -1.516 . . . . 73.319999999999993 106.907 174.312 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 522' ' ' GLU . . . . . 0.46 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 48.9 mt-10 -124.41 138.26 54.38 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 124.093 0.871 . . . . 71.109999999999999 109.949 -178.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . 0.797 HG21 HD21 ' A' ' 642' ' ' LEU . 39.7 t -129.23 140.87 48.06 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 N-CA-C 109.055 -0.72 . . . . 74.150000000000006 109.055 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . 0.576 ' HD2' ' CG2' ' A' ' 568' ' ' VAL . 34.1 mmtp -85.34 134.35 34.1 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 122.243 1.02 . . . . 75.109999999999999 113.18 -178.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 4.2 t -110.57 146.94 15.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-N 113.926 -1.488 . . . . 65.200000000000003 107.349 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . 0.433 HD23 HG23 ' A' ' 506' ' ' THR . 2.8 mm? -87.3 135.58 33.26 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 109.567 -0.531 . . . . 75.409999999999997 109.567 177.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . 0.534 ' HD3' ' HA ' ' A' ' 567' ' ' ILE . 39.2 ttp180 -83.27 150.38 26.2 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-N 115.6 -0.727 . . . . 75.209999999999994 110.468 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . 0.553 ' OG1' ' HA2' ' A' ' 503' ' ' GLY . 1.8 t -50.12 147.36 4.15 Favored 'General case' 0 N--CA 1.435 -1.198 0 C-N-CA 125.866 1.667 . . . . 73.420000000000002 113.2 174.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 19.2 m -65.07 -38.05 89.53 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 114.4 -1.273 . . . . 71.409999999999997 110.035 176.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -107.45 103.24 1.92 Allowed Glycine 0 N--CA 1.419 -2.451 0 N-CA-C 108.994 -1.642 . . . . 63.119999999999997 108.994 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . 0.475 ' HB2' HG23 ' A' ' 528' ' ' THR . . . -122.13 65.76 0.92 Allowed 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.046 0.45 . . . . 64.120000000000005 111.281 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -117.1 90.76 3.4 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.101 -1.444 . . . . 64.349999999999994 107.101 175.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 142.4 -138.31 8.38 Favored Glycine 0 N--CA 1.419 -2.464 0 N-CA-C 110.153 -1.179 . . . . 74.409999999999997 110.153 -175.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 534' ' ' ASN . . . . . 0.524 HD21 ' HG3' ' A' ' 561' ' ' GLU . 2.8 t-20 -146.14 131.34 18.42 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.841 -1.17 . . . . 64.140000000000001 107.841 -178.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 535' ' ' VAL . . . . . 0.452 HG22 HD22 ' A' ' 596' ' ' LEU . 59.2 t -131.01 132.7 63.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.156 -0.683 . . . . 74.439999999999998 109.156 -177.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 536' ' ' ILE . . . . . . . . . . . . . 44.0 mm -105.35 131.04 55.64 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 109.665 -0.495 . . . . 64.239999999999995 109.665 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . 0.484 HG22 ' HB3' ' A' ' 594' ' ' PRO . 20.1 t -118.12 102.36 50.83 Favored Pre-proline 0 C--N 1.311 -1.089 0 O-C-N 123.307 0.38 . . . . 41.549999999999997 110.09 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -73.78 138.64 26.56 Favored 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 122.372 2.048 . . . . 61.549999999999997 111.604 178.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 539' ' ' TYR . . . . . 0.47 ' HB3' HG22 ' A' ' 591' ' ' ILE . 51.5 p90 -142.72 160.6 40.0 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 110.353 -0.24 . . . . 73.319999999999993 110.353 -177.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 540' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 556' ' ' THR . 0.0 OUTLIER -154.67 160.03 41.14 Favored 'General case' 0 C--O 1.247 0.938 0 O-C-N 123.595 0.56 . . . . 72.120000000000005 111.432 176.656 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 31.6 p -96.67 127.03 42.26 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.665 -0.698 . . . . 53.5 111.495 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.8 mp -93.72 111.52 25.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 106.142 -1.799 . . . . 71.400000000000006 106.142 172.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . 0.414 ' H ' ' CD ' ' A' ' 543' ' ' GLU . 1.5 mp0 -51.88 -53.34 41.85 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 124.348 1.059 . . . . 70.540000000000006 111.693 -176.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 68.95 -98.06 0.53 Allowed Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 121.1 -0.571 . . . . 72.329999999999998 111.969 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 545' ' ' THR . . . . . 0.436 HG23 ' H ' ' A' ' 586' ' ' THR . 8.8 t -111.29 -1.91 15.88 Favored 'General case' 0 CA--C 1.553 1.058 0 CA-C-O 121.969 0.89 . . . . 73.310000000000002 109.589 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . 0.42 ' HB2' ' HG2' ' A' ' 585' ' ' LYS . . . -93.8 171.12 9.07 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 108.067 -1.086 . . . . 55.240000000000002 108.067 174.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . 0.481 ' H ' ' HB3' ' A' ' 552' ' ' ASP . 1.4 tmt_? -126.67 121.55 32.44 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.009 -0.737 . . . . 75.540000000000006 109.009 -176.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -79.53 -164.58 28.85 Favored Glycine 0 CA--C 1.518 0.223 0 CA-C-N 116.234 -0.439 . . . . 71.219999999999999 112.892 -177.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 77.58 15.95 80.79 Favored Glycine 0 C--N 1.307 -1.058 0 N-CA-C 112.372 -0.291 . . . . 54.109999999999999 112.372 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 69.97 32.9 69.77 Favored Glycine 0 N--CA 1.431 -1.671 0 N-CA-C 110.5 -1.04 . . . . 74.120000000000005 110.5 -176.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -96.81 -64.58 1.03 Allowed 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 109.025 -0.731 . . . . 73.230000000000004 109.025 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . 0.481 ' HB3' ' H ' ' A' ' 547' ' ' ARG . 12.2 t70 -102.6 -36.62 8.28 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 106.807 -1.553 . . . . 61.5 106.807 177.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 553' ' ' PHE . . . . . 0.416 ' HA ' HG12 ' A' ' 576' ' ' ILE . 11.7 p90 -146.59 163.68 35.03 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 114.735 -1.121 . . . . 74.140000000000001 108.565 174.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -91.79 105.43 17.71 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 107.022 -1.473 . . . . 71.219999999999999 107.022 177.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -71.19 139.38 50.14 Favored 'General case' 0 CA--C 1.486 -1.488 0 N-CA-C 108.343 -0.984 . . . . 75.010000000000005 108.343 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 540' ' ' LYS . 11.0 t -138.16 138.43 38.61 Favored 'General case' 0 N--CA 1.396 -3.149 0 C-N-CA 118.842 -1.143 . . . . 74.329999999999998 111.989 -175.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 23.2 p -131.04 119.75 22.45 Favored 'General case' 0 N--CA 1.415 -2.216 0 N-CA-C 106.255 -1.757 . . . . 61.039999999999999 106.255 173.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -147.83 -170.67 16.1 Favored Glycine 0 N--CA 1.41 -3.057 0 C-N-CA 120.136 -1.031 . . . . 70.450000000000003 111.236 -172.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -139.09 106.6 5.57 Favored 'General case' 0 C--N 1.293 -1.885 0 C-N-CA 122.75 0.42 . . . . 53.5 109.869 -175.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 91.3 mt -73.71 136.79 43.75 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-N 116.043 -0.526 . . . . 72.430000000000007 110.198 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 561' ' ' GLU . . . . . 0.524 ' HG3' HD21 ' A' ' 534' ' ' ASN . 44.6 tt0 -105.62 114.71 29.04 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 116.102 -0.499 . . . . 63.119999999999997 111.235 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -111.17 148.74 32.1 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.656 -0.868 . . . . 75.430000000000007 108.656 174.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . 0.466 ' H ' ' HB3' ' A' ' 566' ' ' GLU . 4.2 pt20 -159.51 -178.16 6.92 Favored 'General case' 0 C--N 1.285 -2.225 0 N-CA-C 108.713 -0.847 . . . . 73.129999999999995 108.713 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -69.08 -29.98 68.2 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 121.712 0.768 . . . . 51.140000000000001 110.728 -178.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -82.74 -0.98 50.13 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.749 0.785 . . . . 73.540000000000006 110.798 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 566' ' ' GLU . . . . . 0.466 ' HB3' ' H ' ' A' ' 563' ' ' GLN . 8.2 tp10 -120.74 142.66 49.33 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.704 -0.623 . . . . 64.129999999999995 110.542 -175.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 567' ' ' ILE . . . . . 0.534 ' HA ' ' HD3' ' A' ' 527' ' ' ARG . 2.4 pt -133.58 150.78 32.31 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.273 0 N-CA-C 106.035 -1.839 . . . . 75.030000000000001 106.035 170.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 568' ' ' VAL . . . . . 0.576 ' CG2' ' HD2' ' A' ' 524' ' ' LYS . 1.2 p 49.77 -177.71 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.59 2.497 0 C-N-CA 124.7 1.2 . . . . 63.520000000000003 111.78 -175.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 569' ' ' LYS . . . . . 0.596 ' HA ' ' HE3' ' A' ' 569' ' ' LYS . 0.2 OUTLIER -173.94 164.55 4.21 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 107.979 -1.119 . . . . 75.230000000000004 107.979 176.032 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 570' ' ' THR . . . . . 0.592 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 36.3 p -127.1 142.85 51.42 Favored 'General case' 0 N--CA 1.436 -1.174 0 O-C-N 123.477 0.486 . . . . 51.109999999999999 110.907 177.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 571' ' ' ILE . . . . . 0.494 HG22 HG23 ' A' ' 573' ' ' VAL . 2.5 mp -91.78 122.48 43.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 N-CA-C 105.849 -1.908 . . . . 71.409999999999997 105.849 170.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 9.7 m -97.25 109.86 22.53 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 109.966 -0.383 . . . . 53.229999999999997 109.966 -179.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 573' ' ' VAL . . . . . 0.494 HG23 HG22 ' A' ' 571' ' ' ILE . 62.2 t -120.94 130.85 74.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 109.305 -0.628 . . . . 74.299999999999997 109.305 178.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -91.36 132.25 36.31 Favored 'General case' 0 C--N 1.312 -1.052 0 O-C-N 123.509 0.506 . . . . 64.299999999999997 111.064 179.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 64.0 t -97.66 137.99 23.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 108.063 -1.088 . . . . 72.310000000000002 108.063 177.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 576' ' ' ILE . . . . . 0.416 HG12 ' HA ' ' A' ' 553' ' ' PHE . 30.4 mm -103.11 160.49 4.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 107.369 -1.345 . . . . 72.340000000000003 107.369 -177.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -69.99 133.69 47.52 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 109.502 -0.555 . . . . 74.329999999999998 109.502 177.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.33 137.84 57.2 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.352 0.596 . . . . 71.030000000000001 111.033 -174.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.78 -35.89 3.8 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 115.925 1.824 . . . . 75.0 115.925 -171.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 580' ' ' GLU . . . . . 0.517 ' HG2' ' CD2' ' A' ' 581' ' ' TYR . 0.0 OUTLIER -93.63 -60.38 1.78 Allowed 'General case' 0 C--N 1.313 -1.01 0 O-C-N 121.482 -0.761 . . . . 70.120000000000005 112.75 -170.52 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 581' ' ' TYR . . . . . 0.517 ' CD2' ' HG2' ' A' ' 580' ' ' GLU . 31.4 p90 -164.38 153.97 13.9 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 106.561 -1.644 . . . . 54.399999999999999 106.561 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -89.87 143.81 26.48 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 119.618 -0.833 . . . . 64.239999999999995 112.218 -177.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -169.74 168.8 8.81 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 107.472 -1.307 . . . . 64.420000000000002 107.472 175.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -88.39 78.47 7.93 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 107.988 -1.115 . . . . 74.420000000000002 107.988 174.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 585' ' ' LYS . . . . . 0.42 ' HG2' ' HB2' ' A' ' 546' ' ' ALA . 0.0 OUTLIER -79.02 166.66 22.09 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 108.243 -1.021 . . . . 72.340000000000003 108.243 -177.417 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 586' ' ' THR . . . . . 0.436 ' H ' HG23 ' A' ' 545' ' ' THR . 6.9 t -154.06 144.36 22.16 Favored 'General case' 0 N--CA 1.415 -2.213 0 C-N-CA 120.258 -0.577 . . . . 73.430000000000007 111.178 -173.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 587' ' ' PHE . . . . . 0.437 ' CE2' HD11 ' A' ' 646' ' ' ILE . 3.6 p90 -126.02 148.54 49.28 Favored 'General case' 0 N--CA 1.418 -2.072 0 CA-C-N 113.799 -1.546 . . . . 62.32 109.407 176.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 588' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -104.77 130.99 52.77 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 108.791 -0.818 . . . . 70.329999999999998 108.791 -174.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . 0.521 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.4 OUTLIER -99.83 124.98 45.69 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 106.308 -1.738 . . . . 75.430000000000007 106.308 176.922 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -124.44 132.12 53.5 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-O 121.013 0.435 . . . . 74.439999999999998 110.11 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 591' ' ' ILE . . . . . 0.47 HG22 ' HB3' ' A' ' 539' ' ' TYR . 24.8 pt -101.33 143.86 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.085 0 N-CA-C 107.224 -1.398 . . . . 75.120000000000005 107.224 174.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -89.41 -148.84 19.69 Favored Glycine 0 C--N 1.292 -1.905 0 N-CA-C 110.47 -1.052 . . . . 31.140000000000001 110.47 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.424 ' CD ' HH21 ' A' ' 633' ' ' ARG . 23.4 tt0 -82.09 128.49 67.83 Favored Pre-proline 0 C--N 1.29 -2.013 0 N-CA-C 108.997 -0.742 . . . . 64.109999999999999 108.997 177.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 594' ' ' PRO . . . . . 0.484 ' HB3' HG22 ' A' ' 537' ' ' VAL . 55.0 Cg_endo -71.55 146.36 49.33 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 121.965 1.777 . . . . 53.350000000000001 109.944 173.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 16.0 ptt-85 -126.93 138.19 53.25 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.593 -0.692 . . . . 61.439999999999998 110.003 -175.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 596' ' ' LEU . . . . . 0.452 HD22 HG22 ' A' ' 535' ' ' VAL . 0.0 OUTLIER -81.8 129.15 34.64 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 106.938 -1.505 . . . . 51.210000000000001 106.938 179.753 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 89.6 t . . . . . 0 C--N 1.307 -1.277 0 CA-C-O 121.245 0.545 . . . . 61.219999999999999 110.073 179.256 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 633' ' ' ARG . . . . . 0.424 HH21 ' CD ' ' A' ' 593' ' ' GLU . 20.7 mtp180 . . . . . 0 N--CA 1.447 -0.582 0 N-CA-C 109.81 -0.441 . . . . 71.420000000000002 109.81 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -68.42 147.47 71.37 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.268 1.979 . . . . 74.319999999999993 110.475 177.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.3 pp -135.1 -175.06 1.26 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.753 0 N-CA-C 114.623 1.342 . . . . 71.200000000000003 114.623 -173.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -78.01 154.87 31.08 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.195 -0.911 . . . . 65.430000000000007 110.641 -177.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . 0.407 ' HA3' ' HB ' ' A' ' 506' ' ' THR . . . -96.48 -107.74 2.41 Favored Glycine 0 C--N 1.297 -1.621 0 C-N-CA 120.664 -0.779 . . . . 73.019999999999996 112.685 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -89.53 -65.4 1.02 Allowed 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 121.494 0.664 . . . . 73.109999999999999 110.953 -176.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -133.81 116.51 15.78 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 115.381 -0.827 . . . . 62.520000000000003 111.645 -174.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 22.1 p -104.42 90.89 3.68 Favored 'General case' 0 N--CA 1.396 -3.161 0 N-CA-C 107.887 -1.153 . . . . 73.219999999999999 107.887 175.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 21.5 tptm -175.71 135.36 0.3 Allowed 'General case' 0 N--CA 1.425 -1.701 0 CA-C-N 113.758 -1.564 . . . . 72.209999999999994 107.204 -175.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 642' ' ' LEU . . . . . 0.797 HD21 HG21 ' A' ' 523' ' ' VAL . 41.5 tp -138.22 110.1 7.19 Favored 'General case' 0 C--N 1.276 -2.606 0 N-CA-C 107.611 -1.255 . . . . 63.420000000000002 107.611 173.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . 0.521 ' HB3' HG22 ' A' ' 511' ' ' VAL . 21.4 tt0 -93.59 106.98 18.9 Favored 'General case' 0 C--N 1.275 -2.644 0 N-CA-C 107.475 -1.306 . . . . 72.25 107.475 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 644' ' ' VAL . . . . . 0.574 HG21 ' HE1' ' A' ' 521' ' ' MET . 25.6 t -96.81 105.6 17.33 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 109.346 -0.613 . . . . 72.310000000000002 109.346 -176.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 3.5 mp -91.54 120.42 40.56 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 107.521 -1.289 . . . . 75.099999999999994 107.521 176.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 646' ' ' ILE . . . . . 0.508 ' N ' HD12 ' A' ' 646' ' ' ILE . 2.7 mp -97.74 109.28 23.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 105.928 -1.879 . . . . 72.140000000000001 105.928 -177.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . 0.401 ' OE2' ' HA ' ' A' ' 515' ' ' SER . 1.5 pp20? -93.3 148.49 22.0 Favored 'General case' 0 N--CA 1.399 -3.007 0 CA-C-N 115.518 -0.764 . . . . 75.209999999999994 110.889 -174.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -73.0 69.46 0.98 Allowed 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 124.416 1.086 . . . . 74.019999999999996 110.993 -178.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 649' ' ' SER . . . . . 0.406 ' HA ' ' HG ' ' A' ' 515' ' ' SER . 14.4 m . . . . . 0 C--O 1.243 0.755 0 C-N-CA 128.422 2.689 . . . . 51.130000000000003 115.525 177.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . 0.708 ' HA3' ' OG1' ' A' ' 528' ' ' THR . . . . . . . . 0 N--CA 1.412 -2.921 0 N-CA-C 116.751 1.46 . . . . 72.040000000000006 116.751 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . 0.51 HG23 ' CA ' ' A' ' 637' ' ' GLY . 3.5 mp -111.35 136.25 48.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 125.521 1.529 . . . . 73.109999999999999 111.471 -168.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -132.6 123.58 26.7 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.898 -0.779 . . . . 71.230000000000004 108.898 170.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . 0.438 ' HB ' ' HA3' ' A' ' 637' ' ' GLY . 14.7 t -150.52 163.15 39.15 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.233 -0.654 . . . . 64.040000000000006 109.233 -176.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -84.35 159.74 20.81 Favored 'General case' 0 CA--C 1.495 -1.145 0 N-CA-C 108.486 -0.931 . . . . 73.010000000000005 108.486 173.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -81.34 -44.29 17.83 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.385 -0.968 . . . . 71.209999999999994 108.385 176.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -124.93 137.06 28.9 Favored Pre-proline 0 C--N 1.313 -0.993 0 N-CA-C 109.076 -0.713 . . . . 75.200000000000003 109.076 177.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 510' ' ' PRO . . . . . 0.511 ' HA ' ' O ' ' A' ' 641' ' ' LYS . 94.6 Cg_endo -90.66 -6.72 4.19 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.0 1.8 . . . . 75.200000000000003 112.734 178.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 74.3 t -143.04 132.99 21.9 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.318 0 N-CA-C 107.02 -1.474 . . . . 74.329999999999998 107.02 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 4.1 t -141.42 143.63 34.02 Favored 'General case' 0 N--CA 1.411 -2.4 0 N-CA-C 106.697 -1.594 . . . . 75.150000000000006 106.697 178.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 28.7 m-70 -114.52 127.85 56.02 Favored 'General case' 0 CA--C 1.484 -1.595 0 N-CA-C 107.471 -1.307 . . . . 70.019999999999996 107.471 177.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.625 HG11 ' SD ' ' A' ' 521' ' ' MET . 33.7 m -113.19 164.43 9.12 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.355 0 C-N-CA 120.271 -0.572 . . . . 52.43 110.853 -173.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 35.4 t -87.5 145.01 26.43 Favored 'General case' 0 N--CA 1.406 -2.657 0 N-CA-C 107.255 -1.387 . . . . 73.420000000000002 107.255 176.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -79.38 -9.98 59.71 Favored 'General case' 0 C--N 1.279 -2.495 0 CA-C-O 121.604 0.716 . . . . 72.140000000000001 109.801 177.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 39.3 m -97.62 17.06 18.65 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.508 0.67 . . . . 75.310000000000002 109.874 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 10.8 tt -96.38 158.25 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.366 0 N-CA-C 108.724 -0.843 . . . . 75.319999999999993 108.724 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -102.89 -59.35 0.74 Allowed Glycine 0 N--CA 1.43 -1.738 0 N-CA-C 111.018 -0.833 . . . . 75.150000000000006 111.018 178.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . 0.406 HD13 ' HA ' ' A' ' 574' ' ' LYS . 36.1 mm -123.36 126.85 73.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 109.224 -0.658 . . . . 61.530000000000001 109.224 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 521' ' ' MET . . . . . 0.625 ' SD ' HG11 ' A' ' 514' ' ' VAL . 25.3 ptt? -104.03 139.34 39.28 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.132 -1.062 . . . . 71.319999999999993 108.132 173.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -120.25 120.13 35.22 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 123.882 0.739 . . . . 74.310000000000002 110.72 177.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . 0.598 ' O ' ' HA ' ' A' ' 570' ' ' THR . 40.4 t -106.33 130.78 57.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 CA-C-N 115.56 -0.746 . . . . 74.340000000000003 109.831 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -77.93 131.84 37.63 Favored 'General case' 0 C--O 1.246 0.894 0 CA-C-O 121.784 0.802 . . . . 72.340000000000003 113.114 -177.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 11.4 t -114.7 135.22 55.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 107.42 -1.326 . . . . 65.420000000000002 107.42 177.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -82.55 151.22 26.52 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.416 0.626 . . . . 61.109999999999999 111.408 -175.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . 0.488 ' HD2' ' HA ' ' A' ' 567' ' ' ILE . 43.7 ttt-85 -98.47 143.55 28.78 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 114.658 -1.155 . . . . 63.549999999999997 110.447 -174.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . 0.708 ' OG1' ' HA3' ' A' ' 503' ' ' GLY . 4.6 t -58.9 151.29 22.05 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.539 -0.755 . . . . 75.239999999999995 112.441 177.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 35.6 t -77.89 -17.94 56.75 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 115.224 -0.898 . . . . 62.119999999999997 108.736 176.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -109.87 52.52 0.63 Allowed Glycine 0 N--CA 1.442 -0.912 0 N-CA-C 111.232 -0.747 . . . . 63.149999999999999 111.232 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -82.36 92.61 7.02 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-O 121.543 0.687 . . . . 73.239999999999995 109.665 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 2.6 ppt_? -133.5 20.36 3.95 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 114.771 -1.104 . . . . 65.0 112.038 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . -177.16 -179.38 47.47 Favored Glycine 0 N--CA 1.427 -1.959 0 N-CA-C 109.524 -1.431 . . . . 63.030000000000001 109.524 -177.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 534' ' ' ASN . . . . . 0.509 HD21 ' HG3' ' A' ' 561' ' ' GLU . 2.5 t-20 -90.41 125.02 35.42 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.047 0.451 . . . . 74.150000000000006 110.082 -179.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 535' ' ' VAL . . . . . 0.467 HG22 HD22 ' A' ' 596' ' ' LEU . 60.1 t -123.95 128.39 74.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 107.533 -1.284 . . . . 72.219999999999999 107.533 176.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 536' ' ' ILE . . . . . 0.547 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 46.5 mm -99.57 135.82 33.36 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.238 0 N-CA-C 109.425 -0.583 . . . . 72.209999999999994 109.425 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 42.5 t -120.15 109.38 37.24 Favored Pre-proline 0 C--N 1.307 -1.268 0 CA-C-N 116.06 -0.518 . . . . 72.299999999999997 109.608 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -74.07 143.69 32.8 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.16 1.906 . . . . 72.0 111.64 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 539' ' ' TYR . . . . . 0.434 ' HB3' HG22 ' A' ' 591' ' ' ILE . 45.1 p90 -144.35 160.66 40.66 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.598 -0.519 . . . . 74.109999999999999 109.598 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -160.48 160.58 32.22 Favored 'General case' 0 C--O 1.243 0.721 0 O-C-N 123.788 0.68 . . . . 70.420000000000002 110.543 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 2.6 p -100.22 108.14 20.16 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 123.676 0.61 . . . . 71.430000000000007 111.53 176.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.5 mp -81.7 128.24 38.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 107.378 -1.341 . . . . 74.209999999999994 107.378 178.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -63.61 -62.94 1.33 Allowed 'General case' 0 C--O 1.237 0.413 0 O-C-N 123.585 0.553 . . . . 72.510000000000005 111.212 -178.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 72.71 -72.48 1.04 Allowed Glycine 0 C--O 1.227 -0.292 0 CA-C-N 116.256 -0.429 . . . . 75.400000000000006 112.205 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 545' ' ' THR . . . . . 0.472 HG23 ' H ' ' A' ' 586' ' ' THR . 6.0 t -138.59 -2.11 1.8 Allowed 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.056 0.455 . . . . 71.099999999999994 110.233 178.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -96.1 171.03 8.86 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 108.969 -0.752 . . . . 70.209999999999994 108.969 174.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . 0.473 ' HG3' ' HG3' ' A' ' 551' ' ' GLU . 2.3 tpt180 -115.65 112.46 22.14 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.902 -0.777 . . . . 73.319999999999993 108.902 -178.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -95.95 166.92 25.05 Favored Glycine 0 CA--C 1.499 -0.962 0 C-N-CA 121.408 -0.425 . . . . 52.350000000000001 113.409 -176.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 100.52 23.44 10.21 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 111.526 -0.63 . . . . 50.32 111.526 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 91.07 6.45 66.82 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.833 -0.698 . . . . 62.130000000000003 111.396 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . 0.473 ' HG3' ' HG3' ' A' ' 547' ' ' ARG . 12.3 mm-40 -76.18 -71.23 0.4 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.553 -0.536 . . . . 75.310000000000002 109.553 -178.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -111.4 -27.65 8.54 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.197 -1.409 . . . . 62.329999999999998 107.197 178.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -141.68 156.68 45.63 Favored 'General case' 0 C--O 1.256 1.415 0 CA-C-N 115.031 -0.986 . . . . 72.319999999999993 109.063 174.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . 0.413 ' HB3' ' HB3' ' A' ' 574' ' ' LYS . 0.4 OUTLIER -90.45 126.77 36.01 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 106.261 -1.755 . . . . 74.209999999999994 106.261 178.393 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -79.02 112.04 15.83 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.77 0.319 . . . . 74.230000000000004 111.784 -173.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . 0.478 HG21 HG22 ' A' ' 573' ' ' VAL . 11.1 t -109.51 122.88 48.41 Favored 'General case' 0 N--CA 1.418 -2.026 0 CA-C-O 122.269 1.033 . . . . 75.439999999999998 110.052 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 1.7 p -142.07 133.04 25.93 Favored 'General case' 0 C--N 1.277 -2.572 0 CA-C-N 114.475 -1.239 . . . . 73.5 107.894 178.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 179.9 -148.98 8.28 Favored Glycine 0 N--CA 1.422 -2.289 0 N-CA-C 110.34 -1.104 . . . . 74.420000000000002 110.34 -176.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 559' ' ' GLU . . . . . 0.547 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 47.5 mt-10 -143.54 133.62 24.28 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 122.964 0.506 . . . . 73.519999999999996 110.706 -176.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . 0.408 ' HG ' ' CD1' ' A' ' 539' ' ' TYR . 87.4 mt -94.21 146.17 24.19 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 123.319 0.648 . . . . 74.299999999999997 110.117 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 561' ' ' GLU . . . . . 0.509 ' HG3' HD21 ' A' ' 534' ' ' ASN . 44.0 tt0 -105.67 112.85 26.09 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-O 121.075 0.464 . . . . 50.43 111.752 -178.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -109.66 144.07 38.53 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.59 -0.892 . . . . 73.319999999999993 108.59 171.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -145.99 -171.42 3.7 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.459 -0.941 . . . . 74.230000000000004 108.459 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 31.9 t30 -78.87 -39.15 35.98 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 107.24 -1.393 . . . . 74.540000000000006 107.24 172.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -88.45 -2.48 58.62 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.731 -1.122 . . . . 65.140000000000001 110.978 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -116.83 123.87 48.14 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.964 -0.754 . . . . 74.540000000000006 108.964 -178.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 567' ' ' ILE . . . . . 0.488 ' HA ' ' HD2' ' A' ' 527' ' ' ARG . 1.5 pp -119.13 139.91 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.73 0 N-CA-C 108.6 -0.889 . . . . 72.099999999999994 108.6 -178.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 1.2 p 56.11 160.18 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 C-N-CA 126.625 1.97 . . . . 61.210000000000001 113.462 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 569' ' ' LYS . . . . . 0.53 ' HA ' ' HE3' ' A' ' 569' ' ' LYS . 0.0 OUTLIER -148.03 162.89 38.44 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.511 -0.743 . . . . 70.319999999999993 109.089 175.444 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 570' ' ' THR . . . . . 0.598 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 11.7 p -135.1 134.3 40.13 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 123.921 0.763 . . . . 71.200000000000003 110.942 178.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 571' ' ' ILE . . . . . 0.476 HG12 HD11 ' A' ' 589' ' ' LEU . 3.1 mp -85.51 118.37 32.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 106.62 -1.622 . . . . 62.310000000000002 106.62 172.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 19.1 m -98.73 120.62 39.47 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 108.709 -0.848 . . . . 73.420000000000002 108.709 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 573' ' ' VAL . . . . . 0.478 HG22 HG21 ' A' ' 556' ' ' THR . 33.2 t -123.67 134.52 66.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 N-CA-C 109.15 -0.685 . . . . 63.140000000000001 109.15 -178.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 574' ' ' LYS . . . . . 0.413 ' HB3' ' HB3' ' A' ' 554' ' ' GLU . 57.9 tptt -88.25 116.26 26.32 Favored 'General case' 0 N--CA 1.435 -1.193 0 O-C-N 123.815 0.697 . . . . 74.219999999999999 109.221 177.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 59.1 t -87.03 133.8 29.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 107.72 -1.215 . . . . 70.209999999999994 107.72 178.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 42.8 mm -96.66 158.22 3.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 107.984 -1.117 . . . . 71.140000000000001 107.984 -177.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -67.78 119.48 12.55 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.645 -0.872 . . . . 73.319999999999993 108.645 176.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -67.32 122.65 18.35 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 114.822 -1.081 . . . . 70.430000000000007 111.628 -173.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 579' ' ' GLU . . . . . 0.407 ' H ' ' CD ' ' A' ' 579' ' ' GLU . 0.2 OUTLIER -87.57 -23.75 24.23 Favored 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 125.502 1.521 . . . . 71.430000000000007 113.557 -172.871 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -117.67 176.84 5.0 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 118.648 -1.221 . . . . 73.230000000000004 111.283 -177.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -60.59 154.37 21.29 Favored 'General case' 0 C--O 1.253 1.283 0 N-CA-C 108.256 -1.016 . . . . 61.329999999999998 108.256 174.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 21.0 tp10 -84.25 101.55 11.99 Favored 'General case' 0 N--CA 1.414 -2.229 0 C-N-CA 118.049 -1.46 . . . . 50.130000000000003 114.091 -175.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -97.22 134.07 41.02 Favored 'General case' 0 N--CA 1.406 -2.665 0 N-CA-C 101.961 -3.348 . . . . 70.409999999999997 101.961 160.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 584' ' ' ASN . . . . . 0.433 HD21 ' HB3' ' A' ' 647' ' ' GLU . 11.3 m120 -76.11 77.89 2.94 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-O 121.733 0.778 . . . . 73.219999999999999 112.391 -174.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.67 167.22 18.45 Favored 'General case' 0 N--CA 1.412 -2.357 0 N-CA-C 106.519 -1.66 . . . . 64.530000000000001 106.519 176.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 586' ' ' THR . . . . . 0.472 ' H ' HG23 ' A' ' 545' ' ' THR . 3.5 t -155.93 144.92 20.53 Favored 'General case' 0 N--CA 1.404 -2.741 0 C-N-CA 120.402 -0.519 . . . . 70.310000000000002 110.736 -176.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 587' ' ' PHE . . . . . 0.426 ' CE2' HD11 ' A' ' 646' ' ' ILE . 2.5 p90 -112.34 149.54 32.3 Favored 'General case' 0 N--CA 1.418 -2.028 0 CA-C-N 114.198 -1.364 . . . . 75.150000000000006 108.865 177.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 588' ' ' PHE . . . . . 0.412 ' CD1' ' HE3' ' A' ' 641' ' ' LYS . 17.5 m-85 -106.47 131.31 53.8 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 116.052 -0.522 . . . . 65.209999999999994 109.735 -173.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . 0.56 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.4 OUTLIER -102.77 118.44 36.83 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 105.016 -2.216 . . . . 73.099999999999994 105.016 173.231 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -129.82 144.51 51.34 Favored 'General case' 0 C--N 1.273 -2.728 0 N-CA-C 108.306 -0.998 . . . . 75.140000000000001 108.306 -178.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 591' ' ' ILE . . . . . 0.434 HG22 ' HB3' ' A' ' 539' ' ' TYR . 27.0 pt -106.27 152.76 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.853 0 N-CA-C 108.748 -0.834 . . . . 74.129999999999995 108.748 178.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -99.14 -163.74 29.75 Favored Glycine 0 N--CA 1.419 -2.46 0 N-CA-C 111.362 -0.695 . . . . 71.420000000000002 111.362 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -66.75 121.18 76.4 Favored Pre-proline 0 C--N 1.298 -1.645 0 C-N-CA 123.211 0.604 . . . . 75.430000000000007 110.612 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 594' ' ' PRO . . . . . 0.422 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 18.9 Cg_endo -67.25 140.84 54.73 Favored 'Trans proline' 0 N--CA 1.437 -1.819 0 C-N-CA 121.856 1.704 . . . . 62.5 110.461 176.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 595' ' ' ARG . . . . . 0.448 ' HG3' ' HB ' ' A' ' 536' ' ' ILE . 9.4 ptm180 -121.88 122.29 39.08 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 115.696 -0.683 . . . . 71.310000000000002 110.101 -173.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 596' ' ' LEU . . . . . 0.467 HD22 HG22 ' A' ' 535' ' ' VAL . 0.0 OUTLIER -75.51 123.9 26.25 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 107.858 -1.164 . . . . 55.140000000000001 107.858 179.282 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 21.8 t . . . . . 0 C--N 1.298 -1.645 0 CA-C-O 122.418 1.104 . . . . 71.549999999999997 109.348 179.703 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 67.9 mtt-85 . . . . . 0 CA--C 1.508 -0.641 0 N-CA-C 109.347 -0.612 . . . . 71.209999999999994 109.347 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . 0.422 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 39.7 Cg_endo -74.83 142.68 28.75 Favored 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 121.635 1.556 . . . . 55.130000000000003 110.548 177.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 635' ' ' ILE . . . . . 0.48 HD13 ' H ' ' A' ' 635' ' ' ILE . 0.1 OUTLIER -131.97 -170.77 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 CA-C-O 121.126 0.489 . . . . 75.219999999999999 109.899 -177.911 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.78 160.53 21.2 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 115.791 -0.641 . . . . 74.340000000000003 111.196 -178.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . 0.51 ' CA ' HG23 ' A' ' 504' ' ' ILE . . . -85.81 -98.53 0.74 Allowed Glycine 0 CA--C 1.483 -1.928 0 CA-C-N 115.337 -0.847 . . . . 64.420000000000002 111.771 177.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -114.52 -49.29 2.83 Favored 'General case' 0 C--N 1.281 -2.392 0 C-N-CA 119.752 -0.779 . . . . 73.540000000000006 110.151 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -131.4 119.15 21.24 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.958 0.885 . . . . 61.109999999999999 113.099 -176.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 23.8 p -115.27 91.15 3.52 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 107.385 -1.339 . . . . 65.140000000000001 107.385 173.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 641' ' ' LYS . . . . . 0.511 ' O ' ' HA ' ' A' ' 510' ' ' PRO . 22.6 tptm -175.27 137.04 0.38 Allowed 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 106.434 -1.691 . . . . 71.519999999999996 106.434 -174.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 642' ' ' LEU . . . . . 0.573 HD21 HG21 ' A' ' 523' ' ' VAL . 38.7 tp -140.69 105.07 4.85 Favored 'General case' 0 C--N 1.277 -2.55 0 N-CA-C 107.961 -1.125 . . . . 73.129999999999995 107.961 172.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -94.35 105.05 17.03 Favored 'General case' 0 C--N 1.276 -2.625 0 N-CA-C 106.646 -1.613 . . . . 70.129999999999995 106.646 178.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 644' ' ' VAL . . . . . 0.547 HG21 ' HE1' ' A' ' 521' ' ' MET . 32.5 t -94.28 106.15 17.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-N 115.765 -0.652 . . . . 45.240000000000002 109.571 -177.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 3.7 mp -89.36 126.32 42.33 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 N-CA-C 108.026 -1.101 . . . . 72.219999999999999 108.026 179.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 646' ' ' ILE . . . . . 0.446 HD12 ' H ' ' A' ' 646' ' ' ILE . 1.7 mp -104.54 140.29 23.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 107.866 -1.161 . . . . 74.239999999999995 107.866 -177.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . 0.433 ' HB3' HD21 ' A' ' 584' ' ' ASN . 7.4 pt-20 -158.4 140.05 13.63 Favored 'General case' 0 N--CA 1.429 -1.508 0 O-C-N 123.722 0.638 . . . . 74.409999999999997 110.822 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -41.62 136.5 1.86 Allowed 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.138 1.375 . . . . 73.549999999999997 110.561 176.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 34.9 t . . . . . 0 C--O 1.243 0.72 0 C-N-CA 126.518 1.927 . . . . 63.009999999999998 114.238 -171.623 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . 0.428 ' HA2' ' O ' ' A' ' 530' ' ' GLY . . . . . . . . 0 N--CA 1.433 -1.543 0 CA-C-O 121.44 0.467 . . . . 72.340000000000003 113.758 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 1.7 mp -107.24 130.31 59.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 N-CA-C 107.956 -1.127 . . . . 53.020000000000003 107.956 177.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . 0.429 ' HA ' ' O ' ' A' ' 526' ' ' LEU . 97.9 m-85 -116.21 121.39 41.91 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.115 0.483 . . . . 65.140000000000001 111.071 -178.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 11.8 t -139.39 156.19 47.15 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.037 -1.098 . . . . 52.25 108.037 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -82.65 154.41 24.92 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.526 -0.916 . . . . 71.329999999999998 108.526 174.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -77.29 -27.71 53.12 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 109.301 -0.629 . . . . 65.040000000000006 109.301 176.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -140.51 135.99 16.29 Favored Pre-proline 0 C--N 1.315 -0.897 0 N-CA-C 108.878 -0.786 . . . . 73.430000000000007 108.878 177.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 510' ' ' PRO . . . . . 0.4 ' HA ' ' O ' ' A' ' 641' ' ' LYS . 73.5 Cg_endo -85.13 -13.84 6.26 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 121.765 1.643 . . . . 72.209999999999994 111.654 178.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . 0.447 HG22 ' HB3' ' A' ' 643' ' ' GLU . 71.7 t -139.0 133.85 41.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 107.693 -1.225 . . . . 63.140000000000001 107.693 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 5.4 t -134.05 136.21 43.86 Favored 'General case' 0 N--CA 1.402 -2.834 0 N-CA-C 108.077 -1.083 . . . . 72.030000000000001 108.077 178.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 32.6 m-70 -108.37 114.75 28.85 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.541 -0.911 . . . . 73.430000000000007 108.541 177.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 16.7 m -118.93 162.49 17.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 CA-C-N 115.935 -0.575 . . . . 55.200000000000003 110.093 -174.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 62.2 m -81.2 148.92 29.3 Favored 'General case' 0 N--CA 1.392 -3.37 0 N-CA-C 108.096 -1.075 . . . . 71.400000000000006 108.096 178.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -85.55 -22.35 28.15 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 118.719 -1.192 . . . . 73.340000000000003 110.632 176.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 16.0 m -90.12 30.39 1.1 Allowed 'General case' 0 C--N 1.293 -1.874 0 CA-C-O 121.605 0.717 . . . . 74.25 110.023 -176.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 13.7 tt -112.81 150.87 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.015 0 N-CA-C 107.342 -1.355 . . . . 65.420000000000002 107.342 -178.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . 0.55 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . -81.83 -61.93 1.99 Allowed Glycine 0 N--CA 1.426 -1.975 0 C-N-CA 120.098 -1.049 . . . . 45.240000000000002 111.06 178.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 35.8 mm -120.82 133.45 67.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 CA-C-N 115.482 -0.359 . . . . 74.219999999999999 110.199 -177.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 521' ' ' MET . . . . . 0.494 ' HE2' HG21 ' A' ' 644' ' ' VAL . 0.0 OUTLIER -116.28 141.23 48.42 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.147 -1.427 . . . . 75.099999999999994 107.147 171.302 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 522' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 44.9 mt-10 -126.38 145.28 50.52 Favored 'General case' 0 C--N 1.316 -0.89 0 O-C-N 123.584 0.552 . . . . 72.409999999999997 111.445 -178.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . 0.677 HG21 HD21 ' A' ' 642' ' ' LEU . 30.2 t -132.58 138.99 50.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 108.512 -0.921 . . . . 65.340000000000003 108.512 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -84.0 133.17 34.69 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 113.043 0.757 . . . . 74.209999999999994 113.043 -177.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . 0.613 ' O ' ' HA ' ' A' ' 568' ' ' VAL . 10.7 t -113.46 125.49 70.74 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 N-CA-C 106.725 -1.583 . . . . 61.140000000000001 106.725 177.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . 0.429 ' O ' ' HA ' ' A' ' 505' ' ' PHE . 2.1 mm? -91.3 140.81 29.43 Favored 'General case' 0 C--N 1.28 -2.427 0 CA-C-O 120.794 0.331 . . . . 60.32 110.397 -176.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . 0.479 HH11 ' HG3' ' A' ' 527' ' ' ARG . 27.9 ttt85 -114.24 93.78 4.51 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 105.06 -2.2 . . . . 62.009999999999998 105.06 173.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 1.4 p -121.55 -168.68 1.73 Allowed 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 114.712 -1.131 . . . . 70.230000000000004 111.967 -173.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 39.6 m 35.01 32.62 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 126.419 1.888 . . . . 70.030000000000001 114.134 -172.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . 0.428 ' O ' ' HA2' ' A' ' 503' ' ' GLY . . . 129.43 151.95 7.47 Favored Glycine 0 N--CA 1.418 -2.53 0 N-CA-C 111.67 -0.572 . . . . 71.200000000000003 111.67 178.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -127.75 -125.44 0.23 Allowed 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 107.798 -1.186 . . . . 53.130000000000003 107.798 176.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 69.37 127.29 0.03 OUTLIER 'General case' 0 C--O 1.244 0.77 0 C-N-CA 124.516 1.126 . . . . 73.329999999999998 113.593 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 533' ' ' GLY . . . . . 0.453 ' H ' ' HB3' ' A' ' 564' ' ' ASN . . . 86.81 162.36 37.32 Favored Glycine 0 N--CA 1.437 -1.278 0 CA-C-N 115.125 -0.943 . . . . 53.210000000000001 113.316 175.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -90.81 122.96 33.98 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.271 -1.381 . . . . 74.109999999999999 107.271 176.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 62.4 t -125.31 125.67 69.45 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 N-CA-C 109.58 -0.526 . . . . 71.219999999999999 109.58 -178.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 536' ' ' ILE . . . . . 0.449 ' O ' ' HG2' ' A' ' 595' ' ' ARG . 40.1 mm -100.25 125.37 54.02 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 N-CA-C 108.396 -0.964 . . . . 61.310000000000002 108.396 177.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . 0.504 HG22 ' HB3' ' A' ' 594' ' ' PRO . 38.6 t -113.54 107.54 53.03 Favored Pre-proline 0 C--N 1.296 -1.757 0 CA-C-N 116.368 -0.378 . . . . 73.510000000000005 110.391 -177.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -74.59 147.19 35.48 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.408 2.072 . . . . 74.019999999999996 111.308 178.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 539' ' ' TYR . . . . . 0.4 ' CD2' ' HG ' ' A' ' 560' ' ' LEU . 50.6 p90 -147.85 156.9 43.21 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 108.255 -1.017 . . . . 75.230000000000004 108.255 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.96 150.9 28.8 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 123.399 0.437 . . . . 72.230000000000004 111.42 178.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 1.1 p -87.54 118.17 26.84 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 123.684 0.794 . . . . 74.340000000000003 112.075 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.419 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 3.7 mp -84.83 123.66 39.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 107.545 -1.28 . . . . 74.25 107.545 176.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -54.3 -54.02 45.87 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 124.225 1.01 . . . . 71.400000000000006 113.059 -175.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 72.18 -90.37 0.51 Allowed Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.898 -0.668 . . . . 63.450000000000003 112.203 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 8.9 t -124.84 -0.78 7.93 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 121.935 0.874 . . . . 73.25 109.299 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -94.9 175.79 6.51 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.586 -0.734 . . . . 54.140000000000001 109.926 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . 0.495 ' N ' ' HD2' ' A' ' 547' ' ' ARG . 4.5 mpt_? -101.58 173.05 6.6 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.716 -0.22 . . . . 74.200000000000003 111.296 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -62.54 -175.42 2.52 Favored Glycine 0 C--O 1.252 1.23 0 N-CA-C 116.116 1.206 . . . . 72.239999999999995 116.116 -174.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . -58.9 119.93 20.16 Favored Glycine 0 N--CA 1.439 -1.113 0 CA-C-N 114.087 -1.056 . . . . 61.229999999999997 114.362 -175.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 83.89 4.98 88.33 Favored Glycine 0 N--CA 1.438 -1.189 0 CA-C-N 115.287 -0.456 . . . . 72.239999999999995 112.028 176.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -103.04 -67.22 0.89 Allowed 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 108.408 -0.96 . . . . 54.32 108.408 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . 0.435 ' CB ' ' H ' ' A' ' 547' ' ' ARG . 12.8 t70 -104.54 -38.33 6.81 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.764 0.793 . . . . 75.400000000000006 109.125 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -138.17 160.77 38.56 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 108.276 -1.009 . . . . 73.120000000000005 108.276 176.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -86.42 110.34 19.66 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 105.411 -2.07 . . . . 74.420000000000002 105.411 176.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -67.61 100.83 0.93 Allowed 'General case' 0 CA--C 1.485 -1.54 0 CA-C-N 115.551 -0.749 . . . . 74.450000000000003 110.587 -174.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . 0.524 HG21 HG22 ' A' ' 573' ' ' VAL . 9.6 t -97.98 95.88 7.78 Favored 'General case' 0 N--CA 1.393 -3.298 0 CA-C-O 123.31 1.529 . . . . 74.109999999999999 110.019 -177.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 1.9 p -115.44 97.76 6.35 Favored 'General case' 0 N--CA 1.399 -2.976 0 CA-C-N 113.015 -1.902 . . . . 61.299999999999997 106.93 176.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -152.79 -156.21 7.45 Favored Glycine 0 N--CA 1.402 -3.586 0 N-CA-C 110.612 -0.995 . . . . 63.140000000000001 110.612 -172.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 559' ' ' GLU . . . . . 0.441 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 41.5 mt-10 -137.11 135.82 37.77 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-O 120.717 0.294 . . . . 74.349999999999994 110.885 -171.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . 0.434 ' HB3' ' HG2' ' A' ' 569' ' ' LYS . 80.2 mt -93.92 138.11 32.41 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 109.284 -0.636 . . . . 71.400000000000006 109.284 175.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -103.39 106.32 16.8 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.77 -0.65 . . . . 74.230000000000004 111.385 -175.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 562' ' ' PHE . . . . . 0.569 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 88.7 m-85 -109.15 143.57 38.37 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 116.088 -0.506 . . . . 75.310000000000002 109.8 176.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -119.24 -167.88 1.48 Allowed 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 108.154 -1.054 . . . . 75.409999999999997 108.154 -178.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 564' ' ' ASN . . . . . 0.453 ' HB3' ' H ' ' A' ' 533' ' ' GLY . 27.6 p-10 -78.33 -42.15 31.5 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 109.636 -0.505 . . . . 72.420000000000002 109.636 178.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -89.35 -29.69 18.94 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.575 -0.738 . . . . 72.120000000000005 110.684 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -79.37 108.19 12.7 Favored 'General case' 0 C--O 1.248 1.012 0 CA-C-N 115.878 -0.601 . . . . 74.140000000000001 110.17 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 567' ' ' ILE . . . . . 0.43 ' O ' HG12 ' A' ' 568' ' ' VAL . 6.1 pt -110.17 166.19 5.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 108.049 -1.093 . . . . 71.040000000000006 108.049 174.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 568' ' ' VAL . . . . . 0.613 ' HA ' ' O ' ' A' ' 525' ' ' VAL . 0.9 OUTLIER 58.77 155.83 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.56 1.336 0 C-N-CA 125.681 1.592 . . . . 73.450000000000003 112.564 -178.814 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 569' ' ' LYS . . . . . 0.569 ' HB2' ' CZ ' ' A' ' 562' ' ' PHE . 0.0 OUTLIER -161.94 166.62 25.87 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 106.985 -1.487 . . . . 64.439999999999998 106.985 179.492 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 570' ' ' THR . . . . . 0.616 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 7.0 p -127.52 138.68 52.98 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 123.427 0.454 . . . . 65.010000000000005 111.363 175.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 571' ' ' ILE . . . . . 0.466 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 3.2 mp -88.61 115.18 28.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 106.763 -1.569 . . . . 72.310000000000002 106.763 171.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 24.2 p -92.82 109.49 20.92 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 109.365 -0.606 . . . . 73.040000000000006 109.365 178.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 573' ' ' VAL . . . . . 0.524 HG22 HG21 ' A' ' 556' ' ' THR . 43.6 t -112.69 129.94 67.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 N-CA-C 109.328 -0.619 . . . . 75.150000000000006 109.328 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 574' ' ' LYS . . . . . 0.55 ' HA ' ' O ' ' A' ' 519' ' ' GLY . 86.9 tttt -89.09 124.12 34.02 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 123.814 0.696 . . . . 61.43 110.156 176.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 46.5 t -91.07 131.61 37.78 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 N-CA-C 108.312 -0.996 . . . . 74.450000000000003 108.312 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 576' ' ' ILE . . . . . 0.411 ' HB ' ' O ' ' A' ' 552' ' ' ASP . 30.1 mm -101.03 160.65 3.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 107.784 -1.191 . . . . 74.409999999999997 107.784 -177.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -76.91 147.73 36.82 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 110.061 -0.348 . . . . 60.149999999999999 110.061 177.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -69.98 132.4 45.87 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 114.55 1.315 . . . . 72.209999999999994 114.55 -175.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 579' ' ' GLU . . . . . 0.486 ' H ' ' CD ' ' A' ' 579' ' ' GLU . 0.0 OUTLIER -96.59 -26.27 15.3 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 112.533 -2.121 . . . . 74.120000000000005 111.394 179.599 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 580' ' ' GLU . . . . . 0.435 ' HG2' ' O ' ' A' ' 581' ' ' TYR . 0.1 OUTLIER -105.11 -174.97 2.66 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 107.192 -1.41 . . . . 70.230000000000004 107.192 178.813 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 581' ' ' TYR . . . . . 0.435 ' O ' ' HG2' ' A' ' 580' ' ' GLU . 24.6 p90 -69.25 145.14 53.38 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 106.31 -1.737 . . . . 75.420000000000002 106.31 176.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 582' ' ' GLU . . . . . . . . . . . . 0.528 18.6 pt-20 -93.79 121.03 34.81 Favored 'General case' 0 N--CA 1.408 -2.56 0 N-CA-C 117.673 2.472 . . . . 73.439999999999998 117.673 -175.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.19 170.94 11.88 Favored 'General case' 0 N--CA 1.417 -2.108 0 CA-C-N 111.407 -2.633 . . . . 72.549999999999997 106.476 178.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -67.71 119.31 12.24 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.36 0.6 . . . . 61.310000000000002 109.468 -177.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 585' ' ' LYS . . . . . 0.498 ' HD2' HD13 ' A' ' 646' ' ' ILE . 1.6 tmmm? -122.58 142.51 50.55 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-N 115.003 -0.999 . . . . 74.430000000000007 109.911 -171.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 6.8 t -148.22 142.99 26.7 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-O 121.14 0.495 . . . . 53.32 110.698 -175.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -129.64 148.23 51.51 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-N 114.113 -1.403 . . . . 75.329999999999998 109.802 177.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 588' ' ' PHE . . . . . 0.507 ' HA ' ' O ' ' A' ' 642' ' ' LEU . 27.2 m-85 -104.14 138.3 40.83 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.978 -0.556 . . . . 74.420000000000002 109.672 -176.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . 0.583 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.5 OUTLIER -113.01 115.24 28.08 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 105.642 -1.985 . . . . 73.400000000000006 105.642 175.573 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -125.59 133.37 52.3 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 109.148 -0.686 . . . . 64.329999999999998 109.148 178.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 591' ' ' ILE . . . . . . . . . . . . . 22.0 pt -85.58 146.96 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-N 115.808 -0.633 . . . . 71.129999999999995 109.412 178.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -93.54 -148.43 23.6 Favored Glycine 0 N--CA 1.427 -1.905 0 C-N-CA 120.911 -0.662 . . . . 71.329999999999998 111.496 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -75.56 117.04 60.42 Favored Pre-proline 0 C--N 1.295 -1.786 0 N-CA-C 108.866 -0.79 . . . . 71.299999999999997 108.866 178.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 594' ' ' PRO . . . . . 0.504 ' HB3' HG22 ' A' ' 537' ' ' VAL . 57.8 Cg_endo -72.81 134.34 21.68 Favored 'Trans proline' 0 N--CA 1.433 -2.045 0 C-N-CA 121.573 1.515 . . . . 61.109999999999999 109.408 176.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 595' ' ' ARG . . . . . 0.449 ' HG2' ' O ' ' A' ' 536' ' ' ILE . 14.2 ptm180 -108.29 121.15 44.31 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-O 121.028 0.442 . . . . 73.019999999999996 111.057 -172.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -76.7 118.44 19.33 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 105.786 -1.931 . . . . 71.030000000000001 105.786 176.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--N 1.29 -2.001 0 CA-C-O 121.905 0.859 . . . . 73.040000000000006 109.46 -178.113 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? . . . . . 0 N--CA 1.435 -1.209 0 N-CA-C 108.919 -0.771 . . . . 73.010000000000005 108.919 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . 0.441 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 4.9 Cg_endo -75.5 154.52 40.22 Favored 'Trans proline' 0 N--CA 1.44 -1.645 0 N-CA-C 107.073 -1.933 . . . . 72.019999999999996 107.073 166.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.6 pp -135.48 173.66 13.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 C-N-CA 118.804 -1.158 . . . . 72.329999999999998 113.928 -175.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . 0.422 ' HB2' HG21 ' A' ' 640' ' ' THR . 0.0 OUTLIER -75.67 146.99 39.8 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.969 -1.014 . . . . 73.340000000000003 110.232 -179.149 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -94.04 -132.16 6.39 Favored Glycine 0 C--N 1.289 -2.044 0 CA-C-N 115.604 -0.725 . . . . 75.120000000000005 113.821 -176.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -69.68 -56.48 7.12 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 111.955 0.354 . . . . 61.299999999999997 111.955 -175.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -137.07 114.62 11.08 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.889 0.852 . . . . 72.150000000000006 112.274 -178.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 640' ' ' THR . . . . . 0.422 HG21 ' HB2' ' A' ' 636' ' ' LEU . 17.5 p -119.68 91.84 3.64 Favored 'General case' 0 N--CA 1.416 -2.158 0 CA-C-N 115.219 -0.9 . . . . 74.030000000000001 110.568 177.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 641' ' ' LYS . . . . . 0.439 ' HE3' ' HB2' ' A' ' 643' ' ' GLU . 0.3 OUTLIER -178.71 126.0 0.1 Allowed 'General case' 0 CA--C 1.482 -1.642 0 N-CA-C 103.988 -2.597 . . . . 74.0 103.988 176.49 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 642' ' ' LEU . . . . . 0.677 HD21 HG21 ' A' ' 523' ' ' VAL . 51.7 tp -115.82 112.99 22.77 Favored 'General case' 0 C--N 1.263 -3.189 0 N-CA-C 108.653 -0.869 . . . . 73.349999999999994 108.653 177.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . 0.447 ' HB3' HG22 ' A' ' 511' ' ' VAL . 19.3 tt0 -97.55 103.47 15.41 Favored 'General case' 0 C--N 1.273 -2.734 0 N-CA-C 107.204 -1.406 . . . . 62.109999999999999 107.204 178.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 644' ' ' VAL . . . . . 0.494 HG21 ' HE2' ' A' ' 521' ' ' MET . 21.8 t -91.95 106.74 18.05 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.289 0 N-CA-C 108.15 -1.056 . . . . 63.200000000000003 108.15 -178.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 4.0 mp -90.99 115.87 31.05 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.293 0 N-CA-C 107.019 -1.475 . . . . 74.409999999999997 107.019 173.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 646' ' ' ILE . . . . . 0.498 HD13 ' HD2' ' A' ' 585' ' ' LYS . 3.2 mp -101.9 112.05 33.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 107.606 -1.257 . . . . 74.540000000000006 107.606 -175.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -111.2 138.2 47.94 Favored 'General case' 0 C--N 1.275 -2.671 0 CA-C-N 115.629 -0.714 . . . . 73.310000000000002 110.889 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -48.75 136.17 14.01 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.888 -1.051 . . . . 74.010000000000005 110.811 178.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 8.6 t . . . . . 0 N--CA 1.426 -1.667 0 CA-C-O 122.191 0.995 . . . . 61.340000000000003 109.987 -175.338 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . 0.461 ' HA2' ' OG1' ' A' ' 528' ' ' THR . . . . . . . . 0 N--CA 1.406 -3.314 0 N-CA-C 113.486 0.154 . . . . 74.120000000000005 113.486 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 2.8 mp -81.84 102.03 7.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 107.483 -1.303 . . . . 64.200000000000003 107.483 174.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . 0.413 ' O ' ' HA3' ' A' ' 637' ' ' GLY . 42.9 m-85 -115.5 124.02 50.03 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.043 -1.095 . . . . 73.299999999999997 108.043 178.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 11.6 t -155.71 168.75 26.17 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.343 -0.984 . . . . 74.329999999999998 108.343 -174.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -87.43 151.4 23.09 Favored 'General case' 0 CA--C 1.494 -1.19 0 N-CA-C 107.639 -1.245 . . . . 72.140000000000001 107.639 175.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -87.0 -39.49 15.62 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 109.367 -0.605 . . . . 72.430000000000007 109.367 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -110.08 128.63 25.04 Favored Pre-proline 0 N--CA 1.437 -1.084 0 N-CA-C 108.469 -0.937 . . . . 73.329999999999998 108.469 176.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -79.42 -14.65 12.93 Favored 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 121.93 1.753 . . . . 64.340000000000003 112.373 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . 0.553 HG22 ' HB3' ' A' ' 643' ' ' GLU . 73.6 t -138.99 135.76 42.57 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.854 0 N-CA-C 108.755 -0.832 . . . . 63.439999999999998 108.755 -178.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 3.5 t -137.76 138.47 39.3 Favored 'General case' 0 N--CA 1.408 -2.536 0 N-CA-C 107.8 -1.185 . . . . 73.109999999999999 107.8 177.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 23.4 m-70 -108.57 124.53 50.61 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 108.366 -0.976 . . . . 71.040000000000006 108.366 178.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 32.1 m -123.2 159.49 27.29 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.383 0 CA-C-O 121.433 0.635 . . . . 62.420000000000002 111.777 -173.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 41.2 m -75.58 152.33 37.73 Favored 'General case' 0 N--CA 1.399 -3.002 0 CA-C-N 114.012 -1.449 . . . . 71.409999999999997 109.961 -179.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -78.08 -48.38 16.19 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 121.408 0.623 . . . . 62.210000000000001 111.889 178.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 29.7 m -90.3 38.61 0.94 Allowed 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 122.157 0.979 . . . . 63.420000000000002 110.12 -171.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 17.4 tt -105.79 155.83 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.433 0 N-CA-C 105.855 -1.906 . . . . 65.019999999999996 105.855 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . -89.93 -57.08 1.75 Allowed Glycine 0 C--N 1.289 -2.063 0 C-N-CA 119.108 -1.52 . . . . 75.219999999999999 111.185 178.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 34.3 mm -126.29 136.41 60.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 CA-C-N 115.27 -0.465 . . . . 71.120000000000005 109.847 -176.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 521' ' ' MET . . . . . 0.637 ' HE2' HG21 ' A' ' 644' ' ' VAL . 0.0 OUTLIER -114.19 130.74 56.61 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 106.419 -1.697 . . . . 71.319999999999993 106.419 170.161 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -113.07 122.84 48.78 Favored 'General case' 0 C--N 1.313 -1.019 0 O-C-N 123.379 0.425 . . . . 72.420000000000002 110.265 -176.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . 0.62 ' O ' ' HA ' ' A' ' 570' ' ' THR . 43.4 t -103.32 126.76 57.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 CA-C-N 116.246 -0.433 . . . . 43.450000000000003 110.521 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 27.8 mmtp -78.22 134.96 37.51 Favored 'General case' 0 C--N 1.317 -0.843 0 O-C-N 123.853 0.721 . . . . 73.510000000000005 111.801 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 21.5 t -115.0 142.12 29.06 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 N-CA-C 108.656 -0.868 . . . . 53.549999999999997 108.656 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -69.57 167.47 16.78 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-O 122.305 1.05 . . . . 73.140000000000001 113.448 -178.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . 0.432 HH11 ' HD3' ' A' ' 527' ' ' ARG . 3.4 tpm_? -106.88 158.81 16.73 Favored 'General case' 0 N--CA 1.426 -1.668 0 CA-C-N 114.027 -1.442 . . . . 73.430000000000007 109.574 -175.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . 0.461 ' OG1' ' HA2' ' A' ' 503' ' ' GLY . 3.3 t -73.03 160.5 31.97 Favored 'General case' 0 N--CA 1.432 -1.374 0 C-N-CA 124.003 0.921 . . . . 50.439999999999998 110.215 176.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 22.2 t -85.2 -11.67 54.41 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 108.575 -0.898 . . . . 62.520000000000003 108.575 178.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -146.51 100.74 0.23 Allowed Glycine 0 N--CA 1.438 -1.194 0 N-CA-C 109.943 -1.263 . . . . 72.030000000000001 109.943 177.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -90.36 88.55 7.24 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.115 0.483 . . . . 60.0 111.754 -176.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 -137.76 100.23 4.13 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.373 -0.973 . . . . 74.430000000000007 108.373 174.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 123.17 154.63 9.07 Favored Glycine 0 N--CA 1.429 -1.825 0 C-N-CA 120.117 -1.039 . . . . 71.430000000000007 112.365 178.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 534' ' ' ASN . . . . . 0.493 HD21 ' HG3' ' A' ' 561' ' ' GLU . 2.6 t-20 -98.54 119.94 38.11 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-O 121.375 0.607 . . . . 74.319999999999993 109.557 176.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 535' ' ' VAL . . . . . 0.528 HG22 HD22 ' A' ' 596' ' ' LEU . 89.9 t -122.45 135.59 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-N 115.124 -0.944 . . . . 64.109999999999999 109.202 -179.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 536' ' ' ILE . . . . . 0.593 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 43.3 mm -102.81 133.4 46.66 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.062 0 N-CA-C 108.961 -0.755 . . . . 74.319999999999993 108.961 178.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 63.6 t -119.55 110.36 37.31 Favored Pre-proline 0 C--N 1.297 -1.683 0 N-CA-C 109.772 -0.455 . . . . 74.120000000000005 109.772 178.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -74.11 152.73 45.94 Favored 'Trans proline' 0 C--O 1.24 0.592 0 C-N-CA 122.644 2.229 . . . . 74.230000000000004 111.93 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 539' ' ' TYR . . . . . 0.534 ' HB3' HG22 ' A' ' 591' ' ' ILE . 53.7 p90 -152.61 159.5 43.23 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.676 -0.861 . . . . 71.219999999999999 108.676 -178.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 540' ' ' LYS . . . . . 0.414 ' HE3' HD11 ' A' ' 542' ' ' ILE . 0.1 OUTLIER -161.35 150.96 16.72 Favored 'General case' 0 C--N 1.309 -1.16 0 O-C-N 123.613 0.57 . . . . 70.409999999999997 110.23 179.025 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 7.3 p -82.17 121.93 27.24 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 114.98 -1.009 . . . . 74.230000000000004 110.858 173.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.426 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 3.5 mp -93.17 118.49 39.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 105.259 -2.126 . . . . 71.109999999999999 105.259 171.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . 0.452 ' H ' ' CD ' ' A' ' 543' ' ' GLU . 1.6 mp0 -48.15 -55.36 10.54 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 124.316 1.046 . . . . 73.219999999999999 112.406 -175.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 72.47 -102.3 1.17 Allowed Glycine 0 N--CA 1.442 -0.939 0 N-CA-C 110.702 -0.959 . . . . 54.450000000000003 110.702 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 11.4 t -118.68 -0.36 11.32 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 122.334 1.064 . . . . 73.040000000000006 109.359 177.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -88.62 143.61 26.83 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 108.342 -0.984 . . . . 61.109999999999999 108.342 173.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . 0.483 ' HG3' ' HG3' ' A' ' 551' ' ' GLU . 27.6 tpt180 -90.19 119.13 30.25 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.826 -0.805 . . . . 75.25 108.826 179.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -86.45 174.29 46.69 Favored Glycine 0 C--N 1.306 -1.13 0 C-N-CA 120.503 -0.856 . . . . 71.120000000000005 113.15 -176.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 86.0 36.2 10.38 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 121.148 -0.549 . . . . 75.540000000000006 113.416 176.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 87.87 10.8 68.95 Favored Glycine 0 N--CA 1.44 -1.055 0 C-N-CA 120.261 -0.971 . . . . 42.450000000000003 112.82 176.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . 0.483 ' HG3' ' HG3' ' A' ' 547' ' ' ARG . 7.8 mm-40 -92.72 -71.83 0.63 Allowed 'General case' 0 C--O 1.213 -0.862 0 N-CA-C 109.412 -0.588 . . . . 74.310000000000002 109.412 179.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -97.55 -30.05 13.09 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 108.626 -0.879 . . . . 74.219999999999999 108.626 176.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 553' ' ' PHE . . . . . 0.504 ' HB3' ' CE2' ' A' ' 587' ' ' PHE . 46.4 p90 -149.76 155.24 39.81 Favored 'General case' 0 N--CA 1.419 -1.989 0 CA-C-N 115.312 -0.858 . . . . 65.140000000000001 110.198 178.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -82.54 123.2 28.97 Favored 'General case' 0 C--N 1.276 -2.6 0 N-CA-C 104.48 -2.415 . . . . 74.439999999999998 104.48 175.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -60.77 121.11 11.47 Favored 'General case' 0 CA--C 1.488 -1.423 0 CA-C-O 122.237 1.017 . . . . 60.32 111.575 -175.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . 0.44 HG21 HG22 ' A' ' 573' ' ' VAL . 98.4 m -120.22 112.64 19.32 Favored 'General case' 0 N--CA 1.388 -3.555 0 CA-C-N 114.5 -1.227 . . . . 51.039999999999999 111.806 -171.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 20.7 p -145.63 128.97 16.83 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.846 -1.168 . . . . 73.540000000000006 107.846 176.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -165.86 -155.61 8.84 Favored Glycine 0 N--CA 1.422 -2.295 0 C-N-CA 120.462 -0.875 . . . . 61.329999999999998 111.139 -176.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 559' ' ' GLU . . . . . 0.593 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 42.1 mt-10 -143.09 125.63 15.8 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 123.06 0.544 . . . . 65.420000000000002 110.269 -176.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . 0.441 ' HG ' ' CE1' ' A' ' 539' ' ' TYR . 87.7 mt -88.7 135.79 33.33 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 122.723 0.409 . . . . 75.140000000000001 110.776 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 561' ' ' GLU . . . . . 0.493 ' HG3' HD21 ' A' ' 534' ' ' ASN . 45.4 tt0 -96.38 108.57 21.11 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.601 -0.727 . . . . 73.319999999999993 110.593 179.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 562' ' ' PHE . . . . . 0.423 ' CE1' ' HG2' ' A' ' 569' ' ' LYS . 8.0 m-85 -107.74 116.92 32.82 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.234 -0.654 . . . . 74.420000000000002 109.234 173.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . 0.509 ' HG3' ' H ' ' A' ' 566' ' ' GLU . 3.5 pt20 -119.56 -175.26 2.91 Favored 'General case' 0 C--N 1.29 -1.995 0 C-N-CA 119.068 -1.053 . . . . 73.120000000000005 112.023 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -59.06 -47.53 84.9 Favored 'General case' 0 C--N 1.318 -0.774 0 O-C-N 123.86 0.725 . . . . 75.209999999999994 109.667 177.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -77.74 -67.19 0.75 Allowed 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.278 -0.873 . . . . 63.030000000000001 111.233 -178.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 566' ' ' GLU . . . . . 0.509 ' H ' ' HG3' ' A' ' 563' ' ' GLN . 15.3 tt0 -56.27 113.86 1.74 Allowed 'General case' 0 C--O 1.247 0.922 0 O-C-N 123.783 0.677 . . . . 72.209999999999994 112.629 -178.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 10.4 pt -102.36 169.14 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.407 -2.591 0 N-CA-C 106.64 -1.615 . . . . 71.409999999999997 106.64 173.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 1.7 p 40.55 124.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.559 1.306 0 C-N-CA 127.069 2.147 . . . . 54.329999999999998 116.628 177.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 569' ' ' LYS . . . . . 0.426 ' HD2' ' HA ' ' A' ' 569' ' ' LYS . 32.8 mmmt -116.85 157.43 25.63 Favored 'General case' 0 C--N 1.265 -3.103 0 CA-C-N 114.921 -1.036 . . . . 71.120000000000005 110.16 178.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 570' ' ' THR . . . . . 0.62 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 1.8 p -129.88 125.27 35.2 Favored 'General case' 0 C--N 1.278 -2.538 0 CA-C-N 114.784 -1.098 . . . . 44.049999999999997 111.307 179.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 3.6 mp -84.52 111.12 19.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 106.277 -1.749 . . . . 71.140000000000001 106.277 173.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 3.1 p -95.66 109.45 21.72 Favored 'General case' 0 N--CA 1.417 -2.093 0 O-C-N 123.87 0.731 . . . . 73.400000000000006 109.918 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 573' ' ' VAL . . . . . 0.44 HG22 HG21 ' A' ' 556' ' ' THR . 59.9 t -111.82 133.68 56.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 108.916 -0.772 . . . . 64.140000000000001 108.916 -178.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 574' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 519' ' ' GLY . 41.4 ttmt -84.81 117.14 23.68 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-O 121.444 0.64 . . . . 75.310000000000002 109.676 177.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 60.2 t -89.44 143.74 10.56 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 N-CA-C 107.08 -1.452 . . . . 71.109999999999999 107.08 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 576' ' ' ILE . . . . . 0.435 HG12 ' HA ' ' A' ' 553' ' ' PHE . 26.0 mm -111.81 132.3 60.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 C-N-CA 119.975 -0.69 . . . . 72.549999999999997 109.196 -177.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -59.65 137.53 58.01 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.301 -0.863 . . . . 73.030000000000001 108.873 178.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 578' ' ' ASP . . . . . . . . . . . . 0.413 15.9 m-20 -59.31 119.65 7.81 Favored 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 117.144 2.276 . . . . 70.230000000000004 117.144 -171.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 579' ' ' GLU . . . . . 0.437 ' H ' ' CD ' ' A' ' 579' ' ' GLU . 6.1 pm0 -97.07 -14.07 21.81 Favored 'General case' 0 N--CA 1.401 -2.888 0 CA-C-N 110.483 -3.053 . . . . 62.43 112.948 -172.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 580' ' ' GLU . . . . . 0.621 ' HG2' ' O ' ' A' ' 581' ' ' TYR . 2.4 pm0 -128.5 -167.23 1.74 Allowed 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 122.897 0.479 . . . . 71.329999999999998 110.016 -173.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 581' ' ' TYR . . . . . 0.621 ' O ' ' HG2' ' A' ' 580' ' ' GLU . 52.5 p90 -58.3 153.41 15.44 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 107.709 -1.219 . . . . 71.439999999999998 107.709 170.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -93.34 134.44 35.55 Favored 'General case' 0 C--N 1.275 -2.668 0 C-N-CA 116.654 -2.019 . . . . 65.129999999999995 113.36 -176.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 583' ' ' LYS . . . . . 0.407 ' HE2' ' HB3' ' A' ' 585' ' ' LYS . 0.0 OUTLIER -145.93 130.79 18.12 Favored 'General case' 0 N--CA 1.412 -2.331 0 N-CA-C 104.584 -2.376 . . . . 70.329999999999998 104.584 171.253 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -66.3 123.72 20.72 Favored 'General case' 0 CA--C 1.488 -1.434 0 N-CA-C 107.364 -1.347 . . . . 72.129999999999995 107.364 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 585' ' ' LYS . . . . . 0.407 ' HB3' ' HE2' ' A' ' 583' ' ' LYS . 0.0 OUTLIER -128.87 166.71 18.56 Favored 'General case' 0 C--N 1.285 -2.216 0 CA-C-N 115.604 -0.725 . . . . 71.140000000000001 109.902 -168.527 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 6.5 t -156.22 145.41 20.59 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-O 120.797 0.332 . . . . 61.520000000000003 110.866 -173.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 587' ' ' PHE . . . . . 0.504 ' CE2' ' HB3' ' A' ' 553' ' ' PHE . 3.4 p90 -125.33 147.76 49.01 Favored 'General case' 0 N--CA 1.42 -1.965 0 O-C-N 125.068 1.48 . . . . 64.319999999999993 109.644 176.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 588' ' ' PHE . . . . . 0.426 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 20.7 m-85 -100.95 127.4 47.46 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.393 -0.966 . . . . 63.450000000000003 108.393 -176.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . 0.498 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.5 OUTLIER -100.96 117.19 34.53 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 104.898 -2.26 . . . . 62.119999999999997 104.898 175.707 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -126.13 125.9 43.28 Favored 'General case' 0 C--N 1.281 -2.372 0 C-N-CA 120.233 -0.587 . . . . 72.430000000000007 109.708 -177.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 591' ' ' ILE . . . . . 0.534 HG22 ' HB3' ' A' ' 539' ' ' TYR . 14.8 pt -87.44 138.67 18.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 N-CA-C 107.828 -1.175 . . . . 52.219999999999999 107.828 173.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -98.88 -136.91 9.54 Favored Glycine 0 N--CA 1.429 -1.819 0 C-N-CA 120.381 -0.914 . . . . 64.239999999999995 114.023 -173.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -84.64 118.36 70.86 Favored Pre-proline 0 C--N 1.294 -1.842 0 C-N-CA 124.555 1.142 . . . . 61.140000000000001 110.133 -176.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.11 150.82 72.61 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.354 2.036 . . . . 72.299999999999997 111.488 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 595' ' ' ARG . . . . . 0.4 ' CG ' ' HB ' ' A' ' 536' ' ' ILE . 10.8 ptm180 -132.57 132.11 42.21 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 109.429 -0.582 . . . . 72.400000000000006 109.429 -177.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 596' ' ' LEU . . . . . 0.528 HD22 HG22 ' A' ' 535' ' ' VAL . 0.0 OUTLIER -80.09 134.61 36.2 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.336 -1.357 . . . . 74.430000000000007 107.336 -178.605 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 597' ' ' VAL . . . . . 0.407 ' CG2' HG12 ' A' ' 536' ' ' ILE . 58.1 t . . . . . 0 C--N 1.303 -1.42 0 CA-C-O 121.868 0.842 . . . . 65.530000000000001 109.098 178.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 80.7 mtt180 . . . . . 0 N--CA 1.428 -1.557 0 N-CA-C 107.963 -1.125 . . . . 74.299999999999997 107.963 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -94.26 151.47 2.05 Favored 'Trans proline' 0 N--CA 1.428 -2.336 0 C-N-CA 121.504 1.47 . . . . 74.049999999999997 110.816 173.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.2 pp -112.91 173.37 2.81 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 CA-C-N 116.375 -0.375 . . . . 63.149999999999999 111.451 -178.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . 0.448 HD11 HG21 ' A' ' 640' ' ' THR . 14.0 tp -78.91 158.37 28.07 Favored 'General case' 0 N--CA 1.433 -1.296 0 O-C-N 123.182 0.301 . . . . 73.340000000000003 110.432 -177.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' A' ' 505' ' ' PHE . . . -76.44 -107.04 0.13 Allowed Glycine 0 N--CA 1.435 -1.424 0 N-CA-C 115.032 0.773 . . . . 25.140000000000001 115.032 -177.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -127.5 -70.66 0.7 Allowed 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.033 -0.729 . . . . 65.540000000000006 109.033 -175.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 12.8 p80 -132.84 114.76 14.46 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 109.059 -0.719 . . . . 75.299999999999997 109.059 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 640' ' ' THR . . . . . 0.448 HG21 HD11 ' A' ' 636' ' ' LEU . 30.8 p -98.46 91.3 5.12 Favored 'General case' 0 N--CA 1.407 -2.622 0 CA-C-O 121.626 0.727 . . . . 65.010000000000005 109.885 -178.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 641' ' ' LYS . . . . . 0.418 ' HE3' ' CD1' ' A' ' 588' ' ' PHE . 23.4 tptm -170.96 129.9 0.77 Allowed 'General case' 0 CA--C 1.498 -1.036 0 CA-C-N 115.437 -0.801 . . . . 75.230000000000004 109.311 -179.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 642' ' ' LEU . . . . . 0.569 HD21 HG21 ' A' ' 523' ' ' VAL . 27.8 tp -137.08 109.88 7.59 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 107.45 -1.315 . . . . 64.310000000000002 107.45 172.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . 0.553 ' HB3' HG22 ' A' ' 511' ' ' VAL . 19.3 tt0 -94.34 104.1 16.09 Favored 'General case' 0 C--N 1.273 -2.741 0 N-CA-C 107.12 -1.437 . . . . 70.319999999999993 107.12 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 644' ' ' VAL . . . . . 0.637 HG21 ' HE2' ' A' ' 521' ' ' MET . 25.4 t -95.56 108.01 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.194 0 N-CA-C 109.559 -0.534 . . . . 74.409999999999997 109.559 -177.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 3.5 mp -94.84 124.81 47.49 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 107.233 -1.395 . . . . 52.109999999999999 107.233 177.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 646' ' ' ILE . . . . . 0.519 ' N ' HD12 ' A' ' 646' ' ' ILE . 2.8 mp -104.35 115.68 46.72 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.438 0 N-CA-C 107.601 -1.259 . . . . 75.430000000000007 107.601 -174.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -121.16 168.92 11.05 Favored 'General case' 0 N--CA 1.419 -2.007 0 O-C-N 123.608 0.568 . . . . 55.450000000000003 109.585 -175.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -69.95 157.9 36.61 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 112.766 0.654 . . . . 65.430000000000007 112.766 -172.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 20.2 t . . . . . 0 N--CA 1.439 -0.994 0 N-CA-C 106.573 -1.64 . . . . 64.019999999999996 106.573 175.335 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . 0.64 ' HA2' ' OG1' ' A' ' 528' ' ' THR . . . . . . . . 0 N--CA 1.415 -2.738 0 CA-C-O 119.947 -0.363 . . . . 64.230000000000004 113.063 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 3.7 mp -116.31 112.39 39.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 107.1 -1.444 . . . . 55.140000000000001 107.1 175.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -119.7 125.56 48.98 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.57 -0.9 . . . . 65.049999999999997 108.57 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . 0.439 ' HB ' ' HA3' ' A' ' 637' ' ' GLY . 15.1 t -155.44 169.44 24.25 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 109.77 -0.456 . . . . 74.140000000000001 109.77 -174.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -98.81 161.15 13.8 Favored 'General case' 0 C--O 1.249 1.063 0 N-CA-C 106.243 -1.762 . . . . 71.519999999999996 106.243 172.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . 0.427 ' HG2' HD21 ' A' ' 526' ' ' LEU . 3.4 pt-20 -99.17 -27.93 13.58 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 120.387 -0.525 . . . . 75.409999999999997 110.734 176.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -114.26 119.16 40.85 Favored Pre-proline 0 N--CA 1.43 -1.463 0 N-CA-C 107.647 -1.242 . . . . 74.25 107.647 174.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -83.39 -4.28 10.92 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 121.902 1.735 . . . . 65.409999999999997 111.951 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . 0.429 HG13 ' CD1' ' A' ' 645' ' ' ILE . 88.3 t -143.27 134.9 23.66 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.069 0 N-CA-C 108.036 -1.098 . . . . 63.229999999999997 108.036 -179.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 4.7 t -139.5 151.49 46.19 Favored 'General case' 0 N--CA 1.404 -2.766 0 N-CA-C 108.099 -1.075 . . . . 50.149999999999999 108.099 176.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 513' ' ' HIS . . . . . 0.441 ' CD2' ' HB ' ' A' ' 645' ' ' ILE . 47.0 m80 -117.3 116.86 28.05 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 109.168 -0.678 . . . . 71.329999999999998 109.168 179.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.673 HG11 ' SD ' ' A' ' 521' ' ' MET . 31.0 m -111.6 153.13 13.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 C-N-CA 120.469 -0.492 . . . . 73.400000000000006 110.909 -177.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . 0.502 ' HA ' ' OE2' ' A' ' 647' ' ' GLU . 40.5 t -76.59 143.88 39.97 Favored 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 114.945 -1.025 . . . . 64.310000000000002 109.715 -178.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . 0.466 ' HG3' ' HB3' ' A' ' 578' ' ' ASP . 35.4 tt0 -68.71 -10.24 55.22 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.449 0.643 . . . . 51.109999999999999 111.195 178.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 20.5 t -115.49 21.93 13.61 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 109.317 -0.623 . . . . 65.010000000000005 109.317 -177.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 518' ' ' ILE . . . . . 0.428 HG22 ' O ' ' A' ' 515' ' ' SER . 15.1 tt -90.29 151.0 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 N-CA-C 108.847 -0.797 . . . . 71.530000000000001 108.847 178.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -96.35 -63.94 0.94 Allowed Glycine 0 N--CA 1.429 -1.822 0 C-N-CA 120.05 -1.071 . . . . 62.219999999999999 111.517 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 30.3 mm -119.04 118.18 56.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 109.635 -0.505 . . . . 73.450000000000003 109.635 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 521' ' ' MET . . . . . 0.673 ' SD ' HG11 ' A' ' 514' ' ' VAL . 25.1 ptt? -99.91 129.48 46.0 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 107.153 -1.425 . . . . 74.019999999999996 107.153 173.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 522' ' ' GLU . . . . . 0.565 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 30.9 mt-10 -117.43 130.18 56.3 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.849 -0.614 . . . . 72.150000000000006 109.95 175.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . 0.565 HG21 HD21 ' A' ' 642' ' ' LEU . 29.3 t -113.52 130.08 68.18 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 CA-C-N 115.207 -0.906 . . . . 75.219999999999999 109.117 -178.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . 0.523 ' HD2' HG21 ' A' ' 568' ' ' VAL . 32.3 mmtp -75.42 126.81 31.77 Favored 'General case' 0 C--N 1.31 -1.122 0 O-C-N 124.045 0.841 . . . . 73.150000000000006 112.4 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 8.9 t -105.16 140.27 23.69 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 N-CA-C 107.188 -1.412 . . . . 73.049999999999997 107.188 177.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . 0.429 HD22 ' N ' ' A' ' 526' ' ' LEU . 2.4 mm? -90.3 139.39 30.71 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 120.804 -0.359 . . . . 71.25 110.033 -178.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . 0.462 ' HG2' ' N ' ' A' ' 528' ' ' THR . 39.0 ttp180 -76.26 158.45 31.56 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 115.349 -0.842 . . . . 71.409999999999997 109.186 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . 0.64 ' OG1' ' HA2' ' A' ' 503' ' ' GLY . 3.2 t -61.87 160.75 11.51 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 123.855 0.862 . . . . 72.219999999999999 111.03 173.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 23.1 t -78.81 -26.49 44.29 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 108.673 -0.862 . . . . 72.310000000000002 108.673 178.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -121.14 104.52 0.96 Allowed Glycine 0 N--CA 1.442 -0.941 0 N-CA-C 109.579 -1.408 . . . . 62.420000000000002 109.579 178.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -100.8 98.47 8.98 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 120.848 0.356 . . . . 63.399999999999999 111.539 -176.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -130.85 119.82 22.77 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.862 -0.608 . . . . 71.450000000000003 110.08 178.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 86.6 -177.85 48.6 Favored Glycine 0 N--CA 1.438 -1.207 0 C-N-CA 120.693 -0.765 . . . . 74.519999999999996 112.433 176.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 534' ' ' ASN . . . . . 0.581 HD21 ' HG3' ' A' ' 561' ' ' GLU . 2.8 t-20 -99.07 130.58 45.41 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.15 -1.055 . . . . 65.310000000000002 108.15 178.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 535' ' ' VAL . . . . . 0.438 HG22 HD22 ' A' ' 596' ' ' LEU . 58.7 t -127.6 131.37 70.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-O 120.84 0.352 . . . . 73.150000000000006 110.095 -176.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 536' ' ' ILE . . . . . 0.529 HG23 ' HB3' ' A' ' 559' ' ' GLU . 33.1 mm -98.41 129.76 48.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 N-CA-C 109.266 -0.642 . . . . 72.140000000000001 109.266 177.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . 0.468 HG22 ' HB3' ' A' ' 594' ' ' PRO . 21.6 t -118.56 101.54 50.72 Favored Pre-proline 0 C--N 1.314 -0.978 0 N-CA-C 109.156 -0.683 . . . . 72.349999999999994 109.156 179.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . 0.429 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 58.1 Cg_endo -72.21 151.12 54.48 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.943 2.428 . . . . 72.329999999999998 112.131 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 539' ' ' TYR . . . . . 0.48 ' HB3' HG22 ' A' ' 591' ' ' ILE . 45.4 p90 -149.45 162.43 40.13 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 109.385 -0.598 . . . . 72.109999999999999 109.385 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -157.59 156.27 31.6 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 123.797 0.686 . . . . 62.130000000000003 109.919 177.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 3.2 p -91.12 122.22 33.58 Favored 'General case' 0 N--CA 1.423 -1.816 0 O-C-N 123.636 0.585 . . . . 44.450000000000003 109.78 173.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.7 mp -92.7 118.63 38.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 105.915 -1.884 . . . . 73.409999999999997 105.915 174.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -50.25 -46.05 54.62 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 124.361 1.038 . . . . 74.120000000000005 111.656 -176.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 67.34 -106.24 1.61 Allowed Glycine 0 N--CA 1.426 -1.971 0 N-CA-C 110.616 -0.994 . . . . 73.219999999999999 110.616 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 11.5 t -118.81 6.64 11.49 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-O 121.615 0.722 . . . . 64.530000000000001 109.973 -178.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -86.06 170.32 12.35 Favored 'General case' 0 N--CA 1.442 -0.874 0 O-C-N 122.029 -0.419 . . . . 54.240000000000002 110.468 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . 0.512 ' HB2' ' HB2' ' A' ' 552' ' ' ASP . 29.8 mmt180 -69.76 174.05 5.57 Favored 'General case' 0 CA--C 1.502 -0.886 0 CA-C-N 116.007 -0.542 . . . . 73.319999999999993 110.964 176.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -68.46 172.89 34.19 Favored Glycine 0 C--N 1.295 -1.731 0 CA-C-N 114.954 -1.021 . . . . 64.510000000000005 114.157 -176.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . -62.37 123.35 30.73 Favored Glycine 0 N--CA 1.435 -1.386 0 CA-C-N 115.131 -0.535 . . . . 62.329999999999998 111.797 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 95.94 -17.75 58.71 Favored Glycine 0 N--CA 1.437 -1.295 0 N-CA-C 111.553 -0.619 . . . . 72.430000000000007 111.553 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -84.72 -66.61 0.87 Allowed 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 109.123 -0.695 . . . . 73.219999999999999 109.123 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . 0.512 ' HB2' ' HB2' ' A' ' 547' ' ' ARG . 1.2 m-20 -107.47 -22.37 12.57 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.664 -0.414 . . . . 72.219999999999999 111.728 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 553' ' ' PHE . . . . . 0.408 ' HB3' ' CE2' ' A' ' 587' ' ' PHE . 35.9 p90 -151.87 151.94 31.94 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 108.849 -0.797 . . . . 63.329999999999998 108.849 177.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.49 122.06 30.74 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 106.048 -1.834 . . . . 73.200000000000003 106.048 177.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -74.38 105.99 5.79 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.128 0.489 . . . . 71.030000000000001 111.231 -175.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 13.5 t -104.08 119.99 40.13 Favored 'General case' 0 N--CA 1.414 -2.271 0 CA-C-O 122.324 1.059 . . . . 74.129999999999995 109.917 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 1.2 p -136.96 105.01 5.63 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-N 114.608 -1.178 . . . . 63.450000000000003 108.728 178.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -151.34 -152.3 5.83 Favored Glycine 0 N--CA 1.416 -2.663 0 N-CA-C 110.743 -0.943 . . . . 64.140000000000001 110.743 -174.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 559' ' ' GLU . . . . . 0.529 ' HB3' HG23 ' A' ' 536' ' ' ILE . 52.2 mt-10 -142.47 129.28 20.53 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.163 0.506 . . . . 74.120000000000005 110.952 -175.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . 0.465 HD13 ' HG2' ' A' ' 569' ' ' LYS . 92.8 mt -91.17 139.47 30.72 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.527 -0.761 . . . . 73.109999999999999 109.678 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 561' ' ' GLU . . . . . 0.581 ' HG3' HD21 ' A' ' 534' ' ' ASN . 28.2 tt0 -100.26 115.68 30.49 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.517 0.675 . . . . 71.549999999999997 111.474 178.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -109.37 158.82 17.54 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 107.355 -1.35 . . . . 73.030000000000001 107.355 171.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . 0.449 ' H ' ' HB2' ' A' ' 566' ' ' GLU . 10.6 pt20 -165.87 179.24 6.0 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 109.803 -0.443 . . . . 74.030000000000001 109.803 177.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -59.47 -32.31 70.13 Favored 'General case' 0 C--N 1.322 -0.612 0 O-C-N 124.083 0.864 . . . . 72.239999999999995 110.468 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -88.85 -12.41 41.98 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.406 -0.816 . . . . 54.109999999999999 111.249 -177.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 566' ' ' GLU . . . . . 0.449 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 26.0 mm-40 -100.96 132.79 46.2 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 113.244 0.831 . . . . 71.329999999999998 113.244 -176.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 3.9 pt -120.27 156.11 23.25 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.065 0 N-CA-C 105.823 -1.917 . . . . 51.409999999999997 105.823 170.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 568' ' ' VAL . . . . . 0.523 HG21 ' HD2' ' A' ' 524' ' ' LYS . 1.0 OUTLIER 48.11 178.34 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.578 2.03 0 C-N-CA 125.708 1.603 . . . . 61.229999999999997 113.003 -177.403 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 569' ' ' LYS . . . . . 0.465 ' HG2' HD13 ' A' ' 560' ' ' LEU . 1.4 tpmt? -172.01 163.59 6.12 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 106.067 -1.827 . . . . 70.299999999999997 106.067 175.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 570' ' ' THR . . . . . 0.551 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 11.5 p -135.58 141.26 45.13 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 123.45 0.469 . . . . 62.229999999999997 110.779 176.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 571' ' ' ILE . . . . . 0.565 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 3.5 mp -97.28 122.13 48.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 N-CA-C 106.166 -1.79 . . . . 62.450000000000003 106.166 169.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 40.4 p -99.96 118.69 36.9 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 109.329 -0.619 . . . . 72.349999999999994 109.329 177.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 573' ' ' VAL . . . . . . . . . . . . . 45.2 t -117.48 126.64 74.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 108.887 -0.783 . . . . 74.409999999999997 108.887 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -77.89 106.73 9.93 Favored 'General case' 0 N--CA 1.421 -1.907 0 N-CA-C 108.608 -0.886 . . . . 63.420000000000002 108.608 174.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 62.1 t -84.19 119.81 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.378 0 N-CA-C 105.757 -1.942 . . . . 75.329999999999998 105.757 175.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 39.4 mm -76.87 131.09 35.49 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 106.776 -1.565 . . . . 61.109999999999999 106.776 -177.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -60.29 99.16 0.07 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 122.092 0.949 . . . . 71.340000000000003 109.773 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 578' ' ' ASP . . . . . 0.466 ' HB3' ' HG3' ' A' ' 516' ' ' GLU . 19.1 t70 -61.64 133.77 56.01 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 114.346 -1.297 . . . . 62.43 113.93 -172.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 579' ' ' GLU . . . . . 0.513 ' H ' ' CD ' ' A' ' 579' ' ' GLU . 0.6 OUTLIER -96.36 -13.83 22.96 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 113.599 -1.637 . . . . 74.140000000000001 113.883 -173.973 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -124.99 166.76 15.76 Favored 'General case' 0 C--O 1.264 1.826 0 C-N-CA 117.936 -1.506 . . . . 70.310000000000002 113.491 -176.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -71.86 153.37 41.94 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 107.664 -1.235 . . . . 64.329999999999998 107.664 178.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 582' ' ' GLU . . . . . 0.459 ' HG3' ' H ' ' A' ' 584' ' ' ASN . 6.1 pt-20 -148.79 166.1 29.48 Favored 'General case' 0 C--N 1.278 -2.531 0 N-CA-C 108.619 -0.882 . . . . 73.439999999999998 108.619 176.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 583' ' ' LYS . . . . . 0.412 ' HD3' ' HA ' ' A' ' 583' ' ' LYS . 34.1 mmtp -106.59 30.22 6.23 Favored 'General case' 0 C--N 1.286 -2.186 0 CA-C-O 122.814 1.293 . . . . 74.209999999999994 107.825 176.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 584' ' ' ASN . . . . . 0.543 ' ND2' ' HA ' ' A' ' 647' ' ' GLU . 19.9 m120 80.26 96.12 0.05 Allowed 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 110.902 -2.863 . . . . 72.329999999999998 111.491 178.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.14 163.0 19.02 Favored 'General case' 0 N--CA 1.434 -1.267 0 C-N-CA 119.434 -0.906 . . . . 65.299999999999997 109.955 176.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 6.0 t -148.49 143.77 26.92 Favored 'General case' 0 N--CA 1.415 -2.188 0 CA-C-O 120.97 0.415 . . . . 65.5 110.059 -177.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 587' ' ' PHE . . . . . 0.41 ' CZ ' HD11 ' A' ' 646' ' ' ILE . 3.1 p90 -129.38 149.62 51.08 Favored 'General case' 0 N--CA 1.418 -2.042 0 CA-C-N 114.305 -1.316 . . . . 75.430000000000007 108.711 177.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 588' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -106.81 136.25 46.96 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 116.41 -0.359 . . . . 75.25 110.086 -172.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . 0.493 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.4 OUTLIER -105.87 122.97 47.2 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 105.466 -2.05 . . . . 44.399999999999999 105.466 174.87 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -130.67 135.38 47.78 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 109.627 -0.508 . . . . 73.329999999999998 109.627 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 591' ' ' ILE . . . . . 0.48 HG22 ' HB3' ' A' ' 539' ' ' TYR . 19.6 pt -96.93 141.06 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.552 0 N-CA-C 106.839 -1.541 . . . . 71.439999999999998 106.839 173.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -95.9 -134.13 7.77 Favored Glycine 0 C--N 1.295 -1.729 0 C-N-CA 120.604 -0.808 . . . . 44.43 113.026 -175.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -85.19 116.05 63.82 Favored Pre-proline 0 C--N 1.303 -1.438 0 C-N-CA 122.958 0.503 . . . . 63.020000000000003 110.667 -177.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 594' ' ' PRO . . . . . 0.478 ' HA ' ' O ' ' A' ' 536' ' ' ILE . 59.8 Cg_endo -75.16 137.07 20.9 Favored 'Trans proline' 0 N--CA 1.431 -2.191 0 C-N-CA 121.316 1.344 . . . . 74.510000000000005 109.377 173.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -129.96 137.9 50.56 Favored 'General case' 0 C--N 1.285 -2.213 0 O-C-N 121.876 -0.515 . . . . 74.519999999999996 111.548 -175.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 596' ' ' LEU . . . . . 0.438 HD22 HG22 ' A' ' 535' ' ' VAL . 0.0 OUTLIER -77.18 124.81 28.35 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 107.905 -1.146 . . . . 64.299999999999997 107.905 -176.434 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 597' ' ' VAL . . . . . 0.418 ' CG2' HG12 ' A' ' 536' ' ' ILE . 23.1 t . . . . . 0 C--N 1.298 -1.644 0 CA-C-O 121.301 0.572 . . . . 61.140000000000001 109.667 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 . . . . . 0 CA--C 1.494 -1.199 0 N-CA-C 107.734 -1.21 . . . . 75.0 107.734 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -66.17 142.05 65.74 Favored 'Trans proline' 0 N--CA 1.437 -1.82 0 N-CA-C 108.204 -1.499 . . . . 71.239999999999995 108.204 171.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.3 pp -122.88 176.26 4.99 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 N-CA-C 113.677 0.992 . . . . 73.230000000000004 113.677 -173.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . 0.488 ' HB2' HG21 ' A' ' 640' ' ' THR . 0.0 OUTLIER -80.91 152.21 28.2 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 114.881 -1.054 . . . . 73.219999999999999 108.5 -179.344 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . 0.439 ' HA3' ' HB ' ' A' ' 506' ' ' THR . . . -80.74 -135.96 1.69 Allowed Glycine 0 C--N 1.293 -1.851 0 C-N-CA 120.864 -0.684 . . . . 73.209999999999994 113.668 -176.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -83.56 -58.67 2.72 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 120.125 -0.63 . . . . 72.450000000000003 109.969 -177.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -125.75 94.38 4.1 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 121.85 0.834 . . . . 62.149999999999999 111.905 -178.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 640' ' ' THR . . . . . 0.488 HG21 ' HB2' ' A' ' 636' ' ' LEU . 17.8 p -96.03 90.67 5.64 Favored 'General case' 0 N--CA 1.407 -2.595 0 N-CA-C 107.878 -1.156 . . . . 74.340000000000003 107.878 174.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 641' ' ' LYS . . . . . 0.446 ' HE2' ' HB2' ' A' ' 643' ' ' GLU . 1.2 tmtp? -172.5 134.4 0.66 Allowed 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 105.583 -2.006 . . . . 71.230000000000004 105.583 -175.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 642' ' ' LEU . . . . . 0.565 HD21 HG21 ' A' ' 523' ' ' VAL . 37.1 tp -134.93 106.34 6.8 Favored 'General case' 0 C--N 1.277 -2.583 0 N-CA-C 108.02 -1.104 . . . . 72.430000000000007 108.02 177.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . 0.446 ' HB2' ' HE2' ' A' ' 641' ' ' LYS . 27.2 tt0 -87.66 104.25 16.35 Favored 'General case' 0 C--N 1.277 -2.565 0 N-CA-C 106.748 -1.575 . . . . 74.310000000000002 106.748 178.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 644' ' ' VAL . . . . . 0.459 HG21 ' HE1' ' A' ' 521' ' ' MET . 40.1 t -94.06 106.02 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.155 0 N-CA-C 108.372 -0.973 . . . . 73.329999999999998 108.372 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 645' ' ' ILE . . . . . 0.441 ' HB ' ' CD2' ' A' ' 513' ' ' HIS . 3.8 mp -93.38 126.89 45.75 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 106.615 -1.624 . . . . 72.340000000000003 106.615 176.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 646' ' ' ILE . . . . . 0.539 ' N ' HD12 ' A' ' 646' ' ' ILE . 2.4 mp -99.11 124.02 52.12 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.249 0 N-CA-C 106.626 -1.62 . . . . 64.040000000000006 106.626 -177.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . 0.543 ' HA ' ' ND2' ' A' ' 584' ' ' ASN . 0.0 OUTLIER -109.07 152.44 25.04 Favored 'General case' 0 C--N 1.266 -3.024 0 CA-C-N 115.598 -0.728 . . . . 63.229999999999997 109.518 -178.599 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 648' ' ' GLU . . . . . 0.432 ' CD ' ' HG2' ' A' ' 582' ' ' GLU . 25.5 mt-10 -83.79 75.31 10.1 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-O 122.327 1.061 . . . . 70.099999999999994 110.788 -176.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 18.2 m . . . . . 0 N--CA 1.446 -0.675 0 C-N-CA 129.024 2.93 . . . . 74.409999999999997 115.31 -176.987 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.41 -3.074 0 N-CA-C 113.803 0.281 . . . . 73.209999999999994 113.803 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . 0.483 ' H ' ' CB ' ' A' ' 528' ' ' THR . 3.6 mp -119.57 96.48 4.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 107.463 -1.31 . . . . 63.149999999999999 107.463 173.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -108.71 115.04 29.34 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 106.135 -1.802 . . . . 74.319999999999993 106.135 178.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . 0.461 ' HB ' ' H ' ' A' ' 638' ' ' GLU . 15.0 t -147.71 164.33 33.91 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 120.232 -0.587 . . . . 73.040000000000006 109.478 -173.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -94.35 160.24 14.76 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 107.658 -1.238 . . . . 62.25 107.658 173.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . 0.434 ' HB2' HD21 ' A' ' 526' ' ' LEU . 24.2 tt0 -91.04 -33.46 15.5 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 107.445 -1.317 . . . . 53.109999999999999 107.445 -179.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -124.16 134.95 25.84 Favored Pre-proline 0 N--CA 1.414 -2.241 0 CA-C-N 114.369 -1.287 . . . . 70.310000000000002 109.538 179.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 510' ' ' PRO . . . . . 0.632 ' HA ' ' O ' ' A' ' 641' ' ' LYS . 81.9 Cg_endo -85.76 -4.64 9.02 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 121.82 1.68 . . . . 63.049999999999997 111.416 174.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . 0.405 HG22 ' HB3' ' A' ' 643' ' ' GLU . 81.9 t -143.64 134.71 22.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 C-N-CA 123.882 0.873 . . . . 72.129999999999995 108.672 -178.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 14.6 t -134.06 132.12 39.62 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 107.265 -1.383 . . . . 71.219999999999999 107.265 175.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 28.5 m-70 -100.52 121.63 41.89 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.485 -0.931 . . . . 64.239999999999995 108.485 177.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.648 HG11 ' SD ' ' A' ' 521' ' ' MET . 33.0 m -115.02 156.66 15.93 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 CA-C-N 116.27 -0.423 . . . . 72.120000000000005 109.983 -177.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 22.9 t -82.89 133.12 35.13 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 107.822 -1.177 . . . . 72.329999999999998 107.822 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -68.31 -7.52 31.74 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 112.07 0.396 . . . . 74.340000000000003 112.07 -177.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 45.6 p -103.09 8.02 38.78 Favored 'General case' 0 C--N 1.313 -0.992 0 O-C-N 121.63 -0.669 . . . . 71.109999999999999 110.655 179.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 12.4 tt -80.23 152.02 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 N-CA-C 109.536 -0.542 . . . . 74.140000000000001 109.536 -177.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . -91.23 -61.45 1.26 Allowed Glycine 0 N--CA 1.426 -1.982 0 C-N-CA 120.253 -0.975 . . . . 55.310000000000002 110.996 177.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 28.3 mm -121.18 128.42 76.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-O 121.068 0.461 . . . . 43.539999999999999 110.849 -177.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 521' ' ' MET . . . . . 0.667 ' HE1' HG21 ' A' ' 644' ' ' VAL . 24.0 ptt? -107.95 140.71 40.68 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 107.3 -1.37 . . . . 73.439999999999998 107.3 171.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -119.61 113.0 20.03 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-O 121.185 0.517 . . . . 70.109999999999999 109.957 -178.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . 0.646 ' O ' ' HA ' ' A' ' 570' ' ' THR . 47.3 t -93.04 126.45 45.47 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.31 0 CA-C-N 115.258 -0.883 . . . . 51.130000000000003 109.769 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . 0.495 ' HD2' HG21 ' A' ' 568' ' ' VAL . 31.4 mmtp -87.47 142.6 27.74 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 124.329 1.018 . . . . 51.130000000000003 111.427 -178.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 26.8 t -120.0 132.8 68.69 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 N-CA-C 107.016 -1.476 . . . . 73.540000000000006 107.016 176.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . 0.434 HD21 ' HB2' ' A' ' 508' ' ' GLU . 3.1 mm? -71.84 139.01 48.7 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-O 121.322 0.582 . . . . 73.420000000000002 110.902 -179.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . 0.507 ' HD3' ' CZ ' ' A' ' 562' ' ' PHE . 13.6 tpt85 -79.37 127.4 32.04 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 114.839 -1.073 . . . . 75.25 110.001 179.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . 0.483 ' CB ' ' H ' ' A' ' 504' ' ' ILE . 2.6 t -60.67 146.65 44.86 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 113.979 -1.464 . . . . 62.030000000000001 111.561 175.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 32.6 t -61.58 -35.58 78.24 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 115.143 -0.935 . . . . 75.329999999999998 109.239 176.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -120.6 110.01 1.67 Allowed Glycine 0 N--CA 1.423 -2.185 0 N-CA-C 110.489 -1.044 . . . . 62.109999999999999 110.489 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . 0.445 ' HB2' HG23 ' A' ' 528' ' ' THR . . . -127.14 112.29 14.99 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.326 -0.99 . . . . 71.230000000000004 108.326 176.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -119.01 102.61 8.88 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 120.891 0.377 . . . . 73.540000000000006 111.192 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 93.54 -153.72 21.42 Favored Glycine 0 N--CA 1.43 -1.724 0 CA-C-N 115.534 -0.757 . . . . 61.43 112.261 175.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 534' ' ' ASN . . . . . 0.582 HD21 ' HG3' ' A' ' 561' ' ' GLU . 2.4 t-20 -104.24 126.16 51.12 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.183 -0.673 . . . . 71.5 109.183 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 535' ' ' VAL . . . . . 0.471 HG22 HD22 ' A' ' 596' ' ' LEU . 55.6 t -121.16 136.42 58.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 123.284 0.634 . . . . 73.209999999999994 109.529 -177.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 536' ' ' ILE . . . . . 0.614 HG23 ' HB3' ' A' ' 559' ' ' GLU . 18.7 mm -101.65 129.26 53.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-N 116.321 -0.4 . . . . 64.140000000000001 110.18 178.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . 0.461 HG22 ' HB3' ' A' ' 594' ' ' PRO . 39.1 t -118.84 108.85 40.33 Favored Pre-proline 0 C--N 1.317 -0.844 0 N-CA-C 108.812 -0.81 . . . . 75.549999999999997 108.812 177.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -72.34 143.07 38.4 Favored 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 122.033 1.822 . . . . 63.119999999999997 111.177 178.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 539' ' ' TYR . . . . . 0.514 ' CE1' ' HG ' ' A' ' 560' ' ' LEU . 35.3 p90 -152.13 155.5 37.97 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 109.865 -0.42 . . . . 50.399999999999999 109.865 -179.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -153.36 154.9 35.41 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 116.208 -0.451 . . . . 73.420000000000002 109.979 176.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 16.8 p -93.71 110.29 21.92 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 115.603 -0.726 . . . . 31.34 109.264 176.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.6 mp -77.57 118.87 25.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 105.69 -1.967 . . . . 65.420000000000002 105.69 176.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -54.83 -36.64 65.23 Favored 'General case' 0 C--N 1.319 -0.728 0 O-C-N 124.28 0.987 . . . . 74.450000000000003 113.578 -173.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 69.93 -97.81 0.59 Allowed Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 111.636 -0.586 . . . . 65.329999999999998 111.636 177.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 6.9 t -122.95 -0.27 9.02 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.472 0.653 . . . . 53.119999999999997 110.553 177.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -99.07 -170.26 1.89 Allowed 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 107.6 -1.259 . . . . 44.229999999999997 107.6 177.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . 0.446 ' HD3' ' N ' ' A' ' 548' ' ' GLY . 0.0 OUTLIER -138.12 130.14 28.59 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.34 -0.985 . . . . 65.120000000000005 108.34 -178.767 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 548' ' ' GLY . . . . . 0.446 ' N ' ' HD3' ' A' ' 547' ' ' ARG . . . -76.89 -146.15 2.12 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 111.346 -0.702 . . . . 72.540000000000006 111.346 177.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 64.44 15.69 59.58 Favored Glycine 0 C--N 1.314 -0.671 0 CA-C-N 117.077 0.438 . . . . 53.229999999999997 113.404 178.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 77.49 18.64 77.52 Favored Glycine 0 N--CA 1.431 -1.65 0 C-N-CA 121.172 -0.537 . . . . 74.109999999999999 112.166 -178.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -84.33 -70.62 0.56 Allowed 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 121.359 0.6 . . . . 65.310000000000002 109.491 178.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -100.63 -39.11 8.04 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 107.331 -1.359 . . . . 72.519999999999996 107.331 -178.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 553' ' ' PHE . . . . . 0.45 ' HA ' HG12 ' A' ' 576' ' ' ILE . 25.1 p90 -144.72 166.27 25.7 Favored 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 108.109 -1.071 . . . . 72.340000000000003 108.109 173.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . 0.411 ' HB3' ' HB3' ' A' ' 574' ' ' LYS . 0.6 OUTLIER -98.56 109.12 21.93 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 106.409 -1.7 . . . . 64.420000000000002 106.409 179.184 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -75.83 122.62 24.37 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-O 121.693 0.759 . . . . 71.420000000000002 111.038 -175.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 7.3 t -111.14 112.63 24.57 Favored 'General case' 0 N--CA 1.409 -2.514 0 CA-C-O 122.081 0.943 . . . . 44.310000000000002 109.957 -177.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 4.4 p -126.17 116.66 21.67 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 114.724 -1.125 . . . . 62.439999999999998 108.773 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -170.71 -156.27 11.26 Favored Glycine 0 N--CA 1.403 -3.547 0 C-N-CA 120.09 -1.053 . . . . 74.310000000000002 110.945 -176.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 559' ' ' GLU . . . . . 0.614 ' HB3' HG23 ' A' ' 536' ' ' ILE . 49.1 mt-10 -133.11 126.5 31.88 Favored 'General case' 0 C--N 1.284 -2.269 0 C-N-CA 122.368 0.267 . . . . 74.239999999999995 110.37 -176.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . 0.514 ' HG ' ' CE1' ' A' ' 539' ' ' TYR . 74.9 mt -82.42 136.26 34.98 Favored 'General case' 0 CA--C 1.5 -0.948 0 CA-C-N 116.064 -0.516 . . . . 65.409999999999997 110.88 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 561' ' ' GLU . . . . . 0.582 ' HG3' HD21 ' A' ' 534' ' ' ASN . 43.1 tt0 -98.32 102.33 14.04 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.096 -0.956 . . . . 75.329999999999998 108.9 178.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 562' ' ' PHE . . . . . 0.507 ' CZ ' ' HD3' ' A' ' 527' ' ' ARG . 1.3 t80 -111.37 147.95 34.05 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 106.559 -1.645 . . . . 71.530000000000001 106.559 -179.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . 0.426 ' H ' ' HB3' ' A' ' 566' ' ' GLU . 46.3 mt-30 -141.68 179.13 7.01 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 121.559 -0.713 . . . . 73.310000000000002 111.065 -173.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -77.63 -35.48 52.62 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 109.314 -0.624 . . . . 74.230000000000004 109.314 175.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -84.09 5.04 27.57 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 122.123 0.963 . . . . 74.409999999999997 109.599 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 566' ' ' GLU . . . . . 0.426 ' HB3' ' H ' ' A' ' 563' ' ' GLN . 6.7 tp10 -121.56 146.51 46.88 Favored 'General case' 0 N--CA 1.422 -1.869 0 CA-C-N 115.09 -0.959 . . . . 70.329999999999998 108.874 -179.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 3.3 pt -135.27 155.92 38.17 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.629 0 N-CA-C 106.707 -1.59 . . . . 71.319999999999993 106.707 173.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 568' ' ' VAL . . . . . 0.495 HG21 ' HD2' ' A' ' 524' ' ' LYS . 0.9 OUTLIER 51.01 170.13 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.624 0 C-N-CA 125.52 1.528 . . . . 75.219999999999999 112.048 -174.824 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 569' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -159.27 149.58 19.25 Favored 'General case' 0 C--N 1.283 -2.303 0 O-C-N 120.394 -1.441 . . . . 54.229999999999997 107.653 176.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 570' ' ' THR . . . . . 0.646 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 9.4 p -124.4 123.8 40.96 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 113.162 0.801 . . . . 50.310000000000002 113.162 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 2.8 mp -85.83 114.29 25.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 104.857 -2.275 . . . . 72.239999999999995 104.857 171.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 572' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 521' ' ' MET . 24.9 m -102.55 109.2 20.75 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.191 0.52 . . . . 70.400000000000006 110.106 -177.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 573' ' ' VAL . . . . . . . . . . . . . 25.5 t -111.53 137.06 45.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 115.735 -0.666 . . . . 70.420000000000002 109.687 -176.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 574' ' ' LYS . . . . . 0.411 ' HB3' ' HB3' ' A' ' 554' ' ' GLU . 5.0 tppp? -95.05 123.87 38.77 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 124.021 0.826 . . . . 62.130000000000003 110.087 178.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 57.9 t -94.33 133.47 35.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 107.03 -1.47 . . . . 71.120000000000005 107.03 175.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 576' ' ' ILE . . . . . 0.45 HG12 ' HA ' ' A' ' 553' ' ' PHE . 25.9 mm -98.55 160.3 3.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 109.261 -0.644 . . . . 62.100000000000001 109.261 -175.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -64.7 109.51 2.05 Favored 'General case' 0 C--O 1.247 0.94 0 C-N-CA 123.096 0.559 . . . . 71.439999999999998 110.054 177.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -55.93 127.7 31.62 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 124.211 0.944 . . . . 64.510000000000005 110.913 -172.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -110.32 -30.5 7.67 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 115.752 1.76 . . . . 53.149999999999999 115.752 -167.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 580' ' ' GLU . . . . . 0.448 ' HG2' ' CD2' ' A' ' 581' ' ' TYR . 0.0 OUTLIER -103.81 -72.26 0.71 Allowed 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 115.009 1.485 . . . . 75.530000000000001 115.009 -162.493 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 581' ' ' TYR . . . . . 0.448 ' CD2' ' HG2' ' A' ' 580' ' ' GLU . 6.3 p90 -141.47 154.03 45.3 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 107.572 -1.27 . . . . 72.450000000000003 107.572 -174.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -109.87 108.14 18.34 Favored 'General case' 0 C--N 1.27 -2.854 0 C-N-CA 119.137 -1.025 . . . . 72.519999999999996 109.809 -177.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 9.9 mmmm -139.03 169.38 17.89 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 105.73 -1.952 . . . . 73.140000000000001 105.73 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -74.94 98.72 3.64 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 108.008 -1.108 . . . . 74.109999999999999 108.008 175.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.09 147.21 30.28 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-O 121.202 0.525 . . . . 62.219999999999999 111.196 -178.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 4.1 t -152.41 152.12 31.64 Favored 'General case' 0 N--CA 1.422 -1.858 0 CA-C-N 115.372 -0.831 . . . . 72.140000000000001 109.643 -175.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -133.83 160.02 38.89 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-N 114.695 -1.139 . . . . 75.400000000000006 109.68 177.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 588' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -116.33 138.38 51.38 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 120.625 0.25 . . . . 73.310000000000002 110.379 -171.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . 0.572 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.6 OUTLIER -106.28 122.26 45.88 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 105.447 -2.057 . . . . 22.030000000000001 105.447 173.161 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -129.6 130.78 46.1 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 107.343 -1.354 . . . . 75.209999999999994 107.343 178.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 591' ' ' ILE . . . . . 0.491 HG22 ' HB3' ' A' ' 539' ' ' TYR . 27.4 pt -103.75 147.82 9.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.495 -0.928 . . . . 74.219999999999999 108.495 179.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -94.29 -168.45 37.33 Favored Glycine 0 N--CA 1.425 -2.1 0 N-CA-C 111.621 -0.591 . . . . 43.310000000000002 111.621 -178.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -77.67 127.18 83.06 Favored Pre-proline 0 N--CA 1.428 -1.556 0 N-CA-C 107.881 -1.155 . . . . 74.219999999999999 107.881 -178.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 594' ' ' PRO . . . . . 0.607 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 72.0 Cg_endo -71.77 171.17 17.02 Favored 'Trans proline' 0 C--N 1.324 -0.715 0 C-N-CA 123.384 2.722 . . . . 74.299999999999997 112.934 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 7.9 ptp85 -150.22 151.41 32.99 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 107.076 -1.453 . . . . 72.340000000000003 107.076 177.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 596' ' ' LEU . . . . . 0.471 HD22 HG22 ' A' ' 535' ' ' VAL . 0.0 OUTLIER -81.04 131.49 35.31 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 104.879 -2.267 . . . . 63.509999999999998 104.879 178.144 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 597' ' ' VAL . . . . . 0.52 ' CG2' HG12 ' A' ' 536' ' ' ILE . 99.3 t . . . . . 0 C--N 1.31 -1.133 0 CA-C-O 122.435 1.112 . . . . 61.509999999999998 108.584 178.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? . . . . . 0 N--CA 1.442 -0.874 0 N-CA-C 106.862 -1.533 . . . . 74.329999999999998 106.862 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . 0.607 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 11.9 Cg_endo -64.94 132.7 33.16 Favored 'Trans proline' 0 N--CA 1.441 -1.588 0 N-CA-C 107.562 -1.745 . . . . 44.25 107.562 167.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.5 pp -112.69 161.28 11.69 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.371 0 C-N-CA 120.194 -0.603 . . . . 63.420000000000002 111.442 -178.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 10.0 tt -63.1 154.57 30.55 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 124.34 1.056 . . . . 65.329999999999998 112.184 -178.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -79.77 -125.41 0.53 Allowed Glycine 0 N--CA 1.431 -1.664 0 N-CA-C 116.298 1.279 . . . . 64.239999999999995 116.298 -173.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 638' ' ' GLU . . . . . 0.461 ' H ' ' HB ' ' A' ' 506' ' ' THR . 34.6 tt0 -90.75 -72.96 0.55 Allowed 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.699 -0.751 . . . . 64.510000000000005 112.668 -169.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -130.84 127.93 39.61 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.113 0.483 . . . . 62.119999999999997 110.191 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 17.1 p -129.51 92.78 3.41 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-O 121.92 0.867 . . . . 73.219999999999999 112.743 -175.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 641' ' ' LYS . . . . . 0.632 ' O ' ' HA ' ' A' ' 510' ' ' PRO . 20.5 tptm -156.12 139.15 15.43 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 106.147 -1.798 . . . . 71.530000000000001 106.147 178.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 642' ' ' LEU . . . . . 0.572 ' HB3' ' HB3' ' A' ' 589' ' ' LEU . 21.8 tp -138.21 103.64 4.98 Favored 'General case' 0 N--CA 1.409 -2.491 0 N-CA-C 108.154 -1.054 . . . . 60.109999999999999 108.154 173.378 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . 0.405 ' HB3' HG22 ' A' ' 511' ' ' VAL . 24.9 tt0 -93.11 107.63 19.39 Favored 'General case' 0 C--N 1.274 -2.681 0 N-CA-C 106.847 -1.538 . . . . 72.420000000000002 106.847 176.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 644' ' ' VAL . . . . . 0.667 HG21 ' HE1' ' A' ' 521' ' ' MET . 24.0 t -93.24 104.89 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.004 0 N-CA-C 109.057 -0.72 . . . . 73.439999999999998 109.057 -177.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 4.0 mp -91.22 118.99 37.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 107.281 -1.377 . . . . 73.439999999999998 107.281 176.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 646' ' ' ILE . . . . . 0.458 ' N ' HD12 ' A' ' 646' ' ' ILE . 2.5 mp -100.15 108.0 22.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 106.607 -1.627 . . . . 64.409999999999997 106.607 -176.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -114.23 152.39 31.34 Favored 'General case' 0 C--N 1.281 -2.405 0 O-C-N 123.371 0.42 . . . . 63.520000000000003 111.241 -175.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -58.1 133.55 55.67 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.321 -0.854 . . . . 53.200000000000003 110.09 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 33.5 t . . . . . 0 N--CA 1.436 -1.151 0 O-C-N 124.218 0.949 . . . . 55.229999999999997 112.383 -174.148 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . 0.561 ' HA2' ' OG1' ' A' ' 528' ' ' THR . . . . . . . . 0 N--CA 1.414 -2.812 0 N-CA-C 112.352 -0.299 . . . . 61.009999999999998 112.352 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 3.8 mp -123.26 104.95 15.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 N-CA-C 107.756 -1.202 . . . . 75.400000000000006 107.756 175.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -118.62 112.42 19.82 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.775 -1.194 . . . . 75.510000000000005 107.775 176.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 14.9 t -141.62 155.22 45.74 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 120.392 -0.523 . . . . 75.510000000000005 110.25 -174.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -81.19 144.81 31.36 Favored 'General case' 0 CA--C 1.489 -1.372 0 N-CA-C 107.559 -1.274 . . . . 74.510000000000005 107.559 175.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -65.28 -43.71 90.3 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 123.88 0.737 . . . . 63.100000000000001 109.757 178.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -123.93 125.71 25.8 Favored Pre-proline 0 N--CA 1.425 -1.675 0 CA-C-N 115.625 -0.716 . . . . 75.420000000000002 109.257 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 510' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 641' ' ' LYS . 58.4 Cg_endo -73.52 -16.61 24.16 Favored 'Trans proline' 0 CA--C 1.53 0.298 0 C-N-CA 122.163 1.909 . . . . 74.219999999999999 111.708 176.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 83.1 t -133.82 131.78 56.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 109.013 -0.736 . . . . 63.229999999999997 109.013 178.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 6.0 t -132.84 143.37 49.49 Favored 'General case' 0 N--CA 1.406 -2.65 0 N-CA-C 107.568 -1.271 . . . . 75.030000000000001 107.568 178.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 36.1 m-70 -114.59 127.72 55.94 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.379 -0.971 . . . . 62.299999999999997 108.379 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.538 HG11 ' SD ' ' A' ' 521' ' ' MET . 34.1 m -124.86 158.94 32.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-O 121.015 0.436 . . . . 53.350000000000001 111.128 -174.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . 0.413 ' O ' HG22 ' A' ' 518' ' ' ILE . 34.9 t -77.74 148.91 34.64 Favored 'General case' 0 N--CA 1.414 -2.227 0 CA-C-N 115.22 -0.9 . . . . 72.510000000000005 110.787 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -68.45 -17.67 64.25 Favored 'General case' 0 N--CA 1.422 -1.844 0 CA-C-N 114.827 -1.079 . . . . 75.0 108.512 172.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 43.6 m -108.75 22.06 16.43 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 116.056 -0.52 . . . . 73.420000000000002 111.375 -176.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 518' ' ' ILE . . . . . 0.413 HG22 ' O ' ' A' ' 515' ' ' SER . 16.1 tt -92.36 159.68 2.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 109.317 -0.623 . . . . 73.200000000000003 109.317 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . 0.481 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . -106.22 -67.08 0.67 Allowed Glycine 0 N--CA 1.417 -2.621 0 C-N-CA 120.281 -0.962 . . . . 74.420000000000002 111.179 177.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 33.5 mm -120.66 124.2 71.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 109.604 -0.517 . . . . 51.219999999999999 109.604 -177.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 521' ' ' MET . . . . . 0.72 ' HE1' HG21 ' A' ' 644' ' ' VAL . 24.6 ptt? -103.86 137.73 41.45 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 107.109 -1.441 . . . . 61.109999999999999 107.109 172.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 15.8 mp0 -114.16 97.37 6.31 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 108.788 -0.819 . . . . 72.030000000000001 108.788 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . 0.579 ' O ' ' HA ' ' A' ' 570' ' ' THR . 26.5 t -84.26 131.72 33.27 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 CA-C-N 116.1 -0.5 . . . . 52.530000000000001 110.308 -177.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . 0.458 ' HD2' HG21 ' A' ' 568' ' ' VAL . 32.3 mmtp -85.27 128.14 34.58 Favored 'General case' 0 C--O 1.247 0.966 0 N-CA-C 113.211 0.819 . . . . 73.519999999999996 113.211 -176.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 21.6 t -117.35 123.84 72.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 CA-C-N 114.251 -1.341 . . . . 75.219999999999999 107.773 177.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -81.69 141.71 33.36 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 109.487 -0.56 . . . . 74.439999999999998 109.487 -176.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . 0.472 ' HG2' ' N ' ' A' ' 528' ' ' THR . 39.3 ttp180 -86.77 161.06 18.58 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.498 -0.774 . . . . 51.32 110.851 -175.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . 0.561 ' OG1' ' HA2' ' A' ' 503' ' ' GLY . 5.7 t -67.68 142.53 56.32 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-N 115.11 -0.95 . . . . 33.409999999999997 110.478 173.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 21.9 t -63.85 -38.85 92.64 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 115.216 -0.902 . . . . 73.319999999999993 108.924 176.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -100.37 80.14 0.47 Allowed Glycine 0 N--CA 1.431 -1.679 0 N-CA-C 110.329 -1.108 . . . . 51.340000000000003 110.329 177.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -93.68 107.8 19.62 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 109.279 -0.637 . . . . 72.519999999999996 109.279 178.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 19.4 mmt180 -119.49 111.06 17.64 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 120.889 0.376 . . . . 72.319999999999993 110.723 -179.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 89.33 -126.45 8.24 Favored Glycine 0 N--CA 1.426 -2.022 0 C-N-CA 120.111 -1.042 . . . . 74.420000000000002 113.504 175.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 534' ' ' ASN . . . . . 0.594 HD21 ' HG3' ' A' ' 561' ' ' GLU . 2.6 t-20 -135.85 124.16 23.27 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.278 -1.008 . . . . 63.43 108.278 -177.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 535' ' ' VAL . . . . . 0.446 HG22 HD22 ' A' ' 596' ' ' LEU . 72.1 t -125.04 125.42 69.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 109.326 -0.62 . . . . 75.409999999999997 109.326 -178.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 536' ' ' ILE . . . . . 0.429 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 36.6 mm -100.57 125.03 54.48 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.134 0 CA-C-N 115.447 -0.797 . . . . 54.219999999999999 109.103 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . 0.457 HG22 ' HB3' ' A' ' 594' ' ' PRO . 30.0 t -116.82 112.41 40.53 Favored Pre-proline 0 C--N 1.312 -1.031 0 CA-C-N 116.202 -0.454 . . . . 61.240000000000002 110.682 -176.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -74.28 140.62 27.83 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.481 2.121 . . . . 74.310000000000002 112.227 177.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 539' ' ' TYR . . . . . 0.494 ' CD1' ' HG ' ' A' ' 560' ' ' LEU . 48.5 p90 -140.99 156.18 46.09 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.004 -1.11 . . . . 62.100000000000001 108.004 -179.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -154.99 157.82 38.24 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 123.28 0.362 . . . . 63.210000000000001 110.659 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 1.6 p -95.09 124.6 39.22 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 115.1 -0.954 . . . . 74.109999999999999 108.812 174.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.5 mp -93.35 128.35 44.85 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 106.275 -1.75 . . . . 65.299999999999997 106.275 175.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -57.9 -50.23 74.03 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 123.782 0.677 . . . . 63.32 111.377 -176.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 69.4 -101.59 0.85 Allowed Glycine 0 N--CA 1.434 -1.477 0 CA-C-N 115.652 -0.703 . . . . 63.43 111.973 178.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 10.0 t -125.89 14.72 8.0 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 122.323 1.058 . . . . 61.100000000000001 109.26 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -116.94 152.92 33.53 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.114 -1.069 . . . . 42.43 108.114 176.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . 0.471 ' HG2' ' HG3' ' A' ' 551' ' ' GLU . 31.8 ttp180 -89.47 130.1 35.86 Favored 'General case' 0 N--CA 1.422 -1.841 0 CA-C-O 121.101 0.477 . . . . 73.219999999999999 111.116 -178.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -96.49 -176.92 35.73 Favored Glycine 0 C--N 1.301 -1.402 0 C-N-CA 120.884 -0.674 . . . . 73.239999999999995 112.774 -175.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 80.72 26.63 53.39 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.927 -0.654 . . . . 64.450000000000003 113.002 177.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 92.08 11.29 60.21 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.743 -0.742 . . . . 74.340000000000003 112.953 177.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . 0.471 ' HG3' ' HG2' ' A' ' 547' ' ' ARG . 5.8 mm-40 -88.99 -70.51 0.65 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 117.273 0.537 . . . . 54.399999999999999 110.287 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -98.86 -27.02 14.1 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.575 -0.898 . . . . 74.230000000000004 108.575 174.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 553' ' ' PHE . . . . . 0.638 ' HB3' ' CE2' ' A' ' 587' ' ' PHE . 40.8 p90 -151.46 154.2 36.11 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.569 -0.741 . . . . 35.5 110.055 176.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.99 129.6 34.81 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 104.948 -2.241 . . . . 75.0 104.948 174.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -86.19 113.48 22.25 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.212 0.529 . . . . 71.299999999999997 111.112 -172.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . 0.428 HG21 HG22 ' A' ' 573' ' ' VAL . 11.3 t -111.51 104.85 13.3 Favored 'General case' 0 N--CA 1.415 -2.206 0 CA-C-O 122.443 1.116 . . . . 74.540000000000006 110.587 -176.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 1.6 p -123.8 110.94 15.53 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 114.778 -1.101 . . . . 74.209999999999994 109.295 176.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -163.01 -153.91 7.42 Favored Glycine 0 N--CA 1.418 -2.547 0 N-CA-C 110.296 -1.122 . . . . 54.329999999999998 110.296 -175.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 559' ' ' GLU . . . . . 0.429 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 39.0 mt-10 -137.99 136.34 36.83 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 120.77 0.319 . . . . 75.040000000000006 111.084 -176.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . 0.494 ' HG ' ' CD1' ' A' ' 539' ' ' TYR . 82.7 mt -93.85 147.82 22.72 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.375 -0.83 . . . . 74.430000000000007 109.866 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 561' ' ' GLU . . . . . 0.594 ' HG3' HD21 ' A' ' 534' ' ' ASN . 40.4 tt0 -104.82 107.73 18.84 Favored 'General case' 0 N--CA 1.424 -1.754 0 CA-C-O 121.213 0.53 . . . . 74.549999999999997 112.152 -178.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -101.74 146.86 27.17 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.443 -0.947 . . . . 72.209999999999994 108.443 172.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . 0.485 ' HB2' ' H ' ' A' ' 566' ' ' GLU . 51.7 mt-30 -144.2 -176.66 5.1 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 108.171 -1.048 . . . . 52.329999999999998 108.171 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -74.77 -31.58 61.81 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 107.76 -1.2 . . . . 75.040000000000006 107.76 174.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -78.87 -49.47 12.82 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.796 -1.093 . . . . 63.210000000000001 110.384 177.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 566' ' ' GLU . . . . . 0.485 ' H ' ' HB2' ' A' ' 563' ' ' GLN . 59.6 mm-40 -65.53 139.41 58.47 Favored 'General case' 0 CA--C 1.503 -0.838 0 CA-C-N 115.725 -0.67 . . . . 54.420000000000002 112.276 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 567' ' ' ILE . . . . . 0.451 ' HA ' ' HD3' ' A' ' 527' ' ' ARG . 21.6 pt -115.8 -170.67 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.412 -2.372 0 N-CA-C 105.649 -1.982 . . . . 64.540000000000006 105.649 172.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 568' ' ' VAL . . . . . 0.458 HG21 ' HD2' ' A' ' 524' ' ' LYS . 3.1 p 0.55 127.71 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.07 0 C-N-CA 128.027 2.531 . . . . 74.209999999999994 116.682 173.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 569' ' ' LYS . . . . . 0.539 ' HA ' ' HE2' ' A' ' 569' ' ' LYS . 8.8 mmpt? -105.74 164.69 11.73 Favored 'General case' 0 C--N 1.271 -2.835 0 CA-C-N 114.683 -1.144 . . . . 74.239999999999995 109.605 178.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 570' ' ' THR . . . . . 0.579 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 5.1 p -137.58 119.3 15.08 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.068 -0.969 . . . . 52.350000000000001 110.781 178.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 3.4 mp -86.92 106.4 15.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 107.291 -1.374 . . . . 65.409999999999997 107.291 176.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 4.1 p -84.27 109.13 17.55 Favored 'General case' 0 N--CA 1.415 -2.204 0 O-C-N 123.976 0.798 . . . . 65.310000000000002 109.685 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 573' ' ' VAL . . . . . 0.428 HG22 HG21 ' A' ' 556' ' ' THR . 44.0 t -113.89 128.44 70.81 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 N-CA-C 108.75 -0.833 . . . . 74.5 108.75 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 574' ' ' LYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 519' ' ' GLY . 58.8 tptt -83.4 103.49 12.8 Favored 'General case' 0 N--CA 1.417 -2.116 0 O-C-N 124.087 0.867 . . . . 75.409999999999997 108.827 177.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 71.5 t -78.75 135.1 26.56 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 105.995 -1.854 . . . . 61.219999999999999 105.995 176.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 32.3 mm -98.64 139.88 19.59 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 N-CA-C 108.715 -0.846 . . . . 65.209999999999994 108.715 -176.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -53.43 117.44 3.08 Favored 'General case' 0 C--O 1.244 0.783 0 O-C-N 124.302 1.001 . . . . 64.5 108.558 175.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 578' ' ' ASP . . . . . 0.44 ' OD2' ' HB2' ' A' ' 582' ' ' GLU . 25.3 t70 -62.29 120.28 10.69 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.265 -0.879 . . . . 55.310000000000002 112.462 -173.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -81.78 -19.13 41.9 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 114.55 1.315 . . . . 65.219999999999999 114.55 -172.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -131.38 -164.02 1.39 Allowed 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 119.668 -0.813 . . . . 74.519999999999996 110.703 -177.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -62.74 152.36 35.93 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 107.444 -1.317 . . . . 72.519999999999996 107.444 173.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 582' ' ' GLU . . . . . 0.44 ' HB2' ' OD2' ' A' ' 578' ' ' ASP . 42.5 tt0 -122.2 110.47 15.77 Favored 'General case' 0 N--CA 1.411 -2.39 0 C-N-CA 118.298 -1.361 . . . . 70.200000000000003 113.256 -172.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -79.54 -179.72 7.0 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 113.79 -1.55 . . . . 74.329999999999998 107.333 173.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -77.47 84.17 3.87 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 106.455 -1.683 . . . . 74.420000000000002 106.455 172.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . 0.262 0.0 OUTLIER -108.61 145.06 35.49 Favored 'General case' 0 N--CA 1.414 -2.262 0 CA-C-N 115.512 -0.767 . . . . 73.329999999999998 111.426 178.329 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 2.9 t -151.39 149.35 29.21 Favored 'General case' 0 N--CA 1.397 -3.094 0 CA-C-N 114.93 -1.032 . . . . 74.450000000000003 110.232 -174.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 587' ' ' PHE . . . . . 0.638 ' CE2' ' HB3' ' A' ' 553' ' ' PHE . 2.2 p90 -117.97 146.77 43.76 Favored 'General case' 0 N--CA 1.416 -2.171 0 CA-C-N 114.097 -1.411 . . . . 64.230000000000004 107.789 176.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 588' ' ' PHE . . . . . 0.526 ' HA ' ' O ' ' A' ' 642' ' ' LEU . 17.1 m-85 -107.36 142.87 36.48 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 120.707 -0.397 . . . . 73.349999999999994 110.218 -171.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . 0.439 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.3 OUTLIER -112.17 125.6 54.3 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 106.424 -1.695 . . . . 71.349999999999994 106.424 175.531 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -133.75 149.22 51.46 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 109.087 -0.708 . . . . 64.299999999999997 109.087 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 591' ' ' ILE . . . . . . . . . . . . . 27.5 pt -109.16 147.97 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.348 0 N-CA-C 108.485 -0.931 . . . . 74.430000000000007 108.485 176.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -102.38 -140.3 10.96 Favored Glycine 0 C--N 1.302 -1.344 0 C-N-CA 120.631 -0.795 . . . . 52.420000000000002 112.529 -177.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -77.8 115.06 47.01 Favored Pre-proline 0 C--N 1.315 -0.934 0 C-N-CA 122.623 0.369 . . . . 73.439999999999998 110.041 179.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 594' ' ' PRO . . . . . 0.457 ' HB3' HG22 ' A' ' 537' ' ' VAL . 73.4 Cg_endo -75.93 146.15 29.13 Favored 'Trans proline' 0 N--CA 1.444 -1.434 0 C-N-CA 121.577 1.518 . . . . 72.099999999999994 109.182 176.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 3.2 ptp180 -123.03 138.26 54.73 Favored 'General case' 0 C--N 1.297 -1.674 0 C-N-CA 119.561 -0.856 . . . . 74.209999999999994 110.527 -174.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 596' ' ' LEU . . . . . 0.446 HD22 HG22 ' A' ' 535' ' ' VAL . 0.0 OUTLIER -86.69 118.23 25.96 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 107.42 -1.326 . . . . 44.299999999999997 107.42 179.576 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 59.2 t . . . . . 0 C--N 1.304 -1.411 0 N-CA-C 108.534 -0.914 . . . . 71.099999999999994 108.534 -179.346 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 . . . . . 0 N--CA 1.427 -1.579 0 N-CA-C 107.239 -1.393 . . . . 52.32 107.239 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . 0.404 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 27.7 Cg_endo -79.28 153.31 24.28 Favored 'Trans proline' 0 N--CA 1.429 -2.267 0 N-CA-C 107.937 -1.601 . . . . 70.109999999999999 107.937 166.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 8.8 pt -122.86 -178.99 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 C-N-CA 119.7 -0.8 . . . . 72.109999999999999 109.98 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.55 -176.67 4.16 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 115.835 -0.621 . . . . 71.219999999999999 109.631 -178.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -83.54 -125.16 1.07 Allowed Glycine 0 N--CA 1.429 -1.811 0 C-N-CA 120.694 -0.765 . . . . 62.420000000000002 113.263 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -114.5 -59.94 1.95 Allowed 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 115.121 -0.54 . . . . 74.239999999999995 110.243 -176.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -107.52 93.82 4.75 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 122.068 0.937 . . . . 71.540000000000006 111.445 -178.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 23.7 p -109.46 91.27 3.58 Favored 'General case' 0 N--CA 1.41 -2.453 0 CA-C-N 115.389 -0.823 . . . . 72.430000000000007 109.788 178.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 641' ' ' LYS . . . . . 0.472 ' HE2' ' HB2' ' A' ' 643' ' ' GLU . 0.3 OUTLIER -168.92 129.26 1.13 Allowed 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 104.305 -2.48 . . . . 73.010000000000005 104.305 -178.021 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 642' ' ' LEU . . . . . 0.526 ' O ' ' HA ' ' A' ' 588' ' ' PHE . 37.0 tp -125.4 112.78 16.7 Favored 'General case' 0 C--N 1.276 -2.588 0 N-CA-C 108.094 -1.076 . . . . 61.100000000000001 108.094 175.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . 0.472 ' HB2' ' HE2' ' A' ' 641' ' ' LYS . 23.6 tt0 -98.07 107.2 19.63 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 107.175 -1.417 . . . . 74.450000000000003 107.175 177.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 644' ' ' VAL . . . . . 0.72 HG21 ' HE1' ' A' ' 521' ' ' MET . 26.6 t -95.05 103.18 14.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 N-CA-C 109.193 -0.669 . . . . 62.210000000000001 109.193 -178.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 3.9 mp -89.79 120.93 39.39 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 N-CA-C 108.401 -0.963 . . . . 74.430000000000007 108.401 178.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 646' ' ' ILE . . . . . 0.496 HD12 ' H ' ' A' ' 646' ' ' ILE . 1.5 mp -104.83 128.64 58.38 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.764 0 N-CA-C 104.982 -2.229 . . . . 72.150000000000006 104.982 -178.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -147.22 170.66 16.77 Favored 'General case' 0 C--N 1.282 -2.356 0 O-C-N 123.551 0.532 . . . . 54.310000000000002 112.078 -176.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -52.77 137.45 31.57 Favored 'General case' 0 C--O 1.249 1.037 0 CA-C-N 114.738 -1.119 . . . . 65.140000000000001 109.692 178.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 9.4 t . . . . . 0 N--CA 1.422 -1.842 0 CA-C-O 121.945 0.879 . . . . 64.200000000000003 111.897 -174.29 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . 0.642 ' HA2' ' OG1' ' A' ' 528' ' ' THR . . . . . . . . 0 N--CA 1.403 -3.505 0 N-CA-C 110.585 -1.006 . . . . 74.340000000000003 110.585 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . 0.416 ' HA ' ' HA2' ' A' ' 637' ' ' GLY . 3.1 mp -90.38 103.61 14.47 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.475 0 N-CA-C 108.783 -0.821 . . . . 61.539999999999999 108.783 177.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -117.15 109.37 16.83 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 106.728 -1.582 . . . . 75.340000000000003 106.728 175.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 12.5 t -150.62 164.39 36.17 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 109.196 -0.668 . . . . 51.310000000000002 109.196 -175.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -96.53 165.2 12.28 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.075 -1.083 . . . . 73.120000000000005 108.075 175.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.1 -30.97 9.89 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 120.781 -0.367 . . . . 74.420000000000002 111.919 175.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -107.85 123.7 37.04 Favored Pre-proline 0 C--N 1.311 -1.091 0 N-CA-C 108.714 -0.847 . . . . 75.219999999999999 108.714 173.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -82.43 -13.11 9.97 Favored 'Trans proline' 0 CA--C 1.532 0.381 0 C-N-CA 121.926 1.75 . . . . 70.439999999999998 111.549 177.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . 0.488 HG22 ' HB3' ' A' ' 643' ' ' GLU . 75.2 t -138.74 133.19 41.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 108.524 -0.917 . . . . 71.329999999999998 108.524 -179.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 5.4 t -136.45 145.86 45.7 Favored 'General case' 0 N--CA 1.41 -2.45 0 N-CA-C 108.613 -0.884 . . . . 53.130000000000003 108.613 176.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 27.8 m-70 -110.46 137.82 47.66 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.935 -0.765 . . . . 65.510000000000005 108.935 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.566 HG11 ' SD ' ' A' ' 521' ' ' MET . 27.7 m -126.74 151.53 33.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-O 121.197 0.522 . . . . 73.219999999999999 110.432 179.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 43.5 t -76.32 146.95 38.49 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 107.849 -1.167 . . . . 64.329999999999998 107.849 176.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . 0.692 ' HB2' ' O ' ' A' ' 647' ' ' GLU . 33.4 tt0 -74.98 -7.4 53.52 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-O 121.905 0.86 . . . . 71.310000000000002 109.683 176.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 10.7 t -110.28 22.72 15.18 Favored 'General case' 0 N--CA 1.415 -2.207 0 N-CA-C 108.382 -0.97 . . . . 53.130000000000003 108.382 -177.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 15.0 tt -94.02 155.61 3.18 Favored 'Isoleucine or valine' 0 C--O 1.247 0.948 0 N-CA-C 109.087 -0.708 . . . . 74.340000000000003 109.087 178.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -101.42 -70.45 0.89 Allowed Glycine 0 N--CA 1.419 -2.457 0 N-CA-C 110.66 -0.976 . . . . 63.210000000000001 110.66 177.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 32.3 mm -116.81 114.04 44.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 CA-C-O 120.689 0.28 . . . . 62.109999999999999 111.029 -177.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 521' ' ' MET . . . . . 0.57 ' HE1' HG21 ' A' ' 644' ' ' VAL . 24.7 ptt? -92.98 137.65 32.17 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.755 -1.202 . . . . 75.030000000000001 107.755 173.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -123.76 114.64 20.19 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 121.4 0.619 . . . . 74.239999999999995 110.794 178.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . 0.559 HG21 HD21 ' A' ' 642' ' ' LEU . 20.5 t -103.54 138.09 29.35 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 CA-C-N 114.639 -1.164 . . . . 71.200000000000003 108.414 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . 0.413 ' HD2' ' CG2' ' A' ' 568' ' ' VAL . 30.8 mmtp -85.13 145.89 27.4 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.664 0.745 . . . . 72.400000000000006 112.329 -177.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 7.9 t -123.13 131.49 73.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 106.49 -1.67 . . . . 72.010000000000005 106.49 175.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -77.54 140.6 39.76 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.064 -0.717 . . . . 72.400000000000006 109.064 -178.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . 0.499 ' HG3' ' HA ' ' A' ' 567' ' ' ILE . 2.7 tmm_? -96.12 135.29 38.1 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 109.202 -0.666 . . . . 70.340000000000003 109.202 -176.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . 0.642 ' OG1' ' HA2' ' A' ' 503' ' ' GLY . 6.0 t -50.85 147.04 5.26 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 125.083 1.353 . . . . 71.129999999999995 114.557 -177.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 35.2 t -63.21 -55.11 27.72 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 114.55 -1.204 . . . . 45.310000000000002 107.811 173.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -85.95 95.5 2.02 Favored Glycine 0 N--CA 1.423 -2.171 0 N-CA-C 109.5 -1.44 . . . . 64.030000000000001 109.5 178.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -111.64 98.93 7.77 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 121.092 0.472 . . . . 64.439999999999998 110.24 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -125.01 131.78 53.35 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 109.299 -0.63 . . . . 73.420000000000002 109.299 177.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 81.07 -144.54 24.94 Favored Glycine 0 N--CA 1.422 -2.286 0 C-N-CA 120.828 -0.701 . . . . 45.399999999999999 113.254 175.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 534' ' ' ASN . . . . . 0.455 HD21 ' HG3' ' A' ' 561' ' ' GLU . 2.5 t-20 -140.2 121.74 15.18 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 107.858 -1.164 . . . . 72.019999999999996 107.858 179.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 535' ' ' VAL . . . . . 0.438 HG22 HD22 ' A' ' 596' ' ' LEU . 58.1 t -126.75 131.74 70.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 108.803 -0.814 . . . . 54.539999999999999 108.803 -178.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 536' ' ' ILE . . . . . 0.62 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 42.5 mm -94.92 129.63 44.81 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 108.888 -0.782 . . . . 74.120000000000005 108.888 178.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 67.9 t -111.97 110.73 54.04 Favored Pre-proline 0 C--N 1.295 -1.783 0 N-CA-C 109.37 -0.604 . . . . 74.400000000000006 109.37 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -73.96 155.95 47.88 Favored 'Trans proline' 0 CA--C 1.512 -0.625 0 C-N-CA 122.513 2.142 . . . . 43.340000000000003 111.495 178.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 539' ' ' TYR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 591' ' ' ILE . 48.2 p90 -150.41 156.34 41.3 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.295 -1.002 . . . . 73.540000000000006 108.295 177.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -152.44 147.9 26.81 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 112.188 0.44 . . . . 73.5 112.188 176.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 3.5 p -84.34 120.92 26.82 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-N 115.474 -0.785 . . . . 70.209999999999994 110.94 176.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.8 mp -88.84 119.92 36.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 N-CA-C 105.728 -1.953 . . . . 64.099999999999994 105.728 173.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -52.47 -41.01 62.97 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 124.479 1.112 . . . . 73.420000000000002 112.716 -174.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 72.34 -92.05 0.57 Allowed Glycine 0 N--CA 1.435 -1.369 0 N-CA-C 110.825 -0.91 . . . . 71.510000000000005 110.825 178.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 10.2 t -146.14 18.13 1.39 Allowed 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 121.382 0.611 . . . . 64.129999999999995 109.812 177.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -101.08 161.03 13.89 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.619 -1.252 . . . . 64.420000000000002 107.619 176.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 18.5 mmm180 -63.86 173.23 1.88 Allowed 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 113.75 1.019 . . . . 72.239999999999995 113.75 -179.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -71.34 -178.47 28.7 Favored Glycine 0 C--O 1.254 1.355 0 CA-C-N 114.254 -1.339 . . . . 62.109999999999999 114.281 -175.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . -59.87 119.38 18.09 Favored Glycine 0 N--CA 1.441 -1.005 0 CA-C-N 114.737 -0.731 . . . . 74.510000000000005 113.287 -176.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 95.28 -10.41 69.51 Favored Glycine 0 N--CA 1.435 -1.399 0 N-CA-C 111.712 -0.555 . . . . 45.520000000000003 111.712 178.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -98.51 -68.36 0.81 Allowed 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.782 -0.822 . . . . 61.399999999999999 108.782 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -94.22 -38.29 11.13 Favored 'General case' 0 CA--C 1.492 -1.264 0 C-N-CA 118.862 -1.135 . . . . 74.219999999999999 111.414 175.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 553' ' ' PHE . . . . . 0.426 ' HB3' ' CE2' ' A' ' 587' ' ' PHE . 48.0 p90 -145.04 155.63 43.47 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 108.316 -0.994 . . . . 71.519999999999996 108.316 -179.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -83.56 119.24 24.48 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 105.329 -2.1 . . . . 75.019999999999996 105.329 174.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -73.53 104.23 4.42 Favored 'General case' 0 CA--C 1.498 -1.035 0 CA-C-O 121.267 0.556 . . . . 61.329999999999998 110.043 -175.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . 0.489 HG21 HG22 ' A' ' 573' ' ' VAL . 11.5 t -103.36 100.8 10.69 Favored 'General case' 0 N--CA 1.395 -3.175 0 CA-C-O 122.793 1.282 . . . . 52.450000000000003 110.978 -176.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 1.8 p -116.61 94.45 4.62 Favored 'General case' 0 N--CA 1.409 -2.502 0 CA-C-N 114.085 -1.416 . . . . 71.409999999999997 108.47 174.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -142.34 -157.54 7.19 Favored Glycine 0 N--CA 1.407 -3.291 0 N-CA-C 110.029 -1.228 . . . . 71.0 110.029 -174.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 559' ' ' GLU . . . . . 0.62 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 49.3 mt-10 -142.23 137.09 30.48 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 120.647 0.26 . . . . 61.119999999999997 111.315 -173.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 95.5 mt -96.82 144.94 26.31 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 123.415 0.686 . . . . 70.120000000000005 109.681 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 561' ' ' GLU . . . . . 0.455 ' HG3' HD21 ' A' ' 534' ' ' ASN . 40.9 tt0 -102.88 113.25 26.54 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 120.923 0.392 . . . . 72.129999999999995 110.665 -178.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -109.08 132.51 54.04 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 110.076 -0.342 . . . . 62.340000000000003 110.076 175.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -121.96 174.22 7.04 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.457 -0.897 . . . . 74.340000000000003 111.343 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -64.68 -38.03 89.59 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 114.122 -1.399 . . . . 65.0 110.222 176.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -94.34 -33.89 13.01 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.529 -0.76 . . . . 54.539999999999999 112.269 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -78.19 132.15 37.47 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.51 -0.313 . . . . 71.129999999999995 111.681 -177.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 567' ' ' ILE . . . . . 0.499 ' HA ' ' HG3' ' A' ' 527' ' ' ARG . 7.8 pt -109.94 163.29 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.617 0 N-CA-C 109.732 -0.47 . . . . 72.209999999999994 109.732 178.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 568' ' ' VAL . . . . . 0.498 ' O ' ' HG2' ' A' ' 569' ' ' LYS . 1.4 p 45.53 171.93 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.574 1.882 0 C-N-CA 127.278 2.231 . . . . 64.530000000000001 114.553 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 569' ' ' LYS . . . . . 0.566 ' HA ' ' HE3' ' A' ' 569' ' ' LYS . 0.0 OUTLIER -158.98 163.98 35.97 Favored 'General case' 0 CA--C 1.497 -1.095 0 C-N-CA 124.39 1.076 . . . . 73.310000000000002 108.235 173.698 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 570' ' ' THR . . . . . 0.537 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 4.7 p -135.4 133.96 39.22 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 124.112 0.883 . . . . 73.129999999999995 110.352 177.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 3.3 mp -93.03 106.26 17.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 106.618 -1.623 . . . . 63.210000000000001 106.618 172.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 572' ' ' SER . . . . . 0.424 ' HA ' ' O ' ' A' ' 521' ' ' MET . 13.0 p -88.14 112.02 22.24 Favored 'General case' 0 N--CA 1.424 -1.733 0 O-C-N 123.575 0.547 . . . . 74.439999999999998 109.797 178.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 573' ' ' VAL . . . . . 0.489 HG22 HG21 ' A' ' 556' ' ' THR . 42.4 t -115.54 131.22 68.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 109.148 -0.686 . . . . 64.150000000000006 109.148 -178.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -88.01 112.69 22.88 Favored 'General case' 0 N--CA 1.423 -1.784 0 O-C-N 123.929 0.768 . . . . 63.520000000000003 109.516 176.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 62.9 t -85.88 133.61 29.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 N-CA-C 106.42 -1.696 . . . . 70.310000000000002 106.42 176.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 25.8 mm -97.78 159.9 3.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 107.914 -1.143 . . . . 72.219999999999999 107.914 -174.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -71.35 114.22 9.19 Favored 'General case' 0 C--O 1.25 1.13 0 N-CA-C 110.007 -0.368 . . . . 74.219999999999999 110.007 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -56.82 142.71 39.91 Favored 'General case' 0 C--O 1.246 0.921 0 C-N-CA 124.614 1.166 . . . . 72.420000000000002 110.969 -176.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 579' ' ' GLU . . . . . 0.441 ' OE1' ' HG3' ' A' ' 580' ' ' GLU . 0.0 OUTLIER -124.88 -28.35 3.5 Favored 'General case' 0 C--N 1.289 -2.055 0 C-N-CA 125.115 1.366 . . . . 71.140000000000001 112.31 -170.439 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 580' ' ' GLU . . . . . 0.441 ' HG3' ' OE1' ' A' ' 579' ' ' GLU 0.3 0.0 OUTLIER -111.49 174.07 6.04 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 114.647 1.351 . . . . 43.140000000000001 114.647 -172.653 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 31.7 p90 -48.8 148.02 2.38 Favored 'General case' 0 CA--C 1.522 -0.122 0 O-C-N 124.778 1.298 . . . . 71.329999999999998 110.287 -178.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -122.99 106.5 10.9 Favored 'General case' 0 N--CA 1.408 -2.573 0 C-N-CA 118.265 -1.374 . . . . 75.340000000000003 114.177 -173.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -98.45 -158.48 0.67 Allowed 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 104.902 -2.258 . . . . 72.219999999999999 104.902 169.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -83.05 88.34 6.87 Favored 'General case' 0 C--N 1.282 -2.353 0 C-N-CA 118.903 -1.119 . . . . 72.329999999999998 108.4 174.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 585' ' ' LYS . . . . . . . . . . . . 0.315 0.5 OUTLIER -100.85 138.36 38.0 Favored 'General case' 0 N--CA 1.425 -1.684 0 C-N-CA 119.429 -0.908 . . . . 53.030000000000001 111.81 -179.014 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 4.1 t -152.42 150.21 29.41 Favored 'General case' 0 N--CA 1.405 -2.681 0 CA-C-N 114.699 -1.137 . . . . 74.329999999999998 109.79 -175.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 587' ' ' PHE . . . . . 0.426 ' CE2' ' HB3' ' A' ' 553' ' ' PHE . 4.1 p90 -124.35 151.23 44.59 Favored 'General case' 0 N--CA 1.411 -2.395 0 CA-C-N 114.221 -1.354 . . . . 63.130000000000003 108.335 176.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 588' ' ' PHE . . . . . 0.5 ' HA ' ' O ' ' A' ' 642' ' ' LEU . 16.5 m-85 -113.35 142.04 46.33 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 116.471 -0.331 . . . . 64.420000000000002 110.281 -171.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . 0.442 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.4 OUTLIER -107.71 131.7 54.14 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 106.481 -1.674 . . . . 75.099999999999994 106.481 175.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -141.77 144.4 33.95 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.396 -0.964 . . . . 64.140000000000001 108.396 -179.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 591' ' ' ILE . . . . . 0.567 HG12 ' OG1' ' A' ' 640' ' ' THR . 20.0 pt -96.37 168.01 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 O-C-N 123.699 0.624 . . . . 73.040000000000006 109.691 177.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -118.03 -154.27 9.76 Favored Glycine 0 C--N 1.303 -1.288 0 C-N-CA 120.444 -0.884 . . . . 62.329999999999998 113.675 -177.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -76.93 118.24 70.47 Favored Pre-proline 0 C--N 1.319 -0.751 0 N-CA-C 108.664 -0.865 . . . . 73.019999999999996 108.664 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -66.72 138.19 48.28 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 122.398 2.065 . . . . 73.319999999999993 112.071 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 595' ' ' ARG . . . . . 0.55 ' CG ' ' HB ' ' A' ' 536' ' ' ILE . 7.2 ptm180 -116.03 119.48 36.02 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.69 -0.686 . . . . 62.149999999999999 109.822 -174.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 596' ' ' LEU . . . . . 0.438 HD22 HG22 ' A' ' 535' ' ' VAL . 0.0 OUTLIER -69.96 129.0 38.31 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 107.92 -1.141 . . . . 72.310000000000002 107.92 179.216 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 597' ' ' VAL . . . . . 0.498 ' CG2' HG12 ' A' ' 536' ' ' ILE . 11.6 t . . . . . 0 C--N 1.317 -0.842 0 CA-C-O 122.696 1.236 . . . . 54.240000000000002 108.286 178.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 . . . . . 0 C--O 1.218 -0.57 0 N-CA-C 108.773 -0.825 . . . . 72.040000000000006 108.773 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -74.31 154.17 45.89 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.39 2.06 . . . . 60.299999999999997 113.188 -175.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 1.9 pp -144.09 -169.81 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.31 -0.859 . . . . 75.430000000000007 110.775 -176.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.61 164.1 19.94 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 123.082 0.239 . . . . 73.319999999999993 110.621 -179.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . 0.416 ' HA2' ' HA ' ' A' ' 504' ' ' ILE . . . -81.16 -85.29 0.7 Allowed Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 121.317 -0.468 . . . . 71.450000000000003 113.78 -177.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -143.02 -63.58 0.41 Allowed 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 120.465 -0.494 . . . . 74.439999999999998 110.425 -178.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 10.7 p80 -127.68 114.77 17.77 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-O 121.913 0.864 . . . . 75.430000000000007 111.598 178.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 640' ' ' THR . . . . . 0.567 ' OG1' HG12 ' A' ' 591' ' ' ILE . 0.7 OUTLIER -111.4 92.28 3.98 Favored 'General case' 0 N--CA 1.416 -2.131 0 CA-C-N 114.811 -1.086 . . . . 53.32 109.674 177.361 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -169.88 125.44 0.81 Allowed 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 106.503 -1.666 . . . . 63.140000000000001 106.503 178.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 642' ' ' LEU . . . . . 0.559 HD21 HG21 ' A' ' 523' ' ' VAL . 31.3 tp -130.43 110.09 11.21 Favored 'General case' 0 C--N 1.277 -2.553 0 N-CA-C 108.312 -0.996 . . . . 72.540000000000006 108.312 177.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . 0.488 ' HB3' HG22 ' A' ' 511' ' ' VAL . 43.1 tt0 -92.31 107.22 19.05 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.062 -1.088 . . . . 71.25 108.062 178.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 644' ' ' VAL . . . . . 0.57 HG21 ' HE1' ' A' ' 521' ' ' MET . 24.3 t -97.73 104.56 16.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 109.248 -0.649 . . . . 74.219999999999999 109.248 -179.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 4.5 mp -86.69 128.21 39.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 108.903 -0.777 . . . . 73.319999999999993 108.903 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 646' ' ' ILE . . . . . 0.443 ' N ' HD12 ' A' ' 646' ' ' ILE . 1.2 mp -110.81 106.94 21.73 Favored 'Isoleucine or valine' 0 C--O 1.255 1.377 0 N-CA-C 108.158 -1.053 . . . . 73.340000000000003 108.158 -177.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . 0.692 ' O ' ' HB2' ' A' ' 516' ' ' GLU . 8.0 pt-20 -109.19 -161.4 0.76 Allowed 'General case' 0 C--N 1.268 -2.958 0 CA-C-N 113.718 -1.583 . . . . 75.310000000000002 107.864 -178.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -81.5 -173.1 4.19 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.3 -0.63 . . . . 74.099999999999994 109.3 177.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 23.1 t . . . . . 0 C--N 1.299 -1.59 0 N-CA-C 108.213 -1.032 . . . . 62.439999999999998 108.213 175.965 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . 0.457 ' HA2' ' OG1' ' A' ' 528' ' ' THR . . . . . . . . 0 N--CA 1.409 -3.113 0 N-CA-C 112.248 -0.341 . . . . 65.319999999999993 112.248 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . 0.443 ' H ' ' CB ' ' A' ' 528' ' ' THR . 3.1 mp -93.57 98.46 8.28 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 N-CA-C 107.826 -1.176 . . . . 74.340000000000003 107.826 174.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -113.9 114.73 26.63 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.922 -1.14 . . . . 71.209999999999994 107.922 176.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . 0.463 ' HB ' ' HA3' ' A' ' 637' ' ' GLY . 15.0 t -149.02 162.66 39.49 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.876 -0.787 . . . . 74.230000000000004 108.876 -176.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -81.71 152.19 27.17 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 108.023 -1.103 . . . . 74.120000000000005 108.023 176.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -76.14 -24.85 54.9 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.551 0.691 . . . . 65.239999999999995 109.691 178.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -139.45 132.78 15.58 Favored Pre-proline 0 N--CA 1.424 -1.765 0 CA-C-N 115.144 -0.935 . . . . 70.329999999999998 108.683 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -84.33 0.33 9.19 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 122.122 1.881 . . . . 62.530000000000001 112.202 176.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . 0.52 HG22 ' HB3' ' A' ' 643' ' ' GLU . 69.3 t -145.57 135.33 18.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 124.193 0.997 . . . . 73.340000000000003 108.413 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 6.2 t -142.03 140.79 32.73 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.198 -1.408 . . . . 63.030000000000001 107.198 177.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -110.79 133.55 53.25 Favored 'General case' 0 CA--C 1.492 -1.258 0 N-CA-C 108.325 -0.991 . . . . 73.299999999999997 108.325 178.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.641 HG11 ' SD ' ' A' ' 521' ' ' MET . 34.0 m -129.62 159.89 41.18 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 CA-C-N 116.209 -0.451 . . . . 62.420000000000002 110.288 -174.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . 0.424 ' HB3' ' HB ' ' A' ' 518' ' ' ILE . 47.3 t -77.7 150.48 34.47 Favored 'General case' 0 N--CA 1.415 -2.216 0 N-CA-C 107.564 -1.273 . . . . 75.450000000000003 107.564 177.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -88.43 -7.06 57.22 Favored 'General case' 0 C--N 1.286 -2.156 0 CA-C-O 122.315 1.055 . . . . 54.009999999999998 108.946 178.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 33.0 t -100.29 2.43 42.62 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 114.97 -1.014 . . . . 74.299999999999997 109.16 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 518' ' ' ILE . . . . . 0.424 ' HB ' ' HB3' ' A' ' 515' ' ' SER . 15.0 tt -78.52 151.99 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-N 115.979 -0.555 . . . . 71.329999999999998 110.039 -176.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -87.52 -70.78 1.29 Allowed Glycine 0 N--CA 1.43 -1.719 0 N-CA-C 110.094 -1.202 . . . . 73.409999999999997 110.094 176.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 31.7 mm -112.54 126.31 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 CA-C-O 120.935 0.398 . . . . 62.350000000000001 110.178 179.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 521' ' ' MET . . . . . 0.67 ' HE1' HG21 ' A' ' 644' ' ' VAL . 23.1 ptt? -105.46 142.96 34.3 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 107.167 -1.42 . . . . 62.039999999999999 107.167 173.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -121.03 151.61 39.58 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 121.395 0.617 . . . . 55.310000000000002 111.555 178.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . 0.641 ' O ' ' HA ' ' A' ' 570' ' ' THR . 33.0 t -130.83 137.17 56.59 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 107.832 -1.173 . . . . 71.329999999999998 107.832 -179.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -90.43 127.33 36.18 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 113.024 0.75 . . . . 61.240000000000002 113.024 -176.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 22.9 t -112.57 121.95 65.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 107.291 -1.374 . . . . 72.519999999999996 107.291 176.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -75.42 145.08 41.83 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.893 0.854 . . . . 74.219999999999999 112.687 -174.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' A' ' 528' ' ' THR . 11.2 tpp85 -75.62 133.08 40.98 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 114.073 -1.422 . . . . 65.120000000000005 109.202 173.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . 0.457 ' OG1' ' HA2' ' A' ' 503' ' ' GLY . 3.0 t -57.64 159.85 4.81 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 114.56 -1.2 . . . . 75.319999999999993 111.965 174.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 35.7 t -62.04 -37.87 86.57 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.73 0.812 . . . . 35.130000000000003 109.126 178.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -137.63 122.78 2.57 Favored Glycine 0 N--CA 1.425 -2.099 0 N-CA-C 109.961 -1.256 . . . . 74.420000000000002 109.961 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . 0.414 ' HB2' ' CG2' ' A' ' 528' ' ' THR . . . -130.25 114.01 15.12 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.332 -0.988 . . . . 75.129999999999995 108.332 176.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -120.79 90.09 3.25 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.696 -0.853 . . . . 71.129999999999995 108.696 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 533' ' ' GLY . . . . . 0.529 ' H ' ' HB3' ' A' ' 564' ' ' ASN . . . 122.57 -178.86 16.3 Favored Glycine 0 N--CA 1.437 -1.256 0 N-CA-C 110.96 -0.856 . . . . 75.400000000000006 110.96 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 534' ' ' ASN . . . . . 0.545 HD22 ' N ' ' A' ' 535' ' ' VAL . 0.2 OUTLIER -91.92 131.1 37.49 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.27 -1.011 . . . . 74.219999999999999 108.27 179.223 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 535' ' ' VAL . . . . . 0.545 ' N ' HD22 ' A' ' 534' ' ' ASN . 89.8 t -119.1 139.03 47.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-O 121.059 0.457 . . . . 73.239999999999995 110.143 179.2 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 536' ' ' ILE . . . . . . . . . . . . . 42.1 mm -105.44 125.01 60.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 108.949 -0.76 . . . . 62.020000000000003 108.949 178.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 22.0 t -113.49 106.24 54.38 Favored Pre-proline 0 C--N 1.302 -1.482 0 O-C-N 123.35 0.406 . . . . 74.319999999999993 109.909 -178.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.9 145.37 25.11 Favored 'Trans proline' 0 CA--C 1.533 0.454 0 C-N-CA 122.369 2.046 . . . . 75.329999999999998 111.71 178.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 539' ' ' TYR . . . . . 0.482 ' HB3' HG22 ' A' ' 591' ' ' ILE . 53.8 p90 -142.45 163.05 33.89 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 110.212 -0.292 . . . . 73.25 110.212 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -151.76 153.78 34.98 Favored 'General case' 0 C--N 1.308 -1.196 0 O-C-N 123.6 0.563 . . . . 65.219999999999999 110.618 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 4.1 p -99.24 125.14 44.78 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.796 -0.638 . . . . 72.040000000000006 110.363 173.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.417 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 3.7 mp -96.06 118.52 42.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 105.937 -1.875 . . . . 53.240000000000002 105.937 174.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -55.84 -50.56 70.23 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 123.868 0.73 . . . . 75.450000000000003 112.273 -176.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 69.51 -103.49 1.11 Allowed Glycine 0 N--CA 1.431 -1.645 0 N-CA-C 111.099 -0.8 . . . . 40.140000000000001 111.099 -179.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 545' ' ' THR . . . . . 0.453 HG23 ' HA ' ' A' ' 585' ' ' LYS . 9.1 t -109.63 -3.96 16.51 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.337 0.589 . . . . 71.450000000000003 110.311 -179.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -96.01 171.54 8.56 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.927 -0.397 . . . . 53.43 109.927 176.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 31.7 tpt180 -115.4 119.51 36.47 Favored 'General case' 0 C--O 1.247 0.968 0 N-CA-C 109.253 -0.647 . . . . 61.229999999999997 109.253 179.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -86.75 -154.03 24.8 Favored Glycine 0 C--N 1.311 -0.828 0 C-N-CA 120.874 -0.679 . . . . 65.439999999999998 112.37 -179.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . 0.441 ' H ' ' HB2' ' A' ' 555' ' ' ASP . . . 72.07 17.44 77.18 Favored Glycine 0 C--N 1.316 -0.567 0 CA-C-O 120.151 -0.249 . . . . 54.43 113.558 178.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 83.85 27.16 38.94 Favored Glycine 0 N--CA 1.439 -1.145 0 N-CA-C 110.817 -0.913 . . . . 74.409999999999997 110.817 -178.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -99.32 -69.75 0.75 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 120.711 0.291 . . . . 73.540000000000006 110.333 -178.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -102.99 -27.91 12.33 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 106.879 -1.526 . . . . 75.150000000000006 106.879 177.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -146.23 158.2 43.86 Favored 'General case' 0 C--O 1.252 1.213 0 CA-C-N 114.526 -1.216 . . . . 74.310000000000002 108.438 174.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -87.81 116.61 26.08 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 106.121 -1.807 . . . . 73.329999999999998 106.121 178.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 555' ' ' ASP . . . . . 0.441 ' HB2' ' H ' ' A' ' 549' ' ' GLY . 14.4 t70 -75.78 132.81 40.68 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.3 -0.63 . . . . 73.409999999999997 109.3 -175.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . 0.455 HG21 HG22 ' A' ' 573' ' ' VAL . 8.9 t -133.76 117.89 17.44 Favored 'General case' 0 N--CA 1.412 -2.348 0 CA-C-O 122.038 0.923 . . . . 75.129999999999995 111.534 -175.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 8.0 p -130.23 100.64 5.47 Favored 'General case' 0 N--CA 1.424 -1.77 0 N-CA-C 107.628 -1.249 . . . . 74.409999999999997 107.628 174.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -145.77 -159.71 8.3 Favored Glycine 0 N--CA 1.411 -2.968 0 N-CA-C 109.984 -1.246 . . . . 41.420000000000002 109.984 -174.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -136.1 136.77 40.41 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-O 120.678 0.275 . . . . 74.329999999999998 110.635 -175.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 89.1 mt -95.16 134.25 38.1 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.642 -0.708 . . . . 73.340000000000003 109.415 178.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 561' ' ' GLU . . . . . 0.47 ' HG3' HD21 ' A' ' 534' ' ' ASN . 43.9 tt0 -93.32 97.03 10.33 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.703 -0.851 . . . . 70.129999999999995 108.703 176.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -101.88 108.27 19.7 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 106.838 -1.542 . . . . 74.099999999999994 106.838 -178.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . 0.496 ' HB2' ' H ' ' A' ' 566' ' ' GLU . 42.9 mt-30 -97.49 172.4 7.77 Favored 'General case' 0 C--N 1.278 -2.506 0 CA-C-N 116.415 -0.357 . . . . 70.540000000000006 110.94 -174.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 564' ' ' ASN . . . . . 0.529 ' HB3' ' H ' ' A' ' 533' ' ' GLY . 2.6 p-10 -79.0 -16.04 57.44 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.98 0.895 . . . . 54.100000000000001 109.107 175.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -96.07 -54.79 3.19 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.211 -0.904 . . . . 75.120000000000005 109.195 176.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 566' ' ' GLU . . . . . 0.496 ' H ' ' HB2' ' A' ' 563' ' ' GLN . 9.7 tp10 -63.78 138.48 58.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.614 -0.721 . . . . 71.049999999999997 109.692 177.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 21.8 pt -106.0 -172.23 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.41 -2.466 0 N-CA-C 108.219 -1.03 . . . . 74.040000000000006 108.219 -178.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 3.4 p 3.19 126.47 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 128.832 2.853 . . . . 62.219999999999999 116.165 173.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 569' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -110.16 149.07 30.62 Favored 'General case' 0 C--N 1.259 -3.342 0 CA-C-N 115.112 -0.949 . . . . 63.229999999999997 110.502 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 570' ' ' THR . . . . . 0.641 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 16.0 p -122.53 128.16 50.43 Favored 'General case' 0 N--CA 1.415 -2.21 0 CA-C-N 115.259 -0.882 . . . . 72.329999999999998 110.188 177.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 3.3 mp -84.0 104.21 12.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 107.033 -1.469 . . . . 62.229999999999997 107.033 174.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 11.0 p -84.72 111.17 19.34 Favored 'General case' 0 N--CA 1.419 -2.009 0 CA-C-N 115.758 -0.655 . . . . 72.430000000000007 110.084 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 573' ' ' VAL . . . . . 0.455 HG22 HG21 ' A' ' 556' ' ' THR . 57.6 t -114.24 136.57 50.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 109.143 -0.688 . . . . 44.340000000000003 109.143 -178.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -95.15 125.05 39.53 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 124.123 0.89 . . . . 75.219999999999999 111.18 -178.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 81.8 t -93.59 132.84 36.63 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 N-CA-C 107.745 -1.206 . . . . 74.329999999999998 107.745 175.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 40.3 mm -91.6 160.44 2.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 109.535 -0.543 . . . . 75.230000000000004 109.535 -173.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -52.4 119.1 4.08 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 124.043 0.937 . . . . 72.120000000000005 109.671 175.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -90.69 151.31 21.3 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.1 0.476 . . . . 75.200000000000003 111.952 -175.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.91 -26.73 2.87 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 114.194 1.183 . . . . 64.109999999999999 114.194 -172.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 580' ' ' GLU . . . . . 0.408 ' HG2' ' O ' ' A' ' 581' ' ' TYR . 0.0 OUTLIER -112.23 178.21 4.38 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 118.741 -1.184 . . . . 62.420000000000002 113.263 -166.943 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 581' ' ' TYR . . . . . 0.408 ' O ' ' HG2' ' A' ' 580' ' ' GLU . 47.8 p90 -61.94 154.34 26.68 Favored 'General case' 0 C--O 1.247 0.969 0 CA-C-N 114.803 -1.09 . . . . 75.219999999999999 108.922 175.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 582' ' ' GLU . . . . . 0.498 ' HB2' ' HG2' ' A' ' 648' ' ' GLU . 5.8 tp10 -94.31 152.78 18.4 Favored 'General case' 0 C--N 1.284 -2.251 0 C-N-CA 119.023 -1.071 . . . . 63.210000000000001 110.633 179.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 583' ' ' LYS . . . . . 0.467 ' O ' ' HG3' ' A' ' 582' ' ' GLU . 18.3 ptpt -137.85 -172.16 3.18 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 103.365 -2.828 . . . . 74.239999999999995 103.365 176.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -79.54 91.69 5.2 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.254 -1.758 . . . . 75.340000000000003 106.254 170.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 585' ' ' LYS . . . . . 0.502 ' HD2' HD13 ' A' ' 646' ' ' ILE . 4.7 tmmm? -106.67 109.23 21.08 Favored 'General case' 0 N--CA 1.396 -3.165 0 N-CA-C 106.756 -1.572 . . . . 73.430000000000007 106.756 -172.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 4.6 t -142.44 145.76 34.11 Favored 'General case' 0 N--CA 1.392 -3.35 0 CA-C-N 113.823 -1.535 . . . . 54.030000000000001 109.306 -174.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -128.85 155.57 45.02 Favored 'General case' 0 N--CA 1.412 -2.35 0 CA-C-N 114.408 -1.269 . . . . 73.099999999999994 108.858 178.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 588' ' ' PHE . . . . . 0.505 ' HA ' ' O ' ' A' ' 642' ' ' LEU . 23.5 m-85 -109.67 138.13 46.49 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-N 116.36 -0.382 . . . . 71.219999999999999 110.23 -171.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . 0.487 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.8 OUTLIER -110.94 125.76 54.02 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 105.777 -1.934 . . . . 73.0 105.777 176.297 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -127.94 131.24 49.34 Favored 'General case' 0 C--N 1.284 -2.248 0 C-N-CA 120.613 -0.435 . . . . 74.439999999999998 110.289 179.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 591' ' ' ILE . . . . . 0.482 HG22 ' HB3' ' A' ' 539' ' ' TYR . 15.2 pt -93.66 134.02 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.621 0 N-CA-C 106.758 -1.571 . . . . 63.310000000000002 106.758 171.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -86.83 -146.95 10.64 Favored Glycine 0 C--N 1.3 -1.47 0 C-N-CA 120.965 -0.636 . . . . 72.049999999999997 111.586 -176.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.575 ' OE1' ' HD3' ' A' ' 633' ' ' ARG . 35.0 tt0 -88.57 123.87 67.11 Favored Pre-proline 0 N--CA 1.425 -1.695 0 N-CA-C 107.967 -1.123 . . . . 75.099999999999994 107.967 177.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -68.42 162.13 41.94 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 123.084 2.523 . . . . 75.430000000000007 111.428 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 29.9 ptt85 -130.12 143.45 50.8 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.263 -0.643 . . . . 75.209999999999994 109.263 178.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 596' ' ' LEU . . . . . 0.489 HD22 HG22 ' A' ' 535' ' ' VAL . 0.0 OUTLIER -85.37 128.56 34.76 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 106.188 -1.782 . . . . 71.549999999999997 106.188 179.207 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 87.2 t . . . . . 0 C--N 1.312 -1.026 0 CA-C-O 121.307 0.575 . . . . 75.430000000000007 109.829 -179.579 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 633' ' ' ARG . . . . . 0.575 ' HD3' ' OE1' ' A' ' 593' ' ' GLU . 95.1 mtt180 . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 106.739 -1.578 . . . . 64.219999999999999 106.739 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -76.08 146.79 29.29 Favored 'Trans proline' 0 N--CA 1.429 -2.3 0 N-CA-C 107.348 -1.828 . . . . 72.519999999999996 107.348 166.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 1.9 pp -126.57 -173.27 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 114.494 1.294 . . . . 61.43 114.494 -172.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.46 150.6 39.83 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.389 -0.823 . . . . 52.340000000000003 109.672 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . 0.463 ' HA3' ' HB ' ' A' ' 506' ' ' THR . . . -76.69 -71.13 1.21 Allowed Glycine 0 C--N 1.297 -1.598 0 C-N-CA 120.763 -0.732 . . . . 73.040000000000006 112.58 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -150.36 -59.72 0.19 Allowed 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 120.408 -0.517 . . . . 74.450000000000003 110.619 178.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 16.7 p80 -120.43 99.63 6.68 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.735 0.779 . . . . 70.209999999999994 111.921 -179.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 36.4 p -98.62 91.26 5.05 Favored 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 109.278 -0.638 . . . . 73.209999999999994 109.278 177.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -177.26 133.14 0.18 Allowed 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 106.159 -1.793 . . . . 71.209999999999994 106.159 -178.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 642' ' ' LEU . . . . . 0.505 ' O ' ' HA ' ' A' ' 588' ' ' PHE . 27.9 tp -133.84 118.03 17.51 Favored 'General case' 0 C--N 1.276 -2.602 0 N-CA-C 108.511 -0.922 . . . . 60.229999999999997 108.511 177.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . 0.52 ' HB3' HG22 ' A' ' 511' ' ' VAL . 33.6 tt0 -99.25 107.44 19.75 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 107.06 -1.459 . . . . 61.439999999999998 107.06 177.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 644' ' ' VAL . . . . . 0.67 HG21 ' HE1' ' A' ' 521' ' ' MET . 38.9 t -95.37 109.84 23.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 108.949 -0.76 . . . . 63.229999999999997 108.949 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 3.9 mp -94.86 119.9 43.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 N-CA-C 108.413 -0.958 . . . . 71.299999999999997 108.413 177.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 646' ' ' ILE . . . . . 0.514 ' N ' HD12 ' A' ' 646' ' ' ILE . 1.8 mp -107.88 134.51 49.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 105.798 -1.926 . . . . 35.009999999999998 105.798 -176.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -136.48 161.48 35.73 Favored 'General case' 0 C--N 1.277 -2.549 0 N-CA-C 112.31 0.485 . . . . 75.439999999999998 112.31 -172.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 648' ' ' GLU . . . . . 0.498 ' HG2' ' HB2' ' A' ' 582' ' ' GLU . 31.2 mm-40 -61.17 100.38 0.12 Allowed 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 106.189 -1.782 . . . . 73.209999999999994 106.189 172.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 10.5 m . . . . . 0 C--N 1.307 -1.265 0 C-N-CA 128.254 2.621 . . . . 71.040000000000006 115.871 -169.95 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.421 -2.34 0 N-CA-C 111.151 -0.779 . . . . 72.239999999999995 111.151 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 3.9 mp -122.27 111.39 30.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 109.255 -0.646 . . . . 74.030000000000001 109.255 -178.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -128.35 104.29 7.64 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 106.492 -1.67 . . . . 75.230000000000004 106.492 173.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 15.0 t -152.02 162.95 40.28 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.631 -0.878 . . . . 75.349999999999994 108.631 -175.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -91.77 168.78 11.22 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.749 -1.204 . . . . 73.340000000000003 107.749 172.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . 0.491 ' HB2' HD21 ' A' ' 526' ' ' LEU . 21.5 tt0 -99.74 -35.88 9.65 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 107.944 -1.132 . . . . 73.420000000000002 107.944 179.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -111.31 134.98 20.99 Favored Pre-proline 0 N--CA 1.419 -2.021 0 CA-C-N 114.377 -1.283 . . . . 64.120000000000005 110.239 -178.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -81.19 -18.7 8.49 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.554 1.503 . . . . 75.209999999999994 111.095 173.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . 0.47 HG22 ' HB3' ' A' ' 643' ' ' GLU . 93.2 t -138.04 141.5 38.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 123.81 0.844 . . . . 73.409999999999997 108.853 -177.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 8.1 t -137.3 140.81 41.78 Favored 'General case' 0 N--CA 1.416 -2.168 0 N-CA-C 107.526 -1.287 . . . . 75.230000000000004 107.526 174.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 55.4 m-70 -105.76 130.04 53.84 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.585 -0.895 . . . . 64.099999999999994 108.585 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 24.2 m -132.33 156.45 42.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 N-CA-C 108.862 -0.792 . . . . 73.219999999999999 108.862 -179.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 40.3 t -82.42 149.16 27.8 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 107.934 -1.136 . . . . 63.009999999999998 107.934 178.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -82.3 -7.5 59.63 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.85 0.833 . . . . 75.420000000000002 109.062 176.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 9.4 t -95.77 10.01 38.5 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.905 -0.776 . . . . 73.349999999999994 108.905 -178.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 12.4 tt -91.68 155.34 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 108.66 -0.867 . . . . 75.510000000000005 108.66 -177.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -91.44 -63.44 1.18 Allowed Glycine 0 N--CA 1.43 -1.755 0 N-CA-C 110.47 -1.052 . . . . 74.140000000000001 110.47 176.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . 0.414 HD13 ' HA ' ' A' ' 574' ' ' LYS . 34.4 mm -116.51 117.02 54.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 109.92 -0.4 . . . . 73.439999999999998 109.92 179.012 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 521' ' ' MET . . . . . 0.69 ' HE2' HG21 ' A' ' 644' ' ' VAL . 0.0 OUTLIER -96.41 128.66 43.53 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 106.609 -1.626 . . . . 73.239999999999995 106.609 172.238 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -117.36 138.74 51.59 Favored 'General case' 0 N--CA 1.424 -1.751 0 CA-C-N 115.829 -0.623 . . . . 72.409999999999997 111.269 178.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . 0.713 HG21 HD21 ' A' ' 642' ' ' LEU . 22.1 t -121.09 134.34 64.8 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.087 0 N-CA-C 106.176 -1.787 . . . . 70.230000000000004 106.176 175.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . 0.563 ' HD3' HG21 ' A' ' 568' ' ' VAL . 55.2 mttp -91.91 163.04 14.16 Favored 'General case' 0 N--CA 1.416 -2.171 0 C-N-CA 120.325 -0.55 . . . . 74.310000000000002 111.904 -178.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 16.0 t -128.5 141.98 45.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-N 115.512 -0.767 . . . . 62.009999999999998 109.115 -175.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . 0.491 HD21 ' HB2' ' A' ' 508' ' ' GLU . 2.0 mm? -78.24 139.08 38.92 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 107.554 -1.276 . . . . 74.349999999999994 107.554 178.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 48.2 ttp180 -92.79 140.5 29.45 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.729 -0.788 . . . . 73.420000000000002 111.199 -175.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 4.2 t -55.17 149.02 13.07 Favored 'General case' 0 N--CA 1.413 -2.28 0 CA-C-N 114.044 -1.434 . . . . 73.409999999999997 111.97 174.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 26.1 t -80.62 -15.89 55.46 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.386 -0.824 . . . . 60.130000000000003 109.038 177.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -127.54 110.92 1.24 Allowed Glycine 0 N--CA 1.433 -1.517 0 N-CA-C 111.163 -0.775 . . . . 62.0 111.163 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -165.06 76.11 0.27 Allowed 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 123.334 0.653 . . . . 75.450000000000003 110.173 177.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -90.36 81.53 6.02 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.751 0.786 . . . . 75.239999999999995 110.064 177.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 533' ' ' GLY . . . . . 0.575 ' H ' ' HB2' ' A' ' 564' ' ' ASN . . . 149.37 -118.97 0.99 Allowed Glycine 0 N--CA 1.414 -2.772 0 CA-C-N 114.828 -1.078 . . . . 64.129999999999995 112.071 179.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 534' ' ' ASN . . . . . 0.519 ' ND2' ' HG2' ' A' ' 563' ' ' GLN . 2.8 t-20 -145.07 131.3 19.49 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 107.234 -1.395 . . . . 72.0 107.234 -178.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 535' ' ' VAL . . . . . 0.428 HG22 HD22 ' A' ' 596' ' ' LEU . 46.8 t -128.36 133.86 65.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 109.387 -0.597 . . . . 65.530000000000001 109.387 -178.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 536' ' ' ILE . . . . . 0.54 HG23 ' HB3' ' A' ' 559' ' ' GLU . 28.5 mm -98.28 126.48 51.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 109.217 -0.66 . . . . 73.109999999999999 109.217 178.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 36.1 t -116.65 103.38 52.59 Favored Pre-proline 0 C--N 1.301 -1.513 0 N-CA-C 108.579 -0.897 . . . . 73.310000000000002 108.579 177.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.56 146.93 50.64 Favored 'Trans proline' 0 C--N 1.331 -0.391 0 C-N-CA 122.264 1.976 . . . . 75.299999999999997 111.169 179.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 539' ' ' TYR . . . . . 0.539 ' CE1' ' HG ' ' A' ' 560' ' ' LEU . 36.0 p90 -151.14 161.58 42.46 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 109.689 -0.485 . . . . 75.140000000000001 109.689 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -155.67 148.6 24.35 Favored 'General case' 0 C--N 1.309 -1.174 0 O-C-N 123.471 0.482 . . . . 61.210000000000001 111.933 178.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 2.4 p -85.82 121.09 27.98 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 115.957 -0.565 . . . . 70.25 110.967 175.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.8 mp -86.96 116.99 30.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 105.271 -2.122 . . . . 65.030000000000001 105.271 172.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -55.2 -43.43 74.4 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 124.163 0.914 . . . . 72.329999999999998 112.146 -174.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 67.96 -94.06 0.29 Allowed Glycine 0 N--CA 1.439 -1.101 0 CA-C-N 115.733 -0.667 . . . . 65.230000000000004 111.757 178.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 545' ' ' THR . . . . . 0.476 HG23 ' HA ' ' A' ' 585' ' ' LYS . 9.2 t -124.41 -2.07 8.04 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 120.788 0.328 . . . . 53.109999999999999 110.488 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -91.19 155.54 18.52 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.71 -0.478 . . . . 74.030000000000001 109.71 178.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 22.1 tpt180 -94.55 108.31 20.27 Favored 'General case' 0 C--O 1.25 1.097 0 N-CA-C 109.546 -0.539 . . . . 62.210000000000001 109.546 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -89.66 -163.57 39.37 Favored Glycine 0 CA--C 1.507 -0.422 0 C-N-CA 121.124 -0.56 . . . . 73.040000000000006 114.046 -175.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 77.75 12.38 84.52 Favored Glycine 0 C--N 1.321 -0.281 0 CA-C-N 115.433 -0.384 . . . . 73.439999999999998 113.593 178.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 95.79 4.56 60.32 Favored Glycine 0 N--CA 1.437 -1.251 0 C-N-CA 120.46 -0.876 . . . . 71.129999999999995 111.644 -178.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -73.98 -69.86 0.42 Allowed 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.912 -0.773 . . . . 71.409999999999997 108.912 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -107.8 -34.12 7.05 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.861 -1.163 . . . . 75.519999999999996 107.861 177.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -135.95 157.27 47.25 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 108.464 -0.939 . . . . 74.109999999999999 108.464 174.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -88.14 121.02 30.06 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.855 -1.165 . . . . 64.209999999999994 107.855 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -78.67 100.96 7.25 Favored 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 109.263 -0.643 . . . . 65.420000000000002 109.263 -177.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 13.9 t -98.51 98.51 9.68 Favored 'General case' 0 N--CA 1.396 -3.134 0 CA-C-O 123.439 1.59 . . . . 53.130000000000003 111.538 -175.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 1.6 p -110.27 129.86 55.65 Favored 'General case' 0 C--N 1.274 -2.675 0 N-CA-C 106.518 -1.66 . . . . 71.340000000000003 106.518 172.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 178.64 -156.66 19.49 Favored Glycine 0 N--CA 1.42 -2.422 0 N-CA-C 110.367 -1.093 . . . . 72.239999999999995 110.367 -176.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 559' ' ' GLU . . . . . 0.54 ' HB3' HG23 ' A' ' 536' ' ' ILE . 40.0 mt-10 -135.97 133.92 38.06 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 121.295 0.569 . . . . 75.349999999999994 111.683 -175.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . 0.539 ' HG ' ' CE1' ' A' ' 539' ' ' TYR . 55.7 mt -87.84 132.77 34.06 Favored 'General case' 0 CA--C 1.491 -1.312 0 N-CA-C 108.795 -0.817 . . . . 72.120000000000005 108.795 174.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 561' ' ' GLU . . . . . 0.438 ' CG ' HD21 ' A' ' 534' ' ' ASN . 36.5 tt0 -105.84 107.37 18.34 Favored 'General case' 0 C--N 1.274 -2.71 0 N-CA-C 108.451 -0.944 . . . . 71.340000000000003 108.451 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 562' ' ' PHE . . . . . 0.419 ' CZ ' ' HG2' ' A' ' 569' ' ' LYS . 0.1 OUTLIER -100.59 132.41 45.99 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 107.744 -1.206 . . . . 60.299999999999997 107.744 -179.2 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . 0.519 ' HG2' ' ND2' ' A' ' 534' ' ' ASN . 6.8 mt-30 -119.81 165.05 15.07 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.2 -1.0 . . . . 41.509999999999998 110.699 -179.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 564' ' ' ASN . . . . . 0.575 ' HB2' ' H ' ' A' ' 533' ' ' GLY . 7.8 t30 -62.57 -33.46 75.01 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.879 -0.6 . . . . 73.319999999999993 111.296 179.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -99.27 -3.66 33.64 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.858 0.837 . . . . 53.020000000000003 111.145 -177.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -102.98 130.34 50.03 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.725 -0.609 . . . . 73.099999999999994 109.406 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 2.0 pp -112.04 145.27 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.728 0 N-CA-C 108.414 -0.958 . . . . 72.349999999999994 108.414 179.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 568' ' ' VAL . . . . . 0.563 HG21 ' HD3' ' A' ' 524' ' ' LYS . 1.8 p 58.91 133.78 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 126.482 1.913 . . . . 75.409999999999997 114.79 176.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 569' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 524' ' ' LYS . 32.6 mmmt -117.82 164.06 15.59 Favored 'General case' 0 C--N 1.284 -2.268 0 O-C-N 121.32 -0.863 . . . . 65.040000000000006 109.868 176.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 570' ' ' THR . . . . . 0.509 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 6.3 p -132.72 134.26 44.56 Favored 'General case' 0 C--N 1.279 -2.499 0 O-C-N 124.413 1.071 . . . . 63.119999999999997 111.851 177.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 2.2 mp -91.17 103.92 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.836 0 N-CA-C 105.207 -2.145 . . . . 64.010000000000005 105.207 170.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 4.5 m -91.93 112.64 24.64 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 108.479 -0.934 . . . . 60.420000000000002 108.479 -177.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 573' ' ' VAL . . . . . . . . . . . . . 61.7 t -116.0 121.88 68.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 109.543 -0.54 . . . . 71.040000000000006 109.543 -178.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 574' ' ' LYS . . . . . 0.414 ' HA ' HD13 ' A' ' 520' ' ' ILE . 23.0 tptm -80.09 120.73 24.63 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-N 114.908 -1.042 . . . . 72.209999999999994 110.548 178.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 60.0 t -94.32 132.36 38.6 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 N-CA-C 105.953 -1.869 . . . . 74.219999999999999 105.953 174.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 34.3 mm -88.84 159.98 2.87 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 107.221 -1.4 . . . . 75.239999999999995 107.221 -175.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -71.53 115.34 10.6 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 109.199 -0.667 . . . . 64.219999999999999 109.199 178.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -61.24 144.44 53.79 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 114.897 -1.047 . . . . 63.539999999999999 112.612 -173.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -92.21 -49.06 6.38 Favored 'General case' 0 C--N 1.29 -1.995 0 C-N-CA 124.289 1.036 . . . . 70.140000000000001 110.424 -176.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.09 -152.64 0.53 Allowed 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.396 -0.82 . . . . 73.040000000000006 109.1 -174.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -111.67 152.12 28.06 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 107.32 -1.363 . . . . 64.349999999999994 107.32 176.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 36.4 mp0 -128.98 164.81 22.38 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.501 -0.555 . . . . 72.430000000000007 109.501 175.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 10.0 mptt -87.59 -152.0 0.19 Allowed 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 105.771 -1.937 . . . . 73.430000000000007 105.771 173.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -57.83 113.05 1.68 Allowed 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 109.115 -0.698 . . . . 72.310000000000002 109.115 172.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 585' ' ' LYS . . . . . 0.476 ' HA ' HG23 ' A' ' 545' ' ' THR . 0.1 OUTLIER -128.32 118.73 23.74 Favored 'General case' 0 N--CA 1.409 -2.496 0 N-CA-C 106.362 -1.718 . . . . 34.420000000000002 106.362 -174.198 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 3.9 t -150.7 146.86 26.73 Favored 'General case' 0 N--CA 1.418 -2.04 0 CA-C-N 115.487 -0.779 . . . . 74.439999999999998 110.795 -172.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -126.58 150.63 48.75 Favored 'General case' 0 N--CA 1.419 -2.011 0 CA-C-N 113.891 -1.504 . . . . 70.329999999999998 109.225 177.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 588' ' ' PHE . . . . . 0.421 ' HA ' ' O ' ' A' ' 642' ' ' LEU . 22.3 m-85 -108.37 139.25 43.36 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 109.381 -0.6 . . . . 73.230000000000004 109.381 -174.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . 0.46 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.3 OUTLIER -107.93 134.36 50.95 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 107.04 -1.467 . . . . 61.240000000000002 107.04 176.83 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -143.05 136.96 28.89 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.803 -0.814 . . . . 72.140000000000001 108.803 -179.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 591' ' ' ILE . . . . . 0.541 HG12 ' OG1' ' A' ' 640' ' ' THR . 22.0 pt -101.95 162.48 3.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 109.206 -0.664 . . . . 63.420000000000002 109.206 178.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -111.15 -162.96 17.92 Favored Glycine 0 N--CA 1.43 -1.732 0 C-N-CA 121.259 -0.496 . . . . 63.240000000000002 112.103 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -67.88 118.11 54.86 Favored Pre-proline 0 C--N 1.309 -1.195 0 C-N-CA 123.979 0.911 . . . . 72.150000000000006 108.803 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 594' ' ' PRO . . . . . 0.46 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 58.1 Cg_endo -73.16 146.56 41.08 Favored 'Trans proline' 0 N--CA 1.437 -1.82 0 C-N-CA 121.916 1.744 . . . . 61.329999999999998 110.593 178.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 14.9 ptt180 -128.24 133.71 48.87 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 109.704 -0.48 . . . . 74.040000000000006 109.704 -175.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 596' ' ' LEU . . . . . 0.428 HD22 HG22 ' A' ' 535' ' ' VAL . 0.0 OUTLIER -73.99 131.82 41.78 Favored 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 104.988 -2.227 . . . . 62.240000000000002 104.988 178.367 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 597' ' ' VAL . . . . . 0.442 ' CG2' HG12 ' A' ' 536' ' ' ILE . 23.8 t . . . . . 0 C--N 1.308 -1.233 0 CA-C-O 121.821 0.819 . . . . 73.120000000000005 110.767 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 . . . . . 0 N--CA 1.447 -0.612 0 N-CA-C 109.46 -0.57 . . . . 72.209999999999994 109.46 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . 0.46 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 10.1 Cg_endo -60.86 145.01 99.66 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.591 1.527 . . . . 62.409999999999997 109.527 172.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.3 pp -123.42 175.96 5.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 114.054 1.131 . . . . 74.430000000000007 114.054 -176.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . 0.454 ' HG ' ' N ' ' A' ' 637' ' ' GLY . 33.3 tp -68.93 158.65 34.19 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 124.8 1.24 . . . . 75.349999999999994 112.716 -176.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . 0.454 ' N ' ' HG ' ' A' ' 636' ' ' LEU . . . -83.06 -100.02 0.52 Allowed Glycine 0 N--CA 1.427 -1.91 0 N-CA-C 109.642 -1.383 . . . . 65.450000000000003 109.642 172.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -126.22 -73.13 0.63 Allowed 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 119.801 -0.76 . . . . 73.450000000000003 111.632 177.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -107.02 114.26 28.23 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 118.715 -1.194 . . . . 63.109999999999999 113.122 -174.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 640' ' ' THR . . . . . 0.541 ' OG1' HG12 ' A' ' 591' ' ' ILE . 1.1 t -107.08 91.53 3.7 Favored 'General case' 0 N--CA 1.41 -2.437 0 N-CA-C 108.367 -0.975 . . . . 75.099999999999994 108.367 169.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -172.17 121.83 0.46 Allowed 'General case' 0 C--N 1.279 -2.466 0 N-CA-C 105.726 -1.953 . . . . 73.140000000000001 105.726 178.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 642' ' ' LEU . . . . . 0.713 HD21 HG21 ' A' ' 523' ' ' VAL . 35.9 tp -129.91 113.13 14.24 Favored 'General case' 0 C--N 1.271 -2.829 0 N-CA-C 108.077 -1.083 . . . . 54.149999999999999 108.077 178.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . 0.47 ' HB3' HG22 ' A' ' 511' ' ' VAL . 30.0 tt0 -95.11 104.77 16.65 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 107.469 -1.308 . . . . 61.119999999999997 107.469 179.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 644' ' ' VAL . . . . . 0.69 HG21 ' HE2' ' A' ' 521' ' ' MET . 30.9 t -94.98 106.66 18.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 109.483 -0.562 . . . . 62.210000000000001 109.483 -177.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 3.9 mp -88.78 118.29 33.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 108.444 -0.947 . . . . 72.209999999999994 108.444 175.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 646' ' ' ILE . . . . . 0.467 ' N ' HD12 ' A' ' 646' ' ' ILE . 2.8 mp -100.73 107.21 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 N-CA-C 106.63 -1.618 . . . . 73.0 106.63 -177.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -103.69 136.42 43.43 Favored 'General case' 0 C--N 1.279 -2.48 0 CA-C-N 115.671 -0.695 . . . . 74.140000000000001 110.832 -176.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -67.47 142.03 56.76 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.626 -0.879 . . . . 73.120000000000005 108.626 -177.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 21.2 t . . . . . 0 N--CA 1.431 -1.39 0 N-CA-C 114.072 1.138 . . . . 74.209999999999994 114.072 -169.558 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.419 -2.448 0 N-CA-C 109.71 -1.356 . . . . 75.510000000000005 109.71 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . 0.642 ' O ' ' HB ' ' A' ' 528' ' ' THR . 3.6 mp -108.87 97.77 6.15 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.263 0 C-N-CA 126.04 1.736 . . . . 63.409999999999997 109.235 -176.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -103.16 124.85 49.36 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 122.035 -0.415 . . . . 74.299999999999997 110.087 -178.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . 0.404 ' HB ' ' HA3' ' A' ' 637' ' ' GLY . 15.3 t -145.89 159.54 43.07 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.378 -0.601 . . . . 73.209999999999994 109.378 -178.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -89.21 155.85 19.14 Favored 'General case' 0 CA--C 1.485 -1.549 0 N-CA-C 108.372 -0.973 . . . . 73.140000000000001 108.372 174.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . 0.418 ' HB2' HD21 ' A' ' 526' ' ' LEU . 24.1 tt0 -89.98 -34.57 15.95 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 106.84 -1.541 . . . . 72.310000000000002 106.84 175.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -96.61 118.84 64.86 Favored Pre-proline 0 N--CA 1.436 -1.137 0 CA-C-N 114.549 -1.205 . . . . 72.430000000000007 110.847 176.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 510' ' ' PRO . . . . . 0.612 ' HA ' ' O ' ' A' ' 641' ' ' LYS . 1.2 Cg_endo -83.22 -16.96 6.87 Favored 'Trans proline' 0 N--CA 1.443 -1.456 0 N-CA-C 108.72 -1.3 . . . . 75.150000000000006 108.72 166.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . 0.487 HG22 ' HB3' ' A' ' 643' ' ' GLU . 78.7 t -144.63 139.56 23.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 C-N-CA 125.575 1.55 . . . . 51.310000000000002 107.268 -179.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 11.4 t -138.63 148.01 43.57 Favored 'General case' 0 N--CA 1.414 -2.234 0 N-CA-C 107.66 -1.237 . . . . 61.140000000000001 107.66 174.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -115.87 127.48 55.05 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 109.024 -0.732 . . . . 74.140000000000001 109.024 177.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 18.2 m -130.24 154.2 40.11 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 N-CA-C 109.103 -0.703 . . . . 43.229999999999997 109.103 -176.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 34.2 t -78.03 154.81 31.1 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.782 -1.192 . . . . 72.349999999999994 107.782 177.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -89.06 -6.83 56.84 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 122.195 0.998 . . . . 71.129999999999995 109.019 173.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 34.0 m -92.26 17.3 9.9 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-O 122.314 1.054 . . . . 73.400000000000006 108.744 177.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 9.5 tt -100.99 154.43 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.06 0 N-CA-C 107.064 -1.458 . . . . 74.409999999999997 107.064 177.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . -95.71 -63.61 0.97 Allowed Glycine 0 N--CA 1.427 -1.946 0 C-N-CA 119.745 -1.217 . . . . 71.209999999999994 110.348 176.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 29.0 mm -116.41 127.73 73.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 114.725 -0.737 . . . . 70.400000000000006 109.865 -178.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 521' ' ' MET . . . . . 0.614 ' HE2' HG21 ' A' ' 644' ' ' VAL . 0.0 OUTLIER -109.99 135.88 50.14 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.76 -1.2 . . . . 72.319999999999993 107.76 172.888 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 522' ' ' GLU . . . . . 0.535 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 36.8 mt-10 -121.15 135.26 55.2 Favored 'General case' 0 CA--C 1.493 -1.25 0 O-C-N 123.947 0.779 . . . . 75.120000000000005 110.711 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . 0.667 HG21 HD21 ' A' ' 642' ' ' LEU . 18.9 t -123.03 140.47 46.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.91 -0.774 . . . . 65.540000000000006 108.91 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . 0.47 ' HD2' HG21 ' A' ' 568' ' ' VAL . 46.2 mmtm -85.35 141.53 29.96 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.912 0.863 . . . . 61.009999999999998 112.603 -178.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 21.3 t -111.88 119.49 60.12 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 N-CA-C 105.154 -2.165 . . . . 74.219999999999999 105.154 172.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . 0.425 ' H ' HD22 ' A' ' 526' ' ' LEU . 2.6 mm? -62.16 136.05 57.77 Favored 'General case' 0 CA--C 1.504 -0.804 0 O-C-N 123.522 0.514 . . . . 74.239999999999995 110.625 -174.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 14.2 ttp180 -84.73 138.7 32.47 Favored 'General case' 0 N--CA 1.423 -1.782 0 N-CA-C 108.612 -0.884 . . . . 75.5 108.612 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . 0.642 ' HB ' ' O ' ' A' ' 504' ' ' ILE . 10.3 t -94.41 169.59 10.1 Favored 'General case' 0 N--CA 1.397 -3.096 0 N-CA-C 114.81 1.411 . . . . 71.219999999999999 114.81 -171.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . 0.309 5.7 m -49.9 -34.06 19.16 Favored 'General case' 0 N--CA 1.417 -2.124 0 C-N-CA 130.658 3.583 . . . . 70.140000000000001 111.35 171.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -121.3 68.41 0.42 Allowed Glycine 0 N--CA 1.428 -1.856 0 C-N-CA 120.722 -0.752 . . . . 61.240000000000002 113.203 -177.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -87.88 83.41 7.1 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 106.704 -1.591 . . . . 65.219999999999999 106.704 173.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -121.05 137.3 54.72 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 115.744 -0.662 . . . . 74.019999999999996 112.321 -174.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 533' ' ' GLY . . . . . 0.477 ' N ' ' HB3' ' A' ' 564' ' ' ASN . . . 69.27 -121.32 11.28 Favored Glycine 0 N--CA 1.438 -1.173 0 CA-C-N 114.741 -1.118 . . . . 33.219999999999999 111.966 176.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -136.47 124.15 22.41 Favored 'General case' 0 C--N 1.286 -2.175 0 N-CA-C 106.079 -1.823 . . . . 43.25 106.079 177.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 535' ' ' VAL . . . . . 0.482 HG22 HD22 ' A' ' 596' ' ' LEU . 57.5 t -126.57 122.97 62.15 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-O 121.398 0.618 . . . . 71.310000000000002 109.494 -175.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 536' ' ' ILE . . . . . 0.459 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 40.2 mm -97.57 127.21 50.1 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.451 0 CA-C-N 115.444 -0.798 . . . . 72.340000000000003 109.968 -178.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . 0.45 HG22 ' HB3' ' A' ' 594' ' ' PRO . 86.1 t -113.0 102.31 54.6 Favored Pre-proline 0 C--N 1.308 -1.22 0 CA-C-N 115.448 -0.797 . . . . 62.039999999999999 110.18 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 63.9 Cg_endo -74.74 150.31 39.31 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.667 2.245 . . . . 62.140000000000001 111.635 178.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 539' ' ' TYR . . . . . 0.498 ' CE1' ' HG ' ' A' ' 560' ' ' LEU . 17.4 p90 -154.9 165.95 35.08 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 110.246 -0.279 . . . . 61.340000000000003 110.246 -178.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -157.86 157.47 33.28 Favored 'General case' 0 C--N 1.316 -0.864 0 O-C-N 123.659 0.599 . . . . 64.310000000000002 110.142 177.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 2.1 p -96.46 112.17 24.01 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 123.337 0.655 . . . . 72.109999999999999 109.775 173.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.428 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 3.5 mp -81.01 122.96 37.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 107.917 -1.142 . . . . 72.319999999999993 107.917 177.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -55.31 -52.73 62.5 Favored 'General case' 0 C--O 1.242 0.704 0 O-C-N 124.223 0.952 . . . . 65.120000000000005 110.851 -178.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 71.53 -80.11 0.54 Allowed Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.837 -0.619 . . . . 65.040000000000006 113.179 175.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 12.8 t -134.43 -7.47 2.55 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.452 0.644 . . . . 70.140000000000001 110.04 -179.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -80.36 -176.37 5.62 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 121.181 0.515 . . . . 52.409999999999997 111.723 -179.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . 0.627 ' HB3' ' OE1' ' A' ' 551' ' ' GLU . 56.9 mmt-85 -85.58 177.29 7.78 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.652 -0.703 . . . . 63.219999999999999 110.917 177.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -64.38 174.57 13.22 Favored Glycine 0 CA--C 1.538 1.521 0 CA-C-N 115.166 -0.925 . . . . 22.329999999999998 114.354 -177.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . -67.63 122.84 18.26 Favored Glycine 0 N--CA 1.441 -0.997 0 CA-C-N 115.259 -0.471 . . . . 70.140000000000001 112.46 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 82.98 2.94 90.68 Favored Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 110.634 -0.987 . . . . 74.549999999999997 110.634 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . 0.627 ' OE1' ' HB3' ' A' ' 547' ' ' ARG . 38.2 tt0 -96.53 -69.99 0.73 Allowed 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 108.958 -0.756 . . . . 64.510000000000005 108.958 -178.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . 0.545 ' CB ' ' HB2' ' A' ' 547' ' ' ARG . 17.4 t70 -106.63 -25.57 11.73 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-O 122.004 0.907 . . . . 42.329999999999998 109.006 177.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -142.84 152.68 42.42 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 106.65 -1.611 . . . . 74.420000000000002 106.65 174.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . 0.407 ' CB ' ' HB3' ' A' ' 574' ' ' LYS . 1.0 OUTLIER -87.48 122.7 31.55 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 107.06 -1.459 . . . . 64.420000000000002 107.06 -179.584 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -79.54 123.14 27.31 Favored 'General case' 0 CA--C 1.491 -1.298 0 CA-C-O 120.888 0.375 . . . . 64.430000000000007 110.725 -174.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 12.1 t -123.98 107.32 11.2 Favored 'General case' 0 N--CA 1.404 -2.762 0 CA-C-O 122.531 1.158 . . . . 73.340000000000003 110.773 -178.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 3.6 p -129.09 130.07 46.02 Favored 'General case' 0 N--CA 1.42 -1.968 0 CA-C-N 114.622 -1.172 . . . . 41.240000000000002 108.679 177.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 174.66 -151.39 12.46 Favored Glycine 0 N--CA 1.41 -3.073 0 N-CA-C 109.81 -1.316 . . . . 55.140000000000001 109.81 -177.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 559' ' ' GLU . . . . . 0.459 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 70.5 mt-10 -129.71 126.66 38.78 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-O 120.933 0.397 . . . . 62.140000000000001 111.533 -175.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . 0.498 ' HG ' ' CE1' ' A' ' 539' ' ' TYR . 83.7 mt -79.67 122.76 26.95 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.787 -0.82 . . . . 64.319999999999993 108.787 175.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -93.22 110.01 21.53 Favored 'General case' 0 N--CA 1.419 -1.976 0 N-CA-C 109.194 -0.669 . . . . 71.329999999999998 109.194 -178.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -129.26 150.52 50.6 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.054 -0.976 . . . . 71.0 108.373 -179.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . 0.57 ' H ' ' HB3' ' A' ' 566' ' ' GLU . 7.3 pt20 -148.88 178.53 8.6 Favored 'General case' 0 C--N 1.288 -2.07 0 O-C-N 121.882 -0.511 . . . . 65.230000000000004 110.746 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 564' ' ' ASN . . . . . 0.477 ' HB3' ' N ' ' A' ' 533' ' ' GLY . 3.7 p-10 -61.89 -33.1 73.61 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 124.347 1.059 . . . . 50.119999999999997 111.447 -176.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -91.46 -6.55 52.5 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.864 0.84 . . . . 74.439999999999998 110.425 -176.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 566' ' ' GLU . . . . . 0.57 ' HB3' ' H ' ' A' ' 563' ' ' GLN . 9.6 tp10 -98.94 155.54 17.36 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.497 -1.298 . . . . 72.420000000000002 107.497 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 1.7 pp -126.75 140.58 48.53 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.625 0 C-N-CA 119.654 -0.818 . . . . 72.25 109.263 177.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 568' ' ' VAL . . . . . 0.47 HG21 ' HD2' ' A' ' 524' ' ' LYS . 1.1 p 53.51 176.58 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.524 0 C-N-CA 126.14 1.776 . . . . 75.340000000000003 113.649 177.016 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 569' ' ' LYS . . . . . 0.603 ' HA ' ' HE2' ' A' ' 569' ' ' LYS . 6.7 mmpt? -146.63 153.9 40.86 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 109.119 -0.697 . . . . 62.340000000000003 109.119 173.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 570' ' ' THR . . . . . 0.519 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 12.0 p -136.72 133.11 35.75 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 124.13 0.894 . . . . 64.319999999999993 110.5 178.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 571' ' ' ILE . . . . . 0.535 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 2.4 mp -95.66 117.8 40.51 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 107.129 -1.434 . . . . 62.109999999999999 107.129 174.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 572' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 521' ' ' MET . 4.1 p -102.1 109.47 21.19 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 123.698 0.624 . . . . 71.409999999999997 110.498 179.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 573' ' ' VAL . . . . . . . . . . . . . 48.0 t -112.32 136.66 47.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 N-CA-C 109.467 -0.568 . . . . 55.329999999999998 109.467 -178.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 574' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 519' ' ' GLY . 58.8 tttp -92.72 126.08 37.64 Favored 'General case' 0 C--N 1.309 -1.159 0 O-C-N 124.046 0.841 . . . . 71.140000000000001 109.849 178.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 47.6 t -94.12 132.42 38.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 107.482 -1.303 . . . . 71.310000000000002 107.482 177.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 30.5 mm -97.43 146.35 7.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 C-N-CA 120.605 -0.438 . . . . 62.030000000000001 109.989 -174.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -61.95 145.14 53.8 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.4 0.68 . . . . 64.349999999999994 110.561 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -70.61 134.35 47.51 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 116.032 1.864 . . . . 62.020000000000003 116.032 -175.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 579' ' ' GLU . . . . . 0.502 ' HG2' ' HG3' ' A' ' 580' ' ' GLU . 0.1 OUTLIER -110.94 -24.82 10.16 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 112.882 -1.963 . . . . 73.219999999999999 109.431 177.824 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 580' ' ' GLU . . . . . 0.502 ' HG3' ' HG2' ' A' ' 579' ' ' GLU . 0.0 OUTLIER -133.14 178.72 6.68 Favored 'General case' 0 C--O 1.249 1.052 0 N-CA-C 113.232 0.827 . . . . 73.420000000000002 113.232 -179.063 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -66.49 152.67 44.72 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.644 -1.162 . . . . 75.219999999999999 107.889 177.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -126.29 138.38 53.59 Favored 'General case' 0 C--N 1.293 -1.849 0 C-N-CA 117.385 -1.726 . . . . 72.530000000000001 113.011 -176.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -97.21 -158.35 0.66 Allowed 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 106.819 -1.549 . . . . 65.010000000000005 106.819 176.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 -79.15 93.54 5.21 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 106.072 -1.825 . . . . 74.439999999999998 106.072 170.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 585' ' ' LYS . . . . . 0.455 ' HD2' HD13 ' A' ' 646' ' ' ILE . 3.8 tmmm? -98.91 121.9 41.47 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 108.364 -0.976 . . . . 65.230000000000004 108.364 -172.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 4.9 t -147.01 144.51 29.2 Favored 'General case' 0 N--CA 1.414 -2.226 0 CA-C-N 114.9 -1.046 . . . . 52.530000000000001 109.291 -177.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -125.9 146.68 49.74 Favored 'General case' 0 N--CA 1.419 -2.016 0 CA-C-N 114.542 -1.208 . . . . 70.329999999999998 109.235 176.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 588' ' ' PHE . . . . . 0.428 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 30.2 m-85 -102.53 128.52 49.14 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 109.294 -0.632 . . . . 52.340000000000003 109.294 -175.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . 0.554 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.5 OUTLIER -101.36 125.72 48.04 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 104.59 -2.374 . . . . 72.239999999999995 104.59 173.506 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -137.9 134.29 34.83 Favored 'General case' 0 C--N 1.273 -2.743 0 N-CA-C 108.92 -0.77 . . . . 74.0 108.92 -178.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 591' ' ' ILE . . . . . 0.481 HG22 ' HB3' ' A' ' 539' ' ' TYR . 28.8 pt -96.64 145.56 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.651 0 N-CA-C 108.158 -1.053 . . . . 70.25 108.158 178.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -89.62 -151.52 24.96 Favored Glycine 0 C--N 1.292 -1.879 0 N-CA-C 111.09 -0.804 . . . . 75.510000000000005 111.09 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -80.88 125.85 79.06 Favored Pre-proline 0 C--N 1.297 -1.68 0 N-CA-C 108.964 -0.754 . . . . 54.310000000000002 108.964 178.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 594' ' ' PRO . . . . . 0.45 ' HB3' HG22 ' A' ' 537' ' ' VAL . 38.4 Cg_endo -69.71 153.07 69.62 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 121.878 1.719 . . . . 75.400000000000006 110.841 176.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -129.79 132.38 46.51 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.844 -0.535 . . . . 71.099999999999994 111.488 -177.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 596' ' ' LEU . . . . . 0.489 ' HB2' ' HD3' ' A' ' 634' ' ' PRO . 0.0 OUTLIER -87.13 125.9 34.44 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 108.221 -1.029 . . . . 71.030000000000001 108.221 -179.567 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 CA--C 1.565 1.55 0 CA-C-O 121.949 0.88 . . . . 61.240000000000002 109.802 -179.452 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 . . . . . 0 C--O 1.215 -0.719 0 N-CA-C 108.589 -0.893 . . . . 70.420000000000002 108.589 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . 0.489 ' HD3' ' HB2' ' A' ' 596' ' ' LEU . 70.8 Cg_endo -75.77 157.19 39.64 Favored 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 121.924 1.749 . . . . 61.200000000000003 111.196 178.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 29.7 pt -132.03 178.21 5.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 CA-C-O 121.655 0.74 . . . . 55.240000000000002 111.048 -173.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . 0.403 HD22 ' O ' ' A' ' 637' ' ' GLY . 0.0 OUTLIER -94.05 152.47 18.76 Favored 'General case' 0 N--CA 1.423 -1.805 0 N-CA-C 106.768 -1.568 . . . . 75.209999999999994 106.768 171.766 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . 0.404 ' HA3' ' HB ' ' A' ' 506' ' ' THR . . . -81.26 -126.04 0.75 Allowed Glycine 0 C--N 1.29 -2.014 0 C-N-CA 120.871 -0.68 . . . . 62.530000000000001 113.445 -176.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -87.5 -50.27 6.65 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 112.072 0.397 . . . . 64.120000000000005 112.072 -175.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -132.99 110.6 10.36 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.999 0.904 . . . . 73.150000000000006 112.939 -177.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 22.3 p -120.32 92.47 3.78 Favored 'General case' 0 N--CA 1.422 -1.861 0 CA-C-N 115.423 -0.808 . . . . 61.350000000000001 110.698 176.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 641' ' ' LYS . . . . . 0.612 ' O ' ' HA ' ' A' ' 510' ' ' PRO . 0.2 OUTLIER -170.51 127.55 0.79 Allowed 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 104.564 -2.384 . . . . 72.430000000000007 104.564 178.204 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 642' ' ' LEU . . . . . 0.667 HD21 HG21 ' A' ' 523' ' ' VAL . 43.8 tp -117.23 107.06 13.97 Favored 'General case' 0 C--N 1.274 -2.713 0 N-CA-C 108.386 -0.968 . . . . 72.030000000000001 108.386 177.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . 0.487 ' HB3' HG22 ' A' ' 511' ' ' VAL . 22.8 tt0 -90.71 100.97 13.72 Favored 'General case' 0 C--N 1.275 -2.64 0 N-CA-C 107.306 -1.368 . . . . 64.010000000000005 107.306 178.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 644' ' ' VAL . . . . . 0.614 HG21 ' HE2' ' A' ' 521' ' ' MET . 19.3 t -91.74 103.55 14.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 109.181 -0.674 . . . . 73.120000000000005 109.181 -177.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 645' ' ' ILE . . . . . 0.4 ' CD1' HG13 ' A' ' 511' ' ' VAL . 3.8 mp -93.42 123.97 45.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 105.704 -1.962 . . . . 72.230000000000004 105.704 174.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 646' ' ' ILE . . . . . 0.523 ' N ' HD12 ' A' ' 646' ' ' ILE . 2.8 mp -97.76 129.15 48.35 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 N-CA-C 108.447 -0.946 . . . . 72.129999999999995 108.447 -173.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -92.38 117.31 29.79 Favored 'General case' 0 N--CA 1.403 -2.787 0 CA-C-N 115.69 -0.686 . . . . 44.030000000000001 110.744 -179.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 33.0 tp10 -61.58 141.37 57.81 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 114.257 -1.338 . . . . 71.340000000000003 107.763 178.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 6.5 t . . . . . 0 C--O 1.241 0.623 0 C-N-CA 123.245 0.618 . . . . 71.239999999999995 109.654 -176.816 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . 0.544 ' HA2' ' OG1' ' A' ' 528' ' ' THR . . . . . . . . 0 N--CA 1.41 -3.077 0 N-CA-C 114.868 0.707 . . . . 42.049999999999997 114.868 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . 0.47 ' H ' ' HA ' ' A' ' 528' ' ' THR . 3.5 mp -129.32 90.53 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 N-CA-C 106.036 -1.839 . . . . 73.019999999999996 106.036 174.07 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . 0.524 ' CZ ' ' HB ' ' A' ' 528' ' ' THR . 89.3 m-85 -112.11 110.52 20.85 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 109.176 -0.676 . . . . 71.040000000000006 109.176 179.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . 0.507 ' HB ' ' HA3' ' A' ' 637' ' ' GLY . 11.7 t -149.25 167.61 25.55 Favored 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 107.229 -1.397 . . . . 73.019999999999996 107.229 -177.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -94.75 155.0 17.02 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.565 -1.642 . . . . 73.030000000000001 106.565 173.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -90.92 -29.74 17.29 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 107.426 -1.324 . . . . 64.140000000000001 107.426 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -112.5 130.9 22.94 Favored Pre-proline 0 N--CA 1.425 -1.711 0 CA-C-N 114.964 -1.016 . . . . 75.120000000000005 109.454 174.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -84.59 -10.17 8.73 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.203 1.935 . . . . 63.039999999999999 111.193 176.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . 0.414 HG22 ' HB3' ' A' ' 643' ' ' GLU . 94.3 t -141.29 135.52 31.88 Favored 'Isoleucine or valine' 0 C--O 1.244 0.813 0 C-N-CA 123.929 0.892 . . . . 63.109999999999999 109.645 -177.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 7.3 t -139.22 138.35 36.77 Favored 'General case' 0 N--CA 1.413 -2.317 0 N-CA-C 107.066 -1.457 . . . . 35.329999999999998 107.066 174.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 25.1 m-70 -107.64 132.87 52.85 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 106.643 -1.614 . . . . 74.019999999999996 106.643 177.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.679 HG11 ' SD ' ' A' ' 521' ' ' MET . 34.6 m -120.27 159.04 22.0 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 CA-C-O 121.826 0.822 . . . . 70.230000000000004 111.534 -174.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . 0.473 ' O ' HG22 ' A' ' 518' ' ' ILE . 51.6 m -82.02 142.08 32.67 Favored 'General case' 0 N--CA 1.387 -3.592 0 CA-C-N 114.13 -1.395 . . . . 61.229999999999997 107.971 178.132 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 647' ' ' GLU . 39.3 tt0 -80.12 -20.84 44.09 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 120.066 -0.653 . . . . 54.210000000000001 110.792 179.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 47.8 m -94.73 22.7 6.07 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.705 0.764 . . . . 51.43 110.613 -177.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 518' ' ' ILE . . . . . 0.473 HG22 ' O ' ' A' ' 515' ' ' SER . 16.2 tt -97.09 149.71 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.756 0 N-CA-C 108.367 -0.975 . . . . 71.219999999999999 108.367 -179.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -83.49 -54.58 3.08 Favored Glycine 0 N--CA 1.43 -1.764 0 C-N-CA 120.359 -0.924 . . . . 73.010000000000005 111.39 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . 0.446 HD13 ' HA ' ' A' ' 574' ' ' LYS . 34.2 mm -132.72 125.4 52.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.85 -0.796 . . . . 74.140000000000001 108.85 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 521' ' ' MET . . . . . 0.679 ' SD ' HG11 ' A' ' 514' ' ' VAL . 23.7 ptt? -94.23 137.75 33.04 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.833 -1.543 . . . . 74.019999999999996 106.833 172.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -125.35 140.43 52.82 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 123.387 0.429 . . . . 61.229999999999997 110.947 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . 0.591 ' O ' ' HA ' ' A' ' 570' ' ' THR . 39.7 t -124.32 126.09 71.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 108.716 -0.846 . . . . 64.540000000000006 108.716 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . 0.446 ' HD2' HG21 ' A' ' 568' ' ' VAL . 28.2 mmtp -77.77 117.42 19.13 Favored 'General case' 0 C--N 1.311 -1.105 0 O-C-N 123.784 0.678 . . . . 71.310000000000002 110.933 -178.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 25.5 t -98.8 140.17 19.03 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.289 0 CA-C-N 115.241 -0.89 . . . . 63.100000000000001 110.858 -175.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -68.7 144.62 54.36 Favored 'General case' 0 C--O 1.238 0.457 0 O-C-N 123.956 0.785 . . . . 70.329999999999998 109.187 177.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . 0.416 ' HG2' ' N ' ' A' ' 528' ' ' THR . 27.1 ttp180 -99.16 157.77 16.14 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.343 0.592 . . . . 73.239999999999995 110.926 -173.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . 0.648 HG23 ' HB2' ' A' ' 531' ' ' ALA . 5.1 t -65.9 135.03 54.24 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 115.547 -0.751 . . . . 72.349999999999994 110.179 173.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 22.6 t -81.87 -37.35 27.07 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.515 -0.92 . . . . 64.099999999999994 108.515 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -87.34 98.03 2.34 Favored Glycine 0 N--CA 1.418 -2.512 0 N-CA-C 108.168 -1.973 . . . . 41.310000000000002 108.168 175.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . 0.648 ' HB2' HG23 ' A' ' 528' ' ' THR . . . -149.38 100.66 3.04 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 120.854 0.359 . . . . 52.119999999999997 110.282 -177.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . 0.415 ' HD2' ' N ' ' A' ' 532' ' ' ARG . 7.5 mpt_? -119.82 12.8 12.21 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 108.4 -0.963 . . . . 73.129999999999995 108.4 172.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . -155.22 -166.16 15.11 Favored Glycine 0 N--CA 1.437 -1.291 0 CA-C-N 115.006 -0.997 . . . . 71.319999999999993 111.013 -172.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 534' ' ' ASN . . . . . 0.402 HD21 ' CG ' ' A' ' 561' ' ' GLU . 3.1 t-20 -97.8 134.54 40.82 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 122.926 0.49 . . . . 70.430000000000007 109.982 -178.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 535' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' A' ' 595' ' ' ARG . 61.3 t -133.06 131.45 58.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 123.025 0.53 . . . . 73.400000000000006 109.856 -178.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 536' ' ' ILE . . . . . 0.425 ' HB ' ' HB2' ' A' ' 595' ' ' ARG . 35.1 mm -103.82 138.17 29.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 110.033 -0.358 . . . . 75.219999999999999 110.033 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . 0.409 HG22 ' HB3' ' A' ' 594' ' ' PRO . 48.8 t -126.28 110.19 23.81 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 110.086 -0.338 . . . . 75.030000000000001 110.086 178.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.04 154.41 37.67 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.369 2.046 . . . . 75.519999999999996 111.754 178.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 539' ' ' TYR . . . . . 0.443 ' HB3' HG22 ' A' ' 591' ' ' ILE . 52.8 p90 -147.23 161.66 40.48 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.243 -0.651 . . . . 72.030000000000001 109.243 177.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -152.5 157.57 41.32 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 123.724 0.64 . . . . 72.409999999999997 109.782 178.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 2.7 p -99.93 122.66 43.18 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 123.469 0.481 . . . . 70.439999999999998 110.649 174.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.4 mp -91.08 112.52 25.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 106.242 -1.762 . . . . 62.310000000000002 106.242 174.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -52.13 -50.68 61.22 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 124.246 0.966 . . . . 61.439999999999998 111.823 -178.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 67.18 -94.68 0.26 Allowed Glycine 0 N--CA 1.442 -0.903 0 CA-C-N 116.058 -0.519 . . . . 71.420000000000002 112.24 176.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 545' ' ' THR . . . . . 0.514 HG23 ' HB2' ' A' ' 585' ' ' LYS . 8.0 t -119.19 9.39 11.73 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 120.759 0.314 . . . . 73.129999999999995 110.575 -178.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . 0.435 ' HB2' ' HD3' ' A' ' 585' ' ' LYS . . . -98.78 166.31 11.37 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.847 -0.427 . . . . 64.510000000000005 109.847 178.065 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . 0.426 ' HB3' ' HB2' ' A' ' 551' ' ' GLU . 2.8 tpp180 -75.55 167.33 22.1 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 108.024 -1.102 . . . . 72.519999999999996 108.024 178.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -65.02 177.25 10.64 Favored Glycine 0 C--O 1.254 1.393 0 CA-C-O 121.513 0.507 . . . . 55.240000000000002 114.36 -178.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . -57.03 127.55 45.13 Favored Glycine 0 N--CA 1.439 -1.141 0 CA-C-N 114.718 -0.741 . . . . 44.100000000000001 114.115 -177.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 94.95 -10.23 70.24 Favored Glycine 0 N--CA 1.434 -1.459 0 CA-C-N 115.311 -0.444 . . . . 75.150000000000006 112.565 176.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . 0.426 ' HB2' ' HB3' ' A' ' 547' ' ' ARG . 61.8 mm-40 -91.08 -70.84 0.66 Allowed 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 120.405 -0.518 . . . . 75.310000000000002 109.754 -179.253 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -96.03 -37.9 10.44 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-O 121.572 0.701 . . . . 63.25 109.97 175.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -142.46 156.82 45.21 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 108.115 -1.069 . . . . 72.329999999999998 108.115 -177.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -87.42 117.41 26.19 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 106.519 -1.66 . . . . 61.240000000000002 106.519 178.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -72.38 107.15 4.81 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.75 -0.659 . . . . 72.200000000000003 109.791 -176.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . 0.47 HG21 HG22 ' A' ' 573' ' ' VAL . 9.6 t -106.58 126.66 52.55 Favored 'General case' 0 N--CA 1.413 -2.32 0 CA-C-O 122.123 0.963 . . . . 64.519999999999996 111.565 -173.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 20.5 p -136.99 109.77 7.57 Favored 'General case' 0 N--CA 1.414 -2.244 0 N-CA-C 107.367 -1.346 . . . . 72.420000000000002 107.367 175.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -152.92 -161.69 10.46 Favored Glycine 0 N--CA 1.418 -2.505 0 N-CA-C 110.607 -0.997 . . . . 70.319999999999993 110.607 -174.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -139.18 131.25 27.98 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 122.983 0.513 . . . . 71.040000000000006 110.454 -176.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 87.7 mt -92.99 143.73 25.95 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 123.725 0.81 . . . . 72.430000000000007 109.123 179.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 561' ' ' GLU . . . . . 0.402 ' CG ' HD21 ' A' ' 534' ' ' ASN . 26.9 tt0 -102.62 123.59 46.61 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-O 121.414 0.626 . . . . 71.5 110.618 178.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -121.35 157.49 30.32 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 108.26 -1.015 . . . . 71.230000000000004 108.26 173.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . 0.401 ' HG3' ' H ' ' A' ' 566' ' ' GLU . 3.6 pt20 -162.92 -178.93 6.41 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 109.769 -0.456 . . . . 70.239999999999995 109.769 176.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 -63.74 -36.36 83.6 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 124.108 0.88 . . . . 72.519999999999996 111.587 178.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -90.11 -17.26 28.01 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.399 -0.819 . . . . 74.510000000000005 112.309 -176.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 566' ' ' GLU . . . . . 0.401 ' H ' ' HG3' ' A' ' 563' ' ' GLN . 6.7 tp10 -109.58 128.65 55.36 Favored 'General case' 0 C--N 1.31 -1.123 0 O-C-N 121.844 -0.535 . . . . 73.239999999999995 111.081 -174.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 4.7 pt -109.43 159.45 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.125 0 N-CA-C 108.735 -0.839 . . . . 72.230000000000004 108.735 176.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 568' ' ' VAL . . . . . 0.446 HG21 ' HD2' ' A' ' 524' ' ' LYS . 1.3 p 49.25 160.89 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.573 1.855 0 C-N-CA 127.081 2.152 . . . . 71.540000000000006 115.182 -179.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 569' ' ' LYS . . . . . 0.543 ' HA ' ' HE3' ' A' ' 569' ' ' LYS . 0.0 OUTLIER -153.23 162.54 41.19 Favored 'General case' 0 CA--C 1.484 -1.578 0 N-CA-C 107.463 -1.31 . . . . 74.209999999999994 107.463 173.114 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 570' ' ' THR . . . . . 0.591 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 4.9 p -136.87 127.96 27.79 Favored 'General case' 0 C--N 1.291 -1.938 0 O-C-N 124.169 0.918 . . . . 71.040000000000006 110.815 178.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 571' ' ' ILE . . . . . 0.45 HG21 HD21 ' A' ' 589' ' ' LEU . 3.3 mp -79.38 106.93 11.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 107.432 -1.321 . . . . 75.439999999999998 107.432 174.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 7.3 p -86.42 111.95 21.02 Favored 'General case' 0 N--CA 1.415 -2.2 0 O-C-N 123.645 0.591 . . . . 61.210000000000001 110.419 179.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 573' ' ' VAL . . . . . 0.47 HG22 HG21 ' A' ' 556' ' ' THR . 42.3 t -114.39 130.7 68.23 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 N-CA-C 109.089 -0.708 . . . . 64.420000000000002 109.089 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 574' ' ' LYS . . . . . 0.446 ' HA ' HD13 ' A' ' 520' ' ' ILE . 86.1 tttt -86.87 121.88 29.97 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 115.476 -0.784 . . . . 64.299999999999997 110.292 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 56.5 t -90.06 139.37 17.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 107.015 -1.476 . . . . 73.120000000000005 107.015 176.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 31.3 mm -103.52 158.31 5.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 107.842 -1.17 . . . . 73.530000000000001 107.842 -175.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -67.31 126.56 29.65 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.019 -0.734 . . . . 55.420000000000002 109.019 178.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -76.23 130.43 38.18 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.818 -0.628 . . . . 61.310000000000002 110.45 -171.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -92.29 -35.34 13.82 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 113.842 1.053 . . . . 35.049999999999997 113.842 -175.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.58 -178.99 3.6 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 120.251 -0.58 . . . . 74.140000000000001 111.009 -174.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -71.48 152.43 43.05 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 106.419 -1.697 . . . . 75.299999999999997 106.419 175.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 582' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 583' ' ' LYS . 40.7 tt0 -145.14 141.81 29.07 Favored 'General case' 0 N--CA 1.409 -2.495 0 C-N-CA 118.517 -1.273 . . . . 74.040000000000006 111.597 -174.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 583' ' ' LYS . . . . . 0.465 ' O ' ' HG2' ' A' ' 582' ' ' GLU . 97.3 mttt -94.57 -179.29 4.84 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 106.555 -1.646 . . . . 61.25 106.555 174.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -74.78 94.49 2.75 Favored 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 119.819 -0.753 . . . . 73.109999999999999 109.125 178.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 585' ' ' LYS . . . . . 0.514 ' HB2' HG23 ' A' ' 545' ' ' THR . 0.0 OUTLIER -102.73 170.43 8.01 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 115.828 -0.624 . . . . 65.019999999999996 109.319 -179.56 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 2.8 t -151.79 148.96 28.48 Favored 'General case' 0 N--CA 1.418 -2.043 0 CA-C-O 121.486 0.66 . . . . 62.009999999999998 111.502 -177.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -128.84 150.09 50.47 Favored 'General case' 0 N--CA 1.411 -2.409 0 CA-C-N 113.537 -1.665 . . . . 70.299999999999997 107.321 174.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 588' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -108.51 135.98 48.88 Favored 'General case' 0 C--N 1.29 -1.993 0 C-N-CA 120.555 -0.458 . . . . 74.150000000000006 110.5 -169.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . 0.473 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.3 OUTLIER -102.85 129.58 49.57 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 105.8 -1.926 . . . . 72.109999999999999 105.8 175.712 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -132.97 127.08 33.42 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 109.392 -0.595 . . . . 72.329999999999998 109.392 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 591' ' ' ILE . . . . . 0.443 HG22 ' HB3' ' A' ' 539' ' ' TYR . 16.3 pt -94.17 138.43 20.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 107.945 -1.132 . . . . 72.140000000000001 107.945 174.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -97.64 -145.3 18.75 Favored Glycine 0 N--CA 1.43 -1.746 0 N-CA-C 115.049 0.779 . . . . 65.109999999999999 115.049 -172.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -84.99 119.67 72.82 Favored Pre-proline 0 C--N 1.302 -1.462 0 CA-C-N 114.081 -1.059 . . . . 63.210000000000001 109.827 -174.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 594' ' ' PRO . . . . . 0.415 ' HA ' ' O ' ' A' ' 536' ' ' ILE . 43.9 Cg_endo -72.5 156.01 54.51 Favored 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 123.082 2.521 . . . . 52.229999999999997 114.202 -177.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 595' ' ' ARG . . . . . 0.51 ' O ' ' HA ' ' A' ' 535' ' ' VAL . 5.7 mmp_? -115.37 118.15 32.43 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 123.713 0.805 . . . . 54.240000000000002 109.284 -175.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 596' ' ' LEU . . . . . 0.421 HD22 HG22 ' A' ' 535' ' ' VAL . 0.0 OUTLIER -82.5 117.99 22.92 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 104.793 -2.299 . . . . 72.209999999999994 104.793 169.586 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 17.0 t . . . . . 0 C--N 1.304 -1.396 0 CA-C-O 121.776 0.798 . . . . 73.219999999999999 112.787 -172.833 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 21.8 mtm180 . . . . . 0 N--CA 1.443 -0.79 0 CA-C-O 121.187 0.518 . . . . 74.409999999999997 112.32 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -77.16 148.82 27.69 Favored 'Trans proline' 0 N--CA 1.437 -1.834 0 C-N-CA 121.795 1.663 . . . . 72.209999999999994 109.532 173.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 11.6 pt -137.33 -171.74 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-O 120.956 0.408 . . . . 74.239999999999995 110.351 -178.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.48 164.42 14.83 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 115.482 -0.781 . . . . 63.030000000000001 110.227 177.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . 0.507 ' HA3' ' HB ' ' A' ' 506' ' ' THR . . . -82.35 -106.51 0.43 Allowed Glycine 0 N--CA 1.435 -1.428 0 CA-C-N 115.917 -0.583 . . . . 50.219999999999999 112.99 -176.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -107.99 -54.16 2.53 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 119.889 -0.724 . . . . 73.040000000000006 111.003 -176.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 14.5 p80 -133.84 116.16 15.34 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 121.79 0.805 . . . . 75.510000000000005 111.423 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 16.2 p -104.3 91.24 3.83 Favored 'General case' 0 N--CA 1.408 -2.552 0 N-CA-C 109.091 -0.707 . . . . 71.230000000000004 109.091 174.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -171.65 126.25 0.61 Allowed 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 105.898 -1.89 . . . . 73.25 105.898 -178.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 642' ' ' LEU . . . . . 0.553 HD21 HG21 ' A' ' 523' ' ' VAL . 42.6 tp -126.28 110.97 14.01 Favored 'General case' 0 C--N 1.281 -2.398 0 N-CA-C 108.086 -1.079 . . . . 73.510000000000005 108.086 176.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . 0.414 ' HB3' HG22 ' A' ' 511' ' ' VAL . 30.6 tt0 -90.9 102.97 15.73 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 107.569 -1.271 . . . . 65.239999999999995 107.569 178.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 644' ' ' VAL . . . . . 0.489 HG21 ' HE1' ' A' ' 521' ' ' MET . 41.2 t -93.2 110.9 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 N-CA-C 109.333 -0.618 . . . . 71.329999999999998 109.333 -179.174 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 3.5 mp -93.07 125.6 45.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 108.425 -0.954 . . . . 72.340000000000003 108.425 176.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 646' ' ' ILE . . . . . 0.514 ' N ' HD12 ' A' ' 646' ' ' ILE . 2.1 mp -110.72 131.14 62.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 N-CA-C 107.424 -1.324 . . . . 61.049999999999997 107.424 -176.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' A' ' 516' ' ' GLU . 2.2 pt-20 -131.22 157.35 43.48 Favored 'General case' 0 C--N 1.28 -2.448 0 N-CA-C 108.511 -0.922 . . . . 75.430000000000007 108.511 178.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -56.5 117.97 4.36 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 106.307 -1.738 . . . . 72.109999999999999 106.307 170.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 2.9 t . . . . . 0 C--N 1.312 -1.028 0 O-C-N 125.802 1.939 . . . . 74.010000000000005 113.784 -165.258 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . 0.474 ' HA2' ' OG1' ' A' ' 528' ' ' THR . . . . . . . . 0 N--CA 1.403 -3.564 0 N-CA-C 110.08 -1.208 . . . . 34.049999999999997 110.08 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 4.1 mp -91.82 119.34 39.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 108.712 -0.847 . . . . 75.400000000000006 108.712 178.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -123.48 126.04 46.0 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 109.627 -0.508 . . . . 64.409999999999997 109.627 177.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . 0.453 ' HB ' ' HA3' ' A' ' 637' ' ' GLY . 8.8 t -153.41 165.18 36.62 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.522 -0.918 . . . . 71.310000000000002 108.522 -177.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -89.31 162.65 15.72 Favored 'General case' 0 C--O 1.251 1.136 0 N-CA-C 107.228 -1.397 . . . . 73.450000000000003 107.228 173.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -88.42 -44.43 10.75 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 106.293 -1.743 . . . . 75.319999999999993 106.293 178.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -105.36 133.73 20.02 Favored Pre-proline 0 N--CA 1.42 -1.93 0 CA-C-N 114.502 -1.226 . . . . 65.540000000000006 109.495 176.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -87.21 -10.63 5.59 Favored 'Trans proline' 0 C--O 1.219 -0.469 0 C-N-CA 121.956 1.77 . . . . 71.530000000000001 110.824 175.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . 0.454 HG22 ' HB3' ' A' ' 643' ' ' GLU . 81.5 t -142.42 138.89 29.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 C-N-CA 124.378 1.071 . . . . 62.140000000000001 108.441 -176.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 11.3 t -142.09 141.71 32.75 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 107.726 -1.213 . . . . 74.129999999999995 107.726 174.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 35.5 m-70 -108.94 130.4 55.45 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.486 -0.561 . . . . 70.239999999999995 109.486 178.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 26.4 m -128.71 162.47 35.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 CA-C-O 120.937 0.398 . . . . 70.239999999999995 110.221 -176.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 45.9 t -84.24 156.68 21.89 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 108.412 -0.959 . . . . 71.140000000000001 108.412 175.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -88.91 -6.77 57.06 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-O 122.089 0.947 . . . . 65.420000000000002 109.659 174.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 8.7 t -96.99 6.34 48.8 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 108.707 -0.849 . . . . 75.510000000000005 108.707 179.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 12.5 tt -85.11 151.03 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.623 0 N-CA-C 108.69 -0.856 . . . . 55.030000000000001 108.69 -178.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . -89.61 -63.38 1.29 Allowed Glycine 0 N--CA 1.426 -2.023 0 C-N-CA 120.366 -0.921 . . . . 75.400000000000006 111.098 179.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 32.1 mm -123.64 124.26 69.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 109.458 -0.571 . . . . 44.109999999999999 109.458 -179.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 521' ' ' MET . . . . . 0.638 ' HE2' HG21 ' A' ' 644' ' ' VAL . 0.0 OUTLIER -102.6 135.51 44.12 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.597 -1.26 . . . . 64.099999999999994 107.597 172.625 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 522' ' ' GLU . . . . . 0.423 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 42.7 mt-10 -120.93 132.29 54.86 Favored 'General case' 0 CA--C 1.494 -1.206 0 O-C-N 123.522 0.514 . . . . 54.450000000000003 110.713 -177.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . 0.566 HG21 ' CD2' ' A' ' 642' ' ' LEU . 29.4 t -112.67 123.46 68.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-N 115.37 -0.832 . . . . 71.209999999999994 108.888 178.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . 0.416 ' HD2' HG21 ' A' ' 568' ' ' VAL . 28.6 mmtp -79.78 122.77 27.02 Favored 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 123.468 0.707 . . . . 65.409999999999997 110.408 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 21.9 t -101.21 150.97 5.59 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 CA-C-N 115.405 -0.816 . . . . 72.109999999999999 109.126 -178.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -95.43 153.53 17.65 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 108.974 -0.75 . . . . 71.120000000000005 108.974 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . 0.472 ' HD3' ' HA ' ' A' ' 567' ' ' ILE . 67.1 mtm180 -94.21 176.81 6.18 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.201 0.524 . . . . 73.340000000000003 109.9 173.091 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . 0.474 ' OG1' ' HA2' ' A' ' 503' ' ' GLY . 8.8 t -87.82 164.26 16.01 Favored 'General case' 0 N--CA 1.411 -2.38 0 CA-C-N 115.079 -0.964 . . . . 75.140000000000001 110.208 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 13.3 t -63.21 -42.75 99.34 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 115.262 -0.881 . . . . 70.209999999999994 108.712 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -100.78 67.4 0.49 Allowed Glycine 0 N--CA 1.434 -1.47 0 N-CA-C 110.764 -0.934 . . . . 41.25 110.764 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -78.89 80.45 5.24 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.261 0.553 . . . . 75.420000000000002 110.742 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -134.63 138.65 44.68 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 106.306 -1.739 . . . . 73.409999999999997 106.306 177.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 533' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' A' ' 563' ' ' GLN . . . 87.93 173.48 47.75 Favored Glycine 0 C--N 1.302 -1.314 0 C-N-CA 119.883 -1.151 . . . . 74.230000000000004 111.156 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 534' ' ' ASN . . . . . 0.484 HD21 ' HG3' ' A' ' 561' ' ' GLU . 2.9 t-20 -105.98 121.27 43.76 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 122.409 -0.465 . . . . 62.119999999999997 109.809 -177.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 535' ' ' VAL . . . . . 0.445 HG22 HD22 ' A' ' 596' ' ' LEU . 59.8 t -124.01 126.21 72.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.409 -0.96 . . . . 62.119999999999997 108.409 178.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 536' ' ' ILE . . . . . 0.51 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 47.4 mm -99.23 137.28 27.17 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 N-CA-C 108.661 -0.866 . . . . 63.240000000000002 108.661 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 57.9 t -122.45 109.82 32.64 Favored Pre-proline 0 C--N 1.307 -1.266 0 CA-C-N 116.417 -0.356 . . . . 74.209999999999994 110.805 -179.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -75.25 135.92 19.23 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 122.541 2.161 . . . . 64.109999999999999 111.668 176.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 539' ' ' TYR . . . . . 0.455 ' CD1' ' HG ' ' A' ' 560' ' ' LEU . 42.9 p90 -134.12 157.49 46.03 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 109.068 -0.716 . . . . 73.010000000000005 109.068 -178.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -156.73 156.85 34.06 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 123.322 0.389 . . . . 74.109999999999999 111.048 177.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 1.6 p -91.45 116.85 29.19 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 115.437 -0.801 . . . . 71.140000000000001 110.663 174.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.6 mp -87.51 112.27 23.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 106.282 -1.747 . . . . 74.409999999999997 106.282 174.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.69 -46.19 74.07 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 114.797 1.406 . . . . 63.399999999999999 114.797 -176.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 63.41 -94.54 0.13 Allowed Glycine 0 CA--C 1.523 0.546 0 CA-C-O 121.349 0.416 . . . . 74.430000000000007 113.146 177.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 10.2 t -114.09 0.4 14.28 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.293 0.568 . . . . 71.129999999999995 110.712 -178.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -104.02 156.7 17.65 Favored 'General case' 0 C--N 1.318 -0.794 0 O-C-N 121.97 -0.457 . . . . 63.43 109.923 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . 0.463 ' HB2' ' HB2' ' A' ' 552' ' ' ASP . 4.6 mpt_? -87.21 125.43 34.18 Favored 'General case' 0 CA--C 1.483 -1.602 0 CA-C-O 121.442 0.639 . . . . 71.219999999999999 110.991 -178.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -86.32 179.92 49.47 Favored Glycine 0 C--N 1.279 -2.633 0 CA-C-N 114.245 -1.343 . . . . 73.030000000000001 112.083 -177.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 74.18 30.86 60.24 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 114.039 0.376 . . . . 72.439999999999998 114.039 177.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 76.08 21.39 76.11 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.259 -0.972 . . . . 52.039999999999999 111.919 178.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -91.67 -66.26 0.94 Allowed 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 110.02 -0.363 . . . . 75.150000000000006 110.02 -177.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . 0.463 ' HB2' ' HB2' ' A' ' 547' ' ' ARG . 1.8 t70 -101.79 -29.84 11.64 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 106.608 -1.627 . . . . 51.439999999999998 106.608 177.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -146.07 160.06 42.41 Favored 'General case' 0 C--O 1.247 0.937 0 CA-C-N 114.963 -1.017 . . . . 73.430000000000007 108.374 175.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -91.21 130.09 37.13 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.404 -1.702 . . . . 75.319999999999993 106.404 178.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -86.17 117.46 25.01 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 116.511 -0.313 . . . . 64.140000000000001 110.579 -174.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . 0.43 ' CG2' HG22 ' A' ' 573' ' ' VAL . 13.8 t -115.99 122.35 44.98 Favored 'General case' 0 N--CA 1.409 -2.477 0 CA-C-O 122.206 1.003 . . . . 65.230000000000004 110.462 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 1.8 p -143.87 128.76 18.42 Favored 'General case' 0 N--CA 1.417 -2.087 0 CA-C-N 114.54 -1.209 . . . . 72.239999999999995 108.693 179.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -177.4 -158.42 20.48 Favored Glycine 0 N--CA 1.419 -2.47 0 N-CA-C 110.103 -1.199 . . . . 73.439999999999998 110.103 -176.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 559' ' ' GLU . . . . . 0.51 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 38.7 mt-10 -129.97 125.73 36.12 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 120.999 0.428 . . . . 65.430000000000007 111.935 -176.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . 0.455 ' HG ' ' CD1' ' A' ' 539' ' ' TYR . 94.9 mt -88.91 144.92 25.86 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 109.07 -0.715 . . . . 74.109999999999999 109.07 177.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 561' ' ' GLU . . . . . 0.484 ' HG3' HD21 ' A' ' 534' ' ' ASN . 37.5 tt0 -103.95 122.17 44.64 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 116.418 -0.355 . . . . 74.439999999999998 110.475 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 562' ' ' PHE . . . . . 0.421 ' CE1' ' HG2' ' A' ' 569' ' ' LYS . 70.0 m-85 -121.24 146.57 46.67 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.445 -0.946 . . . . 73.239999999999995 108.445 171.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . 0.483 ' HA ' ' O ' ' A' ' 533' ' ' GLY . 3.6 pt20 -159.14 -173.16 4.08 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 110.324 -0.25 . . . . 72.409999999999997 110.324 178.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -59.11 -45.41 90.96 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 123.58 0.752 . . . . 72.5 112.24 -177.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -91.95 -41.21 10.7 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 120.17 -0.612 . . . . 54.32 111.748 -178.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 566' ' ' GLU . . . . . 0.406 ' H ' ' HG3' ' A' ' 563' ' ' GLN . 8.2 tp10 -66.94 135.2 53.44 Favored 'General case' 0 C--N 1.317 -0.809 0 O-C-N 123.247 0.342 . . . . 71.0 110.233 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 567' ' ' ILE . . . . . 0.472 ' HA ' ' HD3' ' A' ' 527' ' ' ARG . 31.1 pt -116.94 -172.19 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.412 -2.365 0 N-CA-C 109.057 -0.72 . . . . 73.209999999999994 109.057 -178.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 568' ' ' VAL . . . . . 0.416 HG21 ' HD2' ' A' ' 524' ' ' LYS . 2.8 p 5.9 128.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 C-N-CA 129.628 3.171 . . . . 54.020000000000003 116.944 172.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 569' ' ' LYS . . . . . 0.421 ' HG2' ' CE1' ' A' ' 562' ' ' PHE . 27.7 mmmt -117.11 153.87 32.01 Favored 'General case' 0 C--N 1.266 -3.024 0 CA-C-N 115.234 -0.894 . . . . 72.209999999999994 110.699 177.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 570' ' ' THR . . . . . 0.551 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 8.3 p -126.78 121.2 31.28 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 124.032 0.832 . . . . 63.329999999999998 111.998 177.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 571' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 2.5 mp -77.15 118.15 23.33 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 N-CA-C 105.191 -2.151 . . . . 64.430000000000007 105.191 172.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 5.7 m -105.93 109.36 21.28 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.894 -0.78 . . . . 63.100000000000001 108.894 -176.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 573' ' ' VAL . . . . . 0.43 HG22 ' CG2' ' A' ' 556' ' ' THR . 40.6 t -114.01 135.3 54.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 110.067 -0.346 . . . . 61.219999999999999 110.067 -176.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 574' ' ' LYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 519' ' ' GLY . 15.7 tppt? -90.4 123.98 34.58 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.369 -0.832 . . . . 73.219999999999999 110.112 178.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 64.3 t -94.59 117.66 38.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 107.724 -1.213 . . . . 71.329999999999998 107.724 176.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 36.8 mm -78.96 154.65 4.85 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 N-CA-C 108.347 -0.983 . . . . 74.409999999999997 108.347 -176.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -72.36 86.78 1.13 Allowed 'General case' 0 C--O 1.247 0.947 0 CA-C-O 122.061 0.934 . . . . 43.299999999999997 110.26 173.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -40.6 130.57 2.4 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 127.681 2.392 . . . . 73.319999999999993 113.25 178.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.25 -26.8 60.44 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 114.145 -1.389 . . . . 74.420000000000002 114.126 -171.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 580' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' A' ' 581' ' ' TYR . 0.8 OUTLIER -124.63 178.7 5.3 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 119.549 -0.861 . . . . 73.200000000000003 110.67 -174.742 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 581' ' ' TYR . . . . . 0.477 ' O ' ' HG2' ' A' ' 580' ' ' GLU . 7.2 p90 -86.01 151.43 23.73 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 105.451 -2.055 . . . . 75.540000000000006 105.451 173.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 582' ' ' GLU . . . . . 0.418 ' OE2' ' HG3' ' A' ' 585' ' ' LYS . 9.5 pt-20 -133.4 172.02 13.27 Favored 'General case' 0 C--N 1.277 -2.549 0 C-N-CA 119.194 -1.002 . . . . 75.310000000000002 109.672 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -90.65 -48.87 6.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 N-CA-C 106.812 -1.551 . . . . 72.200000000000003 106.812 173.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 1.4 m120 175.22 101.08 0.01 OUTLIER 'General case' 0 C--N 1.259 -3.344 0 CA-C-N 110.822 -2.899 . . . . 71.5 109.476 177.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 585' ' ' LYS . . . . . 0.418 ' HG3' ' OE2' ' A' ' 582' ' ' GLU 0.263 0.1 OUTLIER -89.87 162.02 15.67 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 118.065 -1.454 . . . . 74.219999999999999 109.676 172.994 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 5.2 t -151.36 142.98 23.66 Favored 'General case' 0 N--CA 1.415 -2.216 0 CA-C-O 121.174 0.512 . . . . 65.400000000000006 110.186 -176.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -126.09 147.01 49.69 Favored 'General case' 0 N--CA 1.421 -1.898 0 CA-C-N 114.104 -1.407 . . . . 74.340000000000003 108.412 176.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 588' ' ' PHE . . . . . 0.437 ' HA ' ' O ' ' A' ' 642' ' ' LEU . 10.5 m-85 -105.92 135.48 47.29 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 116.027 -0.533 . . . . 70.230000000000004 109.708 -172.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . 0.501 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.3 OUTLIER -104.27 124.99 50.15 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 106.096 -1.816 . . . . 63.409999999999997 106.096 175.786 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -131.38 135.72 47.45 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 109.526 -0.546 . . . . 70.140000000000001 109.526 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 591' ' ' ILE . . . . . . . . . . . . . 22.5 pt -99.36 134.71 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.734 0 N-CA-C 107.059 -1.46 . . . . 72.120000000000005 107.059 174.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -90.4 -150.66 24.53 Favored Glycine 0 C--N 1.297 -1.6 0 C-N-CA 120.786 -0.721 . . . . 74.019999999999996 112.965 -175.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -67.83 118.73 60.8 Favored Pre-proline 0 C--N 1.315 -0.935 0 C-N-CA 122.743 0.417 . . . . 74.230000000000004 110.292 179.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -70.51 143.21 46.59 Favored 'Trans proline' 0 N--CA 1.438 -1.772 0 C-N-CA 121.84 1.693 . . . . 71.230000000000004 109.78 175.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 595' ' ' ARG . . . . . 0.493 ' HG3' ' HB ' ' A' ' 536' ' ' ILE . 5.5 ptp180 -120.79 122.46 40.38 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 116.402 -0.363 . . . . 73.340000000000003 111.056 -174.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 596' ' ' LEU . . . . . 0.445 HD22 HG22 ' A' ' 535' ' ' VAL . 0.0 OUTLIER -79.18 122.48 26.32 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 107.735 -1.209 . . . . 55.32 107.735 179.904 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 17.1 t . . . . . 0 C--N 1.303 -1.435 0 CA-C-O 121.676 0.751 . . . . 73.319999999999993 110.111 -178.31 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 55.4 mtt180 . . . . . 0 C--O 1.218 -0.561 0 N-CA-C 112.088 0.403 . . . . 70.519999999999996 112.088 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -89.54 168.21 4.98 Favored 'Trans proline' 0 N--CA 1.441 -1.57 0 C-N-CA 122.661 2.24 . . . . 70.019999999999996 111.293 174.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.1 pp -144.06 178.54 1.72 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 113.416 0.895 . . . . 62.340000000000003 113.416 -175.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -82.67 148.16 28.1 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 108.775 -0.824 . . . . 45.219999999999999 108.775 178.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . 0.453 ' HA3' ' HB ' ' A' ' 506' ' ' THR . . . -90.77 -128.55 3.96 Favored Glycine 0 C--N 1.294 -1.79 0 C-N-CA 120.736 -0.745 . . . . 35.439999999999998 114.46 -176.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -72.1 -56.67 5.19 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.379 -0.41 . . . . 71.120000000000005 111.448 -175.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 20.3 p80 -145.38 109.69 4.93 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.833 0.825 . . . . 72.519999999999996 111.684 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 37.9 p -101.35 90.25 4.04 Favored 'General case' 0 N--CA 1.398 -3.034 0 N-CA-C 107.849 -1.167 . . . . 73.340000000000003 107.849 174.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -178.32 125.74 0.11 Allowed 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 105.01 -2.219 . . . . 64.200000000000003 105.01 -177.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 642' ' ' LEU . . . . . 0.566 ' CD2' HG21 ' A' ' 523' ' ' VAL . 38.0 tp -124.72 111.07 15.13 Favored 'General case' 0 C--N 1.28 -2.435 0 N-CA-C 108.17 -1.048 . . . . 74.140000000000001 108.17 174.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . 0.454 ' HB3' HG22 ' A' ' 511' ' ' VAL . 26.1 tt0 -93.62 101.44 13.6 Favored 'General case' 0 C--N 1.272 -2.767 0 N-CA-C 107.484 -1.302 . . . . 75.310000000000002 107.484 -179.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 644' ' ' VAL . . . . . 0.638 HG21 ' HE2' ' A' ' 521' ' ' MET . 39.4 t -93.04 108.52 20.49 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 108.906 -0.775 . . . . 75.409999999999997 108.906 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 4.2 mp -94.05 121.82 45.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 107.944 -1.132 . . . . 72.319999999999993 107.944 176.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 646' ' ' ILE . . . . . 0.514 ' N ' HD12 ' A' ' 646' ' ' ILE . 2.9 mp -100.19 134.09 40.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 107.091 -1.448 . . . . 75.109999999999999 107.091 -176.063 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -118.02 145.23 44.93 Favored 'General case' 0 N--CA 1.419 -2.023 0 C-N-CA 120.229 -0.589 . . . . 75.129999999999995 109.855 -178.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -60.31 137.56 58.11 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 107.019 -1.474 . . . . 73.109999999999999 107.019 176.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 17.0 t . . . . . 0 N--CA 1.434 -1.253 0 CA-C-O 122.177 0.989 . . . . 74.030000000000001 112.881 -173.12 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . 0.638 ' HA2' ' OG1' ' A' ' 528' ' ' THR . . . . . . . . 1 N--CA 1.395 -4.061 0 N-CA-C 110.952 -0.859 . . . . 73.030000000000001 110.952 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 2.7 mp -105.54 101.01 11.76 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 N-CA-C 106.763 -1.569 . . . . 72.409999999999997 106.763 176.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -114.71 122.87 47.74 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 109.457 -0.571 . . . . 72.230000000000004 109.457 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 11.2 t -148.64 163.99 35.62 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.483 -0.932 . . . . 71.129999999999995 108.483 -176.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -92.51 161.98 14.4 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 107.306 -1.368 . . . . 74.5 107.306 172.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -96.91 -26.3 15.11 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.322 -1.362 . . . . 71.099999999999994 107.322 173.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -97.32 120.57 60.72 Favored Pre-proline 0 N--CA 1.419 -1.989 0 CA-C-N 114.618 -1.174 . . . . 65.400000000000006 110.587 176.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -82.16 -19.09 7.02 Favored 'Trans proline' 0 N--CA 1.429 -2.28 0 N-CA-C 108.065 -1.552 . . . . 74.200000000000003 108.065 168.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . 0.426 HG22 ' HB3' ' A' ' 643' ' ' GLU . 93.7 t -147.89 139.69 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 C-N-CA 126.005 1.722 . . . . 71.239999999999995 107.897 -177.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 14.4 t -137.05 119.47 15.82 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 108.051 -1.092 . . . . 72.209999999999994 108.051 173.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -88.41 128.61 35.52 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 122.085 -0.384 . . . . 73.209999999999994 110.225 175.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 26.8 m -126.25 161.52 31.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-N 115.657 -0.701 . . . . 75.120000000000005 109.717 -178.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 56.9 m -88.21 167.8 13.28 Favored 'General case' 0 N--CA 1.403 -2.807 0 CA-C-N 115.079 -0.964 . . . . 73.510000000000005 109.99 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -94.32 -23.63 17.74 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.497 0.665 . . . . 72.329999999999998 110.608 176.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 14.2 m -85.31 20.77 1.89 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.932 0.873 . . . . 73.209999999999994 110.406 -176.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 15.3 tt -108.3 155.83 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.133 0 N-CA-C 107.554 -1.276 . . . . 74.519999999999996 107.554 -176.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -96.65 -59.85 1.0 Allowed Glycine 0 C--N 1.293 -1.848 0 C-N-CA 120.175 -1.012 . . . . 65.209999999999994 111.297 179.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 41.9 mm -121.48 136.22 59.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 109.402 -0.592 . . . . 75.519999999999996 109.402 -178.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 521' ' ' MET . . . . . 0.594 ' HE1' HG21 ' A' ' 644' ' ' VAL . 0.0 OUTLIER -115.35 132.68 56.54 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 106.368 -1.716 . . . . 72.120000000000005 106.368 171.764 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -109.17 149.29 29.58 Favored 'General case' 0 N--CA 1.428 -1.563 0 C-N-CA 120.509 -0.476 . . . . 65.319999999999993 109.852 -178.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . 0.631 ' O ' ' HA ' ' A' ' 570' ' ' THR . 40.0 t -126.12 121.05 58.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 109.722 -0.473 . . . . 63.32 109.722 178.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . 0.509 ' HD2' HG21 ' A' ' 568' ' ' VAL . 28.0 mmtp -82.09 118.9 23.39 Favored 'General case' 0 C--N 1.313 -1.021 0 O-C-N 124.095 0.872 . . . . 75.140000000000001 110.453 178.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 21.7 t -98.87 139.18 21.28 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 CA-C-N 114.563 -1.199 . . . . 63.210000000000001 108.982 -178.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -79.7 146.36 32.46 Favored 'General case' 0 C--N 1.31 -1.12 0 O-C-N 123.635 0.585 . . . . 74.329999999999998 109.566 -179.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . 0.406 ' HG2' ' N ' ' A' ' 528' ' ' THR . 31.8 ttp180 -87.64 160.16 18.26 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.384 -0.969 . . . . 71.450000000000003 108.384 -179.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . 0.638 ' OG1' ' HA2' ' A' ' 503' ' ' GLY . 4.6 t -61.82 150.76 36.25 Favored 'General case' 0 N--CA 1.421 -1.916 0 CA-C-O 121.362 0.601 . . . . 62.020000000000003 110.71 174.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 42.2 t -69.99 -22.17 63.16 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 114.83 -1.077 . . . . 74.25 109.754 179.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -129.0 89.71 0.31 Allowed Glycine 0 N--CA 1.435 -1.377 0 N-CA-C 109.907 -1.277 . . . . 65.120000000000005 109.907 178.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -86.87 85.93 7.3 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 121.382 0.611 . . . . 64.340000000000003 111.291 -176.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . 0.419 ' HD3' ' HA ' ' A' ' 532' ' ' ARG . 37.5 mmt180 -123.54 101.78 7.51 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.634 -0.712 . . . . 75.150000000000006 110.772 177.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 533' ' ' GLY . . . . . 0.409 ' H ' ' HB3' ' A' ' 564' ' ' ASN . . . 119.07 -148.79 18.26 Favored Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 110.969 -0.852 . . . . 71.230000000000004 110.969 179.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 534' ' ' ASN . . . . . 0.496 HD21 ' CG ' ' A' ' 561' ' ' GLU . 2.9 t-20 -138.2 131.62 30.58 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 106.288 -1.745 . . . . 25.239999999999998 106.288 178.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 535' ' ' VAL . . . . . 0.448 HG22 HD22 ' A' ' 596' ' ' LEU . 67.7 t -127.44 137.6 57.25 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 118.189 0.45 . . . . 62.100000000000001 111.416 -174.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 536' ' ' ILE . . . . . 0.427 HG23 ' HB3' ' A' ' 559' ' ' GLU . 27.9 mm -102.91 126.04 57.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 108.889 -0.782 . . . . 75.150000000000006 108.889 174.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 31.7 t -117.1 106.83 46.68 Favored Pre-proline 0 C--N 1.298 -1.652 0 N-CA-C 108.543 -0.91 . . . . 75.150000000000006 108.543 178.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -75.61 137.81 20.86 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.102 1.868 . . . . 74.519999999999996 111.364 177.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -130.68 160.42 34.33 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.535 -0.543 . . . . 73.519999999999996 109.535 179.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.33 146.91 18.83 Favored 'General case' 0 C--N 1.314 -0.972 0 O-C-N 123.67 0.606 . . . . 73.329999999999998 110.679 175.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 7.9 p -86.77 122.33 30.52 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.053 -0.521 . . . . 53.399999999999999 110.38 176.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.4 mp -82.49 122.47 37.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 105.753 -1.943 . . . . 74.209999999999994 105.753 172.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -63.75 -48.69 75.98 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 123.464 0.478 . . . . 73.120000000000005 109.928 -178.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 67.24 -93.5 0.23 Allowed Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 115.858 -0.61 . . . . 73.439999999999998 112.215 177.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 15.1 t -113.74 -0.61 14.2 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.494 -0.558 . . . . 63.109999999999999 109.494 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -97.34 176.49 5.87 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-N 115.646 -0.706 . . . . 71.200000000000003 111.592 -177.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -127.31 111.97 14.52 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 109.25 -0.648 . . . . 71.409999999999997 109.25 -179.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -78.43 -160.9 17.29 Favored Glycine 0 C--N 1.315 -0.606 0 C-N-CA 121.57 -0.348 . . . . 64.209999999999994 112.602 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 67.37 17.68 68.71 Favored Glycine 0 C--N 1.314 -0.656 0 CA-C-O 120.908 0.171 . . . . 53.140000000000001 113.191 -177.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 77.42 11.58 85.36 Favored Glycine 0 C--O 1.211 -1.29 0 N-CA-C 111.041 -0.824 . . . . 73.099999999999994 111.041 -178.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -78.76 -42.44 28.02 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 122.469 0.308 . . . . 62.409999999999997 111.291 -175.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -135.89 -20.67 1.49 Allowed 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 107.822 -1.177 . . . . 71.140000000000001 107.822 173.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -155.79 163.51 39.74 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 107.181 -1.414 . . . . 75.129999999999995 107.181 169.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . 0.421 ' HB3' ' HB3' ' A' ' 574' ' ' LYS . 0.7 OUTLIER -98.09 109.19 21.99 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 106.761 -1.57 . . . . 52.329999999999998 106.761 -178.855 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -77.54 147.25 35.86 Favored 'General case' 0 CA--C 1.499 -0.993 0 C-N-CA 120.761 -0.375 . . . . 75.349999999999994 110.439 -175.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 8.3 t -139.59 142.22 37.13 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-O 121.605 0.717 . . . . 33.009999999999998 111.778 -174.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 7.6 p -145.46 149.6 34.97 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.214 -1.402 . . . . 70.420000000000002 107.214 176.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 173.47 -167.21 39.8 Favored Glycine 0 N--CA 1.418 -2.543 0 N-CA-C 110.346 -1.101 . . . . 31.43 110.346 -178.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 559' ' ' GLU . . . . . 0.427 ' HB3' HG23 ' A' ' 536' ' ' ILE . 42.2 mt-10 -126.73 124.63 40.22 Favored 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 123.165 0.586 . . . . 75.340000000000003 110.169 -176.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 94.3 mt -95.97 142.05 28.66 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.746 -0.835 . . . . 62.219999999999999 108.746 177.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 561' ' ' GLU . . . . . 0.496 ' CG ' HD21 ' A' ' 534' ' ' ASN . 31.1 tt0 -115.83 115.9 27.06 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 120.912 0.387 . . . . 70.010000000000005 111.143 -176.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -102.05 140.93 35.68 Favored 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 108.982 -0.747 . . . . 74.530000000000001 108.982 176.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . 0.496 ' HB2' ' H ' ' A' ' 566' ' ' GLU . 4.6 mt-30 -119.7 -178.23 3.58 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 119.033 -1.067 . . . . 75.430000000000007 110.337 179.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 564' ' ' ASN . . . . . 0.409 ' HB3' ' H ' ' A' ' 533' ' ' GLY . 28.0 p-10 -74.43 -34.71 63.3 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.916 0.865 . . . . 64.120000000000005 109.001 176.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -94.0 -43.39 8.55 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.437 -1.256 . . . . 60.149999999999999 110.901 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 566' ' ' GLU . . . . . 0.496 ' H ' ' HB2' ' A' ' 563' ' ' GLN . 25.5 tt0 -70.99 123.29 21.72 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.064 0.459 . . . . 74.219999999999999 111.326 -179.086 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 8.7 pt -104.81 166.01 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.564 0 N-CA-C 108.797 -0.816 . . . . 72.019999999999996 108.797 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 568' ' ' VAL . . . . . 0.509 HG21 ' HD2' ' A' ' 524' ' ' LYS . 2.0 p 47.34 159.96 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.58 2.107 0 C-N-CA 127.027 2.131 . . . . 71.340000000000003 115.392 179.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 569' ' ' LYS . . . . . 0.508 ' HA ' ' HE2' ' A' ' 569' ' ' LYS . 4.3 mmpt? -142.67 166.05 25.73 Favored 'General case' 0 CA--C 1.493 -1.217 0 O-C-N 121.16 -0.962 . . . . 73.109999999999999 109.019 172.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 570' ' ' THR . . . . . 0.631 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 1.3 p -138.57 127.16 23.35 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 123.902 0.751 . . . . 74.319999999999993 112.897 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 571' ' ' ILE . . . . . 0.429 HG21 HD21 ' A' ' 589' ' ' LEU . 3.3 mp -96.07 122.06 47.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 106.477 -1.675 . . . . 73.420000000000002 106.477 170.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 49.2 m -107.36 125.08 50.75 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 108.84 -0.8 . . . . 61.439999999999998 108.84 177.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 573' ' ' VAL . . . . . . . . . . . . . 48.1 t -124.68 139.45 50.86 Favored 'Isoleucine or valine' 0 C--O 1.243 0.757 0 N-CA-C 108.458 -0.942 . . . . 63.420000000000002 108.458 -178.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 574' ' ' LYS . . . . . 0.421 ' HB3' ' HB3' ' A' ' 554' ' ' GLU . 87.0 tttt -95.7 129.99 42.74 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-O 121.77 0.795 . . . . 75.409999999999997 111.786 -178.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 59.2 t -94.13 138.72 19.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 107.044 -1.465 . . . . 65.329999999999998 107.044 176.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 45.8 mm -104.62 143.97 15.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 108.659 -0.867 . . . . 74.400000000000006 108.659 -176.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -59.18 129.76 43.7 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 108.535 -0.913 . . . . 74.310000000000002 108.535 174.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -77.96 117.36 19.22 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 115.02 -0.991 . . . . 74.140000000000001 111.911 -167.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.08 -16.81 59.09 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 114.263 1.208 . . . . 73.040000000000006 114.263 -177.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 580' ' ' GLU . . . . . 0.557 ' HG2' ' O ' ' A' ' 581' ' ' TYR . 0.0 OUTLIER -141.21 -176.71 4.81 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 106.553 -1.647 . . . . 61.049999999999997 106.553 173.257 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 581' ' ' TYR . . . . . 0.557 ' O ' ' HG2' ' A' ' 580' ' ' GLU . 12.4 p90 -87.19 152.21 22.52 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 106.825 -1.546 . . . . 72.230000000000004 106.825 174.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 582' ' ' GLU . . . . . 0.701 ' OE1' ' HB3' ' A' ' 585' ' ' LYS . 14.7 pt-20 -132.81 175.84 8.99 Favored 'General case' 0 C--N 1.276 -2.599 0 N-CA-C 108.826 -0.805 . . . . 72.010000000000005 108.826 -178.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 583' ' ' LYS . . . . . 0.446 ' O ' ' HG3' ' A' ' 582' ' ' GLU . 56.3 mtpt -100.05 -165.92 1.27 Allowed 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 105.551 -2.018 . . . . 72.540000000000006 105.551 169.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -74.73 89.16 2.27 Favored 'General case' 0 C--N 1.281 -2.391 0 C-N-CA 118.82 -1.152 . . . . 53.0 111.853 178.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 585' ' ' LYS . . . . . 0.701 ' HB3' ' OE1' ' A' ' 582' ' ' GLU . 0.0 OUTLIER -79.02 143.81 35.29 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 114.879 -1.055 . . . . 74.319999999999993 108.746 -178.964 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 5.9 t -145.14 141.57 28.88 Favored 'General case' 0 N--CA 1.407 -2.604 0 CA-C-O 121.169 0.509 . . . . 70.400000000000006 110.517 -176.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -122.16 144.63 48.83 Favored 'General case' 0 N--CA 1.412 -2.342 0 CA-C-N 113.928 -1.487 . . . . 70.319999999999993 108.468 175.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 588' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -104.66 128.16 52.62 Favored 'General case' 0 C--N 1.284 -2.239 0 N-CA-C 108.732 -0.84 . . . . 75.430000000000007 108.732 -173.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . 0.501 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.7 OUTLIER -98.45 126.08 43.86 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 106.642 -1.614 . . . . 72.030000000000001 106.642 177.381 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -128.43 132.75 48.45 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 109.993 -0.373 . . . . 75.400000000000006 109.993 179.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 591' ' ' ILE . . . . . . . . . . . . . 16.0 pt -97.32 128.71 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.652 0 N-CA-C 106.256 -1.757 . . . . 64.040000000000006 106.256 170.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -87.32 -139.81 6.18 Favored Glycine 0 N--CA 1.435 -1.401 0 CA-C-N 116.104 -0.498 . . . . 42.219999999999999 114.18 -172.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -79.9 112.36 29.19 Favored Pre-proline 0 C--N 1.311 -1.071 0 N-CA-C 109.301 -0.629 . . . . 71.530000000000001 109.301 -178.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -78.53 149.68 24.25 Favored 'Trans proline' 0 N--CA 1.434 -1.974 0 C-N-CA 122.094 1.863 . . . . 73.230000000000004 110.886 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 8.8 ptt-85 -129.23 132.82 47.31 Favored 'General case' 0 C--N 1.28 -2.421 0 CA-C-N 115.912 -0.586 . . . . 61.219999999999999 110.402 -175.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 596' ' ' LEU . . . . . 0.448 HD22 HG22 ' A' ' 535' ' ' VAL . 0.0 OUTLIER -77.06 125.77 29.87 Favored 'General case' 0 N--CA 1.415 -2.181 0 N-CA-C 105.501 -2.037 . . . . 64.150000000000006 105.501 178.703 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 96.6 t . . . . . 0 C--N 1.3 -1.562 0 N-CA-C 108.646 -0.872 . . . . 51.340000000000003 108.646 -179.709 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 . . . . . 0 C--O 1.203 -1.367 0 N-CA-C 108.502 -0.925 . . . . 72.030000000000001 108.502 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -76.18 153.51 36.36 Favored 'Trans proline' 0 N--CA 1.434 -1.98 0 C-N-CA 121.116 1.211 . . . . 64.219999999999999 110.21 176.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.0 pp -138.96 -175.25 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 112.765 0.654 . . . . 74.5 112.765 -175.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.71 146.09 32.58 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 115.425 -0.807 . . . . 74.310000000000002 109.327 178.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -83.97 -107.33 0.57 Allowed Glycine 0 C--N 1.291 -1.96 0 CA-C-N 116.105 -0.498 . . . . 63.399999999999999 112.474 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -94.66 -65.82 0.96 Allowed 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.238 0.542 . . . . 54.119999999999997 110.142 -177.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 17.0 p80 -130.54 114.08 15.04 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.628 0.728 . . . . 64.319999999999993 111.011 -177.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 13.7 p -104.78 89.76 3.27 Favored 'General case' 0 N--CA 1.397 -3.124 0 N-CA-C 107.473 -1.306 . . . . 75.120000000000005 107.473 173.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -176.46 123.62 0.17 Allowed 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 105.175 -2.158 . . . . 72.010000000000005 105.175 -174.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 642' ' ' LEU . . . . . 0.532 ' CD2' HG21 ' A' ' 523' ' ' VAL . 45.1 tp -125.55 106.84 10.06 Favored 'General case' 0 C--N 1.274 -2.681 0 N-CA-C 106.976 -1.49 . . . . 71.049999999999997 106.976 177.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . 0.426 ' HB3' HG22 ' A' ' 511' ' ' VAL . 26.9 tt0 -88.8 100.56 13.25 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 108.029 -1.1 . . . . 53.43 108.029 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 644' ' ' VAL . . . . . 0.594 HG21 ' HE1' ' A' ' 521' ' ' MET . 23.1 t -91.01 105.61 16.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 108.925 -0.769 . . . . 73.409999999999997 108.925 -179.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 4.4 mp -92.36 124.93 45.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 108.426 -0.953 . . . . 74.030000000000001 108.426 175.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 646' ' ' ILE . . . . . 0.567 ' N ' HD12 ' A' ' 646' ' ' ILE . 1.9 mp -106.55 108.02 24.13 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.473 0 N-CA-C 106.492 -1.669 . . . . 71.340000000000003 106.492 -178.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -104.15 143.7 32.58 Favored 'General case' 0 C--N 1.269 -2.905 0 CA-C-N 114.698 -1.137 . . . . 74.129999999999995 109.625 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -57.07 132.48 53.04 Favored 'General case' 0 C--O 1.249 1.068 0 N-CA-C 106.154 -1.795 . . . . 75.239999999999995 106.154 175.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 8.6 t . . . . . 0 C--O 1.245 0.826 0 O-C-N 124.18 0.925 . . . . 45.109999999999999 112.327 -169.11 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . 0.704 ' HA3' ' OG1' ' A' ' 528' ' ' THR . . . . . . . . 1 N--CA 1.394 -4.11 0 CA-C-O 121.593 0.552 . . . . 52.299999999999997 113.505 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 3.1 mp -119.18 126.81 75.68 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 CA-C-N 114.126 -1.037 . . . . 72.019999999999996 108.256 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -134.86 103.99 5.82 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 106.803 -1.555 . . . . 75.329999999999998 106.803 172.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 14.3 t -143.42 160.46 40.52 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 109.66 -0.496 . . . . 73.430000000000007 109.66 -173.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -81.58 153.13 26.88 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 107.171 -1.418 . . . . 74.25 107.171 173.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.02 -50.06 38.19 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.339 -0.985 . . . . 61.310000000000002 108.339 176.168 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -116.02 131.87 23.52 Favored Pre-proline 0 C--N 1.303 -1.431 0 CA-C-N 115.7 -0.682 . . . . 74.400000000000006 109.195 -178.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -83.81 -13.08 8.28 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.477 2.118 . . . . 63.43 112.127 178.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 511' ' ' VAL . . . . . 0.517 HG22 ' HB3' ' A' ' 643' ' ' GLU . 73.9 t -136.52 132.51 48.71 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.461 0 N-CA-C 107.873 -1.158 . . . . 54.43 107.873 178.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 3.8 t -138.61 140.95 39.15 Favored 'General case' 0 N--CA 1.396 -3.153 0 N-CA-C 107.666 -1.235 . . . . 63.119999999999997 107.666 177.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -109.17 137.79 46.52 Favored 'General case' 0 CA--C 1.479 -1.772 0 N-CA-C 107.474 -1.306 . . . . 73.109999999999999 107.474 176.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.649 HG11 ' SD ' ' A' ' 521' ' ' MET . 35.0 m -132.28 155.25 41.28 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.309 0 CA-C-O 121.518 0.675 . . . . 65.530000000000001 110.32 -176.1 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 515' ' ' SER . . . . . 0.425 ' HB2' ' HB ' ' A' ' 518' ' ' ILE . 19.3 m -68.61 141.27 55.47 Favored 'General case' 0 N--CA 1.393 -3.276 0 CA-C-N 113.665 -1.607 . . . . 74.230000000000004 107.877 176.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -73.79 -24.15 59.79 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 119.388 -0.925 . . . . 63.450000000000003 109.718 176.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 24.0 t -107.16 75.71 1.05 Allowed 'General case' 0 N--CA 1.415 -2.192 0 N-CA-C 107.876 -1.157 . . . . 73.200000000000003 107.876 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 518' ' ' ILE . . . . . 0.425 ' HB ' ' HB2' ' A' ' 515' ' ' SER . 17.1 tt -141.04 161.01 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.26 0 CA-C-N 113.766 -1.561 . . . . 62.140000000000001 106.813 176.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -96.15 -69.58 1.02 Allowed Glycine 0 N--CA 1.434 -1.46 0 C-N-CA 119.571 -1.3 . . . . 72.319999999999993 111.596 177.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 40.9 mm -116.24 134.57 59.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 109.361 -0.607 . . . . 74.209999999999994 109.361 -178.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 521' ' ' MET . . . . . 0.649 ' SD ' HG11 ' A' ' 514' ' ' VAL . 23.8 ptt? -114.29 138.74 50.12 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 106.934 -1.506 . . . . 73.430000000000007 106.934 171.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -117.07 132.66 56.63 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 108.837 -0.801 . . . . 64.5 108.837 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 523' ' ' VAL . . . . . 0.688 ' O ' ' HA ' ' A' ' 570' ' ' THR . 24.8 t -114.99 134.11 59.09 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 109.314 -0.625 . . . . 62.219999999999999 109.314 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 524' ' ' LYS . . . . . 0.43 ' HD2' HG21 ' A' ' 568' ' ' VAL . 33.0 mmtp -84.91 128.13 34.48 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 122.027 0.918 . . . . 75.030000000000001 113.1 -175.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 3.3 t -113.68 132.84 61.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 106.951 -1.5 . . . . 61.530000000000001 106.951 177.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -93.77 151.13 19.83 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 108.959 -0.756 . . . . 64.310000000000002 108.959 -177.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 527' ' ' ARG . . . . . 0.536 ' CZ ' HG22 ' A' ' 567' ' ' ILE . 68.9 mtm180 -87.02 179.31 6.71 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-O 122.018 0.913 . . . . 75.519999999999996 111.137 -179.068 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . 0.704 ' OG1' ' HA3' ' A' ' 503' ' ' GLY . 1.0 OUTLIER -78.16 159.71 28.44 Favored 'General case' 0 N--CA 1.408 -2.553 0 CA-C-N 113.796 -1.547 . . . . 62.340000000000003 109.766 176.21 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 17.0 t -74.73 -20.04 59.99 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 107.903 -1.147 . . . . 73.150000000000006 107.903 177.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -118.14 66.3 0.36 Allowed Glycine 0 N--CA 1.438 -1.199 0 N-CA-C 111.07 -0.812 . . . . 72.129999999999995 111.07 175.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 531' ' ' ALA . . . . . 0.403 ' O ' ' HD3' ' A' ' 532' ' ' ARG . . . -76.26 96.13 3.88 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.357 0.599 . . . . 72.310000000000002 111.565 -178.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . 0.403 ' HD3' ' O ' ' A' ' 531' ' ' ALA . 60.5 mmt-85 -134.56 127.68 31.77 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.47 -0.786 . . . . 71.319999999999993 109.984 178.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 93.77 175.66 39.81 Favored Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 121.087 -0.578 . . . . 74.329999999999998 113.642 176.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -95.87 123.22 39.36 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 107.936 -1.135 . . . . 74.450000000000003 107.936 177.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 56.4 t -127.96 131.95 69.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.761 0 N-CA-C 108.71 -0.848 . . . . 74.209999999999994 108.71 -178.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 536' ' ' ILE . . . . . . . . . . . . . 38.6 mm -103.77 129.28 56.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 108.739 -0.837 . . . . 50.149999999999999 108.739 178.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . 0.502 HG22 ' HB3' ' A' ' 594' ' ' PRO . 14.7 t -117.99 111.79 38.72 Favored Pre-proline 0 C--N 1.301 -1.506 0 N-CA-C 109.575 -0.528 . . . . 44.030000000000001 109.575 -178.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -73.98 150.87 44.19 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 121.714 1.609 . . . . 73.019999999999996 110.244 176.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 539' ' ' TYR . . . . . 0.476 ' CD1' ' HG ' ' A' ' 560' ' ' LEU . 48.3 p90 -150.85 157.71 43.25 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 109.119 -0.697 . . . . 74.439999999999998 109.119 179.1 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 540' ' ' LYS . . . . . 0.416 ' O ' ' HD3' ' A' ' 540' ' ' LYS . 0.1 OUTLIER -157.11 145.65 19.65 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 113.3 0.852 . . . . 72.230000000000004 113.3 -179.842 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 541' ' ' THR . . . . . 0.44 HG23 ' HB ' ' A' ' 556' ' ' THR . 2.9 p -76.26 134.08 39.9 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.4 -0.818 . . . . 75.340000000000003 111.074 171.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.2 mp -99.22 126.65 52.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 105.391 -2.077 . . . . 74.420000000000002 105.391 172.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . 0.417 ' H ' ' CD ' ' A' ' 543' ' ' GLU . 1.4 mp0 -48.78 -44.82 39.23 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.288 1.035 . . . . 70.450000000000003 113.06 -174.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 71.89 -100.28 0.91 Allowed Glycine 0 N--CA 1.437 -1.243 0 N-CA-C 110.036 -1.226 . . . . 50.340000000000003 110.036 -178.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 9.0 t -134.12 10.71 3.87 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.926 0.869 . . . . 73.409999999999997 109.37 176.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -85.16 168.06 15.15 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.858 -0.61 . . . . 74.329999999999998 110.027 177.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -85.91 166.83 15.65 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 107.74 -1.207 . . . . 63.439999999999998 107.74 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -57.39 174.75 1.91 Allowed Glycine 0 C--O 1.253 1.306 0 N-CA-C 115.705 1.042 . . . . 64.439999999999998 115.705 -176.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . -57.59 117.15 9.28 Favored Glycine 0 N--CA 1.437 -1.255 0 CA-C-N 114.217 -0.992 . . . . 55.32 113.783 -176.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 104.53 -15.06 50.13 Favored Glycine 0 N--CA 1.428 -1.859 0 N-CA-C 111.719 -0.552 . . . . 41.119999999999997 111.719 177.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -91.58 -63.65 1.22 Allowed 'General case' 0 CA--C 1.499 -1.009 0 CA-C-O 121.084 0.468 . . . . 74.519999999999996 110.422 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -107.39 -43.11 4.63 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.093 -0.958 . . . . 74.340000000000003 108.861 -176.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -133.79 155.83 49.1 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 107.313 -1.366 . . . . 75.519999999999996 107.313 175.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -85.17 128.98 34.88 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 105.532 -2.025 . . . . 71.140000000000001 105.532 177.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -54.78 108.47 0.4 Allowed 'General case' 0 CA--C 1.483 -1.627 0 O-C-N 123.474 0.484 . . . . 73.450000000000003 110.167 -177.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 556' ' ' THR . . . . . 0.44 ' HB ' HG23 ' A' ' 541' ' ' THR . 40.8 m -109.96 97.98 7.37 Favored 'General case' 1 N--CA 1.372 -4.326 0 C-N-CA 118.595 -1.242 . . . . 61.509999999999998 112.234 -175.453 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 24.2 p -137.1 134.25 36.26 Favored 'General case' 0 N--CA 1.418 -2.037 0 N-CA-C 107.399 -1.334 . . . . 70.129999999999995 107.399 174.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -176.83 -156.91 16.73 Favored Glycine 0 N--CA 1.418 -2.541 0 N-CA-C 110.08 -1.208 . . . . 72.530000000000001 110.08 -176.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -135.14 142.96 46.29 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.091 0.472 . . . . 75.310000000000002 110.978 -176.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 560' ' ' LEU . . . . . 0.516 HD13 ' HG2' ' A' ' 569' ' ' LYS . 93.6 mt -104.22 139.91 38.59 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.273 -0.876 . . . . 72.019999999999996 109.275 177.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -106.6 114.03 27.88 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 123.21 0.604 . . . . 71.430000000000007 110.784 -177.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 562' ' ' PHE . . . . . 0.554 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 36.3 m-85 -108.64 145.35 35.09 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 120.695 0.283 . . . . 75.230000000000004 110.386 173.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 563' ' ' GLN . . . . . 0.587 ' HB2' ' HB2' ' A' ' 566' ' ' GLU . 0.2 OUTLIER -131.79 177.27 7.65 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 105.769 -1.938 . . . . 71.439999999999998 105.769 175.33 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -75.98 -30.46 58.58 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 121.111 0.481 . . . . 50.240000000000002 109.962 178.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -94.03 -22.84 18.28 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.259 0.552 . . . . 62.219999999999999 110.996 -179.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 566' ' ' GLU . . . . . 0.587 ' HB2' ' HB2' ' A' ' 563' ' ' GLN . 2.3 tm-20 -84.25 119.52 25.14 Favored 'General case' 0 C--O 1.245 0.84 0 N-CA-C 107.019 -1.475 . . . . 74.450000000000003 107.019 -177.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 567' ' ' ILE . . . . . 0.536 HG22 ' CZ ' ' A' ' 527' ' ' ARG . 6.2 pt -108.51 161.97 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.143 0 C-N-CA 120.65 -0.42 . . . . 74.439999999999998 111.047 -175.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 568' ' ' VAL . . . . . 0.445 HG22 ' H ' ' A' ' 569' ' ' LYS . 2.4 p 47.68 174.66 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.11 0 C-N-CA 126.421 1.889 . . . . 72.340000000000003 113.231 -179.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 569' ' ' LYS . . . . . 0.644 ' HA ' ' HE3' ' A' ' 569' ' ' LYS . 0.2 OUTLIER -156.25 156.98 35.02 Favored 'General case' 0 C--N 1.289 -2.045 0 O-C-N 120.797 -1.189 . . . . 64.430000000000007 107.986 176.057 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 570' ' ' THR . . . . . 0.688 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 4.4 p -134.3 131.74 38.76 Favored 'General case' 0 N--CA 1.412 -2.361 0 O-C-N 123.999 0.812 . . . . 63.020000000000003 110.765 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 2.8 mp -91.3 113.39 26.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 106.728 -1.582 . . . . 72.200000000000003 106.728 170.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 2.6 p -93.85 120.17 33.75 Favored 'General case' 0 C--N 1.29 -2.021 0 O-C-N 123.677 0.61 . . . . 52.240000000000002 109.859 177.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 573' ' ' VAL . . . . . . . . . . . . . 49.1 t -123.38 135.77 62.18 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 108.549 -0.908 . . . . 55.439999999999998 108.549 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -93.45 124.05 37.17 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-O 121.403 0.621 . . . . 71.510000000000005 109.836 175.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 61.5 t -89.51 141.76 13.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 N-CA-C 106.755 -1.572 . . . . 54.509999999999998 106.755 176.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 32.9 mm -105.78 158.21 6.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 107.672 -1.232 . . . . 63.119999999999997 107.672 -178.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -67.22 137.46 56.21 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.228 -1.027 . . . . 74.209999999999994 108.228 177.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.85 158.97 34.51 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 112.295 0.48 . . . . 63.130000000000003 112.295 -172.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.21 -12.73 1.4 Allowed 'General case' 0 CA--C 1.558 1.263 0 N-CA-C 116.141 1.904 . . . . 72.340000000000003 116.141 -172.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 580' ' ' GLU . . . . . 0.491 ' HG2' ' O ' ' A' ' 581' ' ' TYR . 0.1 OUTLIER -127.02 -171.02 2.32 Favored 'General case' 0 C--N 1.317 -0.838 0 O-C-N 121.164 -0.96 . . . . 73.120000000000005 110.138 -177.167 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 581' ' ' TYR . . . . . 0.491 ' O ' ' HG2' ' A' ' 580' ' ' GLU . 46.2 p90 -63.74 152.51 39.09 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 107.931 -1.136 . . . . 73.540000000000006 107.931 174.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -120.89 132.95 55.26 Favored 'General case' 0 C--N 1.288 -2.099 0 C-N-CA 118.824 -1.15 . . . . 72.439999999999998 114.076 -174.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -129.38 -165.95 1.59 Allowed 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 105.562 -2.014 . . . . 73.329999999999998 105.562 176.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -65.52 105.06 1.11 Allowed 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 106.855 -1.535 . . . . 75.340000000000003 106.855 172.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 585' ' ' LYS . . . . . 0.481 ' HD2' HD13 ' A' ' 646' ' ' ILE . 4.2 tmmm? -115.38 117.66 31.06 Favored 'General case' 0 N--CA 1.403 -2.79 0 N-CA-C 107.709 -1.219 . . . . 75.310000000000002 107.709 -175.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 3.4 t -142.39 147.2 35.83 Favored 'General case' 0 N--CA 1.404 -2.74 0 CA-C-N 114.688 -1.142 . . . . 63.049999999999997 110.029 -176.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -129.25 148.56 51.19 Favored 'General case' 0 N--CA 1.405 -2.687 0 CA-C-N 113.857 -1.52 . . . . 51.350000000000001 108.232 176.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 588' ' ' PHE . . . . . 0.512 ' HA ' ' O ' ' A' ' 642' ' ' LEU . 23.0 m-85 -104.8 141.54 36.31 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 109.356 -0.609 . . . . 73.310000000000002 109.356 -173.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . 0.527 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.5 OUTLIER -110.26 126.07 53.78 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 105.813 -1.921 . . . . 54.350000000000001 105.813 174.285 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -134.26 123.09 23.68 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 109.455 -0.572 . . . . 74.409999999999997 109.455 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 591' ' ' ILE . . . . . 0.431 HG22 ' HB3' ' A' ' 539' ' ' TYR . 20.9 pt -79.14 149.49 5.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 N-CA-C 108.0 -1.111 . . . . 71.540000000000006 108.0 173.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -93.23 -142.76 12.05 Favored Glycine 0 N--CA 1.425 -2.086 0 C-N-CA 121.008 -0.615 . . . . 53.329999999999998 112.693 -176.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -93.41 117.88 67.48 Favored Pre-proline 0 C--N 1.3 -1.584 0 N-CA-C 108.636 -0.876 . . . . 70.510000000000005 108.636 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 594' ' ' PRO . . . . . 0.603 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 30.2 Cg_endo -65.69 143.75 75.57 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 121.969 1.78 . . . . 53.539999999999999 110.714 177.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -123.83 135.86 54.02 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.888 -0.508 . . . . 52.210000000000001 110.483 -176.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.58 124.81 28.86 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 107.892 -1.151 . . . . 70.5 107.892 -178.252 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 65.9 t . . . . . 0 C--N 1.305 -1.349 0 N-CA-C 112.574 0.583 . . . . 64.329999999999998 112.574 -176.078 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.5 -0.977 0 N-CA-C 106.739 -1.578 . . . . 70.329999999999998 106.739 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . 0.603 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 10.9 Cg_endo -76.7 135.66 16.28 Favored 'Trans proline' 0 N--CA 1.419 -2.866 0 N-CA-C 106.936 -1.986 . . . . 75.120000000000005 106.936 164.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 635' ' ' ILE . . . . . . . . . . . . 0.255 2.3 pp -118.71 170.12 8.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 114.001 1.112 . . . . 65.150000000000006 114.001 -178.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.07 164.98 25.94 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 114.898 -1.046 . . . . 53.43 112.051 -176.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -85.34 -114.68 0.77 Allowed Glycine 0 N--CA 1.441 -1.001 0 CA-C-N 115.284 -0.871 . . . . 72.420000000000002 112.942 -177.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -98.37 -68.72 0.79 Allowed 'General case' 0 N--CA 1.42 -1.928 0 C-N-CA 120.576 -0.45 . . . . 75.430000000000007 110.611 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 18.7 p80 -113.33 109.2 18.34 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 113.655 0.983 . . . . 73.319999999999993 113.655 -173.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 12.5 p -98.8 90.47 4.69 Favored 'General case' 0 N--CA 1.408 -2.54 0 N-CA-C 107.167 -1.42 . . . . 72.430000000000007 107.167 172.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -173.26 138.6 0.73 Allowed 'General case' 0 N--CA 1.424 -1.73 0 CA-C-N 114.393 -1.276 . . . . 73.439999999999998 107.685 -173.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 642' ' ' LEU . . . . . 0.549 ' CD2' HG21 ' A' ' 523' ' ' VAL . 42.1 tp -145.12 105.26 4.05 Favored 'General case' 0 C--N 1.274 -2.708 0 N-CA-C 107.494 -1.299 . . . . 61.130000000000003 107.494 173.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . 0.517 ' HB3' HG22 ' A' ' 511' ' ' VAL . 28.5 tt0 -92.87 100.5 12.95 Favored 'General case' 0 C--N 1.261 -3.248 0 N-CA-C 107.03 -1.47 . . . . 72.319999999999993 107.03 179.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 644' ' ' VAL . . . . . 0.531 HG21 ' HE1' ' A' ' 521' ' ' MET . 26.3 t -92.73 108.65 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.287 0 CA-C-N 115.792 -0.64 . . . . 60.119999999999997 109.396 -177.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 4.0 mp -94.05 118.42 39.94 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 N-CA-C 107.916 -1.142 . . . . 72.340000000000003 107.916 177.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 646' ' ' ILE . . . . . 0.488 ' N ' HD12 ' A' ' 646' ' ' ILE . 2.5 mp -104.46 112.17 36.97 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.451 0 N-CA-C 107.098 -1.445 . . . . 54.520000000000003 107.098 -175.177 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -115.45 149.35 38.18 Favored 'General case' 0 C--N 1.27 -2.863 0 C-N-CA 120.191 -0.604 . . . . 74.030000000000001 112.519 -177.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 23.1 tp10 -54.69 135.51 46.88 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.188 -1.369 . . . . 72.120000000000005 109.917 -177.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 C--O 1.237 0.403 0 O-C-N 124.209 0.943 . . . . 71.010000000000005 110.768 -176.856 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 12.1 t60 . . . . . 0 N--CA 1.45 -0.474 0 N-CA-C 108.875 -0.787 . . . . 72.109999999999999 108.875 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . 0.529 ' HB1' ' HA ' ' A' ' 634' ' ' PRO . . . 170.79 -70.4 0.0 OUTLIER 'General case' 0 CA--C 1.503 -0.839 0 C-N-CA 125.5 1.52 . . . . 74.010000000000005 107.635 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . 0.607 ' HA2' ' OG1' ' A' ' 528' ' ' THR . . . -161.3 142.79 8.32 Favored Glycine 0 N--CA 1.401 -3.667 0 CA-C-N 114.978 -1.01 . . . . 62.25 110.804 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . 0.412 ' H ' ' HA ' ' A' ' 528' ' ' THR . 3.7 mp -125.98 102.65 10.39 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 106.363 -1.718 . . . . 72.510000000000005 106.363 177.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -123.4 106.1 10.37 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 108.071 -1.085 . . . . 72.030000000000001 108.071 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 13.6 t -139.67 159.63 41.73 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 108.188 -1.041 . . . . 75.329999999999998 108.188 -176.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -84.64 153.6 23.05 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.429 -0.952 . . . . 63.229999999999997 108.429 175.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -77.53 -32.27 53.9 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.353 -0.98 . . . . 74.540000000000006 108.353 176.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -133.4 134.76 24.24 Favored Pre-proline 0 C--N 1.314 -0.942 0 N-CA-C 108.873 -0.788 . . . . 70.530000000000001 108.873 178.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -81.86 -16.54 8.81 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.401 2.067 . . . . 71.450000000000003 111.938 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . 0.461 HG22 ' HB3' ' A' ' 643' ' ' GLU . 69.7 t -136.61 131.96 48.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 107.824 -1.176 . . . . 64.329999999999998 107.824 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 6.3 t -133.93 139.61 46.24 Favored 'General case' 0 N--CA 1.406 -2.633 0 N-CA-C 108.501 -0.926 . . . . 75.230000000000004 108.501 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -109.46 124.43 51.04 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 109.737 -0.468 . . . . 75.209999999999994 109.737 178.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 15.5 m -127.13 157.55 38.58 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 107.905 -1.146 . . . . 62.039999999999999 107.905 -178.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 35.5 t -82.13 156.4 24.52 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 109.541 -0.54 . . . . 74.349999999999994 109.541 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -83.4 -7.94 59.48 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.26 -1.015 . . . . 63.130000000000003 108.26 174.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 14.0 t -98.78 15.71 24.52 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 115.688 -0.687 . . . . 63.229999999999997 109.298 -177.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 12.7 tt -99.62 161.47 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 N-CA-C 108.915 -0.772 . . . . 74.120000000000005 108.915 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . -94.9 -70.69 1.09 Allowed Glycine 0 N--CA 1.43 -1.753 0 N-CA-C 110.554 -1.018 . . . . 71.099999999999994 110.554 176.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 36.7 mm -114.73 126.24 72.24 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 C-N-CA 123.006 0.522 . . . . 74.510000000000005 109.668 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 521' ' ' MET . . . . . 0.701 ' HE2' HG21 ' A' ' 644' ' ' VAL . 0.0 OUTLIER -104.55 140.06 38.54 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.768 -1.197 . . . . 75.409999999999997 107.768 173.431 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -124.73 137.6 54.33 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 123.777 0.673 . . . . 73.400000000000006 111.021 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . 0.72 HG21 HD21 ' A' ' 642' ' ' LEU . 45.7 t -122.99 137.45 56.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 109.048 -0.723 . . . . 44.350000000000001 109.048 -179.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -80.92 131.72 35.37 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.66 0.743 . . . . 74.439999999999998 112.927 -177.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 6.7 t -114.76 134.39 57.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 CA-C-N 114.327 -1.306 . . . . 71.450000000000003 107.873 177.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -86.94 139.49 30.56 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.238 -1.023 . . . . 73.120000000000005 108.238 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . 0.417 ' CZ ' HG22 ' A' ' 567' ' ' ILE . 31.7 ttp180 -93.95 158.59 15.56 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 116.202 -0.454 . . . . 73.319999999999993 110.514 -173.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . 0.607 ' OG1' ' HA2' ' A' ' 503' ' ' GLY . 5.1 t -56.38 145.82 26.12 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.746 -0.661 . . . . 71.319999999999993 111.448 176.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 23.8 t -81.61 -12.74 58.62 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 108.79 -0.818 . . . . 75.239999999999995 108.79 178.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -109.02 52.94 0.61 Allowed Glycine 0 N--CA 1.429 -1.767 0 N-CA-C 109.592 -1.403 . . . . 72.420000000000002 109.592 177.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -82.83 95.49 7.94 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-O 121.591 0.71 . . . . 74.420000000000002 109.129 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -133.78 25.02 4.01 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 114.854 -1.066 . . . . 73.430000000000007 111.665 -178.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 175.76 -169.5 42.21 Favored Glycine 0 N--CA 1.416 -2.644 0 C-N-CA 120.097 -1.049 . . . . 41.32 111.141 -174.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 534' ' ' ASN . . . . . 0.485 HD21 ' HG3' ' A' ' 561' ' ' GLU . 2.7 t-20 -102.23 121.85 43.06 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 122.887 0.475 . . . . 61.200000000000003 110.822 -176.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 535' ' ' VAL . . . . . 0.437 HG22 HD22 ' A' ' 596' ' ' LEU . 79.6 t -125.53 135.73 63.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 123.403 0.681 . . . . 63.310000000000002 109.651 -178.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 536' ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' A' ' 594' ' ' PRO . 22.8 mm -101.18 129.17 52.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 115.881 -0.6 . . . . 70.019999999999996 109.874 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . 0.473 HG22 ' HB3' ' A' ' 594' ' ' PRO . 33.2 t -122.15 105.57 36.95 Favored Pre-proline 0 C--N 1.319 -0.751 0 N-CA-C 108.715 -0.846 . . . . 64.510000000000005 108.715 176.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . 0.409 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 55.8 Cg_endo -73.01 152.05 50.93 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.068 1.845 . . . . 62.219999999999999 110.828 177.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 539' ' ' TYR . . . . . 0.455 ' O ' ' HA ' ' A' ' 557' ' ' CYS . 50.9 p90 -147.38 157.88 43.75 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.409 -0.589 . . . . 65.040000000000006 109.409 178.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -149.52 155.43 40.33 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 120.979 0.419 . . . . 62.219999999999999 111.17 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 10.4 p -96.4 113.39 24.97 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.062 -0.972 . . . . 63.240000000000002 110.871 176.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.403 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 3.6 mp -83.0 115.62 25.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 105.517 -2.031 . . . . 72.310000000000002 105.517 173.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . 0.453 ' HB3' ' O ' ' A' ' 546' ' ' ALA . 47.8 mt-10 -53.5 -49.84 66.66 Favored 'General case' 0 C--N 1.32 -0.686 0 O-C-N 124.156 0.91 . . . . 75.540000000000006 112.667 -174.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 70.26 -101.67 0.92 Allowed Glycine 0 N--CA 1.44 -1.098 0 C-N-CA 120.522 -0.847 . . . . 70.519999999999996 111.259 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 545' ' ' THR . . . . . 0.422 HG23 ' HB2' ' A' ' 585' ' ' LYS . 8.8 t -113.62 0.23 14.55 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.869 0.842 . . . . 62.210000000000001 109.295 178.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . 0.503 ' HB2' ' HG2' ' A' ' 585' ' ' LYS . . . -95.33 170.98 9.0 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 108.132 -1.062 . . . . 73.239999999999995 108.132 175.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . 0.483 ' H ' ' HB3' ' A' ' 552' ' ' ASP . 9.6 tpt180 -130.46 122.72 28.23 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 118.012 0.369 . . . . 64.099999999999994 110.189 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 548' ' ' GLY . . . . . 0.419 ' HA3' ' HB3' ' A' ' 555' ' ' ASP . . . -82.48 -166.4 38.46 Favored Glycine 0 C--N 1.306 -1.135 0 CA-C-N 116.01 -0.541 . . . . 61.439999999999998 111.868 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 78.83 13.93 82.58 Favored Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 120.948 -0.644 . . . . 62.130000000000003 112.587 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 84.37 13.92 72.45 Favored Glycine 0 N--CA 1.435 -1.373 0 C-N-CA 120.212 -0.994 . . . . 63.229999999999997 111.891 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -79.81 -69.92 0.55 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.4 0.619 . . . . 73.519999999999996 109.982 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . 0.633 ' OD2' 'CA ' ' A' ' 850' ' ' ' CA' . 8.4 t70 -109.41 -35.05 6.36 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 107.692 -1.225 . . . . 70.439999999999998 107.692 -176.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 553' ' ' PHE . . . . . 0.439 ' HA ' HG12 ' A' ' 576' ' ' ILE . 14.7 p90 -145.54 164.06 32.81 Favored 'General case' 0 N--CA 1.423 -1.817 0 CA-C-N 115.096 -0.956 . . . . 75.030000000000001 108.544 173.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . 0.463 ' HB3' ' HB3' ' A' ' 574' ' ' LYS . 1.0 OUTLIER -95.45 106.82 18.93 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 105.477 -2.046 . . . . 63.43 105.477 179.082 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 555' ' ' ASP . . . . . 0.419 ' HB3' ' HA3' ' A' ' 548' ' ' GLY . 3.4 p-10 -72.62 149.53 43.83 Favored 'General case' 0 CA--C 1.49 -1.333 0 CA-C-N 116.093 -0.503 . . . . 71.150000000000006 110.095 -174.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 5.6 t -139.57 131.6 27.9 Favored 'General case' 0 N--CA 1.403 -2.779 0 CA-C-O 121.669 0.747 . . . . 63.43 111.274 -177.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 557' ' ' CYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 539' ' ' TYR . 12.5 p -142.38 104.91 4.49 Favored 'General case' 0 N--CA 1.418 -2.037 0 N-CA-C 107.541 -1.281 . . . . 72.420000000000002 107.541 175.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -151.11 -149.33 5.02 Favored Glycine 0 N--CA 1.408 -3.171 0 N-CA-C 109.867 -1.293 . . . . 73.219999999999999 109.867 -176.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 559' ' ' GLU . . . . . 0.442 ' HB3' HG23 ' A' ' 536' ' ' ILE . 52.2 mt-10 -136.94 133.44 35.66 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 120.858 0.361 . . . . 73.510000000000005 110.715 -173.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . 0.455 HD22 ' CG ' ' A' ' 569' ' ' LYS . 92.1 mt -93.45 123.16 36.56 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.979 -1.119 . . . . 74.400000000000006 107.979 173.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 561' ' ' GLU . . . . . 0.485 ' HG3' HD21 ' A' ' 534' ' ' ASN . 43.1 tt0 -97.89 113.53 25.38 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 116.097 -0.501 . . . . 51.409999999999997 110.136 -177.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -103.99 144.36 31.64 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 109.639 -0.504 . . . . 61.43 109.639 176.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . 0.499 ' HB2' ' H ' ' A' ' 566' ' ' GLU . 42.7 mt-30 -136.56 179.85 6.11 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.059 -1.089 . . . . 74.329999999999998 108.059 -178.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 31.6 t30 -73.73 -34.77 64.93 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.669 -0.863 . . . . 64.010000000000005 108.669 176.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -87.64 -36.34 17.52 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 114.969 -1.014 . . . . 71.219999999999999 111.397 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . 0.499 ' H ' ' HB2' ' A' ' 563' ' ' GLN . 10.5 tp10 -77.33 117.08 18.48 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.77 -0.826 . . . . 74.219999999999999 108.77 178.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 567' ' ' ILE . . . . . 0.417 HG22 ' CZ ' ' A' ' 527' ' ' ARG . 6.5 pt -109.2 163.39 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.143 0 N-CA-C 109.317 -0.623 . . . . 63.219999999999999 109.317 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 568' ' ' VAL . . . . . 0.488 HG22 ' H ' ' A' ' 569' ' ' LYS . 2.3 p 44.49 -171.73 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.569 1.699 0 C-N-CA 125.543 1.537 . . . . 72.549999999999997 111.821 -177.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 569' ' ' LYS . . . . . 0.534 ' HA ' ' HE2' ' A' ' 569' ' ' LYS . 0.0 OUTLIER -173.3 158.41 3.56 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 107.142 -1.429 . . . . 75.209999999999994 107.142 174.78 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 570' ' ' THR . . . . . 0.604 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 24.1 p -134.37 137.73 44.33 Favored 'General case' 0 N--CA 1.423 -1.796 0 O-C-N 123.744 0.652 . . . . 71.340000000000003 109.316 175.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 571' ' ' ILE . . . . . 0.464 HG22 HG23 ' A' ' 573' ' ' VAL . 2.9 mp -88.29 114.31 26.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 106.148 -1.797 . . . . 72.519999999999996 106.148 171.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 9.4 p -95.81 111.88 23.75 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 123.215 0.322 . . . . 52.439999999999998 110.429 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 573' ' ' VAL . . . . . 0.464 HG23 HG22 ' A' ' 571' ' ' ILE . 46.9 t -118.82 137.69 51.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.33 -0.618 . . . . 74.519999999999996 109.33 -178.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 574' ' ' LYS . . . . . 0.463 ' HB3' ' HB3' ' A' ' 554' ' ' GLU . 38.7 ttmt -95.71 130.65 42.55 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 123.926 0.767 . . . . 72.239999999999995 110.218 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 58.9 t -95.76 143.63 11.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 107.852 -1.166 . . . . 73.140000000000001 107.852 176.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 576' ' ' ILE . . . . . 0.439 HG12 ' HA ' ' A' ' 553' ' ' PHE . 28.9 mm -112.16 161.12 11.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 108.154 -1.054 . . . . 72.030000000000001 108.154 -177.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -77.68 144.43 37.35 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.021 -0.733 . . . . 55.399999999999999 109.021 176.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 578' ' ' ASP . . . . . 0.611 ' OD2' 'CA ' ' A' ' 800' ' ' ' CA' . 3.2 m-20 -57.89 136.9 57.09 Favored 'General case' 0 CA--C 1.484 -1.562 0 N-CA-C 115.453 1.649 . . . . 74.239999999999995 115.453 -174.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 5.6 pm0 -107.06 -26.01 11.33 Favored 'General case' 0 N--CA 1.421 -1.876 0 CA-C-N 113.413 -1.721 . . . . 63.439999999999998 112.38 -176.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 580' ' ' GLU . . . . . 0.425 ' HG2' ' CD2' ' A' ' 581' ' ' TYR . 0.1 OUTLIER -110.38 -69.26 0.88 Allowed 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 112.753 0.649 . . . . 72.329999999999998 112.753 -170.002 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 581' ' ' TYR . . . . . 0.425 ' CD2' ' HG2' ' A' ' 580' ' ' GLU . 32.1 p90 -162.35 153.71 18.03 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 104.422 -2.436 . . . . 74.099999999999994 104.422 -176.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 582' ' ' GLU . . . . . 0.603 ' OE1' 'CA ' ' A' ' 800' ' ' ' CA' . 20.3 mt-10 -102.98 136.6 42.5 Favored 'General case' 0 C--N 1.274 -2.708 0 C-N-CA 117.604 -1.638 . . . . 73.109999999999999 115.23 -172.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 12.8 ptpt -153.62 167.06 30.82 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 113.239 -1.801 . . . . 74.030000000000001 106.177 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -86.52 123.4 31.69 Favored 'General case' 0 CA--C 1.488 -1.431 0 N-CA-C 105.656 -1.979 . . . . 71.040000000000006 105.656 169.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 585' ' ' LYS . . . . . 0.503 ' HG2' ' HB2' ' A' ' 546' ' ' ALA . 0.0 OUTLIER -121.66 173.67 7.3 Favored 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 108.691 -0.855 . . . . 72.540000000000006 108.691 -171.592 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 8.6 t -153.61 146.77 24.66 Favored 'General case' 0 N--CA 1.428 -1.531 0 C-N-CA 120.042 -0.663 . . . . 63.299999999999997 111.774 -174.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -130.96 149.8 52.41 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-N 114.237 -1.347 . . . . 73.099999999999994 109.891 177.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 588' ' ' PHE . . . . . 0.404 ' HA ' ' O ' ' A' ' 642' ' ' LEU . 25.7 m-85 -104.06 133.36 49.13 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.094 -0.706 . . . . 74.109999999999999 109.094 -176.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . 0.506 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.4 OUTLIER -106.01 123.77 48.52 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 105.895 -1.891 . . . . 70.430000000000007 105.895 175.845 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -130.71 145.66 51.99 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 107.615 -1.254 . . . . 73.129999999999995 107.615 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 591' ' ' ILE . . . . . 0.412 HG22 ' HB3' ' A' ' 539' ' ' TYR . 27.5 pt -106.05 152.48 7.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 108.934 -0.765 . . . . 71.230000000000004 108.934 178.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -97.97 -150.51 26.37 Favored Glycine 0 N--CA 1.429 -1.802 0 C-N-CA 120.792 -0.718 . . . . 64.150000000000006 112.873 -177.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.448 ' CB ' ' HA ' ' A' ' 617' ' ' PRO . 1.4 tm-20 -79.49 121.3 82.55 Favored Pre-proline 0 C--N 1.297 -1.681 0 C-N-CA 123.589 0.756 . . . . 71.400000000000006 111.426 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 594' ' ' PRO . . . . . 0.496 ' HA ' ' O ' ' A' ' 536' ' ' ILE . 68.7 Cg_endo -81.33 145.9 15.3 Favored 'Trans proline' 0 N--CA 1.43 -2.231 0 C-N-CA 121.817 1.678 . . . . 71.439999999999998 110.083 176.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 595' ' ' ARG . . . . . 0.416 ' HB3' ' OE2' ' A' ' 593' ' ' GLU . 14.2 ptp180 -136.7 143.75 43.53 Favored 'General case' 0 C--N 1.273 -2.733 0 CA-C-N 116.286 -0.416 . . . . 72.420000000000002 109.991 -177.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 596' ' ' LEU . . . . . 0.437 HD22 HG22 ' A' ' 535' ' ' VAL . 0.0 OUTLIER -77.25 126.83 31.57 Favored 'General case' 0 N--CA 1.416 -2.155 0 N-CA-C 106.001 -1.851 . . . . 72.310000000000002 106.001 179.469 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 43.6 t -71.61 -38.19 66.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 107.855 -1.165 . . . . 64.010000000000005 107.855 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -87.13 95.89 10.11 Favored 'General case' 0 N--CA 1.417 -2.104 0 N-CA-C 106.311 -1.737 . . . . 65.439999999999998 106.311 174.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 24.0 ptm -71.03 110.71 5.89 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.381 0.61 . . . . 54.210000000000001 111.285 -175.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 13.5 m -56.48 123.33 14.39 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 124.421 1.089 . . . . 62.210000000000001 111.444 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -85.81 90.6 8.09 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 108.696 -0.853 . . . . 73.230000000000004 108.696 177.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -88.69 121.88 31.53 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 106.349 -1.723 . . . . 72.129999999999995 106.349 178.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -79.68 86.71 5.26 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.241 0.543 . . . . 74.409999999999997 111.767 -173.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -87.76 -37.76 7.82 Favored Glycine 0 N--CA 1.432 -1.6 0 N-CA-C 109.486 -1.446 . . . . 42.439999999999998 109.486 175.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 120.03 -178.33 16.48 Favored Glycine 0 N--CA 1.426 -2.015 0 N-CA-C 111.357 -0.697 . . . . 63.039999999999999 111.357 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -68.54 122.95 19.54 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 109.97 -0.381 . . . . 73.510000000000005 109.97 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 5.8 p -129.53 154.4 47.07 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 115.998 -0.547 . . . . 74.409999999999997 109.973 176.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 52.3 mt -78.99 134.48 27.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 108.757 -0.831 . . . . 73.530000000000001 108.757 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 11.4 m 67.01 82.1 0.19 Allowed 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 124.463 1.105 . . . . 62.140000000000001 111.913 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -118.41 89.32 3.1 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.504 -1.295 . . . . 74.450000000000003 107.504 173.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -121.6 -176.56 3.34 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 114.557 -1.201 . . . . 70.439999999999998 108.39 -174.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -85.74 81.32 8.65 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 119.571 -0.852 . . . . 74.209999999999994 110.77 173.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -103.71 -141.04 0.36 Allowed 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 104.053 -2.573 . . . . 52.0 104.053 174.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 32.8 t70 64.29 20.02 12.01 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 122.416 1.103 . . . . 50.030000000000001 110.539 175.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 615' ' ' LYS . . . . . 0.456 ' HD3' ' H ' ' A' ' 615' ' ' LYS . 0.0 OUTLIER -84.05 -9.53 58.55 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-N 114.562 -1.199 . . . . 74.129999999999995 111.545 -175.074 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -78.16 140.05 61.16 Favored Pre-proline 0 C--N 1.307 -1.276 0 N-CA-C 109.272 -0.64 . . . . 52.509999999999998 109.272 178.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 617' ' ' PRO . . . . . 0.448 ' HA ' ' CB ' ' A' ' 593' ' ' GLU . 44.1 Cg_endo -71.39 -159.64 0.07 OUTLIER 'Trans proline' 0 C--O 1.247 0.968 0 C-N-CA 122.336 2.024 . . . . 70.530000000000001 111.175 178.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.462 HD22 ' H ' ' A' ' 618' ' ' LEU . 2.2 mm? -69.55 100.31 1.41 Allowed 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 107.044 -1.465 . . . . 65.129999999999995 107.044 178.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 5.4 p -141.57 7.27 1.91 Allowed 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 113.887 1.069 . . . . 74.530000000000001 113.887 -171.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 620' ' ' SER . . . . . 0.442 ' HB3' ' HB3' ' A' ' 626' ' ' ARG . 17.1 p -73.48 85.04 1.52 Allowed 'General case' 0 N--CA 1.437 -1.077 0 CA-C-O 122.539 1.161 . . . . 61.030000000000001 111.866 -179.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 621' ' ' LYS . . . . . 0.418 ' HB2' ' NZ ' ' A' ' 621' ' ' LYS . 4.7 ttmp? -108.9 -40.77 4.93 Favored 'General case' 0 N--CA 1.426 -1.652 0 CA-C-N 114.407 -1.269 . . . . 73.109999999999999 110.044 -174.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -118.84 -25.92 6.19 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.477 0.656 . . . . 62.210000000000001 109.58 178.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . 0.426 ' H ' ' CD ' ' A' ' 623' ' ' GLU . 0.7 OUTLIER -85.57 109.27 18.41 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-N 115.139 -0.937 . . . . 65.510000000000005 109.367 176.792 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -83.27 -27.74 29.63 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 115.58 -0.736 . . . . 64.239999999999995 110.635 -176.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -68.31 -30.58 69.61 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 111.952 0.353 . . . . 75.319999999999993 111.952 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . 0.442 ' HB3' ' HB3' ' A' ' 620' ' ' SER . 0.0 OUTLIER -70.03 -22.3 63.11 Favored 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 108.175 -1.046 . . . . 71.049999999999997 108.175 179.594 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 627' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -65.96 -29.59 70.01 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.146 -0.479 . . . . 62.119999999999997 110.413 178.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 86.1 mt -62.21 -45.28 99.11 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 N-CA-C 109.2 -0.667 . . . . 72.439999999999998 109.2 177.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 629' ' ' ALA . . . . . 0.635 ' O ' ' HG3' ' A' ' 633' ' ' ARG . . . -66.84 -45.36 78.45 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-N 115.009 -0.996 . . . . 73.109999999999999 110.242 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -65.15 -20.37 66.42 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.031 0.443 . . . . 73.209999999999994 111.855 -178.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 631' ' ' MET . . . . . . . . . . . . . 45.7 ttm -74.65 -28.47 60.87 Favored 'General case' 0 N--CA 1.427 -1.624 0 C-N-CA 123.362 0.665 . . . . 73.219999999999999 109.86 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -96.2 5.98 65.92 Favored Glycine 0 CA--C 1.508 -0.374 0 CA-C-N 115.742 -0.663 . . . . 21.25 111.66 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 633' ' ' ARG . . . . . 0.635 ' HG3' ' O ' ' A' ' 629' ' ' ALA . 6.3 mtp-105 -116.63 163.44 22.32 Favored Pre-proline 0 C--N 1.303 -1.445 0 N-CA-C 107.412 -1.329 . . . . 73.200000000000003 107.412 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.529 ' HA ' ' HB1' ' A' ' 502' ' ' ALA . 24.6 Cg_endo -76.1 155.76 37.99 Favored 'Trans proline' 0 N--CA 1.438 -1.776 0 C-N-CA 120.856 1.038 . . . . 64.319999999999993 110.07 168.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 635' ' ' ILE . . . . . 0.464 HD13 ' H ' ' A' ' 635' ' ' ILE . 0.2 OUTLIER -136.68 -173.54 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 107.798 -1.186 . . . . 53.0 107.798 179.438 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . 0.552 ' H ' HD13 ' A' ' 636' ' ' LEU . 0.0 OUTLIER -87.29 -179.77 6.47 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 123.291 0.37 . . . . 65.319999999999993 111.622 -178.93 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -99.69 -125.18 5.4 Favored Glycine 0 N--CA 1.438 -1.188 0 CA-C-N 116.175 -0.466 . . . . 23.32 113.983 -176.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -84.54 -71.4 0.52 Allowed 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 112.41 0.522 . . . . 75.420000000000002 112.41 -177.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -117.67 107.94 14.82 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 122.466 1.127 . . . . 64.329999999999998 112.436 -174.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 640' ' ' THR . . . . . 0.404 HG21 ' HB2' ' A' ' 636' ' ' LEU . 3.6 p -108.19 92.05 3.9 Favored 'General case' 0 N--CA 1.404 -2.747 0 CA-C-N 114.269 -1.332 . . . . 65.200000000000003 109.855 177.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 641' ' ' LYS . . . . . 0.454 ' HE2' ' HB2' ' A' ' 643' ' ' GLU . 1.2 tmtp? -178.33 129.44 0.13 Allowed 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 104.826 -2.287 . . . . 75.030000000000001 104.826 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 642' ' ' LEU . . . . . 0.72 HD21 HG21 ' A' ' 523' ' ' VAL . 42.6 tp -132.37 114.52 14.46 Favored 'General case' 0 C--N 1.274 -2.681 0 N-CA-C 108.692 -0.855 . . . . 71.549999999999997 108.692 177.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . 0.461 ' HB3' HG22 ' A' ' 511' ' ' VAL . 22.5 tt0 -99.05 104.81 16.87 Favored 'General case' 0 C--N 1.273 -2.734 0 N-CA-C 107.069 -1.456 . . . . 63.130000000000003 107.069 178.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 644' ' ' VAL . . . . . 0.701 HG21 ' HE2' ' A' ' 521' ' ' MET . 33.7 t -92.94 105.12 16.42 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 N-CA-C 108.551 -0.907 . . . . 75.400000000000006 108.551 -179.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 3.9 mp -88.94 115.08 28.16 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 N-CA-C 107.469 -1.308 . . . . 71.239999999999995 107.469 175.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 646' ' ' ILE . . . . . 0.468 ' N ' HD12 ' A' ' 646' ' ' ILE . 2.9 mp -95.48 106.43 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.453 0 N-CA-C 105.383 -2.08 . . . . 64.430000000000007 105.383 -178.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -97.95 132.15 43.78 Favored 'General case' 0 N--CA 1.399 -3.017 0 CA-C-N 115.249 -0.887 . . . . 64.329999999999998 109.275 -178.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . 0.647 ' OE1' 'CA ' ' A' ' 800' ' ' ' CA' . 15.2 tt0 -67.32 144.29 55.94 Favored 'General case' 0 N--CA 1.408 -2.527 0 N-CA-C 107.878 -1.156 . . . . 74.140000000000001 107.878 -177.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 23.1 t -49.5 118.73 2.93 Favored 'General case' 0 N--CA 1.444 -0.748 0 O-C-N 124.442 1.089 . . . . 73.109999999999999 113.342 -170.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -141.42 -68.35 0.39 Allowed 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 114.14 -1.391 . . . . 72.099999999999994 107.509 176.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 173.85 152.93 0.1 Allowed 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 104.569 -2.382 . . . . 73.030000000000001 104.569 -178.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -95.95 163.51 13.11 Favored 'General case' 0 C--N 1.265 -3.069 0 N-CA-C 108.923 -0.769 . . . . 71.299999999999997 108.923 -174.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt 75.44 6.25 4.06 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.938 1.295 . . . . 73.109999999999999 110.739 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 25.3 p -84.39 -43.88 14.27 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 115.335 -0.848 . . . . 65.329999999999998 109.608 -178.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 2.3 m -83.86 88.36 7.11 Favored 'General case' 0 N--CA 1.42 -1.955 0 N-CA-C 109.095 -0.705 . . . . 73.109999999999999 109.095 178.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 7.5 p -107.73 128.12 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.834 0 CA-C-N 115.468 -0.787 . . . . 73.430000000000007 109.726 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 10.0 t70 . . . . . 0 C--O 1.262 1.754 0 CA-C-N 115.621 -0.718 . . . . 63.43 109.804 -179.791 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 800' ' ' ' CA' . . . . . 0.647 'CA ' ' OE1' ' A' ' 648' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 850' ' ' ' CA' . . . . . 0.633 'CA ' ' OD2' ' A' ' 552' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 7.6 t60 . . . . . 0 N--CA 1.446 -0.629 0 N-CA-C 107.575 -1.268 . . . . 61.539999999999999 107.575 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -155.93 -39.38 0.08 Allowed 'General case' 0 C--N 1.308 -1.238 0 O-C-N 123.559 0.537 . . . . 41.130000000000003 109.79 178.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . 0.662 ' HA2' ' OG1' ' A' ' 528' ' ' THR . . . -174.55 131.84 2.09 Favored Glycine 0 N--CA 1.415 -2.735 0 C-N-CA 120.676 -0.773 . . . . 54.439999999999998 111.787 178.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . 0.413 ' H ' ' CB ' ' A' ' 528' ' ' THR . 4.1 mp -119.23 113.97 43.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 107.436 -1.32 . . . . 74.329999999999998 107.436 177.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -123.94 119.74 30.47 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 109.228 -0.656 . . . . 64.099999999999994 109.228 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 14.8 t -148.54 167.54 25.11 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.78 -0.452 . . . . 74.530000000000001 109.78 -174.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -99.66 162.33 13.08 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 107.441 -1.318 . . . . 75.439999999999998 107.441 173.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . 0.436 ' HG3' HD21 ' A' ' 526' ' ' LEU . 0.0 OUTLIER -103.18 -24.39 13.57 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.203 0.525 . . . . 75.299999999999997 111.314 176.245 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -116.66 122.96 30.98 Favored Pre-proline 0 N--CA 1.436 -1.152 0 N-CA-C 108.382 -0.97 . . . . 74.0 108.382 171.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -80.71 -9.96 13.17 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 121.961 1.774 . . . . 74.310000000000002 111.48 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . 0.435 HG22 ' HB3' ' A' ' 643' ' ' GLU . 75.3 t -141.28 135.96 32.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 107.521 -1.289 . . . . 74.439999999999998 107.521 -178.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 5.6 t -136.68 146.71 46.22 Favored 'General case' 0 N--CA 1.41 -2.439 0 N-CA-C 108.005 -1.109 . . . . 74.239999999999995 108.005 177.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -116.69 131.3 56.99 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.429 -0.582 . . . . 75.109999999999999 109.429 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 22.3 m -127.26 160.87 35.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 CA-C-N 115.762 -0.654 . . . . 73.129999999999995 109.753 -175.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 71.1 m -75.73 153.03 37.32 Favored 'General case' 0 N--CA 1.403 -2.803 0 CA-C-N 114.72 -1.127 . . . . 71.239999999999995 108.083 175.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -88.36 -24.8 23.01 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.054 -1.058 . . . . 63.350000000000001 111.121 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 23.3 t -102.6 70.16 1.12 Allowed 'General case' 0 N--CA 1.419 -1.982 0 N-CA-C 107.862 -1.162 . . . . 72.430000000000007 107.862 176.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 18.8 tt -135.85 152.47 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.503 0 N-CA-C 106.73 -1.582 . . . . 73.140000000000001 106.73 176.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -84.93 -59.21 2.0 Allowed Glycine 0 C--N 1.287 -2.154 0 C-N-CA 120.239 -0.982 . . . . 71.310000000000002 111.667 -178.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 36.5 mm -125.98 126.01 69.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 109.486 -0.561 . . . . 73.140000000000001 109.486 -178.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 521' ' ' MET . . . . . 0.741 ' HE1' HG21 ' A' ' 644' ' ' VAL . 0.0 OUTLIER -101.6 134.88 44.05 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 106.38 -1.711 . . . . 43.240000000000002 106.38 171.721 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -121.49 137.54 54.68 Favored 'General case' 0 C--N 1.308 -1.206 0 O-C-N 123.68 0.613 . . . . 72.140000000000001 110.523 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . 0.679 HG21 HD21 ' A' ' 642' ' ' LEU . 41.7 t -121.1 138.26 52.12 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 N-CA-C 108.119 -1.067 . . . . 63.299999999999997 108.119 179.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . 0.571 ' HD2' HG21 ' A' ' 568' ' ' VAL . 29.1 mmtp -88.16 116.07 26.1 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.867 0.841 . . . . 72.019999999999996 111.84 -176.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 22.9 t -97.19 135.62 30.77 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 CA-C-N 114.545 -1.207 . . . . 73.129999999999995 109.178 -178.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . 0.436 HD21 ' HG3' ' A' ' 508' ' ' GLU . 2.5 mm? -79.68 138.86 37.49 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 123.687 0.617 . . . . 63.43 109.804 -178.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . 0.508 ' HG2' ' N ' ' A' ' 528' ' ' THR . 50.5 ttp180 -86.29 160.28 19.18 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.274 -1.01 . . . . 72.209999999999994 108.274 178.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . 0.662 ' OG1' ' HA2' ' A' ' 503' ' ' GLY . 5.3 t -65.43 146.76 54.48 Favored 'General case' 0 N--CA 1.412 -2.347 0 CA-C-N 115.657 -0.701 . . . . 74.25 110.388 172.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 38.0 t -62.37 -46.36 88.99 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-N 114.963 -1.017 . . . . 71.150000000000006 109.042 175.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -114.1 117.28 4.09 Favored Glycine 0 N--CA 1.415 -2.743 0 N-CA-C 109.914 -1.274 . . . . 64.420000000000002 109.914 -177.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . 0.432 ' HB2' HG23 ' A' ' 528' ' ' THR . . . -131.69 119.93 22.06 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 109.372 -0.603 . . . . 70.519999999999996 109.372 178.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -114.94 74.96 0.9 Allowed 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.559 -0.534 . . . . 75.540000000000006 109.559 175.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 533' ' ' GLY . . . . . 0.446 ' H ' ' HB3' ' A' ' 564' ' ' ASN . . . 124.92 -143.39 14.54 Favored Glycine 0 N--CA 1.433 -1.528 0 C-N-CA 120.38 -0.915 . . . . 52.119999999999997 112.628 177.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 534' ' ' ASN . . . . . 0.482 HD21 ' HG3' ' A' ' 561' ' ' GLU . 2.8 t-20 -114.25 134.01 55.24 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.031 -0.729 . . . . 72.109999999999999 109.031 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 535' ' ' VAL . . . . . 0.528 HG22 HD22 ' A' ' 596' ' ' LEU . 59.3 t -126.45 131.45 71.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 109.458 -0.571 . . . . 65.120000000000005 109.458 -178.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 536' ' ' ILE . . . . . . . . . . . . . 39.7 mm -98.89 125.92 52.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 109.061 -0.718 . . . . 61.310000000000002 109.061 178.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . 0.438 HG22 ' HB3' ' A' ' 594' ' ' PRO . 40.6 t -115.82 107.24 48.66 Favored Pre-proline 0 C--N 1.306 -1.325 0 CA-C-N 115.839 -0.619 . . . . 61.210000000000001 109.356 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -73.52 145.95 38.46 Favored 'Trans proline' 0 C--O 1.238 0.484 0 C-N-CA 122.539 2.159 . . . . 74.540000000000006 111.951 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 539' ' ' TYR . . . . . 0.492 ' HB3' HG22 ' A' ' 591' ' ' ILE . 43.7 p90 -147.96 161.3 41.61 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 109.34 -0.615 . . . . 72.230000000000004 109.34 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -157.9 153.95 27.12 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 109.237 -0.653 . . . . 73.409999999999997 109.237 177.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 2.7 p -90.76 128.75 36.79 Favored 'General case' 0 C--N 1.293 -1.886 0 O-C-N 123.625 0.578 . . . . 72.329999999999998 110.152 175.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.428 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 3.7 mp -95.05 117.92 40.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 106.244 -1.762 . . . . 75.200000000000003 106.244 174.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . 0.538 ' HB2' ' O ' ' A' ' 546' ' ' ALA 0.289 0.0 OUTLIER -60.89 -51.51 68.98 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 114.685 1.365 . . . . 64.319999999999993 114.685 -176.759 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 67.63 -79.95 0.17 Allowed Glycine 0 N--CA 1.448 -0.532 0 O-C-N 123.266 0.354 . . . . 70.310000000000002 113.833 175.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 7.9 t -125.64 -1.7 7.37 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 120.956 0.408 . . . . 44.119999999999997 110.325 -178.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . 0.538 ' O ' ' HB2' ' A' ' 543' ' ' GLU . . . -111.11 174.54 5.81 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 108.6 -0.889 . . . . 72.540000000000006 108.6 177.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . 0.483 ' H ' ' HB3' ' A' ' 552' ' ' ASP . 2.4 mpt_? -112.77 128.78 56.52 Favored 'General case' 0 CA--C 1.487 -1.454 0 CA-C-O 121.548 0.689 . . . . 71.530000000000001 112.414 -175.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -84.6 -174.16 50.2 Favored Glycine 0 C--N 1.277 -2.731 0 CA-C-N 114.052 -1.431 . . . . 61.240000000000002 112.532 -177.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 69.78 16.33 72.16 Favored Glycine 0 C--O 1.222 -0.644 0 N-CA-C 114.196 0.438 . . . . 55.009999999999998 114.196 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 84.5 6.21 86.06 Favored Glycine 0 N--CA 1.438 -1.208 0 C-N-CA 119.989 -1.101 . . . . 64.040000000000006 111.297 -177.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -74.12 -43.94 55.65 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 110.542 -0.17 . . . . 64.519999999999996 110.542 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . 0.667 ' OD1' 'CA ' ' A' ' 850' ' ' ' CA' . 10.2 t70 -132.27 -28.88 1.65 Allowed 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.577 -0.897 . . . . 54.310000000000002 108.577 175.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 553' ' ' PHE . . . . . 0.411 ' HA ' HG12 ' A' ' 576' ' ' ILE . 35.1 p90 -144.12 158.39 43.75 Favored 'General case' 0 C--O 1.249 1.053 0 N-CA-C 107.183 -1.414 . . . . 74.510000000000005 107.183 170.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -89.93 119.44 30.29 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 106.974 -1.491 . . . . 74.400000000000006 106.974 178.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -75.45 99.03 4.06 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-N 115.966 -0.561 . . . . 72.209999999999994 110.738 -176.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . 0.485 ' CG2' HG22 ' A' ' 573' ' ' VAL . 10.1 t -89.8 97.03 10.96 Favored 'General case' 0 N--CA 1.41 -2.453 0 CA-C-O 123.295 1.521 . . . . 74.230000000000004 110.48 -178.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 1.6 p -109.4 106.62 16.47 Favored 'General case' 0 C--N 1.275 -2.65 0 CA-C-N 113.8 -1.545 . . . . 71.219999999999999 107.903 175.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -154.92 -157.84 8.42 Favored Glycine 0 N--CA 1.414 -2.804 0 N-CA-C 110.705 -0.958 . . . . 73.25 110.705 -174.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -142.77 131.24 22.33 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 109.584 -0.524 . . . . 55.420000000000002 109.584 -175.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . 0.403 ' HG ' ' CD1' ' A' ' 539' ' ' TYR . 95.1 mt -89.89 138.01 31.86 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.835 -0.62 . . . . 71.239999999999995 109.379 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 561' ' ' GLU . . . . . 0.482 ' HG3' HD21 ' A' ' 534' ' ' ASN . 39.9 tt0 -104.46 106.54 17.08 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 109.384 -0.598 . . . . 74.140000000000001 109.384 -179.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -100.08 132.22 45.57 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 109.9 -0.407 . . . . 60.039999999999999 109.9 177.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -116.43 160.81 20.02 Favored 'General case' 0 C--N 1.289 -2.06 0 C-N-CA 119.635 -0.826 . . . . 63.439999999999998 109.617 177.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 564' ' ' ASN . . . . . 0.446 ' HB3' ' H ' ' A' ' 533' ' ' GLY . 4.6 p-10 -69.93 -25.11 63.5 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 122.214 1.007 . . . . 73.400000000000006 109.545 176.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -90.85 -6.27 54.46 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.386 -1.279 . . . . 61.100000000000001 110.821 -178.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -118.96 154.82 32.41 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.899 -0.778 . . . . 22.219999999999999 108.899 -177.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 567' ' ' ILE . . . . . 0.416 ' HA ' ' HD3' ' A' ' 527' ' ' ARG . 9.4 pt -124.77 164.2 23.83 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 108.318 -0.993 . . . . 63.119999999999997 108.318 170.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 568' ' ' VAL . . . . . 0.571 HG21 ' HD2' ' A' ' 524' ' ' LYS . 1.5 p 49.97 155.5 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.576 1.944 0 C-N-CA 127.072 2.149 . . . . 75.040000000000006 115.734 179.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 569' ' ' LYS . . . . . . . . . . . . . 5.8 mmpt? -140.69 166.29 25.15 Favored 'General case' 0 CA--C 1.486 -1.487 0 N-CA-C 107.806 -1.183 . . . . 64.340000000000003 107.806 172.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 570' ' ' THR . . . . . 0.542 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 18.2 p -137.49 133.49 34.67 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 123.825 0.703 . . . . 70.519999999999996 110.603 175.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 3.1 mp -84.77 122.36 38.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 106.591 -1.633 . . . . 64.310000000000002 106.591 172.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 10.2 p -98.2 109.08 21.9 Favored 'General case' 0 N--CA 1.418 -2.074 0 N-CA-C 109.838 -0.43 . . . . 74.25 109.838 178.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 573' ' ' VAL . . . . . 0.485 HG22 ' CG2' ' A' ' 556' ' ' THR . 58.9 t -110.55 123.7 66.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 N-CA-C 109.869 -0.419 . . . . 73.530000000000001 109.869 178.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -77.91 113.23 15.6 Favored 'General case' 0 N--CA 1.433 -1.29 0 O-C-N 124.036 0.835 . . . . 74.319999999999993 109.067 175.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 57.1 t -87.24 130.32 37.27 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 107.624 -1.25 . . . . 60.200000000000003 107.624 177.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 576' ' ' ILE . . . . . 0.411 HG12 ' HA ' ' A' ' 553' ' ' PHE . 37.4 mm -94.98 150.04 4.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 108.312 -0.996 . . . . 74.209999999999994 108.312 -175.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -68.51 139.81 55.66 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.329 -0.619 . . . . 73.310000000000002 109.329 176.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 578' ' ' ASP . . . . . 0.616 ' OD1' 'CA ' ' A' ' 850' ' ' ' CA' . 0.3 OUTLIER -81.66 -177.74 6.67 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 112.898 0.703 . . . . 73.140000000000001 112.898 -173.264 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 579' ' ' GLU . . . . . 0.593 ' OE1' 'CA ' ' A' ' 850' ' ' ' CA' . 0.3 OUTLIER -166.71 -38.19 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.462 0 N-CA-C 114.566 1.321 . . . . 72.310000000000002 114.566 -173.19 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 580' ' ' GLU . . . . . 0.541 ' HG2' ' O ' ' A' ' 581' ' ' TYR . 0.1 OUTLIER -99.77 -168.08 1.55 Allowed 'General case' 0 C--O 1.25 1.104 0 C-N-CA 122.71 0.404 . . . . 74.209999999999994 111.887 -169.022 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 581' ' ' TYR . . . . . 0.541 ' O ' ' HG2' ' A' ' 580' ' ' GLU . 27.8 p90 -65.48 151.12 47.14 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 106.819 -1.549 . . . . 74.239999999999995 106.819 174.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -130.31 154.81 47.25 Favored 'General case' 0 N--CA 1.412 -2.338 0 C-N-CA 118.467 -1.293 . . . . 64.340000000000003 113.918 178.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -133.82 -174.51 3.55 Favored 'General case' 0 C--N 1.274 -2.692 0 N-CA-C 103.648 -2.723 . . . . 62.049999999999997 103.648 176.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -72.69 107.04 4.95 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.594 -1.261 . . . . 71.439999999999998 107.594 173.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 585' ' ' LYS . . . . . . . . . . . . 0.252 0.0 OUTLIER -113.28 143.7 43.97 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 119.921 -0.712 . . . . 73.019999999999996 111.351 -179.041 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 3.5 t -155.81 148.96 24.52 Favored 'General case' 0 N--CA 1.418 -2.072 0 CA-C-N 115.215 -0.902 . . . . 71.540000000000006 109.764 -172.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -120.14 142.15 49.2 Favored 'General case' 0 N--CA 1.414 -2.272 0 CA-C-N 114.576 -1.193 . . . . 74.420000000000002 109.665 176.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 588' ' ' PHE . . . . . 0.428 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 25.8 m-85 -98.92 133.5 43.11 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.561 -0.904 . . . . 65.329999999999998 108.561 -175.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . 0.522 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.5 OUTLIER -108.01 127.17 53.53 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 106.323 -1.732 . . . . 53.009999999999998 106.323 176.365 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -127.95 126.86 42.24 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 109.242 -0.651 . . . . 54.530000000000001 109.242 176.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 591' ' ' ILE . . . . . 0.492 HG22 ' HB3' ' A' ' 539' ' ' TYR . 17.0 pt -94.22 128.66 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 N-CA-C 106.351 -1.722 . . . . 74.519999999999996 106.351 171.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -93.35 -144.75 15.7 Favored Glycine 0 N--CA 1.431 -1.674 0 CA-C-N 115.793 -0.64 . . . . 63.109999999999999 114.386 -171.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -77.43 116.35 57.13 Favored Pre-proline 0 N--CA 1.435 -1.195 0 CA-C-N 114.635 -0.782 . . . . 71.140000000000001 109.155 -178.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 594' ' ' PRO . . . . . 0.438 ' HB3' HG22 ' A' ' 537' ' ' VAL . 78.1 Cg_endo -76.3 160.25 35.99 Favored 'Trans proline' 0 N--CA 1.446 -1.31 0 C-N-CA 122.475 2.117 . . . . 71.420000000000002 111.283 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 8.3 ptp85 -135.31 139.07 44.04 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 109.046 -0.724 . . . . 75.420000000000002 109.046 -178.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 596' ' ' LEU . . . . . 0.528 HD22 HG22 ' A' ' 535' ' ' VAL . 0.0 OUTLIER -83.39 129.19 34.98 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 105.954 -1.869 . . . . 75.450000000000003 105.954 179.242 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 69.7 t -71.56 -25.25 24.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-O 121.905 0.859 . . . . 73.439999999999998 110.393 -178.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -113.35 159.46 19.39 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.394 -0.965 . . . . 61.119999999999997 108.394 175.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 43.3 ttp -84.74 108.85 17.64 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 119.843 -0.743 . . . . 74.420000000000002 110.278 -178.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 600' ' ' SER . . . . . 0.452 ' OG ' ' HG ' ' A' ' 596' ' ' LEU . 59.9 m -75.55 112.94 12.42 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-N 116.035 -0.529 . . . . 60.399999999999999 112.049 176.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -144.22 142.41 30.48 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 105.504 -2.036 . . . . 71.239999999999995 105.504 172.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -119.59 -23.34 6.6 Favored 'General case' 0 C--N 1.289 -2.053 0 O-C-N 123.365 0.415 . . . . 53.240000000000002 110.625 -173.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -112.88 -73.3 0.67 Allowed 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 112.469 0.544 . . . . 73.109999999999999 112.469 -174.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -159.25 131.07 2.63 Favored Glycine 0 CA--C 1.487 -1.706 0 N-CA-C 110.282 -1.127 . . . . 71.329999999999998 110.282 -177.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . -70.65 118.03 7.44 Favored Glycine 0 N--CA 1.43 -1.76 0 O-C-N 123.893 0.408 . . . . 72.230000000000004 112.675 -177.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -67.4 -33.6 75.52 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.169 -1.049 . . . . 75.430000000000007 108.169 175.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 18.4 p -129.79 159.94 34.97 Favored 'General case' 0 N--CA 1.414 -2.246 0 N-CA-C 105.617 -1.994 . . . . 74.430000000000007 105.617 172.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 15.4 mt -84.43 16.94 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.971 0 CA-C-O 122.508 1.147 . . . . 70.409999999999997 109.402 -177.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 4.8 t -172.81 122.91 0.42 Allowed 'General case' 0 N--CA 1.428 -1.544 0 CA-C-N 114.989 -1.005 . . . . 73.230000000000004 109.666 178.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 610' ' ' GLU . . . . . 0.421 ' CD ' HH12 ' A' ' 633' ' ' ARG . 28.1 mt-10 -119.16 18.89 13.01 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.455 0.645 . . . . 71.450000000000003 109.485 174.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -66.57 104.35 1.26 Allowed 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.724 -1.213 . . . . 62.210000000000001 107.724 177.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 62.32 67.42 0.73 Allowed 'General case' 0 C--N 1.328 -0.365 0 O-C-N 124.772 1.295 . . . . 75.140000000000001 108.125 -175.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 613' ' ' ASP . . . . . 0.503 ' OD1' ' HD3' ' A' ' 633' ' ' ARG . 5.4 p-10 -79.95 -36.66 35.89 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.564 -0.744 . . . . 63.140000000000001 110.749 -177.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -132.37 108.97 9.52 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.464 -1.31 . . . . 70.430000000000007 107.464 177.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -93.49 77.4 4.41 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 112.616 0.599 . . . . 73.349999999999994 112.616 -173.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -135.46 157.74 75.87 Favored Pre-proline 0 C--N 1.295 -1.783 0 N-CA-C 107.302 -1.37 . . . . 75.310000000000002 107.302 173.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -62.94 -168.43 0.08 OUTLIER 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.697 2.265 . . . . 73.340000000000003 113.242 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -61.26 103.43 0.29 Allowed 'General case' 0 C--O 1.243 0.758 0 CA-C-N 115.676 -0.693 . . . . 74.430000000000007 110.506 -177.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 6.3 p -128.46 18.54 6.36 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 115.442 -0.799 . . . . 72.120000000000005 112.55 -172.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -100.78 32.89 2.97 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.022 -0.733 . . . . 74.299999999999997 109.022 -176.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 7.8 mtmp? -82.23 -54.56 5.16 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.815 0.672 . . . . 72.150000000000006 112.815 -171.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -86.48 -54.53 4.36 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 121.636 0.732 . . . . 73.299999999999997 111.339 -170.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . 0.422 ' H ' ' CD ' ' A' ' 623' ' ' GLU . 0.7 OUTLIER -89.58 146.1 24.8 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 114.66 -1.154 . . . . 64.540000000000006 111.493 -174.029 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -92.3 -16.43 26.08 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 115.654 -0.703 . . . . 75.319999999999993 110.071 178.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . 0.415 ' HG2' ' HB2' ' A' ' 623' ' ' GLU . 12.3 pt-20 -59.72 -33.08 71.16 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-O 121.411 0.624 . . . . 74.409999999999997 109.807 178.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -75.84 -33.43 60.04 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 115.296 -0.865 . . . . 74.230000000000004 109.886 178.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 627' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -67.05 -22.6 65.86 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.007 -0.542 . . . . 72.519999999999996 110.58 -178.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . 0.465 ' O ' ' HG2' ' A' ' 631' ' ' MET . 95.3 mt -64.06 -41.38 92.29 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.653 0 CA-C-N 115.866 -0.606 . . . . 73.400000000000006 109.958 175.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -69.12 -36.99 78.1 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-O 122.413 1.101 . . . . 74.239999999999995 108.324 177.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.93 12.69 0.64 Allowed 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 113.877 -1.511 . . . . 73.099999999999994 114.278 177.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 631' ' ' MET . . . . . 0.465 ' HG2' ' O ' ' A' ' 628' ' ' ILE . 21.3 ptp -80.98 -21.17 40.53 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 106.244 -1.761 . . . . 54.140000000000001 106.244 166.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -100.06 -37.05 3.98 Favored Glycine 0 N--CA 1.425 -2.095 0 CA-C-N 114.655 -1.157 . . . . 75.319999999999993 110.886 177.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 633' ' ' ARG . . . . . 0.503 ' HD3' ' OD1' ' A' ' 613' ' ' ASP . 0.0 OUTLIER -94.63 128.28 40.48 Favored Pre-proline 0 C--O 1.207 -1.135 0 N-CA-C 109.527 -0.546 . . . . 74.510000000000005 109.527 176.753 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -75.6 153.89 39.3 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 121.863 1.709 . . . . 54.109999999999999 111.754 178.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.3 pp -130.96 179.78 4.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.798 0.666 . . . . 64.430000000000007 112.798 -177.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . 0.401 HD22 ' O ' ' A' ' 637' ' ' GLY . 0.0 OUTLIER -76.71 153.4 35.13 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.793 -0.64 . . . . 74.349999999999994 109.473 -179.734 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . 0.401 ' O ' HD22 ' A' ' 636' ' ' LEU . . . -83.93 -135.72 2.93 Favored Glycine 0 C--N 1.304 -1.239 0 C-N-CA 120.917 -0.659 . . . . 71.319999999999993 114.18 -175.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -70.32 -56.97 5.41 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.168 0.508 . . . . 74.420000000000002 110.449 -176.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -148.26 122.53 9.6 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.429 0.633 . . . . 71.409999999999997 110.096 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 55.2 p -108.59 91.49 3.67 Favored 'General case' 0 N--CA 1.406 -2.665 0 CA-C-O 121.907 0.86 . . . . 62.43 109.118 178.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -166.39 130.19 2.06 Favored 'General case' 0 CA--C 1.491 -1.295 0 N-CA-C 107.81 -1.181 . . . . 64.409999999999997 107.81 -177.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 642' ' ' LEU . . . . . 0.679 HD21 HG21 ' A' ' 523' ' ' VAL . 29.3 tp -137.91 110.53 7.55 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 108.531 -0.914 . . . . 74.510000000000005 108.531 176.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . 0.435 ' HB3' HG22 ' A' ' 511' ' ' VAL . 36.8 tt0 -93.92 109.69 21.39 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 107.188 -1.412 . . . . 75.200000000000003 107.188 176.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 644' ' ' VAL . . . . . 0.741 HG21 ' HE1' ' A' ' 521' ' ' MET . 34.7 t -96.59 105.44 17.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 109.982 -0.377 . . . . 75.420000000000002 109.982 -177.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 3.7 mp -87.86 120.16 36.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 108.418 -0.956 . . . . 75.510000000000005 108.418 178.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 646' ' ' ILE . . . . . 0.493 HD12 ' H ' ' A' ' 646' ' ' ILE . 2.1 mp -101.7 107.47 21.62 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.746 0 N-CA-C 105.938 -1.875 . . . . 64.510000000000005 105.938 -177.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -110.53 145.92 36.93 Favored 'General case' 0 N--CA 1.406 -2.627 0 C-N-CA 120.273 -0.571 . . . . 70.239999999999995 110.294 -178.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -53.33 132.8 39.82 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.004 -0.998 . . . . 72.040000000000006 110.091 -178.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 3.6 m -56.88 124.01 17.06 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 124.444 1.098 . . . . 63.039999999999999 111.681 -173.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -151.42 -55.94 0.15 Allowed 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.383 -0.826 . . . . 73.439999999999998 110.058 -178.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 651' ' ' GLU . . . . . 0.614 ' HG2' ' H ' ' A' ' 652' ' ' PHE . 21.9 tt0 -164.6 -162.99 0.69 Allowed 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 105.565 -2.013 . . . . 75.439999999999998 105.565 -177.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 652' ' ' PHE . . . . . 0.614 ' H ' ' HG2' ' A' ' 651' ' ' GLU . 69.5 t80 -134.95 130.45 35.83 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.694 -1.224 . . . . 65.430000000000007 107.694 178.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -113.86 143.84 44.02 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 109.047 -0.723 . . . . 74.200000000000003 109.047 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 40.9 m -110.01 99.38 8.49 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 109.59 -0.522 . . . . 71.409999999999997 109.59 177.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 32.7 m -71.91 111.77 7.44 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.386 -0.825 . . . . 62.009999999999998 111.366 -176.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 35.4 m -98.92 155.16 3.93 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 N-CA-C 108.858 -0.793 . . . . 54.229999999999997 108.858 177.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 27.2 t70 . . . . . 0 C--N 1.3 -1.584 0 CA-C-N 116.482 -0.326 . . . . 73.120000000000005 110.291 -179.356 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 800' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 850' ' ' ' CA' . . . . . 0.667 'CA ' ' OD1' ' A' ' 552' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 13.8 t60 . . . . . 0 N--CA 1.445 -0.685 0 N-CA-C 108.037 -1.098 . . . . 74.409999999999997 108.037 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -150.04 15.89 0.84 Allowed 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.76 0.315 . . . . 73.549999999999997 110.975 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 146.72 171.57 16.14 Favored Glycine 0 N--CA 1.419 -2.47 0 C-N-CA 119.912 -1.137 . . . . 35.240000000000002 112.624 179.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . 0.4 ' H ' ' CB ' ' A' ' 528' ' ' THR . 4.1 mp -122.75 114.81 43.83 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 108.54 -0.911 . . . . 74.230000000000004 108.54 178.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -128.88 98.75 5.06 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 107.753 -1.203 . . . . 74.319999999999993 107.753 174.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 15.4 t -134.99 156.83 48.36 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 116.044 -0.526 . . . . 73.430000000000007 109.679 -173.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -85.41 154.28 21.95 Favored 'General case' 0 CA--C 1.487 -1.476 0 N-CA-C 108.583 -0.895 . . . . 73.200000000000003 108.583 175.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -84.38 -26.92 28.02 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.099 -1.075 . . . . 73.329999999999998 108.099 173.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -111.26 121.22 41.03 Favored Pre-proline 0 N--CA 1.436 -1.174 0 CA-C-N 114.636 -1.165 . . . . 74.019999999999996 109.98 -178.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . 0.435 ' HA ' ' O ' ' A' ' 641' ' ' LYS . 56.2 Cg_endo -85.7 -18.48 3.77 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 121.206 1.271 . . . . 42.210000000000001 109.51 169.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . 0.542 HG22 ' HB3' ' A' ' 643' ' ' GLU . 67.6 t -149.32 131.13 5.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 C-N-CA 125.953 1.701 . . . . 61.450000000000003 106.972 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 14.9 t -130.49 143.73 50.95 Favored 'General case' 0 N--CA 1.421 -1.902 0 N-CA-C 107.676 -1.231 . . . . 73.25 107.676 177.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -109.76 131.99 54.56 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 107.504 -1.295 . . . . 63.539999999999999 107.504 178.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 24.7 m -130.19 154.89 41.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 CA-C-O 121.312 0.577 . . . . 72.239999999999995 110.077 -178.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 65.7 m -77.08 150.0 35.7 Favored 'General case' 0 N--CA 1.397 -3.103 0 CA-C-N 114.493 -1.23 . . . . 74.420000000000002 109.955 178.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . 0.627 ' OE2' 'CA ' ' A' ' 800' ' ' ' CA' . 37.9 tt0 -71.69 -29.3 64.43 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.813 0.816 . . . . 64.209999999999994 109.659 174.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 39.7 m -107.95 75.07 0.98 Allowed 'General case' 0 N--CA 1.418 -2.033 0 CA-C-O 122.129 0.966 . . . . 73.230000000000004 109.462 -177.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 13.3 tt -145.3 161.04 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.214 0 CA-C-N 113.069 -1.878 . . . . 71.420000000000002 106.027 176.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . 0.46 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . -92.51 -75.71 1.31 Allowed Glycine 0 N--CA 1.434 -1.449 0 C-N-CA 120.002 -1.094 . . . . 42.109999999999999 110.894 177.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 34.6 mm -107.68 127.03 63.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 109.866 -0.42 . . . . 75.219999999999999 109.866 -178.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 521' ' ' MET . . . . . 0.582 ' HE2' HG21 ' A' ' 644' ' ' VAL . 0.0 OUTLIER -102.95 139.99 37.8 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.075 -1.454 . . . . 72.340000000000003 107.075 172.103 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -113.7 155.67 25.15 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 121.419 0.628 . . . . 72.299999999999997 111.709 -176.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . 0.678 ' O ' ' HA ' ' A' ' 570' ' ' THR . 12.1 t -135.77 126.07 42.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 115.118 -0.947 . . . . 71.120000000000005 108.479 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . 0.54 ' HD2' HG21 ' A' ' 568' ' ' VAL . 31.2 mmtp -79.7 126.08 30.47 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.507 0.67 . . . . 54.530000000000001 112.088 -179.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 19.1 t -110.67 122.87 65.95 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 107.367 -1.346 . . . . 61.119999999999997 107.367 176.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -78.82 144.93 34.59 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.073 -0.714 . . . . 61.25 109.073 -178.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . 0.504 ' HD3' ' HA ' ' A' ' 567' ' ' ILE . 40.3 ttp180 -88.23 151.81 22.4 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.451 0.643 . . . . 64.319999999999993 110.764 -175.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . 0.481 ' N ' ' HG2' ' A' ' 527' ' ' ARG . 4.6 t -59.97 139.63 57.29 Favored 'General case' 0 N--CA 1.418 -2.049 0 CA-C-N 114.514 -1.221 . . . . 62.450000000000003 110.525 172.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 23.3 t -73.92 -40.65 62.98 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 108.553 -0.906 . . . . 75.319999999999993 108.553 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -90.57 56.63 3.46 Favored Glycine 0 N--CA 1.434 -1.459 0 N-CA-C 110.392 -1.083 . . . . 64.109999999999999 110.392 177.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -70.14 99.88 1.56 Allowed 'General case' 0 CA--C 1.505 -0.767 0 C-N-CA 122.972 0.509 . . . . 64.010000000000005 110.884 -178.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -127.33 100.22 5.96 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 115.708 -0.678 . . . . 73.319999999999993 109.899 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 533' ' ' GLY . . . . . 0.561 ' H ' ' HB3' ' A' ' 564' ' ' ASN . . . 102.67 165.23 26.19 Favored Glycine 0 N--CA 1.42 -2.42 0 C-N-CA 120.695 -0.764 . . . . 41.109999999999999 113.161 177.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 534' ' ' ASN . . . . . 0.424 HD21 ' CG ' ' A' ' 561' ' ' GLU . 2.6 t-20 -79.72 123.11 27.38 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.383 -1.34 . . . . 74.409999999999997 107.383 176.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 535' ' ' VAL . . . . . 0.509 HG22 HD22 ' A' ' 596' ' ' LEU . 65.7 t -124.32 139.48 50.54 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-N 116.19 -0.459 . . . . 74.030000000000001 110.023 -175.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 536' ' ' ILE . . . . . 0.503 HG23 ' HB3' ' A' ' 559' ' ' GLU . 30.2 mm -104.24 139.18 25.94 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 109.014 -0.736 . . . . 63.329999999999998 109.014 178.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 41.9 t -118.4 108.53 41.58 Favored Pre-proline 0 C--N 1.306 -1.3 0 N-CA-C 109.474 -0.565 . . . . 73.230000000000004 109.474 177.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -73.93 138.85 26.47 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 122.117 1.878 . . . . 65.349999999999994 110.885 177.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 539' ' ' TYR . . . . . 0.443 ' HB3' HG22 ' A' ' 591' ' ' ILE . 46.0 p90 -146.46 161.47 40.35 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 120.804 -0.358 . . . . 73.340000000000003 110.531 -178.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 540' ' ' LYS . . . . . 0.41 ' HD2' ' O ' ' A' ' 540' ' ' LYS . 0.0 OUTLIER -155.31 147.65 23.87 Favored 'General case' 0 C--N 1.317 -0.807 0 O-C-N 123.518 0.511 . . . . 73.329999999999998 111.495 177.416 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 16.7 p -84.8 132.34 34.43 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 116.2 -0.455 . . . . 72.329999999999998 110.039 173.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.5 mp -93.63 124.22 46.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 106.271 -1.751 . . . . 72.540000000000006 106.271 173.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . 0.413 ' HB3' ' O ' ' A' ' 546' ' ' ALA . 2.7 mp0 -57.12 -52.67 64.36 Favored 'General case' 0 C--O 1.243 0.712 0 O-C-N 123.818 0.699 . . . . 73.5 110.765 -178.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 71.08 -81.91 0.44 Allowed Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 115.45 -0.795 . . . . 62.549999999999997 111.946 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 11.1 t -132.9 5.47 3.9 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.677 0.751 . . . . 74.329999999999998 109.806 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . 0.413 ' O ' ' HB3' ' A' ' 543' ' ' GLU . . . -106.2 178.83 4.45 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.841 -0.618 . . . . 33.350000000000001 109.612 178.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . 0.491 ' HD2' ' HB3' ' A' ' 551' ' ' GLU . 1.7 tmt_? -129.03 124.26 34.46 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 107.677 -1.231 . . . . 72.299999999999997 107.677 -175.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -82.9 -151.36 10.16 Favored Glycine 0 C--N 1.321 -0.264 0 C-N-CA 121.321 -0.466 . . . . 44.229999999999997 112.715 -177.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 66.6 19.4 69.01 Favored Glycine 0 C--N 1.314 -0.672 0 CA-C-N 116.689 0.244 . . . . 61.240000000000002 113.289 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 76.7 32.3 50.87 Favored Glycine 0 N--CA 1.437 -1.289 0 C-N-CA 120.748 -0.739 . . . . 50.329999999999998 111.614 -178.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . 0.491 ' HB3' ' HD2' ' A' ' 547' ' ' ARG . 8.1 tp10 -101.41 -65.75 0.96 Allowed 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.865 -0.42 . . . . 71.510000000000005 109.865 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -101.38 -34.05 9.76 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 106.526 -1.657 . . . . 73.400000000000006 106.526 177.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 553' ' ' PHE . . . . . 0.473 ' HA ' HG12 ' A' ' 576' ' ' ILE . 20.4 p90 -149.46 164.56 34.68 Favored 'General case' 0 N--CA 1.419 -2.023 0 CA-C-N 113.99 -1.459 . . . . 65.420000000000002 108.054 175.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . 0.515 ' HG3' ' HE2' ' A' ' 574' ' ' LYS . 0.5 OUTLIER -94.56 112.3 24.06 Favored 'General case' 0 C--N 1.282 -2.368 0 N-CA-C 105.805 -1.924 . . . . 73.310000000000002 105.805 176.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -76.94 101.06 5.8 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-O 122.525 1.155 . . . . 62.140000000000001 110.736 -175.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . 0.47 ' CG2' HG22 ' A' ' 573' ' ' VAL . 8.9 t -91.44 121.8 33.47 Favored 'General case' 0 N--CA 1.396 -3.148 0 CA-C-O 122.395 1.093 . . . . 71.099999999999994 110.967 -178.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 10.4 p -136.83 119.25 15.79 Favored 'General case' 0 N--CA 1.41 -2.43 0 N-CA-C 106.56 -1.644 . . . . 72.439999999999998 106.56 177.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -170.12 -152.91 8.29 Favored Glycine 0 N--CA 1.415 -2.724 0 N-CA-C 110.596 -1.002 . . . . 72.519999999999996 110.596 -175.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 559' ' ' GLU . . . . . 0.503 ' HB3' HG23 ' A' ' 536' ' ' ILE . 34.7 mt-10 -135.03 127.47 30.48 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 122.364 0.265 . . . . 64.420000000000002 111.124 -176.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 96.1 mt -88.19 155.6 19.68 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.346 -0.612 . . . . 61.350000000000001 109.346 177.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 561' ' ' GLU . . . . . 0.424 ' CG ' HD21 ' A' ' 534' ' ' ASN . 31.9 tt0 -123.37 119.29 29.64 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-O 121.039 0.447 . . . . 74.219999999999999 111.471 -178.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -113.82 148.39 36.69 Favored 'General case' 0 CA--C 1.502 -0.881 0 C-N-CA 123.981 0.912 . . . . 75.329999999999998 109.492 176.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -127.87 167.55 16.43 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 120.243 -0.583 . . . . 72.430000000000007 109.45 177.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 564' ' ' ASN . . . . . 0.561 ' HB3' ' H ' ' A' ' 533' ' ' GLY . 32.1 p30 -66.87 -24.51 66.13 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.272 0.558 . . . . 22.449999999999999 111.142 178.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -102.72 -5.1 24.11 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.577 -0.738 . . . . 72.5 111.0 -177.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -115.35 134.86 54.72 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 116.4 -0.363 . . . . 72.409999999999997 110.599 -175.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 567' ' ' ILE . . . . . 0.504 ' HA ' ' HD3' ' A' ' 527' ' ' ARG . 9.5 pt -114.09 164.73 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 C-N-CA 120.969 -0.292 . . . . 51.109999999999999 110.267 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 568' ' ' VAL . . . . . 0.54 HG21 ' HD2' ' A' ' 524' ' ' LYS . 1.2 p 49.54 165.82 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.566 1.559 0 C-N-CA 127.301 2.24 . . . . 73.209999999999994 114.488 179.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 569' ' ' LYS . . . . . 0.512 ' HA ' ' HE3' ' A' ' 569' ' ' LYS . 1.0 OUTLIER -161.0 160.81 31.13 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 106.087 -1.82 . . . . 73.120000000000005 106.087 177.289 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 570' ' ' THR . . . . . 0.678 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 19.8 p -133.89 127.58 32.82 Favored 'General case' 0 N--CA 1.427 -1.601 0 O-C-N 123.478 0.486 . . . . 64.530000000000001 110.964 177.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 2.9 mp -76.62 125.45 36.4 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 107.016 -1.476 . . . . 70.140000000000001 107.016 173.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 24.4 m -99.44 109.37 21.94 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 120.859 0.361 . . . . 72.109999999999999 110.342 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 573' ' ' VAL . . . . . 0.47 HG22 ' CG2' ' A' ' 556' ' ' THR . 40.1 t -116.45 120.07 63.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 108.97 -0.752 . . . . 71.129999999999995 108.97 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 574' ' ' LYS . . . . . 0.515 ' HE2' ' HG3' ' A' ' 554' ' ' GLU . 38.8 ttpt -82.1 126.6 32.21 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-O 121.457 0.646 . . . . 75.230000000000004 110.938 177.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 82.5 t -91.51 134.84 28.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 107.982 -1.118 . . . . 55.0 107.982 178.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 576' ' ' ILE . . . . . 0.473 HG12 ' HA ' ' A' ' 553' ' ' PHE . 21.9 mm -105.69 160.05 5.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 107.475 -1.306 . . . . 72.129999999999995 107.475 -177.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -68.77 132.17 46.37 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 116.387 -0.37 . . . . 64.439999999999998 110.103 177.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 578' ' ' ASP . . . . . 0.603 ' OD1' 'CA ' ' A' ' 850' ' ' ' CA' . 0.9 OUTLIER -62.36 128.85 37.98 Favored 'General case' 0 CA--C 1.49 -1.342 0 CA-C-O 121.808 0.813 . . . . 64.239999999999995 111.405 -178.095 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 579' ' ' GLU . . . . . 0.602 ' OE2' 'CA ' ' A' ' 850' ' ' ' CA' . 0.0 OUTLIER -100.18 -0.82 38.04 Favored 'General case' 0 C--N 1.275 -2.642 0 CA-C-N 114.02 -1.445 . . . . 73.109999999999999 113.335 -175.231 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 580' ' ' GLU . . . . . 0.542 ' HG2' ' O ' ' A' ' 581' ' ' TYR . 0.5 OUTLIER -137.29 -174.93 3.89 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.93 -0.481 . . . . 64.409999999999997 110.706 -176.63 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 581' ' ' TYR . . . . . 0.542 ' O ' ' HG2' ' A' ' 580' ' ' GLU . 28.5 p90 -65.63 154.32 39.13 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 108.706 -0.85 . . . . 71.230000000000004 108.706 174.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -86.0 152.26 23.06 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 114.988 1.477 . . . . 74.030000000000001 114.988 -176.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -157.71 172.74 17.97 Favored 'General case' 0 N--CA 1.433 -1.283 0 C-N-CA 126.77 2.028 . . . . 75.340000000000003 105.611 176.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -80.77 97.68 7.43 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.075 -1.454 . . . . 75.129999999999995 107.075 176.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 585' ' ' LYS . . . . . 0.474 ' HD2' HD13 ' A' ' 646' ' ' ILE . 0.0 OUTLIER -113.68 136.0 53.32 Favored 'General case' 0 N--CA 1.416 -2.152 0 CA-C-N 115.365 -0.834 . . . . 71.120000000000005 110.363 -175.652 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 3.9 t -151.33 146.97 26.38 Favored 'General case' 0 N--CA 1.421 -1.917 0 CA-C-N 115.137 -0.938 . . . . 75.409999999999997 110.483 -174.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 587' ' ' PHE . . . . . 0.4 ' CE2' HD11 ' A' ' 646' ' ' ILE . 2.5 p90 -122.18 155.62 35.4 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 114.6 -1.182 . . . . 64.129999999999995 109.628 177.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 588' ' ' PHE . . . . . 0.514 ' HA ' ' O ' ' A' ' 642' ' ' LEU . 34.9 m-85 -110.71 145.73 37.51 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.721 -0.474 . . . . 71.340000000000003 109.721 -174.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -116.25 119.62 36.32 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 106.491 -1.67 . . . . 73.329999999999998 106.491 176.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -125.5 138.78 53.99 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 108.847 -0.797 . . . . 60.329999999999998 108.847 -178.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 591' ' ' ILE . . . . . 0.443 HG22 ' HB3' ' A' ' 539' ' ' TYR . 27.3 pt -103.73 151.03 6.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 108.502 -0.925 . . . . 71.030000000000001 108.502 176.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -93.72 -150.09 26.26 Favored Glycine 0 N--CA 1.427 -1.918 0 N-CA-C 110.855 -0.898 . . . . 64.140000000000001 110.855 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -86.3 119.63 71.7 Favored Pre-proline 0 C--N 1.301 -1.53 0 N-CA-C 108.552 -0.907 . . . . 73.530000000000001 108.552 178.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 594' ' ' PRO . . . . . 0.456 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 12.9 Cg_endo -57.47 149.13 68.09 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 122.37 2.047 . . . . 73.439999999999998 111.175 177.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -128.66 132.84 48.1 Favored 'General case' 0 C--N 1.291 -1.959 0 O-C-N 121.996 -0.44 . . . . 72.049999999999997 110.306 -173.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 596' ' ' LEU . . . . . 0.509 HD22 HG22 ' A' ' 535' ' ' VAL . 0.0 OUTLIER -77.43 128.12 33.7 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.671 -1.233 . . . . 71.150000000000006 107.671 -177.337 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 597' ' ' VAL . . . . . 0.459 ' CG2' HG12 ' A' ' 536' ' ' ILE . 52.2 t -76.25 -41.72 36.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-O 121.869 0.842 . . . . 73.409999999999997 109.373 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -85.49 129.33 34.84 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 114.671 -1.15 . . . . 72.219999999999999 110.321 -176.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 18.3 ptm -67.7 121.61 16.31 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-O 122.183 0.992 . . . . 71.409999999999997 110.731 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 8.8 p -118.51 88.94 3.02 Favored 'General case' 0 C--N 1.269 -2.908 0 CA-C-N 114.326 -1.307 . . . . 71.349999999999994 110.339 176.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -77.48 91.76 3.95 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-O 122.195 0.998 . . . . 72.319999999999993 108.332 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . 0.45 ' HG3' ' CD1' ' A' ' 606' ' ' PHE . 7.3 ptpp? -85.03 78.59 9.87 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-O 123.334 1.54 . . . . 63.200000000000003 112.132 -173.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 603' ' ' LYS . . . . . 0.432 ' HZ2' ' HB3' ' A' ' 603' ' ' LYS . 0.7 OUTLIER -79.36 157.58 27.61 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 112.683 -2.053 . . . . 72.140000000000001 111.327 -178.093 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 109.12 -54.6 0.54 Allowed Glycine 0 N--CA 1.428 -1.89 0 N-CA-C 108.113 -1.995 . . . . 72.510000000000005 108.113 -175.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . -92.56 -41.37 4.79 Favored Glycine 0 N--CA 1.428 -1.844 0 N-CA-C 109.721 -1.352 . . . . 72.0 109.721 174.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 606' ' ' PHE . . . . . 0.45 ' CD1' ' HG3' ' A' ' 602' ' ' LYS . 89.4 m-85 -97.16 153.65 17.85 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.313 -0.625 . . . . 73.25 109.313 175.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 11.8 p -85.93 -178.44 6.57 Favored 'General case' 0 C--N 1.292 -1.907 0 C-N-CA 123.658 0.783 . . . . 71.409999999999997 111.998 -175.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 23.1 mm -91.7 63.07 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 N-CA-C 105.343 -2.095 . . . . 62.439999999999998 105.343 175.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 609' ' ' THR . . . . . 0.429 HG22 ' HG2' ' A' ' 611' ' ' GLU . 52.3 m -150.34 137.81 19.71 Favored 'General case' 0 C--N 1.279 -2.472 0 CA-C-N 115.216 -0.902 . . . . 62.43 109.121 -173.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -102.65 80.78 1.95 Allowed 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 109.004 -0.739 . . . . 63.109999999999999 109.004 -177.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 611' ' ' GLU . . . . . 0.429 ' HG2' HG22 ' A' ' 609' ' ' THR . 72.7 mm-40 -136.56 154.21 50.76 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 116.345 -0.388 . . . . 71.049999999999997 110.122 -177.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 65.56 27.59 11.52 Favored 'General case' 0 CA--C 1.511 -0.551 0 O-C-N 124.407 1.067 . . . . 72.040000000000006 113.047 174.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -117.0 127.48 54.22 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 114.5 -1.227 . . . . 73.129999999999995 108.104 173.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -168.62 173.03 7.62 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 105.556 -2.016 . . . . 71.319999999999993 105.556 -177.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -85.24 72.19 10.77 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 119.221 0.918 . . . . 72.239999999999995 109.087 175.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 32.7 mm-40 -93.24 155.45 41.03 Favored Pre-proline 0 N--CA 1.433 -1.285 0 CA-C-N 114.631 -1.168 . . . . 72.019999999999996 109.673 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -79.35 -168.68 0.66 Allowed 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 122.171 1.914 . . . . 64.329999999999998 109.368 172.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -69.44 105.56 2.65 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 107.649 -1.241 . . . . 73.129999999999995 107.649 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 2.2 p -139.09 68.53 1.38 Allowed 'General case' 0 N--CA 1.435 -1.203 0 CA-C-O 121.451 0.643 . . . . 62.119999999999997 112.415 -172.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 620' ' ' SER . . . . . 0.459 ' OG ' ' HG3' ' A' ' 630' ' ' GLU . 2.0 m -88.04 -21.21 24.9 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.819 -0.628 . . . . 72.230000000000004 110.94 -175.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt 67.26 -65.09 0.24 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.891 1.276 . . . . 71.310000000000002 112.751 178.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 171.7 -40.15 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.941 1.296 . . . . 70.430000000000007 107.514 -176.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -47.85 127.07 11.4 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 113.381 -1.736 . . . . 64.349999999999994 111.72 -178.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -62.86 -39.78 95.47 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-N 116.171 -0.468 . . . . 65.299999999999997 110.05 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -56.73 -40.07 75.06 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 123.968 0.792 . . . . 64.129999999999995 109.105 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . 0.656 ' O ' ' HG2' ' A' ' 630' ' ' GLU . 1.9 tpp180 -72.62 -47.09 50.62 Favored 'General case' 0 C--O 1.193 -1.874 0 CA-C-N 115.371 -0.831 . . . . 74.329999999999998 109.307 -179.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 627' ' ' ARG . . . . . . . . . . . . . 39.4 mtm180 -53.66 -40.63 66.05 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.413 0.524 . . . . 73.200000000000003 112.413 178.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 98.2 mt -64.65 -41.76 93.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 120.873 0.368 . . . . 74.129999999999995 110.466 176.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -69.42 -36.19 76.46 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.263 -0.426 . . . . 72.430000000000007 111.214 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 630' ' ' GLU . . . . . 0.656 ' HG2' ' O ' ' A' ' 626' ' ' ARG . 20.3 mm-40 -61.99 -35.31 78.11 Favored 'General case' 0 C--O 1.212 -0.918 0 C-N-CA 123.191 0.596 . . . . 74.239999999999995 110.077 177.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 631' ' ' MET . . . . . . . . . . . . . 24.3 ptt? -89.69 7.1 38.41 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.678 0.751 . . . . 64.120000000000005 109.869 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -78.76 -21.38 68.89 Favored Glycine 0 N--CA 1.437 -1.3 0 N-CA-C 108.316 -1.914 . . . . 71.140000000000001 108.316 173.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 633' ' ' ARG . . . . . 0.41 ' CZ ' ' HA ' ' A' ' 630' ' ' GLU . 0.2 OUTLIER -110.13 151.34 42.47 Favored Pre-proline 0 N--CA 1.43 -1.442 0 N-CA-C 105.894 -1.891 . . . . 75.219999999999999 105.894 174.217 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.456 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 18.2 Cg_endo -63.17 144.81 92.88 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 121.203 1.268 . . . . 72.540000000000006 110.485 175.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.3 pp -122.48 169.25 14.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 113.46 0.911 . . . . 73.340000000000003 113.46 -177.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . 0.445 ' HB2' HG21 ' A' ' 640' ' ' THR . 0.0 OUTLIER -73.85 168.34 19.63 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 123.788 0.835 . . . . 62.5 112.106 -176.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -113.18 -157.51 12.72 Favored Glycine 0 N--CA 1.437 -1.282 0 N-CA-C 115.704 1.042 . . . . 72.049999999999997 115.704 -174.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -42.65 -59.32 1.96 Allowed 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 128.107 2.563 . . . . 64.329999999999998 114.751 -173.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 10.6 p80 -140.06 109.63 6.28 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 122.019 0.914 . . . . 63.340000000000003 111.812 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 640' ' ' THR . . . . . 0.445 HG21 ' HB2' ' A' ' 636' ' ' LEU . 11.0 p -114.61 91.71 3.71 Favored 'General case' 0 N--CA 1.411 -2.412 0 CA-C-N 115.008 -0.996 . . . . 71.519999999999996 111.102 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 641' ' ' LYS . . . . . 0.451 ' HE2' ' HB2' ' A' ' 643' ' ' GLU . 1.0 OUTLIER -175.23 137.25 0.39 Allowed 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 105.353 -2.091 . . . . 75.340000000000003 105.353 178.779 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 642' ' ' LEU . . . . . 0.514 ' O ' ' HA ' ' A' ' 588' ' ' PHE . 27.6 tp -135.31 114.14 11.94 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 108.775 -0.824 . . . . 74.430000000000007 108.775 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . 0.542 ' HB3' HG22 ' A' ' 511' ' ' VAL . 28.6 tt0 -98.31 110.04 22.69 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 107.127 -1.434 . . . . 74.099999999999994 107.127 176.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 644' ' ' VAL . . . . . 0.582 HG21 ' HE2' ' A' ' 521' ' ' MET . 22.0 t -97.46 102.08 13.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 109.77 -0.456 . . . . 63.229999999999997 109.77 -177.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 4.0 mp -89.15 120.18 37.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 N-CA-C 107.799 -1.186 . . . . 74.450000000000003 107.799 177.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 646' ' ' ILE . . . . . 0.474 HD13 ' HD2' ' A' ' 585' ' ' LYS . 2.8 mp -99.83 106.71 19.55 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.505 0 N-CA-C 106.724 -1.584 . . . . 74.540000000000006 106.724 -176.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -104.87 155.43 18.93 Favored 'General case' 0 C--N 1.279 -2.497 0 CA-C-O 121.237 0.541 . . . . 63.43 111.565 -177.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . 0.462 ' C ' ' H ' ' A' ' 650' ' ' TYR . 41.6 mm-40 -60.84 162.61 6.6 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.052 -0.976 . . . . 62.539999999999999 113.479 -174.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 8.3 t -85.52 40.11 0.82 Allowed 'General case' 0 CA--C 1.557 1.223 0 CA-C-O 123.184 1.469 . . . . 75.420000000000002 107.654 177.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 650' ' ' TYR . . . . . 0.462 ' H ' ' C ' ' A' ' 648' ' ' GLU . 1.2 t80 -85.1 -44.21 13.19 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 112.932 -1.94 . . . . 74.140000000000001 108.013 178.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -177.82 174.18 1.48 Allowed 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 100.961 -3.718 . . . . 74.040000000000006 100.961 -178.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -136.71 116.47 13.07 Favored 'General case' 0 C--N 1.263 -3.175 0 CA-C-N 118.682 0.673 . . . . 64.400000000000006 109.886 -175.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.32 174.65 8.8 Favored 'General case' 0 C--N 1.277 -2.55 0 CA-C-N 115.757 -0.656 . . . . 75.439999999999998 109.275 -179.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 50.8 m -148.1 76.82 1.39 Allowed 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 107.27 -1.382 . . . . 60.119999999999997 107.27 172.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 21.0 m -69.32 106.99 3.1 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 115.186 -0.915 . . . . 53.200000000000003 110.978 -176.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . 0.32 11.7 p 46.81 93.18 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.246 0.891 0 C-N-CA 126.455 1.902 . . . . 64.129999999999995 114.506 -178.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 . . . . . 0 C--N 1.306 -1.32 0 CA-C-N 114.137 -1.392 . . . . 70.400000000000006 109.573 -177.605 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 800' ' ' ' CA' . . . . . 0.627 'CA ' ' OE2' ' A' ' 516' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 850' ' ' ' CA' . . . . . 0.603 'CA ' ' OD1' ' A' ' 578' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . 0.511 ' HA ' ' O ' ' A' ' 631' ' ' MET . 6.2 p-80 . . . . . 0 C--O 1.241 0.608 0 N-CA-C 110.266 -0.272 . . . . 64.430000000000007 110.266 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -93.08 -49.07 6.19 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 108.167 -1.049 . . . . 72.319999999999993 108.167 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . 0.45 ' H ' ' HA ' ' A' ' 634' ' ' PRO . . . -164.4 -177.36 37.01 Favored Glycine 0 N--CA 1.406 -3.328 0 C-N-CA 119.258 -1.449 . . . . 71.209999999999994 114.128 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 4.0 mp -125.61 134.88 65.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 123.879 0.871 . . . . 74.0 108.927 -173.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -131.2 127.62 38.29 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.343 -0.614 . . . . 74.239999999999995 109.343 173.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . 0.453 ' HB ' ' HA3' ' A' ' 637' ' ' GLY . 15.0 t -154.25 164.49 38.48 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 109.443 -0.577 . . . . 53.439999999999998 109.443 -177.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -94.8 157.67 15.83 Favored 'General case' 0 CA--C 1.493 -1.242 0 N-CA-C 108.647 -0.871 . . . . 74.140000000000001 108.647 175.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -93.75 -33.81 13.46 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 106.882 -1.525 . . . . 72.420000000000002 106.882 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -95.61 120.9 62.75 Favored Pre-proline 0 CA--C 1.49 -1.362 0 CA-C-N 114.285 -1.325 . . . . 60.340000000000003 110.097 175.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . 0.489 ' HA ' ' O ' ' A' ' 641' ' ' LYS . 2.7 Cg_exo -80.88 -20.88 7.33 Favored 'Trans proline' 0 N--CA 1.44 -1.643 0 N-CA-C 108.251 -1.48 . . . . 72.409999999999997 108.251 165.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 99.2 t -145.06 138.73 22.16 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 C-N-CA 124.876 1.27 . . . . 75.430000000000007 109.061 -178.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 10.1 t -137.02 138.99 41.08 Favored 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 107.025 -1.472 . . . . 62.200000000000003 107.025 175.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 75.7 m-70 -109.99 116.13 31.04 Favored 'General case' 0 CA--C 1.488 -1.414 0 N-CA-C 109.064 -0.717 . . . . 72.230000000000004 109.064 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.627 HG11 ' SD ' ' A' ' 521' ' ' MET . 33.4 m -109.18 155.58 10.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 CA-C-O 122.024 0.916 . . . . 55.109999999999999 112.226 -174.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . 0.465 ' O ' HG22 ' A' ' 518' ' ' ILE . 51.0 m -77.89 156.88 30.07 Favored 'General case' 0 N--CA 1.389 -3.502 0 CA-C-N 113.597 -1.638 . . . . 72.420000000000002 110.286 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . 0.43 ' HB2' ' O ' ' A' ' 647' ' ' GLU . 20.8 tp10 -87.7 -18.68 28.95 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 107.847 -1.168 . . . . 73.319999999999993 107.847 177.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 30.4 m -96.66 18.37 14.43 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.601 -0.727 . . . . 71.409999999999997 110.739 -176.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 518' ' ' ILE . . . . . 0.465 HG22 ' O ' ' A' ' 515' ' ' SER . 13.9 tt -102.81 152.22 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.631 0 N-CA-C 108.388 -0.968 . . . . 75.409999999999997 108.388 -177.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -92.89 -70.05 1.14 Allowed Glycine 0 N--CA 1.424 -2.133 0 C-N-CA 119.832 -1.175 . . . . 42.009999999999998 110.777 176.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 42.6 mm -117.34 125.21 73.87 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 N-CA-C 108.657 -0.868 . . . . 75.310000000000002 108.657 -176.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 521' ' ' MET . . . . . 0.672 ' HE1' HG21 ' A' ' 644' ' ' VAL . 22.6 ptt? -95.96 136.55 36.25 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 107.322 -1.362 . . . . 74.120000000000005 107.322 172.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 29.3 mp0 -115.79 107.56 15.2 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 108.191 -1.04 . . . . 74.430000000000007 108.191 177.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . 0.543 HG21 HD21 ' A' ' 642' ' ' LEU . 35.0 t -98.03 128.05 49.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 109.582 -0.525 . . . . 70.129999999999995 109.582 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -73.87 156.61 37.53 Favored 'General case' 0 C--N 1.317 -0.837 0 O-C-N 123.71 0.631 . . . . 74.109999999999999 111.141 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 27.2 t -127.74 144.4 37.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 N-CA-C 107.067 -1.457 . . . . 54.039999999999999 107.067 176.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -75.74 140.0 42.17 Favored 'General case' 0 CA--C 1.493 -1.237 0 N-CA-C 109.363 -0.606 . . . . 73.319999999999993 109.363 177.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . 0.475 ' CZ ' HG22 ' A' ' 567' ' ' ILE . 35.8 ttt180 -91.03 147.22 23.23 Favored 'General case' 0 N--CA 1.414 -2.24 0 CA-C-N 115.238 -0.892 . . . . 73.140000000000001 109.246 -176.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . 0.447 ' OG1' ' HA3' ' A' ' 503' ' ' GLY . 4.2 t -59.54 146.48 40.46 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 114.737 -1.12 . . . . 71.400000000000006 112.122 177.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 15.7 t -79.54 -15.6 57.41 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 108.128 -1.064 . . . . 72.150000000000006 108.128 176.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -118.75 93.76 0.57 Allowed Glycine 0 N--CA 1.432 -1.598 0 N-CA-C 109.396 -1.481 . . . . 72.25 109.396 176.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -102.17 93.37 5.19 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.393 0.616 . . . . 63.530000000000001 110.572 -177.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -116.52 115.03 25.01 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.738 -0.664 . . . . 74.049999999999997 111.698 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 77.64 -121.17 5.72 Favored Glycine 0 N--CA 1.435 -1.372 0 CA-C-N 115.208 -0.905 . . . . 73.200000000000003 113.275 173.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 534' ' ' ASN . . . . . 0.608 HD21 ' HG3' ' A' ' 561' ' ' GLU . 2.6 t-20 -139.44 127.6 22.5 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.262 -1.014 . . . . 73.340000000000003 108.262 -178.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 535' ' ' VAL . . . . . 0.529 HG22 HD22 ' A' ' 596' ' ' LEU . 54.8 t -123.52 124.57 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.742 0 N-CA-C 109.496 -0.557 . . . . 63.530000000000001 109.496 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 536' ' ' ILE . . . . . 0.504 HG23 ' HB3' ' A' ' 559' ' ' GLU . 29.9 mm -93.66 120.53 43.21 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 CA-C-N 114.966 -1.015 . . . . 64.420000000000002 109.135 178.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . 0.436 HG22 ' HB3' ' A' ' 594' ' ' PRO . 21.9 t -113.84 104.57 55.06 Favored Pre-proline 0 C--N 1.303 -1.451 0 N-CA-C 109.242 -0.651 . . . . 74.340000000000003 109.242 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -70.79 153.05 64.39 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 121.961 1.774 . . . . 72.430000000000007 110.978 177.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 539' ' ' TYR . . . . . 0.407 ' CD1' ' HG ' ' A' ' 560' ' ' LEU . 52.7 p90 -150.97 159.93 44.25 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.021 -0.733 . . . . 72.430000000000007 109.021 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -155.15 154.98 33.14 Favored 'General case' 0 C--N 1.316 -0.851 0 O-C-N 123.721 0.638 . . . . 75.420000000000002 110.605 177.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 18.0 p -93.4 116.11 28.66 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.853 -0.612 . . . . 73.319999999999993 109.369 174.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.5 mp -83.35 122.29 37.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 105.608 -1.997 . . . . 72.439999999999998 105.608 174.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -51.86 -39.45 58.93 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.115 0.783 . . . . 71.420000000000002 113.115 -175.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 74.74 -86.68 0.75 Allowed Glycine 0 N--CA 1.437 -1.273 0 N-CA-C 110.521 -1.032 . . . . 65.230000000000004 110.521 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 11.3 t -143.17 14.07 1.84 Allowed 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 122.488 1.137 . . . . 70.030000000000001 108.899 177.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . 0.456 ' HB2' ' HD3' ' A' ' 585' ' ' LYS . . . -96.74 -167.64 1.59 Allowed 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 114.714 -1.13 . . . . 65.140000000000001 109.512 177.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . 0.489 ' H ' ' HB3' ' A' ' 552' ' ' ASP . 0.0 OUTLIER -136.23 122.79 20.88 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 106.97 -1.493 . . . . 74.140000000000001 106.97 -178.944 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -78.7 -153.97 7.42 Favored Glycine 0 C--N 1.303 -1.261 0 O-C-N 123.587 0.554 . . . . 41.200000000000003 112.802 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 63.92 10.5 39.59 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 114.909 0.723 . . . . 63.009999999999998 114.909 177.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 86.18 14.19 67.13 Favored Glycine 0 N--CA 1.433 -1.561 0 C-N-CA 120.285 -0.96 . . . . 50.539999999999999 112.02 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . 0.481 ' OE2' ' HG3' ' A' ' 547' ' ' ARG . 31.8 tt0 -84.59 -61.45 1.79 Allowed 'General case' 0 C--O 1.236 0.393 0 N-CA-C 109.574 -0.528 . . . . 74.319999999999993 109.574 178.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . 0.666 ' OD2' 'CA ' ' A' ' 850' ' ' ' CA' . 17.4 t70 -105.71 -36.95 6.9 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.628 -0.879 . . . . 74.540000000000006 108.628 177.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 553' ' ' PHE . . . . . 0.515 ' HA ' HG12 ' A' ' 576' ' ' ILE . 14.0 p90 -147.97 162.61 38.98 Favored 'General case' 0 N--CA 1.428 -1.525 0 N-CA-C 108.37 -0.974 . . . . 64.209999999999994 108.37 173.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -93.9 111.42 23.12 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 105.898 -1.89 . . . . 72.329999999999998 105.898 178.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -81.68 123.53 28.8 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-O 121.873 0.844 . . . . 71.420000000000002 110.419 -175.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 10.2 t -119.89 140.97 50.03 Favored 'General case' 0 N--CA 1.412 -2.338 0 CA-C-O 121.84 0.829 . . . . 63.299999999999997 110.664 -174.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 5.9 p -144.85 134.08 22.9 Favored 'General case' 0 N--CA 1.413 -2.324 0 N-CA-C 106.638 -1.615 . . . . 74.219999999999999 106.638 177.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -167.82 -153.87 8.34 Favored Glycine 0 N--CA 1.412 -2.954 0 C-N-CA 119.715 -1.231 . . . . 75.109999999999999 110.83 -175.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 559' ' ' GLU . . . . . 0.504 ' HB3' HG23 ' A' ' 536' ' ' ILE . 35.7 mt-10 -140.86 124.89 17.25 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 122.961 0.504 . . . . 74.030000000000001 109.828 -174.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . 0.407 ' HG ' ' CD1' ' A' ' 539' ' ' TYR . 95.4 mt -90.36 134.81 34.08 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 110.113 -0.329 . . . . 54.020000000000003 110.113 178.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 561' ' ' GLU . . . . . 0.608 ' HG3' HD21 ' A' ' 534' ' ' ASN . 43.7 tt0 -102.47 100.89 11.04 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.461 -0.791 . . . . 72.439999999999998 111.208 -176.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -99.62 144.63 28.49 Favored 'General case' 0 CA--C 1.495 -1.14 0 N-CA-C 109.202 -0.666 . . . . 72.030000000000001 109.202 174.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -138.78 171.28 14.57 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 109.82 -0.437 . . . . 73.030000000000001 109.82 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 19.4 p30 -64.72 -27.53 68.97 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 116.098 -0.501 . . . . 61.100000000000001 111.26 176.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -100.97 -23.88 14.44 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 116.159 -0.473 . . . . 62.509999999999998 111.783 177.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -85.38 128.56 34.76 Favored 'General case' 0 C--O 1.248 0.974 0 N-CA-C 110.227 -0.286 . . . . 75.209999999999994 110.227 -178.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 567' ' ' ILE . . . . . 0.475 HG22 ' CZ ' ' A' ' 527' ' ' ARG . 1.5 pp -116.42 138.49 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.024 0 N-CA-C 109.028 -0.73 . . . . 73.150000000000006 109.028 -179.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 568' ' ' VAL . . . . . 0.424 HG12 ' O ' ' A' ' 567' ' ' ILE . 1.4 p 58.66 153.75 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.153 0 C-N-CA 126.554 1.942 . . . . 62.340000000000003 113.88 177.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 569' ' ' LYS . . . . . 0.638 ' HA ' ' HE2' ' A' ' 569' ' ' LYS . 7.2 mmpt? -141.1 165.93 26.18 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.92 -0.77 . . . . 74.340000000000003 108.92 175.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 570' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 7.2 p -134.48 141.81 46.87 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 124.202 0.939 . . . . 73.209999999999994 110.886 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 2.7 mp -95.4 120.88 45.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 106.656 -1.609 . . . . 70.319999999999993 106.656 173.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 8.5 p -97.39 121.81 39.71 Favored 'General case' 0 N--CA 1.427 -1.618 0 O-C-N 123.683 0.615 . . . . 75.049999999999997 110.193 178.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 573' ' ' VAL . . . . . . . . . . . . . 52.1 t -130.51 134.72 61.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 N-CA-C 109.032 -0.729 . . . . 45.420000000000002 109.032 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -89.8 120.0 30.67 Favored 'General case' 0 C--O 1.248 0.985 0 O-C-N 123.705 0.628 . . . . 74.200000000000003 110.458 177.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 99.5 t -84.57 125.43 40.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 107.74 -1.207 . . . . 71.420000000000002 107.74 175.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 576' ' ' ILE . . . . . 0.515 HG12 ' HA ' ' A' ' 553' ' ' PHE . 31.1 mm -96.44 147.5 6.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 106.899 -1.519 . . . . 74.209999999999994 106.899 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -64.76 125.48 24.94 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 123.533 0.521 . . . . 53.329999999999998 110.387 -178.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 578' ' ' ASP . . . . . 0.631 ' OD1' 'CA ' ' A' ' 850' ' ' ' CA' . 3.1 m-20 -52.25 115.32 1.68 Allowed 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 114.636 1.347 . . . . 74.430000000000007 114.636 176.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 579' ' ' GLU . . . . . 0.648 ' OE1' 'CA ' ' A' ' 850' ' ' ' CA' . 0.0 OUTLIER -73.03 -38.16 66.63 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 112.633 -2.076 . . . . 74.319999999999993 109.035 176.07 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 580' ' ' GLU . . . . . 0.648 ' OE1' 'CA ' ' A' ' 850' ' ' ' CA' . 0.0 OUTLIER -124.98 -176.35 3.53 Favored 'General case' 0 N--CA 1.428 -1.564 0 CA-C-N 114.963 -1.017 . . . . 64.049999999999997 113.169 -176.818 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -52.74 153.71 3.1 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 126.159 1.784 . . . . 73.349999999999994 109.972 175.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 582' ' ' GLU . . . . . 0.507 ' OE2' ' HB ' ' A' ' 646' ' ' ILE . 33.1 tt0 -130.2 113.81 14.91 Favored 'General case' 0 C--N 1.287 -2.118 0 C-N-CA 119.05 -1.06 . . . . 73.420000000000002 111.988 178.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -89.26 -157.73 0.47 Allowed 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 106.285 -1.746 . . . . 71.340000000000003 106.285 173.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -75.19 76.69 2.33 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.392 -1.336 . . . . 65.409999999999997 107.392 171.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 585' ' ' LYS . . . . . 0.456 ' HD3' ' HB2' ' A' ' 546' ' ' ALA . 0.7 OUTLIER -104.42 128.96 52.41 Favored 'General case' 0 N--CA 1.402 -2.838 0 N-CA-C 107.715 -1.217 . . . . 73.310000000000002 107.715 -179.237 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 2.9 t -151.92 153.63 34.5 Favored 'General case' 0 N--CA 1.393 -3.276 0 CA-C-N 114.845 -1.07 . . . . 75.420000000000002 110.093 -172.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 587' ' ' PHE . . . . . 0.522 ' CE2' HD11 ' A' ' 646' ' ' ILE . 0.8 OUTLIER -119.92 148.77 43.1 Favored 'General case' 0 N--CA 1.422 -1.858 0 O-C-N 124.668 1.23 . . . . 75.129999999999995 108.648 175.365 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 588' ' ' PHE . . . . . 0.421 ' CD1' ' HE3' ' A' ' 641' ' ' LYS . 13.8 m-85 -107.26 133.18 52.2 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.769 -0.456 . . . . 72.420000000000002 109.769 -172.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . 0.469 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.3 OUTLIER -102.91 130.42 49.95 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 106.054 -1.832 . . . . 64.430000000000007 106.054 173.638 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -139.33 151.18 46.19 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 107.149 -1.426 . . . . 71.5 107.149 178.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 591' ' ' ILE . . . . . . . . . . . . . 23.4 pt -107.24 152.14 8.91 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 O-C-N 123.234 0.334 . . . . 73.120000000000005 110.18 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -95.7 -164.42 34.26 Favored Glycine 0 N--CA 1.435 -1.38 0 N-CA-C 111.648 -0.581 . . . . 64.340000000000003 111.648 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -68.74 114.77 24.75 Favored Pre-proline 0 C--O 1.248 1.011 0 C-N-CA 122.572 0.349 . . . . 71.409999999999997 110.067 -177.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 594' ' ' PRO . . . . . 0.579 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 39.3 Cg_endo -69.39 134.08 27.86 Favored 'Trans proline' 0 N--CA 1.439 -1.725 0 C-N-CA 121.816 1.677 . . . . 73.519999999999996 109.774 177.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -122.89 127.08 48.49 Favored 'General case' 0 C--N 1.282 -2.349 0 CA-C-O 121.218 0.532 . . . . 62.509999999999998 111.651 -172.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 596' ' ' LEU . . . . . 0.529 HD22 HG22 ' A' ' 535' ' ' VAL . 0.0 OUTLIER -75.31 125.79 29.68 Favored 'General case' 0 N--CA 1.428 -1.525 0 N-CA-C 106.82 -1.548 . . . . 72.420000000000002 106.82 -179.686 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 94.7 t -72.42 -30.32 34.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 N-CA-C 112.38 0.511 . . . . 75.25 112.38 -176.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 598' ' ' GLU . . . . . 0.51 ' HG2' HD12 ' A' ' 596' ' ' LEU . 9.4 pt-20 -76.67 92.05 3.49 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 122.245 1.022 . . . . 73.420000000000002 113.341 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 91.6 mmm 60.64 78.68 0.27 Allowed 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 115.652 1.723 . . . . 73.340000000000003 115.652 174.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 21.1 m -82.4 98.38 8.83 Favored 'General case' 0 N--CA 1.419 -1.988 0 CA-C-O 122.308 1.052 . . . . 75.25 108.814 171.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -89.67 8.6 30.71 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.154 -1.385 . . . . 70.209999999999994 112.851 -172.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . 0.423 ' HD3' ' N ' ' A' ' 602' ' ' LYS . 0.1 OUTLIER 59.15 68.88 0.77 Allowed 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 109.054 -0.721 . . . . 74.549999999999997 109.054 -173.481 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 603' ' ' LYS . . . . . 0.413 ' HB3' ' HZ3' ' A' ' 603' ' ' LYS . 0.7 OUTLIER -87.75 62.85 7.2 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.474 -0.785 . . . . 64.140000000000001 112.1 -174.211 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . 0.524 ' HA3' ' O ' ' A' ' 613' ' ' ASP . . . -130.57 55.81 0.76 Allowed Glycine 0 N--CA 1.423 -2.228 0 CA-C-N 115.322 -0.854 . . . . 44.210000000000001 111.083 -178.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 155.11 -151.32 22.95 Favored Glycine 0 N--CA 1.424 -2.107 0 N-CA-C 110.846 -0.901 . . . . 64.450000000000003 110.846 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -121.33 163.52 18.51 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 106.76 -1.57 . . . . 74.239999999999995 106.76 178.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 1.9 p -83.51 147.04 28.03 Favored 'General case' 0 N--CA 1.416 -2.174 0 N-CA-C 113.302 0.853 . . . . 35.509999999999998 113.302 -178.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 49.5 mt 72.56 79.32 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 C-N-CA 125.892 1.677 . . . . 74.120000000000005 109.392 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 10.9 t 178.77 -175.15 0.2 Allowed 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 105.541 -2.022 . . . . 60.210000000000001 105.541 -178.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -107.5 -6.45 17.03 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 109.367 -0.605 . . . . 73.519999999999996 109.367 176.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -90.97 93.55 9.25 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.828 -0.624 . . . . 71.420000000000002 112.053 -174.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -133.17 93.56 3.19 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 107.516 -1.29 . . . . 73.109999999999999 107.516 175.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 613' ' ' ASP . . . . . 0.524 ' O ' ' HA3' ' A' ' 604' ' ' GLY . 24.5 t70 -101.57 109.55 21.38 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.634 0.73 . . . . 71.439999999999998 112.004 -176.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 614' ' ' ASP . . . . . 0.417 ' OD2' ' HG2' ' A' ' 615' ' ' LYS . 18.1 t70 -151.85 172.39 16.26 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 104.922 -2.251 . . . . 61.549999999999997 104.922 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 615' ' ' LYS . . . . . 0.524 ' HA ' ' HE3' ' A' ' 615' ' ' LYS . 0.0 OUTLIER 72.47 14.23 5.32 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 123.925 0.89 . . . . 74.310000000000002 112.047 176.772 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -90.65 161.03 37.5 Favored Pre-proline 0 N--CA 1.43 -1.438 0 N-CA-C 107.703 -1.221 . . . . 64.5 107.703 172.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -56.24 174.73 0.31 Allowed 'Trans proline' 0 CA--C 1.546 1.115 0 C-N-CA 122.508 2.139 . . . . 55.43 111.748 172.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.472 ' HG ' ' HB2' ' A' ' 636' ' ' LEU . 3.1 mm? -66.49 163.4 18.6 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 116.415 -0.357 . . . . 63.420000000000002 111.639 -176.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 619' ' ' THR . . . . . . . . . . . . 0.399 32.3 p 72.33 131.93 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 125.855 1.662 . . . . 71.519999999999996 112.747 -175.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 620' ' ' SER . . . . . 0.489 ' OG ' ' HB3' ' A' ' 626' ' ' ARG . 2.3 t -73.28 -7.74 52.82 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 115.45 1.648 . . . . 63.149999999999999 115.45 -165.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 59.07 29.55 19.14 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 118.07 0.395 . . . . 74.439999999999998 111.496 175.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 74.93 -7.24 1.79 Allowed 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.997 1.319 . . . . 75.040000000000006 112.553 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -80.46 132.32 35.7 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 109.51 -0.552 . . . . 74.349999999999994 109.51 -179.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -88.57 -17.2 30.7 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 116.529 -0.305 . . . . 71.109999999999999 111.568 -176.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -70.0 -40.52 75.25 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.667 -1.234 . . . . 72.430000000000007 107.667 173.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . 0.489 ' HB3' ' OG ' ' A' ' 620' ' ' SER . 0.0 OUTLIER -64.13 -31.25 72.38 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.372 -1.285 . . . . 62.340000000000003 108.001 179.904 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 627' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -63.34 -31.11 72.18 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 116.145 -0.48 . . . . 72.219999999999999 112.087 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 82.6 mt -63.28 -43.74 98.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 108.299 -1.0 . . . . 55.009999999999998 108.299 177.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -67.5 -39.82 85.17 Favored 'General case' 0 C--O 1.192 -1.941 0 CA-C-N 114.741 -1.118 . . . . 54.229999999999997 110.078 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -58.56 -30.12 66.9 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.061 0.458 . . . . 64.349999999999994 111.374 178.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 631' ' ' MET . . . . . 0.511 ' O ' ' HA ' ' A' ' 501' ' ' HIS . 66.9 mtm -91.72 -27.04 18.31 Favored 'General case' 0 CA--C 1.491 -1.314 0 CA-C-O 121.313 0.577 . . . . 73.030000000000001 110.69 -179.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -85.84 -29.33 26.51 Favored Glycine 0 N--CA 1.407 -3.266 0 C-N-CA 119.834 -1.174 . . . . 73.099999999999994 112.525 -177.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.48 160.15 59.88 Favored Pre-proline 0 C--N 1.307 -1.244 0 C-N-CA 124.642 1.177 . . . . 70.109999999999999 111.69 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.579 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 8.0 Cg_endo -70.25 143.13 47.56 Favored 'Trans proline' 0 N--CA 1.432 -2.112 0 N-CA-C 105.815 -2.417 . . . . 73.219999999999999 105.815 162.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.0 pp -129.43 -178.28 2.41 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 N-CA-C 115.54 1.681 . . . . 73.030000000000001 115.54 -174.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . 0.472 ' HB2' ' HG ' ' A' ' 618' ' ' LEU . 2.5 tp -70.79 148.22 48.12 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 113.635 -1.62 . . . . 71.040000000000006 109.959 -178.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . 0.453 ' HA3' ' HB ' ' A' ' 506' ' ' THR . . . -89.39 -133.04 4.78 Favored Glycine 0 N--CA 1.423 -2.219 0 C-N-CA 120.631 -0.795 . . . . 52.119999999999997 111.698 174.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -98.09 -54.2 3.15 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 122.638 -0.331 . . . . 75.230000000000004 111.555 -175.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -124.58 93.98 4.06 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 122.285 1.04 . . . . 74.430000000000007 112.904 -178.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 3.1 p -100.7 91.21 4.53 Favored 'General case' 0 N--CA 1.404 -2.75 0 CA-C-N 114.545 -1.207 . . . . 73.219999999999999 108.992 174.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 641' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 510' ' ' PRO . 21.0 tptm -169.76 130.44 1.03 Allowed 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 106.992 -1.484 . . . . 74.430000000000007 106.992 -175.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 642' ' ' LEU . . . . . 0.543 HD21 HG21 ' A' ' 523' ' ' VAL . 41.5 tp -132.57 103.45 6.16 Favored 'General case' 0 C--N 1.272 -2.778 0 N-CA-C 107.225 -1.398 . . . . 74.420000000000002 107.225 175.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . 0.429 ' HB2' ' HE2' ' A' ' 641' ' ' LYS . 22.0 tt0 -91.4 104.91 17.37 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 107.196 -1.409 . . . . 71.310000000000002 107.196 178.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 644' ' ' VAL . . . . . 0.672 HG21 ' HE1' ' A' ' 521' ' ' MET . 21.6 t -92.4 99.03 9.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-N 115.904 -0.589 . . . . 64.120000000000005 110.085 -176.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 3.5 mp -87.6 127.12 41.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 107.928 -1.138 . . . . 74.310000000000002 107.928 177.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 646' ' ' ILE . . . . . 0.522 HD11 ' CE2' ' A' ' 587' ' ' PHE . 1.7 mp -101.58 141.62 17.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 106.691 -1.596 . . . . 72.299999999999997 106.691 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . 0.49 ' OE2' ' HB3' ' A' ' 650' ' ' TYR . 2.0 pt-20 -135.43 159.65 40.92 Favored 'General case' 0 C--N 1.264 -3.144 0 N-CA-C 107.38 -1.341 . . . . 74.430000000000007 107.38 178.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . 0.618 ' OE2' 'CA ' ' A' ' 800' ' ' ' CA' . 3.0 mp0 -72.62 77.1 1.09 Allowed 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 121.829 0.823 . . . . 61.119999999999997 110.296 174.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 4.3 t 28.56 85.93 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 129.372 3.069 . . . . 65.319999999999993 115.886 177.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 650' ' ' TYR . . . . . 0.49 ' HB3' ' OE2' ' A' ' 647' ' ' GLU . 32.1 t80 -96.18 -72.09 0.65 Allowed 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 107.65 -1.241 . . . . 65.040000000000006 107.65 169.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -175.55 164.5 3.08 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 107.905 -1.146 . . . . 65.219999999999999 107.905 -178.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -79.84 127.89 32.78 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 116.015 -0.539 . . . . 73.310000000000002 111.232 -177.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -141.57 150.7 42.41 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 123.828 0.851 . . . . 61.109999999999999 110.524 176.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 34.1 t -152.7 91.44 1.56 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 106.839 -1.541 . . . . 71.230000000000004 106.839 173.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 28.4 m -96.95 96.6 8.62 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.356 0.598 . . . . 70.530000000000001 110.197 -177.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 46.8 t -112.54 143.89 21.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 108.04 -1.096 . . . . 72.219999999999999 108.04 178.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 . . . . . 0 C--N 1.301 -1.533 0 N-CA-C 109.189 -0.671 . . . . 75.430000000000007 109.189 179.707 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 800' ' ' ' CA' . . . . . 0.63 'CA ' ' OD2' ' A' ' 578' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 850' ' ' ' CA' . . . . . 0.666 'CA ' ' OD2' ' A' ' 552' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 8.6 p-80 . . . . . 0 N--CA 1.451 -0.394 0 N-CA-C 108.596 -0.89 . . . . 74.430000000000007 108.596 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -136.44 6.72 3.03 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 109.322 -0.622 . . . . 54.439999999999998 109.322 174.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . 0.598 ' HA2' ' OG1' ' A' ' 528' ' ' THR . . . -160.46 148.11 15.91 Favored Glycine 0 N--CA 1.414 -2.825 0 C-N-CA 117.953 -2.07 . . . . 43.530000000000001 114.979 -178.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 4.0 mp -138.58 96.3 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 N-CA-C 105.624 -1.991 . . . . 51.030000000000001 105.624 171.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -120.86 108.32 13.78 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 108.869 -0.789 . . . . 71.030000000000001 108.869 178.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 11.4 t -139.26 160.81 38.93 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 108.02 -1.104 . . . . 72.150000000000006 108.02 -176.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -85.68 148.9 25.66 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.675 -0.491 . . . . 70.340000000000003 109.675 175.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -73.51 -31.23 63.59 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.435 -0.95 . . . . 73.319999999999993 108.435 177.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -138.72 135.89 18.23 Favored Pre-proline 0 N--CA 1.44 -0.964 0 N-CA-C 109.431 -0.581 . . . . 75.010000000000005 109.431 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -82.2 -13.04 10.28 Favored 'Trans proline' 0 C--O 1.218 -0.485 0 C-N-CA 122.671 2.247 . . . . 33.409999999999997 112.08 178.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . 0.545 HG22 ' HB3' ' A' ' 643' ' ' GLU . 70.6 t -140.63 137.66 35.79 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.858 0 N-CA-C 108.365 -0.976 . . . . 63.409999999999997 108.365 -178.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 4.9 t -143.6 137.06 28.07 Favored 'General case' 0 N--CA 1.419 -1.993 0 N-CA-C 107.925 -1.139 . . . . 73.25 107.925 177.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -106.82 126.49 52.37 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 109.106 -0.702 . . . . 75.120000000000005 109.106 176.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 29.1 m -126.92 161.47 33.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 115.751 -0.659 . . . . 64.209999999999994 109.373 -175.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 33.8 t -85.54 161.86 19.15 Favored 'General case' 0 N--CA 1.424 -1.759 0 N-CA-C 108.527 -0.916 . . . . 73.329999999999998 108.527 178.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -99.3 -11.83 20.89 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-O 121.376 0.608 . . . . 73.010000000000005 109.366 177.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 48.8 m -91.41 8.94 33.84 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.637 0.732 . . . . 70.129999999999995 109.885 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 13.6 tt -90.29 157.16 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 N-CA-C 108.122 -1.066 . . . . 65.010000000000005 108.122 -178.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -88.48 -57.07 1.91 Allowed Glycine 0 N--CA 1.438 -1.199 0 C-N-CA 120.201 -1.0 . . . . 61.340000000000003 111.282 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . 0.456 HD13 ' HA ' ' A' ' 574' ' ' LYS . 44.9 mm -127.39 136.65 60.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 108.778 -0.823 . . . . 43.329999999999998 108.778 -178.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 521' ' ' MET . . . . . 0.587 ' HE2' HG21 ' A' ' 644' ' ' VAL . 0.0 OUTLIER -111.03 133.28 53.54 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.077 -1.453 . . . . 72.099999999999994 107.077 171.103 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 -117.38 128.78 55.37 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 109.294 -0.632 . . . . 72.519999999999996 109.294 -176.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . 0.64 HG21 HD21 ' A' ' 642' ' ' LEU . 20.5 t -119.81 134.87 61.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.239 0 N-CA-C 109.746 -0.464 . . . . 65.049999999999997 109.746 179.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . 0.419 ' HD2' HG21 ' A' ' 568' ' ' VAL . 29.3 mmtp -80.39 129.45 34.51 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 113.792 1.034 . . . . 62.210000000000001 113.792 -177.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 3.3 t -112.46 133.5 58.02 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 N-CA-C 106.644 -1.613 . . . . 55.32 106.644 177.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -86.76 139.67 30.49 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 120.477 -0.489 . . . . 72.209999999999994 109.723 -178.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . 0.472 ' HG2' ' N ' ' A' ' 528' ' ' THR . 37.6 ttp180 -86.96 157.73 19.42 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.103 0.478 . . . . 65.040000000000006 111.176 -176.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . 0.598 ' OG1' ' HA2' ' A' ' 503' ' ' GLY . 4.2 t -58.36 158.48 7.29 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 125.006 1.323 . . . . 71.209999999999994 111.674 173.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 32.8 t -87.94 -7.37 57.22 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 115.021 -0.99 . . . . 70.310000000000002 109.406 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -132.13 110.39 0.94 Allowed Glycine 0 N--CA 1.436 -1.324 0 N-CA-C 109.409 -1.476 . . . . 60.119999999999997 109.409 178.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . 0.408 ' HB2' HG23 ' A' ' 528' ' ' THR . . . -155.35 92.85 1.45 Allowed 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 109.3 -0.63 . . . . 65.219999999999999 109.3 -175.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.54 23.8 13.88 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 115.318 -0.856 . . . . 75.030000000000001 111.085 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . -177.26 -168.26 36.8 Favored Glycine 0 N--CA 1.42 -2.392 0 N-CA-C 110.461 -1.056 . . . . 64.120000000000005 110.461 -174.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 534' ' ' ASN . . . . . 0.534 HD21 ' HG3' ' A' ' 561' ' ' GLU . 2.9 t-20 -85.37 132.82 34.17 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 123.482 0.713 . . . . 75.549999999999997 110.304 -177.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 535' ' ' VAL . . . . . 0.513 HG22 HD22 ' A' ' 596' ' ' LEU . 58.0 t -128.13 124.74 63.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 108.871 -0.789 . . . . 50.299999999999997 108.871 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 536' ' ' ILE . . . . . 0.506 HG23 ' HB3' ' A' ' 559' ' ' GLU . 19.7 mm -97.85 127.8 49.87 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 CA-C-N 115.921 -0.581 . . . . 62.039999999999999 109.931 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . 0.521 HG22 ' HB3' ' A' ' 594' ' ' PRO . 41.5 t -117.1 103.74 51.48 Favored Pre-proline 0 C--N 1.309 -1.187 0 N-CA-C 108.684 -0.858 . . . . 73.420000000000002 108.684 176.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -71.95 144.47 43.04 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.193 1.929 . . . . 63.119999999999997 110.769 178.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 539' ' ' TYR . . . . . 0.487 ' HB3' HG22 ' A' ' 591' ' ' ILE . 49.0 p90 -145.75 167.31 23.46 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 109.414 -0.587 . . . . 73.0 109.414 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -158.97 157.14 30.73 Favored 'General case' 0 C--N 1.308 -1.222 0 O-C-N 123.711 0.632 . . . . 74.530000000000001 109.781 177.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 3.3 p -93.17 113.6 25.88 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 115.143 -0.935 . . . . 55.310000000000002 110.546 175.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.3 mp -78.47 118.01 24.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 N-CA-C 104.781 -2.303 . . . . 70.040000000000006 104.781 173.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -53.65 -43.12 68.55 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 124.019 0.825 . . . . 52.140000000000001 112.76 -174.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 67.19 -89.71 0.17 Allowed Glycine 0 N--CA 1.451 -0.327 0 O-C-N 123.491 0.494 . . . . 71.510000000000005 112.258 176.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 7.4 t -137.2 20.06 2.97 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.3 0.571 . . . . 74.040000000000006 110.166 178.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . 0.434 ' HB2' ' HG2' ' A' ' 585' ' ' LYS . . . -119.37 166.41 13.08 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.465 -0.939 . . . . 74.140000000000001 108.465 175.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . 0.444 ' HB2' ' HB2' ' A' ' 551' ' ' GLU . 0.0 OUTLIER -95.72 114.04 25.74 Favored 'General case' 0 CA--C 1.488 -1.438 0 C-N-CA 120.012 -0.675 . . . . 71.230000000000004 112.643 176.872 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -94.77 108.81 3.74 Favored Glycine 0 C--N 1.291 -1.928 0 N-CA-C 110.061 -1.216 . . . . 74.519999999999996 110.061 178.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 154.43 8.76 0.08 OUTLIER Glycine 0 C--N 1.295 -1.735 0 C-N-CA 119.341 -1.409 . . . . 53.32 112.703 -178.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 109.3 5.18 30.42 Favored Glycine 0 N--CA 1.431 -1.649 0 C-N-CA 119.234 -1.46 . . . . 71.200000000000003 113.585 178.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . 0.444 ' HB2' ' HB2' ' A' ' 547' ' ' ARG . 15.2 mm-40 -84.29 -70.39 0.58 Allowed 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 117.614 0.707 . . . . 63.240000000000002 109.212 177.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . 0.592 ' OD1' 'CA ' ' A' ' 850' ' ' ' CA' . 13.8 m-20 -101.31 -39.56 7.54 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 108.276 -1.009 . . . . 62.119999999999997 108.276 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -139.33 160.88 38.8 Favored 'General case' 0 C--O 1.262 1.715 0 CA-C-O 121.238 0.542 . . . . 71.120000000000005 109.617 179.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.21 119.28 29.56 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 106.675 -1.602 . . . . 72.400000000000006 106.675 179.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -67.06 101.81 0.92 Allowed 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 122.979 0.512 . . . . 73.549999999999997 109.671 -178.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . 0.509 HG21 HG22 ' A' ' 573' ' ' VAL . 12.4 t -100.78 110.75 22.87 Favored 'General case' 0 N--CA 1.413 -2.308 0 CA-C-O 122.689 1.233 . . . . 72.030000000000001 110.779 -176.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 1.7 p -133.39 96.69 3.78 Favored 'General case' 0 N--CA 1.413 -2.297 0 CA-C-N 114.234 -1.348 . . . . 62.329999999999998 108.66 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -147.03 -153.33 5.88 Favored Glycine 0 N--CA 1.408 -3.167 0 N-CA-C 110.518 -1.033 . . . . 61.039999999999999 110.518 -173.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 559' ' ' GLU . . . . . 0.506 ' HB3' HG23 ' A' ' 536' ' ' ILE . 33.3 mt-10 -133.73 124.64 27.02 Favored 'General case' 0 C--N 1.29 -2.001 0 O-C-N 123.605 0.238 . . . . 61.039999999999999 111.289 -172.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . 0.455 ' HG ' ' CD2' ' A' ' 539' ' ' TYR . 93.2 mt -80.99 133.03 35.42 Favored 'General case' 0 C--O 1.247 0.929 0 N-CA-C 109.765 -0.457 . . . . 64.0 109.765 177.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 561' ' ' GLU . . . . . 0.534 ' HG3' HD21 ' A' ' 534' ' ' ASN . 43.9 tt0 -96.78 98.19 9.94 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 115.986 -0.552 . . . . 74.319999999999993 111.475 -178.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -96.98 150.88 20.27 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 107.004 -1.48 . . . . 71.549999999999997 107.004 172.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . 0.406 ' HA ' ' HA ' ' A' ' 534' ' ' ASN . 1.9 pt20 -156.53 172.7 18.08 Favored 'General case' 0 C--N 1.28 -2.434 0 O-C-N 121.926 -0.484 . . . . 72.109999999999999 111.044 -178.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -52.14 -47.15 65.54 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 124.687 1.195 . . . . 62.020000000000003 111.012 -177.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -90.15 4.84 49.25 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 114.061 1.134 . . . . 75.209999999999994 114.061 -177.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 24.8 tp10 -121.79 126.63 49.27 Favored 'General case' 0 C--N 1.309 -1.189 0 O-C-N 121.76 -0.587 . . . . 74.409999999999997 110.555 -178.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 567' ' ' ILE . . . . . 0.456 ' HA ' ' HD3' ' A' ' 527' ' ' ARG . 4.9 pt -111.39 159.72 11.18 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.868 0 N-CA-C 109.266 -0.642 . . . . 72.319999999999993 109.266 174.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 568' ' ' VAL . . . . . 0.419 HG21 ' HD2' ' A' ' 524' ' ' LYS . 1.4 p 50.14 176.28 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.57 1.748 0 C-N-CA 125.955 1.702 . . . . 73.030000000000001 111.487 -176.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 569' ' ' LYS . . . . . 0.575 ' HA ' ' HE3' ' A' ' 569' ' ' LYS . 0.0 OUTLIER -165.72 167.83 16.71 Favored 'General case' 0 C--N 1.313 -1.017 0 O-C-N 120.911 -1.118 . . . . 73.400000000000006 108.28 173.941 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 570' ' ' THR . . . . . 0.612 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 7.1 p -132.28 138.66 47.94 Favored 'General case' 0 N--CA 1.421 -1.881 0 O-C-N 123.719 0.637 . . . . 71.400000000000006 109.971 179.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 571' ' ' ILE . . . . . 0.407 HG21 HD21 ' A' ' 589' ' ' LEU . 3.3 mp -90.66 117.07 33.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 106.618 -1.623 . . . . 74.230000000000004 106.618 170.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 15.7 p -95.29 110.8 22.75 Favored 'General case' 0 N--CA 1.426 -1.646 0 CA-C-O 121.059 0.457 . . . . 74.030000000000001 109.892 177.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 573' ' ' VAL . . . . . 0.509 HG22 HG21 ' A' ' 556' ' ' THR . 48.6 t -108.73 132.29 57.08 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 N-CA-C 109.113 -0.699 . . . . 54.119999999999997 109.113 -179.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 574' ' ' LYS . . . . . 0.456 ' HA ' HD13 ' A' ' 520' ' ' ILE . 22.3 tptm -86.91 119.74 27.45 Favored 'General case' 0 N--CA 1.434 -1.262 0 O-C-N 123.569 0.543 . . . . 75.140000000000001 110.463 179.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 56.3 t -89.91 132.87 33.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 106.674 -1.602 . . . . 71.109999999999999 106.674 175.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 39.5 mm -94.32 153.36 3.45 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 N-CA-C 109.16 -0.682 . . . . 64.109999999999999 109.16 -173.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -61.73 106.36 0.67 Allowed 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.582 -0.896 . . . . 72.510000000000005 108.582 172.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 578' ' ' ASP . . . . . 0.658 ' OD2' 'CA ' ' A' ' 800' ' ' ' CA' . 44.1 t0 -62.29 142.18 57.88 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 113.944 -1.48 . . . . 70.310000000000002 112.949 -169.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -80.18 -51.91 8.39 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.844 0.83 . . . . 72.209999999999994 110.052 -177.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.64 -156.27 0.69 Allowed 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.803 -0.814 . . . . 70.549999999999997 108.803 -176.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -113.51 150.28 33.15 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 105.557 -2.016 . . . . 73.010000000000005 105.557 172.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 582' ' ' GLU . . . . . 0.645 ' OE1' 'CA ' ' A' ' 800' ' ' ' CA' . 41.1 mp0 -126.68 -174.43 3.13 Favored 'General case' 0 C--N 1.282 -2.365 0 N-CA-C 108.785 -0.82 . . . . 64.230000000000004 108.785 176.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -85.64 -158.75 0.41 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 106.633 -1.617 . . . . 54.329999999999998 106.633 174.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 584' ' ' ASN . . . . . 0.403 ' ND2' ' HB3' ' A' ' 647' ' ' GLU . 15.0 m120 -85.63 79.81 9.23 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 106.437 -1.69 . . . . 71.030000000000001 106.437 173.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 585' ' ' LYS . . . . . 0.434 ' HG2' ' HB2' ' A' ' 546' ' ' ALA . 0.0 OUTLIER -88.55 168.03 12.92 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 115.411 -0.813 . . . . 64.439999999999998 110.131 -172.86 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 5.0 t -155.29 149.92 26.33 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-O 121.742 0.782 . . . . 74.239999999999995 112.873 -173.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -126.55 148.68 49.71 Favored 'General case' 0 N--CA 1.412 -2.33 0 CA-C-N 112.894 -1.957 . . . . 74.209999999999994 108.167 174.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 588' ' ' PHE . . . . . 0.515 ' HA ' ' O ' ' A' ' 642' ' ' LEU . 28.3 m-85 -105.61 129.74 53.79 Favored 'General case' 0 C--N 1.292 -1.935 0 N-CA-C 109.177 -0.675 . . . . 63.240000000000002 109.177 -175.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . 0.407 HD21 HG21 ' A' ' 571' ' ' ILE . 0.3 OUTLIER -97.83 121.09 39.34 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 106.034 -1.839 . . . . 72.519999999999996 106.034 176.814 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -125.34 129.89 50.86 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 109.712 -0.477 . . . . 72.239999999999995 109.712 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 591' ' ' ILE . . . . . 0.487 HG22 ' HB3' ' A' ' 539' ' ' TYR . 22.8 pt -98.44 138.4 23.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 107.229 -1.397 . . . . 73.510000000000005 107.229 174.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -91.06 -144.95 13.29 Favored Glycine 0 N--CA 1.431 -1.642 0 C-N-CA 121.0 -0.619 . . . . 71.319999999999993 112.897 -176.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -83.33 119.28 73.73 Favored Pre-proline 0 C--N 1.301 -1.516 0 N-CA-C 109.451 -0.574 . . . . 73.120000000000005 109.451 -178.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 594' ' ' PRO . . . . . 0.521 ' HB3' HG22 ' A' ' 537' ' ' VAL . 30.2 Cg_endo -67.15 152.7 79.36 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 121.966 1.777 . . . . 62.140000000000001 111.016 176.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -137.21 133.42 35.12 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 110.051 -0.351 . . . . 74.420000000000002 110.051 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 596' ' ' LEU . . . . . 0.513 HD22 HG22 ' A' ' 535' ' ' VAL . 0.0 OUTLIER -79.01 130.91 36.04 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 106.643 -1.614 . . . . 63.340000000000003 106.643 179.832 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 16.8 t -91.2 16.97 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 CA-C-O 122.071 0.939 . . . . 73.319999999999993 109.954 -177.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -78.15 85.7 4.32 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-O 122.857 1.313 . . . . 71.25 110.626 176.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 83.0 mmm -99.39 82.36 2.66 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 114.644 -1.162 . . . . 71.5 108.624 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 25.8 t -93.73 -33.94 13.42 Favored 'General case' 0 N--CA 1.417 -2.116 0 CA-C-N 114.029 -1.441 . . . . 72.400000000000006 108.619 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 59.38 92.59 0.04 OUTLIER 'General case' 0 C--O 1.242 0.682 0 C-N-CA 124.363 1.065 . . . . 71.109999999999999 108.76 -176.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -99.79 147.93 24.95 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 115.072 -0.967 . . . . 72.239999999999995 112.863 -168.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 1.7 tmmm? -132.99 75.56 1.63 Allowed 'General case' 0 N--CA 1.423 -1.79 0 N-CA-C 106.104 -1.813 . . . . 64.200000000000003 106.104 175.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -86.26 -26.95 32.0 Favored Glycine 0 CA--C 1.491 -1.415 0 N-CA-C 109.227 -1.549 . . . . 75.109999999999999 109.227 178.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 176.68 178.66 46.62 Favored Glycine 0 N--CA 1.412 -2.946 0 N-CA-C 107.267 -2.333 . . . . 63.310000000000002 107.267 178.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -93.96 85.46 4.76 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 107.734 -1.21 . . . . 71.329999999999998 107.734 177.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 28.9 p -78.52 121.99 25.3 Favored 'General case' 0 N--CA 1.418 -2.066 0 CA-C-N 114.603 -1.18 . . . . 53.149999999999999 111.962 -174.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 57.3 mt -89.02 96.4 6.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 106.078 -1.823 . . . . 64.299999999999997 106.078 175.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 12.8 t -156.16 146.92 21.95 Favored 'General case' 0 C--N 1.286 -2.186 0 CA-C-N 115.536 -0.756 . . . . 63.100000000000001 109.802 -173.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -93.57 93.25 7.97 Favored 'General case' 0 N--CA 1.418 -2.046 0 CA-C-N 115.567 -0.742 . . . . 71.099999999999994 109.072 174.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -131.53 67.25 1.52 Allowed 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 105.92 -1.882 . . . . 53.439999999999998 105.92 172.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -107.35 134.92 49.7 Favored 'General case' 0 N--CA 1.404 -2.759 0 CA-C-N 113.904 -1.498 . . . . 74.25 108.857 -174.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -72.91 90.03 1.44 Allowed 'General case' 0 CA--C 1.498 -1.041 0 CA-C-O 121.666 0.746 . . . . 63.240000000000002 109.088 175.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -85.47 101.98 13.09 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 107.909 -1.145 . . . . 55.310000000000002 107.909 176.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -74.87 83.2 2.18 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 122.526 1.155 . . . . 71.140000000000001 112.837 -173.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -135.21 166.87 25.7 Favored Pre-proline 0 C--N 1.296 -1.747 0 CA-C-N 113.026 -1.897 . . . . 53.310000000000002 106.912 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -62.4 167.74 10.78 Favored 'Trans proline' 0 C--O 1.253 1.263 0 C-N-CA 121.418 1.412 . . . . 71.519999999999996 109.824 172.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -67.27 99.55 0.72 Allowed 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.809 0.814 . . . . 74.209999999999994 111.457 -175.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 5.6 p -140.72 145.86 37.03 Favored 'General case' 0 N--CA 1.42 -1.962 0 CA-C-N 114.074 -1.421 . . . . 71.239999999999995 107.686 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 5.7 p -107.48 -20.96 13.09 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-O 120.599 0.238 . . . . 52.509999999999998 110.38 177.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm 62.99 11.43 5.11 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.307 1.043 . . . . 74.510000000000005 111.339 175.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 68.6 -3.82 1.29 Allowed 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 124.96 1.304 . . . . 75.329999999999998 111.007 -174.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -76.54 128.38 34.65 Favored 'General case' 0 N--CA 1.432 -1.342 0 C-N-CA 124.278 1.031 . . . . 73.049999999999997 109.087 -175.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -69.63 -33.4 72.58 Favored 'General case' 0 C--O 1.201 -1.495 0 C-N-CA 120.246 -0.581 . . . . 75.319999999999993 110.263 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 16.2 mp0 -56.94 -40.42 76.38 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 123.383 0.427 . . . . 73.409999999999997 110.954 178.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . 0.647 ' O ' ' HG2' ' A' ' 630' ' ' GLU . 11.4 tpt180 -70.75 -47.04 61.74 Favored 'General case' 0 C--O 1.204 -1.293 0 N-CA-C 108.705 -0.85 . . . . 75.010000000000005 108.705 176.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 627' ' ' ARG . . . . . . . . . . . . . 70.4 mtm180 -59.67 -39.6 85.0 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 113.103 0.779 . . . . 71.450000000000003 113.103 -177.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . 0.418 ' O ' ' HG2' ' A' ' 631' ' ' MET . 96.8 mt -64.74 -36.04 76.54 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 CA-C-O 121.301 0.572 . . . . 51.229999999999997 110.015 177.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -69.52 -39.21 77.66 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.842 -0.617 . . . . 64.439999999999998 109.995 177.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 630' ' ' GLU . . . . . 0.647 ' HG2' ' O ' ' A' ' 626' ' ' ARG . 3.7 mm-40 -72.88 -1.14 15.65 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 112.527 0.566 . . . . 74.25 112.527 -176.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 631' ' ' MET . . . . . 0.418 ' HG2' ' O ' ' A' ' 628' ' ' ILE . 26.1 ptt? -102.58 -13.23 17.25 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 119.838 -0.745 . . . . 73.019999999999996 110.539 173.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -100.12 -27.87 7.56 Favored Glycine 0 C--N 1.319 -0.388 0 N-CA-C 108.844 -1.703 . . . . 75.430000000000007 108.844 174.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 15.2 mtp85 -98.72 139.91 21.41 Favored Pre-proline 0 C--N 1.297 -1.717 0 C-N-CA 124.968 1.307 . . . . 71.319999999999993 108.412 176.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.493 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 51.0 Cg_endo -73.08 139.58 29.93 Favored 'Trans proline' 0 N--CA 1.441 -1.578 0 C-N-CA 121.545 1.497 . . . . 75.209999999999994 110.697 176.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.4 pp -126.68 -175.96 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 111.904 0.335 . . . . 71.340000000000003 111.904 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -77.61 178.29 7.41 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.228 0.537 . . . . 75.319999999999993 111.29 -174.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -96.58 -85.18 1.74 Allowed Glycine 0 N--CA 1.421 -2.343 0 C-N-CA 120.554 -0.831 . . . . 43.109999999999999 111.606 178.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -127.53 -66.78 0.86 Allowed 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 115.509 -0.346 . . . . 72.310000000000002 110.08 -175.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 13.3 p80 -123.14 119.05 29.11 Favored 'General case' 0 C--O 1.246 0.9 0 CA-C-O 121.627 0.727 . . . . 61.030000000000001 111.51 -177.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 6.3 p -109.12 90.98 3.46 Favored 'General case' 0 N--CA 1.412 -2.356 0 CA-C-N 115.145 -0.934 . . . . 73.319999999999993 108.747 175.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -177.49 132.1 0.16 Allowed 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 106.49 -1.67 . . . . 72.030000000000001 106.49 -176.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 642' ' ' LEU . . . . . 0.64 HD21 HG21 ' A' ' 523' ' ' VAL . 41.8 tp -138.24 111.83 8.2 Favored 'General case' 0 C--N 1.29 -2.007 0 O-C-N 123.705 0.628 . . . . 73.040000000000006 109.61 177.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . 0.545 ' HB3' HG22 ' A' ' 511' ' ' VAL . 35.7 tt0 -90.74 104.01 16.64 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 107.392 -1.336 . . . . 53.109999999999999 107.392 177.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 644' ' ' VAL . . . . . 0.587 HG21 ' HE2' ' A' ' 521' ' ' MET . 39.8 t -95.01 110.07 23.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 108.804 -0.813 . . . . 71.010000000000005 108.804 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 3.9 mp -91.82 117.74 35.76 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 N-CA-C 108.013 -1.106 . . . . 64.109999999999999 108.013 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 646' ' ' ILE . . . . . 0.494 HD12 ' H ' ' A' ' 646' ' ' ILE . 1.5 mp -107.13 109.54 28.53 Favored 'Isoleucine or valine' 0 CA--C 1.473 -2.018 0 N-CA-C 106.115 -1.809 . . . . 62.420000000000002 106.115 -176.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . 0.403 ' HB3' ' ND2' ' A' ' 584' ' ' ASN . 3.8 pt-20 -111.33 150.35 29.83 Favored 'General case' 0 C--N 1.249 -3.787 0 C-N-CA 120.417 -0.513 . . . . 73.549999999999997 111.401 -178.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -63.3 133.9 54.92 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 105.552 -2.018 . . . . 72.519999999999996 105.552 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 8.2 t -60.98 107.46 0.72 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.827 0.822 . . . . 34.350000000000001 112.05 -169.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -132.87 -60.63 0.86 Allowed 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 114.579 -1.191 . . . . 74.299999999999997 110.158 -178.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 179.96 160.22 0.85 Allowed 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 106.255 -1.758 . . . . 60.420000000000002 106.255 -176.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -130.0 104.77 7.55 Favored 'General case' 0 N--CA 1.409 -2.483 0 CA-C-O 121.279 0.561 . . . . 72.239999999999995 111.714 -173.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -111.22 117.48 33.3 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.376 -1.342 . . . . 74.219999999999999 107.376 175.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 30.4 t -71.36 113.56 8.53 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.35 0.595 . . . . 74.319999999999993 112.068 -173.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 9.0 t -143.28 79.29 1.63 Allowed 'General case' 0 N--CA 1.417 -2.117 0 CA-C-O 122.921 1.343 . . . . 74.140000000000001 107.848 174.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 6.5 p -83.52 110.48 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.244 0 CA-C-N 114.505 -1.225 . . . . 64.25 111.318 -176.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 16.5 t70 . . . . . 0 C--N 1.303 -1.444 0 CA-C-N 115.151 -0.931 . . . . 73.109999999999999 111.009 -179.344 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 800' ' ' ' CA' . . . . . 0.658 'CA ' ' OD2' ' A' ' 578' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 850' ' ' ' CA' . . . . . 0.625 'CA ' ' OD1' ' A' ' 578' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 . . . . . 0 N--CA 1.443 -0.782 0 N-CA-C 108.972 -0.751 . . . . 73.120000000000005 108.972 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . 0.421 ' HB3' ' HA ' ' A' ' 634' ' ' PRO . . . -130.62 -52.13 1.07 Allowed 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 107.606 -1.257 . . . . 72.010000000000005 107.606 174.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . 0.553 ' HA2' ' OG1' ' A' ' 528' ' ' THR . . . -147.83 146.17 15.56 Favored Glycine 0 N--CA 1.398 -3.838 0 CA-C-N 114.311 -1.313 . . . . 64.219999999999999 110.938 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 2.9 mp -123.58 105.81 16.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 108.096 -1.076 . . . . 44.219999999999999 108.096 -178.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . 0.428 ' CE1' ' HB ' ' A' ' 528' ' ' THR . 93.1 m-85 -114.9 121.49 43.37 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.178 0.513 . . . . 52.119999999999997 110.59 178.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . 0.433 HG23 HD23 ' A' ' 526' ' ' LEU . 13.8 t -147.21 163.01 37.71 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.022 -1.103 . . . . 74.030000000000001 108.022 -177.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -85.61 148.32 25.97 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 120.844 0.354 . . . . 75.019999999999996 110.961 176.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -84.44 -20.5 31.68 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 107.264 -1.384 . . . . 71.519999999999996 107.264 176.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . 0.432 ' HG3' ' O ' ' A' ' 511' ' ' VAL . 1.9 tp10 -129.01 120.58 20.34 Favored Pre-proline 0 N--CA 1.431 -1.389 0 CA-C-N 114.734 -1.121 . . . . 62.399999999999999 108.169 -178.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -80.38 -24.3 5.51 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 120.908 1.072 . . . . 74.409999999999997 110.147 173.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . 0.521 HG22 ' HB3' ' A' ' 643' ' ' GLU . 76.4 t -142.93 129.02 17.13 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 C-N-CA 124.561 1.145 . . . . 44.140000000000001 108.722 -178.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 14.6 t -128.2 142.94 51.03 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 108.284 -1.006 . . . . 70.219999999999999 108.284 177.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 52.6 m80 -108.42 120.85 43.6 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.861 -0.792 . . . . 61.310000000000002 108.861 175.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 23.1 m -118.13 150.15 20.36 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.394 0 N-CA-C 107.919 -1.141 . . . . 71.120000000000005 107.919 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . 0.406 ' HG ' ' HA ' ' A' ' 649' ' ' SER . 2.7 t -83.95 152.71 24.33 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 108.74 -0.837 . . . . 54.439999999999998 108.74 -178.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . 0.659 ' OE2' 'CA ' ' A' ' 800' ' ' ' CA' . 38.8 tt0 -70.33 -21.08 62.95 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 120.934 0.397 . . . . 70.340000000000003 110.928 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 45.2 m -90.35 12.21 19.04 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-O 121.226 0.536 . . . . 61.210000000000001 110.709 -175.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 12.7 tt -86.57 153.46 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.877 0 N-CA-C 108.871 -0.788 . . . . 74.25 108.871 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -90.98 -63.92 1.2 Allowed Glycine 0 N--CA 1.432 -1.596 0 C-N-CA 119.959 -1.115 . . . . 71.239999999999995 110.568 178.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 37.1 mm -120.25 121.44 65.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 107.905 -1.146 . . . . 72.409999999999997 107.905 178.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 521' ' ' MET . . . . . 0.574 ' HE1' HG21 ' A' ' 644' ' ' VAL . 0.0 OUTLIER -94.92 136.37 35.32 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 106.907 -1.516 . . . . 73.319999999999993 106.907 174.312 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 522' ' ' GLU . . . . . 0.46 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 48.9 mt-10 -124.41 138.26 54.38 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 124.093 0.871 . . . . 71.109999999999999 109.949 -178.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . 0.797 HG21 HD21 ' A' ' 642' ' ' LEU . 39.7 t -129.23 140.87 48.06 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 N-CA-C 109.055 -0.72 . . . . 74.150000000000006 109.055 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . 0.576 ' HD2' ' CG2' ' A' ' 568' ' ' VAL . 34.1 mmtp -85.34 134.35 34.1 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 122.243 1.02 . . . . 75.109999999999999 113.18 -178.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 4.2 t -110.57 146.94 15.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-N 113.926 -1.488 . . . . 65.200000000000003 107.349 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . 0.433 HD23 HG23 ' A' ' 506' ' ' THR . 2.8 mm? -87.3 135.58 33.26 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 109.567 -0.531 . . . . 75.409999999999997 109.567 177.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . 0.534 ' HD3' ' HA ' ' A' ' 567' ' ' ILE . 39.2 ttp180 -83.27 150.38 26.2 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-N 115.6 -0.727 . . . . 75.209999999999994 110.468 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . 0.553 ' OG1' ' HA2' ' A' ' 503' ' ' GLY . 1.8 t -50.12 147.36 4.15 Favored 'General case' 0 N--CA 1.435 -1.198 0 C-N-CA 125.866 1.667 . . . . 73.420000000000002 113.2 174.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 19.2 m -65.07 -38.05 89.53 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 114.4 -1.273 . . . . 71.409999999999997 110.035 176.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -107.45 103.24 1.92 Allowed Glycine 0 N--CA 1.419 -2.451 0 N-CA-C 108.994 -1.642 . . . . 63.119999999999997 108.994 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . 0.475 ' HB2' HG23 ' A' ' 528' ' ' THR . . . -122.13 65.76 0.92 Allowed 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.046 0.45 . . . . 64.120000000000005 111.281 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -117.1 90.76 3.4 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.101 -1.444 . . . . 64.349999999999994 107.101 175.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 142.4 -138.31 8.38 Favored Glycine 0 N--CA 1.419 -2.464 0 N-CA-C 110.153 -1.179 . . . . 74.409999999999997 110.153 -175.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 534' ' ' ASN . . . . . 0.524 HD21 ' HG3' ' A' ' 561' ' ' GLU . 2.8 t-20 -146.14 131.34 18.42 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.841 -1.17 . . . . 64.140000000000001 107.841 -178.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 535' ' ' VAL . . . . . 0.452 HG22 HD22 ' A' ' 596' ' ' LEU . 59.2 t -131.01 132.7 63.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.156 -0.683 . . . . 74.439999999999998 109.156 -177.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 536' ' ' ILE . . . . . . . . . . . . . 44.0 mm -105.35 131.04 55.64 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 109.665 -0.495 . . . . 64.239999999999995 109.665 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . 0.484 HG22 ' HB3' ' A' ' 594' ' ' PRO . 20.1 t -118.12 102.36 50.83 Favored Pre-proline 0 C--N 1.311 -1.089 0 O-C-N 123.307 0.38 . . . . 41.549999999999997 110.09 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -73.78 138.64 26.56 Favored 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 122.372 2.048 . . . . 61.549999999999997 111.604 178.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 539' ' ' TYR . . . . . 0.47 ' HB3' HG22 ' A' ' 591' ' ' ILE . 51.5 p90 -142.72 160.6 40.0 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 110.353 -0.24 . . . . 73.319999999999993 110.353 -177.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 540' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 556' ' ' THR . 0.0 OUTLIER -154.67 160.03 41.14 Favored 'General case' 0 C--O 1.247 0.938 0 O-C-N 123.595 0.56 . . . . 72.120000000000005 111.432 176.656 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 31.6 p -96.67 127.03 42.26 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.665 -0.698 . . . . 53.5 111.495 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.8 mp -93.72 111.52 25.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 106.142 -1.799 . . . . 71.400000000000006 106.142 172.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . 0.414 ' H ' ' CD ' ' A' ' 543' ' ' GLU . 1.5 mp0 -51.88 -53.34 41.85 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 124.348 1.059 . . . . 70.540000000000006 111.693 -176.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 68.95 -98.06 0.53 Allowed Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 121.1 -0.571 . . . . 72.329999999999998 111.969 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 545' ' ' THR . . . . . 0.436 HG23 ' H ' ' A' ' 586' ' ' THR . 8.8 t -111.29 -1.91 15.88 Favored 'General case' 0 CA--C 1.553 1.058 0 CA-C-O 121.969 0.89 . . . . 73.310000000000002 109.589 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . 0.42 ' HB2' ' HG2' ' A' ' 585' ' ' LYS . . . -93.8 171.12 9.07 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 108.067 -1.086 . . . . 55.240000000000002 108.067 174.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . 0.481 ' H ' ' HB3' ' A' ' 552' ' ' ASP . 1.4 tmt_? -126.67 121.55 32.44 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.009 -0.737 . . . . 75.540000000000006 109.009 -176.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -79.53 -164.58 28.85 Favored Glycine 0 CA--C 1.518 0.223 0 CA-C-N 116.234 -0.439 . . . . 71.219999999999999 112.892 -177.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 77.58 15.95 80.79 Favored Glycine 0 C--N 1.307 -1.058 0 N-CA-C 112.372 -0.291 . . . . 54.109999999999999 112.372 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 69.97 32.9 69.77 Favored Glycine 0 N--CA 1.431 -1.671 0 N-CA-C 110.5 -1.04 . . . . 74.120000000000005 110.5 -176.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -96.81 -64.58 1.03 Allowed 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 109.025 -0.731 . . . . 73.230000000000004 109.025 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . 0.636 ' OD2' 'CA ' ' A' ' 850' ' ' ' CA' . 12.2 t70 -102.6 -36.62 8.28 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 106.807 -1.553 . . . . 61.5 106.807 177.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 553' ' ' PHE . . . . . 0.416 ' HA ' HG12 ' A' ' 576' ' ' ILE . 11.7 p90 -146.59 163.68 35.03 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 114.735 -1.121 . . . . 74.140000000000001 108.565 174.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -91.79 105.43 17.71 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 107.022 -1.473 . . . . 71.219999999999999 107.022 177.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -71.19 139.38 50.14 Favored 'General case' 0 CA--C 1.486 -1.488 0 N-CA-C 108.343 -0.984 . . . . 75.010000000000005 108.343 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 540' ' ' LYS . 11.0 t -138.16 138.43 38.61 Favored 'General case' 0 N--CA 1.396 -3.149 0 C-N-CA 118.842 -1.143 . . . . 74.329999999999998 111.989 -175.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 23.2 p -131.04 119.75 22.45 Favored 'General case' 0 N--CA 1.415 -2.216 0 N-CA-C 106.255 -1.757 . . . . 61.039999999999999 106.255 173.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -147.83 -170.67 16.1 Favored Glycine 0 N--CA 1.41 -3.057 0 C-N-CA 120.136 -1.031 . . . . 70.450000000000003 111.236 -172.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -139.09 106.6 5.57 Favored 'General case' 0 C--N 1.293 -1.885 0 C-N-CA 122.75 0.42 . . . . 53.5 109.869 -175.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 91.3 mt -73.71 136.79 43.75 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-N 116.043 -0.526 . . . . 72.430000000000007 110.198 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 561' ' ' GLU . . . . . 0.524 ' HG3' HD21 ' A' ' 534' ' ' ASN . 44.6 tt0 -105.62 114.71 29.04 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 116.102 -0.499 . . . . 63.119999999999997 111.235 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -111.17 148.74 32.1 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.656 -0.868 . . . . 75.430000000000007 108.656 174.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . 0.466 ' H ' ' HB3' ' A' ' 566' ' ' GLU . 4.2 pt20 -159.51 -178.16 6.92 Favored 'General case' 0 C--N 1.285 -2.225 0 N-CA-C 108.713 -0.847 . . . . 73.129999999999995 108.713 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -69.08 -29.98 68.2 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 121.712 0.768 . . . . 51.140000000000001 110.728 -178.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -82.74 -0.98 50.13 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.749 0.785 . . . . 73.540000000000006 110.798 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . 0.466 ' HB3' ' H ' ' A' ' 563' ' ' GLN . 8.2 tp10 -120.74 142.66 49.33 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.704 -0.623 . . . . 64.129999999999995 110.542 -175.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 567' ' ' ILE . . . . . 0.534 ' HA ' ' HD3' ' A' ' 527' ' ' ARG . 2.4 pt -133.58 150.78 32.31 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.273 0 N-CA-C 106.035 -1.839 . . . . 75.030000000000001 106.035 170.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 568' ' ' VAL . . . . . 0.576 ' CG2' ' HD2' ' A' ' 524' ' ' LYS . 1.2 p 49.77 -177.71 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.59 2.497 0 C-N-CA 124.7 1.2 . . . . 63.520000000000003 111.78 -175.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 569' ' ' LYS . . . . . 0.596 ' HA ' ' HE3' ' A' ' 569' ' ' LYS . 0.2 OUTLIER -173.94 164.55 4.21 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 107.979 -1.119 . . . . 75.230000000000004 107.979 176.032 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 570' ' ' THR . . . . . 0.592 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 36.3 p -127.1 142.85 51.42 Favored 'General case' 0 N--CA 1.436 -1.174 0 O-C-N 123.477 0.486 . . . . 51.109999999999999 110.907 177.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 571' ' ' ILE . . . . . 0.494 HG22 HG23 ' A' ' 573' ' ' VAL . 2.5 mp -91.78 122.48 43.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 N-CA-C 105.849 -1.908 . . . . 71.409999999999997 105.849 170.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 9.7 m -97.25 109.86 22.53 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 109.966 -0.383 . . . . 53.229999999999997 109.966 -179.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 573' ' ' VAL . . . . . 0.494 HG23 HG22 ' A' ' 571' ' ' ILE . 62.2 t -120.94 130.85 74.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 109.305 -0.628 . . . . 74.299999999999997 109.305 178.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -91.36 132.25 36.31 Favored 'General case' 0 C--N 1.312 -1.052 0 O-C-N 123.509 0.506 . . . . 64.299999999999997 111.064 179.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 64.0 t -97.66 137.99 23.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 108.063 -1.088 . . . . 72.310000000000002 108.063 177.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 576' ' ' ILE . . . . . 0.416 HG12 ' HA ' ' A' ' 553' ' ' PHE . 30.4 mm -103.11 160.49 4.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 107.369 -1.345 . . . . 72.340000000000003 107.369 -177.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -69.99 133.69 47.52 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 109.502 -0.555 . . . . 74.329999999999998 109.502 177.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 578' ' ' ASP . . . . . 0.602 ' OD1' 'CA ' ' A' ' 850' ' ' ' CA' . 0.8 OUTLIER -66.33 137.84 57.2 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.352 0.596 . . . . 71.030000000000001 111.033 -174.355 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.78 -35.89 3.8 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 115.925 1.824 . . . . 75.0 115.925 -171.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 580' ' ' GLU . . . . . 0.517 ' HG2' ' CD2' ' A' ' 581' ' ' TYR . 0.0 OUTLIER -93.63 -60.38 1.78 Allowed 'General case' 0 C--N 1.313 -1.01 0 O-C-N 121.482 -0.761 . . . . 70.120000000000005 112.75 -170.52 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 581' ' ' TYR . . . . . 0.517 ' CD2' ' HG2' ' A' ' 580' ' ' GLU . 31.4 p90 -164.38 153.97 13.9 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 106.561 -1.644 . . . . 54.399999999999999 106.561 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 582' ' ' GLU . . . . . 0.641 ' OE1' 'CA ' ' A' ' 800' ' ' ' CA' . 43.1 mm-40 -89.87 143.81 26.48 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 119.618 -0.833 . . . . 64.239999999999995 112.218 -177.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -169.74 168.8 8.81 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 107.472 -1.307 . . . . 64.420000000000002 107.472 175.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -88.39 78.47 7.93 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 107.988 -1.115 . . . . 74.420000000000002 107.988 174.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 585' ' ' LYS . . . . . 0.42 ' HG2' ' HB2' ' A' ' 546' ' ' ALA . 0.0 OUTLIER -79.02 166.66 22.09 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 108.243 -1.021 . . . . 72.340000000000003 108.243 -177.417 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 586' ' ' THR . . . . . 0.436 ' H ' HG23 ' A' ' 545' ' ' THR . 6.9 t -154.06 144.36 22.16 Favored 'General case' 0 N--CA 1.415 -2.213 0 C-N-CA 120.258 -0.577 . . . . 73.430000000000007 111.178 -173.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 587' ' ' PHE . . . . . 0.437 ' CE2' HD11 ' A' ' 646' ' ' ILE . 3.6 p90 -126.02 148.54 49.28 Favored 'General case' 0 N--CA 1.418 -2.072 0 CA-C-N 113.799 -1.546 . . . . 62.32 109.407 176.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 588' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -104.77 130.99 52.77 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 108.791 -0.818 . . . . 70.329999999999998 108.791 -174.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . 0.521 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.4 OUTLIER -99.83 124.98 45.69 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 106.308 -1.738 . . . . 75.430000000000007 106.308 176.922 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -124.44 132.12 53.5 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-O 121.013 0.435 . . . . 74.439999999999998 110.11 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 591' ' ' ILE . . . . . 0.47 HG22 ' HB3' ' A' ' 539' ' ' TYR . 24.8 pt -101.33 143.86 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.085 0 N-CA-C 107.224 -1.398 . . . . 75.120000000000005 107.224 174.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -89.41 -148.84 19.69 Favored Glycine 0 C--N 1.292 -1.905 0 N-CA-C 110.47 -1.052 . . . . 31.140000000000001 110.47 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.424 ' CD ' HH21 ' A' ' 633' ' ' ARG . 23.4 tt0 -82.09 128.49 67.83 Favored Pre-proline 0 C--N 1.29 -2.013 0 N-CA-C 108.997 -0.742 . . . . 64.109999999999999 108.997 177.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 594' ' ' PRO . . . . . 0.484 ' HB3' HG22 ' A' ' 537' ' ' VAL . 55.0 Cg_endo -71.55 146.36 49.33 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 121.965 1.777 . . . . 53.350000000000001 109.944 173.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 16.0 ptt-85 -126.93 138.19 53.25 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.593 -0.692 . . . . 61.439999999999998 110.003 -175.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 596' ' ' LEU . . . . . 0.452 HD22 HG22 ' A' ' 535' ' ' VAL . 0.0 OUTLIER -81.8 129.15 34.64 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 106.938 -1.505 . . . . 51.210000000000001 106.938 179.753 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 89.6 t -75.58 -27.67 19.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-O 121.245 0.545 . . . . 61.219999999999999 110.073 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 598' ' ' GLU . . . . . 0.449 ' H ' HD12 ' A' ' 596' ' ' LEU . 10.9 pt-20 -128.72 95.95 4.25 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 122.061 0.934 . . . . 74.319999999999993 111.453 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.41 7.47 5.86 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.579 -0.737 . . . . 63.43 112.182 -177.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 16.6 m -91.99 132.57 36.43 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 120.676 -0.41 . . . . 73.310000000000002 111.639 -175.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 58.02 77.07 0.3 Allowed 'General case' 0 C--O 1.237 0.434 0 C-N-CA 125.196 1.398 . . . . 74.109999999999999 114.491 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 48.3 pttt -99.51 173.57 6.68 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.259 -1.385 . . . . 71.400000000000006 107.259 172.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -92.06 103.35 15.87 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.547 0.689 . . . . 73.420000000000002 110.143 175.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 134.8 146.84 5.45 Favored Glycine 0 N--CA 1.435 -1.427 0 N-CA-C 110.216 -1.154 . . . . 72.230000000000004 110.216 -177.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . -144.09 98.31 0.2 Allowed Glycine 0 N--CA 1.431 -1.685 0 C-N-CA 120.03 -1.081 . . . . 64.129999999999995 112.734 -177.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -104.74 173.4 6.32 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.525 -0.917 . . . . 75.400000000000006 108.525 176.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 10.5 p -72.52 110.95 7.27 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 121.892 0.853 . . . . 73.209999999999994 113.221 -176.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 7.5 mt -80.06 166.81 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.565 0 N-CA-C 106.612 -1.625 . . . . 74.219999999999999 106.612 177.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 7.3 t -93.08 10.04 33.25 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-O 122.006 0.908 . . . . 62.030000000000001 109.804 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 60.11 -1.99 0.17 Allowed 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 116.005 1.854 . . . . 71.540000000000006 116.005 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -75.7 90.31 2.84 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 106.055 -1.832 . . . . 70.239999999999995 106.055 171.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -101.09 129.9 47.05 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 115.268 -0.878 . . . . 74.209999999999994 109.351 -174.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 11.9 t70 74.87 -55.02 0.66 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.823 1.249 . . . . 71.25 112.71 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -45.88 114.14 0.73 Allowed 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 125.392 1.477 . . . . 72.150000000000006 113.415 -176.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 615' ' ' LYS . . . . . 0.412 ' H ' ' HG2' ' A' ' 615' ' ' LYS . 22.5 pttm -85.13 97.78 10.08 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 114.605 -1.179 . . . . 62.340000000000003 111.518 -178.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -104.82 167.81 9.35 Favored Pre-proline 0 C--N 1.291 -1.971 0 CA-C-N 115.52 -0.764 . . . . 63.149999999999999 110.245 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -67.49 172.21 10.66 Favored 'Trans proline' 0 C--O 1.255 1.366 0 C-N-CA 121.748 1.632 . . . . 62.109999999999999 110.868 174.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -70.7 104.43 2.85 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.641 0.734 . . . . 72.0 110.462 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -106.94 6.58 29.33 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 114.403 -1.271 . . . . 64.540000000000006 113.308 -173.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 1.7 p -82.56 108.53 16.02 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 121.453 0.644 . . . . 64.450000000000003 111.782 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 5.1 ttmp? -136.9 -62.85 0.63 Allowed 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 115.448 -0.796 . . . . 55.219999999999999 108.885 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -113.73 -35.22 5.24 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.128 -0.487 . . . . 74.349999999999994 111.76 -179.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . 0.589 ' HG3' ' H ' ' A' ' 626' ' ' ARG . 9.2 tp10 -65.38 126.18 27.43 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 120.888 0.375 . . . . 54.340000000000003 110.178 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -92.24 -24.41 19.02 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.543 -0.54 . . . . 73.109999999999999 109.543 -179.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -56.77 -44.12 81.48 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.834 0.825 . . . . 73.200000000000003 108.937 177.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . 0.615 ' O ' ' HG3' ' A' ' 630' ' ' GLU . 14.4 tpt180 -59.87 -48.27 82.35 Favored 'General case' 0 C--O 1.209 -1.032 0 CA-C-N 114.604 -1.18 . . . . 53.119999999999997 109.542 175.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 627' ' ' ARG . . . . . 0.406 ' HA ' ' OE1' ' A' ' 630' ' ' GLU . 64.7 mtm180 -64.31 -34.39 78.02 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 113.073 0.768 . . . . 74.329999999999998 113.073 -176.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . 0.651 ' O ' ' HG2' ' A' ' 631' ' ' MET . 98.0 mt -69.25 -38.98 78.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 N-CA-C 109.42 -0.585 . . . . 72.420000000000002 109.42 175.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -68.85 -18.39 64.14 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.169 0.509 . . . . 64.409999999999997 110.594 176.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 630' ' ' GLU . . . . . 0.615 ' HG3' ' O ' ' A' ' 626' ' ' ARG . 77.6 mt-10 -82.19 9.79 8.03 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.905 -0.589 . . . . 74.019999999999996 111.288 178.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 631' ' ' MET . . . . . 0.651 ' HG2' ' O ' ' A' ' 628' ' ' ILE . 20.8 ptp -82.31 -22.39 35.64 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 106.729 -1.582 . . . . 73.549999999999997 106.729 167.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -100.87 -43.74 2.2 Favored Glycine 0 N--CA 1.44 -1.067 0 CA-C-N 115.099 -0.955 . . . . 41.310000000000002 110.86 177.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 633' ' ' ARG . . . . . 0.424 HH21 ' CD ' ' A' ' 593' ' ' GLU . 20.7 mtp180 -87.29 120.95 71.51 Favored Pre-proline 0 C--N 1.32 -0.694 0 N-CA-C 109.81 -0.441 . . . . 71.420000000000002 109.81 178.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.421 ' HA ' ' HB3' ' A' ' 502' ' ' ALA . 36.7 Cg_endo -68.42 147.47 71.37 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.268 1.979 . . . . 74.319999999999993 110.475 177.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 635' ' ' ILE . . . . . 0.43 HG21 ' OE2' ' A' ' 630' ' ' GLU . 2.3 pp -135.1 -175.06 1.26 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.753 0 N-CA-C 114.623 1.342 . . . . 71.200000000000003 114.623 -173.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -78.01 154.87 31.08 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.195 -0.911 . . . . 65.430000000000007 110.641 -177.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . 0.407 ' HA3' ' HB ' ' A' ' 506' ' ' THR . . . -96.48 -107.74 2.41 Favored Glycine 0 C--N 1.297 -1.621 0 C-N-CA 120.664 -0.779 . . . . 73.019999999999996 112.685 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -89.53 -65.4 1.02 Allowed 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 121.494 0.664 . . . . 73.109999999999999 110.953 -176.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -133.81 116.51 15.78 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 115.381 -0.827 . . . . 62.520000000000003 111.645 -174.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 22.1 p -104.42 90.89 3.68 Favored 'General case' 0 N--CA 1.396 -3.161 0 N-CA-C 107.887 -1.153 . . . . 73.219999999999999 107.887 175.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 21.5 tptm -175.71 135.36 0.3 Allowed 'General case' 0 N--CA 1.425 -1.701 0 CA-C-N 113.758 -1.564 . . . . 72.209999999999994 107.204 -175.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 642' ' ' LEU . . . . . 0.797 HD21 HG21 ' A' ' 523' ' ' VAL . 41.5 tp -138.22 110.1 7.19 Favored 'General case' 0 C--N 1.276 -2.606 0 N-CA-C 107.611 -1.255 . . . . 63.420000000000002 107.611 173.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . 0.521 ' HB3' HG22 ' A' ' 511' ' ' VAL . 21.4 tt0 -93.59 106.98 18.9 Favored 'General case' 0 C--N 1.275 -2.644 0 N-CA-C 107.475 -1.306 . . . . 72.25 107.475 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 644' ' ' VAL . . . . . 0.574 HG21 ' HE1' ' A' ' 521' ' ' MET . 25.6 t -96.81 105.6 17.33 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 109.346 -0.613 . . . . 72.310000000000002 109.346 -176.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 3.5 mp -91.54 120.42 40.56 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 107.521 -1.289 . . . . 75.099999999999994 107.521 176.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 646' ' ' ILE . . . . . 0.508 ' N ' HD12 ' A' ' 646' ' ' ILE . 2.7 mp -97.74 109.28 23.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 105.928 -1.879 . . . . 72.140000000000001 105.928 -177.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . 0.401 ' OE2' ' HA ' ' A' ' 515' ' ' SER . 1.5 pp20? -93.3 148.49 22.0 Favored 'General case' 0 N--CA 1.399 -3.007 0 CA-C-N 115.518 -0.764 . . . . 75.209999999999994 110.889 -174.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -73.0 69.46 0.98 Allowed 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 124.416 1.086 . . . . 74.019999999999996 110.993 -178.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 649' ' ' SER . . . . . 0.406 ' HA ' ' HG ' ' A' ' 515' ' ' SER . 14.4 m 28.14 74.46 0.04 OUTLIER 'General case' 0 C--O 1.243 0.755 0 C-N-CA 128.422 2.689 . . . . 51.130000000000003 115.525 177.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -128.75 -63.33 0.98 Allowed 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.37 -0.832 . . . . 74.120000000000005 111.609 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -159.9 -174.25 4.49 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 121.625 0.726 . . . . 75.140000000000001 111.945 -175.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -132.96 101.9 5.41 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 115.009 -0.996 . . . . 74.310000000000002 110.287 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -140.47 113.38 8.26 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 114.428 -1.26 . . . . 70.200000000000003 108.098 175.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 48.8 m -108.0 110.69 22.46 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 120.97 0.414 . . . . 51.119999999999997 111.517 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 25.3 m -83.87 102.2 12.21 Favored 'General case' 0 N--CA 1.431 -1.376 0 N-CA-C 108.881 -0.785 . . . . 74.450000000000003 108.881 176.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 21.1 m -131.25 -174.76 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 C-N-CA 123.151 0.58 . . . . 65.120000000000005 109.481 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 . . . . . 0 C--N 1.311 -1.076 0 N-CA-C 110.462 -0.199 . . . . 63.439999999999998 110.462 179.652 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 800' ' ' ' CA' . . . . . 0.659 'CA ' ' OE2' ' A' ' 516' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 850' ' ' ' CA' . . . . . 0.636 'CA ' ' OD2' ' A' ' 552' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . 0.614 ' HA ' ' O ' ' A' ' 631' ' ' MET . 15.5 t-160 . . . . . 0 N--CA 1.448 -0.561 0 N-CA-C 109.017 -0.735 . . . . 73.510000000000005 109.017 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -80.69 -52.49 7.49 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 109.321 -0.622 . . . . 62.43 109.321 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . 0.708 ' HA3' ' OG1' ' A' ' 528' ' ' THR . . . 140.35 -167.99 25.3 Favored Glycine 0 N--CA 1.412 -2.921 0 C-N-CA 118.18 -1.962 . . . . 72.040000000000006 116.751 170.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . 0.51 HG23 ' CA ' ' A' ' 637' ' ' GLY . 3.5 mp -111.35 136.25 48.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 125.521 1.529 . . . . 73.109999999999999 111.471 -168.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -132.6 123.58 26.7 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.898 -0.779 . . . . 71.230000000000004 108.898 170.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . 0.438 ' HB ' ' HA3' ' A' ' 637' ' ' GLY . 14.7 t -150.52 163.15 39.15 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.233 -0.654 . . . . 64.040000000000006 109.233 -176.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -84.35 159.74 20.81 Favored 'General case' 0 CA--C 1.495 -1.145 0 N-CA-C 108.486 -0.931 . . . . 73.010000000000005 108.486 173.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -81.34 -44.29 17.83 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.385 -0.968 . . . . 71.209999999999994 108.385 176.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . 0.553 ' HB3' ' O ' ' A' ' 655' ' ' THR . 10.6 pt-20 -124.93 137.06 28.9 Favored Pre-proline 0 C--N 1.313 -0.993 0 N-CA-C 109.076 -0.713 . . . . 75.200000000000003 109.076 177.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . 0.511 ' HA ' ' O ' ' A' ' 641' ' ' LYS . 94.6 Cg_endo -90.66 -6.72 4.19 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.0 1.8 . . . . 75.200000000000003 112.734 178.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 74.3 t -143.04 132.99 21.9 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.318 0 N-CA-C 107.02 -1.474 . . . . 74.329999999999998 107.02 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 4.1 t -141.42 143.63 34.02 Favored 'General case' 0 N--CA 1.411 -2.4 0 N-CA-C 106.697 -1.594 . . . . 75.150000000000006 106.697 178.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 513' ' ' HIS . . . . . 0.523 ' HB2' ' HB2' ' A' ' 653' ' ' LYS . 28.7 m-70 -114.52 127.85 56.02 Favored 'General case' 0 CA--C 1.484 -1.595 0 N-CA-C 107.471 -1.307 . . . . 70.019999999999996 107.471 177.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.625 HG11 ' SD ' ' A' ' 521' ' ' MET . 33.7 m -113.19 164.43 9.12 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.355 0 C-N-CA 120.271 -0.572 . . . . 52.43 110.853 -173.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 35.4 t -87.5 145.01 26.43 Favored 'General case' 0 N--CA 1.406 -2.657 0 N-CA-C 107.255 -1.387 . . . . 73.420000000000002 107.255 176.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . 0.628 ' OE1' 'CA ' ' A' ' 800' ' ' ' CA' . 32.6 tt0 -79.38 -9.98 59.71 Favored 'General case' 0 C--N 1.279 -2.495 0 CA-C-O 121.604 0.716 . . . . 72.140000000000001 109.801 177.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 39.3 m -97.62 17.06 18.65 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.508 0.67 . . . . 75.310000000000002 109.874 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 10.8 tt -96.38 158.25 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.366 0 N-CA-C 108.724 -0.843 . . . . 75.319999999999993 108.724 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -102.89 -59.35 0.74 Allowed Glycine 0 N--CA 1.43 -1.738 0 N-CA-C 111.018 -0.833 . . . . 75.150000000000006 111.018 178.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . 0.406 HD13 ' HA ' ' A' ' 574' ' ' LYS . 36.1 mm -123.36 126.85 73.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 109.224 -0.658 . . . . 61.530000000000001 109.224 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 521' ' ' MET . . . . . 0.625 ' SD ' HG11 ' A' ' 514' ' ' VAL . 25.3 ptt? -104.03 139.34 39.28 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.132 -1.062 . . . . 71.319999999999993 108.132 173.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -120.25 120.13 35.22 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 123.882 0.739 . . . . 74.310000000000002 110.72 177.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . 0.598 ' O ' ' HA ' ' A' ' 570' ' ' THR . 40.4 t -106.33 130.78 57.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 CA-C-N 115.56 -0.746 . . . . 74.340000000000003 109.831 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -77.93 131.84 37.63 Favored 'General case' 0 C--O 1.246 0.894 0 CA-C-O 121.784 0.802 . . . . 72.340000000000003 113.114 -177.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 11.4 t -114.7 135.22 55.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 107.42 -1.326 . . . . 65.420000000000002 107.42 177.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -82.55 151.22 26.52 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.416 0.626 . . . . 61.109999999999999 111.408 -175.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . 0.488 ' HD2' ' HA ' ' A' ' 567' ' ' ILE . 43.7 ttt-85 -98.47 143.55 28.78 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 114.658 -1.155 . . . . 63.549999999999997 110.447 -174.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . 0.708 ' OG1' ' HA3' ' A' ' 503' ' ' GLY . 4.6 t -58.9 151.29 22.05 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.539 -0.755 . . . . 75.239999999999995 112.441 177.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 35.6 t -77.89 -17.94 56.75 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 115.224 -0.898 . . . . 62.119999999999997 108.736 176.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -109.87 52.52 0.63 Allowed Glycine 0 N--CA 1.442 -0.912 0 N-CA-C 111.232 -0.747 . . . . 63.149999999999999 111.232 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -82.36 92.61 7.02 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-O 121.543 0.687 . . . . 73.239999999999995 109.665 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 2.6 ppt_? -133.5 20.36 3.95 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 114.771 -1.104 . . . . 65.0 112.038 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . -177.16 -179.38 47.47 Favored Glycine 0 N--CA 1.427 -1.959 0 N-CA-C 109.524 -1.431 . . . . 63.030000000000001 109.524 -177.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 534' ' ' ASN . . . . . 0.509 HD21 ' HG3' ' A' ' 561' ' ' GLU . 2.5 t-20 -90.41 125.02 35.42 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.047 0.451 . . . . 74.150000000000006 110.082 -179.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 535' ' ' VAL . . . . . 0.467 HG22 HD22 ' A' ' 596' ' ' LEU . 60.1 t -123.95 128.39 74.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 107.533 -1.284 . . . . 72.219999999999999 107.533 176.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 536' ' ' ILE . . . . . 0.547 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 46.5 mm -99.57 135.82 33.36 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.238 0 N-CA-C 109.425 -0.583 . . . . 72.209999999999994 109.425 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 42.5 t -120.15 109.38 37.24 Favored Pre-proline 0 C--N 1.307 -1.268 0 CA-C-N 116.06 -0.518 . . . . 72.299999999999997 109.608 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -74.07 143.69 32.8 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.16 1.906 . . . . 72.0 111.64 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 539' ' ' TYR . . . . . 0.434 ' HB3' HG22 ' A' ' 591' ' ' ILE . 45.1 p90 -144.35 160.66 40.66 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.598 -0.519 . . . . 74.109999999999999 109.598 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -160.48 160.58 32.22 Favored 'General case' 0 C--O 1.243 0.721 0 O-C-N 123.788 0.68 . . . . 70.420000000000002 110.543 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 2.6 p -100.22 108.14 20.16 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 123.676 0.61 . . . . 71.430000000000007 111.53 176.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.5 mp -81.7 128.24 38.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 107.378 -1.341 . . . . 74.209999999999994 107.378 178.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -63.61 -62.94 1.33 Allowed 'General case' 0 C--O 1.237 0.413 0 O-C-N 123.585 0.553 . . . . 72.510000000000005 111.212 -178.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 72.71 -72.48 1.04 Allowed Glycine 0 C--O 1.227 -0.292 0 CA-C-N 116.256 -0.429 . . . . 75.400000000000006 112.205 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 545' ' ' THR . . . . . 0.472 HG23 ' H ' ' A' ' 586' ' ' THR . 6.0 t -138.59 -2.11 1.8 Allowed 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.056 0.455 . . . . 71.099999999999994 110.233 178.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -96.1 171.03 8.86 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 108.969 -0.752 . . . . 70.209999999999994 108.969 174.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . 0.473 ' HG3' ' HG3' ' A' ' 551' ' ' GLU . 2.3 tpt180 -115.65 112.46 22.14 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.902 -0.777 . . . . 73.319999999999993 108.902 -178.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -95.95 166.92 25.05 Favored Glycine 0 CA--C 1.499 -0.962 0 C-N-CA 121.408 -0.425 . . . . 52.350000000000001 113.409 -176.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 100.52 23.44 10.21 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 111.526 -0.63 . . . . 50.32 111.526 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 91.07 6.45 66.82 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.833 -0.698 . . . . 62.130000000000003 111.396 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . 0.473 ' HG3' ' HG3' ' A' ' 547' ' ' ARG . 12.3 mm-40 -76.18 -71.23 0.4 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.553 -0.536 . . . . 75.310000000000002 109.553 -178.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -111.4 -27.65 8.54 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.197 -1.409 . . . . 62.329999999999998 107.197 178.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -141.68 156.68 45.63 Favored 'General case' 0 C--O 1.256 1.415 0 CA-C-N 115.031 -0.986 . . . . 72.319999999999993 109.063 174.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . 0.413 ' HB3' ' HB3' ' A' ' 574' ' ' LYS . 0.4 OUTLIER -90.45 126.77 36.01 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 106.261 -1.755 . . . . 74.209999999999994 106.261 178.393 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -79.02 112.04 15.83 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.77 0.319 . . . . 74.230000000000004 111.784 -173.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . 0.478 HG21 HG22 ' A' ' 573' ' ' VAL . 11.1 t -109.51 122.88 48.41 Favored 'General case' 0 N--CA 1.418 -2.026 0 CA-C-O 122.269 1.033 . . . . 75.439999999999998 110.052 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 1.7 p -142.07 133.04 25.93 Favored 'General case' 0 C--N 1.277 -2.572 0 CA-C-N 114.475 -1.239 . . . . 73.5 107.894 178.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 179.9 -148.98 8.28 Favored Glycine 0 N--CA 1.422 -2.289 0 N-CA-C 110.34 -1.104 . . . . 74.420000000000002 110.34 -176.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 559' ' ' GLU . . . . . 0.547 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 47.5 mt-10 -143.54 133.62 24.28 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 122.964 0.506 . . . . 73.519999999999996 110.706 -176.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . 0.408 ' HG ' ' CD1' ' A' ' 539' ' ' TYR . 87.4 mt -94.21 146.17 24.19 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 123.319 0.648 . . . . 74.299999999999997 110.117 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 561' ' ' GLU . . . . . 0.509 ' HG3' HD21 ' A' ' 534' ' ' ASN . 44.0 tt0 -105.67 112.85 26.09 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-O 121.075 0.464 . . . . 50.43 111.752 -178.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -109.66 144.07 38.53 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.59 -0.892 . . . . 73.319999999999993 108.59 171.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -145.99 -171.42 3.7 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.459 -0.941 . . . . 74.230000000000004 108.459 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 31.9 t30 -78.87 -39.15 35.98 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 107.24 -1.393 . . . . 74.540000000000006 107.24 172.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -88.45 -2.48 58.62 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.731 -1.122 . . . . 65.140000000000001 110.978 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -116.83 123.87 48.14 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.964 -0.754 . . . . 74.540000000000006 108.964 -178.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 567' ' ' ILE . . . . . 0.488 ' HA ' ' HD2' ' A' ' 527' ' ' ARG . 1.5 pp -119.13 139.91 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.73 0 N-CA-C 108.6 -0.889 . . . . 72.099999999999994 108.6 -178.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 1.2 p 56.11 160.18 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 C-N-CA 126.625 1.97 . . . . 61.210000000000001 113.462 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 569' ' ' LYS . . . . . 0.53 ' HA ' ' HE3' ' A' ' 569' ' ' LYS . 0.0 OUTLIER -148.03 162.89 38.44 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.511 -0.743 . . . . 70.319999999999993 109.089 175.444 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 570' ' ' THR . . . . . 0.598 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 11.7 p -135.1 134.3 40.13 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 123.921 0.763 . . . . 71.200000000000003 110.942 178.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 571' ' ' ILE . . . . . 0.476 HG12 HD11 ' A' ' 589' ' ' LEU . 3.1 mp -85.51 118.37 32.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 106.62 -1.622 . . . . 62.310000000000002 106.62 172.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 19.1 m -98.73 120.62 39.47 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 108.709 -0.848 . . . . 73.420000000000002 108.709 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 573' ' ' VAL . . . . . 0.478 HG22 HG21 ' A' ' 556' ' ' THR . 33.2 t -123.67 134.52 66.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 N-CA-C 109.15 -0.685 . . . . 63.140000000000001 109.15 -178.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 574' ' ' LYS . . . . . 0.413 ' HB3' ' HB3' ' A' ' 554' ' ' GLU . 57.9 tptt -88.25 116.26 26.32 Favored 'General case' 0 N--CA 1.435 -1.193 0 O-C-N 123.815 0.697 . . . . 74.219999999999999 109.221 177.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 59.1 t -87.03 133.8 29.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 107.72 -1.215 . . . . 70.209999999999994 107.72 178.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 42.8 mm -96.66 158.22 3.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 107.984 -1.117 . . . . 71.140000000000001 107.984 -177.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -67.78 119.48 12.55 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.645 -0.872 . . . . 73.319999999999993 108.645 176.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 578' ' ' ASP . . . . . 0.617 ' OD1' 'CA ' ' A' ' 850' ' ' ' CA' . 25.9 t0 -67.32 122.65 18.35 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 114.822 -1.081 . . . . 70.430000000000007 111.628 -173.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 579' ' ' GLU . . . . . 0.613 ' OE1' 'CA ' ' A' ' 850' ' ' ' CA' . 0.2 OUTLIER -87.57 -23.75 24.23 Favored 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 125.502 1.521 . . . . 71.430000000000007 113.557 -172.871 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 580' ' ' GLU . . . . . 0.622 ' OE2' 'CA ' ' A' ' 850' ' ' ' CA' . 0.1 OUTLIER -117.67 176.84 5.0 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 118.648 -1.221 . . . . 73.230000000000004 111.283 -177.057 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -60.59 154.37 21.29 Favored 'General case' 0 C--O 1.253 1.283 0 N-CA-C 108.256 -1.016 . . . . 61.329999999999998 108.256 174.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 582' ' ' GLU . . . . . 0.62 ' OE1' 'CA ' ' A' ' 800' ' ' ' CA' . 21.0 tp10 -84.25 101.55 11.99 Favored 'General case' 0 N--CA 1.414 -2.229 0 C-N-CA 118.049 -1.46 . . . . 50.130000000000003 114.091 -175.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -97.22 134.07 41.02 Favored 'General case' 0 N--CA 1.406 -2.665 0 N-CA-C 101.961 -3.348 . . . . 70.409999999999997 101.961 160.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 584' ' ' ASN . . . . . 0.433 HD21 ' HB3' ' A' ' 647' ' ' GLU . 11.3 m120 -76.11 77.89 2.94 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-O 121.733 0.778 . . . . 73.219999999999999 112.391 -174.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.67 167.22 18.45 Favored 'General case' 0 N--CA 1.412 -2.357 0 N-CA-C 106.519 -1.66 . . . . 64.530000000000001 106.519 176.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 586' ' ' THR . . . . . 0.472 ' H ' HG23 ' A' ' 545' ' ' THR . 3.5 t -155.93 144.92 20.53 Favored 'General case' 0 N--CA 1.404 -2.741 0 C-N-CA 120.402 -0.519 . . . . 70.310000000000002 110.736 -176.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 587' ' ' PHE . . . . . 0.426 ' CE2' HD11 ' A' ' 646' ' ' ILE . 2.5 p90 -112.34 149.54 32.3 Favored 'General case' 0 N--CA 1.418 -2.028 0 CA-C-N 114.198 -1.364 . . . . 75.150000000000006 108.865 177.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 588' ' ' PHE . . . . . 0.412 ' CD1' ' HE3' ' A' ' 641' ' ' LYS . 17.5 m-85 -106.47 131.31 53.8 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 116.052 -0.522 . . . . 65.209999999999994 109.735 -173.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . 0.56 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.4 OUTLIER -102.77 118.44 36.83 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 105.016 -2.216 . . . . 73.099999999999994 105.016 173.231 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -129.82 144.51 51.34 Favored 'General case' 0 C--N 1.273 -2.728 0 N-CA-C 108.306 -0.998 . . . . 75.140000000000001 108.306 -178.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 591' ' ' ILE . . . . . 0.434 HG22 ' HB3' ' A' ' 539' ' ' TYR . 27.0 pt -106.27 152.76 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.853 0 N-CA-C 108.748 -0.834 . . . . 74.129999999999995 108.748 178.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -99.14 -163.74 29.75 Favored Glycine 0 N--CA 1.419 -2.46 0 N-CA-C 111.362 -0.695 . . . . 71.420000000000002 111.362 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -66.75 121.18 76.4 Favored Pre-proline 0 C--N 1.298 -1.645 0 C-N-CA 123.211 0.604 . . . . 75.430000000000007 110.612 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 594' ' ' PRO . . . . . 0.422 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 18.9 Cg_endo -67.25 140.84 54.73 Favored 'Trans proline' 0 N--CA 1.437 -1.819 0 C-N-CA 121.856 1.704 . . . . 62.5 110.461 176.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 595' ' ' ARG . . . . . 0.448 ' HG3' ' HB ' ' A' ' 536' ' ' ILE . 9.4 ptm180 -121.88 122.29 39.08 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 115.696 -0.683 . . . . 71.310000000000002 110.101 -173.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 596' ' ' LEU . . . . . 0.467 HD22 HG22 ' A' ' 535' ' ' VAL . 0.0 OUTLIER -75.51 123.9 26.25 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 107.858 -1.164 . . . . 55.140000000000001 107.858 179.282 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 21.8 t -89.85 70.62 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-O 122.418 1.104 . . . . 71.549999999999997 109.348 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -148.84 149.45 31.31 Favored 'General case' 0 C--N 1.261 -3.255 0 CA-C-N 113.915 -1.493 . . . . 54.130000000000003 108.146 174.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 599' ' ' MET . . . . . 0.456 ' O ' ' HG3' ' A' ' 599' ' ' MET . 14.6 ptm -84.99 113.91 21.78 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.575 -0.898 . . . . 63.240000000000002 108.575 176.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 49.3 m -123.17 102.48 7.98 Favored 'General case' 0 C--N 1.276 -2.602 0 CA-C-O 121.257 0.551 . . . . 34.539999999999999 110.746 177.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -150.02 124.13 9.43 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.28 -0.873 . . . . 70.299999999999997 109.897 178.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . 0.609 ' HA ' ' HE2' ' A' ' 602' ' ' LYS . 0.3 OUTLIER -126.26 96.84 4.84 Favored 'General case' 0 N--CA 1.416 -2.163 0 N-CA-C 106.767 -1.568 . . . . 72.510000000000005 106.767 175.95 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 603' ' ' LYS . . . . . 0.44 ' O ' ' HD3' ' A' ' 603' ' ' LYS . 0.0 OUTLIER -131.37 139.6 49.51 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.447 -0.797 . . . . 74.129999999999995 111.817 -178.196 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -112.27 -45.74 0.78 Allowed Glycine 0 C--N 1.288 -2.111 0 N-CA-C 110.096 -1.202 . . . . 55.509999999999998 110.096 177.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 153.09 -102.85 0.23 Allowed Glycine 0 N--CA 1.425 -2.067 0 C-N-CA 120.772 -0.728 . . . . 71.409999999999997 111.827 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -62.51 94.42 0.06 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.844 0.831 . . . . 74.109999999999999 112.786 -177.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 1.3 p -145.95 135.64 23.3 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 115.367 -0.833 . . . . 62.509999999999998 111.115 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 62.6 mt -103.06 112.29 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.814 0 N-CA-C 107.496 -1.298 . . . . 73.510000000000005 107.496 176.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 15.4 t -176.36 159.5 2.0 Allowed 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.107 -1.442 . . . . 74.25 107.107 -177.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -115.08 80.94 1.49 Allowed 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.441 0.639 . . . . 73.329999999999998 109.437 174.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -84.39 100.56 11.38 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 114.884 -1.053 . . . . 63.119999999999997 109.829 178.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -86.6 134.46 33.63 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.479 -0.782 . . . . 75.120000000000005 111.665 -175.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 613' ' ' ASP . . . . . 0.434 ' HA ' ' NH2' ' A' ' 633' ' ' ARG . 23.6 m-20 -117.41 11.45 13.92 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 106.76 -1.57 . . . . 73.549999999999997 106.76 171.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -57.21 128.46 37.09 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 113.219 -1.81 . . . . 72.25 111.494 -179.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -87.42 94.86 9.82 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.869 0.842 . . . . 71.120000000000005 111.572 -178.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -101.13 164.04 16.81 Favored Pre-proline 0 C--N 1.302 -1.462 0 CA-C-N 114.992 -1.004 . . . . 75.409999999999997 109.041 178.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -70.31 -177.17 1.92 Allowed 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 121.517 1.478 . . . . 73.430000000000007 109.552 173.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.403 ' HG ' ' HB3' ' A' ' 636' ' ' LEU . 3.4 mm? -75.87 103.77 6.1 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 121.824 0.821 . . . . 53.539999999999999 110.719 -179.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 9.9 t -162.65 167.55 22.99 Favored 'General case' 0 N--CA 1.416 -2.161 0 N-CA-C 106.639 -1.615 . . . . 72.010000000000005 106.639 -177.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 11.2 t -120.39 -13.06 8.89 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.161 -1.051 . . . . 61.409999999999997 108.161 173.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 621' ' ' LYS . . . . . 0.503 ' HA ' ' HE3' ' A' ' 621' ' ' LYS . 0.0 OUTLIER 58.5 18.49 5.74 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 123.68 0.792 . . . . 61.140000000000001 111.994 179.637 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 57.99 30.01 18.55 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 124.633 1.173 . . . . 64.239999999999995 111.68 -177.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -105.55 135.5 46.83 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 116.256 -0.429 . . . . 72.510000000000005 110.804 -178.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -61.82 -37.6 85.04 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.755 -0.832 . . . . 61.329999999999998 108.755 175.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -58.45 -35.44 72.14 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.57 -1.196 . . . . 74.329999999999998 110.254 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . 0.431 ' O ' ' HG3' ' A' ' 630' ' ' GLU . 14.3 tpp180 -77.93 -29.26 49.92 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 120.511 -0.476 . . . . 74.420000000000002 109.816 -175.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 627' ' ' ARG . . . . . . . . . . . . . 21.7 mmm180 -60.92 -38.51 86.0 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 122.083 0.944 . . . . 73.329999999999998 109.729 178.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 77.2 mt -66.6 -41.64 88.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 CA-C-N 113.874 -1.512 . . . . 63.009999999999998 110.296 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -68.69 -40.74 79.94 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.705 -0.68 . . . . 54.329999999999998 110.274 177.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 630' ' ' GLU . . . . . 0.431 ' HG3' ' O ' ' A' ' 626' ' ' ARG . 45.4 mt-10 -66.36 -19.71 65.88 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 121.375 0.607 . . . . 61.0 111.243 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 631' ' ' MET . . . . . 0.614 ' O ' ' HA ' ' A' ' 501' ' ' HIS . 56.9 ttp -76.85 -30.15 56.17 Favored 'General case' 0 N--CA 1.414 -2.261 0 CA-C-N 115.828 -0.624 . . . . 74.200000000000003 110.194 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -99.96 -27.23 7.96 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.329 -0.939 . . . . 71.030000000000001 112.39 -178.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 633' ' ' ARG . . . . . 0.434 ' NH2' ' HA ' ' A' ' 613' ' ' ASP . 67.9 mtt-85 -102.34 149.62 36.81 Favored Pre-proline 0 C--N 1.305 -1.344 0 N-CA-C 109.347 -0.612 . . . . 71.209999999999994 109.347 -177.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.422 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 39.7 Cg_endo -74.83 142.68 28.75 Favored 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 121.635 1.556 . . . . 55.130000000000003 110.548 177.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 635' ' ' ILE . . . . . 0.48 HD13 ' H ' ' A' ' 635' ' ' ILE . 0.1 OUTLIER -131.97 -170.77 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 CA-C-O 121.126 0.489 . . . . 75.219999999999999 109.899 -177.911 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . 0.403 ' HB3' ' HG ' ' A' ' 618' ' ' LEU . 0.0 OUTLIER -83.78 160.53 21.2 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 115.791 -0.641 . . . . 74.340000000000003 111.196 -178.827 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . 0.51 ' CA ' HG23 ' A' ' 504' ' ' ILE . . . -85.81 -98.53 0.74 Allowed Glycine 0 CA--C 1.483 -1.928 0 CA-C-N 115.337 -0.847 . . . . 64.420000000000002 111.771 177.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -114.52 -49.29 2.83 Favored 'General case' 0 C--N 1.281 -2.392 0 C-N-CA 119.752 -0.779 . . . . 73.540000000000006 110.151 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -131.4 119.15 21.24 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.958 0.885 . . . . 61.109999999999999 113.099 -176.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 23.8 p -115.27 91.15 3.52 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 107.385 -1.339 . . . . 65.140000000000001 107.385 173.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 641' ' ' LYS . . . . . 0.511 ' O ' ' HA ' ' A' ' 510' ' ' PRO . 22.6 tptm -175.27 137.04 0.38 Allowed 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 106.434 -1.691 . . . . 71.519999999999996 106.434 -174.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 642' ' ' LEU . . . . . 0.573 HD21 HG21 ' A' ' 523' ' ' VAL . 38.7 tp -140.69 105.07 4.85 Favored 'General case' 0 C--N 1.277 -2.55 0 N-CA-C 107.961 -1.125 . . . . 73.129999999999995 107.961 172.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -94.35 105.05 17.03 Favored 'General case' 0 C--N 1.276 -2.625 0 N-CA-C 106.646 -1.613 . . . . 70.129999999999995 106.646 178.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 644' ' ' VAL . . . . . 0.547 HG21 ' HE1' ' A' ' 521' ' ' MET . 32.5 t -94.28 106.15 17.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-N 115.765 -0.652 . . . . 45.240000000000002 109.571 -177.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 3.7 mp -89.36 126.32 42.33 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 N-CA-C 108.026 -1.101 . . . . 72.219999999999999 108.026 179.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 646' ' ' ILE . . . . . 0.446 HD12 ' H ' ' A' ' 646' ' ' ILE . 1.7 mp -104.54 140.29 23.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 107.866 -1.161 . . . . 74.239999999999995 107.866 -177.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . 0.433 ' HB3' HD21 ' A' ' 584' ' ' ASN . 7.4 pt-20 -158.4 140.05 13.63 Favored 'General case' 0 N--CA 1.429 -1.508 0 O-C-N 123.722 0.638 . . . . 74.409999999999997 110.822 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -41.62 136.5 1.86 Allowed 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.138 1.375 . . . . 73.549999999999997 110.561 176.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 34.9 t -33.31 104.93 0.03 OUTLIER 'General case' 0 C--O 1.243 0.72 0 C-N-CA 126.518 1.927 . . . . 63.009999999999998 114.238 -171.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -120.77 -63.93 1.3 Allowed 'General case' 0 N--CA 1.426 -1.668 0 CA-C-N 113.423 -1.717 . . . . 74.340000000000003 107.808 175.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -176.25 168.5 2.82 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 105.781 -1.933 . . . . 73.310000000000002 105.781 -177.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -104.09 127.13 51.65 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 108.182 -1.044 . . . . 74.25 108.182 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 653' ' ' LYS . . . . . 0.523 ' HB2' ' HB2' ' A' ' 513' ' ' HIS . 31.9 mmmt -110.36 93.88 4.72 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 116.486 -0.324 . . . . 63.32 111.421 -176.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 34.9 t -100.12 115.01 28.81 Favored 'General case' 0 N--CA 1.423 -1.805 0 N-CA-C 104.447 -2.427 . . . . 70.340000000000003 104.447 170.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 655' ' ' THR . . . . . 0.553 ' O ' ' HB3' ' A' ' 509' ' ' GLU . 8.9 t -107.71 131.79 54.04 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-O 121.453 0.645 . . . . 75.099999999999994 110.936 -176.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 7.7 p -83.18 131.93 32.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.12 -1.067 . . . . 74.549999999999997 108.12 176.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 14.6 t70 . . . . . 0 C--N 1.307 -1.27 0 CA-C-N 116.527 -0.306 . . . . 61.100000000000001 111.06 -177.456 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 800' ' ' ' CA' . . . . . 0.628 'CA ' ' OE1' ' A' ' 516' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 850' ' ' ' CA' . . . . . 0.622 'CA ' ' OE2' ' A' ' 580' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 8.1 p80 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 121.861 0.839 . . . . 62.219999999999999 108.874 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -162.8 -49.85 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 107.078 -1.453 . . . . 74.219999999999999 107.078 -177.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . 0.428 ' HA2' ' O ' ' A' ' 530' ' ' GLY . . . 108.53 145.74 11.65 Favored Glycine 0 N--CA 1.433 -1.543 0 CA-C-N 115.029 -0.987 . . . . 72.340000000000003 113.758 174.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 1.7 mp -107.24 130.31 59.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 N-CA-C 107.956 -1.127 . . . . 53.020000000000003 107.956 177.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . 0.429 ' HA ' ' O ' ' A' ' 526' ' ' LEU . 97.9 m-85 -116.21 121.39 41.91 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.115 0.483 . . . . 65.140000000000001 111.071 -178.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 11.8 t -139.39 156.19 47.15 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.037 -1.098 . . . . 52.25 108.037 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -82.65 154.41 24.92 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.526 -0.916 . . . . 71.329999999999998 108.526 174.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -77.29 -27.71 53.12 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 109.301 -0.629 . . . . 65.040000000000006 109.301 176.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -140.51 135.99 16.29 Favored Pre-proline 0 C--N 1.315 -0.897 0 N-CA-C 108.878 -0.786 . . . . 73.430000000000007 108.878 177.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . 0.4 ' HA ' ' O ' ' A' ' 641' ' ' LYS . 73.5 Cg_endo -85.13 -13.84 6.26 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 121.765 1.643 . . . . 72.209999999999994 111.654 178.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . 0.447 HG22 ' HB3' ' A' ' 643' ' ' GLU . 71.7 t -139.0 133.85 41.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 107.693 -1.225 . . . . 63.140000000000001 107.693 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 5.4 t -134.05 136.21 43.86 Favored 'General case' 0 N--CA 1.402 -2.834 0 N-CA-C 108.077 -1.083 . . . . 72.030000000000001 108.077 178.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 32.6 m-70 -108.37 114.75 28.85 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 108.541 -0.911 . . . . 73.430000000000007 108.541 177.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 16.7 m -118.93 162.49 17.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 CA-C-N 115.935 -0.575 . . . . 55.200000000000003 110.093 -174.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 62.2 m -81.2 148.92 29.3 Favored 'General case' 0 N--CA 1.392 -3.37 0 N-CA-C 108.096 -1.075 . . . . 71.400000000000006 108.096 178.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -85.55 -22.35 28.15 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 118.719 -1.192 . . . . 73.340000000000003 110.632 176.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 16.0 m -90.12 30.39 1.1 Allowed 'General case' 0 C--N 1.293 -1.874 0 CA-C-O 121.605 0.717 . . . . 74.25 110.023 -176.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 13.7 tt -112.81 150.87 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.015 0 N-CA-C 107.342 -1.355 . . . . 65.420000000000002 107.342 -178.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . 0.55 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . -81.83 -61.93 1.99 Allowed Glycine 0 N--CA 1.426 -1.975 0 C-N-CA 120.098 -1.049 . . . . 45.240000000000002 111.06 178.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 35.8 mm -120.82 133.45 67.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 CA-C-N 115.482 -0.359 . . . . 74.219999999999999 110.199 -177.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 521' ' ' MET . . . . . 0.494 ' HE2' HG21 ' A' ' 644' ' ' VAL . 0.0 OUTLIER -116.28 141.23 48.42 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.147 -1.427 . . . . 75.099999999999994 107.147 171.302 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 522' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 44.9 mt-10 -126.38 145.28 50.52 Favored 'General case' 0 C--N 1.316 -0.89 0 O-C-N 123.584 0.552 . . . . 72.409999999999997 111.445 -178.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . 0.677 HG21 HD21 ' A' ' 642' ' ' LEU . 30.2 t -132.58 138.99 50.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 108.512 -0.921 . . . . 65.340000000000003 108.512 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -84.0 133.17 34.69 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 113.043 0.757 . . . . 74.209999999999994 113.043 -177.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . 0.613 ' O ' ' HA ' ' A' ' 568' ' ' VAL . 10.7 t -113.46 125.49 70.74 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 N-CA-C 106.725 -1.583 . . . . 61.140000000000001 106.725 177.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . 0.429 ' O ' ' HA ' ' A' ' 505' ' ' PHE . 2.1 mm? -91.3 140.81 29.43 Favored 'General case' 0 C--N 1.28 -2.427 0 CA-C-O 120.794 0.331 . . . . 60.32 110.397 -176.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . 0.479 HH11 ' HG3' ' A' ' 527' ' ' ARG . 27.9 ttt85 -114.24 93.78 4.51 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 105.06 -2.2 . . . . 62.009999999999998 105.06 173.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 1.4 p -121.55 -168.68 1.73 Allowed 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 114.712 -1.131 . . . . 70.230000000000004 111.967 -173.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 39.6 m 35.01 32.62 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 126.419 1.888 . . . . 70.030000000000001 114.134 -172.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . 0.428 ' O ' ' HA2' ' A' ' 503' ' ' GLY . . . 129.43 151.95 7.47 Favored Glycine 0 N--CA 1.418 -2.53 0 N-CA-C 111.67 -0.572 . . . . 71.200000000000003 111.67 178.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -127.75 -125.44 0.23 Allowed 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 107.798 -1.186 . . . . 53.130000000000003 107.798 176.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 69.37 127.29 0.03 OUTLIER 'General case' 0 C--O 1.244 0.77 0 C-N-CA 124.516 1.126 . . . . 73.329999999999998 113.593 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 533' ' ' GLY . . . . . 0.453 ' H ' ' HB3' ' A' ' 564' ' ' ASN . . . 86.81 162.36 37.32 Favored Glycine 0 N--CA 1.437 -1.278 0 CA-C-N 115.125 -0.943 . . . . 53.210000000000001 113.316 175.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -90.81 122.96 33.98 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.271 -1.381 . . . . 74.109999999999999 107.271 176.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 62.4 t -125.31 125.67 69.45 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 N-CA-C 109.58 -0.526 . . . . 71.219999999999999 109.58 -178.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 536' ' ' ILE . . . . . 0.449 ' O ' ' HG2' ' A' ' 595' ' ' ARG . 40.1 mm -100.25 125.37 54.02 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 N-CA-C 108.396 -0.964 . . . . 61.310000000000002 108.396 177.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . 0.504 HG22 ' HB3' ' A' ' 594' ' ' PRO . 38.6 t -113.54 107.54 53.03 Favored Pre-proline 0 C--N 1.296 -1.757 0 CA-C-N 116.368 -0.378 . . . . 73.510000000000005 110.391 -177.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -74.59 147.19 35.48 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.408 2.072 . . . . 74.019999999999996 111.308 178.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 539' ' ' TYR . . . . . 0.4 ' CD2' ' HG ' ' A' ' 560' ' ' LEU . 50.6 p90 -147.85 156.9 43.21 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 108.255 -1.017 . . . . 75.230000000000004 108.255 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.96 150.9 28.8 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 123.399 0.437 . . . . 72.230000000000004 111.42 178.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 1.1 p -87.54 118.17 26.84 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 123.684 0.794 . . . . 74.340000000000003 112.075 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.419 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 3.7 mp -84.83 123.66 39.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 107.545 -1.28 . . . . 74.25 107.545 176.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -54.3 -54.02 45.87 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 124.225 1.01 . . . . 71.400000000000006 113.059 -175.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 72.18 -90.37 0.51 Allowed Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.898 -0.668 . . . . 63.450000000000003 112.203 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 8.9 t -124.84 -0.78 7.93 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 121.935 0.874 . . . . 73.25 109.299 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -94.9 175.79 6.51 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.586 -0.734 . . . . 54.140000000000001 109.926 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . 0.495 ' N ' ' HD2' ' A' ' 547' ' ' ARG . 4.5 mpt_? -101.58 173.05 6.6 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.716 -0.22 . . . . 74.200000000000003 111.296 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -62.54 -175.42 2.52 Favored Glycine 0 C--O 1.252 1.23 0 N-CA-C 116.116 1.206 . . . . 72.239999999999995 116.116 -174.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . -58.9 119.93 20.16 Favored Glycine 0 N--CA 1.439 -1.113 0 CA-C-N 114.087 -1.056 . . . . 61.229999999999997 114.362 -175.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 83.89 4.98 88.33 Favored Glycine 0 N--CA 1.438 -1.189 0 CA-C-N 115.287 -0.456 . . . . 72.239999999999995 112.028 176.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -103.04 -67.22 0.89 Allowed 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 108.408 -0.96 . . . . 54.32 108.408 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . 0.643 ' OD2' 'CA ' ' A' ' 850' ' ' ' CA' . 12.8 t70 -104.54 -38.33 6.81 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.764 0.793 . . . . 75.400000000000006 109.125 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -138.17 160.77 38.56 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 108.276 -1.009 . . . . 73.120000000000005 108.276 176.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -86.42 110.34 19.66 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 105.411 -2.07 . . . . 74.420000000000002 105.411 176.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -67.61 100.83 0.93 Allowed 'General case' 0 CA--C 1.485 -1.54 0 CA-C-N 115.551 -0.749 . . . . 74.450000000000003 110.587 -174.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . 0.524 HG21 HG22 ' A' ' 573' ' ' VAL . 9.6 t -97.98 95.88 7.78 Favored 'General case' 0 N--CA 1.393 -3.298 0 CA-C-O 123.31 1.529 . . . . 74.109999999999999 110.019 -177.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 1.9 p -115.44 97.76 6.35 Favored 'General case' 0 N--CA 1.399 -2.976 0 CA-C-N 113.015 -1.902 . . . . 61.299999999999997 106.93 176.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -152.79 -156.21 7.45 Favored Glycine 0 N--CA 1.402 -3.586 0 N-CA-C 110.612 -0.995 . . . . 63.140000000000001 110.612 -172.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 559' ' ' GLU . . . . . 0.441 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 41.5 mt-10 -137.11 135.82 37.77 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-O 120.717 0.294 . . . . 74.349999999999994 110.885 -171.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . 0.434 ' HB3' ' HG2' ' A' ' 569' ' ' LYS . 80.2 mt -93.92 138.11 32.41 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 109.284 -0.636 . . . . 71.400000000000006 109.284 175.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -103.39 106.32 16.8 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.77 -0.65 . . . . 74.230000000000004 111.385 -175.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 562' ' ' PHE . . . . . 0.569 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 88.7 m-85 -109.15 143.57 38.37 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 116.088 -0.506 . . . . 75.310000000000002 109.8 176.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -119.24 -167.88 1.48 Allowed 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 108.154 -1.054 . . . . 75.409999999999997 108.154 -178.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 564' ' ' ASN . . . . . 0.453 ' HB3' ' H ' ' A' ' 533' ' ' GLY . 27.6 p-10 -78.33 -42.15 31.5 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 109.636 -0.505 . . . . 72.420000000000002 109.636 178.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -89.35 -29.69 18.94 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.575 -0.738 . . . . 72.120000000000005 110.684 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -79.37 108.19 12.7 Favored 'General case' 0 C--O 1.248 1.012 0 CA-C-N 115.878 -0.601 . . . . 74.140000000000001 110.17 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 567' ' ' ILE . . . . . 0.43 ' O ' HG12 ' A' ' 568' ' ' VAL . 6.1 pt -110.17 166.19 5.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 108.049 -1.093 . . . . 71.040000000000006 108.049 174.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 568' ' ' VAL . . . . . 0.613 ' HA ' ' O ' ' A' ' 525' ' ' VAL . 0.9 OUTLIER 58.77 155.83 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.56 1.336 0 C-N-CA 125.681 1.592 . . . . 73.450000000000003 112.564 -178.814 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 569' ' ' LYS . . . . . 0.569 ' HB2' ' CZ ' ' A' ' 562' ' ' PHE . 0.0 OUTLIER -161.94 166.62 25.87 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 106.985 -1.487 . . . . 64.439999999999998 106.985 179.492 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 570' ' ' THR . . . . . 0.616 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 7.0 p -127.52 138.68 52.98 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 123.427 0.454 . . . . 65.010000000000005 111.363 175.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 571' ' ' ILE . . . . . 0.466 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 3.2 mp -88.61 115.18 28.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 106.763 -1.569 . . . . 72.310000000000002 106.763 171.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 24.2 p -92.82 109.49 20.92 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 109.365 -0.606 . . . . 73.040000000000006 109.365 178.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 573' ' ' VAL . . . . . 0.524 HG22 HG21 ' A' ' 556' ' ' THR . 43.6 t -112.69 129.94 67.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 N-CA-C 109.328 -0.619 . . . . 75.150000000000006 109.328 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 574' ' ' LYS . . . . . 0.55 ' HA ' ' O ' ' A' ' 519' ' ' GLY . 86.9 tttt -89.09 124.12 34.02 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 123.814 0.696 . . . . 61.43 110.156 176.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 46.5 t -91.07 131.61 37.78 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 N-CA-C 108.312 -0.996 . . . . 74.450000000000003 108.312 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 576' ' ' ILE . . . . . 0.411 ' HB ' ' O ' ' A' ' 552' ' ' ASP . 30.1 mm -101.03 160.65 3.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 107.784 -1.191 . . . . 74.409999999999997 107.784 -177.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -76.91 147.73 36.82 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 110.061 -0.348 . . . . 60.149999999999999 110.061 177.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 578' ' ' ASP . . . . . 0.637 ' OD2' 'CA ' ' A' ' 800' ' ' ' CA' . 5.5 m-20 -69.98 132.4 45.87 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 114.55 1.315 . . . . 72.209999999999994 114.55 -175.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 579' ' ' GLU . . . . . 0.631 ' OE2' 'CA ' ' A' ' 850' ' ' ' CA' . 0.0 OUTLIER -96.59 -26.27 15.3 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 112.533 -2.121 . . . . 74.120000000000005 111.394 179.599 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 580' ' ' GLU . . . . . 0.435 ' HG2' ' O ' ' A' ' 581' ' ' TYR . 0.1 OUTLIER -105.11 -174.97 2.66 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 107.192 -1.41 . . . . 70.230000000000004 107.192 178.813 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 581' ' ' TYR . . . . . 0.435 ' O ' ' HG2' ' A' ' 580' ' ' GLU . 24.6 p90 -69.25 145.14 53.38 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 106.31 -1.737 . . . . 75.420000000000002 106.31 176.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 582' ' ' GLU . . . . . 0.604 ' OE1' 'CA ' ' A' ' 800' ' ' ' CA' 0.528 18.6 pt-20 -93.79 121.03 34.81 Favored 'General case' 0 N--CA 1.408 -2.56 0 N-CA-C 117.673 2.472 . . . . 73.439999999999998 117.673 -175.133 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.19 170.94 11.88 Favored 'General case' 0 N--CA 1.417 -2.108 0 CA-C-N 111.407 -2.633 . . . . 72.549999999999997 106.476 178.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -67.71 119.31 12.24 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.36 0.6 . . . . 61.310000000000002 109.468 -177.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 585' ' ' LYS . . . . . 0.498 ' HD2' HD13 ' A' ' 646' ' ' ILE . 1.6 tmmm? -122.58 142.51 50.55 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-N 115.003 -0.999 . . . . 74.430000000000007 109.911 -171.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 6.8 t -148.22 142.99 26.7 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-O 121.14 0.495 . . . . 53.32 110.698 -175.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -129.64 148.23 51.51 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-N 114.113 -1.403 . . . . 75.329999999999998 109.802 177.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 588' ' ' PHE . . . . . 0.507 ' HA ' ' O ' ' A' ' 642' ' ' LEU . 27.2 m-85 -104.14 138.3 40.83 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.978 -0.556 . . . . 74.420000000000002 109.672 -176.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . 0.583 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.5 OUTLIER -113.01 115.24 28.08 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 105.642 -1.985 . . . . 73.400000000000006 105.642 175.573 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -125.59 133.37 52.3 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 109.148 -0.686 . . . . 64.329999999999998 109.148 178.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 591' ' ' ILE . . . . . . . . . . . . . 22.0 pt -85.58 146.96 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-N 115.808 -0.633 . . . . 71.129999999999995 109.412 178.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -93.54 -148.43 23.6 Favored Glycine 0 N--CA 1.427 -1.905 0 C-N-CA 120.911 -0.662 . . . . 71.329999999999998 111.496 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -75.56 117.04 60.42 Favored Pre-proline 0 C--N 1.295 -1.786 0 N-CA-C 108.866 -0.79 . . . . 71.299999999999997 108.866 178.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 594' ' ' PRO . . . . . 0.504 ' HB3' HG22 ' A' ' 537' ' ' VAL . 57.8 Cg_endo -72.81 134.34 21.68 Favored 'Trans proline' 0 N--CA 1.433 -2.045 0 C-N-CA 121.573 1.515 . . . . 61.109999999999999 109.408 176.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 595' ' ' ARG . . . . . 0.449 ' HG2' ' O ' ' A' ' 536' ' ' ILE . 14.2 ptm180 -108.29 121.15 44.31 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-O 121.028 0.442 . . . . 73.019999999999996 111.057 -172.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -76.7 118.44 19.33 Favored 'General case' 0 N--CA 1.414 -2.245 0 N-CA-C 105.786 -1.931 . . . . 71.030000000000001 105.786 176.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 21.4 t -83.49 72.8 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 CA-C-O 121.905 0.859 . . . . 73.040000000000006 109.46 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -124.64 -27.32 3.7 Favored 'General case' 0 C--N 1.276 -2.62 0 CA-C-N 114.003 -1.453 . . . . 73.099999999999994 110.218 172.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 58.7 mtm 61.57 31.92 18.74 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.178 0.991 . . . . 73.439999999999998 111.119 175.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 29.1 t -113.96 142.54 46.01 Favored 'General case' 0 N--CA 1.423 -1.803 0 CA-C-N 115.841 -0.618 . . . . 75.129999999999995 110.522 -175.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.57 97.55 6.96 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-N 115.4 -0.818 . . . . 74.519999999999996 109.147 177.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 65.4 tttp -141.86 148.87 39.49 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.194 -0.669 . . . . 74.319999999999993 109.194 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? 73.24 -46.88 0.65 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.454 1.502 . . . . 74.209999999999994 112.174 178.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . 0.463 ' HA3' ' HA ' ' A' ' 629' ' ' ALA . . . -84.05 -69.05 1.39 Allowed Glycine 0 N--CA 1.436 -1.304 0 N-CA-C 111.167 -0.773 . . . . 63.520000000000003 111.167 178.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . -61.06 110.0 2.79 Favored Glycine 0 N--CA 1.442 -0.91 0 O-C-N 123.844 0.379 . . . . 75.219999999999999 113.194 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -89.53 -25.96 21.12 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.625 -0.88 . . . . 73.099999999999994 108.625 176.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 5.4 p -76.29 151.26 36.8 Favored 'General case' 0 N--CA 1.416 -2.139 0 CA-C-N 114.827 -1.079 . . . . 72.540000000000006 110.455 178.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 23.5 mt -86.9 16.26 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 CA-C-O 123.265 1.507 . . . . 72.5 108.9 -176.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 92.5 m -152.72 131.57 12.47 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 107.099 -1.445 . . . . 65.030000000000001 107.099 179.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -78.77 83.75 4.89 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 108.38 -0.97 . . . . 71.0 108.38 176.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.31 136.17 34.46 Favored 'General case' 0 N--CA 1.421 -1.893 0 CA-C-N 115.737 -0.665 . . . . 73.519999999999996 112.403 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 59.43 66.16 1.06 Allowed 'General case' 0 C--O 1.243 0.728 0 C-N-CA 125.016 1.326 . . . . 74.310000000000002 112.327 -176.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -98.59 100.32 11.54 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 122.205 1.003 . . . . 74.540000000000006 109.239 177.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -120.21 118.65 31.03 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.404 -0.816 . . . . 63.219999999999999 109.107 -178.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -77.73 106.82 9.79 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 122.185 0.993 . . . . 60.140000000000001 111.539 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -117.42 176.63 1.51 Allowed Pre-proline 0 C--N 1.288 -2.099 0 CA-C-N 113.394 -1.73 . . . . 73.329999999999998 107.315 -176.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -67.01 167.34 20.12 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 N-CA-C 108.037 -1.563 . . . . 74.439999999999998 108.037 169.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -62.2 104.36 0.47 Allowed 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.346 0.593 . . . . 74.099999999999994 111.824 -176.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 7.3 p -135.33 143.6 46.24 Favored 'General case' 0 N--CA 1.423 -1.806 0 CA-C-N 114.864 -1.062 . . . . 70.25 109.231 -178.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 50.6 m -129.74 -5.09 4.62 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 120.489 -0.485 . . . . 71.430000000000007 111.785 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 621' ' ' LYS . . . . . 0.493 ' HA ' ' HE3' ' A' ' 621' ' ' LYS . 1.1 tpmt? 60.96 16.01 6.6 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.614 0.766 . . . . 73.150000000000006 110.599 176.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 66.27 7.58 4.99 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.921 1.289 . . . . 71.239999999999995 112.068 -174.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -79.7 121.9 25.9 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 109.334 -0.617 . . . . 75.109999999999999 109.334 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 624' ' ' GLU . . . . . 0.436 ' O ' HG13 ' A' ' 628' ' ' ILE . 45.7 mt-10 -61.96 -37.9 86.49 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.597 -0.274 . . . . 64.219999999999999 111.695 -179.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -71.38 -22.02 61.94 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.239 0.543 . . . . 72.299999999999997 111.547 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . . . . . . . . . 24.2 tpt180 -80.82 -36.37 31.71 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 107.437 -1.32 . . . . 75.409999999999997 107.437 174.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 627' ' ' ARG . . . . . . . . . . . . . 84.8 mtt180 -61.99 -38.92 90.4 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.893 -0.594 . . . . 63.130000000000003 110.258 175.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . 0.462 ' O ' ' HB3' ' A' ' 631' ' ' MET . 98.8 mt -65.14 -36.61 78.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 123.078 0.551 . . . . 72.450000000000003 110.932 176.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 629' ' ' ALA . . . . . 0.463 ' HA ' ' HA3' ' A' ' 604' ' ' GLY . . . -69.98 -44.57 69.17 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 109.662 -0.496 . . . . 52.140000000000001 109.662 177.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -79.43 4.59 15.03 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.463 -0.789 . . . . 74.099999999999994 111.119 -178.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 631' ' ' MET . . . . . 0.462 ' HB3' ' O ' ' A' ' 628' ' ' ILE . 46.0 ttm -79.05 -27.57 43.14 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 108.542 -0.91 . . . . 65.349999999999994 108.542 174.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -84.51 -9.93 80.6 Favored Glycine 0 CA--C 1.503 -0.658 0 N-CA-C 110.458 -1.057 . . . . 53.420000000000002 110.458 177.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -91.7 148.1 36.51 Favored Pre-proline 0 C--N 1.305 -1.359 0 CA-C-N 114.394 -0.903 . . . . 73.010000000000005 108.919 178.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.441 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 4.9 Cg_endo -75.5 154.52 40.22 Favored 'Trans proline' 0 N--CA 1.44 -1.645 0 N-CA-C 107.073 -1.933 . . . . 72.019999999999996 107.073 166.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.6 pp -135.48 173.66 13.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 C-N-CA 118.804 -1.158 . . . . 72.329999999999998 113.928 -175.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . 0.422 ' HB2' HG21 ' A' ' 640' ' ' THR . 0.0 OUTLIER -75.67 146.99 39.8 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.969 -1.014 . . . . 73.340000000000003 110.232 -179.149 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -94.04 -132.16 6.39 Favored Glycine 0 C--N 1.289 -2.044 0 CA-C-N 115.604 -0.725 . . . . 75.120000000000005 113.821 -176.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -69.68 -56.48 7.12 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 111.955 0.354 . . . . 61.299999999999997 111.955 -175.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -137.07 114.62 11.08 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.889 0.852 . . . . 72.150000000000006 112.274 -178.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 640' ' ' THR . . . . . 0.422 HG21 ' HB2' ' A' ' 636' ' ' LEU . 17.5 p -119.68 91.84 3.64 Favored 'General case' 0 N--CA 1.416 -2.158 0 CA-C-N 115.219 -0.9 . . . . 74.030000000000001 110.568 177.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 641' ' ' LYS . . . . . 0.439 ' HE3' ' HB2' ' A' ' 643' ' ' GLU . 0.3 OUTLIER -178.71 126.0 0.1 Allowed 'General case' 0 CA--C 1.482 -1.642 0 N-CA-C 103.988 -2.597 . . . . 74.0 103.988 176.49 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 642' ' ' LEU . . . . . 0.677 HD21 HG21 ' A' ' 523' ' ' VAL . 51.7 tp -115.82 112.99 22.77 Favored 'General case' 0 C--N 1.263 -3.189 0 N-CA-C 108.653 -0.869 . . . . 73.349999999999994 108.653 177.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . 0.447 ' HB3' HG22 ' A' ' 511' ' ' VAL . 19.3 tt0 -97.55 103.47 15.41 Favored 'General case' 0 C--N 1.273 -2.734 0 N-CA-C 107.204 -1.406 . . . . 62.109999999999999 107.204 178.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 644' ' ' VAL . . . . . 0.494 HG21 ' HE2' ' A' ' 521' ' ' MET . 21.8 t -91.95 106.74 18.05 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.289 0 N-CA-C 108.15 -1.056 . . . . 63.200000000000003 108.15 -178.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 4.0 mp -90.99 115.87 31.05 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.293 0 N-CA-C 107.019 -1.475 . . . . 74.409999999999997 107.019 173.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 646' ' ' ILE . . . . . 0.498 HD13 ' HD2' ' A' ' 585' ' ' LYS . 3.2 mp -101.9 112.05 33.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 107.606 -1.257 . . . . 74.540000000000006 107.606 -175.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -111.2 138.2 47.94 Favored 'General case' 0 C--N 1.275 -2.671 0 CA-C-N 115.629 -0.714 . . . . 73.310000000000002 110.889 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . 0.635 ' OE2' 'CA ' ' A' ' 800' ' ' ' CA' . 9.5 mp0 -48.75 136.17 14.01 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.888 -1.051 . . . . 74.010000000000005 110.811 178.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 8.6 t -86.67 81.71 8.13 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-O 122.191 0.995 . . . . 61.340000000000003 109.987 -175.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -105.46 -49.3 3.47 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 113.769 -1.56 . . . . 72.319999999999993 107.813 173.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 651' ' ' GLU . . . . . 0.637 ' HG3' ' H ' ' A' ' 652' ' ' PHE . 9.3 tp10 -157.99 -161.14 0.98 Allowed 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 103.179 -2.897 . . . . 73.310000000000002 103.179 -178.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 652' ' ' PHE . . . . . 0.637 ' H ' ' HG3' ' A' ' 651' ' ' GLU . 11.1 t80 -148.03 162.37 39.5 Favored 'General case' 0 C--N 1.276 -2.595 0 N-CA-C 105.37 -2.085 . . . . 72.209999999999994 105.37 177.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.83 -74.93 0.59 Allowed 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 120.545 -0.462 . . . . 71.129999999999995 110.69 -179.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 44.4 p 55.25 18.16 2.36 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 124.547 1.139 . . . . 72.310000000000002 112.483 -176.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 7.5 p -86.21 125.29 33.44 Favored 'General case' 0 N--CA 1.423 -1.79 0 CA-C-N 115.409 -0.814 . . . . 53.240000000000002 110.668 -177.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 7.2 p -98.4 125.15 51.81 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.082 0 N-CA-C 108.182 -1.044 . . . . 70.540000000000006 108.182 178.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 13.6 t70 . . . . . 0 C--N 1.299 -1.607 0 C-N-CA 119.732 -0.787 . . . . 73.349999999999994 110.391 -176.008 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 800' ' ' ' CA' . . . . . 0.637 'CA ' ' OD2' ' A' ' 578' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 850' ' ' ' CA' . . . . . 0.643 'CA ' ' OD2' ' A' ' 552' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.469 0.49 0 CA-C-O 121.743 0.783 . . . . 74.319999999999993 110.087 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -178.61 -169.37 0.17 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 104.75 -2.315 . . . . 42.219999999999999 104.75 -177.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . 0.461 ' HA2' ' OG1' ' A' ' 528' ' ' THR . . . -164.08 130.64 2.25 Favored Glycine 0 N--CA 1.406 -3.314 0 C-N-CA 118.015 -2.04 . . . . 74.120000000000005 113.486 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 2.8 mp -81.84 102.03 7.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 107.483 -1.303 . . . . 64.200000000000003 107.483 174.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . 0.413 ' O ' ' HA3' ' A' ' 637' ' ' GLY . 42.9 m-85 -115.5 124.02 50.03 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.043 -1.095 . . . . 73.299999999999997 108.043 178.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 11.6 t -155.71 168.75 26.17 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.343 -0.984 . . . . 74.329999999999998 108.343 -174.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -87.43 151.4 23.09 Favored 'General case' 0 CA--C 1.494 -1.19 0 N-CA-C 107.639 -1.245 . . . . 72.140000000000001 107.639 175.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -87.0 -39.49 15.62 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 109.367 -0.605 . . . . 72.430000000000007 109.367 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -110.08 128.63 25.04 Favored Pre-proline 0 N--CA 1.437 -1.084 0 N-CA-C 108.469 -0.937 . . . . 73.329999999999998 108.469 176.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -79.42 -14.65 12.93 Favored 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 121.93 1.753 . . . . 64.340000000000003 112.373 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . 0.553 HG22 ' HB3' ' A' ' 643' ' ' GLU . 73.6 t -138.99 135.76 42.57 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.854 0 N-CA-C 108.755 -0.832 . . . . 63.439999999999998 108.755 -178.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 3.5 t -137.76 138.47 39.3 Favored 'General case' 0 N--CA 1.408 -2.536 0 N-CA-C 107.8 -1.185 . . . . 73.109999999999999 107.8 177.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 513' ' ' HIS . . . . . 0.536 ' CE1' ' HA ' ' A' ' 654' ' ' SER . 23.4 m-70 -108.57 124.53 50.61 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 108.366 -0.976 . . . . 71.040000000000006 108.366 178.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 32.1 m -123.2 159.49 27.29 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.383 0 CA-C-O 121.433 0.635 . . . . 62.420000000000002 111.777 -173.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 41.2 m -75.58 152.33 37.73 Favored 'General case' 0 N--CA 1.399 -3.002 0 CA-C-N 114.012 -1.449 . . . . 71.409999999999997 109.961 -179.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . 0.673 ' OE2' 'CA ' ' A' ' 800' ' ' ' CA' . 21.7 tt0 -78.08 -48.38 16.19 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 121.408 0.623 . . . . 62.210000000000001 111.889 178.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 29.7 m -90.3 38.61 0.94 Allowed 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 122.157 0.979 . . . . 63.420000000000002 110.12 -171.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 17.4 tt -105.79 155.83 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.433 0 N-CA-C 105.855 -1.906 . . . . 65.019999999999996 105.855 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . -89.93 -57.08 1.75 Allowed Glycine 0 C--N 1.289 -2.063 0 C-N-CA 119.108 -1.52 . . . . 75.219999999999999 111.185 178.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 34.3 mm -126.29 136.41 60.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 CA-C-N 115.27 -0.465 . . . . 71.120000000000005 109.847 -176.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 521' ' ' MET . . . . . 0.637 ' HE2' HG21 ' A' ' 644' ' ' VAL . 0.0 OUTLIER -114.19 130.74 56.61 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 106.419 -1.697 . . . . 71.319999999999993 106.419 170.161 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -113.07 122.84 48.78 Favored 'General case' 0 C--N 1.313 -1.019 0 O-C-N 123.379 0.425 . . . . 72.420000000000002 110.265 -176.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . 0.62 ' O ' ' HA ' ' A' ' 570' ' ' THR . 43.4 t -103.32 126.76 57.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 CA-C-N 116.246 -0.433 . . . . 43.450000000000003 110.521 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 27.8 mmtp -78.22 134.96 37.51 Favored 'General case' 0 C--N 1.317 -0.843 0 O-C-N 123.853 0.721 . . . . 73.510000000000005 111.801 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 21.5 t -115.0 142.12 29.06 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 N-CA-C 108.656 -0.868 . . . . 53.549999999999997 108.656 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -69.57 167.47 16.78 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-O 122.305 1.05 . . . . 73.140000000000001 113.448 -178.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . 0.432 HH11 ' HD3' ' A' ' 527' ' ' ARG . 3.4 tpm_? -106.88 158.81 16.73 Favored 'General case' 0 N--CA 1.426 -1.668 0 CA-C-N 114.027 -1.442 . . . . 73.430000000000007 109.574 -175.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . 0.461 ' OG1' ' HA2' ' A' ' 503' ' ' GLY . 3.3 t -73.03 160.5 31.97 Favored 'General case' 0 N--CA 1.432 -1.374 0 C-N-CA 124.003 0.921 . . . . 50.439999999999998 110.215 176.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 22.2 t -85.2 -11.67 54.41 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 108.575 -0.898 . . . . 62.520000000000003 108.575 178.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -146.51 100.74 0.23 Allowed Glycine 0 N--CA 1.438 -1.194 0 N-CA-C 109.943 -1.263 . . . . 72.030000000000001 109.943 177.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -90.36 88.55 7.24 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.115 0.483 . . . . 60.0 111.754 -176.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 -137.76 100.23 4.13 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.373 -0.973 . . . . 74.430000000000007 108.373 174.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 123.17 154.63 9.07 Favored Glycine 0 N--CA 1.429 -1.825 0 C-N-CA 120.117 -1.039 . . . . 71.430000000000007 112.365 178.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 534' ' ' ASN . . . . . 0.493 HD21 ' HG3' ' A' ' 561' ' ' GLU . 2.6 t-20 -98.54 119.94 38.11 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-O 121.375 0.607 . . . . 74.319999999999993 109.557 176.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 535' ' ' VAL . . . . . 0.528 HG22 HD22 ' A' ' 596' ' ' LEU . 89.9 t -122.45 135.59 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-N 115.124 -0.944 . . . . 64.109999999999999 109.202 -179.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 536' ' ' ILE . . . . . 0.593 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 43.3 mm -102.81 133.4 46.66 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.062 0 N-CA-C 108.961 -0.755 . . . . 74.319999999999993 108.961 178.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 63.6 t -119.55 110.36 37.31 Favored Pre-proline 0 C--N 1.297 -1.683 0 N-CA-C 109.772 -0.455 . . . . 74.120000000000005 109.772 178.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -74.11 152.73 45.94 Favored 'Trans proline' 0 C--O 1.24 0.592 0 C-N-CA 122.644 2.229 . . . . 74.230000000000004 111.93 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 539' ' ' TYR . . . . . 0.534 ' HB3' HG22 ' A' ' 591' ' ' ILE . 53.7 p90 -152.61 159.5 43.23 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.676 -0.861 . . . . 71.219999999999999 108.676 -178.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 540' ' ' LYS . . . . . 0.414 ' HE3' HD11 ' A' ' 542' ' ' ILE . 0.1 OUTLIER -161.35 150.96 16.72 Favored 'General case' 0 C--N 1.309 -1.16 0 O-C-N 123.613 0.57 . . . . 70.409999999999997 110.23 179.025 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 7.3 p -82.17 121.93 27.24 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 114.98 -1.009 . . . . 74.230000000000004 110.858 173.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.426 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 3.5 mp -93.17 118.49 39.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 105.259 -2.126 . . . . 71.109999999999999 105.259 171.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . 0.452 ' H ' ' CD ' ' A' ' 543' ' ' GLU . 1.6 mp0 -48.15 -55.36 10.54 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 124.316 1.046 . . . . 73.219999999999999 112.406 -175.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 72.47 -102.3 1.17 Allowed Glycine 0 N--CA 1.442 -0.939 0 N-CA-C 110.702 -0.959 . . . . 54.450000000000003 110.702 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 11.4 t -118.68 -0.36 11.32 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 122.334 1.064 . . . . 73.040000000000006 109.359 177.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -88.62 143.61 26.83 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 108.342 -0.984 . . . . 61.109999999999999 108.342 173.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . 0.483 ' HG3' ' HG3' ' A' ' 551' ' ' GLU . 27.6 tpt180 -90.19 119.13 30.25 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.826 -0.805 . . . . 75.25 108.826 179.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -86.45 174.29 46.69 Favored Glycine 0 C--N 1.306 -1.13 0 C-N-CA 120.503 -0.856 . . . . 71.120000000000005 113.15 -176.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 86.0 36.2 10.38 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 121.148 -0.549 . . . . 75.540000000000006 113.416 176.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 87.87 10.8 68.95 Favored Glycine 0 N--CA 1.44 -1.055 0 C-N-CA 120.261 -0.971 . . . . 42.450000000000003 112.82 176.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . 0.483 ' HG3' ' HG3' ' A' ' 547' ' ' ARG . 7.8 mm-40 -92.72 -71.83 0.63 Allowed 'General case' 0 C--O 1.213 -0.862 0 N-CA-C 109.412 -0.588 . . . . 74.310000000000002 109.412 179.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . 0.606 ' OD1' 'CA ' ' A' ' 850' ' ' ' CA' . 56.5 m-20 -97.55 -30.05 13.09 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 108.626 -0.879 . . . . 74.219999999999999 108.626 176.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 553' ' ' PHE . . . . . 0.504 ' HB3' ' CE2' ' A' ' 587' ' ' PHE . 46.4 p90 -149.76 155.24 39.81 Favored 'General case' 0 N--CA 1.419 -1.989 0 CA-C-N 115.312 -0.858 . . . . 65.140000000000001 110.198 178.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -82.54 123.2 28.97 Favored 'General case' 0 C--N 1.276 -2.6 0 N-CA-C 104.48 -2.415 . . . . 74.439999999999998 104.48 175.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -60.77 121.11 11.47 Favored 'General case' 0 CA--C 1.488 -1.423 0 CA-C-O 122.237 1.017 . . . . 60.32 111.575 -175.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . 0.44 HG21 HG22 ' A' ' 573' ' ' VAL . 98.4 m -120.22 112.64 19.32 Favored 'General case' 0 N--CA 1.388 -3.555 0 CA-C-N 114.5 -1.227 . . . . 51.039999999999999 111.806 -171.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 20.7 p -145.63 128.97 16.83 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.846 -1.168 . . . . 73.540000000000006 107.846 176.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -165.86 -155.61 8.84 Favored Glycine 0 N--CA 1.422 -2.295 0 C-N-CA 120.462 -0.875 . . . . 61.329999999999998 111.139 -176.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 559' ' ' GLU . . . . . 0.593 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 42.1 mt-10 -143.09 125.63 15.8 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 123.06 0.544 . . . . 65.420000000000002 110.269 -176.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . 0.441 ' HG ' ' CE1' ' A' ' 539' ' ' TYR . 87.7 mt -88.7 135.79 33.33 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 122.723 0.409 . . . . 75.140000000000001 110.776 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 561' ' ' GLU . . . . . 0.493 ' HG3' HD21 ' A' ' 534' ' ' ASN . 45.4 tt0 -96.38 108.57 21.11 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.601 -0.727 . . . . 73.319999999999993 110.593 179.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 562' ' ' PHE . . . . . 0.423 ' CE1' ' HG2' ' A' ' 569' ' ' LYS . 8.0 m-85 -107.74 116.92 32.82 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.234 -0.654 . . . . 74.420000000000002 109.234 173.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . 0.509 ' HG3' ' H ' ' A' ' 566' ' ' GLU . 3.5 pt20 -119.56 -175.26 2.91 Favored 'General case' 0 C--N 1.29 -1.995 0 C-N-CA 119.068 -1.053 . . . . 73.120000000000005 112.023 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -59.06 -47.53 84.9 Favored 'General case' 0 C--N 1.318 -0.774 0 O-C-N 123.86 0.725 . . . . 75.209999999999994 109.667 177.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -77.74 -67.19 0.75 Allowed 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.278 -0.873 . . . . 63.030000000000001 111.233 -178.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . 0.509 ' H ' ' HG3' ' A' ' 563' ' ' GLN . 15.3 tt0 -56.27 113.86 1.74 Allowed 'General case' 0 C--O 1.247 0.922 0 O-C-N 123.783 0.677 . . . . 72.209999999999994 112.629 -178.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 10.4 pt -102.36 169.14 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.407 -2.591 0 N-CA-C 106.64 -1.615 . . . . 71.409999999999997 106.64 173.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 1.7 p 40.55 124.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.559 1.306 0 C-N-CA 127.069 2.147 . . . . 54.329999999999998 116.628 177.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 569' ' ' LYS . . . . . 0.426 ' HD2' ' HA ' ' A' ' 569' ' ' LYS . 32.8 mmmt -116.85 157.43 25.63 Favored 'General case' 0 C--N 1.265 -3.103 0 CA-C-N 114.921 -1.036 . . . . 71.120000000000005 110.16 178.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 570' ' ' THR . . . . . 0.62 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 1.8 p -129.88 125.27 35.2 Favored 'General case' 0 C--N 1.278 -2.538 0 CA-C-N 114.784 -1.098 . . . . 44.049999999999997 111.307 179.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 3.6 mp -84.52 111.12 19.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 106.277 -1.749 . . . . 71.140000000000001 106.277 173.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 3.1 p -95.66 109.45 21.72 Favored 'General case' 0 N--CA 1.417 -2.093 0 O-C-N 123.87 0.731 . . . . 73.400000000000006 109.918 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 573' ' ' VAL . . . . . 0.44 HG22 HG21 ' A' ' 556' ' ' THR . 59.9 t -111.82 133.68 56.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 108.916 -0.772 . . . . 64.140000000000001 108.916 -178.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 574' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 519' ' ' GLY . 41.4 ttmt -84.81 117.14 23.68 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-O 121.444 0.64 . . . . 75.310000000000002 109.676 177.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 60.2 t -89.44 143.74 10.56 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 N-CA-C 107.08 -1.452 . . . . 71.109999999999999 107.08 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 576' ' ' ILE . . . . . 0.435 HG12 ' HA ' ' A' ' 553' ' ' PHE . 26.0 mm -111.81 132.3 60.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 C-N-CA 119.975 -0.69 . . . . 72.549999999999997 109.196 -177.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -59.65 137.53 58.01 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.301 -0.863 . . . . 73.030000000000001 108.873 178.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 578' ' ' ASP . . . . . 0.596 ' OD2' 'CA ' ' A' ' 800' ' ' ' CA' 0.413 15.9 m-20 -59.31 119.65 7.81 Favored 'General case' 0 CA--C 1.491 -1.305 0 N-CA-C 117.144 2.276 . . . . 70.230000000000004 117.144 -171.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 579' ' ' GLU . . . . . 0.437 ' H ' ' CD ' ' A' ' 579' ' ' GLU . 6.1 pm0 -97.07 -14.07 21.81 Favored 'General case' 0 N--CA 1.401 -2.888 0 CA-C-N 110.483 -3.053 . . . . 62.43 112.948 -172.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 580' ' ' GLU . . . . . 0.621 ' HG2' ' O ' ' A' ' 581' ' ' TYR . 2.4 pm0 -128.5 -167.23 1.74 Allowed 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 122.897 0.479 . . . . 71.329999999999998 110.016 -173.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 581' ' ' TYR . . . . . 0.621 ' O ' ' HG2' ' A' ' 580' ' ' GLU . 52.5 p90 -58.3 153.41 15.44 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 107.709 -1.219 . . . . 71.439999999999998 107.709 170.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -93.34 134.44 35.55 Favored 'General case' 0 C--N 1.275 -2.668 0 C-N-CA 116.654 -2.019 . . . . 65.129999999999995 113.36 -176.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . 0.407 ' HE2' ' HB3' ' A' ' 585' ' ' LYS . 0.0 OUTLIER -145.93 130.79 18.12 Favored 'General case' 0 N--CA 1.412 -2.331 0 N-CA-C 104.584 -2.376 . . . . 70.329999999999998 104.584 171.253 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -66.3 123.72 20.72 Favored 'General case' 0 CA--C 1.488 -1.434 0 N-CA-C 107.364 -1.347 . . . . 72.129999999999995 107.364 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 585' ' ' LYS . . . . . 0.407 ' HB3' ' HE2' ' A' ' 583' ' ' LYS . 0.0 OUTLIER -128.87 166.71 18.56 Favored 'General case' 0 C--N 1.285 -2.216 0 CA-C-N 115.604 -0.725 . . . . 71.140000000000001 109.902 -168.527 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 6.5 t -156.22 145.41 20.59 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-O 120.797 0.332 . . . . 61.520000000000003 110.866 -173.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 587' ' ' PHE . . . . . 0.504 ' CE2' ' HB3' ' A' ' 553' ' ' PHE . 3.4 p90 -125.33 147.76 49.01 Favored 'General case' 0 N--CA 1.42 -1.965 0 O-C-N 125.068 1.48 . . . . 64.319999999999993 109.644 176.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 588' ' ' PHE . . . . . 0.426 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 20.7 m-85 -100.95 127.4 47.46 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.393 -0.966 . . . . 63.450000000000003 108.393 -176.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . 0.498 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.5 OUTLIER -100.96 117.19 34.53 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 104.898 -2.26 . . . . 62.119999999999997 104.898 175.707 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -126.13 125.9 43.28 Favored 'General case' 0 C--N 1.281 -2.372 0 C-N-CA 120.233 -0.587 . . . . 72.430000000000007 109.708 -177.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 591' ' ' ILE . . . . . 0.534 HG22 ' HB3' ' A' ' 539' ' ' TYR . 14.8 pt -87.44 138.67 18.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 N-CA-C 107.828 -1.175 . . . . 52.219999999999999 107.828 173.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -98.88 -136.91 9.54 Favored Glycine 0 N--CA 1.429 -1.819 0 C-N-CA 120.381 -0.914 . . . . 64.239999999999995 114.023 -173.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.577 ' OE1' ' HA ' ' A' ' 617' ' ' PRO . 23.5 tt0 -84.64 118.36 70.86 Favored Pre-proline 0 C--N 1.294 -1.842 0 C-N-CA 124.555 1.142 . . . . 61.140000000000001 110.133 -176.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.11 150.82 72.61 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.354 2.036 . . . . 72.299999999999997 111.488 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 595' ' ' ARG . . . . . 0.4 ' CG ' ' HB ' ' A' ' 536' ' ' ILE . 10.8 ptm180 -132.57 132.11 42.21 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 109.429 -0.582 . . . . 72.400000000000006 109.429 -177.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 596' ' ' LEU . . . . . 0.528 HD22 HG22 ' A' ' 535' ' ' VAL . 0.0 OUTLIER -80.09 134.61 36.2 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.336 -1.357 . . . . 74.430000000000007 107.336 -178.605 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 597' ' ' VAL . . . . . 0.407 ' CG2' HG12 ' A' ' 536' ' ' ILE . 58.1 t -81.78 -49.05 18.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-O 121.868 0.842 . . . . 65.530000000000001 109.098 178.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -89.34 99.69 12.64 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 114.619 -1.173 . . . . 60.229999999999997 108.69 -177.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 4.5 tpt -81.31 86.18 6.29 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 121.194 0.521 . . . . 70.200000000000003 109.835 -177.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 30.6 m -141.72 156.52 45.6 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.846 -0.798 . . . . 75.420000000000002 108.846 178.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -104.82 142.65 34.34 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 120.857 0.361 . . . . 70.150000000000006 110.252 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -140.68 127.23 20.13 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 106.918 -1.512 . . . . 74.129999999999995 106.918 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 603' ' ' LYS . . . . . 0.411 ' HA ' ' HE2' ' A' ' 603' ' ' LYS . 4.4 mmpt? 64.65 23.17 12.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 123.465 0.478 . . . . 71.430000000000007 111.497 -178.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -102.25 -127.02 5.98 Favored Glycine 0 N--CA 1.42 -2.374 0 C-N-CA 120.795 -0.717 . . . . 73.450000000000003 111.501 -176.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 149.47 -137.01 6.02 Favored Glycine 0 N--CA 1.416 -2.695 0 N-CA-C 107.803 -2.119 . . . . 71.120000000000005 107.803 -176.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -149.09 107.38 3.76 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 117.595 0.698 . . . . 75.040000000000006 110.775 176.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 22.0 p -84.85 127.19 34.03 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 107.029 -1.471 . . . . 74.340000000000003 107.029 171.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 41.4 mt -73.9 99.0 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 109.047 -0.723 . . . . 74.109999999999999 109.047 -177.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 8.9 t -143.89 167.99 21.01 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 114.935 -1.029 . . . . 74.200000000000003 108.813 -176.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -97.16 4.72 51.04 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.004 0.43 . . . . 71.329999999999998 110.082 -177.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -70.24 83.78 0.55 Allowed 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 113.666 0.987 . . . . 62.030000000000001 113.666 -177.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -104.22 84.83 2.27 Favored 'General case' 0 CA--C 1.475 -1.931 0 N-CA-C 107.7 -1.222 . . . . 74.209999999999994 107.7 171.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -81.3 108.78 15.21 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 114.299 -1.319 . . . . 72.400000000000006 109.238 -176.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -97.21 92.7 6.14 Favored 'General case' 0 C--N 1.28 -2.438 0 C-N-CA 119.447 -0.901 . . . . 65.010000000000005 109.37 175.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 22.2 pttm 42.21 47.88 4.14 Favored 'General case' 0 C--N 1.319 -0.737 0 O-C-N 125.356 1.66 . . . . 71.409999999999997 114.329 177.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -78.67 162.88 63.81 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 108.749 -0.834 . . . . 74.230000000000004 108.749 176.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 617' ' ' PRO . . . . . 0.577 ' HA ' ' OE1' ' A' ' 593' ' ' GLU . 32.4 Cg_exo -63.47 -165.1 0.05 OUTLIER 'Trans proline' 0 C--O 1.25 1.084 0 C-N-CA 122.703 2.269 . . . . 62.530000000000001 112.664 176.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -55.57 116.22 2.77 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.78 0.8 . . . . 72.209999999999994 109.889 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 1.2 p -129.32 -173.82 3.11 Favored 'General case' 0 C--N 1.287 -2.118 0 CA-C-N 114.77 -1.104 . . . . 73.299999999999997 109.751 -174.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 620' ' ' SER . . . . . 0.456 ' OG ' ' HB3' ' A' ' 626' ' ' ARG . 30.0 t 72.23 24.59 3.05 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 123.833 0.708 . . . . 74.230000000000004 112.629 174.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.68 -8.09 58.41 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.141 -0.623 . . . . 71.299999999999997 110.782 178.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -115.41 -59.48 2.0 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.246 0.546 . . . . 71.329999999999998 110.874 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . 0.432 ' HB2' ' HB2' ' A' ' 626' ' ' ARG . 9.0 mm-40 -73.92 125.14 27.54 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.748 -0.66 . . . . 74.439999999999998 111.485 -176.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -76.15 -33.59 59.38 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.528 -0.76 . . . . 74.420000000000002 108.966 178.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -66.54 -23.69 66.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.634 -0.712 . . . . 54.32 110.367 177.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . 0.492 ' O ' ' HG2' ' A' ' 630' ' ' GLU . 0.5 OUTLIER -66.86 -41.21 87.71 Favored 'General case' 0 C--O 1.205 -1.258 0 CA-C-N 115.306 -0.861 . . . . 75.439999999999998 109.38 176.617 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 627' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -61.89 -24.08 66.72 Favored 'General case' 0 C--O 1.22 -0.494 0 CA-C-N 116.048 -0.524 . . . . 65.209999999999994 111.543 -178.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 74.5 mt -71.05 -43.9 75.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 121.652 0.739 . . . . 75.439999999999998 109.341 176.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -72.02 -38.26 69.6 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.377 -0.829 . . . . 61.539999999999999 109.603 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 630' ' ' GLU . . . . . 0.492 ' HG2' ' O ' ' A' ' 626' ' ' ARG . 24.0 mm-40 -74.61 -4.11 35.19 Favored 'General case' 0 C--O 1.211 -0.969 0 CA-C-N 115.627 -0.715 . . . . 64.430000000000007 110.972 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 631' ' ' MET . . . . . . . . . . . . . 44.4 ttm -81.52 -11.24 59.25 Favored 'General case' 0 N--CA 1.422 -1.839 0 N-CA-C 108.757 -0.831 . . . . 72.209999999999994 108.757 177.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -93.85 5.34 72.73 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 108.789 -1.724 . . . . 62.119999999999997 108.789 172.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 80.7 mtt180 -125.26 174.17 4.17 Favored Pre-proline 0 N--CA 1.428 -1.557 0 C-N-CA 125.632 1.573 . . . . 74.299999999999997 107.963 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -94.26 151.47 2.05 Favored 'Trans proline' 0 N--CA 1.428 -2.336 0 C-N-CA 121.504 1.47 . . . . 74.049999999999997 110.816 173.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.2 pp -112.91 173.37 2.81 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 CA-C-N 116.375 -0.375 . . . . 63.149999999999999 111.451 -178.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . 0.448 HD11 HG21 ' A' ' 640' ' ' THR . 14.0 tp -78.91 158.37 28.07 Favored 'General case' 0 N--CA 1.433 -1.296 0 O-C-N 123.182 0.301 . . . . 73.340000000000003 110.432 -177.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' A' ' 505' ' ' PHE . . . -76.44 -107.04 0.13 Allowed Glycine 0 N--CA 1.435 -1.424 0 N-CA-C 115.032 0.773 . . . . 25.140000000000001 115.032 -177.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -127.5 -70.66 0.7 Allowed 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.033 -0.729 . . . . 65.540000000000006 109.033 -175.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 12.8 p80 -132.84 114.76 14.46 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 109.059 -0.719 . . . . 75.299999999999997 109.059 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 640' ' ' THR . . . . . 0.448 HG21 HD11 ' A' ' 636' ' ' LEU . 30.8 p -98.46 91.3 5.12 Favored 'General case' 0 N--CA 1.407 -2.622 0 CA-C-O 121.626 0.727 . . . . 65.010000000000005 109.885 -178.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 641' ' ' LYS . . . . . 0.418 ' HE3' ' CD1' ' A' ' 588' ' ' PHE . 23.4 tptm -170.96 129.9 0.77 Allowed 'General case' 0 CA--C 1.498 -1.036 0 CA-C-N 115.437 -0.801 . . . . 75.230000000000004 109.311 -179.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 642' ' ' LEU . . . . . 0.569 HD21 HG21 ' A' ' 523' ' ' VAL . 27.8 tp -137.08 109.88 7.59 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 107.45 -1.315 . . . . 64.310000000000002 107.45 172.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . 0.553 ' HB3' HG22 ' A' ' 511' ' ' VAL . 19.3 tt0 -94.34 104.1 16.09 Favored 'General case' 0 C--N 1.273 -2.741 0 N-CA-C 107.12 -1.437 . . . . 70.319999999999993 107.12 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 644' ' ' VAL . . . . . 0.637 HG21 ' HE2' ' A' ' 521' ' ' MET . 25.4 t -95.56 108.01 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.194 0 N-CA-C 109.559 -0.534 . . . . 74.409999999999997 109.559 -177.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 3.5 mp -94.84 124.81 47.49 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 107.233 -1.395 . . . . 52.109999999999999 107.233 177.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 646' ' ' ILE . . . . . 0.519 ' N ' HD12 ' A' ' 646' ' ' ILE . 2.8 mp -104.35 115.68 46.72 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.438 0 N-CA-C 107.601 -1.259 . . . . 75.430000000000007 107.601 -174.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -121.16 168.92 11.05 Favored 'General case' 0 N--CA 1.419 -2.007 0 O-C-N 123.608 0.568 . . . . 55.450000000000003 109.585 -175.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -69.95 157.9 36.61 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 112.766 0.654 . . . . 65.430000000000007 112.766 -172.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 20.2 t -75.94 85.37 2.86 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 106.573 -1.64 . . . . 64.019999999999996 106.573 175.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -163.33 -66.9 0.04 OUTLIER 'General case' 0 N--CA 1.433 -1.315 0 C-N-CA 124.977 1.311 . . . . 74.420000000000002 108.077 -174.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -161.81 -174.11 4.03 Favored 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 106.4 -1.704 . . . . 74.340000000000003 106.4 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -126.6 154.52 43.83 Favored 'General case' 0 N--CA 1.397 -3.082 0 N-CA-C 108.164 -1.05 . . . . 54.399999999999999 108.164 178.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -115.44 67.43 0.7 Allowed 'General case' 0 C--N 1.271 -2.808 0 N-CA-C 105.782 -1.933 . . . . 72.329999999999998 105.782 177.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 654' ' ' SER . . . . . 0.536 ' HA ' ' CE1' ' A' ' 513' ' ' HIS . 41.0 m -61.79 94.43 0.05 OUTLIER 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 114.88 -1.055 . . . . 75.239999999999995 110.342 -177.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 4.2 t -94.98 80.22 3.64 Favored 'General case' 0 N--CA 1.405 -2.712 0 CA-C-O 121.977 0.894 . . . . 42.229999999999997 111.794 -177.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 5.1 p -90.76 82.33 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.081 0 N-CA-C 106.397 -1.705 . . . . 51.240000000000002 106.397 172.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 9.3 t70 . . . . . 0 C--N 1.289 -2.053 0 CA-C-N 112.739 -2.028 . . . . 73.209999999999994 109.844 -169.565 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 800' ' ' ' CA' . . . . . 0.673 'CA ' ' OE2' ' A' ' 516' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 850' ' ' ' CA' . . . . . 0.606 'CA ' ' OD1' ' A' ' 552' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 17.2 t-160 . . . . . 0 N--CA 1.454 -0.269 0 CA-C-O 120.917 0.389 . . . . 72.340000000000003 111.714 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . 0.401 ' HB3' ' HA ' ' A' ' 634' ' ' PRO . . . -115.07 -40.18 3.52 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.533 -0.914 . . . . 31.32 108.533 171.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . 0.64 ' HA2' ' OG1' ' A' ' 528' ' ' THR . . . -171.14 139.67 5.54 Favored Glycine 0 N--CA 1.415 -2.738 0 C-N-CA 119.214 -1.47 . . . . 64.230000000000004 113.063 179.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 3.7 mp -116.31 112.39 39.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 107.1 -1.444 . . . . 55.140000000000001 107.1 175.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -119.7 125.56 48.98 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.57 -0.9 . . . . 65.049999999999997 108.57 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . 0.439 ' HB ' ' HA3' ' A' ' 637' ' ' GLY . 15.1 t -155.44 169.44 24.25 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 109.77 -0.456 . . . . 74.140000000000001 109.77 -174.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -98.81 161.15 13.8 Favored 'General case' 0 C--O 1.249 1.063 0 N-CA-C 106.243 -1.762 . . . . 71.519999999999996 106.243 172.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . 0.427 ' HG2' HD21 ' A' ' 526' ' ' LEU . 3.4 pt-20 -99.17 -27.93 13.58 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 120.387 -0.525 . . . . 75.409999999999997 110.734 176.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -114.26 119.16 40.85 Favored Pre-proline 0 N--CA 1.43 -1.463 0 N-CA-C 107.647 -1.242 . . . . 74.25 107.647 174.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -83.39 -4.28 10.92 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 121.902 1.735 . . . . 65.409999999999997 111.951 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . 0.429 HG13 ' CD1' ' A' ' 645' ' ' ILE . 88.3 t -143.27 134.9 23.66 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.069 0 N-CA-C 108.036 -1.098 . . . . 63.229999999999997 108.036 -179.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 4.7 t -139.5 151.49 46.19 Favored 'General case' 0 N--CA 1.404 -2.766 0 N-CA-C 108.099 -1.075 . . . . 50.149999999999999 108.099 176.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 513' ' ' HIS . . . . . 0.441 ' CD2' ' HB ' ' A' ' 645' ' ' ILE . 47.0 m80 -117.3 116.86 28.05 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 109.168 -0.678 . . . . 71.329999999999998 109.168 179.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.673 HG11 ' SD ' ' A' ' 521' ' ' MET . 31.0 m -111.6 153.13 13.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 C-N-CA 120.469 -0.492 . . . . 73.400000000000006 110.909 -177.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . 0.502 ' HA ' ' OE2' ' A' ' 647' ' ' GLU . 40.5 t -76.59 143.88 39.97 Favored 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 114.945 -1.025 . . . . 64.310000000000002 109.715 -178.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . 0.639 ' OE2' 'CA ' ' A' ' 800' ' ' ' CA' . 35.4 tt0 -68.71 -10.24 55.22 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.449 0.643 . . . . 51.109999999999999 111.195 178.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 20.5 t -115.49 21.93 13.61 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 109.317 -0.623 . . . . 65.010000000000005 109.317 -177.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 518' ' ' ILE . . . . . 0.428 HG22 ' O ' ' A' ' 515' ' ' SER . 15.1 tt -90.29 151.0 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 N-CA-C 108.847 -0.797 . . . . 71.530000000000001 108.847 178.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -96.35 -63.94 0.94 Allowed Glycine 0 N--CA 1.429 -1.822 0 C-N-CA 120.05 -1.071 . . . . 62.219999999999999 111.517 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 30.3 mm -119.04 118.18 56.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 109.635 -0.505 . . . . 73.450000000000003 109.635 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 521' ' ' MET . . . . . 0.673 ' SD ' HG11 ' A' ' 514' ' ' VAL . 25.1 ptt? -99.91 129.48 46.0 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 107.153 -1.425 . . . . 74.019999999999996 107.153 173.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 522' ' ' GLU . . . . . 0.565 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 30.9 mt-10 -117.43 130.18 56.3 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.849 -0.614 . . . . 72.150000000000006 109.95 175.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . 0.565 HG21 HD21 ' A' ' 642' ' ' LEU . 29.3 t -113.52 130.08 68.18 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 CA-C-N 115.207 -0.906 . . . . 75.219999999999999 109.117 -178.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . 0.523 ' HD2' HG21 ' A' ' 568' ' ' VAL . 32.3 mmtp -75.42 126.81 31.77 Favored 'General case' 0 C--N 1.31 -1.122 0 O-C-N 124.045 0.841 . . . . 73.150000000000006 112.4 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 8.9 t -105.16 140.27 23.69 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 N-CA-C 107.188 -1.412 . . . . 73.049999999999997 107.188 177.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . 0.429 HD22 ' N ' ' A' ' 526' ' ' LEU . 2.4 mm? -90.3 139.39 30.71 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 120.804 -0.359 . . . . 71.25 110.033 -178.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . 0.462 ' HG2' ' N ' ' A' ' 528' ' ' THR . 39.0 ttp180 -76.26 158.45 31.56 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 115.349 -0.842 . . . . 71.409999999999997 109.186 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . 0.64 ' OG1' ' HA2' ' A' ' 503' ' ' GLY . 3.2 t -61.87 160.75 11.51 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 123.855 0.862 . . . . 72.219999999999999 111.03 173.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 23.1 t -78.81 -26.49 44.29 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 108.673 -0.862 . . . . 72.310000000000002 108.673 178.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -121.14 104.52 0.96 Allowed Glycine 0 N--CA 1.442 -0.941 0 N-CA-C 109.579 -1.408 . . . . 62.420000000000002 109.579 178.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -100.8 98.47 8.98 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 120.848 0.356 . . . . 63.399999999999999 111.539 -176.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -130.85 119.82 22.77 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.862 -0.608 . . . . 71.450000000000003 110.08 178.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 86.6 -177.85 48.6 Favored Glycine 0 N--CA 1.438 -1.207 0 C-N-CA 120.693 -0.765 . . . . 74.519999999999996 112.433 176.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 534' ' ' ASN . . . . . 0.581 HD21 ' HG3' ' A' ' 561' ' ' GLU . 2.8 t-20 -99.07 130.58 45.41 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.15 -1.055 . . . . 65.310000000000002 108.15 178.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 535' ' ' VAL . . . . . 0.438 HG22 HD22 ' A' ' 596' ' ' LEU . 58.7 t -127.6 131.37 70.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-O 120.84 0.352 . . . . 73.150000000000006 110.095 -176.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 536' ' ' ILE . . . . . 0.529 HG23 ' HB3' ' A' ' 559' ' ' GLU . 33.1 mm -98.41 129.76 48.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 N-CA-C 109.266 -0.642 . . . . 72.140000000000001 109.266 177.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . 0.468 HG22 ' HB3' ' A' ' 594' ' ' PRO . 21.6 t -118.56 101.54 50.72 Favored Pre-proline 0 C--N 1.314 -0.978 0 N-CA-C 109.156 -0.683 . . . . 72.349999999999994 109.156 179.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . 0.429 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 58.1 Cg_endo -72.21 151.12 54.48 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.943 2.428 . . . . 72.329999999999998 112.131 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 539' ' ' TYR . . . . . 0.48 ' HB3' HG22 ' A' ' 591' ' ' ILE . 45.4 p90 -149.45 162.43 40.13 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 109.385 -0.598 . . . . 72.109999999999999 109.385 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -157.59 156.27 31.6 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 123.797 0.686 . . . . 62.130000000000003 109.919 177.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 3.2 p -91.12 122.22 33.58 Favored 'General case' 0 N--CA 1.423 -1.816 0 O-C-N 123.636 0.585 . . . . 44.450000000000003 109.78 173.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.7 mp -92.7 118.63 38.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 105.915 -1.884 . . . . 73.409999999999997 105.915 174.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -50.25 -46.05 54.62 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 124.361 1.038 . . . . 74.120000000000005 111.656 -176.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 67.34 -106.24 1.61 Allowed Glycine 0 N--CA 1.426 -1.971 0 N-CA-C 110.616 -0.994 . . . . 73.219999999999999 110.616 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 11.5 t -118.81 6.64 11.49 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-O 121.615 0.722 . . . . 64.530000000000001 109.973 -178.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -86.06 170.32 12.35 Favored 'General case' 0 N--CA 1.442 -0.874 0 O-C-N 122.029 -0.419 . . . . 54.240000000000002 110.468 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . 0.512 ' HB2' ' HB2' ' A' ' 552' ' ' ASP . 29.8 mmt180 -69.76 174.05 5.57 Favored 'General case' 0 CA--C 1.502 -0.886 0 CA-C-N 116.007 -0.542 . . . . 73.319999999999993 110.964 176.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -68.46 172.89 34.19 Favored Glycine 0 C--N 1.295 -1.731 0 CA-C-N 114.954 -1.021 . . . . 64.510000000000005 114.157 -176.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . -62.37 123.35 30.73 Favored Glycine 0 N--CA 1.435 -1.386 0 CA-C-N 115.131 -0.535 . . . . 62.329999999999998 111.797 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 95.94 -17.75 58.71 Favored Glycine 0 N--CA 1.437 -1.295 0 N-CA-C 111.553 -0.619 . . . . 72.430000000000007 111.553 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -84.72 -66.61 0.87 Allowed 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 109.123 -0.695 . . . . 73.219999999999999 109.123 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . 0.63 ' OD1' 'CA ' ' A' ' 850' ' ' ' CA' . 1.2 m-20 -107.47 -22.37 12.57 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.664 -0.414 . . . . 72.219999999999999 111.728 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 553' ' ' PHE . . . . . 0.408 ' HB3' ' CE2' ' A' ' 587' ' ' PHE . 35.9 p90 -151.87 151.94 31.94 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 108.849 -0.797 . . . . 63.329999999999998 108.849 177.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.49 122.06 30.74 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 106.048 -1.834 . . . . 73.200000000000003 106.048 177.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -74.38 105.99 5.79 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.128 0.489 . . . . 71.030000000000001 111.231 -175.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 13.5 t -104.08 119.99 40.13 Favored 'General case' 0 N--CA 1.414 -2.271 0 CA-C-O 122.324 1.059 . . . . 74.129999999999995 109.917 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 1.2 p -136.96 105.01 5.63 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-N 114.608 -1.178 . . . . 63.450000000000003 108.728 178.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -151.34 -152.3 5.83 Favored Glycine 0 N--CA 1.416 -2.663 0 N-CA-C 110.743 -0.943 . . . . 64.140000000000001 110.743 -174.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 559' ' ' GLU . . . . . 0.529 ' HB3' HG23 ' A' ' 536' ' ' ILE . 52.2 mt-10 -142.47 129.28 20.53 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.163 0.506 . . . . 74.120000000000005 110.952 -175.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . 0.465 HD13 ' HG2' ' A' ' 569' ' ' LYS . 92.8 mt -91.17 139.47 30.72 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.527 -0.761 . . . . 73.109999999999999 109.678 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 561' ' ' GLU . . . . . 0.581 ' HG3' HD21 ' A' ' 534' ' ' ASN . 28.2 tt0 -100.26 115.68 30.49 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 121.517 0.675 . . . . 71.549999999999997 111.474 178.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -109.37 158.82 17.54 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 107.355 -1.35 . . . . 73.030000000000001 107.355 171.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . 0.449 ' H ' ' HB2' ' A' ' 566' ' ' GLU . 10.6 pt20 -165.87 179.24 6.0 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 109.803 -0.443 . . . . 74.030000000000001 109.803 177.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -59.47 -32.31 70.13 Favored 'General case' 0 C--N 1.322 -0.612 0 O-C-N 124.083 0.864 . . . . 72.239999999999995 110.468 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -88.85 -12.41 41.98 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.406 -0.816 . . . . 54.109999999999999 111.249 -177.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . 0.449 ' HB2' ' H ' ' A' ' 563' ' ' GLN . 26.0 mm-40 -100.96 132.79 46.2 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 113.244 0.831 . . . . 71.329999999999998 113.244 -176.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 3.9 pt -120.27 156.11 23.25 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.065 0 N-CA-C 105.823 -1.917 . . . . 51.409999999999997 105.823 170.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 568' ' ' VAL . . . . . 0.523 HG21 ' HD2' ' A' ' 524' ' ' LYS . 1.0 OUTLIER 48.11 178.34 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.578 2.03 0 C-N-CA 125.708 1.603 . . . . 61.229999999999997 113.003 -177.403 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 569' ' ' LYS . . . . . 0.465 ' HG2' HD13 ' A' ' 560' ' ' LEU . 1.4 tpmt? -172.01 163.59 6.12 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 106.067 -1.827 . . . . 70.299999999999997 106.067 175.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 570' ' ' THR . . . . . 0.551 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 11.5 p -135.58 141.26 45.13 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 123.45 0.469 . . . . 62.229999999999997 110.779 176.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 571' ' ' ILE . . . . . 0.565 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 3.5 mp -97.28 122.13 48.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 N-CA-C 106.166 -1.79 . . . . 62.450000000000003 106.166 169.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 40.4 p -99.96 118.69 36.9 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 109.329 -0.619 . . . . 72.349999999999994 109.329 177.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 573' ' ' VAL . . . . . . . . . . . . . 45.2 t -117.48 126.64 74.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 108.887 -0.783 . . . . 74.409999999999997 108.887 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -77.89 106.73 9.93 Favored 'General case' 0 N--CA 1.421 -1.907 0 N-CA-C 108.608 -0.886 . . . . 63.420000000000002 108.608 174.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 62.1 t -84.19 119.81 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.378 0 N-CA-C 105.757 -1.942 . . . . 75.329999999999998 105.757 175.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 39.4 mm -76.87 131.09 35.49 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 106.776 -1.565 . . . . 61.109999999999999 106.776 -177.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -60.29 99.16 0.07 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 122.092 0.949 . . . . 71.340000000000003 109.773 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 578' ' ' ASP . . . . . 0.616 ' OD1' 'CA ' ' A' ' 850' ' ' ' CA' . 19.1 t70 -61.64 133.77 56.01 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 114.346 -1.297 . . . . 62.43 113.93 -172.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 579' ' ' GLU . . . . . 0.59 ' OE2' 'CA ' ' A' ' 850' ' ' ' CA' . 0.6 OUTLIER -96.36 -13.83 22.96 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 113.599 -1.637 . . . . 74.140000000000001 113.883 -173.973 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 580' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -124.99 166.76 15.76 Favored 'General case' 0 C--O 1.264 1.826 0 C-N-CA 117.936 -1.506 . . . . 70.310000000000002 113.491 -176.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -71.86 153.37 41.94 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 107.664 -1.235 . . . . 64.329999999999998 107.664 178.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 582' ' ' GLU . . . . . 0.61 ' OE1' 'CA ' ' A' ' 800' ' ' ' CA' . 6.1 pt-20 -148.79 166.1 29.48 Favored 'General case' 0 C--N 1.278 -2.531 0 N-CA-C 108.619 -0.882 . . . . 73.439999999999998 108.619 176.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . 0.412 ' HD3' ' HA ' ' A' ' 583' ' ' LYS . 34.1 mmtp -106.59 30.22 6.23 Favored 'General case' 0 C--N 1.286 -2.186 0 CA-C-O 122.814 1.293 . . . . 74.209999999999994 107.825 176.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 584' ' ' ASN . . . . . 0.543 ' ND2' ' HA ' ' A' ' 647' ' ' GLU . 19.9 m120 80.26 96.12 0.05 Allowed 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 110.902 -2.863 . . . . 72.329999999999998 111.491 178.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.14 163.0 19.02 Favored 'General case' 0 N--CA 1.434 -1.267 0 C-N-CA 119.434 -0.906 . . . . 65.299999999999997 109.955 176.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 6.0 t -148.49 143.77 26.92 Favored 'General case' 0 N--CA 1.415 -2.188 0 CA-C-O 120.97 0.415 . . . . 65.5 110.059 -177.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 587' ' ' PHE . . . . . 0.41 ' CZ ' HD11 ' A' ' 646' ' ' ILE . 3.1 p90 -129.38 149.62 51.08 Favored 'General case' 0 N--CA 1.418 -2.042 0 CA-C-N 114.305 -1.316 . . . . 75.430000000000007 108.711 177.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 588' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -106.81 136.25 46.96 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 116.41 -0.359 . . . . 75.25 110.086 -172.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . 0.493 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.4 OUTLIER -105.87 122.97 47.2 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 105.466 -2.05 . . . . 44.399999999999999 105.466 174.87 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -130.67 135.38 47.78 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 109.627 -0.508 . . . . 73.329999999999998 109.627 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 591' ' ' ILE . . . . . 0.48 HG22 ' HB3' ' A' ' 539' ' ' TYR . 19.6 pt -96.93 141.06 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.552 0 N-CA-C 106.839 -1.541 . . . . 71.439999999999998 106.839 173.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -95.9 -134.13 7.77 Favored Glycine 0 C--N 1.295 -1.729 0 C-N-CA 120.604 -0.808 . . . . 44.43 113.026 -175.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -85.19 116.05 63.82 Favored Pre-proline 0 C--N 1.303 -1.438 0 C-N-CA 122.958 0.503 . . . . 63.020000000000003 110.667 -177.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 594' ' ' PRO . . . . . 0.478 ' HA ' ' O ' ' A' ' 536' ' ' ILE . 59.8 Cg_endo -75.16 137.07 20.9 Favored 'Trans proline' 0 N--CA 1.431 -2.191 0 C-N-CA 121.316 1.344 . . . . 74.510000000000005 109.377 173.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -129.96 137.9 50.56 Favored 'General case' 0 C--N 1.285 -2.213 0 O-C-N 121.876 -0.515 . . . . 74.519999999999996 111.548 -175.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 596' ' ' LEU . . . . . 0.438 HD22 HG22 ' A' ' 535' ' ' VAL . 0.0 OUTLIER -77.18 124.81 28.35 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 107.905 -1.146 . . . . 64.299999999999997 107.905 -176.434 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 597' ' ' VAL . . . . . 0.418 ' CG2' HG12 ' A' ' 536' ' ' ILE . 23.1 t -86.31 -45.74 16.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 CA-C-O 121.301 0.572 . . . . 61.140000000000001 109.667 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -83.47 141.99 31.26 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.688 -0.687 . . . . 73.420000000000002 110.863 -176.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 17.9 ptm -96.48 100.26 11.87 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-O 121.977 0.894 . . . . 75.010000000000005 109.964 178.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 33.5 t -144.42 120.8 10.95 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 107.431 -1.322 . . . . 55.509999999999998 107.431 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 60.79 27.3 17.09 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.299 1.039 . . . . 70.230000000000004 109.904 -177.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . 0.535 ' HA ' ' HE2' ' A' ' 602' ' ' LYS . 0.5 OUTLIER -88.73 96.15 10.55 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-N 114.509 -1.223 . . . . 74.120000000000005 108.426 -175.855 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -139.99 151.07 45.2 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.239 0.542 . . . . 73.109999999999999 112.048 -179.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -116.51 77.88 0.28 Allowed Glycine 0 C--N 1.303 -1.298 0 N-CA-C 108.87 -1.692 . . . . 64.409999999999997 108.87 175.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . -71.59 104.16 1.4 Allowed Glycine 0 N--CA 1.428 -1.859 0 CA-C-N 115.264 -0.468 . . . . 71.120000000000005 113.091 -175.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 60.78 32.43 20.16 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.581 1.153 . . . . 72.140000000000001 111.971 174.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 2.0 p -72.7 127.5 32.74 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-O 121.07 0.462 . . . . 74.140000000000001 111.23 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 608' ' ' ILE . . . . . 0.402 ' O ' ' HB ' ' A' ' 609' ' ' THR . 36.6 mm -92.94 79.38 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 N-CA-C 108.577 -0.897 . . . . 73.310000000000002 108.577 -177.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 609' ' ' THR . . . . . 0.402 ' HB ' ' O ' ' A' ' 608' ' ' ILE . 11.5 t 176.54 169.68 0.47 Allowed 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 114.901 -1.045 . . . . 72.140000000000001 108.554 -179.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -111.25 -3.79 15.22 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 107.97 -1.122 . . . . 74.109999999999999 107.97 171.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 611' ' ' GLU . . . . . 0.513 ' HB3' ' HB3' ' A' ' 614' ' ' ASP . 23.4 mm-40 -82.52 52.67 2.13 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 115.0 -1.0 . . . . 72.239999999999995 110.033 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 612' ' ' TYR . . . . . 0.471 ' OH ' ' HG3' ' A' ' 602' ' ' LYS . 73.3 t80 -75.98 119.01 19.35 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 108.013 -1.106 . . . . 73.420000000000002 108.013 177.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 613' ' ' ASP . . . . . 0.404 ' CG ' ' HZ2' ' A' ' 602' ' ' LYS . 0.9 OUTLIER 51.96 43.86 29.94 Favored 'General case' 0 CA--C 1.512 -0.494 0 O-C-N 124.24 0.962 . . . . 63.049999999999997 109.92 -177.541 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 614' ' ' ASP . . . . . 0.513 ' HB3' ' HB3' ' A' ' 611' ' ' GLU . 3.8 p30 -55.31 167.83 0.42 Allowed 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 125.419 1.488 . . . . 74.129999999999995 114.762 -174.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -112.1 24.21 12.86 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 114.22 -1.355 . . . . 73.120000000000005 110.963 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -75.37 148.43 83.41 Favored Pre-proline 0 C--O 1.249 1.072 0 N-CA-C 106.312 -1.736 . . . . 74.109999999999999 106.312 175.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -57.41 164.48 7.01 Favored 'Trans proline' 0 C--O 1.245 0.874 0 C-N-CA 121.235 1.29 . . . . 61.149999999999999 110.64 175.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -57.49 112.54 1.45 Allowed 'General case' 0 C--N 1.319 -0.742 0 O-C-N 123.312 0.382 . . . . 70.329999999999998 111.494 -174.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 15.3 t -149.37 161.91 41.13 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 108.967 -0.753 . . . . 64.120000000000005 108.967 -178.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 620' ' ' SER . . . . . 0.532 ' HA ' ' HG3' ' A' ' 626' ' ' ARG . 12.0 p -150.1 -36.67 0.15 Allowed 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 123.345 0.658 . . . . 73.329999999999998 110.142 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 66.5 mttm 61.75 20.95 11.81 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.87 0.868 . . . . 72.150000000000006 111.732 173.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 55.97 24.46 7.71 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.559 1.144 . . . . 74.420000000000002 111.154 -174.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . 0.516 ' O ' ' HB3' ' A' ' 626' ' ' ARG . 32.8 tt0 -75.24 139.45 42.57 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 109.081 -0.711 . . . . 70.329999999999998 109.081 -179.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.81 -53.66 30.54 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.496 -0.928 . . . . 54.520000000000003 108.496 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -54.0 -29.8 44.71 Favored 'General case' 0 C--O 1.249 1.068 0 C-N-CA 123.894 0.878 . . . . 75.319999999999993 113.346 -179.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . 0.532 ' HG3' ' HA ' ' A' ' 620' ' ' SER . 0.0 OUTLIER -47.79 -35.04 9.38 Favored 'General case' 0 N--CA 1.435 -1.209 0 C-N-CA 124.511 1.124 . . . . 75.219999999999999 113.351 174.921 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 627' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -63.14 -26.59 68.88 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.367 0.877 . . . . 73.439999999999998 113.367 -177.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 95.7 mt -67.58 -38.27 80.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 N-CA-C 108.981 -0.748 . . . . 73.329999999999998 108.981 176.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -73.32 -32.54 64.64 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.444 -0.798 . . . . 61.020000000000003 110.382 178.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 630' ' ' GLU . . . . . 0.474 ' HG2' ' O ' ' A' ' 626' ' ' ARG . 13.7 mm-40 -66.09 -24.53 66.72 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.167 0.587 . . . . 70.310000000000002 111.407 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 631' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -95.22 -7.15 39.87 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 119.927 -0.709 . . . . 62.130000000000003 110.57 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -97.58 -44.24 2.75 Favored Glycine 0 N--CA 1.43 -1.705 0 N-CA-C 110.019 -1.233 . . . . 52.329999999999998 110.019 177.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -101.75 126.64 33.4 Favored Pre-proline 0 C--N 1.306 -1.323 0 N-CA-C 107.734 -1.21 . . . . 75.0 107.734 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.401 ' HA ' ' HB3' ' A' ' 502' ' ' ALA . 13.4 Cg_endo -66.17 142.05 65.74 Favored 'Trans proline' 0 N--CA 1.437 -1.82 0 N-CA-C 108.204 -1.499 . . . . 71.239999999999995 108.204 171.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.3 pp -122.88 176.26 4.99 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 N-CA-C 113.677 0.992 . . . . 73.230000000000004 113.677 -173.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . 0.488 ' HB2' HG21 ' A' ' 640' ' ' THR . 0.0 OUTLIER -80.91 152.21 28.2 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 114.881 -1.054 . . . . 73.219999999999999 108.5 -179.344 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . 0.439 ' HA3' ' HB ' ' A' ' 506' ' ' THR . . . -80.74 -135.96 1.69 Allowed Glycine 0 C--N 1.293 -1.851 0 C-N-CA 120.864 -0.684 . . . . 73.209999999999994 113.668 -176.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -83.56 -58.67 2.72 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 120.125 -0.63 . . . . 72.450000000000003 109.969 -177.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -125.75 94.38 4.1 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 121.85 0.834 . . . . 62.149999999999999 111.905 -178.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 640' ' ' THR . . . . . 0.488 HG21 ' HB2' ' A' ' 636' ' ' LEU . 17.8 p -96.03 90.67 5.64 Favored 'General case' 0 N--CA 1.407 -2.595 0 N-CA-C 107.878 -1.156 . . . . 74.340000000000003 107.878 174.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 641' ' ' LYS . . . . . 0.446 ' HE2' ' HB2' ' A' ' 643' ' ' GLU . 1.2 tmtp? -172.5 134.4 0.66 Allowed 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 105.583 -2.006 . . . . 71.230000000000004 105.583 -175.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 642' ' ' LEU . . . . . 0.565 HD21 HG21 ' A' ' 523' ' ' VAL . 37.1 tp -134.93 106.34 6.8 Favored 'General case' 0 C--N 1.277 -2.583 0 N-CA-C 108.02 -1.104 . . . . 72.430000000000007 108.02 177.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . 0.446 ' HB2' ' HE2' ' A' ' 641' ' ' LYS . 27.2 tt0 -87.66 104.25 16.35 Favored 'General case' 0 C--N 1.277 -2.565 0 N-CA-C 106.748 -1.575 . . . . 74.310000000000002 106.748 178.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 644' ' ' VAL . . . . . 0.459 HG21 ' HE1' ' A' ' 521' ' ' MET . 40.1 t -94.06 106.02 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.155 0 N-CA-C 108.372 -0.973 . . . . 73.329999999999998 108.372 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 645' ' ' ILE . . . . . 0.441 ' HB ' ' CD2' ' A' ' 513' ' ' HIS . 3.8 mp -93.38 126.89 45.75 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 106.615 -1.624 . . . . 72.340000000000003 106.615 176.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 646' ' ' ILE . . . . . 0.539 ' N ' HD12 ' A' ' 646' ' ' ILE . 2.4 mp -99.11 124.02 52.12 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.249 0 N-CA-C 106.626 -1.62 . . . . 64.040000000000006 106.626 -177.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . 0.543 ' HA ' ' ND2' ' A' ' 584' ' ' ASN . 0.0 OUTLIER -109.07 152.44 25.04 Favored 'General case' 0 C--N 1.266 -3.024 0 CA-C-N 115.598 -0.728 . . . . 63.229999999999997 109.518 -178.599 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . 0.432 ' CD ' ' HG2' ' A' ' 582' ' ' GLU . 25.5 mt-10 -83.79 75.31 10.1 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-O 122.327 1.061 . . . . 70.099999999999994 110.788 -176.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 18.2 m 30.88 82.5 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 129.024 2.93 . . . . 74.409999999999997 115.31 -176.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -114.83 -65.06 1.23 Allowed 'General case' 0 N--CA 1.431 -1.388 0 CA-C-N 114.83 -1.077 . . . . 74.239999999999995 108.728 174.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 178.02 167.33 0.75 Allowed 'General case' 0 CA--C 1.552 1.02 0 O-C-N 123.677 0.61 . . . . 74.400000000000006 109.371 -176.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -86.32 127.43 34.79 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 123.607 0.763 . . . . 74.219999999999999 108.98 -177.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -126.5 115.01 18.89 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 116.246 -0.434 . . . . 73.329999999999998 112.006 -177.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 25.6 m -95.18 96.4 9.18 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.284 0.564 . . . . 74.200000000000003 109.746 176.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 51.8 m -145.5 107.31 4.28 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 109.435 -0.58 . . . . 65.319999999999993 109.435 179.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.424 HG22 ' HB ' ' A' ' 511' ' ' VAL . 56.5 t -107.78 119.26 57.08 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-N 115.976 -0.556 . . . . 72.439999999999998 109.87 -179.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 . . . . . 0 C--N 1.307 -1.272 0 N-CA-C 109.212 -0.662 . . . . 71.040000000000006 109.212 176.79 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 800' ' ' ' CA' . . . . . 0.639 'CA ' ' OE2' ' A' ' 516' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 850' ' ' ' CA' . . . . . 0.63 'CA ' ' OD1' ' A' ' 552' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 4.4 t60 . . . . . 0 N--CA 1.446 -0.652 0 N-CA-C 108.711 -0.848 . . . . 65.219999999999999 108.711 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . 0.546 ' HB1' ' H ' ' A' ' 635' ' ' ILE . . . -138.15 -165.48 1.8 Allowed 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 107.136 -1.431 . . . . 74.239999999999995 107.136 177.114 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -129.5 173.62 19.57 Favored Glycine 0 N--CA 1.41 -3.074 0 C-N-CA 118.328 -1.891 . . . . 73.209999999999994 113.803 -175.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . 0.483 ' H ' ' CB ' ' A' ' 528' ' ' THR . 3.6 mp -119.57 96.48 4.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 107.463 -1.31 . . . . 63.149999999999999 107.463 173.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -108.71 115.04 29.34 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 106.135 -1.802 . . . . 74.319999999999993 106.135 178.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . 0.461 ' HB ' ' H ' ' A' ' 638' ' ' GLU . 15.0 t -147.71 164.33 33.91 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 120.232 -0.587 . . . . 73.040000000000006 109.478 -173.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -94.35 160.24 14.76 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 107.658 -1.238 . . . . 62.25 107.658 173.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . 0.434 ' HB2' HD21 ' A' ' 526' ' ' LEU . 24.2 tt0 -91.04 -33.46 15.5 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 107.445 -1.317 . . . . 53.109999999999999 107.445 -179.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -124.16 134.95 25.84 Favored Pre-proline 0 N--CA 1.414 -2.241 0 CA-C-N 114.369 -1.287 . . . . 70.310000000000002 109.538 179.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . 0.632 ' HA ' ' O ' ' A' ' 641' ' ' LYS . 81.9 Cg_endo -85.76 -4.64 9.02 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 121.82 1.68 . . . . 63.049999999999997 111.416 174.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . 0.564 ' HB ' HG11 ' A' ' 656' ' ' VAL . 81.9 t -143.64 134.71 22.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 C-N-CA 123.882 0.873 . . . . 72.129999999999995 108.672 -178.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 14.6 t -134.06 132.12 39.62 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 107.265 -1.383 . . . . 71.219999999999999 107.265 175.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 28.5 m-70 -100.52 121.63 41.89 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.485 -0.931 . . . . 64.239999999999995 108.485 177.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.648 HG11 ' SD ' ' A' ' 521' ' ' MET . 33.0 m -115.02 156.66 15.93 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 CA-C-N 116.27 -0.423 . . . . 72.120000000000005 109.983 -177.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 22.9 t -82.89 133.12 35.13 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 107.822 -1.177 . . . . 72.329999999999998 107.822 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -68.31 -7.52 31.74 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 112.07 0.396 . . . . 74.340000000000003 112.07 -177.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 45.6 p -103.09 8.02 38.78 Favored 'General case' 0 C--N 1.313 -0.992 0 O-C-N 121.63 -0.669 . . . . 71.109999999999999 110.655 179.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 12.4 tt -80.23 152.02 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 N-CA-C 109.536 -0.542 . . . . 74.140000000000001 109.536 -177.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . -91.23 -61.45 1.26 Allowed Glycine 0 N--CA 1.426 -1.982 0 C-N-CA 120.253 -0.975 . . . . 55.310000000000002 110.996 177.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 28.3 mm -121.18 128.42 76.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-O 121.068 0.461 . . . . 43.539999999999999 110.849 -177.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 521' ' ' MET . . . . . 0.667 ' HE1' HG21 ' A' ' 644' ' ' VAL . 24.0 ptt? -107.95 140.71 40.68 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 107.3 -1.37 . . . . 73.439999999999998 107.3 171.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -119.61 113.0 20.03 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-O 121.185 0.517 . . . . 70.109999999999999 109.957 -178.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . 0.646 ' O ' ' HA ' ' A' ' 570' ' ' THR . 47.3 t -93.04 126.45 45.47 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.31 0 CA-C-N 115.258 -0.883 . . . . 51.130000000000003 109.769 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . 0.495 ' HD2' HG21 ' A' ' 568' ' ' VAL . 31.4 mmtp -87.47 142.6 27.74 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 124.329 1.018 . . . . 51.130000000000003 111.427 -178.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 26.8 t -120.0 132.8 68.69 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 N-CA-C 107.016 -1.476 . . . . 73.540000000000006 107.016 176.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . 0.434 HD21 ' HB2' ' A' ' 508' ' ' GLU . 3.1 mm? -71.84 139.01 48.7 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-O 121.322 0.582 . . . . 73.420000000000002 110.902 -179.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . 0.507 ' HD3' ' CZ ' ' A' ' 562' ' ' PHE . 13.6 tpt85 -79.37 127.4 32.04 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 114.839 -1.073 . . . . 75.25 110.001 179.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . 0.483 ' CB ' ' H ' ' A' ' 504' ' ' ILE . 2.6 t -60.67 146.65 44.86 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-N 113.979 -1.464 . . . . 62.030000000000001 111.561 175.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 32.6 t -61.58 -35.58 78.24 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 115.143 -0.935 . . . . 75.329999999999998 109.239 176.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -120.6 110.01 1.67 Allowed Glycine 0 N--CA 1.423 -2.185 0 N-CA-C 110.489 -1.044 . . . . 62.109999999999999 110.489 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . 0.445 ' HB2' HG23 ' A' ' 528' ' ' THR . . . -127.14 112.29 14.99 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.326 -0.99 . . . . 71.230000000000004 108.326 176.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -119.01 102.61 8.88 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 120.891 0.377 . . . . 73.540000000000006 111.192 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 93.54 -153.72 21.42 Favored Glycine 0 N--CA 1.43 -1.724 0 CA-C-N 115.534 -0.757 . . . . 61.43 112.261 175.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 534' ' ' ASN . . . . . 0.582 HD21 ' HG3' ' A' ' 561' ' ' GLU . 2.4 t-20 -104.24 126.16 51.12 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.183 -0.673 . . . . 71.5 109.183 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 535' ' ' VAL . . . . . 0.471 HG22 HD22 ' A' ' 596' ' ' LEU . 55.6 t -121.16 136.42 58.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 123.284 0.634 . . . . 73.209999999999994 109.529 -177.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 536' ' ' ILE . . . . . 0.614 HG23 ' HB3' ' A' ' 559' ' ' GLU . 18.7 mm -101.65 129.26 53.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-N 116.321 -0.4 . . . . 64.140000000000001 110.18 178.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . 0.461 HG22 ' HB3' ' A' ' 594' ' ' PRO . 39.1 t -118.84 108.85 40.33 Favored Pre-proline 0 C--N 1.317 -0.844 0 N-CA-C 108.812 -0.81 . . . . 75.549999999999997 108.812 177.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -72.34 143.07 38.4 Favored 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 122.033 1.822 . . . . 63.119999999999997 111.177 178.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 539' ' ' TYR . . . . . 0.514 ' CE1' ' HG ' ' A' ' 560' ' ' LEU . 35.3 p90 -152.13 155.5 37.97 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 109.865 -0.42 . . . . 50.399999999999999 109.865 -179.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -153.36 154.9 35.41 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 116.208 -0.451 . . . . 73.420000000000002 109.979 176.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 16.8 p -93.71 110.29 21.92 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 115.603 -0.726 . . . . 31.34 109.264 176.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.6 mp -77.57 118.87 25.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 105.69 -1.967 . . . . 65.420000000000002 105.69 176.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -54.83 -36.64 65.23 Favored 'General case' 0 C--N 1.319 -0.728 0 O-C-N 124.28 0.987 . . . . 74.450000000000003 113.578 -173.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 69.93 -97.81 0.59 Allowed Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 111.636 -0.586 . . . . 65.329999999999998 111.636 177.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 6.9 t -122.95 -0.27 9.02 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.472 0.653 . . . . 53.119999999999997 110.553 177.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -99.07 -170.26 1.89 Allowed 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 107.6 -1.259 . . . . 44.229999999999997 107.6 177.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . 0.446 ' HD3' ' N ' ' A' ' 548' ' ' GLY . 0.0 OUTLIER -138.12 130.14 28.59 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.34 -0.985 . . . . 65.120000000000005 108.34 -178.767 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 548' ' ' GLY . . . . . 0.446 ' N ' ' HD3' ' A' ' 547' ' ' ARG . . . -76.89 -146.15 2.12 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 111.346 -0.702 . . . . 72.540000000000006 111.346 177.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 64.44 15.69 59.58 Favored Glycine 0 C--N 1.314 -0.671 0 CA-C-N 117.077 0.438 . . . . 53.229999999999997 113.404 178.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 77.49 18.64 77.52 Favored Glycine 0 N--CA 1.431 -1.65 0 C-N-CA 121.172 -0.537 . . . . 74.109999999999999 112.166 -178.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -84.33 -70.62 0.56 Allowed 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 121.359 0.6 . . . . 65.310000000000002 109.491 178.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . 0.648 ' OD2' 'CA ' ' A' ' 850' ' ' ' CA' . 9.3 t70 -100.63 -39.11 8.04 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 107.331 -1.359 . . . . 72.519999999999996 107.331 -178.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 553' ' ' PHE . . . . . 0.45 ' HA ' HG12 ' A' ' 576' ' ' ILE . 25.1 p90 -144.72 166.27 25.7 Favored 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 108.109 -1.071 . . . . 72.340000000000003 108.109 173.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . 0.411 ' HB3' ' HB3' ' A' ' 574' ' ' LYS . 0.6 OUTLIER -98.56 109.12 21.93 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 106.409 -1.7 . . . . 64.420000000000002 106.409 179.184 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -75.83 122.62 24.37 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-O 121.693 0.759 . . . . 71.420000000000002 111.038 -175.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 7.3 t -111.14 112.63 24.57 Favored 'General case' 0 N--CA 1.409 -2.514 0 CA-C-O 122.081 0.943 . . . . 44.310000000000002 109.957 -177.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 4.4 p -126.17 116.66 21.67 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 114.724 -1.125 . . . . 62.439999999999998 108.773 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -170.71 -156.27 11.26 Favored Glycine 0 N--CA 1.403 -3.547 0 C-N-CA 120.09 -1.053 . . . . 74.310000000000002 110.945 -176.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 559' ' ' GLU . . . . . 0.614 ' HB3' HG23 ' A' ' 536' ' ' ILE . 49.1 mt-10 -133.11 126.5 31.88 Favored 'General case' 0 C--N 1.284 -2.269 0 C-N-CA 122.368 0.267 . . . . 74.239999999999995 110.37 -176.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . 0.514 ' HG ' ' CE1' ' A' ' 539' ' ' TYR . 74.9 mt -82.42 136.26 34.98 Favored 'General case' 0 CA--C 1.5 -0.948 0 CA-C-N 116.064 -0.516 . . . . 65.409999999999997 110.88 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 561' ' ' GLU . . . . . 0.582 ' HG3' HD21 ' A' ' 534' ' ' ASN . 43.1 tt0 -98.32 102.33 14.04 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.096 -0.956 . . . . 75.329999999999998 108.9 178.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 562' ' ' PHE . . . . . 0.507 ' CZ ' ' HD3' ' A' ' 527' ' ' ARG . 1.3 t80 -111.37 147.95 34.05 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 106.559 -1.645 . . . . 71.530000000000001 106.559 -179.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . 0.426 ' H ' ' HB3' ' A' ' 566' ' ' GLU . 46.3 mt-30 -141.68 179.13 7.01 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 121.559 -0.713 . . . . 73.310000000000002 111.065 -173.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -77.63 -35.48 52.62 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 109.314 -0.624 . . . . 74.230000000000004 109.314 175.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -84.09 5.04 27.57 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 122.123 0.963 . . . . 74.409999999999997 109.599 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . 0.426 ' HB3' ' H ' ' A' ' 563' ' ' GLN . 6.7 tp10 -121.56 146.51 46.88 Favored 'General case' 0 N--CA 1.422 -1.869 0 CA-C-N 115.09 -0.959 . . . . 70.329999999999998 108.874 -179.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 3.3 pt -135.27 155.92 38.17 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.629 0 N-CA-C 106.707 -1.59 . . . . 71.319999999999993 106.707 173.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 568' ' ' VAL . . . . . 0.495 HG21 ' HD2' ' A' ' 524' ' ' LYS . 0.9 OUTLIER 51.01 170.13 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.624 0 C-N-CA 125.52 1.528 . . . . 75.219999999999999 112.048 -174.824 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 569' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -159.27 149.58 19.25 Favored 'General case' 0 C--N 1.283 -2.303 0 O-C-N 120.394 -1.441 . . . . 54.229999999999997 107.653 176.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 570' ' ' THR . . . . . 0.646 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 9.4 p -124.4 123.8 40.96 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 113.162 0.801 . . . . 50.310000000000002 113.162 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 2.8 mp -85.83 114.29 25.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 104.857 -2.275 . . . . 72.239999999999995 104.857 171.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 572' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 521' ' ' MET . 24.9 m -102.55 109.2 20.75 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.191 0.52 . . . . 70.400000000000006 110.106 -177.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 573' ' ' VAL . . . . . . . . . . . . . 25.5 t -111.53 137.06 45.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-N 115.735 -0.666 . . . . 70.420000000000002 109.687 -176.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 574' ' ' LYS . . . . . 0.411 ' HB3' ' HB3' ' A' ' 554' ' ' GLU . 5.0 tppp? -95.05 123.87 38.77 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 124.021 0.826 . . . . 62.130000000000003 110.087 178.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 57.9 t -94.33 133.47 35.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 107.03 -1.47 . . . . 71.120000000000005 107.03 175.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 576' ' ' ILE . . . . . 0.45 HG12 ' HA ' ' A' ' 553' ' ' PHE . 25.9 mm -98.55 160.3 3.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 109.261 -0.644 . . . . 62.100000000000001 109.261 -175.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -64.7 109.51 2.05 Favored 'General case' 0 C--O 1.247 0.94 0 C-N-CA 123.096 0.559 . . . . 71.439999999999998 110.054 177.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 578' ' ' ASP . . . . . 0.596 ' OD1' 'CA ' ' A' ' 850' ' ' ' CA' . 11.1 t0 -55.93 127.7 31.62 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 124.211 0.944 . . . . 64.510000000000005 110.913 -172.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 579' ' ' GLU . . . . . 0.599 ' OE1' 'CA ' ' A' ' 850' ' ' ' CA' . 1.3 pm0 -110.32 -30.5 7.67 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 115.752 1.76 . . . . 53.149999999999999 115.752 -167.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 580' ' ' GLU . . . . . 0.448 ' HG2' ' CD2' ' A' ' 581' ' ' TYR . 0.0 OUTLIER -103.81 -72.26 0.71 Allowed 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 115.009 1.485 . . . . 75.530000000000001 115.009 -162.493 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 581' ' ' TYR . . . . . 0.448 ' CD2' ' HG2' ' A' ' 580' ' ' GLU . 6.3 p90 -141.47 154.03 45.3 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 107.572 -1.27 . . . . 72.450000000000003 107.572 -174.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -109.87 108.14 18.34 Favored 'General case' 0 C--N 1.27 -2.854 0 C-N-CA 119.137 -1.025 . . . . 72.519999999999996 109.809 -177.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 9.9 mmmm -139.03 169.38 17.89 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 105.73 -1.952 . . . . 73.140000000000001 105.73 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -74.94 98.72 3.64 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 108.008 -1.108 . . . . 74.109999999999999 108.008 175.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 585' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.09 147.21 30.28 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-O 121.202 0.525 . . . . 62.219999999999999 111.196 -178.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 4.1 t -152.41 152.12 31.64 Favored 'General case' 0 N--CA 1.422 -1.858 0 CA-C-N 115.372 -0.831 . . . . 72.140000000000001 109.643 -175.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -133.83 160.02 38.89 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-N 114.695 -1.139 . . . . 75.400000000000006 109.68 177.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 588' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -116.33 138.38 51.38 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 120.625 0.25 . . . . 73.310000000000002 110.379 -171.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . 0.572 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.6 OUTLIER -106.28 122.26 45.88 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 105.447 -2.057 . . . . 22.030000000000001 105.447 173.161 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -129.6 130.78 46.1 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 107.343 -1.354 . . . . 75.209999999999994 107.343 178.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 591' ' ' ILE . . . . . 0.491 HG22 ' HB3' ' A' ' 539' ' ' TYR . 27.4 pt -103.75 147.82 9.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.495 -0.928 . . . . 74.219999999999999 108.495 179.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -94.29 -168.45 37.33 Favored Glycine 0 N--CA 1.425 -2.1 0 N-CA-C 111.621 -0.591 . . . . 43.310000000000002 111.621 -178.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.502 ' HB2' HD22 ' A' ' 618' ' ' LEU . 5.5 tp10 -77.67 127.18 83.06 Favored Pre-proline 0 N--CA 1.428 -1.556 0 N-CA-C 107.881 -1.155 . . . . 74.219999999999999 107.881 -178.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 594' ' ' PRO . . . . . 0.607 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 72.0 Cg_endo -71.77 171.17 17.02 Favored 'Trans proline' 0 C--N 1.324 -0.715 0 C-N-CA 123.384 2.722 . . . . 74.299999999999997 112.934 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 595' ' ' ARG . . . . . 0.409 ' NH2' ' HG3' ' A' ' 615' ' ' LYS . 7.9 ptp85 -150.22 151.41 32.99 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 107.076 -1.453 . . . . 72.340000000000003 107.076 177.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 596' ' ' LEU . . . . . 0.471 HD22 HG22 ' A' ' 535' ' ' VAL . 0.0 OUTLIER -81.04 131.49 35.31 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 104.879 -2.267 . . . . 63.509999999999998 104.879 178.144 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 597' ' ' VAL . . . . . 0.52 ' CG2' HG12 ' A' ' 536' ' ' ILE . 99.3 t -66.99 -28.75 43.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-O 122.435 1.112 . . . . 61.509999999999998 108.584 178.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 598' ' ' GLU . . . . . 0.424 ' H ' HD12 ' A' ' 596' ' ' LEU . 31.9 mt-10 -107.37 86.28 2.28 Favored 'General case' 0 N--CA 1.406 -2.647 0 CA-C-N 114.144 -1.389 . . . . 74.209999999999994 108.594 177.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 86.7 mmm -85.25 88.86 7.53 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.584 -0.735 . . . . 75.239999999999995 110.741 -178.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 20.9 m -89.97 122.67 33.2 Favored 'General case' 0 N--CA 1.426 -1.643 0 CA-C-N 115.298 -0.864 . . . . 71.510000000000005 109.539 178.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 601' ' ' GLU . . . . . 0.481 ' HB3' ' HB2' ' A' ' 610' ' ' GLU . 12.0 pt-20 -74.79 153.53 38.72 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 109.873 -0.417 . . . . 75.400000000000006 109.873 177.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 2.7 tmtp? -76.22 81.73 3.02 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 122.198 0.999 . . . . 75.109999999999999 109.71 -176.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -75.9 130.8 39.07 Favored 'General case' 0 N--CA 1.42 -1.937 0 CA-C-N 114.023 -1.444 . . . . 74.010000000000005 109.357 178.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . 94.62 21.53 26.25 Favored Glycine 0 C--N 1.302 -1.306 0 N-CA-C 109.959 -1.256 . . . . 32.530000000000001 109.959 -176.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . -137.21 -139.56 3.93 Favored Glycine 0 N--CA 1.429 -1.82 0 N-CA-C 110.54 -1.024 . . . . 75.219999999999999 110.54 178.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -92.36 -28.71 16.74 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 120.813 0.339 . . . . 74.430000000000007 111.257 -178.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 8.2 p -86.25 130.1 34.63 Favored 'General case' 0 N--CA 1.421 -1.893 0 N-CA-C 115.133 1.531 . . . . 61.530000000000001 115.133 -173.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 54.7 mt -128.42 132.32 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.85 0 N-CA-C 106.052 -1.833 . . . . 62.210000000000001 106.052 174.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 24.3 m 67.84 73.11 0.31 Allowed 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 123.985 0.914 . . . . 23.34 111.342 179.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 610' ' ' GLU . . . . . 0.481 ' HB2' ' HB3' ' A' ' 601' ' ' GLU . 42.1 mt-10 -102.34 95.23 6.15 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 107.415 -1.328 . . . . 53.039999999999999 107.415 174.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -126.56 -160.57 1.0 Allowed 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 114.953 -1.021 . . . . 61.549999999999997 109.667 -178.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 73.54 54.91 0.11 Allowed 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 125.043 1.337 . . . . 74.219999999999999 111.249 -177.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -94.75 130.38 41.31 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 114.035 -1.439 . . . . 63.340000000000003 108.873 176.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -167.94 -166.08 0.7 Allowed 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 106.531 -1.655 . . . . 73.25 106.531 -178.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 615' ' ' LYS . . . . . 0.439 ' HD3' ' N ' ' A' ' 615' ' ' LYS . 0.1 OUTLIER -78.45 96.9 5.5 Favored 'General case' 0 N--CA 1.426 -1.651 0 N-CA-C 107.335 -1.357 . . . . 62.310000000000002 107.335 177.298 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -83.14 148.57 56.7 Favored Pre-proline 0 C--N 1.299 -1.588 0 CA-C-N 115.506 -0.77 . . . . 73.120000000000005 111.871 -175.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -80.94 174.21 11.18 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 C-N-CA 122.19 1.927 . . . . 72.019999999999996 108.417 170.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.502 HD22 ' HB2' ' A' ' 593' ' ' GLU . 4.0 mm? -69.12 100.77 1.31 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 113.011 0.745 . . . . 71.510000000000005 113.011 -177.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 619' ' ' THR . . . . . 0.436 HG22 ' HB2' ' A' ' 630' ' ' GLU . 8.0 p 25.32 -91.27 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 127.623 2.369 . . . . 70.129999999999995 115.348 -177.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 620' ' ' SER . . . . . 0.595 ' OG ' ' HB3' ' A' ' 623' ' ' GLU . 1.8 t -158.45 120.75 3.65 Favored 'General case' 0 N--CA 1.397 -3.086 0 N-CA-C 103.732 -2.692 . . . . 64.519999999999996 103.732 178.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -66.33 -72.41 0.16 Allowed 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 113.105 0.78 . . . . 71.430000000000007 113.105 -171.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -93.84 -24.9 17.58 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.832 0.825 . . . . 71.0 109.196 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . 0.595 ' HB3' ' OG ' ' A' ' 620' ' ' SER . 2.8 tm-20 -80.52 147.36 30.87 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 107.788 -1.19 . . . . 75.310000000000002 107.788 -176.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -104.92 -28.73 10.93 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 113.793 1.034 . . . . 71.519999999999996 113.793 -174.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -70.74 -33.0 70.35 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 113.166 0.802 . . . . 55.329999999999998 113.166 -170.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . 0.445 ' CB ' ' HB2' ' A' ' 620' ' ' SER . 11.5 mmt180 -67.74 -27.32 66.7 Favored 'General case' 0 C--O 1.19 -2.036 0 C-N-CA 119.572 -0.851 . . . . 73.099999999999994 111.042 172.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 627' ' ' ARG . . . . . . . . . . . . . 82.1 mtt180 -67.73 -45.71 74.25 Favored 'General case' 0 C--O 1.213 -0.846 0 N-CA-C 107.805 -1.183 . . . . 70.239999999999995 107.805 176.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . 0.572 ' O ' ' HG2' ' A' ' 631' ' ' MET . 69.2 mt -57.24 -44.01 82.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 115.465 -0.789 . . . . 64.530000000000001 110.198 177.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -71.24 -38.44 71.95 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.082 -0.508 . . . . 74.120000000000005 111.703 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 630' ' ' GLU . . . . . 0.436 ' HB2' HG22 ' A' ' 619' ' ' THR . 32.0 mm-40 -87.4 -2.82 58.89 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 113.129 0.789 . . . . 52.229999999999997 113.129 -175.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 631' ' ' MET . . . . . 0.572 ' HG2' ' O ' ' A' ' 628' ' ' ILE . 25.7 ptt? -72.46 -7.86 52.04 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 120.46 -0.496 . . . . 74.099999999999994 111.684 -178.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -72.3 -21.75 79.19 Favored Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 109.954 -1.258 . . . . 64.439999999999998 109.954 173.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -91.18 153.35 44.65 Favored Pre-proline 0 N--CA 1.442 -0.874 0 N-CA-C 106.862 -1.533 . . . . 74.329999999999998 106.862 176.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.607 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 11.9 Cg_endo -64.94 132.7 33.16 Favored 'Trans proline' 0 N--CA 1.441 -1.588 0 N-CA-C 107.562 -1.745 . . . . 44.25 107.562 167.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 635' ' ' ILE . . . . . 0.546 ' H ' ' HB1' ' A' ' 502' ' ' ALA . 2.5 pp -112.69 161.28 11.69 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.371 0 C-N-CA 120.194 -0.603 . . . . 63.420000000000002 111.442 -178.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . 0.429 ' HB3' HD11 ' A' ' 618' ' ' LEU . 10.0 tt -63.1 154.57 30.55 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 124.34 1.056 . . . . 65.329999999999998 112.184 -178.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -79.77 -125.41 0.53 Allowed Glycine 0 N--CA 1.431 -1.664 0 N-CA-C 116.298 1.279 . . . . 64.239999999999995 116.298 -173.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . 0.461 ' H ' ' HB ' ' A' ' 506' ' ' THR . 34.6 tt0 -90.75 -72.96 0.55 Allowed 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 114.699 -0.751 . . . . 64.510000000000005 112.668 -169.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -130.84 127.93 39.61 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.113 0.483 . . . . 62.119999999999997 110.191 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 17.1 p -129.51 92.78 3.41 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-O 121.92 0.867 . . . . 73.219999999999999 112.743 -175.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 641' ' ' LYS . . . . . 0.632 ' O ' ' HA ' ' A' ' 510' ' ' PRO . 20.5 tptm -156.12 139.15 15.43 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 106.147 -1.798 . . . . 71.530000000000001 106.147 178.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 642' ' ' LEU . . . . . 0.572 ' HB3' ' HB3' ' A' ' 589' ' ' LEU . 21.8 tp -138.21 103.64 4.98 Favored 'General case' 0 N--CA 1.409 -2.491 0 N-CA-C 108.154 -1.054 . . . . 60.109999999999999 108.154 173.378 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . 0.405 ' HB3' HG22 ' A' ' 511' ' ' VAL . 24.9 tt0 -93.11 107.63 19.39 Favored 'General case' 0 C--N 1.274 -2.681 0 N-CA-C 106.847 -1.538 . . . . 72.420000000000002 106.847 176.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 644' ' ' VAL . . . . . 0.667 HG21 ' HE1' ' A' ' 521' ' ' MET . 24.0 t -93.24 104.89 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.004 0 N-CA-C 109.057 -0.72 . . . . 73.439999999999998 109.057 -177.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 4.0 mp -91.22 118.99 37.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 107.281 -1.377 . . . . 73.439999999999998 107.281 176.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 646' ' ' ILE . . . . . 0.458 ' N ' HD12 ' A' ' 646' ' ' ILE . 2.5 mp -100.15 108.0 22.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 106.607 -1.627 . . . . 64.409999999999997 106.607 -176.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -114.23 152.39 31.34 Favored 'General case' 0 C--N 1.281 -2.405 0 O-C-N 123.371 0.42 . . . . 63.520000000000003 111.241 -175.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . 0.598 ' OE2' 'CA ' ' A' ' 800' ' ' ' CA' . 5.2 mp0 -58.1 133.55 55.67 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.321 -0.854 . . . . 53.200000000000003 110.09 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 33.5 t -58.42 108.52 0.63 Allowed 'General case' 0 N--CA 1.436 -1.151 0 O-C-N 124.218 0.949 . . . . 55.229999999999997 112.383 -174.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -134.21 -68.41 0.55 Allowed 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 115.099 -0.955 . . . . 74.230000000000004 108.641 174.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -136.06 -163.12 1.35 Allowed 'General case' 0 C--O 1.246 0.905 0 N-CA-C 108.4 -0.963 . . . . 62.530000000000001 108.4 -178.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -134.55 90.0 2.61 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-O 121.276 0.56 . . . . 64.219999999999999 112.451 178.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -114.95 101.46 9.05 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 115.071 -0.968 . . . . 74.219999999999999 108.583 174.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 9.5 t -141.07 90.24 2.31 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 106.605 -1.628 . . . . 75.030000000000001 106.605 179.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 4.1 t -138.63 112.66 8.54 Favored 'General case' 0 N--CA 1.426 -1.628 0 CA-C-N 115.638 -0.71 . . . . 63.509999999999998 110.673 -174.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.564 HG11 ' HB ' ' A' ' 511' ' ' VAL . 12.9 m -136.38 -177.81 2.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.892 -0.595 . . . . 74.030000000000001 109.656 179.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 . . . . . 0 C--N 1.299 -1.59 0 N-CA-C 109.807 -0.442 . . . . 75.040000000000006 109.807 179.257 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 800' ' ' ' CA' . . . . . 0.598 'CA ' ' OE2' ' A' ' 648' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 850' ' ' ' CA' . . . . . 0.648 'CA ' ' OD2' ' A' ' 552' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 16.2 p-80 . . . . . 0 C--O 1.236 0.39 0 N-CA-C 110.147 -0.316 . . . . 54.420000000000002 110.147 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . 0.478 ' HB1' ' HA ' ' A' ' 634' ' ' PRO . . . -99.57 -48.23 4.83 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.446 -0.946 . . . . 53.399999999999999 108.446 177.049 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . 0.561 ' HA2' ' OG1' ' A' ' 528' ' ' THR . . . 178.57 153.0 10.87 Favored Glycine 0 N--CA 1.414 -2.812 0 C-N-CA 120.317 -0.944 . . . . 61.009999999999998 112.352 177.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 3.8 mp -123.26 104.95 15.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 N-CA-C 107.756 -1.202 . . . . 75.400000000000006 107.756 175.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -118.62 112.42 19.82 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.775 -1.194 . . . . 75.510000000000005 107.775 176.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 14.9 t -141.62 155.22 45.74 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 120.392 -0.523 . . . . 75.510000000000005 110.25 -174.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -81.19 144.81 31.36 Favored 'General case' 0 CA--C 1.489 -1.372 0 N-CA-C 107.559 -1.274 . . . . 74.510000000000005 107.559 175.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -65.28 -43.71 90.3 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 123.88 0.737 . . . . 63.100000000000001 109.757 178.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -123.93 125.71 25.8 Favored Pre-proline 0 N--CA 1.425 -1.675 0 CA-C-N 115.625 -0.716 . . . . 75.420000000000002 109.257 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 641' ' ' LYS . 58.4 Cg_endo -73.52 -16.61 24.16 Favored 'Trans proline' 0 CA--C 1.53 0.298 0 C-N-CA 122.163 1.909 . . . . 74.219999999999999 111.708 176.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . . . . . . . . . 83.1 t -133.82 131.78 56.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 109.013 -0.736 . . . . 63.229999999999997 109.013 178.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 6.0 t -132.84 143.37 49.49 Favored 'General case' 0 N--CA 1.406 -2.65 0 N-CA-C 107.568 -1.271 . . . . 75.030000000000001 107.568 178.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 513' ' ' HIS . . . . . 0.522 ' CD2' ' HA ' ' A' ' 654' ' ' SER . 36.1 m-70 -114.59 127.72 55.94 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.379 -0.971 . . . . 62.299999999999997 108.379 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.538 HG11 ' SD ' ' A' ' 521' ' ' MET . 34.1 m -124.86 158.94 32.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-O 121.015 0.436 . . . . 53.350000000000001 111.128 -174.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . 0.682 ' HA ' ' CZ ' ' A' ' 652' ' ' PHE . 34.9 t -77.74 148.91 34.64 Favored 'General case' 0 N--CA 1.414 -2.227 0 CA-C-N 115.22 -0.9 . . . . 72.510000000000005 110.787 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . 0.659 ' OE2' 'CA ' ' A' ' 800' ' ' ' CA' . 29.6 tt0 -68.45 -17.67 64.25 Favored 'General case' 0 N--CA 1.422 -1.844 0 CA-C-N 114.827 -1.079 . . . . 75.0 108.512 172.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 43.6 m -108.75 22.06 16.43 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 116.056 -0.52 . . . . 73.420000000000002 111.375 -176.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 518' ' ' ILE . . . . . 0.413 HG22 ' O ' ' A' ' 515' ' ' SER . 16.1 tt -92.36 159.68 2.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 109.317 -0.623 . . . . 73.200000000000003 109.317 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . 0.481 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . -106.22 -67.08 0.67 Allowed Glycine 0 N--CA 1.417 -2.621 0 C-N-CA 120.281 -0.962 . . . . 74.420000000000002 111.179 177.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 33.5 mm -120.66 124.2 71.94 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 109.604 -0.517 . . . . 51.219999999999999 109.604 -177.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 521' ' ' MET . . . . . 0.72 ' HE1' HG21 ' A' ' 644' ' ' VAL . 24.6 ptt? -103.86 137.73 41.45 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 107.109 -1.441 . . . . 61.109999999999999 107.109 172.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 15.8 mp0 -114.16 97.37 6.31 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 108.788 -0.819 . . . . 72.030000000000001 108.788 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . 0.579 ' O ' ' HA ' ' A' ' 570' ' ' THR . 26.5 t -84.26 131.72 33.27 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 CA-C-N 116.1 -0.5 . . . . 52.530000000000001 110.308 -177.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . 0.458 ' HD2' HG21 ' A' ' 568' ' ' VAL . 32.3 mmtp -85.27 128.14 34.58 Favored 'General case' 0 C--O 1.247 0.966 0 N-CA-C 113.211 0.819 . . . . 73.519999999999996 113.211 -176.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 21.6 t -117.35 123.84 72.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 CA-C-N 114.251 -1.341 . . . . 75.219999999999999 107.773 177.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -81.69 141.71 33.36 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 109.487 -0.56 . . . . 74.439999999999998 109.487 -176.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . 0.472 ' HG2' ' N ' ' A' ' 528' ' ' THR . 39.3 ttp180 -86.77 161.06 18.58 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.498 -0.774 . . . . 51.32 110.851 -175.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . 0.561 ' OG1' ' HA2' ' A' ' 503' ' ' GLY . 5.7 t -67.68 142.53 56.32 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-N 115.11 -0.95 . . . . 33.409999999999997 110.478 173.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 21.9 t -63.85 -38.85 92.64 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 115.216 -0.902 . . . . 73.319999999999993 108.924 176.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -100.37 80.14 0.47 Allowed Glycine 0 N--CA 1.431 -1.679 0 N-CA-C 110.329 -1.108 . . . . 51.340000000000003 110.329 177.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -93.68 107.8 19.62 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 109.279 -0.637 . . . . 72.519999999999996 109.279 178.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 19.4 mmt180 -119.49 111.06 17.64 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 120.889 0.376 . . . . 72.319999999999993 110.723 -179.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 89.33 -126.45 8.24 Favored Glycine 0 N--CA 1.426 -2.022 0 C-N-CA 120.111 -1.042 . . . . 74.420000000000002 113.504 175.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 534' ' ' ASN . . . . . 0.594 HD21 ' HG3' ' A' ' 561' ' ' GLU . 2.6 t-20 -135.85 124.16 23.27 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.278 -1.008 . . . . 63.43 108.278 -177.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 535' ' ' VAL . . . . . 0.446 HG22 HD22 ' A' ' 596' ' ' LEU . 72.1 t -125.04 125.42 69.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 109.326 -0.62 . . . . 75.409999999999997 109.326 -178.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 536' ' ' ILE . . . . . 0.429 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 36.6 mm -100.57 125.03 54.48 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.134 0 CA-C-N 115.447 -0.797 . . . . 54.219999999999999 109.103 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . 0.457 HG22 ' HB3' ' A' ' 594' ' ' PRO . 30.0 t -116.82 112.41 40.53 Favored Pre-proline 0 C--N 1.312 -1.031 0 CA-C-N 116.202 -0.454 . . . . 61.240000000000002 110.682 -176.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -74.28 140.62 27.83 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.481 2.121 . . . . 74.310000000000002 112.227 177.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 539' ' ' TYR . . . . . 0.494 ' CD1' ' HG ' ' A' ' 560' ' ' LEU . 48.5 p90 -140.99 156.18 46.09 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.004 -1.11 . . . . 62.100000000000001 108.004 -179.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -154.99 157.82 38.24 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 123.28 0.362 . . . . 63.210000000000001 110.659 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 1.6 p -95.09 124.6 39.22 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 115.1 -0.954 . . . . 74.109999999999999 108.812 174.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.5 mp -93.35 128.35 44.85 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 106.275 -1.75 . . . . 65.299999999999997 106.275 175.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -57.9 -50.23 74.03 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 123.782 0.677 . . . . 63.32 111.377 -176.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 69.4 -101.59 0.85 Allowed Glycine 0 N--CA 1.434 -1.477 0 CA-C-N 115.652 -0.703 . . . . 63.43 111.973 178.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 10.0 t -125.89 14.72 8.0 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 122.323 1.058 . . . . 61.100000000000001 109.26 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -116.94 152.92 33.53 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.114 -1.069 . . . . 42.43 108.114 176.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . 0.471 ' HG2' ' HG3' ' A' ' 551' ' ' GLU . 31.8 ttp180 -89.47 130.1 35.86 Favored 'General case' 0 N--CA 1.422 -1.841 0 CA-C-O 121.101 0.477 . . . . 73.219999999999999 111.116 -178.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -96.49 -176.92 35.73 Favored Glycine 0 C--N 1.301 -1.402 0 C-N-CA 120.884 -0.674 . . . . 73.239999999999995 112.774 -175.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 80.72 26.63 53.39 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.927 -0.654 . . . . 64.450000000000003 113.002 177.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 92.08 11.29 60.21 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.743 -0.742 . . . . 74.340000000000003 112.953 177.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . 0.471 ' HG3' ' HG2' ' A' ' 547' ' ' ARG . 5.8 mm-40 -88.99 -70.51 0.65 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 117.273 0.537 . . . . 54.399999999999999 110.287 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . 0.652 ' OD1' 'CA ' ' A' ' 850' ' ' ' CA' . 23.5 m-20 -98.86 -27.02 14.1 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.575 -0.898 . . . . 74.230000000000004 108.575 174.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 553' ' ' PHE . . . . . 0.638 ' HB3' ' CE2' ' A' ' 587' ' ' PHE . 40.8 p90 -151.46 154.2 36.11 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.569 -0.741 . . . . 35.5 110.055 176.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.99 129.6 34.81 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 104.948 -2.241 . . . . 75.0 104.948 174.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -86.19 113.48 22.25 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.212 0.529 . . . . 71.299999999999997 111.112 -172.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . 0.428 HG21 HG22 ' A' ' 573' ' ' VAL . 11.3 t -111.51 104.85 13.3 Favored 'General case' 0 N--CA 1.415 -2.206 0 CA-C-O 122.443 1.116 . . . . 74.540000000000006 110.587 -176.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 1.6 p -123.8 110.94 15.53 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 114.778 -1.101 . . . . 74.209999999999994 109.295 176.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -163.01 -153.91 7.42 Favored Glycine 0 N--CA 1.418 -2.547 0 N-CA-C 110.296 -1.122 . . . . 54.329999999999998 110.296 -175.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 559' ' ' GLU . . . . . 0.429 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 39.0 mt-10 -137.99 136.34 36.83 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 120.77 0.319 . . . . 75.040000000000006 111.084 -176.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . 0.494 ' HG ' ' CD1' ' A' ' 539' ' ' TYR . 82.7 mt -93.85 147.82 22.72 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.375 -0.83 . . . . 74.430000000000007 109.866 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 561' ' ' GLU . . . . . 0.594 ' HG3' HD21 ' A' ' 534' ' ' ASN . 40.4 tt0 -104.82 107.73 18.84 Favored 'General case' 0 N--CA 1.424 -1.754 0 CA-C-O 121.213 0.53 . . . . 74.549999999999997 112.152 -178.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -101.74 146.86 27.17 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.443 -0.947 . . . . 72.209999999999994 108.443 172.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . 0.485 ' HB2' ' H ' ' A' ' 566' ' ' GLU . 51.7 mt-30 -144.2 -176.66 5.1 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 108.171 -1.048 . . . . 52.329999999999998 108.171 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -74.77 -31.58 61.81 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 107.76 -1.2 . . . . 75.040000000000006 107.76 174.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -78.87 -49.47 12.82 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.796 -1.093 . . . . 63.210000000000001 110.384 177.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . 0.485 ' H ' ' HB2' ' A' ' 563' ' ' GLN . 59.6 mm-40 -65.53 139.41 58.47 Favored 'General case' 0 CA--C 1.503 -0.838 0 CA-C-N 115.725 -0.67 . . . . 54.420000000000002 112.276 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 567' ' ' ILE . . . . . 0.451 ' HA ' ' HD3' ' A' ' 527' ' ' ARG . 21.6 pt -115.8 -170.67 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.412 -2.372 0 N-CA-C 105.649 -1.982 . . . . 64.540000000000006 105.649 172.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 568' ' ' VAL . . . . . 0.458 HG21 ' HD2' ' A' ' 524' ' ' LYS . 3.1 p 0.55 127.71 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.07 0 C-N-CA 128.027 2.531 . . . . 74.209999999999994 116.682 173.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 569' ' ' LYS . . . . . 0.539 ' HA ' ' HE2' ' A' ' 569' ' ' LYS . 8.8 mmpt? -105.74 164.69 11.73 Favored 'General case' 0 C--N 1.271 -2.835 0 CA-C-N 114.683 -1.144 . . . . 74.239999999999995 109.605 178.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 570' ' ' THR . . . . . 0.579 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 5.1 p -137.58 119.3 15.08 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.068 -0.969 . . . . 52.350000000000001 110.781 178.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 3.4 mp -86.92 106.4 15.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 107.291 -1.374 . . . . 65.409999999999997 107.291 176.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 4.1 p -84.27 109.13 17.55 Favored 'General case' 0 N--CA 1.415 -2.204 0 O-C-N 123.976 0.798 . . . . 65.310000000000002 109.685 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 573' ' ' VAL . . . . . 0.428 HG22 HG21 ' A' ' 556' ' ' THR . 44.0 t -113.89 128.44 70.81 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 N-CA-C 108.75 -0.833 . . . . 74.5 108.75 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 574' ' ' LYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 519' ' ' GLY . 58.8 tptt -83.4 103.49 12.8 Favored 'General case' 0 N--CA 1.417 -2.116 0 O-C-N 124.087 0.867 . . . . 75.409999999999997 108.827 177.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 71.5 t -78.75 135.1 26.56 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 105.995 -1.854 . . . . 61.219999999999999 105.995 176.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 32.3 mm -98.64 139.88 19.59 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 N-CA-C 108.715 -0.846 . . . . 65.209999999999994 108.715 -176.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -53.43 117.44 3.08 Favored 'General case' 0 C--O 1.244 0.783 0 O-C-N 124.302 1.001 . . . . 64.5 108.558 175.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 578' ' ' ASP . . . . . 0.646 ' OD1' 'CA ' ' A' ' 850' ' ' ' CA' . 25.3 t70 -62.29 120.28 10.69 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.265 -0.879 . . . . 55.310000000000002 112.462 -173.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 579' ' ' GLU . . . . . 0.636 ' OE1' 'CA ' ' A' ' 850' ' ' ' CA' . 1.7 pm0 -81.78 -19.13 41.9 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 114.55 1.315 . . . . 65.219999999999999 114.55 -172.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 580' ' ' GLU . . . . . 0.67 ' OE2' 'CA ' ' A' ' 850' ' ' ' CA' . 0.4 OUTLIER -131.38 -164.02 1.39 Allowed 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 119.668 -0.813 . . . . 74.519999999999996 110.703 -177.357 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -62.74 152.36 35.93 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 107.444 -1.317 . . . . 72.519999999999996 107.444 173.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 582' ' ' GLU . . . . . 0.647 ' OE1' 'CA ' ' A' ' 800' ' ' ' CA' . 42.5 tt0 -122.2 110.47 15.77 Favored 'General case' 0 N--CA 1.411 -2.39 0 C-N-CA 118.298 -1.361 . . . . 70.200000000000003 113.256 -172.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -79.54 -179.72 7.0 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 113.79 -1.55 . . . . 74.329999999999998 107.333 173.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -77.47 84.17 3.87 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 106.455 -1.683 . . . . 74.420000000000002 106.455 172.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 585' ' ' LYS . . . . . . . . . . . . 0.262 0.0 OUTLIER -108.61 145.06 35.49 Favored 'General case' 0 N--CA 1.414 -2.262 0 CA-C-N 115.512 -0.767 . . . . 73.329999999999998 111.426 178.329 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 2.9 t -151.39 149.35 29.21 Favored 'General case' 0 N--CA 1.397 -3.094 0 CA-C-N 114.93 -1.032 . . . . 74.450000000000003 110.232 -174.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 587' ' ' PHE . . . . . 0.638 ' CE2' ' HB3' ' A' ' 553' ' ' PHE . 2.2 p90 -117.97 146.77 43.76 Favored 'General case' 0 N--CA 1.416 -2.171 0 CA-C-N 114.097 -1.411 . . . . 64.230000000000004 107.789 176.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 588' ' ' PHE . . . . . 0.526 ' HA ' ' O ' ' A' ' 642' ' ' LEU . 17.1 m-85 -107.36 142.87 36.48 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 120.707 -0.397 . . . . 73.349999999999994 110.218 -171.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . 0.439 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.3 OUTLIER -112.17 125.6 54.3 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 106.424 -1.695 . . . . 71.349999999999994 106.424 175.531 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -133.75 149.22 51.46 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 109.087 -0.708 . . . . 64.299999999999997 109.087 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 591' ' ' ILE . . . . . . . . . . . . . 27.5 pt -109.16 147.97 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.348 0 N-CA-C 108.485 -0.931 . . . . 74.430000000000007 108.485 176.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -102.38 -140.3 10.96 Favored Glycine 0 C--N 1.302 -1.344 0 C-N-CA 120.631 -0.795 . . . . 52.420000000000002 112.529 -177.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.443 ' HA ' HD21 ' A' ' 618' ' ' LEU . 14.9 tt0 -77.8 115.06 47.01 Favored Pre-proline 0 C--N 1.315 -0.934 0 C-N-CA 122.623 0.369 . . . . 73.439999999999998 110.041 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 594' ' ' PRO . . . . . 0.457 ' HB3' HG22 ' A' ' 537' ' ' VAL . 73.4 Cg_endo -75.93 146.15 29.13 Favored 'Trans proline' 0 N--CA 1.444 -1.434 0 C-N-CA 121.577 1.518 . . . . 72.099999999999994 109.182 176.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 3.2 ptp180 -123.03 138.26 54.73 Favored 'General case' 0 C--N 1.297 -1.674 0 C-N-CA 119.561 -0.856 . . . . 74.209999999999994 110.527 -174.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 596' ' ' LEU . . . . . 0.446 HD22 HG22 ' A' ' 535' ' ' VAL . 0.0 OUTLIER -86.69 118.23 25.96 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 107.42 -1.326 . . . . 44.299999999999997 107.42 179.576 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 59.2 t -78.3 -35.42 19.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 108.534 -0.914 . . . . 71.099999999999994 108.534 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -86.19 -168.79 2.36 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 106.95 -1.5 . . . . 75.010000000000005 106.95 175.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 599' ' ' MET . . . . . 0.422 ' CE ' ' HA ' ' A' ' 599' ' ' MET . 1.0 OUTLIER 64.62 47.86 2.75 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.656 0.741 . . . . 72.409999999999997 109.692 -179.644 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 17.1 m -73.59 -40.1 64.12 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.19 -0.914 . . . . 70.319999999999993 109.701 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -89.93 95.24 10.14 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 115.423 -0.808 . . . . 61.350000000000001 110.34 -177.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 57.7 tttp -157.15 135.87 11.55 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 104.766 -2.309 . . . . 73.129999999999995 104.766 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 603' ' ' LYS . . . . . 0.427 ' HD2' ' O ' ' A' ' 603' ' ' LYS 0.309 0.0 OUTLIER -73.51 108.62 6.47 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 114.546 1.313 . . . . 53.039999999999999 114.546 -175.431 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -86.58 78.7 1.89 Allowed Glycine 0 N--CA 1.426 -1.969 0 N-CA-C 109.546 -1.422 . . . . 60.43 109.546 176.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 160.43 62.69 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.733 0 N-CA-C 110.281 -1.128 . . . . 64.319999999999993 110.281 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -90.54 -46.49 8.28 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 120.887 0.375 . . . . 74.230000000000004 111.122 -178.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 21.3 p -130.0 129.91 44.33 Favored 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 108.992 -0.744 . . . . 74.420000000000002 108.992 175.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 13.3 mt 60.88 16.27 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 C-N-CA 124.646 1.178 . . . . 60.530000000000001 111.451 175.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 6.3 m 67.0 29.03 8.25 Favored 'General case' 0 CA--C 1.562 1.441 0 C-N-CA 124.466 1.107 . . . . 60.340000000000003 110.758 -177.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -64.07 108.11 1.45 Allowed 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.937 -0.574 . . . . 74.329999999999998 110.079 174.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -117.3 33.82 5.43 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.482 -0.933 . . . . 74.409999999999997 108.482 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 612' ' ' TYR . . . . . 0.452 ' CE1' ' HG3' ' A' ' 633' ' ' ARG . 89.6 m-85 73.84 68.14 0.1 Allowed 'General case' 0 CA--C 1.494 -1.194 0 CA-C-N 113.769 -1.56 . . . . 53.219999999999999 107.907 -171.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -95.35 65.92 2.8 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 113.582 -1.645 . . . . 63.229999999999997 110.18 -176.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -161.8 178.23 9.15 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-N 114.284 -1.325 . . . . 42.240000000000002 107.456 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -147.8 31.98 0.86 Allowed 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.635 -0.876 . . . . 74.0 108.635 173.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -108.66 166.89 10.02 Favored Pre-proline 0 C--N 1.31 -1.136 0 CA-C-N 115.281 -0.872 . . . . 74.040000000000006 109.665 -176.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -62.54 -167.91 0.07 OUTLIER 'Trans proline' 0 C--N 1.362 1.274 0 C-N-CA 122.735 2.29 . . . . 75.510000000000005 112.944 177.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.463 HD22 ' H ' ' A' ' 618' ' ' LEU . 2.5 mm? -63.97 113.7 3.64 Favored 'General case' 0 C--O 1.245 0.843 0 N-CA-C 109.484 -0.561 . . . . 72.420000000000002 109.484 -177.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 1.4 p -135.11 131.17 36.58 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 113.371 0.878 . . . . 61.329999999999998 113.371 -172.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 48.2 m -163.97 132.73 3.73 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 106.227 -1.768 . . . . 44.439999999999998 106.227 175.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -120.6 -71.19 0.75 Allowed 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 120.83 -0.348 . . . . 75.019999999999996 111.225 175.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -118.89 -1.65 10.99 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.645 0.736 . . . . 71.219999999999999 109.601 178.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . 0.432 ' HB2' ' CB ' ' A' ' 626' ' ' ARG . 8.2 mp0 -84.7 107.61 16.98 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 115.044 -0.98 . . . . 63.140000000000001 110.463 -171.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 624' ' ' GLU . . . . . 0.461 ' H ' ' CD ' ' A' ' 624' ' ' GLU . 0.7 OUTLIER -70.76 -35.2 72.51 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.271 -0.64 . . . . 75.010000000000005 109.271 176.678 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -59.13 -37.56 77.54 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.908 -0.587 . . . . 70.340000000000003 110.048 174.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . 0.526 ' O ' ' HG2' ' A' ' 630' ' ' GLU . 11.4 tpt180 -68.16 -39.3 82.65 Favored 'General case' 0 C--O 1.2 -1.537 0 N-CA-C 109.32 -0.622 . . . . 65.140000000000001 109.32 -178.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 627' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -60.26 -31.46 70.24 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.393 0.616 . . . . 74.040000000000006 111.522 176.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 98.2 mt -72.41 -40.63 64.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-N 115.371 -0.832 . . . . 73.109999999999999 110.022 177.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -65.85 -38.43 88.84 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 109.339 -0.615 . . . . 63.130000000000003 109.339 175.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 630' ' ' GLU . . . . . 0.526 ' HG2' ' O ' ' A' ' 626' ' ' ARG . 6.5 mm-40 -73.96 -0.94 17.76 Favored 'General case' 0 C--O 1.217 -0.658 0 C-N-CA 123.785 0.834 . . . . 71.420000000000002 112.272 -179.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 631' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -107.53 0.51 22.75 Favored 'General case' 0 CA--C 1.507 -0.68 0 C-N-CA 119.728 -0.789 . . . . 75.299999999999997 109.814 172.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -88.34 -35.8 8.52 Favored Glycine 0 CA--C 1.497 -1.09 0 N-CA-C 106.324 -2.711 . . . . 54.43 106.324 169.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 633' ' ' ARG . . . . . 0.479 ' HD2' ' OE1' ' A' ' 630' ' ' GLU . 91.0 mtt180 -80.38 147.65 64.68 Favored Pre-proline 0 N--CA 1.427 -1.579 0 N-CA-C 107.239 -1.393 . . . . 52.32 107.239 169.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.478 ' HA ' ' HB1' ' A' ' 502' ' ' ALA . 27.7 Cg_endo -79.28 153.31 24.28 Favored 'Trans proline' 0 N--CA 1.429 -2.267 0 N-CA-C 107.937 -1.601 . . . . 70.109999999999999 107.937 166.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 635' ' ' ILE . . . . . 0.447 HG12 ' HB3' ' A' ' 502' ' ' ALA . 8.8 pt -122.86 -178.99 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 C-N-CA 119.7 -0.8 . . . . 72.109999999999999 109.98 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.55 -176.67 4.16 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 115.835 -0.621 . . . . 71.219999999999999 109.631 -178.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -83.54 -125.16 1.07 Allowed Glycine 0 N--CA 1.429 -1.811 0 C-N-CA 120.694 -0.765 . . . . 62.420000000000002 113.263 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -114.5 -59.94 1.95 Allowed 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 115.121 -0.54 . . . . 74.239999999999995 110.243 -176.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -107.52 93.82 4.75 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 122.068 0.937 . . . . 71.540000000000006 111.445 -178.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 23.7 p -109.46 91.27 3.58 Favored 'General case' 0 N--CA 1.41 -2.453 0 CA-C-N 115.389 -0.823 . . . . 72.430000000000007 109.788 178.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 641' ' ' LYS . . . . . 0.472 ' HE2' ' HB2' ' A' ' 643' ' ' GLU . 0.3 OUTLIER -168.92 129.26 1.13 Allowed 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 104.305 -2.48 . . . . 73.010000000000005 104.305 -178.021 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 642' ' ' LEU . . . . . 0.526 ' O ' ' HA ' ' A' ' 588' ' ' PHE . 37.0 tp -125.4 112.78 16.7 Favored 'General case' 0 C--N 1.276 -2.588 0 N-CA-C 108.094 -1.076 . . . . 61.100000000000001 108.094 175.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . 0.472 ' HB2' ' HE2' ' A' ' 641' ' ' LYS . 23.6 tt0 -98.07 107.2 19.63 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 107.175 -1.417 . . . . 74.450000000000003 107.175 177.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 644' ' ' VAL . . . . . 0.72 HG21 ' HE1' ' A' ' 521' ' ' MET . 26.6 t -95.05 103.18 14.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 N-CA-C 109.193 -0.669 . . . . 62.210000000000001 109.193 -178.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 3.9 mp -89.79 120.93 39.39 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 N-CA-C 108.401 -0.963 . . . . 74.430000000000007 108.401 178.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 646' ' ' ILE . . . . . 0.496 HD12 ' H ' ' A' ' 646' ' ' ILE . 1.5 mp -104.83 128.64 58.38 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.764 0 N-CA-C 104.982 -2.229 . . . . 72.150000000000006 104.982 -178.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -147.22 170.66 16.77 Favored 'General case' 0 C--N 1.282 -2.356 0 O-C-N 123.551 0.532 . . . . 54.310000000000002 112.078 -176.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . 0.643 ' OE2' 'CA ' ' A' ' 800' ' ' ' CA' . 14.6 mm-40 -52.77 137.45 31.57 Favored 'General case' 0 C--O 1.249 1.037 0 CA-C-N 114.738 -1.119 . . . . 65.140000000000001 109.692 178.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 649' ' ' SER . . . . . 0.452 ' HA ' ' CZ ' ' A' ' 652' ' ' PHE . 9.4 t -79.15 86.01 4.99 Favored 'General case' 0 N--CA 1.422 -1.842 0 CA-C-O 121.945 0.879 . . . . 64.200000000000003 111.897 -174.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -109.2 -58.27 2.05 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 107.299 -1.371 . . . . 73.439999999999998 107.299 173.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -179.84 160.05 0.88 Allowed 'General case' 0 N--CA 1.422 -1.87 0 N-CA-C 101.941 -3.355 . . . . 70.439999999999998 101.941 175.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 652' ' ' PHE . . . . . 0.682 ' CZ ' ' HA ' ' A' ' 515' ' ' SER . 60.0 m-85 -121.0 99.74 6.67 Favored 'General case' 0 N--CA 1.397 -3.095 0 N-CA-C 109.192 -0.67 . . . . 72.230000000000004 109.192 -174.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 27.6 mmmt -78.78 92.23 4.8 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.541 -1.281 . . . . 54.420000000000002 107.541 -178.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 654' ' ' SER . . . . . 0.522 ' HA ' ' CD2' ' A' ' 513' ' ' HIS . 21.8 t -62.18 125.45 23.92 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.847 -1.07 . . . . 73.430000000000007 111.838 -172.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 90.7 m -75.26 92.82 2.78 Favored 'General case' 0 N--CA 1.434 -1.248 0 N-CA-C 107.999 -1.112 . . . . 61.329999999999998 107.999 174.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 56.7 t -75.69 116.39 18.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 N-CA-C 109.517 -0.549 . . . . 73.310000000000002 109.517 -178.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 13.9 t70 . . . . . 0 C--N 1.299 -1.617 0 N-CA-C 109.313 -0.625 . . . . 72.120000000000005 109.313 -179.355 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 800' ' ' ' CA' . . . . . 0.659 'CA ' ' OE2' ' A' ' 516' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 850' ' ' ' CA' . . . . . 0.67 'CA ' ' OE2' ' A' ' 580' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 23.5 t-160 . . . . . 0 N--CA 1.447 -0.594 0 CA-C-O 121.061 0.458 . . . . 72.239999999999995 110.015 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . 0.489 ' HB2' ' O ' ' A' ' 630' ' ' GLU . . . -151.81 -59.64 0.16 Allowed 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 107.299 -1.371 . . . . 51.119999999999997 107.299 175.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . 0.642 ' HA2' ' OG1' ' A' ' 528' ' ' THR . . . -155.29 113.15 0.56 Allowed Glycine 0 N--CA 1.403 -3.505 0 CA-C-N 114.642 -1.163 . . . . 74.340000000000003 110.585 177.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . 0.416 ' HA ' ' HA2' ' A' ' 637' ' ' GLY . 3.1 mp -90.38 103.61 14.47 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.475 0 N-CA-C 108.783 -0.821 . . . . 61.539999999999999 108.783 177.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -117.15 109.37 16.83 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 106.728 -1.582 . . . . 75.340000000000003 106.728 175.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 12.5 t -150.62 164.39 36.17 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 109.196 -0.668 . . . . 51.310000000000002 109.196 -175.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -96.53 165.2 12.28 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.075 -1.083 . . . . 73.120000000000005 108.075 175.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.1 -30.97 9.89 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 120.781 -0.367 . . . . 74.420000000000002 111.919 175.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -107.85 123.7 37.04 Favored Pre-proline 0 C--N 1.311 -1.091 0 N-CA-C 108.714 -0.847 . . . . 75.219999999999999 108.714 173.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -82.43 -13.11 9.97 Favored 'Trans proline' 0 CA--C 1.532 0.381 0 C-N-CA 121.926 1.75 . . . . 70.439999999999998 111.549 177.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . 0.488 HG22 ' HB3' ' A' ' 643' ' ' GLU . 75.2 t -138.74 133.19 41.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 108.524 -0.917 . . . . 71.329999999999998 108.524 -179.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 5.4 t -136.45 145.86 45.7 Favored 'General case' 0 N--CA 1.41 -2.45 0 N-CA-C 108.613 -0.884 . . . . 53.130000000000003 108.613 176.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 27.8 m-70 -110.46 137.82 47.66 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.935 -0.765 . . . . 65.510000000000005 108.935 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.566 HG11 ' SD ' ' A' ' 521' ' ' MET . 27.7 m -126.74 151.53 33.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-O 121.197 0.522 . . . . 73.219999999999999 110.432 179.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 43.5 t -76.32 146.95 38.49 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 107.849 -1.167 . . . . 64.329999999999998 107.849 176.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . 0.692 ' HB2' ' O ' ' A' ' 647' ' ' GLU . 33.4 tt0 -74.98 -7.4 53.52 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-O 121.905 0.86 . . . . 71.310000000000002 109.683 176.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 10.7 t -110.28 22.72 15.18 Favored 'General case' 0 N--CA 1.415 -2.207 0 N-CA-C 108.382 -0.97 . . . . 53.130000000000003 108.382 -177.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 15.0 tt -94.02 155.61 3.18 Favored 'Isoleucine or valine' 0 C--O 1.247 0.948 0 N-CA-C 109.087 -0.708 . . . . 74.340000000000003 109.087 178.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -101.42 -70.45 0.89 Allowed Glycine 0 N--CA 1.419 -2.457 0 N-CA-C 110.66 -0.976 . . . . 63.210000000000001 110.66 177.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 32.3 mm -116.81 114.04 44.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 CA-C-O 120.689 0.28 . . . . 62.109999999999999 111.029 -177.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 521' ' ' MET . . . . . 0.57 ' HE1' HG21 ' A' ' 644' ' ' VAL . 24.7 ptt? -92.98 137.65 32.17 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.755 -1.202 . . . . 75.030000000000001 107.755 173.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -123.76 114.64 20.19 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 121.4 0.619 . . . . 74.239999999999995 110.794 178.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . 0.559 HG21 HD21 ' A' ' 642' ' ' LEU . 20.5 t -103.54 138.09 29.35 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 CA-C-N 114.639 -1.164 . . . . 71.200000000000003 108.414 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . 0.413 ' HD2' ' CG2' ' A' ' 568' ' ' VAL . 30.8 mmtp -85.13 145.89 27.4 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.664 0.745 . . . . 72.400000000000006 112.329 -177.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 7.9 t -123.13 131.49 73.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 106.49 -1.67 . . . . 72.010000000000005 106.49 175.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -77.54 140.6 39.76 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.064 -0.717 . . . . 72.400000000000006 109.064 -178.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . 0.499 ' HG3' ' HA ' ' A' ' 567' ' ' ILE . 2.7 tmm_? -96.12 135.29 38.1 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 109.202 -0.666 . . . . 70.340000000000003 109.202 -176.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . 0.642 ' OG1' ' HA2' ' A' ' 503' ' ' GLY . 6.0 t -50.85 147.04 5.26 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 125.083 1.353 . . . . 71.129999999999995 114.557 -177.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 35.2 t -63.21 -55.11 27.72 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 114.55 -1.204 . . . . 45.310000000000002 107.811 173.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -85.95 95.5 2.02 Favored Glycine 0 N--CA 1.423 -2.171 0 N-CA-C 109.5 -1.44 . . . . 64.030000000000001 109.5 178.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -111.64 98.93 7.77 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 121.092 0.472 . . . . 64.439999999999998 110.24 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -125.01 131.78 53.35 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 109.299 -0.63 . . . . 73.420000000000002 109.299 177.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 81.07 -144.54 24.94 Favored Glycine 0 N--CA 1.422 -2.286 0 C-N-CA 120.828 -0.701 . . . . 45.399999999999999 113.254 175.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 534' ' ' ASN . . . . . 0.455 HD21 ' HG3' ' A' ' 561' ' ' GLU . 2.5 t-20 -140.2 121.74 15.18 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 107.858 -1.164 . . . . 72.019999999999996 107.858 179.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 535' ' ' VAL . . . . . 0.438 HG22 HD22 ' A' ' 596' ' ' LEU . 58.1 t -126.75 131.74 70.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 N-CA-C 108.803 -0.814 . . . . 54.539999999999999 108.803 -178.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 536' ' ' ILE . . . . . 0.62 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 42.5 mm -94.92 129.63 44.81 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 108.888 -0.782 . . . . 74.120000000000005 108.888 178.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 67.9 t -111.97 110.73 54.04 Favored Pre-proline 0 C--N 1.295 -1.783 0 N-CA-C 109.37 -0.604 . . . . 74.400000000000006 109.37 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -73.96 155.95 47.88 Favored 'Trans proline' 0 CA--C 1.512 -0.625 0 C-N-CA 122.513 2.142 . . . . 43.340000000000003 111.495 178.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 539' ' ' TYR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 591' ' ' ILE . 48.2 p90 -150.41 156.34 41.3 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.295 -1.002 . . . . 73.540000000000006 108.295 177.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -152.44 147.9 26.81 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 112.188 0.44 . . . . 73.5 112.188 176.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 3.5 p -84.34 120.92 26.82 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-N 115.474 -0.785 . . . . 70.209999999999994 110.94 176.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.8 mp -88.84 119.92 36.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 N-CA-C 105.728 -1.953 . . . . 64.099999999999994 105.728 173.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -52.47 -41.01 62.97 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 124.479 1.112 . . . . 73.420000000000002 112.716 -174.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 72.34 -92.05 0.57 Allowed Glycine 0 N--CA 1.435 -1.369 0 N-CA-C 110.825 -0.91 . . . . 71.510000000000005 110.825 178.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 10.2 t -146.14 18.13 1.39 Allowed 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 121.382 0.611 . . . . 64.129999999999995 109.812 177.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -101.08 161.03 13.89 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.619 -1.252 . . . . 64.420000000000002 107.619 176.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 18.5 mmm180 -63.86 173.23 1.88 Allowed 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 113.75 1.019 . . . . 72.239999999999995 113.75 -179.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -71.34 -178.47 28.7 Favored Glycine 0 C--O 1.254 1.355 0 CA-C-N 114.254 -1.339 . . . . 62.109999999999999 114.281 -175.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . -59.87 119.38 18.09 Favored Glycine 0 N--CA 1.441 -1.005 0 CA-C-N 114.737 -0.731 . . . . 74.510000000000005 113.287 -176.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 95.28 -10.41 69.51 Favored Glycine 0 N--CA 1.435 -1.399 0 N-CA-C 111.712 -0.555 . . . . 45.520000000000003 111.712 178.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -98.51 -68.36 0.81 Allowed 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.782 -0.822 . . . . 61.399999999999999 108.782 179.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -94.22 -38.29 11.13 Favored 'General case' 0 CA--C 1.492 -1.264 0 C-N-CA 118.862 -1.135 . . . . 74.219999999999999 111.414 175.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 553' ' ' PHE . . . . . 0.426 ' HB3' ' CE2' ' A' ' 587' ' ' PHE . 48.0 p90 -145.04 155.63 43.47 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 108.316 -0.994 . . . . 71.519999999999996 108.316 -179.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -83.56 119.24 24.48 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 105.329 -2.1 . . . . 75.019999999999996 105.329 174.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -73.53 104.23 4.42 Favored 'General case' 0 CA--C 1.498 -1.035 0 CA-C-O 121.267 0.556 . . . . 61.329999999999998 110.043 -175.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . 0.489 HG21 HG22 ' A' ' 573' ' ' VAL . 11.5 t -103.36 100.8 10.69 Favored 'General case' 0 N--CA 1.395 -3.175 0 CA-C-O 122.793 1.282 . . . . 52.450000000000003 110.978 -176.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 1.8 p -116.61 94.45 4.62 Favored 'General case' 0 N--CA 1.409 -2.502 0 CA-C-N 114.085 -1.416 . . . . 71.409999999999997 108.47 174.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -142.34 -157.54 7.19 Favored Glycine 0 N--CA 1.407 -3.291 0 N-CA-C 110.029 -1.228 . . . . 71.0 110.029 -174.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 559' ' ' GLU . . . . . 0.62 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 49.3 mt-10 -142.23 137.09 30.48 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 120.647 0.26 . . . . 61.119999999999997 111.315 -173.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 95.5 mt -96.82 144.94 26.31 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 123.415 0.686 . . . . 70.120000000000005 109.681 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 561' ' ' GLU . . . . . 0.455 ' HG3' HD21 ' A' ' 534' ' ' ASN . 40.9 tt0 -102.88 113.25 26.54 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 120.923 0.392 . . . . 72.129999999999995 110.665 -178.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -109.08 132.51 54.04 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 110.076 -0.342 . . . . 62.340000000000003 110.076 175.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -121.96 174.22 7.04 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.457 -0.897 . . . . 74.340000000000003 111.343 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -64.68 -38.03 89.59 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 114.122 -1.399 . . . . 65.0 110.222 176.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -94.34 -33.89 13.01 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.529 -0.76 . . . . 54.539999999999999 112.269 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -78.19 132.15 37.47 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.51 -0.313 . . . . 71.129999999999995 111.681 -177.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 567' ' ' ILE . . . . . 0.499 ' HA ' ' HG3' ' A' ' 527' ' ' ARG . 7.8 pt -109.94 163.29 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.617 0 N-CA-C 109.732 -0.47 . . . . 72.209999999999994 109.732 178.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 568' ' ' VAL . . . . . 0.498 ' O ' ' HG2' ' A' ' 569' ' ' LYS . 1.4 p 45.53 171.93 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.574 1.882 0 C-N-CA 127.278 2.231 . . . . 64.530000000000001 114.553 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 569' ' ' LYS . . . . . 0.566 ' HA ' ' HE3' ' A' ' 569' ' ' LYS . 0.0 OUTLIER -158.98 163.98 35.97 Favored 'General case' 0 CA--C 1.497 -1.095 0 C-N-CA 124.39 1.076 . . . . 73.310000000000002 108.235 173.698 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 570' ' ' THR . . . . . 0.537 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 4.7 p -135.4 133.96 39.22 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 124.112 0.883 . . . . 73.129999999999995 110.352 177.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 3.3 mp -93.03 106.26 17.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 106.618 -1.623 . . . . 63.210000000000001 106.618 172.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 572' ' ' SER . . . . . 0.424 ' HA ' ' O ' ' A' ' 521' ' ' MET . 13.0 p -88.14 112.02 22.24 Favored 'General case' 0 N--CA 1.424 -1.733 0 O-C-N 123.575 0.547 . . . . 74.439999999999998 109.797 178.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 573' ' ' VAL . . . . . 0.489 HG22 HG21 ' A' ' 556' ' ' THR . 42.4 t -115.54 131.22 68.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 109.148 -0.686 . . . . 64.150000000000006 109.148 -178.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -88.01 112.69 22.88 Favored 'General case' 0 N--CA 1.423 -1.784 0 O-C-N 123.929 0.768 . . . . 63.520000000000003 109.516 176.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 62.9 t -85.88 133.61 29.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 N-CA-C 106.42 -1.696 . . . . 70.310000000000002 106.42 176.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 25.8 mm -97.78 159.9 3.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 107.914 -1.143 . . . . 72.219999999999999 107.914 -174.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -71.35 114.22 9.19 Favored 'General case' 0 C--O 1.25 1.13 0 N-CA-C 110.007 -0.368 . . . . 74.219999999999999 110.007 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 578' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -56.82 142.71 39.91 Favored 'General case' 0 C--O 1.246 0.921 0 C-N-CA 124.614 1.166 . . . . 72.420000000000002 110.969 -176.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 579' ' ' GLU . . . . . 0.655 ' OE1' 'CA ' ' A' ' 850' ' ' ' CA' . 0.0 OUTLIER -124.88 -28.35 3.5 Favored 'General case' 0 C--N 1.289 -2.055 0 C-N-CA 125.115 1.366 . . . . 71.140000000000001 112.31 -170.439 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 580' ' ' GLU . . . . . 0.624 ' OE2' 'CA ' ' A' ' 850' ' ' ' CA' 0.3 0.0 OUTLIER -111.49 174.07 6.04 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 114.647 1.351 . . . . 43.140000000000001 114.647 -172.653 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 31.7 p90 -48.8 148.02 2.38 Favored 'General case' 0 CA--C 1.522 -0.122 0 O-C-N 124.778 1.298 . . . . 71.329999999999998 110.287 -178.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -122.99 106.5 10.9 Favored 'General case' 0 N--CA 1.408 -2.573 0 C-N-CA 118.265 -1.374 . . . . 75.340000000000003 114.177 -173.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -98.45 -158.48 0.67 Allowed 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 104.902 -2.258 . . . . 72.219999999999999 104.902 169.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -83.05 88.34 6.87 Favored 'General case' 0 C--N 1.282 -2.353 0 C-N-CA 118.903 -1.119 . . . . 72.329999999999998 108.4 174.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 585' ' ' LYS . . . . . . . . . . . . 0.315 0.5 OUTLIER -100.85 138.36 38.0 Favored 'General case' 0 N--CA 1.425 -1.684 0 C-N-CA 119.429 -0.908 . . . . 53.030000000000001 111.81 -179.014 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 4.1 t -152.42 150.21 29.41 Favored 'General case' 0 N--CA 1.405 -2.681 0 CA-C-N 114.699 -1.137 . . . . 74.329999999999998 109.79 -175.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 587' ' ' PHE . . . . . 0.426 ' CE2' ' HB3' ' A' ' 553' ' ' PHE . 4.1 p90 -124.35 151.23 44.59 Favored 'General case' 0 N--CA 1.411 -2.395 0 CA-C-N 114.221 -1.354 . . . . 63.130000000000003 108.335 176.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 588' ' ' PHE . . . . . 0.5 ' HA ' ' O ' ' A' ' 642' ' ' LEU . 16.5 m-85 -113.35 142.04 46.33 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 116.471 -0.331 . . . . 64.420000000000002 110.281 -171.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . 0.442 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.4 OUTLIER -107.71 131.7 54.14 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 106.481 -1.674 . . . . 75.099999999999994 106.481 175.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -141.77 144.4 33.95 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.396 -0.964 . . . . 64.140000000000001 108.396 -179.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 591' ' ' ILE . . . . . 0.567 HG12 ' OG1' ' A' ' 640' ' ' THR . 20.0 pt -96.37 168.01 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 O-C-N 123.699 0.624 . . . . 73.040000000000006 109.691 177.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -118.03 -154.27 9.76 Favored Glycine 0 C--N 1.303 -1.288 0 C-N-CA 120.444 -0.884 . . . . 62.329999999999998 113.675 -177.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -76.93 118.24 70.47 Favored Pre-proline 0 C--N 1.319 -0.751 0 N-CA-C 108.664 -0.865 . . . . 73.019999999999996 108.664 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -66.72 138.19 48.28 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 122.398 2.065 . . . . 73.319999999999993 112.071 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 595' ' ' ARG . . . . . 0.55 ' CG ' ' HB ' ' A' ' 536' ' ' ILE . 7.2 ptm180 -116.03 119.48 36.02 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.69 -0.686 . . . . 62.149999999999999 109.822 -174.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 596' ' ' LEU . . . . . 0.438 HD22 HG22 ' A' ' 535' ' ' VAL . 0.0 OUTLIER -69.96 129.0 38.31 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 107.92 -1.141 . . . . 72.310000000000002 107.92 179.216 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 597' ' ' VAL . . . . . 0.498 ' CG2' HG12 ' A' ' 536' ' ' ILE . 11.6 t -91.0 36.7 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 122.696 1.236 . . . . 54.240000000000002 108.286 178.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 70.14 -39.95 0.45 Allowed 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 126.292 1.837 . . . . 73.409999999999997 115.922 177.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 62.6 ttp -53.5 109.61 0.46 Allowed 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 112.578 0.585 . . . . 61.420000000000002 112.578 -174.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 600' ' ' SER . . . . . 0.402 ' HB3' ' HB ' ' A' ' 608' ' ' ILE . 32.8 t 178.48 116.3 0.04 OUTLIER 'General case' 0 N--CA 1.421 -1.903 0 N-CA-C 103.807 -2.664 . . . . 71.530000000000001 103.807 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -122.19 131.65 54.05 Favored 'General case' 0 C--N 1.284 -2.281 0 C-N-CA 119.411 -0.915 . . . . 73.439999999999998 112.819 -173.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -90.42 129.0 36.66 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 104.821 -2.289 . . . . 70.439999999999998 104.821 167.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -75.36 7.22 3.69 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.463 0.649 . . . . 63.109999999999999 111.302 -174.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -90.63 20.36 38.92 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 116.237 -0.438 . . . . 42.109999999999999 112.142 178.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 85.91 42.08 6.9 Favored Glycine 0 N--CA 1.438 -1.189 0 C-N-CA 120.913 -0.66 . . . . 65.439999999999998 113.217 176.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -160.57 126.88 4.09 Favored 'General case' 0 C--O 1.245 0.817 0 CA-C-N 117.142 0.471 . . . . 74.530000000000001 110.643 178.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 15.3 p -97.53 135.33 39.53 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-N 116.141 -0.482 . . . . 75.420000000000002 109.962 176.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 608' ' ' ILE . . . . . 0.402 ' HB ' ' HB3' ' A' ' 600' ' ' SER . 49.7 mm -74.58 152.29 6.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 C-N-CA 122.881 0.472 . . . . 62.43 110.413 -174.263 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 7.6 t -153.33 75.18 1.05 Allowed 'General case' 0 N--CA 1.405 -2.69 0 CA-C-O 122.766 1.269 . . . . 75.549999999999997 111.295 176.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -86.62 84.2 7.45 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 106.979 -1.489 . . . . 74.340000000000003 106.979 176.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -88.21 92.24 9.08 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-O 121.997 0.903 . . . . 73.25 113.382 -175.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -118.21 84.89 2.25 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 105.767 -1.938 . . . . 71.040000000000006 105.767 170.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -126.75 22.37 6.86 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 112.709 -2.042 . . . . 75.030000000000001 107.834 -169.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -94.52 2.99 55.68 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.8 -1.091 . . . . 72.409999999999997 111.915 -172.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp 51.5 72.44 0.37 Allowed 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 114.064 -1.425 . . . . 74.409999999999997 112.35 -179.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 80.1 mm-40 -108.31 170.93 4.97 Favored Pre-proline 0 C--N 1.282 -2.362 0 CA-C-N 114.704 -1.135 . . . . 74.409999999999997 108.609 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -65.82 162.64 33.97 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 121.096 1.197 . . . . 71.400000000000006 109.3 171.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -60.54 137.36 58.17 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 121.555 0.693 . . . . 72.310000000000002 111.329 -178.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 619' ' ' THR . . . . . 0.433 ' O ' ' HG2' ' A' ' 626' ' ' ARG . 19.4 p -66.34 -9.34 32.3 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 116.502 2.038 . . . . 72.409999999999997 116.502 -167.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 7.6 p -74.08 78.23 1.73 Allowed 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 114.496 1.295 . . . . 63.340000000000003 114.496 -175.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 44.1 tttm -86.32 -49.44 7.67 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 114.677 -1.147 . . . . 71.219999999999999 108.166 174.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 25.8 mp0 -103.71 148.53 25.95 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 107.01 -1.478 . . . . 73.230000000000004 107.01 175.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -93.02 -33.57 14.07 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 107.668 -1.234 . . . . 75.209999999999994 107.668 171.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -58.97 -67.34 0.38 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.751 -1.113 . . . . 64.400000000000006 112.534 -178.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -87.31 -33.63 19.15 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 113.556 0.947 . . . . 63.109999999999999 113.556 -173.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . 0.439 ' O ' ' HG3' ' A' ' 630' ' ' GLU . 6.4 tpp180 -66.61 -37.5 84.99 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 112.704 0.631 . . . . 75.040000000000006 112.704 -171.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 627' ' ' ARG . . . . . . . . . . . . . 81.6 mtm180 -55.6 -28.59 56.03 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 112.81 0.67 . . . . 72.549999999999997 112.81 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . 0.446 ' O ' ' HG2' ' A' ' 631' ' ' MET . 93.7 mt -64.56 -36.99 78.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-N 115.441 -0.8 . . . . 64.230000000000004 110.362 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -86.22 -30.57 22.28 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.933 -0.576 . . . . 74.239999999999995 109.569 178.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 630' ' ' GLU . . . . . 0.489 ' O ' ' HB2' ' A' ' 502' ' ' ALA . 50.4 mt-10 -80.45 2.54 24.71 Favored 'General case' 0 C--O 1.216 -0.679 0 CA-C-N 115.671 -0.695 . . . . 43.039999999999999 112.36 -177.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 631' ' ' MET . . . . . 0.446 ' HG2' ' O ' ' A' ' 628' ' ' ILE . 19.4 ptp -85.58 -30.81 23.04 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 119.176 -1.01 . . . . 71.409999999999997 109.208 174.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -92.57 -40.76 4.94 Favored Glycine 0 N--CA 1.431 -1.66 0 N-CA-C 110.979 -0.848 . . . . 72.230000000000004 110.979 177.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -88.97 138.82 29.05 Favored Pre-proline 0 C--N 1.314 -0.954 0 N-CA-C 108.773 -0.825 . . . . 72.040000000000006 108.773 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -74.31 154.17 45.89 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.39 2.06 . . . . 60.299999999999997 113.188 -175.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 1.9 pp -144.09 -169.81 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.31 -0.859 . . . . 75.430000000000007 110.775 -176.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.61 164.1 19.94 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 123.082 0.239 . . . . 73.319999999999993 110.621 -179.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . 0.416 ' HA2' ' HA ' ' A' ' 504' ' ' ILE . . . -81.16 -85.29 0.7 Allowed Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 121.317 -0.468 . . . . 71.450000000000003 113.78 -177.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -143.02 -63.58 0.41 Allowed 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 120.465 -0.494 . . . . 74.439999999999998 110.425 -178.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 10.7 p80 -127.68 114.77 17.77 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-O 121.913 0.864 . . . . 75.430000000000007 111.598 178.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 640' ' ' THR . . . . . 0.567 ' OG1' HG12 ' A' ' 591' ' ' ILE . 0.7 OUTLIER -111.4 92.28 3.98 Favored 'General case' 0 N--CA 1.416 -2.131 0 CA-C-N 114.811 -1.086 . . . . 53.32 109.674 177.361 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -169.88 125.44 0.81 Allowed 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 106.503 -1.666 . . . . 63.140000000000001 106.503 178.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 642' ' ' LEU . . . . . 0.559 HD21 HG21 ' A' ' 523' ' ' VAL . 31.3 tp -130.43 110.09 11.21 Favored 'General case' 0 C--N 1.277 -2.553 0 N-CA-C 108.312 -0.996 . . . . 72.540000000000006 108.312 177.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . 0.488 ' HB3' HG22 ' A' ' 511' ' ' VAL . 43.1 tt0 -92.31 107.22 19.05 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.062 -1.088 . . . . 71.25 108.062 178.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 644' ' ' VAL . . . . . 0.57 HG21 ' HE1' ' A' ' 521' ' ' MET . 24.3 t -97.73 104.56 16.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 109.248 -0.649 . . . . 74.219999999999999 109.248 -179.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 4.5 mp -86.69 128.21 39.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 108.903 -0.777 . . . . 73.319999999999993 108.903 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 646' ' ' ILE . . . . . 0.443 ' N ' HD12 ' A' ' 646' ' ' ILE . 1.2 mp -110.81 106.94 21.73 Favored 'Isoleucine or valine' 0 C--O 1.255 1.377 0 N-CA-C 108.158 -1.053 . . . . 73.340000000000003 108.158 -177.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . 0.692 ' O ' ' HB2' ' A' ' 516' ' ' GLU . 8.0 pt-20 -109.19 -161.4 0.76 Allowed 'General case' 0 C--N 1.268 -2.958 0 CA-C-N 113.718 -1.583 . . . . 75.310000000000002 107.864 -178.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . 0.656 ' OE1' 'CA ' ' A' ' 800' ' ' ' CA' . 7.8 mm-40 -81.5 -173.1 4.19 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.3 -0.63 . . . . 74.099999999999994 109.3 177.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 23.1 t -79.76 80.41 6.15 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.213 -1.032 . . . . 62.439999999999998 108.213 175.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -143.52 -61.96 0.4 Allowed 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 114.557 -1.201 . . . . 74.109999999999999 108.516 -177.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 71.86 121.09 0.04 OUTLIER 'General case' 0 C--O 1.247 0.966 0 C-N-CA 126.199 1.8 . . . . 72.109999999999999 111.425 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -122.81 164.66 17.96 Favored 'General case' 0 C--N 1.27 -2.865 0 N-CA-C 106.884 -1.524 . . . . 73.140000000000001 106.884 -179.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -118.03 98.91 6.56 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 120.802 0.334 . . . . 72.430000000000007 110.777 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 23.4 t -135.65 79.28 1.77 Allowed 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 108.722 -0.844 . . . . 53.310000000000002 108.722 176.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 15.0 m -95.84 100.96 12.59 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 115.252 -0.886 . . . . 55.020000000000003 109.337 -178.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 31.5 m -91.15 164.76 2.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 CA-C-N 115.78 -0.645 . . . . 71.329999999999998 110.343 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 . . . . . 0 C--O 1.253 1.286 0 N-CA-C 110.058 -0.349 . . . . 62.340000000000003 110.058 -179.546 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 800' ' ' ' CA' . . . . . 0.675 'CA ' ' OE1' ' A' ' 516' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 850' ' ' ' CA' . . . . . 0.655 'CA ' ' OE1' ' A' ' 579' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 9.7 t-160 . . . . . 0 CA--C 1.515 -0.395 0 CA-C-O 121.669 0.747 . . . . 71.109999999999999 111.764 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . 0.406 ' HB1' ' HA ' ' A' ' 634' ' ' PRO . . . -145.82 -64.07 0.32 Allowed 'General case' 0 C--N 1.279 -2.459 0 N-CA-C 106.302 -1.74 . . . . 73.239999999999995 106.302 173.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . 0.457 ' HA2' ' OG1' ' A' ' 528' ' ' THR . . . 137.38 125.82 2.44 Favored Glycine 0 N--CA 1.409 -3.113 0 C-N-CA 120.31 -0.948 . . . . 65.319999999999993 112.248 176.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . 0.443 ' H ' ' CB ' ' A' ' 528' ' ' THR . 3.1 mp -93.57 98.46 8.28 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 N-CA-C 107.826 -1.176 . . . . 74.340000000000003 107.826 174.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -113.9 114.73 26.63 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.922 -1.14 . . . . 71.209999999999994 107.922 176.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . 0.463 ' HB ' ' HA3' ' A' ' 637' ' ' GLY . 15.0 t -149.02 162.66 39.49 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.876 -0.787 . . . . 74.230000000000004 108.876 -176.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -81.71 152.19 27.17 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 108.023 -1.103 . . . . 74.120000000000005 108.023 176.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -76.14 -24.85 54.9 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.551 0.691 . . . . 65.239999999999995 109.691 178.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . 0.462 ' OE1' ' HB ' ' A' ' 655' ' ' THR . 24.2 pt-20 -139.45 132.78 15.58 Favored Pre-proline 0 N--CA 1.424 -1.765 0 CA-C-N 115.144 -0.935 . . . . 70.329999999999998 108.683 -179.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -84.33 0.33 9.19 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 122.122 1.881 . . . . 62.530000000000001 112.202 176.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . 0.52 HG22 ' HB3' ' A' ' 643' ' ' GLU . 69.3 t -145.57 135.33 18.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 124.193 0.997 . . . . 73.340000000000003 108.413 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 6.2 t -142.03 140.79 32.73 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.198 -1.408 . . . . 63.030000000000001 107.198 177.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 513' ' ' HIS . . . . . 0.414 ' HB2' ' HB2' ' A' ' 654' ' ' SER . 11.8 m170 -110.79 133.55 53.25 Favored 'General case' 0 CA--C 1.492 -1.258 0 N-CA-C 108.325 -0.991 . . . . 73.299999999999997 108.325 178.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.641 HG11 ' SD ' ' A' ' 521' ' ' MET . 34.0 m -129.62 159.89 41.18 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 CA-C-N 116.209 -0.451 . . . . 62.420000000000002 110.288 -174.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . 0.424 ' HB3' ' HB ' ' A' ' 518' ' ' ILE . 47.3 t -77.7 150.48 34.47 Favored 'General case' 0 N--CA 1.415 -2.216 0 N-CA-C 107.564 -1.273 . . . . 75.450000000000003 107.564 177.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -88.43 -7.06 57.22 Favored 'General case' 0 C--N 1.286 -2.156 0 CA-C-O 122.315 1.055 . . . . 54.009999999999998 108.946 178.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 33.0 t -100.29 2.43 42.62 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 114.97 -1.014 . . . . 74.299999999999997 109.16 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 518' ' ' ILE . . . . . 0.424 ' HB ' ' HB3' ' A' ' 515' ' ' SER . 15.0 tt -78.52 151.99 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-N 115.979 -0.555 . . . . 71.329999999999998 110.039 -176.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -87.52 -70.78 1.29 Allowed Glycine 0 N--CA 1.43 -1.719 0 N-CA-C 110.094 -1.202 . . . . 73.409999999999997 110.094 176.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 31.7 mm -112.54 126.31 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 CA-C-O 120.935 0.398 . . . . 62.350000000000001 110.178 179.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 521' ' ' MET . . . . . 0.67 ' HE1' HG21 ' A' ' 644' ' ' VAL . 23.1 ptt? -105.46 142.96 34.3 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 107.167 -1.42 . . . . 62.039999999999999 107.167 173.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -121.03 151.61 39.58 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 121.395 0.617 . . . . 55.310000000000002 111.555 178.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . 0.641 ' O ' ' HA ' ' A' ' 570' ' ' THR . 33.0 t -130.83 137.17 56.59 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 107.832 -1.173 . . . . 71.329999999999998 107.832 -179.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -90.43 127.33 36.18 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 113.024 0.75 . . . . 61.240000000000002 113.024 -176.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 22.9 t -112.57 121.95 65.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 107.291 -1.374 . . . . 72.519999999999996 107.291 176.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -75.42 145.08 41.83 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.893 0.854 . . . . 74.219999999999999 112.687 -174.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' A' ' 528' ' ' THR . 11.2 tpp85 -75.62 133.08 40.98 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 114.073 -1.422 . . . . 65.120000000000005 109.202 173.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . 0.457 ' OG1' ' HA2' ' A' ' 503' ' ' GLY . 3.0 t -57.64 159.85 4.81 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 114.56 -1.2 . . . . 75.319999999999993 111.965 174.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 35.7 t -62.04 -37.87 86.57 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.73 0.812 . . . . 35.130000000000003 109.126 178.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -137.63 122.78 2.57 Favored Glycine 0 N--CA 1.425 -2.099 0 N-CA-C 109.961 -1.256 . . . . 74.420000000000002 109.961 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . 0.414 ' HB2' ' CG2' ' A' ' 528' ' ' THR . . . -130.25 114.01 15.12 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.332 -0.988 . . . . 75.129999999999995 108.332 176.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -120.79 90.09 3.25 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.696 -0.853 . . . . 71.129999999999995 108.696 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 533' ' ' GLY . . . . . 0.529 ' H ' ' HB3' ' A' ' 564' ' ' ASN . . . 122.57 -178.86 16.3 Favored Glycine 0 N--CA 1.437 -1.256 0 N-CA-C 110.96 -0.856 . . . . 75.400000000000006 110.96 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 534' ' ' ASN . . . . . 0.545 HD22 ' N ' ' A' ' 535' ' ' VAL . 0.2 OUTLIER -91.92 131.1 37.49 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.27 -1.011 . . . . 74.219999999999999 108.27 179.223 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 535' ' ' VAL . . . . . 0.545 ' N ' HD22 ' A' ' 534' ' ' ASN . 89.8 t -119.1 139.03 47.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-O 121.059 0.457 . . . . 73.239999999999995 110.143 179.2 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 536' ' ' ILE . . . . . . . . . . . . . 42.1 mm -105.44 125.01 60.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 108.949 -0.76 . . . . 62.020000000000003 108.949 178.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 22.0 t -113.49 106.24 54.38 Favored Pre-proline 0 C--N 1.302 -1.482 0 O-C-N 123.35 0.406 . . . . 74.319999999999993 109.909 -178.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.9 145.37 25.11 Favored 'Trans proline' 0 CA--C 1.533 0.454 0 C-N-CA 122.369 2.046 . . . . 75.329999999999998 111.71 178.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 539' ' ' TYR . . . . . 0.482 ' HB3' HG22 ' A' ' 591' ' ' ILE . 53.8 p90 -142.45 163.05 33.89 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 110.212 -0.292 . . . . 73.25 110.212 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -151.76 153.78 34.98 Favored 'General case' 0 C--N 1.308 -1.196 0 O-C-N 123.6 0.563 . . . . 65.219999999999999 110.618 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 4.1 p -99.24 125.14 44.78 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.796 -0.638 . . . . 72.040000000000006 110.363 173.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.417 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 3.7 mp -96.06 118.52 42.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 105.937 -1.875 . . . . 53.240000000000002 105.937 174.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -55.84 -50.56 70.23 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 123.868 0.73 . . . . 75.450000000000003 112.273 -176.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 69.51 -103.49 1.11 Allowed Glycine 0 N--CA 1.431 -1.645 0 N-CA-C 111.099 -0.8 . . . . 40.140000000000001 111.099 -179.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 545' ' ' THR . . . . . 0.453 HG23 ' HA ' ' A' ' 585' ' ' LYS . 9.1 t -109.63 -3.96 16.51 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.337 0.589 . . . . 71.450000000000003 110.311 -179.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -96.01 171.54 8.56 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.927 -0.397 . . . . 53.43 109.927 176.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 31.7 tpt180 -115.4 119.51 36.47 Favored 'General case' 0 C--O 1.247 0.968 0 N-CA-C 109.253 -0.647 . . . . 61.229999999999997 109.253 179.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -86.75 -154.03 24.8 Favored Glycine 0 C--N 1.311 -0.828 0 C-N-CA 120.874 -0.679 . . . . 65.439999999999998 112.37 -179.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . 0.441 ' H ' ' HB2' ' A' ' 555' ' ' ASP . . . 72.07 17.44 77.18 Favored Glycine 0 C--N 1.316 -0.567 0 CA-C-O 120.151 -0.249 . . . . 54.43 113.558 178.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 83.85 27.16 38.94 Favored Glycine 0 N--CA 1.439 -1.145 0 N-CA-C 110.817 -0.913 . . . . 74.409999999999997 110.817 -178.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -99.32 -69.75 0.75 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 120.711 0.291 . . . . 73.540000000000006 110.333 -178.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . 0.655 ' OD1' 'CA ' ' A' ' 850' ' ' ' CA' . 1.2 t70 -102.99 -27.91 12.33 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 106.879 -1.526 . . . . 75.150000000000006 106.879 177.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -146.23 158.2 43.86 Favored 'General case' 0 C--O 1.252 1.213 0 CA-C-N 114.526 -1.216 . . . . 74.310000000000002 108.438 174.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -87.81 116.61 26.08 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 106.121 -1.807 . . . . 73.329999999999998 106.121 178.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 555' ' ' ASP . . . . . 0.441 ' HB2' ' H ' ' A' ' 549' ' ' GLY . 14.4 t70 -75.78 132.81 40.68 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.3 -0.63 . . . . 73.409999999999997 109.3 -175.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . 0.455 HG21 HG22 ' A' ' 573' ' ' VAL . 8.9 t -133.76 117.89 17.44 Favored 'General case' 0 N--CA 1.412 -2.348 0 CA-C-O 122.038 0.923 . . . . 75.129999999999995 111.534 -175.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 8.0 p -130.23 100.64 5.47 Favored 'General case' 0 N--CA 1.424 -1.77 0 N-CA-C 107.628 -1.249 . . . . 74.409999999999997 107.628 174.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -145.77 -159.71 8.3 Favored Glycine 0 N--CA 1.411 -2.968 0 N-CA-C 109.984 -1.246 . . . . 41.420000000000002 109.984 -174.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -136.1 136.77 40.41 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-O 120.678 0.275 . . . . 74.329999999999998 110.635 -175.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 89.1 mt -95.16 134.25 38.1 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.642 -0.708 . . . . 73.340000000000003 109.415 178.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 561' ' ' GLU . . . . . 0.47 ' HG3' HD21 ' A' ' 534' ' ' ASN . 43.9 tt0 -93.32 97.03 10.33 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.703 -0.851 . . . . 70.129999999999995 108.703 176.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -101.88 108.27 19.7 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 106.838 -1.542 . . . . 74.099999999999994 106.838 -178.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . 0.496 ' HB2' ' H ' ' A' ' 566' ' ' GLU . 42.9 mt-30 -97.49 172.4 7.77 Favored 'General case' 0 C--N 1.278 -2.506 0 CA-C-N 116.415 -0.357 . . . . 70.540000000000006 110.94 -174.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 564' ' ' ASN . . . . . 0.529 ' HB3' ' H ' ' A' ' 533' ' ' GLY . 2.6 p-10 -79.0 -16.04 57.44 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.98 0.895 . . . . 54.100000000000001 109.107 175.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -96.07 -54.79 3.19 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.211 -0.904 . . . . 75.120000000000005 109.195 176.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . 0.496 ' H ' ' HB2' ' A' ' 563' ' ' GLN . 9.7 tp10 -63.78 138.48 58.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.614 -0.721 . . . . 71.049999999999997 109.692 177.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 21.8 pt -106.0 -172.23 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.41 -2.466 0 N-CA-C 108.219 -1.03 . . . . 74.040000000000006 108.219 -178.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 568' ' ' VAL . . . . . . . . . . . . . 3.4 p 3.19 126.47 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 128.832 2.853 . . . . 62.219999999999999 116.165 173.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 569' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -110.16 149.07 30.62 Favored 'General case' 0 C--N 1.259 -3.342 0 CA-C-N 115.112 -0.949 . . . . 63.229999999999997 110.502 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 570' ' ' THR . . . . . 0.641 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 16.0 p -122.53 128.16 50.43 Favored 'General case' 0 N--CA 1.415 -2.21 0 CA-C-N 115.259 -0.882 . . . . 72.329999999999998 110.188 177.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 3.3 mp -84.0 104.21 12.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 107.033 -1.469 . . . . 62.229999999999997 107.033 174.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 11.0 p -84.72 111.17 19.34 Favored 'General case' 0 N--CA 1.419 -2.009 0 CA-C-N 115.758 -0.655 . . . . 72.430000000000007 110.084 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 573' ' ' VAL . . . . . 0.455 HG22 HG21 ' A' ' 556' ' ' THR . 57.6 t -114.24 136.57 50.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 109.143 -0.688 . . . . 44.340000000000003 109.143 -178.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -95.15 125.05 39.53 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 124.123 0.89 . . . . 75.219999999999999 111.18 -178.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 81.8 t -93.59 132.84 36.63 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 N-CA-C 107.745 -1.206 . . . . 74.329999999999998 107.745 175.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 40.3 mm -91.6 160.44 2.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 109.535 -0.543 . . . . 75.230000000000004 109.535 -173.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -52.4 119.1 4.08 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 124.043 0.937 . . . . 72.120000000000005 109.671 175.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 578' ' ' ASP . . . . . 0.637 ' OD1' 'CA ' ' A' ' 850' ' ' ' CA' . 35.0 t70 -90.69 151.31 21.3 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.1 0.476 . . . . 75.200000000000003 111.952 -175.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 579' ' ' GLU . . . . . 0.616 ' OE1' 'CA ' ' A' ' 850' ' ' ' CA' . 0.0 OUTLIER -127.91 -26.73 2.87 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 114.194 1.183 . . . . 64.109999999999999 114.194 -172.363 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 580' ' ' GLU . . . . . 0.408 ' HG2' ' O ' ' A' ' 581' ' ' TYR . 0.0 OUTLIER -112.23 178.21 4.38 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 118.741 -1.184 . . . . 62.420000000000002 113.263 -166.943 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 581' ' ' TYR . . . . . 0.408 ' O ' ' HG2' ' A' ' 580' ' ' GLU . 47.8 p90 -61.94 154.34 26.68 Favored 'General case' 0 C--O 1.247 0.969 0 CA-C-N 114.803 -1.09 . . . . 75.219999999999999 108.922 175.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 582' ' ' GLU . . . . . 0.498 ' HB2' ' HG2' ' A' ' 648' ' ' GLU . 5.8 tp10 -94.31 152.78 18.4 Favored 'General case' 0 C--N 1.284 -2.251 0 C-N-CA 119.023 -1.071 . . . . 63.210000000000001 110.633 179.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . 0.467 ' O ' ' HG3' ' A' ' 582' ' ' GLU . 18.3 ptpt -137.85 -172.16 3.18 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 103.365 -2.828 . . . . 74.239999999999995 103.365 176.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -79.54 91.69 5.2 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.254 -1.758 . . . . 75.340000000000003 106.254 170.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 585' ' ' LYS . . . . . 0.502 ' HD2' HD13 ' A' ' 646' ' ' ILE . 4.7 tmmm? -106.67 109.23 21.08 Favored 'General case' 0 N--CA 1.396 -3.165 0 N-CA-C 106.756 -1.572 . . . . 73.430000000000007 106.756 -172.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 4.6 t -142.44 145.76 34.11 Favored 'General case' 0 N--CA 1.392 -3.35 0 CA-C-N 113.823 -1.535 . . . . 54.030000000000001 109.306 -174.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -128.85 155.57 45.02 Favored 'General case' 0 N--CA 1.412 -2.35 0 CA-C-N 114.408 -1.269 . . . . 73.099999999999994 108.858 178.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 588' ' ' PHE . . . . . 0.505 ' HA ' ' O ' ' A' ' 642' ' ' LEU . 23.5 m-85 -109.67 138.13 46.49 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-N 116.36 -0.382 . . . . 71.219999999999999 110.23 -171.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . 0.487 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.8 OUTLIER -110.94 125.76 54.02 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 105.777 -1.934 . . . . 73.0 105.777 176.297 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -127.94 131.24 49.34 Favored 'General case' 0 C--N 1.284 -2.248 0 C-N-CA 120.613 -0.435 . . . . 74.439999999999998 110.289 179.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 591' ' ' ILE . . . . . 0.482 HG22 ' HB3' ' A' ' 539' ' ' TYR . 15.2 pt -93.66 134.02 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.621 0 N-CA-C 106.758 -1.571 . . . . 63.310000000000002 106.758 171.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -86.83 -146.95 10.64 Favored Glycine 0 C--N 1.3 -1.47 0 C-N-CA 120.965 -0.636 . . . . 72.049999999999997 111.586 -176.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.575 ' OE1' ' HD3' ' A' ' 633' ' ' ARG . 35.0 tt0 -88.57 123.87 67.11 Favored Pre-proline 0 N--CA 1.425 -1.695 0 N-CA-C 107.967 -1.123 . . . . 75.099999999999994 107.967 177.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -68.42 162.13 41.94 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 123.084 2.523 . . . . 75.430000000000007 111.428 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 29.9 ptt85 -130.12 143.45 50.8 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.263 -0.643 . . . . 75.209999999999994 109.263 178.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 596' ' ' LEU . . . . . 0.489 HD22 HG22 ' A' ' 535' ' ' VAL . 0.0 OUTLIER -85.37 128.56 34.76 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 106.188 -1.782 . . . . 71.549999999999997 106.188 179.207 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 87.2 t -68.43 -39.64 81.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-O 121.307 0.575 . . . . 75.430000000000007 109.829 -179.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -112.95 151.66 30.28 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.083 -1.081 . . . . 74.019999999999996 108.083 176.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 10.2 mmt -82.88 115.86 21.94 Favored 'General case' 0 C--N 1.284 -2.254 0 C-N-CA 118.874 -1.13 . . . . 52.340000000000003 112.161 176.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 29.8 m -49.23 113.64 0.85 Allowed 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 113.492 -1.685 . . . . 62.240000000000002 110.631 176.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -76.16 75.65 2.99 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-O 121.731 0.777 . . . . 73.209999999999994 112.307 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -105.12 124.82 50.19 Favored 'General case' 0 C--N 1.28 -2.432 0 N-CA-C 104.259 -2.497 . . . . 42.149999999999999 104.259 172.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -81.92 94.65 7.15 Favored 'General case' 0 N--CA 1.412 -2.328 0 C-N-CA 118.892 -1.123 . . . . 73.230000000000004 112.11 -172.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -106.31 -53.77 0.72 Allowed Glycine 0 N--CA 1.418 -2.55 0 N-CA-C 107.366 -2.294 . . . . 72.109999999999999 107.366 172.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 66.96 32.99 82.49 Favored Glycine 0 N--CA 1.434 -1.456 0 CA-C-N 114.341 -0.929 . . . . 54.140000000000001 112.515 175.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -118.2 160.68 21.17 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.731 -0.84 . . . . 74.319999999999993 108.731 -177.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 10.2 p -92.58 179.5 5.49 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 122.66 0.384 . . . . 63.240000000000002 111.348 -179.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 608' ' ' ILE . . . . . 0.572 HG22 ' H ' ' A' ' 609' ' ' THR . 18.7 mt -110.39 176.44 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 N-CA-C 105.757 -1.942 . . . . 61.399999999999999 105.757 177.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 609' ' ' THR . . . . . 0.572 ' H ' HG22 ' A' ' 608' ' ' ILE . 2.7 m -71.23 23.71 0.04 OUTLIER 'General case' 0 CA--C 1.577 2.01 0 C-N-CA 124.483 1.113 . . . . 65.219999999999999 113.733 -175.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 61.06 14.42 5.38 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 114.952 1.464 . . . . 63.039999999999999 114.952 177.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.79 178.56 5.54 Favored 'General case' 0 N--CA 1.415 -2.206 0 N-CA-C 110.448 -0.204 . . . . 73.329999999999998 110.448 177.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -99.02 133.14 43.71 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 113.619 0.97 . . . . 53.32 113.619 -176.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 613' ' ' ASP . . . . . 0.435 ' O ' ' HG2' ' A' ' 616' ' ' GLN . 14.6 t70 -80.0 -44.42 20.24 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 113.961 -1.472 . . . . 72.329999999999998 110.066 178.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 4.2 p30 48.78 22.13 0.51 Allowed 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 127.4 2.28 . . . . 75.030000000000001 116.037 176.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 98.3 mttt 61.03 29.53 19.03 Favored 'General case' 0 C--N 1.313 -1.012 0 C-N-CA 124.456 1.103 . . . . 62.310000000000002 112.455 177.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 616' ' ' GLN . . . . . 0.435 ' HG2' ' O ' ' A' ' 613' ' ' ASP . 29.4 pt20 -66.0 146.7 99.01 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 108.531 -0.915 . . . . 74.109999999999999 108.531 175.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -65.66 -156.64 0.03 OUTLIER 'Trans proline' 0 CA--C 1.549 1.232 0 C-N-CA 123.062 2.508 . . . . 74.530000000000001 113.505 -177.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.465 HD22 ' H ' ' A' ' 618' ' ' LEU . 2.9 mm? -58.52 120.23 8.45 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 116.129 -0.487 . . . . 74.140000000000001 110.47 -178.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 619' ' ' THR . . . . . 0.462 HG23 ' H ' ' A' ' 620' ' ' SER . 2.1 t -144.1 -72.81 0.27 Allowed 'General case' 0 N--CA 1.425 -1.686 0 N-CA-C 114.241 1.2 . . . . 61.299999999999997 114.241 -179.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 620' ' ' SER . . . . . 0.517 ' HB3' ' HG3' ' A' ' 630' ' ' GLU . 77.7 p 51.31 14.14 0.22 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.261 1.424 . . . . 72.510000000000005 112.765 -168.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 6.4 tppt? -97.03 92.46 6.08 Favored 'General case' 0 N--CA 1.421 -1.92 0 CA-C-O 121.463 0.649 . . . . 73.400000000000006 109.516 -173.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -167.77 -66.33 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.846 -1.168 . . . . 70.519999999999996 107.846 -176.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -168.48 164.1 12.6 Favored 'General case' 0 N--CA 1.422 -1.856 0 N-CA-C 105.247 -2.131 . . . . 75.239999999999995 105.247 -177.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 624' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' A' ' 627' ' ' ARG . 9.7 pt-20 -65.61 -21.39 66.57 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 122.507 0.323 . . . . 72.219999999999999 111.649 -176.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -64.67 -29.48 70.48 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 116.607 -0.269 . . . . 73.219999999999999 111.375 176.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . 0.607 ' O ' ' HG2' ' A' ' 630' ' ' GLU . 12.9 mtp85 -71.02 -34.34 71.21 Favored 'General case' 0 CA--C 1.471 -2.092 0 C-N-CA 119.513 -0.875 . . . . 64.519999999999996 111.657 176.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 627' ' ' ARG . . . . . 0.457 ' HB2' ' O ' ' A' ' 624' ' ' GLU . 9.3 mmm180 -46.82 -33.81 4.78 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 123.941 0.776 . . . . 73.329999999999998 112.621 177.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . 0.46 ' O ' ' HG2' ' A' ' 631' ' ' MET . 88.1 mt -74.99 -38.28 42.72 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 CA-C-N 115.47 -0.787 . . . . 75.319999999999993 110.913 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -73.56 -34.17 65.03 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 121.412 0.625 . . . . 74.430000000000007 109.415 176.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 630' ' ' GLU . . . . . 0.607 ' HG2' ' O ' ' A' ' 626' ' ' ARG . 22.0 mm-40 -67.08 -26.72 66.87 Favored 'General case' 0 C--O 1.213 -0.837 0 CA-C-N 115.281 -0.872 . . . . 73.450000000000003 110.175 177.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 631' ' ' MET . . . . . 0.46 ' HG2' ' O ' ' A' ' 628' ' ' ILE . 21.1 ptp -90.05 -3.58 57.87 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.664 0.745 . . . . 53.240000000000002 109.097 177.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -82.24 -20.35 62.76 Favored Glycine 0 N--CA 1.434 -1.468 0 N-CA-C 108.68 -1.768 . . . . 73.400000000000006 108.68 174.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 633' ' ' ARG . . . . . 0.575 ' HD3' ' OE1' ' A' ' 593' ' ' GLU . 95.1 mtt180 -95.85 150.3 37.17 Favored Pre-proline 0 N--CA 1.426 -1.672 0 N-CA-C 106.739 -1.578 . . . . 64.219999999999999 106.739 176.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.406 ' HA ' ' HB1' ' A' ' 502' ' ' ALA . 37.2 Cg_endo -76.08 146.79 29.29 Favored 'Trans proline' 0 N--CA 1.429 -2.3 0 N-CA-C 107.348 -1.828 . . . . 72.519999999999996 107.348 166.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 1.9 pp -126.57 -173.27 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 114.494 1.294 . . . . 61.43 114.494 -172.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.46 150.6 39.83 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.389 -0.823 . . . . 52.340000000000003 109.672 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . 0.463 ' HA3' ' HB ' ' A' ' 506' ' ' THR . . . -76.69 -71.13 1.21 Allowed Glycine 0 C--N 1.297 -1.598 0 C-N-CA 120.763 -0.732 . . . . 73.040000000000006 112.58 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -150.36 -59.72 0.19 Allowed 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 120.408 -0.517 . . . . 74.450000000000003 110.619 178.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 16.7 p80 -120.43 99.63 6.68 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.735 0.779 . . . . 70.209999999999994 111.921 -179.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 36.4 p -98.62 91.26 5.05 Favored 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 109.278 -0.638 . . . . 73.209999999999994 109.278 177.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -177.26 133.14 0.18 Allowed 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 106.159 -1.793 . . . . 71.209999999999994 106.159 -178.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 642' ' ' LEU . . . . . 0.505 ' O ' ' HA ' ' A' ' 588' ' ' PHE . 27.9 tp -133.84 118.03 17.51 Favored 'General case' 0 C--N 1.276 -2.602 0 N-CA-C 108.511 -0.922 . . . . 60.229999999999997 108.511 177.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . 0.52 ' HB3' HG22 ' A' ' 511' ' ' VAL . 33.6 tt0 -99.25 107.44 19.75 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 107.06 -1.459 . . . . 61.439999999999998 107.06 177.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 644' ' ' VAL . . . . . 0.67 HG21 ' HE1' ' A' ' 521' ' ' MET . 38.9 t -95.37 109.84 23.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 108.949 -0.76 . . . . 63.229999999999997 108.949 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 3.9 mp -94.86 119.9 43.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 N-CA-C 108.413 -0.958 . . . . 71.299999999999997 108.413 177.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 646' ' ' ILE . . . . . 0.514 ' N ' HD12 ' A' ' 646' ' ' ILE . 1.8 mp -107.88 134.51 49.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 105.798 -1.926 . . . . 35.009999999999998 105.798 -176.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -136.48 161.48 35.73 Favored 'General case' 0 C--N 1.277 -2.549 0 N-CA-C 112.31 0.485 . . . . 75.439999999999998 112.31 -172.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . 0.63 ' OE2' 'CA ' ' A' ' 800' ' ' ' CA' . 31.2 mm-40 -61.17 100.38 0.12 Allowed 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 106.189 -1.782 . . . . 73.209999999999994 106.189 172.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 10.5 m -24.72 92.78 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 128.254 2.621 . . . . 71.040000000000006 115.871 -169.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -135.03 -51.94 0.78 Allowed 'General case' 0 C--O 1.246 0.886 0 CA-C-N 114.797 -1.092 . . . . 75.129999999999995 110.686 175.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -68.99 144.29 54.15 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-N 116.194 -0.457 . . . . 74.299999999999997 110.975 -176.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 652' ' ' PHE . . . . . 0.439 ' CD2' ' HG2' ' A' ' 653' ' ' LYS . 55.7 t80 -140.06 124.76 18.23 Favored 'General case' 0 N--CA 1.398 -3.042 0 N-CA-C 107.003 -1.48 . . . . 73.409999999999997 107.003 -179.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 653' ' ' LYS . . . . . 0.572 ' HE2' ' HA ' ' A' ' 653' ' ' LYS . 9.8 mmpt? 72.91 8.74 5.48 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.041 1.336 . . . . 72.230000000000004 112.202 178.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 654' ' ' SER . . . . . 0.414 ' HB2' ' HB2' ' A' ' 513' ' ' HIS . 69.0 m -66.97 103.76 1.22 Allowed 'General case' 0 N--CA 1.443 -0.811 0 CA-C-O 121.899 0.857 . . . . 72.430000000000007 110.415 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 655' ' ' THR . . . . . 0.462 ' HB ' ' OE1' ' A' ' 509' ' ' GLU . 4.5 p -142.38 156.72 45.24 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.736 -1.209 . . . . 74.209999999999994 107.736 -176.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 511' ' ' VAL . 34.0 m -104.76 -176.89 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 C-N-CA 119.8 -0.76 . . . . 62.240000000000002 112.013 -175.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 . . . . . 0 C--N 1.309 -1.187 0 CA-C-N 115.662 -0.699 . . . . 74.310000000000002 110.92 -178.627 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 800' ' ' ' CA' . . . . . 0.63 'CA ' ' OE2' ' A' ' 648' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 850' ' ' ' CA' . . . . . 0.655 'CA ' ' OD1' ' A' ' 552' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 27.0 t60 . . . . . 0 N--CA 1.445 -0.701 0 N-CA-C 108.845 -0.798 . . . . 72.140000000000001 108.845 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . 0.461 ' HB3' HG13 ' A' ' 635' ' ' ILE . . . -138.06 -48.77 0.55 Allowed 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.748 -0.464 . . . . 73.540000000000006 109.748 177.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -159.65 -179.0 34.16 Favored Glycine 0 N--CA 1.421 -2.34 0 C-N-CA 120.663 -0.78 . . . . 72.239999999999995 111.151 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 3.9 mp -122.27 111.39 30.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 109.255 -0.646 . . . . 74.030000000000001 109.255 -178.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -128.35 104.29 7.64 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 106.492 -1.67 . . . . 75.230000000000004 106.492 173.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 15.0 t -152.02 162.95 40.28 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.631 -0.878 . . . . 75.349999999999994 108.631 -175.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -91.77 168.78 11.22 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.749 -1.204 . . . . 73.340000000000003 107.749 172.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . 0.491 ' HB2' HD21 ' A' ' 526' ' ' LEU . 21.5 tt0 -99.74 -35.88 9.65 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 107.944 -1.132 . . . . 73.420000000000002 107.944 179.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -111.31 134.98 20.99 Favored Pre-proline 0 N--CA 1.419 -2.021 0 CA-C-N 114.377 -1.283 . . . . 64.120000000000005 110.239 -178.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -81.19 -18.7 8.49 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 121.554 1.503 . . . . 75.209999999999994 111.095 173.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . 0.47 HG22 ' HB3' ' A' ' 643' ' ' GLU . 93.2 t -138.04 141.5 38.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 123.81 0.844 . . . . 73.409999999999997 108.853 -177.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 8.1 t -137.3 140.81 41.78 Favored 'General case' 0 N--CA 1.416 -2.168 0 N-CA-C 107.526 -1.287 . . . . 75.230000000000004 107.526 174.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 55.4 m-70 -105.76 130.04 53.84 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.585 -0.895 . . . . 64.099999999999994 108.585 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 24.2 m -132.33 156.45 42.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 N-CA-C 108.862 -0.792 . . . . 73.219999999999999 108.862 -179.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 40.3 t -82.42 149.16 27.8 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 107.934 -1.136 . . . . 63.009999999999998 107.934 178.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -82.3 -7.5 59.63 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.85 0.833 . . . . 75.420000000000002 109.062 176.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 9.4 t -95.77 10.01 38.5 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.905 -0.776 . . . . 73.349999999999994 108.905 -178.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 12.4 tt -91.68 155.34 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 108.66 -0.867 . . . . 75.510000000000005 108.66 -177.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -91.44 -63.44 1.18 Allowed Glycine 0 N--CA 1.43 -1.755 0 N-CA-C 110.47 -1.052 . . . . 74.140000000000001 110.47 176.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . 0.414 HD13 ' HA ' ' A' ' 574' ' ' LYS . 34.4 mm -116.51 117.02 54.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 109.92 -0.4 . . . . 73.439999999999998 109.92 179.012 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 521' ' ' MET . . . . . 0.69 ' HE2' HG21 ' A' ' 644' ' ' VAL . 0.0 OUTLIER -96.41 128.66 43.53 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 106.609 -1.626 . . . . 73.239999999999995 106.609 172.238 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -117.36 138.74 51.59 Favored 'General case' 0 N--CA 1.424 -1.751 0 CA-C-N 115.829 -0.623 . . . . 72.409999999999997 111.269 178.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . 0.713 HG21 HD21 ' A' ' 642' ' ' LEU . 22.1 t -121.09 134.34 64.8 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.087 0 N-CA-C 106.176 -1.787 . . . . 70.230000000000004 106.176 175.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . 0.563 ' HD3' HG21 ' A' ' 568' ' ' VAL . 55.2 mttp -91.91 163.04 14.16 Favored 'General case' 0 N--CA 1.416 -2.171 0 C-N-CA 120.325 -0.55 . . . . 74.310000000000002 111.904 -178.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 16.0 t -128.5 141.98 45.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-N 115.512 -0.767 . . . . 62.009999999999998 109.115 -175.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . 0.491 HD21 ' HB2' ' A' ' 508' ' ' GLU . 2.0 mm? -78.24 139.08 38.92 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 107.554 -1.276 . . . . 74.349999999999994 107.554 178.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 48.2 ttp180 -92.79 140.5 29.45 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.729 -0.788 . . . . 73.420000000000002 111.199 -175.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 4.2 t -55.17 149.02 13.07 Favored 'General case' 0 N--CA 1.413 -2.28 0 CA-C-N 114.044 -1.434 . . . . 73.409999999999997 111.97 174.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 26.1 t -80.62 -15.89 55.46 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.386 -0.824 . . . . 60.130000000000003 109.038 177.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -127.54 110.92 1.24 Allowed Glycine 0 N--CA 1.433 -1.517 0 N-CA-C 111.163 -0.775 . . . . 62.0 111.163 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -165.06 76.11 0.27 Allowed 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 123.334 0.653 . . . . 75.450000000000003 110.173 177.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -90.36 81.53 6.02 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.751 0.786 . . . . 75.239999999999995 110.064 177.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 533' ' ' GLY . . . . . 0.575 ' H ' ' HB2' ' A' ' 564' ' ' ASN . . . 149.37 -118.97 0.99 Allowed Glycine 0 N--CA 1.414 -2.772 0 CA-C-N 114.828 -1.078 . . . . 64.129999999999995 112.071 179.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 534' ' ' ASN . . . . . 0.519 ' ND2' ' HG2' ' A' ' 563' ' ' GLN . 2.8 t-20 -145.07 131.3 19.49 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 107.234 -1.395 . . . . 72.0 107.234 -178.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 535' ' ' VAL . . . . . 0.428 HG22 HD22 ' A' ' 596' ' ' LEU . 46.8 t -128.36 133.86 65.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 109.387 -0.597 . . . . 65.530000000000001 109.387 -178.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 536' ' ' ILE . . . . . 0.54 HG23 ' HB3' ' A' ' 559' ' ' GLU . 28.5 mm -98.28 126.48 51.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 109.217 -0.66 . . . . 73.109999999999999 109.217 178.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 36.1 t -116.65 103.38 52.59 Favored Pre-proline 0 C--N 1.301 -1.513 0 N-CA-C 108.579 -0.897 . . . . 73.310000000000002 108.579 177.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.56 146.93 50.64 Favored 'Trans proline' 0 C--N 1.331 -0.391 0 C-N-CA 122.264 1.976 . . . . 75.299999999999997 111.169 179.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 539' ' ' TYR . . . . . 0.539 ' CE1' ' HG ' ' A' ' 560' ' ' LEU . 36.0 p90 -151.14 161.58 42.46 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 109.689 -0.485 . . . . 75.140000000000001 109.689 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -155.67 148.6 24.35 Favored 'General case' 0 C--N 1.309 -1.174 0 O-C-N 123.471 0.482 . . . . 61.210000000000001 111.933 178.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 2.4 p -85.82 121.09 27.98 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 115.957 -0.565 . . . . 70.25 110.967 175.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.8 mp -86.96 116.99 30.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 105.271 -2.122 . . . . 65.030000000000001 105.271 172.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -55.2 -43.43 74.4 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 124.163 0.914 . . . . 72.329999999999998 112.146 -174.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 67.96 -94.06 0.29 Allowed Glycine 0 N--CA 1.439 -1.101 0 CA-C-N 115.733 -0.667 . . . . 65.230000000000004 111.757 178.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 545' ' ' THR . . . . . 0.476 HG23 ' HA ' ' A' ' 585' ' ' LYS . 9.2 t -124.41 -2.07 8.04 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 120.788 0.328 . . . . 53.109999999999999 110.488 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -91.19 155.54 18.52 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.71 -0.478 . . . . 74.030000000000001 109.71 178.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 22.1 tpt180 -94.55 108.31 20.27 Favored 'General case' 0 C--O 1.25 1.097 0 N-CA-C 109.546 -0.539 . . . . 62.210000000000001 109.546 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -89.66 -163.57 39.37 Favored Glycine 0 CA--C 1.507 -0.422 0 C-N-CA 121.124 -0.56 . . . . 73.040000000000006 114.046 -175.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 77.75 12.38 84.52 Favored Glycine 0 C--N 1.321 -0.281 0 CA-C-N 115.433 -0.384 . . . . 73.439999999999998 113.593 178.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 95.79 4.56 60.32 Favored Glycine 0 N--CA 1.437 -1.251 0 C-N-CA 120.46 -0.876 . . . . 71.129999999999995 111.644 -178.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -73.98 -69.86 0.42 Allowed 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.912 -0.773 . . . . 71.409999999999997 108.912 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . 0.635 ' OD2' 'CA ' ' A' ' 850' ' ' ' CA' . 5.8 t70 -107.8 -34.12 7.05 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.861 -1.163 . . . . 75.519999999999996 107.861 177.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -135.95 157.27 47.25 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 108.464 -0.939 . . . . 74.109999999999999 108.464 174.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -88.14 121.02 30.06 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.855 -1.165 . . . . 64.209999999999994 107.855 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -78.67 100.96 7.25 Favored 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 109.263 -0.643 . . . . 65.420000000000002 109.263 -177.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 13.9 t -98.51 98.51 9.68 Favored 'General case' 0 N--CA 1.396 -3.134 0 CA-C-O 123.439 1.59 . . . . 53.130000000000003 111.538 -175.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 1.6 p -110.27 129.86 55.65 Favored 'General case' 0 C--N 1.274 -2.675 0 N-CA-C 106.518 -1.66 . . . . 71.340000000000003 106.518 172.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 178.64 -156.66 19.49 Favored Glycine 0 N--CA 1.42 -2.422 0 N-CA-C 110.367 -1.093 . . . . 72.239999999999995 110.367 -176.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 559' ' ' GLU . . . . . 0.54 ' HB3' HG23 ' A' ' 536' ' ' ILE . 40.0 mt-10 -135.97 133.92 38.06 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 121.295 0.569 . . . . 75.349999999999994 111.683 -175.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . 0.539 ' HG ' ' CE1' ' A' ' 539' ' ' TYR . 55.7 mt -87.84 132.77 34.06 Favored 'General case' 0 CA--C 1.491 -1.312 0 N-CA-C 108.795 -0.817 . . . . 72.120000000000005 108.795 174.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 561' ' ' GLU . . . . . 0.438 ' CG ' HD21 ' A' ' 534' ' ' ASN . 36.5 tt0 -105.84 107.37 18.34 Favored 'General case' 0 C--N 1.274 -2.71 0 N-CA-C 108.451 -0.944 . . . . 71.340000000000003 108.451 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 562' ' ' PHE . . . . . 0.419 ' CZ ' ' HG2' ' A' ' 569' ' ' LYS . 0.1 OUTLIER -100.59 132.41 45.99 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 107.744 -1.206 . . . . 60.299999999999997 107.744 -179.2 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . 0.519 ' HG2' ' ND2' ' A' ' 534' ' ' ASN . 6.8 mt-30 -119.81 165.05 15.07 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.2 -1.0 . . . . 41.509999999999998 110.699 -179.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 564' ' ' ASN . . . . . 0.575 ' HB2' ' H ' ' A' ' 533' ' ' GLY . 7.8 t30 -62.57 -33.46 75.01 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.879 -0.6 . . . . 73.319999999999993 111.296 179.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -99.27 -3.66 33.64 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.858 0.837 . . . . 53.020000000000003 111.145 -177.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -102.98 130.34 50.03 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.725 -0.609 . . . . 73.099999999999994 109.406 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 2.0 pp -112.04 145.27 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.728 0 N-CA-C 108.414 -0.958 . . . . 72.349999999999994 108.414 179.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 568' ' ' VAL . . . . . 0.563 HG21 ' HD3' ' A' ' 524' ' ' LYS . 1.8 p 58.91 133.78 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 126.482 1.913 . . . . 75.409999999999997 114.79 176.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 569' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 524' ' ' LYS . 32.6 mmmt -117.82 164.06 15.59 Favored 'General case' 0 C--N 1.284 -2.268 0 O-C-N 121.32 -0.863 . . . . 65.040000000000006 109.868 176.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 570' ' ' THR . . . . . 0.509 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 6.3 p -132.72 134.26 44.56 Favored 'General case' 0 C--N 1.279 -2.499 0 O-C-N 124.413 1.071 . . . . 63.119999999999997 111.851 177.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 2.2 mp -91.17 103.92 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.836 0 N-CA-C 105.207 -2.145 . . . . 64.010000000000005 105.207 170.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 4.5 m -91.93 112.64 24.64 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 108.479 -0.934 . . . . 60.420000000000002 108.479 -177.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 573' ' ' VAL . . . . . . . . . . . . . 61.7 t -116.0 121.88 68.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 109.543 -0.54 . . . . 71.040000000000006 109.543 -178.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 574' ' ' LYS . . . . . 0.414 ' HA ' HD13 ' A' ' 520' ' ' ILE . 23.0 tptm -80.09 120.73 24.63 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-N 114.908 -1.042 . . . . 72.209999999999994 110.548 178.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 60.0 t -94.32 132.36 38.6 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 N-CA-C 105.953 -1.869 . . . . 74.219999999999999 105.953 174.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 34.3 mm -88.84 159.98 2.87 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 107.221 -1.4 . . . . 75.239999999999995 107.221 -175.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -71.53 115.34 10.6 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 109.199 -0.667 . . . . 64.219999999999999 109.199 178.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 578' ' ' ASP . . . . . 0.66 ' OD2' 'CA ' ' A' ' 800' ' ' ' CA' . 44.9 t0 -61.24 144.44 53.79 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 114.897 -1.047 . . . . 63.539999999999999 112.612 -173.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -92.21 -49.06 6.38 Favored 'General case' 0 C--N 1.29 -1.995 0 C-N-CA 124.289 1.036 . . . . 70.140000000000001 110.424 -176.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 580' ' ' GLU . . . . . 0.582 ' OE1' 'CA ' ' A' ' 850' ' ' ' CA' . 0.0 OUTLIER -127.09 -152.64 0.53 Allowed 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.396 -0.82 . . . . 73.040000000000006 109.1 -174.305 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -111.67 152.12 28.06 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 107.32 -1.363 . . . . 64.349999999999994 107.32 176.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 582' ' ' GLU . . . . . 0.62 ' OE1' 'CA ' ' A' ' 800' ' ' ' CA' . 36.4 mp0 -128.98 164.81 22.38 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.501 -0.555 . . . . 72.430000000000007 109.501 175.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 10.0 mptt -87.59 -152.0 0.19 Allowed 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 105.771 -1.937 . . . . 73.430000000000007 105.771 173.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -57.83 113.05 1.68 Allowed 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 109.115 -0.698 . . . . 72.310000000000002 109.115 172.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 585' ' ' LYS . . . . . 0.476 ' HA ' HG23 ' A' ' 545' ' ' THR . 0.1 OUTLIER -128.32 118.73 23.74 Favored 'General case' 0 N--CA 1.409 -2.496 0 N-CA-C 106.362 -1.718 . . . . 34.420000000000002 106.362 -174.198 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 3.9 t -150.7 146.86 26.73 Favored 'General case' 0 N--CA 1.418 -2.04 0 CA-C-N 115.487 -0.779 . . . . 74.439999999999998 110.795 -172.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -126.58 150.63 48.75 Favored 'General case' 0 N--CA 1.419 -2.011 0 CA-C-N 113.891 -1.504 . . . . 70.329999999999998 109.225 177.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 588' ' ' PHE . . . . . 0.421 ' HA ' ' O ' ' A' ' 642' ' ' LEU . 22.3 m-85 -108.37 139.25 43.36 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 109.381 -0.6 . . . . 73.230000000000004 109.381 -174.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . 0.46 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.3 OUTLIER -107.93 134.36 50.95 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 107.04 -1.467 . . . . 61.240000000000002 107.04 176.83 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -143.05 136.96 28.89 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.803 -0.814 . . . . 72.140000000000001 108.803 -179.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 591' ' ' ILE . . . . . 0.541 HG12 ' OG1' ' A' ' 640' ' ' THR . 22.0 pt -101.95 162.48 3.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 109.206 -0.664 . . . . 63.420000000000002 109.206 178.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -111.15 -162.96 17.92 Favored Glycine 0 N--CA 1.43 -1.732 0 C-N-CA 121.259 -0.496 . . . . 63.240000000000002 112.103 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -67.88 118.11 54.86 Favored Pre-proline 0 C--N 1.309 -1.195 0 C-N-CA 123.979 0.911 . . . . 72.150000000000006 108.803 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 594' ' ' PRO . . . . . 0.46 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 58.1 Cg_endo -73.16 146.56 41.08 Favored 'Trans proline' 0 N--CA 1.437 -1.82 0 C-N-CA 121.916 1.744 . . . . 61.329999999999998 110.593 178.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 14.9 ptt180 -128.24 133.71 48.87 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 109.704 -0.48 . . . . 74.040000000000006 109.704 -175.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 596' ' ' LEU . . . . . 0.428 HD22 HG22 ' A' ' 535' ' ' VAL . 0.0 OUTLIER -73.99 131.82 41.78 Favored 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 104.988 -2.227 . . . . 62.240000000000002 104.988 178.367 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 597' ' ' VAL . . . . . 0.442 ' CG2' HG12 ' A' ' 536' ' ' ILE . 23.8 t -81.51 61.42 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-O 121.821 0.819 . . . . 73.120000000000005 110.767 -178.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 598' ' ' GLU . . . . . 0.453 ' OE1' ' HG3' ' A' ' 603' ' ' LYS . 32.8 mt-10 58.99 -7.42 0.05 OUTLIER 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 128.491 2.716 . . . . 73.329999999999998 117.322 166.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 71.5 mtm 67.09 19.12 10.5 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 124.762 1.225 . . . . 32.119999999999997 109.145 -174.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 600' ' ' SER . . . . . 0.416 ' O ' ' HB2' ' A' ' 598' ' ' GLU . 22.6 t -166.46 149.38 6.96 Favored 'General case' 0 N--CA 1.405 -2.689 0 N-CA-C 101.762 -3.422 . . . . 73.340000000000003 101.762 -178.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -69.11 -28.2 66.27 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 119.228 0.922 . . . . 60.420000000000002 110.514 -176.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -145.63 146.91 31.52 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 106.625 -1.62 . . . . 75.5 106.625 173.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 603' ' ' LYS . . . . . 0.453 ' HG3' ' OE1' ' A' ' 598' ' ' GLU . 38.4 mtmm -82.66 84.92 7.13 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-O 121.614 0.721 . . . . 75.129999999999995 110.171 175.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -102.08 11.34 57.22 Favored Glycine 0 N--CA 1.434 -1.454 0 CA-C-N 114.736 -1.12 . . . . 50.240000000000002 111.743 -178.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . -83.51 -54.97 2.97 Favored Glycine 0 N--CA 1.434 -1.445 0 N-CA-C 109.749 -1.34 . . . . 70.519999999999996 109.749 176.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -173.82 158.0 3.15 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 106.363 -1.717 . . . . 71.450000000000003 106.363 176.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 28.1 p -74.88 134.83 41.57 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 120.323 -0.551 . . . . 72.549999999999997 110.901 177.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 24.9 mm -97.85 160.46 3.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 106.384 -1.709 . . . . 65.299999999999997 106.384 -179.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 609' ' ' THR . . . . . 0.508 HG22 ' HG3' ' A' ' 611' ' ' GLU . 20.1 m -74.17 88.46 1.96 Allowed 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 106.433 -1.692 . . . . 54.210000000000001 106.433 172.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -88.07 -20.16 26.11 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.549 -0.75 . . . . 72.329999999999998 111.213 -175.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 611' ' ' GLU . . . . . 0.508 ' HG3' HG22 ' A' ' 609' ' ' THR . 33.1 mt-10 52.66 44.79 29.73 Favored 'General case' 0 C--O 1.247 0.936 0 O-C-N 124.436 1.085 . . . . 71.299999999999997 110.964 178.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 66.88 84.31 0.16 Allowed 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.886 1.274 . . . . 74.420000000000002 112.02 -176.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 613' ' ' ASP . . . . . 0.455 ' HA ' ' NH2' ' A' ' 633' ' ' ARG . 28.0 t70 -89.58 117.29 28.36 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.78 -1.1 . . . . 63.009999999999998 109.906 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -137.48 -164.38 1.59 Allowed 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 108.491 -0.929 . . . . 63.240000000000002 108.491 -174.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 48.3 pttt -133.01 85.67 2.24 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 122.815 1.293 . . . . 63.149999999999999 108.0 -178.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 616' ' ' GLN . . . . . 0.419 ' HB3' ' HD2' ' A' ' 617' ' ' PRO . 17.9 mt-30 -96.53 -170.8 0.23 Allowed Pre-proline 0 C--N 1.292 -1.91 0 CA-C-N 114.494 -1.23 . . . . 65.530000000000001 108.716 -170.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 617' ' ' PRO . . . . . 0.419 ' HD2' ' HB3' ' A' ' 616' ' ' GLN . 53.2 Cg_endo -86.62 160.81 9.33 Favored 'Trans proline' 0 N--CA 1.443 -1.473 0 N-CA-C 108.979 -1.201 . . . . 71.420000000000002 108.979 163.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.507 ' HG ' ' HB2' ' A' ' 636' ' ' LEU . 3.5 mm? -74.22 99.73 3.51 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.54 -0.911 . . . . 73.239999999999995 108.54 177.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 1.8 p -135.62 103.33 5.4 Favored 'General case' 0 N--CA 1.42 -1.957 0 CA-C-N 115.185 -0.916 . . . . 70.109999999999999 112.021 -173.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 620' ' ' SER . . . . . 0.559 ' HB3' ' HG2' ' A' ' 623' ' ' GLU . 16.2 m -109.6 109.98 20.91 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.525 -0.917 . . . . 53.450000000000003 108.525 176.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 11.2 tmtt? -92.5 -71.86 0.62 Allowed 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.024 -0.732 . . . . 73.5 109.024 -176.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -76.25 -25.64 55.19 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.095 -0.705 . . . . 64.099999999999994 109.095 178.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . 0.559 ' HG2' ' HB3' ' A' ' 620' ' ' SER . 47.4 mt-10 74.41 -40.1 0.44 Allowed 'General case' 0 C--O 1.213 -0.849 0 C-N-CA 125.526 1.53 . . . . 74.349999999999994 115.035 177.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -53.03 -61.87 2.02 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.947 1.092 . . . . 75.209999999999994 113.947 -176.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -76.14 -25.93 55.82 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.071 0.462 . . . . 70.409999999999997 110.806 -178.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -67.07 -34.36 77.49 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.903 -0.589 . . . . 74.209999999999994 110.048 178.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 627' ' ' ARG . . . . . . . . . . . . . 46.7 ttp180 -56.73 -29.06 62.13 Favored 'General case' 0 N--CA 1.424 -1.728 0 C-N-CA 125.111 1.364 . . . . 64.099999999999994 111.425 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 88.2 mt -71.89 -39.62 67.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 121.695 0.76 . . . . 72.230000000000004 109.821 177.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -70.11 -40.83 74.68 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.658 -0.701 . . . . 62.340000000000003 109.639 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -68.04 -17.71 64.48 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 115.392 -0.822 . . . . 72.209999999999994 110.569 178.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 631' ' ' MET . . . . . . . . . . . . . 42.6 ttm -83.6 -36.99 23.49 Favored 'General case' 0 N--CA 1.425 -1.68 0 C-N-CA 123.277 0.631 . . . . 70.400000000000006 110.579 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -86.19 -37.27 9.19 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.715 -0.755 . . . . 62.119999999999997 112.282 -178.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 633' ' ' ARG . . . . . 0.455 ' NH2' ' HA ' ' A' ' 613' ' ' ASP . 98.3 mtt180 -93.35 146.12 31.27 Favored Pre-proline 0 C--N 1.302 -1.475 0 N-CA-C 109.46 -0.57 . . . . 72.209999999999994 109.46 -177.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.46 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 10.1 Cg_endo -60.86 145.01 99.66 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.591 1.527 . . . . 62.409999999999997 109.527 172.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 635' ' ' ILE . . . . . 0.461 HG13 ' HB3' ' A' ' 502' ' ' ALA . 2.3 pp -123.42 175.96 5.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 114.054 1.131 . . . . 74.430000000000007 114.054 -176.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . 0.507 ' HB2' ' HG ' ' A' ' 618' ' ' LEU . 33.3 tp -68.93 158.65 34.19 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 124.8 1.24 . . . . 75.349999999999994 112.716 -176.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . 0.454 ' N ' ' HG ' ' A' ' 636' ' ' LEU . . . -83.06 -100.02 0.52 Allowed Glycine 0 N--CA 1.427 -1.91 0 N-CA-C 109.642 -1.383 . . . . 65.450000000000003 109.642 172.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -126.22 -73.13 0.63 Allowed 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 119.801 -0.76 . . . . 73.450000000000003 111.632 177.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -107.02 114.26 28.23 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 118.715 -1.194 . . . . 63.109999999999999 113.122 -174.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 640' ' ' THR . . . . . 0.541 ' OG1' HG12 ' A' ' 591' ' ' ILE . 1.1 t -107.08 91.53 3.7 Favored 'General case' 0 N--CA 1.41 -2.437 0 N-CA-C 108.367 -0.975 . . . . 75.099999999999994 108.367 169.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -172.17 121.83 0.46 Allowed 'General case' 0 C--N 1.279 -2.466 0 N-CA-C 105.726 -1.953 . . . . 73.140000000000001 105.726 178.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 642' ' ' LEU . . . . . 0.713 HD21 HG21 ' A' ' 523' ' ' VAL . 35.9 tp -129.91 113.13 14.24 Favored 'General case' 0 C--N 1.271 -2.829 0 N-CA-C 108.077 -1.083 . . . . 54.149999999999999 108.077 178.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . 0.47 ' HB3' HG22 ' A' ' 511' ' ' VAL . 30.0 tt0 -95.11 104.77 16.65 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 107.469 -1.308 . . . . 61.119999999999997 107.469 179.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 644' ' ' VAL . . . . . 0.69 HG21 ' HE2' ' A' ' 521' ' ' MET . 30.9 t -94.98 106.66 18.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 109.483 -0.562 . . . . 62.210000000000001 109.483 -177.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 3.9 mp -88.78 118.29 33.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 108.444 -0.947 . . . . 72.209999999999994 108.444 175.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 646' ' ' ILE . . . . . 0.467 ' N ' HD12 ' A' ' 646' ' ' ILE . 2.8 mp -100.73 107.21 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 N-CA-C 106.63 -1.618 . . . . 73.0 106.63 -177.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -103.69 136.42 43.43 Favored 'General case' 0 C--N 1.279 -2.48 0 CA-C-N 115.671 -0.695 . . . . 74.140000000000001 110.832 -176.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . 0.625 ' OE2' 'CA ' ' A' ' 800' ' ' ' CA' . 14.6 mt-10 -67.47 142.03 56.76 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.626 -0.879 . . . . 73.120000000000005 108.626 -177.128 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 21.2 t -74.95 81.33 2.18 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 114.072 1.138 . . . . 74.209999999999994 114.072 -169.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -93.95 -44.78 7.91 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 106.675 -1.602 . . . . 72.209999999999994 106.675 168.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 651' ' ' GLU . . . . . 0.574 ' HG2' ' H ' ' A' ' 652' ' ' PHE . 23.1 tt0 -163.84 -160.33 0.56 Allowed 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 102.663 -3.088 . . . . 72.420000000000002 102.663 179.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 652' ' ' PHE . . . . . 0.574 ' H ' ' HG2' ' A' ' 651' ' ' GLU . 48.3 t80 -157.2 144.51 18.68 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 105.635 -1.987 . . . . 73.450000000000003 105.635 178.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 653' ' ' LYS . . . . . 0.495 ' HG3' ' CD2' ' A' ' 652' ' ' PHE . 53.7 mtmt 69.0 22.13 7.12 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.704 0.802 . . . . 73.5 112.269 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 50.3 m -72.16 -37.66 69.31 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-O 121.257 0.551 . . . . 52.210000000000001 109.71 178.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 88.7 m -159.27 135.77 9.21 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 108.413 -0.958 . . . . 73.5 108.413 178.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 33.2 m -90.58 153.15 3.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 108.498 -0.927 . . . . 71.329999999999998 108.498 175.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 16.4 t70 . . . . . 0 C--N 1.299 -1.624 0 N-CA-C 108.847 -0.797 . . . . 73.140000000000001 108.847 -177.339 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 800' ' ' ' CA' . . . . . 0.66 'CA ' ' OD2' ' A' ' 578' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 850' ' ' ' CA' . . . . . 0.635 'CA ' ' OD2' ' A' ' 552' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . 0.403 ' N ' ' HA ' ' A' ' 631' ' ' MET . 4.5 t60 . . . . . 0 N--CA 1.445 -0.719 0 N-CA-C 109.644 -0.502 . . . . 72.109999999999999 109.644 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . 0.529 ' O ' ' HA3' ' A' ' 530' ' ' GLY . . . -124.55 -74.03 0.62 Allowed 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 107.71 -1.218 . . . . 74.439999999999998 107.71 172.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -136.6 134.29 7.04 Favored Glycine 0 N--CA 1.419 -2.448 0 N-CA-C 109.71 -1.356 . . . . 75.510000000000005 109.71 177.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . 0.642 ' O ' ' HB ' ' A' ' 528' ' ' THR . 3.6 mp -108.87 97.77 6.15 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.263 0 C-N-CA 126.04 1.736 . . . . 63.409999999999997 109.235 -176.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -103.16 124.85 49.36 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 122.035 -0.415 . . . . 74.299999999999997 110.087 -178.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . 0.404 ' HB ' ' HA3' ' A' ' 637' ' ' GLY . 15.3 t -145.89 159.54 43.07 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.378 -0.601 . . . . 73.209999999999994 109.378 -178.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -89.21 155.85 19.14 Favored 'General case' 0 CA--C 1.485 -1.549 0 N-CA-C 108.372 -0.973 . . . . 73.140000000000001 108.372 174.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . 0.418 ' HB2' HD21 ' A' ' 526' ' ' LEU . 24.1 tt0 -89.98 -34.57 15.95 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 106.84 -1.541 . . . . 72.310000000000002 106.84 175.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -96.61 118.84 64.86 Favored Pre-proline 0 N--CA 1.436 -1.137 0 CA-C-N 114.549 -1.205 . . . . 72.430000000000007 110.847 176.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . 0.612 ' HA ' ' O ' ' A' ' 641' ' ' LYS . 1.2 Cg_endo -83.22 -16.96 6.87 Favored 'Trans proline' 0 N--CA 1.443 -1.456 0 N-CA-C 108.72 -1.3 . . . . 75.150000000000006 108.72 166.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . 0.487 HG22 ' HB3' ' A' ' 643' ' ' GLU . 78.7 t -144.63 139.56 23.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 C-N-CA 125.575 1.55 . . . . 51.310000000000002 107.268 -179.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 11.4 t -138.63 148.01 43.57 Favored 'General case' 0 N--CA 1.414 -2.234 0 N-CA-C 107.66 -1.237 . . . . 61.140000000000001 107.66 174.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -115.87 127.48 55.05 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 109.024 -0.732 . . . . 74.140000000000001 109.024 177.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 18.2 m -130.24 154.2 40.11 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 N-CA-C 109.103 -0.703 . . . . 43.229999999999997 109.103 -176.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 34.2 t -78.03 154.81 31.1 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.782 -1.192 . . . . 72.349999999999994 107.782 177.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -89.06 -6.83 56.84 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 122.195 0.998 . . . . 71.129999999999995 109.019 173.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 34.0 m -92.26 17.3 9.9 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-O 122.314 1.054 . . . . 73.400000000000006 108.744 177.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 9.5 tt -100.99 154.43 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.06 0 N-CA-C 107.064 -1.458 . . . . 74.409999999999997 107.064 177.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . -95.71 -63.61 0.97 Allowed Glycine 0 N--CA 1.427 -1.946 0 C-N-CA 119.745 -1.217 . . . . 71.209999999999994 110.348 176.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 29.0 mm -116.41 127.73 73.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 114.725 -0.737 . . . . 70.400000000000006 109.865 -178.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 521' ' ' MET . . . . . 0.614 ' HE2' HG21 ' A' ' 644' ' ' VAL . 0.0 OUTLIER -109.99 135.88 50.14 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.76 -1.2 . . . . 72.319999999999993 107.76 172.888 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 522' ' ' GLU . . . . . 0.535 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 36.8 mt-10 -121.15 135.26 55.2 Favored 'General case' 0 CA--C 1.493 -1.25 0 O-C-N 123.947 0.779 . . . . 75.120000000000005 110.711 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . 0.667 HG21 HD21 ' A' ' 642' ' ' LEU . 18.9 t -123.03 140.47 46.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.91 -0.774 . . . . 65.540000000000006 108.91 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . 0.47 ' HD2' HG21 ' A' ' 568' ' ' VAL . 46.2 mmtm -85.35 141.53 29.96 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.912 0.863 . . . . 61.009999999999998 112.603 -178.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 21.3 t -111.88 119.49 60.12 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 N-CA-C 105.154 -2.165 . . . . 74.219999999999999 105.154 172.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . 0.425 ' H ' HD22 ' A' ' 526' ' ' LEU . 2.6 mm? -62.16 136.05 57.77 Favored 'General case' 0 CA--C 1.504 -0.804 0 O-C-N 123.522 0.514 . . . . 74.239999999999995 110.625 -174.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . . . . . . . . . 14.2 ttp180 -84.73 138.7 32.47 Favored 'General case' 0 N--CA 1.423 -1.782 0 N-CA-C 108.612 -0.884 . . . . 75.5 108.612 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . 0.642 ' HB ' ' O ' ' A' ' 504' ' ' ILE . 10.3 t -94.41 169.59 10.1 Favored 'General case' 0 N--CA 1.397 -3.096 0 N-CA-C 114.81 1.411 . . . . 71.219999999999999 114.81 -171.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . 0.309 5.7 m -49.9 -34.06 19.16 Favored 'General case' 0 N--CA 1.417 -2.124 0 C-N-CA 130.658 3.583 . . . . 70.140000000000001 111.35 171.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . 0.529 ' HA3' ' O ' ' A' ' 502' ' ' ALA . . . -121.3 68.41 0.42 Allowed Glycine 0 N--CA 1.428 -1.856 0 C-N-CA 120.722 -0.752 . . . . 61.240000000000002 113.203 -177.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -87.88 83.41 7.1 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 106.704 -1.591 . . . . 65.219999999999999 106.704 173.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -121.05 137.3 54.72 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 115.744 -0.662 . . . . 74.019999999999996 112.321 -174.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 533' ' ' GLY . . . . . 0.477 ' N ' ' HB3' ' A' ' 564' ' ' ASN . . . 69.27 -121.32 11.28 Favored Glycine 0 N--CA 1.438 -1.173 0 CA-C-N 114.741 -1.118 . . . . 33.219999999999999 111.966 176.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -136.47 124.15 22.41 Favored 'General case' 0 C--N 1.286 -2.175 0 N-CA-C 106.079 -1.823 . . . . 43.25 106.079 177.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 535' ' ' VAL . . . . . 0.482 HG22 HD22 ' A' ' 596' ' ' LEU . 57.5 t -126.57 122.97 62.15 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-O 121.398 0.618 . . . . 71.310000000000002 109.494 -175.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 536' ' ' ILE . . . . . 0.459 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 40.2 mm -97.57 127.21 50.1 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.451 0 CA-C-N 115.444 -0.798 . . . . 72.340000000000003 109.968 -178.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . 0.45 HG22 ' HB3' ' A' ' 594' ' ' PRO . 86.1 t -113.0 102.31 54.6 Favored Pre-proline 0 C--N 1.308 -1.22 0 CA-C-N 115.448 -0.797 . . . . 62.039999999999999 110.18 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 559' ' ' GLU . 63.9 Cg_endo -74.74 150.31 39.31 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.667 2.245 . . . . 62.140000000000001 111.635 178.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 539' ' ' TYR . . . . . 0.498 ' CE1' ' HG ' ' A' ' 560' ' ' LEU . 17.4 p90 -154.9 165.95 35.08 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 110.246 -0.279 . . . . 61.340000000000003 110.246 -178.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -157.86 157.47 33.28 Favored 'General case' 0 C--N 1.316 -0.864 0 O-C-N 123.659 0.599 . . . . 64.310000000000002 110.142 177.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 2.1 p -96.46 112.17 24.01 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 123.337 0.655 . . . . 72.109999999999999 109.775 173.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.428 ' HB ' ' HB2' ' A' ' 588' ' ' PHE . 3.5 mp -81.01 122.96 37.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 107.917 -1.142 . . . . 72.319999999999993 107.917 177.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -55.31 -52.73 62.5 Favored 'General case' 0 C--O 1.242 0.704 0 O-C-N 124.223 0.952 . . . . 65.120000000000005 110.851 -178.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 71.53 -80.11 0.54 Allowed Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.837 -0.619 . . . . 65.040000000000006 113.179 175.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 12.8 t -134.43 -7.47 2.55 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.452 0.644 . . . . 70.140000000000001 110.04 -179.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -80.36 -176.37 5.62 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 121.181 0.515 . . . . 52.409999999999997 111.723 -179.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . 0.627 ' HB3' ' OE1' ' A' ' 551' ' ' GLU . 56.9 mmt-85 -85.58 177.29 7.78 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.652 -0.703 . . . . 63.219999999999999 110.917 177.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -64.38 174.57 13.22 Favored Glycine 0 CA--C 1.538 1.521 0 CA-C-N 115.166 -0.925 . . . . 22.329999999999998 114.354 -177.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . -67.63 122.84 18.26 Favored Glycine 0 N--CA 1.441 -0.997 0 CA-C-N 115.259 -0.471 . . . . 70.140000000000001 112.46 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 82.98 2.94 90.68 Favored Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 110.634 -0.987 . . . . 74.549999999999997 110.634 179.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . 0.627 ' OE1' ' HB3' ' A' ' 547' ' ' ARG . 38.2 tt0 -96.53 -69.99 0.73 Allowed 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 108.958 -0.756 . . . . 64.510000000000005 108.958 -178.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . 0.652 ' OD2' 'CA ' ' A' ' 850' ' ' ' CA' . 17.4 t70 -106.63 -25.57 11.73 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-O 122.004 0.907 . . . . 42.329999999999998 109.006 177.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -142.84 152.68 42.42 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 106.65 -1.611 . . . . 74.420000000000002 106.65 174.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . 0.407 ' CB ' ' HB3' ' A' ' 574' ' ' LYS . 1.0 OUTLIER -87.48 122.7 31.55 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 107.06 -1.459 . . . . 64.420000000000002 107.06 -179.584 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -79.54 123.14 27.31 Favored 'General case' 0 CA--C 1.491 -1.298 0 CA-C-O 120.888 0.375 . . . . 64.430000000000007 110.725 -174.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 12.1 t -123.98 107.32 11.2 Favored 'General case' 0 N--CA 1.404 -2.762 0 CA-C-O 122.531 1.158 . . . . 73.340000000000003 110.773 -178.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 3.6 p -129.09 130.07 46.02 Favored 'General case' 0 N--CA 1.42 -1.968 0 CA-C-N 114.622 -1.172 . . . . 41.240000000000002 108.679 177.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 174.66 -151.39 12.46 Favored Glycine 0 N--CA 1.41 -3.073 0 N-CA-C 109.81 -1.316 . . . . 55.140000000000001 109.81 -177.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 559' ' ' GLU . . . . . 0.459 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 70.5 mt-10 -129.71 126.66 38.78 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-O 120.933 0.397 . . . . 62.140000000000001 111.533 -175.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . 0.498 ' HG ' ' CE1' ' A' ' 539' ' ' TYR . 83.7 mt -79.67 122.76 26.95 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.787 -0.82 . . . . 64.319999999999993 108.787 175.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -93.22 110.01 21.53 Favored 'General case' 0 N--CA 1.419 -1.976 0 N-CA-C 109.194 -0.669 . . . . 71.329999999999998 109.194 -178.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -129.26 150.52 50.6 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.054 -0.976 . . . . 71.0 108.373 -179.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . 0.57 ' H ' ' HB3' ' A' ' 566' ' ' GLU . 7.3 pt20 -148.88 178.53 8.6 Favored 'General case' 0 C--N 1.288 -2.07 0 O-C-N 121.882 -0.511 . . . . 65.230000000000004 110.746 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 564' ' ' ASN . . . . . 0.477 ' HB3' ' N ' ' A' ' 533' ' ' GLY . 3.7 p-10 -61.89 -33.1 73.61 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 124.347 1.059 . . . . 50.119999999999997 111.447 -176.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -91.46 -6.55 52.5 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.864 0.84 . . . . 74.439999999999998 110.425 -176.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . 0.57 ' HB3' ' H ' ' A' ' 563' ' ' GLN . 9.6 tp10 -98.94 155.54 17.36 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.497 -1.298 . . . . 72.420000000000002 107.497 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 1.7 pp -126.75 140.58 48.53 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.625 0 C-N-CA 119.654 -0.818 . . . . 72.25 109.263 177.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 568' ' ' VAL . . . . . 0.47 HG21 ' HD2' ' A' ' 524' ' ' LYS . 1.1 p 53.51 176.58 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.524 0 C-N-CA 126.14 1.776 . . . . 75.340000000000003 113.649 177.016 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 569' ' ' LYS . . . . . 0.603 ' HA ' ' HE2' ' A' ' 569' ' ' LYS . 6.7 mmpt? -146.63 153.9 40.86 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 109.119 -0.697 . . . . 62.340000000000003 109.119 173.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 570' ' ' THR . . . . . 0.519 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 12.0 p -136.72 133.11 35.75 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 124.13 0.894 . . . . 64.319999999999993 110.5 178.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 571' ' ' ILE . . . . . 0.535 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 2.4 mp -95.66 117.8 40.51 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 107.129 -1.434 . . . . 62.109999999999999 107.129 174.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 572' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 521' ' ' MET . 4.1 p -102.1 109.47 21.19 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 123.698 0.624 . . . . 71.409999999999997 110.498 179.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 573' ' ' VAL . . . . . . . . . . . . . 48.0 t -112.32 136.66 47.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 N-CA-C 109.467 -0.568 . . . . 55.329999999999998 109.467 -178.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 574' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 519' ' ' GLY . 58.8 tttp -92.72 126.08 37.64 Favored 'General case' 0 C--N 1.309 -1.159 0 O-C-N 124.046 0.841 . . . . 71.140000000000001 109.849 178.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 47.6 t -94.12 132.42 38.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 107.482 -1.303 . . . . 71.310000000000002 107.482 177.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 30.5 mm -97.43 146.35 7.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 C-N-CA 120.605 -0.438 . . . . 62.030000000000001 109.989 -174.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -61.95 145.14 53.8 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.4 0.68 . . . . 64.349999999999994 110.561 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 578' ' ' ASP . . . . . 0.658 ' OD1' 'CA ' ' A' ' 850' ' ' ' CA' . 1.9 m-20 -70.61 134.35 47.51 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 116.032 1.864 . . . . 62.020000000000003 116.032 -175.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 579' ' ' GLU . . . . . 0.646 ' OE1' 'CA ' ' A' ' 850' ' ' ' CA' . 0.1 OUTLIER -110.94 -24.82 10.16 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 112.882 -1.963 . . . . 73.219999999999999 109.431 177.824 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 580' ' ' GLU . . . . . 0.654 ' OE1' 'CA ' ' A' ' 850' ' ' ' CA' . 0.0 OUTLIER -133.14 178.72 6.68 Favored 'General case' 0 C--O 1.249 1.052 0 N-CA-C 113.232 0.827 . . . . 73.420000000000002 113.232 -179.063 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -66.49 152.67 44.72 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.644 -1.162 . . . . 75.219999999999999 107.889 177.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 582' ' ' GLU . . . . . 0.616 ' OE1' 'CA ' ' A' ' 800' ' ' ' CA' . 31.4 tt0 -126.29 138.38 53.59 Favored 'General case' 0 C--N 1.293 -1.849 0 C-N-CA 117.385 -1.726 . . . . 72.530000000000001 113.011 -176.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -97.21 -158.35 0.66 Allowed 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 106.819 -1.549 . . . . 65.010000000000005 106.819 176.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 -79.15 93.54 5.21 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 106.072 -1.825 . . . . 74.439999999999998 106.072 170.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 585' ' ' LYS . . . . . 0.455 ' HD2' HD13 ' A' ' 646' ' ' ILE . 3.8 tmmm? -98.91 121.9 41.47 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 108.364 -0.976 . . . . 65.230000000000004 108.364 -172.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 4.9 t -147.01 144.51 29.2 Favored 'General case' 0 N--CA 1.414 -2.226 0 CA-C-N 114.9 -1.046 . . . . 52.530000000000001 109.291 -177.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -125.9 146.68 49.74 Favored 'General case' 0 N--CA 1.419 -2.016 0 CA-C-N 114.542 -1.208 . . . . 70.329999999999998 109.235 176.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 588' ' ' PHE . . . . . 0.428 ' HB2' ' HB ' ' A' ' 542' ' ' ILE . 30.2 m-85 -102.53 128.52 49.14 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 109.294 -0.632 . . . . 52.340000000000003 109.294 -175.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . 0.554 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.5 OUTLIER -101.36 125.72 48.04 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 104.59 -2.374 . . . . 72.239999999999995 104.59 173.506 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -137.9 134.29 34.83 Favored 'General case' 0 C--N 1.273 -2.743 0 N-CA-C 108.92 -0.77 . . . . 74.0 108.92 -178.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 591' ' ' ILE . . . . . 0.481 HG22 ' HB3' ' A' ' 539' ' ' TYR . 28.8 pt -96.64 145.56 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.651 0 N-CA-C 108.158 -1.053 . . . . 70.25 108.158 178.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -89.62 -151.52 24.96 Favored Glycine 0 C--N 1.292 -1.879 0 N-CA-C 111.09 -0.804 . . . . 75.510000000000005 111.09 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -80.88 125.85 79.06 Favored Pre-proline 0 C--N 1.297 -1.68 0 N-CA-C 108.964 -0.754 . . . . 54.310000000000002 108.964 178.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 594' ' ' PRO . . . . . 0.45 ' HB3' HG22 ' A' ' 537' ' ' VAL . 38.4 Cg_endo -69.71 153.07 69.62 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 121.878 1.719 . . . . 75.400000000000006 110.841 176.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -129.79 132.38 46.51 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.844 -0.535 . . . . 71.099999999999994 111.488 -177.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 596' ' ' LEU . . . . . 0.489 ' HB2' ' HD3' ' A' ' 634' ' ' PRO . 0.0 OUTLIER -87.13 125.9 34.44 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 108.221 -1.029 . . . . 71.030000000000001 108.221 -179.567 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 21.4 t -91.77 20.93 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.55 0 CA-C-O 121.949 0.88 . . . . 61.240000000000002 109.802 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -57.44 -42.17 81.95 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.616 -0.72 . . . . 71.109999999999999 111.43 179.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 31.4 ttp -103.51 98.72 8.57 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 106.919 -1.512 . . . . 71.129999999999995 106.919 174.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 12.6 m -77.01 151.71 35.48 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 108.671 -0.863 . . . . 71.299999999999997 108.671 178.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -70.61 92.64 0.86 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.572 0.701 . . . . 74.120000000000005 109.195 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -177.39 -33.37 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 125.579 1.552 . . . . 35.219999999999999 106.934 -174.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.66 -179.37 3.72 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 114.554 -1.203 . . . . 62.140000000000001 109.164 177.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -166.95 -43.34 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.705 0 N-CA-C 110.004 -1.238 . . . . 71.109999999999999 110.004 177.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 97.16 -114.19 4.91 Favored Glycine 0 N--CA 1.437 -1.296 0 N-CA-C 110.485 -1.046 . . . . 74.519999999999996 110.485 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -115.55 97.4 6.13 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.677 -1.231 . . . . 72.049999999999997 107.677 176.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 607' ' ' THR . . . . . 0.533 ' HB ' ' O ' ' A' ' 609' ' ' THR . 18.8 p -131.52 130.47 42.39 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 115.802 -0.636 . . . . 51.329999999999998 110.699 -177.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 608' ' ' ILE . . . . . 0.412 HD12 ' H ' ' A' ' 608' ' ' ILE . 3.2 mp -65.52 -43.69 94.25 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.867 0 CA-C-O 123.438 1.589 . . . . 73.329999999999998 107.235 174.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 609' ' ' THR . . . . . 0.533 ' O ' ' HB ' ' A' ' 607' ' ' THR . 13.8 p -139.82 152.09 46.24 Favored 'General case' 0 C--N 1.246 -3.931 0 CA-C-N 111.167 -2.742 . . . . 63.229999999999997 105.532 175.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -98.32 9.32 43.33 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.555 -0.858 . . . . 73.329999999999998 110.345 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -77.05 76.49 3.6 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 114.046 1.128 . . . . 73.230000000000004 114.046 -177.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -98.79 72.32 1.96 Allowed 'General case' 0 C--N 1.281 -2.385 0 N-CA-C 104.937 -2.246 . . . . 74.319999999999993 104.937 167.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -84.27 62.85 7.41 Favored 'General case' 0 N--CA 1.427 -1.62 0 CA-C-N 112.134 -2.303 . . . . 62.43 109.804 -170.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -80.9 79.55 7.54 Favored 'General case' 0 CA--C 1.483 -1.623 0 CA-C-O 122.571 1.176 . . . . 53.25 109.364 176.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -124.29 20.27 8.9 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 105.941 -1.874 . . . . 75.319999999999993 105.941 177.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -96.32 170.92 6.83 Favored Pre-proline 0 N--CA 1.433 -1.321 0 CA-C-N 112.485 -2.143 . . . . 72.239999999999995 108.61 -176.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -75.43 177.67 8.35 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 121.656 1.571 . . . . 62.219999999999999 109.278 169.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.403 ' HG ' ' CD1' ' A' ' 636' ' ' LEU . 3.6 mm? -67.42 117.71 9.76 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.133 0.492 . . . . 72.329999999999998 111.581 -177.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 36.0 p -109.64 28.13 8.87 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.397 -0.82 . . . . 71.299999999999997 108.993 178.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 620' ' ' SER . . . . . 0.432 ' HA ' ' HB3' ' A' ' 626' ' ' ARG . 2.4 m -61.76 -35.66 78.77 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 124.365 1.066 . . . . 61.039999999999999 113.214 -172.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -103.64 5.44 36.45 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.465 0.65 . . . . 41.149999999999999 110.212 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -93.46 -51.13 5.11 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 107.859 -1.163 . . . . 65.049999999999997 107.859 179.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . 0.471 ' HB2' ' HB2' ' A' ' 626' ' ' ARG . 39.2 mt-10 -98.9 123.47 43.2 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 106.883 -1.525 . . . . 74.230000000000004 106.883 177.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -78.77 -12.54 60.03 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 119.883 -0.727 . . . . 51.240000000000002 112.016 -176.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -87.52 -16.66 34.06 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 123.13 0.572 . . . . 73.310000000000002 110.989 174.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . 0.6 ' O ' ' HG3' ' A' ' 630' ' ' GLU . 0.0 OUTLIER -51.03 -44.05 61.0 Favored 'General case' 0 C--O 1.2 -1.501 0 N-CA-C 113.163 0.801 . . . . 70.420000000000002 113.163 -173.367 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 627' ' ' ARG . . . . . 0.402 ' HA ' ' HB2' ' A' ' 630' ' ' GLU . 78.0 mtt180 -71.29 -24.42 62.14 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 118.585 0.63 . . . . 74.319999999999993 112.535 -175.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . 0.434 ' O ' ' HB3' ' A' ' 631' ' ' MET . 96.4 mt -70.41 -36.93 68.77 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 N-CA-C 108.306 -0.998 . . . . 72.239999999999995 108.306 172.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -72.02 -30.39 65.15 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 109.138 -0.69 . . . . 75.409999999999997 109.138 175.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 630' ' ' GLU . . . . . 0.6 ' HG3' ' O ' ' A' ' 626' ' ' ARG . 76.3 mt-10 -77.76 10.31 2.84 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.606 0.762 . . . . 74.140000000000001 111.014 177.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 631' ' ' MET . . . . . 0.434 ' HB3' ' O ' ' A' ' 628' ' ' ILE . 43.3 ttp -84.84 -29.19 25.52 Favored 'General case' 0 N--CA 1.409 -2.501 0 N-CA-C 106.819 -1.549 . . . . 71.299999999999997 106.819 170.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -100.95 -17.7 22.23 Favored Glycine 0 N--CA 1.438 -1.18 0 CA-C-N 115.102 -0.954 . . . . 64.099999999999994 111.805 175.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -109.89 134.85 20.54 Favored Pre-proline 0 C--N 1.313 -1.021 0 N-CA-C 108.589 -0.893 . . . . 70.420000000000002 108.589 -179.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.489 ' HD3' ' HB2' ' A' ' 596' ' ' LEU . 70.8 Cg_endo -75.77 157.19 39.64 Favored 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 121.924 1.749 . . . . 61.200000000000003 111.196 178.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 29.7 pt -132.03 178.21 5.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 CA-C-O 121.655 0.74 . . . . 55.240000000000002 111.048 -173.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . 0.403 ' CD1' ' HG ' ' A' ' 618' ' ' LEU . 0.0 OUTLIER -94.05 152.47 18.76 Favored 'General case' 0 N--CA 1.423 -1.805 0 N-CA-C 106.768 -1.568 . . . . 75.209999999999994 106.768 171.766 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . 0.404 ' HA3' ' HB ' ' A' ' 506' ' ' THR . . . -81.26 -126.04 0.75 Allowed Glycine 0 C--N 1.29 -2.014 0 C-N-CA 120.871 -0.68 . . . . 62.530000000000001 113.445 -176.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -87.5 -50.27 6.65 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 112.072 0.397 . . . . 64.120000000000005 112.072 -175.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -132.99 110.6 10.36 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.999 0.904 . . . . 73.150000000000006 112.939 -177.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 22.3 p -120.32 92.47 3.78 Favored 'General case' 0 N--CA 1.422 -1.861 0 CA-C-N 115.423 -0.808 . . . . 61.350000000000001 110.698 176.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 641' ' ' LYS . . . . . 0.612 ' O ' ' HA ' ' A' ' 510' ' ' PRO . 0.2 OUTLIER -170.51 127.55 0.79 Allowed 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 104.564 -2.384 . . . . 72.430000000000007 104.564 178.204 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 642' ' ' LEU . . . . . 0.667 HD21 HG21 ' A' ' 523' ' ' VAL . 43.8 tp -117.23 107.06 13.97 Favored 'General case' 0 C--N 1.274 -2.713 0 N-CA-C 108.386 -0.968 . . . . 72.030000000000001 108.386 177.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . 0.487 ' HB3' HG22 ' A' ' 511' ' ' VAL . 22.8 tt0 -90.71 100.97 13.72 Favored 'General case' 0 C--N 1.275 -2.64 0 N-CA-C 107.306 -1.368 . . . . 64.010000000000005 107.306 178.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 644' ' ' VAL . . . . . 0.614 HG21 ' HE2' ' A' ' 521' ' ' MET . 19.3 t -91.74 103.55 14.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 109.181 -0.674 . . . . 73.120000000000005 109.181 -177.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 645' ' ' ILE . . . . . 0.4 ' CD1' HG13 ' A' ' 511' ' ' VAL . 3.8 mp -93.42 123.97 45.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 105.704 -1.962 . . . . 72.230000000000004 105.704 174.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 646' ' ' ILE . . . . . 0.523 ' N ' HD12 ' A' ' 646' ' ' ILE . 2.8 mp -97.76 129.15 48.35 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 N-CA-C 108.447 -0.946 . . . . 72.129999999999995 108.447 -173.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -92.38 117.31 29.79 Favored 'General case' 0 N--CA 1.403 -2.787 0 CA-C-N 115.69 -0.686 . . . . 44.030000000000001 110.744 -179.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . 0.642 ' OE1' 'CA ' ' A' ' 800' ' ' ' CA' . 33.0 tp10 -61.58 141.37 57.81 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 114.257 -1.338 . . . . 71.340000000000003 107.763 178.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 6.5 t -55.99 113.74 1.64 Allowed 'General case' 0 C--O 1.241 0.623 0 C-N-CA 123.245 0.618 . . . . 71.239999999999995 109.654 -176.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -168.68 -63.08 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.508 -0.769 . . . . 73.310000000000002 109.629 -175.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 651' ' ' GLU . . . . . 0.418 ' OE2' ' HD3' ' A' ' 653' ' ' LYS . 35.2 tt0 -175.37 174.34 2.36 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 104.214 -2.513 . . . . 74.209999999999994 104.214 -175.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -100.04 110.37 22.68 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.41 -1.33 . . . . 75.109999999999999 107.41 -178.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 653' ' ' LYS . . . . . 0.418 ' HD3' ' OE2' ' A' ' 651' ' ' GLU . 14.3 mmmm -135.75 49.67 2.14 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 124.027 0.931 . . . . 65.310000000000002 109.356 -173.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 15.2 m -50.86 110.12 0.39 Allowed 'General case' 0 C--O 1.243 0.72 0 C-N-CA 124.209 1.004 . . . . 71.430000000000007 111.303 179.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 4.0 t -82.56 80.52 8.67 Favored 'General case' 0 N--CA 1.418 -2.038 0 CA-C-O 122.467 1.127 . . . . 73.510000000000005 111.092 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 46.2 t -125.99 95.48 3.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 N-CA-C 107.289 -1.375 . . . . 74.150000000000006 107.289 177.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 . . . . . 0 C--N 1.285 -2.238 0 CA-C-N 114.588 -1.187 . . . . 74.219999999999999 109.218 -176.327 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 800' ' ' ' CA' . . . . . 0.642 'CA ' ' OE1' ' A' ' 648' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 850' ' ' ' CA' . . . . . 0.658 'CA ' ' OD1' ' A' ' 578' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . 0.419 ' HA ' ' O ' ' A' ' 630' ' ' GLU . 4.7 p-80 . . . . . 0 N--CA 1.448 -0.549 0 CA-C-O 120.642 0.258 . . . . 64.25 110.707 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -127.18 -47.73 1.47 Allowed 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 108.924 -0.769 . . . . 71.420000000000002 108.924 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . 0.544 ' HA2' ' OG1' ' A' ' 528' ' ' THR . . . -100.95 147.41 17.84 Favored Glycine 0 N--CA 1.41 -3.077 0 C-N-CA 119.912 -1.137 . . . . 42.049999999999997 114.868 -172.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . 0.47 ' H ' ' HA ' ' A' ' 528' ' ' THR . 3.5 mp -129.32 90.53 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.326 0 N-CA-C 106.036 -1.839 . . . . 73.019999999999996 106.036 174.07 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . 0.524 ' CZ ' ' HB ' ' A' ' 528' ' ' THR . 89.3 m-85 -112.11 110.52 20.85 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 109.176 -0.676 . . . . 71.040000000000006 109.176 179.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . 0.507 ' HB ' ' HA3' ' A' ' 637' ' ' GLY . 11.7 t -149.25 167.61 25.55 Favored 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 107.229 -1.397 . . . . 73.019999999999996 107.229 -177.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -94.75 155.0 17.02 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.565 -1.642 . . . . 73.030000000000001 106.565 173.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -90.92 -29.74 17.29 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 107.426 -1.324 . . . . 64.140000000000001 107.426 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -112.5 130.9 22.94 Favored Pre-proline 0 N--CA 1.425 -1.711 0 CA-C-N 114.964 -1.016 . . . . 75.120000000000005 109.454 174.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 656' ' ' VAL . 73.8 Cg_endo -84.59 -10.17 8.73 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.203 1.935 . . . . 63.039999999999999 111.193 176.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . 0.414 HG22 ' HB3' ' A' ' 643' ' ' GLU . 94.3 t -141.29 135.52 31.88 Favored 'Isoleucine or valine' 0 C--O 1.244 0.813 0 C-N-CA 123.929 0.892 . . . . 63.109999999999999 109.645 -177.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 7.3 t -139.22 138.35 36.77 Favored 'General case' 0 N--CA 1.413 -2.317 0 N-CA-C 107.066 -1.457 . . . . 35.329999999999998 107.066 174.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 25.1 m-70 -107.64 132.87 52.85 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 106.643 -1.614 . . . . 74.019999999999996 106.643 177.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.679 HG11 ' SD ' ' A' ' 521' ' ' MET . 34.6 m -120.27 159.04 22.0 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 CA-C-O 121.826 0.822 . . . . 70.230000000000004 111.534 -174.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . 0.473 ' O ' HG22 ' A' ' 518' ' ' ILE . 51.6 m -82.02 142.08 32.67 Favored 'General case' 0 N--CA 1.387 -3.592 0 CA-C-N 114.13 -1.395 . . . . 61.229999999999997 107.971 178.132 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . 0.647 ' OE2' 'CA ' ' A' ' 800' ' ' ' CA' . 39.3 tt0 -80.12 -20.84 44.09 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 120.066 -0.653 . . . . 54.210000000000001 110.792 179.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 47.8 m -94.73 22.7 6.07 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.705 0.764 . . . . 51.43 110.613 -177.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 518' ' ' ILE . . . . . 0.473 HG22 ' O ' ' A' ' 515' ' ' SER . 16.2 tt -97.09 149.71 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.756 0 N-CA-C 108.367 -0.975 . . . . 71.219999999999999 108.367 -179.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -83.49 -54.58 3.08 Favored Glycine 0 N--CA 1.43 -1.764 0 C-N-CA 120.359 -0.924 . . . . 73.010000000000005 111.39 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . 0.446 HD13 ' HA ' ' A' ' 574' ' ' LYS . 34.2 mm -132.72 125.4 52.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.85 -0.796 . . . . 74.140000000000001 108.85 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 521' ' ' MET . . . . . 0.679 ' SD ' HG11 ' A' ' 514' ' ' VAL . 23.7 ptt? -94.23 137.75 33.04 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.833 -1.543 . . . . 74.019999999999996 106.833 172.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -125.35 140.43 52.82 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 123.387 0.429 . . . . 61.229999999999997 110.947 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . 0.591 ' O ' ' HA ' ' A' ' 570' ' ' THR . 39.7 t -124.32 126.09 71.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 108.716 -0.846 . . . . 64.540000000000006 108.716 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . 0.446 ' HD2' HG21 ' A' ' 568' ' ' VAL . 28.2 mmtp -77.77 117.42 19.13 Favored 'General case' 0 C--N 1.311 -1.105 0 O-C-N 123.784 0.678 . . . . 71.310000000000002 110.933 -178.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 25.5 t -98.8 140.17 19.03 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.289 0 CA-C-N 115.241 -0.89 . . . . 63.100000000000001 110.858 -175.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -68.7 144.62 54.36 Favored 'General case' 0 C--O 1.238 0.457 0 O-C-N 123.956 0.785 . . . . 70.329999999999998 109.187 177.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . 0.416 ' HG2' ' N ' ' A' ' 528' ' ' THR . 27.1 ttp180 -99.16 157.77 16.14 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.343 0.592 . . . . 73.239999999999995 110.926 -173.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . 0.648 HG23 ' HB2' ' A' ' 531' ' ' ALA . 5.1 t -65.9 135.03 54.24 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 115.547 -0.751 . . . . 72.349999999999994 110.179 173.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 22.6 t -81.87 -37.35 27.07 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.515 -0.92 . . . . 64.099999999999994 108.515 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -87.34 98.03 2.34 Favored Glycine 0 N--CA 1.418 -2.512 0 N-CA-C 108.168 -1.973 . . . . 41.310000000000002 108.168 175.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . 0.648 ' HB2' HG23 ' A' ' 528' ' ' THR . . . -149.38 100.66 3.04 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 120.854 0.359 . . . . 52.119999999999997 110.282 -177.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . 0.415 ' HD2' ' N ' ' A' ' 532' ' ' ARG . 7.5 mpt_? -119.82 12.8 12.21 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 108.4 -0.963 . . . . 73.129999999999995 108.4 172.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . -155.22 -166.16 15.11 Favored Glycine 0 N--CA 1.437 -1.291 0 CA-C-N 115.006 -0.997 . . . . 71.319999999999993 111.013 -172.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 534' ' ' ASN . . . . . 0.402 HD21 ' CG ' ' A' ' 561' ' ' GLU . 3.1 t-20 -97.8 134.54 40.82 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 122.926 0.49 . . . . 70.430000000000007 109.982 -178.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 535' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' A' ' 595' ' ' ARG . 61.3 t -133.06 131.45 58.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 123.025 0.53 . . . . 73.400000000000006 109.856 -178.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 536' ' ' ILE . . . . . 0.425 ' HB ' ' HB2' ' A' ' 595' ' ' ARG . 35.1 mm -103.82 138.17 29.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 110.033 -0.358 . . . . 75.219999999999999 110.033 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . 0.409 HG22 ' HB3' ' A' ' 594' ' ' PRO . 48.8 t -126.28 110.19 23.81 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 110.086 -0.338 . . . . 75.030000000000001 110.086 178.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.04 154.41 37.67 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.369 2.046 . . . . 75.519999999999996 111.754 178.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 539' ' ' TYR . . . . . 0.443 ' HB3' HG22 ' A' ' 591' ' ' ILE . 52.8 p90 -147.23 161.66 40.48 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.243 -0.651 . . . . 72.030000000000001 109.243 177.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -152.5 157.57 41.32 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 123.724 0.64 . . . . 72.409999999999997 109.782 178.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 2.7 p -99.93 122.66 43.18 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 123.469 0.481 . . . . 70.439999999999998 110.649 174.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.4 mp -91.08 112.52 25.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 106.242 -1.762 . . . . 62.310000000000002 106.242 174.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -52.13 -50.68 61.22 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 124.246 0.966 . . . . 61.439999999999998 111.823 -178.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 67.18 -94.68 0.26 Allowed Glycine 0 N--CA 1.442 -0.903 0 CA-C-N 116.058 -0.519 . . . . 71.420000000000002 112.24 176.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 545' ' ' THR . . . . . 0.514 HG23 ' HB2' ' A' ' 585' ' ' LYS . 8.0 t -119.19 9.39 11.73 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 120.759 0.314 . . . . 73.129999999999995 110.575 -178.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . 0.435 ' HB2' ' HD3' ' A' ' 585' ' ' LYS . . . -98.78 166.31 11.37 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.847 -0.427 . . . . 64.510000000000005 109.847 178.065 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . 0.426 ' HB3' ' HB2' ' A' ' 551' ' ' GLU . 2.8 tpp180 -75.55 167.33 22.1 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 108.024 -1.102 . . . . 72.519999999999996 108.024 178.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -65.02 177.25 10.64 Favored Glycine 0 C--O 1.254 1.393 0 CA-C-O 121.513 0.507 . . . . 55.240000000000002 114.36 -178.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . -57.03 127.55 45.13 Favored Glycine 0 N--CA 1.439 -1.141 0 CA-C-N 114.718 -0.741 . . . . 44.100000000000001 114.115 -177.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 94.95 -10.23 70.24 Favored Glycine 0 N--CA 1.434 -1.459 0 CA-C-N 115.311 -0.444 . . . . 75.150000000000006 112.565 176.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . 0.426 ' HB2' ' HB3' ' A' ' 547' ' ' ARG . 61.8 mm-40 -91.08 -70.84 0.66 Allowed 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 120.405 -0.518 . . . . 75.310000000000002 109.754 -179.253 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . 0.657 ' OD1' 'CA ' ' A' ' 850' ' ' ' CA' . 71.1 m-20 -96.03 -37.9 10.44 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-O 121.572 0.701 . . . . 63.25 109.97 175.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -142.46 156.82 45.21 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 108.115 -1.069 . . . . 72.329999999999998 108.115 -177.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -87.42 117.41 26.19 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 106.519 -1.66 . . . . 61.240000000000002 106.519 178.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -72.38 107.15 4.81 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.75 -0.659 . . . . 72.200000000000003 109.791 -176.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . 0.47 HG21 HG22 ' A' ' 573' ' ' VAL . 9.6 t -106.58 126.66 52.55 Favored 'General case' 0 N--CA 1.413 -2.32 0 CA-C-O 122.123 0.963 . . . . 64.519999999999996 111.565 -173.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 20.5 p -136.99 109.77 7.57 Favored 'General case' 0 N--CA 1.414 -2.244 0 N-CA-C 107.367 -1.346 . . . . 72.420000000000002 107.367 175.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -152.92 -161.69 10.46 Favored Glycine 0 N--CA 1.418 -2.505 0 N-CA-C 110.607 -0.997 . . . . 70.319999999999993 110.607 -174.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -139.18 131.25 27.98 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 122.983 0.513 . . . . 71.040000000000006 110.454 -176.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 87.7 mt -92.99 143.73 25.95 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 123.725 0.81 . . . . 72.430000000000007 109.123 179.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 561' ' ' GLU . . . . . 0.402 ' CG ' HD21 ' A' ' 534' ' ' ASN . 26.9 tt0 -102.62 123.59 46.61 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-O 121.414 0.626 . . . . 71.5 110.618 178.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -121.35 157.49 30.32 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 108.26 -1.015 . . . . 71.230000000000004 108.26 173.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . 0.401 ' HG3' ' H ' ' A' ' 566' ' ' GLU . 3.6 pt20 -162.92 -178.93 6.41 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 109.769 -0.456 . . . . 70.239999999999995 109.769 176.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 -63.74 -36.36 83.6 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 124.108 0.88 . . . . 72.519999999999996 111.587 178.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -90.11 -17.26 28.01 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.399 -0.819 . . . . 74.510000000000005 112.309 -176.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . 0.401 ' H ' ' HG3' ' A' ' 563' ' ' GLN . 6.7 tp10 -109.58 128.65 55.36 Favored 'General case' 0 C--N 1.31 -1.123 0 O-C-N 121.844 -0.535 . . . . 73.239999999999995 111.081 -174.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 4.7 pt -109.43 159.45 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.125 0 N-CA-C 108.735 -0.839 . . . . 72.230000000000004 108.735 176.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 568' ' ' VAL . . . . . 0.446 HG21 ' HD2' ' A' ' 524' ' ' LYS . 1.3 p 49.25 160.89 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.573 1.855 0 C-N-CA 127.081 2.152 . . . . 71.540000000000006 115.182 -179.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 569' ' ' LYS . . . . . 0.543 ' HA ' ' HE3' ' A' ' 569' ' ' LYS . 0.0 OUTLIER -153.23 162.54 41.19 Favored 'General case' 0 CA--C 1.484 -1.578 0 N-CA-C 107.463 -1.31 . . . . 74.209999999999994 107.463 173.114 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 570' ' ' THR . . . . . 0.591 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 4.9 p -136.87 127.96 27.79 Favored 'General case' 0 C--N 1.291 -1.938 0 O-C-N 124.169 0.918 . . . . 71.040000000000006 110.815 178.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 571' ' ' ILE . . . . . 0.45 HG21 HD21 ' A' ' 589' ' ' LEU . 3.3 mp -79.38 106.93 11.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 107.432 -1.321 . . . . 75.439999999999998 107.432 174.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 7.3 p -86.42 111.95 21.02 Favored 'General case' 0 N--CA 1.415 -2.2 0 O-C-N 123.645 0.591 . . . . 61.210000000000001 110.419 179.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 573' ' ' VAL . . . . . 0.47 HG22 HG21 ' A' ' 556' ' ' THR . 42.3 t -114.39 130.7 68.23 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 N-CA-C 109.089 -0.708 . . . . 64.420000000000002 109.089 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 574' ' ' LYS . . . . . 0.446 ' HA ' HD13 ' A' ' 520' ' ' ILE . 86.1 tttt -86.87 121.88 29.97 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 115.476 -0.784 . . . . 64.299999999999997 110.292 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 56.5 t -90.06 139.37 17.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 107.015 -1.476 . . . . 73.120000000000005 107.015 176.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 31.3 mm -103.52 158.31 5.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 107.842 -1.17 . . . . 73.530000000000001 107.842 -175.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -67.31 126.56 29.65 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.019 -0.734 . . . . 55.420000000000002 109.019 178.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 578' ' ' ASP . . . . . 0.641 ' OD1' 'CA ' ' A' ' 850' ' ' ' CA' . 26.8 t0 -76.23 130.43 38.18 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.818 -0.628 . . . . 61.310000000000002 110.45 -171.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 579' ' ' GLU . . . . . 0.634 ' OE1' 'CA ' ' A' ' 850' ' ' ' CA' . 0.6 OUTLIER -92.29 -35.34 13.82 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 113.842 1.053 . . . . 35.049999999999997 113.842 -175.718 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 580' ' ' GLU . . . . . 0.656 ' OE1' 'CA ' ' A' ' 850' ' ' ' CA' . 0.0 OUTLIER -117.58 -178.99 3.6 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 120.251 -0.58 . . . . 74.140000000000001 111.009 -174.573 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 581' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -71.48 152.43 43.05 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 106.419 -1.697 . . . . 75.299999999999997 106.419 175.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 582' ' ' GLU . . . . . 0.658 ' OE1' 'CA ' ' A' ' 800' ' ' ' CA' . 40.7 tt0 -145.14 141.81 29.07 Favored 'General case' 0 N--CA 1.409 -2.495 0 C-N-CA 118.517 -1.273 . . . . 74.040000000000006 111.597 -174.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . 0.465 ' O ' ' HG2' ' A' ' 582' ' ' GLU . 97.3 mttt -94.57 -179.29 4.84 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 106.555 -1.646 . . . . 61.25 106.555 174.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -74.78 94.49 2.75 Favored 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 119.819 -0.753 . . . . 73.109999999999999 109.125 178.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 585' ' ' LYS . . . . . 0.514 ' HB2' HG23 ' A' ' 545' ' ' THR . 0.0 OUTLIER -102.73 170.43 8.01 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 115.828 -0.624 . . . . 65.019999999999996 109.319 -179.56 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 2.8 t -151.79 148.96 28.48 Favored 'General case' 0 N--CA 1.418 -2.043 0 CA-C-O 121.486 0.66 . . . . 62.009999999999998 111.502 -177.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -128.84 150.09 50.47 Favored 'General case' 0 N--CA 1.411 -2.409 0 CA-C-N 113.537 -1.665 . . . . 70.299999999999997 107.321 174.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 588' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -108.51 135.98 48.88 Favored 'General case' 0 C--N 1.29 -1.993 0 C-N-CA 120.555 -0.458 . . . . 74.150000000000006 110.5 -169.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . 0.473 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.3 OUTLIER -102.85 129.58 49.57 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 105.8 -1.926 . . . . 72.109999999999999 105.8 175.712 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -132.97 127.08 33.42 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 109.392 -0.595 . . . . 72.329999999999998 109.392 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 591' ' ' ILE . . . . . 0.443 HG22 ' HB3' ' A' ' 539' ' ' TYR . 16.3 pt -94.17 138.43 20.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 107.945 -1.132 . . . . 72.140000000000001 107.945 174.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -97.64 -145.3 18.75 Favored Glycine 0 N--CA 1.43 -1.746 0 N-CA-C 115.049 0.779 . . . . 65.109999999999999 115.049 -172.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -84.99 119.67 72.82 Favored Pre-proline 0 C--N 1.302 -1.462 0 CA-C-N 114.081 -1.059 . . . . 63.210000000000001 109.827 -174.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 594' ' ' PRO . . . . . 0.415 ' HA ' ' O ' ' A' ' 536' ' ' ILE . 43.9 Cg_endo -72.5 156.01 54.51 Favored 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 123.082 2.521 . . . . 52.229999999999997 114.202 -177.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 595' ' ' ARG . . . . . 0.51 ' O ' ' HA ' ' A' ' 535' ' ' VAL . 5.7 mmp_? -115.37 118.15 32.43 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 123.713 0.805 . . . . 54.240000000000002 109.284 -175.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 596' ' ' LEU . . . . . 0.421 HD22 HG22 ' A' ' 535' ' ' VAL . 0.0 OUTLIER -82.5 117.99 22.92 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 104.793 -2.299 . . . . 72.209999999999994 104.793 169.586 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 17.0 t -83.68 59.63 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-O 121.776 0.798 . . . . 73.219999999999999 112.787 -172.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 63.67 -32.54 0.12 Allowed 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 118.082 2.623 . . . . 73.120000000000005 118.082 167.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 44.5 tpp -47.78 -64.62 0.74 Allowed 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 114.345 1.239 . . . . 63.130000000000003 114.345 -174.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 17.4 p -137.67 173.15 11.96 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 109.706 -0.479 . . . . 71.219999999999999 109.706 -175.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 61.02 26.76 16.69 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 124.185 0.928 . . . . 71.420000000000002 112.102 173.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.51 32.5 1.37 Allowed 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.968 0.89 . . . . 54.219999999999999 111.475 -176.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -88.96 81.7 6.83 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.927 -1.033 . . . . 71.25 110.432 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -151.11 -51.71 0.01 OUTLIER Glycine 0 C--N 1.307 -1.081 0 N-CA-C 109.583 -1.407 . . . . 44.130000000000003 109.583 177.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . -117.62 76.95 0.29 Allowed Glycine 0 N--CA 1.432 -1.623 0 N-CA-C 109.206 -1.558 . . . . 25.550000000000001 109.206 174.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -71.33 -26.14 62.7 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 122.827 0.451 . . . . 72.510000000000005 111.43 -175.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -67.57 129.16 39.02 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 123.535 0.734 . . . . 43.130000000000003 112.689 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 39.1 mm -77.16 77.63 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-O 122.55 1.167 . . . . 65.230000000000004 112.337 -175.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 8.9 t -146.56 11.58 1.13 Allowed 'General case' 0 C--N 1.273 -2.738 0 CA-C-N 114.51 -1.223 . . . . 51.329999999999998 108.044 176.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 42.95 76.67 0.07 Allowed 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 114.109 -1.405 . . . . 73.230000000000004 111.924 -171.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -95.27 26.51 3.74 Favored 'General case' 0 C--N 1.286 -2.18 0 CA-C-O 122.364 1.078 . . . . 73.310000000000002 112.711 -178.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -87.9 82.12 7.36 Favored 'General case' 0 N--CA 1.414 -2.227 0 CA-C-N 114.08 -1.418 . . . . 74.040000000000006 107.667 171.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 17.4 p-10 -90.44 3.02 55.05 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 111.799 -2.455 . . . . 51.039999999999999 110.96 -173.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -73.66 98.81 2.95 Favored 'General case' 0 C--N 1.287 -2.119 0 C-N-CA 123.199 0.6 . . . . 74.5 112.179 -177.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -147.97 19.03 1.12 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 107.814 -1.18 . . . . 71.430000000000007 107.814 172.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 616' ' ' GLN . . . . . 0.49 ' HB3' ' HD2' ' A' ' 617' ' ' PRO . 1.2 mp0 -109.13 173.46 2.95 Favored Pre-proline 0 C--N 1.313 -1.004 0 C-N-CA 123.752 0.821 . . . . 74.299999999999997 110.174 -174.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 617' ' ' PRO . . . . . 0.49 ' HD2' ' HB3' ' A' ' 616' ' ' GLN . 33.3 Cg_endo -69.62 168.87 20.13 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 121.702 1.602 . . . . 44.240000000000002 110.139 170.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -77.96 105.57 9.24 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 120.844 0.354 . . . . 72.430000000000007 111.783 -175.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 8.8 t -163.96 159.0 20.33 Favored 'General case' 0 N--CA 1.426 -1.641 0 N-CA-C 109.129 -0.693 . . . . 75.239999999999995 109.129 176.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 620' ' ' SER . . . . . 0.681 ' HB3' ' NE ' ' A' ' 626' ' ' ARG . 14.9 p -144.96 -8.95 0.61 Allowed 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 115.691 -0.686 . . . . 42.399999999999999 111.153 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm 64.38 21.45 12.49 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 107.881 -1.155 . . . . 74.230000000000004 107.881 -170.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 65.41 21.88 11.91 Favored 'General case' 0 CA--C 1.558 1.277 0 C-N-CA 126.634 1.974 . . . . 65.0 110.577 -175.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -71.18 124.03 23.53 Favored 'General case' 0 C--O 1.258 1.517 0 CA-C-O 121.719 0.771 . . . . 61.329999999999998 110.488 176.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -61.83 -39.35 91.5 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-N 113.984 -1.462 . . . . 63.409999999999997 112.05 -177.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . 0.272 1.7 pp20? -64.6 -28.46 69.64 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 119.378 -0.929 . . . . 71.439999999999998 112.521 -178.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . 0.681 ' NE ' ' HB3' ' A' ' 620' ' ' SER . 1.9 tmm_? -70.75 -42.62 70.24 Favored 'General case' 0 C--O 1.202 -1.421 0 N-CA-C 106.759 -1.571 . . . . 73.349999999999994 106.759 175.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 627' ' ' ARG . . . . . . . . . . . . . 72.9 mtp180 -63.72 -34.67 78.4 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 116.144 -0.48 . . . . 71.510000000000005 110.924 -178.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 96.2 mt -64.76 -37.56 80.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 121.316 0.579 . . . . 64.239999999999995 110.479 175.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -69.0 -31.29 70.01 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.523 0.678 . . . . 74.530000000000001 110.028 178.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 630' ' ' GLU . . . . . 0.62 ' HG2' ' O ' ' A' ' 626' ' ' ARG . 4.5 mm-40 -81.0 2.96 24.69 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.249 -0.887 . . . . 54.310000000000002 110.436 -179.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 631' ' ' MET . . . . . . . . . . . . . 44.6 ttm -78.27 -27.43 47.43 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 107.647 -1.242 . . . . 65.030000000000001 107.647 175.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -96.87 -44.94 2.75 Favored Glycine 0 N--CA 1.427 -1.958 0 N-CA-C 110.289 -1.124 . . . . 51.439999999999998 110.289 177.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 21.8 mtm180 -70.37 152.69 95.48 Favored Pre-proline 0 N--CA 1.443 -0.79 0 CA-C-O 121.187 0.518 . . . . 74.409999999999997 112.32 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.533 ' HA ' ' H ' ' A' ' 503' ' ' GLY . 61.3 Cg_endo -77.16 148.82 27.69 Favored 'Trans proline' 0 N--CA 1.437 -1.834 0 C-N-CA 121.795 1.663 . . . . 72.209999999999994 109.532 173.193 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 635' ' ' ILE . . . . . 0.402 HG12 ' HB2' ' A' ' 501' ' ' HIS . 11.6 pt -137.33 -171.74 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-O 120.956 0.408 . . . . 74.239999999999995 110.351 -178.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.48 164.42 14.83 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 115.482 -0.781 . . . . 63.030000000000001 110.227 177.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . 0.507 ' HA3' ' HB ' ' A' ' 506' ' ' THR . . . -82.35 -106.51 0.43 Allowed Glycine 0 N--CA 1.435 -1.428 0 CA-C-N 115.917 -0.583 . . . . 50.219999999999999 112.99 -176.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -107.99 -54.16 2.53 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 119.889 -0.724 . . . . 73.040000000000006 111.003 -176.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 14.5 p80 -133.84 116.16 15.34 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 121.79 0.805 . . . . 75.510000000000005 111.423 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 16.2 p -104.3 91.24 3.83 Favored 'General case' 0 N--CA 1.408 -2.552 0 N-CA-C 109.091 -0.707 . . . . 71.230000000000004 109.091 174.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -171.65 126.25 0.61 Allowed 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 105.898 -1.89 . . . . 73.25 105.898 -178.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 642' ' ' LEU . . . . . 0.553 HD21 HG21 ' A' ' 523' ' ' VAL . 42.6 tp -126.28 110.97 14.01 Favored 'General case' 0 C--N 1.281 -2.398 0 N-CA-C 108.086 -1.079 . . . . 73.510000000000005 108.086 176.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . 0.414 ' HB3' HG22 ' A' ' 511' ' ' VAL . 30.6 tt0 -90.9 102.97 15.73 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 107.569 -1.271 . . . . 65.239999999999995 107.569 178.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 644' ' ' VAL . . . . . 0.489 HG21 ' HE1' ' A' ' 521' ' ' MET . 41.2 t -93.2 110.9 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 N-CA-C 109.333 -0.618 . . . . 71.329999999999998 109.333 -179.174 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 3.5 mp -93.07 125.6 45.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 108.425 -0.954 . . . . 72.340000000000003 108.425 176.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 646' ' ' ILE . . . . . 0.514 ' N ' HD12 ' A' ' 646' ' ' ILE . 2.1 mp -110.72 131.14 62.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 N-CA-C 107.424 -1.324 . . . . 61.049999999999997 107.424 -176.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' A' ' 516' ' ' GLU . 2.2 pt-20 -131.22 157.35 43.48 Favored 'General case' 0 C--N 1.28 -2.448 0 N-CA-C 108.511 -0.922 . . . . 75.430000000000007 108.511 178.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . 0.656 ' OE2' 'CA ' ' A' ' 800' ' ' ' CA' . 6.5 mp0 -56.5 117.97 4.36 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 106.307 -1.738 . . . . 72.109999999999999 106.307 170.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 2.9 t -45.95 97.74 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.028 0 O-C-N 125.802 1.939 . . . . 74.010000000000005 113.784 -165.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -138.7 -60.34 0.6 Allowed 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 115.382 -0.826 . . . . 74.5 110.472 174.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -102.5 160.39 14.6 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-O 121.572 0.701 . . . . 74.439999999999998 110.576 -173.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -133.3 125.13 28.58 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 114.817 -1.083 . . . . 74.400000000000006 109.18 179.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -148.71 166.4 28.48 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 123.375 0.67 . . . . 73.129999999999995 109.795 -178.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 14.4 t -165.38 86.23 0.39 Allowed 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 106.321 -1.733 . . . . 52.520000000000003 106.321 172.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 14.1 t -80.22 131.46 35.7 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-N 115.497 -0.774 . . . . 72.420000000000002 111.152 -174.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.419 ' HA ' ' HD2' ' A' ' 510' ' ' PRO . 17.3 m -94.48 160.36 2.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-N 115.144 -0.934 . . . . 74.409999999999997 109.005 177.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 20.1 t70 . . . . . 0 C--N 1.313 -1.006 0 CA-C-O 119.417 -0.325 . . . . 73.129999999999995 110.369 -174.709 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 800' ' ' ' CA' . . . . . 0.658 'CA ' ' OE1' ' A' ' 582' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 850' ' ' ' CA' . . . . . 0.657 'CA ' ' OD1' ' A' ' 552' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 . . . . . 0 CA--C 1.516 -0.34 0 N-CA-C 109.717 -0.475 . . . . 73.439999999999998 109.717 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . 0.406 ' HB1' ' HA ' ' A' ' 634' ' ' PRO . . . -129.29 151.13 50.28 Favored 'General case' 0 CA--C 1.465 -2.298 0 N-CA-C 106.402 -1.703 . . . . 41.149999999999999 106.402 176.084 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . 0.474 ' HA2' ' OG1' ' A' ' 528' ' ' THR . . . -86.55 124.48 6.96 Favored Glycine 0 N--CA 1.403 -3.564 0 C-N-CA 119.021 -1.561 . . . . 34.049999999999997 110.08 175.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 4.1 mp -91.82 119.34 39.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 108.712 -0.847 . . . . 75.400000000000006 108.712 178.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -123.48 126.04 46.0 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 109.627 -0.508 . . . . 64.409999999999997 109.627 177.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . 0.453 ' HB ' ' HA3' ' A' ' 637' ' ' GLY . 8.8 t -153.41 165.18 36.62 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.522 -0.918 . . . . 71.310000000000002 108.522 -177.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -89.31 162.65 15.72 Favored 'General case' 0 C--O 1.251 1.136 0 N-CA-C 107.228 -1.397 . . . . 73.450000000000003 107.228 173.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -88.42 -44.43 10.75 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 106.293 -1.743 . . . . 75.319999999999993 106.293 178.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -105.36 133.73 20.02 Favored Pre-proline 0 N--CA 1.42 -1.93 0 CA-C-N 114.502 -1.226 . . . . 65.540000000000006 109.495 176.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -87.21 -10.63 5.59 Favored 'Trans proline' 0 C--O 1.219 -0.469 0 C-N-CA 121.956 1.77 . . . . 71.530000000000001 110.824 175.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . 0.454 HG22 ' HB3' ' A' ' 643' ' ' GLU . 81.5 t -142.42 138.89 29.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 C-N-CA 124.378 1.071 . . . . 62.140000000000001 108.441 -176.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 11.3 t -142.09 141.71 32.75 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 107.726 -1.213 . . . . 74.129999999999995 107.726 174.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 35.5 m-70 -108.94 130.4 55.45 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.486 -0.561 . . . . 70.239999999999995 109.486 178.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 26.4 m -128.71 162.47 35.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 CA-C-O 120.937 0.398 . . . . 70.239999999999995 110.221 -176.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 45.9 t -84.24 156.68 21.89 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 108.412 -0.959 . . . . 71.140000000000001 108.412 175.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -88.91 -6.77 57.06 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-O 122.089 0.947 . . . . 65.420000000000002 109.659 174.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 8.7 t -96.99 6.34 48.8 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 108.707 -0.849 . . . . 75.510000000000005 108.707 179.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 12.5 tt -85.11 151.03 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.623 0 N-CA-C 108.69 -0.856 . . . . 55.030000000000001 108.69 -178.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 574' ' ' LYS . . . -89.61 -63.38 1.29 Allowed Glycine 0 N--CA 1.426 -2.023 0 C-N-CA 120.366 -0.921 . . . . 75.400000000000006 111.098 179.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 32.1 mm -123.64 124.26 69.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 109.458 -0.571 . . . . 44.109999999999999 109.458 -179.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 521' ' ' MET . . . . . 0.638 ' HE2' HG21 ' A' ' 644' ' ' VAL . 0.0 OUTLIER -102.6 135.51 44.12 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.597 -1.26 . . . . 64.099999999999994 107.597 172.625 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 522' ' ' GLU . . . . . 0.423 ' HA ' ' O ' ' A' ' 571' ' ' ILE . 42.7 mt-10 -120.93 132.29 54.86 Favored 'General case' 0 CA--C 1.494 -1.206 0 O-C-N 123.522 0.514 . . . . 54.450000000000003 110.713 -177.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . 0.566 HG21 ' CD2' ' A' ' 642' ' ' LEU . 29.4 t -112.67 123.46 68.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-N 115.37 -0.832 . . . . 71.209999999999994 108.888 178.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . 0.416 ' HD2' HG21 ' A' ' 568' ' ' VAL . 28.6 mmtp -79.78 122.77 27.02 Favored 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 123.468 0.707 . . . . 65.409999999999997 110.408 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 21.9 t -101.21 150.97 5.59 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 CA-C-N 115.405 -0.816 . . . . 72.109999999999999 109.126 -178.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -95.43 153.53 17.65 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 108.974 -0.75 . . . . 71.120000000000005 108.974 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . 0.472 ' HD3' ' HA ' ' A' ' 567' ' ' ILE . 67.1 mtm180 -94.21 176.81 6.18 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.201 0.524 . . . . 73.340000000000003 109.9 173.091 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . 0.474 ' OG1' ' HA2' ' A' ' 503' ' ' GLY . 8.8 t -87.82 164.26 16.01 Favored 'General case' 0 N--CA 1.411 -2.38 0 CA-C-N 115.079 -0.964 . . . . 75.140000000000001 110.208 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 13.3 t -63.21 -42.75 99.34 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 115.262 -0.881 . . . . 70.209999999999994 108.712 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -100.78 67.4 0.49 Allowed Glycine 0 N--CA 1.434 -1.47 0 N-CA-C 110.764 -0.934 . . . . 41.25 110.764 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -78.89 80.45 5.24 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.261 0.553 . . . . 75.420000000000002 110.742 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -134.63 138.65 44.68 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 106.306 -1.739 . . . . 73.409999999999997 106.306 177.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 533' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' A' ' 563' ' ' GLN . . . 87.93 173.48 47.75 Favored Glycine 0 C--N 1.302 -1.314 0 C-N-CA 119.883 -1.151 . . . . 74.230000000000004 111.156 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 534' ' ' ASN . . . . . 0.484 HD21 ' HG3' ' A' ' 561' ' ' GLU . 2.9 t-20 -105.98 121.27 43.76 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 122.409 -0.465 . . . . 62.119999999999997 109.809 -177.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 535' ' ' VAL . . . . . 0.445 HG22 HD22 ' A' ' 596' ' ' LEU . 59.8 t -124.01 126.21 72.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.409 -0.96 . . . . 62.119999999999997 108.409 178.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 536' ' ' ILE . . . . . 0.51 ' CG2' ' HB3' ' A' ' 559' ' ' GLU . 47.4 mm -99.23 137.28 27.17 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 N-CA-C 108.661 -0.866 . . . . 63.240000000000002 108.661 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 57.9 t -122.45 109.82 32.64 Favored Pre-proline 0 C--N 1.307 -1.266 0 CA-C-N 116.417 -0.356 . . . . 74.209999999999994 110.805 -179.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -75.25 135.92 19.23 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 122.541 2.161 . . . . 64.109999999999999 111.668 176.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 539' ' ' TYR . . . . . 0.455 ' CD1' ' HG ' ' A' ' 560' ' ' LEU . 42.9 p90 -134.12 157.49 46.03 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 109.068 -0.716 . . . . 73.010000000000005 109.068 -178.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -156.73 156.85 34.06 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 123.322 0.389 . . . . 74.109999999999999 111.048 177.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 1.6 p -91.45 116.85 29.19 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 115.437 -0.801 . . . . 71.140000000000001 110.663 174.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.6 mp -87.51 112.27 23.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 106.282 -1.747 . . . . 74.409999999999997 106.282 174.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.69 -46.19 74.07 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 114.797 1.406 . . . . 63.399999999999999 114.797 -176.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 63.41 -94.54 0.13 Allowed Glycine 0 CA--C 1.523 0.546 0 CA-C-O 121.349 0.416 . . . . 74.430000000000007 113.146 177.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 10.2 t -114.09 0.4 14.28 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.293 0.568 . . . . 71.129999999999995 110.712 -178.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -104.02 156.7 17.65 Favored 'General case' 0 C--N 1.318 -0.794 0 O-C-N 121.97 -0.457 . . . . 63.43 109.923 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . 0.463 ' HB2' ' HB2' ' A' ' 552' ' ' ASP . 4.6 mpt_? -87.21 125.43 34.18 Favored 'General case' 0 CA--C 1.483 -1.602 0 CA-C-O 121.442 0.639 . . . . 71.219999999999999 110.991 -178.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -86.32 179.92 49.47 Favored Glycine 0 C--N 1.279 -2.633 0 CA-C-N 114.245 -1.343 . . . . 73.030000000000001 112.083 -177.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 74.18 30.86 60.24 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 114.039 0.376 . . . . 72.439999999999998 114.039 177.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 76.08 21.39 76.11 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.259 -0.972 . . . . 52.039999999999999 111.919 178.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -91.67 -66.26 0.94 Allowed 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 110.02 -0.363 . . . . 75.150000000000006 110.02 -177.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . 0.463 ' HB2' ' HB2' ' A' ' 547' ' ' ARG . 1.8 t70 -101.79 -29.84 11.64 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 106.608 -1.627 . . . . 51.439999999999998 106.608 177.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -146.07 160.06 42.41 Favored 'General case' 0 C--O 1.247 0.937 0 CA-C-N 114.963 -1.017 . . . . 73.430000000000007 108.374 175.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -91.21 130.09 37.13 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 106.404 -1.702 . . . . 75.319999999999993 106.404 178.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -86.17 117.46 25.01 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 116.511 -0.313 . . . . 64.140000000000001 110.579 -174.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . 0.43 ' CG2' HG22 ' A' ' 573' ' ' VAL . 13.8 t -115.99 122.35 44.98 Favored 'General case' 0 N--CA 1.409 -2.477 0 CA-C-O 122.206 1.003 . . . . 65.230000000000004 110.462 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 1.8 p -143.87 128.76 18.42 Favored 'General case' 0 N--CA 1.417 -2.087 0 CA-C-N 114.54 -1.209 . . . . 72.239999999999995 108.693 179.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -177.4 -158.42 20.48 Favored Glycine 0 N--CA 1.419 -2.47 0 N-CA-C 110.103 -1.199 . . . . 73.439999999999998 110.103 -176.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 559' ' ' GLU . . . . . 0.51 ' HB3' ' CG2' ' A' ' 536' ' ' ILE . 38.7 mt-10 -129.97 125.73 36.12 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 120.999 0.428 . . . . 65.430000000000007 111.935 -176.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . 0.455 ' HG ' ' CD1' ' A' ' 539' ' ' TYR . 94.9 mt -88.91 144.92 25.86 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 109.07 -0.715 . . . . 74.109999999999999 109.07 177.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 561' ' ' GLU . . . . . 0.484 ' HG3' HD21 ' A' ' 534' ' ' ASN . 37.5 tt0 -103.95 122.17 44.64 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 116.418 -0.355 . . . . 74.439999999999998 110.475 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 562' ' ' PHE . . . . . 0.421 ' CE1' ' HG2' ' A' ' 569' ' ' LYS . 70.0 m-85 -121.24 146.57 46.67 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.445 -0.946 . . . . 73.239999999999995 108.445 171.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . 0.483 ' HA ' ' O ' ' A' ' 533' ' ' GLY . 3.6 pt20 -159.14 -173.16 4.08 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 110.324 -0.25 . . . . 72.409999999999997 110.324 178.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -59.11 -45.41 90.96 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 123.58 0.752 . . . . 72.5 112.24 -177.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -91.95 -41.21 10.7 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 120.17 -0.612 . . . . 54.32 111.748 -178.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . 0.406 ' H ' ' HG3' ' A' ' 563' ' ' GLN . 8.2 tp10 -66.94 135.2 53.44 Favored 'General case' 0 C--N 1.317 -0.809 0 O-C-N 123.247 0.342 . . . . 71.0 110.233 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 567' ' ' ILE . . . . . 0.472 ' HA ' ' HD3' ' A' ' 527' ' ' ARG . 31.1 pt -116.94 -172.19 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.412 -2.365 0 N-CA-C 109.057 -0.72 . . . . 73.209999999999994 109.057 -178.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 568' ' ' VAL . . . . . 0.416 HG21 ' HD2' ' A' ' 524' ' ' LYS . 2.8 p 5.9 128.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 C-N-CA 129.628 3.171 . . . . 54.020000000000003 116.944 172.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 569' ' ' LYS . . . . . 0.421 ' HG2' ' CE1' ' A' ' 562' ' ' PHE . 27.7 mmmt -117.11 153.87 32.01 Favored 'General case' 0 C--N 1.266 -3.024 0 CA-C-N 115.234 -0.894 . . . . 72.209999999999994 110.699 177.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 570' ' ' THR . . . . . 0.551 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 8.3 p -126.78 121.2 31.28 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 124.032 0.832 . . . . 63.329999999999998 111.998 177.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 571' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' A' ' 522' ' ' GLU . 2.5 mp -77.15 118.15 23.33 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 N-CA-C 105.191 -2.151 . . . . 64.430000000000007 105.191 172.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 5.7 m -105.93 109.36 21.28 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.894 -0.78 . . . . 63.100000000000001 108.894 -176.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 573' ' ' VAL . . . . . 0.43 HG22 ' CG2' ' A' ' 556' ' ' THR . 40.6 t -114.01 135.3 54.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 110.067 -0.346 . . . . 61.219999999999999 110.067 -176.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 574' ' ' LYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 519' ' ' GLY . 15.7 tppt? -90.4 123.98 34.58 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.369 -0.832 . . . . 73.219999999999999 110.112 178.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 64.3 t -94.59 117.66 38.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 107.724 -1.213 . . . . 71.329999999999998 107.724 176.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 36.8 mm -78.96 154.65 4.85 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 N-CA-C 108.347 -0.983 . . . . 74.409999999999997 108.347 -176.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -72.36 86.78 1.13 Allowed 'General case' 0 C--O 1.247 0.947 0 CA-C-O 122.061 0.934 . . . . 43.299999999999997 110.26 173.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 578' ' ' ASP . . . . . 0.625 ' OD2' 'CA ' ' A' ' 800' ' ' ' CA' . 4.4 t0 -40.6 130.57 2.4 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 127.681 2.392 . . . . 73.319999999999993 113.25 178.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 579' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.25 -26.8 60.44 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 114.145 -1.389 . . . . 74.420000000000002 114.126 -171.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 580' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' A' ' 581' ' ' TYR . 0.8 OUTLIER -124.63 178.7 5.3 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 119.549 -0.861 . . . . 73.200000000000003 110.67 -174.742 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 581' ' ' TYR . . . . . 0.477 ' O ' ' HG2' ' A' ' 580' ' ' GLU . 7.2 p90 -86.01 151.43 23.73 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 105.451 -2.055 . . . . 75.540000000000006 105.451 173.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 582' ' ' GLU . . . . . 0.611 ' OE1' 'CA ' ' A' ' 800' ' ' ' CA' . 9.5 pt-20 -133.4 172.02 13.27 Favored 'General case' 0 C--N 1.277 -2.549 0 C-N-CA 119.194 -1.002 . . . . 75.310000000000002 109.672 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 58.5 mttp -90.65 -48.87 6.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 N-CA-C 106.812 -1.551 . . . . 72.200000000000003 106.812 173.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 1.4 m120 175.22 101.08 0.01 OUTLIER 'General case' 0 C--N 1.259 -3.344 0 CA-C-N 110.822 -2.899 . . . . 71.5 109.476 177.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 585' ' ' LYS . . . . . 0.418 ' HG3' ' OE2' ' A' ' 582' ' ' GLU 0.263 0.1 OUTLIER -89.87 162.02 15.67 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 118.065 -1.454 . . . . 74.219999999999999 109.676 172.994 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 5.2 t -151.36 142.98 23.66 Favored 'General case' 0 N--CA 1.415 -2.216 0 CA-C-O 121.174 0.512 . . . . 65.400000000000006 110.186 -176.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -126.09 147.01 49.69 Favored 'General case' 0 N--CA 1.421 -1.898 0 CA-C-N 114.104 -1.407 . . . . 74.340000000000003 108.412 176.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 588' ' ' PHE . . . . . 0.437 ' HA ' ' O ' ' A' ' 642' ' ' LEU . 10.5 m-85 -105.92 135.48 47.29 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 116.027 -0.533 . . . . 70.230000000000004 109.708 -172.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . 0.501 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.3 OUTLIER -104.27 124.99 50.15 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 106.096 -1.816 . . . . 63.409999999999997 106.096 175.786 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -131.38 135.72 47.45 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 109.526 -0.546 . . . . 70.140000000000001 109.526 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 591' ' ' ILE . . . . . . . . . . . . . 22.5 pt -99.36 134.71 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.734 0 N-CA-C 107.059 -1.46 . . . . 72.120000000000005 107.059 174.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -90.4 -150.66 24.53 Favored Glycine 0 C--N 1.297 -1.6 0 C-N-CA 120.786 -0.721 . . . . 74.019999999999996 112.965 -175.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -67.83 118.73 60.8 Favored Pre-proline 0 C--N 1.315 -0.935 0 C-N-CA 122.743 0.417 . . . . 74.230000000000004 110.292 179.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -70.51 143.21 46.59 Favored 'Trans proline' 0 N--CA 1.438 -1.772 0 C-N-CA 121.84 1.693 . . . . 71.230000000000004 109.78 175.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 595' ' ' ARG . . . . . 0.493 ' HG3' ' HB ' ' A' ' 536' ' ' ILE . 5.5 ptp180 -120.79 122.46 40.38 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 116.402 -0.363 . . . . 73.340000000000003 111.056 -174.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 596' ' ' LEU . . . . . 0.445 HD22 HG22 ' A' ' 535' ' ' VAL . 0.0 OUTLIER -79.18 122.48 26.32 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 107.735 -1.209 . . . . 55.32 107.735 179.904 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 17.1 t -93.28 -42.68 13.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-O 121.676 0.751 . . . . 73.319999999999993 110.111 -178.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -166.39 155.95 11.57 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.109 -0.95 . . . . 73.409999999999997 108.898 -174.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 22.4 ptt? -174.74 -36.98 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.675 0 O-C-N 123.851 0.72 . . . . 73.140000000000001 110.948 -173.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 25.5 m -142.33 84.39 1.86 Allowed 'General case' 0 N--CA 1.433 -1.284 0 CA-C-O 121.717 0.77 . . . . 60.130000000000003 111.261 -178.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -91.5 148.29 22.4 Favored 'General case' 0 C--N 1.283 -2.311 0 CA-C-N 114.698 -1.137 . . . . 73.450000000000003 107.96 179.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 95.4 mttt 79.35 -12.88 1.02 Allowed 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.95 1.3 . . . . 72.140000000000001 113.649 174.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.94 26.22 2.74 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-O 122.155 0.978 . . . . 74.120000000000005 110.347 176.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -96.98 -2.23 59.49 Favored Glycine 0 N--CA 1.439 -1.166 0 CA-C-N 114.757 -1.11 . . . . 73.299999999999997 110.986 177.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 94.35 178.13 38.62 Favored Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 111.728 -0.549 . . . . 54.420000000000002 111.728 178.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -89.75 -6.21 56.22 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.626 0.727 . . . . 65.200000000000003 110.368 179.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 8.9 p -76.56 129.08 35.93 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 108.841 -0.799 . . . . 73.349999999999994 108.841 174.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 18.7 mm -73.2 152.11 7.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 107.888 -1.153 . . . . 63.530000000000001 107.888 -175.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 18.7 m -59.17 124.94 21.65 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 106.628 -1.619 . . . . 62.210000000000001 106.628 175.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 610' ' ' GLU . . . . . 0.436 ' HG3' ' NH2' ' A' ' 633' ' ' ARG . 11.0 pt-20 -63.65 -7.19 6.71 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 113.814 1.042 . . . . 50.399999999999999 113.814 -175.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.3 110.33 15.63 Favored 'General case' 0 C--O 1.246 0.917 0 N-CA-C 109.065 -0.717 . . . . 74.230000000000004 109.065 169.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -114.81 69.65 0.72 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.577 -1.268 . . . . 73.340000000000003 107.577 178.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 33.6 t70 55.71 72.17 0.5 Allowed 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 114.788 -1.096 . . . . 74.150000000000006 108.617 -171.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -107.21 141.77 37.98 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 115.292 -0.867 . . . . 74.140000000000001 112.936 -174.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 615' ' ' LYS . . . . . 0.515 ' HD3' ' N ' ' A' ' 615' ' ' LYS . 0.0 OUTLIER -137.66 82.46 1.92 Allowed 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 113.876 -1.511 . . . . 73.129999999999995 107.385 179.758 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 616' ' ' GLN . . . . . 0.437 ' HB3' ' HD2' ' A' ' 617' ' ' PRO . 17.3 mm-40 -117.84 173.27 3.36 Favored Pre-proline 0 C--N 1.289 -2.039 0 CA-C-N 114.32 -1.309 . . . . 64.420000000000002 109.587 -173.113 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 617' ' ' PRO . . . . . 0.437 ' HD2' ' HB3' ' A' ' 616' ' ' GLN . 48.8 Cg_endo -71.36 171.13 16.75 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 121.639 1.559 . . . . 63.210000000000001 108.823 168.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.434 ' HG ' HD12 ' A' ' 636' ' ' LEU . 3.9 mm? -67.03 129.04 38.62 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.069 0.462 . . . . 62.549999999999997 110.813 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 9.0 t -65.46 -16.86 64.07 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 115.015 -0.993 . . . . 62.020000000000003 112.601 -175.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 620' ' ' SER . . . . . 0.415 ' HA ' ' CD ' ' A' ' 626' ' ' ARG . 6.1 p -77.61 76.89 4.13 Favored 'General case' 0 N--CA 1.423 -1.787 0 CA-C-O 121.617 0.722 . . . . 63.530000000000001 111.94 -178.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -129.24 -160.22 1.02 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.424 -0.807 . . . . 74.150000000000006 110.277 -178.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -58.54 -34.19 70.72 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 114.545 1.313 . . . . 64.540000000000006 114.545 -174.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -70.93 112.85 7.42 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 119.836 -0.745 . . . . 74.209999999999994 110.976 178.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 624' ' ' GLU . . . . . 0.439 ' H ' ' CD ' ' A' ' 624' ' ' GLU . 0.5 OUTLIER -65.68 -10.65 38.33 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 124.848 1.259 . . . . 74.0 114.108 -173.121 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -61.39 -18.31 58.2 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.608 0.718 . . . . 74.209999999999994 109.272 174.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . 0.415 ' CD ' ' HA ' ' A' ' 620' ' ' SER . 14.3 ptt180 -52.0 -30.95 27.38 Favored 'General case' 0 C--O 1.184 -2.358 0 CA-C-N 115.256 -0.884 . . . . 63.219999999999999 111.998 176.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 627' ' ' ARG . . . . . . . . . . . . . 58.6 mtp180 -58.9 -35.23 72.68 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.081 0.467 . . . . 75.150000000000006 110.407 178.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 95.1 mt -76.55 -43.08 35.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 108.586 -0.894 . . . . 72.319999999999993 108.586 176.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -59.5 -46.02 90.01 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.955 -1.02 . . . . 60.420000000000002 111.311 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -69.84 -9.4 54.63 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 124.632 1.173 . . . . 75.319999999999993 112.295 -177.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 631' ' ' MET . . . . . . . . . . . . . 49.3 ttp -82.99 -27.64 30.28 Favored 'General case' 0 N--CA 1.419 -2.005 0 CA-C-O 121.337 0.589 . . . . 73.129999999999995 109.441 179.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -101.85 -45.66 1.74 Allowed Glycine 0 N--CA 1.442 -0.93 0 CA-C-N 115.489 -0.778 . . . . 44.219999999999999 112.181 175.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 633' ' ' ARG . . . . . 0.436 ' NH2' ' HG3' ' A' ' 610' ' ' GLU . 55.4 mtt180 -87.38 153.56 53.57 Favored Pre-proline 0 C--N 1.311 -1.103 0 C-N-CA 123.984 0.914 . . . . 70.519999999999996 112.088 -174.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.406 ' HA ' ' HB1' ' A' ' 502' ' ' ALA . 67.1 Cg_endo -89.54 168.21 4.98 Favored 'Trans proline' 0 N--CA 1.441 -1.57 0 C-N-CA 122.661 2.24 . . . . 70.019999999999996 111.293 174.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.1 pp -144.06 178.54 1.72 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.455 0 N-CA-C 113.416 0.895 . . . . 62.340000000000003 113.416 -175.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . 0.434 HD12 ' HG ' ' A' ' 618' ' ' LEU . 0.0 OUTLIER -82.67 148.16 28.1 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 108.775 -0.824 . . . . 45.219999999999999 108.775 178.916 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . 0.453 ' HA3' ' HB ' ' A' ' 506' ' ' THR . . . -90.77 -128.55 3.96 Favored Glycine 0 C--N 1.294 -1.79 0 C-N-CA 120.736 -0.745 . . . . 35.439999999999998 114.46 -176.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -72.1 -56.67 5.19 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.379 -0.41 . . . . 71.120000000000005 111.448 -175.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 20.3 p80 -145.38 109.69 4.93 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.833 0.825 . . . . 72.519999999999996 111.684 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 37.9 p -101.35 90.25 4.04 Favored 'General case' 0 N--CA 1.398 -3.034 0 N-CA-C 107.849 -1.167 . . . . 73.340000000000003 107.849 174.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -178.32 125.74 0.11 Allowed 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 105.01 -2.219 . . . . 64.200000000000003 105.01 -177.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 642' ' ' LEU . . . . . 0.566 ' CD2' HG21 ' A' ' 523' ' ' VAL . 38.0 tp -124.72 111.07 15.13 Favored 'General case' 0 C--N 1.28 -2.435 0 N-CA-C 108.17 -1.048 . . . . 74.140000000000001 108.17 174.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . 0.454 ' HB3' HG22 ' A' ' 511' ' ' VAL . 26.1 tt0 -93.62 101.44 13.6 Favored 'General case' 0 C--N 1.272 -2.767 0 N-CA-C 107.484 -1.302 . . . . 75.310000000000002 107.484 -179.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 644' ' ' VAL . . . . . 0.638 HG21 ' HE2' ' A' ' 521' ' ' MET . 39.4 t -93.04 108.52 20.49 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 108.906 -0.775 . . . . 75.409999999999997 108.906 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 4.2 mp -94.05 121.82 45.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 107.944 -1.132 . . . . 72.319999999999993 107.944 176.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 646' ' ' ILE . . . . . 0.514 ' N ' HD12 ' A' ' 646' ' ' ILE . 2.9 mp -100.19 134.09 40.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 107.091 -1.448 . . . . 75.109999999999999 107.091 -176.063 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -118.02 145.23 44.93 Favored 'General case' 0 N--CA 1.419 -2.023 0 C-N-CA 120.229 -0.589 . . . . 75.129999999999995 109.855 -178.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . 0.63 ' OE1' 'CA ' ' A' ' 800' ' ' ' CA' . 5.8 mm-40 -60.31 137.56 58.11 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 107.019 -1.474 . . . . 73.109999999999999 107.019 176.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 17.0 t -64.79 123.19 18.71 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-O 122.177 0.989 . . . . 74.030000000000001 112.881 -173.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 650' ' ' TYR . . . . . 0.478 ' O ' ' HG2' ' A' ' 651' ' ' GLU . 48.5 t80 -147.42 -75.35 0.19 Allowed 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 105.934 -1.876 . . . . 72.420000000000002 105.934 173.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 651' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 650' ' ' TYR . 12.4 mm-40 -176.59 176.08 1.62 Allowed 'General case' 0 CA--C 1.501 -0.917 0 C-N-CA 127.618 2.367 . . . . 70.409999999999997 105.878 -178.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -100.0 111.87 24.17 Favored 'General case' 0 C--N 1.296 -1.717 0 N-CA-C 108.807 -0.812 . . . . 62.119999999999997 108.807 -179.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -118.72 167.94 11.2 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-N 115.202 -0.908 . . . . 73.510000000000005 108.898 -176.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 22.2 t -156.65 -68.51 0.11 Allowed 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.831 -0.803 . . . . 71.329999999999998 108.831 177.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 22.1 m -115.28 101.71 9.2 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.314 -0.624 . . . . 74.519999999999996 109.314 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 92.5 t -80.97 117.49 27.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 109.687 -0.486 . . . . 75.409999999999997 109.687 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 23.2 t70 . . . . . 0 C--N 1.313 -0.982 0 CA-C-N 115.659 -0.7 . . . . 73.140000000000001 110.394 -177.831 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 800' ' ' ' CA' . . . . . 0.63 'CA ' ' OE1' ' A' ' 648' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 850' ' ' ' CA' . . . . . 0.625 'CA ' ' OD1' ' A' ' 578' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 . . . . . 0 N--CA 1.447 -0.618 0 CA-C-O 121.084 0.469 . . . . 73.340000000000003 110.644 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . . . . . . . . . . . -123.56 -62.2 1.33 Allowed 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.014 -1.106 . . . . 74.5 108.014 172.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . 0.638 ' HA2' ' OG1' ' A' ' 528' ' ' THR . . . -140.34 120.52 1.79 Allowed Glycine 1 N--CA 1.395 -4.061 0 C-N-CA 119.985 -1.103 . . . . 73.030000000000001 110.952 179.476 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 2.7 mp -105.54 101.01 11.76 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 N-CA-C 106.763 -1.569 . . . . 72.409999999999997 106.763 176.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -114.71 122.87 47.74 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 109.457 -0.571 . . . . 72.230000000000004 109.457 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 11.2 t -148.64 163.99 35.62 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.483 -0.932 . . . . 71.129999999999995 108.483 -176.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -92.51 161.98 14.4 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 107.306 -1.368 . . . . 74.5 107.306 172.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -96.91 -26.3 15.11 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.322 -1.362 . . . . 71.099999999999994 107.322 173.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -97.32 120.57 60.72 Favored Pre-proline 0 N--CA 1.419 -1.989 0 CA-C-N 114.618 -1.174 . . . . 65.400000000000006 110.587 176.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -82.16 -19.09 7.02 Favored 'Trans proline' 0 N--CA 1.429 -2.28 0 N-CA-C 108.065 -1.552 . . . . 74.200000000000003 108.065 168.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . 0.426 HG22 ' HB3' ' A' ' 643' ' ' GLU . 93.7 t -147.89 139.69 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 C-N-CA 126.005 1.722 . . . . 71.239999999999995 107.897 -177.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 14.4 t -137.05 119.47 15.82 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 108.051 -1.092 . . . . 72.209999999999994 108.051 173.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -88.41 128.61 35.52 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 122.085 -0.384 . . . . 73.209999999999994 110.225 175.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 26.8 m -126.25 161.52 31.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-N 115.657 -0.701 . . . . 75.120000000000005 109.717 -178.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . . . . . . . . . 56.9 m -88.21 167.8 13.28 Favored 'General case' 0 N--CA 1.403 -2.807 0 CA-C-N 115.079 -0.964 . . . . 73.510000000000005 109.99 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . 0.65 ' OE2' 'CA ' ' A' ' 800' ' ' ' CA' . 38.2 tt0 -94.32 -23.63 17.74 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.497 0.665 . . . . 72.329999999999998 110.608 176.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 14.2 m -85.31 20.77 1.89 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.932 0.873 . . . . 73.209999999999994 110.406 -176.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 518' ' ' ILE . . . . . . . . . . . . . 15.3 tt -108.3 155.83 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.133 0 N-CA-C 107.554 -1.276 . . . . 74.519999999999996 107.554 -176.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -96.65 -59.85 1.0 Allowed Glycine 0 C--N 1.293 -1.848 0 C-N-CA 120.175 -1.012 . . . . 65.209999999999994 111.297 179.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 41.9 mm -121.48 136.22 59.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 109.402 -0.592 . . . . 75.519999999999996 109.402 -178.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 521' ' ' MET . . . . . 0.594 ' HE1' HG21 ' A' ' 644' ' ' VAL . 0.0 OUTLIER -115.35 132.68 56.54 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 106.368 -1.716 . . . . 72.120000000000005 106.368 171.764 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -109.17 149.29 29.58 Favored 'General case' 0 N--CA 1.428 -1.563 0 C-N-CA 120.509 -0.476 . . . . 65.319999999999993 109.852 -178.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . 0.631 ' O ' ' HA ' ' A' ' 570' ' ' THR . 40.0 t -126.12 121.05 58.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 109.722 -0.473 . . . . 63.32 109.722 178.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . 0.509 ' HD2' HG21 ' A' ' 568' ' ' VAL . 28.0 mmtp -82.09 118.9 23.39 Favored 'General case' 0 C--N 1.313 -1.021 0 O-C-N 124.095 0.872 . . . . 75.140000000000001 110.453 178.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 21.7 t -98.87 139.18 21.28 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 CA-C-N 114.563 -1.199 . . . . 63.210000000000001 108.982 -178.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -79.7 146.36 32.46 Favored 'General case' 0 C--N 1.31 -1.12 0 O-C-N 123.635 0.585 . . . . 74.329999999999998 109.566 -179.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . 0.406 ' HG2' ' N ' ' A' ' 528' ' ' THR . 31.8 ttp180 -87.64 160.16 18.26 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.384 -0.969 . . . . 71.450000000000003 108.384 -179.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . 0.638 ' OG1' ' HA2' ' A' ' 503' ' ' GLY . 4.6 t -61.82 150.76 36.25 Favored 'General case' 0 N--CA 1.421 -1.916 0 CA-C-O 121.362 0.601 . . . . 62.020000000000003 110.71 174.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 42.2 t -69.99 -22.17 63.16 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 114.83 -1.077 . . . . 74.25 109.754 179.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -129.0 89.71 0.31 Allowed Glycine 0 N--CA 1.435 -1.377 0 N-CA-C 109.907 -1.277 . . . . 65.120000000000005 109.907 178.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . . . . . . . . . . . -86.87 85.93 7.3 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 121.382 0.611 . . . . 64.340000000000003 111.291 -176.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . 0.419 ' HD3' ' HA ' ' A' ' 532' ' ' ARG . 37.5 mmt180 -123.54 101.78 7.51 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.634 -0.712 . . . . 75.150000000000006 110.772 177.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 533' ' ' GLY . . . . . 0.409 ' H ' ' HB3' ' A' ' 564' ' ' ASN . . . 119.07 -148.79 18.26 Favored Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 110.969 -0.852 . . . . 71.230000000000004 110.969 179.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 534' ' ' ASN . . . . . 0.496 HD21 ' CG ' ' A' ' 561' ' ' GLU . 2.9 t-20 -138.2 131.62 30.58 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 106.288 -1.745 . . . . 25.239999999999998 106.288 178.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 535' ' ' VAL . . . . . 0.448 HG22 HD22 ' A' ' 596' ' ' LEU . 67.7 t -127.44 137.6 57.25 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 118.189 0.45 . . . . 62.100000000000001 111.416 -174.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 536' ' ' ILE . . . . . 0.427 HG23 ' HB3' ' A' ' 559' ' ' GLU . 27.9 mm -102.91 126.04 57.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 108.889 -0.782 . . . . 75.150000000000006 108.889 174.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 31.7 t -117.1 106.83 46.68 Favored Pre-proline 0 C--N 1.298 -1.652 0 N-CA-C 108.543 -0.91 . . . . 75.150000000000006 108.543 178.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -75.61 137.81 20.86 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.102 1.868 . . . . 74.519999999999996 111.364 177.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 539' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -130.68 160.42 34.33 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.535 -0.543 . . . . 73.519999999999996 109.535 179.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 540' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.33 146.91 18.83 Favored 'General case' 0 C--N 1.314 -0.972 0 O-C-N 123.67 0.606 . . . . 73.329999999999998 110.679 175.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . . . . . . . . . 7.9 p -86.77 122.33 30.52 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.053 -0.521 . . . . 53.399999999999999 110.38 176.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.4 mp -82.49 122.47 37.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 105.753 -1.943 . . . . 74.209999999999994 105.753 172.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -63.75 -48.69 75.98 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 123.464 0.478 . . . . 73.120000000000005 109.928 -178.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 67.24 -93.5 0.23 Allowed Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 115.858 -0.61 . . . . 73.439999999999998 112.215 177.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 15.1 t -113.74 -0.61 14.2 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.494 -0.558 . . . . 63.109999999999999 109.494 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -97.34 176.49 5.87 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-N 115.646 -0.706 . . . . 71.200000000000003 111.592 -177.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -127.31 111.97 14.52 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 109.25 -0.648 . . . . 71.409999999999997 109.25 -179.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -78.43 -160.9 17.29 Favored Glycine 0 C--N 1.315 -0.606 0 C-N-CA 121.57 -0.348 . . . . 64.209999999999994 112.602 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . 67.37 17.68 68.71 Favored Glycine 0 C--N 1.314 -0.656 0 CA-C-O 120.908 0.171 . . . . 53.140000000000001 113.191 -177.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 77.42 11.58 85.36 Favored Glycine 0 C--O 1.211 -1.29 0 N-CA-C 111.041 -0.824 . . . . 73.099999999999994 111.041 -178.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -78.76 -42.44 28.02 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 122.469 0.308 . . . . 62.409999999999997 111.291 -175.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . 0.654 ' OD1' 'CA ' ' A' ' 850' ' ' ' CA' . 15.0 t70 -135.89 -20.67 1.49 Allowed 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 107.822 -1.177 . . . . 71.140000000000001 107.822 173.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -155.79 163.51 39.74 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 107.181 -1.414 . . . . 75.129999999999995 107.181 169.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . 0.421 ' HB3' ' HB3' ' A' ' 574' ' ' LYS . 0.7 OUTLIER -98.09 109.19 21.99 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 106.761 -1.57 . . . . 52.329999999999998 106.761 -178.855 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -77.54 147.25 35.86 Favored 'General case' 0 CA--C 1.499 -0.993 0 C-N-CA 120.761 -0.375 . . . . 75.349999999999994 110.439 -175.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . . . . . . . . . 8.3 t -139.59 142.22 37.13 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-O 121.605 0.717 . . . . 33.009999999999998 111.778 -174.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 7.6 p -145.46 149.6 34.97 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.214 -1.402 . . . . 70.420000000000002 107.214 176.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . 173.47 -167.21 39.8 Favored Glycine 0 N--CA 1.418 -2.543 0 N-CA-C 110.346 -1.101 . . . . 31.43 110.346 -178.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 559' ' ' GLU . . . . . 0.427 ' HB3' HG23 ' A' ' 536' ' ' ILE . 42.2 mt-10 -126.73 124.63 40.22 Favored 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 123.165 0.586 . . . . 75.340000000000003 110.169 -176.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . . . . . . . . . 94.3 mt -95.97 142.05 28.66 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.746 -0.835 . . . . 62.219999999999999 108.746 177.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 561' ' ' GLU . . . . . 0.496 ' CG ' HD21 ' A' ' 534' ' ' ASN . 31.1 tt0 -115.83 115.9 27.06 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 120.912 0.387 . . . . 70.010000000000005 111.143 -176.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 562' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -102.05 140.93 35.68 Favored 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 108.982 -0.747 . . . . 74.530000000000001 108.982 176.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . 0.496 ' HB2' ' H ' ' A' ' 566' ' ' GLU . 4.6 mt-30 -119.7 -178.23 3.58 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 119.033 -1.067 . . . . 75.430000000000007 110.337 179.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 564' ' ' ASN . . . . . 0.409 ' HB3' ' H ' ' A' ' 533' ' ' GLY . 28.0 p-10 -74.43 -34.71 63.3 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.916 0.865 . . . . 64.120000000000005 109.001 176.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -94.0 -43.39 8.55 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.437 -1.256 . . . . 60.149999999999999 110.901 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . 0.496 ' H ' ' HB2' ' A' ' 563' ' ' GLN . 25.5 tt0 -70.99 123.29 21.72 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.064 0.459 . . . . 74.219999999999999 111.326 -179.086 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 567' ' ' ILE . . . . . . . . . . . . . 8.7 pt -104.81 166.01 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.564 0 N-CA-C 108.797 -0.816 . . . . 72.019999999999996 108.797 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 568' ' ' VAL . . . . . 0.509 HG21 ' HD2' ' A' ' 524' ' ' LYS . 2.0 p 47.34 159.96 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.58 2.107 0 C-N-CA 127.027 2.131 . . . . 71.340000000000003 115.392 179.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 569' ' ' LYS . . . . . 0.508 ' HA ' ' HE2' ' A' ' 569' ' ' LYS . 4.3 mmpt? -142.67 166.05 25.73 Favored 'General case' 0 CA--C 1.493 -1.217 0 O-C-N 121.16 -0.962 . . . . 73.109999999999999 109.019 172.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 570' ' ' THR . . . . . 0.631 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 1.3 p -138.57 127.16 23.35 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 123.902 0.751 . . . . 74.319999999999993 112.897 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 571' ' ' ILE . . . . . 0.429 HG21 HD21 ' A' ' 589' ' ' LEU . 3.3 mp -96.07 122.06 47.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 106.477 -1.675 . . . . 73.420000000000002 106.477 170.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 49.2 m -107.36 125.08 50.75 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 108.84 -0.8 . . . . 61.439999999999998 108.84 177.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 573' ' ' VAL . . . . . . . . . . . . . 48.1 t -124.68 139.45 50.86 Favored 'Isoleucine or valine' 0 C--O 1.243 0.757 0 N-CA-C 108.458 -0.942 . . . . 63.420000000000002 108.458 -178.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 574' ' ' LYS . . . . . 0.421 ' HB3' ' HB3' ' A' ' 554' ' ' GLU . 87.0 tttt -95.7 129.99 42.74 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-O 121.77 0.795 . . . . 75.409999999999997 111.786 -178.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 59.2 t -94.13 138.72 19.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 107.044 -1.465 . . . . 65.329999999999998 107.044 176.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 45.8 mm -104.62 143.97 15.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 108.659 -0.867 . . . . 74.400000000000006 108.659 -176.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -59.18 129.76 43.7 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 108.535 -0.913 . . . . 74.310000000000002 108.535 174.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 578' ' ' ASP . . . . . 0.621 ' OD1' 'CA ' ' A' ' 850' ' ' ' CA' . 15.4 t0 -77.96 117.36 19.22 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 115.02 -0.991 . . . . 74.140000000000001 111.911 -167.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 579' ' ' GLU . . . . . 0.64 ' OE2' 'CA ' ' A' ' 850' ' ' ' CA' . 0.0 OUTLIER -77.08 -16.81 59.09 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 114.263 1.208 . . . . 73.040000000000006 114.263 -177.705 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 580' ' ' GLU . . . . . 0.64 ' OE1' 'CA ' ' A' ' 850' ' ' ' CA' . 0.0 OUTLIER -141.21 -176.71 4.81 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 106.553 -1.647 . . . . 61.049999999999997 106.553 173.257 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 581' ' ' TYR . . . . . 0.557 ' O ' ' HG2' ' A' ' 580' ' ' GLU . 12.4 p90 -87.19 152.21 22.52 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 106.825 -1.546 . . . . 72.230000000000004 106.825 174.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 582' ' ' GLU . . . . . 0.701 ' OE1' ' HB3' ' A' ' 585' ' ' LYS . 14.7 pt-20 -132.81 175.84 8.99 Favored 'General case' 0 C--N 1.276 -2.599 0 N-CA-C 108.826 -0.805 . . . . 72.010000000000005 108.826 -178.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . 0.446 ' O ' ' HG3' ' A' ' 582' ' ' GLU . 56.3 mtpt -100.05 -165.92 1.27 Allowed 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 105.551 -2.018 . . . . 72.540000000000006 105.551 169.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -74.73 89.16 2.27 Favored 'General case' 0 C--N 1.281 -2.391 0 C-N-CA 118.82 -1.152 . . . . 53.0 111.853 178.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 585' ' ' LYS . . . . . 0.701 ' HB3' ' OE1' ' A' ' 582' ' ' GLU . 0.0 OUTLIER -79.02 143.81 35.29 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 114.879 -1.055 . . . . 74.319999999999993 108.746 -178.964 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 5.9 t -145.14 141.57 28.88 Favored 'General case' 0 N--CA 1.407 -2.604 0 CA-C-O 121.169 0.509 . . . . 70.400000000000006 110.517 -176.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -122.16 144.63 48.83 Favored 'General case' 0 N--CA 1.412 -2.342 0 CA-C-N 113.928 -1.487 . . . . 70.319999999999993 108.468 175.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 588' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -104.66 128.16 52.62 Favored 'General case' 0 C--N 1.284 -2.239 0 N-CA-C 108.732 -0.84 . . . . 75.430000000000007 108.732 -173.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . 0.501 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.7 OUTLIER -98.45 126.08 43.86 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 106.642 -1.614 . . . . 72.030000000000001 106.642 177.381 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -128.43 132.75 48.45 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 109.993 -0.373 . . . . 75.400000000000006 109.993 179.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 591' ' ' ILE . . . . . . . . . . . . . 16.0 pt -97.32 128.71 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.652 0 N-CA-C 106.256 -1.757 . . . . 64.040000000000006 106.256 170.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -87.32 -139.81 6.18 Favored Glycine 0 N--CA 1.435 -1.401 0 CA-C-N 116.104 -0.498 . . . . 42.219999999999999 114.18 -172.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -79.9 112.36 29.19 Favored Pre-proline 0 C--N 1.311 -1.071 0 N-CA-C 109.301 -0.629 . . . . 71.530000000000001 109.301 -178.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 594' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -78.53 149.68 24.25 Favored 'Trans proline' 0 N--CA 1.434 -1.974 0 C-N-CA 122.094 1.863 . . . . 73.230000000000004 110.886 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 8.8 ptt-85 -129.23 132.82 47.31 Favored 'General case' 0 C--N 1.28 -2.421 0 CA-C-N 115.912 -0.586 . . . . 61.219999999999999 110.402 -175.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 596' ' ' LEU . . . . . 0.448 HD22 HG22 ' A' ' 535' ' ' VAL . 0.0 OUTLIER -77.06 125.77 29.87 Favored 'General case' 0 N--CA 1.415 -2.181 0 N-CA-C 105.501 -2.037 . . . . 64.150000000000006 105.501 178.703 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 96.6 t -71.03 -31.62 45.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 108.646 -0.872 . . . . 51.340000000000003 108.646 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 598' ' ' GLU . . . . . 0.402 ' H ' HD12 ' A' ' 596' ' ' LEU . 7.3 mm-40 -90.38 155.4 18.97 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 114.068 -1.424 . . . . 75.049999999999997 107.926 178.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 42.3 mtm -87.72 -20.87 25.63 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.719 -0.845 . . . . 73.430000000000007 108.719 178.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 10.2 m -50.36 118.09 2.8 Favored 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 125.289 1.436 . . . . 72.310000000000002 112.274 -176.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 601' ' ' GLU . . . . . 0.453 ' HB2' ' HA2' ' A' ' 632' ' ' GLY . 17.0 pt-20 -141.68 144.29 34.03 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 108.436 -0.95 . . . . 65.450000000000003 108.436 177.25 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 21.9 ttmm -88.4 89.59 8.05 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 105.63 -1.989 . . . . 72.540000000000006 105.63 173.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 603' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -54.44 158.05 2.58 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.179 -1.373 . . . . 63.539999999999999 114.324 -173.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -87.9 58.82 4.3 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.024 -0.989 . . . . 75.099999999999994 112.089 177.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . 84.07 -71.92 2.9 Favored Glycine 0 C--O 1.244 0.764 0 N-CA-C 110.881 -0.888 . . . . 62.200000000000003 110.881 -179.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -155.21 132.52 11.03 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.312 -0.995 . . . . 74.200000000000003 108.312 178.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 10.2 p -107.82 123.28 48.33 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 109.051 -0.722 . . . . 71.219999999999999 109.051 175.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 56.4 mt -78.32 -28.19 14.7 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.891 0 CA-C-O 123.53 1.634 . . . . 74.310000000000002 108.166 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 609' ' ' THR . . . . . . . . . . . . . 8.1 m -96.11 91.73 6.08 Favored 'General case' 0 C--N 1.248 -3.806 0 CA-C-N 112.466 -2.152 . . . . 52.549999999999997 109.862 -178.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -84.23 -5.87 59.32 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 107.799 -1.185 . . . . 65.450000000000003 107.799 173.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -74.47 89.27 2.14 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 114.498 -1.228 . . . . 75.530000000000001 109.864 178.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -93.51 83.3 4.5 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 107.517 -1.29 . . . . 74.530000000000001 107.517 174.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -116.21 71.27 0.78 Allowed 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 106.642 -1.614 . . . . 73.310000000000002 106.642 -177.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -138.9 93.52 2.71 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 114.917 -1.038 . . . . 52.539999999999999 111.196 -176.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 2.4 mmmp? -121.31 82.66 1.96 Allowed 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 104.882 -2.266 . . . . 71.409999999999997 104.882 169.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -139.3 173.54 5.05 Favored Pre-proline 0 C--N 1.3 -1.57 0 CA-C-N 113.609 -1.632 . . . . 72.239999999999995 107.152 -171.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -66.42 171.34 10.68 Favored 'Trans proline' 0 N--CA 1.442 -1.503 0 N-CA-C 109.374 -1.049 . . . . 53.240000000000002 109.374 169.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -72.65 121.2 19.38 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 109.745 -0.465 . . . . 74.030000000000001 109.745 -176.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 9.8 t -155.44 141.12 17.99 Favored 'General case' 0 N--CA 1.425 -1.71 0 CA-C-O 121.502 0.668 . . . . 51.340000000000003 111.459 -176.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 620' ' ' SER . . . . . . . . . . . . . 3.1 p -146.64 113.31 6.02 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.538 -1.282 . . . . 72.0 107.538 176.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 621' ' ' LYS . . . . . 0.445 ' HD2' ' N ' ' A' ' 621' ' ' LYS . 0.1 OUTLIER -86.25 -71.26 0.55 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.398 0.618 . . . . 73.430000000000007 110.382 -173.273 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -92.55 -7.69 46.51 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.704 -1.221 . . . . 74.219999999999999 107.704 177.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . 0.296 10.7 pt-20 60.18 -39.71 0.09 Allowed 'General case' 0 C--O 1.186 -2.256 0 C-N-CA 129.314 3.046 . . . . 71.120000000000005 116.894 176.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 624' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -39.63 -68.76 0.15 Allowed 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 124.356 1.063 . . . . 74.140000000000001 113.819 -174.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -67.78 -37.18 81.7 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.466 -0.334 . . . . 72.129999999999995 110.505 -176.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . 0.66 ' O ' ' HG2' ' A' ' 630' ' ' GLU . 0.0 OUTLIER -63.4 -47.56 81.51 Favored 'General case' 0 C--O 1.202 -1.425 0 N-CA-C 109.434 -0.58 . . . . 71.129999999999995 109.434 -178.199 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 627' ' ' ARG . . . . . . . . . . . . . 51.0 ttp180 -60.71 -29.78 69.56 Favored 'General case' 0 N--CA 1.424 -1.748 0 C-N-CA 125.693 1.597 . . . . 63.549999999999997 111.991 -176.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 97.5 mt -65.67 -36.84 78.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-O 121.615 0.722 . . . . 63.539999999999999 109.578 175.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -78.07 -29.34 49.11 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.602 -0.727 . . . . 51.100000000000001 109.369 176.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 630' ' ' GLU . . . . . 0.66 ' HG2' ' O ' ' A' ' 626' ' ' ARG . 4.4 mm-40 -76.84 -3.04 36.4 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 123.975 0.91 . . . . 63.409999999999997 109.717 177.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 631' ' ' MET . . . . . . . . . . . . . 48.1 ttp -95.05 -15.89 23.11 Favored 'General case' 0 N--CA 1.402 -2.83 0 N-CA-C 108.031 -1.099 . . . . 61.409999999999997 108.031 175.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 632' ' ' GLY . . . . . 0.453 ' HA2' ' HB2' ' A' ' 601' ' ' GLU . . . -100.51 -39.08 3.3 Favored Glycine 0 N--CA 1.439 -1.119 0 N-CA-C 110.365 -1.094 . . . . 64.129999999999995 110.365 175.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 -92.82 144.02 27.88 Favored Pre-proline 0 C--O 1.203 -1.367 0 N-CA-C 108.502 -0.925 . . . . 72.030000000000001 108.502 173.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -76.18 153.51 36.36 Favored 'Trans proline' 0 N--CA 1.434 -1.98 0 C-N-CA 121.116 1.211 . . . . 64.219999999999999 110.21 176.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . . 2.0 pp -138.96 -175.25 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 112.765 0.654 . . . . 74.5 112.765 -175.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.71 146.09 32.58 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 115.425 -0.807 . . . . 74.310000000000002 109.327 178.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -83.97 -107.33 0.57 Allowed Glycine 0 C--N 1.291 -1.96 0 CA-C-N 116.105 -0.498 . . . . 63.399999999999999 112.474 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -94.66 -65.82 0.96 Allowed 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.238 0.542 . . . . 54.119999999999997 110.142 -177.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 17.0 p80 -130.54 114.08 15.04 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.628 0.728 . . . . 64.319999999999993 111.011 -177.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 13.7 p -104.78 89.76 3.27 Favored 'General case' 0 N--CA 1.397 -3.124 0 N-CA-C 107.473 -1.306 . . . . 75.120000000000005 107.473 173.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -176.46 123.62 0.17 Allowed 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 105.175 -2.158 . . . . 72.010000000000005 105.175 -174.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 642' ' ' LEU . . . . . 0.532 ' CD2' HG21 ' A' ' 523' ' ' VAL . 45.1 tp -125.55 106.84 10.06 Favored 'General case' 0 C--N 1.274 -2.681 0 N-CA-C 106.976 -1.49 . . . . 71.049999999999997 106.976 177.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . 0.426 ' HB3' HG22 ' A' ' 511' ' ' VAL . 26.9 tt0 -88.8 100.56 13.25 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 108.029 -1.1 . . . . 53.43 108.029 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 644' ' ' VAL . . . . . 0.594 HG21 ' HE1' ' A' ' 521' ' ' MET . 23.1 t -91.01 105.61 16.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 108.925 -0.769 . . . . 73.409999999999997 108.925 -179.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 4.4 mp -92.36 124.93 45.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 108.426 -0.953 . . . . 74.030000000000001 108.426 175.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 646' ' ' ILE . . . . . 0.567 ' N ' HD12 ' A' ' 646' ' ' ILE . 1.9 mp -106.55 108.02 24.13 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.473 0 N-CA-C 106.492 -1.669 . . . . 71.340000000000003 106.492 -178.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -104.15 143.7 32.58 Favored 'General case' 0 C--N 1.269 -2.905 0 CA-C-N 114.698 -1.137 . . . . 74.129999999999995 109.625 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -57.07 132.48 53.04 Favored 'General case' 0 C--O 1.249 1.068 0 N-CA-C 106.154 -1.795 . . . . 75.239999999999995 106.154 175.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 8.6 t -52.36 123.4 10.75 Favored 'General case' 0 C--O 1.245 0.826 0 O-C-N 124.18 0.925 . . . . 45.109999999999999 112.327 -169.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -135.63 -65.12 0.61 Allowed 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 113.281 -1.781 . . . . 74.329999999999998 107.161 -177.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -152.26 -166.6 2.53 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 124.832 1.253 . . . . 54.32 107.813 177.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -140.73 90.18 2.32 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-O 121.949 0.881 . . . . 72.239999999999995 109.625 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 653' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -126.25 121.16 31.88 Favored 'General case' 0 C--N 1.277 -2.548 0 CA-C-N 114.411 -1.268 . . . . 70.329999999999998 108.813 176.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 16.9 p -87.57 82.77 7.36 Favored 'General case' 0 N--CA 1.424 -1.738 0 C-N-CA 120.518 -0.473 . . . . 63.340000000000003 110.838 -178.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 9.2 t -70.06 128.41 36.2 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 108.358 -0.979 . . . . 63.240000000000002 108.358 177.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 46.4 t 67.1 82.16 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-O 122.448 1.118 . . . . 64.120000000000005 107.99 -171.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 . . . . . 0 C--N 1.293 -1.861 0 CA-C-N 113.858 -1.519 . . . . 51.420000000000002 110.221 -176.19 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 800' ' ' ' CA' . . . . . 0.65 'CA ' ' OE2' ' A' ' 516' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 850' ' ' ' CA' . . . . . 0.654 'CA ' ' OD1' ' A' ' 552' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 501' ' ' HIS . . . . . . . . . . . . . 16.5 t60 . . . . . 0 N--CA 1.449 -0.497 0 N-CA-C 105.908 -1.886 . . . . 63.340000000000003 105.908 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 502' ' ' ALA . . . . . 0.438 ' CB ' ' HA ' ' A' ' 634' ' ' PRO . . . -131.54 -149.9 0.4 Allowed 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 106.914 -1.513 . . . . 60.520000000000003 106.914 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . 0.704 ' HA3' ' OG1' ' A' ' 528' ' ' THR . . . 153.16 -136.33 5.27 Favored Glycine 1 N--CA 1.394 -4.11 0 C-N-CA 117.608 -2.234 . . . . 52.299999999999997 113.505 178.284 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 504' ' ' ILE . . . . . . . . . . . . . 3.1 mp -119.18 126.81 75.68 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 CA-C-N 114.126 -1.037 . . . . 72.019999999999996 108.256 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 505' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -134.86 103.99 5.82 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 106.803 -1.555 . . . . 75.329999999999998 106.803 172.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 14.3 t -143.42 160.46 40.52 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 109.66 -0.496 . . . . 73.430000000000007 109.66 -173.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 507' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -81.58 153.13 26.88 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 107.171 -1.418 . . . . 74.25 107.171 173.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.02 -50.06 38.19 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.339 -0.985 . . . . 61.310000000000002 108.339 176.168 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 509' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -116.02 131.87 23.52 Favored Pre-proline 0 C--N 1.303 -1.431 0 CA-C-N 115.7 -0.682 . . . . 74.400000000000006 109.195 -178.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 510' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -83.81 -13.08 8.28 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.477 2.118 . . . . 63.43 112.127 178.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 511' ' ' VAL . . . . . 0.517 HG22 ' HB3' ' A' ' 643' ' ' GLU . 73.9 t -136.52 132.51 48.71 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.461 0 N-CA-C 107.873 -1.158 . . . . 54.43 107.873 178.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 512' ' ' THR . . . . . . . . . . . . . 3.8 t -138.61 140.95 39.15 Favored 'General case' 0 N--CA 1.396 -3.153 0 N-CA-C 107.666 -1.235 . . . . 63.119999999999997 107.666 177.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 513' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -109.17 137.79 46.52 Favored 'General case' 0 CA--C 1.479 -1.772 0 N-CA-C 107.474 -1.306 . . . . 73.109999999999999 107.474 176.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.649 HG11 ' SD ' ' A' ' 521' ' ' MET . 35.0 m -132.28 155.25 41.28 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.309 0 CA-C-O 121.518 0.675 . . . . 65.530000000000001 110.32 -176.1 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 515' ' ' SER . . . . . 0.425 ' HB2' ' HB ' ' A' ' 518' ' ' ILE . 19.3 m -68.61 141.27 55.47 Favored 'General case' 0 N--CA 1.393 -3.276 0 CA-C-N 113.665 -1.607 . . . . 74.230000000000004 107.877 176.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 516' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -73.79 -24.15 59.79 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 119.388 -0.925 . . . . 63.450000000000003 109.718 176.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 24.0 t -107.16 75.71 1.05 Allowed 'General case' 0 N--CA 1.415 -2.192 0 N-CA-C 107.876 -1.157 . . . . 73.200000000000003 107.876 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 518' ' ' ILE . . . . . 0.425 ' HB ' ' HB2' ' A' ' 515' ' ' SER . 17.1 tt -141.04 161.01 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.26 0 CA-C-N 113.766 -1.561 . . . . 62.140000000000001 106.813 176.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 519' ' ' GLY . . . . . . . . . . . . . . . -96.15 -69.58 1.02 Allowed Glycine 0 N--CA 1.434 -1.46 0 C-N-CA 119.571 -1.3 . . . . 72.319999999999993 111.596 177.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 520' ' ' ILE . . . . . . . . . . . . . 40.9 mm -116.24 134.57 59.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 109.361 -0.607 . . . . 74.209999999999994 109.361 -178.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 521' ' ' MET . . . . . 0.649 ' SD ' HG11 ' A' ' 514' ' ' VAL . 23.8 ptt? -114.29 138.74 50.12 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 106.934 -1.506 . . . . 73.430000000000007 106.934 171.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 522' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -117.07 132.66 56.63 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 108.837 -0.801 . . . . 64.5 108.837 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . 0.688 ' O ' ' HA ' ' A' ' 570' ' ' THR . 24.8 t -114.99 134.11 59.09 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 109.314 -0.625 . . . . 62.219999999999999 109.314 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 524' ' ' LYS . . . . . 0.43 ' HD2' HG21 ' A' ' 568' ' ' VAL . 33.0 mmtp -84.91 128.13 34.48 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 122.027 0.918 . . . . 75.030000000000001 113.1 -175.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 525' ' ' VAL . . . . . . . . . . . . . 3.3 t -113.68 132.84 61.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 106.951 -1.5 . . . . 61.530000000000001 106.951 177.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -93.77 151.13 19.83 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 108.959 -0.756 . . . . 64.310000000000002 108.959 -177.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 527' ' ' ARG . . . . . 0.536 ' CZ ' HG22 ' A' ' 567' ' ' ILE . 68.9 mtm180 -87.02 179.31 6.71 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-O 122.018 0.913 . . . . 75.519999999999996 111.137 -179.068 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . 0.704 ' OG1' ' HA3' ' A' ' 503' ' ' GLY . 1.0 OUTLIER -78.16 159.71 28.44 Favored 'General case' 0 N--CA 1.408 -2.553 0 CA-C-N 113.796 -1.547 . . . . 62.340000000000003 109.766 176.21 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 17.0 t -74.73 -20.04 59.99 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 107.903 -1.147 . . . . 73.150000000000006 107.903 177.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -118.14 66.3 0.36 Allowed Glycine 0 N--CA 1.438 -1.199 0 N-CA-C 111.07 -0.812 . . . . 72.129999999999995 111.07 175.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 531' ' ' ALA . . . . . 0.403 ' O ' ' HD3' ' A' ' 532' ' ' ARG . . . -76.26 96.13 3.88 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.357 0.599 . . . . 72.310000000000002 111.565 -178.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . 0.403 ' HD3' ' O ' ' A' ' 531' ' ' ALA . 60.5 mmt-85 -134.56 127.68 31.77 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.47 -0.786 . . . . 71.319999999999993 109.984 178.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 533' ' ' GLY . . . . . . . . . . . . . . . 93.77 175.66 39.81 Favored Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 121.087 -0.578 . . . . 74.329999999999998 113.642 176.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 534' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -95.87 123.22 39.36 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 107.936 -1.135 . . . . 74.450000000000003 107.936 177.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 535' ' ' VAL . . . . . . . . . . . . . 56.4 t -127.96 131.95 69.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.761 0 N-CA-C 108.71 -0.848 . . . . 74.209999999999994 108.71 -178.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 536' ' ' ILE . . . . . . . . . . . . . 38.6 mm -103.77 129.28 56.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 108.739 -0.837 . . . . 50.149999999999999 108.739 178.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . 0.502 HG22 ' HB3' ' A' ' 594' ' ' PRO . 14.7 t -117.99 111.79 38.72 Favored Pre-proline 0 C--N 1.301 -1.506 0 N-CA-C 109.575 -0.528 . . . . 44.030000000000001 109.575 -178.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 538' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -73.98 150.87 44.19 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 121.714 1.609 . . . . 73.019999999999996 110.244 176.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 539' ' ' TYR . . . . . 0.476 ' CD1' ' HG ' ' A' ' 560' ' ' LEU . 48.3 p90 -150.85 157.71 43.25 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 109.119 -0.697 . . . . 74.439999999999998 109.119 179.1 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 540' ' ' LYS . . . . . 0.416 ' O ' ' HD3' ' A' ' 540' ' ' LYS . 0.1 OUTLIER -157.11 145.65 19.65 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 113.3 0.852 . . . . 72.230000000000004 113.3 -179.842 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 541' ' ' THR . . . . . 0.44 HG23 ' HB ' ' A' ' 556' ' ' THR . 2.9 p -76.26 134.08 39.9 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.4 -0.818 . . . . 75.340000000000003 111.074 171.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . . . . . . . . . 3.2 mp -99.22 126.65 52.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 105.391 -2.077 . . . . 74.420000000000002 105.391 172.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . 0.417 ' H ' ' CD ' ' A' ' 543' ' ' GLU . 1.4 mp0 -48.78 -44.82 39.23 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.288 1.035 . . . . 70.450000000000003 113.06 -174.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 544' ' ' GLY . . . . . . . . . . . . . . . 71.89 -100.28 0.91 Allowed Glycine 0 N--CA 1.437 -1.243 0 N-CA-C 110.036 -1.226 . . . . 50.340000000000003 110.036 -178.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 545' ' ' THR . . . . . . . . . . . . . 9.0 t -134.12 10.71 3.87 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.926 0.869 . . . . 73.409999999999997 109.37 176.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -85.16 168.06 15.15 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.858 -0.61 . . . . 74.329999999999998 110.027 177.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 547' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -85.91 166.83 15.65 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 107.74 -1.207 . . . . 63.439999999999998 107.74 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 548' ' ' GLY . . . . . . . . . . . . . . . -57.39 174.75 1.91 Allowed Glycine 0 C--O 1.253 1.306 0 N-CA-C 115.705 1.042 . . . . 64.439999999999998 115.705 -176.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 549' ' ' GLY . . . . . . . . . . . . . . . -57.59 117.15 9.28 Favored Glycine 0 N--CA 1.437 -1.255 0 CA-C-N 114.217 -0.992 . . . . 55.32 113.783 -176.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 550' ' ' GLY . . . . . . . . . . . . . . . 104.53 -15.06 50.13 Favored Glycine 0 N--CA 1.428 -1.859 0 N-CA-C 111.719 -0.552 . . . . 41.119999999999997 111.719 177.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 551' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -91.58 -63.65 1.22 Allowed 'General case' 0 CA--C 1.499 -1.009 0 CA-C-O 121.084 0.468 . . . . 74.519999999999996 110.422 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . 0.645 ' OD2' 'CA ' ' A' ' 850' ' ' ' CA' . 5.0 t70 -107.39 -43.11 4.63 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.093 -0.958 . . . . 74.340000000000003 108.861 -176.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 553' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -133.79 155.83 49.1 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 107.313 -1.366 . . . . 75.519999999999996 107.313 175.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -85.17 128.98 34.88 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 105.532 -2.025 . . . . 71.140000000000001 105.532 177.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 555' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -54.78 108.47 0.4 Allowed 'General case' 0 CA--C 1.483 -1.627 0 O-C-N 123.474 0.484 . . . . 73.450000000000003 110.167 -177.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 556' ' ' THR . . . . . 0.44 ' HB ' HG23 ' A' ' 541' ' ' THR . 40.8 m -109.96 97.98 7.37 Favored 'General case' 1 N--CA 1.372 -4.326 0 C-N-CA 118.595 -1.242 . . . . 61.509999999999998 112.234 -175.453 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 557' ' ' CYS . . . . . . . . . . . . . 24.2 p -137.1 134.25 36.26 Favored 'General case' 0 N--CA 1.418 -2.037 0 N-CA-C 107.399 -1.334 . . . . 70.129999999999995 107.399 174.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 558' ' ' GLY . . . . . . . . . . . . . . . -176.83 -156.91 16.73 Favored Glycine 0 N--CA 1.418 -2.541 0 N-CA-C 110.08 -1.208 . . . . 72.530000000000001 110.08 -176.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 559' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -135.14 142.96 46.29 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.091 0.472 . . . . 75.310000000000002 110.978 -176.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 560' ' ' LEU . . . . . 0.516 HD13 ' HG2' ' A' ' 569' ' ' LYS . 93.6 mt -104.22 139.91 38.59 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.273 -0.876 . . . . 72.019999999999996 109.275 177.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 561' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -106.6 114.03 27.88 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 123.21 0.604 . . . . 71.430000000000007 110.784 -177.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 562' ' ' PHE . . . . . 0.554 ' CZ ' ' HB2' ' A' ' 569' ' ' LYS . 36.3 m-85 -108.64 145.35 35.09 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 120.695 0.283 . . . . 75.230000000000004 110.386 173.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 563' ' ' GLN . . . . . 0.587 ' HB2' ' HB2' ' A' ' 566' ' ' GLU . 0.2 OUTLIER -131.79 177.27 7.65 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 105.769 -1.938 . . . . 71.439999999999998 105.769 175.33 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 564' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -75.98 -30.46 58.58 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 121.111 0.481 . . . . 50.240000000000002 109.962 178.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 565' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -94.03 -22.84 18.28 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.259 0.552 . . . . 62.219999999999999 110.996 -179.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 566' ' ' GLU . . . . . 0.587 ' HB2' ' HB2' ' A' ' 563' ' ' GLN . 2.3 tm-20 -84.25 119.52 25.14 Favored 'General case' 0 C--O 1.245 0.84 0 N-CA-C 107.019 -1.475 . . . . 74.450000000000003 107.019 -177.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 567' ' ' ILE . . . . . 0.536 HG22 ' CZ ' ' A' ' 527' ' ' ARG . 6.2 pt -108.51 161.97 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.143 0 C-N-CA 120.65 -0.42 . . . . 74.439999999999998 111.047 -175.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 568' ' ' VAL . . . . . 0.445 HG22 ' H ' ' A' ' 569' ' ' LYS . 2.4 p 47.68 174.66 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.11 0 C-N-CA 126.421 1.889 . . . . 72.340000000000003 113.231 -179.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 569' ' ' LYS . . . . . 0.644 ' HA ' ' HE3' ' A' ' 569' ' ' LYS . 0.2 OUTLIER -156.25 156.98 35.02 Favored 'General case' 0 C--N 1.289 -2.045 0 O-C-N 120.797 -1.189 . . . . 64.430000000000007 107.986 176.057 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 570' ' ' THR . . . . . 0.688 ' HA ' ' O ' ' A' ' 523' ' ' VAL . 4.4 p -134.3 131.74 38.76 Favored 'General case' 0 N--CA 1.412 -2.361 0 O-C-N 123.999 0.812 . . . . 63.020000000000003 110.765 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 571' ' ' ILE . . . . . . . . . . . . . 2.8 mp -91.3 113.39 26.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 106.728 -1.582 . . . . 72.200000000000003 106.728 170.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 572' ' ' SER . . . . . . . . . . . . . 2.6 p -93.85 120.17 33.75 Favored 'General case' 0 C--N 1.29 -2.021 0 O-C-N 123.677 0.61 . . . . 52.240000000000002 109.859 177.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 573' ' ' VAL . . . . . . . . . . . . . 49.1 t -123.38 135.77 62.18 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 108.549 -0.908 . . . . 55.439999999999998 108.549 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -93.45 124.05 37.17 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-O 121.403 0.621 . . . . 71.510000000000005 109.836 175.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 575' ' ' VAL . . . . . . . . . . . . . 61.5 t -89.51 141.76 13.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 N-CA-C 106.755 -1.572 . . . . 54.509999999999998 106.755 176.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 576' ' ' ILE . . . . . . . . . . . . . 32.9 mm -105.78 158.21 6.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 107.672 -1.232 . . . . 63.119999999999997 107.672 -178.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 577' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -67.22 137.46 56.21 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.228 -1.027 . . . . 74.209999999999994 108.228 177.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 578' ' ' ASP . . . . . 0.61 ' OD1' 'CA ' ' A' ' 850' ' ' ' CA' . 0.5 OUTLIER -69.85 158.97 34.51 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 112.295 0.48 . . . . 63.130000000000003 112.295 -172.857 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 579' ' ' GLU . . . . . 0.638 ' OE1' 'CA ' ' A' ' 850' ' ' ' CA' . 0.0 OUTLIER -138.21 -12.73 1.4 Allowed 'General case' 0 CA--C 1.558 1.263 0 N-CA-C 116.141 1.904 . . . . 72.340000000000003 116.141 -172.479 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 580' ' ' GLU . . . . . 0.491 ' HG2' ' O ' ' A' ' 581' ' ' TYR . 0.1 OUTLIER -127.02 -171.02 2.32 Favored 'General case' 0 C--N 1.317 -0.838 0 O-C-N 121.164 -0.96 . . . . 73.120000000000005 110.138 -177.167 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 581' ' ' TYR . . . . . 0.491 ' O ' ' HG2' ' A' ' 580' ' ' GLU . 46.2 p90 -63.74 152.51 39.09 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 107.931 -1.136 . . . . 73.540000000000006 107.931 174.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 582' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -120.89 132.95 55.26 Favored 'General case' 0 C--N 1.288 -2.099 0 C-N-CA 118.824 -1.15 . . . . 72.439999999999998 114.076 -174.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 583' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -129.38 -165.95 1.59 Allowed 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 105.562 -2.014 . . . . 73.329999999999998 105.562 176.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 584' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -65.52 105.06 1.11 Allowed 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 106.855 -1.535 . . . . 75.340000000000003 106.855 172.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 585' ' ' LYS . . . . . 0.481 ' HD2' HD13 ' A' ' 646' ' ' ILE . 4.2 tmmm? -115.38 117.66 31.06 Favored 'General case' 0 N--CA 1.403 -2.79 0 N-CA-C 107.709 -1.219 . . . . 75.310000000000002 107.709 -175.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 586' ' ' THR . . . . . . . . . . . . . 3.4 t -142.39 147.2 35.83 Favored 'General case' 0 N--CA 1.404 -2.74 0 CA-C-N 114.688 -1.142 . . . . 63.049999999999997 110.029 -176.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 587' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -129.25 148.56 51.19 Favored 'General case' 0 N--CA 1.405 -2.687 0 CA-C-N 113.857 -1.52 . . . . 51.350000000000001 108.232 176.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 588' ' ' PHE . . . . . 0.512 ' HA ' ' O ' ' A' ' 642' ' ' LEU . 23.0 m-85 -104.8 141.54 36.31 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 109.356 -0.609 . . . . 73.310000000000002 109.356 -173.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . 0.527 ' HB3' ' HB3' ' A' ' 642' ' ' LEU . 0.5 OUTLIER -110.26 126.07 53.78 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 105.813 -1.921 . . . . 54.350000000000001 105.813 174.285 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 590' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -134.26 123.09 23.68 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 109.455 -0.572 . . . . 74.409999999999997 109.455 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 591' ' ' ILE . . . . . 0.431 HG22 ' HB3' ' A' ' 539' ' ' TYR . 20.9 pt -79.14 149.49 5.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 N-CA-C 108.0 -1.111 . . . . 71.540000000000006 108.0 173.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 592' ' ' GLY . . . . . . . . . . . . . . . -93.23 -142.76 12.05 Favored Glycine 0 N--CA 1.425 -2.086 0 C-N-CA 121.008 -0.615 . . . . 53.329999999999998 112.693 -176.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -93.41 117.88 67.48 Favored Pre-proline 0 C--N 1.3 -1.584 0 N-CA-C 108.636 -0.876 . . . . 70.510000000000005 108.636 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 594' ' ' PRO . . . . . 0.603 ' HG2' ' O ' ' A' ' 634' ' ' PRO . 30.2 Cg_endo -65.69 143.75 75.57 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 121.969 1.78 . . . . 53.539999999999999 110.714 177.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 595' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -123.83 135.86 54.02 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.888 -0.508 . . . . 52.210000000000001 110.483 -176.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.58 124.81 28.86 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 107.892 -1.151 . . . . 70.5 107.892 -178.252 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 597' ' ' VAL . . . . . . . . . . . . . 65.9 t -75.5 -39.59 40.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 112.574 0.583 . . . . 64.329999999999998 112.574 -176.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -76.27 158.21 31.8 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 112.541 0.571 . . . . 74.120000000000005 112.541 -178.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 599' ' ' MET . . . . . . . . . . . . . 27.4 ptt? -89.73 23.34 2.72 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 123.831 0.852 . . . . 74.299999999999997 111.857 -172.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 32.0 t -74.35 99.11 3.41 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.117 0.484 . . . . 64.329999999999998 110.8 -178.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -91.6 131.86 36.72 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 108.789 -0.819 . . . . 75.400000000000006 108.789 177.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . 0.433 ' HD2' ' N ' ' A' ' 602' ' ' LYS . 3.6 mptp? -94.08 139.46 30.95 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 108.151 -1.055 . . . . 75.430000000000007 108.151 177.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 603' ' ' LYS . . . . . 0.42 ' HD3' ' H ' ' A' ' 603' ' ' LYS . 0.3 OUTLIER -135.28 177.08 8.09 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 121.482 0.658 . . . . 72.209999999999994 112.386 -173.064 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 604' ' ' GLY . . . . . . . . . . . . . . . -116.72 -166.0 14.15 Favored Glycine 0 N--CA 1.428 -1.843 0 N-CA-C 108.696 -1.762 . . . . 75.109999999999999 108.696 174.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 605' ' ' GLY . . . . . . . . . . . . . . . -101.9 -63.74 0.75 Allowed Glycine 0 C--N 1.293 -1.81 0 C-N-CA 120.274 -0.965 . . . . 74.5 111.177 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 606' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -93.33 -3.71 52.95 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.413 0.625 . . . . 75.340000000000003 110.38 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 607' ' ' THR . . . . . . . . . . . . . 3.7 p -104.82 171.62 7.23 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 115.859 -0.609 . . . . 54.229999999999997 112.132 -177.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 12.6 pt -139.92 160.01 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.594 0 CA-C-N 114.745 -1.116 . . . . 63.109999999999999 109.441 177.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 609' ' ' THR . . . . . 0.57 HG22 ' HB2' ' A' ' 611' ' ' GLU . 4.4 m -94.19 117.15 29.69 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.986 -1.116 . . . . 74.400000000000006 107.986 177.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 610' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -81.43 14.75 2.33 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 121.708 0.766 . . . . 74.530000000000001 111.479 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 611' ' ' GLU . . . . . 0.57 ' HB2' HG22 ' A' ' 609' ' ' THR . 2.3 tm-20 -88.88 174.93 7.67 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.601 -0.889 . . . . 73.310000000000002 108.601 178.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 612' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -125.22 10.62 8.08 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.513 -1.291 . . . . 75.120000000000005 107.513 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 613' ' ' ASP . . . . . . . . . . . . . 11.0 t70 53.39 31.64 12.37 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 112.883 -1.962 . . . . 75.450000000000003 108.16 -172.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 614' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -76.86 135.55 38.86 Favored 'General case' 0 CA--C 1.488 -1.404 0 CA-C-N 114.05 -1.432 . . . . 70.510000000000005 110.511 -173.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 615' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -77.4 101.09 6.21 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-O 122.273 1.035 . . . . 72.310000000000002 108.959 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 616' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -98.04 174.45 3.17 Favored Pre-proline 0 C--N 1.286 -2.162 0 CA-C-N 113.527 -1.669 . . . . 74.230000000000004 110.705 -172.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 617' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -86.23 161.15 9.91 Favored 'Trans proline' 0 N--CA 1.438 -1.768 0 N-CA-C 108.267 -1.474 . . . . 64.329999999999998 108.267 162.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.29 110.01 1.76 Allowed 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 120.6 -0.44 . . . . 75.310000000000002 110.691 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 619' ' ' THR . . . . . . . . . . . . . 9.3 t -136.15 139.6 43.02 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 116.134 -0.484 . . . . 61.310000000000002 109.829 -179.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 620' ' ' SER . . . . . 0.433 ' HA ' ' HD3' ' A' ' 626' ' ' ARG . 13.3 p -134.69 124.37 25.18 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.581 0.705 . . . . 54.119999999999997 111.785 -178.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 621' ' ' LYS . . . . . . . . . . . . . 54.5 mttm -90.37 0.14 57.4 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.249 -0.887 . . . . 74.209999999999994 109.536 178.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 622' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 73.93 -46.77 0.63 Allowed 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 125.918 1.687 . . . . 63.140000000000001 110.986 -174.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -51.43 149.28 4.32 Favored 'General case' 0 C--O 1.251 1.159 0 C-N-CA 124.159 0.983 . . . . 71.430000000000007 110.628 177.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 624' ' ' GLU . . . . . 0.418 ' O ' HG13 ' A' ' 628' ' ' ILE . 16.3 pt-20 -62.66 -15.19 51.01 Favored 'General case' 0 C--O 1.211 -0.932 0 N-CA-C 113.672 0.99 . . . . 72.329999999999998 113.672 -174.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -61.53 -34.35 75.4 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 118.118 0.417 . . . . 75.329999999999998 110.485 174.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . 0.535 ' O ' ' HG2' ' A' ' 630' ' ' GLU . 0.2 OUTLIER -64.22 -38.36 90.77 Favored 'General case' 0 C--O 1.193 -1.883 0 N-CA-C 108.626 -0.879 . . . . 62.100000000000001 108.626 173.838 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 627' ' ' ARG . . . . . . . . . . . . . 62.6 mtt-85 -74.89 -29.68 61.07 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 116.052 -0.522 . . . . 72.319999999999993 110.182 -176.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . 0.588 ' O ' ' HG2' ' A' ' 631' ' ' MET . 97.8 mt -68.52 -44.99 82.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.257 -0.646 . . . . 64.329999999999998 109.257 173.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -63.64 -45.41 90.36 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.94 -0.573 . . . . 72.230000000000004 110.561 179.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 630' ' ' GLU . . . . . 0.535 ' HG2' ' O ' ' A' ' 626' ' ' ARG . 8.7 mm-40 -79.59 2.3 22.86 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 113.476 0.917 . . . . 63.530000000000001 113.476 -174.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 631' ' ' MET . . . . . 0.588 ' HG2' ' O ' ' A' ' 628' ' ' ILE . 27.6 ptt? -93.39 -12.94 28.71 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 118.686 -1.206 . . . . 73.120000000000005 107.951 172.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 632' ' ' GLY . . . . . . . . . . . . . . . -85.3 -23.56 47.48 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 110.167 -1.173 . . . . 74.129999999999995 110.167 176.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 633' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.91 151.84 37.71 Favored Pre-proline 0 CA--C 1.5 -0.977 0 N-CA-C 106.739 -1.578 . . . . 70.329999999999998 106.739 174.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.603 ' O ' ' HG2' ' A' ' 594' ' ' PRO . 10.9 Cg_endo -76.7 135.66 16.28 Favored 'Trans proline' 0 N--CA 1.419 -2.866 0 N-CA-C 106.936 -1.986 . . . . 75.120000000000005 106.936 164.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 635' ' ' ILE . . . . . . . . . . . . 0.255 2.3 pp -118.71 170.12 8.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 114.001 1.112 . . . . 65.150000000000006 114.001 -178.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.07 164.98 25.94 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 114.898 -1.046 . . . . 53.43 112.051 -176.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 637' ' ' GLY . . . . . . . . . . . . . . . -85.34 -114.68 0.77 Allowed Glycine 0 N--CA 1.441 -1.001 0 CA-C-N 115.284 -0.871 . . . . 72.420000000000002 112.942 -177.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 638' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -98.37 -68.72 0.79 Allowed 'General case' 0 N--CA 1.42 -1.928 0 C-N-CA 120.576 -0.45 . . . . 75.430000000000007 110.611 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 639' ' ' HIS . . . . . . . . . . . . . 18.7 p80 -113.33 109.2 18.34 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 113.655 0.983 . . . . 73.319999999999993 113.655 -173.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 640' ' ' THR . . . . . . . . . . . . . 12.5 p -98.8 90.47 4.69 Favored 'General case' 0 N--CA 1.408 -2.54 0 N-CA-C 107.167 -1.42 . . . . 72.430000000000007 107.167 172.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 641' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -173.26 138.6 0.73 Allowed 'General case' 0 N--CA 1.424 -1.73 0 CA-C-N 114.393 -1.276 . . . . 73.439999999999998 107.685 -173.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 642' ' ' LEU . . . . . 0.549 ' CD2' HG21 ' A' ' 523' ' ' VAL . 42.1 tp -145.12 105.26 4.05 Favored 'General case' 0 C--N 1.274 -2.708 0 N-CA-C 107.494 -1.299 . . . . 61.130000000000003 107.494 173.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . 0.517 ' HB3' HG22 ' A' ' 511' ' ' VAL . 28.5 tt0 -92.87 100.5 12.95 Favored 'General case' 0 C--N 1.261 -3.248 0 N-CA-C 107.03 -1.47 . . . . 72.319999999999993 107.03 179.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 644' ' ' VAL . . . . . 0.531 HG21 ' HE1' ' A' ' 521' ' ' MET . 26.3 t -92.73 108.65 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.287 0 CA-C-N 115.792 -0.64 . . . . 60.119999999999997 109.396 -177.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 645' ' ' ILE . . . . . . . . . . . . . 4.0 mp -94.05 118.42 39.94 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 N-CA-C 107.916 -1.142 . . . . 72.340000000000003 107.916 177.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 646' ' ' ILE . . . . . 0.488 ' N ' HD12 ' A' ' 646' ' ' ILE . 2.5 mp -104.46 112.17 36.97 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.451 0 N-CA-C 107.098 -1.445 . . . . 54.520000000000003 107.098 -175.177 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . 0.599 ' OE1' ' HG3' ' A' ' 653' ' ' LYS . 6.7 pt-20 -115.45 149.35 38.18 Favored 'General case' 0 C--N 1.27 -2.863 0 C-N-CA 120.191 -0.604 . . . . 74.030000000000001 112.519 -177.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . 0.622 ' OE1' 'CA ' ' A' ' 800' ' ' ' CA' . 23.1 tp10 -54.69 135.51 46.88 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.188 -1.369 . . . . 72.120000000000005 109.917 -177.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 22.9 t -51.4 119.67 4.33 Favored 'General case' 0 C--O 1.237 0.403 0 O-C-N 124.209 0.943 . . . . 71.010000000000005 110.768 -176.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 650' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -152.05 -62.06 0.17 Allowed 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.704 -1.134 . . . . 62.32 109.058 -174.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 651' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -151.25 -175.49 5.19 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 106.317 -1.734 . . . . 60.43 106.317 177.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 652' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -98.87 121.29 40.63 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 108.626 -0.879 . . . . 73.140000000000001 108.626 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 653' ' ' LYS . . . . . 0.599 ' HG3' ' OE1' ' A' ' 647' ' ' GLU . 9.2 mmmm -111.1 136.72 49.72 Favored 'General case' 0 C--N 1.281 -2.394 0 CA-C-N 115.229 -0.896 . . . . 52.130000000000003 109.829 -177.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 654' ' ' SER . . . . . . . . . . . . . 33.3 p -153.18 128.2 9.66 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 109.305 -0.628 . . . . 72.409999999999997 109.305 177.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 655' ' ' THR . . . . . . . . . . . . . 98.9 m -94.11 104.51 16.53 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.458 -0.571 . . . . 62.450000000000003 109.458 178.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 27.9 m -81.58 161.34 3.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 116.079 -0.509 . . . . 62.32 110.758 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 657' ' ' ASP . . . . . . . . . . . . . 27.0 t70 . . . . . 0 C--N 1.305 -1.334 0 CA-C-N 116.127 -0.488 . . . . 75.150000000000006 110.757 -176.405 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 800' ' ' ' CA' . . . . . 0.622 'CA ' ' OE1' ' A' ' 648' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 850' ' ' ' CA' . . . . . 0.645 'CA ' ' OD2' ' A' ' 552' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_